<SEC-DOCUMENT>0000310764-23-000017.txt : 20230210
<SEC-HEADER>0000310764-23-000017.hdr.sgml : 20230210
<ACCEPTANCE-DATETIME>20230210161801
ACCESSION NUMBER:		0000310764-23-000017
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		116
CONFORMED PERIOD OF REPORT:	20221231
FILED AS OF DATE:		20230210
DATE AS OF CHANGE:		20230210

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			STRYKER CORP
		CENTRAL INDEX KEY:			0000310764
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				381239739
		STATE OF INCORPORATION:			MI
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13149
		FILM NUMBER:		23612163

	BUSINESS ADDRESS:	
		STREET 1:		2825 AIRVIEW BLVD
		CITY:			KALAMAZOO
		STATE:			MI
		ZIP:			49002
		BUSINESS PHONE:		2693892600

	MAIL ADDRESS:	
		STREET 1:		2825 AIRVIEW BLVD
		CITY:			KALAMAZOO
		STATE:			MI
		ZIP:			49002
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>syk-20221231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:2349b3b0-68ea-4cbc-845b-39a36087e2b4,g:780e132c-de96-43a0-a8bf-d2cffc0e012a,d:cec46013a0ad4608b89f97e433dd3417--><html xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:syk="http://www.stryker.com/20221231" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:srt="http://fasb.org/srt/2022" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>syk-20221231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN180L2ZyYWc6NWZlYmRlY2E4N2RjNDRkZWFiMjM4NjExNGE0ZmNkY2MvdGFibGU6NDc1ZjQ5NzZmYjE5NDE1NWI4NDg4ZjVlN2JiZWQ2MjcvdGFibGVyYW5nZTo0NzVmNDk3NmZiMTk0MTU1Yjg0ODhmNWU3YmJlZDYyN180LTEtMS0xLTcyMTUx_1c3d425b-3669-427d-9f48-8809b7ef928e">false</ix:nonNumeric><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN180L2ZyYWc6NWZlYmRlY2E4N2RjNDRkZWFiMjM4NjExNGE0ZmNkY2MvdGFibGU6NDc1ZjQ5NzZmYjE5NDE1NWI4NDg4ZjVlN2JiZWQ2MjcvdGFibGVyYW5nZTo0NzVmNDk3NmZiMTk0MTU1Yjg0ODhmNWU3YmJlZDYyN182LTEtMS0xLTcyMTUx_5e468ebe-d275-4602-9d34-b49338793089">2022</ix:nonNumeric><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN180L2ZyYWc6NWZlYmRlY2E4N2RjNDRkZWFiMjM4NjExNGE0ZmNkY2MvdGFibGU6NDc1ZjQ5NzZmYjE5NDE1NWI4NDg4ZjVlN2JiZWQ2MjcvdGFibGVyYW5nZTo0NzVmNDk3NmZiMTk0MTU1Yjg0ODhmNWU3YmJlZDYyN183LTEtMS0xLTcyMTUx_4b1d02cb-e181-40f5-b84c-62f2b286433a">FY</ix:nonNumeric><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN180L2ZyYWc6NWZlYmRlY2E4N2RjNDRkZWFiMjM4NjExNGE0ZmNkY2MvdGFibGU6NDc1ZjQ5NzZmYjE5NDE1NWI4NDg4ZjVlN2JiZWQ2MjcvdGFibGVyYW5nZTo0NzVmNDk3NmZiMTk0MTU1Yjg0ODhmNWU3YmJlZDYyN18xMC0xLTEtMS03MjE1MQ_88d38d9d-9844-4c0a-b55f-dffee7cc23b1">0000310764</ix:nonNumeric><ix:nonFraction unitRef="shares" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xNzU3L2ZyYWc6Zjc0NzkwN2Q4Y2JkNDE4NzkzNDM1YzE3Zjc1ODcyYjcvdGFibGU6YTNiNGJiNGFlNjc4NDA4NzgwZGQxOWQwYWEzMjhkNGIvdGFibGVyYW5nZTphM2I0YmI0YWU2Nzg0MDg3ODBkZDE5ZDBhYTMyOGQ0Yl8xLTMtMS0xLTgzOTU4_8d3f547a-d93d-402e-9fd7-968e0ff96aac">&#8212;</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xNzU3L2ZyYWc6Zjc0NzkwN2Q4Y2JkNDE4NzkzNDM1YzE3Zjc1ODcyYjcvdGFibGU6YTNiNGJiNGFlNjc4NDA4NzgwZGQxOWQwYWEzMjhkNGIvdGFibGVyYW5nZTphM2I0YmI0YWU2Nzg0MDg3ODBkZDE5ZDBhYTMyOGQ0Yl8xLTUtMS0xLTgzOTYw_7acb3598-407c-4acb-8817-f84cad4d62df">&#8212;</ix:nonFraction><ix:nonNumeric contextRef="id98b4736a0a349b09845650ad3f9c399_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzEzMjA2_7c8fdcfc-54e2-4b81-91c7-7404bca5b6f4">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="i2a548a74fc5c4c9cb418b21cd08ceca3_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzEzMjU2_a5156acf-7357-4ad7-88ef-00f8b1876f98">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="i6a82af02b4f44599ac62c2a47c8eeeb2_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzE0NDEx_42bfd4f4-7388-4875-97fa-bc119a8ba2cf">P4Y</ix:nonNumeric><ix:nonNumeric contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" name="us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzItMC0xLTEtNzIxNTE_9731ce2e-d82a-4967-b042-db8cc99630f8">http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" name="us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzItMC0xLTEtNzIxNTE_f24b63f9-9795-4048-881d-72c0ef014936">http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzMtMC0xLTEtNzIxNTE_4a79c8d2-7e9e-4a69-8e7c-3f2c45ccd096">http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzMtMC0xLTEtNzIxNTE_582bcc35-c25f-4f59-a914-b85367fcbaf4">http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" name="us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzQtMC0xLTEtNzIxNTE_3e00ae6d-1860-4511-a971-3c7d349014a4">http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" name="us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzQtMC0xLTEtNzIxNTE_b077084d-a166-4834-a410-c652caa7aed3">http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="syk-20221231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i767af96f95ca4aee85700946429afb87_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if231cb99329846998fbe0b34abe79ea7_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7dd02fbab10d4e00b5bcd9c2dedb8209_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syk:SeniorUnsecuredNotes1.125Due2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71648630b05f40fba5ebd37a3211f4b4_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syk:SeniorUnsecuredNotes0.250due2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic78b7239217245f9b7ba422e50d29a35_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syk:SeniorUnsecuredNotes2.125Due2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1174c5b8346493d97c292962b5734e9_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syk:SeniorUnsecuredNotes0.750due2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied914c836e1441c7890112782c149468_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syk:SeniorUnsecuredNotes2.625Due2030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa9f50c457574b7daccc82821729b9e5_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syk:SeniorUnsecuredNotes1.000due2031Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28ee37853fb34f8596d0f60ff923f553_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="ia86e7290435746bc83636123dd097ec2_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i6192daadf4b64fcd96cda7971eb2051f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3dd203be44e24244894ceb5a74354945_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4006898201a7425fb94bc2294d0b0392_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i576cd39821c64afe9e29c4e4b0a645cc_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b7dcd3a92534102aafd86a58bd12396_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i176c600905174175b724a109ca220959_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b9d8d8eefe34b4f8f369cfda156c6e2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida5e85091b7148e19fbf01b77d79492c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e9fecf68eab4b96910415c71a11f0f0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41ce397bfa0541e29e021952f1d0010a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ba0930c6af2497b925e9c5d6155812a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d9e19fe61e242fd8263057ff7c25299_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2881079343842a19318fe837350c64d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63b9f6da76294d1a9a151cff381a2952_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46dac7583cde41d8a83d606ac118cd95_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieec3502c9db549fea81e263b3f2c2a92_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94825bd2fefe45ddabf26724a368310b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i795f6d2070234daa91b8880b8539c9c8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c2a71ba269549d1ae308a0a70bc7f3a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9d8bd5dcacb4d8d812c9d60d5f7f768_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i517940432d6242d3b90448a4cdb7932b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a6c70e8449a4b4ea94bebf9dff36ff6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icad1df1351fd4afe9e2355bb6693a77d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1895b0971f404a2dad14c28b8302a8ea_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe9a125a8f4f4a4b9275e4e42854e3f3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i339c16bfef17406a8c4a7d11ac15a147_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id755d6c5467d4b40bdce4ebfa9392650_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie37658dfd9f847b59178e8bc31697fd2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98963cf23d234ec1ac275e66bcfd76dc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd06d67e889a491bb0c3d598c1a2047c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id98b4736a0a349b09845650ad3f9c399_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia81297125f074a4291d33c550b8d6a47_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a548a74fc5c4c9cb418b21cd08ceca3_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia886c987bacc41c694724a58b11edae4_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a82af02b4f44599ac62c2a47c8eeeb2_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idbfae01100bf43918ee77d14424aebd2_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i708148310e2c45b79502852cc7ddd42d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb6424572e1a40e48c885f2c92dfe789_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8117cc9161634207825ffb3719f67191_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">syk:PerformanceStockUnitPsusMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="ib40edc6b554f484e81172008a1b935cd_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:InstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5cd09663d2064e428131942655918cc4_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:InstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if10d0627114c4a58a2be1e34e4b5625d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:InstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0cc5548a8984d22bd046caa3043eb0b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:EndoscopyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5020782036574b31a5831f83949362a4_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:EndoscopyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b9f3564aca841c3ae0ea79a17077a20_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:EndoscopyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e819fe7e1d840638447a95eff013b31_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if4e6f58b0e9f477f87313ee9043d9e30_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f101fadf7674ec28a0116a48b22b520_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib17c6235040048e8ae37d408059878aa_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeurovascularMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief7335a3982a47459171c93ed23a8f47_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeurovascularMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2be681678ea4436faff2709791d5137f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeurovascularMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5f7fd67d1c1485c9f7691e9a1809a38_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeuroCranialMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4ec9d69bf524a148549268e0c42215d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeuroCranialMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iadd844730bb54ab2a251db4875dd0cc2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeuroCranialMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b975aad2ca64d32a11f0b1aa57d74bc_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98f3442517e54ff18879b74015965f7b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i264f9d32cf56445f819b9231bed80ef2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i953031f47dfd4ab48296f976c579f48f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idac1c88764c44335aba1807e0a6c5920_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62d3222aba4540cdb06bcf65a6a3bfd2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ecee5a3b59948519fdbfa67f9373a2b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:KneesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i474cb49aa2d24434a691b5420651c447_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:KneesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c6154902bf04aeeb004c9e54c981d28_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:KneesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if4b19248ed5d4294b50748ae4ea4aee0_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:HipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i269eeb7c7e4141e8bf2d3c9c447f3e98_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:HipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id675a2fbf95744c4be3290137773c281_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:HipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9b5b615c9924c07a819ee875818589c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:TraumaandExtremitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i013403153cd64c79a7f3a8634e364ea1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:TraumaandExtremitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c5b695e084e4496a0671e329ae3381e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:TraumaandExtremitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d0108479d3b484d80725dc2c041ad97_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:SpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0fdc7482bea448a93867fd96f5dcbac_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:SpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i331257e825de49c58489bfb866ddce44_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:SpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i666cd5b0c83c456bae79773bcf7f03e1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1801afd3ee7f4dfaac31a549f6ae0482_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6aca02c723d4fb4ace6192cccb9de77_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59e41efd1cf44cedb5a90caceaa03aff_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i383cf58c47f8466aaa98e0e267a0ec66_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if132773438c747ef8b1fe48831a7e72d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ed4ee29f6714ea69ad3fad40ed030cb_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:InstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d7fbd10640d4d3dbb9a7da83fdc93c2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:InstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id09fcf99189f4b1998d8d9734940d624_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:InstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98867d5b69f347a49e32704030d048c1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:EndoscopyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08e13185dfad49da800a2a08a9f432a1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:EndoscopyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27792d541a2c4696a01a98be72919963_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:EndoscopyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5cea099951df4ff7bbdc41425b5529b6_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i543a25a9f1ec4250931a708a947c22f0_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc72c4be0f714dff82bfbdceba60770f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaefd465e33384342bb74bc7d62b86fcb_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeurovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6601ea0a52494abfb803a90cb4cac08b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeurovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5206b2de2164734afce54d5a8ff985d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeurovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifff0fc2d089c44d3aa2f9d5df4e83ff4_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeuroCranialMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1f97bfe9b3544df927161980c8b37e7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeuroCranialMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62b4c459d2c147fcb0cfa4526e86d72b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeuroCranialMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i663246eda49749d997c0d746cabbb4ee_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6a66c36657d43f4a75ef31f2507e955_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0a11a2714074a598220e8541795a994_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46e1cd337be44b57b9b1d332b129f69c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d04a4d184e54baaa0500525454dce8a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie649374514094ad1a1d1a16c42b218da_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6078ad8012384f338b9a92a484d14c65_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:KneesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i797fa079f8f54e3a9a6da8545bed4ed3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:KneesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2dd6e330b6ad41d9b7422a4b7e00bf79_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:KneesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i235f0602f0b049698f8ebba9516a25f6_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:HipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71a3f354032646189f007311bac60024_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:HipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie56858cf83c046b994c5c997f9f03e4d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:HipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf66a24721c449dabc5abd76d714c686_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:TraumaandExtremitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic219c45e9bad4e20b8083e43a0aeb4eb_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:TraumaandExtremitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5a1567757054e22a14abcfa4521d1d8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:TraumaandExtremitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if21f6d50ec354218a38c8290af16e623_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:SpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8b02a7bd5e949d7bf3a6197a4b398c0_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:SpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5586d2399af142dabc67a9bee22f6a8a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:SpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1758ceab8dc4cba84c860bf0c70ec7e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i323b04cbc9d248b1b1d4d71d946c7fa3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie50bbe6a5e6d46d4a93975ba9d0688c8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53c57bd651fd45a185259d088cd6d65c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc1a1dbfa4b940c183d1a894a442e7dc_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5e99b74e17b4087a5567c9b9b9bc240_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaff1db63800141a4a0f466e4edd07697_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c40ed4f092642e6ae3512f7b314ae33_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia16521f0e141452ca6e75ab7d3a68848_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i483d950410414fe59ab9e2fa4d84d5df_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:InstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63a90fa6e8e148b19df1238fd6a1f7c2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:InstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1dc8e759d5044d0aaa1f41483df1232a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:InstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae1685480e7f4fcbbb1e5f05830d684d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:EndoscopyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1df304d4eb44faf833fe1d888e9f579_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:EndoscopyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e65f49264c64a349b9d521fc9f4b8f9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:EndoscopyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30234a3281d14003a6892b71356e9d0a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if70a16dd5e6945bf9c6e8cf9b8788075_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3fe26adfdbc545c99ea371ee84ab0982_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5018938caadf49a898cc06c5f84bc191_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeurovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id25f8772d4b14bb897d5701f19e7d4f1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeurovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4b3fca57c9545df8ece61f69e1e1fdc_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeurovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7c37ca29a884860a690d73964155c6e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeuroCranialMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57807bf2142f4f7faa936c1cacf88c52_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeuroCranialMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82f610c3881d4092950ff3ee3559f332_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeuroCranialMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69286e78969c425b95fb1a1af5a7ffee_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idded536d0af14e3a827698652b7ec361_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife69af0daf204c34b24444fefcdc4593_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e1d87a1079040de8d74635a08480d51_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f994fa175e14f7fbb0230508d4017b7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90fb567d63414192b40cf0ac5a8561bb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c5ee2c8d6a245409c7113431408c137_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:KneesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1521748c0f8b464492226525de5d7eab_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:KneesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1cc4e6c8bedd45858a7ca12a5301a3ae_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:KneesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i502050c566d846e2a9eebc8d4f42d251_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:HipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i087a6044fb0f4d06ab4771d7a6615b22_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:HipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78a574b38eb84b4e9ddbdec1b8422bb5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:HipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9848e15d5e03446e85be30206896834a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:TraumaandExtremitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09f67744858942b2ade6faf4e7109a1e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:TraumaandExtremitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7dbd5a4933a46c3880c5c627cb44975_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:TraumaandExtremitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if21ff3221f9e4f94b678fa254a2b6165_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:SpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i111c61299cd54de1a129bb3bb7c82c44_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:SpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb4bfa7f666a42c694d9c69757624555_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:SpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib088580a0b7f4d77b2ec885ae6c1c459_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4da717909f6849eb981891e24024b2a9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i584907bcc13a4da3b2f67d81b5e349e3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i322205428fdb4dd1b9ee8eb34e18bbf1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7c8e07052dd4d1c91726191ed386ac8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17bfdc6681b54daf82fee40a6fb5aa86_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaab182c6b3bb44d086bbe15590d6e157_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c358267d06c4c30bddf69fbbdad3c82_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide98561cf401454c96fa8600baf5b8f9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec7ff50d4aea4a64b1a222ed6cddad1e_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2d532877fe14293a0c7af8376dd383a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb345be38a2145ec8f2df1b4c28dc6d4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9f7092c7cfe4497bab25e1f403f24c9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i684697892eef43b0a398f7e1d3644140_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib50e1688c3054d648339c3791063d5da_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b0b881c3cc645c8a20d828cc3a3ab1f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6cd00f7e2984a7197f65f6758fc8f77_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6da21472d42444c2a5f87b4170b8a18a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b2fac2f3fc9459ab4c0932e6ed5c5b6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1bfd9b18ac254aea9b31268dda67d715_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idba6690bc56542ebab849eb8e0a831d0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic30c4a9be3cb4b41aca184361c77845a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic08aa5d78620463481ca8783fa037ecb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2cfe6ff3822e44e4ae63056b2596b8ae_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27d980565f3148fe831139d2e7a16efb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3861b631300548c2ab44cbbf58d07920_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5847988c48e945ff89b5383f616f507c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e94767eea5f4452a8497953475e7b32_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33ec7e34209e4d64ba95fe5eb1edee60_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1061b720f0314243956e705d577b0331_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i555016f434ae4cd48b50f24fbe1586b3_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f534a107f4d40bb987de62c5eca2398_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d64b78c8a794c42aa5ea20736299864_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaec94f18ada042fabb7f1ebdc25a07d4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d27f73c86aa47cba1db7a41f08807cd_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf36006040a941c9932b2b52a950a31a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f5265baf4a34824aa6bfc4b935f0cc6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18c253d682754db68c1f963844f236c0_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i502841656af74f0abcbfa0b5b4d5edde_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f7602ed300f40099fb5e3d0ccea433c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if623c08c13104816b3eec3b501299d90_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc0b84fb75164adf807974c23c81f865_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f5c13561a6441838aa726a95c450a0a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd8e471ce1d84cd0b7332d1e15689be0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic862e33128874fba9c59da29a661709c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ed382ff805947e282a6b64d016d24f4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i871ebfa1e7e24e09bd4a205545a24e83_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3f7b3b320914b9dae575c52b5fe8b56_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50af63eb8b4d4347af19a411f82385bc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30db394dfc2a41a8b8826988775431cb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibad6a6771ef34df3ae26b4bf524b94cf_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie01905fa5e254373b0ff7bd6859daf50_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7984d6aa73d346b396014350b01a0a8b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i442c41e773ba4c8393f770f45cac23e6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21b19e56e61b4c329c04eac6cfc4cd58_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id60b785d2b584ee1be26545ea0a1b66f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if244473f9960480abc9486fac01737d2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e1acc8de3644b2583b558aed3472970_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i526560b9237b4753b4d62b8c0ac70ad0_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iebcaf79884c44374aed5e2028c2ef520_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36b9ed429956467a99e25dcfa90149c9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c812d2135a0456199da61bf38ed7721_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id55223eafacf499d89f879372cbf9597_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b3bc6f133044291a549410c3cf66f4d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b39e27e21304ce894cab7826e32ac09_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iebe1f9b479ea44f69f1c26a1d8bc2fd8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i785da713e5504f1cac04a1e0354dfa48_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie029123d930d43c8a47136e8b7c03300_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ed5e0163a634738abd15b3643a5c3f5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b2e6b2fb13e405d95f685da59183e93_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf0622bdb40c4cbd87d21f3c67334c2a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:context id="i7e8c5b89171143fbbff1d92557f393af_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5dc0a291f3a4f67bfac579e681b910f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd05c426dad44fd5b836e9f3d2fa90e5_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3dca98f754544fae91bc2be4aa0d5f9c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5fa607b61e244bc0b9d78c50a056da63_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i858bf63c159847d6b3ed57f57eb1ff65_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i900a7f9055784544a570f4f177f0f2f7_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35651c99f68b487cb5cb0aaf787aa0ed_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8ba1cabf909458ba3e5abe497e0b36d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2cccc96d34764cf58cc915568b1e6270_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae3102b5052e4f9792a88230869505ae_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id329aed50c074920944be6fd7b940cf8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic804fede9d9b48fca7326ace0f6cda8a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3133dd3e2174a0fab3f99c31f3a1c0c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i073bfd5a955943a1910ed816f9ae5c27_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i618987c1cdac4e83bae6d50a1ddc1358_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30d00fa7ea3a436494f1bd7ba5373101_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2acfbbc785a4dcba1e0d80a471cf36e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99212e6414ed4182be360bb4600e1593_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i989cd3b1dfc14409946f1bd46844917f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e70ca42855942a5a650f69045393b9b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i976b214a31df4949b83c93e6da795727_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64382fff96cc4d37a1272abc8d08a5b1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf0ef3bec3594225be5f4136d591a70a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if03ac61671704ce4b4624fc35057af34_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if4546ff3df1c4906be5936247a46f7b0_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie42d6abca47642698150701f8b361b9f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6d6069512b142969a9bd9af9461da85_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8301b5b781954e5cab4cec0d280848d8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56560a3d5b6f482fb1362de4ae05404a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie342040266664c0697ed0bb113671458_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c613d72567b4a16a99b20a430597575_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b467ba124624433b5dde0c999c6d48c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20d1fb9afb38451ca9e6cb8fe56983f4_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1dd8a1332a14539a8a3ec1b816d046a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i709e6e037bfd466aa715d869eb7ef424_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03590bf15d844678bd0f164d99ca4949_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0519930af2964fea9f28a898c17d838f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia02e7e1cc90e4e87a48f39f4f3e33376_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1917a31882a249a2adf69310c998c7de_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99ab40e0eb8d45a9abce0e0cd3109e0c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27e420a9891e411095e99eaeb5a2021a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e9f0e75f256464eb07e962100d56a05_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i823914fb5eb4408998556e61e5fe9f04_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b23b51f78e64690aca64f7624b9d18b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i31974aa90e594af395bc99e745210e04_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf37d1b5ba934c02852349cf34dae000_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4624597685941fb98a05555c8d17182_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8820c2b08814387afe9320dfdf9b54a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e1908513627494bb6e9fc5eebd933fa_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i102b956e06124e8aa1a5792f644f35dc_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icecc44177f9c4483aaa2d013aef04666_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8053af52dacf4e0a9c8f9dcfbcc32961_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a65bdddfec44880a63f89575a6757b0_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d20d404d8984a96b12853bc045fd7e1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i181aa9e6db8d4da6a8f9d5751bc9b195_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5a208a660784ecd8fafc1ab3b4650ae_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d21dceba0df4948b9211257ad5aa554_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6796554675ff4f1f973d3c595bd3e499_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic99004e7285a44e0a449ff60ca2c5433_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6766e2f3ba404e94b97b133b143443ec_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09ab23df9d8d46d6b99f210842561aad_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ce78b990cc3435b974774303b8f1500_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id36e8e59f17a4fd2b1810524c32bdb32_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iedb144142fe44106a0298139475b1b7e_D20220201-20220228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:VoceraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-01</xbrli:startDate><xbrli:endDate>2022-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if643644842344c0ab2e0d9a12b06b426_I20201130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:A150ConvertibleNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:VoceraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="rate"><xbrli:measure>utr:Rate</xbrli:measure></xbrli:unit><xbrli:context id="i22182f50ad11452dba95524874b934aa_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:A050ConvertibleNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:VoceraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c9e3c188be94e4c980232bc3fbcb14b_D20201101-20201130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:A150ConvertibleNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:VoceraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2020-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89f1c0806ea84da2867f98aea716c643_D20201201-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:A050ConvertibleNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:VoceraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0eadaeefb6b844b7bcb7e34005c139af_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:VoceraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e2ff09ffaf04bd7b9e7b8d473abbcb6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:VoceraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i101c3d1a12034ac38fe2e5f8c0168405_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">syk:CustomerAndDistributorRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:VoceraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic19a68dc4f2647639ab8a2956791d892_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:VoceraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1d22140738841ca90e737fe8f886088_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:VoceraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4889250342a0437bb3b31f671106d385_D20210901-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:GaussMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i771ee623eaf644bbb46406b9ab01d509_D20220301-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">syk:PureWickMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc3a04258fee41d5854dbca8209b7188_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">syk:PureWickMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieaab15c857b047cb895f5e84a16ec8e5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">syk:RecallMattersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bcc369cedab4f869853e6b7824ab18f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">syk:RecallMattersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia066883b5f184c74a8299f3acdca8fc6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">syk:SpineReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99398de802564a348fcf815e890ee556_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66bd7e5d901d4e1ba0db77e7d94fe17f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic886ff9d842041ae963fe57a90894324_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2984e4fb7f95431db5d16c82e29be4ae_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i249998c655604f398e1944b84271a97b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf16c26d2de44c14872459c255d8e314_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib35db1f319504c6ea1b123bab6945625_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82108a7656a74aa1ba61a08ab02857ce_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb79db6333c349f3923f8d6854ee0198_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7267f78ac6824fc7b4d41470e9de6320_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i616a24284ffb4103824360aa36bae0d7_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6769f38cd4f4dbe805725de19af7ac7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7705b5434d5d4d54a9a81030e299a394_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7803940663364a5c97229c2f0f778b60_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d7b307071314b9b90794e54e6a0095f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id47b79ebee3845f3b4c19c471642577f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53d447ff0f8a4e76984a7d915abea8ee_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7a556e07b064f9e94a25653076cc521_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb5f69c7b49241dfb194a09187e3c17c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29eb6be58138460d98a6d32e536dd9e2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a84ea92e53146cc99a4bd1d326471a9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaaf6d5d43b13406a9b3c80676ac72655_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i305db0433c34417b92b5c6dbeea5f263_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9538fc60a2cf48fe973a5ff07071a757_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icfee61742ac544ed9c226764b8dc1c9e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1626fc828d9642beb146389e00b7d1aa_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaaf12506ce6349e290da46b1889b2f07_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2ed7e2a97b147f5a5e2f0cb1a1b8bdc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i568e131aeee143118e9dfb0c69d84d35_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76d037e2508d493fb9c5c79f64d84deb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">syk:PerformanceStockUnitPsusMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8910a4c2b7d74f3fb6c50af1f492e5a0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6221c941312452b8581e8a9deb3ac6a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">syk:PerformanceStockUnitPsusMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f212fe7e7364a549804bccdf2f81667_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1b406c0949449359e921c7191771a27_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d3d3f84201a45599e436e212113af2a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i105ea3d2ed224740a6a5bfb85f70a5e2_I20220228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:TermLoanDueFebruary222025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibaa4215050f640eda208f1aaca9866a2_D20220201-20220228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:TermLoanDueFebruary222025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-01</xbrli:startDate><xbrli:endDate>2022-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2854c59895d84a0383a8b9cde207fe65_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:TermLoanDueFebruary222025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89795855715a44adb779c848669d4ad1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64f47956dd0f44a5985d1c8aa38b28cc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic31b7c04d93e4f11bdf14d0d9b0aad34_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotesDueNovember2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic02d163166494d6f94e0bd14a160bf17_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotesDueNovember2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i808ca3fe28c44ce78c70e8cfba12ca6e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes0600Due2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15d5d81e0cbe495ebd1b69e9445e539d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes0600Due2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86a207f857004a4ca1e3d7fed25c46b2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes3.375due2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60b7b81e39cd453c88fb43773dc15431_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes3.375due2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a78ebbcbe3e4dcf9d2beb2467073be6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes0.250due2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibdf8e8ff01d04f45a825b8e390068345_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes0.250due2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i035cd0b8f658462394a986d81f43d40e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes1.150Due2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i145b85c88ec4481b842411a5bb47e395_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes1.150Due2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i108518ce09f84a519f3962310c1ed597_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes3.375due2025MemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia21862c342c44911bef866b8e514369b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes3.375due2025MemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i572a1adc5855495dbbba16f658625569_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes350Due2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54a412d21e93418fb2e9f285ffe87359_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes350Due2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23d883af8da240e0b193f0fe43f8fbb8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotesDueNovember2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5156547d31f84feabfdeab3c39626aba_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotesDueNovember2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31b266ec9bca421caa681746ca0a9c57_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes3650Due2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i430f0c280b194413b7ab95bbebb3398f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes3650Due2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ad767f11d7d42f088c022b95d7ed747_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes0.750due2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0bccfa8780e4d148e971bf570bdb5c4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes0.750due2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3bbbaa43580143a18111b7f7460a8613_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes1.950Due2030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10299326fcbd4cab9365281e63e32023_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes1.950Due2030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39597499ab164dd79f0aa42aa4d4a453_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotesDueNovember2030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if06b8b9ac7554a2bb66792f8bc6ae5ec_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotesDueNovember2030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83cf0776e2f74e6bb340c1c44d9c4873_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes1.000due2031Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i188acddc79bd49c9a2dd28df60de44d3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes1.000due2031Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1be77f0f83e44f2a4a4070a55aa9cf1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes410Due2043Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib936df3bfdbb4791a87fadc6fbd30cdf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes410Due2043Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf00788f9e364a80a3fab4c2aee1223b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes4.375due2044Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ebc69fb1cb1488c9aebf005afdcf234_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes4.375due2044Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d645bb615244a36b00b94de383a4937_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes4625Due2046Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied6226864dea487e92398c823ac01c59_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes4625Due2046Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c8be8bcd82a4fbbbf309cf8da292a70_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes2.900due2050Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5c498b0b83c4ce0a21003147411b100_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes2.900due2050Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i097ff20722bb47a2b7d2385fd5c8093b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1b7a9d52e504b799c8afe34dbd39ccb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e50f83f7596461c955c6b530bef94eb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7a76123b7f64330919b0f229f73daa6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic116179f0d574741a8ce9a0151e5f880_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i054f5c7fa9df497fafb3f4d6748a7c59_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8603ec155204c1e91b9af77be41b5ec_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">syk:AccruedCompensationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0aab17a929c4fdf94f5c9f278870a98_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">syk:AccruedCompensationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic37ff66ffd7045788387e658a219637c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iafd18aa56bd8454499c7770cf7cae651_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id79a9c944a1046b6aaca9c9fb9f6bebe_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5af6528a025a4ecc83f861806bda8793_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58b96ce29b8a42aea4c5893906463ce3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e072f5fbda04e4ca99129d167dfe999_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1683d20c41d847f185c1386f0f3dc4c4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanDebtSecurityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe98d7ecbed04b7286e7baabd289cc71_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanDebtSecurityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i779788123a93436181d9161accb7424e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherLongTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i561834c74eee46c8bba248e767b8abd2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherLongTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic638fcfdbb6a416d92b8a3b7c9c78967_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id537c1a6699e44bd890ba7e54ef23a6d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a7ea0b36abd4a6cb52f66b4b312169e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4059183a5b54d6798538edc19c050cf_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8522801ceae048788c0fce97e5d37ab5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6eb65c14e5914f63978a0d0069999ab8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2cc1146a58874a6eb8ef302951c2aecd_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5df6f1a799424f859f0ab765aa4d61d1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica6e290960a44739ba644626546b3852_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a0b0ee47ce04183ad042932b91b34ce_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5010ff9bb614d35ae3367ed2df39f6b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1eaacfb68128466f93e71b1251c20bea_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ffb4a3bde3947f88266050517970e80_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3d6dbee4de64017afe0c8e13e01299a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib19f498ef30f4326a72ede1108304255_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34080018fa394c35b4a7f8033b8e1796_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i210fd2367de749efa9a2e625851d0bd8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa8b9dcdddf64372b0059d96cea46c50_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6bb811c5e3d4e62aa7eb329cbe0c9b7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee87b668135841238e75f21caf1cda6f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd8cfa9e07864166b0bc1f6192348149_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib37f5d53c40e4ad5af1d22e367b1ff8c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ecf88ddf1cd4958a23d17b1f094f7d0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a8294b0f5d74e708266fe817d78a47a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5570209ef64543bfba07e2abea804238_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f7e6cbe52c44cb79b943e8593f46867_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i848d92fcbcf64897bfd1cc126a3aa1a9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibade722fea764961b1d9d387629073e2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6c76d2fefcd444b82889ab47088a661_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7dfe7c27f3e347c2825a7b6348357a60_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8beea1d5ee1f4b6081ce02f6910e2cab_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d0292cedd974224858a44410249e5e0_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05c365347626469281b193639de4b1a1_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1975d811d9f4de7bc2dc66e567577a2_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06d24da15c2a4301868cb2cf91cc084f_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28ee17ac872e4181a4e2ee167127995d_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b8d2fac04db45dda920f25320d94772_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>syk:segment</xbrli:measure></xbrli:unit><xbrli:context id="i47bbb5ea95dc45349b14191d69f1c992_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49c69f29d3694f059d9bf2a004976b17_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60771115f5654e2ba9c33e5226dec383_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6324e0271e4c436692bbcb9e623fc2e8_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81c6954ba7174d4d90e932296c08e140_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i378661c47c334191b9979c19bbafc9b1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f531e84880c46bbbe92b1c8ce7c31a6_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie984aa38d0f0495d8a86b02fb27192a6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3f309c92d20420689d59a657fb1d10b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90ea3f9a188b4371a80590a32f3162a6_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95cdabbaebc1412494ff81e987370623_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idba55220993f4de4874efcaf00cabe63_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8e39c420c4d438997d9ba32c31cd4a4_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if20e557008044e5fb9d0332c0e98ca51_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5cccfcfd1f224a4e8c544848a6c32027_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8fc2a97b3bea475a937cf78e3d486fb9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0025a70b3c024f7ead4a7871ca53fd09_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2dd3298582d043a884e887664abad745_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd7588c5ae9148c78b08f844142d9e5f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i715d57ade67c48388266154e58153628_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if13c14f2e2cb47afbc845ae42bcab920_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29115a5568cc447b9a3b7fc6da47a4c0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4aef5c47c71047fe98565c8a3de0fb4a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d0d6ebb9d7845e3a21c28c263da57f5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33ba2adb3bd4472c8913fc71b0db21bd_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07d6396dc54146d6aee48aa19fc60e02_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf905d3d98e04a87989918e7e14042cb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32ee708de8b14883887f6bab85af5750_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8163b2c12c64eeaab735b00242896b8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2968c9c4a80487baea572af89e9b685_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5182e3f5e754340a7c52da0e4f360ec_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5147ef358704bf8901cba0f588770d3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3272d42ee7e948fbb68b77a14396aa85_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33d7288e19cb441d99394153a6e748b6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78278663438d4595a6f4289bf181420b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83b775090133468ca2cef1c982a32a0c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10ac7111c8bc45da98d1f4aa86d42db5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4879614c45bc4f1a9d1ba8afae2d3a18_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida0ef91d6b564bd5942bcd3208562cde_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b32b057330540a1b4c98f8a0860c359_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">syk:OtherForeignCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63f67a9dc38243c0bc739802cfd40502_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">syk:OtherForeignCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b61af8b172d4c17bf0aaddfbae515ae_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">syk:OtherForeignCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05478418b05443d89b6397fa59b450bc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">syk:OtherForeignCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c78e2c8fe11461fa0a6bbdff48c2aad_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">syk:OtherForeignCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9dcd044683643db85814ccb7429b46b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ImpairedLongLivedAssetsHeldAndUsedByTypeAxis">syk:LongLivedAssetsAndIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if6f51256944449edba93c596bb051076_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86612b3448fd4cf8a845faec1531511e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ImpairedLongLivedAssetsHeldAndUsedByTypeAxis">syk:InProcessRDOtherIntangibleAssetsAndPropertyPlantAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a67a3c2c8da44f8b02b124c5c7e4f00_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForNotesReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icad1710138264073bfe29669fd2b4227_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForNotesReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i558ca518d7ef47a69b7c90dd2d54b4c0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForNotesReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb94cefe14cf4d4ca3781d438a3518be_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForNotesReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i318eeab7dffd46df8caadd99e8f388be_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForNotesReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3f2576e657245638084e8d8a7407dfb_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForNotesReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5211b3936fb24755baa1b6cb7bb0a9ad_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForNotesReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="icec46013a0ad4608b89f97e433dd3417_1"></div><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGV4dHJlZ2lvbjowOTk1YjY4YTRjNjU0MDNjOGU4Yjc5NWY5NTNhYjA1Y18yNzcx_d6237cc0-6901-440d-8b65-be5d996a1577">10-K</ix:nonNumeric> </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:540.00pt"><tr><td style="width:1.0pt"></td><td style="width:49.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:486.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:14pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="dei:DocumentAnnualReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6NGNlNTUwZWY5YTQ0NGFlYmE1NTIxNmY5OWUyMDY4ZDEvdGFibGVyYW5nZTo0Y2U1NTBlZjlhNDQ0YWViYTU1MjE2Zjk5ZTIwNjhkMV8wLTAtMS0xLTcyMTUx_cb87db42-8a71-443a-b6e9-a22fd6e7896e">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">For the fiscal year ended <ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGV4dHJlZ2lvbjowOTk1YjY4YTRjNjU0MDNjOGU4Yjc5NWY5NTNhYjA1Y18xMTk_12607b16-fdfa-4c08-8c20-efd07c701ed5"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGV4dHJlZ2lvbjowOTk1YjY4YTRjNjU0MDNjOGU4Yjc5NWY5NTNhYjA1Y18xMTk_99da9a8d-da21-4361-b371-6f451da9f20c">December 31</ix:nonNumeric>, 2022</ix:nonNumeric></span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">OR</span></div><div style="margin-top:2pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:540.00pt"><tr><td style="width:1.0pt"></td><td style="width:49.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:486.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:14pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6OTM5MjI4NDcyZmM3NGU1OTljOTk0ZjQxOGIyMWQ2Y2QvdGFibGVyYW5nZTo5MzkyMjg0NzJmYzc0ZTU5OWM5OTRmNDE4YjIxZDZjZF8wLTAtMS0xLTcyMTUx_06d9836f-cc70-4fe2-9505-16518d98ef4e">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Commission file number: <ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGV4dHJlZ2lvbjowOTk1YjY4YTRjNjU0MDNjOGU4Yjc5NWY5NTNhYjA1Y18yNzcy_40df68c0-a40a-40ec-96be-64f75b535cf4">001-13149</ix:nonNumeric> </span></div><div style="text-align:center"><img src="syk-20221231_g1.jpg" alt="syk-20221231_g1.jpg" style="height:53px;margin-bottom:5pt;vertical-align:text-bottom;width:201px"/><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGV4dHJlZ2lvbjowOTk1YjY4YTRjNjU0MDNjOGU4Yjc5NWY5NTNhYjA1Y18yNzY1_818be3b1-af31-42f9-a6e7-f3c4410a3293">STRYKER CORP</ix:nonNumeric>ORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:83.194%"><tr><td style="width:1.0%"></td><td style="width:15.093%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.093%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.407%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.748%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.095%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.407%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.457%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6MWQwOTM3NThmNTA4NGQ3MTllMWY5NzNlYTM1OGM0NjYvdGFibGVyYW5nZToxZDA5Mzc1OGY1MDg0ZDcxOWUxZjk3M2VhMzU4YzQ2Nl8wLTAtMS0xLTcyMTUx_41b4633d-0747-4923-8604-612f7b00ac88">Michigan</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6MWQwOTM3NThmNTA4NGQ3MTllMWY5NzNlYTM1OGM0NjYvdGFibGVyYW5nZToxZDA5Mzc1OGY1MDg0ZDcxOWUxZjk3M2VhMzU4YzQ2Nl8wLTYtMS0xLTcyMTUx_855bad6f-3131-4888-a2de-6b6d240c00b3">38-1239739</ix:nonNumeric></span></td></tr><tr><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(State of incorporation)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6MWQwOTM3NThmNTA4NGQ3MTllMWY5NzNlYTM1OGM0NjYvdGFibGVyYW5nZToxZDA5Mzc1OGY1MDg0ZDcxOWUxZjk3M2VhMzU4YzQ2Nl8zLTAtMS0xLTcyMTUx_a2f0ec1e-6cf4-455e-a60b-51111fca40f5">2825 Airview Boulevard,</ix:nonNumeric></span></td><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6MWQwOTM3NThmNTA4NGQ3MTllMWY5NzNlYTM1OGM0NjYvdGFibGVyYW5nZToxZDA5Mzc1OGY1MDg0ZDcxOWUxZjk3M2VhMzU4YzQ2Nl8zLTItMS0xLTcyMTUx_7761f481-3a75-4ff9-88b0-a9a5909287be">Kalamazoo,</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6MWQwOTM3NThmNTA4NGQ3MTllMWY5NzNlYTM1OGM0NjYvdGFibGVyYW5nZToxZDA5Mzc1OGY1MDg0ZDcxOWUxZjk3M2VhMzU4YzQ2Nl8zLTQtMS0xLTcyMTUx_9854618b-9794-43e0-9749-d77c04f5c57f">Michigan</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6MWQwOTM3NThmNTA4NGQ3MTllMWY5NzNlYTM1OGM0NjYvdGFibGVyYW5nZToxZDA5Mzc1OGY1MDg0ZDcxOWUxZjk3M2VhMzU4YzQ2Nl8zLTYtMS0xLTcyMTUx_659a5e0d-5ab0-444e-a35f-ae5f09831b3b">49002</ix:nonNumeric></span></td></tr><tr><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(Zip Code)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6MWQwOTM3NThmNTA4NGQ3MTllMWY5NzNlYTM1OGM0NjYvdGFibGVyYW5nZToxZDA5Mzc1OGY1MDg0ZDcxOWUxZjk3M2VhMzU4YzQ2Nl82LTMtMS0xLTcyMTUx_78e3f465-2e67-46d2-a023-01ddb9ca023f">(269)</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6MWQwOTM3NThmNTA4NGQ3MTllMWY5NzNlYTM1OGM0NjYvdGFibGVyYW5nZToxZDA5Mzc1OGY1MDg0ZDcxOWUxZjk3M2VhMzU4YzQ2Nl82LTQtMS0xLTcyMTUx_676e12a7-711c-4073-938e-faab2b0e1c9a">385-2600</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(Registrant&#8217;s telephone number, including area code)</span></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.816%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.873%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Securities registered pursuant to Section&#160;12(b) of the Act:</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if231cb99329846998fbe0b34abe79ea7_D20220101-20221231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6MDM0YzgyODcyODgwNGE5N2E1MDcwNmE5MWEzYmU2ODcvdGFibGVyYW5nZTowMzRjODI4NzI4ODA0YTk3YTUwNzA2YTkxYTNiZTY4N18yLTAtMS0xLTcyMTUx_215cacc8-2998-4d77-a1c6-abbe47434698">Common Stock, $.10 Par Value</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if231cb99329846998fbe0b34abe79ea7_D20220101-20221231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6MDM0YzgyODcyODgwNGE5N2E1MDcwNmE5MWEzYmU2ODcvdGFibGVyYW5nZTowMzRjODI4NzI4ODA0YTk3YTUwNzA2YTkxYTNiZTY4N18yLTEtMS0xLTcyMTUx_54682d5c-64d2-4f45-a769-dda147953619">SYK</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if231cb99329846998fbe0b34abe79ea7_D20220101-20221231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6MDM0YzgyODcyODgwNGE5N2E1MDcwNmE5MWEzYmU2ODcvdGFibGVyYW5nZTowMzRjODI4NzI4ODA0YTk3YTUwNzA2YTkxYTNiZTY4N18yLTItMS0xLTcyMTUx_def3958f-0222-4f4f-b81a-5c986e34fb85">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7dd02fbab10d4e00b5bcd9c2dedb8209_D20220101-20221231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6MDM0YzgyODcyODgwNGE5N2E1MDcwNmE5MWEzYmU2ODcvdGFibGVyYW5nZTowMzRjODI4NzI4ODA0YTk3YTUwNzA2YTkxYTNiZTY4N18zLTAtMS0xLTcyMTUx_d1fd8fce-0a50-4973-b02a-1c265159e32e">1.125% Notes due 2023</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7dd02fbab10d4e00b5bcd9c2dedb8209_D20220101-20221231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6MDM0YzgyODcyODgwNGE5N2E1MDcwNmE5MWEzYmU2ODcvdGFibGVyYW5nZTowMzRjODI4NzI4ODA0YTk3YTUwNzA2YTkxYTNiZTY4N18zLTEtMS0xLTcyMTUx_012487ac-8f87-4908-8b8c-14f9d1810ddb">SYK23</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7dd02fbab10d4e00b5bcd9c2dedb8209_D20220101-20221231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6MDM0YzgyODcyODgwNGE5N2E1MDcwNmE5MWEzYmU2ODcvdGFibGVyYW5nZTowMzRjODI4NzI4ODA0YTk3YTUwNzA2YTkxYTNiZTY4N18zLTItMS0xLTcyMTUx_89d1ea8e-e974-4604-a9cf-2e638a1bc739">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i71648630b05f40fba5ebd37a3211f4b4_D20220101-20221231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6MDM0YzgyODcyODgwNGE5N2E1MDcwNmE5MWEzYmU2ODcvdGFibGVyYW5nZTowMzRjODI4NzI4ODA0YTk3YTUwNzA2YTkxYTNiZTY4N180LTAtMS0xLTcyMTUx_a83ca036-cfc7-4f00-9eb1-bd5b5735e855">0.250% Notes due 2024</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i71648630b05f40fba5ebd37a3211f4b4_D20220101-20221231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6MDM0YzgyODcyODgwNGE5N2E1MDcwNmE5MWEzYmU2ODcvdGFibGVyYW5nZTowMzRjODI4NzI4ODA0YTk3YTUwNzA2YTkxYTNiZTY4N180LTEtMS0xLTcyMTUx_106f0422-e74a-402b-84a5-bb897dd4265c">SYK24A</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i71648630b05f40fba5ebd37a3211f4b4_D20220101-20221231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6MDM0YzgyODcyODgwNGE5N2E1MDcwNmE5MWEzYmU2ODcvdGFibGVyYW5nZTowMzRjODI4NzI4ODA0YTk3YTUwNzA2YTkxYTNiZTY4N180LTItMS0xLTcyMTUx_19c3ed47-c685-4653-88c3-0f8884a7ff80">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic78b7239217245f9b7ba422e50d29a35_D20220101-20221231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6MDM0YzgyODcyODgwNGE5N2E1MDcwNmE5MWEzYmU2ODcvdGFibGVyYW5nZTowMzRjODI4NzI4ODA0YTk3YTUwNzA2YTkxYTNiZTY4N181LTAtMS0xLTcyMTUx_af296770-c46b-46c9-b1df-f871f7cc27bf">2.125% Notes due 2027</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic78b7239217245f9b7ba422e50d29a35_D20220101-20221231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6MDM0YzgyODcyODgwNGE5N2E1MDcwNmE5MWEzYmU2ODcvdGFibGVyYW5nZTowMzRjODI4NzI4ODA0YTk3YTUwNzA2YTkxYTNiZTY4N181LTEtMS0xLTcyMTUx_7fd0ebaf-0fe3-4bcc-b392-8d4f8662d3fa">SYK27</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic78b7239217245f9b7ba422e50d29a35_D20220101-20221231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6MDM0YzgyODcyODgwNGE5N2E1MDcwNmE5MWEzYmU2ODcvdGFibGVyYW5nZTowMzRjODI4NzI4ODA0YTk3YTUwNzA2YTkxYTNiZTY4N181LTItMS0xLTcyMTUx_25b0880f-d8b8-440f-90e1-ea67cf6aa6fa">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic1174c5b8346493d97c292962b5734e9_D20220101-20221231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6MDM0YzgyODcyODgwNGE5N2E1MDcwNmE5MWEzYmU2ODcvdGFibGVyYW5nZTowMzRjODI4NzI4ODA0YTk3YTUwNzA2YTkxYTNiZTY4N182LTAtMS0xLTcyMTUx_62ccc67a-e4ff-4735-9b6d-cd8d167a75f3">0.750% Notes due 2029</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic1174c5b8346493d97c292962b5734e9_D20220101-20221231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6MDM0YzgyODcyODgwNGE5N2E1MDcwNmE5MWEzYmU2ODcvdGFibGVyYW5nZTowMzRjODI4NzI4ODA0YTk3YTUwNzA2YTkxYTNiZTY4N182LTEtMS0xLTcyMTUx_1da3ec07-20b1-4c69-bc4e-baa55845acb9">SYK29</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic1174c5b8346493d97c292962b5734e9_D20220101-20221231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6MDM0YzgyODcyODgwNGE5N2E1MDcwNmE5MWEzYmU2ODcvdGFibGVyYW5nZTowMzRjODI4NzI4ODA0YTk3YTUwNzA2YTkxYTNiZTY4N182LTItMS0xLTcyMTUx_411d72f7-b4b7-4ab8-ac61-ca78d2a8c500">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ied914c836e1441c7890112782c149468_D20220101-20221231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6MDM0YzgyODcyODgwNGE5N2E1MDcwNmE5MWEzYmU2ODcvdGFibGVyYW5nZTowMzRjODI4NzI4ODA0YTk3YTUwNzA2YTkxYTNiZTY4N183LTAtMS0xLTcyMTUx_a21c7e94-0fa4-4bcf-bcee-4eb1731d5bfa">2.625% Notes due 2030</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ied914c836e1441c7890112782c149468_D20220101-20221231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6MDM0YzgyODcyODgwNGE5N2E1MDcwNmE5MWEzYmU2ODcvdGFibGVyYW5nZTowMzRjODI4NzI4ODA0YTk3YTUwNzA2YTkxYTNiZTY4N183LTEtMS0xLTcyMTUx_d1316cc5-2035-491d-a54c-46a89e20b942">SYK30</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ied914c836e1441c7890112782c149468_D20220101-20221231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6MDM0YzgyODcyODgwNGE5N2E1MDcwNmE5MWEzYmU2ODcvdGFibGVyYW5nZTowMzRjODI4NzI4ODA0YTk3YTUwNzA2YTkxYTNiZTY4N183LTItMS0xLTcyMTUx_b9a29487-a0e7-4306-beb0-e89a124d46fe">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="iaa9f50c457574b7daccc82821729b9e5_D20220101-20221231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6MDM0YzgyODcyODgwNGE5N2E1MDcwNmE5MWEzYmU2ODcvdGFibGVyYW5nZTowMzRjODI4NzI4ODA0YTk3YTUwNzA2YTkxYTNiZTY4N184LTAtMS0xLTcyMTUx_c3eabdcd-5d22-45e0-a952-e0ac858866cb">1.000% Notes due 2031</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="iaa9f50c457574b7daccc82821729b9e5_D20220101-20221231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6MDM0YzgyODcyODgwNGE5N2E1MDcwNmE5MWEzYmU2ODcvdGFibGVyYW5nZTowMzRjODI4NzI4ODA0YTk3YTUwNzA2YTkxYTNiZTY4N184LTEtMS0xLTcyMTUx_c26e0b3b-cfcd-4f2e-8f25-3bff9c4f2dea">SYK31</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="iaa9f50c457574b7daccc82821729b9e5_D20220101-20221231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6MDM0YzgyODcyODgwNGE5N2E1MDcwNmE5MWEzYmU2ODcvdGFibGVyYW5nZTowMzRjODI4NzI4ODA0YTk3YTUwNzA2YTkxYTNiZTY4N184LTItMS0xLTcyMTUx_2bd14f59-aeb8-4ee9-8449-98e5dba7b3f7">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Securities registered pursuant to Section&#160;12(g) of the Act: <ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="dei:Security12gTitle" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGV4dHJlZ2lvbjowOTk1YjY4YTRjNjU0MDNjOGU4Yjc5NWY5NTNhYjA1Y18yNzY2_f613461f-82ef-4db9-966a-5ad74044c980">None</ix:nonNumeric> </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.&#160;&#160;&#160;&#160;Yes </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGV4dHJlZ2lvbjowOTk1YjY4YTRjNjU0MDNjOGU4Yjc5NWY5NTNhYjA1Y181NDk3NTU4MjQ0MTE_2d326c1f-e704-46a7-8a12-da074978cba4">No</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section&#160;13 or 15(d) of the Act.&#160;&#160;&#160;&#160;Yes&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#9744;   &#160;&#160;&#160;&#160; </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGV4dHJlZ2lvbjowOTk1YjY4YTRjNjU0MDNjOGU4Yjc5NWY5NTNhYjA1Y18yNzcz_1c908f23-963f-4674-9c99-75e20613dd00">No</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities and Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGV4dHJlZ2lvbjowOTk1YjY4YTRjNjU0MDNjOGU4Yjc5NWY5NTNhYjA1Y181NDk3NTU4MjQ0MTM_78bb1356-7a8c-47cc-9dc9-26e297ff385a">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#160;&#9744;</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGV4dHJlZ2lvbjowOTk1YjY4YTRjNjU0MDNjOGU4Yjc5NWY5NTNhYjA1Y18yNzc1_8aa63953-c8a3-4377-8785-913a72e51c67">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.274%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.228%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.997%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.435%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.274%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.092%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6ZjdiNTNmNjgzMDEwNDA0ZDkyN2VmMzg1MThhNWVmODcvdGFibGVyYW5nZTpmN2I1M2Y2ODMwMTA0MDRkOTI3ZWYzODUxOGE1ZWY4N18wLTAtMS0xLTcyMTUx_0e5a81b8-4bd0-4cdb-a5cc-53c5ae77fcd2">Large accelerated filer</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6ZjdiNTNmNjgzMDEwNDA0ZDkyN2VmMzg1MThhNWVmODcvdGFibGVyYW5nZTpmN2I1M2Y2ODMwMTA0MDRkOTI3ZWYzODUxOGE1ZWY4N18wLTUtMS0xLTcyMTUx_6393563b-c9f7-414b-abac-bd3cadf7c710">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Small reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6ZjdiNTNmNjgzMDEwNDA0ZDkyN2VmMzg1MThhNWVmODcvdGFibGVyYW5nZTpmN2I1M2Y2ODMwMTA0MDRkOTI3ZWYzODUxOGE1ZWY4N18xLTMtMS0xLTcyMTUx_4ad23bfa-b238-4f26-831f-4a0b993203c6">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C.7262(b)) by the registered public accounting firm that prepared or issued its audit report.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="dei:IcfrAuditorAttestationFlag" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGV4dHJlZ2lvbjowOTk1YjY4YTRjNjU0MDNjOGU4Yjc5NWY5NTNhYjA1Y18yNzY4_6b931c0e-6a83-4000-9660-96a04a79346f">&#9746;</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.                                                                                                                                        </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b).                                                                                                </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).&#160;&#160;&#160;&#160;Yes&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGV4dHJlZ2lvbjowOTk1YjY4YTRjNjU0MDNjOGU4Yjc5NWY5NTNhYjA1Y18yNzcw_c954886f-bb6e-4dbe-9437-262282260167">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">The aggregate market value of the voting stock held by non-affiliates of the registrant was approximately $<ix:nonFraction unitRef="usd" contextRef="i28ee37853fb34f8596d0f60ff923f553_I20220630" decimals="0" name="dei:EntityPublicFloat" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGV4dHJlZ2lvbjowOTk1YjY4YTRjNjU0MDNjOGU4Yjc5NWY5NTNhYjA1Y18yNDE1_3a620ef8-38a0-4438-89f4-f0b2580f7a03">70,965,162,853</ix:nonFraction> at June&#160;30, 2022. There were <ix:nonFraction unitRef="shares" contextRef="ia86e7290435746bc83636123dd097ec2_I20230131" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGV4dHJlZ2lvbjowOTk1YjY4YTRjNjU0MDNjOGU4Yjc5NWY5NTNhYjA1Y18yNDM2_79b7cf66-307d-41aa-9f6d-9ca5c7e78f98">378,831,249</ix:nonFraction> shares outstanding of the registrant&#8217;s common stock, $0.10 par value, on January&#160;31, 2023.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGV4dHJlZ2lvbjowOTk1YjY4YTRjNjU0MDNjOGU4Yjc5NWY5NTNhYjA1Y18yNzY5_ca4507d0-64c9-4e3b-a979-e76c5ca6c263" escape="true">Portions of the proxy statement to be filed with the U.S. Securities and Exchange Commission relating to the 2023 Annual Meeting of Shareholders (the 2023 proxy statement) are incorporated by reference into Part III.</ix:nonNumeric></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="icec46013a0ad4608b89f97e433dd3417_7"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2022 FORM 10-K</span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.929%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PART I</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item&#160;1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Business</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icec46013a0ad4608b89f97e433dd3417_13">1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item 1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk Factors</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icec46013a0ad4608b89f97e433dd3417_16">4</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item 1B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unresolved Staff Comments</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icec46013a0ad4608b89f97e433dd3417_19">9</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Properties</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icec46013a0ad4608b89f97e433dd3417_22">9</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Legal Proceedings</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icec46013a0ad4608b89f97e433dd3417_25">10</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mine Safety Disclosures</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icec46013a0ad4608b89f97e433dd3417_28">10</a></span></div></td></tr><tr style="height:15pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PART II</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item&#160;5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Market for the Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icec46013a0ad4608b89f97e433dd3417_34">10</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item 6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selected Financial Data</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icec46013a0ad4608b89f97e433dd3417_37">11</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item 7.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icec46013a0ad4608b89f97e433dd3417_40">12</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item 7A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quantitative and Qualitative Disclosures About Market Risk</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icec46013a0ad4608b89f97e433dd3417_73">19</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item 8.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financial Statements and Supplementary Data</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icec46013a0ad4608b89f97e433dd3417_76">21</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Report of Independent Registered Public Accounting Firm (PCAOB ID: <ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="dei:AuditorFirmId" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183L2ZyYWc6YjE4NzY4NTg4ZDFmNGYyNjhlZjk4ZTk3YTlkNDBhZjMvdGFibGU6YjU2MjA1MzBlOWIzNGUxNmE4MGFlZTE4MjhjN2VjMzkvdGFibGVyYW5nZTpiNTYyMDUzMGU5YjM0ZTE2YTgwYWVlMTgyOGM3ZWMzOV8xNC0xLTEtMS03MjE1MS90ZXh0cmVnaW9uOmZiYTBjZDUyNzUzZDRlYmU5MzRhN2E1ODZlODE3M2I5Xzcx_2e730fbb-9694-4666-bb14-b6ab7f62c4f5">42</ix:nonNumeric>)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icec46013a0ad4608b89f97e433dd3417_76">21</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consolidated Statements of Earnings</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icec46013a0ad4608b89f97e433dd3417_79">23</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consolidated Statements of Comprehensive Income</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icec46013a0ad4608b89f97e433dd3417_82">23</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consolidated Balance Sheets</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icec46013a0ad4608b89f97e433dd3417_85">24</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consolidated Statements of Shareholders&#8217; Equity</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icec46013a0ad4608b89f97e433dd3417_91">25</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consolidated Statements of Cash Flows</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icec46013a0ad4608b89f97e433dd3417_94">26</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Notes to Consolidated Financial Statements</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icec46013a0ad4608b89f97e433dd3417_97">27</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item 9.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in and Disagreements With Accountants on Accounting and Financial Disclosure</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icec46013a0ad4608b89f97e433dd3417_145">39</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item&#160;9A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Controls and Procedures</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icec46013a0ad4608b89f97e433dd3417_148">39</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item&#160;9B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other Information</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icec46013a0ad4608b89f97e433dd3417_151">40</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item&#160;9C.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Disclosure Regarding Foreign Jurisdictions That Prevent Inspections</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icec46013a0ad4608b89f97e433dd3417_151">40</a></span></div></td></tr><tr style="height:15pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PART III</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item 10.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Directors, Executive Officers and Corporate Governance</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icec46013a0ad4608b89f97e433dd3417_160">40</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item 11.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Executive Compensation</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icec46013a0ad4608b89f97e433dd3417_163">40</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item 12.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icec46013a0ad4608b89f97e433dd3417_166">40</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item 13.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Certain Relationships and Related Transactions, and Director Independence</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icec46013a0ad4608b89f97e433dd3417_169">41</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item 14.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal Accountant Fees and Services</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icec46013a0ad4608b89f97e433dd3417_172">41</a></span></div></td></tr><tr style="height:15pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PART IV</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item 15.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibits, Financial Statement Schedules</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icec46013a0ad4608b89f97e433dd3417_178">42</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item 16.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Form 10-K Summary</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icec46013a0ad4608b89f97e433dd3417_184">45</a></span></div></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="icec46013a0ad4608b89f97e433dd3417_10"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2022 FORM 10-K</span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART I</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div id="icec46013a0ad4608b89f97e433dd3417_13"></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:261.00pt"><tr><td style="width:1.0pt"></td><td style="width:58.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:198.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 1.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BUSINESS.</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stryker Corporation (Stryker or the Company) is one of the world's leading medical technology companies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in Medical and Surgical, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside our customers around the world, Stryker impacts more than 130 million patients annually.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our core values guide our behaviors and actions and are fundamental to how we execute our mission.</span></div><div style="margin-bottom:6pt;text-align:center"><img src="syk-20221231_g2.jpg" alt="syk-20221231_g2.jpg" style="height:186px;margin-bottom:5pt;vertical-align:text-bottom;width:348px"/></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stryker was incorporated in Michigan in 1946 as the successor company to a business founded in 1941 by Dr. Homer H. Stryker, a prominent orthopaedic surgeon and inventor of several medical products. Our products are sold in over 75 countries through company-owned subsidiaries and branches as well as third-party dealers and distributors, and include surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling, emergency medical equipment and intensive care disposable products; clinical communication and workflow solutions; neurosurgical and neurovascular devices; implants used in joint replacement and trauma surgeries; Mako Robotic-Arm Assisted technology; spinal devices; as well as other products used in a variety of medical specialties. Most of our products are marketed directly to doctors, hospitals and other healthcare facilities.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As used herein, and except where the context otherwise requires, "Stryker," "we," "us," and "our" refer to Stryker Corporation and its consolidated subsidiaries.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Business Segments and Geographic Information</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We segregate our operations into two reportable business segments: (i) MedSurg and Neurotechnology and (ii) Orthopaedics and Spine. Financial information regarding our reportable business segments and certain geographic information is included under "Consolidated Results of Operations" in Item 7 of this report and Note 14 to our Consolidated Financial Statements. </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"></td><td style="width:30.312%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.291%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.291%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.291%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.415%"></td><td style="width:0.1%"></td></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Net Sales by Reportable Segment</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedSurg and Neurotechnology</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10,611&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9,538&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8,345&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Orthopaedics and Spine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,838&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,570&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6,006&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">18,449</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">17,108</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14,351</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr></table></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">MedSurg and Neurotechnology</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">MedSurg products include surgical equipment, patient and caregiver safety technologies, and navigation systems (Instruments), endoscopic and communications systems (Endoscopy), patient handling, emergency medical equipment, intensive care disposable products and clinical communication and workflow solutions (Medical), reprocessed and remanufactured medical devices, and other medical device products used in a variety of medical specialties. Neurotechnology includes neurosurgical, neurovascular and craniomaxillofacial implant products. Our neurotechnology offering includes products used for minimally invasive endovascular procedures; a comprehensive line of products for traditional brain and open skull based surgical procedures; orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products (Neuro Cranial); and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke (Neurovascular). The craniomaxillofacial implant offering includes cranial, maxillofacial and chest wall devices as well as dural substitutes and sealants. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are one of five leading global competitors in Instruments; the other four being Zimmer Biomet Holdings, Inc. (Zimmer), Medtronic plc., Johnson &amp; Johnson and ConMed Linvatec, Inc. (a subsidiary of CONMED Corporation). In Endoscopy we compete with Karl Storz GmbH &amp; Co., Olympus Optical Co. Ltd., Smith &amp; Nephew plc (Smith &amp; Nephew), ConMed Linvatec, Arthrex, Inc. and STERIS plc. In Medical our primary competitors are Baxter/Hill-Rom, Inc., Zoll Medical Corporation, Medline Industries and Ferno-Washington, Inc. Stryker is also one of five leading global competitors in Neurotechnology; the other four being Medtronic, Johnson &amp; Johnson, Terumo Corporation and Penumbra, Inc.</span></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"></td><td style="width:30.312%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.291%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.291%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.291%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.415%"></td><td style="width:0.1%"></td></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Composition of MedSurg and Neurotechnology Net Sales</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Instruments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,279&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,111&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,863&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Endoscopy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,763&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,031&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,607&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,524&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neurovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">973&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neuro Cranial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,376&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,214&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">972&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">277&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,611</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,538</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,345</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">In 2022 Instruments launched the next generation of the System 9 total joint power tool and the CD NXT power tool with automatic depth measurement allowing for fast, accurate and consistent digital depth measurement across a variety of procedures. Endoscopy expanded its product offering for the Ambulatory Surgery Center (ASC) market with the launch of a new 4K 1688 Autoclavable Camera and SDC4K image capture device. Endoscopy also launched a new line of fluorescent capable laparoscopes to improve image quality in laparoscopic procedures. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Medical completed the acquisition of Vocera Communications, Inc. (Vocera), a leader in digital care coordination and communication. Vocera brings a highly complementary and innovative portfolio to Medical that is expected to enhance our Advanced Digital Healthcare offerings and further advance our focus on preventing adverse events throughout the continuum of care. In addition, Medical launched the Power Pro 2 cot, the industry&#8217;s first connected ambulance cot.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In 2022 Neurovascular launched the Vecta 71/74 aspiration system in Japan, Korea, Australia and New Zealand as well as the Cat 7 distal access catheter in China. We also continued the launch of the next generation of the market leading Synchro guidewire in Asia Pacific.</span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2022 FORM 10-K</span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Orthopaedics and Spine</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Orthopaedics products consist primarily of implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. We bring patients and physicians advanced implant designs and specialized instrumentation that make orthopaedic surgery and recovery simpler, faster and more effective. We support surgeons with the technology and services they need as they develop new surgical techniques. The Mako Robotic-Arm Assisted Surgical System was designed to help surgeons provide patients with a personalized surgical experience based on their specific diagnosis and anatomy. The Mako System currently offers three applications supporting Partial Knee, Total Hip and Total Knee procedures. Mako is the only robotic-arm assisted technology enabled by 3D CT-based pre-operative planning and, with AccuStop&#8482; haptic technology, Mako provides surgeons the ability to know more about their patients' anatomy so they can cut less in bone preparation and implant placement with intra-operative haptic guidance. </span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our spinal implant offering includes cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. Our spine enabling technologies portfolio includes best in class imaging solutions, image-guided surgical technology, patient specific implants and digital health solutions supporting surgeons and their patients throughout the continuum of care.</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are one of four leading global competitors for joint replacement and trauma and extremities products and robotics; the other three being Zimmer, DePuy Synthes (a Johnson &amp; Johnson company) and Smith &amp; Nephew. We are one of five leading global competitors in Spine; the other four being Medtronic Sofamor Danek, Inc. (a subsidiary of Medtronic), DePuy Synthes, Nuvasive, Inc. and Globus Medical, Inc.</span></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"></td><td style="width:30.312%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.291%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.291%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.291%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.415%"></td><td style="width:0.1%"></td></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Composition of Orthopaedics and Spine Net Sales</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Knees</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,997&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,848&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,567&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Hips</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,342&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Trauma and Extremities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,807&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,664&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,722&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Spine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,047&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">475&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">464&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,838</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,570</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,006</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">In 2022 we moved to a full commercial launch of Insignia hip stem in the United States after first clinical use in December 2021. United States Food and Drug Administration (FDA) approval was received in 2021, Health Canada approval was received in the fourth quarter of 2022 and Japan&#8217;s Pharmaceuticals and Medical Devices Agency (PMDA) approval is anticipated in the second half of 2023.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Raw Materials and Inventory</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Raw materials essential to our business are generally readily available from multiple sources; however, certain of our raw materials are currently sourced from single suppliers. Substantially all products we manufacture are stocked in inventory, while certain MedSurg products are assembled to order. Where some electronic components have had limited availability due to recent global shortages, we have worked closely with suppliers to ensure this temporary supply constraint did not have a material adverse effect on continuity of supply.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Patents and Trademarks</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Patents and trademarks are significant to our business to the extent that a product or an attribute of a product represents a unique design or process. Patent protection of such products restricts competitors from duplicating these unique designs and features. We seek to obtain patent protection on our products </span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">whenever appropriate for protecting our competitive advantage. On December&#160;31, 2022 we owned approximately 4,800 United States patents and approximately 7,300 patents in other countries.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Seasonality</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our business is generally not seasonal in nature; however, the number of orthopaedic implant surgeries is typically lower in the summer months, and sales of capital equipment are generally higher in the fourth quarter.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Competition</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In each of our product lines we compete with local and global companies. The development of new and innovative products is important to our success in all areas of our business. Competition in research involving the development and improvement of new and existing products and processes is particularly significant. The competitive environment requires substantial investments in continuing research and maintaining sales forces.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We believe our commitment to innovation, quality and service and our reputation differentiates us in the highly competitive product categories in which we operate and enables us to compete effectively. We believe that our competitive position in the future will depend to a large degree on our ability to develop new products and make improvements to existing products. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Regulation</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our businesses are subject to varying degrees of governmental regulation in the countries in which we operate, and the general trend is toward increasingly stringent regulation. We are required to comply with the unique regulatory requirements of each country within which we market and sell our products.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the United States the Medical Device Amendments of 1976 to the Federal Food, Drug and Cosmetic Act and its subsequent amendments and the regulations issued and proposed thereunder provide for federal regulation by the FDA of the design, manufacture and marketing of medical devices, including most of our products. In addition, state licensing requirements often apply to certain of our business operations and products. On the federal level, many of our new products fall into FDA classifications that require notification submitted as a 510(k) and review by the FDA before we begin marketing them. Certain of our products require extensive clinical testing, consisting of safety and efficacy studies, followed by pre-market approval (PMA) applications for specific surgical indications. Certain of our products also fall under other FDA classifications, such as drugs and Human Cells, Tissues, and Cellular and Tissue-Based Products.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The FDA's Quality System regulations set forth standards for our product design and manufacturing processes, require the maintenance of certain records and provide for inspections of our facilities by the FDA. There are also certain requirements of state, local and foreign governments that must be complied with in the manufacture and marketing of our products.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The European Union enacted the European Union Medical Device Regulation in May 2017 with an original effective date of May 2021 (the transition timeline is currently being reevaluated by the European Parliament), which imposes stricter requirements for the marketing and sale of medical devices, including in the areas of clinical evaluation requirements, quality systems, labeling and post-market surveillance. Additionally, as a result of the exit of the United Kingdom from the European Union (Brexit), new medical device regulations were released by the United Kingdom, which became effective January 1, 2021. A gap analysis against the prior Medical Device Directive (MDD) has </span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2022 FORM 10-K</span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">been completed and a plan is being executed for both the European Union and United Kingdom regulations to ensure compliance and minimize business disruption. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Initiatives to limit the growth of general healthcare expenses and hospital costs are ongoing in the markets in which we do business. These initiatives are sponsored by government agencies, legislative bodies and the private sector and include price regulation and competitive pricing. It is not possible to predict at this time the long-term impact of such cost containment measures on our future business. In addition, business practices in the healthcare industry are scrutinized, particularly in the United States, by federal and state government agencies. The resulting investigations and prosecutions carry the risk of significant civil and criminal penalties.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Environment</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are subject to various rules and regulation in the United States and internationally related to the protection of human health and the environment. Our operations involve the use of substances regulated under environmental laws, primarily in manufacturing and sterilization processes. We believe our policies, practices and procedures are properly designed to comply, in all material respects, with applicable environmental laws and regulations. We do not expect compliance with these requirements to have a material effect on purchases of property, plant and equipment, cash flows, net earnings or competitive position. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Employees </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On December&#160;31, 2022 we had approximately 51,000 employees globally, with approximately 27,000 employees in the United States. Our talented employees are an integral reason for our standing as one of the world's leading medical technology companies where, together with our customers, we are driven to make healthcare better. Our company values of integrity, accountability, people and performance are a key component of that mission. Our people, as one of our core values, continue to be a key focus.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our success is dependent on our ability to attract the best talent that reflects our diverse communities. To do so, we continue to focus on creating and maintaining a great workplace. We believe in attracting the right people, maintaining and building employee engagement and developing our employees. We believe when people are able to do what they do best, they will look forward to coming to work and, in turn, will deliver great business results.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our leadership team and Board of Directors receive regular updates on our people and culture strategy and provide feedback on our strategy and goals, including alignment to our mission and values, peer benchmarking and stakeholder feedback.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Employee Development</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our employee development is extensive and exists at all levels of the organization, including company-wide training on our Code of Conduct, job-related technical training and management and leadership training. Our development programs include on-the-job learning, coaching and mentoring, management and leadership development courses, team building and collaboration training and immersive experiences with expert partners. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We encourage all employees to establish individual development plans, in partnership with their manager, to help employees gain the needed development experience to grow their careers. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Employee Engagement</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">An engaged workplace culture that drives performance and business outcomes is central to our mission. Listening to and </span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">learning from our employees forms the foundation of an engaging culture. More than 90% of our global employees participate in our annual engagement survey, which provides a valued platform for listening and allows us to take action based on the feedback collected. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We supplement our annual engagement survey with targeted pulse surveys to gather feedback on topics relevant to the current climate. Additionally, we establish forums for collecting qualitative feedback to gain insights and identify actions we can take to ensure all employees feel included, engaged and able to achieve their full potential.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We also provide tools and resources that enable managers and teams to act on the insights we gain from our surveys and to drive employee engagement and strong business outcomes.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Diversity, Equity and Inclusion (DE&amp;I)</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">An essential part of our culture is respecting each individual&#8217;s strengths and values. Building on this foundation, we are focused on maintaining an inclusive, engaging work environment and prioritizing DE&amp;I in keeping with our values of integrity and people. Our DE&amp;I strategy is centered around these three commitments:</span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Strengthen the diversity of our workforce</span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Advance a culture of inclusion, engagement and belonging</span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Maximize the power of inclusion to drive innovation and growth</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are advancing our commitments through the following actions, among others:</span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Holding leadership accountable through transparent data, performance objectives and inclusion in our business review process</span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Engaging and inspiring all talent and empowering every employee to take action</span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Developing our people and processes by removing barriers and optimizing the power of diverse backgrounds, talents and perspectives</span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Attracting a diverse talent pool through focused outreach and ensuring an objective hiring process</span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Advancing our employee resource groups (ERGs) to expand reach through executive leadership, global presence, funding and aligned strategies</span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Positively impacting our customers and communities through building and strengthening external partnerships</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December 31, 2022 approximately 37.5% of our global employees were women and 27.5% of our employees in the United States identified as racially or ethnically diverse.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Attracting and Hiring</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We understand that every employee drives our success. We focus on attracting, identifying and selecting strong candidates who will be successful at Stryker and ensuring that each person we hire brings the talent, expertise and passion we need to continue to be successful.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Health and Safety</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Ensuring our employees' safety is a top priority. It is a responsibility that we share throughout the company and one that has evolved to meet the needs of our workforce. Employees' safety risks vary depending on the roles they perform, so we tailor our safety efforts accordingly.</span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2022 FORM 10-K</span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Competitive Pay and Benefits</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our compensation and benefits programs are designed to attract and retain top talent and to incentivize performance and alignment to our mission and values.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We offer market-competitive base pay and benefits to our employees in countries around the world. We regularly evaluate our compensation and benefit offerings and levels, using recognized outside consulting firms to ensure fairness and competitiveness in our offerings.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Most of our employees also have variable components to their compensation packages that reward employees based on individual, business unit and/or company-wide performance.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our proxy statement provides more detail on the competitive compensation programs we offer.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Information about our Executive Officers</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.636%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.604%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.099%"></td><td style="width:0.1%"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">As of January 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Age</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Title</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">First Became an Executive Officer</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Kevin A. Lobo</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">57</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Chair, Chief Executive Officer and President</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2011</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Yin C. Becker</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">59</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Vice President, Communications, Public Affairs and Corporate Marketing</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2016</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">William E. Berry Jr.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">57</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Vice President, Chief Accounting Officer</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2014</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Glenn S. Boehnlein</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">61</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Vice President, Chief Financial Officer</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2016</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">M. Kathryn Fink</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">53</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Vice President, Chief Human Resources Officer</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2016</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Robert S. Fletcher</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">52</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Vice President, Chief Legal Officer</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Viju S. Menon</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">55</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Group President, Global Quality and Operations</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">J. Andrew Pierce</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">49</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Group President, MedSurg and Neurotechnology</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Spencer S. Stiles</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">46</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Group President, Orthopaedics and Spine</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2021</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Each of our executive officers was elected by our Board of Directors to serve in the office indicated until the first meeting of the Board of Directors following the annual meeting of shareholders in 2023 or until a successor is chosen and qualified or until his or her resignation or removal. Each of our executive officers held the position above or served Stryker in various executive or administrative capacities for at least five years, except for Mr. Fletcher and Mr. Menon. Prior to joining Stryker in April 2019, Mr. Fletcher held various legal leadership roles with Johnson &amp; Johnson for the previous 14 years, most recently as the Worldwide Vice President, Litigation. Prior to joining Stryker in April 2018, Mr. Menon held various senior supply chain leadership roles with Verizon Communications Inc. during the previous eight years, most recently as the Chief Supply Chain Officer.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Available Information</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our main corporate website address is </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">www.stryker.com. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Copies of our filings with the United States Securities and Exchange Commission (SEC) are available free of charge on our website within the "Investors Relations" section as soon as reasonably practicable after having been electronically filed or furnished to the SEC. All SEC filings are also available at the SEC's website at </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">www.sec.gov</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div id="icec46013a0ad4608b89f97e433dd3417_16"></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.175%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;1A.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">RISK FACTORS.</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">This report contains statements that are not historical facts and are considered "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on current projections about operations, industry conditions, financial condition and liquidity. Words that </span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">identify forward-looking statements include, without limitation, words such as "may," "could," "will," "should," "possible," "plan," "predict," "forecast," "potential," "anticipate," "estimate," "expect," "project," "intend," "believe," "may impact," "on track," "goal," "strategy" and words and terms of similar substance used in connection with any discussion of future operating or financial performance, an acquisition or our businesses. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. Those statements are not guarantees and are subject to risks, uncertainties and assumptions that are difficult to predict. Therefore, actual results could differ materially and adversely from these forward-looking statements, historical experience or our present expectations. Some important factors that could cause our actual results to differ from our expectations in any forward-looking statements include the risks discussed below. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our operations and financial results are subject to various risks and uncertainties discussed below that could materially and adversely affect our business, cash flows, financial condition and results of operations. Additional risks and uncertainties not currently known to us or that we currently deem not to be material or that could apply to any company may also materially and adversely affect our business, cash flows, financial condition or results of operations. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We disclaim any intention or obligation to publicly update or revise any forward-looking statement to reflect any change in our expectations or in events, conditions or circumstances on which those expectations may be based, or that affect the likelihood that actual results will differ from those contained in the forward-looking statements.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">BUSINESS AND OPERATIONAL RISKS</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">We use a variety of raw materials, components, devices and third-party services in our global supply chains, production and distribution processes; significant shortages, price increases or unavailability of third-party services could increase our operating costs, require significant capital expenditures, or adversely impact the competitive position of our products:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Our reliance on certain suppliers to secure raw materials, components and finished devices, and on certain third-party service providers, such as sterilization service providers, exposes us to product shortages and unanticipated increases in prices, whether due to inflationary pressure, regulatory changes, litigation exposure or otherwise. For example, certain of our products contain electronic components and we have experienced, and could continue to experience, limited product availability due to the electronic components shortage in certain product lines. If the shortage persists, we may not be able to obtain electronic components from our suppliers on a timely basis, or at all, or identify any alternative suppliers to provide the electronic components we need to produce our products. In addition, several raw materials, components, finished devices and services are procured from a sole source due to the quality considerations, unique intellectual property considerations or constraints associated with regulatory requirements. If sole-source suppliers or service providers are acquired or were unable or unwilling to deliver these materials or services, we may not be able to manufacture or have available one or more products during such period of unavailability and our business could suffer. In certain cases, we may not be able to establish additional or replacement suppliers for such materials or service providers for such services in a timely or cost-effective manner, largely as a result of FDA and other regulations that require, among other things, validation of materials, components and services prior to </span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2022 FORM 10-K</span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">their use in or with our products. In addition, during 2022 the market experienced increasing inflationary pressures in part due to global supply chain disruptions, labor shortages and other impacts following the COVID-19 pandemic. We expect these inflationary pressures will continue. Inflation in the United States and in many of the countries where we conduct business has resulted in, and may continue to result in, higher interest rates and increased capital, shipping and labor costs, weakening exchange rates against the United States Dollar and other similar effects. We have experienced, and may continue to experience, inflationary increases in manufacturing costs and operating expenses, as well as negative impacts from weakening exchange rates against the United States Dollar, and we may not be able to pass these cost increases on to our customers in a timely manner, which could have a material adverse impact on our profitability and results of operations. Inflation may also cause our customers to reduce or delay orders for our products and services, which could have a material adverse impact on our sales and results of operations.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">We are subject to cost containment measures in the United States and other countries resulting in pricing pressures:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Initiatives to limit the growth of general healthcare expenses and hospital costs are ongoing in the markets in which we do business. These initiatives are sponsored by government agencies, legislative bodies and the private sector and include price regulation and competitive pricing. For example, China has implemented a volume-based procurement process designed to decrease prices for medical devices and other products. This has already impacted our joint replacement and spine businesses on a national level, and our trauma and certain neurovascular products on a provincial level, and we expect further adoption of volume-based procurement provincially or nationally in China in 2023. Pricing pressure has also increased due to continued consolidation among healthcare providers, trends toward managed care, the shift toward governments becoming the primary payers of healthcare expenses, reduction in reimbursement levels and medical procedure volumes and government laws and regulations relating to sales and promotion, reimbursement and pricing generally. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">We operate in a highly competitive industry in which competition in the development and improvement of new and existing products is significant: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The markets in which we compete are highly competitive. New business models, products and surgical procedures are introduced on an ongoing basis and our present or future products could be rendered obsolete or uneconomical by technological advances by us, as we continue to innovate to address physician and patient needs, or by our existing competitors and new market entrants. Our existing competitors and new market entrants may respond more quickly to new or emerging technologies, undertake more extensive marketing campaigns, have greater access to clinical information to support ongoing product position in the market, have greater financial, marketing and other resources or be more successful in attracting potential customers, employees and strategic partners. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">We may be unable to maintain adequate working relationships with healthcare professionals:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> We seek to maintain close working relationships with respected physicians and medical personnel in healthcare organizations, such as hospitals and universities, who assist in product research and development. We rely on these professionals to assist us in the development and improvement of proprietary products. If we are unable to maintain these relationships due to regulatory restrictions, hospital access restrictions for non-patients or for </span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">other reasons, our ability to develop, market and sell new and improved products could be adversely affected.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">We rely on indirect distribution channels and major distributors that are independent of Stryker: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In many markets we rely on indirect distribution channels to market, distribute and sell our products. These indirect channels often are the main point of contact for the healthcare professionals and healthcare organization customers who buy and use our products. Our ability to continue to market, distribute and sell our products may be at risk if the indirect channels become insolvent, choose to sell competitive products, choose to stop selling medical technology or are subject to new or additional government regulation.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">We are subject to risks associated with our extensive global operations:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> We develop, manufacture and distribute our products globally. Our global operations are subject to risks and potential costs, including changes in reimbursement, changes in regulatory requirements (such as the implementation timeline for the European Union Medical Device Regulation (MDR) enacted by the European Union in May 2017 and originally effective in May 2021), differing local product preferences and product requirements, diminished protection of intellectual property in some countries, tariffs and other trade protection measures, international trade disputes and import or export requirements, difficulty in staffing and managing foreign operations, introduction of new internal business structures and programs, political and economic instability, such as the United Kingdom's exit from the European Union (Brexit), and disruptions of transportation due to military conflicts, a global pandemic of contagious diseases like COVID-19 or otherwise, such as reduced availability of transportation, port closures, increased border controls or closures, increased transportation costs and increased security threats to our supply chain. Our business could be adversely impacted if we are unable to successfully manage these and other risks of global operations in an increasingly volatile environment.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">The ongoing war between Russia and Ukraine, and the global response to it, may adversely affect our business and results of operations: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The war between Russia and Ukraine has resulted in the implementation of sanctions by the United States and other governments against Russia and has caused significant volatility and disruptions to the global markets. It is not possible to predict the short- and long-term implications of this war, which could include but are not limited to further sanctions, economic and political instability, increases in inflation rate and energy prices, supply chain challenges and adverse effects on currency exchange rates and financial markets. In addition, the United States government reported that United States sanctions against Russia in response to the conflict could lead to an increased threat of cyberattacks against United States companies. These increased threats could pose risks to the security of our information technology systems, networks and product offerings, as well as the confidentiality, availability and integrity of our data. Further, if the war expands beyond Ukraine or further intensifies, it could have an adverse impact on our operations in Poland or other areas. We are continuing to monitor the situation in Ukraine and globally as well as assess its potential impact on our business. Although Russia does not constitute a material portion of our business, and we do not rely significantly on Russian or Ukrainian sources of supply, a significant escalation or further expansion of the war or related disruptions to the global markets could have a material adverse effect on our results of operations.</span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2022 FORM 10-K</span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">We may be unable to capitalize on previous or future acquisitions:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> In addition to internally developed products, we invest in new products and technologies through acquisitions, including our acquisition of Vocera. Such investments are inherently risky, and we cannot guarantee that any acquisition will be successful or will not have a material unfavorable impact on us. The risks include the activities required and resources allocated to integrate new businesses, diversion of management time that could adversely affect management's ability to focus on other projects, the inability to realize the expected benefits, savings or synergies from the acquisition, the loss of key personnel, litigation resulting from the acquisition and exposure to unexpected liabilities of acquired companies. In addition, we cannot be certain that the businesses we acquire will become or remain profitable.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">We could experience a failure of a key information technology system, process or site or a breach of information security, including a cybersecurity breach or failure of one or more key information technology systems, networks, processes, associated sites or service providers: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We rely extensively on information technology (IT) systems to conduct business. In addition, we rely on networks and services, including internet sites, cloud and software-as-a-service solutions, data hosting and processing facilities and tools and other hardware, software (including open-source software) and technical applications and platforms, some of which are managed, hosted, provided and/or used by third parties or their vendors, to assist in conducting our business. Numerous and evolving cybersecurity threats have posed, and will continue to pose, risks to the security of our IT systems, networks and product offerings, as well as the confidentiality, availability and integrity of our data. Some of our products and services, and information technology systems, contain or use open-source software, which poses particular risks, including potential security vulnerabilities, licensing compliance issues and quality issues. A security breach, whether of our products, of our customers&#8217; network security and systems or of third-party hosting services, could impact the use of such products and the security of information stored therein. Although we have made investments seeking to address these threats, including monitoring of networks and systems, hiring of experts, employee training and security policies for employees and third-party providers, the techniques used in these attacks change frequently and may be difficult to detect for periods of time and we may face difficulties in anticipating and implementing adequate preventative measures. When cybersecurity incidents occur, we follow our incident response protocols and address them in accordance with applicable governmental regulations and other legal requirements. Our response to these incidents and our investments to protect our information technology infrastructure and data may not shield us from significant losses and potential liability or prevent any future interruption or breach of our systems. In addition, a greater number of our employees working remotely has exposed us, and may continue to expose us, to greater risks related to cybersecurity and cyber-liability. If our IT systems are damaged or cease to function properly, the networks or service providers we rely upon fail to function properly, or we or one of our third-party providers suffer a loss or disclosure of our business or stakeholder information due to any number of causes ranging from catastrophic events or power outages to improper data handling or security breaches and our business continuity plans do not effectively address these failures on a timely basis, we may be exposed to reputational, competitive and business harm as well as litigation and regulatory action.</span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">An inability to successfully manage the implementation of our new commercial global enterprise resource planning (ERP) system could adversely affect our operations and operating results: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are in the process of implementing a new commercial global ERP system. This system will replace many of our existing operating and financial systems. The implementation is a major undertaking, both financially and from a management and personnel perspective. Any disruptions, delays or deficiencies in the design and implementation of our new ERP system could adversely affect our ability to process orders, ship products, provide services and customer support, send invoices and track payments, fulfill contractual obligations or otherwise operate our business.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">We may be unable to attract and retain key employees:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Our sales, technical and other key personnel play an integral role in the development, marketing and selling of new and existing products. If we are unable to recruit, hire, develop and retain a talented, competitive work force in our highly competitive industry, or if we are unable to plan effective succession for the future, we may not be able to meet our strategic business objectives. Ongoing inflationary pressures and other macroeconomic factors could also increase the cost of labor and harm our ability to recruit, hire and retain talented employees. In addition, if we are unable to maintain an inclusive culture that aligns our diverse workforce with our mission and values, this could adversely impact our ability to recruit, hire, develop and retain key talent. Further, the remote or hybrid work environment that has become commonplace as a result of the COVID-19 pandemic could harm our culture and/or decrease employee engagement, which could adversely impact our ability to recruit, hire, develop and retain a talented, competitive workforce.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Interruption of manufacturing operations could adversely affect our business:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> We and our suppliers have manufacturing and supply sites all over the world. However, the manufacturing of certain of our product lines is concentrated in one or more plants or geographic regions. We have principal manufacturing and distribution facilities in the United States in Arizona, California, Florida, Illinois, Indiana, Michigan, Minnesota, New Jersey, Puerto Rico, Tennessee, Texas, Utah, Virginia and Washington, and outside the United States in China, France, Germany, Ireland, Mexico, the Netherlands, Switzerland and Turkey. Damage to our facilities, to our suppliers&#8217; or service providers' facilities, or to our central distribution centers as a result of natural disasters, fires, explosions or otherwise, as well as issues in our manufacturing arising from a failure to follow specific internal protocols and procedures, compliance concerns relating to the quality systems regulation, equipment breakdown or malfunction, IT system failures or cybersecurity incidents, environmental hazard incidents or changes to environmental regulations or other factors, could adversely affect the availability of our products. In the event of an interruption in manufacturing, we may be unable to move quickly to alternate means of producing affected products to meet customer demand. In the event of a significant interruption, we may experience lengthy delays in resuming production of affected products due to the need for regulatory approvals, and we may experience loss of market share, additional expense and harm to our reputation.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Our insurance program may not be adequate to cover future losses: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We maintain third-party insurance to cover our exposure to certain property and casualty losses and are self-insured for claims and expenses related to other property and casualty losses, including product liability, intellectual property infringement and enforcement, environmental, and cybersecurity and data privacy losses. We manage a portion of our exposure to </span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2022 FORM 10-K</span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">self-insured losses through a wholly-owned captive insurance company. Insurance coverage limits provided by third-party insurers and/or our captive insurance company may not be sufficient to fully cover unanticipated losses.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">The COVID-19 pandemic has materially adversely affected, and could continue to materially adversely affect, our operations, supply chain, manufacturing, product distribution, customers and other business activities: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The global COVID-19 pandemic led to severe disruptions in the market in the United States and international economies that may continue for a prolonged duration and trigger a recession or a period of economic slowdown. In response, various governmental authorities and private enterprises implemented, and may continue to implement or reimplement, numerous measures, such as travel bans and restrictions, quarantines, shelter-in-place orders and shutdowns. A significant number of our customers, global suppliers, distributors and manufacturing facilities are located in regions that were affected by the pandemic and those operations have been, and could continue to be, materially affected by restrictive measures implemented in response to the pandemic. As a result, some of our customers, distributors and indirect sales channels have at times been unable to retain employees, distribute or use our products or provide required services. We have experienced, and could continue to experience, delays and shortages in the supply of components or materials and delays in delivering our products that may result in our inability to satisfy consumer demand for our products in a timely manner or at </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">all, which could harm our reputation, future sales and profitability. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition, the pandemic adversely impacted the ability of certain third-party suppliers, manufacturers, distributors and customers to retain key employees and ensure the continued service and availability of skilled personnel necessary to run their complex operations. To the extent management or other personnel of our third-party suppliers, manufacturers, distributors and customers are impacted again in significant numbers and are not available to perform their job duties, we could experience delays in, or the suspension of, our manufacturing operations, sales activities, research and product development activities, regulatory work streams, clinical development programs and other important commercial and corporate functions.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Moreover, we have observed an overall tightening and increasingly competitive labor market due to labor shortages caused in part by the COVID-19 pandemic and responsive measures, which has included increased wages offered by other employers and voluntary attrition of our employees and the employees of our third-party suppliers, manufacturers, distributors and customers.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The extent of the pandemic&#8217;s continuing effect on our business and industry will depend on future developments, including future resurgences and/or the spread of variants, and the successful development, distribution and acceptance of vaccines for those variants, all of which are uncertain and difficult to predict. We are not able at this time to estimate with certainty the effect of these and other unforeseen factors on our business, but the adverse impact on our business, cash flows, financial condition and results of operations has been, and could in the future be, material. A prolonged or reemerging impact of COVID-19 (or other pandemics in the future) also could heighten many of the other risks described in this report.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">We have experienced, and may continue to experience, a significant and unpredictable need to adjust our operations as market demand for certain of our products has shifted </span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">and continues to shift or as may be mandated by governmental authorities:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Some of our products are particularly sensitive to reductions in elective medical procedures. Elective medical procedures were suspended or reduced at various times since the beginning of the COVID-19 pandemic in many of the markets where our products are marketed and sold, which negatively affected our business, cash flows, financial condition and results of operations. It is not possible to predict whether elective medical procedures will again be suspended or reduced in the future and, to the extent individuals and customers are required to delay or cancel elective procedures as a result of a resurgence of the COVID-19 pandemic or otherwise, our business, cash flows, financial condition and results of operations could be negatively affected.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition, our products in certain divisions, such as Medical, have experienced, and could continue to experience, higher demand as our customers have focused on treating COVID-19 patients and preparing for future public health emergencies. Unpredictable increases in demand for certain of our products have exceeded in the past, and could exceed in the future, our capacity to meet such demand timely, which could adversely affect our customer relationships and result in negative publicity. In this regard, the accelerated development and production of products and services to address medical and other requirements could increase the risk of regulatory enforcement actions, product defects or related claims.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">LEGAL AND REGULATORY RISKS</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Current economic and political conditions make tax rules in jurisdictions subject to significant change</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">: Our future results of operations could be affected by changes in the effective tax rate as a result of changes in tax laws, regulations and judicial rulings. We are continuing to evaluate the impact of tax reform in the countries in which we operate as new guidance and regulations are published. In addition, further changes in the tax laws could arise, including as a result of the base erosion and profit shifting (BEPS) project undertaken by the Organisation for Economic Cooperation and Development (OECD). The OECD, which represents a coalition of member countries, has issued recommendations that, in some cases, would make substantial changes to numerous long-standing tax positions and principles. These contemplated changes, to the extent adopted by OECD members and/or other countries, could increase tax uncertainty and may adversely affect our provision for income taxes.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">We could be negatively impacted by future changes in the allocation of income to each of the income tax</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">jurisdictions in which we operate:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> We operate in multiple income tax jurisdictions both in the United States and internationally. Accordingly, our management must determine the appropriate allocation of income to each jurisdiction based on current interpretations of complex income tax regulations. Income tax authorities regularly perform audits of our income tax filings. Income tax audits associated with the allocation of income and other complex issues, including inventory transfer pricing and cost sharing, product royalty and foreign branch arrangements, may require an extended period to resolve and may result in significant income tax adjustments. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">The impact of United States healthcare reform legislation on our business remains uncertain: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In 2010 the Patient Protection and Affordable Care Act (ACA) was enacted. While the provisions of the ACA are intended to expand access to health insurance coverage and improve the quality of healthcare over time, other provisions of the legislation, including Medicare provisions aimed at decreasing costs, comparative effectiveness research, an </span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2022 FORM 10-K</span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">independent payment advisory board and pilot programs to evaluate alternative payment methodologies, are having a meaningful effect on the way healthcare is developed and delivered and could have a significant effect on our business. There have been ongoing litigation and congressional efforts to modify or repeal all or certain provisions of the ACA. We face uncertainties that might result from modification or repeal of any of the provisions of the ACA, including as a result of current and future executive orders and legislative actions. We cannot predict what other healthcare programs and regulations will ultimately be implemented at the federal or state level or the effect that any future legislation or regulation in the United States may have on our business.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">We are subject to extensive governmental regulation relating to the classification, manufacturing, sterilization, licensing, labeling, marketing and sale of our products:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> The classification, manufacturing, sterilization, licensing, labeling, marketing and sale of our products are subject to extensive and evolving regulations and rigorous regulatory enforcement by the FDA, state governments, European Union and other governmental authorities in the United States and internationally. The process of obtaining licenses, regulatory clearances and/or approvals to market and sell our products can be costly and time consuming and the clearances and/or approvals might not be granted timely. We have ongoing responsibilities under the laws and regulations applicable to the manufacturing of products within our facilities and those contracted by third parties that are subject to periodic inspections by the FDA, state Boards of Pharmacy and other governmental authorities to determine compliance with the quality system, medical device reporting regulations and other requirements. We incur significant costs to comply with regulations, including the MDR, the free trade agreement between the United Kingdom and the European Union that became effective January 1, 2021, and the regulatory laws established by the National Medical Products Administration in China. If we fail to comply with applicable regulatory requirements, we may be subject to a range of sanctions, including substantial fines, warning letters that require corrective action, product seizures, recalls, the suspension of product manufacturing, revocation of approvals, exclusion from future participation in government healthcare programs, substantial fines and criminal prosecution.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">We are subject to federal, state and foreign healthcare regulations, including anti-bribery, anti-corruption, anti-kickback and false claims laws, globally and could face substantial penalties if we fail to comply with such regulations and laws:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> The relationships that we, and third parties that market and/or sell our products, have with healthcare professionals, such as physicians, hospitals, healthcare organizations and others, are subject to scrutiny under various state and federal laws often referred to collectively as healthcare fraud and abuse laws. In addition, the United States and foreign government regulators have increased the enforcement of the Foreign Corrupt Practices Act (FCPA) and other anti-bribery and anti-kickback laws. We also must comply with a variety of other laws that impose extensive tracking and reporting related to all transfers of value provided to certain healthcare professionals and others. These laws and regulations are broad in scope and are subject to evolving interpretation and we have in the past been, and in the future could be, required to incur substantial costs to investigate, audit and monitor compliance or to alter our practices. Violations or alleged violations of these laws could result in litigation and we may be subject to criminal or civil penalties and sanctions, including substantial fines, imprisonment of current or former employees and exclusion from participation in governmental healthcare programs. In 2013 and 2018 we </span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">settled claims brought by the United States Securities and Exchange Commission (SEC) related to the FCPA. Pursuant to these settlements, we paid fines and penalties and retained an independent compliance consultant. We continue to implement recommendations that resulted from the independent compliance consultant&#8217;s review of our commercial practices to enhance our commercial business practices.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">We are subject to privacy, data protection and data security regulations and laws globally, and could face substantial penalties if we fail to comply with such regulations and laws: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are subject to a variety of laws and regulations globally regarding privacy, data protection, and data security, including those related to the collection, storage, handling, use, disclosure, transfer and security of personally identifiable healthcare information. For example, in the United States, privacy and security regulations under the Health Insurance Portability and Accountability Act of 1996, including the expanded requirements under the Health Information Technology for Economic and Clinical Health Act of 2009, establish comprehensive standards with respect to the use and disclosure of protected health information (PHI), by covered entities, in addition to setting standards to protect the confidentiality, integrity and security of PHI. Regulators are also imposing new data privacy and security requirements, including new and greater monetary fines for privacy violations. For example, the European Union&#8217;s General Data Protection Regulation (GDPR) established rules regarding the handling of personal data. Non-compliance with the GDPR may result in monetary penalties of up to 4% of total company revenue. Other governmental authorities around the world are imposing similar types of laws and regulations, data breach reporting and penalties for non-compliance and increasing security requirements. These laws and regulations are broad in scope and are subject to evolving interpretation and we have in the past been, and in the future could be, required to incur substantial costs to monitor compliance or to alter our practices.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">We may be adversely affected by product liability claims, unfavorable court decisions or legal settlements:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> We are exposed to potential product liability risks inherent in the design, manufacture and marketing of medical devices, many of which are implanted in the human body for long periods of time or indefinitely. We may be exposed to additional potential product liability risks related to products designed, manufactured and marketed in response to the COVID-19 pandemic, including discretionary products and products permitted under the Emergency Use Authorization granted by the FDA. We are currently defendants in a number of product liability matters, including those relating to our Rejuvenate and ABGII Modular-Neck hip stems, LFIT Anatomic CoCr V40 Femoral Heads and the product liability lawsuits and claims relating to Wright Medical Group N.V. (Wright) legacy hip products discussed in Note 7 to our Consolidated Financial Statements. These matters are subject to many uncertainties and outcomes are not predictable. Further, in November 2020 the European Parliament voted in favor of the European Representative Actions Directive (the Collective Redress Directive), which mandates a class action regime in each member state to facilitate domestic and cross-border class actions in a wide range of areas, including product liability claims with medical devices. The Collective Redress Directive will take effect in 2023 after a 24-month implementation period. The Collective Redress Directive, when implemented, could result in additional litigation risks and significant legal expenses for us. In addition, we may incur significant legal expenses for product liability claims regardless of whether we are found to be liable. </span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2022 FORM 10-K</span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Intellectual property litigation and infringement claims could cause us to incur significant expenses or prevent us from selling certain of our products: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The medical device industry is characterized by extensive intellectual property litigation and, from time to time, we are the subject of claims of infringement or misappropriation. Regardless of outcome, such claims are expensive to defend and divert management and operating personnel from other business issues. A successful claim or claims of patent or other intellectual property infringement against us could result in payment of significant monetary damages and/or royalty payments or negatively impact our ability to sell current or future products in the affected category.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Dependence on patent and other proprietary rights and failing to protect such rights or to be successful in litigation related to such rights may impact offerings in our product portfolios: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our long-term success largely depends on our ability to market technologically competitive products. If we fail to obtain or maintain adequate intellectual property protection, it could allow others to sell products that directly compete with proprietary features in our product portfolio. Also, our issued patents may be subject to claims challenging their validity and scope and raising other issues. In addition, currently pending or future patent applications may not result in issued patents.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">MARKET RISKS</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">We have exposure to exchange rate fluctuations on cross border transactions and translation of local currency results into United States Dollars:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> We report our financial results in United States Dollars and approximately 30% of our net sales are denominated in foreign currencies, including the Australian Dollar, British Pound, Canadian Dollar, Chinese Yuan, Euro and Japanese Yen. Cross border transactions with external parties and intercompany relationships result in increased exposure to foreign currency exchange effects. While we use derivative instruments to manage the impact of currency exchange, our hedging strategies may not be successful, and our unhedged exposures continue to be subject to currency fluctuations. In addition, the weakening or strengthening of the United States Dollar results in favorable or unfavorable translation effects when the results of our foreign locations are translated into United States Dollars.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Additional capital that we may require in the future may not be available to us or may only be available to us on unfavorable terms, which could negatively affect our liquidity: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our future capital requirements will depend on many factors, including operating requirements, current and future acquisitions and the need to refinance existing debt. Our ability to issue additional debt or enter into other financing arrangements on acceptable terms could be adversely affected by our debt levels, unfavorable changes in economic conditions or uncertainties that affect the capital markets. Changes in credit ratings issued by nationally recognized credit rating agencies could also adversely affect our access to and cost of financing. Higher borrowing costs or the inability to access capital markets could adversely affect our ability to support future growth and operating requirements. In addition, we have experienced, and could continue to experience, loss of sales and profits due to delayed payments or insolvency of healthcare professionals, hospitals and other customers and suppliers facing liquidity issues due to the current macroeconomic environment, type and number of conditions being treated or for other reasons. As a result, we may be compelled to take additional measures to preserve our cash flow, including through the reduction of operating expenses or suspension of dividend payments.</span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ENVIRONMENTAL, SOCIAL AND GOVERNANCE (ESG) RISKS</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">We could be negatively impacted by ESG and sustainability-related matters:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Governments, investors, customers, employees and other stakeholders are increasingly focusing on corporate ESG practices and disclosures, and expectations in this area are rapidly evolving. On occasion, we announce new initiatives, including goals, under our Corporate Responsibility framework. This framework is aligned with our areas of interest, which include environment and sustainability, social impact, diversity, equity and inclusion and supply chain management, among others. The criteria by which our ESG practices are assessed may change due to the quickly evolving landscape, which could result in greater regulatory requirements or expectations of us and cause us to undertake costly initiatives to satisfy such new criteria. Moreover, the increasing attention to corporate ESG initiatives could also result in reduced demand for our products, reduced profits and increased investigations and litigation. If we are unable to satisfy evolving criteria, investors may conclude that our policies and/or actions with respect to ESG matters are inadequate. If we fail or are perceived to have failed to achieve previously announced initiatives or goals or to accurately disclose our progress, our reputation, business, financial condition and results of operations could be adversely impacted.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Physical effects of climate change or legal, regulatory or market measures intended to address climate change could adversely affect our operations and operating results:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Risks associated with climate change are subject to increasing societal, regulatory and political focus in the United States and globally. Shifts in weather patterns caused by climate change are expected to increase the frequency, severity or duration of certain adverse weather conditions and natural disasters, such as hurricanes, tornadoes, earthquakes, wildfires, droughts, extreme temperatures or flooding, which could cause more significant business and supply chain interruptions, damage to our products and facilities as well as the infrastructure of hospitals, medical care facilities and other customers, reduced workforce availability, increased costs of raw materials and components, increased liabilities and decreased revenues than what we have experienced in the past from such events. In addition, increased public concern over climate change could result in new legal or regulatory requirements designed to mitigate the effects of climate change, which could include the adoption of more stringent environmental laws and regulations or stricter enforcement of existing laws and regulations. Such developments could result in increased compliance costs and adverse impacts on raw material sourcing, manufacturing operations and the distribution of our products, which could adversely affect our operations and operating results.</span></div><div id="icec46013a0ad4608b89f97e433dd3417_19"></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.175%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;1B.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">UNRESOLVED STAFF COMMENTS.</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">None.</span></div><div id="icec46013a0ad4608b89f97e433dd3417_22"></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.175%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;2.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PROPERTIES.</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have approximately 27 company-owned and 322 leased locations worldwide including 48 manufacturing locations. We believe that our properties are in good operating condition and adequate for the manufacture and distribution of our products. We do not anticipate difficulty in renewing existing leases as they expire or in finding alternative facilities.</span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9</span></div></td></tr></table></div></div></div><div id="icec46013a0ad4608b89f97e433dd3417_25"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2022 FORM 10-K</span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.175%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;3.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LEGAL PROCEEDINGS.</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are involved in various proceedings, legal actions and claims arising in the normal course of business, including proceedings related to product, labor and intellectual property, and the matters described in more detail in Note 7 to our Consolidated Financial Statements.</span></div><div id="icec46013a0ad4608b89f97e433dd3417_28"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.175%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;4.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">MINE SAFETY DISCLOSURES.</span></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="icec46013a0ad4608b89f97e433dd3417_31"></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PART II</span></td></tr></table></div><div id="icec46013a0ad4608b89f97e433dd3417_34"></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.175%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;5.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">MARKET FOR THE REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES.</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our common stock is traded on the New York Stock Exchange under the symbol SYK.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our Board of Directors considers payment of cash dividends at its quarterly meetings. On January&#160;31, 2023 there were 2,523 shareholders of record of our common stock.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We did not repurchase any shares in the three months ended December&#160;31, 2022 and the total dollar value of shares that could be acquired under our authorized repurchase program at December&#160;31, 2022 was $1,033. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the fourth quarter 2022 we issued 48 shares of our common stock as performance incentive awards to employees. These shares were not registered under the Securities Act of 1933 based on the conclusion that the awards were not events of sale within the meaning of Section 2(a)(3) of the Act.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following graph compares our total returns (including reinvestment of dividends) against the Standard&#160;&amp; Poor&#8217;s (S&amp;P) 500 Index and the S&amp;P 500 Health Care Index. The graph assumes $100 (not in millions) invested on December&#160;31, 2017 in our common stock and each of the indices.</span></div><div style="text-align:center"><img src="syk-20221231_g3.jpg" alt="syk-20221231_g3.jpg" style="height:300px;margin-bottom:5pt;vertical-align:text-bottom;width:348px"/></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.934%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.396%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Company / Index</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Stryker Corporation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100.00</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">102.43</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">138.62</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">163.81</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">180.56</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">167.16</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">S&amp;P 500 Index</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">95.62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">125.72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">148.85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">191.58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">156.88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">S&amp;P 500 Health Care Index</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">106.47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">128.64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">145.93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">184.07&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">180.47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10</span></div></td></tr></table></div></div></div><div id="icec46013a0ad4608b89f97e433dd3417_37"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2022 FORM 10-K</span></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.650%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;6.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">SELECTED FINANCIAL DATA.</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:53.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.105%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.244%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.105%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.244%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.251%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Statement of Earnings Data</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">18,449</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">17,108</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">14,351</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">14,884</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">13,601</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,871&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,663&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross profit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">11,578</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">10,968</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9,057</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9,696</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8,938</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research, development and engineering expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,454&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">984&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">971&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">862&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,455&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,427&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,361&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,356&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,099&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Recall charges, net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">627&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">619&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">464&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">417&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill impairment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,737&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,384&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,834&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,983&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,401&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,841</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,584</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,223</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,713</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,537</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(158)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(303)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(269)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(151)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(181)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Earnings before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,683</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,281</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,954</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,562</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,356</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">479&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,197)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,358</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,994</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,599</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,083</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,553</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net earnings per share of common stock:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.17&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.48&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Dividends declared per share of common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2.835</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2.585</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2.355</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2.135</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1.930</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet Data</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents and current marketable securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,928&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,019&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,024&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,425&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,699&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,565&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,022&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,701&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,893&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,332&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,995&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,980&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,955&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,970&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,833&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,752&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,567&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,291&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">36,884</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">34,631</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">34,330</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">30,167</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">27,229</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">810&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">675&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">646&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,048&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,479&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,991&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,090&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,859&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">16,616</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">14,877</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">13,084</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12,807</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">11,730</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash Flow Data </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net cash provided by operating activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,624</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,263</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,277</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,191</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,610</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of property, plant and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">588&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">525&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">487&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">649&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">572&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">371&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">371&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisitions, net of cash acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,563&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">339&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,222&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">802&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,451&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">627&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">619&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">464&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">417&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments of dividends</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,051&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">950&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">863&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">778&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">703&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">307&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Data</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Number of shareholders of record</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,551&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,597&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,636&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,732&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Approximate number of employees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span><br/></span></div><div style="margin-bottom:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11</span></div></td></tr></table></div></div></div><div id="icec46013a0ad4608b89f97e433dd3417_40"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2022 FORM 10-K</span></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.650%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;7.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.</span></td></tr></table></div><div id="icec46013a0ad4608b89f97e433dd3417_43"></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">About Stryker</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stryker is one of the world's leading medical technology companies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in Medical and Surgical, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside our customers around the world, Stryker impacts more than 130 million patients annually. Our goal is to achieve sales growth at the high-end of the medical technology (MedTech) industry and maintain our long-term capital allocation strategy that prioritizes: (1) Acquisitions, (2) Dividends and (3) Share repurchases.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Macroeconomic Environment</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The global economy is experiencing increased inflationary pressures in part due to global supply chain disruptions, labor shortages and other impacts of the COVID-19 pandemic and current macroeconomic environment which we anticipate will continue. Higher interest rates and capital costs, higher shipping costs, increased costs of labor and weakening foreign currency exchange rates are creating additional economic challenges. These conditions may cause our customers to decrease or delay orders for our products and services, and we expect the higher interest rates to impact demand for our capital products.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our operations have been adversely impacted by the inflationary pressures primarily related to labor, steel and transportation costs as well as the impact of purchasing electronic components at premium prices on the spot market. Sales growth in certain products has been constrained by the continuing supply chain challenges and electronic component shortages, especially impacting the capital products in our MedSurg businesses, although the supply chain constraints eased somewhat in the fourth quarter. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Russia and Ukraine Conflict</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The military conflict in Russia and Ukraine and the sanctions imposed by the United States government and other nations in response to this conflict have caused significant volatility and disruptions to the global markets. Given that we provide life-saving and life-enhancing products, we plan to continue operating in Russia provided we can safely do so. In 2022 net sales in Russia were approximately 0.3% of our revenues. Although Russia does not constitute a material portion of our business, there is uncertainty around the impact it will have on the global economy, supply chains and fuel and energy prices generally, and therefore our business.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">China Volume-Based Procurement and Import Purchase Evaluation</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The government in China has launched regional and national programs for volume-based procurement (VBP) of high-value medical consumables to reduce healthcare costs. Each VBP program has specific requirements to award contracts to the lowest bidders who are able to satisfy the quality and quantity requirements. The successful bidders may be guaranteed sales volume for certain products, while unsuccessful bidders may lose unit sales volume. We have been a winning bidder in certain national and regional VBP programs, including those for joint </span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">replacement and trauma products in 2021 and certain neurovascular products in the fourth quarter of 2022. The prices required for a successful bid have negatively impacted the commercial operations of joint replacement, trauma and certain neurovascular products in China.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We were unsuccessful in our bids in the VBP program for spine products that took place in the third quarter of 2022 and as a result we are exiting the spine business in China. To date our other businesses have not been significantly impacted, but may be in the future as a result of additional VBP programs. China has also issued national guiding standards for Import Purchase Evaluation (IPE) which has increased the purchase of locally sourced equipment in China's public hospitals and is impacting our MedSurg business in China. Our business in China represented approximately 2.4% our revenues in 2022.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Overview of 2022</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In 2022 we achieved reported net sales growth of 7.8%. Excluding the impact of acquisitions and divestitures, sales grew 9.7% in constant currency. We reported net earnings of $2,358 and net earnings per diluted share</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">of</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$6.17. Excluding the impact of certain items, we achieved adjusted net earnings</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> of $3,571 and adjusted net earnings per diluted share</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">of $9.34 representing growth of 2.8%. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We continued our capital allocation strategy by investing $2,563 in acquisitions and paying $1,051 in dividends to our shareholders. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In February 2022 we entered into a $1.5 billion term loan agreement that matures on February 22, 2025 and bears interest at a base rate based on the Term Secured Overnight Financing Rate (SOFR) plus 0.725%. In 2022 we repaid $650 of this term loan. Refer to Note 10 to our Consolidated Financial Statements for further information.</span></div><div style="margin-bottom:2pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In February 2022 we completed the acquisition of Vocera for $79.25 per share, or an aggregate purchase price of $2.6 billion, net of cash acquired ($3.0 billion including convertible notes). Vocera is a leader in the digital care coordination and communication category. Vocera is part of our Medical business within MedSurg and Neurotechnology. Goodwill attributable to the acquisition reflects the strategic benefits of expanding our presence in adjacent markets, diversifying our product portfolio, advancing innovations, and accelerating our digital aspirations. Refer to Note 6 to our Consolidated Financial Statements for further information.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In 2022 we recorded a goodwill impairment charge of $216 related to our Spine business. Refer to Note 8 to our Consolidated Financial Statements for further information.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On August 16, 2022 the Inflation Reduction Act (IRA) was enacted into law. The IRA includes a 15% corporate alternative minimum tax effective in 2023 and a 1% tax on share repurchases after December 31, 2022. We do not expect the tax-related provisions of the IRA to have a material impact on our Consolidated Financial Statements. The impact of the excise tax on share repurchases will be dependent on the extent of share repurchases made in future periods.</span></div><div id="icec46013a0ad4608b89f97e433dd3417_46"></div></div></div><div style="margin-top:15pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Refer to "Non-GAAP Financial Measures" for a discussion of non-GAAP financial measures used in this report and a reconciliation to the most directly comparable GAAP financial measure.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2022 FORM 10-K</span></div></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONSOLIDATED RESULTS OF OPERATIONS</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:34.922%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.688%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.575%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.389%"></td><td style="width:0.1%"></td></tr><tr style="height:9pt"><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent Net Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percentage Change</span></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022 vs. 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021 vs. 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">18,449</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">17,108</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14,351</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7.8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">19.2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11,578&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10,968&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9,057&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">62.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">64.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">63.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Research, development and engineering expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,454&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,235&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">984&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">25.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6,455&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6,427&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5,361&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">35.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">37.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">37.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">19.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Recall charges, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">nm</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">nm</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">627&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">619&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">31.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Goodwill impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">nm</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">nm</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(158)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(303)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(269)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(47.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">nm</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">nm</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">nm</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13.2</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(19.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net earnings</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,358</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,994</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,599</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12.8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11.7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">18.3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">24.7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net earnings per diluted share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6.17</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5.21</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4.20</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">18.4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">24.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Adjusted net earnings per diluted share</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9.34</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9.09</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7.43</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2.8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">22.3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"></td><td style="width:40.125%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.699%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.699%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.699%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.395%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.401%"></td><td style="width:0.1%"></td></tr><tr style="height:9pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Geographic and Segment Net Sales</span></div></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percentage Change</span></td></tr><tr style="height:9pt"><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022 vs. 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021 vs. 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">As Reported</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Constant<br/>Currency</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">As Reported</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Constant<br/>Currency</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Geographic:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13,638&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12,321&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10,455&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,811&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,787&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,896&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">22.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">18,449</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">17,108</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14,351</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7.8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">19.2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">18.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Segment:</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedSurg and Neurotechnology</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10,611&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9,538&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8,345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Orthopaedics and Spine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,838&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,570&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6,006&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">26.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">24.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">18,449</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">17,108</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14,351</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7.8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">19.2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">18.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.444%"><tr><td style="width:1.0%"></td><td style="width:20.687%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.486%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.486%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.486%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.905%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.905%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.905%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.905%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.905%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.905%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.905%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.905%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.905%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="48" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Supplemental Net Sales Growth Information</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Percentage Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2022 vs. 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2021 vs. 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">United States</span></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">United States</span></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">International</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">As Reported</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Constant Currency</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">As Reported</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">As Reported</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Constant Currency</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">As Reported</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Constant Currency</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">As Reported</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">As Reported</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Constant Currency</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">MedSurg and Neurotechnology:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Instruments</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,279&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,111&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,863&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Endoscopy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,763&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">32.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">29.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,031&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,607&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,524&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neurovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">973&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">22.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">19.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">24.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neuro Cranial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,376&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,214&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">972&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">24.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">32.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">28.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">277&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">25.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">29.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">48.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">40.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,611</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,538</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,345</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11.2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14.2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13.8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14.3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13.3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">18.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Orthopaedics and Spine:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Knees</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,848&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">25.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Hips</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,342&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Trauma and Extremities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,807&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,664&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,722&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">54.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">53.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">63.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">36.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">32.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Spine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,047&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">19.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">475&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">464&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(13.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(10.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(16.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">58.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">57.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,838</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,570</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,006</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3.5</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(2.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9.3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">26.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">24.8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">25.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">28.6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">24.5</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">18,449</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">17,108</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14,351</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7.8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10.7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">0.5</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11.7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">19.2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">18.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">17.9</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">22.8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">18.8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">nm - not meaningful</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div id="icec46013a0ad4608b89f97e433dd3417_49"></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Consolidated Net Sales</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Consolidated net sales increased 7.8% as reported and 11.0% in constant currency, as foreign currency exchange rates negatively impacted net sales by 3.2%. Excluding the 1.3% impact of acquisitions and divestitures, net sales in constant currency increased by 10.6% from increased unit volume partially offset by 0.9% due to lower prices. The unit volume increase was primarily due to higher shipments across all MedSurg and Neurotechnology products and most Orthopaedics and Spine products.</span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Consolidated net sales in 2021 increased 19.2% as reported and 18.1% in constant currency. Excluding the 5.5% impact of acquisitions and divestitures, net sales in constant currency increased by 13.4% from increased unit volume partially offset by 0.8% due to lower prices. The unit volume increase was primarily due to higher shipments across all product lines.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">MedSurg and Neurotechnology Net Sales</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">MedSurg and Neurotechnology net sales in 2022 increased 11.2% as reported and 14.1% in constant currency, as foreign currency exchange rates negatively impacted net sales by 2.9%. </span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2022 FORM 10-K</span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Excluding the 2.3% impact of acquisitions and divestitures, net sales in constant currency increased by 11.2% from increased unit volume and 0.6% due to higher prices. The unit volume increase was due to higher shipments across all MedSurg and Neurotechnology products. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">MedSurg and Neurotechnology net sales in 2021 increased 14.3% as reported and 13.3% in constant currency, as foreign currency exchange rates positively impacted net sales by 1.0%. Excluding the 0.2% impact of acquisitions and divestitures, net sales in constant currency increased by 13.6% from increased unit volume partially offset by 0.5% due to lower prices. The unit volume increase was due to higher shipments across all MedSurg and Neurotechnology products. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Orthopaedics and Spine Net Sales</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Orthopaedics and Spine net sales in 2022 increased 3.5% as reported and 7.0% in constant currency, as foreign currency exchange rates negatively impacted net sales by 3.5%. Net sales in constant currency increased by 9.9% from increased unit volume partially offset by 2.9% due to lower prices. The unit volume increase was primarily due to higher shipments across most Orthopaedics and Spine products.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Orthopaedics and Spine net sales in&#160;2021&#160;increased 26.0% as reported and 24.8% in constant currency, as foreign currency exchange rates positively impacted net sales by 1.2%. Excluding the 12.8% impact of acquisitions and divestitures, net sales in constant currency increased by 13.2% from increased unit volume partially offset by 1.2% due to lower prices. The unit volume increase was due to higher shipments across all Orthopaedics and Spine products. </span></div><div id="icec46013a0ad4608b89f97e433dd3417_52"></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Gross Profit</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Gross profit as a percentage of net sales decreased to 62.8% in 2022 from 64.1% in 2021. Excluding the impact of the items noted below, gross profit decreased to 63.1% from 65.9% in 2021 primarily due to increased costs from purchases of electronic components at premium prices on the spot market and other inflationary pressures, primarily related to labor, steel and transportation, as well as inefficiencies from supply chain disruptions and unfavorable product mix. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Gross profit as a percentage of net sales increased to 64.1% in 2021 from 63.1% in 2020. Excluding the impact of the items noted below, gross profit increased to 65.9% from 63.8% in 2020 primarily due to leverage from higher sales volumes and favorable product mix, partially offset by lower selling prices.</span></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.185%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.228%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.190%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent Net Sales</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reported </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11,578</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,968</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,057</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">62.8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">64.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">63.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Inventory stepped up to fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Restructuring-related and other charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medical device regulations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Adjusted </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11,649</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11,267</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,160</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">63.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">65.9</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">63.8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Research, Development and Engineering Expenses</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Research, development and engineering expenses as a percentage of net sales increased to 7.9% in 2022 from 7.2% in 2021 and 6.9% in 2020. Expenses in 2022 included the write-off of certain intangible assets. Excluding the impact of the items noted below, expenses increased to 6.7% in 2022 from 6.6% in 2021 and 6.3% in 2020. The increases reflect our continued investment in innovation and integration of recent acquisitions.</span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.185%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.228%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.190%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent Net Sales</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reported </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,454</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,235</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">984</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7.9</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7.2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6.9</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Restructuring-related and other charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medical device regulations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(137)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(102)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(79)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Adjusted </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,230</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,133</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">905</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6.7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6.6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6.3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Selling, General and Administrative Expenses </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Selling, general and administrative expenses as a percentage of net sales in 2022 decreased to 35.0% from 37.6% in 2021 and 37.4% in 2020. Both 2022 and 2021 included charges related to certain asset impairments. Refer to Note 15 to our Consolidated Financial Statements for further information. In 2022 we determined that certain commercial and regulatory milestones related to technology acquired in the purchase of Mobius Imaging and Cardan Robotics were no longer probable of being achieved and recorded $110 to reduce the fair value of contingent consideration. In addition, share-based awards for Vocera employees vested upon our acquisition in 2022 and a charge of $132 was recorded.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Excluding the impact of the items noted below, expenses decreased to 32.7% in 2022 from 33.6% in 2021 and 33.1% in 2020 which reflects our increased focus on discretionary cost control and headcount discipline to offset inflationary pressures.</span></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.185%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.228%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.190%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent Net Sales</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reported </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,455</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,427</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,361</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">35.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">37.6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">37.4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other acquisition and integration-related</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(138)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(319)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(194)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Restructuring-related and other charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(206)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(358)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(406)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Regulatory and legal matters</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Adjusted </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,035</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,752</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,755</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">32.7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">33.6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">33.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Recall Charges, Net</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Recall charges, net were ($15), $103 and $17 in 2022, 2021 and 2020. In 2022 we recorded a net benefit for recall matters related to adjusting existing reserves to reflect our best estimate of our remaining obligation for LFIT Anatomic CoCr V40 Femoral Heads voluntary recalls partially offset by charges primarily related to Wright hip products. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In 2021 charges were primarily due to the previously disclosed Rejuvenate and ABGII Modular-Neck hip stems and LFIT Anatomic CoCr V40 Femoral Heads voluntary recalls. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">Refer to Note 7 to our Consolidated Financial Statements for further information.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Amortization of Intangible Assets</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Amortization of intangible assets was $627, $619 and $472 in 2022, 2021 and 2020. Compared to 2020, the increases in 2022 and 2021 were due to the first quarter 2022 and fourth quarter 2020 acquisitions of Vocera and Wright. Refer to Notes 6 and 8 to our Consolidated Financial Statements for further information.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Goodwill Impairment</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In 2022 we recorded a goodwill impairment charge of $216 related to our Spine business. Refer to Note 8 to our Consolidated Financial Statements for further information.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Operating Income</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating income increased as a percentage of sales to 15.4% in 2022 from 15.1% in 2021. Excluding the impact of the items </span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2022 FORM 10-K</span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">noted below, operating income decreased to 23.8% of sales in 2022 from 25.6% in 2021, primarily due to inflationary pressures and unfavorable foreign exchange partially offset by cost discipline.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating income as a percentage of sales in 2021 decreased to 15.1% from 15.5% in 2020. Excluding the impact of the items noted below, operating income increased to 25.6% in 2021 from 24.4% in 2020 primarily due to leverage from higher sales volumes partially offset by disciplined spending. </span></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.185%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.228%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.190%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent Net Sales</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reported </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,841</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,584</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,223</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">15.4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">15.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">15.5</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Inventory stepped up to fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other acquisition and integration-related</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">627&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">619&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Restructuring-related and other charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">386&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">458&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Goodwill impairment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medical device regulations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Recall-related matters</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Regulatory and legal matters</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Adjusted </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,384</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,382</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,499</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">23.8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">25.6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">24.4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Other Income (Expense), Net</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other income (expense), net was ($158), ($303) and ($269) in 2022, 2021 and 2020. The decrease in net expense in 2022 was primarily due to favorable investment returns and the reversal of accrued interest of $50 related to the effective settlement of the United States federal income tax audit for years 2014 through 2018. Refer to Note 11 to our Consolidated Financial Statements for further information. The increase in net expense in 2021 compared to 2020 was primarily due to increased interest expense driven by the additional debt from the bond offerings completed in June 2020 and November 2020 related to the Wright acquisition.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our effective tax rate was 12.1%, 12.6% and 18.2% for 2022, 2021 and 2020. The effective income tax rate for 2022 decreased due to the effective settlement of the United States federal income tax audit for years 2014 through 2018 of $162 and the reversal of deferred income tax on undistributed earnings of foreign subsidiaries. In addition, the effective income tax rates for 2022, 2021 and 2020 reflect the continued lower effective income tax rates as a result of our European operations, the tax effect related to the transfers of intellectual property between tax jurisdictions, the tax effect of future remittances of the undistributed earnings of foreign subsidiaries and certain discrete tax items. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Net Earnings</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net earnings increased to $2,358 or $6.17 per diluted share from $1,994 or $5.21 per diluted share in 2021 and $1,599 or $4.20 per diluted share in 2020. Adjusted net earnings per diluted share</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> was $9.34 in 2022 compared to $9.09 in 2021 and $7.43 in 2020. </span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.185%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.228%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.190%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent Net Sales</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reported </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,358</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,994</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,599</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12.8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11.7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Inventory stepped up to fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other acquisition and integration-related</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">489&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Restructuring-related and other charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Goodwill impairment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medical device regulations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Recall-related matters</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Regulatory and legal matters</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Tax matters</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Adjusted </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,571</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,474</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,827</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">19.4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">20.3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">19.7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div id="icec46013a0ad4608b89f97e433dd3417_55"></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Non-GAAP Financial Measures</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We supplement the reporting of our financial information determined under accounting principles generally accepted in the United States (GAAP) with certain non-GAAP financial measures, including percentage sales growth in constant currency; percentage organic sales growth; adjusted gross profit; adjusted selling, general and administrative expenses; adjusted research, development and engineering expenses; adjusted operating income; adjusted other income (expense), net; adjusted effective income tax rate; adjusted net earnings; adjusted net earnings per diluted share (Diluted EPS); free cash flow; and free cash flow conversion. We believe these non-GAAP financial measures provide meaningful information to assist investors and shareholders in understanding our financial results and assessing our prospects for future performance. Management believes percentage sales growth in constant currency and the other adjusted measures described above are important indicators of our operations because they exclude items that may not be indicative of or are unrelated to our core operating results and provide a baseline for analyzing trends in our underlying businesses. Management uses these non-GAAP financial measures for reviewing the operating results of reportable business segments and analyzing potential future business trends in connection with our budget process and bases certain management incentive compensation on these non-GAAP financial measures. To measure percentage sales growth in constant currency, we remove the impact of changes in foreign currency exchange rates that affect the comparability and trend of sales. Percentage sales&#160;growth in constant currency is calculated by translating current and prior year results at the same foreign currency exchange rate. To measure percentage organic sales growth, we remove the impact of changes in foreign currency exchange rates, acquisitions and divestitures, which affect the comparability and trend of sales. Percentage organic sales growth is calculated by translating current year and prior year results at the same foreign currency exchange rates excluding the impact of acquisitions and divestitures. To measure earnings performance on a consistent and comparable basis, we exclude certain items that affect the comparability of operating results and the trend of earnings. To measure free cash flow, we adjust cash provided by operating activities by the amount of purchases of property, plant and equipment and proceeds from long-lived asset disposals and remove the impact of certain legal settlements and recall payments. To measure free cash flow </span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">15</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2022 FORM 10-K</span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">conversion we divide free cash flow by adjusted net earnings. These adjustments are irregular in timing and may not be indicative of our past and future performance. The following are examples of the types of adjustments that may be included in a period:</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10.5pt">Acquisition and integration-related costs</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. Costs related to integrating recently acquired businesses (e.g., costs associated with the termination of sales relationships, workforce reductions and other integration-related activities), changes in the fair value of contingent consideration and specific costs (e.g., inventory step-up and deal costs) related to the consummation of the acquisition process.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10.5pt">Amortization of purchased intangible assets</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. Periodic amortization expense related to purchased intangible assets. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10.5pt">Restructuring-related and other charges</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. Costs associated with the termination of sales relationships in certain countries, workforce reductions, elimination of product lines, certain long-lived and intangible asset write-offs and impairments and associated costs and other restructuring-related activities.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">4.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10.5pt">Goodwill impairment. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Charges to impair the carrying value of goodwill.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">5.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10.5pt">Medical device regulations.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Costs specific to updating our quality system, product labeling, asset write-offs and product remanufacturing to comply with the new medical device reporting regulations and other requirements of the European Union.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">6.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10.5pt">Recall-related matters</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. Our best estimate of the minimum of the range of probable loss to resolve the Rejuvenate, LFIT </span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">V40, Wright legacy hip products and other product recalls.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10.5pt">Regulatory and legal matters</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. Our best estimate of the minimum of the range of probable loss to resolve certain regulatory matters and other legal settlements. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10.5pt">Tax matters</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. Charges represent the impact of accounting for certain significant and discrete tax items.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Because non-GAAP financial measures are not standardized, it may not be possible to compare these financial measures with other companies' non-GAAP financial measures having the same or similar names. These adjusted financial measures should not be considered in isolation or as a substitute for reported sales growth, gross profit, selling, general and administrative expenses, research, development and engineering expenses, operating income, other income (expense), net, effective income tax rate, net earnings and net earnings per diluted share, the most directly comparable GAAP financial measures. These non-GAAP financial measures are an additional way of viewing aspects of our operations when viewed with our GAAP results and the reconciliations to corresponding GAAP financial measures at the end of the discussion of Consolidated Results of Operations below. We strongly encourage investors and shareholders to review our financial statements and publicly-filed reports in their entirety and not to rely on any single financial measure.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The weighted-average diluted shares outstanding used in the calculation of non-GAAP net earnings per diluted share are the same as those used in the calculation of reported net earnings per diluted share for the respective period.</span></div><div id="icec46013a0ad4608b89f97e433dd3417_58"></div></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Reconciliation of the Most Directly Comparable GAAP Financial Measure to Non-GAAP Financial Measure</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:26.299%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.132%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.582%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.059%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.271%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.271%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.441%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross Profit</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Selling, General &amp; Administrative Expenses</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Research, Development &amp; Engineering Expenses</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Operating Income</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other Income (Expense), Net</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Earnings</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Effective<br/>Tax Rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Diluted EPS</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reported</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11,578</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,455</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,454</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,841</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(158)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,358</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6.17</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisition and integration-related costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Inventory stepped-up to fair value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other acquisition and integration-related</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(138)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization of purchased intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">627&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Restructuring-related and other charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(206)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Goodwill impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medical device regulations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(137)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Recall-related matters</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Regulatory and legal matters</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Tax matters</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Adjusted</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11,649</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,035</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,230</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,384</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(233)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,571</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9.34</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:26.299%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.132%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.582%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.059%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.271%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.271%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.441%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross Profit</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Selling, General &amp; Administrative Expenses</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Research, Development &amp; Engineering Expenses</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Operating Income</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other Income (Expense), Net</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Earnings</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Effective<br/>Tax Rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Diluted EPS</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reported</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,968</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,427</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,235</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,584</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(303)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,994</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12.6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5.21</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisition and integration-related costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Inventory stepped-up to fair value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other acquisition and integration-related</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(319)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization of purchased intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">619&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">489&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Restructuring-related and other charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(358)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">386&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">345&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Goodwill impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medical device regulations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(102)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Recall-related matters</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Regulatory and legal matters</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.02)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Tax matters</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.08&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Adjusted</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11,267</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,752</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,133</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,382</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(299)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,474</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14.9</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9.09</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">16</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2022 FORM 10-K</span></div></div><div style="margin-bottom:4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:26.299%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.132%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.582%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.059%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.271%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.271%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.441%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross Profit</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Selling, General &amp; Administrative Expenses</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Research, Development &amp; Engineering Expenses</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Operating Income</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other Income (Expense), Net</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Earnings</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Effective<br/>Tax Rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Diluted EPS</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reported</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,057</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,361</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">984</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,223</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(269)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,599</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">18.2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4.20</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisition and integration-related costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Inventory stepped-up to fair value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other acquisition and integration-related</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(194)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization of purchased intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">381&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Restructuring-related and other charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(406)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">458&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">397&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.04&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Goodwill impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medical device regulations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(79)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Recall-related matters</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.03&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Regulatory and legal matters</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Tax matters</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(8.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Adjusted</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,160</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,755</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">905</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,499</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(265)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,827</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12.6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7.43</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div id="icec46013a0ad4608b89f97e433dd3417_61"></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FINANCIAL CONDITION AND LIQUIDITY</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.980%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.681%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.681%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.258%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net cash provided by (used in):</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,624&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,263&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,277&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,924)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(859)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4,701)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(749)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,365)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Effect of exchange rate changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change in cash and cash equivalents</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1,100)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1,394)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We believe our financial condition continues to be of high quality, as evidenced by our ability to generate substantial cash from operations and to readily access capital markets at competitive rates despite the current macroeconomic environment. Operating cash flow provides the primary source of cash to fund operating needs and capital expenditures. Excess operating cash is used first to fund acquisitions to complement our portfolio of businesses. Other discretionary uses include dividends and share repurchases. We supplement operating cash flow with debt to fund our activities as necessary. Our overall cash position reflects our business results and a global cash management strategy that takes into account liquidity management, economic factors and tax considerations.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Operating Activities</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash provided by operating activities was $2,624, $3,263 and $3,277 in 2022, 2021 and 2020. The decrease from 2021 was primarily due to higher costs for certain electronic components and pre-buying of critical raw materials to manage supply chain delays as well as higher accounts receivable as a result of sales occurring near the end of the year, partially offset by increased net earnings. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Investing Activities</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash used in investing activities was $2,924, $859 and $4,701 in 2022, 2021 and 2020. The increase in cash used in 2022 was primarily due to the acquisition of Vocera and investments in capital projects, partially offset by settlements of certain foreign currency forward contracts designated as net investment hedges.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Financing Activities</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash provided by (used in) financing activities was ($749), ($2,365) and ($11) in 2022, 2021 and 2020. Cash used in 2022 was primarily driven by dividend payments of $1,051 and repayments of debt, including $650 of payments on the $1,500 term loan used to fund the acquisition of Vocera. In 2021 we made payments of $1,151 on long-term debt and dividend payments of $950. In 2020 we secured a $400 term loan in November, and issued $600 of notes in November and $2,300 of notes in June, which was offset by total debt repayments of $2,297 and dividend payments of $863. There were no share repurchases in 2022, 2021 or 2020.</span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We maintain debt levels that we consider appropriate after evaluating a number of factors including cash requirements for ongoing operations, investment and financing plans (including acquisitions and share repurchase activities) and overall cost of capital. Refer to Note 10 to our Consolidated Financial Statements for further information.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"></td><td style="width:63.453%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.715%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.715%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.717%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dividends paid per common share</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.78&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.52&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total dividends paid to common shareholders</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,051&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">950&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">863&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Liquidity</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash, cash equivalents and marketable securities were $1,928 and $3,019, and our current assets exceeded current liabilities by $3,972 and $5,468 on December&#160;31, 2022 and 2021. We anticipate being able to support our short-term liquidity and operating needs from a variety of sources including cash from operations, commercial paper and existing credit lines. In October 2021 we entered into a new revolving credit agreement that replaces our previous agreement dated August 19, 2016. The primary changes were to increase the aggregate principal amount of the facility by $750 to $2,250, extend the maturity date to October 26, 2026, increase the leverage ratio to 3.75 and provide LIBOR replacement language.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We raised funds in the capital markets in the past and may continue to do so from time-to-time. We continue to have strong investment-grade short-term and long-term debt ratings that we believe should enable us to refinance our debt as needed.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our cash, cash equivalents and marketable securities held in locations outside the United States was approximately 36% and 26% on December&#160;31, 2022 and 2021.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Guarantees and Other Off-Balance Sheet Arrangements</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We do not have guarantees or other off-balance sheet financing arrangements, including variable interest entities, of a magnitude that we believe could have a material impact on our financial condition or liquidity.</span></div><div id="icec46013a0ad4608b89f97e433dd3417_64"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONTRACTUAL OBLIGATIONS AND FORWARD-LOOKING CASH REQUIREMENTS</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In 2022 we recorded a net benefit for recall matters related to adjusting existing reserves to reflect our best estimate of our remaining obligation for LFIT Anatomic CoCr V40 Femoral Heads recall matters partially offset by charges primarily related to Wright hip products recall matters. As further described in Note 7 to our Consolidated Financial Statements, our recorded product liabilities include Wright hip products, Rejuvenate and ABG II and LFIT Anatomic CoCr V40 Femoral Heads recall matters. Recorded reserves represent the minimum of the range of probable cost remaining to resolve these matters. The final outcome of these matters is dependent on many variables that </span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">17</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2022 FORM 10-K</span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">are difficult to predict. The ultimate cost to entirely resolve these matters may be materially different from the amount of the current estimates and could have a material adverse effect on our financial position, results of operations and cash flows. We are not able to reasonably estimate the future periods in which payments will be made.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As further described in Note 11 to our Consolidated Financial Statements, on December&#160;31, 2022 we had a reserve for uncertain income tax positions of $286. Due to uncertainties regarding the ultimate resolution of income tax audits, we are not able to reasonably estimate the future periods in which any income tax payments to settle these uncertain income tax positions will be made.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As further described in Note 12 to our Consolidated Financial Statements, on December&#160;31, 2022 our defined benefit pension plans were underfunded by $253, of which approximately $250 related to plans outside the United States. Due to the rules affecting tax-deductible contributions in the jurisdictions in which the plans are offered and the impact of future plan asset performance, changes in interest rates and potential changes in legislation in the United States and other foreign jurisdictions, we are not able to reasonably estimate the amounts that may be required to fund defined benefit pension plans. </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.865%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.256%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.106%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.109%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Contractual Obligations</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024 - 2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026 - 2027</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">After 2027</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total debt</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12,958&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,208&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,700&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6,300&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest payments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">290&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">524&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">397&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,982&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Unconditional purchase obligations</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,845&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,595&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Operating leases</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States Tax Cuts and Jobs Act Transition Tax</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">463&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">19,100</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,340</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,884</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,369</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,507</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div id="icec46013a0ad4608b89f97e433dd3417_67"></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CRITICAL ACCOUNTING POLICIES AND ESTIMATES</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In preparing our financial statements in accordance with generally accepted accounting principles, there are certain accounting policies, which may require substantial judgment or estimation in their application. We believe these accounting policies and the others set forth in Note 1 to our Consolidated Financial Statements are critical to understanding our results of operations and financial condition.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Actual results could differ from our estimates and assumptions, and any such differences could be material to our results of operations and financial condition. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Inventory Reserves</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We maintain reserves for excess and obsolete inventory resulting from the potential inability to sell certain products at prices in excess of current carrying costs. We make estimates regarding the future recoverability of the costs of these products and record provisions based on historical experience, expiration of sterilization dates and expected future trends. If actual product life cycles, product demand or acceptance of new product introductions are less favorable than projected by management, additional inventory write downs may be required, which could unfavorably affect future operating results.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our annual tax rate is determined based on our income, statutory tax rates and the tax impacts of items treated differently for tax purposes than for financial reporting purposes. Tax law requires certain items be included in the tax return at different times than the items are reflected in the financial statements. Some of these differences are permanent, such as expenses that are not deductible in our tax return, and some differences are temporary </span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">and reverse over time, such as depreciation expense. These temporary differences create deferred tax assets and liabilities.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deferred tax assets generally represent the tax effect of items that can be used as a tax deduction or credit in future years for which we have already recorded the tax benefit in our income statement. Deferred tax liabilities generally represent tax expense recognized in our financial statements for which payment was deferred, the tax effect of expenditures for which a deduction was taken in our tax return but has not yet been recognized in our financial statements or assets recorded at fair value in business combinations for which there was no corresponding tax basis adjustment.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Inherent in determining our annual tax rate are judgments regarding business plans, tax planning opportunities and expectations about future outcomes. Realization of certain deferred tax assets is dependent upon generating sufficient taxable income in the appropriate jurisdiction prior to the expiration of the carryforward periods. Although realization is not assured, management believes it is more likely than not that our deferred tax assets, net of valuation allowances, will be realized.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We operate in multiple jurisdictions with complex tax policy and regulatory environments. In certain of these jurisdictions, we may take tax positions that management believes are supportable but are potentially subject to successful challenge by the applicable taxing authority. These differences of interpretation with the respective governmental taxing authorities can be impacted by the local economic and fiscal environment. We evaluate our tax positions and establish liabilities in accordance with the applicable accounting guidance on uncertainty in income taxes. We review these tax uncertainties in light of changing facts and circumstances, such as the progress of tax audits, and adjust them accordingly. We have a number of audits in process in various jurisdictions. Although the resolution of these tax positions is uncertain, based on currently available information, we believe that it is more likely than not that the ultimate outcomes will not have a material adverse effect on our financial position, results of operations or cash flows.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Due to the number of estimates and assumptions inherent in calculating the various components of our tax provision, certain changes or future events, such as changes in tax legislation, geographic mix of earnings, completion of tax audits or earnings repatriation plans, could have an impact on those estimates and our effective tax rate.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Acquisitions, Goodwill and Intangibles, and Long-Lived Assets</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our financial statements include the operations of an acquired business starting from the completion of the acquisition. In addition, the assets acquired and liabilities assumed are recorded on the date of acquisition at their respective estimated fair values, with any excess of the purchase price over the estimated fair values of the net assets acquired recorded as goodwill. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Significant judgment is required in estimating the fair value of intangible assets and in assigning their respective useful lives. Accordingly, we typically obtain the assistance of third-party valuation specialists for significant items. The fair value estimates are based on available historical information and on future expectations and assumptions deemed reasonable by management but are inherently uncertain. We typically use an income method to estimate the fair value of intangible assets, which is based on forecasts of the expected future cash flows attributable to the respective assets. Significant estimates and assumptions inherent in the valuations reflect a consideration of other marketplace participants and include the amount and timing </span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">18</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2022 FORM 10-K</span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">of future cash flows (including expected growth rates and profitability), the underlying product or technology life cycles, the economic barriers to entry and the discount rate applied to the cash flows. Unanticipated market or macroeconomic events and circumstances may occur that could affect the accuracy or validity of the estimates and assumptions. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Determining the useful life of an intangible asset also requires judgment. With the exception of certain trade names, the majority of our acquired intangible assets (e.g., certain trademarks or brands, customer and distributor relationships, patents and technologies) are expected to have determinable useful lives. Our assessment as to the useful lives of these intangible assets is based on a number of factors including competitive environment, market share, trademark, brand history, underlying product life cycles, operating plans and the macroeconomic environment of the countries in which the trademarked or branded products are sold. Our estimates of the useful lives of determinable-lived intangibles are primarily based on these same factors. Determinable-lived intangible assets are amortized to expense over their estimated useful life. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In some of our acquisitions, we acquire in-process research and development (IPRD) intangible assets. For acquisitions accounted for as business combinations, IPRD is considered to be an indefinite-lived intangible asset until the research is completed (then it becomes a determinable-lived intangible asset) or determined to have no future use (then it is impaired). For asset acquisitions, IPRD is expensed immediately unless there is an alternative future use.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indefinite-lived intangible assets and goodwill are not amortized but are tested annually for impairment or whenever events or circumstances indicate such assets may be impaired. We perform our annual impairment test for goodwill as of October 31 each year. For indefinite-lived intangible assets and goodwill, we perform a qualitative assessment when it is unlikely that an asset or reporting unit is impaired. For our goodwill impairment test, we periodically corroborate our qualitative assessment with quantitative information. When necessary, we determine the fair value of our indefinite-lived intangible assets and reporting units using an income approach. The income approach calculates the present value of estimated future cash flows and requires certain assumptions and estimates be made regarding market conditions and our future profitability. Considerable management judgment is necessary to evaluate the impact of operating and macroeconomic changes and to estimate future cash flows used to measure fair value. Assumptions used in our impairment evaluations, such as forecasted growth rates and cost of capital, are consistent with internal business plans. We believe such assumptions and estimates are also comparable to those that would be used by other marketplace participants. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the fourth quarter of 2022 we determined that our Spine reporting unit&#8217;s carrying value was in excess of its estimated fair value and recognized an impairment charge of $<ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN182Ny9mcmFnOmQ0NWFiNjFmYjMyZjRjMTc4NWRhMjkwYzczOGFkYzY4L3RleHRyZWdpb246ZDQ1YWI2MWZiMzJmNGMxNzg1ZGEyOTBjNzM4YWRjNjhfNzY5NjU4MTQzMjQ2MA_c03e4d83-80f7-4923-9b6e-33741caac327">216</ix:nonFraction>. The fair value of the Spine reporting unit was determined using a discounted cash flow analysis, which is a form of the income approach. Significant inputs to the analysis included assumptions for future revenue growth, operating margin and the weighted average cost of capital. A hypothetical 1% increase in our estimate of the rate used to discount the estimated future cash flows to their present value would result in an additional impairment charge of $220. Refer to Note 8 to our Consolidated Financial Statements for further discussion and the factors that contributed to these impairment charges.</span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">For our other reporting units, we considered qualitative indicators of impairment as it was considered more likely than not that the fair values of those reporting units exceeded their respective carrying values. No impairment was identified for those reporting units in 2022. Future changes in the judgments, assumptions and estimates that are used in our impairment testing for goodwill and indefinite-lived intangible assets, including discount and tax rates and future cash flow projections, could result in significantly different estimates of the fair values. A significant reduction in the estimated fair values could result in impairment charges that could materially affect our results of operations.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We review our other long-lived assets for indicators of impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. The evaluation is performed at the lowest level of identifiable cash flows, which is at the individual asset level or the asset group level. The undiscounted cash flows expected to be generated by the related assets are estimated over their useful life based on updated projections. If the evaluation indicates that the carrying amount of the assets may not be recoverable, any potential impairment is measured based upon the fair value of the related assets or asset group as determined by an appropriate market appraisal or other valuation technique. Assets classified as held for sale, if any, are recorded at the lower of carrying amount or fair value less costs to sell. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Legal and Other Contingencies</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are involved in various ongoing proceedings, legal actions and claims arising in the normal course of business, including proceedings related to product, labor and intellectual property, and other matters that are more fully described in Note 7 to our Consolidated Financial Statements. The outcomes of these matters will generally not be known for prolonged periods of time. In certain of the legal proceedings, the claimants seek damages, as well as other compensatory and equitable relief, that could result in the payment of significant claims and settlements and/or the imposition of injunctions or other equitable relief. For legal matters for which management had sufficient information to reasonably estimate our future obligations, a liability representing management's best estimate of the probable loss, or the minimum of the range of probable losses when a best estimate within the range is not known, for the resolution of these legal matters is recorded. The estimates are based on consultation with legal counsel, previous settlement experience and settlement strategies. If actual outcomes are less favorable than those projected by management, additional expense may be incurred, which could unfavorably affect future operating results. We are currently self-insured for certain claims and expenses. The ultimate cost to us with respect to product liability claims could be materially different than the amount of the current estimates and accruals and could have a material adverse effect on our financial position, results of operations and cash flows.</span></div><div id="icec46013a0ad4608b89f97e433dd3417_70"></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NEW ACCOUNTING PRONOUNCEMENTS</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Refer to Note 1 to our Consolidated Financial Statements for further information.</span></div><div id="icec46013a0ad4608b89f97e433dd3417_73"></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.471%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:72.329%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;7A.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We sell our products globally and, as a result, our operations and financial results could be significantly affected by market risk exposure from exchange rate risk. Our operating results are primarily exposed to changes in exchange rates among the United States Dollar, Australian Dollar, British Pound, Canadian Dollar, Chinese Yuan, Euro and Japanese Yen. We develop and manufacture products in the United States, Canada, China, </span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">19</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2022 FORM 10-K</span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Costa Rica, France, Germany, India, Ireland, Mexico, Switzerland, Turkey and United Kingdom and incur costs in the applicable local currencies. This global deployment of facilities serves to partially mitigate the impact of currency exchange rate changes on our cost of sales. Refer to Notes 1, 4 and 5 to our Consolidated Financial Statements for information regarding our use of derivative instruments to mitigate these risks. A hypothetical 10% change in foreign currencies relative to the United States Dollar would change the December&#160;31, 2022 fair value of these instruments by approximately $388. </span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">20</span></div></td></tr></table></div></div></div><div id="icec46013a0ad4608b89f97e433dd3417_76"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2022 FORM 10-K</span></div></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.816%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.984%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;8.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA.</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">To the Shareholders and the Board of Directors of Stryker Corporation</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Opinion on the Financial Statements</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">We have audited the accompanying consolidated balance sheets of Stryker Corporation and subsidiaries (the Company) as of December 31, 2022 and 2021, the related consolidated statements of earnings and comprehensive income, shareholders&#8217; equity, and cash flows, for each of the three years in the period ended December 31, 2022, and the related notes and the financial statement schedule listed in the Index at Item 15(a) (collectively referred to as the &#8220;consolidated financial statements&#8220;). In our opinion, the consolidated financial statements present fairly, in all material respects, the consolidated financial position of the Company at December 31, 2022 and 2021, and the consolidated results of its operations and its cash flows for each of the three years in the period ended December 31, 2022, in conformity with U.S. generally accepted accounting principles. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of December 31, 2022, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) and our report dated February 10, 2023 expressed an unqualified opinion thereon.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Critical Audit Matters</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.316%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.484%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Uncertain Tax Positions</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Description of the Matter</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">As described in Note 11 to the consolidated financial statements, the Company operates in multiple jurisdictions with complex tax policy and regulatory environments and establishes reserves for uncertain tax positions in accordance with the accounting guidance governing uncertainty in income taxes. Assessing tax positions involves judgment including interpreting tax laws of multiple jurisdictions and assumptions relevant to the measurement of an unrecognized tax benefit, including the estimated amount of tax liability that may be incurred should the tax position not be sustained upon inspection by a tax authority. These judgments and assumptions can significantly affect the reserve for uncertain tax positions. At December 31, 2022, the Company had accrued liabilities of $286 million relating to uncertain tax positions. </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">How We Addressed the Matter in Our Audit</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">We obtained an understanding, evaluated the design and tested the operating effectiveness of controls over the Company&#8217;s accounting process for uncertain tax positions. For example, we tested controls over management&#8217;s identification of uncertain tax positions and its application of the recognition and measurement principles, including management&#8217;s review of the inputs and calculations of unrecognized income tax benefits when recorded.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Our audit procedures to test the Company&#8217;s uncertain tax positions included, among others, involvement of our tax professionals, including transfer pricing professionals. This included evaluating third-party transfer pricing studies obtained by the Company and assessing the Company&#8217;s correspondence with the relevant tax authorities. We analyzed the Company&#8217;s assumptions and data used to determine the amount of tax benefit to recognize and tested the accuracy of the calculations. Our testing also included the evaluation of the ongoing positions and consideration of changes, the recording of penalties and interest and the ultimate settlement and payment of certain tax matters. We also evaluated the adequacy of the Company&#8217;s disclosures included in Note 11 related to these tax matters.</span></div></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">21</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2022 FORM 10-K</span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.316%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.484%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Valuation of Goodwill for the Spine Reporting Unit</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Description of the Matter</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">At December 31, 2022, the Company&#8217;s goodwill was $14,880 million. As discussed in Note 1 of the consolidated financial statements, goodwill is not amortized but rather is tested for impairment at least annually at the reporting unit level. The Company&#8217;s goodwill is initially assigned to its reporting units as of the acquisition date in connection with business combinations. In connection with the Company&#8217;s annual impairment analysis, the Company recorded a goodwill impairment charge of $216 million for the year ended December 31, 2022 in the Spine reporting unit. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Auditing management&#8217;s quantitative goodwill impairment test is complex and highly judgmental due to the significant measurement uncertainty in determining the fair value of a reporting unit. In particular, the fair value estimate for the Spine reporting unit was sensitive to significant assumptions such as revenue growth, operating margins, and discount rate, which are affected by expected future market and economic conditions.  </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">How We Addressed the Matter in Our Audit</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">We obtained an understanding, evaluated the design and tested the operating effectiveness of controls over the Company&#8217;s goodwill impairment assessment process. For example, we tested controls over the Company&#8217;s forecast process as well as controls over management&#8217;s review of the significant assumptions discussed above in estimating the fair value of the Spine reporting unit.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">To test the fair value of the Company&#8217;s Spine reporting unit, our audit procedures included, among others, assessing methodologies used and testing the significant assumptions discussed above as well as the completeness and accuracy of the underlying data used by the Company. For example, we compared the significant assumptions used by management to current industry and economic trends, changes in the Company&#8217;s business model, and other relevant factors. We performed sensitivity analyses of the significant assumptions to evaluate the change in the fair value of the reporting unit resulting from changes in the assumptions. We also reviewed the reconciliation of the fair value of the reporting units to the market capitalization of the Company and evaluated the implied control premium. The evaluation of the Company&#8217;s methodology and significant assumptions was performed with the assistance of our valuation specialists. We also evaluated the adequacy of the Company&#8217;s disclosures included in Note 8 related to the impairment.</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">/s/&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="dei:AuditorName" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183Ni9mcmFnOmQ2OGU5MjdjY2E4NDRjMzk5NjRkYjRjMzNjODhiOTI2L3RleHRyZWdpb246ZDY4ZTkyN2NjYTg0NGMzOTk2NGRiNGMzM2M4OGI5MjZfMzY1MQ_19202f6e-4d31-48fe-9b7e-263667e8acbb">Ernst&#160;&amp; Young LLP</ix:nonNumeric></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have served as the Company's auditor since 1974</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="dei:AuditorLocation" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183Ni9mcmFnOmQ2OGU5MjdjY2E4NDRjMzk5NjRkYjRjMzNjODhiOTI2L3RleHRyZWdpb246ZDY4ZTkyN2NjYTg0NGMzOTk2NGRiNGMzM2M4OGI5MjZfMzY1Mg_c4ebacd7-ad01-4c90-be6b-d5dafbd62f48">Grand Rapids, Michigan</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">February&#160;10, 2023 </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">22</span></div></td></tr></table></div></div></div><div id="icec46013a0ad4608b89f97e433dd3417_79"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2022 FORM 10-K</span></div></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stryker Corporation and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF EARNINGS</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"></td><td style="width:60.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.295%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.295%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.298%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMS0xLTEtMS03MjE1MQ_b555fe4c-5fa9-46d1-863d-217fca4a23fc">18,449</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMS0zLTEtMS03MjE1MQ_443dc4dc-ff44-4add-9720-a2442753ce00">17,108</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMS01LTEtMS03MjE1MQ_f069d865-13a0-4d28-abc6-27db37b83465">14,351</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMi0xLTEtMS03MjE1MQ_259ba803-3c75-43c7-86bc-84594ace92c1">6,871</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMi0zLTEtMS03MjE1MQ_5fa923ae-b3db-42d7-b122-e567dc080084">6,140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMi01LTEtMS03MjE1MQ_ac74550b-d41f-44d1-baf2-09c0685d102e">5,294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross profit</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMy0xLTEtMS03MjE1MQ_b490513a-f969-4f4e-91ef-a5f6820a8386">11,578</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMy0zLTEtMS03MjE1MQ_51bdf7ac-1655-46df-8d86-37c60b8bde5a">10,968</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMy01LTEtMS03MjE1MQ_c417d975-fd6f-49b2-a201-3b69a60dc7b7">9,057</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research, development and engineering expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfNC0xLTEtMS03MjE1MQ_64bc1d29-af2e-4336-8e7b-014883c4dd64">1,454</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfNC0zLTEtMS03MjE1MQ_8f872cbe-a3b5-4d4c-9851-0b6aed5ca7f7">1,235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfNC01LTEtMS03MjE1MQ_a9b31509-30ab-4aff-95c6-71ceaac0ce0b">984</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfNS0xLTEtMS03MjE1MQ_83c7f965-4d19-4c1f-a56b-74cf4317a003">6,455</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfNS0zLTEtMS03MjE1MQ_23c9624c-0646-44c6-bf12-be8a49862d89">6,427</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfNS01LTEtMS03MjE1MQ_f1fc44b6-4a23-41c8-bd4b-625b6dae4a09">5,361</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Recall charges, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:ProductLiabilityAccrualPeriodExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfNi0xLTEtMS03MjE1MQ_98aee8da-f6fa-403d-bb2d-bc25c46787ba">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:ProductLiabilityAccrualPeriodExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfNi0zLTEtMS03MjE1MQ_850f513e-d46f-4b3a-ac45-782cdecdee4c">103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:ProductLiabilityAccrualPeriodExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfNi01LTEtMS03MjE1MQ_be0d72cc-0d5b-462e-9f6c-1da73b54e99b">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfNy0xLTEtMS03MjE1MQ_97e5e167-43a4-4a16-ac33-93b74a1e69d6">627</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfNy0zLTEtMS03MjE1MQ_68d13eb8-4b73-477e-8a4c-8dd493a85cfb">619</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfNy01LTEtMS03MjE1MQ_5125f134-e044-4793-ba75-dfb7ddb94f7c">472</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill impairment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfOC0xLTEtMS03NTk5MA_c03e4d83-80f7-4923-9b6e-33741caac327">216</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfOC0zLTEtMS03NjAxOQ_0930ee2b-1687-4b2a-8799-b0ed7e049750">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfOC01LTEtMS03NjAyNw_fdac06a2-fd50-4e82-b733-8152f371213a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfOC0xLTEtMS03MjE1MQ_80012d91-e90b-4deb-ab98-7c53efbdb773">8,737</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfOC0zLTEtMS03MjE1MQ_ff5a2b1e-6696-4324-8acb-9415e701f669">8,384</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfOC01LTEtMS03MjE1MQ_d9bbbba4-df5b-4739-a00c-660854710a6c">6,834</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating income</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfOS0xLTEtMS03MjE1MQ_651c8ef9-1a19-419b-aa55-927cd13f58db">2,841</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfOS0zLTEtMS03MjE1MQ_06bbc172-e21c-469d-b1a8-4352ac4fba04">2,584</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfOS01LTEtMS03MjE1MQ_ddfe70f1-c621-4e25-bfae-ec534ee48780">2,223</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMTAtMS0xLTEtNzIxNTE_4c1d742f-05d9-4f27-922d-5a0de8878983">158</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMTAtMy0xLTEtNzIxNTE_6a13d98b-17c2-4abf-8451-babc7e435178">303</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMTAtNS0xLTEtNzIxNTE_5698ed1b-0c11-489b-9e42-f90414a6f4e2">269</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Earnings before income taxes</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMTEtMS0xLTEtNzIxNTE_aa01200c-0278-49c9-a4e5-45b24b4a06a8">2,683</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMTEtMy0xLTEtNzIxNTE_4395f7a1-98ed-4e35-9071-4b57e71a9b57">2,281</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMTEtNS0xLTEtNzIxNTE_60b5d50a-da48-41b5-9251-77f05341bf39">1,954</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMTItMS0xLTEtNzIxNTE_2854ae5f-328c-4e89-a828-496d4b2bfd21">325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMTItMy0xLTEtNzIxNTE_f5408d94-1665-427d-8b7b-20061133a772">287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMTItNS0xLTEtNzIxNTE_2c07f271-544e-4aa6-b3ba-fedfe510fc18">355</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net earnings</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMTMtMS0xLTEtNzIxNTE_351a2f4f-8080-40a7-ae55-6f750ac81398">2,358</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMTMtMy0xLTEtNzIxNTE_0be39e12-0e45-4c4d-825e-69a297b933c6">1,994</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMTMtNS0xLTEtNzIxNTE_ebc15db0-2e15-49b8-a53b-3a84cd3da855">1,599</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net earnings per share of common stock:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMTYtMS0xLTEtNzIxNTE_994baef6-88d7-4a5f-b39b-2d534a242948">6.23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMTYtMy0xLTEtNzIxNTE_ab3fa1de-c844-41a1-b36c-d4cc88062afe">5.29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMTYtNS0xLTEtNzIxNTE_79442e76-af0a-47ef-9189-08bf481f55e6">4.26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMTctMS0xLTEtNzIxNTE_cd0c48ac-0c86-439a-835e-af9cacbba4a2">6.17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMTctMy0xLTEtNzIxNTE_d1a6dcde-415b-4adb-9a50-a273ea9870af">5.21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMTctNS0xLTEtNzIxNTE_520f28b6-8050-428b-b1a2-20657ef47204">4.20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-average shares outstanding (in millions):</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMjAtMS0xLTEtNzIxNTE_4ad1c9ae-5b9b-4be2-aea9-9fd5d20db9e2">378.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMjAtMy0xLTEtNzIxNTE_86ec3f75-94f9-42c1-9982-a64fff919958">377.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMjAtNS0xLTEtNzIxNTE_66421e7f-8ecb-4f76-a1f1-ad302f4e32f2">375.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of dilutive employee stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-5" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMjEtMS0xLTEtNzIxNTE_fd7edcc7-b808-400c-ae25-f3c33c2929da">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-5" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMjEtMy0xLTEtNzIxNTE_d6ead0f8-8cae-4896-84cf-9b29509e2e05">5.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-5" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMjEtNS0xLTEtNzIxNTE_bb0a7889-5385-4f53-b994-d7760cd57f20">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMjItMS0xLTEtNzIxNTE_5a3afa46-9ec0-4b30-87af-e1c9c6e3f455">382.2</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMjItMy0xLTEtNzIxNTE_73f6803f-29a4-4420-86ad-22f70e49d34c">382.3</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMjItNS0xLTEtNzIxNTE_36ea811d-b5a6-47e6-8903-f8b0a8d646b0">380.3</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Anti-dilutive shares excluded from the calculation of dilutive employee stock options were <ix:nonFraction unitRef="shares" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RleHRyZWdpb246Njg4NjE5MTgwMTA4NDk5YmIyNWRhZGE2YTJiODA2MzJfNTQ5NzU1ODE0MTgx_c87e47f7-3c7e-4073-b4ee-770a1cb6a490">4.3</ix:nonFraction> in 2022 and de minimis in all other periods.</span></div><div><span><br/></span></div><div id="icec46013a0ad4608b89f97e433dd3417_82"></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"></td><td style="width:60.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.295%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.295%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.298%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net earnings</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184Mi9mcmFnOjdjN2MwNmQ0OTQxNjQwMWQ4MTA4NTQwN2E2NGI2MWYxL3RhYmxlOjkyMjc2MmJkZmYzNzQ0MGRhZjk1ZDc3OGY3YjFkZjYwL3RhYmxlcmFuZ2U6OTIyNzYyYmRmZjM3NDQwZGFmOTVkNzc4ZjdiMWRmNjBfMS0xLTEtMS03MjE1MQ_351a2f4f-8080-40a7-ae55-6f750ac81398">2,358</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184Mi9mcmFnOjdjN2MwNmQ0OTQxNjQwMWQ4MTA4NTQwN2E2NGI2MWYxL3RhYmxlOjkyMjc2MmJkZmYzNzQ0MGRhZjk1ZDc3OGY3YjFkZjYwL3RhYmxlcmFuZ2U6OTIyNzYyYmRmZjM3NDQwZGFmOTVkNzc4ZjdiMWRmNjBfMS0zLTEtMS03MjE1MQ_0be39e12-0e45-4c4d-825e-69a297b933c6">1,994</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184Mi9mcmFnOjdjN2MwNmQ0OTQxNjQwMWQ4MTA4NTQwN2E2NGI2MWYxL3RhYmxlOjkyMjc2MmJkZmYzNzQ0MGRhZjk1ZDc3OGY3YjFkZjYwL3RhYmxlcmFuZ2U6OTIyNzYyYmRmZjM3NDQwZGFmOTVkNzc4ZjdiMWRmNjBfMS01LTEtMS03MjE1MQ_ebc15db0-2e15-49b8-a53b-3a84cd3da855">1,599</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other comprehensive income (loss), net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184Mi9mcmFnOjdjN2MwNmQ0OTQxNjQwMWQ4MTA4NTQwN2E2NGI2MWYxL3RhYmxlOjkyMjc2MmJkZmYzNzQ0MGRhZjk1ZDc3OGY3YjFkZjYwL3RhYmxlcmFuZ2U6OTIyNzYyYmRmZjM3NDQwZGFmOTVkNzc4ZjdiMWRmNjBfMy0xLTEtMS03MjE1MQ_2f11bfe6-aea6-4f15-b76d-318cb5b229f5">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184Mi9mcmFnOjdjN2MwNmQ0OTQxNjQwMWQ4MTA4NTQwN2E2NGI2MWYxL3RhYmxlOjkyMjc2MmJkZmYzNzQ0MGRhZjk1ZDc3OGY3YjFkZjYwL3RhYmxlcmFuZ2U6OTIyNzYyYmRmZjM3NDQwZGFmOTVkNzc4ZjdiMWRmNjBfMy0zLTEtMS03MjE1MQ_41cfaa5f-a70f-4d37-becf-71f8735df63e">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184Mi9mcmFnOjdjN2MwNmQ0OTQxNjQwMWQ4MTA4NTQwN2E2NGI2MWYxL3RhYmxlOjkyMjc2MmJkZmYzNzQ0MGRhZjk1ZDc3OGY3YjFkZjYwL3RhYmxlcmFuZ2U6OTIyNzYyYmRmZjM3NDQwZGFmOTVkNzc4ZjdiMWRmNjBfMy01LTEtMS03MjE1MQ_98e377e0-192f-4e26-a358-996ec21109eb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pension plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184Mi9mcmFnOjdjN2MwNmQ0OTQxNjQwMWQ4MTA4NTQwN2E2NGI2MWYxL3RhYmxlOjkyMjc2MmJkZmYzNzQ0MGRhZjk1ZDc3OGY3YjFkZjYwL3RhYmxlcmFuZ2U6OTIyNzYyYmRmZjM3NDQwZGFmOTVkNzc4ZjdiMWRmNjBfNC0xLTEtMS03MjE1MQ_01076189-dfd6-45d2-b2b5-c474d5aa144e">186</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184Mi9mcmFnOjdjN2MwNmQ0OTQxNjQwMWQ4MTA4NTQwN2E2NGI2MWYxL3RhYmxlOjkyMjc2MmJkZmYzNzQ0MGRhZjk1ZDc3OGY3YjFkZjYwL3RhYmxlcmFuZ2U6OTIyNzYyYmRmZjM3NDQwZGFmOTVkNzc4ZjdiMWRmNjBfNC0zLTEtMS03MjE1MQ_d6d94609-3031-4c2b-88c8-6f8895630749">104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184Mi9mcmFnOjdjN2MwNmQ0OTQxNjQwMWQ4MTA4NTQwN2E2NGI2MWYxL3RhYmxlOjkyMjc2MmJkZmYzNzQ0MGRhZjk1ZDc3OGY3YjFkZjYwL3RhYmxlcmFuZ2U6OTIyNzYyYmRmZjM3NDQwZGFmOTVkNzc4ZjdiMWRmNjBfNC01LTEtMS03MjE1MQ_acc1c5fa-634c-448a-ae7e-93b4be3dc327">80</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized gains (losses) on designated hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184Mi9mcmFnOjdjN2MwNmQ0OTQxNjQwMWQ4MTA4NTQwN2E2NGI2MWYxL3RhYmxlOjkyMjc2MmJkZmYzNzQ0MGRhZjk1ZDc3OGY3YjFkZjYwL3RhYmxlcmFuZ2U6OTIyNzYyYmRmZjM3NDQwZGFmOTVkNzc4ZjdiMWRmNjBfNS0xLTEtMS03MjE1MQ_facc957e-8de0-423f-a465-0967075eaa92">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184Mi9mcmFnOjdjN2MwNmQ0OTQxNjQwMWQ4MTA4NTQwN2E2NGI2MWYxL3RhYmxlOjkyMjc2MmJkZmYzNzQ0MGRhZjk1ZDc3OGY3YjFkZjYwL3RhYmxlcmFuZ2U6OTIyNzYyYmRmZjM3NDQwZGFmOTVkNzc4ZjdiMWRmNjBfNS0zLTEtMS03MjE1MQ_2cb639c9-907e-4a15-8605-a2baf3639b34">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184Mi9mcmFnOjdjN2MwNmQ0OTQxNjQwMWQ4MTA4NTQwN2E2NGI2MWYxL3RhYmxlOjkyMjc2MmJkZmYzNzQ0MGRhZjk1ZDc3OGY3YjFkZjYwL3RhYmxlcmFuZ2U6OTIyNzYyYmRmZjM3NDQwZGFmOTVkNzc4ZjdiMWRmNjBfNS01LTEtMS03MjE1MQ_bee50e43-c896-485b-b40f-553a2f1df261">57</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financial statement translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184Mi9mcmFnOjdjN2MwNmQ0OTQxNjQwMWQ4MTA4NTQwN2E2NGI2MWYxL3RhYmxlOjkyMjc2MmJkZmYzNzQ0MGRhZjk1ZDc3OGY3YjFkZjYwL3RhYmxlcmFuZ2U6OTIyNzYyYmRmZjM3NDQwZGFmOTVkNzc4ZjdiMWRmNjBfNi0xLTEtMS03MjE1MQ_858ab52f-0880-4705-a137-1ff8e9e290d5">113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184Mi9mcmFnOjdjN2MwNmQ0OTQxNjQwMWQ4MTA4NTQwN2E2NGI2MWYxL3RhYmxlOjkyMjc2MmJkZmYzNzQ0MGRhZjk1ZDc3OGY3YjFkZjYwL3RhYmxlcmFuZ2U6OTIyNzYyYmRmZjM3NDQwZGFmOTVkNzc4ZjdiMWRmNjBfNi0zLTEtMS03MjE1MQ_e0c4a17a-16b3-41ea-b500-596376321f3c">469</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184Mi9mcmFnOjdjN2MwNmQ0OTQxNjQwMWQ4MTA4NTQwN2E2NGI2MWYxL3RhYmxlOjkyMjc2MmJkZmYzNzQ0MGRhZjk1ZDc3OGY3YjFkZjYwL3RhYmxlcmFuZ2U6OTIyNzYyYmRmZjM3NDQwZGFmOTVkNzc4ZjdiMWRmNjBfNi01LTEtMS03MjE1MQ_674fd48e-777d-422f-af80-9aec52ec5b48">414</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total other comprehensive income (loss), net of tax</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184Mi9mcmFnOjdjN2MwNmQ0OTQxNjQwMWQ4MTA4NTQwN2E2NGI2MWYxL3RhYmxlOjkyMjc2MmJkZmYzNzQ0MGRhZjk1ZDc3OGY3YjFkZjYwL3RhYmxlcmFuZ2U6OTIyNzYyYmRmZjM3NDQwZGFmOTVkNzc4ZjdiMWRmNjBfNy0xLTEtMS03MjE1MQ_798bedf8-2977-47df-a246-8f9e390cb2a0">310</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184Mi9mcmFnOjdjN2MwNmQ0OTQxNjQwMWQ4MTA4NTQwN2E2NGI2MWYxL3RhYmxlOjkyMjc2MmJkZmYzNzQ0MGRhZjk1ZDc3OGY3YjFkZjYwL3RhYmxlcmFuZ2U6OTIyNzYyYmRmZjM3NDQwZGFmOTVkNzc4ZjdiMWRmNjBfNy0zLTEtMS03MjE1MQ_1919325a-e979-4b19-a953-909eee46cdd3">626</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184Mi9mcmFnOjdjN2MwNmQ0OTQxNjQwMWQ4MTA4NTQwN2E2NGI2MWYxL3RhYmxlOjkyMjc2MmJkZmYzNzQ0MGRhZjk1ZDc3OGY3YjFkZjYwL3RhYmxlcmFuZ2U6OTIyNzYyYmRmZjM3NDQwZGFmOTVkNzc4ZjdiMWRmNjBfNy01LTEtMS03MjE1MQ_cca45acc-2d33-43c1-988c-5ef9946fc489">551</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Comprehensive income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184Mi9mcmFnOjdjN2MwNmQ0OTQxNjQwMWQ4MTA4NTQwN2E2NGI2MWYxL3RhYmxlOjkyMjc2MmJkZmYzNzQ0MGRhZjk1ZDc3OGY3YjFkZjYwL3RhYmxlcmFuZ2U6OTIyNzYyYmRmZjM3NDQwZGFmOTVkNzc4ZjdiMWRmNjBfOC0xLTEtMS03MjE1MQ_b8e519a2-8ccc-4de8-9d9a-7f58d340415f">2,668</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184Mi9mcmFnOjdjN2MwNmQ0OTQxNjQwMWQ4MTA4NTQwN2E2NGI2MWYxL3RhYmxlOjkyMjc2MmJkZmYzNzQ0MGRhZjk1ZDc3OGY3YjFkZjYwL3RhYmxlcmFuZ2U6OTIyNzYyYmRmZjM3NDQwZGFmOTVkNzc4ZjdiMWRmNjBfOC0zLTEtMS03MjE1MQ_2c503df9-61df-4a3a-ad67-72c5a56476e3">2,620</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184Mi9mcmFnOjdjN2MwNmQ0OTQxNjQwMWQ4MTA4NTQwN2E2NGI2MWYxL3RhYmxlOjkyMjc2MmJkZmYzNzQ0MGRhZjk1ZDc3OGY3YjFkZjYwL3RhYmxlcmFuZ2U6OTIyNzYyYmRmZjM3NDQwZGFmOTVkNzc4ZjdiMWRmNjBfOC01LTEtMS03MjE1MQ_a98ebdaf-6d7c-4f88-83b3-b2c9595ed06a">1,048</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to Consolidated Financial Statements.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">23</span></div></td></tr></table></div></div></div><div id="icec46013a0ad4608b89f97e433dd3417_85"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2022 FORM 10-K</span></div></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stryker Corporation and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.012%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMy0xLTEtMS03MjE1MQ_ac7c6b3a-f893-4411-ac17-f85a839db211">1,844</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMy0zLTEtMS03MjE1MQ_1832490f-ae19-4564-8b91-0af2b1b82942">2,944</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfNC0xLTEtMS03MjE1MQ_ea0c8a15-63a6-439a-a074-f28352c134ff">84</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfNC0zLTEtMS03MjE1MQ_27bca679-4a9f-4dbb-9e84-e7f8e547a498">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable, less allowance of $<ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfNS0wLTEtMS03MjE1MS90ZXh0cmVnaW9uOjc5Zjk5NjczNmNlMDQzYzA5MzEyZjc4MmRlN2I4ZjI1XzQz_57373350-bdb3-49ea-a483-2b8fbc473541">154</ix:nonFraction> ($<ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfNS0wLTEtMS03MjE1MS90ZXh0cmVnaW9uOjc5Zjk5NjczNmNlMDQzYzA5MzEyZjc4MmRlN2I4ZjI1XzQ3_7cda816d-b6e4-4fb2-8034-4308e1eccd8f">167</ix:nonFraction> in 2021)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfNS0xLTEtMS03MjE1MQ_96f8b0b5-f942-42be-9703-b2e52c77afb9">3,565</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfNS0zLTEtMS03MjE1MQ_0f44641a-188e-4121-bd18-150d53ad34e7">3,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Inventories:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Materials and supplies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfNy0xLTEtMS03MjE1MQ_61266958-e093-45fb-a7b2-55c35f76d323">1,006</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfNy0zLTEtMS03MjE1MQ_c34111f8-a7c4-496e-aba2-e32395214a34">691</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfOC0xLTEtMS03MjE1MQ_d3fcc133-2c07-43c1-b1bf-01d8c9077b68">348</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfOC0zLTEtMS03MjE1MQ_c8648028-85c3-4e5b-abec-4bb3781cf5ac">264</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfOS0xLTEtMS03MjE1MQ_94e49021-2d19-41f2-8e2b-9836ee5ea0fb">2,641</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfOS0zLTEtMS03MjE1MQ_6ac36e47-e62f-491c-b48d-b7971c5b5abb">2,359</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMTAtMS0xLTEtNzIxNTE_5b37cbd8-834c-4af2-88d4-765994f5b8c5">3,995</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMTAtMy0xLTEtNzIxNTE_7b77b0c2-5c00-499a-89b3-23420ea06422">3,314</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:PrepaidExpenseCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMTEtMS0xLTEtNzIxNTE_fb470084-a0be-4120-8118-c5bdd49431d4">787</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:PrepaidExpenseCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMTEtMy0xLTEtNzIxNTE_acf1a8ee-80bb-4b79-b46d-1b77184ba633">662</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total current assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMTItMS0xLTEtNzIxNTE_8a62c189-4b85-4f51-accc-ba234d2757fa">10,275</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMTItMy0xLTEtNzIxNTE_c6907258-77cd-41cd-9c02-5fccf8a5cc17">10,017</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Property, plant and equipment:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Land, buildings and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="syk:LandBuildingsAndImprovementsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMTQtMS0xLTEtNzIxNTE_51fb4ecc-1971-4d8e-8cba-b930268aa973">1,739</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="syk:LandBuildingsAndImprovementsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMTQtMy0xLTEtNzIxNTE_c1906ebf-93d9-4688-bd74-7229a6cdb33c">1,656</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:MachineryAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMTUtMS0xLTEtNzIxNTE_59fdb635-7176-424b-9b9a-61b3dba80a4e">4,066</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:MachineryAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMTUtMy0xLTEtNzIxNTE_d0883260-be0d-48c7-875a-d3e70638d8ce">3,842</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMTYtMS0xLTEtNzIxNTE_7d58f98d-89c2-42dd-9562-41008d0d2398">5,805</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMTYtMy0xLTEtNzIxNTE_3458da59-0d07-41a4-a6e7-e12816eea31e">5,498</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less allowance for depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMTctMS0xLTEtNzIxNTE_2340c4a7-5eaa-4230-b6d0-7949cba951d5">2,835</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMTctMy0xLTEtNzIxNTE_e7bf7715-cf7f-4a39-9d5a-2a5c899a04cd">2,665</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMTgtMS0xLTEtNzIxNTE_3597c982-99cc-4dea-aea6-e04aadae891b">2,970</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMTgtMy0xLTEtNzIxNTE_14af34cb-62e3-4437-84fb-b9bc80fd8b8d">2,833</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMTktMS0xLTEtNzIxNTE_fc64257a-48a0-472a-98db-cf81b1bbbe56">14,880</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMTktMy0xLTEtNzIxNTE_6e98818c-82a1-4226-ab43-79bcdc6d23b5">12,918</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other intangibles, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMjAtMS0xLTEtNzIxNTE_54eb39c8-45b8-4341-9aa2-748af8a83411">4,885</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMjAtMy0xLTEtNzIxNTE_4d205b4d-cb6c-42fd-83d3-71c2ef79b496">4,840</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncurrent deferred income tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMjEtMS0xLTEtNzIxNTE_9d535bee-3f71-45b0-8c0b-4702a52b0520">1,410</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMjEtMy0xLTEtNzIxNTE_66897cb0-f0ca-4fc5-aee0-9434ca22e9d8">1,760</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other noncurrent assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMjItMS0xLTEtNzIxNTE_05d1f27a-b8db-44f0-a372-46fd401ad7ad">2,464</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMjItMy0xLTEtNzIxNTE_9e5e348a-afd8-48e8-abca-a2181be8ddbc">2,263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMjMtMS0xLTEtNzIxNTE_6e4c11b7-a73e-4c83-8938-e3137937342c">36,884</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMjMtMy0xLTEtNzIxNTE_117e79d5-7a46-470c-a49c-6ed38eded1a1">34,631</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities and shareholders' equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:AccountsPayableTradeCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMjctMS0xLTEtNzIxNTE_76ba9ac8-7a66-4d39-b972-b543be950c00">1,413</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:AccountsPayableTradeCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMjctMy0xLTEtNzIxNTE_e9a7a2fd-dfbc-455b-b420-71211d8da855">1,129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMjgtMS0xLTEtNzIxNTE_0bb8e9b0-d6ad-4d26-98ac-67f85b6be36e">1,149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMjgtMy0xLTEtNzIxNTE_57c577cf-02e4-4237-a51f-ca738e273eaa">1,092</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMjktMS0xLTEtNzIxNTE_905ef566-cba0-4300-a6ac-66dd8bfa217e">292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMjktMy0xLTEtNzIxNTE_96e2685e-0c2c-4a00-bdf7-f2bd7dc98006">192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:DividendsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMzAtMS0xLTEtNzIxNTE_80fd027f-c748-4c81-8199-0c7bb9d045a0">284</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:DividendsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMzAtMy0xLTEtNzIxNTE_8cc57a9c-2921-41ab-a60f-09cfa26ce44e">263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued product liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:CustomerRefundLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMzEtMS0xLTEtNzIxNTE_1dd6a40d-ae4e-4dba-a097-cf1217007814">230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:CustomerRefundLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMzEtMy0xLTEtNzIxNTE_e7fb4b3d-f52c-4a93-a80c-1019b66d01dc">401</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMzItMS0xLTEtNzIxNTE_aae6f10c-9f7d-43c7-917e-844495974068">1,744</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMzItMy0xLTEtNzIxNTE_ca3b8696-25a8-4b9b-bb22-54b27f3dd8d8">1,465</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current maturities of debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:DebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMzMtMS0xLTEtNzIxNTE_ffce4d42-47eb-4e7d-b247-cee0411af29b">1,191</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:DebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMzMtMy0xLTEtNzIxNTE_fbdf0ff2-3f1f-4e35-9c5f-fc008d102890">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total current liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMzQtMS0xLTEtNzIxNTE_6f0d66bc-b78e-495b-8d85-4787abb19bcc">6,303</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMzQtMy0xLTEtNzIxNTE_f613887d-19a9-44a4-8c3a-9ebf46eac561">4,549</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt, excluding current maturities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMzUtMS0xLTEtNzIxNTE_67abafda-dc64-4a93-ad68-1357ed45d16b">11,857</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMzUtMy0xLTEtNzIxNTE_360239c6-2639-48be-9462-bad9141d61c1">12,472</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:AccruedIncomeTaxesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMzYtMS0xLTEtNzIxNTE_ac24b42e-0eb7-4cf8-ba7f-b62e2c8abbb1">641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:AccruedIncomeTaxesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMzYtMy0xLTEtNzIxNTE_fc8e5d18-f4aa-4310-9388-14b67b56f45f">913</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other noncurrent liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMzctMS0xLTEtNzIxNTE_095a9847-a4db-487c-afd1-35108d4cc3ac">1,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMzctMy0xLTEtNzIxNTE_ee3e3c26-1257-4b5e-a327-a0a67d6c121d">1,820</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMzgtMS0xLTEtNzIxNTE_517fac13-165e-4583-8ba9-b767ce5c921d">20,268</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMzgtMy0xLTEtNzIxNTE_a9f0242f-1a86-4e08-9aa3-1e92b27cd565">19,754</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shareholders' equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfNDAtMC0xLTEtNzIxNTEvdGV4dHJlZ2lvbjo4ZGMwM2NmYzIzOTA0MDgyYjY0N2NkM2VlMGY4Njg3ZF8xOA_1b0c9bed-17af-47bc-a062-146054209b99"><ix:nonFraction unitRef="usdPerShare" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfNDAtMC0xLTEtNzIxNTEvdGV4dHJlZ2lvbjo4ZGMwM2NmYzIzOTA0MDgyYjY0N2NkM2VlMGY4Njg3ZF8xOA_40cfa560-3397-4764-939e-4a94034752a3">0.10</ix:nonFraction></ix:nonFraction> par value</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:CommonStockValueOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfNDAtMS0xLTEtNzIxNTE_5d00b83e-8058-4c62-ad23-626dfd9a8b80">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:CommonStockValueOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfNDAtMy0xLTEtNzIxNTE_2d5f1222-777d-432a-86bd-d55db4876cdc">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfNDEtMS0xLTEtNzIxNTE_53d18a3f-3500-47fa-b52a-652d825b0d99">2,034</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfNDEtMy0xLTEtNzIxNTE_bd9e8a2c-4141-488c-bae0-e4e41dbc4d39">1,890</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfNDItMS0xLTEtNzIxNTE_700d4cc4-69dd-403f-a6d6-939aff16ff41">14,765</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfNDItMy0xLTEtNzIxNTE_e1523b0c-87fb-4961-836b-d96515063751">13,480</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfNDMtMS0xLTEtNzIxNTE_1c563c7f-f45c-4f6b-8e45-65b7964f1c46">221</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfNDMtMy0xLTEtNzIxNTE_7bae69b9-29a6-4db9-8b19-1a68a9b56c52">531</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total shareholders' equity</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfNDYtMS0xLTEtNzIxNTE_985e3838-5aa1-4cd1-95b2-d942ee14248e">16,616</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfNDYtMy0xLTEtNzIxNTE_59a693d9-7524-4934-bc5d-25bf84441b40">14,877</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total liabilities &amp; shareholders' equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfNDctMS0xLTEtNzIxNTE_ddef6483-8084-4bd1-a419-1e52e3a47a36">36,884</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfNDctMy0xLTEtNzIxNTE_eb679e01-e524-49d4-b763-3d67055833a4">34,631</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to Consolidated Financial Statements.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">24</span></div></td></tr></table></div></div></div><div id="icec46013a0ad4608b89f97e433dd3417_91"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2022 FORM 10-K</span></div></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stryker Corporation and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF SHAREHOLDERS&#8217; EQUITY</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:44.727%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.684%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.684%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.684%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.684%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.684%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.689%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Common stock</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3dd203be44e24244894ceb5a74354945_I20211231" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMy0xLTEtMS03MjE1MQ_18db9f8d-878e-4a34-a62b-5d6aa0e0fc93">377.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dd203be44e24244894ceb5a74354945_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMy0yLTEtMS03MjE1MQ_d951f8b8-7dfb-44c4-a491-f5ff5af84a1c">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4006898201a7425fb94bc2294d0b0392_I20201231" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMy00LTEtMS03MjE1MQ_26e3f0ae-4548-4741-a550-080a5c42d9a7">376.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4006898201a7425fb94bc2294d0b0392_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMy01LTEtMS03MjE1MQ_f591afc5-9f07-43dc-b593-e2737f4f0c37">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i576cd39821c64afe9e29c4e4b0a645cc_I20191231" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMy03LTEtMS03MjE1MQ_f19335c2-1616-4c84-8a9c-5e1411f843bf">374.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i576cd39821c64afe9e29c4e4b0a645cc_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMy04LTEtMS03MjE1MQ_8b2b7c3b-1c81-4421-a580-bb825286d1c0">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock under stock compensation and benefit plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0b7dcd3a92534102aafd86a58bd12396_D20220101-20221231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfNC0xLTEtMS03MjE1MQ_7625c60e-660e-4982-8731-01b0742cca5d">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7dcd3a92534102aafd86a58bd12396_D20220101-20221231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfNC0yLTEtMS03MjE1MQ_70e2998e-fc73-4f65-b65e-d6b6cb6a62f9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i176c600905174175b724a109ca220959_D20210101-20211231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfNC00LTEtMS03MjE1MQ_d20f92f6-0d58-46e1-8b5d-1f994f67d295">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i176c600905174175b724a109ca220959_D20210101-20211231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfNC01LTEtMS03MjE1MQ_b4c000fc-e82b-42d4-8b38-122ed1bfdc62">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3b9d8d8eefe34b4f8f369cfda156c6e2_D20200101-20201231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfNC03LTEtMS03MjE1MQ_891286e8-aec0-4754-9725-3e808ef61421">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b9d8d8eefe34b4f8f369cfda156c6e2_D20200101-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfNC04LTEtMS03MjE1MQ_7d1af928-5a3a-4fef-baab-6cc1f2a1af59">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ending</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ida5e85091b7148e19fbf01b77d79492c_I20221231" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfNi0xLTEtMS03MjE1MQ_5e257342-816c-4122-996f-ec6f5935eca3">378.7</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida5e85091b7148e19fbf01b77d79492c_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfNi0yLTEtMS03MjE1MQ_e23c0ede-ec2f-401d-b33f-1e1100451f04">38</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3dd203be44e24244894ceb5a74354945_I20211231" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfNi00LTEtMS03MjE1MQ_9027c435-3e09-4360-bdcf-73b6d6d66f19">377.5</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dd203be44e24244894ceb5a74354945_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfNi01LTEtMS03MjE1MQ_1b64b15d-435e-4dcf-8eea-d1f5b000a6c3">38</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4006898201a7425fb94bc2294d0b0392_I20201231" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfNi03LTEtMS03MjE1MQ_e162391a-2c94-400e-841e-91d880c1d6f3">376.1</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4006898201a7425fb94bc2294d0b0392_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfNi04LTEtMS03MjE1MQ_36228421-cec5-44cb-8599-b3881c78836b">38</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Additional paid-in capital</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e9fecf68eab4b96910415c71a11f0f0_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfOC0yLTEtMS03MjE1MQ_c7247456-f6ba-485e-a94a-da501f4f93a2">1,890</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41ce397bfa0541e29e021952f1d0010a_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfOC01LTEtMS03MjE1MQ_544bff86-968e-446f-aad0-13f92a6cc110">1,741</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ba0930c6af2497b925e9c5d6155812a_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfOC04LTEtMS03MjE1MQ_15237111-5ebe-4a14-a915-471a9883e455">1,628</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock under stock compensation and benefit plans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d9e19fe61e242fd8263057ff7c25299_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfOS0yLTEtMS03MjE1MQ_6789fdc0-9ddb-4dea-9626-d0185a9daca7">24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2881079343842a19318fe837350c64d_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfOS01LTEtMS03MjE1MQ_3357acbb-1140-4498-b17d-1b71cbbe46cb">22</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i63b9f6da76294d1a9a151cff381a2952_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfOS04LTEtMS03MjE1MQ_dad1381a-0ec1-4134-9073-ee393c80ae7f">29</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d9e19fe61e242fd8263057ff7c25299_D20220101-20221231" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMTEtMi0xLTEtNzIxNTE_8e284020-b06c-4404-abfa-3bee29742e39">168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2881079343842a19318fe837350c64d_D20210101-20211231" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMTEtNS0xLTEtNzIxNTE_17602e2f-73f2-4b81-a5ea-e12b7aa1b279">171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63b9f6da76294d1a9a151cff381a2952_D20200101-20201231" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMTEtOC0xLTEtNzIxNTE_7f3fb941-f5e9-43ba-93f1-49a566480e6d">142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ending</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46dac7583cde41d8a83d606ac118cd95_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMTItMi0xLTEtNzIxNTE_75bf21a5-1a28-4365-b8be-710dd15b1aa5">2,034</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e9fecf68eab4b96910415c71a11f0f0_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMTItNS0xLTEtNzIxNTE_5d2e7149-f7e9-42e9-84b1-fb16ad47fb0e">1,890</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41ce397bfa0541e29e021952f1d0010a_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMTItOC0xLTEtNzIxNTE_fa0a12fc-11c5-4c74-8e4c-80ce7afa85dc">1,741</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retained earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec3502c9db549fea81e263b3f2c2a92_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMTQtMi0xLTEtNzIxNTE_8f6cf2f3-32a6-4776-8fff-caffd39b60a0">13,480</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94825bd2fefe45ddabf26724a368310b_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMTQtNS0xLTEtNzIxNTE_87b5df8d-0133-4fef-82a6-b8f037ddaaa7">12,462</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i795f6d2070234daa91b8880b8539c9c8_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMTQtOC0xLTEtNzIxNTE_4c5385e9-2501-4a02-a0e4-6284f15ee6b4">11,748</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c2a71ba269549d1ae308a0a70bc7f3a_D20220101-20221231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMTYtMi0xLTEtNzIxNTE_75701729-2eb0-4568-92b7-607b267131f2">2,358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9d8bd5dcacb4d8d812c9d60d5f7f768_D20210101-20211231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMTYtNS0xLTEtNzIxNTE_05eeb41b-c343-4d00-9313-080f59d5f70c">1,994</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i517940432d6242d3b90448a4cdb7932b_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMTYtOC0xLTEtNzIxNTE_268b811c-c592-47a2-864f-6a73da192d1c">1,599</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash dividends declared</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1c2a71ba269549d1ae308a0a70bc7f3a_D20220101-20221231" decimals="-6" name="us-gaap:DividendsCash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMTgtMi0xLTEtNzIxNTE_a18ce1ed-6fe5-49f3-af66-659135921cf8">1,073</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9d8bd5dcacb4d8d812c9d60d5f7f768_D20210101-20211231" decimals="-6" name="us-gaap:DividendsCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMTgtNS0xLTEtNzIxNTE_7710272e-fd50-4e02-b713-391be6590855">976</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i517940432d6242d3b90448a4cdb7932b_D20200101-20201231" decimals="-6" name="us-gaap:DividendsCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMTgtOC0xLTEtNzIxNTE_b37f6ee1-0996-4aec-80dd-67cc0ad3b204">885</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ending</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a6c70e8449a4b4ea94bebf9dff36ff6_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMTktMi0xLTEtNzIxNTE_ee53849f-1038-4259-9db0-683e371b4d06">14,765</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec3502c9db549fea81e263b3f2c2a92_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMTktNS0xLTEtNzIxNTE_1d0a43a5-a671-4bb3-9d8f-0344a19aaba5">13,480</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94825bd2fefe45ddabf26724a368310b_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMTktOC0xLTEtNzIxNTE_ecd075be-8c46-4619-b7ef-19fc8bcb596a">12,462</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated other comprehensive (loss) income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icad1df1351fd4afe9e2355bb6693a77d_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMjEtMi0xLTEtNzIxNTE_f241b383-84dc-4628-a65b-a4c7787d15db">531</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1895b0971f404a2dad14c28b8302a8ea_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMjEtNS0xLTEtNzIxNTE_58fb04f1-1936-4ba5-af6d-65efcd419d44">1,157</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe9a125a8f4f4a4b9275e4e42854e3f3_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMjEtOC0xLTEtNzIxNTE_b21b093e-5628-4d87-b74d-cd6a66c00c12">606</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMjItMi0xLTEtNzIxNTE_798bedf8-2977-47df-a246-8f9e390cb2a0">310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i339c16bfef17406a8c4a7d11ac15a147_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMjItNS0xLTEtNzIxNTE_5da24b91-5cd2-4212-8a33-67be27e1a32f">626</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id755d6c5467d4b40bdce4ebfa9392650_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMjItOC0xLTEtNzIxNTE_85a38c5d-89e7-42eb-a3c7-6e006b3a0914">551</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ending</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie37658dfd9f847b59178e8bc31697fd2_I20221231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMjMtMi0xLTEtNzIxNTE_35dc01b4-4d13-43c0-a9a9-b5ae5805dd1b">221</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icad1df1351fd4afe9e2355bb6693a77d_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMjMtNS0xLTEtNzIxNTE_bf1091ee-563d-4962-995d-2b9c43be20a5">531</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1895b0971f404a2dad14c28b8302a8ea_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMjMtOC0xLTEtNzIxNTE_46738cd8-9ee8-4142-b8c0-37ce3a0ab24d">1,157</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total shareholders' equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMzItMi0xLTEtNzIxNTE_e8a734e0-34ec-4dc5-b8e8-0f9960a575bb">16,616</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMzItNS0xLTEtNzIxNTE_904994ea-d3ce-4e30-8d3a-28250d4505b4">14,877</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98963cf23d234ec1ac275e66bcfd76dc_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMzItOC0xLTEtNzIxNTE_3a57b493-8af1-4374-935c-1d334ae82d4c">13,084</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to Consolidated Financial Statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">25</span></div></td></tr></table></div></div></div><div id="icec46013a0ad4608b89f97e433dd3417_94"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2022 FORM 10-K</span></div></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stryker Corporation and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:64.129%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.026%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.026%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.029%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating activities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net earnings</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMi0xLTEtMS03MjE1MQ_34d76a0a-124e-4f86-99b2-d4e67d11f50f">2,358</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMi0zLTEtMS03MjE1MQ_92a4c0c3-86ba-4c5d-b8c6-b535d49284d1">1,994</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMi01LTEtMS03MjE1MQ_a681a79f-2ec9-41bb-aa11-db42e8819313">1,599</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net earnings to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfNC0xLTEtMS03MjE1MQ_f837fa97-3a20-4ba7-8f18-6c5b8ecb7acf">371</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfNC0zLTEtMS03MjE1MQ_23aa35a6-126f-49e1-a5ab-d04d293b37d8">371</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfNC01LTEtMS03MjE1MQ_c1e00327-8059-4243-acda-43abf76e00c4">340</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfNS0xLTEtMS03MjE1MQ_e4c3a76e-050c-4e5d-8d32-4a2922c8cbca">627</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfNS0zLTEtMS03MjE1MQ_984c06f4-a24a-495f-806e-b40a39f0b29b">619</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfNS01LTEtMS03MjE1MQ_1bf7ec10-0d35-4f9b-ba15-fbbc7b52832c">472</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfNi0xLTEtMS04MDk0OQ_ff6ac74c-87b7-4633-bbe2-649e3835064a">216</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfNi0zLTEtMS04MDk0OQ_96542535-bda9-44b4-b26b-a03326863c3f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfNi01LTEtMS04MDk0OQ_c8a99f86-870d-45c6-a23d-d1f317db731b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asset impairments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="syk:AssetImpairmentsOtherThanGoodwillImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfNi0xLTEtMS03MjE1MQ_a48135e5-a33b-4992-87a7-3da4f6366bf3">54</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="syk:AssetImpairmentsOtherThanGoodwillImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfNi0zLTEtMS03MjE1MQ_c5fb4e2a-0ff7-4e65-90c3-15714c25b1b8">264</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="syk:AssetImpairmentsOtherThanGoodwillImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfNi01LTEtMS03MjE1MQ_1f40f66d-2933-4b32-9e32-c0bdf1e3cc9e">215</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfNy0xLTEtMS03MjE1MQ_4a518645-87e2-4368-b2a6-66c0c4780f1f">168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfNy0zLTEtMS03MjE1MQ_c7f67012-5fb3-4ac6-b4ec-6e64d42f6da4">171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfNy01LTEtMS03MjE1MQ_bd4d500f-f7c8-453e-b8fd-b9a1716ac138">142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Recall charges, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:ProductLiabilityAccrualPeriodExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfOC0xLTEtMS03MjE1MQ_01d3419d-e728-4345-938d-aaa5b41acc42">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:ProductLiabilityAccrualPeriodExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfOC0zLTEtMS03MjE1MQ_eee76380-5345-45da-8808-a03c5c6e6e3a">103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:ProductLiabilityAccrualPeriodExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfOC01LTEtMS03MjE1MQ_8503b70c-3f4d-469d-9edd-4cb2c99ef0de">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sale of inventory stepped up to fair value at acquisition</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="syk:SaleOfInventorySteppedUpToFairValueAtAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfOS0xLTEtMS03MjE1MQ_81530a1b-663e-4b65-9e5f-b116dfe7ccfb">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="syk:SaleOfInventorySteppedUpToFairValueAtAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfOS0zLTEtMS03MjE1MQ_dafbe0c2-c349-4a70-95f5-74331083385c">266</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="syk:SaleOfInventorySteppedUpToFairValueAtAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfOS01LTEtMS03MjE1MQ_da67dcd8-7e2b-4a66-ad1b-82265344ad26">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income tax (benefit) expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMTAtMS0xLTEtNzIxNTE_cfd7ee9f-eb44-438d-a6d0-afbb8c593e2c">58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMTAtMy0xLTEtNzIxNTE_443919a9-4784-4136-bcd4-79addae32c26">237</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMTAtNS0xLTEtNzIxNTE_ecdfaed9-a8c4-4346-b120-ae184d425c3b">48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMTItMS0xLTEtNzIxNTE_235eb6ba-d506-48b2-89cc-4ae3132505fc">579</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMTItMy0xLTEtNzIxNTE_53b751e9-4989-4d23-95b7-fd924c604995">377</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMTItNS0xLTEtNzIxNTE_594ae58f-1a02-447c-b7c8-fcd5d322266b">354</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMTMtMS0xLTEtNzIxNTE_b0b3269b-b131-4d9d-821f-f461774744ef">762</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMTMtMy0xLTEtNzIxNTE_8adecee7-07b4-4b82-9fcd-dd19755bc5b0">189</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMTMtNS0xLTEtNzIxNTE_ca5cfa8c-0ed4-443e-a233-6132b2ca3d2e">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMTQtMS0xLTEtNzIxNTE_f78fa08d-33b1-4e66-9d6e-0f9d5a81a650">290</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMTQtMy0xLTEtNzIxNTE_3de29d5b-c420-4bf7-8c8a-54007e199733">329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMTQtNS0xLTEtNzIxNTE_dfaf43a4-2c3c-4132-874f-753e407c466c">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMTUtMS0xLTEtNzIxNTE_11ac4640-2a1b-497c-b721-90b916e097d7">328</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMTUtMy0xLTEtNzIxNTE_74301246-2701-4855-a97a-3530865f75f3">315</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMTUtNS0xLTEtNzIxNTE_177efcbc-a715-4d59-82b7-b56f3c91af1f">54</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Recall-related payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" sign="-" name="syk:Changeinaccrualforrecallexpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMTYtMS0xLTEtNzIxNTE_1df7fde0-5d3c-4bb9-a6f9-11178e63f439">157</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" sign="-" name="syk:Changeinaccrualforrecallexpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMTYtMy0xLTEtNzIxNTE_8a61a9f2-d189-4d21-afa2-50a8628e7874">221</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" sign="-" name="syk:Changeinaccrualforrecallexpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMTYtNS0xLTEtNzIxNTE_6c7ea30b-f974-40b1-8e0d-a96519e19f12">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMTctMS0xLTEtNzIxNTE_bc8a626f-0149-4b75-b158-dabde09eda4e">238</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMTctMy0xLTEtNzIxNTE_e5ffd952-a7bd-4a90-8d1f-363d04b952cd">98</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMTctNS0xLTEtNzIxNTE_db5b3b7d-e7be-4484-b17f-0b6660438bb0">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMTgtMS0xLTEtNzIxNTE_a3ebccf0-671c-41dd-b7bf-d0888bb533fc">107</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMTgtMy0xLTEtNzIxNTE_e7bd7c41-c96c-4c26-b83a-3b135d4cb2b9">47</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMTgtNS0xLTEtNzIxNTE_ba746b95-13f0-4ff7-98e5-bc75942d5b62">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net cash provided by operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMTktMS0xLTEtNzIxNTE_1127a8fc-9d3f-4e03-bc41-5e31b26055c5">2,624</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMTktMy0xLTEtNzIxNTE_525e028c-7d6c-4029-8465-573502ddc614">3,263</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMTktNS0xLTEtNzIxNTE_8f27eea4-54ae-484b-9b06-f6b268881647">3,277</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisitions, net of cash acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMjEtMS0xLTEtNzIxNTE_645f0245-90c5-48e1-bd3f-6bf7816ca670">2,563</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMjEtMy0xLTEtNzIxNTE_a384c956-cc09-44cd-8737-a664024b04b1">339</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMjEtNS0xLTEtNzIxNTE_4963e75b-0b29-4b65-9e7b-5ae386b53148">4,222</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsToAcquireMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMjItMS0xLTEtNzIxNTE_ad6f5778-654f-464f-a56f-285c8f8e33ba">52</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquireMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMjItMy0xLTEtNzIxNTE_eaf8bb44-309d-4bb2-bef1-f65f64ed022e">49</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquireMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMjItNS0xLTEtNzIxNTE_c7fd2d87-f23e-4287-9c53-ea7bc4245296">54</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from sales of marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMjMtMS0xLTEtNzIxNTE_aa27b9a8-dde0-472c-b64e-ba63d52d3116">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMjMtMy0xLTEtNzIxNTE_d3edeadf-f7b0-4294-bbef-26ae22e7c7b6">55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMjMtNS0xLTEtNzIxNTE_2721c736-b86f-4f9c-8850-3c79d75313a4">61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMjQtMS0xLTEtNzIxNTE_6806fea7-aaf9-42fc-9c5a-cac2094c109d">588</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMjQtMy0xLTEtNzIxNTE_7f757a88-d83d-4ca5-930a-6acc2062482a">525</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMjQtNS0xLTEtNzIxNTE_d0eb0b53-fa4a-458d-ae7a-e46820456f11">487</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from settlement of net investment hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:ProceedsFromHedgeInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMjUtMS0xLTEtNzgzODY_6672e980-96c6-422f-bd2a-b74991891d72">197</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromHedgeInvestingActivities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMjUtMy0xLTEtNzc5Mjc_4db67178-3a43-450c-a89d-43bab4790ec9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromHedgeInvestingActivities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMjUtNS0xLTEtNzc5Mjc_dbe9e6b0-b680-48af-bea0-6ec81d875c66">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other investing, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMjUtMS0xLTEtNzIxNTE_d100904a-6ff8-4b23-a9d4-3e53400f6997">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMjUtMy0xLTEtNzIxNTE_0aff94d8-f220-4239-944d-7029fa8dbec5">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMjUtNS0xLTEtNzIxNTE_2501e33e-9747-4142-97fb-fdd10ae68fac">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net cash used in investing activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMjYtMS0xLTEtNzIxNTE_a8ce523e-f883-4ebf-8666-455ba7fe0b0f">2,924</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMjYtMy0xLTEtNzIxNTE_73c80da5-fe81-4e65-9e0c-112b028e869d">859</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMjYtNS0xLTEtNzIxNTE_131b5222-775d-4327-ba99-7252d8895d61">4,701</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Financing activities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds and payments on short-term borrowings, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMjgtMS0xLTEtNzIxNTE_9dd9ea21-e759-4f22-98ee-97036d4f591d">375</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMjgtMy0xLTEtNzIxNTE_2b453f9d-9d6e-43df-ad4c-4b99a5f32357">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMjgtNS0xLTEtNzIxNTE_3feedead-b682-43b9-a4ba-af8f18ecaa24">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from issuance of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMjktMS0xLTEtNzIxNTE_7523b81d-4cb8-4862-bf32-6efb19fbfaba">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMjktMy0xLTEtNzIxNTE_391ae2ce-4ad8-4027-8e2d-d87715095e11">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMjktNS0xLTEtNzIxNTE_34582d8a-18bd-4fe8-9af3-a3f83bc8cc2b">3,292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments on long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMzAtMS0xLTEtNzIxNTE_a415ef8e-269d-40d2-b60d-f2dc6dbd739a">653</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMzAtMy0xLTEtNzIxNTE_122b2585-88d7-4929-a197-dcb5169483aa">1,151</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMzAtNS0xLTEtNzIxNTE_ebcc515b-ee0f-4cdb-8c2d-46ee5d71d6ad">2,297</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments of dividends </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsOfDividends" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMzEtMS0xLTEtNzIxNTE_08ec27a9-ccb3-4408-a714-63cc09b86efa">1,051</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMzEtMy0xLTEtNzIxNTE_30e72d2c-106c-4650-b296-76bc0b83350f">950</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMzEtNS0xLTEtNzIxNTE_e3a4686a-2fb6-4273-9cf9-7e25a972f624">863</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for taxes from withheld shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMzMtMS0xLTEtNzIxNTE_1f565360-44cf-4373-b095-ac4c03ac5c4f">122</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMzMtMy0xLTEtNzIxNTE_d842eb86-8805-44bc-b6bd-56253c17bd74">114</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMzMtNS0xLTEtNzIxNTE_7844bae7-1715-47bc-9bb3-830f33ca3c71">110</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other financing, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMzUtMS0xLTEtNzIxNTE_f51a2a1e-a184-4d78-a916-d2ca89cac19a">48</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMzUtMy0xLTEtNzIxNTE_4fe94f53-b659-4dd8-a2fa-afa780931efb">148</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMzUtNS0xLTEtNzIxNTE_6925e62e-e2d1-43e7-b1f9-b12c50b149d5">27</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net cash provided by (used in) financing activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMzYtMS0xLTEtNzIxNTE_d85a790a-a5c3-4cde-a39f-abaf7097658b">749</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMzYtMy0xLTEtNzIxNTE_65c6ca2b-54f2-4ffc-a795-8baea03ba305">2,365</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMzYtNS0xLTEtNzIxNTE_49a529d0-3c02-4ee8-aeeb-31eff175fdfe">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMzctMS0xLTEtNzIxNTE_6bf34dc8-5d5b-49be-b2b1-e8d7d4e6bd44">51</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMzctMy0xLTEtNzIxNTE_f2cf052b-9918-48ac-b605-e1a741331abb">38</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMzctNS0xLTEtNzIxNTE_e14c9af1-c471-49a4-a51c-572958ce3989">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMzgtMS0xLTEtNzIxNTE_71ae5112-bebf-4dda-b055-04e3fbf9254d">1,100</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMzgtMy0xLTEtNzIxNTE_2a5d5d07-c7cc-4dcd-8ce4-6bbdb67ba5ea">1</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMzgtNS0xLTEtNzIxNTE_642b5d2c-344c-471c-a6f1-ddea387b0c3a">1,394</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents at beginning of year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMzktMS0xLTEtNzIxNTE_540ef410-9ce7-4bd5-bbe8-cf09fb6e1712">2,944</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98963cf23d234ec1ac275e66bcfd76dc_I20201231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMzktMy0xLTEtNzIxNTE_eb9844cd-f395-4c80-831d-2e32d6fd0e86">2,943</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd06d67e889a491bb0c3d598c1a2047c_I20191231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMzktNS0xLTEtNzIxNTE_2142fb04-852f-4fb7-9621-1c1a1222f433">4,337</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash and cash equivalents at end of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfNDAtMS0xLTEtNzIxNTE_f47059a4-5685-43f9-ad2b-1ab7ff49d42b">1,844</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfNDAtMy0xLTEtNzIxNTE_f6cad0e7-f783-4f56-b394-a90ba1ec34ca">2,944</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98963cf23d234ec1ac275e66bcfd76dc_I20201231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfNDAtNS0xLTEtNzIxNTE_ccb31a23-bd02-45bc-8efa-1d59fcb662b2">2,943</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supplemental cash flow disclosure:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for income taxes, net of refunds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfNDMtMS0xLTEtNzIxNTE_8eaccb41-5199-4d1c-9661-0acda6ea6275">505</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfNDMtMy0xLTEtNzIxNTE_eb53fb6c-151c-4131-b74b-c20326189c39">622</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfNDMtNS0xLTEtNzIxNTE_2114964c-6457-4851-b69a-7f107cffba28">323</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for interest on debt</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfNDQtMS0xLTEtNzIxNTE_ac882f66-1b04-455b-be73-cc13bf7b782c">324</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfNDQtMy0xLTEtNzIxNTE_b926b9a1-5704-41d0-8807-f68ef90de63e">325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfNDQtNS0xLTEtNzIxNTE_883a2eb0-9784-40b4-991f-609c6cc62885">304</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to Consolidated Financial Statements.</span></div><div style="text-align:right"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">26</span></div></td></tr></table></div></div></div><div id="icec46013a0ad4608b89f97e433dd3417_97"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2022 FORM 10-K</span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div id="icec46013a0ad4608b89f97e433dd3417_100"></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTE 1 - <ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzIwODI0_3fbab5d3-177e-4d8b-aa0d-6f0b86b58d9d" continuedAt="i6dce43ba709f48a9a4945d6ea2a430da" escape="true">SIGNIFICANT ACCOUNTING POLICIES</ix:nonNumeric></span></div><ix:continuation id="i6dce43ba709f48a9a4945d6ea2a430da" continuedAt="ic151a5666984402b9535f51243768b80"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Nature of Operations: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:NatureOfOperations" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzIwODcy_b7e2822c-ce23-4b43-a9fc-e58f98337425" escape="true">Stryker (the "Company," "we," "us," or "our") is one of the world's leading medical technology companies and, together with its customers, is driven to make healthcare better. The Company offers innovative products and services in Medical and Surgical, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Our products include surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling, emergency medical equipment and intensive care disposable products; clinical communication and workflow solutions; neurosurgical and neurovascular devices; implants used in joint replacement and trauma surgeries; Mako Robotic-Arm Assisted technology; spinal devices; as well as other products used in a variety of medical specialties.</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Basis of Presentation and Consolidation: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzIwODUy_53a0022b-26bb-4084-b6c1-7da2a9760352" escape="true">The Consolidated Financial Statements include the Company and its subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation. We have no material interests in variable interest entities and none that require consolidation.</ix:nonNumeric> </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Use of Estimates: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzIwOTgw_0755a046-361c-42bc-98f7-7cc7bd1cfc36" escape="true">The preparation of financial statements in conformity with accounting principles generally accepted in the United States (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities on the date of the financial statements and the reported amounts of net sales and expenses in the reporting period. Actual results could differ from those estimates.</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Revenue Recognition: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:RevenueRecognitionPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzIwOTM4_9098fbf1-8537-483e-b86c-01c5875ee3a1" continuedAt="iee1292adaaef4e5f9ac413e1b4e57aeb" escape="true">Sales are recognized as the performance obligations to deliver products or services are satisfied and are recorded based on the amount of consideration we expect to receive in exchange for satisfying the performance obligations. Our sales are recognized primarily when we transfer control to the customer, which can be on the date of shipment, the date of receipt by the customer or, for most Orthopaedics products, when we have received a purchase order and appropriate notification the product has been used or implanted. Products and services are primarily transferred to customers at a point in time, with some transfers of services taking place over time.</ix:nonNumeric></span></div><ix:continuation id="iee1292adaaef4e5f9ac413e1b4e57aeb"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sales represent the amount of consideration we expect to receive from customers in exchange for transferring products and services. Net sales exclude sales, value added and other taxes we collect from customers. Other costs to obtain and fulfill contracts are generally expensed as incurred due to the short-term nature of most of our sales. We extend terms of payment to our customers based on commercially reasonable terms for the markets of our customers, while also considering their credit quality.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A provision for estimated sales returns, discounts and rebates is recognized as a reduction of sales in the same period that the sales are recognized. Our estimate of the provision for sales returns has been established based on contract terms with our customers and historical business practices and current trends. Shipping and handling costs charged to customers are included in net sales.</span></div></ix:continuation><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Cost of Sales: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:CostOfSalesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzIwODg3_c09fb818-7838-492d-8457-6244ff168e9b" continuedAt="i93cca78f1f4b46fc975e6e8ff026746a" escape="true">Cost of sales is primarily comprised of direct materials and supplies consumed in the manufacture of product, as well as manufacturing labor, depreciation expense and direct overhead expense necessary to acquire and convert the purchased materials and supplies into finished product. Cost of </ix:nonNumeric></span></div></ix:continuation></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><ix:continuation id="ic151a5666984402b9535f51243768b80" continuedAt="ibd1f40fcc29149cb82e6c91126ad9d70"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i93cca78f1f4b46fc975e6e8ff026746a">sales also includes the cost to distribute products to customers, inbound freight costs, warehousing costs and other shipping and handling activity.</ix:continuation></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Research, Development and Engineering Expenses: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzIwOTY3_34411c06-4459-425c-b848-5c861a3d4b38" escape="true">Research, development and engineering costs are charged to expense as incurred. Costs include research, development and engineering activities relating to the development of new products, improvement of existing products, technical support of products and compliance with governmental regulations for the protection of customers and patients. Costs primarily consist of salaries, wages, consulting and depreciation and maintenance of research facilities and equipment.</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Selling, General and Administrative Expenses: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzIwODkz_f6b6bd34-e297-45eb-a8c8-0411e2de55a4" escape="true">Selling, general and administrative expense is primarily comprised of selling expenses, marketing expenses, administrative and other indirect overhead costs, amortization of loaner instrumentation, depreciation and amortization expense of non-manufacturing assets and other miscellaneous operating items.</ix:nonNumeric> </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Currency Translation: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzIwODM5_618aca1d-3d31-4ada-9d1c-11b8695f14cf" escape="true">Financial statements of subsidiaries outside the United States generally are measured using the local currency as the functional currency. Adjustments to translate those statements into United States Dollars are recorded in other comprehensive income (OCI). Transactional exchange gains and losses are included in other income (expense), net.</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Cash Equivalents: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzIwODYx_58270ab3-ce8b-49b1-b47e-cccf1566b74f" escape="true">Highly liquid investments with remaining stated maturities of three months or less when purchased or other money market instruments that are redeemable upon demand are considered cash equivalents and recorded at cost.</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Marketable Securities: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:MarketableSecuritiesPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzIwODk0_614beac8-d894-4291-9e6f-1256d6fe9366" escape="true">Marketable securities consist of marketable debt securities, certificates of deposit and mutual funds. Mutual funds are acquired to offset changes in certain liabilities related to deferred compensation arrangements and are expected to be used to settle these liabilities and are recognized in other noncurrent assets. Pursuant to our investment policy, all individual marketable security investments must have a minimum credit quality of single A (Standard&#160;&amp; Poor&#8217;s and Fitch) and A2 (Moody&#8217;s Corporation) at the time of acquisition, while the overall portfolio of marketable securities must maintain a minimum average credit quality of double A (Standard&#160;&amp; Poor&#8217;s and Fitch) or Aa (Moody&#8217;s Corporation). In the event of a rating downgrade below the minimum credit quality subsequent to purchase, the marketable security investment is evaluated to determine the appropriate action to take to minimize the overall risk to our marketable security investment portfolio. Our marketable securities are classified as available-for-sale and trading securities. Investments in trading securities represent participant-directed investments of deferred employee compensation.</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Accounts Receivable: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:ReceivablesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzIwOTcy_743cbae1-c85e-4c4a-a614-ff553a4368d4" escape="true">Accounts receivable consists of trade and other miscellaneous receivables. An allowance is maintained for doubtful accounts for estimated losses in the collection of accounts receivable. Estimates are made regarding the ability of customers to make required payments based on historical credit experience, current market conditions and expected credit losses. Accounts receivable are written off when all reasonable collection efforts are exhausted.</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Inventories: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzIwODY5_1b4c2e66-a0e0-4240-b740-c8b7510d5e2b" escape="true">Inventories are stated at the lower of cost or net realizable value, with cost generally determined using the first-in, first-out (FIFO) cost method. For excess and obsolete inventory resulting from the potential inability to sell specific products at prices in excess of current carrying costs, reserves are maintained to reduce current carrying cost to net realizable value.</ix:nonNumeric></span></div></ix:continuation></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">27</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2022 FORM 10-K</span></div></div><div style="width:100.000%"><ix:continuation id="ibd1f40fcc29149cb82e6c91126ad9d70" continuedAt="i2a23ec2dadf8408d8cd66684cb25d7e5"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Financial Instruments:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:FairValueOptionTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzIwODQ0_9ee629ec-c44e-4d2e-b942-560769f5f299" continuedAt="i6882e245556340b0b2274f4c077b9530" escape="true">Our financial instruments consist of cash, cash equivalents, marketable securities, accounts receivable, other investments, accounts payable, debt and foreign currency exchange contracts. The carrying value of our financial instruments, with the exception of our senior unsecured notes, approximates fair value on December&#160;31, 2022 and 2021. Refer to Notes 3 and 10 for further details. </ix:nonNumeric></span></div><ix:continuation id="i6882e245556340b0b2274f4c077b9530"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">All marketable securities are recognized at fair value. Adjustments to the fair value of marketable securities that are classified as available-for-sale are recognized as increases or decreases, net of income taxes, within accumulated other comprehensive income (AOCI) in shareholders&#8217; equity and adjustments to the fair value of marketable securities that are classified as trading are recognized in earnings. The amortized cost of marketable debt securities is adjusted for amortization of premiums and discounts to maturity computed under the effective interest method. Such amortization and interest and realized gains and losses are included in other income (expense), net. The cost of securities sold is determined by the specific identification method.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We review declines in the fair value of our investments classified as available-for-sale to determine whether the decline in fair value is a result of credit loss or other factors. Impairments of available-for-sale marketable debt securities related to credit loss are included in earnings and impairments related to other factors are recognized within AOCI.</span></div></ix:continuation><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Derivatives:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzIwOTUw_e46ddb00-5000-4912-8ed0-97317814ae08" continuedAt="i9e3caf6f6a69459287d303c60f421039" escape="true">All derivatives are recognized at fair value and reported on a gross basis. We enter into forward currency exchange contracts to mitigate the impact of currency fluctuations on transactions denominated in nonfunctional currencies, thereby limiting our risk that would otherwise result from changes in exchange rates. The periods of the forward currency exchange contracts correspond to the periods of the exposed transactions, with realized gains and losses included in the measurement and recording of transactions denominated in the nonfunctional currencies. All forward currency exchange contracts are recorded at their fair value each period.</ix:nonNumeric></span></div><ix:continuation id="i9e3caf6f6a69459287d303c60f421039" continuedAt="i61f16f37fb514f40a7857496969c2fdd"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Forward currency exchange contracts designated as cash flow hedges are designed to hedge the variability of cash flows associated with forecasted transactions denominated in a foreign currency that will take place in the future. These nonfunctional currency exposures principally relate to forecasted intercompany sales and purchases of manufactured products and generally have maturities up to <ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:DerivativeTermOfContract" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzU0OTc1NTgzOTY3Mg_9e390694-4b05-4324-a329-723feacb1965">eighteen months</ix:nonNumeric>. Changes in value of derivatives designated as cash flow hedges are recorded in AOCI on the Consolidated Balance Sheets until earnings are affected by the variability of the underlying cash flows. At that time, the applicable amount of gain or loss from the derivative instrument that is deferred in shareholders&#8217; equity is reclassified into earnings and is included in cost of goods sold in the Consolidated Statements of Earnings. Cash flows associated with these hedges are included in cash from operations in the same category as the cash flows from the items being hedged.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Forward currency exchange contracts are used to offset our exposure to the change in value of specific foreign currency denominated assets and liabilities, primarily intercompany payables and receivables. These derivatives are not designated as hedges and, therefore, changes in the value of these forward contracts are recognized in earnings, thereby offsetting the current earnings effect of the related changes in value of foreign currency denominated assets and liabilities. The estimated fair value of our forward currency exchange contracts represents the </span></div></ix:continuation></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><ix:continuation id="i61f16f37fb514f40a7857496969c2fdd" continuedAt="i264ed0b2b4d849e3ae8dc27e86a4d3d2"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">measurement of the contracts at month-end spot rates as adjusted by current forward points. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">From time to time, we designate derivative and non-derivative financial instruments as net investment hedges of our investments in certain international subsidiaries. For derivative instruments that are designated and qualify as a net investment hedge, the effective portion of the derivative's gain or loss is recognized in OCI and reported as a component of AOCI. We have elected to use the spot method to assess effectiveness for our derivatives designated as net investment hedges. Accordingly, the change in fair value attributable to changes in the spot rate is recorded in AOCI. We exclude the spot-forward difference from the assessment of hedge effectiveness and amortize this amount separately on a straight-line basis over the term of the forward contracts. This amortization is recognized in other income (expense), net.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">From time to time, we designate forward starting interest rate derivative instruments as cash flow hedges to manage the exposure to interest rate volatility with regard to future issuance and refinancing of debt. Changes in value of derivatives designated as cash flow hedges are recorded in AOCI on the Consolidated Balance Sheets until earnings are affected by the variability of the underlying cash flows. At that time, the applicable amount of gain or loss from the derivative instrument that is deferred in shareholders&#8217; equity is reclassified into earnings and is included in interest expense within other income (expense), net in the Consolidated Statements of Earnings. </span></div></ix:continuation><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i264ed0b2b4d849e3ae8dc27e86a4d3d2">Interest rate derivative instruments designated as fair value hedges have been used in the past to manage the exposure to interest rate movements and to reduce borrowing costs by converting fixed-rate debt into floating-rate debt. Under these agreements, we agree to exchange, at specified intervals, the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional principal amount.</ix:continuation> </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Property, Plant and Equipment:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzIwODI4_d9118dfc-2d46-4130-90fd-b11158e55dd8" escape="true">Property, plant and equipment is stated at cost. Depreciation is generally computed by the straight-line method over the estimated useful lives of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzEzMjA2_7c8fdcfc-54e2-4b81-91c7-7404bca5b6f4">three</span> to <ix:nonNumeric contextRef="ia81297125f074a4291d33c550b8d6a47_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzEzMjEy_d8c99370-4373-474e-97af-5086b91d16cb">30</ix:nonNumeric> years for buildings and improvements and <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzEzMjU2_a5156acf-7357-4ad7-88ef-00f8b1876f98">three</span> to <ix:nonNumeric contextRef="ia886c987bacc41c694724a58b11edae4_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzEzMjYy_b708859d-f730-4f72-913c-b5550d5a079e">15</ix:nonNumeric> years for machinery and equipment.</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Goodwill and Other Intangible Assets:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzIwODQy_9567199b-b5c9-4d6b-8946-d536595174ab" continuedAt="i2050a4070aa9404f883f381e3c78ba41" escape="true">Goodwill represents the excess of purchase price over fair value of tangible net assets of acquired businesses at the acquisition date, after amounts allocated to other identifiable intangible assets. Factors that contribute to the recognition of goodwill include synergies that are specific to our business and not available to other market participants and are expected to increase net sales and profits; acquisition of a talented workforce; cost savings opportunities; the strategic benefit of expanding our presence in core and adjacent markets; and diversifying our product portfolio.</ix:nonNumeric></span></div><ix:continuation id="i2050a4070aa9404f883f381e3c78ba41" continuedAt="iafee05fb8dcd4046b9f7eb0f858e2338"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair values of other identifiable intangible assets acquired in a business combination are primarily determined using the income approach. Other intangible assets include, but are not limited to, developed technology, customer and distributor relationships (which reflect expected continued customer or distributor patronage) and trademarks and patents. Intangible assets with determinable useful lives are amortized on a straight-line basis over their estimated useful lives of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzE0NDEx_42bfd4f4-7388-4875-97fa-bc119a8ba2cf">four</span> to <ix:nonNumeric contextRef="idbfae01100bf43918ee77d14424aebd2_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzE0NDE3_b98354b6-5a33-47c1-bd2f-05f7a5eabea1">40</ix:nonNumeric> years. Certain acquired trade names are considered to have indefinite lives and are not amortized, but are assessed annually for potential impairment as described below.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In some of our acquisitions, we acquire in-process research and development (IPRD) intangible assets. For acquisitions accounted for as business combinations IPRD is considered to </span></div></ix:continuation></div></ix:continuation></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">28</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2022 FORM 10-K</span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><ix:continuation id="i2a23ec2dadf8408d8cd66684cb25d7e5" continuedAt="i5dd258ad35864853aac66047c87c0d3b"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="iafee05fb8dcd4046b9f7eb0f858e2338">be an indefinite-lived intangible asset until the research is completed (then it becomes a determinable-lived intangible asset) or determined to have no future use (then it is impaired). For asset acquisitions IPRD is expensed immediately unless there is an alternative future use.</ix:continuation></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Goodwill, Intangibles and Long-Lived Asset Impairment Tests:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="syk:GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzIwOTQy_6d797982-1acd-4467-b598-8485c0e97bce" continuedAt="i42da3acd309d4de485d1ce8455b4663e" escape="true">We perform our annual impairment test for goodwill as of October 31 each year. We consider qualitative indicators of the fair value of a reporting unit when it is unlikely that a reporting unit has impaired goodwill and periodically corroborate that assessment with quantitative information. In certain circumstances, we may also utilize a discounted cash flow analysis that requires certain assumptions and estimates be made regarding market conditions and our future profitability. Indefinite-lived intangible assets are also tested at least annually for impairment by comparing the individual carrying values to the fair value.</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i42da3acd309d4de485d1ce8455b4663e">We review long-lived assets for indicators of impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. The evaluation is performed at the lowest level of identifiable cash flows. Undiscounted cash flows expected to be generated by the related assets are estimated over the asset's useful life based on updated projections. If the evaluation indicates that the carrying amount of the asset may not be recoverable, any potential impairment is measured based upon the fair value of the related asset or asset group as determined by an appropriate market appraisal or other valuation technique. Assets classified as held for sale are recorded at the lower of carrying amount or fair value less costs to sell.</ix:continuation></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Share-Based Compensation:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> S<ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzIwODIx_ee9ef58e-ff93-4d9b-bd98-6e3a1a213a9b" continuedAt="if0d20d44b40f4fc5b9fbda4bb216efa0" escape="true">hare-based compensation is in the form of stock options, restricted stock units (RSUs) and performance stock units (PSUs). Stock options are granted under long-term incentive plans to certain key employees and non-employee directors at an exercise price not less than the fair market value of the underlying common stock, which is the quoted closing price of our common stock on the day prior to the date of grant. The options are granted for periods of up to <ix:nonNumeric contextRef="i708148310e2c45b79502852cc7ddd42d_D20220101-20221231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzE3MDAw_9a7f558c-81bb-4206-89ee-6fdf4581784e">10</ix:nonNumeric> years and become exercisable in varying installments.</ix:nonNumeric></span></div><ix:continuation id="if0d20d44b40f4fc5b9fbda4bb216efa0" continuedAt="i627ae2c5e01542a2be677c630a6715a9"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We grant RSUs to key employees and non-employee directors and PSUs to certain key employees under our long-term incentive plans. The fair value of RSUs is determined based on the number of shares granted and the quoted closing price of our common stock on the date of grant, adjusted for the fact that RSUs do not include anticipated dividends. RSUs generally vest in one-third increments over a <ix:nonNumeric contextRef="icb6424572e1a40e48c885f2c92dfe789_D20220101-20221231" name="syk:SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzIwODIy_8d393fce-70da-4f4f-9459-e24ce575fc0c">three-year</ix:nonNumeric> period and are settled in stock. PSUs are earned over a <ix:nonNumeric contextRef="i8117cc9161634207825ffb3719f67191_D20220101-20221231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzIwODU3_3b36a885-64c2-4f9f-888d-aadf36e4129d">three-year</ix:nonNumeric> performance cycle and vest in March of the year following the end of that performance cycle. The number of PSUs that will ultimately be earned is based on our performance relative to pre-established goals in that <ix:nonNumeric contextRef="i8117cc9161634207825ffb3719f67191_D20220101-20221231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzIwOTM1_04c1bf88-6bbb-4e28-9a6b-73b1471f39a8">three-year</ix:nonNumeric> performance cycle. The fair value of PSUs is determined based on the quoted closing price of our common stock on the day of grant.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Compensation expense is recognized in the Consolidated Statements of Earnings based on the estimated fair value of the awards on the grant date. Compensation expense recognized reflects an estimate of the number of awards expected to vest after taking into consideration an estimate of award forfeitures based on actual experience and is recognized on a straight-line basis over the requisite service period, which is generally the period required to obtain full vesting. Management expectations related to the achievement of performance goals associated with PSU grants is assessed regularly and that assessment is used to </span></div></ix:continuation></ix:continuation></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><ix:continuation id="i5dd258ad35864853aac66047c87c0d3b"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i627ae2c5e01542a2be677c630a6715a9">determine whether PSU grants are expected to vest. If performance-based milestones related to PSU grants are not met or not expected to be met, any compensation expense recognized associated with such grants will be reversed.</ix:continuation></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Income Taxes:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzIwOTE2_308c4ecf-2c52-4209-8b26-6b70f08a934d" continuedAt="i5ae77acebf7d4a32a7a66965b9e0c5e3" escape="true">Deferred income tax assets and liabilities are determined based on differences between financial reporting and income tax bases of assets and liabilities and are measured using the enacted income tax rates in effect for the years in which the differences are expected to reverse. Deferred income tax benefits generally represent the change in net deferred income tax assets and liabilities in the year. Other amounts result from adjustments related to acquisitions and foreign currency as appropriate.</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i5ae77acebf7d4a32a7a66965b9e0c5e3">We operate in multiple income tax jurisdictions both within the United States and internationally. Accordingly, management must determine the appropriate allocation of income to each of these jurisdictions based on current interpretations of complex income tax regulations. Income tax authorities in these jurisdictions regularly perform audits of our income tax filings. Income tax audits associated with the allocation of this income and other complex issues, including inventory transfer pricing and cost sharing, product royalty and foreign branch arrangements, may require an extended period of time to resolve and may result in significant income tax adjustments if changes to the income allocation are required between jurisdictions with different income tax rates.</ix:continuation></span></div><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzIwODY1_2c7b9c88-bf86-447b-a2ff-3dce201f5b20" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">New Accounting Pronouncements Not Yet Adopted</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In September 2022 the Financial Accounting Standards Board issued ASU 2022-04, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Liabilities - Supplier Finance Programs: Disclosure of Supplier Finance Program Obligations</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, which requires entities that utilize supplier finance programs in connection with the purchase of goods and services to disclose information about the key terms of the programs, a rollforward of the obligations under the programs and where those obligations are presented in the balance sheet. The new disclosure requirements are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. Currently our obligations under these programs are not material.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Accounting Pronouncements Recently Adopted </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On January 1, 2022 we adopted ASU 2021-08, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations: Accounting for Contract Assets and Contract Liabilities from Contracts with Customers</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. This update requires an entity to recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Accounting Standards Codification 606, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. The adoption of this update did not have a material impact on our Consolidated Financial Statements.</span></div></ix:nonNumeric></ix:continuation><div id="icec46013a0ad4608b89f97e433dd3417_103"></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTE 2 - <ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90ZXh0cmVnaW9uOjhmZjc1ZjcxODE5OTRhNjBiNWZjMDhmOTI5ODQxZDhmXzM2ODc_db873c25-ef42-4289-972b-8fc543d8753d" continuedAt="i205fdb3738374fc18852f5087d689603" escape="true">REVENUE RECOGNITION</ix:nonNumeric></span></div><ix:continuation id="i205fdb3738374fc18852f5087d689603" continuedAt="i9a59d8924a8d420d9a17cc92f86ba6cf"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We disaggregate our net sales by product line and geographic location for each of our segments as we believe it best depicts how the nature, amount, timing and certainty of our net sales and cash flows are affected by economic factors.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Products and services are primarily transferred to customers at a point in time, with some transfers of services taking place over time. In 2022 less than <ix:nonFraction unitRef="number" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="2" name="syk:PercentageofServiceRevenueRecognizeoverTime" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90ZXh0cmVnaW9uOjhmZjc1ZjcxODE5OTRhNjBiNWZjMDhmOTI5ODQxZDhmXzQyMw_52e530e3-5663-46ff-a4dc-f58ace831ad3">10</ix:nonFraction>% of our sales were recognized as services transferred over time. Refer to Note 1 for further discussion on our revenue recognition policies. </span></div></ix:continuation></div></div><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90ZXh0cmVnaW9uOjhmZjc1ZjcxODE5OTRhNjBiNWZjMDhmOTI5ODQxZDhmXzM2ODQ_dc21e7f4-65d4-44ac-aade-25196b70ee82" continuedAt="i79d311eddff84059ae82ee200e916b47" escape="true"></ix:nonNumeric><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">29</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2022 FORM 10-K</span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><ix:continuation id="i9a59d8924a8d420d9a17cc92f86ba6cf" continuedAt="ic87e41c5919145c8bff044f44cb7fa9b"><ix:continuation id="i79d311eddff84059ae82ee200e916b47"><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.259%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Segment Net Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">MedSurg and Neurotechnology:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Instruments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib40edc6b554f484e81172008a1b935cd_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzItMS0xLTEtNzIxNTE_c6334990-c99b-46f8-9b89-0ac72a415d65">2,279</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cd09663d2064e428131942655918cc4_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzItMy0xLTEtNzIxNTE_ea93c57c-b177-4260-8a8d-5e745f215415">2,111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if10d0627114c4a58a2be1e34e4b5625d_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzItNS0xLTEtNzIxNTE_1b1817a3-239b-42b2-81e2-198ab1a9168e">1,863</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Endoscopy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0cc5548a8984d22bd046caa3043eb0b_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzMtMS0xLTEtNzIxNTE_3aca6a56-5ab0-492c-bfad-01ded993b802">2,423</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5020782036574b31a5831f83949362a4_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzMtMy0xLTEtNzIxNTE_f0f54b6b-d725-440d-b136-89af8611b2ed">2,141</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b9f3564aca841c3ae0ea79a17077a20_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzMtNS0xLTEtNzIxNTE_4253f8a2-f3cc-4ad7-b67a-92304c03108d">1,763</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e819fe7e1d840638447a95eff013b31_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzQtMS0xLTEtNzIxNTE_dd8df677-f700-41b8-b1ae-504dfb26386c">3,031</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4e6f58b0e9f477f87313ee9043d9e30_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzQtMy0xLTEtNzIxNTE_d91705d6-f96f-4843-b553-4d2e47e54329">2,607</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f101fadf7674ec28a0116a48b22b520_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzQtNS0xLTEtNzIxNTE_bcbeba57-8bea-45de-b026-7b8a456e65a2">2,524</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neurovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib17c6235040048e8ae37d408059878aa_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzUtMS0xLTEtNzIxNTE_d0193144-2c78-4995-a64a-6754dde71c79">1,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief7335a3982a47459171c93ed23a8f47_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzUtMy0xLTEtNzIxNTE_b4014421-97f0-45c0-81c7-e0183c1f75d7">1,188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2be681678ea4436faff2709791d5137f_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzUtNS0xLTEtNzIxNTE_070dc4b0-aa99-4d46-8a01-88570af77788">973</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neuro Cranial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f7fd67d1c1485c9f7691e9a1809a38_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzYtMS0xLTEtNzIxNTE_5acbca02-25d1-4a46-a45e-e1b53d26acf6">1,376</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4ec9d69bf524a148549268e0c42215d_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzYtMy0xLTEtNzIxNTE_7ac6c695-c329-49d2-b9d0-22e3b336a9ac">1,214</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadd844730bb54ab2a251db4875dd0cc2_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzYtNS0xLTEtNzIxNTE_9de8337e-7163-48c9-9322-6f4c99078530">972</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b975aad2ca64d32a11f0b1aa57d74bc_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzctMS0xLTEtNzIxNTE_82b252e1-e152-41f3-9a88-22555d4ea98f">302</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98f3442517e54ff18879b74015965f7b_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzctMy0xLTEtNzIxNTE_7f64489b-626a-4a3e-b408-9bf21054906e">277</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i264f9d32cf56445f819b9231bed80ef2_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzctNS0xLTEtNzIxNTE_e2569573-4829-4105-a4d4-ffb4f0352b09">250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i953031f47dfd4ab48296f976c579f48f_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzgtMS0xLTEtNzIxNTE_dbf12ce4-9280-4722-a08f-1b812cb23b9e">10,611</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idac1c88764c44335aba1807e0a6c5920_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzgtMy0xLTEtNzIxNTE_a54a36a7-fe6c-48c9-9171-97850bb527a5">9,538</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62d3222aba4540cdb06bcf65a6a3bfd2_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzgtNS0xLTEtNzIxNTE_f066b807-6130-4102-b382-ac8111479f4a">8,345</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Orthopaedics and Spine:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Knees</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ecee5a3b59948519fdbfa67f9373a2b_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzEwLTEtMS0xLTcyMTUx_7941c549-babe-4a66-912b-6bcfd84f7408">1,997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i474cb49aa2d24434a691b5420651c447_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzEwLTMtMS0xLTcyMTUx_d0fca103-0e9c-4ff4-8325-2295959fc2dc">1,848</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c6154902bf04aeeb004c9e54c981d28_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzEwLTUtMS0xLTcyMTUx_62a77144-ef27-4f68-ab0a-cc4181721bd8">1,567</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Hips</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4b19248ed5d4294b50748ae4ea4aee0_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzExLTEtMS0xLTcyMTUx_3942b7b4-e366-48c4-98eb-61eadbd092ce">1,413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i269eeb7c7e4141e8bf2d3c9c447f3e98_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzExLTMtMS0xLTcyMTUx_40be2205-f8e0-4d49-a7c2-8f77e5c480ce">1,342</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id675a2fbf95744c4be3290137773c281_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzExLTUtMS0xLTcyMTUx_5a39463c-25b5-49d8-bb2b-653e424ed65e">1,206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Trauma and Extremities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9b5b615c9924c07a819ee875818589c_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzEyLTEtMS0xLTcyMTUx_5fcfa395-b769-410c-b60e-c372aed9e32e">2,807</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i013403153cd64c79a7f3a8634e364ea1_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzEyLTMtMS0xLTcyMTUx_6437d6ce-ebfc-4840-8deb-450fa5bb0c39">2,664</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c5b695e084e4496a0671e329ae3381e_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzEyLTUtMS0xLTcyMTUx_4d83dc16-f63d-40c1-903b-12c69ab6840e">1,722</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Spine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d0108479d3b484d80725dc2c041ad97_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzEzLTEtMS0xLTcyMTUx_19448a4f-7069-49e1-be9b-38ff3a8906b6">1,146</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0fdc7482bea448a93867fd96f5dcbac_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzEzLTMtMS0xLTcyMTUx_94dc5750-d89d-488d-aae1-08f8899caf23">1,167</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i331257e825de49c58489bfb866ddce44_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzEzLTUtMS0xLTcyMTUx_2d9330fe-597d-425b-a923-6f9502347926">1,047</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i666cd5b0c83c456bae79773bcf7f03e1_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzE0LTEtMS0xLTcyMTUx_e826129c-6313-4f0e-b232-afabcc414a57">475</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1801afd3ee7f4dfaac31a549f6ae0482_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzE0LTMtMS0xLTcyMTUx_8638e178-8298-4d29-849d-f48059ef8f25">549</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6aca02c723d4fb4ace6192cccb9de77_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzE0LTUtMS0xLTcyMTUx_00173c80-cf8e-4546-89c9-17975bc8760c">464</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59e41efd1cf44cedb5a90caceaa03aff_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzE1LTEtMS0xLTcyMTUx_c861346f-d0e7-4949-9d73-5b58ef48c45f">7,838</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i383cf58c47f8466aaa98e0e267a0ec66_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzE1LTMtMS0xLTcyMTUx_48e072ce-850f-4f55-9743-c97875064869">7,570</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if132773438c747ef8b1fe48831a7e72d_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzE1LTUtMS0xLTcyMTUx_4f17f97d-03f6-43c8-b447-bee112934316">6,006</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzE2LTEtMS0xLTcyMTUx_4fa2bb08-7c0c-46ce-9b71-3fae3c8b0268">18,449</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzE2LTMtMS0xLTcyMTUx_d6d89122-6065-4298-8c5a-1ed0399aa9c2">17,108</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzE2LTUtMS0xLTcyMTUx_47c0fd33-46cb-4dcd-8083-36f6cf78d0ce">14,351</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.259%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">United States Net Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">MedSurg and Neurotechnology:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Instruments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ed4ee29f6714ea69ad3fad40ed030cb_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzItMS0xLTEtNzIxNTE_344ae307-0f2d-4911-ad6f-7c9728fcf500">1,810</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d7fbd10640d4d3dbb9a7da83fdc93c2_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzItMy0xLTEtNzIxNTE_97644be2-8a0a-4e0e-b4a6-0893d1912038">1,637</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id09fcf99189f4b1998d8d9734940d624_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzItNS0xLTEtNzIxNTE_ea41bb92-7a40-40d4-b418-2ce34da3fa7b">1,471</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Endoscopy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98867d5b69f347a49e32704030d048c1_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzMtMS0xLTEtNzIxNTE_0ad1aba0-1616-46dd-be71-4887d1f9e064">1,914</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08e13185dfad49da800a2a08a9f432a1_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzMtMy0xLTEtNzIxNTE_5e4a8407-252e-42bf-8c4b-ded9791482b2">1,670</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27792d541a2c4696a01a98be72919963_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzMtNS0xLTEtNzIxNTE_672b86c6-d1fd-4b79-9b19-1bc2aefaf5bd">1,408</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cea099951df4ff7bbdc41425b5529b6_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzQtMS0xLTEtNzIxNTE_050406ae-3056-4492-90dd-d78689360196">2,422</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i543a25a9f1ec4250931a708a947c22f0_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzQtMy0xLTEtNzIxNTE_ff8c7751-737a-4fd5-89be-d6187b876db4">2,007</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc72c4be0f714dff82bfbdceba60770f_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzQtNS0xLTEtNzIxNTE_40141f12-ee5f-4357-84ac-d663b5b86782">1,910</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neurovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaefd465e33384342bb74bc7d62b86fcb_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzUtMS0xLTEtNzIxNTE_09ff3e1e-406b-4f96-bca3-eb67ef2abe17">446</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6601ea0a52494abfb803a90cb4cac08b_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzUtMy0xLTEtNzIxNTE_b66a6d17-45e6-4a4d-9c5e-84208149aa41">451</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5206b2de2164734afce54d5a8ff985d_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzUtNS0xLTEtNzIxNTE_d1a0d510-b876-4e6d-be27-2776e9c60962">381</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neuro Cranial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifff0fc2d089c44d3aa2f9d5df4e83ff4_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzYtMS0xLTEtNzIxNTE_1e28a57a-a60a-4638-ac3f-fc72da9dae4a">1,135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1f97bfe9b3544df927161980c8b37e7_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzYtMy0xLTEtNzIxNTE_59551ffd-c118-4f0a-a163-05ceb7e0f46f">988</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62b4c459d2c147fcb0cfa4526e86d72b_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzYtNS0xLTEtNzIxNTE_d7b924f7-787c-4b8e-9233-d729cbfce381">801</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663246eda49749d997c0d746cabbb4ee_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzctMS0xLTEtNzIxNTE_afdf8939-83d9-4724-984b-7cb4a47b5a70">297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6a66c36657d43f4a75ef31f2507e955_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzctMy0xLTEtNzIxNTE_23dff8dc-18e3-4f3e-a0a2-f7a965afabb9">273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0a11a2714074a598220e8541795a994_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzctNS0xLTEtNzIxNTE_a8d82abf-4bef-413f-a10c-4e3095f55bbe">247</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e1cd337be44b57b9b1d332b129f69c_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzgtMS0xLTEtNzIxNTE_3de4c389-ff24-45d7-816d-fdcbe32e80d2">8,024</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d04a4d184e54baaa0500525454dce8a_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzgtMy0xLTEtNzIxNTE_61b42c10-bcc0-4298-a669-8ef767133fbd">7,026</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie649374514094ad1a1d1a16c42b218da_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzgtNS0xLTEtNzIxNTE_dac7d7c5-b4e2-41e0-832a-1a6eebd6c7ee">6,218</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Orthopaedics and Spine:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Knees</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6078ad8012384f338b9a92a484d14c65_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzEwLTEtMS0xLTcyMTUx_843b1f2e-6b2c-4281-972a-f3d5dacd5f88">1,493</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i797fa079f8f54e3a9a6da8545bed4ed3_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzEwLTMtMS0xLTcyMTUx_d7b1536b-4dbb-4ad2-9e28-fd5284124039">1,351</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd6e330b6ad41d9b7422a4b7e00bf79_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzEwLTUtMS0xLTcyMTUx_3f6c6c89-8160-4829-a350-87c3ae59eab4">1,170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Hips</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i235f0602f0b049698f8ebba9516a25f6_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzExLTEtMS0xLTcyMTUx_64d1b031-c2cb-4685-9fc0-a46e98f59ca0">896</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71a3f354032646189f007311bac60024_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzExLTMtMS0xLTcyMTUx_214d5479-f033-49b2-8191-3560dd2bc3ef">822</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie56858cf83c046b994c5c997f9f03e4d_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzExLTUtMS0xLTcyMTUx_abb983f8-55d3-494e-a436-5a7f1107fc55">777</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Trauma and Extremities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf66a24721c449dabc5abd76d714c686_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzEyLTEtMS0xLTcyMTUx_c9b63d5c-c404-4f1e-83c8-911bf2e874f7">2,035</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic219c45e9bad4e20b8083e43a0aeb4eb_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzEyLTMtMS0xLTcyMTUx_14e4c5b3-dc02-4905-a894-e1042b8cab07">1,866</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5a1567757054e22a14abcfa4521d1d8_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzEyLTUtMS0xLTcyMTUx_ff633685-5938-47d8-aeb5-be408b47d902">1,139</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Spine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if21f6d50ec354218a38c8290af16e623_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzEzLTEtMS0xLTcyMTUx_049adfef-ac5a-420a-b933-757d4aa82830">836</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8b02a7bd5e949d7bf3a6197a4b398c0_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzEzLTMtMS0xLTcyMTUx_e29d6f40-9c08-46ae-bea7-ef94a0ed64c7">831</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5586d2399af142dabc67a9bee22f6a8a_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzEzLTUtMS0xLTcyMTUx_f5987821-7c38-4505-a06d-a43ed4d2b5ca">764</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1758ceab8dc4cba84c860bf0c70ec7e_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzE0LTEtMS0xLTcyMTUx_32821223-c836-4125-b2bf-3fc4b31dde0e">354</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i323b04cbc9d248b1b1d4d71d946c7fa3_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzE0LTMtMS0xLTcyMTUx_fd7efef0-c725-445a-8ba4-5e16df93a668">425</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie50bbe6a5e6d46d4a93975ba9d0688c8_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzE0LTUtMS0xLTcyMTUx_8d49ba56-6c88-4b1d-a9a9-b3f3a3b4c29b">387</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53c57bd651fd45a185259d088cd6d65c_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzE1LTEtMS0xLTcyMTUx_df1e6488-7f20-4b98-98aa-7c7402a8e758">5,614</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc1a1dbfa4b940c183d1a894a442e7dc_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzE1LTMtMS0xLTcyMTUx_2c20a29b-634c-4403-a3d6-74c85e18f68c">5,295</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5e99b74e17b4087a5567c9b9b9bc240_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzE1LTUtMS0xLTcyMTUx_b206da9e-cb7a-4d83-a1b8-e80131680fed">4,237</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaff1db63800141a4a0f466e4edd07697_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzE2LTEtMS0xLTcyMTUx_0d62c0f9-3efc-4075-805d-271beca85304">13,638</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c40ed4f092642e6ae3512f7b314ae33_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzE2LTMtMS0xLTcyMTUx_79892389-745f-4438-bac3-71e690e646b7">12,321</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia16521f0e141452ca6e75ab7d3a68848_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzE2LTUtMS0xLTcyMTUx_d28317ce-dae1-47cb-8374-005c73d1ebf8">10,455</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.259%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">International Net Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">MedSurg and Neurotechnology:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Instruments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i483d950410414fe59ab9e2fa4d84d5df_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzItMS0xLTEtNzIxNTE_81df82f9-1f9e-4d82-8471-b83cf310228d">469</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63a90fa6e8e148b19df1238fd6a1f7c2_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzItMy0xLTEtNzIxNTE_1d020557-a31e-44c8-9899-828c55973002">474</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1dc8e759d5044d0aaa1f41483df1232a_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzItNS0xLTEtNzIxNTE_75577910-d6fd-4861-a85a-9201b0dc9ee8">392</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Endoscopy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae1685480e7f4fcbbb1e5f05830d684d_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzMtMS0xLTEtNzIxNTE_d9a64f7c-bbfa-4b88-86bb-0b4b8426a91c">509</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1df304d4eb44faf833fe1d888e9f579_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzMtMy0xLTEtNzIxNTE_9a774e1f-a48f-44cc-abcc-940779043cfd">471</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e65f49264c64a349b9d521fc9f4b8f9_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzMtNS0xLTEtNzIxNTE_5659a6e6-61a1-4dac-99da-d769f0f206ad">355</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30234a3281d14003a6892b71356e9d0a_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzQtMS0xLTEtNzIxNTE_bbc69fc6-c0ff-4a02-9246-adf9b05d7317">609</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if70a16dd5e6945bf9c6e8cf9b8788075_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzQtMy0xLTEtNzIxNTE_f89a8dbc-65e8-4915-879d-98c2517e1ddd">600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fe26adfdbc545c99ea371ee84ab0982_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzQtNS0xLTEtNzIxNTE_a75872f6-0274-4502-a25d-8eab999a94c4">614</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neurovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5018938caadf49a898cc06c5f84bc191_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzUtMS0xLTEtNzIxNTE_abc80db1-695f-4d52-8e9e-8d0528c89b0c">754</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id25f8772d4b14bb897d5701f19e7d4f1_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzUtMy0xLTEtNzIxNTE_6cb0099d-4b21-40f2-b34a-9fd9e1b97152">737</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4b3fca57c9545df8ece61f69e1e1fdc_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzUtNS0xLTEtNzIxNTE_3380e73e-00e3-418c-8f9f-4a6ea6b0e78b">592</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neuro Cranial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7c37ca29a884860a690d73964155c6e_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzYtMS0xLTEtNzIxNTE_6f8fc26c-a0e3-4e4c-ad99-2e79dd1418c3">241</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57807bf2142f4f7faa936c1cacf88c52_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzYtMy0xLTEtNzIxNTE_48d43700-4da0-412f-ab36-8e341c55bbb4">226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82f610c3881d4092950ff3ee3559f332_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzYtNS0xLTEtNzIxNTE_705db25e-d814-4e7a-866b-30d1ff21f9dd">171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69286e78969c425b95fb1a1af5a7ffee_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzctMS0xLTEtNzIxNTE_0ca76517-cbb7-4a25-a43c-a0956d135fd3">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idded536d0af14e3a827698652b7ec361_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzctMy0xLTEtNzIxNTE_7bf0904b-a119-467d-8698-a44303fe9a4a">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife69af0daf204c34b24444fefcdc4593_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzctNS0xLTEtNzIxNTE_a8b618b3-fdf9-43c9-968f-c6de03f4cba0">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e1d87a1079040de8d74635a08480d51_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzgtMS0xLTEtNzIxNTE_1a881d87-4a43-43a9-82ef-a841385ea065">2,587</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f994fa175e14f7fbb0230508d4017b7_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzgtMy0xLTEtNzIxNTE_61dd214c-6c45-488c-b06b-13ecc1cf97fe">2,512</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90fb567d63414192b40cf0ac5a8561bb_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzgtNS0xLTEtNzIxNTE_1b995daa-d2ee-49b2-98af-495a481d20a8">2,127</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Orthopaedics and Spine:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Knees</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c5ee2c8d6a245409c7113431408c137_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzEwLTEtMS0xLTcyMTUx_ebf5e8ee-7021-4c19-83a3-ff994a377c33">504</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1521748c0f8b464492226525de5d7eab_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzEwLTMtMS0xLTcyMTUx_898fe2e2-e736-4266-a602-7c52a2172565">497</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cc4e6c8bedd45858a7ca12a5301a3ae_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzEwLTUtMS0xLTcyMTUx_a6882970-528f-419d-b513-2b0b990b5d30">397</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Hips</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i502050c566d846e2a9eebc8d4f42d251_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzExLTEtMS0xLTcyMTUx_8316a876-60ed-41e5-9fd4-e87a2cdbe689">517</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i087a6044fb0f4d06ab4771d7a6615b22_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzExLTMtMS0xLTcyMTUx_125de2e8-6728-4368-a070-d5acdb6e6392">520</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78a574b38eb84b4e9ddbdec1b8422bb5_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzExLTUtMS0xLTcyMTUx_3359f0e0-29db-45d6-b8b1-c4fba55c2820">429</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Trauma and Extremities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9848e15d5e03446e85be30206896834a_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzEyLTEtMS0xLTcyMTUx_8ddc9d5c-40db-451e-80b3-3046cb652fff">772</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f67744858942b2ade6faf4e7109a1e_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzEyLTMtMS0xLTcyMTUx_dfb2d0ce-545c-4d5c-852a-aca61de8d89e">798</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7dbd5a4933a46c3880c5c627cb44975_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzEyLTUtMS0xLTcyMTUx_d183d016-b2c9-400b-a707-2d9bbdf1516d">583</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Spine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if21ff3221f9e4f94b678fa254a2b6165_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzEzLTEtMS0xLTcyMTUx_cc25bbe0-d6df-4767-9045-5de0a061d0d1">310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i111c61299cd54de1a129bb3bb7c82c44_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzEzLTMtMS0xLTcyMTUx_60f45500-cbd8-4a40-99b8-76da28edcb1b">336</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb4bfa7f666a42c694d9c69757624555_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzEzLTUtMS0xLTcyMTUx_9a9f53fd-1412-4ba5-81ff-016c10000cf4">283</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib088580a0b7f4d77b2ec885ae6c1c459_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzE0LTEtMS0xLTcyMTUx_ac305b03-506c-4dee-8f3e-825472f43894">121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4da717909f6849eb981891e24024b2a9_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzE0LTMtMS0xLTcyMTUx_c00a3ec6-d53b-4e12-8b05-64842c9f4744">124</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i584907bcc13a4da3b2f67d81b5e349e3_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzE0LTUtMS0xLTcyMTUx_1d410e61-baca-44fe-8d00-8bb147f2efe9">77</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i322205428fdb4dd1b9ee8eb34e18bbf1_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzE1LTEtMS0xLTcyMTUx_c423736d-bd34-4817-be4f-586ff4ecaeb4">2,224</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7c8e07052dd4d1c91726191ed386ac8_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzE1LTMtMS0xLTcyMTUx_a35ac656-fee2-4927-885a-39a232051222">2,275</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17bfdc6681b54daf82fee40a6fb5aa86_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzE1LTUtMS0xLTcyMTUx_65000e89-bb1c-47ee-aed0-fd1d58afff65">1,769</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaab182c6b3bb44d086bbe15590d6e157_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzE2LTEtMS0xLTcyMTUx_687d63e1-92a0-429a-86aa-79f9041d5860">4,811</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c358267d06c4c30bddf69fbbdad3c82_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzE2LTMtMS0xLTcyMTUx_7c3500cc-be3a-4b55-b7a6-4de0aa9f2561">4,787</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide98561cf401454c96fa8600baf5b8f9_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzE2LTUtMS0xLTcyMTUx_e5225743-568b-4c68-b53b-9d200ee11726">3,896</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">MedSurg and Neurotechnology</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">MedSurg and Neurotechnology products include surgical equipment and navigation systems (Instruments), endoscopic and communications systems (Endoscopy), patient handling, emergency medical equipment, intensive care disposable products and clinical communication and workflow solutions (Medical), minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke (Neurovascular), a comprehensive line of products for traditional brain and open skull based surgical procedures; orthobiologic and biosurgery </span></div></ix:continuation></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><ix:continuation id="ic87e41c5919145c8bff044f44cb7fa9b"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">products, including synthetic bone grafts and vertebral augmentation products (Neuro Cranial) and other medical device products used in a variety of medical specialties. Substantially all MedSurg and Neurotechnology sales are recognized when a purchase order has been received and control has transferred. For certain Endoscopy, Instruments and Medical services, we may recognize sales over time as we satisfy performance obligations that may include an obligation to complete installation, provide training and perform ongoing services, generally performed within one year.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Orthopaedics and Spine</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Orthopaedics and Spine products consist primarily of implants used in hip and knee joint replacements and trauma and extremity surgeries, and cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies. Substantially all Orthopaedics sales are recognized when we have received a purchase order and appropriate notification the product has been used or implanted. Substantially all Spine sales are recognized when a purchase order has been received and control has transferred. For certain Orthopaedic products in the "other" category, we recognize sales at a point in time, as well as over time for performance obligations that may include an obligation to complete installation and provide training and ongoing services. Performance obligations are generally satisfied within one year.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Contract Assets and Liabilities </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The nature of our products and services do not generally give rise to contract assets as we typically do not incur costs to fulfill a contract before a product or service is provided to a customer. Our costs to obtain contracts are typically in the form of sales commissions paid to employees or third-party agents. Certain sales commissions paid to employees prior to recognition of sales are recorded as contract assets. We expense sales commissions associated with obtaining a contract at the time of the sale or as incurred as the amortization period is generally less than one year. These costs have been presented within selling, general and administrative expenses. On December&#160;31, 2022 contract assets recorded in our Consolidated Balance Sheets were not significant.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our contract liabilities arise as a result of consideration received from customers at inception of contracts for certain businesses or where the timing of billing for services precedes satisfaction of our performance obligations. We generally satisfy performance obligations within one year from the contract inception date. Our contract liabilities were $<ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90ZXh0cmVnaW9uOjhmZjc1ZjcxODE5OTRhNjBiNWZjMDhmOTI5ODQxZDhmXzMyOTg1MzQ4ODcxNzY_4d3e9ab8-5fca-470b-9087-155594ff6045">741</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90ZXh0cmVnaW9uOjhmZjc1ZjcxODE5OTRhNjBiNWZjMDhmOTI5ODQxZDhmXzMyOTg1MzQ4ODcxODA_30d32f03-21f9-4988-9fa3-a10947eceb75">529</ix:nonFraction> on December&#160;31, 2022 and 2021. <ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90ZXh0cmVnaW9uOjhmZjc1ZjcxODE5OTRhNjBiNWZjMDhmOTI5ODQxZDhmXzU0OTc1NTgxNzc0Mw_3b6416cb-94af-4852-b2ad-ca5d2a4459a8" continuedAt="i257db9ea3f5340c8a8bdd5e668fc2dc2" escape="true">Changes in contract liabilities during the year were as follows:</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:justify"><ix:continuation id="i257db9ea3f5340c8a8bdd5e668fc2dc2"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.658%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.142%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Beginning contract liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTo3ZmRiYmI4MzA5ZDE0ZGQ0OTBkYjFlMWVmYzgyODZjMC90YWJsZXJhbmdlOjdmZGJiYjgzMDlkMTRkZDQ5MGRiMWUxZWZjODI4NmMwXzEtMS0xLTEtODQ2MjQ_30d32f03-21f9-4988-9fa3-a10947eceb75">529</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Revenue recognized from beginning of year contract liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTo3ZmRiYmI4MzA5ZDE0ZGQ0OTBkYjFlMWVmYzgyODZjMC90YWJsZXJhbmdlOjdmZGJiYjgzMDlkMTRkZDQ5MGRiMWUxZWZjODI4NmMwXzItMS0xLTEtODQ2NTU_97436309-a881-4033-985c-0f9500dcc5b4">329</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Contract liabilities acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTo3ZmRiYmI4MzA5ZDE0ZGQ0OTBkYjFlMWVmYzgyODZjMC90YWJsZXJhbmdlOjdmZGJiYjgzMDlkMTRkZDQ5MGRiMWUxZWZjODI4NmMwXzMtMS0xLTEtODQ2NTU_07e3ca05-8a02-4312-94d2-73a38d79976d">80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net advance consideration received during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="syk:ContractWithCustomerLiabilityNetAdvanceConsiderationReceivedDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTo3ZmRiYmI4MzA5ZDE0ZGQ0OTBkYjFlMWVmYzgyODZjMC90YWJsZXJhbmdlOjdmZGJiYjgzMDlkMTRkZDQ5MGRiMWUxZWZjODI4NmMwXzQtMS0xLTEtODQ2NTU_aa28e3e4-22e0-4179-92f9-98652b2b0058">461</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Ending contract liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTo3ZmRiYmI4MzA5ZDE0ZGQ0OTBkYjFlMWVmYzgyODZjMC90YWJsZXJhbmdlOjdmZGJiYjgzMDlkMTRkZDQ5MGRiMWUxZWZjODI4NmMwXzUtMS0xLTEtODQ2OTA_4d3e9ab8-5fca-470b-9087-155594ff6045">741</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></ix:continuation></div></ix:continuation><div id="icec46013a0ad4608b89f97e433dd3417_106"></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTE 3 - <ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90ZXh0cmVnaW9uOjE1MmJmZDZhNWExZTQ1ZDg5NzQxZWY4MWNkYWQzYWZmXzI2NzE_79dcc376-2f31-473f-b054-55d5ba5f2043" continuedAt="ic8e6bcf7ddb7460aa5944f37b2590d41" escape="true">FAIR VALUE MEASUREMENTS </ix:nonNumeric></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="ic8e6bcf7ddb7460aa5944f37b2590d41" continuedAt="i322b6edee76646d4ad802b750716006d">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Financial assets and liabilities carried at fair value are classified in their entirety based on the lowest level of input and disclosed in one of the following three categories:</ix:continuation></span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">30</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2022 FORM 10-K</span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><ix:continuation id="i322b6edee76646d4ad802b750716006d" continuedAt="i0300591af3ed4bf48ee03122c47258df"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:12.693%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.107%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Quoted market prices in active markets for identical assets or liabilities.</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Observable market-based inputs or unobservable inputs that are corroborated by market data.</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level 3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unobservable inputs reflecting our assumptions or external inputs from active markets.</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Use of observable market data, when available, is required in making fair value measurements. When inputs used fall within different levels of the hierarchy, the level within which the fair value measurement is categorized is based on the lowest level input that is significant to the fair value measurement. We determine fair value for Level 1 instruments using exchange-traded prices for identical instruments. We determine fair value of Level 2 instruments using exchange-traded prices of similar instruments, where available, or utilizing other observable inputs that take into account our credit risk and that of our counterparties. Foreign currency exchange contracts and interest rate hedges, when outstanding, are included in Level 2 and are primarily valued using standard calculations and models that use readily observable market data as their basis. Our Level 3 liabilities are comprised of contingent consideration arising from recently completed acquisitions. We determine fair value of these Level 3 liabilities using a discounted cash flow technique. Significant unobservable inputs were used in our assessment of fair value, including assumptions regarding future business results, discount rates, discount periods and probability assessments based on the likelihood of reaching various targets. We remeasure the fair value of our assets and liabilities each reporting period. We record the changes in fair value within selling, general and administrative expense.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the third quarter 2022 we determined that certain commercial and regulatory milestones related to technology acquired in the purchase of Mobius Imaging and Cardan Robotics were no longer probable of being achieved and recorded a $<ix:nonFraction unitRef="usd" contextRef="iec7ff50d4aea4a64b1a222ed6cddad1e_D20220701-20220930" decimals="-6" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90ZXh0cmVnaW9uOjE1MmJmZDZhNWExZTQ1ZDg5NzQxZWY4MWNkYWQzYWZmXzM4NDgyOTA3MDAzMTM_a86370d0-1fd6-4c51-922c-8a220dcee5bd">110</ix:nonFraction> reduction in the fair value of contingent consideration reflected in selling, general and administrative expenses.</span></div><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90ZXh0cmVnaW9uOjE1MmJmZDZhNWExZTQ1ZDg5NzQxZWY4MWNkYWQzYWZmXzI2NjY_476b42d1-2ac8-4885-a165-625721ff2487" escape="true"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.417%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.141%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.142%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Assets Measured at Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2d532877fe14293a0c7af8376dd383a_I20221231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTo0MGZhNDNmN2E3NWI0YjUwYTQzODA3ZWIxZDRhZTVhZS90YWJsZXJhbmdlOjQwZmE0M2Y3YTc1YjRiNTBhNDM4MDdlYjFkNGFlNWFlXzItMS0xLTEtNzIxNTE_dc865eb2-07ca-4636-bdec-3f3c415c49f1">1,844</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb345be38a2145ec8f2df1b4c28dc6d4_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTo0MGZhNDNmN2E3NWI0YjUwYTQzODA3ZWIxZDRhZTVhZS90YWJsZXJhbmdlOjQwZmE0M2Y3YTc1YjRiNTBhNDM4MDdlYjFkNGFlNWFlXzItMi0xLTEtNzIxNTE_92b01e25-3d82-4634-a914-8a982e9a9393">2,944</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Trading marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2d532877fe14293a0c7af8376dd383a_I20221231" decimals="-6" name="us-gaap:TradingSecuritiesDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTo0MGZhNDNmN2E3NWI0YjUwYTQzODA3ZWIxZDRhZTVhZS90YWJsZXJhbmdlOjQwZmE0M2Y3YTc1YjRiNTBhNDM4MDdlYjFkNGFlNWFlXzMtMS0xLTEtNzIxNTE_342b85ee-416c-44a1-a05c-a0f02f75d2c2">166</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb345be38a2145ec8f2df1b4c28dc6d4_I20211231" decimals="-6" name="us-gaap:TradingSecuritiesDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTo0MGZhNDNmN2E3NWI0YjUwYTQzODA3ZWIxZDRhZTVhZS90YWJsZXJhbmdlOjQwZmE0M2Y3YTc1YjRiNTBhNDM4MDdlYjFkNGFlNWFlXzMtMi0xLTEtNzIxNTE_1b24ef11-b01a-4a88-b82d-a65bb99531f5">193</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 1 - Assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2d532877fe14293a0c7af8376dd383a_I20221231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTo0MGZhNDNmN2E3NWI0YjUwYTQzODA3ZWIxZDRhZTVhZS90YWJsZXJhbmdlOjQwZmE0M2Y3YTc1YjRiNTBhNDM4MDdlYjFkNGFlNWFlXzQtMS0xLTEtNzIxNTE_c5b8f592-adc9-4224-843d-580cee4507bd">2,010</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb345be38a2145ec8f2df1b4c28dc6d4_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTo0MGZhNDNmN2E3NWI0YjUwYTQzODA3ZWIxZDRhZTVhZS90YWJsZXJhbmdlOjQwZmE0M2Y3YTc1YjRiNTBhNDM4MDdlYjFkNGFlNWFlXzQtMi0xLTEtNzIxNTE_731bc5af-498d-4766-8a74-825316437153">3,137</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Available-for-sale marketable securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Corporate and asset-backed debt securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9f7092c7cfe4497bab25e1f403f24c9_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTo0MGZhNDNmN2E3NWI0YjUwYTQzODA3ZWIxZDRhZTVhZS90YWJsZXJhbmdlOjQwZmE0M2Y3YTc1YjRiNTBhNDM4MDdlYjFkNGFlNWFlXzYtMS0xLTEtNzIxNTE_a81547c2-cd29-4106-8532-474731130c54">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i684697892eef43b0a398f7e1d3644140_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTo0MGZhNDNmN2E3NWI0YjUwYTQzODA3ZWIxZDRhZTVhZS90YWJsZXJhbmdlOjQwZmE0M2Y3YTc1YjRiNTBhNDM4MDdlYjFkNGFlNWFlXzYtMi0xLTEtNzIxNTE_6b9d05ad-b46b-4a60-9335-ac044611c373">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign government debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib50e1688c3054d648339c3791063d5da_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTo0MGZhNDNmN2E3NWI0YjUwYTQzODA3ZWIxZDRhZTVhZS90YWJsZXJhbmdlOjQwZmE0M2Y3YTc1YjRiNTBhNDM4MDdlYjFkNGFlNWFlXzctMS0xLTEtNzIxNTE_e561d128-2fb3-4b9b-9608-cbf85c305e9e">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b0b881c3cc645c8a20d828cc3a3ab1f_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTo0MGZhNDNmN2E3NWI0YjUwYTQzODA3ZWIxZDRhZTVhZS90YWJsZXJhbmdlOjQwZmE0M2Y3YTc1YjRiNTBhNDM4MDdlYjFkNGFlNWFlXzctMi0xLTEtNzIxNTE_dd4809fb-5171-4243-a59f-56e9dde3d3f2">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States agency debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6cd00f7e2984a7197f65f6758fc8f77_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTo0MGZhNDNmN2E3NWI0YjUwYTQzODA3ZWIxZDRhZTVhZS90YWJsZXJhbmdlOjQwZmE0M2Y3YTc1YjRiNTBhNDM4MDdlYjFkNGFlNWFlXzgtMS0xLTEtNzIxNTE_d3591e7c-b50d-4e7f-a9d8-7bbba109f727">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6da21472d42444c2a5f87b4170b8a18a_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTo0MGZhNDNmN2E3NWI0YjUwYTQzODA3ZWIxZDRhZTVhZS90YWJsZXJhbmdlOjQwZmE0M2Y3YTc1YjRiNTBhNDM4MDdlYjFkNGFlNWFlXzgtMi0xLTEtNzIxNTE_1bdee13f-67c2-42dc-9246-1548fc18008c">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States treasury debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b2fac2f3fc9459ab4c0932e6ed5c5b6_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTo0MGZhNDNmN2E3NWI0YjUwYTQzODA3ZWIxZDRhZTVhZS90YWJsZXJhbmdlOjQwZmE0M2Y3YTc1YjRiNTBhNDM4MDdlYjFkNGFlNWFlXzktMS0xLTEtNzIxNTE_3273dc60-2c5c-4c3d-b1bd-e83929af5014">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bfd9b18ac254aea9b31268dda67d715_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTo0MGZhNDNmN2E3NWI0YjUwYTQzODA3ZWIxZDRhZTVhZS90YWJsZXJhbmdlOjQwZmE0M2Y3YTc1YjRiNTBhNDM4MDdlYjFkNGFlNWFlXzktMi0xLTEtNzIxNTE_d1ba3062-0d8a-4653-9028-d0d8d5e46b51">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idba6690bc56542ebab849eb8e0a831d0_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTo0MGZhNDNmN2E3NWI0YjUwYTQzODA3ZWIxZDRhZTVhZS90YWJsZXJhbmdlOjQwZmE0M2Y3YTc1YjRiNTBhNDM4MDdlYjFkNGFlNWFlXzEwLTEtMS0xLTcyMTUx_21d0e8d9-aa1a-4c98-8977-3156709fb8db">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic30c4a9be3cb4b41aca184361c77845a_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTo0MGZhNDNmN2E3NWI0YjUwYTQzODA3ZWIxZDRhZTVhZS90YWJsZXJhbmdlOjQwZmE0M2Y3YTc1YjRiNTBhNDM4MDdlYjFkNGFlNWFlXzEwLTItMS0xLTcyMTUx_32c24fe9-2780-4197-a631-828eb308f61d">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total available-for-sale marketable securities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic08aa5d78620463481ca8783fa037ecb_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTo0MGZhNDNmN2E3NWI0YjUwYTQzODA3ZWIxZDRhZTVhZS90YWJsZXJhbmdlOjQwZmE0M2Y3YTc1YjRiNTBhNDM4MDdlYjFkNGFlNWFlXzExLTEtMS0xLTcyMTUx_97fc29a6-ea91-4db8-88b4-8c856b617c9f">84</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cfe6ff3822e44e4ae63056b2596b8ae_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTo0MGZhNDNmN2E3NWI0YjUwYTQzODA3ZWIxZDRhZTVhZS90YWJsZXJhbmdlOjQwZmE0M2Y3YTc1YjRiNTBhNDM4MDdlYjFkNGFlNWFlXzExLTItMS0xLTcyMTUx_75a8a678-5cc9-438c-b620-d6d61b9f3316">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign currency exchange forward contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27d980565f3148fe831139d2e7a16efb_I20221231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTo0MGZhNDNmN2E3NWI0YjUwYTQzODA3ZWIxZDRhZTVhZS90YWJsZXJhbmdlOjQwZmE0M2Y3YTc1YjRiNTBhNDM4MDdlYjFkNGFlNWFlXzEyLTEtMS0xLTcyMTUx_5e5d0267-7088-4db5-a3e4-88a99311bb0f">119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3861b631300548c2ab44cbbf58d07920_I20211231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTo0MGZhNDNmN2E3NWI0YjUwYTQzODA3ZWIxZDRhZTVhZS90YWJsZXJhbmdlOjQwZmE0M2Y3YTc1YjRiNTBhNDM4MDdlYjFkNGFlNWFlXzEyLTItMS0xLTcyMTUx_24b1a8ab-52f1-4804-89bd-e03b9503db9f">212</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 2 - Assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5847988c48e945ff89b5383f616f507c_I20221231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTo0MGZhNDNmN2E3NWI0YjUwYTQzODA3ZWIxZDRhZTVhZS90YWJsZXJhbmdlOjQwZmE0M2Y3YTc1YjRiNTBhNDM4MDdlYjFkNGFlNWFlXzE0LTEtMS0xLTcyMTUx_db9c7e47-4f5d-49bd-9b24-52ec983f736a">203</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e94767eea5f4452a8497953475e7b32_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTo0MGZhNDNmN2E3NWI0YjUwYTQzODA3ZWIxZDRhZTVhZS90YWJsZXJhbmdlOjQwZmE0M2Y3YTc1YjRiNTBhNDM4MDdlYjFkNGFlNWFlXzE0LTItMS0xLTcyMTUx_b118893c-7328-4f2a-a34c-469cff6d7866">287</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTo0MGZhNDNmN2E3NWI0YjUwYTQzODA3ZWIxZDRhZTVhZS90YWJsZXJhbmdlOjQwZmE0M2Y3YTc1YjRiNTBhNDM4MDdlYjFkNGFlNWFlXzE1LTEtMS0xLTcyMTUx_401effa8-d5b4-4fef-9413-3e3f3cdb199d">2,213</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTo0MGZhNDNmN2E3NWI0YjUwYTQzODA3ZWIxZDRhZTVhZS90YWJsZXJhbmdlOjQwZmE0M2Y3YTc1YjRiNTBhNDM4MDdlYjFkNGFlNWFlXzE1LTItMS0xLTcyMTUx_a9194564-8deb-4ee1-9cf6-0adb784b27da">3,424</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.417%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.141%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.142%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Liabilities Measured at Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deferred compensation arrangements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2d532877fe14293a0c7af8376dd383a_I20221231" decimals="-6" name="syk:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTpmYjEzY2UzYjkwOTg0MDY0YTJmZDJhMTc4MmIwZjM5MS90YWJsZXJhbmdlOmZiMTNjZTNiOTA5ODQwNjRhMmZkMmExNzgyYjBmMzkxXzItMS0xLTEtNzIxNTE_2dd2c440-254b-4a3a-87d9-c312b3030d83">166</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb345be38a2145ec8f2df1b4c28dc6d4_I20211231" decimals="-6" name="syk:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTpmYjEzY2UzYjkwOTg0MDY0YTJmZDJhMTc4MmIwZjM5MS90YWJsZXJhbmdlOmZiMTNjZTNiOTA5ODQwNjRhMmZkMmExNzgyYjBmMzkxXzItMi0xLTEtNzIxNTE_f3093555-ee9b-4ab8-9b11-a002317329d0">193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 1 - Liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2d532877fe14293a0c7af8376dd383a_I20221231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTpmYjEzY2UzYjkwOTg0MDY0YTJmZDJhMTc4MmIwZjM5MS90YWJsZXJhbmdlOmZiMTNjZTNiOTA5ODQwNjRhMmZkMmExNzgyYjBmMzkxXzMtMS0xLTEtNzIxNTE_dacd82ec-194a-4a7b-a3ef-72325aefadfc">166</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb345be38a2145ec8f2df1b4c28dc6d4_I20211231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTpmYjEzY2UzYjkwOTg0MDY0YTJmZDJhMTc4MmIwZjM5MS90YWJsZXJhbmdlOmZiMTNjZTNiOTA5ODQwNjRhMmZkMmExNzgyYjBmMzkxXzMtMi0xLTEtNzIxNTE_4d7fa849-83e5-4884-a85c-de0b88691481">193</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign currency exchange forward contracts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27d980565f3148fe831139d2e7a16efb_I20221231" decimals="-6" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTpmYjEzY2UzYjkwOTg0MDY0YTJmZDJhMTc4MmIwZjM5MS90YWJsZXJhbmdlOmZiMTNjZTNiOTA5ODQwNjRhMmZkMmExNzgyYjBmMzkxXzQtMS0xLTEtNzIxNTE_e5e1de1d-0858-4401-a4ea-ff50bd52f34e">102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3861b631300548c2ab44cbbf58d07920_I20211231" decimals="-6" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTpmYjEzY2UzYjkwOTg0MDY0YTJmZDJhMTc4MmIwZjM5MS90YWJsZXJhbmdlOmZiMTNjZTNiOTA5ODQwNjRhMmZkMmExNzgyYjBmMzkxXzQtMi0xLTEtNzIxNTE_b6fdbd19-dbe5-47fe-8aeb-1707cb1338fd">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 2 - Liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5847988c48e945ff89b5383f616f507c_I20221231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTpmYjEzY2UzYjkwOTg0MDY0YTJmZDJhMTc4MmIwZjM5MS90YWJsZXJhbmdlOmZiMTNjZTNiOTA5ODQwNjRhMmZkMmExNzgyYjBmMzkxXzYtMS0xLTEtNzIxNTE_26e4a714-43fa-4e64-8196-777b2c576472">102</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e94767eea5f4452a8497953475e7b32_I20211231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTpmYjEzY2UzYjkwOTg0MDY0YTJmZDJhMTc4MmIwZjM5MS90YWJsZXJhbmdlOmZiMTNjZTNiOTA5ODQwNjRhMmZkMmExNzgyYjBmMzkxXzYtMi0xLTEtNzIxNTE_a975a368-730b-476a-b8ee-c12c37ca313f">17</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Contingent consideration:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Beginning</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33ec7e34209e4d64ba95fe5eb1edee60_I20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTpmYjEzY2UzYjkwOTg0MDY0YTJmZDJhMTc4MmIwZjM5MS90YWJsZXJhbmdlOmZiMTNjZTNiOTA5ODQwNjRhMmZkMmExNzgyYjBmMzkxXzgtMS0xLTEtNzIxNTE_ad714375-f59a-494c-a0e2-5861b391b903">306</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1061b720f0314243956e705d577b0331_I20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTpmYjEzY2UzYjkwOTg0MDY0YTJmZDJhMTc4MmIwZjM5MS90YWJsZXJhbmdlOmZiMTNjZTNiOTA5ODQwNjRhMmZkMmExNzgyYjBmMzkxXzgtMi0xLTEtNzIxNTE_9ff6575d-8309-449a-ba65-bf81cd4efb55">393</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i555016f434ae4cd48b50f24fbe1586b3_D20220101-20221231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTpmYjEzY2UzYjkwOTg0MDY0YTJmZDJhMTc4MmIwZjM5MS90YWJsZXJhbmdlOmZiMTNjZTNiOTA5ODQwNjRhMmZkMmExNzgyYjBmMzkxXzktMS0xLTEtNzIxNTE_bdfb4caf-cc6a-4616-ae0c-20685ab42654">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f534a107f4d40bb987de62c5eca2398_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTpmYjEzY2UzYjkwOTg0MDY0YTJmZDJhMTc4MmIwZjM5MS90YWJsZXJhbmdlOmZiMTNjZTNiOTA5ODQwNjRhMmZkMmExNzgyYjBmMzkxXzktMi0xLTEtNzIxNTE_aceb7e44-7023-4d2c-b75f-c16c11daf5a9">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in estimate </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i555016f434ae4cd48b50f24fbe1586b3_D20220101-20221231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTpmYjEzY2UzYjkwOTg0MDY0YTJmZDJhMTc4MmIwZjM5MS90YWJsZXJhbmdlOmZiMTNjZTNiOTA5ODQwNjRhMmZkMmExNzgyYjBmMzkxXzEwLTEtMS0xLTcyMTUx_165a9379-1e91-4636-bafe-0738f70b808e">137</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f534a107f4d40bb987de62c5eca2398_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTpmYjEzY2UzYjkwOTg0MDY0YTJmZDJhMTc4MmIwZjM5MS90YWJsZXJhbmdlOmZiMTNjZTNiOTA5ODQwNjRhMmZkMmExNzgyYjBmMzkxXzEwLTItMS0xLTcyMTUx_ec03c2f1-b4e4-4031-baba-aae94e4821cc">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i555016f434ae4cd48b50f24fbe1586b3_D20220101-20221231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTpmYjEzY2UzYjkwOTg0MDY0YTJmZDJhMTc4MmIwZjM5MS90YWJsZXJhbmdlOmZiMTNjZTNiOTA5ODQwNjRhMmZkMmExNzgyYjBmMzkxXzExLTEtMS0xLTcyMTUx_48404d31-e71b-4f73-b930-150d55f91ba3">49</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f534a107f4d40bb987de62c5eca2398_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTpmYjEzY2UzYjkwOTg0MDY0YTJmZDJhMTc4MmIwZjM5MS90YWJsZXJhbmdlOmZiMTNjZTNiOTA5ODQwNjRhMmZkMmExNzgyYjBmMzkxXzExLTItMS0xLTcyMTUx_95813df9-82da-4784-aa93-59fe47cd8d09">148</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Ending</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d64b78c8a794c42aa5ea20736299864_I20221231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTpmYjEzY2UzYjkwOTg0MDY0YTJmZDJhMTc4MmIwZjM5MS90YWJsZXJhbmdlOmZiMTNjZTNiOTA5ODQwNjRhMmZkMmExNzgyYjBmMzkxXzEyLTEtMS0xLTcyMTUx_537ffb17-4111-4fd3-9e2b-50dfda3b4360">121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33ec7e34209e4d64ba95fe5eb1edee60_I20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTpmYjEzY2UzYjkwOTg0MDY0YTJmZDJhMTc4MmIwZjM5MS90YWJsZXJhbmdlOmZiMTNjZTNiOTA5ODQwNjRhMmZkMmExNzgyYjBmMzkxXzEyLTItMS0xLTcyMTUx_91211ade-120d-4a48-adb8-9abf542b17f7">306</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 3 - Liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d64b78c8a794c42aa5ea20736299864_I20221231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTpmYjEzY2UzYjkwOTg0MDY0YTJmZDJhMTc4MmIwZjM5MS90YWJsZXJhbmdlOmZiMTNjZTNiOTA5ODQwNjRhMmZkMmExNzgyYjBmMzkxXzEzLTEtMS0xLTcyMTUx_4f097198-95a1-4289-a43c-caa6073809bf">121</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33ec7e34209e4d64ba95fe5eb1edee60_I20211231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTpmYjEzY2UzYjkwOTg0MDY0YTJmZDJhMTc4MmIwZjM5MS90YWJsZXJhbmdlOmZiMTNjZTNiOTA5ODQwNjRhMmZkMmExNzgyYjBmMzkxXzEzLTItMS0xLTcyMTUx_a9ec5099-09d5-4830-9d58-6ae38b0857ca">306</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total liabilities measured at fair value</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTpmYjEzY2UzYjkwOTg0MDY0YTJmZDJhMTc4MmIwZjM5MS90YWJsZXJhbmdlOmZiMTNjZTNiOTA5ODQwNjRhMmZkMmExNzgyYjBmMzkxXzE0LTEtMS0xLTcyMTUx_898ea437-927f-4ea2-bc73-5d48438dc465">389</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTpmYjEzY2UzYjkwOTg0MDY0YTJmZDJhMTc4MmIwZjM5MS90YWJsZXJhbmdlOmZiMTNjZTNiOTA5ODQwNjRhMmZkMmExNzgyYjBmMzkxXzE0LTItMS0xLTcyMTUx_ca123cf3-5458-4067-a369-3a07fb23016e">516</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><ix:continuation id="i0300591af3ed4bf48ee03122c47258df"><div style="text-align:justify"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90ZXh0cmVnaW9uOjE1MmJmZDZhNWExZTQ1ZDg5NzQxZWY4MWNkYWQzYWZmXzI2ODA_345942d6-00d0-4482-8889-80e6c61346f9" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.417%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.141%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.142%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Fair Value of Available for Sale Securities by Maturity</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Due in one year or less</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTpkMzEzYjQyZGNjMGY0NDMyOGZiMjJlNjhmMjE4MWRkMy90YWJsZXJhbmdlOmQzMTNiNDJkY2MwZjQ0MzI4ZmIyMmU2OGYyMTgxZGQzXzItMS0xLTEtNzIxNTE_44bdef4c-c114-4bc2-a89e-0b2eb0efba4b">53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTpkMzEzYjQyZGNjMGY0NDMyOGZiMjJlNjhmMjE4MWRkMy90YWJsZXJhbmdlOmQzMTNiNDJkY2MwZjQ0MzI4ZmIyMmU2OGYyMTgxZGQzXzItMi0xLTEtNzIxNTE_0326a2c4-f1dd-40c7-850a-4c411ecc2ca4">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Due after one year through three years</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="syk:AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTpkMzEzYjQyZGNjMGY0NDMyOGZiMjJlNjhmMjE4MWRkMy90YWJsZXJhbmdlOmQzMTNiNDJkY2MwZjQ0MzI4ZmIyMmU2OGYyMTgxZGQzXzMtMS0xLTEtNzIxNTE_cf6dad9e-4ba2-4e0b-b4a4-2d47aacb20cc">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="syk:AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTpkMzEzYjQyZGNjMGY0NDMyOGZiMjJlNjhmMjE4MWRkMy90YWJsZXJhbmdlOmQzMTNiNDJkY2MwZjQ0MzI4ZmIyMmU2OGYyMTgxZGQzXzMtMi0xLTEtNzIxNTE_3c9c2c2f-27ee-4544-9365-d51c34e7fc86">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On December&#160;31, 2022 the aggregate difference between the cost and fair value of available-for-sale marketable securities was nominal. Interest and marketable securities income was $<ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:MarketableSecuritiesGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90ZXh0cmVnaW9uOjE1MmJmZDZhNWExZTQ1ZDg5NzQxZWY4MWNkYWQzYWZmXzM4NDgyOTA3MDA0MDI_29e9025d-d6f2-49cb-980e-4d0da3a0c053">94</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:MarketableSecuritiesGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90ZXh0cmVnaW9uOjE1MmJmZDZhNWExZTQ1ZDg5NzQxZWY4MWNkYWQzYWZmXzM4NDgyOTA3MDA0MTE_144bf492-beb0-49dc-a397-6bf894a4c6ec">68</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:MarketableSecuritiesGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90ZXh0cmVnaW9uOjE1MmJmZDZhNWExZTQ1ZDg5NzQxZWY4MWNkYWQzYWZmXzM4NDgyOTA3MDA0MjA_ea24ca27-732f-485d-88c2-1f0b97feee64">102</ix:nonFraction> in 2022, 2021 and 2020, which was recorded in other income (expense), net.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our investments in available-for-sale marketable securities had a minimum credit quality rating of A2 (Moody's), A (Standard &amp; Poor's) and A (Fitch). We do not plan to sell the investments, and it is not more likely than not that we will be required to sell the investments before recovery of their amortized cost basis, which may be maturity.</span></div></ix:continuation><div id="icec46013a0ad4608b89f97e433dd3417_109"></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTE 4 - <ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90ZXh0cmVnaW9uOjRkYjAxMWE4ZTNkNzQ4ZWFhNTQwMTYzM2ExOGUxNDdhXzI4MTU_962ea0ca-4606-4c28-a503-ac0b0189e5d3" continuedAt="ie56d8cabc81c4a42b2630386b8ddd840" escape="true">DERIVATIVE INSTRUMENTS</ix:nonNumeric></span></div><ix:continuation id="ie56d8cabc81c4a42b2630386b8ddd840" continuedAt="i098f434ea6224d9eb0708479989de34f"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We use operational and economic hedges, foreign currency exchange forward contracts, net investment hedges (both derivative and non-derivative financial instruments) and interest rate derivative instruments to manage the impact of currency exchange and interest rate fluctuations on earnings, cash flow and equity. We do not enter into derivative instruments for speculative purposes. We are exposed to potential credit loss in the event of nonperformance by counterparties on our outstanding derivative instruments but do not anticipate nonperformance by any of our counterparties. Should a counterparty default, our maximum loss exposure is the asset balance of the instrument. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Foreign Currency Hedges</span></div><div style="text-align:justify"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90ZXh0cmVnaW9uOjRkYjAxMWE4ZTNkNzQ4ZWFhNTQwMTYzM2ExOGUxNDdhXzI4Mjc_79a2a07d-0063-4a32-88ee-96950798e98d" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.805%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.805%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.805%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.661%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cash Flow</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Investment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-Designated</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross notional amount</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec94f18ada042fabb7f1ebdc25a07d4_I20221231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzEtMS0xLTEtNzIxNTE_df398ff5-fe06-4179-8e1b-e81b2010cb5f">1,053</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d27f73c86aa47cba1db7a41f08807cd_I20221231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzEtMi0xLTEtNzIxNTE_fb1f1a7f-7e2a-4203-a46a-61f3bd1327a3">1,598</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf36006040a941c9932b2b52a950a31a_I20221231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzEtMy0xLTEtNzIxNTE_2e97c798-bdcb-43ee-b4a8-e717109d28d5">3,417</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f5265baf4a34824aa6bfc4b935f0cc6_I20221231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzEtNC0xLTEtNzIxNTE_2bdf6a1a-880f-434e-a341-86e282549426">6,068</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Maximum term in years</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i18c253d682754db68c1f963844f236c0_D20220101-20221231" name="us-gaap:MaximumRemainingMaturityOfForeignCurrencyDerivatives1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzItNC0xLTEtNzIxNTE_cdef0303-e5f5-43c5-b7de-c38223583600">3.9</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i502841656af74f0abcbfa0b5b4d5edde_I20221231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzQtMS0xLTEtNzIxNTE_71ef0416-059e-4331-988f-bbffe59aaf5d">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f7602ed300f40099fb5e3d0ccea433c_I20221231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzQtMi0xLTEtNzIxNTE_20932be0-1221-4f8d-b143-7aa374f0a956">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if623c08c13104816b3eec3b501299d90_I20221231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzQtMy0xLTEtNzIxNTE_abe94c71-546b-4f0f-994e-d555e7525a96">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc0b84fb75164adf807974c23c81f865_I20221231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzQtNC0xLTEtNzIxNTE_2b188503-cb26-4cc8-99a4-446c2f6f9832">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other noncurrent assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f5c13561a6441838aa726a95c450a0a_I20221231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzUtMS0xLTEtNzIxNTE_17300859-9a59-4602-abd2-d67d0d45ce03">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd8e471ce1d84cd0b7332d1e15689be0_I20221231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzUtMi0xLTEtNzIxNTE_1287fed3-6c82-4a62-b13a-c7e6df939128">89</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic862e33128874fba9c59da29a661709c_I20221231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzUtMy0xLTEtNzIxNTE_c5219b4d-8765-4370-a8b8-359659fac7b2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed382ff805947e282a6b64d016d24f4_I20221231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzUtNC0xLTEtNzIxNTE_f50e1fbf-a12c-4541-89e3-92344523033d">90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i871ebfa1e7e24e09bd4a205545a24e83_I20221231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzYtMS0xLTEtNzIxNTE_b8ff077a-8cda-43ae-9b6b-1d40603ad51a">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3f7b3b320914b9dae575c52b5fe8b56_I20221231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzYtMi0xLTEtNzIxNTE_05dc1e43-46a4-4859-912e-d7171ecf1d4d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i50af63eb8b4d4347af19a411f82385bc_I20221231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzYtMy0xLTEtNzIxNTE_5a8654f8-655f-42c3-bb7a-4bf2a149cf5a">79</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i30db394dfc2a41a8b8826988775431cb_I20221231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzYtNC0xLTEtNzIxNTE_79e59cec-706c-4f00-81a5-0d1f05f34022">85</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other noncurrent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibad6a6771ef34df3ae26b4bf524b94cf_I20221231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzctMS0xLTEtNzIxNTE_31f524cb-352a-4ceb-b59b-7596bb360458">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie01905fa5e254373b0ff7bd6859daf50_I20221231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzctMi0xLTEtNzIxNTE_ab406a5b-2b17-4254-a5a3-c2c6fe06d508">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7984d6aa73d346b396014350b01a0a8b_I20221231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzctMy0xLTEtNzIxNTE_51e3cff5-d6e5-454f-9ff7-3257674edfe0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i442c41e773ba4c8393f770f45cac23e6_I20221231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzctNC0xLTEtNzIxNTE_bba3c279-b4b9-40ce-abb4-883407e03d8f">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total fair value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec94f18ada042fabb7f1ebdc25a07d4_I20221231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzgtMS0xLTEtNzIxNTE_1c0e9c00-9e52-459f-b888-cccb7ad4098d">14</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d27f73c86aa47cba1db7a41f08807cd_I20221231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzgtMi0xLTEtNzIxNTE_7ac1397b-6d05-4174-8744-43e7b568a770">73</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf36006040a941c9932b2b52a950a31a_I20221231" decimals="-6" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzgtMy0xLTEtNzIxNTE_8802f9e3-dc39-43f5-8580-49d6335a5136">70</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f5265baf4a34824aa6bfc4b935f0cc6_I20221231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzgtNC0xLTEtNzIxNTE_0db6fb59-2401-4252-abaa-5a934a6fe4d6">17</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross notional amount</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b19e56e61b4c329c04eac6cfc4cd58_I20211231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzEwLTEtMS0xLTcyMTUx_bf5d8a59-e4fb-4b4e-bb66-c443c48994d4">973</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id60b785d2b584ee1be26545ea0a1b66f_I20211231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzEwLTItMS0xLTcyMTUx_fdb0ac26-8ea9-4e24-a0c5-237f44acbbcc">2,266</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if244473f9960480abc9486fac01737d2_I20211231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzEwLTMtMS0xLTcyMTUx_f8fd6d0c-64e7-406a-8de6-30732e2051fb">5,512</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e1acc8de3644b2583b558aed3472970_I20211231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzEwLTQtMS0xLTcyMTUx_aa2d3817-08bf-45b7-8ab7-79df0c77de9e">8,751</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Maximum term in years</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i526560b9237b4753b4d62b8c0ac70ad0_D20210101-20211231" name="us-gaap:MaximumRemainingMaturityOfForeignCurrencyDerivatives1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzExLTQtMS0xLTcyMTUx_81ab0792-2992-46a0-95f9-b3974d0cd8db">4.9</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebcaf79884c44374aed5e2028c2ef520_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzEzLTEtMS0xLTcyMTUx_ee63a813-6ae9-4f72-9e41-689847530b28">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36b9ed429956467a99e25dcfa90149c9_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzEzLTItMS0xLTcyMTUx_6a174f4a-fe36-4379-b0f2-43b97966de15">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c812d2135a0456199da61bf38ed7721_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzEzLTMtMS0xLTcyMTUx_828ee807-84f1-4ec8-a018-1fad0cf2abd4">92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id55223eafacf499d89f879372cbf9597_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzEzLTQtMS0xLTcyMTUx_ba98b1b4-c1ac-4537-8b4e-01d1814e05f6">146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other noncurrent assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b3bc6f133044291a549410c3cf66f4d_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzE0LTEtMS0xLTcyMTUx_4380d9e8-f4c0-499f-8310-35764499dfb8">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b39e27e21304ce894cab7826e32ac09_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzE0LTItMS0xLTcyMTUx_524ac928-1a99-4437-95c4-2d86b6594ac9">65</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebe1f9b479ea44f69f1c26a1d8bc2fd8_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzE0LTMtMS0xLTcyMTUx_492c07ae-e60b-40f0-993d-5d175c757b23">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i785da713e5504f1cac04a1e0354dfa48_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzE0LTQtMS0xLTcyMTUx_414a2515-bdb4-4991-ae9d-414718c63321">66</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie029123d930d43c8a47136e8b7c03300_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzE1LTEtMS0xLTcyMTUx_158a3998-1eed-487e-a370-1dca58f5b2c7">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5e0163a634738abd15b3643a5c3f5_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzE1LTItMS0xLTcyMTUx_257e3d70-db01-413e-826c-227c248e2369">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b2e6b2fb13e405d95f685da59183e93_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzE1LTMtMS0xLTcyMTUx_5bda8100-ed34-4e2b-923e-3f1cc4c58e8e">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf0622bdb40c4cbd87d21f3c67334c2a_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzE1LTQtMS0xLTcyMTUx_c56cdab5-7d06-4edd-b9f1-5ff3fdaf50b7">17</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total fair value</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b19e56e61b4c329c04eac6cfc4cd58_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzE3LTEtMS0xLTcyMTUx_920ffb70-f609-45c7-aff3-d852597024ce">9</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id60b785d2b584ee1be26545ea0a1b66f_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzE3LTItMS0xLTcyMTUx_ba8ae946-1898-4661-97a9-a5f06b4a8833">104</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if244473f9960480abc9486fac01737d2_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzE3LTMtMS0xLTcyMTUx_cade87a2-dcfd-4991-bbb1-71bdf7f02738">82</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e1acc8de3644b2583b558aed3472970_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzE3LTQtMS0xLTcyMTUx_c81edf03-739c-4b8b-a694-c00d4368f13a">195</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:3pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We had &#8364;<ix:nonFraction unitRef="eur" contextRef="i8d27f73c86aa47cba1db7a41f08807cd_I20221231" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90ZXh0cmVnaW9uOjRkYjAxMWE4ZTNkNzQ4ZWFhNTQwMTYzM2ExOGUxNDdhXzc1MQ_98aa627f-d57c-4379-8c54-22dd7da16b69">1.5</ix:nonFraction>&#160;billion and &#8364;<ix:nonFraction unitRef="eur" contextRef="id60b785d2b584ee1be26545ea0a1b66f_I20211231" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90ZXh0cmVnaW9uOjRkYjAxMWE4ZTNkNzQ4ZWFhNTQwMTYzM2ExOGUxNDdhXzc1OA_cd2b16f6-72bd-4bb3-b098-0abba35e220c">2.0</ix:nonFraction>&#160;billion at December 31, 2022 and 2021 in certain forward currency contracts designated as net investment hedges to hedge a portion of our investments in certain of our entities with functional currencies denominated in Euros. In addition to these derivative financial instruments designated as net investment hedges, we had &#8364;<ix:nonFraction unitRef="eur" contextRef="i7e8c5b89171143fbbff1d92557f393af_I20221231" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90ZXh0cmVnaW9uOjRkYjAxMWE4ZTNkNzQ4ZWFhNTQwMTYzM2ExOGUxNDdhXzEwNzM_9a5134e8-fd0e-406a-bd10-b6b1ad1ea99c"><ix:nonFraction unitRef="eur" contextRef="if5dc0a291f3a4f67bfac579e681b910f_I20211231" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90ZXh0cmVnaW9uOjRkYjAxMWE4ZTNkNzQ4ZWFhNTQwMTYzM2ExOGUxNDdhXzEwNzM_e5641b95-a186-4c04-919d-27825ba28555">4.4</ix:nonFraction></ix:nonFraction>&#160;billion at December 31, 2022 and 2021 of senior unsecured notes designated as net investment hedges to selectively hedge portions of our investment in certain international subsidiaries. The currency effects of our Euro-denominated senior unsecured notes are reflected in AOCI within shareholders' equity where they offset gains and losses recorded on our net investment in international subsidiaries.</span></div><div style="margin-bottom:3pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In 2022 we settled certain foreign currency forward contracts designated as net investment hedges resulting in cash proceeds of $<ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:ProceedsFromHedgeInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90ZXh0cmVnaW9uOjRkYjAxMWE4ZTNkNzQ4ZWFhNTQwMTYzM2ExOGUxNDdhXzQzOTgwNDY1MTQwODA_85981c9c-79af-4b65-b561-2e86b1cae470">197</ix:nonFraction>. The amounts in AOCI related to settled net investment </span></div></ix:continuation></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">31</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2022 FORM 10-K</span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><ix:continuation id="i098f434ea6224d9eb0708479989de34f"><div style="margin-bottom:3pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">hedges will remain in AOCI until the hedged investment is either sold or substantially liquidated.</span></div><div style="margin-bottom:3pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The total after-tax gain (loss) recognized in OCI related to designated net investment hedges was $<ix:nonFraction unitRef="usd" contextRef="icd05c426dad44fd5b836e9f3d2fa90e5_D20220101-20221231" decimals="-6" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90ZXh0cmVnaW9uOjRkYjAxMWE4ZTNkNzQ4ZWFhNTQwMTYzM2ExOGUxNDdhXzE1NjA_9b76fec0-f59f-4745-85c1-d37ae24c74d7">321</ix:nonFraction> in 2022.</span></div><div style="margin-top:6pt;text-align:justify"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90ZXh0cmVnaW9uOjRkYjAxMWE4ZTNkNzQ4ZWFhNTQwMTYzM2ExOGUxNDdhXzI4MjQ_0a3d550a-9daa-4461-9be6-64178e32927c" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"></td><td style="width:28.871%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.804%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.274%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.274%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.277%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Net Currency Exchange Rate Gains (Losses)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Derivative Instrument</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Recorded in:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash Flow</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cost of sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dca98f754544fae91bc2be4aa0d5f9c_D20220101-20221231" decimals="-6" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpiNWQ5MDk5ODQ5OGY0N2YxYWMwZGMyODg3N2EwNDJhMS90YWJsZXJhbmdlOmI1ZDkwOTk4NDk4ZjQ3ZjFhYzBkYzI4ODc3YTA0MmExXzItMi0xLTEtNzIxNTE_cd8b0fa7-5f5d-462e-8451-a8571a4a97a4">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5fa607b61e244bc0b9d78c50a056da63_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpiNWQ5MDk5ODQ5OGY0N2YxYWMwZGMyODg3N2EwNDJhMS90YWJsZXJhbmdlOmI1ZDkwOTk4NDk4ZjQ3ZjFhYzBkYzI4ODc3YTA0MmExXzItMy0xLTEtNzIxNTE_d425365d-005c-49c9-9bba-21e4f92b98ab">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i858bf63c159847d6b3ed57f57eb1ff65_D20200101-20201231" decimals="-6" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpiNWQ5MDk5ODQ5OGY0N2YxYWMwZGMyODg3N2EwNDJhMS90YWJsZXJhbmdlOmI1ZDkwOTk4NDk4ZjQ3ZjFhYzBkYzI4ODc3YTA0MmExXzItNC0xLTEtNzIxNTE_21cbe8b3-87b6-4abf-bf81-f1122249b820">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net Investment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i900a7f9055784544a570f4f177f0f2f7_D20220101-20221231" decimals="-6" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpiNWQ5MDk5ODQ5OGY0N2YxYWMwZGMyODg3N2EwNDJhMS90YWJsZXJhbmdlOmI1ZDkwOTk4NDk4ZjQ3ZjFhYzBkYzI4ODc3YTA0MmExXzMtMi0xLTEtNzIxNTE_931841a3-2eef-426a-9326-ad1daa5f9807">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35651c99f68b487cb5cb0aaf787aa0ed_D20210101-20211231" decimals="-6" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpiNWQ5MDk5ODQ5OGY0N2YxYWMwZGMyODg3N2EwNDJhMS90YWJsZXJhbmdlOmI1ZDkwOTk4NDk4ZjQ3ZjFhYzBkYzI4ODc3YTA0MmExXzMtMy0xLTEtNzIxNTE_c6953ba9-2cc2-4daf-a83b-2fb904f40865">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8ba1cabf909458ba3e5abe497e0b36d_D20200101-20201231" decimals="-6" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpiNWQ5MDk5ODQ5OGY0N2YxYWMwZGMyODg3N2EwNDJhMS90YWJsZXJhbmdlOmI1ZDkwOTk4NDk4ZjQ3ZjFhYzBkYzI4ODc3YTA0MmExXzMtNC0xLTEtNzIxNTE_f4234636-935d-4a3b-b6cc-78691a275bfd">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Non-Designated</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cccc96d34764cf58cc915568b1e6270_D20220101-20221231" decimals="-6" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpiNWQ5MDk5ODQ5OGY0N2YxYWMwZGMyODg3N2EwNDJhMS90YWJsZXJhbmdlOmI1ZDkwOTk4NDk4ZjQ3ZjFhYzBkYzI4ODc3YTA0MmExXzQtMi0xLTEtNzIxNTE_c0b8e7f4-45cc-48db-b040-269ffddd5e0a">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae3102b5052e4f9792a88230869505ae_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpiNWQ5MDk5ODQ5OGY0N2YxYWMwZGMyODg3N2EwNDJhMS90YWJsZXJhbmdlOmI1ZDkwOTk4NDk4ZjQ3ZjFhYzBkYzI4ODc3YTA0MmExXzQtMy0xLTEtNzIxNTE_a87394f9-2f52-4b29-b4c6-98b369a1b7c9">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id329aed50c074920944be6fd7b940cf8_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpiNWQ5MDk5ODQ5OGY0N2YxYWMwZGMyODg3N2EwNDJhMS90YWJsZXJhbmdlOmI1ZDkwOTk4NDk4ZjQ3ZjFhYzBkYzI4ODc3YTA0MmExXzQtNC0xLTEtNzIxNTE_e3e0dabf-05b5-4781-91c4-0d7b2ba8bd6f">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18c253d682754db68c1f963844f236c0_D20220101-20221231" decimals="-6" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpiNWQ5MDk5ODQ5OGY0N2YxYWMwZGMyODg3N2EwNDJhMS90YWJsZXJhbmdlOmI1ZDkwOTk4NDk4ZjQ3ZjFhYzBkYzI4ODc3YTA0MmExXzUtMi0xLTEtNzIxNTE_8aec15a8-4371-473e-ab8e-3dfb1d23d2c4">63</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i526560b9237b4753b4d62b8c0ac70ad0_D20210101-20211231" decimals="-6" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpiNWQ5MDk5ODQ5OGY0N2YxYWMwZGMyODg3N2EwNDJhMS90YWJsZXJhbmdlOmI1ZDkwOTk4NDk4ZjQ3ZjFhYzBkYzI4ODc3YTA0MmExXzUtMy0xLTEtNzIxNTE_1420ac94-2fd8-4993-bfc8-2151dfde4951">13</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic804fede9d9b48fca7326ace0f6cda8a_D20200101-20201231" decimals="-6" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpiNWQ5MDk5ODQ5OGY0N2YxYWMwZGMyODg3N2EwNDJhMS90YWJsZXJhbmdlOmI1ZDkwOTk4NDk4ZjQ3ZjFhYzBkYzI4ODc3YTA0MmExXzUtNC0xLTEtNzIxNTE_1e082db8-03aa-487d-b375-0765c649f601">20</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:3pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pretax gains (losses) on derivatives designated as cash flow hedges of $<ix:nonFraction unitRef="usd" contextRef="icd05c426dad44fd5b836e9f3d2fa90e5_D20220101-20221231" decimals="-6" name="us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90ZXh0cmVnaW9uOjRkYjAxMWE4ZTNkNzQ4ZWFhNTQwMTYzM2ExOGUxNDdhXzE2Mzc_bc01207c-36db-4f3e-8ebb-f720a029266f">32</ix:nonFraction> and net investment hedges of $<ix:nonFraction unitRef="usd" contextRef="icd05c426dad44fd5b836e9f3d2fa90e5_D20220101-20221231" decimals="-6" name="us-gaap:DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90ZXh0cmVnaW9uOjRkYjAxMWE4ZTNkNzQ4ZWFhNTQwMTYzM2ExOGUxNDdhXzE2Njk_a4cb33de-1b8d-4189-a11d-69a0d6660dff">34</ix:nonFraction> recorded in AOCI are expected to be reclassified to cost of sales and other income (expense), net in earnings within 12 months as of December&#160;31, 2022. This cash flow hedge reclassification is primarily due to the sale of inventory that includes previously hedged purchases. A component of the AOCI amounts related to net investment hedges is reclassified over the life of the hedge instruments as we elected to exclude the initial value of the component related to the spot-forward difference from the effectiveness assessment. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Interest Rate Hedges</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pretax gains of $<ix:nonFraction unitRef="usd" contextRef="ic3133dd3e2174a0fab3f99c31f3a1c0c_D20220101-20221231" decimals="-6" name="us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90ZXh0cmVnaW9uOjRkYjAxMWE4ZTNkNzQ4ZWFhNTQwMTYzM2ExOGUxNDdhXzI1MzE_ff672fd4-a2f1-41ab-a164-5af4f627e349">5</ix:nonFraction> recorded in AOCI related to other interest rate hedges closed in conjunction with debt issuances are expected to be reclassified to other income (expense), net in earnings within 12 months of December&#160;31, 2022. The cash flow effect of interest rate hedges is recorded in cash flow from operations.</span></div></ix:continuation><div id="icec46013a0ad4608b89f97e433dd3417_112"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTE 5 - <ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90ZXh0cmVnaW9uOjgyMTdkZGIxNGNkMjQxODE4YjM3NGMyNjZlYTcxOTZmXzgx_1bf6bc85-9bf8-47d7-a60d-72c3568f02a8" continuedAt="i8967057a702640cd8b40d6fb9877cb13" escape="true">ACCUMULATED OTHER COMPREHENSIVE (LOSS) INCOME (AOCI)</ix:nonNumeric></span></div><div style="margin-bottom:1pt;text-align:justify"><ix:continuation id="i8967057a702640cd8b40d6fb9877cb13"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90ZXh0cmVnaW9uOjgyMTdkZGIxNGNkMjQxODE4YjM3NGMyNjZlYTcxOTZmXzgw_2e6534f9-1e34-4c05-8a48-cac2149ff996" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"></td><td style="width:26.565%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.326%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.868%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.868%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.902%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.871%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Marketable Securities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pension Plans</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Hedges</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Financial Statement Translation</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i073bfd5a955943a1910ed816f9ae5c27_I20201231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzEtMS0xLTEtNzIxNTE_0e5f1325-a96f-4e32-9101-5182f25f053e">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i618987c1cdac4e83bae6d50a1ddc1358_I20201231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzEtMi0xLTEtNzIxNTE_983410ad-c8fb-4cfb-b451-57db30907764">259</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i30d00fa7ea3a436494f1bd7ba5373101_I20201231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzEtMy0xLTEtNzIxNTE_e965a266-1456-4e02-8020-d81a8c56d425">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2acfbbc785a4dcba1e0d80a471cf36e_I20201231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzEtNC0xLTEtNzIxNTE_9b366b0d-7b36-4297-8d1d-913905bfd284">885</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98963cf23d234ec1ac275e66bcfd76dc_I20201231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzEtNS0xLTEtNzIxNTE_548d54b8-9a72-46fb-93e4-02da60c6739f">1,157</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">OCI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99212e6414ed4182be360bb4600e1593_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzItMS0xLTEtNzIxNTE_511a7a2a-9d35-425f-9d3c-213c6b25c153">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i989cd3b1dfc14409946f1bd46844917f_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzItMi0xLTEtNzIxNTE_e3067750-b7b4-4dcb-92ea-6d7bfe1f6502">123</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e70ca42855942a5a650f69045393b9b_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzItMy0xLTEtNzIxNTE_240bdb75-4cc5-4a20-a3e2-39ea1fbf33c9">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i976b214a31df4949b83c93e6da795727_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzItNC0xLTEtNzIxNTE_eace840a-99ec-47e1-82e4-b0ea578a335c">551</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzItNS0xLTEtNzIxNTE_ea00a1f3-b07e-4b46-b90b-2652a54dbf1b">724</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99212e6414ed4182be360bb4600e1593_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzMtMS0xLTEtNzIxNTE_483a5434-0ab8-478a-8322-f807c6ad7561">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i989cd3b1dfc14409946f1bd46844917f_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzMtMi0xLTEtNzIxNTE_b123be6a-7a26-40eb-aeea-7c65f0aefcc6">32</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2e70ca42855942a5a650f69045393b9b_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzMtMy0xLTEtNzIxNTE_68a923ab-717e-4443-aa82-16d95b8f328f">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i976b214a31df4949b83c93e6da795727_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzMtNC0xLTEtNzIxNTE_af5a3ef1-98c0-4caa-8cb4-8dd5840619b2">54</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzMtNS0xLTEtNzIxNTE_faff60eb-b32b-4845-b023-61623a7a1011">101</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Reclassifications to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64382fff96cc4d37a1272abc8d08a5b1_D20210101-20211231" decimals="-6" name="us-gaap:CostOfRevenue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzUtMS0xLTEtNzIxNTE_5e3574cb-e5f5-4a4c-b175-444c913eb0ec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf0ef3bec3594225be5f4136d591a70a_D20210101-20211231" decimals="-6" name="us-gaap:CostOfRevenue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzUtMi0xLTEtNzIxNTE_616efb54-8786-4df1-afc7-7a816ad71402">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if03ac61671704ce4b4624fc35057af34_D20210101-20211231" decimals="-6" name="us-gaap:CostOfRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzUtMy0xLTEtNzIxNTE_12b96986-aa1b-4ad4-b88b-c9f3c9878758">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4546ff3df1c4906be5936247a46f7b0_D20210101-20211231" decimals="-6" name="us-gaap:CostOfRevenue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzUtNC0xLTEtNzIxNTE_ed7b9570-101e-42ae-9829-77c4148007c1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie42d6abca47642698150701f8b361b9f_D20210101-20211231" decimals="-6" name="us-gaap:CostOfRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzUtNS0xLTEtNzIxNTE_c7cde32f-7ece-41d8-aa1c-a9a94f20d312">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6d6069512b142969a9bd9af9461da85_D20210101-20211231" decimals="-6" name="us-gaap:NonoperatingIncomeExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzYtMS0xLTEtNzIxNTE_a9f5d768-e994-43a3-be81-5a4c54faab8d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8301b5b781954e5cab4cec0d280848d8_D20210101-20211231" decimals="-6" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzYtMi0xLTEtNzIxNTE_4972ee75-9cb0-4e01-8f5c-0891051c8c73">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56560a3d5b6f482fb1362de4ae05404a_D20210101-20211231" decimals="-6" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzYtMy0xLTEtNzIxNTE_901428c5-54ef-4bd5-8fe0-6c932276813f">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie342040266664c0697ed0bb113671458_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzYtNC0xLTEtNzIxNTE_c3f80899-7b74-4b1f-95e7-675a2efd0860">35</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1c613d72567b4a16a99b20a430597575_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzYtNS0xLTEtNzIxNTE_de41c577-7f33-4c94-9baf-22c68d84fbb7">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b467ba124624433b5dde0c999c6d48c_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzctMS0xLTEtNzIxNTE_87be343b-fee2-4061-a7e2-93d53f29fa74">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i20d1fb9afb38451ca9e6cb8fe56983f4_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzctMi0xLTEtNzIxNTE_1078b840-49f8-4758-b3ec-d5301b7e6aa7">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1dd8a1332a14539a8a3ec1b816d046a_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzctMy0xLTEtNzIxNTE_556f8dc2-8ad2-4a3c-97d9-ec0d653131f2">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i709e6e037bfd466aa715d869eb7ef424_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzctNC0xLTEtNzIxNTE_3d1a2c4f-e61b-4b4a-94c2-338c51644cbf">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03590bf15d844678bd0f164d99ca4949_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzctNS0xLTEtNzIxNTE_723773df-a3dd-4fb8-8410-1af5640ee941">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net OCI</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b467ba124624433b5dde0c999c6d48c_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzgtMS0xLTEtNzIxNTE_d4a05321-3278-432a-a7f1-d3bf03976e83">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20d1fb9afb38451ca9e6cb8fe56983f4_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzgtMi0xLTEtNzIxNTE_75b92b46-b35a-4ac9-8cdd-cf93dce85bc6">104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1dd8a1332a14539a8a3ec1b816d046a_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzgtMy0xLTEtNzIxNTE_1a203216-f710-427e-b8c8-58e1a91c9a72">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i709e6e037bfd466aa715d869eb7ef424_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzgtNC0xLTEtNzIxNTE_ef23720c-c73f-4752-9718-05e4b54305cc">469</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03590bf15d844678bd0f164d99ca4949_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzgtNS0xLTEtNzIxNTE_eabb6e34-671f-457e-b8f2-f615d8d6c0f3">626</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0519930af2964fea9f28a898c17d838f_I20211231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzktMS0xLTEtNzIxNTE_d06d2b1d-7fd4-4c6e-bbf5-a947443e4921">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia02e7e1cc90e4e87a48f39f4f3e33376_I20211231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzktMi0xLTEtNzIxNTE_933625bf-931d-4d91-a9b5-00e7e82d3f66">155</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1917a31882a249a2adf69310c998c7de_I20211231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzktMy0xLTEtNzIxNTE_e11e86fa-bfe5-4c08-98ef-eb27e8258148">40</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99ab40e0eb8d45a9abce0e0cd3109e0c_I20211231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzktNC0xLTEtNzIxNTE_b9ce8826-356f-4279-b620-7db6438676c2">416</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzktNS0xLTEtNzIxNTE_1d377e82-1f7c-4eef-93d2-c77160e53e15">531</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">OCI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27e420a9891e411095e99eaeb5a2021a_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzEwLTEtMS0xLTcyMTUx_a49b2641-22c4-422b-924f-0fa6fdc2e67d">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e9f0e75f256464eb07e962100d56a05_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzEwLTItMS0xLTcyMTUx_8f94292e-e286-4b5c-bb4e-a108eddcd9d7">244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i823914fb5eb4408998556e61e5fe9f04_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzEwLTMtMS0xLTcyMTUx_455f7e3f-9bf4-433b-a5b2-5bf5fb6e5fb2">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b23b51f78e64690aca64f7624b9d18b_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzEwLTQtMS0xLTcyMTUx_304d0659-473b-4870-b4f0-ef13fcc52d64">253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzEwLTUtMS0xLTcyMTUx_3b8b85c2-697a-4f12-81a1-6c9cb3db05cf">539</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27e420a9891e411095e99eaeb5a2021a_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzExLTEtMS0xLTcyMTUx_bb6e38a2-697b-4c1e-afea-0f9c6f14463a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4e9f0e75f256464eb07e962100d56a05_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzExLTItMS0xLTcyMTUx_e639100e-cac7-42f9-a1a5-dc218499ff3e">64</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i823914fb5eb4408998556e61e5fe9f04_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzExLTMtMS0xLTcyMTUx_a393288b-376f-4929-91b0-8efeb57c4b83">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b23b51f78e64690aca64f7624b9d18b_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzExLTQtMS0xLTcyMTUx_cd3a18fb-5aa0-4262-9a0d-a0ef9a61a3a6">110</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzExLTUtMS0xLTcyMTUx_fe6d30da-3705-43b0-a018-b6cab7e78cf4">173</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Reclassifications to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31974aa90e594af395bc99e745210e04_D20220101-20221231" decimals="-6" name="us-gaap:CostOfRevenue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzEzLTEtMS0xLTcyMTUx_5f62abab-f622-4983-9bda-0c7e80c6baf9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf37d1b5ba934c02852349cf34dae000_D20220101-20221231" decimals="-6" name="us-gaap:CostOfRevenue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzEzLTItMS0xLTcyMTUx_8b9c785c-b7b4-4281-b4a5-6d43f9f50869">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic4624597685941fb98a05555c8d17182_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:CostOfRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzEzLTMtMS0xLTcyMTUx_9fe2577a-06bb-4b76-ab33-3292f24f845b">23</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8820c2b08814387afe9320dfdf9b54a_D20220101-20221231" decimals="-6" name="us-gaap:CostOfRevenue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzEzLTQtMS0xLTcyMTUx_34569407-5a23-46ee-8061-5d7bd98b1e80">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e1908513627494bb6e9fc5eebd933fa_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:CostOfRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzEzLTUtMS0xLTcyMTUx_3c8655e9-a1dc-435d-bde7-cfa278ac863c">23</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i102b956e06124e8aa1a5792f644f35dc_D20220101-20221231" decimals="-6" name="us-gaap:NonoperatingIncomeExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzE0LTEtMS0xLTcyMTUx_a8ba9f09-bd82-4903-b7c3-40ad58d71ec4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icecc44177f9c4483aaa2d013aef04666_D20220101-20221231" decimals="-6" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzE0LTItMS0xLTcyMTUx_61f75200-a8a5-45e2-9aae-9da9847e5b39">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8053af52dacf4e0a9c8f9dcfbcc32961_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzE0LTMtMS0xLTcyMTUx_e37373c3-8be1-46fe-a1e4-54583ab9ddb1">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a65bdddfec44880a63f89575a6757b0_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzE0LTQtMS0xLTcyMTUx_1bf19b50-ad90-48c6-9f2e-3fc700b3a401">39</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d20d404d8984a96b12853bc045fd7e1_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzE0LTUtMS0xLTcyMTUx_aee4e133-2d3f-40a3-b6b3-4ad6d7027433">36</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i181aa9e6db8d4da6a8f9d5751bc9b195_D20220101-20221231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzE1LTEtMS0xLTcyMTUx_b60a736b-6630-4101-bb88-c194b2de15f8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5a208a660784ecd8fafc1ab3b4650ae_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzE1LTItMS0xLTcyMTUx_b6b29e49-e6ff-4e7c-bcb7-6cb82bc871ce">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d21dceba0df4948b9211257ad5aa554_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzE1LTMtMS0xLTcyMTUx_ba44d9bd-26a5-41ce-8edb-40d07c7d153f">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6796554675ff4f1f973d3c595bd3e499_D20220101-20221231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzE1LTQtMS0xLTcyMTUx_ab4ab914-0a5b-409a-a3ef-ad604f939a48">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic99004e7285a44e0a449ff60ca2c5433_D20220101-20221231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzE1LTUtMS0xLTcyMTUx_c5da1f65-5957-4d84-a75d-6169dbb6707e">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net OCI</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i181aa9e6db8d4da6a8f9d5751bc9b195_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzE2LTEtMS0xLTcyMTUx_ed4addd2-5b70-4c64-9868-e8706601a4bf">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5a208a660784ecd8fafc1ab3b4650ae_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzE2LTItMS0xLTcyMTUx_5e303abe-bf62-4d28-807d-193291fce92b">186</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d21dceba0df4948b9211257ad5aa554_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzE2LTMtMS0xLTcyMTUx_aa6c7c5d-ccbf-4033-a361-c16046b17bcd">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6796554675ff4f1f973d3c595bd3e499_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzE2LTQtMS0xLTcyMTUx_a0c5c798-f9ff-4956-994e-c4762fbdc3fc">113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic99004e7285a44e0a449ff60ca2c5433_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzE2LTUtMS0xLTcyMTUx_5e23ed03-9d87-4919-8791-2df0c3effb3d">310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6766e2f3ba404e94b97b133b143443ec_I20221231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzE3LTEtMS0xLTcyMTUx_7b465dc2-0075-49e2-b97c-47f18f9275b1">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09ab23df9d8d46d6b99f210842561aad_I20221231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzE3LTItMS0xLTcyMTUx_4bd14903-be52-43a8-83f8-a51eb90108a7">31</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ce78b990cc3435b974774303b8f1500_I20221231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzE3LTMtMS0xLTcyMTUx_27f892f2-c9ed-4ef0-a9d4-b8a110ff814a">52</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id36e8e59f17a4fd2b1810524c32bdb32_I20221231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzE3LTQtMS0xLTcyMTUx_691a81ed-0a05-4c83-ad40-dbf28df5016a">303</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzE3LTUtMS0xLTcyMTUx_4a736a1f-8e7e-4dd1-a081-1c3478c9d251">221</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:continuation></div><div id="icec46013a0ad4608b89f97e433dd3417_115"></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTE 6 - <ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTUvZnJhZzo4NDYwZTAzYzhlZjg0Y2I1YjhkZWQyMjI2ZWIxNDE5Yi90ZXh0cmVnaW9uOjg0NjBlMDNjOGVmODRjYjViOGRlZDIyMjZlYjE0MTliXzMyNzA_7e185176-000f-44dd-a12a-4625fd51d288" continuedAt="i8ba508d260b242fa8c37c08d24815074" escape="true">ACQUISITIONS</ix:nonNumeric></span></div><ix:continuation id="i8ba508d260b242fa8c37c08d24815074" continuedAt="i574fce37362e4c2f84bf3c1a014a06f6"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We acquire stock in companies and various assets that continue to support our capital deployment and product development strategies. The aggregate purchase price of our acquisitions, net of cash acquired was $<ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTUvZnJhZzo4NDYwZTAzYzhlZjg0Y2I1YjhkZWQyMjI2ZWIxNDE5Yi90ZXh0cmVnaW9uOjg0NjBlMDNjOGVmODRjYjViOGRlZDIyMjZlYjE0MTliXzIzNQ_025d2895-649c-439c-8120-92a5dda32159">2,563</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTUvZnJhZzo4NDYwZTAzYzhlZjg0Y2I1YjhkZWQyMjI2ZWIxNDE5Yi90ZXh0cmVnaW9uOjg0NjBlMDNjOGVmODRjYjViOGRlZDIyMjZlYjE0MTliXzI0Mg_71500055-f8e0-4940-b2a1-7e42e82798c4">393</ix:nonFraction> in 2022 and 2021. </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In February 2022 we completed the acquisition of Vocera for $<ix:nonFraction unitRef="usdPerShare" contextRef="iedb144142fe44106a0298139475b1b7e_D20220201-20220228" decimals="2" name="syk:BusinessCombinationConsiderationTransferredPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTUvZnJhZzo4NDYwZTAzYzhlZjg0Y2I1YjhkZWQyMjI2ZWIxNDE5Yi90ZXh0cmVnaW9uOjg0NjBlMDNjOGVmODRjYjViOGRlZDIyMjZlYjE0MTliXzEwOTk1MTE2MzExNDk_ff9655a1-1ad9-4338-923e-d33a1dbb4b53">79.25</ix:nonFraction> per share, or an aggregate purchase price of $<ix:nonFraction unitRef="usd" contextRef="iedb144142fe44106a0298139475b1b7e_D20220201-20220228" decimals="-7" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTUvZnJhZzo4NDYwZTAzYzhlZjg0Y2I1YjhkZWQyMjI2ZWIxNDE5Yi90ZXh0cmVnaW9uOjg0NjBlMDNjOGVmODRjYjViOGRlZDIyMjZlYjE0MTliXzEwOTk1MTE2MzExOTg_8742e467-f48f-4d6c-80b3-830f7a392f51">2.6</ix:nonFraction>&#160;billion, net of cash acquired ($<ix:nonFraction unitRef="usd" contextRef="iedb144142fe44106a0298139475b1b7e_D20220201-20220228" decimals="-7" name="syk:BusinessCombinationConsiderationTransferredIncludingConvertibleNotes" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTUvZnJhZzo4NDYwZTAzYzhlZjg0Y2I1YjhkZWQyMjI2ZWIxNDE5Yi90ZXh0cmVnaW9uOjg0NjBlMDNjOGVmODRjYjViOGRlZDIyMjZlYjE0MTliXzEwOTk1MTE2MzEyMjU_2dd71086-309c-40d3-9a5b-7cb11b160f01">3.0</ix:nonFraction>&#160;billion including convertible notes). Vocera is a leader in the digital care coordination and communication category. Vocera is part of our Medical business within MedSurg and Neurotechnology. Goodwill attributable to the acquisition reflects the strategic benefits of expanding our </span></div></ix:continuation></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><ix:continuation id="i574fce37362e4c2f84bf3c1a014a06f6"><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">presence in adjacent markets, diversifying our product portfolio, advancing innovations and accelerating our digital aspirations. This goodwill is not deductible for tax purposes</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During 2022 note holders elected to redeem the <ix:nonFraction unitRef="rate" contextRef="if643644842344c0ab2e0d9a12b06b426_I20201130" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTUvZnJhZzo4NDYwZTAzYzhlZjg0Y2I1YjhkZWQyMjI2ZWIxNDE5Yi90ZXh0cmVnaW9uOjg0NjBlMDNjOGVmODRjYjViOGRlZDIyMjZlYjE0MTliXzExOTI_a683eb5a-5cc1-448c-bcc8-8a285f83205c">1.50</ix:nonFraction>% and <ix:nonFraction unitRef="rate" contextRef="i22182f50ad11452dba95524874b934aa_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTUvZnJhZzo4NDYwZTAzYzhlZjg0Y2I1YjhkZWQyMjI2ZWIxNDE5Yi90ZXh0cmVnaW9uOjg0NjBlMDNjOGVmODRjYjViOGRlZDIyMjZlYjE0MTliXzExOTk_3ffde49a-bede-4fbc-8c1f-f1074522b0e6">0.50</ix:nonFraction>% convertible notes assumed in the Vocera acquisition for $<ix:nonFraction unitRef="usd" contextRef="i2c9e3c188be94e4c980232bc3fbcb14b_D20201101-20201130" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTUvZnJhZzo4NDYwZTAzYzhlZjg0Y2I1YjhkZWQyMjI2ZWIxNDE5Yi90ZXh0cmVnaW9uOjg0NjBlMDNjOGVmODRjYjViOGRlZDIyMjZlYjE0MTliXzMyNjY_0e813f62-1fe5-4c3f-9af8-e08780f35d47">101</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i89f1c0806ea84da2867f98aea716c643_D20201201-20201231" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTUvZnJhZzo4NDYwZTAzYzhlZjg0Y2I1YjhkZWQyMjI2ZWIxNDE5Yi90ZXh0cmVnaW9uOjg0NjBlMDNjOGVmODRjYjViOGRlZDIyMjZlYjE0MTliXzEyNjU_6449566b-53f1-4760-9d28-1dd84de760b9">324</ix:nonFraction>. These repayments are classified as financing activities in the Consolidated Statements of Cash Flows.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Share-based awards for Vocera employees vested upon our acquisition and a charge of $<ix:nonFraction unitRef="usd" contextRef="i0eadaeefb6b844b7bcb7e34005c139af_D20220101-20221231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTUvZnJhZzo4NDYwZTAzYzhlZjg0Y2I1YjhkZWQyMjI2ZWIxNDE5Yi90ZXh0cmVnaW9uOjg0NjBlMDNjOGVmODRjYjViOGRlZDIyMjZlYjE0MTliXzg3OTYwOTMwMjc1Mzc_c480121a-fae0-4e0f-8c18-d4356c45cc97">132</ix:nonFraction> was recorded in selling, general and administrative expenses in 2022.</span></div><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTUvZnJhZzo4NDYwZTAzYzhlZjg0Y2I1YjhkZWQyMjI2ZWIxNDE5Yi90ZXh0cmVnaW9uOjg0NjBlMDNjOGVmODRjYjViOGRlZDIyMjZlYjE0MTliXzMyNzQ_a902e96c-69fd-4def-a93e-e4ed152c255c" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Purchase price allocations for our significant acquisitions are:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.486%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.878%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Purchase Price Allocation of Acquired Net Assets</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Vocera</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Tangible assets acquired:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e2ff09ffaf04bd7b9e7b8d473abbcb6_I20221231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTUvZnJhZzo4NDYwZTAzYzhlZjg0Y2I1YjhkZWQyMjI2ZWIxNDE5Yi90YWJsZTo3M2E2NGRiYzk4NGI0YjBiYmJmZTdkNTQ3NDUzNmY3ZC90YWJsZXJhbmdlOjczYTY0ZGJjOTg0YjRiMGJiYmZlN2Q1NDc0NTM2ZjdkXzMtMi0xLTEtNzIxNTE_95bdaa85-29fb-4556-a848-806448e5249f">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e2ff09ffaf04bd7b9e7b8d473abbcb6_I20221231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTUvZnJhZzo4NDYwZTAzYzhlZjg0Y2I1YjhkZWQyMjI2ZWIxNDE5Yi90YWJsZTo3M2E2NGRiYzk4NGI0YjBiYmJmZTdkNTQ3NDUzNmY3ZC90YWJsZXJhbmdlOjczYTY0ZGJjOTg0YjRiMGJiYmZlN2Q1NDc0NTM2ZjdkXzQtMi0xLTEtODM0NTA_abe24ae6-994f-4489-bc17-1114ed36e82e">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deferred income tax assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e2ff09ffaf04bd7b9e7b8d473abbcb6_I20221231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTUvZnJhZzo4NDYwZTAzYzhlZjg0Y2I1YjhkZWQyMjI2ZWIxNDE5Yi90YWJsZTo3M2E2NGRiYzk4NGI0YjBiYmJmZTdkNTQ3NDUzNmY3ZC90YWJsZXJhbmdlOjczYTY0ZGJjOTg0YjRiMGJiYmZlN2Q1NDc0NTM2ZjdkXzQtMi0xLTEtNzIxNTE_f14a478d-576f-4ff5-94e0-e1ce5766d830">73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e2ff09ffaf04bd7b9e7b8d473abbcb6_I20221231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTUvZnJhZzo4NDYwZTAzYzhlZjg0Y2I1YjhkZWQyMjI2ZWIxNDE5Yi90YWJsZTo3M2E2NGRiYzk4NGI0YjBiYmJmZTdkNTQ3NDUzNmY3ZC90YWJsZXJhbmdlOjczYTY0ZGJjOTg0YjRiMGJiYmZlN2Q1NDc0NTM2ZjdkXzYtMi0xLTEtNzIxNTE_f0d6449b-58a0-4f69-83fa-71616a2447cf">92</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e2ff09ffaf04bd7b9e7b8d473abbcb6_I20221231" decimals="-6" name="syk:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTUvZnJhZzo4NDYwZTAzYzhlZjg0Y2I1YjhkZWQyMjI2ZWIxNDE5Yi90YWJsZTo3M2E2NGRiYzk4NGI0YjBiYmJmZTdkNTQ3NDUzNmY3ZC90YWJsZXJhbmdlOjczYTY0ZGJjOTg0YjRiMGJiYmZlN2Q1NDc0NTM2ZjdkXzctMi0xLTEtNzIxNTE_61606f54-d612-498b-bb9d-e10213954823">425</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deferred income tax liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e2ff09ffaf04bd7b9e7b8d473abbcb6_I20221231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTUvZnJhZzo4NDYwZTAzYzhlZjg0Y2I1YjhkZWQyMjI2ZWIxNDE5Yi90YWJsZTo3M2E2NGRiYzk4NGI0YjBiYmJmZTdkNTQ3NDUzNmY3ZC90YWJsZXJhbmdlOjczYTY0ZGJjOTg0YjRiMGJiYmZlN2Q1NDc0NTM2ZjdkXzgtMi0xLTEtNzIxNTE_a824dade-cc3b-4079-83c3-048a70b7e10d">182</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e2ff09ffaf04bd7b9e7b8d473abbcb6_I20221231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTUvZnJhZzo4NDYwZTAzYzhlZjg0Y2I1YjhkZWQyMjI2ZWIxNDE5Yi90YWJsZTo3M2E2NGRiYzk4NGI0YjBiYmJmZTdkNTQ3NDUzNmY3ZC90YWJsZXJhbmdlOjczYTY0ZGJjOTg0YjRiMGJiYmZlN2Q1NDc0NTM2ZjdkXzEwLTItMS0xLTcyMTUx_f979bce3-fc11-4d44-a0a9-26e516d867b9">115</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Intangible assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Customer and distributor relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i101c3d1a12034ac38fe2e5f8c0168405_I20221231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTUvZnJhZzo4NDYwZTAzYzhlZjg0Y2I1YjhkZWQyMjI2ZWIxNDE5Yi90YWJsZTo3M2E2NGRiYzk4NGI0YjBiYmJmZTdkNTQ3NDUzNmY3ZC90YWJsZXJhbmdlOjczYTY0ZGJjOTg0YjRiMGJiYmZlN2Q1NDc0NTM2ZjdkXzEyLTItMS0xLTcyMTUx_9e736e55-f124-4b80-8fa6-7d5f3e212083">550</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic19a68dc4f2647639ab8a2956791d892_I20221231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTUvZnJhZzo4NDYwZTAzYzhlZjg0Y2I1YjhkZWQyMjI2ZWIxNDE5Yi90YWJsZTo3M2E2NGRiYzk4NGI0YjBiYmJmZTdkNTQ3NDUzNmY3ZC90YWJsZXJhbmdlOjczYTY0ZGJjOTg0YjRiMGJiYmZlN2Q1NDc0NTM2ZjdkXzEzLTItMS0xLTcyMTUx_0d80ec08-ea95-47d9-a8ba-f54d0ace5776">178</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Trade name</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1d22140738841ca90e737fe8f886088_I20221231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTUvZnJhZzo4NDYwZTAzYzhlZjg0Y2I1YjhkZWQyMjI2ZWIxNDE5Yi90YWJsZTo3M2E2NGRiYzk4NGI0YjBiYmJmZTdkNTQ3NDUzNmY3ZC90YWJsZXJhbmdlOjczYTY0ZGJjOTg0YjRiMGJiYmZlN2Q1NDc0NTM2ZjdkXzE0LTItMS0xLTcyMTUx_1854ea8b-2f73-4ee8-a171-a58c2189e744">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e2ff09ffaf04bd7b9e7b8d473abbcb6_I20221231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTUvZnJhZzo4NDYwZTAzYzhlZjg0Y2I1YjhkZWQyMjI2ZWIxNDE5Yi90YWJsZTo3M2E2NGRiYzk4NGI0YjBiYmJmZTdkNTQ3NDUzNmY3ZC90YWJsZXJhbmdlOjczYTY0ZGJjOTg0YjRiMGJiYmZlN2Q1NDc0NTM2ZjdkXzE2LTItMS0xLTcyMTUx_ed8d6e0a-be3a-49a2-b661-945a0c92ef71">2,328</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Purchase price, net of cash acquired of $<ix:nonFraction unitRef="usd" contextRef="i0eadaeefb6b844b7bcb7e34005c139af_D20220101-20221231" decimals="-6" name="us-gaap:CashAcquiredFromAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTUvZnJhZzo4NDYwZTAzYzhlZjg0Y2I1YjhkZWQyMjI2ZWIxNDE5Yi90YWJsZTo3M2E2NGRiYzk4NGI0YjBiYmJmZTdkNTQ3NDUzNmY3ZC90YWJsZXJhbmdlOjczYTY0ZGJjOTg0YjRiMGJiYmZlN2Q1NDc0NTM2ZjdkXzE3LTAtMS0xLTcyMTUxL3RleHRyZWdpb246MDkwZDlmOWZhZTFhNGFkZmJiOTAyZDQzMjgxNjI0MDBfMTA5OTUxMTYyNzgzMA_a333a478-77d0-4391-8368-fbbe17574542">281</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e2ff09ffaf04bd7b9e7b8d473abbcb6_I20221231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTUvZnJhZzo4NDYwZTAzYzhlZjg0Y2I1YjhkZWQyMjI2ZWIxNDE5Yi90YWJsZTo3M2E2NGRiYzk4NGI0YjBiYmJmZTdkNTQ3NDUzNmY3ZC90YWJsZXJhbmdlOjczYTY0ZGJjOTg0YjRiMGJiYmZlN2Q1NDc0NTM2ZjdkXzE3LTItMS0xLTcyMTUx_ceceee4b-1de2-4297-b999-5a757f42ad84">2,563</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Weighted average life of intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0eadaeefb6b844b7bcb7e34005c139af_D20220101-20221231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTUvZnJhZzo4NDYwZTAzYzhlZjg0Y2I1YjhkZWQyMjI2ZWIxNDE5Yi90YWJsZTo3M2E2NGRiYzk4NGI0YjBiYmJmZTdkNTQ3NDUzNmY3ZC90YWJsZXJhbmdlOjczYTY0ZGJjOTg0YjRiMGJiYmZlN2Q1NDc0NTM2ZjdkXzE4LTItMS0xLTcyMTUx_9dac117d-0aa3-4b7d-a06f-d3b1d4599782">13</ix:nonNumeric></span></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our allocation of the Vocera purchase price to intangible assets and residual goodwill is preliminary. These amounts are subject to review and potential change during the measurement period, which will extend to February 2023. The subsequent adjustment of the preliminary amounts may be material.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In September 2021 we completed the acquisition of Gauss Surgical, Inc. (Gauss) for $<ix:nonFraction unitRef="usd" contextRef="i4889250342a0437bb3b31f671106d385_D20210901-20210930" decimals="-6" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTUvZnJhZzo4NDYwZTAzYzhlZjg0Y2I1YjhkZWQyMjI2ZWIxNDE5Yi90ZXh0cmVnaW9uOjg0NjBlMDNjOGVmODRjYjViOGRlZDIyMjZlYjE0MTliXzU0OTc1NTgyMzE2MQ_fbbdfd47-d235-4b38-9b16-83f133fd667a">120</ix:nonFraction> in cash and up to $<ix:nonFraction unitRef="usd" contextRef="i4889250342a0437bb3b31f671106d385_D20210901-20210930" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTUvZnJhZzo4NDYwZTAzYzhlZjg0Y2I1YjhkZWQyMjI2ZWIxNDE5Yi90ZXh0cmVnaW9uOjg0NjBlMDNjOGVmODRjYjViOGRlZDIyMjZlYjE0MTliXzU0OTc1NTgyMzE3MA_4f251aa1-d8f2-40aa-8cfc-6d00fa7a52b8">40</ix:nonFraction> in future milestone payments. Gauss is a medical device company that has developed Triton, an artificial intelligence-enabled platform for real-time monitoring of blood loss during surgery. Gauss is part of our Instruments business within MedSurg and Neurotechnology. Goodwill attributable to the acquisition is not deductible for tax purposes. The purchase price allocations for Gauss and other 2021 acquisitions were finalized in 2022 without material adjustments.</span></div></ix:continuation><div id="icec46013a0ad4608b89f97e433dd3417_118"></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTE 7 - <ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90ZXh0cmVnaW9uOjg1ZTMyMWZhOTM4YjQ3OGI5MDMzZmY1ZGM3ZDQ2NTg3XzYyNjg_8cef3d33-73bf-4fa7-8999-2c22b0fb4388" continuedAt="i1f93fba57a62408a8105d6e3197b8c59" escape="true">CONTINGENCIES AND COMMITMENTS</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i1f93fba57a62408a8105d6e3197b8c59" continuedAt="i883c20cea7f34b7aa971a30ef04e5dc3">We are involved in various ongoing proceedings, legal actions and claims arising in the normal course of business, including proceedings related to product, labor, intellectual property and other matters, the most significant of which are more fully described below. The outcomes of these matters will generally not be known for prolonged periods of time. In certain of the legal proceedings the claimants seek damages as well as other compensatory and equitable relief that could result in the payment of significant claims and settlements and/or the imposition of injunctions or other equitable relief. For legal matters for which management had sufficient information to reasonably estimate our future obligations, a liability representing management's best estimate of the probable loss, or the minimum of the range of probable losses when a best estimate within the range is not known, is recorded. The estimates are based on consultation with legal counsel, previous settlement experience and settlement strategies. If actual outcomes are less favorable than those estimated by management, additional expense may be incurred, which could unfavorably affect future </ix:continuation></span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">32</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2022 FORM 10-K</span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><ix:continuation id="i883c20cea7f34b7aa971a30ef04e5dc3" continuedAt="icf53b4f8c1b84547a104709853e35798"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">operating results. We are self-insured for certain claims and expenses. The ultimate cost to us with respect to product liability claims could be materially different than the amount of the current estimates and accruals and could have a material adverse effect on our financial position, results of operations and cash flows.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In April 2022 the United States District Court for the District of Delaware issued a judgment following a jury verdict in favor of PureWick Corporation (PureWick) for its 2019 complaint seeking patent infringement damages related to our PrimaFit and PrimoFit products. The court awarded damages and we recorded charges of $<ix:nonFraction unitRef="usd" contextRef="i771ee623eaf644bbb46406b9ab01d509_D20220301-20220331" decimals="-6" name="us-gaap:LossContingencyLossInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90ZXh0cmVnaW9uOjg1ZTMyMWZhOTM4YjQ3OGI5MDMzZmY1ZGM3ZDQ2NTg3XzEwOTk1MTE2MzczNzE_63922709-de40-4635-b611-673a4078d588">28</ix:nonFraction> in March 2022. In June 2022 PureWick filed a motion to seek enhancement of the judgment and if successful, the judgment could total approximately $<ix:nonFraction unitRef="usd" contextRef="ifc3a04258fee41d5854dbca8209b7188_I20220630" decimals="-6" name="us-gaap:LossContingencyEstimateOfPossibleLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90ZXh0cmVnaW9uOjg1ZTMyMWZhOTM4YjQ3OGI5MDMzZmY1ZGM3ZDQ2NTg3XzEwOTk1MTE2Mzc1MjE_6d14096a-553b-4c44-ab8e-2e0d0bb24145">100</ix:nonFraction> and include an injunction against future sales. We intend to appeal the outcome of this case. In 2022 PureWick filed additional patent infringement claims related to our PrimaFit products.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Recall Matters</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In June 2012 we voluntarily recalled our Rejuvenate and ABG II Modular-Neck hip stems and terminated global distribution of these hip products. Product liability lawsuits relating to this voluntary recall have been filed against us. In November 2014 we entered into a settlement agreement to compensate eligible United States patients who had revision surgery prior to November 3, 2014 and in December 2016 the settlement program was extended to patients who had revision surgery prior to December 19, 2016. In September 2020 we entered into a second settlement agreement to compensate eligible United States patients who had revision surgery prior to September 9, 2020. There are remaining lawsuits that we will continue to defend against. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In August 2016 and May 2018 we voluntarily recalled certain lot-specific sizes and offsets of LFIT Anatomic CoCr V40 Femoral Heads. Product liability lawsuits and claims relating to this voluntary recall have been filed against us. In November 2018 we entered into a settlement agreement to resolve a significant number of claims and lawsuits related to the recalls. In April 2022 we executed a second agreement to resolve a significant number of claims and lawsuits related to the recalls. The specific terms of the settlement agreement, including the financial terms, are confidential. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">With the acquisition of Wright Medical Group N.V. (Wright) in November 2020, we are responsible for certain product liability claims, primarily related to certain hip products sold by Wright prior to its 2014 divestiture of the OrthoRecon business. We will continue to evaluate each claim and the possible loss we may incur.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">We have incurred, and expect to incur in the future, costs associated with the defense and settlement of these matters. In 2022 we made payments of $<ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" sign="-" name="syk:Changeinaccrualforrecallexpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90ZXh0cmVnaW9uOjg1ZTMyMWZhOTM4YjQ3OGI5MDMzZmY1ZGM3ZDQ2NTg3XzM4NDgyOTA3MTA2NzU_1df7fde0-5d3c-4bb9-a6f9-11178e63f439">157</ix:nonFraction>, primarily related to LFIT femoral heads and Wright hip products. Based on the information that has been received, we have estimated the remaining range of probable loss related to these recall matters to be approximately $<ix:nonFraction unitRef="usd" contextRef="ieaab15c857b047cb895f5e84a16ec8e5_I20221231" decimals="-6" name="us-gaap:LossContingencyEstimateOfPossibleLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90ZXh0cmVnaW9uOjg1ZTMyMWZhOTM4YjQ3OGI5MDMzZmY1ZGM3ZDQ2NTg3XzM4MzY_79e33eb9-97d5-4441-b83c-6261c35e243d">213</ix:nonFraction> to $<ix:nonFraction unitRef="usd" contextRef="i5bcc369cedab4f869853e6b7824ab18f_I20221231" decimals="-6" name="us-gaap:LossContingencyEstimateOfPossibleLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90ZXh0cmVnaW9uOjg1ZTMyMWZhOTM4YjQ3OGI5MDMzZmY1ZGM3ZDQ2NTg3XzM4NDI_3f6c4b20-d32a-401e-888a-4ce1bf02d7d2">347</ix:nonFraction>. We have recorded reserves representing the remaining minimum of the range of probable loss. The final outcomes of these matters are dependent on many factors that are difficult to predict. Accordingly, the ultimate cost related to these matters may be materially different than the amount of our current estimate and accruals and could have a material adverse effect on our results of operations and cash flows.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Leases</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">We lease various manufacturing, warehousing and distribution facilities, administrative and sales offices as well as equipment </span></div></ix:continuation></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><ix:continuation id="icf53b4f8c1b84547a104709853e35798"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">under operating leases. We evaluate our contracts to identify leases, which is generally if there is an identified asset and we have the right to direct the use of and obtain substantially all of the economic benefit from the use of the identified asset. Certain of our lease agreements contain rent escalation clauses (including index-based escalations), rent holidays, capital improvement funding or other lease incentives. We recognize our minimum rental expense on a straight-line basis over the term of the lease beginning with the date of initial control of the asset. Right-of-use assets are recorded in Other noncurrent assets on our Consolidated Balance Sheets. Current and noncurrent lease liabilities are recorded in Accrued expenses and other liabilities and Other noncurrent liabilities, respectively.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have made certain significant assumptions and judgments when recording leases. For all asset classes, we elected to not recognize a right-of-use asset and lease liability for short-term leases and not separate non-lease components from lease components to which they relate and have accounted for the combined lease and non-lease components as a single lease component. The determination of the discount rate used in a lease is our incremental borrowing rate which is based on what we would normally pay to borrow on a collateralized basis over a similar term an amount equal to the lease payments.</span></div><div style="text-align:justify"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90ZXh0cmVnaW9uOjg1ZTMyMWZhOTM4YjQ3OGI5MDMzZmY1ZGM3ZDQ2NTg3XzYyNzY_5b0275d3-8e0e-489c-87d8-ab65e24d5711" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.850%"><tr><td style="width:1.0%"></td><td style="width:58.493%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.376%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.253%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.378%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzItMC0xLTEtNzIxNTE_9731ce2e-d82a-4967-b042-db8cc99630f8"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzItMC0xLTEtNzIxNTE_f24b63f9-9795-4048-881d-72c0ef014936">Right-of-use assets</span></span> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzItMS0xLTEtNzIxNTE_50b75d19-362e-4626-baeb-ab66f0368c7c">473</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzItMy0xLTEtNzIxNTE_98edeb58-c934-4b41-9812-55903ea89688">419</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzMtMC0xLTEtNzIxNTE_4a79c8d2-7e9e-4a69-8e7c-3f2c45ccd096"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzMtMC0xLTEtNzIxNTE_582bcc35-c25f-4f59-a914-b85367fcbaf4">Lease liabilities, current</span></span> </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzMtMS0xLTEtNzIxNTE_f31c4d56-9221-4518-8857-2dfb9c135057">121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzMtMy0xLTEtNzIxNTE_c42aca32-ebcc-4752-bc62-1b9e2bde144e">112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzQtMC0xLTEtNzIxNTE_3e00ae6d-1860-4511-a971-3c7d349014a4"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzQtMC0xLTEtNzIxNTE_b077084d-a166-4834-a410-c652caa7aed3">Lease liabilities, noncurrent</span></span> </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzQtMS0xLTEtNzIxNTE_6494d2f3-477c-4ab7-b031-760b5cb56353">357</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzQtMy0xLTEtNzIxNTE_76fa510a-5c17-439f-bb19-57a0a4e66af3">310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other information:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Weighted-average remaining lease term (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzktMS0xLTEtNzIxNTE_8ff95868-390b-43b8-9da2-f16d0ede6a7f">5.5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;text-indent:-0.01pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzktMy0xLTEtNzIxNTE_91dde324-226b-4c34-907f-d0da9d75a5ee">5.4</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Weighted-average discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzExLTEtMS0xLTcyMTUx_f1dce60b-59bf-41a3-a075-d914a08099c7">3.22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzExLTMtMS0xLTcyMTUx_b3b0e52e-8bdc-4822-915c-138cb0de7619">2.86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease expense totaled $<ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:OperatingLeaseExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90ZXh0cmVnaW9uOjg1ZTMyMWZhOTM4YjQ3OGI5MDMzZmY1ZGM3ZDQ2NTg3XzM4NDgyOTA3MTA2Mzg_27b73ee3-78b0-4cec-b9aa-c20ba8c23aa0">149</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:OperatingLeaseExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90ZXh0cmVnaW9uOjg1ZTMyMWZhOTM4YjQ3OGI5MDMzZmY1ZGM3ZDQ2NTg3XzM4NDgyOTA3MTA2NDY_22625487-1204-43c3-b28e-44271cb814e6">133</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:OperatingLeaseExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90ZXh0cmVnaW9uOjg1ZTMyMWZhOTM4YjQ3OGI5MDMzZmY1ZGM3ZDQ2NTg3XzM4NDgyOTA3MTA2NTA_45af8567-1566-4422-ba9d-baefc68916fc">130</ix:nonFraction> in 2022, 2021 and 2020.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Future Obligations</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have purchase commitments for materials, supplies, services and property, plant and equipment as part of the normal course of business. In addition, we lease various manufacturing, warehousing and distribution facilities, administrative and sales offices as well as equipment under operating leases. Refer to Note 10 for more information on the debt obligations.</span></div><div style="text-align:justify"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90ZXh0cmVnaW9uOjg1ZTMyMWZhOTM4YjQ3OGI5MDMzZmY1ZGM3ZDQ2NTg3XzYyNjc_70aa996f-a9b1-4915-8694-d921044a8422" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.945%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2027</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Thereafter</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Debt repayments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTpiNWU3ZjZjNjAwOTQ0ZDkwYjJlNWQ5MmJjMmUwMTAxMC90YWJsZXJhbmdlOmI1ZTdmNmM2MDA5NDRkOTBiMmU1ZDkyYmMyZTAxMDEwXzItMS0xLTEtNzIxNTE_d8d4597f-8f71-4f16-8361-5dfa2b31e1ba">1,208</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTpiNWU3ZjZjNjAwOTQ0ZDkwYjJlNWQ5MmJjMmUwMTAxMC90YWJsZXJhbmdlOmI1ZTdmNmM2MDA5NDRkOTBiMmU1ZDkyYmMyZTAxMDEwXzItMi0xLTEtNzIxNTE_6f14647e-97ea-4805-b9d2-5782ff4a8b7d">1,450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTpiNWU3ZjZjNjAwOTQ0ZDkwYjJlNWQ5MmJjMmUwMTAxMC90YWJsZXJhbmdlOmI1ZTdmNmM2MDA5NDRkOTBiMmU1ZDkyYmMyZTAxMDEwXzItMy0xLTEtNzIxNTE_471eb099-1800-4c9b-96d2-783a245eae4a">2,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTpiNWU3ZjZjNjAwOTQ0ZDkwYjJlNWQ5MmJjMmUwMTAxMC90YWJsZXJhbmdlOmI1ZTdmNmM2MDA5NDRkOTBiMmU1ZDkyYmMyZTAxMDEwXzItNC0xLTEtNzIxNTE_72acc67a-ea64-404e-913a-71cea81226ad">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTpiNWU3ZjZjNjAwOTQ0ZDkwYjJlNWQ5MmJjMmUwMTAxMC90YWJsZXJhbmdlOmI1ZTdmNmM2MDA5NDRkOTBiMmU1ZDkyYmMyZTAxMDEwXzItNS0xLTEtNzIxNTE_70c144de-1ad6-46e9-927c-2d9957bf6b5c">750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTpiNWU3ZjZjNjAwOTQ0ZDkwYjJlNWQ5MmJjMmUwMTAxMC90YWJsZXJhbmdlOmI1ZTdmNmM2MDA5NDRkOTBiMmU1ZDkyYmMyZTAxMDEwXzItNi0xLTEtNzIxNTE_4ad883fc-e4db-4a29-b7ee-8426b7a41c17">6,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Purchase obligations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:RecordedUnconditionalPurchaseObligationDueWithinOneYear" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTpiNWU3ZjZjNjAwOTQ0ZDkwYjJlNWQ5MmJjMmUwMTAxMC90YWJsZXJhbmdlOmI1ZTdmNmM2MDA5NDRkOTBiMmU1ZDkyYmMyZTAxMDEwXzMtMS0xLTEtNzIxNTE_212101b4-ba5f-4846-98fc-1d495a933f92">1,595</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:RecordedUnconditionalPurchaseObligationDueInSecondYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTpiNWU3ZjZjNjAwOTQ0ZDkwYjJlNWQ5MmJjMmUwMTAxMC90YWJsZXJhbmdlOmI1ZTdmNmM2MDA5NDRkOTBiMmU1ZDkyYmMyZTAxMDEwXzMtMi0xLTEtNzIxNTE_66365457-7dc4-4ce6-b388-0167f3195b83">68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:RecordedUnconditionalPurchaseObligationDueInThirdYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTpiNWU3ZjZjNjAwOTQ0ZDkwYjJlNWQ5MmJjMmUwMTAxMC90YWJsZXJhbmdlOmI1ZTdmNmM2MDA5NDRkOTBiMmU1ZDkyYmMyZTAxMDEwXzMtMy0xLTEtNzIxNTE_08c601c6-8664-49e7-825b-face2470bbe9">53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:RecordedUnconditionalPurchaseObligationDueInFourthYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTpiNWU3ZjZjNjAwOTQ0ZDkwYjJlNWQ5MmJjMmUwMTAxMC90YWJsZXJhbmdlOmI1ZTdmNmM2MDA5NDRkOTBiMmU1ZDkyYmMyZTAxMDEwXzMtNC0xLTEtNzIxNTE_56243b6a-35cf-4946-b718-485f442e2628">56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:RecordedUnconditionalPurchaseObligationDueInFifthYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTpiNWU3ZjZjNjAwOTQ0ZDkwYjJlNWQ5MmJjMmUwMTAxMC90YWJsZXJhbmdlOmI1ZTdmNmM2MDA5NDRkOTBiMmU1ZDkyYmMyZTAxMDEwXzMtNS0xLTEtNzIxNTE_3fd1d662-3bb4-4ebf-959d-a71fb0679f6b">59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:RecordedUnconditionalPurchaseObligationDueAfterFifthYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTpiNWU3ZjZjNjAwOTQ0ZDkwYjJlNWQ5MmJjMmUwMTAxMC90YWJsZXJhbmdlOmI1ZTdmNmM2MDA5NDRkOTBiMmU1ZDkyYmMyZTAxMDEwXzMtNi0xLTEtNzIxNTE_44b070a2-5edc-48cc-ac70-aab9100590a6">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Minimum lease payments</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTpiNWU3ZjZjNjAwOTQ0ZDkwYjJlNWQ5MmJjMmUwMTAxMC90YWJsZXJhbmdlOmI1ZTdmNmM2MDA5NDRkOTBiMmU1ZDkyYmMyZTAxMDEwXzQtMS0xLTEtNzIxNTE_2e573eb0-d6ee-4516-a171-85d6a242d067">126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTpiNWU3ZjZjNjAwOTQ0ZDkwYjJlNWQ5MmJjMmUwMTAxMC90YWJsZXJhbmdlOmI1ZTdmNmM2MDA5NDRkOTBiMmU1ZDkyYmMyZTAxMDEwXzQtMi0xLTEtNzIxNTE_26c6ffc2-4218-4e4f-80e3-5494fafc3351">96</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTpiNWU3ZjZjNjAwOTQ0ZDkwYjJlNWQ5MmJjMmUwMTAxMC90YWJsZXJhbmdlOmI1ZTdmNmM2MDA5NDRkOTBiMmU1ZDkyYmMyZTAxMDEwXzQtMy0xLTEtNzIxNTE_72145c84-3baa-41ef-9f34-5bf725421603">73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTpiNWU3ZjZjNjAwOTQ0ZDkwYjJlNWQ5MmJjMmUwMTAxMC90YWJsZXJhbmdlOmI1ZTdmNmM2MDA5NDRkOTBiMmU1ZDkyYmMyZTAxMDEwXzQtNC0xLTEtNzIxNTE_343d4510-5643-4b13-8d43-b9a3409a1b9f">54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTpiNWU3ZjZjNjAwOTQ0ZDkwYjJlNWQ5MmJjMmUwMTAxMC90YWJsZXJhbmdlOmI1ZTdmNmM2MDA5NDRkOTBiMmU1ZDkyYmMyZTAxMDEwXzQtNS0xLTEtNzIxNTE_b4affd28-9ca2-47b8-8471-72894f288f8f">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTpiNWU3ZjZjNjAwOTQ0ZDkwYjJlNWQ5MmJjMmUwMTAxMC90YWJsZXJhbmdlOmI1ZTdmNmM2MDA5NDRkOTBiMmU1ZDkyYmMyZTAxMDEwXzQtNi0xLTEtNzIxNTE_d620cdb4-08f3-47ff-a21a-81f351d956cb">76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div id="icec46013a0ad4608b89f97e433dd3417_121"></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTE 8 - <ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90ZXh0cmVnaW9uOjc5YjQ2OTE1MzQzZjRiNDI4ZmFlMjNjNGQwZWYzZjFjXzE4MA_692977af-ab66-4200-8398-ee332e6a211a" continuedAt="i48481157b74249e5b97732b21d2b55b6" escape="true">GOODWILL AND OTHER INTANGIBLE ASSETS</ix:nonNumeric></span></div><ix:continuation id="i48481157b74249e5b97732b21d2b55b6" continuedAt="ie3e58d5bfe17486fafcd99b837314b0c"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We performed our annual impairment test for goodwill as of October 31, 2022 and determined that the carrying value of the Spine reporting unit exceeded its fair value. As a result an impairment charge of $<ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90ZXh0cmVnaW9uOjc5YjQ2OTE1MzQzZjRiNDI4ZmFlMjNjNGQwZWYzZjFjXzc2OTY1ODE0MDgwNzM_c03e4d83-80f7-4923-9b6e-33741caac327">216</ix:nonFraction> was recognized in the Goodwill impairment line in the Consolidated Statements of Earnings in 2022. As of December&#160;31, 2022 goodwill of the Spine reporting unit is $<ix:nonFraction unitRef="usd" contextRef="ia066883b5f184c74a8299f3acdca8fc6_I20221231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90ZXh0cmVnaW9uOjc5YjQ2OTE1MzQzZjRiNDI4ZmFlMjNjNGQwZWYzZjFjXzYwNDczMTM5NjY1MjU_637fd543-f8f1-47d9-9ae2-e86e849277c3">1,002</ix:nonFraction> after the impairment charge.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We estimated the fair value of the Spine reporting unit using a discounted cash flow analysis. Significant inputs to the analysis include assumptions for future revenue growth and operating margin. The analysis also included a rate to discount the estimated future cash flow projections to their present value, based on the reporting unit&#8217;s estimated weighted average cost of capital. The impairment charge for the Spine reporting unit was primarily driven by the slower than anticipated recovery of surgery volumes as we emerge from the COVID-19 pandemic, the competitive pressures in the spine market and rising interest rates in the current macroeconomic environment.</span></div></ix:continuation></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">33</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2022 FORM 10-K</span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><ix:continuation id="ie3e58d5bfe17486fafcd99b837314b0c"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">For our other reporting units, we considered qualitative indicators of impairment as it was considered more likely than not that the fair values of those reporting units exceeded their respective carrying values. No impairment was identified for those reporting units in 2022. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Future changes in the judgments, assumptions and estimates that are used in our impairment testing for goodwill, including discount and tax rates and future cash flow projections, could result in significantly different estimates of the fair values. A significant reduction in the estimated fair values could result in impairment charges that could materially affect our results of operations.</span></div><div style="text-align:justify"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90ZXh0cmVnaW9uOjc5YjQ2OTE1MzQzZjRiNDI4ZmFlMjNjNGQwZWYzZjFjXzE4Nw_52fc8999-0c15-4609-82fb-021dce7cb18c" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.681%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.612%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.407%"></td><td style="width:0.1%"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Changes in the Net Carrying Value of Goodwill by Segment</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">MedSurg and Neurotechnology</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Orthopaedics and Spine</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99398de802564a348fcf815e890ee556_I20201231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTowNGI0Zjk1Y2MyMWY0OTdiYTRkZmMxNjYyM2YwZmU4Zi90YWJsZXJhbmdlOjA0YjRmOTVjYzIxZjQ5N2JhNGRmYzE2NjIzZjBmZThmXzItMS0xLTEtNzIxNTE_09671d1b-1895-4714-849f-12fb3688b56c">5,459</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66bd7e5d901d4e1ba0db77e7d94fe17f_I20201231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTowNGI0Zjk1Y2MyMWY0OTdiYTRkZmMxNjYyM2YwZmU4Zi90YWJsZXJhbmdlOjA0YjRmOTVjYzIxZjQ5N2JhNGRmYzE2NjIzZjBmZThmXzItMi0xLTEtNzIxNTE_41247353-08fb-4ad2-abe9-85d6f4dcdee6">7,319</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98963cf23d234ec1ac275e66bcfd76dc_I20201231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTowNGI0Zjk1Y2MyMWY0OTdiYTRkZmMxNjYyM2YwZmU4Zi90YWJsZXJhbmdlOjA0YjRmOTVjYzIxZjQ5N2JhNGRmYzE2NjIzZjBmZThmXzItMy0xLTEtNzIxNTE_a351f07b-353e-4ef9-9941-1e6026e4d7a7">12,778</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Additions and adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idac1c88764c44335aba1807e0a6c5920_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTowNGI0Zjk1Y2MyMWY0OTdiYTRkZmMxNjYyM2YwZmU4Zi90YWJsZXJhbmdlOjA0YjRmOTVjYzIxZjQ5N2JhNGRmYzE2NjIzZjBmZThmXzMtMS0xLTEtNzIxNTE_48ec5b26-368e-430a-aa72-306325a7aa58">223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i383cf58c47f8466aaa98e0e267a0ec66_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTowNGI0Zjk1Y2MyMWY0OTdiYTRkZmMxNjYyM2YwZmU4Zi90YWJsZXJhbmdlOjA0YjRmOTVjYzIxZjQ5N2JhNGRmYzE2NjIzZjBmZThmXzMtMi0xLTEtNzIxNTE_6fbb80d4-9a34-4df5-833b-58e66846660b">59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTowNGI0Zjk1Y2MyMWY0OTdiYTRkZmMxNjYyM2YwZmU4Zi90YWJsZXJhbmdlOjA0YjRmOTVjYzIxZjQ5N2JhNGRmYzE2NjIzZjBmZThmXzMtMy0xLTEtNzIxNTE_fd86fd70-a521-47f0-a4ab-1962cef78459">282</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign exchange</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idac1c88764c44335aba1807e0a6c5920_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTowNGI0Zjk1Y2MyMWY0OTdiYTRkZmMxNjYyM2YwZmU4Zi90YWJsZXJhbmdlOjA0YjRmOTVjYzIxZjQ5N2JhNGRmYzE2NjIzZjBmZThmXzQtMS0xLTEtNzIxNTE_ea6a3f42-3dc9-48b9-bab5-6ad79554f7e3">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i383cf58c47f8466aaa98e0e267a0ec66_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTowNGI0Zjk1Y2MyMWY0OTdiYTRkZmMxNjYyM2YwZmU4Zi90YWJsZXJhbmdlOjA0YjRmOTVjYzIxZjQ5N2JhNGRmYzE2NjIzZjBmZThmXzQtMi0xLTEtNzIxNTE_9f95e3dd-f195-4729-afb4-2f51d030a42b">129</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTowNGI0Zjk1Y2MyMWY0OTdiYTRkZmMxNjYyM2YwZmU4Zi90YWJsZXJhbmdlOjA0YjRmOTVjYzIxZjQ5N2JhNGRmYzE2NjIzZjBmZThmXzQtMy0xLTEtNzIxNTE_d365a50d-1d84-4026-a02e-9eb67be12805">142</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic886ff9d842041ae963fe57a90894324_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTowNGI0Zjk1Y2MyMWY0OTdiYTRkZmMxNjYyM2YwZmU4Zi90YWJsZXJhbmdlOjA0YjRmOTVjYzIxZjQ5N2JhNGRmYzE2NjIzZjBmZThmXzUtMS0xLTEtNzIxNTE_e4009029-d728-446d-b8a4-f944d573e937">5,669</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2984e4fb7f95431db5d16c82e29be4ae_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTowNGI0Zjk1Y2MyMWY0OTdiYTRkZmMxNjYyM2YwZmU4Zi90YWJsZXJhbmdlOjA0YjRmOTVjYzIxZjQ5N2JhNGRmYzE2NjIzZjBmZThmXzUtMi0xLTEtNzIxNTE_b425ec94-35fa-4316-9b82-eb17268f0a6f">7,249</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTowNGI0Zjk1Y2MyMWY0OTdiYTRkZmMxNjYyM2YwZmU4Zi90YWJsZXJhbmdlOjA0YjRmOTVjYzIxZjQ5N2JhNGRmYzE2NjIzZjBmZThmXzUtMy0xLTEtNzIxNTE_ce6870e0-7f9e-4697-8895-2cad9391529c">12,918</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Goodwill impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i953031f47dfd4ab48296f976c579f48f_D20220101-20221231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTowNGI0Zjk1Y2MyMWY0OTdiYTRkZmMxNjYyM2YwZmU4Zi90YWJsZXJhbmdlOjA0YjRmOTVjYzIxZjQ5N2JhNGRmYzE2NjIzZjBmZThmXzctMS0xLTEtODE4ODU_17dd00fb-664d-4d95-80ee-cafb9d89b83d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i59e41efd1cf44cedb5a90caceaa03aff_D20220101-20221231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTowNGI0Zjk1Y2MyMWY0OTdiYTRkZmMxNjYyM2YwZmU4Zi90YWJsZXJhbmdlOjA0YjRmOTVjYzIxZjQ5N2JhNGRmYzE2NjIzZjBmZThmXzctMi0xLTEtODE4ODU_1f16f444-bcf6-46d2-83c2-10e0fb83de2b">216</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTowNGI0Zjk1Y2MyMWY0OTdiYTRkZmMxNjYyM2YwZmU4Zi90YWJsZXJhbmdlOjA0YjRmOTVjYzIxZjQ5N2JhNGRmYzE2NjIzZjBmZThmXzctMy0xLTEtODE4ODU_c18be369-bf88-4299-a72c-8ab208a1f1b0">216</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Additions and adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i953031f47dfd4ab48296f976c579f48f_D20220101-20221231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTowNGI0Zjk1Y2MyMWY0OTdiYTRkZmMxNjYyM2YwZmU4Zi90YWJsZXJhbmdlOjA0YjRmOTVjYzIxZjQ5N2JhNGRmYzE2NjIzZjBmZThmXzYtMS0xLTEtNzIxNTE_59563cab-8870-4f6c-99af-bf5ab5ba3898">2,320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59e41efd1cf44cedb5a90caceaa03aff_D20220101-20221231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTowNGI0Zjk1Y2MyMWY0OTdiYTRkZmMxNjYyM2YwZmU4Zi90YWJsZXJhbmdlOjA0YjRmOTVjYzIxZjQ5N2JhNGRmYzE2NjIzZjBmZThmXzYtMi0xLTEtNzIxNTE_1c3d896f-1089-4609-8b49-ffd3d4e9c450">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTowNGI0Zjk1Y2MyMWY0OTdiYTRkZmMxNjYyM2YwZmU4Zi90YWJsZXJhbmdlOjA0YjRmOTVjYzIxZjQ5N2JhNGRmYzE2NjIzZjBmZThmXzYtMy0xLTEtNzIxNTE_8ba497b3-746c-4add-941e-d09338f91046">2,320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign exchange</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i953031f47dfd4ab48296f976c579f48f_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTowNGI0Zjk1Y2MyMWY0OTdiYTRkZmMxNjYyM2YwZmU4Zi90YWJsZXJhbmdlOjA0YjRmOTVjYzIxZjQ5N2JhNGRmYzE2NjIzZjBmZThmXzctMS0xLTEtNzIxNTE_957e442c-716c-4846-b6de-c2e508ef1358">54</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i59e41efd1cf44cedb5a90caceaa03aff_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTowNGI0Zjk1Y2MyMWY0OTdiYTRkZmMxNjYyM2YwZmU4Zi90YWJsZXJhbmdlOjA0YjRmOTVjYzIxZjQ5N2JhNGRmYzE2NjIzZjBmZThmXzctMi0xLTEtNzIxNTE_d818bbb0-16ff-4b68-860e-35c54a3375a6">88</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTowNGI0Zjk1Y2MyMWY0OTdiYTRkZmMxNjYyM2YwZmU4Zi90YWJsZXJhbmdlOjA0YjRmOTVjYzIxZjQ5N2JhNGRmYzE2NjIzZjBmZThmXzctMy0xLTEtNzIxNTE_317a9406-8cde-4445-8115-79e862f607c9">142</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i249998c655604f398e1944b84271a97b_I20221231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTowNGI0Zjk1Y2MyMWY0OTdiYTRkZmMxNjYyM2YwZmU4Zi90YWJsZXJhbmdlOjA0YjRmOTVjYzIxZjQ5N2JhNGRmYzE2NjIzZjBmZThmXzgtMS0xLTEtNzIxNTE_6f3afe92-f2e8-4a10-960b-330627d5e824">7,935</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf16c26d2de44c14872459c255d8e314_I20221231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTowNGI0Zjk1Y2MyMWY0OTdiYTRkZmMxNjYyM2YwZmU4Zi90YWJsZXJhbmdlOjA0YjRmOTVjYzIxZjQ5N2JhNGRmYzE2NjIzZjBmZThmXzgtMi0xLTEtNzIxNTE_8bdf9d18-132f-4847-a0dd-5f5b4c29606c">6,945</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTowNGI0Zjk1Y2MyMWY0OTdiYTRkZmMxNjYyM2YwZmU4Zi90YWJsZXJhbmdlOjA0YjRmOTVjYzIxZjQ5N2JhNGRmYzE2NjIzZjBmZThmXzgtMy0xLTEtNzIxNTE_e325a3d5-005f-4a5e-8253-ecb8ce65f6f8">14,880</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90ZXh0cmVnaW9uOjc5YjQ2OTE1MzQzZjRiNDI4ZmFlMjNjNGQwZWYzZjFjXzE5NQ_d2d403a6-cad1-44ed-8c5b-24e4042fc9ed" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.440%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.888%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.141%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.888%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.143%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Summary of Other Intangible Assets</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted Average Amortization Period (Years)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Less<br/>Accumulated<br/>Amortization</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Developed technologies</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib35db1f319504c6ea1b123bab6945625_D20220101-20221231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzMtMS0xLTEtNzIxNTE_8359760c-9363-433b-8e34-df6b0db0261b">14</ix:nonNumeric></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82108a7656a74aa1ba61a08ab02857ce_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzMtMi0xLTEtNzIxNTE_1aa08396-7417-4bfc-9a48-23a5dd31d32e">5,440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82108a7656a74aa1ba61a08ab02857ce_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzMtMy0xLTEtNzIxNTE_dc5b6b97-1af0-4210-a8a7-4ed42f465e45">2,363</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82108a7656a74aa1ba61a08ab02857ce_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzMtNC0xLTEtNzIxNTE_c285dacc-21ae-4417-b416-830242b02dbb">3,077</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="icb79db6333c349f3923f8d6854ee0198_D20210101-20211231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzQtMS0xLTEtNzIxNTE_5b3350c7-7d55-46a9-ad1e-1b2544c46c53">13</ix:nonNumeric></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7267f78ac6824fc7b4d41470e9de6320_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzQtMi0xLTEtNzIxNTE_38de429c-676e-4c9d-a250-0bd43e91f631">5,326</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7267f78ac6824fc7b4d41470e9de6320_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzQtMy0xLTEtNzIxNTE_03f9705d-6191-441f-ae62-94c43de205a4">1,956</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7267f78ac6824fc7b4d41470e9de6320_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzQtNC0xLTEtNzIxNTE_2fbc4901-c690-49d2-8dd6-91aabbc258f2">3,370</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Customer relationships</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i616a24284ffb4103824360aa36bae0d7_D20220101-20221231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzYtMS0xLTEtNzIxNTE_6fbb7cfd-753d-4b8a-88df-da63738e0042">15</ix:nonNumeric></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6769f38cd4f4dbe805725de19af7ac7_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzYtMi0xLTEtNzIxNTE_c5e67cbc-abdd-4645-a301-f4943329ef63">2,847</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6769f38cd4f4dbe805725de19af7ac7_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzYtMy0xLTEtNzIxNTE_857c5896-9cf4-42dd-aea0-dcdd213234a9">1,322</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6769f38cd4f4dbe805725de19af7ac7_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzYtNC0xLTEtNzIxNTE_bbfd6ce9-e030-4ed9-9500-21514a8101db">1,525</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7705b5434d5d4d54a9a81030e299a394_D20210101-20211231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzctMS0xLTEtNzIxNTE_fdcb7a86-6132-45eb-beaf-4b2ddbf3c923">15</ix:nonNumeric></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7803940663364a5c97229c2f0f778b60_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzctMi0xLTEtNzIxNTE_cab67830-2a85-4230-9eac-7c2eb8c7d576">2,324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7803940663364a5c97229c2f0f778b60_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzctMy0xLTEtNzIxNTE_7a43b4d1-4d0e-434c-b795-11c6f37249b7">1,174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7803940663364a5c97229c2f0f778b60_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzctNC0xLTEtNzIxNTE_c3e3ae82-e2c6-410b-88da-63363e66162e">1,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Patents</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0d7b307071314b9b90794e54e6a0095f_D20220101-20221231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzktMS0xLTEtNzIxNTE_a29207e0-7b7d-4e4c-a66b-c58679b71ca8">11</ix:nonNumeric></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id47b79ebee3845f3b4c19c471642577f_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzktMi0xLTEtNzIxNTE_dff0ec85-b341-4115-b73b-6e17c07e2e4f">343</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id47b79ebee3845f3b4c19c471642577f_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzktMy0xLTEtNzIxNTE_3f2289e0-4c8a-40ea-b08d-1f4d587cddca">297</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id47b79ebee3845f3b4c19c471642577f_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzktNC0xLTEtNzIxNTE_1a01985e-bbbc-41bf-8d01-d7016cbfcbd9">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i53d447ff0f8a4e76984a7d915abea8ee_D20210101-20211231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzEwLTEtMS0xLTcyMTUx_92dff02e-fa3e-471d-a250-06770c6cf2a4">12</ix:nonNumeric></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7a556e07b064f9e94a25653076cc521_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzEwLTItMS0xLTcyMTUx_7f798e11-89e7-41df-b553-3ef702e7ba41">343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7a556e07b064f9e94a25653076cc521_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzEwLTMtMS0xLTcyMTUx_8211422a-115e-4f0e-acdb-ea6a3b1ad550">286</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7a556e07b064f9e94a25653076cc521_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzEwLTQtMS0xLTcyMTUx_4e072f6d-a4da-4165-bce8-b6a6f512f803">57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Trademarks</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ifb5f69c7b49241dfb194a09187e3c17c_D20220101-20221231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzEyLTEtMS0xLTcyMTUx_66d4188e-6769-43b2-8325-9731867391d2">16</ix:nonNumeric></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29eb6be58138460d98a6d32e536dd9e2_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzEyLTItMS0xLTcyMTUx_fae3d496-d9c7-4c1c-8b2a-fbbf8a2b0703">425</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29eb6be58138460d98a6d32e536dd9e2_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzEyLTMtMS0xLTcyMTUx_dd1b9370-25fa-405d-9bbc-d8e3e0d93466">220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29eb6be58138460d98a6d32e536dd9e2_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzEyLTQtMS0xLTcyMTUx_4bc7149e-da48-4f65-b1fe-a6a846a48172">205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2a84ea92e53146cc99a4bd1d326471a9_D20210101-20211231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzEzLTEtMS0xLTcyMTUx_379129f7-08c2-4d3e-96a4-a538aa13bdbf">16</ix:nonNumeric></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaf6d5d43b13406a9b3c80676ac72655_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzEzLTItMS0xLTcyMTUx_eda3b5c7-9d79-45e5-a82c-a5d30d2dd1bd">415</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaf6d5d43b13406a9b3c80676ac72655_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzEzLTMtMS0xLTcyMTUx_7a3c4481-1a7f-462f-9991-613edf62a7c9">199</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaf6d5d43b13406a9b3c80676ac72655_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzEzLTQtMS0xLTcyMTUx_cd42a1cc-6386-424b-9a66-7530370fdc2b">216</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">In-process research and development</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i305db0433c34417b92b5c6dbeea5f263_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzE1LTItMS0xLTcyMTUx_3568ab24-cea5-4e1e-8e5b-55bf09d048c6">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i305db0433c34417b92b5c6dbeea5f263_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzE1LTMtMS0xLTcyMTUx_6433e99d-5644-4c24-a955-a3fc5a06ae87">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i305db0433c34417b92b5c6dbeea5f263_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzE1LTQtMS0xLTcyMTUx_e3d6da47-8dfc-46e0-b9af-62fb9f40c7d3">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9538fc60a2cf48fe973a5ff07071a757_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzE2LTItMS0xLTcyMTUx_1c232ff6-2ca3-4adb-b48f-67a05c67a8a2">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9538fc60a2cf48fe973a5ff07071a757_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzE2LTMtMS0xLTcyMTUx_e5e02235-0b6f-4c74-9500-9695a60084c2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9538fc60a2cf48fe973a5ff07071a757_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzE2LTQtMS0xLTcyMTUx_4773566b-d42f-4648-8082-49a62dcfc142">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="icfee61742ac544ed9c226764b8dc1c9e_D20220101-20221231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzE4LTEtMS0xLTcyMTUx_be90e19e-dafd-46a3-9914-15800bdf7d14">6</ix:nonNumeric></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1626fc828d9642beb146389e00b7d1aa_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzE4LTItMS0xLTcyMTUx_e923c374-cfa1-47a2-8a31-fc2a47a62d17">105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1626fc828d9642beb146389e00b7d1aa_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzE4LTMtMS0xLTcyMTUx_8402dfd2-ca86-4a2f-af5c-c48f0a093b39">94</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1626fc828d9642beb146389e00b7d1aa_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzE4LTQtMS0xLTcyMTUx_ef82c77b-2834-4fd0-938c-09a26df7aa13">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iaaf12506ce6349e290da46b1889b2f07_D20210101-20211231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzE5LTEtMS0xLTcyMTUx_0ae1bb79-5e06-4328-8532-31d45dc8d8b9">9</ix:nonNumeric></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2ed7e2a97b147f5a5e2f0cb1a1b8bdc_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzE5LTItMS0xLTcyMTUx_79deee27-1158-410a-a256-86752cf67966">105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2ed7e2a97b147f5a5e2f0cb1a1b8bdc_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzE5LTMtMS0xLTcyMTUx_4721b625-c731-4da0-8653-79862b7729f0">87</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2ed7e2a97b147f5a5e2f0cb1a1b8bdc_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzE5LTQtMS0xLTcyMTUx_a0f84eb8-adb8-4d42-a9b5-1215cd1cde5c">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzIxLTEtMS0xLTcyMTUx_66ed4ec9-66c0-4934-ba62-2de7840df130">14</ix:nonNumeric></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzIxLTItMS0xLTcyMTUx_b88479f4-b8af-4a68-baf1-1f3e4112df8c">9,181</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzIxLTMtMS0xLTcyMTUx_d3640849-170c-46ac-9337-f385f387b2c7">4,296</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzIxLTQtMS0xLTcyMTUx_2f0838fa-e4ba-4842-8ad5-8652977f88bc">4,885</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzIyLTEtMS0xLTcyMTUx_1847cc38-db60-4122-82f0-2e50e06b4c69">14</ix:nonNumeric></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzIyLTItMS0xLTcyMTUx_8a6e47b1-9c85-44fb-bb37-6869f9089fd3">8,542</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzIyLTMtMS0xLTcyMTUx_11554282-564c-4505-aa5f-26eb77afb14a">3,702</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzIyLTQtMS0xLTcyMTUx_7d6345fc-2114-4140-b1a9-b928587def89">4,840</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90ZXh0cmVnaW9uOjc5YjQ2OTE1MzQzZjRiNDI4ZmFlMjNjNGQwZWYzZjFjXzE3OA_64f45b04-c84c-454f-a097-6abeb054b4aa" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"></td><td style="width:19.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.784%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.784%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.784%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.787%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Estimated Amortization Expense</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2027</span></td></tr><tr><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTowOWMxMjViY2Q3YzQ0ZjM0OWZlOWVmNTYzMDllNmMwMi90YWJsZXJhbmdlOjA5YzEyNWJjZDdjNDRmMzQ5ZmU5ZWY1NjMwOWU2YzAyXzItMC0xLTEtNzIxNTE_6f59ea4f-5616-4bda-8a25-991bd01a2378">620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTowOWMxMjViY2Q3YzQ0ZjM0OWZlOWVmNTYzMDllNmMwMi90YWJsZXJhbmdlOjA5YzEyNWJjZDdjNDRmMzQ5ZmU5ZWY1NjMwOWU2YzAyXzItMS0xLTEtNzIxNTE_7ac52c72-aa94-4526-9189-ab7157d37235">588</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTowOWMxMjViY2Q3YzQ0ZjM0OWZlOWVmNTYzMDllNmMwMi90YWJsZXJhbmdlOjA5YzEyNWJjZDdjNDRmMzQ5ZmU5ZWY1NjMwOWU2YzAyXzItMi0xLTEtNzIxNTE_44cc1953-0b2f-48e1-8bc9-51d3ab130f30">568</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTowOWMxMjViY2Q3YzQ0ZjM0OWZlOWVmNTYzMDllNmMwMi90YWJsZXJhbmdlOjA5YzEyNWJjZDdjNDRmMzQ5ZmU5ZWY1NjMwOWU2YzAyXzItMy0xLTEtNzIxNTE_acc82ddb-9234-4d73-81d3-4776fb91ca23">510</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTowOWMxMjViY2Q3YzQ0ZjM0OWZlOWVmNTYzMDllNmMwMi90YWJsZXJhbmdlOjA5YzEyNWJjZDdjNDRmMzQ5ZmU5ZWY1NjMwOWU2YzAyXzItNC0xLTEtNzIxNTE_6ffd5f4e-2db8-4470-9e94-aabf8060989f">490</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div id="icec46013a0ad4608b89f97e433dd3417_124"></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTE 9 - <ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzMxNDA_44dd1f89-095b-435c-a7c9-d92540f9b284" continuedAt="i55095f8297fc4294bf8e73904ab7cf9b" escape="true">CAPITAL STOCK</ix:nonNumeric></span></div><ix:continuation id="i55095f8297fc4294bf8e73904ab7cf9b" continuedAt="ie812a778230b4d68bc85c6a2e0ad9350"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The aggregate number of shares of all classes of stock which we are authorized to issue is up to <ix:nonFraction unitRef="shares" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="INF" name="syk:CommonAndPreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzEyNQ_eb893227-df7e-446a-ad0f-8d7baffceae1">1,000,500,000</ix:nonFraction>, divided into two classes consisting of <ix:nonFraction unitRef="shares" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzE2OA_c3467406-c8c1-4638-89c7-5a0e2f1bde19">500,000</ix:nonFraction> shares of $<ix:nonFraction unitRef="usdPerShare" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzE4MQ_0633215f-3058-411b-9532-a5bffa28dbdd">1</ix:nonFraction> par value preferred stock and <ix:nonFraction unitRef="shares" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzIxNA_06c5be7e-ef80-4684-bdb8-40e1176f8b0a">1,000,000,000</ix:nonFraction> shares of common stock with a par value of $<ix:nonFraction unitRef="usdPerShare" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzI2MA_6e28b085-aabe-4ffb-a6b7-4e4656bcbe04">0.10</ix:nonFraction>. <ix:nonFraction unitRef="shares" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzI2NA_255282ee-b5fa-43b1-bae8-78d63974a0e4">No</ix:nonFraction> shares of preferred stock were outstanding on December&#160;31, 2022.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We made no repurchases of shares in 2022. The manner, timing and amount of repurchases are determined by management based on an evaluation of market conditions, stock price and other factors and are subject to regulatory considerations. Purchases are made from time-to-time in the open market, in privately negotiated transactions or otherwise. On December&#160;31, </span></div></ix:continuation></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><ix:continuation id="ie812a778230b4d68bc85c6a2e0ad9350" continuedAt="i885ef968e2c04fceb9a86aac59758e30"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2022 the total dollar value of shares that could be purchased under our authorized repurchase program was $<ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzc2Nw_880025e7-a8df-44a8-9769-9cb74ae913dd">1,033</ix:nonFraction>.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Shares reserved for future compensation grants of our common stock were <ix:nonFraction unitRef="shares" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzg0Mw_242abf8d-3e0c-4eb9-b010-42d03f4dc4d6">23</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzg1OA_f8ebcdf3-cf55-41d1-bb3f-fc6efc6fc33d">25</ix:nonFraction> million&#160;on December&#160;31, 2022 and 2021. </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Stock Options</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We measure the cost of employee stock options based on the grant-date fair value and recognize that cost using the straight-line method over the period in which a recipient is required to provide services in exchange for the options, typically the vesting period. The weighted-average fair value per share of options is estimated on the date of grant using the Black-Scholes option pricing model. </span></div><div style="text-align:justify"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzMxMzE_fc9537d3-8519-435f-b994-99198b3317f3" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.060%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.555%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.555%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.558%"></td><td style="width:0.1%"></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Option Value and Assumptions</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Weighted-average fair value per share</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTpkZjdjOWFkMzFiODY0MDNlOGM4MDE1Y2UyMDVhOThlZS90YWJsZXJhbmdlOmRmN2M5YWQzMWI4NjQwM2U4YzgwMTVjZTIwNWE5OGVlXzItMS0xLTEtNzIxNTE_627e8f32-6163-4d42-8319-60949bcdce55">68.08</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTpkZjdjOWFkMzFiODY0MDNlOGM4MDE1Y2UyMDVhOThlZS90YWJsZXJhbmdlOmRmN2M5YWQzMWI4NjQwM2U4YzgwMTVjZTIwNWE5OGVlXzItMy0xLTEtNzIxNTE_4a4755b3-da82-459a-b021-1ba006b7557d">53.35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTpkZjdjOWFkMzFiODY0MDNlOGM4MDE1Y2UyMDVhOThlZS90YWJsZXJhbmdlOmRmN2M5YWQzMWI4NjQwM2U4YzgwMTVjZTIwNWE5OGVlXzItNS0xLTEtNzIxNTE_aacb38c6-6cdd-489b-bbae-af160594f8c0">39.34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Assumptions:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTpkZjdjOWFkMzFiODY0MDNlOGM4MDE1Y2UyMDVhOThlZS90YWJsZXJhbmdlOmRmN2M5YWQzMWI4NjQwM2U4YzgwMTVjZTIwNWE5OGVlXzQtMS0xLTEtNzIxNTE_3ea34bd9-27de-4cfd-b42a-f39c14a079a7">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTpkZjdjOWFkMzFiODY0MDNlOGM4MDE1Y2UyMDVhOThlZS90YWJsZXJhbmdlOmRmN2M5YWQzMWI4NjQwM2U4YzgwMTVjZTIwNWE5OGVlXzQtMy0xLTEtNzIxNTE_bd56e752-8da3-4627-bb91-8280e24ef61c">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTpkZjdjOWFkMzFiODY0MDNlOGM4MDE1Y2UyMDVhOThlZS90YWJsZXJhbmdlOmRmN2M5YWQzMWI4NjQwM2U4YzgwMTVjZTIwNWE5OGVlXzQtNS0xLTEtNzIxNTE_d659b758-e323-49a6-b04d-19f06a0688de">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTpkZjdjOWFkMzFiODY0MDNlOGM4MDE1Y2UyMDVhOThlZS90YWJsZXJhbmdlOmRmN2M5YWQzMWI4NjQwM2U4YzgwMTVjZTIwNWE5OGVlXzUtMS0xLTEtNzIxNTE_ea0a8c36-90dd-4f2c-bb09-df5a554dd0c7">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTpkZjdjOWFkMzFiODY0MDNlOGM4MDE1Y2UyMDVhOThlZS90YWJsZXJhbmdlOmRmN2M5YWQzMWI4NjQwM2U4YzgwMTVjZTIwNWE5OGVlXzUtMy0xLTEtNzIxNTE_d0591de0-0133-4ebf-a5d1-aa3485c19f59">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTpkZjdjOWFkMzFiODY0MDNlOGM4MDE1Y2UyMDVhOThlZS90YWJsZXJhbmdlOmRmN2M5YWQzMWI4NjQwM2U4YzgwMTVjZTIwNWE5OGVlXzUtNS0xLTEtNzIxNTE_8f5cef7a-f583-499b-a07b-aa28f089b42a">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expected stock price volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTpkZjdjOWFkMzFiODY0MDNlOGM4MDE1Y2UyMDVhOThlZS90YWJsZXJhbmdlOmRmN2M5YWQzMWI4NjQwM2U4YzgwMTVjZTIwNWE5OGVlXzYtMS0xLTEtNzIxNTE_08ca54e4-e937-4fcf-b8f8-a34dac9d911d">27.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTpkZjdjOWFkMzFiODY0MDNlOGM4MDE1Y2UyMDVhOThlZS90YWJsZXJhbmdlOmRmN2M5YWQzMWI4NjQwM2U4YzgwMTVjZTIwNWE5OGVlXzYtMy0xLTEtNzIxNTE_9759abb1-2599-4883-999b-8b02d8cbabc1">26.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTpkZjdjOWFkMzFiODY0MDNlOGM4MDE1Y2UyMDVhOThlZS90YWJsZXJhbmdlOmRmN2M5YWQzMWI4NjQwM2U4YzgwMTVjZTIwNWE5OGVlXzYtNS0xLTEtNzIxNTE_3b591fa7-5c31-404c-a52f-3c27cec6cf1d">18.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expected option life (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTpkZjdjOWFkMzFiODY0MDNlOGM4MDE1Y2UyMDVhOThlZS90YWJsZXJhbmdlOmRmN2M5YWQzMWI4NjQwM2U4YzgwMTVjZTIwNWE5OGVlXzctMS0xLTEtNzIxNTE_0dc4e224-b35d-4bcb-b1ed-a34120a74a88">5.9</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTpkZjdjOWFkMzFiODY0MDNlOGM4MDE1Y2UyMDVhOThlZS90YWJsZXJhbmdlOmRmN2M5YWQzMWI4NjQwM2U4YzgwMTVjZTIwNWE5OGVlXzctMy0xLTEtNzIxNTE_37440adc-0ae0-4f64-a397-0c9d0bf001b0">5.9</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTpkZjdjOWFkMzFiODY0MDNlOGM4MDE1Y2UyMDVhOThlZS90YWJsZXJhbmdlOmRmN2M5YWQzMWI4NjQwM2U4YzgwMTVjZTIwNWE5OGVlXzctNS0xLTEtNzIxNTE_85c15c8d-ccb3-4213-8b6a-3bfaab422b78">5.8</ix:nonNumeric></span></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The risk-free interest rate for periods within the expected life of options granted is based on the United States Treasury yield curve in effect at the time of grant. Expected stock price volatility is based on the historical volatility of our stock. The expected option life, representing the period of time that options granted are expected to be outstanding, is based on historical option exercise and employee termination data. </span></div><div style="margin-bottom:3pt;text-align:justify"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzMxMzQ_04ac0e8e-2bfb-42ab-b30b-947e0f6d8c97" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"></td><td style="width:22.819%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.479%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.173%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.513%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.196%"></td><td style="width:0.1%"></td></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">2022 Stock Option Activity</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares <br/>(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise&#160;Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted-Average<br/>Remaining<br/>Term (in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>&#160;Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Outstanding January&#160;1</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTo0MmVjMzUwOTZiM2Y0MTU2OGQ1ZDA4ODM0YmYzMzgxNi90YWJsZXJhbmdlOjQyZWMzNTA5NmIzZjQxNTY4ZDVkMDg4MzRiZjMzODE2XzItMS0xLTEtNzIxNTE_6957f917-6100-48fd-b196-bf55595f78db">12.1</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTo0MmVjMzUwOTZiM2Y0MTU2OGQ1ZDA4ODM0YmYzMzgxNi90YWJsZXJhbmdlOjQyZWMzNTA5NmIzZjQxNTY4ZDVkMDg4MzRiZjMzODE2XzItMy0xLTEtNzIxNTE_99f8fa5a-d174-4bab-9442-254a12fee409">150.17</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTo0MmVjMzUwOTZiM2Y0MTU2OGQ1ZDA4ODM0YmYzMzgxNi90YWJsZXJhbmdlOjQyZWMzNTA5NmIzZjQxNTY4ZDVkMDg4MzRiZjMzODE2XzMtMS0xLTEtNzIxNTE_e12c4e14-0b9e-4533-97e3-8fb9f34b10ea">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTo0MmVjMzUwOTZiM2Y0MTU2OGQ1ZDA4ODM0YmYzMzgxNi90YWJsZXJhbmdlOjQyZWMzNTA5NmIzZjQxNTY4ZDVkMDg4MzRiZjMzODE2XzMtMy0xLTEtNzIxNTE_9558acbd-8316-4821-946a-21c7490a60ac">248.36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTo0MmVjMzUwOTZiM2Y0MTU2OGQ1ZDA4ODM0YmYzMzgxNi90YWJsZXJhbmdlOjQyZWMzNTA5NmIzZjQxNTY4ZDVkMDg4MzRiZjMzODE2XzQtMS0xLTEtNzIxNTE_04a9e41e-6a41-457d-a6a1-4303c69fd46c">1.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTo0MmVjMzUwOTZiM2Y0MTU2OGQ1ZDA4ODM0YmYzMzgxNi90YWJsZXJhbmdlOjQyZWMzNTA5NmIzZjQxNTY4ZDVkMDg4MzRiZjMzODE2XzQtMy0xLTEtNzIxNTE_52936ccc-f6de-44ef-885f-e7661b08d282">102.85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Canceled or forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTo0MmVjMzUwOTZiM2Y0MTU2OGQ1ZDA4ODM0YmYzMzgxNi90YWJsZXJhbmdlOjQyZWMzNTA5NmIzZjQxNTY4ZDVkMDg4MzRiZjMzODE2XzUtMS0xLTEtNzIxNTE_ccea0bc6-e3a0-470b-9f41-88be47457462">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTo0MmVjMzUwOTZiM2Y0MTU2OGQ1ZDA4ODM0YmYzMzgxNi90YWJsZXJhbmdlOjQyZWMzNTA5NmIzZjQxNTY4ZDVkMDg4MzRiZjMzODE2XzUtMy0xLTEtNzIxNTE_f07b04b3-ef1b-4f5c-9c54-16ed7ce6919e">220.16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Outstanding December&#160;31</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTo0MmVjMzUwOTZiM2Y0MTU2OGQ1ZDA4ODM0YmYzMzgxNi90YWJsZXJhbmdlOjQyZWMzNTA5NmIzZjQxNTY4ZDVkMDg4MzRiZjMzODE2XzYtMS0xLTEtNzIxNTE_d40f67e6-82f8-4a92-8025-f5b7af7cc78b">12.1</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTo0MmVjMzUwOTZiM2Y0MTU2OGQ1ZDA4ODM0YmYzMzgxNi90YWJsZXJhbmdlOjQyZWMzNTA5NmIzZjQxNTY4ZDVkMDg4MzRiZjMzODE2XzYtMy0xLTEtNzIxNTE_6adedb9e-3158-4b16-b6cc-c3902db211ad">168.80</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTo0MmVjMzUwOTZiM2Y0MTU2OGQ1ZDA4ODM0YmYzMzgxNi90YWJsZXJhbmdlOjQyZWMzNTA5NmIzZjQxNTY4ZDVkMDg4MzRiZjMzODE2XzYtNS0xLTEtNzIxNTE_9266f6fe-6a44-4809-8719-715954bed63f">5.4</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTo0MmVjMzUwOTZiM2Y0MTU2OGQ1ZDA4ODM0YmYzMzgxNi90YWJsZXJhbmdlOjQyZWMzNTA5NmIzZjQxNTY4ZDVkMDg4MzRiZjMzODE2XzYtNy0xLTEtNzIxNTE_1fd6ccb7-3476-4664-8fbb-c24d01be7cab">925.3</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Exercisable December&#160;31</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTo0MmVjMzUwOTZiM2Y0MTU2OGQ1ZDA4ODM0YmYzMzgxNi90YWJsZXJhbmdlOjQyZWMzNTA5NmIzZjQxNTY4ZDVkMDg4MzRiZjMzODE2XzctMS0xLTEtNzIxNTE_f6148dc7-59a8-41de-80d0-dee5cc4780fc">7.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTo0MmVjMzUwOTZiM2Y0MTU2OGQ1ZDA4ODM0YmYzMzgxNi90YWJsZXJhbmdlOjQyZWMzNTA5NmIzZjQxNTY4ZDVkMDg4MzRiZjMzODE2XzctMy0xLTEtNzIxNTE_320cdcd8-564b-4ca3-b0e6-d62dcf469a63">131.38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTo0MmVjMzUwOTZiM2Y0MTU2OGQ1ZDA4ODM0YmYzMzgxNi90YWJsZXJhbmdlOjQyZWMzNTA5NmIzZjQxNTY4ZDVkMDg4MzRiZjMzODE2XzctNS0xLTEtNzIxNTE_cfeb04c7-598e-4a6e-ac67-116bdd017b1c">3.1</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTo0MmVjMzUwOTZiM2Y0MTU2OGQ1ZDA4ODM0YmYzMzgxNi90YWJsZXJhbmdlOjQyZWMzNTA5NmIzZjQxNTY4ZDVkMDg4MzRiZjMzODE2XzctNy0xLTEtNzIxNTE_b4682d2d-8dcb-4d1c-89f6-af83b92ebe94">819.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Options expected to vest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTo0MmVjMzUwOTZiM2Y0MTU2OGQ1ZDA4ODM0YmYzMzgxNi90YWJsZXJhbmdlOjQyZWMzNTA5NmIzZjQxNTY4ZDVkMDg4MzRiZjMzODE2XzgtMS0xLTEtNzIxNTE_130a2fa7-0e7f-474b-aa41-e2f89a338384">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTo0MmVjMzUwOTZiM2Y0MTU2OGQ1ZDA4ODM0YmYzMzgxNi90YWJsZXJhbmdlOjQyZWMzNTA5NmIzZjQxNTY4ZDVkMDg4MzRiZjMzODE2XzgtMy0xLTEtNzIxNTE_778c4531-03e0-4541-a4af-9c5f55b2673f">222.62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTo0MmVjMzUwOTZiM2Y0MTU2OGQ1ZDA4ODM0YmYzMzgxNi90YWJsZXJhbmdlOjQyZWMzNTA5NmIzZjQxNTY4ZDVkMDg4MzRiZjMzODE2XzgtNS0xLTEtNzIxNTE_9ea0b8cd-5d47-48e5-b44b-fd345b905fb2">7.7</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTo0MmVjMzUwOTZiM2Y0MTU2OGQ1ZDA4ODM0YmYzMzgxNi90YWJsZXJhbmdlOjQyZWMzNTA5NmIzZjQxNTY4ZDVkMDg4MzRiZjMzODE2XzgtNy0xLTEtNzIxNTE_0418f460-112c-401e-bf5a-263d3728c398">102.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The aggregate intrinsic value of options, which represents the cumulative difference between the fair market value of the underlying common stock and the option exercise prices, exercised was $<ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzE5MjU_6dc0aba8-bdf1-4448-ad7b-acebbe7f139a">218</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzE5Mjk_f3a4bea7-9358-4a61-95fe-8fab486c2ca6">253</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzE5Mzc_2973d659-a071-4e6c-a6df-27f6754f8130">258</ix:nonFraction> in 2022, 2021 and 2020. Exercise prices for options outstanding ranged from $<ix:nonFraction unitRef="usdPerShare" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzIwMTA_673fd089-d47b-4fcd-9324-a1e5a5e1c6f7">64.01</ix:nonFraction> to $<ix:nonFraction unitRef="usdPerShare" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzIwMTY_ff6f0f19-77bb-498d-897c-e4109c26dc04">270.94</ix:nonFraction> on December&#160;31, 2022. On December&#160;31, 2022 there was $<ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzIwNDI_56fa46b8-bab3-4591-9625-d016783a1012">111</ix:nonFraction> of unrecognized compensation cost related to nonvested stock options granted under the long-term incentive plans; that cost is expected to be recognized over the weighted-average period of approximately <ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzIyNDg_00e38356-1b09-4576-b004-daf91cf62e42">1.6</ix:nonNumeric> years.</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzMxNDg_554b6530-9939-4c63-9bc1-362bce432513" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"><tr><td style="width:1.0%"></td><td style="width:40.807%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.460%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.245%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.460%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.245%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.217%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.245%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.221%"></td><td style="width:0.1%"></td></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Restricted Stock Units (RSUs) and Performance Stock Units (PSUs) Activity</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares<br/>(in&#160;millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted Average<br/>Grant&#160;Date Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">RSUs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">PSUs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">RSUs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">PSUs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nonvested on January 1</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i568e131aeee143118e9dfb0c69d84d35_I20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTozNGY3ZWUzNzVjMTU0NGJhYWE2YzdiZjhhMjc0MjRjYy90YWJsZXJhbmdlOjM0ZjdlZTM3NWMxNTQ0YmFhYTZjN2JmOGEyNzQyNGNjXzMtMS0xLTEtNzIxNTE_c1a022f0-fcf6-4840-80f8-8f82959ae530">0.7</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i76d037e2508d493fb9c5c79f64d84deb_I20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTozNGY3ZWUzNzVjMTU0NGJhYWE2YzdiZjhhMjc0MjRjYy90YWJsZXJhbmdlOjM0ZjdlZTM3NWMxNTQ0YmFhYTZjN2JmOGEyNzQyNGNjXzMtMy0xLTEtNzIxNTE_0973b0c2-1bf6-4c84-bc9f-f3e64ce4811a">0.2</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i568e131aeee143118e9dfb0c69d84d35_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTozNGY3ZWUzNzVjMTU0NGJhYWE2YzdiZjhhMjc0MjRjYy90YWJsZXJhbmdlOjM0ZjdlZTM3NWMxNTQ0YmFhYTZjN2JmOGEyNzQyNGNjXzMtNS0xLTEtNzIxNTE_34b5e956-4764-45ba-84b6-1e24d56527ad">213.16</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i76d037e2508d493fb9c5c79f64d84deb_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTozNGY3ZWUzNzVjMTU0NGJhYWE2YzdiZjhhMjc0MjRjYy90YWJsZXJhbmdlOjM0ZjdlZTM3NWMxNTQ0YmFhYTZjN2JmOGEyNzQyNGNjXzMtNy0xLTEtNzIxNTE_bca1f711-2438-4c34-8f82-eeb77af0baa6">210.73</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icb6424572e1a40e48c885f2c92dfe789_D20220101-20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTozNGY3ZWUzNzVjMTU0NGJhYWE2YzdiZjhhMjc0MjRjYy90YWJsZXJhbmdlOjM0ZjdlZTM3NWMxNTQ0YmFhYTZjN2JmOGEyNzQyNGNjXzQtMS0xLTEtNzIxNTE_33812f6d-fff1-4991-a86e-395377c66d4b">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8117cc9161634207825ffb3719f67191_D20220101-20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTozNGY3ZWUzNzVjMTU0NGJhYWE2YzdiZjhhMjc0MjRjYy90YWJsZXJhbmdlOjM0ZjdlZTM3NWMxNTQ0YmFhYTZjN2JmOGEyNzQyNGNjXzQtMy0xLTEtNzIxNTE_fa7fa064-5feb-4387-b8f9-32e27e95e4fb">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icb6424572e1a40e48c885f2c92dfe789_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTozNGY3ZWUzNzVjMTU0NGJhYWE2YzdiZjhhMjc0MjRjYy90YWJsZXJhbmdlOjM0ZjdlZTM3NWMxNTQ0YmFhYTZjN2JmOGEyNzQyNGNjXzQtNS0xLTEtNzIxNTE_e75f35e8-974c-4846-b5b1-6c008d8ad04a">239.76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8117cc9161634207825ffb3719f67191_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTozNGY3ZWUzNzVjMTU0NGJhYWE2YzdiZjhhMjc0MjRjYy90YWJsZXJhbmdlOjM0ZjdlZTM3NWMxNTQ0YmFhYTZjN2JmOGEyNzQyNGNjXzQtNy0xLTEtNzIxNTE_92bad318-49ba-4494-af15-dbc1b7a48132">237.17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="icb6424572e1a40e48c885f2c92dfe789_D20220101-20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTozNGY3ZWUzNzVjMTU0NGJhYWE2YzdiZjhhMjc0MjRjYy90YWJsZXJhbmdlOjM0ZjdlZTM3NWMxNTQ0YmFhYTZjN2JmOGEyNzQyNGNjXzUtMS0xLTEtNzIxNTE_55f95196-6101-4615-9ec3-269fbebe3f64">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i8117cc9161634207825ffb3719f67191_D20220101-20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTozNGY3ZWUzNzVjMTU0NGJhYWE2YzdiZjhhMjc0MjRjYy90YWJsZXJhbmdlOjM0ZjdlZTM3NWMxNTQ0YmFhYTZjN2JmOGEyNzQyNGNjXzUtMy0xLTEtNzIxNTE_04cf8999-fb1e-4713-b8de-3f2b14f876b6">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icb6424572e1a40e48c885f2c92dfe789_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTozNGY3ZWUzNzVjMTU0NGJhYWE2YzdiZjhhMjc0MjRjYy90YWJsZXJhbmdlOjM0ZjdlZTM3NWMxNTQ0YmFhYTZjN2JmOGEyNzQyNGNjXzUtNS0xLTEtNzIxNTE_629cd269-11d2-4463-9fe3-d1276c3431b1">204.62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8117cc9161634207825ffb3719f67191_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTozNGY3ZWUzNzVjMTU0NGJhYWE2YzdiZjhhMjc0MjRjYy90YWJsZXJhbmdlOjM0ZjdlZTM3NWMxNTQ0YmFhYTZjN2JmOGEyNzQyNGNjXzUtNy0xLTEtNzIxNTE_6ce51dfa-744b-4afc-b664-8543ca48f08e">179.35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Canceled or forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="icb6424572e1a40e48c885f2c92dfe789_D20220101-20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTozNGY3ZWUzNzVjMTU0NGJhYWE2YzdiZjhhMjc0MjRjYy90YWJsZXJhbmdlOjM0ZjdlZTM3NWMxNTQ0YmFhYTZjN2JmOGEyNzQyNGNjXzYtMS0xLTEtNzIxNTE_830d3780-8349-4322-b9ef-34d5598bf9e3">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8117cc9161634207825ffb3719f67191_D20220101-20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTozNGY3ZWUzNzVjMTU0NGJhYWE2YzdiZjhhMjc0MjRjYy90YWJsZXJhbmdlOjM0ZjdlZTM3NWMxNTQ0YmFhYTZjN2JmOGEyNzQyNGNjXzYtMy0xLTEtNzIxNTE_16ab5986-94be-4ffd-b414-96254771274f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icb6424572e1a40e48c885f2c92dfe789_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTozNGY3ZWUzNzVjMTU0NGJhYWE2YzdiZjhhMjc0MjRjYy90YWJsZXJhbmdlOjM0ZjdlZTM3NWMxNTQ0YmFhYTZjN2JmOGEyNzQyNGNjXzYtNS0xLTEtNzIxNTE_7d44218d-0e78-4126-8864-d14af234bfa6">225.83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8117cc9161634207825ffb3719f67191_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTozNGY3ZWUzNzVjMTU0NGJhYWE2YzdiZjhhMjc0MjRjYy90YWJsZXJhbmdlOjM0ZjdlZTM3NWMxNTQ0YmFhYTZjN2JmOGEyNzQyNGNjXzYtNy0xLTEtNzIxNTE_822f4b74-b5aa-4d59-900e-2d93d9618c6b">179.35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nonvested on December 31</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8910a4c2b7d74f3fb6c50af1f492e5a0_I20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTozNGY3ZWUzNzVjMTU0NGJhYWE2YzdiZjhhMjc0MjRjYy90YWJsZXJhbmdlOjM0ZjdlZTM3NWMxNTQ0YmFhYTZjN2JmOGEyNzQyNGNjXzctMS0xLTEtNzIxNTE_f78fbebc-3a29-4d0a-a3fb-aa1640ec3fb7">0.7</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie6221c941312452b8581e8a9deb3ac6a_I20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTozNGY3ZWUzNzVjMTU0NGJhYWE2YzdiZjhhMjc0MjRjYy90YWJsZXJhbmdlOjM0ZjdlZTM3NWMxNTQ0YmFhYTZjN2JmOGEyNzQyNGNjXzctMy0xLTEtNzIxNTE_adc5497f-401f-4ba0-a067-f5a16c84cedf">0.2</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8910a4c2b7d74f3fb6c50af1f492e5a0_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTozNGY3ZWUzNzVjMTU0NGJhYWE2YzdiZjhhMjc0MjRjYy90YWJsZXJhbmdlOjM0ZjdlZTM3NWMxNTQ0YmFhYTZjN2JmOGEyNzQyNGNjXzctNS0xLTEtNzIxNTE_15c76154-215c-4299-aa1c-13395b2a6425">232.02</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie6221c941312452b8581e8a9deb3ac6a_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTozNGY3ZWUzNzVjMTU0NGJhYWE2YzdiZjhhMjc0MjRjYy90YWJsZXJhbmdlOjM0ZjdlZTM3NWMxNTQ0YmFhYTZjN2JmOGEyNzQyNGNjXzctNy0xLTEtNzIxNTE_2d539ebc-0323-4a67-8e07-0d64be8cbe16">234.70</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">34</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2022 FORM 10-K</span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><ix:continuation id="i885ef968e2c04fceb9a86aac59758e30"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On December&#160;31, 2022 there was $<ix:nonFraction unitRef="usd" contextRef="i8910a4c2b7d74f3fb6c50af1f492e5a0_I20221231" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzIyNzA_d468fcce-e2c8-482c-a5f9-8336587fd9ac">72</ix:nonFraction> of unrecognized compensation cost related to nonvested RSUs. That cost is expected to be recognized as expense over the weighted-average period of approximately <ix:nonNumeric contextRef="icb6424572e1a40e48c885f2c92dfe789_D20220101-20221231" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzI0MzQ_7af961c3-a24f-4806-a4c5-5d50b25cce5b">one year</ix:nonNumeric>. The weighted-average grant date fair value per share of RSUs granted was $<ix:nonFraction unitRef="usdPerShare" contextRef="icb6424572e1a40e48c885f2c92dfe789_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzI1MTE_2226477d-ae9f-48a7-a51a-068f53aac8f0">239.76</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i3f212fe7e7364a549804bccdf2f81667_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzI1MTg_ce8e21d1-829b-4092-93f0-a568b645ce25">230.61</ix:nonFraction> in 2022 and 2021. The fair value of RSUs and PSUs vested in 2022 was $<ix:nonFraction unitRef="usd" contextRef="icb6424572e1a40e48c885f2c92dfe789_D20220101-20221231" decimals="-6" name="syk:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzI1ODQ_5a290433-dd73-4f90-88d6-5defb46b5062">75</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i8117cc9161634207825ffb3719f67191_D20220101-20221231" decimals="-6" name="syk:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzI1OTE_501c7c98-33df-43e5-9708-db8847d930fb">14</ix:nonFraction>. On December&#160;31, 2022 there was $<ix:nonFraction unitRef="usd" contextRef="ie6221c941312452b8581e8a9deb3ac6a_I20221231" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzI2MTE_3ceebfb6-2213-4454-8b75-e60ceb900635">18</ix:nonFraction> of unrecognized compensation cost related to nonvested PSUs; the cost is expected to be recognized as expense over the weighted-average period of approximately <ix:nonNumeric contextRef="i8117cc9161634207825ffb3719f67191_D20220101-20221231" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzI3NzQ_5a88bb35-8b4c-490b-9276-9f23f39c7bd7">one year</ix:nonNumeric>. </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Employee Stock Purchase Plans (ESPP)</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Employees may participate in our ESPP provided they meet certain eligibility requirements. The purchase price for our common stock under the terms of the ESPP is defined as <ix:nonFraction unitRef="number" contextRef="ic1b406c0949449359e921c7191771a27_D20220101-20221231" decimals="INF" name="syk:PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzI5ODk_03190f67-11e8-4681-87bf-82b4f12aaec6">95</ix:nonFraction>% of the closing stock price on the last trading day of a purchase period. We issued <ix:nonFraction unitRef="shares" contextRef="ic1b406c0949449359e921c7191771a27_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzMwNzU_7e3a977a-0595-43a7-b9b6-98de80fcfcff">221,387</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i6d3d3f84201a45599e436e212113af2a_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzMwODI_880961af-8fd6-4c29-a0fa-022304a030aa">183,964</ix:nonFraction> shares under the ESPP in 2022 and 2021.</span></div></ix:continuation><div id="icec46013a0ad4608b89f97e433dd3417_127"></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTE 10 - <ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90ZXh0cmVnaW9uOmQ3NGM1OGM3ZmZlODQ4OWFhNWJhMDc0ZjJmN2NhMTI4XzE2OTQ_69088723-39da-4be6-839b-8bbfd5aaa4b1" continuedAt="iea3bedf3db5a46d29f7bc8ba35daac5c" escape="true">DEBT AND CREDIT FACILITIES</ix:nonNumeric></span></div><ix:continuation id="iea3bedf3db5a46d29f7bc8ba35daac5c" continuedAt="i6221f6979757400a8491eb6715067f9b"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have lines of credit issued by various financial institutions that are available to fund our day-to-day operating needs. Certain of our credit facilities require us to comply with financial and other covenants. We were in compliance with all covenants on December&#160;31, 2022. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In February 2022 we entered into a $<ix:nonFraction unitRef="usd" contextRef="i105ea3d2ed224740a6a5bfb85f70a5e2_I20220228" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90ZXh0cmVnaW9uOmQ3NGM1OGM3ZmZlODQ4OWFhNWJhMDc0ZjJmN2NhMTI4XzEwOTk1MTE2MzAyNDg_9e5d7e21-2e70-46b8-9bec-634df33fd327">1.5</ix:nonFraction>&#160;billion term loan agreement that matures on February 22, 2025 and bears interest at a base rate based on the Term Secured Overnight Financing Rate (SOFR) plus <ix:nonFraction unitRef="number" contextRef="ibaa4215050f640eda208f1aaca9866a2_D20220201-20220228" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90ZXh0cmVnaW9uOmQ3NGM1OGM3ZmZlODQ4OWFhNWJhMDc0ZjJmN2NhMTI4XzEwOTk1MTE2MzAyNjk_6361070a-947a-44f4-a388-40fdafad8dff">0.725</ix:nonFraction>%. In 2022 we repaid $<ix:nonFraction unitRef="usd" contextRef="i2854c59895d84a0383a8b9cde207fe65_D20220101-20221231" decimals="-6" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90ZXh0cmVnaW9uOmQ3NGM1OGM3ZmZlODQ4OWFhNWJhMDc0ZjJmN2NhMTI4XzEwOTk1MTE2MzAyODI_2323488c-333a-4b67-95e8-fecac707f47c">650</ix:nonFraction> on the term loan.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In 2022 our Board of Directors approved an increase to the maximum amount of commercial paper that can be outstanding from $<ix:nonFraction unitRef="usd" contextRef="i89795855715a44adb779c848669d4ad1_I20211231" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90ZXh0cmVnaW9uOmQ3NGM1OGM3ZmZlODQ4OWFhNWJhMDc0ZjJmN2NhMTI4XzYwNDczMTM5NTU4OTc_7b9753a0-0bf9-410b-a16c-6221dd2acd02">1,500</ix:nonFraction> to $<ix:nonFraction unitRef="usd" contextRef="i64f47956dd0f44a5985d1c8aa38b28cc_I20221231" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90ZXh0cmVnaW9uOmQ3NGM1OGM3ZmZlODQ4OWFhNWJhMDc0ZjJmN2NhMTI4XzEwOTk1MTE2Mjk4NjQ_3452994c-f6ee-4e43-8014-84a9072ade85">2,250</ix:nonFraction>.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">On December&#160;31, 2022 there were <ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="INF" name="us-gaap:CommercialPaper" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90ZXh0cmVnaW9uOmQ3NGM1OGM3ZmZlODQ4OWFhNWJhMDc0ZjJmN2NhMTI4XzkxMg_b366a7a8-e168-4ad4-a039-a02c6e276542">no</ix:nonFraction> borrowings outstanding under our credit facility or commercial paper program which allows for maturities up to 397 days from the date of issuance.</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90ZXh0cmVnaW9uOmQ3NGM1OGM3ZmZlODQ4OWFhNWJhMDc0ZjJmN2NhMTI4XzE2OTk_4513416f-f3ef-43c3-a3ee-17c930563975" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"><tr><td style="width:0.1%"></td><td style="width:2.401%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.616%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.245%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.865%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.460%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.245%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.463%"></td><td style="width:0.1%"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Summary of Total Debt</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Due</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Senior unsecured notes:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic31b7c04d93e4f11bdf14d0d9b0aad34_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzQtMS0xLTEtNzIxNTE_9e53bbda-e90e-4fc1-84d2-b0c23be1ed19">1.125</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">November 30, 2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic31b7c04d93e4f11bdf14d0d9b0aad34_I20221231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzQtNS0xLTEtNzIxNTE_efe71a19-2122-42f7-8800-f00f589638d7">585</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic02d163166494d6f94e0bd14a160bf17_I20211231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzQtNy0xLTEtNzIxNTE_bfd7e77b-5e07-43ff-bec4-8d7a753a108e">622</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i808ca3fe28c44ce78c70e8cfba12ca6e_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzUtMS0xLTEtNzIxNTE_b36d93b8-6c06-4023-8be0-8a1710960992">0.600</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 1, 2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i808ca3fe28c44ce78c70e8cfba12ca6e_I20221231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzUtNS0xLTEtNzIxNTE_1d7e24ff-7851-451f-bef3-59a303719e14">599</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15d5d81e0cbe495ebd1b69e9445e539d_I20211231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzUtNy0xLTEtNzIxNTE_0046b7e1-29e2-4ea9-8260-c34b8a1255c6">598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i86a207f857004a4ca1e3d7fed25c46b2_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzYtMS0xLTEtNzIxNTE_478ff2f5-33c3-42ec-9cb0-d4158ad8e876">3.375</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">May 15, 2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86a207f857004a4ca1e3d7fed25c46b2_I20221231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzYtNS0xLTEtNzIxNTE_67a797aa-7a84-4aea-8f38-178766fcaea9">596</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60b7b81e39cd453c88fb43773dc15431_I20211231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzYtNy0xLTEtNzIxNTE_3285e1d7-a7ef-419b-98a0-9ff17d8b0eb2">593</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2a78ebbcbe3e4dcf9d2beb2467073be6_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzctMS0xLTEtNzIxNTE_43b25e0e-7b44-4ed2-ba17-07ad8e5f61e7">0.250</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 3, 2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a78ebbcbe3e4dcf9d2beb2467073be6_I20221231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzctNS0xLTEtNzIxNTE_c54d37e1-fdfd-43d8-b4a5-b41b7a61b3ee">903</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdf8e8ff01d04f45a825b8e390068345_I20211231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzctNy0xLTEtNzIxNTE_44edc09f-1d49-4847-b29d-3b281000911c">958</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i035cd0b8f658462394a986d81f43d40e_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzgtMS0xLTEtNzIxNTE_7afccd03-395f-4732-a43d-12ab5ebb7b50">1.150</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 15, 2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i035cd0b8f658462394a986d81f43d40e_I20221231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzgtNS0xLTEtNzIxNTE_ff163c8c-a61d-4b35-a582-718676ffc32b">647</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i145b85c88ec4481b842411a5bb47e395_I20211231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzgtNy0xLTEtNzIxNTE_37e2557d-35fb-47f5-9126-bea11fe16964">645</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i108518ce09f84a519f3962310c1ed597_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzktMS0xLTEtNzIxNTE_c4ab10ad-3fb8-461f-b8d0-ef6fac084c58">3.375</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">November 1, 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i108518ce09f84a519f3962310c1ed597_I20221231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzktNS0xLTEtNzIxNTE_33264b0d-db06-4e89-af64-bf173970579c">748</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia21862c342c44911bef866b8e514369b_I20211231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzktNy0xLTEtNzIxNTE_d5b1d8eb-3f90-43c4-a5a3-83957f0f8ff4">748</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i572a1adc5855495dbbba16f658625569_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzEwLTEtMS0xLTcyMTUx_a2cd4f0f-fc82-4023-8824-53e9ab55ccc3">3.500</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 15, 2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i572a1adc5855495dbbba16f658625569_I20221231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzEwLTUtMS0xLTcyMTUx_962f59ad-f875-4713-abc9-22d145b9445c">995</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54a412d21e93418fb2e9f285ffe87359_I20211231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzEwLTctMS0xLTcyMTUx_44ea9dae-62cd-466c-a81d-1e8d9b4943f1">994</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i23d883af8da240e0b193f0fe43f8fbb8_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzExLTEtMS0xLTcyMTUx_d5e6944c-9c8b-4b89-a9c1-2191d167cbb3">2.125</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">November 30, 2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23d883af8da240e0b193f0fe43f8fbb8_I20221231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzExLTUtMS0xLTcyMTUx_3d214e2b-3d0f-40f3-a9d2-8b9ad3bae2dc">795</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5156547d31f84feabfdeab3c39626aba_I20211231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzExLTctMS0xLTcyMTUx_3e8cee71-f1b3-4a78-a48c-bd6c101cd41a">845</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i31b266ec9bca421caa681746ca0a9c57_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzEyLTEtMS0xLTcyMTUx_cfc266c6-04f1-4e70-9484-d01d7ebf8919">3.650</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 7, 2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31b266ec9bca421caa681746ca0a9c57_I20221231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzEyLTUtMS0xLTcyMTUx_87343814-84b6-4f3c-969d-d3dcf1a11c30">597</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430f0c280b194413b7ab95bbebb3398f_I20211231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzEyLTctMS0xLTcyMTUx_d2b91778-0e15-42d8-8104-5996d93a6225">597</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ad767f11d7d42f088c022b95d7ed747_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzEzLTEtMS0xLTcyMTUx_35590164-60f8-4a34-979b-691c25baee25">0.750</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 1, 2029</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ad767f11d7d42f088c022b95d7ed747_I20221231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzEzLTUtMS0xLTcyMTUx_f87b9433-6b54-431e-951c-458d2a535cc6">848</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0bccfa8780e4d148e971bf570bdb5c4_I20211231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzEzLTctMS0xLTcyMTUx_e1645bec-6460-42dd-9a03-8fec7f9ab20c">901</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3bbbaa43580143a18111b7f7460a8613_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzE0LTEtMS0xLTcyMTUx_fb5919cf-4c85-4161-bd76-627c59f72580">1.950</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 15, 2030</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bbbaa43580143a18111b7f7460a8613_I20221231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzE0LTUtMS0xLTcyMTUx_d3181d34-6bd7-492f-b62b-29cf7a110f98">991</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10299326fcbd4cab9365281e63e32023_I20211231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzE0LTctMS0xLTcyMTUx_1be0d0e7-c869-43e6-872a-25ca303329db">990</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i39597499ab164dd79f0aa42aa4d4a453_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzE1LTEtMS0xLTcyMTUx_4089bc14-538a-4fd3-b6e7-fb4113ad9ea5">2.625</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">November 30, 2030</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39597499ab164dd79f0aa42aa4d4a453_I20221231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzE1LTUtMS0xLTcyMTUx_c33759c6-e28c-4b40-aa48-af5c658b9fbf">684</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if06b8b9ac7554a2bb66792f8bc6ae5ec_I20211231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzE1LTctMS0xLTcyMTUx_ee6a5004-6e74-4d7b-9905-8802c078aad7">727</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i83cf0776e2f74e6bb340c1c44d9c4873_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzE2LTEtMS0xLTcyMTUx_28f00a18-dbbf-44ae-9bdd-fafcf6799335">1.000</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 3, 2031</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83cf0776e2f74e6bb340c1c44d9c4873_I20221231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzE2LTUtMS0xLTcyMTUx_d2c4d5a2-95f1-42b3-83b4-33f2bd13b71d">790</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i188acddc79bd49c9a2dd28df60de44d3_I20211231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzE2LTctMS0xLTcyMTUx_2789c0e4-e82f-4987-8ef7-adcdd33bef13">840</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib1be77f0f83e44f2a4a4070a55aa9cf1_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzE3LTEtMS0xLTcyMTUx_fa0381d6-864f-4156-840f-a1ed25ee387b">4.100</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">April 1, 2043</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1be77f0f83e44f2a4a4070a55aa9cf1_I20221231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzE3LTUtMS0xLTcyMTUx_4562032f-6918-41aa-bfc0-ff635fadd34e">392</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib936df3bfdbb4791a87fadc6fbd30cdf_I20211231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzE3LTctMS0xLTcyMTUx_d89a3efe-224d-40c3-af1e-984eb9132df7">392</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idf00788f9e364a80a3fab4c2aee1223b_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzE4LTEtMS0xLTcyMTUx_bc910f70-3e7e-4aca-87c1-0fcd1c6da9de">4.375</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">May 15, 2044</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf00788f9e364a80a3fab4c2aee1223b_I20221231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzE4LTUtMS0xLTcyMTUx_7b8054a8-cf81-42e5-8760-062d89399037">396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ebc69fb1cb1488c9aebf005afdcf234_I20211231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzE4LTctMS0xLTcyMTUx_2a3cab82-32c8-4bc5-be8d-c1ba13a09274">395</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0d645bb615244a36b00b94de383a4937_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzE5LTEtMS0xLTcyMTUx_d2814b8b-b1fc-4c70-80b6-b03dac722801">4.625</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 15, 2046</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d645bb615244a36b00b94de383a4937_I20221231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzE5LTUtMS0xLTcyMTUx_5cdab1ca-a5bd-4f4b-bc02-2597bc06e547">983</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied6226864dea487e92398c823ac01c59_I20211231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzE5LTctMS0xLTcyMTUx_c23268d6-0764-4a0f-86ff-cc56337c56cf">982</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2c8be8bcd82a4fbbbf309cf8da292a70_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzIwLTEtMS0xLTcyMTUx_d22a4e56-b4a1-4249-a26a-c6d8c95fbd1a">2.900</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 15, 2050</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c8be8bcd82a4fbbbf309cf8da292a70_I20221231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzIwLTUtMS0xLTcyMTUx_5ca4d87e-f300-4c42-a38e-d041561d562a">642</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5c498b0b83c4ce0a21003147411b100_I20211231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzIwLTctMS0xLTcyMTUx_fd06a227-031b-4280-8395-36cdac59162b">642</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Term loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i097ff20722bb47a2b7d2385fd5c8093b_I20221231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzIxLTUtMS0xLTcyMTUx_98f2a3c1-81ef-4540-99d9-08e3bbe6fd68">850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1b7a9d52e504b799c8afe34dbd39ccb_I20211231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzIxLTctMS0xLTcyMTUx_7a315063-d54a-4832-9b45-1a859ab546aa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:OtherLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzIzLTUtMS0xLTcyMTUx_aa8312c0-aa53-4815-8bed-c945e37a3933">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:OtherLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzIzLTctMS0xLTcyMTUx_e6a6fc32-700f-426c-ac3a-af98a9160995">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:DebtLongtermAndShorttermCombinedAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzI0LTUtMS0xLTcyMTUx_1fcf2d28-73f0-4701-83c7-9bb460430e5c">13,048</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:DebtLongtermAndShorttermCombinedAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzI0LTctMS0xLTcyMTUx_63b92b58-359d-4856-902b-ae55eddf5b6c">12,479</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Less current maturities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:DebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzI1LTUtMS0xLTcyMTUx_64481554-72a3-403c-b67f-a30eefe7bca9">1,191</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:DebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzI1LTctMS0xLTcyMTUx_1401369c-6678-4c80-8fae-449e679af533">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzI2LTUtMS0xLTcyMTUx_34543841-ea1c-4ca2-87c5-cd5b0c218f17">11,857</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzI2LTctMS0xLTcyMTUx_5f68fccc-ae10-4f1d-84cf-aff9f85dcb61">12,472</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="15" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Unamortized debt issuance costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:UnamortizedDebtIssuanceExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzI4LTUtMS0xLTcyMTUx_993b6c4e-b601-46c1-93e8-76b6c23e0d7d">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:UnamortizedDebtIssuanceExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzI4LTctMS0xLTcyMTUx_614dc9d6-de14-4566-99ed-9d3bb9b5758b">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Borrowing capacity on existing facilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzI5LTUtMS0xLTcyMTUx_e77aaf2a-7335-4386-b2ed-0a2cdb4386ec">2,162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzI5LTctMS0xLTcyMTUx_1e977fd6-d095-4ddf-bc13-d0fca726edc0">2,162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value of senior unsecured notes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzMwLTUtMS0xLTcyMTUx_ebccde91-ca8a-42f8-86e2-b8928cc6eb50">10,910</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzMwLTctMS0xLTcyMTUx_f78723a8-dfec-45a7-a460-57ced7112a47">13,391</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i6221f6979757400a8491eb6715067f9b" continuedAt="i9f5bfbde6762437e88cbd38f3f165769">The fair value of the senior unsecured notes was estimated using quoted interest rates, maturities and amounts of borrowings based on quoted active market prices and yields that took into account the underlying terms of the debt instruments. Substantially all of our debt is classified within Level 2 of the fair value hierarchy.</ix:continuation></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i9f5bfbde6762437e88cbd38f3f165769">Interest expense, including required fees incurred on outstanding debt and credit facilities that were included in other income (expense), net, totaled $<ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:InterestExpenseDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90ZXh0cmVnaW9uOmQ3NGM1OGM3ZmZlODQ4OWFhNWJhMDc0ZjJmN2NhMTI4XzE2NjA_624f5f66-4675-43d4-bd25-2a4fc5ed2291">337</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:InterestExpenseDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90ZXh0cmVnaW9uOmQ3NGM1OGM3ZmZlODQ4OWFhNWJhMDc0ZjJmN2NhMTI4XzE2NjQ_50836bae-acfe-4c11-b899-9f434f09caed">337</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:InterestExpenseDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90ZXh0cmVnaW9uOmQ3NGM1OGM3ZmZlODQ4OWFhNWJhMDc0ZjJmN2NhMTI4XzE2NzI_f411ac96-6706-443a-821d-e3eeb080daf9">315</ix:nonFraction> in 2022, 2021 and 2020.</ix:continuation> </span></div><div id="icec46013a0ad4608b89f97e433dd3417_130"></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTE 11 - <ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90ZXh0cmVnaW9uOmU3ZWQ4YWYyMzA4NDQxODdiZThlNGNkYTNkMGQ3M2U4XzQxNDA_2a2ff8fc-d970-4a2f-bd46-f371d3e0ab0f" continuedAt="i2c2ced1bc79b4ead95e8b218bf394e88" escape="true">INCOME TAXES</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i2c2ced1bc79b4ead95e8b218bf394e88" continuedAt="i0fc88742f39d493f8f9042240c7c3656"> </ix:continuation></span></div><ix:continuation id="i0fc88742f39d493f8f9042240c7c3656" continuedAt="ibe721f5298e14da0ac572b82838be36a"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our effective tax rate was <ix:nonFraction unitRef="number" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90ZXh0cmVnaW9uOmU3ZWQ4YWYyMzA4NDQxODdiZThlNGNkYTNkMGQ3M2U4XzU2_89d0162b-e8be-491e-8dac-e6644333cdbd">12.1</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90ZXh0cmVnaW9uOmU3ZWQ4YWYyMzA4NDQxODdiZThlNGNkYTNkMGQ3M2U4XzYw_8d103b7d-51a4-41c8-9c67-d7245f80a7e0">12.6</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90ZXh0cmVnaW9uOmU3ZWQ4YWYyMzA4NDQxODdiZThlNGNkYTNkMGQ3M2U4XzY3_53da14f5-3b1f-4caf-8b9b-721612658736">18.2</ix:nonFraction>% for 2022, 2021 and 2020. The effective income tax rate for 2022 decreased due to the effective settlement of the United States federal income tax audit for years 2014 through 2018 and the reversal of deferred income tax on undistributed earnings of foreign subsidiaries. In addition, the effective income tax rates for 2022, 2021 and 2020 reflect the continued lower effective income tax rates as a result of our European operations, the tax effect related to the transfers of intellectual property between tax jurisdictions, the tax effect of future remittances of the undistributed earnings of foreign subsidiaries and certain discrete tax items. </span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:center"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90ZXh0cmVnaW9uOmU3ZWQ4YWYyMzA4NDQxODdiZThlNGNkYTNkMGQ3M2U4XzQxMTQ_44495174-7868-4564-b575-8fe0ef8f4544" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.259%"></td><td style="width:0.1%"></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Effective Income Tax Rate Reconciliation</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">United States federal statutory rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZToyMmVmZGUxMjIxMTY0MTg0YjE2MTlmNTRjODZkOTc1Yy90YWJsZXJhbmdlOjIyZWZkZTEyMjExNjQxODRiMTYxOWY1NGM4NmQ5NzVjXzItMS0xLTEtNzIxNTE_66ae6f99-36bb-42b4-8afd-f1b0119bbfa7">21.0</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZToyMmVmZGUxMjIxMTY0MTg0YjE2MTlmNTRjODZkOTc1Yy90YWJsZXJhbmdlOjIyZWZkZTEyMjExNjQxODRiMTYxOWY1NGM4NmQ5NzVjXzItMy0xLTEtNzIxNTE_f1f201ca-6d26-42eb-a134-60c32fb5a97e">21.0</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZToyMmVmZGUxMjIxMTY0MTg0YjE2MTlmNTRjODZkOTc1Yy90YWJsZXJhbmdlOjIyZWZkZTEyMjExNjQxODRiMTYxOWY1NGM4NmQ5NzVjXzItNS0xLTEtNzIxNTE_f49f9fe6-e0f7-4853-a63a-aba0ff2583e1">21.0</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States state and local income taxes, less federal deduction</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZToyMmVmZGUxMjIxMTY0MTg0YjE2MTlmNTRjODZkOTc1Yy90YWJsZXJhbmdlOjIyZWZkZTEyMjExNjQxODRiMTYxOWY1NGM4NmQ5NzVjXzMtMS0xLTEtNzIxNTE_5e2cec9a-8b2d-4aee-9332-ce3c61865d11">2.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZToyMmVmZGUxMjIxMTY0MTg0YjE2MTlmNTRjODZkOTc1Yy90YWJsZXJhbmdlOjIyZWZkZTEyMjExNjQxODRiMTYxOWY1NGM4NmQ5NzVjXzMtMy0xLTEtNzIxNTE_182e230e-f033-4d74-add5-af06e1f403b5">2.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZToyMmVmZGUxMjIxMTY0MTg0YjE2MTlmNTRjODZkOTc1Yy90YWJsZXJhbmdlOjIyZWZkZTEyMjExNjQxODRiMTYxOWY1NGM4NmQ5NzVjXzMtNS0xLTEtNzIxNTE_477b45b5-633f-44fd-bd9e-038fdf699b91">0.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign income tax at rates other than 21%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZToyMmVmZGUxMjIxMTY0MTg0YjE2MTlmNTRjODZkOTc1Yy90YWJsZXJhbmdlOjIyZWZkZTEyMjExNjQxODRiMTYxOWY1NGM4NmQ5NzVjXzQtMS0xLTEtNzIxNTE_cc16d36e-90c4-42e7-b5fd-8aaad6d6fc9a">4.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZToyMmVmZGUxMjIxMTY0MTg0YjE2MTlmNTRjODZkOTc1Yy90YWJsZXJhbmdlOjIyZWZkZTEyMjExNjQxODRiMTYxOWY1NGM4NmQ5NzVjXzQtMy0xLTEtNzIxNTE_a4dbc2c9-e93b-4d3b-9434-501b1f80b334">6.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZToyMmVmZGUxMjIxMTY0MTg0YjE2MTlmNTRjODZkOTc1Yy90YWJsZXJhbmdlOjIyZWZkZTEyMjExNjQxODRiMTYxOWY1NGM4NmQ5NzVjXzQtNS0xLTEtNzIxNTE_c6a9cfde-4828-4ee1-9f74-1950c5c931db">3.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Tax related to repatriation of foreign earnings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="3" sign="-" name="syk:EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZToyMmVmZGUxMjIxMTY0MTg0YjE2MTlmNTRjODZkOTc1Yy90YWJsZXJhbmdlOjIyZWZkZTEyMjExNjQxODRiMTYxOWY1NGM4NmQ5NzVjXzUtMS0xLTEtNzIxNTE_bb9e1b8a-3127-4b86-82d9-ac49cc7031ec">2.4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="3" name="syk:EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZToyMmVmZGUxMjIxMTY0MTg0YjE2MTlmNTRjODZkOTc1Yy90YWJsZXJhbmdlOjIyZWZkZTEyMjExNjQxODRiMTYxOWY1NGM4NmQ5NzVjXzUtMy0xLTEtNzIxNTE_69fa017d-da9f-49b4-aaa2-3f47ded6fd43">1.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="3" name="syk:EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZToyMmVmZGUxMjIxMTY0MTg0YjE2MTlmNTRjODZkOTc1Yy90YWJsZXJhbmdlOjIyZWZkZTEyMjExNjQxODRiMTYxOWY1NGM4NmQ5NzVjXzUtNS0xLTEtNzIxNTE_3dbf9c61-59d4-4fc6-8c8e-2f092946db1c">3.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Intellectual property transfers</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="3" name="syk:EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZToyMmVmZGUxMjIxMTY0MTg0YjE2MTlmNTRjODZkOTc1Yy90YWJsZXJhbmdlOjIyZWZkZTEyMjExNjQxODRiMTYxOWY1NGM4NmQ5NzVjXzYtMS0xLTEtNzIxNTE_38c283d6-265e-4b57-9a9c-ba0c6ff0913d">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="3" sign="-" name="syk:EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZToyMmVmZGUxMjIxMTY0MTg0YjE2MTlmNTRjODZkOTc1Yy90YWJsZXJhbmdlOjIyZWZkZTEyMjExNjQxODRiMTYxOWY1NGM4NmQ5NzVjXzYtMy0xLTEtNzIxNTE_b9a9d51e-735f-4df8-8186-97b630bb8d07">2.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="3" sign="-" name="syk:EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZToyMmVmZGUxMjIxMTY0MTg0YjE2MTlmNTRjODZkOTc1Yy90YWJsZXJhbmdlOjIyZWZkZTEyMjExNjQxODRiMTYxOWY1NGM4NmQ5NzVjXzYtNS0xLTEtNzIxNTE_e795eac9-82a3-43f8-941a-f6d2bad4b045">1.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States federal audit settlement</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="INF" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZToyMmVmZGUxMjIxMTY0MTg0YjE2MTlmNTRjODZkOTc1Yy90YWJsZXJhbmdlOjIyZWZkZTEyMjExNjQxODRiMTYxOWY1NGM4NmQ5NzVjXzctMS0xLTEtODMzODg_4f992ec0-a709-4e09-9da6-c032b4621061">6.1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZToyMmVmZGUxMjIxMTY0MTg0YjE2MTlmNTRjODZkOTc1Yy90YWJsZXJhbmdlOjIyZWZkZTEyMjExNjQxODRiMTYxOWY1NGM4NmQ5NzVjXzctMy0xLTEtODMzODg_0c32ed41-b315-4795-8d47-c2bbdbb59b3f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZToyMmVmZGUxMjIxMTY0MTg0YjE2MTlmNTRjODZkOTc1Yy90YWJsZXJhbmdlOjIyZWZkZTEyMjExNjQxODRiMTYxOWY1NGM4NmQ5NzVjXzctNS0xLTEtODMzODg_d9051363-b283-4591-b094-f8a9a7578341">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Goodwill impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZToyMmVmZGUxMjIxMTY0MTg0YjE2MTlmNTRjODZkOTc1Yy90YWJsZXJhbmdlOjIyZWZkZTEyMjExNjQxODRiMTYxOWY1NGM4NmQ5NzVjXzgtMS0xLTEtODMzOTY_17dbe23a-4a68-4ff7-860e-d615ea248df9">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZToyMmVmZGUxMjIxMTY0MTg0YjE2MTlmNTRjODZkOTc1Yy90YWJsZXJhbmdlOjIyZWZkZTEyMjExNjQxODRiMTYxOWY1NGM4NmQ5NzVjXzgtMy0xLTEtODMzOTY_b6daf3b7-b934-4471-afa4-820462808a63">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZToyMmVmZGUxMjIxMTY0MTg0YjE2MTlmNTRjODZkOTc1Yy90YWJsZXJhbmdlOjIyZWZkZTEyMjExNjQxODRiMTYxOWY1NGM4NmQ5NzVjXzgtNS0xLTEtODMzOTY_335e6ab4-4e53-4f6a-835b-48f50383b041">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZToyMmVmZGUxMjIxMTY0MTg0YjE2MTlmNTRjODZkOTc1Yy90YWJsZXJhbmdlOjIyZWZkZTEyMjExNjQxODRiMTYxOWY1NGM4NmQ5NzVjXzctMS0xLTEtNzIxNTE_2f24e818-1fab-4e6d-811d-a71ea7179d02">0.1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZToyMmVmZGUxMjIxMTY0MTg0YjE2MTlmNTRjODZkOTc1Yy90YWJsZXJhbmdlOjIyZWZkZTEyMjExNjQxODRiMTYxOWY1NGM4NmQ5NzVjXzctMy0xLTEtNzIxNTE_816ed039-aff6-43f4-be63-f1239d1212d5">3.3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZToyMmVmZGUxMjIxMTY0MTg0YjE2MTlmNTRjODZkOTc1Yy90YWJsZXJhbmdlOjIyZWZkZTEyMjExNjQxODRiMTYxOWY1NGM4NmQ5NzVjXzctNS0xLTEtNzIxNTE_dfac3f4e-51c7-4c23-964c-0af3f5144544">1.2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Effective income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZToyMmVmZGUxMjIxMTY0MTg0YjE2MTlmNTRjODZkOTc1Yy90YWJsZXJhbmdlOjIyZWZkZTEyMjExNjQxODRiMTYxOWY1NGM4NmQ5NzVjXzgtMS0xLTEtNzIxNTE_95447fee-a3d3-441c-983c-037d3f2cb24b">12.1</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZToyMmVmZGUxMjIxMTY0MTg0YjE2MTlmNTRjODZkOTc1Yy90YWJsZXJhbmdlOjIyZWZkZTEyMjExNjQxODRiMTYxOWY1NGM4NmQ5NzVjXzgtMy0xLTEtNzIxNTE_ea9f88c3-ffef-4d8b-8516-c7f465c88b46">12.6</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZToyMmVmZGUxMjIxMTY0MTg0YjE2MTlmNTRjODZkOTc1Yy90YWJsZXJhbmdlOjIyZWZkZTEyMjExNjQxODRiMTYxOWY1NGM4NmQ5NzVjXzgtNS0xLTEtNzIxNTE_64a7e672-2193-4e6c-b622-4ce85624071e">18.2</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr></table></ix:nonNumeric></div><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90ZXh0cmVnaW9uOmU3ZWQ4YWYyMzA4NDQxODdiZThlNGNkYTNkMGQ3M2U4XzQxNDE_a342e4ab-7c6e-49fe-a1c9-c0582535caed" escape="true"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.259%"></td><td style="width:0.1%"></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Earnings Before Income Taxes&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTpiNzU0NjE5YWZjODg0MjVjOTU0Y2I2NzUyNjhkMDRmOC90YWJsZXJhbmdlOmI3NTQ2MTlhZmM4ODQyNWM5NTRjYjY3NTI2OGQwNGY4XzItMS0xLTEtNzIxNTE_dd92b245-adcd-47d3-adf5-4e4cb2d0d12b">407</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTpiNzU0NjE5YWZjODg0MjVjOTU0Y2I2NzUyNjhkMDRmOC90YWJsZXJhbmdlOmI3NTQ2MTlhZmM4ODQyNWM5NTRjYjY3NTI2OGQwNGY4XzItMy0xLTEtNzIxNTE_6ba92c5f-c35a-462b-a714-cdc8541baeae">433</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTpiNzU0NjE5YWZjODg0MjVjOTU0Y2I2NzUyNjhkMDRmOC90YWJsZXJhbmdlOmI3NTQ2MTlhZmM4ODQyNWM5NTRjYjY3NTI2OGQwNGY4XzItNS0xLTEtNzIxNTE_24294128-3ad3-4305-814a-4efc27f96e58">239</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTpiNzU0NjE5YWZjODg0MjVjOTU0Y2I2NzUyNjhkMDRmOC90YWJsZXJhbmdlOmI3NTQ2MTlhZmM4ODQyNWM5NTRjYjY3NTI2OGQwNGY4XzMtMS0xLTEtNzIxNTE_e290fb16-d338-4929-ab89-ffbd5479c78e">2,276</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTpiNzU0NjE5YWZjODg0MjVjOTU0Y2I2NzUyNjhkMDRmOC90YWJsZXJhbmdlOmI3NTQ2MTlhZmM4ODQyNWM5NTRjYjY3NTI2OGQwNGY4XzMtMy0xLTEtNzIxNTE_aa13e124-3c8b-4284-b4cf-1d25da29e050">1,848</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTpiNzU0NjE5YWZjODg0MjVjOTU0Y2I2NzUyNjhkMDRmOC90YWJsZXJhbmdlOmI3NTQ2MTlhZmM4ODQyNWM5NTRjYjY3NTI2OGQwNGY4XzMtNS0xLTEtNzIxNTE_0070993d-d952-4c43-aec3-602c5c5a34bc">1,715</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTpiNzU0NjE5YWZjODg0MjVjOTU0Y2I2NzUyNjhkMDRmOC90YWJsZXJhbmdlOmI3NTQ2MTlhZmM4ODQyNWM5NTRjYjY3NTI2OGQwNGY4XzQtMS0xLTEtNzIxNTE_0c2b71c9-220b-4aa1-b0ac-f6f686e7d340">2,683</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTpiNzU0NjE5YWZjODg0MjVjOTU0Y2I2NzUyNjhkMDRmOC90YWJsZXJhbmdlOmI3NTQ2MTlhZmM4ODQyNWM5NTRjYjY3NTI2OGQwNGY4XzQtMy0xLTEtNzIxNTE_84a9400e-2476-4082-93f0-d07dca975375">2,281</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTpiNzU0NjE5YWZjODg0MjVjOTU0Y2I2NzUyNjhkMDRmOC90YWJsZXJhbmdlOmI3NTQ2MTlhZmM4ODQyNWM5NTRjYjY3NTI2OGQwNGY4XzQtNS0xLTEtNzIxNTE_8cc27292-0f01-4944-9de9-09a5174aa807">1,954</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.259%"></td><td style="width:0.1%"></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Components of Income Tax Expense (Benefit)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Current income tax expense (benefit):</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States federal</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTozNjFmOWMzZDRhN2I0ZGM2ODEyNWFmNzk5ZTkxZmIyNy90YWJsZXJhbmdlOjM2MWY5YzNkNGE3YjRkYzY4MTI1YWY3OTllOTFmYjI3XzItMS0xLTEtNzIxNTE_2f4e8d55-53c6-4ed6-818f-25ca16668b79">76</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTozNjFmOWMzZDRhN2I0ZGM2ODEyNWFmNzk5ZTkxZmIyNy90YWJsZXJhbmdlOjM2MWY5YzNkNGE3YjRkYzY4MTI1YWY3OTllOTFmYjI3XzItMy0xLTEtNzIxNTE_9d52f0fc-25ab-41ad-b4a9-388eba5eabf9">155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTozNjFmOWMzZDRhN2I0ZGM2ODEyNWFmNzk5ZTkxZmIyNy90YWJsZXJhbmdlOjM2MWY5YzNkNGE3YjRkYzY4MTI1YWY3OTllOTFmYjI3XzItNS0xLTEtNzIxNTE_a9ee012f-af41-49eb-b103-1878e1e9311b">80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States state and local</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTozNjFmOWMzZDRhN2I0ZGM2ODEyNWFmNzk5ZTkxZmIyNy90YWJsZXJhbmdlOjM2MWY5YzNkNGE3YjRkYzY4MTI1YWY3OTllOTFmYjI3XzMtMS0xLTEtNzIxNTE_c7ea7402-4c39-47c8-9bbe-fb3891f7b052">64</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTozNjFmOWMzZDRhN2I0ZGM2ODEyNWFmNzk5ZTkxZmIyNy90YWJsZXJhbmdlOjM2MWY5YzNkNGE3YjRkYzY4MTI1YWY3OTllOTFmYjI3XzMtMy0xLTEtNzIxNTE_b181ae0b-69bc-4b09-aa39-a4be0e743a44">97</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTozNjFmOWMzZDRhN2I0ZGM2ODEyNWFmNzk5ZTkxZmIyNy90YWJsZXJhbmdlOjM2MWY5YzNkNGE3YjRkYzY4MTI1YWY3OTllOTFmYjI3XzMtNS0xLTEtNzIxNTE_76b4c063-a311-4c86-9084-9cbe209c4437">20</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTozNjFmOWMzZDRhN2I0ZGM2ODEyNWFmNzk5ZTkxZmIyNy90YWJsZXJhbmdlOjM2MWY5YzNkNGE3YjRkYzY4MTI1YWY3OTllOTFmYjI3XzQtMS0xLTEtNzIxNTE_25914789-199e-4e12-a208-1d111a06f7c6">279</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTozNjFmOWMzZDRhN2I0ZGM2ODEyNWFmNzk5ZTkxZmIyNy90YWJsZXJhbmdlOjM2MWY5YzNkNGE3YjRkYzY4MTI1YWY3OTllOTFmYjI3XzQtMy0xLTEtNzIxNTE_7a38d92c-4ea7-4c93-bfb9-dd631e4fa606">272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTozNjFmOWMzZDRhN2I0ZGM2ODEyNWFmNzk5ZTkxZmIyNy90YWJsZXJhbmdlOjM2MWY5YzNkNGE3YjRkYzY4MTI1YWY3OTllOTFmYjI3XzQtNS0xLTEtNzIxNTE_8d68d0bc-dc58-47b0-9679-a9f91bee33a4">207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total current income tax expense</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTozNjFmOWMzZDRhN2I0ZGM2ODEyNWFmNzk5ZTkxZmIyNy90YWJsZXJhbmdlOjM2MWY5YzNkNGE3YjRkYzY4MTI1YWY3OTllOTFmYjI3XzUtMS0xLTEtNzIxNTE_f23d2e60-02f2-460e-94f8-62be3bc9d7ad">267</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTozNjFmOWMzZDRhN2I0ZGM2ODEyNWFmNzk5ZTkxZmIyNy90YWJsZXJhbmdlOjM2MWY5YzNkNGE3YjRkYzY4MTI1YWY3OTllOTFmYjI3XzUtMy0xLTEtNzIxNTE_48d803bb-5708-4fe0-b4d8-c924ae5d7e7b">524</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTozNjFmOWMzZDRhN2I0ZGM2ODEyNWFmNzk5ZTkxZmIyNy90YWJsZXJhbmdlOjM2MWY5YzNkNGE3YjRkYzY4MTI1YWY3OTllOTFmYjI3XzUtNS0xLTEtNzIxNTE_0638ec82-6caf-47ab-b043-9bd53026b24a">307</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Deferred income tax expense (benefit):</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States federal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTozNjFmOWMzZDRhN2I0ZGM2ODEyNWFmNzk5ZTkxZmIyNy90YWJsZXJhbmdlOjM2MWY5YzNkNGE3YjRkYzY4MTI1YWY3OTllOTFmYjI3XzctMS0xLTEtNzIxNTE_87c53128-e648-444e-ba1d-28e387f56e5a">179</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTozNjFmOWMzZDRhN2I0ZGM2ODEyNWFmNzk5ZTkxZmIyNy90YWJsZXJhbmdlOjM2MWY5YzNkNGE3YjRkYzY4MTI1YWY3OTllOTFmYjI3XzctMy0xLTEtNzIxNTE_fd1834db-c1d5-4896-956d-1e982b97b894">82</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTozNjFmOWMzZDRhN2I0ZGM2ODEyNWFmNzk5ZTkxZmIyNy90YWJsZXJhbmdlOjM2MWY5YzNkNGE3YjRkYzY4MTI1YWY3OTllOTFmYjI3XzctNS0xLTEtNzIxNTE_ff119c43-4d2f-4976-979f-c0e8a9117a22">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States state and local</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTozNjFmOWMzZDRhN2I0ZGM2ODEyNWFmNzk5ZTkxZmIyNy90YWJsZXJhbmdlOjM2MWY5YzNkNGE3YjRkYzY4MTI1YWY3OTllOTFmYjI3XzgtMS0xLTEtNzIxNTE_0ab53d34-d6b9-44d7-a11a-bb073d581466">30</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTozNjFmOWMzZDRhN2I0ZGM2ODEyNWFmNzk5ZTkxZmIyNy90YWJsZXJhbmdlOjM2MWY5YzNkNGE3YjRkYzY4MTI1YWY3OTllOTFmYjI3XzgtMy0xLTEtNzIxNTE_480bb27d-b8dd-485a-a132-d957a1d16226">23</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTozNjFmOWMzZDRhN2I0ZGM2ODEyNWFmNzk5ZTkxZmIyNy90YWJsZXJhbmdlOjM2MWY5YzNkNGE3YjRkYzY4MTI1YWY3OTllOTFmYjI3XzgtNS0xLTEtNzIxNTE_0d59a5b8-fa8b-41b1-b45e-3e1eefa719a9">25</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTozNjFmOWMzZDRhN2I0ZGM2ODEyNWFmNzk5ZTkxZmIyNy90YWJsZXJhbmdlOjM2MWY5YzNkNGE3YjRkYzY4MTI1YWY3OTllOTFmYjI3XzktMS0xLTEtNzIxNTE_3e524303-1249-4a90-9e46-4fcad2955d49">267</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTozNjFmOWMzZDRhN2I0ZGM2ODEyNWFmNzk5ZTkxZmIyNy90YWJsZXJhbmdlOjM2MWY5YzNkNGE3YjRkYzY4MTI1YWY3OTllOTFmYjI3XzktMy0xLTEtNzIxNTE_15fbfcad-d936-472b-831e-bd31fc9271df">132</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTozNjFmOWMzZDRhN2I0ZGM2ODEyNWFmNzk5ZTkxZmIyNy90YWJsZXJhbmdlOjM2MWY5YzNkNGE3YjRkYzY4MTI1YWY3OTllOTFmYjI3XzktNS0xLTEtNzIxNTE_1a55592b-2731-4655-88dc-7ac0fab4a0bd">72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total deferred income tax expense (benefit)</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTozNjFmOWMzZDRhN2I0ZGM2ODEyNWFmNzk5ZTkxZmIyNy90YWJsZXJhbmdlOjM2MWY5YzNkNGE3YjRkYzY4MTI1YWY3OTllOTFmYjI3XzEwLTEtMS0xLTcyMTUx_2a5be7ba-a5e5-4ae8-8c80-c4d8cbff053d">58</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTozNjFmOWMzZDRhN2I0ZGM2ODEyNWFmNzk5ZTkxZmIyNy90YWJsZXJhbmdlOjM2MWY5YzNkNGE3YjRkYzY4MTI1YWY3OTllOTFmYjI3XzEwLTMtMS0xLTcyMTUx_e346e13c-a611-41c9-93b8-a55c36afc906">237</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTozNjFmOWMzZDRhN2I0ZGM2ODEyNWFmNzk5ZTkxZmIyNy90YWJsZXJhbmdlOjM2MWY5YzNkNGE3YjRkYzY4MTI1YWY3OTllOTFmYjI3XzEwLTUtMS0xLTcyMTUx_6bedf318-1616-4069-9a29-70d01e5978ea">48</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total income tax expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTozNjFmOWMzZDRhN2I0ZGM2ODEyNWFmNzk5ZTkxZmIyNy90YWJsZXJhbmdlOjM2MWY5YzNkNGE3YjRkYzY4MTI1YWY3OTllOTFmYjI3XzExLTEtMS0xLTcyMTUx_783ac827-957e-4e6f-8067-510d5f70032d">325</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTozNjFmOWMzZDRhN2I0ZGM2ODEyNWFmNzk5ZTkxZmIyNy90YWJsZXJhbmdlOjM2MWY5YzNkNGE3YjRkYzY4MTI1YWY3OTllOTFmYjI3XzExLTMtMS0xLTcyMTUx_ab69d807-806a-4434-a131-41dddd65a566">287</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTozNjFmOWMzZDRhN2I0ZGM2ODEyNWFmNzk5ZTkxZmIyNy90YWJsZXJhbmdlOjM2MWY5YzNkNGE3YjRkYzY4MTI1YWY3OTllOTFmYjI3XzExLTUtMS0xLTcyMTUx_059612cb-9da0-4cde-a961-0db51e9fc834">355</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Interest and penalties included in other income (expense), net were income of $<ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90ZXh0cmVnaW9uOmU3ZWQ4YWYyMzA4NDQxODdiZThlNGNkYTNkMGQ3M2U4XzU0OTc1NTgxOTU5Mg_010c6715-2f72-446e-8e60-29521ee4c9b7">71</ix:nonFraction> in 2022, and expense of ($<ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90ZXh0cmVnaW9uOmU3ZWQ4YWYyMzA4NDQxODdiZThlNGNkYTNkMGQ3M2U4Xzg0MA_517e3a9d-5796-4938-b390-fd8cb7dcea9d">23</ix:nonFraction>) and ($<ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90ZXh0cmVnaW9uOmU3ZWQ4YWYyMzA4NDQxODdiZThlNGNkYTNkMGQ3M2U4Xzg0NA_df968d2b-5c5c-4854-ae0a-209d9e6d0ca1">35</ix:nonFraction>) in 2021 and 2020. The United States federal deferred income tax benefit (expense) includes the utilization of net operating loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="syk:IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90ZXh0cmVnaW9uOmU3ZWQ4YWYyMzA4NDQxODdiZThlNGNkYTNkMGQ3M2U4XzU0OTc1NTgxOTYwMA_fb8f3655-5210-4fe8-8219-f3bfa9a9663a">56</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="syk:IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90ZXh0cmVnaW9uOmU3ZWQ4YWYyMzA4NDQxODdiZThlNGNkYTNkMGQ3M2U4XzEwMDA_90b13117-6d18-43e9-8b28-98a59208071d">283</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="syk:IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90ZXh0cmVnaW9uOmU3ZWQ4YWYyMzA4NDQxODdiZThlNGNkYTNkMGQ3M2U4XzEwMDQ_b159c916-bf8f-4f86-94d2-5197f5a2312a">41</ix:nonFraction> in 2022, 2021 and 2020.</span></div></ix:continuation></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">35</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2022 FORM 10-K</span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><ix:continuation id="ibe721f5298e14da0ac572b82838be36a" continuedAt="i2f36c0337af74538842110ab01f51067"><div><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90ZXh0cmVnaW9uOmU3ZWQ4YWYyMzA4NDQxODdiZThlNGNkYTNkMGQ3M2U4XzQxMjg_8ec67f87-1b26-4dba-a954-49e8f797bbec" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.463%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.545%"></td><td style="width:0.1%"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Deferred Income Tax Assets and Liabilities</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Deferred income tax assets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:DeferredTaxAssetsInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzItMS0xLTEtNzIxNTE_9e76b32c-8802-4220-84b9-1b1b49e43e25">516</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzItMy0xLTEtNzIxNTE_aa619e20-ad74-42dc-ae92-b07553bc17f0">513</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Product-related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzMtMS0xLTEtNzIxNTE_12491e5f-3560-4f38-b089-c29dca33de74">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzMtMy0xLTEtNzIxNTE_c6edb87b-90d7-4bd8-a1b2-f64360d4e314">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzQtMS0xLTEtNzIxNTE_eaa4dea5-1bd4-4a54-9a99-2828acdd51aa">155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzQtMy0xLTEtNzIxNTE_299c6881-f349-4a0e-8501-5805ef113d41">501</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="syk:DeferredTaxAssetsDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzUtMS0xLTEtNzIxNTE_006a9352-0272-4a9e-b906-8cccf2598977">1,038</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="syk:DeferredTaxAssetsDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzUtMy0xLTEtNzIxNTE_04cfb655-367f-48d6-bdaa-b7ad565e3625">1,194</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">State income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:DeferredTaxAssetsStateTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzYtMS0xLTEtNzIxNTE_d8f7eb39-f8f4-49e8-b6e2-b75005dc7fc0">153</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsStateTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzYtMy0xLTEtNzIxNTE_a6a3d8fd-8bfb-4352-a1e4-45b7e6cdbe82">128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzctMS0xLTEtNzIxNTE_fd02aa80-6248-411f-b426-63e6e82a756a">73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzctMy0xLTEtNzIxNTE_705dd734-824e-47d5-b793-5f45205c5ed4">63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Research and development capitalization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="syk:DeferredTaxAssetsResearchAndDevelopmentCapitalization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzgtMS0xLTEtODI5NzM_9d462828-14d6-4fec-ab84-4c4cf262efd1">204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="syk:DeferredTaxAssetsResearchAndDevelopmentCapitalization" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzgtMy0xLTEtODI5NzM_7595ecd1-adea-42fe-90ef-6954b49694af">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">International interest expense carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:DeferredTaxAssetInterestCarryforward" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzktMS0xLTEtODI5ODM_42a019d7-5378-4161-94a3-c42d0f32fac0">135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetInterestCarryforward" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzktMy0xLTEtODI5ODM_0da4a9ef-8d08-487b-b5a4-806d25184bc8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net operating loss and other credit carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzgtMS0xLTEtNzIxNTE_69d5f4b0-9a5a-4538-a9d6-934c45758c6d">247</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzgtMy0xLTEtNzIxNTE_7367d67e-382e-4de2-b7a1-3a78a9978612">232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzktMS0xLTEtNzIxNTE_c1c78528-459e-4993-ba2a-72dbab0cb19d">165</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzktMy0xLTEtNzIxNTE_83b2de38-363f-4ff3-a6ef-2f1e18a8f57f">191</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total deferred income tax assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzEwLTEtMS0xLTcyMTUx_fa773ae4-7bc4-4101-8750-f886156c4fce">2,712</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzEwLTMtMS0xLTcyMTUx_074535dd-8024-4eed-ab83-1a0216b5bbc2">2,861</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Less valuation allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzExLTEtMS0xLTcyMTUx_1e4a14b5-b8e3-4023-bdd1-65d50c1e000f">285</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzExLTMtMS0xLTcyMTUx_53840986-9435-4570-880d-51502cfbe9f4">164</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net deferred income tax assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzEyLTEtMS0xLTcyMTUx_48e6c0f5-2411-4de9-a76b-83e4ff00f248">2,427</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzEyLTMtMS0xLTcyMTUx_f7fc8fea-4de9-475d-b12e-3be9453b92bd">2,697</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Deferred income tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="syk:DeferredTaxLiabilitiesDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzE0LTEtMS0xLTcyMTUx_4936186d-f97f-49a2-837e-80bbd2d55abb">1,037</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="syk:DeferredTaxLiabilitiesDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzE0LTMtMS0xLTcyMTUx_dbc31d66-4f62-46d3-a431-4dc3dc861694">891</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Undistributed earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzE1LTEtMS0xLTcyMTUx_3ec22372-dbdb-4f04-847f-471e8356c75f">47</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzE1LTMtMS0xLTcyMTUx_04d7e931-d7c1-4cb5-b7ae-450aef1ec736">114</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total deferred income tax liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzE3LTEtMS0xLTcyMTUx_533d52d1-79b4-4394-9db3-97442e1eec21">1,084</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzE3LTMtMS0xLTcyMTUx_23de48b1-1159-4075-9ee5-28d12f94a777">1,005</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net deferred income tax assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzE4LTEtMS0xLTcyMTUx_be9fbd47-a406-4e2b-a468-ea56eec84009">1,343</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzE4LTMtMS0xLTcyMTUx_53cefd60-c505-4b42-a47e-16330e8618f8">1,692</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reported as:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Noncurrent deferred income tax assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzIwLTEtMS0xLTcyMTUx_5335bc7a-0b5d-4a44-a60e-098ad5848f7f">1,410</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzIwLTMtMS0xLTcyMTUx_b6dcd622-d41c-4c2e-b9c8-7e24d52e0ae7">1,760</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Noncurrent liabilities&#8212;Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzIxLTEtMS0xLTcyMTUx_e91b33bd-6836-487c-babe-0b3a54a03edf">67</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzIxLTMtMS0xLTcyMTUx_d276fd91-31c3-4e71-894e-394a79889037">68</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzIyLTEtMS0xLTcyMTUx_e9232f8a-770c-4262-9df8-33e2660b4209">1,343</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzIyLTMtMS0xLTcyMTUx_4c9cde52-e57d-4ba8-a3c6-5e5d5cb3152e">1,692</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accrued interest and penalties were $<ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90ZXh0cmVnaW9uOmU3ZWQ4YWYyMzA4NDQxODdiZThlNGNkYTNkMGQ3M2U4XzEwNzA_3b360267-0cda-4c13-bbec-079b2f199f78">66</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90ZXh0cmVnaW9uOmU3ZWQ4YWYyMzA4NDQxODdiZThlNGNkYTNkMGQ3M2U4XzEwNzc_2244674a-cddc-45dc-976e-d11dd1fa0912">150</ix:nonFraction> on December&#160;31, 2022 and 2021 which were reported in accrued expenses and other liabilities and other noncurrent liabilities.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net operating loss carryforwards totaling $<ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90ZXh0cmVnaW9uOmU3ZWQ4YWYyMzA4NDQxODdiZThlNGNkYTNkMGQ3M2U4XzEyMjE_73c26fa7-84b8-46f1-a734-600dcdaf0f4a">544</ix:nonFraction> with $<ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="syk:OperatingLossCarryforwardsSubjectToValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90ZXh0cmVnaW9uOmU3ZWQ4YWYyMzA4NDQxODdiZThlNGNkYTNkMGQ3M2U4XzEyMjk_989316c2-8ab6-4b1d-9958-54f9d1633852">155</ix:nonFraction> being subject to a full valuation allowance on December&#160;31, 2022 are available to reduce future taxable earnings of certain domestic and foreign subsidiaries. United States loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="i8e50f83f7596461c955c6b530bef94eb_I20221231" decimals="-6" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90ZXh0cmVnaW9uOmU3ZWQ4YWYyMzA4NDQxODdiZThlNGNkYTNkMGQ3M2U4XzE0NTg_af0c7999-688e-4a23-be91-4ad16335e3e5">377</ix:nonFraction> begin to expire in 2023. International loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="ia7a76123b7f64330919b0f229f73daa6_I20221231" decimals="-6" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90ZXh0cmVnaW9uOmU3ZWQ4YWYyMzA4NDQxODdiZThlNGNkYTNkMGQ3M2U4XzE1MTg_484a5d9a-b8fe-41c7-b947-76a3e923349e">167</ix:nonFraction> begin to expire in 2023; however, some have no expiration. We also have tax credit carryforwards of $<ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:TaxCreditCarryforwardAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90ZXh0cmVnaW9uOmU3ZWQ4YWYyMzA4NDQxODdiZThlNGNkYTNkMGQ3M2U4XzE2MjE_4a697158-523b-4132-88a2-6e10bbea5756">133</ix:nonFraction> with $<ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:TaxCreditCarryforwardValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90ZXh0cmVnaW9uOmU3ZWQ4YWYyMzA4NDQxODdiZThlNGNkYTNkMGQ3M2U4XzE2Mjk_bcff555c-6dac-4028-9fe3-f74c9b961d26">91</ix:nonFraction> being subject to a full valuation allowance. The credits with a full valuation allowance begin to expire in 2023. We do not anticipate generating income tax in excess of the non-expiring credits in the foreseeable future.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">The Tax Cuts and Jobs Act (the Act) was enacted in 2017 in the United States. We recorded a one-time transition tax on earnings of certain foreign subsidiaries that were previously deferred. The Act also subjects a United States shareholder to tax on Global Intangible Low-Taxed Income (GILTI) earned by certain foreign subsidiaries. We have elected to account for GILTI tax in the year the tax is incurred.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">We recorded deferred income tax on undistributed earnings of foreign subsidiaries not determined to be indefinitely reinvested. Determination of the total amount of unrecognized deferred income tax on undistributed earnings of foreign subsidiaries is not practicable.</span></div><div style="text-align:justify"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:SummaryOfIncomeTaxContingenciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90ZXh0cmVnaW9uOmU3ZWQ4YWYyMzA4NDQxODdiZThlNGNkYTNkMGQ3M2U4XzQxMzY_d9577d0f-7f49-41eb-a848-320f20a688e8" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.750%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.258%"></td><td style="width:0.1%"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Uncertain Income Tax Positions</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Beginning uncertain tax positions</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTowOGVhMDQ2OTY1Njc0ZGIwYTRiNWIyNWJlYjEyZTY1NS90YWJsZXJhbmdlOjA4ZWEwNDY5NjU2NzRkYjBhNGI1YjI1YmViMTJlNjU1XzItMS0xLTEtNzIxNTE_0e89cea8-960c-48cf-a45a-77c015e1673e">444</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98963cf23d234ec1ac275e66bcfd76dc_I20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTowOGVhMDQ2OTY1Njc0ZGIwYTRiNWIyNWJlYjEyZTY1NS90YWJsZXJhbmdlOjA4ZWEwNDY5NjU2NzRkYjBhNGI1YjI1YmViMTJlNjU1XzItMy0xLTEtNzIxNTE_ede183b6-30d2-4147-a4f2-7c79ec17cfac">457</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Increases related to current year income tax positions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTowOGVhMDQ2OTY1Njc0ZGIwYTRiNWIyNWJlYjEyZTY1NS90YWJsZXJhbmdlOjA4ZWEwNDY5NjU2NzRkYjBhNGI1YjI1YmViMTJlNjU1XzMtMS0xLTEtNzIxNTE_5e111e2b-55bc-4d11-abf3-e09e44ed734a">17</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTowOGVhMDQ2OTY1Njc0ZGIwYTRiNWIyNWJlYjEyZTY1NS90YWJsZXJhbmdlOjA4ZWEwNDY5NjU2NzRkYjBhNGI1YjI1YmViMTJlNjU1XzMtMy0xLTEtNzIxNTE_eed722f5-eb78-49b8-80d0-3decb4c92a6d">13</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Increases related to prior year income tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTowOGVhMDQ2OTY1Njc0ZGIwYTRiNWIyNWJlYjEyZTY1NS90YWJsZXJhbmdlOjA4ZWEwNDY5NjU2NzRkYjBhNGI1YjI1YmViMTJlNjU1XzQtMS0xLTEtNzIxNTE_d74fbb01-60d0-48be-bba3-8ad27d3e84ec">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTowOGVhMDQ2OTY1Njc0ZGIwYTRiNWIyNWJlYjEyZTY1NS90YWJsZXJhbmdlOjA4ZWEwNDY5NjU2NzRkYjBhNGI1YjI1YmViMTJlNjU1XzQtMy0xLTEtNzIxNTE_aca2f7a7-2beb-449c-99c4-b5a39ff5142a">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Decreases related to prior year income tax positions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTowOGVhMDQ2OTY1Njc0ZGIwYTRiNWIyNWJlYjEyZTY1NS90YWJsZXJhbmdlOjA4ZWEwNDY5NjU2NzRkYjBhNGI1YjI1YmViMTJlNjU1XzUtMS0xLTEtODYyNDA_e3fa2aff-6510-4a32-b67e-9a7b35b1bcbf">178</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTowOGVhMDQ2OTY1Njc0ZGIwYTRiNWIyNWJlYjEyZTY1NS90YWJsZXJhbmdlOjA4ZWEwNDY5NjU2NzRkYjBhNGI1YjI1YmViMTJlNjU1XzUtMy0xLTEtODYyNDg_79916f71-6e01-4581-9cbe-0dc0fdbf5fdf">18</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Settlements of income tax audits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTowOGVhMDQ2OTY1Njc0ZGIwYTRiNWIyNWJlYjEyZTY1NS90YWJsZXJhbmdlOjA4ZWEwNDY5NjU2NzRkYjBhNGI1YjI1YmViMTJlNjU1XzYtMS0xLTEtNzIxNTE_db27e285-8a7b-42ef-8bdc-a0c1a13504fe">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTowOGVhMDQ2OTY1Njc0ZGIwYTRiNWIyNWJlYjEyZTY1NS90YWJsZXJhbmdlOjA4ZWEwNDY5NjU2NzRkYjBhNGI1YjI1YmViMTJlNjU1XzYtMy0xLTEtNzIxNTE_81a5518b-237c-49d6-b811-4389543a05b6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Statute of limitations expirations and other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTowOGVhMDQ2OTY1Njc0ZGIwYTRiNWIyNWJlYjEyZTY1NS90YWJsZXJhbmdlOjA4ZWEwNDY5NjU2NzRkYjBhNGI1YjI1YmViMTJlNjU1XzctMS0xLTEtNzIxNTE_c59938fc-66a7-440b-a7b6-c921cddfc918">6</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTowOGVhMDQ2OTY1Njc0ZGIwYTRiNWIyNWJlYjEyZTY1NS90YWJsZXJhbmdlOjA4ZWEwNDY5NjU2NzRkYjBhNGI1YjI1YmViMTJlNjU1XzctMy0xLTEtNzIxNTE_3c54dfe4-0b04-4832-bb84-2b487789564f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTowOGVhMDQ2OTY1Njc0ZGIwYTRiNWIyNWJlYjEyZTY1NS90YWJsZXJhbmdlOjA4ZWEwNDY5NjU2NzRkYjBhNGI1YjI1YmViMTJlNjU1XzgtMS0xLTEtNzIxNTE_e82311e0-9941-4339-9989-8629120ce8bb">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTowOGVhMDQ2OTY1Njc0ZGIwYTRiNWIyNWJlYjEyZTY1NS90YWJsZXJhbmdlOjA4ZWEwNDY5NjU2NzRkYjBhNGI1YjI1YmViMTJlNjU1XzgtMy0xLTEtNzIxNTE_150251e7-c26c-48c8-8e6f-1bd8ec814168">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Ending uncertain tax positions</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTowOGVhMDQ2OTY1Njc0ZGIwYTRiNWIyNWJlYjEyZTY1NS90YWJsZXJhbmdlOjA4ZWEwNDY5NjU2NzRkYjBhNGI1YjI1YmViMTJlNjU1XzEwLTEtMS0xLTcyMTUx_2f29081e-5e7c-4f48-8b31-1877f5a9869b">286</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTowOGVhMDQ2OTY1Njc0ZGIwYTRiNWIyNWJlYjEyZTY1NS90YWJsZXJhbmdlOjA4ZWEwNDY5NjU2NzRkYjBhNGI1YjI1YmViMTJlNjU1XzEwLTMtMS0xLTcyMTUx_f4ca387e-2e27-4ef8-a3a0-c6a14341ee20">444</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reported as:</span></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Noncurrent liabilities&#8212;Income taxes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTowOGVhMDQ2OTY1Njc0ZGIwYTRiNWIyNWJlYjEyZTY1NS90YWJsZXJhbmdlOjA4ZWEwNDY5NjU2NzRkYjBhNGI1YjI1YmViMTJlNjU1XzEyLTEtMS0xLTcyMTUx_6036c189-e7ba-467a-bdcb-ebf5d3459791">286</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTowOGVhMDQ2OTY1Njc0ZGIwYTRiNWIyNWJlYjEyZTY1NS90YWJsZXJhbmdlOjA4ZWEwNDY5NjU2NzRkYjBhNGI1YjI1YmViMTJlNjU1XzEyLTMtMS0xLTcyMTUx_d80fd1c9-34ac-4539-a3f2-5634436c4dfb">444</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our income tax expense would have been reduced by $<ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90ZXh0cmVnaW9uOmU3ZWQ4YWYyMzA4NDQxODdiZThlNGNkYTNkMGQ3M2U4XzI2MTg_5f5e0608-8390-4408-89a4-fd932d6f2da3">289</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90ZXh0cmVnaW9uOmU3ZWQ4YWYyMzA4NDQxODdiZThlNGNkYTNkMGQ3M2U4XzI2MjU_2bdd0dd0-a535-4ceb-adfe-0c9c7fcd2aa9">445</ix:nonFraction> in 2022 and 2021 had these uncertain income tax positions been favorably resolved. It is reasonably possible that the amount of unrecognized tax benefits will significantly change due </span></div></ix:continuation></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i2f36c0337af74538842110ab01f51067" continuedAt="i53771044e7b34011a6f5f8a2e9813063">to one or more of the following events in the next 12 months: expiring statutes, audit activity, tax payments, competent authority proceedings related to transfer pricing or final decisions in matters that are the subject of controversy in various taxing jurisdictions in which we operate, including inventory transfer pricing, cost sharing, product royalty and foreign branch arrangements. We are not able to reasonably estimate the amount or the future periods in which changes in unrecognized tax benefits may be resolved. Interest and penalties incurred associated with uncertain tax positions are included in other income (expense), net.</ix:continuation></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i53771044e7b34011a6f5f8a2e9813063">In the normal course of business, income tax authorities in various income tax jurisdictions both within the United States and internationally conduct routine audits of our income tax returns filed in prior years.&#160;These audits are generally designed to determine if individual income tax authorities are in agreement with our interpretations of complex income tax regulations regarding the allocation of income to the various income tax jurisdictions. Income tax expense in 2022 decreased $<ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:IncomeTaxReconciliationTaxSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90ZXh0cmVnaW9uOmU3ZWQ4YWYyMzA4NDQxODdiZThlNGNkYTNkMGQ3M2U4XzU0OTc1NTgxOTYwOA_4a581936-681e-4560-ab5d-b865a79c1876">162</ix:nonFraction> due to the effective settlement of the United States federal income tax audit for years 2014 through 2018. In addition, 2022 other income (expense), net includes a benefit of $<ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" sign="-" name="syk:IncomeTaxExpenseBenefitTaxSettlementReleaseOfAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90ZXh0cmVnaW9uOmU3ZWQ4YWYyMzA4NDQxODdiZThlNGNkYTNkMGQ3M2U4XzU0OTc1NTgxOTYxNw_b3b02f9b-7a8e-4667-877f-03fb23d31d72">50</ix:nonFraction> related to the release of accrued interest associated with this settlement. Income tax years are open from 2019 through the current year for the United States federal jurisdiction. Income tax years open for our other major jurisdictions range from 2007 through the current year.</ix:continuation> </span></div><div id="icec46013a0ad4608b89f97e433dd3417_133"></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTE 12 - <ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90ZXh0cmVnaW9uOjU2Yjk3OTZmMzkxZTQ1YTRhMzVjOGE4ZjJjYWZhMjhiXzE5NDA_90acb7e8-8850-43c1-a40b-e8d09b763944" continuedAt="i2da18fe3c6d3445d8a4aeb0f334bf66e" escape="true">RETIREMENT PLANS</ix:nonNumeric></span></div><ix:continuation id="i2da18fe3c6d3445d8a4aeb0f334bf66e" continuedAt="id08c041ddbce4d789c0909f4d360331f"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Defined Contribution Plans</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We provide certain employees with defined contribution plans and other types of retirement plans. A portion of our retirement plan expense under the defined contribution plans is funded with Stryker common stock. The use of Stryker common stock represents a non-cash operating activity that is not reflected in our Consolidated Statements of Cash Flows.</span></div><div style="text-align:justify"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:DefinedContributionPlanDisclosuresTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90ZXh0cmVnaW9uOjU2Yjk3OTZmMzkxZTQ1YTRhMzVjOGE4ZjJjYWZhMjhiXzE5MjA_302b6d2c-ef99-40e8-9eb7-6326056a62b6" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"></td><td style="width:61.436%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.427%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.427%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.430%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Plan expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:DefinedContributionPlanCostRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTowNTIyMjMxOGU1OTE0ZjFkYmU5ZWRkOTA5OWVlZDkwMC90YWJsZXJhbmdlOjA1MjIyMzE4ZTU5MTRmMWRiZTllZGQ5MDk5ZWVkOTAwXzEtMS0xLTEtNzIxNTE_60f83b9e-fd42-4757-89c5-1ebe5e50c049">305</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:DefinedContributionPlanCostRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTowNTIyMjMxOGU1OTE0ZjFkYmU5ZWRkOTA5OWVlZDkwMC90YWJsZXJhbmdlOjA1MjIyMzE4ZTU5MTRmMWRiZTllZGQ5MDk5ZWVkOTAwXzEtMy0xLTEtNzIxNTE_6d3e5ad8-0b7e-4fa6-98a3-02f7c1b92c69">259</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:DefinedContributionPlanCostRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTowNTIyMjMxOGU1OTE0ZjFkYmU5ZWRkOTA5OWVlZDkwMC90YWJsZXJhbmdlOjA1MjIyMzE4ZTU5MTRmMWRiZTllZGQ5MDk5ZWVkOTAwXzEtNS0xLTEtNzIxNTE_eb0e797e-c6b7-4669-b966-4a44d3321070">235</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expense funded with Stryker common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTowNTIyMjMxOGU1OTE0ZjFkYmU5ZWRkOTA5OWVlZDkwMC90YWJsZXJhbmdlOjA1MjIyMzE4ZTU5MTRmMWRiZTllZGQ5MDk5ZWVkOTAwXzItMS0xLTEtNzIxNTE_627d38bc-384e-4b34-a9a1-3e09d4a2ed15">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTowNTIyMjMxOGU1OTE0ZjFkYmU5ZWRkOTA5OWVlZDkwMC90YWJsZXJhbmdlOjA1MjIyMzE4ZTU5MTRmMWRiZTllZGQ5MDk5ZWVkOTAwXzItMy0xLTEtNzIxNTE_6c872665-e5ea-4a2b-80e8-a1ae16d1dc7a">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTowNTIyMjMxOGU1OTE0ZjFkYmU5ZWRkOTA5OWVlZDkwMC90YWJsZXJhbmdlOjA1MjIyMzE4ZTU5MTRmMWRiZTllZGQ5MDk5ZWVkOTAwXzItNS0xLTEtNzIxNTE_51eb9dcd-6638-48ea-9d7c-bd3d19dbc1ca">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Stryker common stock held by plan:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dollar amount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="syk:DefinedContributionRetirementPlansCommonStockValueHeldByCompany" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTowNTIyMjMxOGU1OTE0ZjFkYmU5ZWRkOTA5OWVlZDkwMC90YWJsZXJhbmdlOjA1MjIyMzE4ZTU5MTRmMWRiZTllZGQ5MDk5ZWVkOTAwXzQtMS0xLTEtNzIxNTE_9785c03c-056a-4d5a-ae8b-2fc883b20467">522</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="syk:DefinedContributionRetirementPlansCommonStockValueHeldByCompany" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTowNTIyMjMxOGU1OTE0ZjFkYmU5ZWRkOTA5OWVlZDkwMC90YWJsZXJhbmdlOjA1MjIyMzE4ZTU5MTRmMWRiZTllZGQ5MDk5ZWVkOTAwXzQtMy0xLTEtNzIxNTE_27450322-1dca-4fe1-9c84-b6559099bae9">582</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="syk:DefinedContributionRetirementPlansCommonStockValueHeldByCompany" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTowNTIyMjMxOGU1OTE0ZjFkYmU5ZWRkOTA5OWVlZDkwMC90YWJsZXJhbmdlOjA1MjIyMzE4ZTU5MTRmMWRiZTllZGQ5MDk5ZWVkOTAwXzQtNS0xLTEtNzIxNTE_6c4621fc-37a1-434c-bf96-6b82a96ef4b6">542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Shares (in millions)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-5" name="syk:DefinedContributionRetirementPlansCommonStockHeldByCompany" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTowNTIyMjMxOGU1OTE0ZjFkYmU5ZWRkOTA5OWVlZDkwMC90YWJsZXJhbmdlOjA1MjIyMzE4ZTU5MTRmMWRiZTllZGQ5MDk5ZWVkOTAwXzUtMS0xLTEtNzIxNTE_ab574414-b0e4-4a3e-9ef9-0064fbf6aff6">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-5" name="syk:DefinedContributionRetirementPlansCommonStockHeldByCompany" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTowNTIyMjMxOGU1OTE0ZjFkYmU5ZWRkOTA5OWVlZDkwMC90YWJsZXJhbmdlOjA1MjIyMzE4ZTU5MTRmMWRiZTllZGQ5MDk5ZWVkOTAwXzUtMy0xLTEtNzIxNTE_b560ec7b-c6ef-45c3-a764-de318d80b582">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-5" name="syk:DefinedContributionRetirementPlansCommonStockHeldByCompany" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTowNTIyMjMxOGU1OTE0ZjFkYmU5ZWRkOTA5OWVlZDkwMC90YWJsZXJhbmdlOjA1MjIyMzE4ZTU5MTRmMWRiZTllZGQ5MDk5ZWVkOTAwXzUtNS0xLTEtNzIxNTE_cc8c7a4b-b0c4-4252-a945-2799b9d3ae70">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Value as a percentage of total plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="2" name="syk:TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTowNTIyMjMxOGU1OTE0ZjFkYmU5ZWRkOTA5OWVlZDkwMC90YWJsZXJhbmdlOjA1MjIyMzE4ZTU5MTRmMWRiZTllZGQ5MDk5ZWVkOTAwXzYtMS0xLTEtNzIxNTE_be9ac28a-1a26-4928-a1b3-f291b7f80a8a">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="2" name="syk:TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTowNTIyMjMxOGU1OTE0ZjFkYmU5ZWRkOTA5OWVlZDkwMC90YWJsZXJhbmdlOjA1MjIyMzE4ZTU5MTRmMWRiZTllZGQ5MDk5ZWVkOTAwXzYtMy0xLTEtNzIxNTE_f1dfe0b1-79ea-41a6-a189-59f88fe45110">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="2" name="syk:TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTowNTIyMjMxOGU1OTE0ZjFkYmU5ZWRkOTA5OWVlZDkwMC90YWJsZXJhbmdlOjA1MjIyMzE4ZTU5MTRmMWRiZTllZGQ5MDk5ZWVkOTAwXzYtNS0xLTEtNzIxNTE_121631a8-1b88-4d0a-85a3-125c4192cee6">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:3pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Defined Benefit Plans</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain of our subsidiaries have both funded and unfunded defined benefit pension plans covering some or all of their employees. The majority of our defined benefit pension plans have projected benefit obligations in excess of plan assets.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Discount Rate</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The discount rates were selected using a hypothetical portfolio of high quality bonds on December 31 that would provide the necessary cash flows to match our projected benefit payments. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Expected Return on Plan Assets</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The expected return on plan assets is determined by applying the target allocation in each asset category of plan investments to the anticipated return for each asset category based on historical and projected returns. </span></div></ix:continuation></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">36</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2022 FORM 10-K</span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><ix:continuation id="id08c041ddbce4d789c0909f4d360331f" continuedAt="i26828814ef3b488daed8556af3cec5a2"><div style="margin-bottom:3pt;text-align:justify"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:ScheduleOfCostsOfRetirementPlansTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90ZXh0cmVnaW9uOjU2Yjk3OTZmMzkxZTQ1YTRhMzVjOGE4ZjJjYWZhMjhiXzE5Mzc_eed571e7-7afc-47b1-987f-3c1f9d945ead" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"></td><td style="width:61.436%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.427%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.427%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.430%"></td><td style="width:0.1%"></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Components of Net Periodic Pension Cost</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net periodic benefit cost:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzItMS0xLTEtNzIxNTE_137d5c0a-3193-46a3-b047-5901b44eb899">56</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzItMy0xLTEtNzIxNTE_5de2dbee-4a8d-4ac3-9149-d0d06663ed8c">72</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzItNS0xLTEtNzIxNTE_72b3274b-05d5-44f5-b71c-56c5fa12b6cb">63</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzMtMS0xLTEtNzIxNTE_f9e23426-9bbe-4c47-97e1-536986f24c44">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzMtMy0xLTEtNzIxNTE_1d60b5be-7a68-4fad-bf6f-59ded5fef4f0">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzMtNS0xLTEtNzIxNTE_221f43b8-6b62-46fa-bc4f-0c9785b86766">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzQtMS0xLTEtNzIxNTE_3890a843-1f03-4837-87ff-2cbbe1d1f778">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzQtMy0xLTEtNzIxNTE_0db2e0c6-dd26-41f9-bb14-10503373ae04">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzQtNS0xLTEtNzIxNTE_0b2c8768-4c33-439d-a7b4-d7cf6f03f5ee">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization of prior service credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzUtMS0xLTEtNzIxNTE_1acaa279-c4fa-4a9b-81d6-509c8d8a099e">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzUtMy0xLTEtNzIxNTE_778981fa-1d52-4d1e-8c8b-ae7e7585a62b">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzUtNS0xLTEtNzIxNTE_df1fdb38-a27f-40c5-872a-1b2846300b6b">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Recognized actuarial loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzYtMS0xLTEtNzIxNTE_f2795b64-a454-4fa5-8e0e-c79fc78747be">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzYtMy0xLTEtNzIxNTE_e0bb229c-1373-412f-812f-613ef3ccf623">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzYtNS0xLTEtNzIxNTE_1769ff82-eaa4-4688-9f4b-bff8948291f9">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Curtailment gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzctMy0xLTEtNzIxNTE_721df5a9-75b6-4218-9421-7ffafc1e71ef">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net periodic benefit cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzgtMS0xLTEtNzIxNTE_61610930-4123-4f5e-b08c-a899498a80be">59</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzgtMy0xLTEtNzIxNTE_0a634809-3bfd-48c3-9fdd-b3cd9de81b4c">74</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzgtNS0xLTEtNzIxNTE_84e0bfc2-2c43-4979-9ee2-a90be251a5e6">70</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Changes in assets and benefit obligations recognized in OCI:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net actuarial gain (loss)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzEwLTEtMS0xLTcyMTUx_c14310b1-a7ea-4210-a6ee-886c4baadbbe">244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzEwLTMtMS0xLTcyMTUx_974c11d3-93bd-4d55-910a-a862abd19496">132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzEwLTUtMS0xLTcyMTUx_ab0a16f3-027c-4353-8a78-4ae099cb893a">117</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Recognized net actuarial loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzExLTEtMS0xLTcyMTUx_31fa7d57-4d25-4cbc-9de4-0f223d433c7a">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzExLTMtMS0xLTcyMTUx_73d11572-d108-46c6-91b7-3f1d28710e3a">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzExLTUtMS0xLTcyMTUx_0bd0c71a-1520-4f93-b197-bb05c4dc41fa">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Prior service credit and transition amount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzEyLTEtMS0xLTcyMTUx_bd83aa21-55ca-474c-90fe-fa2832c73e18">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzEyLTMtMS0xLTcyMTUx_03366e51-005a-4618-90a2-c977752d421e">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzEyLTUtMS0xLTcyMTUx_e7f9e511-2193-43fb-b57b-a57571e16e0b">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Curtailment gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzEzLTMtMS0xLTcyMTUx_d94e0e3f-0f81-49d1-863b-13eabb64b941">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzEzLTUtMS0xLTcyMTUx_ebfb7c50-41d7-40de-b7c0-42df0063d4c0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total recognized in other comprehensive income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzE0LTEtMS0xLTcyMTUx_f15077b1-fdf8-40d0-9d27-acad3a5f6a17">252</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzE0LTMtMS0xLTcyMTUx_be0ab169-dcae-4d63-8448-29129ac252fe">138</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzE0LTUtMS0xLTcyMTUx_4b0df818-1c26-492b-a9ee-055beaeef937">105</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total recognized in net periodic benefit cost and OCI</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzE1LTEtMS0xLTcyMTUx_fd42abb1-76e2-406f-8fe7-8d127f77d50a">193</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzE1LTMtMS0xLTcyMTUx_f176b370-b951-4930-89ad-e24a7339ab46">64</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzE1LTUtMS0xLTcyMTUx_61e5ff8c-2521-43e4-bf4b-8f41f288ee09">175</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted-average rates used to determine net periodic benefit cost:</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzE4LTEtMS0xLTcyMTUx_bbc27537-4261-4f31-b30d-269bf0e54312">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzE4LTMtMS0xLTcyMTUx_ce7e8c35-a745-4df8-9b8e-52e2db1c5cee">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzE4LTUtMS0xLTcyMTUx_c9068688-0d00-471d-bccb-90b696c3f53c">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzE5LTEtMS0xLTcyMTUx_4a152bbd-63f7-4558-9d96-fd7a8bfd2904">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzE5LTMtMS0xLTcyMTUx_a06e8c94-c5f2-45b0-915d-37da23316e6b">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzE5LTUtMS0xLTcyMTUx_9f53e608-5dcc-433c-8cca-533479da21b7">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzIwLTEtMS0xLTcyMTUx_c1728cfd-7409-4f6a-8bc4-0e7299f45612">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzIwLTMtMS0xLTcyMTUx_64e34663-98e9-4e49-bbe4-9540b9977601">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzIwLTUtMS0xLTcyMTUx_43623222-88e8-4ec0-a499-38c85586ea20">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Weighted-average discount rate used to determine projected benefit obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="3" name="syk:WeightedAverageUsedInDeterminationOfProjectedBenefitObligations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzIxLTEtMS0xLTcyMTUx_3b9f0112-d624-40c8-b924-a090d4c3e463">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="3" name="syk:WeightedAverageUsedInDeterminationOfProjectedBenefitObligations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzIxLTMtMS0xLTcyMTUx_c99da592-5209-4a18-ae57-94d510c44e9a">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="3" name="syk:WeightedAverageUsedInDeterminationOfProjectedBenefitObligations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzIxLTUtMS0xLTcyMTUx_ff6ed87c-9398-471a-b916-e11b34ae6ff7">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The actuarial gain (loss) for all pension plans was primarily related to a change in the discount rate used to measure the benefit obligations of those plans.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Investment Strategy</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The investment strategy for our defined benefit pension plans is to meet the liabilities of the plans as they fall due and to maximize the return on invested assets within appropriate risk tolerances.</span></div><div style="margin-bottom:3pt;text-align:justify"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90ZXh0cmVnaW9uOjU2Yjk3OTZmMzkxZTQ1YTRhMzVjOGE4ZjJjYWZhMjhiXzE5Mzg_22692aa6-7b38-44f5-b302-d0b70433f053" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.474%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.396%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo2YTExZGY5ZjA4MDM0NmZmOGRkMWY4MzJmNjAyZmNkMi90YWJsZXJhbmdlOjZhMTFkZjlmMDgwMzQ2ZmY4ZGQxZjgzMmY2MDJmY2QyXzEtMS0xLTEtNzIxNTE_e3e1dfe0-cc43-436b-afd8-b222e7b095e9">420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo2YTExZGY5ZjA4MDM0NmZmOGRkMWY4MzJmNjAyZmNkMi90YWJsZXJhbmdlOjZhMTFkZjlmMDgwMzQ2ZmY4ZGQxZjgzMmY2MDJmY2QyXzEtMy0xLTEtNzIxNTE_2c95fe7e-7cfd-451a-af5b-c56880691b8d">543</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Benefit obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo2YTExZGY5ZjA4MDM0NmZmOGRkMWY4MzJmNjAyZmNkMi90YWJsZXJhbmdlOjZhMTFkZjlmMDgwMzQ2ZmY4ZGQxZjgzMmY2MDJmY2QyXzItMS0xLTEtNzIxNTE_1b4ba712-4783-4271-a759-3cf34fb74876">673</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo2YTExZGY5ZjA4MDM0NmZmOGRkMWY4MzJmNjAyZmNkMi90YWJsZXJhbmdlOjZhMTFkZjlmMDgwMzQ2ZmY4ZGQxZjgzMmY2MDJmY2QyXzItMy0xLTEtNzIxNTE_11765ec5-4bef-473e-a50f-245dcd5a1f3b">1,036</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Funded status</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo2YTExZGY5ZjA4MDM0NmZmOGRkMWY4MzJmNjAyZmNkMi90YWJsZXJhbmdlOjZhMTFkZjlmMDgwMzQ2ZmY4ZGQxZjgzMmY2MDJmY2QyXzMtMS0xLTEtNzIxNTE_a87be1cc-395e-4728-8f5a-6efc3ab9bffc">253</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo2YTExZGY5ZjA4MDM0NmZmOGRkMWY4MzJmNjAyZmNkMi90YWJsZXJhbmdlOjZhMTFkZjlmMDgwMzQ2ZmY4ZGQxZjgzMmY2MDJmY2QyXzMtMy0xLTEtNzIxNTE_9e7b789a-960f-42cb-b320-b9fde4f0c261">493</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reported as:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Noncurrent assets&#8212;other assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic116179f0d574741a8ce9a0151e5f880_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo2YTExZGY5ZjA4MDM0NmZmOGRkMWY4MzJmNjAyZmNkMi90YWJsZXJhbmdlOjZhMTFkZjlmMDgwMzQ2ZmY4ZGQxZjgzMmY2MDJmY2QyXzUtMS0xLTEtODExMjM_1d224ac5-c528-41d8-8a0c-14697607637f">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i054f5c7fa9df497fafb3f4d6748a7c59_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo2YTExZGY5ZjA4MDM0NmZmOGRkMWY4MzJmNjAyZmNkMi90YWJsZXJhbmdlOjZhMTFkZjlmMDgwMzQ2ZmY4ZGQxZjgzMmY2MDJmY2QyXzUtMy0xLTEtODQxNzY_de4b4b25-c94d-4195-85e4-36aacd09ced2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Current liabilities&#8212;accrued compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id8603ec155204c1e91b9af77be41b5ec_I20221231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo2YTExZGY5ZjA4MDM0NmZmOGRkMWY4MzJmNjAyZmNkMi90YWJsZXJhbmdlOjZhMTFkZjlmMDgwMzQ2ZmY4ZGQxZjgzMmY2MDJmY2QyXzUtMS0xLTEtNzIxNTE_07187597-d3b7-4a5c-81c5-8a63f437675a">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id0aab17a929c4fdf94f5c9f278870a98_I20211231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo2YTExZGY5ZjA4MDM0NmZmOGRkMWY4MzJmNjAyZmNkMi90YWJsZXJhbmdlOjZhMTFkZjlmMDgwMzQ2ZmY4ZGQxZjgzMmY2MDJmY2QyXzUtMy0xLTEtNzIxNTE_8f075452-e9a6-4fe6-aeae-df31e6d3edd5">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Noncurrent liabilities&#8212;other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic37ff66ffd7045788387e658a219637c_I20221231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo2YTExZGY5ZjA4MDM0NmZmOGRkMWY4MzJmNjAyZmNkMi90YWJsZXJhbmdlOjZhMTFkZjlmMDgwMzQ2ZmY4ZGQxZjgzMmY2MDJmY2QyXzYtMS0xLTEtNzIxNTE_4dd126b1-4c4e-4c17-9a14-85926cc8db18">271</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iafd18aa56bd8454499c7770cf7cae651_I20211231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo2YTExZGY5ZjA4MDM0NmZmOGRkMWY4MzJmNjAyZmNkMi90YWJsZXJhbmdlOjZhMTFkZjlmMDgwMzQ2ZmY4ZGQxZjgzMmY2MDJmY2QyXzYtMy0xLTEtNzIxNTE_d1542429-41fe-4e8f-9848-fedfa337c2a9">491</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pre-tax amounts recognized in AOCI:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Unrecognized net actuarial gain (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id79a9c944a1046b6aaca9c9fb9f6bebe_I20221231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo2YTExZGY5ZjA4MDM0NmZmOGRkMWY4MzJmNjAyZmNkMi90YWJsZXJhbmdlOjZhMTFkZjlmMDgwMzQ2ZmY4ZGQxZjgzMmY2MDJmY2QyXzgtMS0xLTEtNzIxNTE_4dd7126a-2b1d-470a-a859-2ddb9e0d0bd7">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5af6528a025a4ecc83f861806bda8793_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo2YTExZGY5ZjA4MDM0NmZmOGRkMWY4MzJmNjAyZmNkMi90YWJsZXJhbmdlOjZhMTFkZjlmMDgwMzQ2ZmY4ZGQxZjgzMmY2MDJmY2QyXzgtMy0xLTEtNzIxNTE_ccd546a8-decc-4c8e-b5de-246789eb9f02">215</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Unrecognized prior service credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id79a9c944a1046b6aaca9c9fb9f6bebe_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo2YTExZGY5ZjA4MDM0NmZmOGRkMWY4MzJmNjAyZmNkMi90YWJsZXJhbmdlOjZhMTFkZjlmMDgwMzQ2ZmY4ZGQxZjgzMmY2MDJmY2QyXzktMS0xLTEtNzIxNTE_637b9405-5636-4f3f-8dc3-77b207eab21f">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5af6528a025a4ecc83f861806bda8793_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo2YTExZGY5ZjA4MDM0NmZmOGRkMWY4MzJmNjAyZmNkMi90YWJsZXJhbmdlOjZhMTFkZjlmMDgwMzQ2ZmY4ZGQxZjgzMmY2MDJmY2QyXzktMy0xLTEtNzIxNTE_e67d2372-bc68-4a8a-ad2e-85061a916d48">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo2YTExZGY5ZjA4MDM0NmZmOGRkMWY4MzJmNjAyZmNkMi90YWJsZXJhbmdlOjZhMTFkZjlmMDgwMzQ2ZmY4ZGQxZjgzMmY2MDJmY2QyXzEwLTEtMS0xLTcyMTUx_1450a223-6c1c-4f19-acef-11807d1b90df">44</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo2YTExZGY5ZjA4MDM0NmZmOGRkMWY4MzJmNjAyZmNkMi90YWJsZXJhbmdlOjZhMTFkZjlmMDgwMzQ2ZmY4ZGQxZjgzMmY2MDJmY2QyXzEwLTMtMS0xLTcyMTUx_d7d627db-0633-47e0-86bf-ea1732932880">208</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90ZXh0cmVnaW9uOjU2Yjk3OTZmMzkxZTQ1YTRhMzVjOGE4ZjJjYWZhMjhiXzE5NTU_9d14108c-7432-4952-9968-5b1e51e331ea" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.474%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.396%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change in Benefit Obligations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Beginning projected benefit obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo0YWY4NmM4NDVjM2M0OTYwYTlmZjU5N2M2NzkwNDJjNi90YWJsZXJhbmdlOjRhZjg2Yzg0NWMzYzQ5NjBhOWZmNTk3YzY3OTA0MmM2XzItMS0xLTEtNzIxNTE_931ad2bb-3989-4f73-b311-7c2a63319728">1,036</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98963cf23d234ec1ac275e66bcfd76dc_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo0YWY4NmM4NDVjM2M0OTYwYTlmZjU5N2M2NzkwNDJjNi90YWJsZXJhbmdlOjRhZjg2Yzg0NWMzYzQ5NjBhOWZmNTk3YzY3OTA0MmM2XzItMy0xLTEtNzIxNTE_fd8243fe-7e17-4e77-b738-5dd2a5b24ad0">1,118</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo0YWY4NmM4NDVjM2M0OTYwYTlmZjU5N2M2NzkwNDJjNi90YWJsZXJhbmdlOjRhZjg2Yzg0NWMzYzQ5NjBhOWZmNTk3YzY3OTA0MmM2XzMtMS0xLTEtNzIxNTE_effabd9c-10f8-439d-a146-033045f924d5">56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo0YWY4NmM4NDVjM2M0OTYwYTlmZjU5N2M2NzkwNDJjNi90YWJsZXJhbmdlOjRhZjg2Yzg0NWMzYzQ5NjBhOWZmNTk3YzY3OTA0MmM2XzMtMy0xLTEtNzIxNTE_4f316759-a12b-4f8c-a0ac-316cfa11be47">72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo0YWY4NmM4NDVjM2M0OTYwYTlmZjU5N2M2NzkwNDJjNi90YWJsZXJhbmdlOjRhZjg2Yzg0NWMzYzQ5NjBhOWZmNTk3YzY3OTA0MmM2XzQtMS0xLTEtNzIxNTE_8a81c7f8-8465-4156-a457-0a5669cb02f4">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo0YWY4NmM4NDVjM2M0OTYwYTlmZjU5N2M2NzkwNDJjNi90YWJsZXJhbmdlOjRhZjg2Yzg0NWMzYzQ5NjBhOWZmNTk3YzY3OTA0MmM2XzQtMy0xLTEtNzIxNTE_da66b8e5-553d-4783-a287-41356ad403b3">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign exchange impact</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo0YWY4NmM4NDVjM2M0OTYwYTlmZjU5N2M2NzkwNDJjNi90YWJsZXJhbmdlOjRhZjg2Yzg0NWMzYzQ5NjBhOWZmNTk3YzY3OTA0MmM2XzUtMS0xLTEtNzIxNTE_446a88dc-d833-439f-8d96-bf03b8e323b5">56</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo0YWY4NmM4NDVjM2M0OTYwYTlmZjU5N2M2NzkwNDJjNi90YWJsZXJhbmdlOjRhZjg2Yzg0NWMzYzQ5NjBhOWZmNTk3YzY3OTA0MmM2XzUtMy0xLTEtNzIxNTE_3cc53474-ff55-4172-a68e-1fea19fdbf8e">70</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Employee contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo0YWY4NmM4NDVjM2M0OTYwYTlmZjU5N2M2NzkwNDJjNi90YWJsZXJhbmdlOjRhZjg2Yzg0NWMzYzQ5NjBhOWZmNTk3YzY3OTA0MmM2XzYtMS0xLTEtNzIxNTE_2c2da7d4-5a31-4f81-b6bd-b3938f812621">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo0YWY4NmM4NDVjM2M0OTYwYTlmZjU5N2M2NzkwNDJjNi90YWJsZXJhbmdlOjRhZjg2Yzg0NWMzYzQ5NjBhOWZmNTk3YzY3OTA0MmM2XzYtMy0xLTEtNzIxNTE_2f1d3ced-480d-44f2-aedf-4665b1c99589">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Actuarial (gains) losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo0YWY4NmM4NDVjM2M0OTYwYTlmZjU5N2M2NzkwNDJjNi90YWJsZXJhbmdlOjRhZjg2Yzg0NWMzYzQ5NjBhOWZmNTk3YzY3OTA0MmM2XzctMS0xLTEtNzIxNTE_3ae5e3ae-667d-425b-9151-9980d0416fbd">354</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo0YWY4NmM4NDVjM2M0OTYwYTlmZjU5N2M2NzkwNDJjNi90YWJsZXJhbmdlOjRhZjg2Yzg0NWMzYzQ5NjBhOWZmNTk3YzY3OTA0MmM2XzctMy0xLTEtNzIxNTE_aefc2ab7-c274-4aa3-bbe2-def4a0670767">71</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Curtailment gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanCurtailments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo0YWY4NmM4NDVjM2M0OTYwYTlmZjU5N2M2NzkwNDJjNi90YWJsZXJhbmdlOjRhZjg2Yzg0NWMzYzQ5NjBhOWZmNTk3YzY3OTA0MmM2XzktMS0xLTEtNzIxNTE_9d026896-7e2b-4f21-88d0-7270b374440b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanCurtailments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo0YWY4NmM4NDVjM2M0OTYwYTlmZjU5N2M2NzkwNDJjNi90YWJsZXJhbmdlOjRhZjg2Yzg0NWMzYzQ5NjBhOWZmNTk3YzY3OTA0MmM2XzktMy0xLTEtNzIxNTE_93f40cf9-0afa-4720-81e7-d9941c5b39c9">23</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo0YWY4NmM4NDVjM2M0OTYwYTlmZjU5N2M2NzkwNDJjNi90YWJsZXJhbmdlOjRhZjg2Yzg0NWMzYzQ5NjBhOWZmNTk3YzY3OTA0MmM2XzEwLTEtMS0xLTcyMTUx_a26a855a-8ad8-44e1-972c-34a3ea1f4fc4">24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo0YWY4NmM4NDVjM2M0OTYwYTlmZjU5N2M2NzkwNDJjNi90YWJsZXJhbmdlOjRhZjg2Yzg0NWMzYzQ5NjBhOWZmNTk3YzY3OTA0MmM2XzEwLTMtMS0xLTcyMTUx_64fb6b5d-16e3-4d82-a74b-077de8ddcc48">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Ending projected benefit obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo0YWY4NmM4NDVjM2M0OTYwYTlmZjU5N2M2NzkwNDJjNi90YWJsZXJhbmdlOjRhZjg2Yzg0NWMzYzQ5NjBhOWZmNTk3YzY3OTA0MmM2XzExLTEtMS0xLTcyMTUx_73330dc8-8cbe-47be-bd99-01be0b16a526">673</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo0YWY4NmM4NDVjM2M0OTYwYTlmZjU5N2M2NzkwNDJjNi90YWJsZXJhbmdlOjRhZjg2Yzg0NWMzYzQ5NjBhOWZmNTk3YzY3OTA0MmM2XzExLTMtMS0xLTcyMTUx_88248231-cc37-4728-82a4-b4bc5403962e">1,036</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Ending accumulated benefit obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo0YWY4NmM4NDVjM2M0OTYwYTlmZjU5N2M2NzkwNDJjNi90YWJsZXJhbmdlOjRhZjg2Yzg0NWMzYzQ5NjBhOWZmNTk3YzY3OTA0MmM2XzEyLTEtMS0xLTcyMTUx_6f95b478-8735-4759-a28c-18225f55494f">645</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo0YWY4NmM4NDVjM2M0OTYwYTlmZjU5N2M2NzkwNDJjNi90YWJsZXJhbmdlOjRhZjg2Yzg0NWMzYzQ5NjBhOWZmNTk3YzY3OTA0MmM2XzEyLTMtMS0xLTcyMTUx_91b5ef39-4c19-480d-bb48-59b4f46e53e1">987</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90ZXh0cmVnaW9uOjU2Yjk3OTZmMzkxZTQ1YTRhMzVjOGE4ZjJjYWZhMjhiXzE5MTU_2e6b46c2-cdc1-4614-afb8-add5a9abfe56" continuedAt="if87c8cd02ee04be882766370868e4d09" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.474%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.396%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change in Plan Assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Beginning fair value of plan assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTozYTFiYTI5YjZjYWM0NTI5YjBmZDQ2ZjBhNjc3ODNlYi90YWJsZXJhbmdlOjNhMWJhMjliNmNhYzQ1MjliMGZkNDZmMGE2Nzc4M2ViXzItMS0xLTEtNzIxNTE_f0465f48-56d4-49fc-8930-fb489f4a9a52">543</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98963cf23d234ec1ac275e66bcfd76dc_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTozYTFiYTI5YjZjYWM0NTI5YjBmZDQ2ZjBhNjc3ODNlYi90YWJsZXJhbmdlOjNhMWJhMjliNmNhYzQ1MjliMGZkNDZmMGE2Nzc4M2ViXzItMy0xLTEtNzIxNTE_47421595-9e0b-4760-931a-41b1f109c850">522</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Actual return</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTozYTFiYTI5YjZjYWM0NTI5YjBmZDQ2ZjBhNjc3ODNlYi90YWJsZXJhbmdlOjNhMWJhMjliNmNhYzQ1MjliMGZkNDZmMGE2Nzc4M2ViXzMtMS0xLTEtNzIxNTE_6ade1a9b-e34a-4198-94b3-37ce61858316">109</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTozYTFiYTI5YjZjYWM0NTI5YjBmZDQ2ZjBhNjc3ODNlYi90YWJsZXJhbmdlOjNhMWJhMjliNmNhYzQ1MjliMGZkNDZmMGE2Nzc4M2ViXzMtMy0xLTEtNzIxNTE_c159dbbe-dc2e-46a4-8b86-13154467954c">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTozYTFiYTI5YjZjYWM0NTI5YjBmZDQ2ZjBhNjc3ODNlYi90YWJsZXJhbmdlOjNhMWJhMjliNmNhYzQ1MjliMGZkNDZmMGE2Nzc4M2ViXzQtMS0xLTEtNzIxNTE_5c457035-aeef-41d4-9f98-5b9204fcb222">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTozYTFiYTI5YjZjYWM0NTI5YjBmZDQ2ZjBhNjc3ODNlYi90YWJsZXJhbmdlOjNhMWJhMjliNmNhYzQ1MjliMGZkNDZmMGE2Nzc4M2ViXzQtMy0xLTEtNzIxNTE_4cae7497-866c-4654-a3d0-0743fe2c693e">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Employee contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTozYTFiYTI5YjZjYWM0NTI5YjBmZDQ2ZjBhNjc3ODNlYi90YWJsZXJhbmdlOjNhMWJhMjliNmNhYzQ1MjliMGZkNDZmMGE2Nzc4M2ViXzUtMS0xLTEtNzIxNTE_70667279-4a75-446f-ae62-b70306beb9e6">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTozYTFiYTI5YjZjYWM0NTI5YjBmZDQ2ZjBhNjc3ODNlYi90YWJsZXJhbmdlOjNhMWJhMjliNmNhYzQ1MjliMGZkNDZmMGE2Nzc4M2ViXzUtMy0xLTEtNzIxNTE_d9d8f91a-ce29-4597-9e58-1d52dacd9df4">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign exchange impact</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTozYTFiYTI5YjZjYWM0NTI5YjBmZDQ2ZjBhNjc3ODNlYi90YWJsZXJhbmdlOjNhMWJhMjliNmNhYzQ1MjliMGZkNDZmMGE2Nzc4M2ViXzYtMS0xLTEtNzIxNTE_e7164858-368e-45f0-a3fa-2c877039cb66">24</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTozYTFiYTI5YjZjYWM0NTI5YjBmZDQ2ZjBhNjc3ODNlYi90YWJsZXJhbmdlOjNhMWJhMjliNmNhYzQ1MjliMGZkNDZmMGE2Nzc4M2ViXzYtMy0xLTEtNzIxNTE_43500f3c-ef08-4c72-86af-34ab0777f740">29</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTozYTFiYTI5YjZjYWM0NTI5YjBmZDQ2ZjBhNjc3ODNlYi90YWJsZXJhbmdlOjNhMWJhMjliNmNhYzQ1MjliMGZkNDZmMGE2Nzc4M2ViXzgtMS0xLTEtNzIxNTE_15bb946e-1c93-4e34-a67b-3c1b8299da91">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTozYTFiYTI5YjZjYWM0NTI5YjBmZDQ2ZjBhNjc3ODNlYi90YWJsZXJhbmdlOjNhMWJhMjliNmNhYzQ1MjliMGZkNDZmMGE2Nzc4M2ViXzgtMy0xLTEtNzIxNTE_fb36e37a-8dce-468b-8b96-f9d716269d64">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Ending fair value of plan assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTozYTFiYTI5YjZjYWM0NTI5YjBmZDQ2ZjBhNjc3ODNlYi90YWJsZXJhbmdlOjNhMWJhMjliNmNhYzQ1MjliMGZkNDZmMGE2Nzc4M2ViXzktMS0xLTEtNzIxNTE_d659ffc2-21ed-4784-abe4-b9582c5e5c8c">420</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTozYTFiYTI5YjZjYWM0NTI5YjBmZDQ2ZjBhNjc3ODNlYi90YWJsZXJhbmdlOjNhMWJhMjliNmNhYzQ1MjliMGZkNDZmMGE2Nzc4M2ViXzktMy0xLTEtNzIxNTE_c955ce48-7281-4764-8b11-2d46a6b5ff1b">543</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><ix:continuation id="i26828814ef3b488daed8556af3cec5a2"><div style="text-align:justify"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90ZXh0cmVnaW9uOjU2Yjk3OTZmMzkxZTQ1YTRhMzVjOGE4ZjJjYWZhMjhiXzE5MjY_f8bbb8d2-c766-4d34-9a1d-ecd201a1642f" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"></td><td style="width:33.770%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.649%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.649%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.652%"></td><td style="width:0.1%"></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Allocation of Plan Assets</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023 Target</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022 Actual</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021 Actual</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i58b96ce29b8a42aea4c5893906463ce3_I20221231" decimals="2" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpmMjFjMTgyMDE1ODU0ZjY1OGU3MzgzZTdjMjhjNDUwYS90YWJsZXJhbmdlOmYyMWMxODIwMTU4NTRmNjU4ZTczODNlN2MyOGM0NTBhXzItMS0xLTEtNzIxNTE_ddb2d66f-246d-4992-a636-b2c0399c0799">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i58b96ce29b8a42aea4c5893906463ce3_I20221231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpmMjFjMTgyMDE1ODU0ZjY1OGU3MzgzZTdjMjhjNDUwYS90YWJsZXJhbmdlOmYyMWMxODIwMTU4NTRmNjU4ZTczODNlN2MyOGM0NTBhXzItMy0xLTEtNzIxNTE_5c24cef2-25e9-46e6-a4dc-ecf053da403e">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0e072f5fbda04e4ca99129d167dfe999_I20211231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpmMjFjMTgyMDE1ODU0ZjY1OGU3MzgzZTdjMjhjNDUwYS90YWJsZXJhbmdlOmYyMWMxODIwMTU4NTRmNjU4ZTczODNlN2MyOGM0NTBhXzItNS0xLTEtNzIxNTE_2111b919-f0b8-4f7a-944d-6e266f60dc44">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1683d20c41d847f185c1386f0f3dc4c4_I20221231" decimals="2" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpmMjFjMTgyMDE1ODU0ZjY1OGU3MzgzZTdjMjhjNDUwYS90YWJsZXJhbmdlOmYyMWMxODIwMTU4NTRmNjU4ZTczODNlN2MyOGM0NTBhXzMtMS0xLTEtNzIxNTE_eacd49de-4605-4025-aea0-e24df177fa37">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1683d20c41d847f185c1386f0f3dc4c4_I20221231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpmMjFjMTgyMDE1ODU0ZjY1OGU3MzgzZTdjMjhjNDUwYS90YWJsZXJhbmdlOmYyMWMxODIwMTU4NTRmNjU4ZTczODNlN2MyOGM0NTBhXzMtMy0xLTEtNzIxNTE_7d415ce3-7760-4715-8295-cdb5da1d09b7">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibe98d7ecbed04b7286e7baabd289cc71_I20211231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpmMjFjMTgyMDE1ODU0ZjY1OGU3MzgzZTdjMjhjNDUwYS90YWJsZXJhbmdlOmYyMWMxODIwMTU4NTRmNjU4ZTczODNlN2MyOGM0NTBhXzMtNS0xLTEtNzIxNTE_8b5595c6-1dd6-493b-8a43-750dede18fd6">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i779788123a93436181d9161accb7424e_I20221231" decimals="2" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpmMjFjMTgyMDE1ODU0ZjY1OGU3MzgzZTdjMjhjNDUwYS90YWJsZXJhbmdlOmYyMWMxODIwMTU4NTRmNjU4ZTczODNlN2MyOGM0NTBhXzQtMS0xLTEtNzIxNTE_7ae03a4f-7cb2-48af-b403-8d826c62f00d">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i779788123a93436181d9161accb7424e_I20221231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpmMjFjMTgyMDE1ODU0ZjY1OGU3MzgzZTdjMjhjNDUwYS90YWJsZXJhbmdlOmYyMWMxODIwMTU4NTRmNjU4ZTczODNlN2MyOGM0NTBhXzQtMy0xLTEtNzIxNTE_ed542f58-a10e-4a77-9b38-9840ea65880f">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i561834c74eee46c8bba248e767b8abd2_I20211231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpmMjFjMTgyMDE1ODU0ZjY1OGU3MzgzZTdjMjhjNDUwYS90YWJsZXJhbmdlOmYyMWMxODIwMTU4NTRmNjU4ZTczODNlN2MyOGM0NTBhXzQtNS0xLTEtNzIxNTE_c65aaf21-1522-400b-abec-705a12fd5660">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="INF" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpmMjFjMTgyMDE1ODU0ZjY1OGU3MzgzZTdjMjhjNDUwYS90YWJsZXJhbmdlOmYyMWMxODIwMTU4NTRmNjU4ZTczODNlN2MyOGM0NTBhXzUtMS0xLTEtNzIxNTE_4eca798d-0b4c-4323-aff8-1218dd671353">100</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="INF" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpmMjFjMTgyMDE1ODU0ZjY1OGU3MzgzZTdjMjhjNDUwYS90YWJsZXJhbmdlOmYyMWMxODIwMTU4NTRmNjU4ZTczODNlN2MyOGM0NTBhXzUtMy0xLTEtNzIxNTE_07a838d0-fd94-40c0-82cd-c507d2cfc3b7">100</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="INF" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpmMjFjMTgyMDE1ODU0ZjY1OGU3MzgzZTdjMjhjNDUwYS90YWJsZXJhbmdlOmYyMWMxODIwMTU4NTRmNjU4ZTczODNlN2MyOGM0NTBhXzUtNS0xLTEtNzIxNTE_92a950ab-708c-497d-ac2a-65c891a8e91b">100</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><ix:continuation id="if87c8cd02ee04be882766370868e4d09"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.329%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.220%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.220%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.220%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.511%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Valuation of Plan Assets </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic638fcfdbb6a416d92b8a3b7c9c78967_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzItMS0xLTEtNzIxNTE_1fd2d7f0-4547-450c-8829-c235bd14e72a">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id537c1a6699e44bd890ba7e54ef23a6d_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzItMi0xLTEtNzIxNTE_47fd97e8-b3cc-4299-82ad-469da15a2da7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a7ea0b36abd4a6cb52f66b4b312169e_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzItMy0xLTEtNzIxNTE_da5ac394-edc6-49b2-aa91-8c07d3e1f1a7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4059183a5b54d6798538edc19c050cf_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzItNC0xLTEtNzIxNTE_b664fa83-f79f-46f8-8bfe-9495d4e6bc1c">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8522801ceae048788c0fce97e5d37ab5_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzMtMS0xLTEtNzIxNTE_3adc3666-cee9-4400-8627-df7cf4b9f27e">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6eb65c14e5914f63978a0d0069999ab8_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzMtMi0xLTEtNzIxNTE_bdaa3fed-4ee1-4826-9879-6297e5b9b66e">99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cc1146a58874a6eb8ef302951c2aecd_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzMtMy0xLTEtNzIxNTE_cce58250-d614-4bce-aaf0-e332e1ffd6ab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58b96ce29b8a42aea4c5893906463ce3_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzMtNC0xLTEtNzIxNTE_49738a63-722b-43ab-9b39-707be307f18c">120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Corporate debt securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5df6f1a799424f859f0ab765aa4d61d1_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzQtMS0xLTEtNzIxNTE_cc522919-f191-45f7-832a-b42baadeca34">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica6e290960a44739ba644626546b3852_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzQtMi0xLTEtNzIxNTE_ebe844e7-da08-4846-aa4d-4e4b41ac4ed6">151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0b0ee47ce04183ad042932b91b34ce_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzQtMy0xLTEtNzIxNTE_303eea08-6a88-4670-a422-3d64431dc254">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5010ff9bb614d35ae3367ed2df39f6b_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzQtNC0xLTEtNzIxNTE_a0abb8f2-8524-4ffa-9347-27be8a2056f3">153</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eaacfb68128466f93e71b1251c20bea_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzUtMS0xLTEtNzIxNTE_74338329-19a8-483c-b8e5-13e3caf528d2">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ffb4a3bde3947f88266050517970e80_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzUtMi0xLTEtNzIxNTE_f35d2ed2-484d-4454-b95e-f1f48fbf3db5">69</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3d6dbee4de64017afe0c8e13e01299a_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzUtMy0xLTEtNzIxNTE_bc3b1dbd-896a-4002-90c0-f25ac38ef9c8">55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19f498ef30f4326a72ede1108304255_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzUtNC0xLTEtNzIxNTE_758083cf-447e-452c-8884-daa8c8a44a6b">129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2d532877fe14293a0c7af8376dd383a_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzYtMS0xLTEtNzIxNTE_50162eca-d7a9-4877-bf82-7b46ff79cfc4">46</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5847988c48e945ff89b5383f616f507c_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzYtMi0xLTEtNzIxNTE_21871946-dd75-4928-99b1-f983e90fd8ab">319</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d64b78c8a794c42aa5ea20736299864_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzYtMy0xLTEtNzIxNTE_ccc86d09-362d-4a75-90d6-46cf168f0b75">55</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzYtNC0xLTEtNzIxNTE_10d26de1-ad60-4225-b33a-b059658bfab3">420</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34080018fa394c35b4a7f8033b8e1796_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzgtMS0xLTEtNzIxNTE_6637712f-5b1e-4192-9036-c742152acb16">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i210fd2367de749efa9a2e625851d0bd8_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzgtMi0xLTEtNzIxNTE_3fecb000-de12-41ac-a38c-b92475d926f8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa8b9dcdddf64372b0059d96cea46c50_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzgtMy0xLTEtNzIxNTE_91334d83-6961-4f86-962d-bc2f5368a86c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6bb811c5e3d4e62aa7eb329cbe0c9b7_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzgtNC0xLTEtNzIxNTE_73bfd3d2-9ae5-4b77-9ae1-c50ba535b1b2">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee87b668135841238e75f21caf1cda6f_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzktMS0xLTEtNzIxNTE_bae66a46-f924-489f-8b97-d5a1e20683a3">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd8cfa9e07864166b0bc1f6192348149_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzktMi0xLTEtNzIxNTE_5ebb2cfc-dac4-4c84-91df-3cfe1dadcc51">119</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib37f5d53c40e4ad5af1d22e367b1ff8c_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzktMy0xLTEtNzIxNTE_449695c0-1eef-4d8c-b4eb-ddb9c8c4a2e6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e072f5fbda04e4ca99129d167dfe999_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzktNC0xLTEtNzIxNTE_347bc88e-2171-474d-be3e-20e83426dac2">147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ecf88ddf1cd4958a23d17b1f094f7d0_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzEwLTEtMS0xLTcyMTUx_ec37c5f7-5b1c-4390-a600-315ab7a77d95">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a8294b0f5d74e708266fe817d78a47a_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzEwLTItMS0xLTcyMTUx_dbeb077b-f5ce-41ba-bdc8-6b9e55942e9c">202</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5570209ef64543bfba07e2abea804238_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzEwLTMtMS0xLTcyMTUx_c931b24a-6c87-4f06-989b-8400acc6a5c5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f7e6cbe52c44cb79b943e8593f46867_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzEwLTQtMS0xLTcyMTUx_f00b473b-3560-40a6-895f-bc3e3dec59a6">204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i848d92fcbcf64897bfd1cc126a3aa1a9_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzExLTEtMS0xLTcyMTUx_9b85357d-69cb-478e-88ad-bb7270fa6f01">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibade722fea764961b1d9d387629073e2_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzExLTItMS0xLTcyMTUx_73d0b56d-2edc-4324-8d22-0db669841ca2">68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6c76d2fefcd444b82889ab47088a661_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzExLTMtMS0xLTcyMTUx_0ed4137b-9b5d-450f-aaa0-93b511c94d6a">99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfe7c27f3e347c2825a7b6348357a60_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzExLTQtMS0xLTcyMTUx_97504416-360c-46e1-9081-0a070e2e7340">171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb345be38a2145ec8f2df1b4c28dc6d4_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzEyLTEtMS0xLTcyMTUx_85473527-289a-48d7-a564-7289d82d8138">55</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e94767eea5f4452a8497953475e7b32_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzEyLTItMS0xLTcyMTUx_37b5aa92-df90-486b-8ae5-994357cf9c6a">389</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33ec7e34209e4d64ba95fe5eb1edee60_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzEyLTMtMS0xLTcyMTUx_77f619c5-2331-4902-8d68-c4047115f54f">99</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzEyLTQtMS0xLTcyMTUx_ef8246f7-0490-4a55-b25f-1bdda23b00d4">543</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our Level 3 pension plan assets consist primarily of guaranteed investment contracts with insurance companies. The insurance contracts guarantee us principal repayment and a fixed rate of return. The $<ix:nonFraction unitRef="usd" contextRef="i555016f434ae4cd48b50f24fbe1586b3_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90ZXh0cmVnaW9uOjU2Yjk3OTZmMzkxZTQ1YTRhMzVjOGE4ZjJjYWZhMjhiXzE3MjY_35f33624-a25a-4fd7-8fb9-3a06cad765e1">44</ix:nonFraction> decrease in Level 3 pension plan assets is primarily driven by the change in the corresponding pension liability. We expect to contribute $<ix:nonFraction unitRef="usd" contextRef="i6d64b78c8a794c42aa5ea20736299864_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90ZXh0cmVnaW9uOjU2Yjk3OTZmMzkxZTQ1YTRhMzVjOGE4ZjJjYWZhMjhiXzE4Njc_1247fd41-0c75-4162-b4e5-eb62e6f221f7">19</ix:nonFraction> to our defined benefit pension plans in 2023.</span></div><div style="margin-bottom:3pt;text-align:justify"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90ZXh0cmVnaW9uOjU2Yjk3OTZmMzkxZTQ1YTRhMzVjOGE4ZjJjYWZhMjhiXzE5Mjk_4fdd0181-b713-4ca5-b4df-a70f6dfb4fe0" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"><tr><td style="width:1.0%"></td><td style="width:15.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.535%"></td><td style="width:0.1%"></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Estimated Future Benefit Payments</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2027</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2028-2032</span></td></tr><tr><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo2MWNkN2NjMmE1YWY0NDlhODY3YmEwMzNjY2MxOTMwMC90YWJsZXJhbmdlOjYxY2Q3Y2MyYTVhZjQ0OWE4NjdiYTAzM2NjYzE5MzAwXzItMC0xLTEtNzIxNTE_3dcf0beb-cada-4112-b5d9-297cc404b287">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo2MWNkN2NjMmE1YWY0NDlhODY3YmEwMzNjY2MxOTMwMC90YWJsZXJhbmdlOjYxY2Q3Y2MyYTVhZjQ0OWE4NjdiYTAzM2NjYzE5MzAwXzItMS0xLTEtNzIxNTE_3e2a0d8d-f399-477c-b5e5-feb527fa8849">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo2MWNkN2NjMmE1YWY0NDlhODY3YmEwMzNjY2MxOTMwMC90YWJsZXJhbmdlOjYxY2Q3Y2MyYTVhZjQ0OWE4NjdiYTAzM2NjYzE5MzAwXzItMi0xLTEtNzIxNTE_6e282277-20ac-4044-93eb-e25ede565de9">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo2MWNkN2NjMmE1YWY0NDlhODY3YmEwMzNjY2MxOTMwMC90YWJsZXJhbmdlOjYxY2Q3Y2MyYTVhZjQ0OWE4NjdiYTAzM2NjYzE5MzAwXzItMy0xLTEtNzIxNTE_5ceafd37-68f3-4f7d-a812-9934ef83d69f">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo2MWNkN2NjMmE1YWY0NDlhODY3YmEwMzNjY2MxOTMwMC90YWJsZXJhbmdlOjYxY2Q3Y2MyYTVhZjQ0OWE4NjdiYTAzM2NjYzE5MzAwXzItNC0xLTEtNzIxNTE_b3fdc00f-c899-44fe-bf13-8d0d35262663">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo2MWNkN2NjMmE1YWY0NDlhODY3YmEwMzNjY2MxOTMwMC90YWJsZXJhbmdlOjYxY2Q3Y2MyYTVhZjQ0OWE4NjdiYTAzM2NjYzE5MzAwXzItNS0xLTEtNzIxNTE_0976c1a2-5559-4fc6-bae6-76a8e392f757">146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div id="icec46013a0ad4608b89f97e433dd3417_136"></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTE 13 - <ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:QuarterlyFinancialInformationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90ZXh0cmVnaW9uOjBjZjk2ZDhiMTlhMDQ4NTJiZjdiMGRlNjhhZGM3ODBjXzYw_7a48193f-c507-4783-9f51-ad92e527f18e" continuedAt="i433531bb5dd645329189f1dd9850ad34" escape="true">SUMMARY OF QUARTERLY DATA (UNAUDITED)</ix:nonNumeric></span></div><div style="margin-top:3pt;text-align:justify"><ix:continuation id="i433531bb5dd645329189f1dd9850ad34"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90ZXh0cmVnaW9uOjBjZjk2ZDhiMTlhMDQ4NTJiZjdiMGRlNjhhZGM3ODBjXzY3_8364b0fe-a8c6-4f40-8418-af60eec580d1" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.031%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.368%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022 Quarters</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Mar 31</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Jun&#160;30</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Sep 30</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dec 31</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8beea1d5ee1f4b6081ce02f6910e2cab_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzEtMS0xLTEtNzIxNTE_6fac5ff8-18e5-49ad-a561-89aee6ccd155">4,275</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d0292cedd974224858a44410249e5e0_D20220401-20220630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzEtMi0xLTEtNzIxNTE_d18f118d-31ee-4b25-8d8b-45be77c4ca97">4,493</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec7ff50d4aea4a64b1a222ed6cddad1e_D20220701-20220930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzEtMy0xLTEtNzIxNTE_18b8bff5-86af-427d-8f30-c8d2bbe78163">4,479</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05c365347626469281b193639de4b1a1_D20221001-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzEtNC0xLTEtNzIxNTE_7d71b452-b39e-4ca0-a9a3-1988d5f92197">5,202</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8beea1d5ee1f4b6081ce02f6910e2cab_D20220101-20220331" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzItMS0xLTEtNzIxNTE_d62052a1-a73c-485d-ac71-292f2a9bdeb1">2,734</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d0292cedd974224858a44410249e5e0_D20220401-20220630" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzItMi0xLTEtNzIxNTE_14ee1fef-7c1a-459c-8f44-80f7163ab348">2,826</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec7ff50d4aea4a64b1a222ed6cddad1e_D20220701-20220930" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzItMy0xLTEtNzIxNTE_4d0c2df8-1201-4b8e-91df-014030ef4aa4">2,782</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05c365347626469281b193639de4b1a1_D20221001-20221231" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzItNC0xLTEtNzIxNTE_ccf68032-307a-4e8c-8a47-c4ebec6aa64c">3,236</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Earnings (loss) before income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8beea1d5ee1f4b6081ce02f6910e2cab_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzMtMS0xLTEtNzIxNTE_ffafabb0-e890-45a7-a098-f567ee09c2b0">386</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d0292cedd974224858a44410249e5e0_D20220401-20220630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzMtMi0xLTEtNzIxNTE_a4804128-e2e9-4fb8-b413-6348260ea4e5">720</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec7ff50d4aea4a64b1a222ed6cddad1e_D20220701-20220930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzMtMy0xLTEtNzIxNTE_3af08352-f93d-42b9-9110-6e242e58c19f">816</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05c365347626469281b193639de4b1a1_D20221001-20221231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzMtNC0xLTEtNzIxNTE_32e2ec42-d487-460b-8d15-3650c0771651">761</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net earnings (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8beea1d5ee1f4b6081ce02f6910e2cab_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzQtMS0xLTEtNzIxNTE_18fb759a-21c0-4542-b20f-39a016ad372d">323</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d0292cedd974224858a44410249e5e0_D20220401-20220630" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzQtMi0xLTEtNzIxNTE_996ca8f1-aeef-4913-99ba-6a222ff951ff">656</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec7ff50d4aea4a64b1a222ed6cddad1e_D20220701-20220930" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzQtMy0xLTEtNzIxNTE_61b3107c-1225-42e9-af0f-8c044f2534aa">816</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05c365347626469281b193639de4b1a1_D20221001-20221231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzQtNC0xLTEtNzIxNTE_f3d42405-5826-4a53-8a32-eafb8b90f80a">563</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net earnings (loss) per share of common stock:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8beea1d5ee1f4b6081ce02f6910e2cab_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzYtMS0xLTEtNzIxNTE_e1b57293-8ca3-4afc-acc7-1532dac3286f">0.86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7d0292cedd974224858a44410249e5e0_D20220401-20220630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzYtMi0xLTEtNzIxNTE_bd841383-7408-4a68-91a4-e96a54ba6417">1.73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iec7ff50d4aea4a64b1a222ed6cddad1e_D20220701-20220930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzYtMy0xLTEtNzIxNTE_11a15855-aa48-45f5-8164-d5b6b935746f">2.16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i05c365347626469281b193639de4b1a1_D20221001-20221231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzYtNC0xLTEtNzIxNTE_a1e19bd4-a863-4427-add9-46a63366d913">1.48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8beea1d5ee1f4b6081ce02f6910e2cab_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzctMS0xLTEtNzIxNTE_f9332811-ee5a-4992-8081-f344ea97eb82">0.84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7d0292cedd974224858a44410249e5e0_D20220401-20220630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzctMi0xLTEtNzIxNTE_364be7e8-d647-4cf4-951d-3ef78f3bb556">1.72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iec7ff50d4aea4a64b1a222ed6cddad1e_D20220701-20220930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzctMy0xLTEtNzIxNTE_907eff18-bf46-489f-87bc-6cdc58a15967">2.14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i05c365347626469281b193639de4b1a1_D20221001-20221231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzctNC0xLTEtNzIxNTE_757cc93d-e575-472c-9852-9337b721b945">1.47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dividends declared per share of common stock</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8beea1d5ee1f4b6081ce02f6910e2cab_D20220101-20220331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzExLTEtMS0xLTcyMTUx_12c30dcf-9b25-49a3-b9be-97a4577f54df">0.695</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7d0292cedd974224858a44410249e5e0_D20220401-20220630" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzExLTItMS0xLTcyMTUx_06f16154-b0c3-44ee-9ee8-b13c8af5da0f">0.695</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iec7ff50d4aea4a64b1a222ed6cddad1e_D20220701-20220930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzExLTMtMS0xLTcyMTUx_9fa633de-e398-41bb-977a-e197faca18a3">0.695</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i05c365347626469281b193639de4b1a1_D20221001-20221231" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzExLTQtMS0xLTcyMTUx_a9e34bcf-7bc4-463e-92b9-61c239031ff2">0.750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021 Quarters</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Mar 31</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Jun&#160;30</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Sep 30</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dec 31</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1975d811d9f4de7bc2dc66e567577a2_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzE0LTEtMS0xLTcyMTUx_3e399d0f-c322-4b2e-b1df-47cc9797413a">3,953</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06d24da15c2a4301868cb2cf91cc084f_D20210401-20210630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzE0LTItMS0xLTcyMTUx_9e20a8e9-f573-4c74-a95c-a790cf6d5cfe">4,294</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28ee17ac872e4181a4e2ee167127995d_D20210701-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzE0LTMtMS0xLTcyMTUx_34f0fe35-a180-4d5e-a801-136c3f0b7f06">4,160</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b8d2fac04db45dda920f25320d94772_D20211001-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzE0LTQtMS0xLTcyMTUx_f4bae1d7-9f98-42b5-ae9a-dff21ac71a8c">4,701</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1975d811d9f4de7bc2dc66e567577a2_D20210101-20210331" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzE1LTEtMS0xLTcyMTUx_67a9e264-aa26-4698-9a58-3a247304e779">2,509</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06d24da15c2a4301868cb2cf91cc084f_D20210401-20210630" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzE1LTItMS0xLTcyMTUx_c04e67c5-5b3f-45fc-b6f1-40b7513d7b56">2,772</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28ee17ac872e4181a4e2ee167127995d_D20210701-20210930" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzE1LTMtMS0xLTcyMTUx_cebda823-ffea-4936-b790-c8e0fc1c951e">2,642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b8d2fac04db45dda920f25320d94772_D20211001-20211231" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzE1LTQtMS0xLTcyMTUx_d16db7a5-d9d8-418d-be01-afda51851bf9">3,045</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1975d811d9f4de7bc2dc66e567577a2_D20210101-20210331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzE2LTEtMS0xLTcyMTUx_0cabb52f-3380-43f8-b173-fe4d1ab1f78b">367</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06d24da15c2a4301868cb2cf91cc084f_D20210401-20210630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzE2LTItMS0xLTcyMTUx_82e89c7a-4128-4e70-b472-167b579f8061">662</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28ee17ac872e4181a4e2ee167127995d_D20210701-20210930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzE2LTMtMS0xLTcyMTUx_27dee18b-57e9-48f6-9b78-1560035db137">495</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b8d2fac04db45dda920f25320d94772_D20211001-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzE2LTQtMS0xLTcyMTUx_0aae9ed7-1fa9-4cb9-aba1-7cbc6e57756d">757</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1975d811d9f4de7bc2dc66e567577a2_D20210101-20210331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzE3LTEtMS0xLTcyMTUx_e505b850-abf8-493c-86ec-930788943267">302</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06d24da15c2a4301868cb2cf91cc084f_D20210401-20210630" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzE3LTItMS0xLTcyMTUx_e50aa7ad-26ff-46bb-a64f-e0af221e023b">592</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28ee17ac872e4181a4e2ee167127995d_D20210701-20210930" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzE3LTMtMS0xLTcyMTUx_1c0a73b8-6a14-45c1-a90e-a6dc0f904b81">438</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b8d2fac04db45dda920f25320d94772_D20211001-20211231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzE3LTQtMS0xLTcyMTUx_eab9d061-7749-4350-9048-7f167ae04b7b">662</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net earnings per share of common stock:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib1975d811d9f4de7bc2dc66e567577a2_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzE5LTEtMS0xLTcyMTUx_2459cb1b-a957-42e2-a63e-e539a33c744e">0.80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i06d24da15c2a4301868cb2cf91cc084f_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzE5LTItMS0xLTcyMTUx_6bffbbf6-23bf-4ac2-ad47-a5ba3a77e03c">1.57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i28ee17ac872e4181a4e2ee167127995d_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzE5LTMtMS0xLTcyMTUx_2438b470-0453-4f30-8148-21eb0d1a9678">1.17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6b8d2fac04db45dda920f25320d94772_D20211001-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzE5LTQtMS0xLTcyMTUx_c5748027-0254-4946-b609-e938b3787e54">1.75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib1975d811d9f4de7bc2dc66e567577a2_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzIwLTEtMS0xLTcyMTUx_1c41fbd0-c02e-47a4-b681-48bd5bd21c7c">0.79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i06d24da15c2a4301868cb2cf91cc084f_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzIwLTItMS0xLTcyMTUx_816932ac-16d1-4df6-8852-de53ca5bd5eb">1.55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i28ee17ac872e4181a4e2ee167127995d_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzIwLTMtMS0xLTcyMTUx_2038cab9-e116-4c82-a6fc-099450b6dfe9">1.14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6b8d2fac04db45dda920f25320d94772_D20211001-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzIwLTQtMS0xLTcyMTUx_f92af474-731b-4582-bad8-6302b4024f6b">1.73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dividends declared per share of common stock</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib1975d811d9f4de7bc2dc66e567577a2_D20210101-20210331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzI0LTEtMS0xLTcyMTUx_50751d18-5a19-4122-ae36-b2ac42cecb26">0.630</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i06d24da15c2a4301868cb2cf91cc084f_D20210401-20210630" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzI0LTItMS0xLTcyMTUx_7b522d2e-8de5-4496-8366-7f25a6a3512f">0.630</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i28ee17ac872e4181a4e2ee167127995d_D20210701-20210930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzI0LTMtMS0xLTcyMTUx_d853aa41-5cb3-4c73-b412-f881fa4963da">0.630</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6b8d2fac04db45dda920f25320d94772_D20211001-20211231" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzI0LTQtMS0xLTcyMTUx_cc20bdfc-82a1-4fcd-9450-0c68a9fa3638">0.695</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:continuation></div><div id="icec46013a0ad4608b89f97e433dd3417_139"></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTE 14 - <ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90ZXh0cmVnaW9uOjU1ZjRhZjk2ZTllODQ3NmJiODMxZTU1MTE1MDBmZWRhXzE5NTA_964760d2-4b77-48f4-9cbd-4fff0d61cad5" continuedAt="i2fdc24f86ee44f33be9aeb9ca4e15a45" escape="true">SEGMENT AND GEOGRAPHIC DATA</ix:nonNumeric></span></div><ix:continuation id="i2fdc24f86ee44f33be9aeb9ca4e15a45" continuedAt="i2776a17b79584f98bd0987586c1953f1"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We segregate our operations into <ix:nonFraction unitRef="segment" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90ZXh0cmVnaW9uOjU1ZjRhZjk2ZTllODQ3NmJiODMxZTU1MTE1MDBmZWRhXzEwNA_64f070c7-6fa8-456d-b727-2c4be0ff81e5">two</ix:nonFraction> reportable business segments: (i) MedSurg and Neurotechnology and (ii) Orthopaedics and Spine which aligns to our internal reporting structure and how the Company manages its businesses.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Corporate and Other category shown in the table below includes corporate and administration, corporate initiatives and share-based compensation, which includes compensation related to employee stock options, restricted stock units and performance stock unit grants and director stock options and restricted stock unit grants.</span></div></ix:continuation></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">37</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2022 FORM 10-K</span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><ix:continuation id="i2776a17b79584f98bd0987586c1953f1"><div style="text-align:justify"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90ZXh0cmVnaW9uOjU1ZjRhZjk2ZTllODQ3NmJiODMxZTU1MTE1MDBmZWRhXzE5NTM_77b370f0-27f4-4773-834c-1a52aedddc6b" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.693%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.693%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.694%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Segment Results</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedSurg and Neurotechnology</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47bbb5ea95dc45349b14191d69f1c992_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzEtMS0xLTEtNzIxNTE_bb5b30f0-9439-4f01-9633-8c84e80ad484">10,611</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49c69f29d3694f059d9bf2a004976b17_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzEtMi0xLTEtNzIxNTE_62a20652-827f-4081-a994-c30111e4d1b2">9,538</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60771115f5654e2ba9c33e5226dec383_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzEtMy0xLTEtNzIxNTE_e91f8a02-95af-4d79-954e-87e89b152dbc">8,345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Orthopaedics and Spine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6324e0271e4c436692bbcb9e623fc2e8_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzItMS0xLTEtNzIxNTE_a4ffe27d-c919-4ffb-8499-888157f08fdd">7,838</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81c6954ba7174d4d90e932296c08e140_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzItMi0xLTEtNzIxNTE_ccae3ca4-0fcf-4a5b-ba91-a1a5ad4d66f0">7,570</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i378661c47c334191b9979c19bbafc9b1_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzItMy0xLTEtNzIxNTE_0908ca23-8788-4590-84eb-0760484d3d02">6,006</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzMtMS0xLTEtNzIxNTE_98bcdcdc-3f2f-4c00-bc46-44ff0f4529d4">18,449</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzMtMi0xLTEtNzIxNTE_6d875a94-7eb6-4323-8b8d-4ce5f06abd4a">17,108</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzMtMy0xLTEtNzIxNTE_608224b8-248a-4107-929f-19eb61977978">14,351</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedSurg and Neurotechnology</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47bbb5ea95dc45349b14191d69f1c992_D20220101-20221231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzQtMS0xLTEtNzIxNTE_2956f4e9-b747-42a2-a598-d97f0b6d1c5f">540</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49c69f29d3694f059d9bf2a004976b17_D20210101-20211231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzQtMi0xLTEtNzIxNTE_f811945b-1c40-4e47-ad93-1e4408b221fa">518</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60771115f5654e2ba9c33e5226dec383_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzQtMy0xLTEtNzIxNTE_142bac26-3922-4037-82a3-6a3bd228a82e">496</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Orthopaedics and Spine</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6324e0271e4c436692bbcb9e623fc2e8_D20220101-20221231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzUtMS0xLTEtNzIxNTE_e3e9e071-078f-4fab-a4d9-9cd1b5a9e3c0">614</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81c6954ba7174d4d90e932296c08e140_D20210101-20211231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzUtMi0xLTEtNzIxNTE_05c72769-eac8-4906-a7fe-d43af57e1da2">629</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i378661c47c334191b9979c19bbafc9b1_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzUtMy0xLTEtNzIxNTE_ccd82c69-bbd7-4efc-bcb1-ab155707b1c4">458</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Segment depreciation and amortization </span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f531e84880c46bbbe92b1c8ce7c31a6_D20220101-20221231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzYtMS0xLTEtNzIxNTE_5fcb1c3c-c528-44c2-9967-62a4a6b910ba">1,154</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie984aa38d0f0495d8a86b02fb27192a6_D20210101-20211231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzYtMi0xLTEtNzIxNTE_d6ad46f9-3664-4ed3-ab60-56013d39d6ee">1,147</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3f309c92d20420689d59a657fb1d10b_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzYtMy0xLTEtNzIxNTE_e78db8f5-2f23-4706-9ca2-eaf8f26281b9">954</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Corporate and Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90ea3f9a188b4371a80590a32f3162a6_D20220101-20221231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzctMS0xLTEtNzIxNTE_18a1688f-c4f3-47e5-9edd-9b357cee2f17">124</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95cdabbaebc1412494ff81e987370623_D20210101-20211231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzctMi0xLTEtNzIxNTE_00213b65-43d9-4d4e-bf62-53eceebf7667">125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idba55220993f4de4874efcaf00cabe63_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzctMy0xLTEtNzIxNTE_63d00607-b037-4ba6-8185-4035cc59d78b">122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total depreciation and amortization</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzgtMS0xLTEtNzIxNTE_58e051f8-199a-4962-8e98-2614456f9c65">1,278</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzgtMi0xLTEtNzIxNTE_a55614d1-ea60-4894-8b9a-f76709a3b0ce">1,272</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzgtMy0xLTEtNzIxNTE_58b72e42-e6f0-409a-9c85-101c1368e647">1,076</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedSurg and Neurotechnology</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47bbb5ea95dc45349b14191d69f1c992_D20220101-20221231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzktMS0xLTEtNzIxNTE_ef2ec429-79f3-4c54-bd3d-065a313c98e4">2,737</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49c69f29d3694f059d9bf2a004976b17_D20210101-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzktMi0xLTEtNzIxNTE_c8c950d9-fe95-4f4b-82b2-114987c89e96">2,807</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60771115f5654e2ba9c33e5226dec383_D20200101-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzktMy0xLTEtNzIxNTE_ece30319-1524-49db-8da9-e8320f0ceb21">2,414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Orthopaedics and Spine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6324e0271e4c436692bbcb9e623fc2e8_D20220101-20221231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzEwLTEtMS0xLTcyMTUx_b622532a-8994-46ee-879f-70604ee6bb8b">2,296</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81c6954ba7174d4d90e932296c08e140_D20210101-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzEwLTItMS0xLTcyMTUx_b82f5c46-5bb0-418e-8986-ceadfb2a953f">2,180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i378661c47c334191b9979c19bbafc9b1_D20200101-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzEwLTMtMS0xLTcyMTUx_92f99e7b-619b-470c-8be8-b7a0f8c972df">1,588</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Segment operating income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f531e84880c46bbbe92b1c8ce7c31a6_D20220101-20221231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzExLTEtMS0xLTcyMTUx_654fd3ce-878c-42db-b6ab-7d7eb4d5948c">5,033</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie984aa38d0f0495d8a86b02fb27192a6_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzExLTItMS0xLTcyMTUx_db956ff6-a6ea-4ed0-928d-39546686c338">4,987</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3f309c92d20420689d59a657fb1d10b_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzExLTMtMS0xLTcyMTUx_58a0be55-1638-4f35-b1d3-c1a856ffb6cd">4,002</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Items not allocated to segments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Corporate and Other</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8e39c420c4d438997d9ba32c31cd4a4_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzEzLTEtMS0xLTcyMTUx_d97d2ec3-3070-4eca-ae43-69879de3b57d">649</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if20e557008044e5fb9d0332c0e98ca51_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzEzLTItMS0xLTcyMTUx_c6bcf21f-a375-4681-b132-7ea4622a35c8">605</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cccfcfd1f224a4e8c544848a6c32027_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzEzLTMtMS0xLTcyMTUx_0ac36a01-e99a-469c-99b4-9cf86dea0a99">503</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisition and integration-related charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8e39c420c4d438997d9ba32c31cd4a4_D20220101-20221231" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzE0LTEtMS0xLTcyMTUx_43f5c894-5168-481e-ab72-cd377e7c3435">150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if20e557008044e5fb9d0332c0e98ca51_D20210101-20211231" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzE0LTItMS0xLTcyMTUx_286f19d1-ba42-45de-8d0f-65d48e5e478b">585</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cccfcfd1f224a4e8c544848a6c32027_D20200101-20201231" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzE0LTMtMS0xLTcyMTUx_1ac73b36-5b02-4532-a57c-b9390bbc8964">242</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8e39c420c4d438997d9ba32c31cd4a4_D20220101-20221231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzE1LTEtMS0xLTcyMTUx_d13312f7-cc1e-492e-b765-4f9d0eca9085">627</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if20e557008044e5fb9d0332c0e98ca51_D20210101-20211231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzE1LTItMS0xLTcyMTUx_facc26fa-0415-4086-8707-691a652e3174">619</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cccfcfd1f224a4e8c544848a6c32027_D20200101-20201231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzE1LTMtMS0xLTcyMTUx_59dd5f03-02bf-477d-ae2c-f89e84a2fd42">472</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Restructuring-related and other charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8e39c420c4d438997d9ba32c31cd4a4_D20220101-20221231" decimals="-6" name="us-gaap:RestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzE2LTEtMS0xLTcyMTUx_ea16927d-67d1-4c00-bdaf-6994daa016f6">349</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if20e557008044e5fb9d0332c0e98ca51_D20210101-20211231" decimals="-6" name="us-gaap:RestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzE2LTItMS0xLTcyMTUx_41d5c87d-7a75-4119-a6cd-87c40fce57eb">386</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cccfcfd1f224a4e8c544848a6c32027_D20200101-20201231" decimals="-6" name="us-gaap:RestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzE2LTMtMS0xLTcyMTUx_e9230a2f-b932-4c32-8b3c-07af566dda7e">458</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Goodwill impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8e39c420c4d438997d9ba32c31cd4a4_D20220101-20221231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzE3LTEtMS0xLTgyMTU5_6f6a669b-14ed-49c9-8253-e400431e9322">216</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if20e557008044e5fb9d0332c0e98ca51_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzE3LTItMS0xLTgyNjEz_18a50b60-04bf-4c10-b0e0-435d672bb5c8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cccfcfd1f224a4e8c544848a6c32027_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzE3LTMtMS0xLTg0MjE4_590d7223-17e9-41c9-b70f-c549a2c88298">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medical device regulations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8e39c420c4d438997d9ba32c31cd4a4_D20220101-20221231" decimals="-6" name="syk:MedicalDeviceRegulationsExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzE3LTEtMS0xLTcyMTUx_aada19d8-9c5b-4a08-8fcf-a51bcb652330">140</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if20e557008044e5fb9d0332c0e98ca51_D20210101-20211231" decimals="-6" name="syk:MedicalDeviceRegulationsExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzE3LTItMS0xLTcyMTUx_8eb5fb17-05b8-4146-a8d5-bf9f55f81bb3">107</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cccfcfd1f224a4e8c544848a6c32027_D20200101-20201231" decimals="-6" name="syk:MedicalDeviceRegulationsExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzE3LTMtMS0xLTcyMTUx_b06ca359-2623-40c3-9f44-d47de0af73f8">81</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Recall-related matters</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8e39c420c4d438997d9ba32c31cd4a4_D20220101-20221231" decimals="-6" sign="-" name="syk:RejuvenateABGIIHipRecallCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzE4LTEtMS0xLTcyMTUx_25869dfe-d58b-4f5c-b7f4-99070acf40d0">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if20e557008044e5fb9d0332c0e98ca51_D20210101-20211231" decimals="-6" name="syk:RejuvenateABGIIHipRecallCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzE4LTItMS0xLTcyMTUx_5a262a67-51c6-44b5-a8c8-b39c59e43548">103</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cccfcfd1f224a4e8c544848a6c32027_D20200101-20201231" decimals="-6" name="syk:RejuvenateABGIIHipRecallCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzE4LTMtMS0xLTcyMTUx_d5d34fdc-a224-4dd8-96ff-f92f0ca94c0b">17</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Regulatory and legal matters</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8e39c420c4d438997d9ba32c31cd4a4_D20220101-20221231" decimals="-6" name="us-gaap:LegalFees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzE5LTEtMS0xLTcyMTUx_9620ef3c-4dbf-40ed-8166-52ecb9fb9553">76</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if20e557008044e5fb9d0332c0e98ca51_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:LegalFees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzE5LTItMS0xLTcyMTUx_3925071a-8226-45db-89cf-8ffe08d9417a">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cccfcfd1f224a4e8c544848a6c32027_D20200101-20201231" decimals="-6" name="us-gaap:LegalFees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzE5LTMtMS0xLTcyMTUx_107c3218-9565-46dd-9902-b427ecda8ceb">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated operating income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8e39c420c4d438997d9ba32c31cd4a4_D20220101-20221231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzIwLTEtMS0xLTcyMTUx_6fe138c8-3a49-4d2d-bc49-715ef0332878">2,841</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if20e557008044e5fb9d0332c0e98ca51_D20210101-20211231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzIwLTItMS0xLTcyMTUx_293400ce-213c-4255-9e1b-bbde8c383da2">2,584</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cccfcfd1f224a4e8c544848a6c32027_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzIwLTMtMS0xLTcyMTUx_54245ea0-8c74-4410-8b8d-f2d389007872">2,223</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90ZXh0cmVnaW9uOjU1ZjRhZjk2ZTllODQ3NmJiODMxZTU1MTE1MDBmZWRhXzE5NTk_2d68f97c-f5ff-491a-ba3d-3565048aeced" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.693%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.693%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.694%"></td><td style="width:0.1%"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Segment Assets and Capital Spending</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedSurg and Neurotechnology</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fc2a97b3bea475a937cf78e3d486fb9_I20221231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo2YmNmOWE4MjUzYzY0OThiYWFhZmQ4MjA2ZGNlYzkyMi90YWJsZXJhbmdlOjZiY2Y5YTgyNTNjNjQ5OGJhYWFmZDgyMDZkY2VjOTIyXzItMS0xLTEtNzIxNTE_8979fe23-b62a-4fb0-93cc-55a033f55867">18,283</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0025a70b3c024f7ead4a7871ca53fd09_I20211231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo2YmNmOWE4MjUzYzY0OThiYWFhZmQ4MjA2ZGNlYzkyMi90YWJsZXJhbmdlOjZiY2Y5YTgyNTNjNjQ5OGJhYWFmZDgyMDZkY2VjOTIyXzItMi0xLTEtNzIxNTE_f8bd7fe7-227c-48fd-a001-ade36b7809e5">15,218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd3298582d043a884e887664abad745_I20201231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo2YmNmOWE4MjUzYzY0OThiYWFhZmQ4MjA2ZGNlYzkyMi90YWJsZXJhbmdlOjZiY2Y5YTgyNTNjNjQ5OGJhYWFmZDgyMDZkY2VjOTIyXzItMy0xLTEtNzIxNTE_faff5561-d43a-47e7-85e4-c97462e14c32">15,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Orthopaedics and Spine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd7588c5ae9148c78b08f844142d9e5f_I20221231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo2YmNmOWE4MjUzYzY0OThiYWFhZmQ4MjA2ZGNlYzkyMi90YWJsZXJhbmdlOjZiY2Y5YTgyNTNjNjQ5OGJhYWFmZDgyMDZkY2VjOTIyXzMtMS0xLTEtNzIxNTE_60246455-6649-4116-8ab3-51dd4d375e74">17,295</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i715d57ade67c48388266154e58153628_I20211231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo2YmNmOWE4MjUzYzY0OThiYWFhZmQ4MjA2ZGNlYzkyMi90YWJsZXJhbmdlOjZiY2Y5YTgyNTNjNjQ5OGJhYWFmZDgyMDZkY2VjOTIyXzMtMi0xLTEtNzIxNTE_6de25165-ab7b-49ce-810c-e210cb0c5055">18,149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if13c14f2e2cb47afbc845ae42bcab920_I20201231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo2YmNmOWE4MjUzYzY0OThiYWFhZmQ4MjA2ZGNlYzkyMi90YWJsZXJhbmdlOjZiY2Y5YTgyNTNjNjQ5OGJhYWFmZDgyMDZkY2VjOTIyXzMtMy0xLTEtNzIxNTE_3b2cdcdc-9c46-4a97-9067-0b5be7f61cc4">18,090</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total segment assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29115a5568cc447b9a3b7fc6da47a4c0_I20221231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo2YmNmOWE4MjUzYzY0OThiYWFhZmQ4MjA2ZGNlYzkyMi90YWJsZXJhbmdlOjZiY2Y5YTgyNTNjNjQ5OGJhYWFmZDgyMDZkY2VjOTIyXzQtMS0xLTEtNzIxNTE_10e42960-d78b-44a0-94a9-102ccec939c8">35,578</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4aef5c47c71047fe98565c8a3de0fb4a_I20211231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo2YmNmOWE4MjUzYzY0OThiYWFhZmQ4MjA2ZGNlYzkyMi90YWJsZXJhbmdlOjZiY2Y5YTgyNTNjNjQ5OGJhYWFmZDgyMDZkY2VjOTIyXzQtMi0xLTEtNzIxNTE_3d8aa018-2219-4568-9567-45db5c5a1209">33,367</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d0d6ebb9d7845e3a21c28c263da57f5_I20201231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo2YmNmOWE4MjUzYzY0OThiYWFhZmQ4MjA2ZGNlYzkyMi90YWJsZXJhbmdlOjZiY2Y5YTgyNTNjNjQ5OGJhYWFmZDgyMDZkY2VjOTIyXzQtMy0xLTEtNzIxNTE_dd13dbbf-7de6-4161-bb06-43cc8cb88261">33,340</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Corporate and Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33ba2adb3bd4472c8913fc71b0db21bd_I20221231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo2YmNmOWE4MjUzYzY0OThiYWFhZmQ4MjA2ZGNlYzkyMi90YWJsZXJhbmdlOjZiY2Y5YTgyNTNjNjQ5OGJhYWFmZDgyMDZkY2VjOTIyXzUtMS0xLTEtNzIxNTE_6fb78fab-bc23-4946-aab7-ba7445444e3f">1,306</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07d6396dc54146d6aee48aa19fc60e02_I20211231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo2YmNmOWE4MjUzYzY0OThiYWFhZmQ4MjA2ZGNlYzkyMi90YWJsZXJhbmdlOjZiY2Y5YTgyNTNjNjQ5OGJhYWFmZDgyMDZkY2VjOTIyXzUtMi0xLTEtNzIxNTE_c7f687d6-c0f7-4ae1-9fb8-f01298daba19">1,264</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf905d3d98e04a87989918e7e14042cb_I20201231" decimals="-6" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo2YmNmOWE4MjUzYzY0OThiYWFhZmQ4MjA2ZGNlYzkyMi90YWJsZXJhbmdlOjZiY2Y5YTgyNTNjNjQ5OGJhYWFmZDgyMDZkY2VjOTIyXzUtMy0xLTEtNzIxNTE_dd3d09f7-cab9-498e-8c4e-94e7c21a91bd">990</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo2YmNmOWE4MjUzYzY0OThiYWFhZmQ4MjA2ZGNlYzkyMi90YWJsZXJhbmdlOjZiY2Y5YTgyNTNjNjQ5OGJhYWFmZDgyMDZkY2VjOTIyXzYtMS0xLTEtNzIxNTE_dbd97b65-e676-4701-ad42-c2f67047c285">36,884</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo2YmNmOWE4MjUzYzY0OThiYWFhZmQ4MjA2ZGNlYzkyMi90YWJsZXJhbmdlOjZiY2Y5YTgyNTNjNjQ5OGJhYWFmZDgyMDZkY2VjOTIyXzYtMi0xLTEtNzIxNTE_7d058b5a-f649-48b8-8395-245b3a3e4e4f">34,631</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98963cf23d234ec1ac275e66bcfd76dc_I20201231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo2YmNmOWE4MjUzYzY0OThiYWFhZmQ4MjA2ZGNlYzkyMi90YWJsZXJhbmdlOjZiY2Y5YTgyNTNjNjQ5OGJhYWFmZDgyMDZkY2VjOTIyXzYtMy0xLTEtNzIxNTE_1f131e95-ceeb-444d-a865-c4433a768ffe">34,330</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Purchases of property, plant and equipment:</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedSurg and Neurotechnology</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47bbb5ea95dc45349b14191d69f1c992_D20220101-20221231" decimals="-6" name="syk:CapitalExpendituresDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo2YmNmOWE4MjUzYzY0OThiYWFhZmQ4MjA2ZGNlYzkyMi90YWJsZXJhbmdlOjZiY2Y5YTgyNTNjNjQ5OGJhYWFmZDgyMDZkY2VjOTIyXzgtMS0xLTEtNzIxNTE_fe83b386-63fd-4934-adf6-bb7392970a19">173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49c69f29d3694f059d9bf2a004976b17_D20210101-20211231" decimals="-6" name="syk:CapitalExpendituresDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo2YmNmOWE4MjUzYzY0OThiYWFhZmQ4MjA2ZGNlYzkyMi90YWJsZXJhbmdlOjZiY2Y5YTgyNTNjNjQ5OGJhYWFmZDgyMDZkY2VjOTIyXzgtMi0xLTEtNzIxNTE_599aa2cf-d724-4340-9bce-e051688dadd5">197</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60771115f5654e2ba9c33e5226dec383_D20200101-20201231" decimals="-6" name="syk:CapitalExpendituresDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo2YmNmOWE4MjUzYzY0OThiYWFhZmQ4MjA2ZGNlYzkyMi90YWJsZXJhbmdlOjZiY2Y5YTgyNTNjNjQ5OGJhYWFmZDgyMDZkY2VjOTIyXzgtMy0xLTEtNzIxNTE_18ef41e2-ff55-492e-88ce-3eedd3e48ad3">192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Orthopaedics and Spine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6324e0271e4c436692bbcb9e623fc2e8_D20220101-20221231" decimals="-6" name="syk:CapitalExpendituresDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo2YmNmOWE4MjUzYzY0OThiYWFhZmQ4MjA2ZGNlYzkyMi90YWJsZXJhbmdlOjZiY2Y5YTgyNTNjNjQ5OGJhYWFmZDgyMDZkY2VjOTIyXzktMS0xLTEtNzIxNTE_a8c4554a-70a0-4440-aa7f-085583525534">175</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81c6954ba7174d4d90e932296c08e140_D20210101-20211231" decimals="-6" name="syk:CapitalExpendituresDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo2YmNmOWE4MjUzYzY0OThiYWFhZmQ4MjA2ZGNlYzkyMi90YWJsZXJhbmdlOjZiY2Y5YTgyNTNjNjQ5OGJhYWFmZDgyMDZkY2VjOTIyXzktMi0xLTEtNzIxNTE_771fd6a9-ae55-40a9-9730-38b64f66e877">165</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i378661c47c334191b9979c19bbafc9b1_D20200101-20201231" decimals="-6" name="syk:CapitalExpendituresDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo2YmNmOWE4MjUzYzY0OThiYWFhZmQ4MjA2ZGNlYzkyMi90YWJsZXJhbmdlOjZiY2Y5YTgyNTNjNjQ5OGJhYWFmZDgyMDZkY2VjOTIyXzktMy0xLTEtNzIxNTE_ff65b4a9-490f-4eca-baba-f906582d3f4c">150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total segment purchases of property, plant and equipment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f531e84880c46bbbe92b1c8ce7c31a6_D20220101-20221231" decimals="-6" name="syk:CapitalExpendituresDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo2YmNmOWE4MjUzYzY0OThiYWFhZmQ4MjA2ZGNlYzkyMi90YWJsZXJhbmdlOjZiY2Y5YTgyNTNjNjQ5OGJhYWFmZDgyMDZkY2VjOTIyXzEwLTEtMS0xLTcyMTUx_9feab779-a831-4f5d-8109-46059a12dc53">348</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie984aa38d0f0495d8a86b02fb27192a6_D20210101-20211231" decimals="-6" name="syk:CapitalExpendituresDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo2YmNmOWE4MjUzYzY0OThiYWFhZmQ4MjA2ZGNlYzkyMi90YWJsZXJhbmdlOjZiY2Y5YTgyNTNjNjQ5OGJhYWFmZDgyMDZkY2VjOTIyXzEwLTItMS0xLTcyMTUx_7dd53be7-b5f5-41a4-bc43-81f8d7e5dca0">362</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3f309c92d20420689d59a657fb1d10b_D20200101-20201231" decimals="-6" name="syk:CapitalExpendituresDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo2YmNmOWE4MjUzYzY0OThiYWFhZmQ4MjA2ZGNlYzkyMi90YWJsZXJhbmdlOjZiY2Y5YTgyNTNjNjQ5OGJhYWFmZDgyMDZkY2VjOTIyXzEwLTMtMS0xLTcyMTUx_9a5b0eef-4cd2-4e91-95a0-9849010bdccb">342</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Corporate and Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90ea3f9a188b4371a80590a32f3162a6_D20220101-20221231" decimals="-6" name="syk:CapitalExpendituresDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo2YmNmOWE4MjUzYzY0OThiYWFhZmQ4MjA2ZGNlYzkyMi90YWJsZXJhbmdlOjZiY2Y5YTgyNTNjNjQ5OGJhYWFmZDgyMDZkY2VjOTIyXzExLTEtMS0xLTcyMTUx_6980cb5b-aa39-407e-be90-0c982d309d61">240</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95cdabbaebc1412494ff81e987370623_D20210101-20211231" decimals="-6" name="syk:CapitalExpendituresDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo2YmNmOWE4MjUzYzY0OThiYWFhZmQ4MjA2ZGNlYzkyMi90YWJsZXJhbmdlOjZiY2Y5YTgyNTNjNjQ5OGJhYWFmZDgyMDZkY2VjOTIyXzExLTItMS0xLTcyMTUx_dd9740a0-fb68-4fb2-beb8-9d3046e53aea">163</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idba55220993f4de4874efcaf00cabe63_D20200101-20201231" decimals="-6" name="syk:CapitalExpendituresDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo2YmNmOWE4MjUzYzY0OThiYWFhZmQ4MjA2ZGNlYzkyMi90YWJsZXJhbmdlOjZiY2Y5YTgyNTNjNjQ5OGJhYWFmZDgyMDZkY2VjOTIyXzExLTMtMS0xLTcyMTUx_0305a379-2fa5-404f-95f8-a500ef987f46">145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total purchases of property, plant and equipment</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="syk:CapitalExpendituresDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo2YmNmOWE4MjUzYzY0OThiYWFhZmQ4MjA2ZGNlYzkyMi90YWJsZXJhbmdlOjZiY2Y5YTgyNTNjNjQ5OGJhYWFmZDgyMDZkY2VjOTIyXzEyLTEtMS0xLTcyMTUx_4fe3ac48-be23-4f39-af29-8d1f38587079">588</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="syk:CapitalExpendituresDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo2YmNmOWE4MjUzYzY0OThiYWFhZmQ4MjA2ZGNlYzkyMi90YWJsZXJhbmdlOjZiY2Y5YTgyNTNjNjQ5OGJhYWFmZDgyMDZkY2VjOTIyXzEyLTItMS0xLTcyMTUx_94b35e28-8e5b-48ce-856f-c2c2765321c4">525</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="syk:CapitalExpendituresDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo2YmNmOWE4MjUzYzY0OThiYWFhZmQ4MjA2ZGNlYzkyMi90YWJsZXJhbmdlOjZiY2Y5YTgyNTNjNjQ5OGJhYWFmZDgyMDZkY2VjOTIyXzEyLTMtMS0xLTcyMTUx_3cddddd5-99f1-4296-bf4e-f6d4d941ab50">487</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We measure the financial results of our reportable segments using an internal performance measure that excludes acquisition and integration-related charges, restructuring-related and other charges, goodwill impairment, reserves for certain product recall matters and reserves for certain legal and regulatory matters. Identifiable assets are those assets used exclusively in the operations of each business segment or allocated when used jointly. Corporate assets are principally property, plant and equipment, and noncurrent assets. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The countries in which we have local revenue generating operations have been combined into the following geographic areas: the United States (including Puerto Rico); Europe, Middle East, Africa; Asia Pacific; and other foreign countries, which include Canada and countries in the Latin American region. Net sales are reported based on the geographic area of the Stryker location where the sales to the customer originated. </span></div><div style="margin-bottom:3pt;text-align:justify"><ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90ZXh0cmVnaW9uOjU1ZjRhZjk2ZTllODQ3NmJiODMxZTU1MTE1MDBmZWRhXzE5NTU_8104b673-d64b-4563-83c4-38f84fbdb55c" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.750%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.842%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.842%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.842%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.846%"></td><td style="width:0.1%"></td></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Geographic Information</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Property, Plant and Equipment</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaff1db63800141a4a0f466e4edd07697_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTphZmEzY2Y2ZjU1OTQ0MjViYmQyNWQxMjAxYTcxYzVmNC90YWJsZXJhbmdlOmFmYTNjZjZmNTU5NDQyNWJiZDI1ZDEyMDFhNzFjNWY0XzMtMS0xLTEtNzIxNTE_17e694b1-9581-4e4c-b7e0-454d2985c0a3">13,638</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c40ed4f092642e6ae3512f7b314ae33_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTphZmEzY2Y2ZjU1OTQ0MjViYmQyNWQxMjAxYTcxYzVmNC90YWJsZXJhbmdlOmFmYTNjZjZmNTU5NDQyNWJiZDI1ZDEyMDFhNzFjNWY0XzMtMi0xLTEtNzIxNTE_590f270c-c60e-4b77-8fb3-73ba2e695bb3">12,321</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia16521f0e141452ca6e75ab7d3a68848_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTphZmEzY2Y2ZjU1OTQ0MjViYmQyNWQxMjAxYTcxYzVmNC90YWJsZXJhbmdlOmFmYTNjZjZmNTU5NDQyNWJiZDI1ZDEyMDFhNzFjNWY0XzMtMy0xLTEtNzIxNTE_77152d53-0c12-4ef3-8ad0-d8ba8d70369e">10,455</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32ee708de8b14883887f6bab85af5750_I20221231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTphZmEzY2Y2ZjU1OTQ0MjViYmQyNWQxMjAxYTcxYzVmNC90YWJsZXJhbmdlOmFmYTNjZjZmNTU5NDQyNWJiZDI1ZDEyMDFhNzFjNWY0XzMtNS0xLTEtNzIxNTE_17ba9ebc-0ab6-4336-8597-6227b2032500">1,791</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8163b2c12c64eeaab735b00242896b8_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTphZmEzY2Y2ZjU1OTQ0MjViYmQyNWQxMjAxYTcxYzVmNC90YWJsZXJhbmdlOmFmYTNjZjZmNTU5NDQyNWJiZDI1ZDEyMDFhNzFjNWY0XzMtNi0xLTEtNzIxNTE_a2e8c824-8362-4877-877c-1925a1c1cca7">1,717</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Europe, Middle East, Africa</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2968c9c4a80487baea572af89e9b685_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTphZmEzY2Y2ZjU1OTQ0MjViYmQyNWQxMjAxYTcxYzVmNC90YWJsZXJhbmdlOmFmYTNjZjZmNTU5NDQyNWJiZDI1ZDEyMDFhNzFjNWY0XzQtMS0xLTEtNzIxNTE_266542a4-d4b3-46ce-bd54-8b6e2215324e">2,348</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5182e3f5e754340a7c52da0e4f360ec_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTphZmEzY2Y2ZjU1OTQ0MjViYmQyNWQxMjAxYTcxYzVmNC90YWJsZXJhbmdlOmFmYTNjZjZmNTU5NDQyNWJiZDI1ZDEyMDFhNzFjNWY0XzQtMi0xLTEtNzIxNTE_3ee68657-59f2-405b-99a3-0184685faa73">2,299</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5147ef358704bf8901cba0f588770d3_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTphZmEzY2Y2ZjU1OTQ0MjViYmQyNWQxMjAxYTcxYzVmNC90YWJsZXJhbmdlOmFmYTNjZjZmNTU5NDQyNWJiZDI1ZDEyMDFhNzFjNWY0XzQtMy0xLTEtNzIxNTE_02282f07-5605-496c-9032-fff79ab3cf59">1,818</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3272d42ee7e948fbb68b77a14396aa85_I20221231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTphZmEzY2Y2ZjU1OTQ0MjViYmQyNWQxMjAxYTcxYzVmNC90YWJsZXJhbmdlOmFmYTNjZjZmNTU5NDQyNWJiZDI1ZDEyMDFhNzFjNWY0XzQtNS0xLTEtNzIxNTE_7d8adcfe-27b3-4600-9632-2c7e3668f171">995</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33d7288e19cb441d99394153a6e748b6_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTphZmEzY2Y2ZjU1OTQ0MjViYmQyNWQxMjAxYTcxYzVmNC90YWJsZXJhbmdlOmFmYTNjZjZmNTU5NDQyNWJiZDI1ZDEyMDFhNzFjNWY0XzQtNi0xLTEtNzIxNTE_8e0f018b-fe19-4971-8003-2f5d20271059">941</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78278663438d4595a6f4289bf181420b_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTphZmEzY2Y2ZjU1OTQ0MjViYmQyNWQxMjAxYTcxYzVmNC90YWJsZXJhbmdlOmFmYTNjZjZmNTU5NDQyNWJiZDI1ZDEyMDFhNzFjNWY0XzUtMS0xLTEtNzIxNTE_9edae722-361d-4e81-bc76-f17fd3121fea">1,885</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b775090133468ca2cef1c982a32a0c_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTphZmEzY2Y2ZjU1OTQ0MjViYmQyNWQxMjAxYTcxYzVmNC90YWJsZXJhbmdlOmFmYTNjZjZmNTU5NDQyNWJiZDI1ZDEyMDFhNzFjNWY0XzUtMi0xLTEtNzIxNTE_57a0d058-cd91-485c-8428-66c4f6a7811c">1,973</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10ac7111c8bc45da98d1f4aa86d42db5_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTphZmEzY2Y2ZjU1OTQ0MjViYmQyNWQxMjAxYTcxYzVmNC90YWJsZXJhbmdlOmFmYTNjZjZmNTU5NDQyNWJiZDI1ZDEyMDFhNzFjNWY0XzUtMy0xLTEtNzIxNTE_f0f13095-0b72-4895-a3c6-da5382edfcc4">1,630</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4879614c45bc4f1a9d1ba8afae2d3a18_I20221231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTphZmEzY2Y2ZjU1OTQ0MjViYmQyNWQxMjAxYTcxYzVmNC90YWJsZXJhbmdlOmFmYTNjZjZmNTU5NDQyNWJiZDI1ZDEyMDFhNzFjNWY0XzUtNS0xLTEtNzIxNTE_fdb61d6a-91b6-46da-a5ec-6cb4646416ad">76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida0ef91d6b564bd5942bcd3208562cde_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTphZmEzY2Y2ZjU1OTQ0MjViYmQyNWQxMjAxYTcxYzVmNC90YWJsZXJhbmdlOmFmYTNjZjZmNTU5NDQyNWJiZDI1ZDEyMDFhNzFjNWY0XzUtNi0xLTEtNzIxNTE_8efc7426-ee5b-4732-9391-225e9aa0e4a5">76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other countries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b32b057330540a1b4c98f8a0860c359_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTphZmEzY2Y2ZjU1OTQ0MjViYmQyNWQxMjAxYTcxYzVmNC90YWJsZXJhbmdlOmFmYTNjZjZmNTU5NDQyNWJiZDI1ZDEyMDFhNzFjNWY0XzYtMS0xLTEtNzIxNTE_d9cd30c0-b0d5-45c4-abdc-ab48d3a6859a">578</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63f67a9dc38243c0bc739802cfd40502_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTphZmEzY2Y2ZjU1OTQ0MjViYmQyNWQxMjAxYTcxYzVmNC90YWJsZXJhbmdlOmFmYTNjZjZmNTU5NDQyNWJiZDI1ZDEyMDFhNzFjNWY0XzYtMi0xLTEtNzIxNTE_c83c2c9b-74ea-4a09-a398-1ece57b3f273">515</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b61af8b172d4c17bf0aaddfbae515ae_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTphZmEzY2Y2ZjU1OTQ0MjViYmQyNWQxMjAxYTcxYzVmNC90YWJsZXJhbmdlOmFmYTNjZjZmNTU5NDQyNWJiZDI1ZDEyMDFhNzFjNWY0XzYtMy0xLTEtNzIxNTE_c25d79c3-0e7e-4f19-84ac-138c69bf183c">448</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05478418b05443d89b6397fa59b450bc_I20221231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTphZmEzY2Y2ZjU1OTQ0MjViYmQyNWQxMjAxYTcxYzVmNC90YWJsZXJhbmdlOmFmYTNjZjZmNTU5NDQyNWJiZDI1ZDEyMDFhNzFjNWY0XzYtNS0xLTEtNzIxNTE_63b12b82-121b-4ab3-9f5f-b09554a7ab8e">108</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c78e2c8fe11461fa0a6bbdff48c2aad_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTphZmEzY2Y2ZjU1OTQ0MjViYmQyNWQxMjAxYTcxYzVmNC90YWJsZXJhbmdlOmFmYTNjZjZmNTU5NDQyNWJiZDI1ZDEyMDFhNzFjNWY0XzYtNi0xLTEtNzIxNTE_91973596-4077-4adc-85a4-d75b232933af">99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTphZmEzY2Y2ZjU1OTQ0MjViYmQyNWQxMjAxYTcxYzVmNC90YWJsZXJhbmdlOmFmYTNjZjZmNTU5NDQyNWJiZDI1ZDEyMDFhNzFjNWY0XzctMS0xLTEtNzIxNTE_b97e10cd-9fea-4416-9ae7-d465ed1a0a11">18,449</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTphZmEzY2Y2ZjU1OTQ0MjViYmQyNWQxMjAxYTcxYzVmNC90YWJsZXJhbmdlOmFmYTNjZjZmNTU5NDQyNWJiZDI1ZDEyMDFhNzFjNWY0XzctMi0xLTEtNzIxNTE_db3d8778-2d78-45d6-bf0e-2dc59fe5f77b">17,108</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTphZmEzY2Y2ZjU1OTQ0MjViYmQyNWQxMjAxYTcxYzVmNC90YWJsZXJhbmdlOmFmYTNjZjZmNTU5NDQyNWJiZDI1ZDEyMDFhNzFjNWY0XzctMy0xLTEtNzIxNTE_057fcc4c-2c26-477e-a2c5-6de7a355b98b">14,351</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTphZmEzY2Y2ZjU1OTQ0MjViYmQyNWQxMjAxYTcxYzVmNC90YWJsZXJhbmdlOmFmYTNjZjZmNTU5NDQyNWJiZDI1ZDEyMDFhNzFjNWY0XzctNS0xLTEtNzIxNTE_fff7b713-1155-49b9-b112-f2fbe98cdce2">2,970</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTphZmEzY2Y2ZjU1OTQ0MjViYmQyNWQxMjAxYTcxYzVmNC90YWJsZXJhbmdlOmFmYTNjZjZmNTU5NDQyNWJiZDI1ZDEyMDFhNzFjNWY0XzctNi0xLTEtNzIxNTE_b2c6a83a-6c75-4987-b8f8-a5eaa5909aa3">2,833</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div id="icec46013a0ad4608b89f97e433dd3417_142"></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTE 15 - <ix:nonNumeric contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231" name="us-gaap:AssetImpairmentChargesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xNDIvZnJhZzpiYzY3MDMzM2RlYWE0NTlmYWFiYzAyYjVkMjEyODYzMS90ZXh0cmVnaW9uOmJjNjcwMzMzZGVhYTQ1OWZhYWJjMDJiNWQyMTI4NjMxXzIwNTI_08f8fe53-ef89-45d3-9c15-65921f2a9db1" continuedAt="iab0f5c2f5a5c4e52955a673d7aeb31f4" escape="true">ASSET IMPAIRMENTS</ix:nonNumeric></span></div><ix:continuation id="iab0f5c2f5a5c4e52955a673d7aeb31f4" continuedAt="i49fe795b96e0416cae07e8d753bf4213"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The government in China has launched regional and national programs for volume-based procurement (VBP) of high-value medical consumables to reduce healthcare costs. Each VBP program has specific requirements to award contracts to the lowest bidders who are able to satisfy the quality and quantity requirements. The successful bidders may be guaranteed sales volume for certain products, while unsuccessful bidders may lose unit sales volume. The prices required for a successful bid have negatively impact our affected commercial operations in China, including those for joint replacement, trauma and certain neurovascular products. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As a result of the outcome of certain regional programs for our trauma products and the national VBP program for hips and knees we recorded charges of $<ix:nonFraction unitRef="usd" contextRef="id9dcd044683643db85814ccb7429b46b_D20210101-20211231" decimals="-6" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xNDIvZnJhZzpiYzY3MDMzM2RlYWE0NTlmYWFiYzAyYjVkMjEyODYzMS90ZXh0cmVnaW9uOmJjNjcwMzMzZGVhYTQ1OWZhYWJjMDJiNWQyMTI4NjMxXzEwOTk1MTE2MzE0Mjk_31ec4f50-ebac-4358-888c-604c782eb1a7">105</ix:nonFraction> to impair certain long-lived and intangible assets in 2021. These charges were included in selling, general and administrative expenses. The national VBP program for spine products took place in the third quarter of 2022 and we were unsuccessful in our bid. As a result we are exiting the spine business in China. Related asset impairments recognized in 2022 were not significant and we do not expect any significant impairments related to future VBP programs. Our business in China represented approximately <ix:nonFraction unitRef="number" contextRef="if6f51256944449edba93c596bb051076_D20220101-20221231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xNDIvZnJhZzpiYzY3MDMzM2RlYWE0NTlmYWFiYzAyYjVkMjEyODYzMS90ZXh0cmVnaW9uOmJjNjcwMzMzZGVhYTQ1OWZhYWJjMDJiNWQyMTI4NjMxXzEyODI_84906e69-b433-4f4c-93e8-00376d2f5260">2.4</ix:nonFraction>% of our revenues for the year ended December&#160;31, 2022.</span></div></ix:continuation><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i49fe795b96e0416cae07e8d753bf4213">In addition to asset impairments in connection with VBP program results, we recognized asset impairments of $<ix:nonFraction unitRef="usd" contextRef="i86612b3448fd4cf8a845faec1531511e_D20220101-20221231" decimals="-6" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xNDIvZnJhZzpiYzY3MDMzM2RlYWE0NTlmYWFiYzAyYjVkMjEyODYzMS90ZXh0cmVnaW9uOmJjNjcwMzMzZGVhYTQ1OWZhYWJjMDJiNWQyMTI4NjMxXzE0MDc_bc4c8866-b8ea-49f5-96e9-208363253144">47</ix:nonFraction> in 2022 for long-lived and intangible assets primarily as a result of the exit of certain product lines.</ix:continuation> </span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">38</span></div></td></tr></table></div></div></div><div id="icec46013a0ad4608b89f97e433dd3417_145"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2022 FORM 10-K</span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.175%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;9.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE.</span></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.&#160;</span></div><div id="icec46013a0ad4608b89f97e433dd3417_148"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.175%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;9A.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CONTROLS AND PROCEDURES.</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's management, with the participation of the Chief Executive Officer and Chief Financial Officer (the Certifying Officers), evaluated the effectiveness of the Company&#8217;s disclosure controls and procedures (as defined in Rules 13a-15(e) or 15d-15(e) promulgated under the Securities Exchange Act of 1934, as amended) (Exchange Act) as of December&#160;31, 2022. Based on that evaluation, the Certifying Officers concluded that the Company&#8217;s disclosure controls and procedures were effective as of December&#160;31, 2022.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There was no change to our internal control over financial reporting during the fourth quarter of 2022 that materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">MANAGEMENT'S REPORT ON INTERNAL CONTROL OVER FINANCIAL REPORTING</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rule 13a-15(f). The Company's internal control over financial reporting was designed to provide reasonable assurance to the Company's management and Board of Directors regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles and includes those policies and procedures that: (i) pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the Company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company's assets that could have a material effect on the financial statements.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's management assessed the effectiveness of our internal control over financial reporting on December&#160;31, 2022. In making this assessment, we used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Internal Control-Integrated Framework (2013)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. We have excluded from our assessment the operations and related assets of Vocera, which we acquired in February 2022. As of December&#160;31, 2022 Vocera represented approximately 8.2% of our total assets, including the goodwill and intangible assets recorded as part of the purchase price allocation and approximately 1.1% of our net sales for the year ended December&#160;31, 2022. Based on its assessment, management concluded that our internal control over financial reporting was effective as of December&#160;31, 2022.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stryker&#8217;s independent registered public accounting firm has issued an audit report on their assessment of the effectiveness of the Company&#8217;s internal control over financial reporting.</span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">To the Shareholders and the Board of Directors of Stryker Corporation</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Opinion on Internal Control over Financial Reporting </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have audited Stryker Corporation and subsidiaries&#8217; internal control over financial reporting as of December 31, 2022, based on criteria established in Internal Control&#8212;Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria). In our opinion, Stryker Corporation and subsidiaries (the Company) maintained, in all material respects, effective internal control over financial reporting as of December 31, 2022, based on the COSO criteria. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As indicated in the accompanying Management&#8217;s Report on Internal Control Over Financial Reporting, management&#8217;s assessment of and conclusion on the effectiveness of internal control over financial reporting did not include the internal controls of Vocera Communications, Inc. (Vocera), which is included in the 2022 consolidated financial statements of the Company and constituted 8.2% of total assets as of December 31, 2022 and 1.1% of net sales for the year then ended. Our audit of internal control over financial reporting of the Company also did not include an evaluation of the internal control over financial reporting of Vocera.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the 2022 consolidated financial statements of the Company and our report dated February 10, 2023 expressed an unqualified opinion thereon. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Basis for Opinion </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management&#8217;s Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Definition and Limitations of Internal Control Over Financial Reporting </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over </span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">39</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2022 FORM 10-K</span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">/s/&#160;&#160;&#160;&#160;Ernst&#160;&amp; Young LLP</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Grand Rapids, Michigan</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">February&#160;10, 2023 </span></div><div id="icec46013a0ad4608b89f97e433dd3417_151"></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.175%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;9B.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">OTHER INFORMATION.</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Section 13(r) of the Securities Exchange Act of 1934, as amended, requires an issuer to disclose in its annual or quarterly reports whether it or any of its affiliates knowingly engaged in certain activities, transactions or dealings relating to parties subject to sanctions administered by the Office of Foreign Assets Control (OFAC) within the United States Department of the Treasury, whether or not such activities are prohibited or sanctionable under United States law. On March 2, 2021, the United States government designated the Russian Federal Security Service (FSB) under additional sanctions authorities. On the same day, OFAC issued General License No. 1B (OFAC General License), which generally authorizes certain licensing, permitting, certification, notification and related transactions with the FSB as may be required pursuant to Russian encryption product import controls for the importation, distribution or use of certain information technology products and radio frequency technology products in the Russian Federation.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">As required under Russian law and as permitted under the OFAC General License, one of our subsidiaries in Russia periodically files notifications with or applies for import licenses and permits from the FSB on our behalf in connection with the importation of our products into Russia. These notification and licensing activities are free of charge, and none of our gross revenue or net profits are attributable to such activities. We expect to continue to file notifications with and apply for import licenses and permits from the FSB to qualify our products for importation and distribution in the Russian Federation to the extent required under Russian law, but only so long as such notification and licensing activities are authorized by the OFAC General License, any successor general license or other authorization issued by OFAC.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the year ended December 31, 2022 we filed two notifications with the FSB as described above.</span></div><div id="icec46013a0ad4608b89f97e433dd3417_154"></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.175%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;9C.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS.</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div id="icec46013a0ad4608b89f97e433dd3417_157"></div><div style="margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PART III</span></td></tr></table></div><div id="icec46013a0ad4608b89f97e433dd3417_160"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.175%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;10.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE.</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Information regarding our executive officers appears under the caption "Information about our Executive Officers" in Part I, Item 1 of this report.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Information regarding our directors and certain corporate governance and other matters appearing under the captions "Proposal 1&#8212;Election of Directors," "Corporate Governance," and "Additional Information&#8212;Delinquent Section 16(a) Reports" in the 2023 proxy statement is incorporated herein by reference.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Corporate Governance Guidelines adopted by our Board of Directors, as well as the charters of each of the Audit Committee, the Governance and Nominating Committee and the Compensation Committee and the Code of Conduct applicable to the principal executive officer, president, principal financial officer and principal accounting officer or controller or persons performing similar functions are posted on the "Corporate Governance" section of our website at </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">www.stryker.com</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">. The Code of Conduct replaces our previous Code of Ethics applicable to the principal executive officer, president, principal financial officer and principal accounting officer or controller or persons performing similar functions, which was retired on February 9, 2023.</span></div><div id="icec46013a0ad4608b89f97e433dd3417_163"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.175%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;11.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">EXECUTIVE COMPENSATION.</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Information regarding the compensation of our management appearing under the captions "Compensation Discussion and Analysis," "Compensation Committee Report," "Executive Compensation" and "Compensation of Directors" in the 2023 proxy statement is incorporated herein by reference.</span></div><div id="icec46013a0ad4608b89f97e433dd3417_166"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.175%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;12.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS.</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The information under the caption "Stock Ownership" in the 2023 proxy statement is incorporated herein by reference. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On December&#160;31, 2022 we had an equity compensation plan under which options were granted at a price not less than fair market value at the date of grant and under which awards of restricted stock units (RSUs) and performance stock units (PSUs) were made. Options and RSUs were also awarded under a previous plan. Additional information regarding our equity compensation plans appears in Note 1 and Note 9 to our Consolidated Financial Statements. On December&#160;31, 2022 we also had a stock performance incentive award program pursuant to which shares of our common stock were and may be issued to certain employees with respect to performance. The status of these plans, each of which were previously submitted to and approved by our shareholders, on December&#160;31, 2022 is as follows:</span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">40</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2022 FORM 10-K</span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"></td><td style="width:23.107%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.090%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.042%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Plan</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number&#160;of&#160;<br/>securities to be issued upon exercise&#160;of&#160;<br/>outstanding&#160;<br/>options, warrants and rights</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted-average exercise price of outstanding&#160;<br/>options, warrants and rights</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number&#160;of&#160;securities remaining available for future issuance under equity compensation&#160;<br/>plans (excluding shares&#160;reflected&#160;in&#160;<br/>the&#160;first&#160;column)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2006 Long-Term Incentive Plan</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">302,744&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">64.01&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2008 Employee Stock Purchase Plan</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">N/A</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,967,851</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2011 Long-Term Incentive Plan</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:4.55pt;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12,707,533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">171.48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">22,654,814</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2011 Performance Incentive Award Plan</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">276,718</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Total </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">26,899,383</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The 2011 Long-Term Incentive Plan securities to be issued upon exercise include 689,043 RSUs and 193,496 PSUs. The weighted-average exercise prices does not take these awards into account. </span></div><div id="icec46013a0ad4608b89f97e433dd3417_169"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.175%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;13.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE.</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The information under the caption "Corporate Governance" and "Corporate Governance&#8212;Certain Relationships and Related Party Transactions" in the 2023 proxy statement is incorporated herein by reference.</span></div><div id="icec46013a0ad4608b89f97e433dd3417_172"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.175%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;14.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PRINCIPAL ACCOUNTANT FEES AND SERVICES.</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The information under the caption "Proposal 2&#8212;Ratification of Appointment of our Independent Registered Public Accounting Firm" in the 2023 proxy statement is incorporated herein by reference.</span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">41</span></div></td></tr></table></div></div></div><div id="icec46013a0ad4608b89f97e433dd3417_175"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2022 FORM 10-K</span></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PART IV</span></td></tr></table></div><div id="icec46013a0ad4608b89f97e433dd3417_178"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.650%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;15.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">EXHIBITS, FINANCIAL STATEMENT SCHEDULES.</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"><tr><td style="width:1.0%"></td><td style="width:4.478%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.254%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.754%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.086%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)&#160;1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financial Statements</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The following Consolidated Financial Statements are set forth in Part II, Item 8 of this report.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Report of Independent Registered Public Accounting Firm</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icec46013a0ad4608b89f97e433dd3417_76">21</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consolidated Statements of Earnings for 2022, 2021 and 2020</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icec46013a0ad4608b89f97e433dd3417_79">23</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consolidated Statements of Comprehensive Income for 2022, 2021 and 2020</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icec46013a0ad4608b89f97e433dd3417_82">23</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consolidated Balance Sheets on 2022 and 2021</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icec46013a0ad4608b89f97e433dd3417_85">24</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consolidated Statements of Shareholders&#8217; Equity for 2022, 2021 and 2020</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icec46013a0ad4608b89f97e433dd3417_91">25</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consolidated Statements of Cash Flows for 2022, 2021 and 2020</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icec46013a0ad4608b89f97e433dd3417_94">26</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Notes to Consolidated Financial Statements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icec46013a0ad4608b89f97e433dd3417_97">27</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a) 2.</span></td><td colspan="33" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financial Statement Schedules</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The Consolidated Financial Statement schedule of Stryker Corporation and its subsidiaries is:</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Additions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Deductions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance&#160;at<br/>Beginning<br/>of Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Charged&#160;to<br/>Costs &amp;<br/>Expenses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Uncollectible Amounts Written Off, Net of Recoveries</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effect of Changes in Foreign Currency Exchange Rates</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance<br/>at End<br/>of Period</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DEDUCTED FROM ASSET ACCOUNTS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Allowance for Doubtful Accounts:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year ended December&#160;31, 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a67a3c2c8da44f8b02b124c5c7e4f00_I20211231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xNzgvZnJhZzpkM2Y2NjgxNTE1NDc0ZWM5YTE0ZTRkYjliNjIxYWYwNC90YWJsZTo3YmFmYjJmZGViYzY0YWExYmQ0MTQyODM0MzMyOGU0ZS90YWJsZXJhbmdlOjdiYWZiMmZkZWJjNjRhYTFiZDQxNDI4MzQzMzI4ZTRlXzE3LTMtMS0xLTcyMTUx_5a267da6-22d8-40f9-a26e-a9a3eead04f2">167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icad1710138264073bfe29669fd2b4227_D20220101-20221231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xNzgvZnJhZzpkM2Y2NjgxNTE1NDc0ZWM5YTE0ZTRkYjliNjIxYWYwNC90YWJsZTo3YmFmYjJmZGViYzY0YWExYmQ0MTQyODM0MzMyOGU0ZS90YWJsZXJhbmdlOjdiYWZiMmZkZWJjNjRhYTFiZDQxNDI4MzQzMzI4ZTRlXzE3LTUtMS0xLTcyMTUx_0a9a9709-34b7-48c4-927f-c34ee7fdfd3a">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icad1710138264073bfe29669fd2b4227_D20220101-20221231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xNzgvZnJhZzpkM2Y2NjgxNTE1NDc0ZWM5YTE0ZTRkYjliNjIxYWYwNC90YWJsZTo3YmFmYjJmZGViYzY0YWExYmQ0MTQyODM0MzMyOGU0ZS90YWJsZXJhbmdlOjdiYWZiMmZkZWJjNjRhYTFiZDQxNDI4MzQzMzI4ZTRlXzE3LTctMS0xLTcyMTUx_107efa3d-5436-4302-b616-dc044f26391f">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icad1710138264073bfe29669fd2b4227_D20220101-20221231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xNzgvZnJhZzpkM2Y2NjgxNTE1NDc0ZWM5YTE0ZTRkYjliNjIxYWYwNC90YWJsZTo3YmFmYjJmZGViYzY0YWExYmQ0MTQyODM0MzMyOGU0ZS90YWJsZXJhbmdlOjdiYWZiMmZkZWJjNjRhYTFiZDQxNDI4MzQzMzI4ZTRlXzE3LTktMS0xLTcyMTUx_8092ee1b-728d-485f-a059-16ae35a0caf9">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i558ca518d7ef47a69b7c90dd2d54b4c0_I20221231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xNzgvZnJhZzpkM2Y2NjgxNTE1NDc0ZWM5YTE0ZTRkYjliNjIxYWYwNC90YWJsZTo3YmFmYjJmZGViYzY0YWExYmQ0MTQyODM0MzMyOGU0ZS90YWJsZXJhbmdlOjdiYWZiMmZkZWJjNjRhYTFiZDQxNDI4MzQzMzI4ZTRlXzE3LTExLTEtMS03MjE1MQ_ae418d2c-017e-40cd-85a6-ccfddb14ed06">154</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year ended December&#160;31, 2021</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb94cefe14cf4d4ca3781d438a3518be_I20201231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xNzgvZnJhZzpkM2Y2NjgxNTE1NDc0ZWM5YTE0ZTRkYjliNjIxYWYwNC90YWJsZTo3YmFmYjJmZGViYzY0YWExYmQ0MTQyODM0MzMyOGU0ZS90YWJsZXJhbmdlOjdiYWZiMmZkZWJjNjRhYTFiZDQxNDI4MzQzMzI4ZTRlXzE4LTMtMS0xLTcyMTUx_064e81a7-96c5-45b1-917f-59a930ee70ef">131</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i318eeab7dffd46df8caadd99e8f388be_D20210101-20211231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xNzgvZnJhZzpkM2Y2NjgxNTE1NDc0ZWM5YTE0ZTRkYjliNjIxYWYwNC90YWJsZTo3YmFmYjJmZGViYzY0YWExYmQ0MTQyODM0MzMyOGU0ZS90YWJsZXJhbmdlOjdiYWZiMmZkZWJjNjRhYTFiZDQxNDI4MzQzMzI4ZTRlXzE4LTUtMS0xLTcyMTUx_54eadad4-3aa6-4189-8d2e-21123704b58a">61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i318eeab7dffd46df8caadd99e8f388be_D20210101-20211231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xNzgvZnJhZzpkM2Y2NjgxNTE1NDc0ZWM5YTE0ZTRkYjliNjIxYWYwNC90YWJsZTo3YmFmYjJmZGViYzY0YWExYmQ0MTQyODM0MzMyOGU0ZS90YWJsZXJhbmdlOjdiYWZiMmZkZWJjNjRhYTFiZDQxNDI4MzQzMzI4ZTRlXzE4LTctMS0xLTcyMTUx_fe10be90-fe74-4da8-85e9-39df553fd432">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i318eeab7dffd46df8caadd99e8f388be_D20210101-20211231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xNzgvZnJhZzpkM2Y2NjgxNTE1NDc0ZWM5YTE0ZTRkYjliNjIxYWYwNC90YWJsZTo3YmFmYjJmZGViYzY0YWExYmQ0MTQyODM0MzMyOGU0ZS90YWJsZXJhbmdlOjdiYWZiMmZkZWJjNjRhYTFiZDQxNDI4MzQzMzI4ZTRlXzE4LTktMS0xLTcyMTUx_aacdb613-7da6-4a55-937d-f74f510c3418">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a67a3c2c8da44f8b02b124c5c7e4f00_I20211231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xNzgvZnJhZzpkM2Y2NjgxNTE1NDc0ZWM5YTE0ZTRkYjliNjIxYWYwNC90YWJsZTo3YmFmYjJmZGViYzY0YWExYmQ0MTQyODM0MzMyOGU0ZS90YWJsZXJhbmdlOjdiYWZiMmZkZWJjNjRhYTFiZDQxNDI4MzQzMzI4ZTRlXzE4LTExLTEtMS03MjE1MQ_8274822e-ab57-4ea7-aaec-018320d403c7">167</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year ended December&#160;31, 2020</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3f2576e657245638084e8d8a7407dfb_I20191231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xNzgvZnJhZzpkM2Y2NjgxNTE1NDc0ZWM5YTE0ZTRkYjliNjIxYWYwNC90YWJsZTo3YmFmYjJmZGViYzY0YWExYmQ0MTQyODM0MzMyOGU0ZS90YWJsZXJhbmdlOjdiYWZiMmZkZWJjNjRhYTFiZDQxNDI4MzQzMzI4ZTRlXzE5LTMtMS0xLTcyMTUx_75035cae-0303-40b1-be7c-64b7aaf402fa">88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5211b3936fb24755baa1b6cb7bb0a9ad_D20200101-20201231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xNzgvZnJhZzpkM2Y2NjgxNTE1NDc0ZWM5YTE0ZTRkYjliNjIxYWYwNC90YWJsZTo3YmFmYjJmZGViYzY0YWExYmQ0MTQyODM0MzMyOGU0ZS90YWJsZXJhbmdlOjdiYWZiMmZkZWJjNjRhYTFiZDQxNDI4MzQzMzI4ZTRlXzE5LTUtMS0xLTcyMTUx_e49e4505-40a8-45f3-a71b-1c8a8a08a582">65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5211b3936fb24755baa1b6cb7bb0a9ad_D20200101-20201231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xNzgvZnJhZzpkM2Y2NjgxNTE1NDc0ZWM5YTE0ZTRkYjliNjIxYWYwNC90YWJsZTo3YmFmYjJmZGViYzY0YWExYmQ0MTQyODM0MzMyOGU0ZS90YWJsZXJhbmdlOjdiYWZiMmZkZWJjNjRhYTFiZDQxNDI4MzQzMzI4ZTRlXzE5LTctMS0xLTcyMTUx_6b2cc6f2-c442-4877-89ce-8998695bfe9e">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5211b3936fb24755baa1b6cb7bb0a9ad_D20200101-20201231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesAdjustments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xNzgvZnJhZzpkM2Y2NjgxNTE1NDc0ZWM5YTE0ZTRkYjliNjIxYWYwNC90YWJsZTo3YmFmYjJmZGViYzY0YWExYmQ0MTQyODM0MzMyOGU0ZS90YWJsZXJhbmdlOjdiYWZiMmZkZWJjNjRhYTFiZDQxNDI4MzQzMzI4ZTRlXzE5LTktMS0xLTcyMTUx_4812beb0-fdde-4a18-a5aa-70a030ae8999">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb94cefe14cf4d4ca3781d438a3518be_I20201231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xNzgvZnJhZzpkM2Y2NjgxNTE1NDc0ZWM5YTE0ZTRkYjliNjIxYWYwNC90YWJsZTo3YmFmYjJmZGViYzY0YWExYmQ0MTQyODM0MzMyOGU0ZS90YWJsZXJhbmdlOjdiYWZiMmZkZWJjNjRhYTFiZDQxNDI4MzQzMzI4ZTRlXzE5LTExLTEtMS03MjE1MQ_a963d821-e9a9-4dcb-b8dd-422c393241d1">131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All other schedules for which provision is made in the applicable accounting regulation of the United States Securities and Exchange Commission are not required under the related instructions or are inapplicable and, therefore, have been omitted.</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a) 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div id="icec46013a0ad4608b89f97e433dd3417_181"></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FORM 10-K&#8212;ITEM 15(a) 3. AND ITEM&#160;15(c)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">STRYKER CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">EXHIBIT INDEX</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.316%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.707%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exhibit 2&#8212;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Plan of Acquisition, Reorganization, Arrangement, Liquidation or Succession</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(i)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076418000195/sykex21agreementandplanofm.htm">Agreement and Plan of Merger, dated as of August 29, 2018, by and among Stryker Corporation, Austin Merger Sub Corp. and K2M Group Holdings, Inc. &#8212; Incorporated by reference to Exhibit 2.1 to the Company's Form 8-K dated August 30, 2018 (Commission File No. 000-09165).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(ii)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000119312519285387/d818709dex21.htm">Purchase Agreement, dated as of November 4, 2019, among Stryker Corporation, Stryker B.V. and Wright Medical Group N.V. &#8212; Incorporated by reference to Exhibit 2.1 to the Company&#8217;s Form 8-K dated November 6, 2019 (Commission File No. 001-13149).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(iii)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#169;</span></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000119312522006816/d105293dex21.htm">Agreement and Plan of Merger, dated as of January 6, 2022, by and among Stryker Corporation, Voice Merger Sub Corp., and Vocera Communications, Inc. &#8212; Incorporated by reference to Exhibit 2.1 to the Company&#8217;s Form 8-K dated January 11, 2022 (Commission File No. 001-13149).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exhibit 3&#8212;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Articles of Incorporation and By-Laws</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(i)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076418000205/ex3i10qq32018.htm">Restated Articles of Incorporation &#8212; Incorporated by reference to Exhibit 3(i) to the Company's Form 10-Q for the quarterly period ended September 30, 2018 (Commission File No. 00-09165).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(ii)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8224;</span></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex3iiamendedbylaws-nov2022.htm">Amended and Restated Bylaws.</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(iii)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076422000113/syk-8xkex31bylawsamendments.htm">Amendments to the Amended and Restated Bylaws (adopted and effective November 1, 2022) &#8212; Incorporated by reference to Exhibit 3.1 to the Company&#8217;s Form 8-K dated November 15, 2022 (Commission File No. 001-13149).</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exhibit 4&#8212;</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Instruments defining the rights of security holders, including indentures&#8212;We agree to furnish to the Commission upon request a copy of each instrument pursuant to which long-term debt of Stryker Corporation and its subsidiaries not exceeding 10% of the total assets of Stryker Corporation and its consolidated subsidiaries is authorized.</span></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">42</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2022 FORM 10-K</span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.316%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.707%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(i)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000119312510007135/dex41.htm">Indenture, dated January 15, 2010, between Stryker Corporation and U.S. Bank National Association.&#8212; Incorporated by reference to Exhibit 4.1 to the Company's Form 8-K dated January 15, 2010 (Commission File No. 000-09165).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(ii)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000119312513123574/d508904dex43.htm">Fifth Supplemental Indenture (including the form of 2043 note) dated March 25, 2013, between Stryker Corporation and U.S. Bank National Association.&#8212; Incorporated by reference to Exhibit 4.3 to the Company's Form 8-K dated March 25, 2013 (Commission File No. 000-09165).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(iii)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000119312514175095/d720177dex42.htm">Sixth Supplemental Indenture (including the form of 2024 note), dated May 1, 2014, between Stryker Corporation and U.S. Bank National Association.&#8212; Incorporated by reference to Exhibit 4.2 to the Company's Form 8-K dated May 1, 2014 (Commission File No. 000-09165).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(iv)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000119312514175095/d720177dex43.htm">Seventh Supplemental Indenture (including the form of 2044 note), dated May 1, 2014, between Stryker Corporation and U.S. Bank National Association.&#8212; Incorporated by reference to Exhibit 4.3 to the Company's Form 8-K dated May 1, 2014 (Commission File No. 000-09165).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(v)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000119312515358209/d46878dex42.htm">Eighth Supplemental Indenture (including the form of 2025 note), dated October 29, 2015, between Stryker Corporation and U.S. Bank National association.&#8212; Incorporated by reference to Exhibit 4.2 to the Company's Form 8-K dated October 29, 2015 (Commission File No. 000-09165).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(vi)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000119312516499457/d159431dex43.htm">Tenth Supplemental Indenture (including the form of the 2021 note), dated March 10, 2016, between Stryker Corporation and U.S. Bank National Association. &#8212; Incorporated by reference to Exhibit 4.3 to the Company's Form 8-K dated March 10, 2016 (Commission File No. 000-09615).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(vii)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000119312516499457/d159431dex44.htm">Eleventh Supplemental Indenture (including the form of the 2026 note), dated March 10, 2016, between Stryker Corporation and U.S. Bank National Association.&#8212; Incorporated by reference to Exhibit 4.4 to the Company's Form 8-K dated March 10, 2016 (Commission File No. 000-09615).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(viii)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000119312516499457/d159431dex45.htm">Twelfth Supplemental Indenture (including the form of the 2046 note), dated March 10, 2016, between Stryker Corporation and U.S. Bank National Association. &#8212; Incorporated by reference to Exhibit 4.5 to the Company's Form 8-K dated March 10, 2016 (Commission File No. 000-09615).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(ix)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000119312518073610/d518544dex42.htm">Fourteenth Supplemental Indenture (including the form of the 2028 note), dated March 7, 2018, between Stryker Corporation and U.S. Bank National Association. &#8212; Incorporated by reference to Exhibit 4.2 to the Company's Form 8-K dated March 7, 2018 (Commission File No. 000-09615).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(x)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000119312518339720/d661644dex42.htm">Fifteenth Supplemental Indenture (including the form of the 2023 note), dated November 30, 2018, between Stryker Corporation and U.S. Bank National Association. &#8212; Incorporated by reference to Exhibit 4.2 to the Company's Form 8-K dated November 30, 2018 (Commission File No. 000-09615).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xi)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000119312518339720/d661644dex43.htm">Sixteenth Supplemental Indenture (including the form of the 2027 note), dated November 30, 2018, between Stryker Corporation and U.S. Bank National Association. &#8212; Incorporated by reference to Exhibit 4.3 to the Company's Form 8-K dated November 30, 2018 (Commission File No. 000-09615).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xii)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000119312518339720/d661644dex44.htm">Seventeenth Supplemental Indenture (including the form of the 2030 note), dated November 30, 2018, between Stryker Corporation and U.S. Bank National Association. &#8212; Incorporated by reference to Exhibit 4.4 to the Company's Form 8-K dated November 30, 2018 (Commission File No. 000-09615).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xiii)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000119312519305266/d103227dex42.htm">Nineteenth Supplemental Indenture (including the form of the 2024 note), dated December 3, 2019, between Stryker Corporation and U.S. Bank National Association. &#8212; Incorporated by reference to Exhibit 4.2 to the Company's Form 8-K dated December 3, 2019 (Commission File No. 001-13149).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xiv)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000119312519305266/d103227dex43.htm">Twentieth Supplemental Indenture (including the form of the 2029 note), dated December 3, 2019, between Stryker Corporation and U.S. Bank National Association. &#8212; Incorporated by reference to Exhibit 4.3 to the Company's Form 8-K dated December 3, 2019 (Commission File No. 001-13149).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xv)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000119312519305266/d103227dex44.htm">Twenty-First Supplemental Indenture (including the form of the 2031 note), dated December 3, 2019, between Stryker Corporation and U.S. Bank National Association. &#8212; Incorporated by reference to Exhibit 4.4 to the Company's Form 8-K dated December 3, 2019 (Commission File No. 001-13149).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xvi)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000119312520160734/d927297dex42.htm">Twenty-Second Supplemental Indenture (including the form of the 2025 note), dated June 4, 2020, between Stryker Corporation and U.S. Bank National Association, as trustee - Incorporated by reference to Exhibit 4.2 to the Company&#8217;s Form 8-K dated June 4, 2020 (Commission File No. 001-13149).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xvii)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000119312520160734/d927297dex43.htm">Twenty-Third Supplemental Indenture (including the form of the 2030 note), dated June 4, 2020, between Stryker Corporation and U.S. Bank National Association &#8212; Incorporated by reference to Exhibit 4.3 to the Company&#8217;s Form 8-K dated June 4, 2020 (Commission File No. 001-13149).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xviii)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000119312520160734/d927297dex44.htm">Twenty-Fourth Supplemental Indenture (including the form of the 2050 note), dated June 4, 2020, between Stryker Corporation and U.S. Bank National Association &#8212; Incorporated by reference to Exhibit 4.4 to the Company&#8217;s Form 8-K dated June 4, 2020 (Commission File No. 001-13149).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xix)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000119312520301421/d36871dex42.htm">Twenty-Fifth Supplemental Indenture (including the form of the 2023 note), dated November 23, 2020, between Stryker Corporation and U.S. Bank National Association, as trustee &#8212; Incorporated by reference to Exhibit 4.2 to the Company&#8217;s Form 8-K dated November 23, 2020 (Commission File No. 001-13149).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xx)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8224;</span></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex4xx1231202210k.htm">Description of Securities</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exhibit&#160;10&#8212;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Material contracts</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(i)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8224;</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="ex10i2023nqstockoptionawar.htm">Form of grant notice and terms and conditions for stock options granted in 2023 under the 2011 Long-Term Incentive Plan.</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(ii)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8224;</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="ex10ii2023rsuawardletteran.htm">Form of grant notice and terms and conditions for restricted stock units granted in 2023 under the 2011 Long-Term Incentive Plan.</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(iii)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8224;</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="ex10iii2023psuawardlettera.htm">Form of grant notice and terms and conditions for performance stock units granted in 2023 under the 2011 Long-Term Incentive Plan.</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(iv)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076422000028/ex10i2022nqstockoptionawar.htm">Form of grant notice and terms and conditions for stock options granted in 2022 under the 2011 Long-Term Incentive Plan &#8212; Incorporated by reference to Exhibit 10(i) to the Company's Form 10-K for the year ended December 31, 2021 (Commission File No. 001-13149).</a></span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(v)*</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076422000028/ex10ii2022rsustockoptionaw.htm">Form of grant notice and terms and conditions for restricted stock units granted in 2022 under the 2011 Long-Term Incentive Plan &#8212; Incorporated by reference to Exhibit 10(ii) to the Company's Form 10-K for the year ended December 31, 2021 (Commission File No. 001-13149).</a></span></div></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">43</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2022 FORM 10-K</span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.316%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.707%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(vi)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076422000028/ex10iii2022psustockoptiona.htm">Form of grant notice and terms and conditions for performance stock units granted in 2022 under the 2011 Long-Term Incentive Plan &#8212; Incorporated by reference to Exhibit 10(iii) to the Company's Form 10-K for the year ended December 31, 2021 (Commission File No. 001-13149).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(vii)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076421000027/ex10i2021nqstockoptionawar.htm">Form of grant notice and terms and conditions for stock options granted in 2021 under the 2011 Long-Term Incentive Plan &#8212; Incorporated by reference to Exhibit 10(i) to the Company's Form 10-K for the year ended December 31, 2020 (Commission File No. 001-13149).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(viii)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076421000027/ex10ii2021rsuawardletteran.htm">Form of grant notice and terms and conditions for restricted stock units granted in 2021 under the 2011 Long-Term Incentive Plan &#8212; Incorporated by reference to Exhibit 10(ii) to the Company's Form 10-K for the year ended December 31, 2020 (Commission File No. 001-13149).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(ix)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076421000027/ex10iii2021psuawardlettera.htm">Form of grant notice and terms and conditions for performance stock units granted in 2021 under the 2011 Long-Term Incentive Plan &#8212; Incorporated by reference to Exhibit 10(iii) to the Company's Form 10-K for the year ended December 31, 2020 (Commission File No. 001-13149).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(x)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076422000092/ex10i630202210q.htm">Form of grant notice and terms and conditions for restricted stock units granted in 2022 under the 2011 Long-Term Incentive Plan to non-employee directors &#8212; Incorporated by reference to Exhibit 10(i) to the Company's Form 10-Q for the quarterly period ended June 30, 2022 (Commission File No. 001-13149).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xi)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076421000111/ex10i630202110q.htm">Form of grant notice and terms and conditions for restricted stock units granted in 2021 under the 2011 Long-Term Incentive Plan to non-employee directors &#8212; Incorporated by reference to Exhibit 10(i) to the Company's Form 10-Q for the quarterly period ended June 30, 2021 (Commission File No. 001-13149).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xii)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076420000125/ex10i-630202010q.htm">Form of grant notice and terms and conditions for restricted stock units granted in 2020 under the 2011 Long-Term Incentive Plan to non-employee directors &#8212; Incorporated by reference to Exhibit 10(i) to the Company's Form 10-Q for the quarterly period ended June 30, 2020 (Commission File No. 001-13149).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xiii)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076420000014/ex10i1231201910k.htm">2011 Long-Term Incentive Plan (as amended effective February 4, 2020) &#8212; Incorporated by reference to Exhibit 10(i) to the Company's Form 10-K for the year ended December 31, 2019 (Commission File No. 001-13149).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xiv)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076420000014/ex10ii1231201910k.htm">Form of grant notice and terms and conditions for stock options granted in 2020 under the 2011 Long-Term Incentive Plan &#8212; Incorporated by reference to Exhibit 10(ii) to the Company's Form 10-K for the year ended December 31, 2019 (Commission File No. 001-13149).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xv)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076420000014/ex10iii1231201910k.htm">Form of grant notice and terms and conditions for restricted stock units granted in 2020 under the 2011 Long-Term Incentive Plan</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076418000195/sykex21agreementandplanofm.htm"> &#8212; </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076420000014/ex10iii1231201910k.htm">Incorporated by reference to Exhibit 10(iii) to the Company's Form 10-K for the year ended December 31, 2019 (Commission File No. 001-13149).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xvi)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076420000014/ex10iv1231201910k.htm">Form of grant notice and terms and conditions for performance stock units granted in 2020 under the 2011 Long-Term Incentive Plan</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076418000195/sykex21agreementandplanofm.htm"> &#8212; </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076420000014/ex10iv1231201910k.htm">Incorporated by reference to Exhibit 10(iv) to the Company's Form 10-K for the year ended December 31, 2019 (Commission File No. 001-13149).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xvii)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076420000014/ex10v1231201910k.htm">Form of terms and conditions for restricted stock units granted to non-employee directors in 2019 under the 2011 Long-Term Incentive Plan</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076418000195/sykex21agreementandplanofm.htm"> &#8212; </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076420000014/ex10v1231201910k.htm">Incorporated by reference to Exhibit 10(v) to the Company's Form 10-K for the year ended December 31, 2019 (Commission File No. 001-13149).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xviii)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076420000014/ex10vi1231201910k.htm">Supplemental Savings and Retirement Plan (as amended effective January 1, 2008 and January 1, 2019)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076418000195/sykex21agreementandplanofm.htm"> &#8212; </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076420000014/ex10vi1231201910k.htm">Incorporated by reference to Exhibit 10(vi) to the Company's Form 10-K for the year ended December 31, 2019 (Commission File No. 001-13149).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xix)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076419000014/ex10ii12311810k.htm">Form of grant notice and terms and conditions for stock options granted in 2019 under the 2011 Long-Term Incentive Plan</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076418000195/sykex21agreementandplanofm.htm"> &#8212; </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076419000014/ex10ii12311810k.htm">Incorporated by reference to Exhibit 10(ii) to the Company's Form 10-K for the year ended December 31, 2018 (Commission File No. 001-13149).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xx)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076419000014/ex10iii12311810k.htm">Form of grant notice and terms and conditions for restricted stock units granted in 2019 under the 2011 Long-Term Incentive Plan</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076418000195/sykex21agreementandplanofm.htm"> &#8212; </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076419000014/ex10iii12311810k.htm">Incorporated by reference to Exhibit 10(iii) to the Company's Form 10-K for the year ended December 31, 2018 (Commission File No. 001-13149).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xxi)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076419000014/ex10iv12311810k.htm">Form of grant notice and terms and conditions for performance stock units granted in 2019 under the 2011 Long-Term Incentive Plan</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076418000195/sykex21agreementandplanofm.htm"> &#8212; </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076419000014/ex10iv12311810k.htm">Incorporated by reference to Exhibit 10(iv) to the Company's Form 10-K for the year ended December 31, 2018 (Commission File No 001-13149).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xxii)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076417000034/sykex10ii12311610k.htm">2006 Long-Term Incentive Plan (as amended effective February 7, 2017)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076418000195/sykex21agreementandplanofm.htm"> &#8212; </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076417000034/sykex10ii12311610k.htm">Incorporated by reference to Exhibit 10(ii) to the Company's Form 10-K for the year ended December 31, 2016 (Commission File No. 000-09165).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xxiii)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076418000031/ex10ii12311710k.htm">Form of grant notice and terms and conditions for stock options granted in 2018 under the 2011 Long-Term Incentive Plan &#8212; Incorporated by reference to Exhibit 10(ii) to the Company's Form 10-K for the year ended December 31, 2017 (Commission File No. 000-09165).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xxiv)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076418000031/ex10iii12311710k.htm">Form of grant notice and terms and conditions for restricted stock units granted in 2018 under the 2011 Long-Term Incentive Plan &#8212; Incorporated by reference to Exhibit 10(iii) to the Company&#8217;s Form 10-K for the year ended December 31, 2017 (Commission File No. 000-09165).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xxv)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076418000031/ex10iv12311710k.htm">Form of grant notice and terms and conditions for performance stock units granted in 2018 under the 2011 Long-Term Incentive Plan &#8212; Incorporated by reference to Exhibit 10(iv) to the Company&#8217;s Form 10-K for the year ended December 31, 2017 (Commission File No. 000-09165).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xxvi)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076418000185/ex10ii10qq22018.htm">Form of grant notice and terms and conditions for restricted stock units granted in 2018 under the 2011 Long-Term Incentive Plan to non-employee directors</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076418000195/sykex21agreementandplanofm.htm"> &#8212; </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076418000185/ex10ii10qq22018.htm">Incorporated by reference to Exhibit 10(ii) to the Company&#8217;s Form 10-Q for the quarterly period ended June 30, 2018 (Commission File No. 000-09165).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xxvii)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076407000052/sykex101.htm">Stryker Corporation Executive Bonus Plan</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076418000195/sykex21agreementandplanofm.htm"> &#8212; </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076407000052/sykex101.htm">Incorporated by reference to Exhibit 10.1 to the Company's Form 8-K dated February 21, 2007 (Commission File No. 000-09165).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xxviii)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076416000206/syk8kex10212616.htm">Letter Agreement between Stryker Corporation and Glenn Boehnlein</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076418000195/sykex21agreementandplanofm.htm"> &#8212; </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076416000206/syk8kex10212616.htm">Incorporated by reference to Exhibit 10.2 to the Company's Form 8-K dated January 26, 2016 (Commission File No. 000-09165).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xxix)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076421000123/sykex1018162021.htm">Letter Agreement between Stryker Corporation and Timothy J. Scannell &#8212; Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Form 8-K dated August 18, 2021 (Commission File No. 001-13149).</a></span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xxx)</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076409000035/sykex10xiv.htm">Form of Indemnification Agreement for Directors</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076418000195/sykex21agreementandplanofm.htm"> &#8212; </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076409000035/sykex10xiv.htm">Incorporated by reference to Exhibit 10 (xiv) to the Company's Form 10-K for the year ended December 31, 2008 (Commission File No. 000-09165).</a></span></div></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">44</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2022 FORM 10-K</span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.316%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.707%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xxxi)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076409000035/sykex10xv.htm">Form of Indemnification Agreement for Certain Officers&#8212;Incorporated by reference to Exhibit 10 (xv) to the Company's Form 10-K for the year ended December 31, 2008 (Commission File No. 000-09165).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xxxii)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076415000022/ex10xxiii10k2014.htm">Settlement Agreement between Howmedica Osteonics Corp. and the counsel listed on the signature pages thereto, dated as of November 3, 2014 (Rejuvenate and ABF II Hip Implant Products Liability Litigation) &#8212; Incorporated by reference to Exhibit 10xxiii to the Company's Form 10-K for the year ended December 31, 2014 (Commission File No. 000-09165).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xxxiii)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#169;</span></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000119312516688904/d245821dex41.htm">Credit Agreement, dated as of August 19, 2016, among Stryker Corporation and certain subsidiaries, as designated borrowers; the lenders party thereto; and Bank of America, N.A., as administrative agent</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076418000195/sykex21agreementandplanofm.htm"> &#8212; </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000119312516688904/d245821dex41.htm">Incorporated by reference to Exhibit 4.1 to the Company&#8217;s 8-K dated August 23, 2016 (Commission File No. 000-09165).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xxxiv)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076420000069/ex10iamendcreditagreement.htm">Amendment No. 1, dated as of April 30, 2020, to Credit Agreement, dated as of August 19, 2016, among Stryker Corporation and certain of its subsidiaries, as designated borrowers; the lenders party thereto; and Bank of America, N.A., as administrative agent</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076418000195/sykex21agreementandplanofm.htm"> &#8212; </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076420000069/ex10iamendcreditagreement.htm">Incorporated by reference to Exhibit 10(i) to the Company's Form 10-Q for the quarterly period ended March 31, 2020 (Commission File No. 001-13149).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xxxv)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076420000069/ex10ii364creditagreement.htm">Credit Agreement, dated as of April 30, 2020, among Stryker Corporation as borrower; the lenders party thereto; and Bank of America, N.A., as administrative agent &#8212; Incorporated by reference to Exhibit 10(ii) to the Company's Form 10-Q for the quarterly period ended March 31, 2020 (Commission File No. 001-13149).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xxxvi)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000119312520292302/d77015dex101.htm">Term Loan Agreement, dated as of November 10, 2020, among Stryker Corporation, as borrower, the lenders party thereto and Bank of America, N.A., as administrative agent</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076418000195/sykex21agreementandplanofm.htm"> &#8212; </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000119312520292302/d77015dex101.htm">Incorporated by reference to Exhibit 10.1 to the Company's Form 8-K dated November 13, 2020 (Commission File No. 001-13149).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xxxvii)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076421000146/ex10i2021creditagreement.htm">Credit Agreement, dated as of October 26, 2021, among Stryker Corporation as borrower; the lenders party thereto; and Wells Fargo Bank, N.A., as administrative agent &#8212; Incorporated by reference to Exhibit 10(i) to the Company's Form 10-Q for the quarterly period ended September 30, 2021 (Commission File No. 001-13149). </a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xxxviii)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076422000035/syk2022-termloanagreement.htm">Term Loan Agreement, dated as of February 22, 2022, among Stryker Corporation, as borrower, the lenders party thereto and Wells Fargo Bank, National Association, as administrative agent &#8212; Incorporated by reference to Exhibit 10.1 to the Company's Form 8-K dated February 25, 2022 (Commission File No. 001-13149).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exhibit 21&#8212;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Subsidiaries of the registrant</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(i)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8224;</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex21i1231202210k.htm">List of Subsidiaries.</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exhibit 23&#8212;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Consent of experts and counsel</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(i)</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8224;</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex23i1231202210k.htm">Consent of Independent Registered Public Accounting Firm.</a></span></div></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.316%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.707%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exhibit 31&#8212;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Rule 13a-14(a) Certifications</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(i)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8224;</span></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex31i1231202210k.htm">Certification by Principal Executive Officer of Stryker Corporation.</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(ii)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8224;</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex31ii1231202210k.htm">Certification by Principal Financial Officer of Stryker Corporation.</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exhibit 32&#8212;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18 U.S.C. Section 1350 Certifications</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(i)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8224;</span></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex32i1231202210k.htm">Certification by Principal Executive Officer of Stryker Corporation.</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(ii)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8224;</span></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex32ii1231202210k.htm">Certification by Principal Financial Officer of Stryker Corporation.</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exhibit&#160;101&#8212;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">iXBRL (Inline Extensible Business Reporting Language) Documents</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">iXBRL Instance Document</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">iXBRL Schema Document</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">iXBRL Calculation Linkbase Document</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">iXBRL Definition Linkbase Document</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">iXBRL Label Linkbase Document</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">iXBRL Presentation Linkbase Document</span></td></tr><tr><td colspan="2" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document)</span></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:96.123%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Compensation arrangement</span></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:96.123%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8224;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Furnished with this Form 10-K</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:96.123%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#169;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Schedules have been omitted pursuant to Item 601(a)(5) of Regulation S-K. Stryker hereby agrees to furnish supplementally a copy of any omitted schedule upon request by the U.S. Securities and Exchange Commission.</span></td></tr></table></div><div id="icec46013a0ad4608b89f97e433dd3417_184"></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.650%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;16.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">FORM 10-K SUMMARY.</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">None.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">45</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2022 FORM 10-K</span></div></div><div style="text-align:justify"><span><br/></span></div><div id="icec46013a0ad4608b89f97e433dd3417_187"></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section&#160;13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.929%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">STRYKER CORPORATION</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 10, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ GLENN S. BOEHNLEIN</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Glenn S. Boehnlein</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vice President, Chief Financial Officer</span></td></tr></table></div><div style="margin-top:4pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on the date indicated above on behalf of the registrant and in the capacities indicated.&#160;</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:47.995%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.608%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.997%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ KEVIN A. LOBO</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ GLENN S. BOEHNLEIN</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Kevin A. Lobo</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Glenn S. Boehnlein</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chair, Chief Executive Officer and President</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vice President, Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Principal Executive Officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Principal Financial Officer)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ WILLIAM E. BERRY JR.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">William E. Berry, Jr.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vice President, Chief Accounting Officer</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Principal Accounting Officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ SHERILYN S. MCCOY</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ ANDREW K. SILVERNAIL</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sherilyn S. McCoy</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Andrew K. Silvernail</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lead Independent Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ MARY K. BRAINERD</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ LISA M. SKEETE TATUM</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mary K. Brainerd</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lisa M. Skeete Tatum</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ GIOVANNI CAFORIO</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ RONDA E. STRYKER</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Giovanni Caforio, M.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ronda E. Stryker</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ SRIKANT M. DATAR</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ RAJEEV SURI</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Srikant M. Datar, Ph.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rajeev Suri</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ ALLAN C. GOLSTON</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Allan C. Golston</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">46</span></div></td></tr></table></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.2
<SEQUENCE>2
<FILENAME>ex3iiamendedbylaws-nov2022.htm
<DESCRIPTION>EX-3.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="if92af57dad9c4829b6aa75a40a119479_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 3(ii)</font></div></div><div><font style="background-color:#ffffff;color:#ffb500;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:100%">Bylaws</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%"><br></font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:700;line-height:100%">of<br>STRYKER CORPORATION<br>a Michigan corporation (the &#8220;Corporation&#8221;)<br>(As amended through November 1, 2022)</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.75pt solid #b2b4ae;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:18.5pt;font-weight:700;line-height:133%">Article 1</font></td></tr></table></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:400;line-height:100%">Registered office&#59; Registered agent</font></div><div style="margin-bottom:11.25pt"><font><br></font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Section 1.1.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">Address of Registered Office&#59; Name of Registered Agent.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#160;The address of the registered office of the Corporation in the State of Michigan and the name of the registered agent at such address shall be as specified in the most recent statement filed pursuant to the Michigan Business Corporation Act (the &#8220;MBCA&#8221;). The Corporation may also have other offices at such places within or without the State of Michigan as the Board of Directors may from time to time designate or the business of the Corporation may require.</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Section 1.2.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">Change of Registered Office or Registered Agent.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#160;The address of the Corporation&#8217;s registered office in the State of Michigan or the designation of the registered agent may be changed upon filing of a statement in the manner permitted by the MBCA.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.75pt solid #b2b4ae;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:11.25pt;padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="margin-bottom:11.25pt;padding-left:2.75pt;padding-right:2.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:18.5pt;font-weight:700;line-height:100%">Article II</font></div></td></tr></table></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:400;line-height:100%">Meetings of shareholders</font></div><div style="margin-bottom:11.25pt"><font><br></font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Section 2.1.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">Annual Meeting</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">. The annual meeting of the shareholders of the Corporation for the election of directors and for the transaction of such other business as may properly come before the meeting shall be held at such place as the Board of Directors may determine at 2 o'clock p.m. on the third Monday in April of each year or on such other date or at such other time as the Board of Directors may determine.</font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Section 2.2.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">Nature of Business at Meetings of Shareholders.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#160;No business (other than nominations for election to the Board of Directors, which must comply with the provisions of Section 2.3 hereof) may be transacted at an annual meeting of shareholders other than business that is either (a) specified in the notice of meeting (or any supplement thereto) given at the direction of the Board of Directors (or any duly authorized committee thereof), (b) otherwise properly brought before the annual meeting at the direction of the Board of Directors (or any duly authorized committee thereof), or (c) otherwise properly brought before the annual meeting by any shareholder of the Corporation who (i) is a shareholder of record on the date of the giving of the notice provided for in this Section 2.2 and on the record date for the determination of shareholders entitled to notice of and to vote at such annual meeting and (ii) complies with the notice procedures set forth in this Section 2.2.</font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">For business to be properly brought before an annual meeting by a shareholder, such shareholder must have given timely notice thereof in proper written form to the Secretary. To be timely, a shareholder&#8217;s notice to the Secretary must be received at the principal executive offices of the Corporation not less than ninety (90) days nor more than one hundred twenty (120) days prior to the anniversary date of the immediately preceding annual meeting of shareholders&#59; provided, however, that in the event that the annual meeting is called for a date that is not within twenty-five (25) days before or after such </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">anniversary date, notice by the shareholder in order to be timely must be so received not later than the close of business on the tenth (10th) day following the day on which public disclosure of the date of the annual meeting was made. In no event shall the adjournment or postponement of an annual meeting, or the public announcement of such an adjournment or postponement, commence a new time period (or extend any time period) for the giving of a shareholder&#8217;s notice as described above.</font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">To be in proper written form, a shareholder&#8217;s notice to the Secretary must set forth as to each matter such shareholder proposes to bring before the annual meeting a brief description of the business desired to be brought before the annual meeting and the proposed text of any proposal regarding such business (including the text of any resolutions proposed for consideration and, if such business includes a proposal to amend these Bylaws, the text of the proposed amendment), and the reasons for conducting such business at the annual meeting, and as to the shareholder giving the notice and any &#8220;Shareholder Associated Person&#8221; (which for purposes of these Bylaws shall mean (a) any person acting in concert, directly or indirectly, with such shareholder and (b) any person controlling, controlled by or under common control with such shareholder or any Shareholder Associated Person), (i) the name and record address of such person, (ii) the class or series and number of shares of capital stock of the Corporation which are owned beneficially or of record by such person, (iii) the nominee holder for, and number of, shares owned beneficially but not of record by such person, (iv) whether and the extent to which any hedging or other transaction or series of transactions has been entered into by or on behalf of, or any other agreement, arrangement or understanding (including any derivative or short positions, profit interests, options or borrowed or loaned shares) has been made, the effect or intent of which is to mitigate loss to or manage risk or benefit of share price changes for, or to increase or decrease the voting power or pecuniary or economic interest of, such person with respect to any share of stock of the Corporation, (v) to the extent known by the shareholder giving the notice, the name and address of any other shareholder supporting the proposal of business on the date of such shareholder&#8217;s notice, (vi) a description of all arrangements or understandings between or among such persons in connection with (A) the Corporation or (B) the proposal of such business by such shareholder and any material interest in such business, (vii) a representation that the shareholder giving the notice intends to appear in person or by proxy at the annual meeting to bring such business before the meeting and (viii) any other information relating to such person that would be required to be disclosed in a proxy statement or other filings required to be made in connection with the solicitation of proxies with respect to the proposed business to be brought before the annual meeting pursuant to Section 14 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), and the rules and regulations promulgated thereunder. A shareholder providing notice of business proposed to be brought before an annual meeting shall further update and supplement such notice, if necessary, so that the information provided or required to be provided in such notice pursuant to this Section 2.2 shall be true and correct as of the record date for determining the shareholders entitled to receive notice of and to vote at the annual meeting and such update and supplement must be received by the Secretary at the principal executive offices of the Corporation not later than five (5) business days following the later of the record date for the determination of shareholders entitled to receive notice of and to vote at the annual meeting and the date notice of the record date is first publicly disclosed.</font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">No business shall be conducted at a special meeting of shareholders except for such business as shall have been brought before the meeting pursuant to the Corporation&#8217;s notice of meeting. If the chair of an annual or special meeting determines that business was not properly brought before the meeting in accordance with the procedures set forth in this Section 2.2 (including the provision of the information required pursuant to the immediately preceding paragraph), the chair shall declare to the meeting that the business was not properly brought before the meeting and such business shall not be transacted.</font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Nothing contained in this Section 2.2 shall be deemed to affect any rights of shareholders to request inclusion of proposals in the Corporation&#8217;s proxy statement pursuant to Rule 14a-8 under the Exchange Act (or any successor provision of law).</font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Section 2.3.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">Nomination of Directors.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#160;Only persons who are nominated in accordance with the following procedures shall be eligible for election as directors of the Corporation, except as may be otherwise provided in the Articles of Incorporation with respect to the right of holders of preferred stock of the Corporation to nominate and elect a specified number of directors in certain circumstances. Nominations of persons for election to the Board of Directors may be made at any annual meeting of shareholders, or at any special meeting of shareholders called for the purpose of electing directors, (a) at the direction of the Board of Directors (or any duly authorized committee thereof), (b) by any shareholder of the Corporation who (i) is a shareholder of record on the date of the giving of the notice </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">provided for in this Section 2.3 and on the record date for the determination of shareholders entitled to vote at such meeting and (ii) complies with (A) the notice procedures set forth in this Section 2.3 and (B) the applicable requirements of Rule 14a-19 under the Exchange Act or (c) in the case of an annual meeting, by any Eligible Shareholder (as defined in Section 2.13) who complies with the procedures set forth in Section 2.13 hereof.</font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">For a nomination to be made by a shareholder pursuant to clause (b) of the first paragraph of this Section 2.3, such shareholder must have given timely notice thereof in proper written form to the Secretary. To be timely, a shareholder&#8217;s notice to the Secretary must be received at the principal executive offices of the Corporation (a) in the case of an annual meeting, not less than ninety (90) days nor more than one hundred twenty (120) days prior to the anniversary date of the immediately preceding annual meeting of shareholders&#59; provided, however, that in the event that the annual meeting is called for a date that is not within twenty-five (25) days before or after such anniversary date, notice by the shareholder in order to be timely must be so received not later than the close of business on the tenth (10th) day following the day on which public disclosure of the date of the annual meeting was made&#59; and (b) in the case of a special meeting of shareholders called for the purpose of electing directors, not later than the close of business on the tenth (10th) day following the day on which public disclosure of the date of the special meeting was made. In no event shall the adjournment or postponement of an annual meeting or a special meeting of shareholders called for the purpose of electing directors, or the public announcement of such an adjournment or postponement, commence a new time period (or extend any time period) for the giving of a shareholder&#8217;s notice as described above.</font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">To be in proper written form, a shareholder&#8217;s notice to the Secretary must set forth as to each person whom the shareholder proposes to nominate for election as a director and as to the shareholder giving the notice and any Shareholder Associated Person (i) all information relating to such person that would be required to be disclosed in a proxy statement or other filings required to be made in connection with the solicitation of proxies for election of directors pursuant to Section 14 of the Exchange Act and the rules and regulations promulgated thereunder, (ii) the name and record address of such person, (iii) the class or series and number of shares of capital stock of the Corporation which are owned beneficially or of record by such person, (iv) the nominee holder for, and number of, shares owned beneficially but not of record by such person, (v) whether and the extent to which any hedging or other transaction or series of transactions has been entered into by or on behalf of, or any other agreement, arrangement or understanding (including any derivative or short positions, profit interests, options or borrowed or loaned shares) has been made, the effect or intent of which is to mitigate the loss to or manage risk or benefit of share price changes for, or to increase or decrease the voting power or pecuniary or economic interest of, such person with respect to any share of stock of the Corporation, (vi) to the extent known by the shareholder giving the notice, the name and address of any other shareholder supporting the nominee for election or reelection as a director on the date of such shareholder&#8217;s notice, (vii) a description of all arrangements or understandings between or among such persons pursuant to which the nomination(s) are to be made by the shareholder, any material interest of such person in the nomination(s), including any anticipated benefit therefrom to such person, and any relationship between or among the shareholder giving notice and any Shareholder Associated Person, on the one hand, and each proposed nominee, on the other hand, (viii) a representation that the shareholder intends to appear in person or by proxy at the meeting to nominate the persons named in its notice and (ix) all other information required by Rule 14a-19 under the Exchange Act. Such notice must be accompanied by a written consent of each proposed nominee to being named as a nominee in any proxy statement relating to the annual meeting or special meeting of shareholders, as applicable, and to serve as a director if elected and the completed and signed written representation and agreement (executed by the proposed nominee) required pursuant to Section 3.3 hereof. A shareholder providing notice of any nomination proposed to be made at an annual meeting or special meeting of shareholders called for the purpose of electing directors shall further update and supplement such notice (i) if necessary, so that the information provided or required to be provided in such notice pursuant to this Section 2.3 shall be true and correct as of the record date for determining the shareholders entitled to receive notice of and to vote at such annual meeting or special meeting, and such update and supplement must be received by the Secretary at the principal executive offices of the Corporation not later than five (5) business days following the later of the record date for the determination of shareholders entitled to receive notice of and to vote at the annual meeting or special meeting and the date notice of the record date is first publicly disclosed and (ii) to provide evidence that the shareholder providing the notice has solicited proxies from holders representing at least 67% of the voting power of the shares entitled to vote in the election of directors, and such update and supplement must be received by the Secretary at the principal executive offices of the Corporation not later than five (5) business days after the shareholder files a </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">definitive proxy statement in connection with the annual meeting or special meeting. The Corporation may require any proposed nominee to furnish such other information as may reasonably be required by the Corporation to determine the eligibility of such proposed nominee to serve as an independent director of the Corporation or that could be material to a reasonable shareholder&#8217;s understanding of the independence, or lack thereof, of such nominee.</font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">If the chair of the meeting determines that a nomination was not made in accordance with the foregoing procedures (including the provision of the information required pursuant to the immediately preceding paragraph), or that the solicitation in support of such nominee was not conducted in compliance with Rule 14a-19 under the Exchange Act, the chair shall declare to the meeting that the nomination was defective and such defective nomination shall be disregarded.</font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Section 2.4.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">Special Meetings.</font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">(a) Special meetings of shareholders may be called at any time by the Chair of the Board, the Chief Executive Officer, the President, or by order of the Board of Directors. A special meeting shall be called by the Chief Executive Officer in accordance with Section 2.4(b). Subject to Section 2.4(b), special meetings of shareholders shall be held at such place and on such date and at such time as shall be designated in the notice of meeting.</font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">(b) Subject to the provisions of this Section 2.4(b) and all other applicable sections of these Bylaws, a special meeting shall be called by the Chief Executive Officer upon written request (a &#8220;Special Meeting Request&#8221;) of one or more record holders of shares of common stock of the Corporation representing not less than twenty-five percent (25%) of the Corporation&#8217;s issued and outstanding shares of common stock (the &#8220;Requisite Percentage&#8221;). The Board of Directors shall determine in good faith whether all requirements set forth in this Section 2.4(b) have been satisfied and such determination shall be binding on the Corporation and its shareholders.</font></div><div style="margin-bottom:11.25pt;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">(i) A Special Meeting Request must be delivered to the attention of the Secretary at the principal executive offices of the Corporation. A Special Meeting Request shall be valid only if it is signed and dated by each shareholder of record submitting the Special Meeting Request, or such shareholder&#8217;s duly authorized agent (each, a &#8220;Requesting Shareholder&#8221;), collectively representing the Requisite Percentage, and includes (A) a statement of the specific purpose(s) of the special meeting and the reasons for conducting such business at the special meeting&#59; (B) as to any director nominations proposed to be presented at the special meeting, and any matter (other than a director nomination) proposed to be conducted at the special meeting, and as to each Requesting Shareholder, the information, statements, representations, agreements and other documents that would be required to be set forth in or included with a shareholder&#8217;s notice of a nomination pursuant to Section 2.3 and&#47;or a shareholder&#8217;s notice of business proposed to be brought before a meeting pursuant to Section 2.2, as applicable&#59; (C) a representation that each Requesting Shareholder, or one or more representatives of each such shareholder, intends to appear in person or by proxy at the special meeting to present the proposal(s) or business to be brought before the special meeting&#59; (D) an agreement by each Requesting Shareholder to notify the Corporation promptly in the event of any disposition prior to the record date for the special meeting of shares of common stock of the Corporation owned of record and an acknowledgement that any such disposition shall be deemed to be a revocation of such Special Meeting Request with respect to such disposed shares&#59; (E) the number of shares of common stock owned of record by each such Requesting Shareholder&#59; and (F) documentary evidence that the Requesting Shareholders in the aggregate own the Requisite Percentage as of the date on which the Special Meeting Request is delivered to the Secretary. In addition, the Requesting Shareholders shall (x) further update and supplement the information provided in the Special Meeting Request, if necessary, so that all information provided or required to be provided therein shall be true and correct as of the record date for the special meeting, and such update and supplement (or a written certification that no such updates or supplements are necessary and that the information previously provided remains true and correct as of the record date) shall be delivered to or be mailed and received by the Secretary at the principal executive offices of the Corporation not later than five (5) business days following the later of the record date for the special meeting and the date notice of the record date is first publicly disclosed and (y) promptly provide any other information reasonably requested by the Corporation.</font></div><div style="margin-bottom:11.25pt;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">(ii) A Special Meeting Request shall not be valid, and a special meeting requested by shareholders shall not be held, if (A) the Special Meeting Request does not comply with this Section 2.4(b)&#59; (B) the Special Meeting Request relates to an item of business that is not a proper subject for </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">shareholder action under applicable law (as determined in good faith by the Board of Directors)&#59; (C) the Special Meeting Request is delivered during the period commencing one hundred twenty (120) days prior to the first anniversary of the date of the immediately preceding annual meeting and ending on the earlier of (x) the date of the next annual meeting and (y) thirty (30) days after the first anniversary of the date of the previous annual meeting&#59; (D) an identical or substantially similar item (as determined in good faith by the Board of Directors, a &#8220;Similar Item&#8221;), other than the election of directors, was presented at an annual meeting or special meeting held not more than twelve (12) months before the Special Meeting Request is delivered&#59; (E) a Similar Item was presented at an annual meeting or special meeting held not more than one hundred twenty (120) days before the Special Meeting Request is delivered (and, for purposes of this clause (E), the election of directors shall be deemed to be a &#8220;Similar Item&#8221; with respect to all items of business involving the election or removal of directors, changing the size of the Board of Directors and the filling of vacancies and&#47;or newly created directorships resulting from any increase in the authorized number of directors)&#59; (F) a Similar Item is included in the Corporation&#8217;s notice of meeting as an item of business to be brought before an annual meeting or special meeting that has been called but not yet held or that is called for a date within one hundred twenty (120) days of the receipt by the Corporation of a Special Meeting Request&#59; or (G) the Special Meeting Request was made in a manner that involved a violation of Regulation 14A under the Exchange Act, or other applicable law.</font></div><div style="margin-bottom:11.25pt;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">(iii) Special meetings called pursuant to this Section 2.4(b) shall be held at such place, on such date, and at such time as the Board of Directors shall fix&#59; provided, however, that the special meeting shall not be held more than one hundred twenty (120) days after receipt by the corporation of a valid Special Meeting Request.</font></div><div style="margin-bottom:11.25pt;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">(iv) The Requesting Shareholders may revoke a Special Meeting Request by written revocation delivered to the Secretary at the principal executive offices of the Corporation at any time prior to the special meeting. If, at any point following the earliest dated Special Meeting Request, the unrevoked requests from Requesting Shareholders (whether by specific written revocation or deemed revocation pursuant to clause (D) of Section 2.4(b)(i)), represent in the aggregate less than the Requisite Percentage, the Board of Directors, in its discretion, may cancel the special meeting.</font></div><div style="margin-bottom:11.25pt;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">(v) In determining whether a special meeting has been requested by the Requesting Shareholders representing in the aggregate at the least the Requisite Percentage, multiple Special Meeting Requests delivered to the Secretary will be considered together only if (A) each Special Meeting Request identifies substantially the same purpose or purposes of the special meeting and substantially the same matters proposed to be acted on at the special meeting, in each case as determined by the Board of Directors (which, if such purpose is the election or removal of directors, changing the size of the Board of Directors and&#47;or the filling of vacancies and&#47;or newly created directorships resulting from any increase in the authorized number of directors, will mean that the exact same person or persons are proposed for election or removal in each relevant Shareholder Meeting Request), and (B) such Special Meeting Requests have been dated and delivered to the Secretary within sixty (60) days of the earliest dated Special Meeting Request.</font></div><div style="margin-bottom:11.25pt;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">(vi) If none of the Requesting Shareholders appear or send a duly authorized agent to present the business to be presented for consideration specified in the Special Meeting Request, the Corporation need not present such business for a vote at the special meeting, notwithstanding that proxies in respect of such matter may have been received by the Corporation.</font></div><div style="margin-bottom:11.25pt;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">(vii) Business transacted at any special meeting called pursuant to this Section 2.4(b) shall be limited to (A) the purpose(s) stated in the valid Special Meeting Request received from the Requisite Percentage of record holders, and (B) any additional matters that the Board of Directors determines to include in the Corporation&#8217;s notice of the special meeting.</font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Section 2.5.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">Notice of Meetings.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#160;Written notice of each annual and special meeting of shareholders, stating the time, place and purposes thereof, shall be given not less than ten (10) or more than sixty (60) days before the date of such meeting to each shareholder of record entitled to vote at the meeting. Such notice may be given personally, by mail or by a form of electronic transmission to which the shareholder has consented. If a shareholder or proxy holder may be present and vote at a meeting by remote communication, the means of remote communication allowed shall be included in the notice of the meeting.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Section 2.6.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">Participation by Remote Communication.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#160;If authorized by the Board of Directors in its sole discretion, and subject to such guidelines and procedures as the Board of Directors may adopt, shareholders and proxy holders not physically present at a meeting of shareholders may participate in a meeting of shareholders by conference telephone or other means of remote communication through which all persons participating in the meeting may communicate with the other participants and shall be considered present in person and may vote at the meeting, whether such meeting is held at a designated place or solely by means of remote communication, provided that (a) the Corporation implements reasonable measures to verify that each person considered present and permitted to vote at the meeting by means of remote communication is a shareholder or proxy holder&#59; (b) the Corporation implements reasonable measures to provide each shareholder and proxy holder a reasonable opportunity to participate in the meeting and to vote on matters submitted to the shareholders, including an opportunity to read or hear the proceedings of the meeting substantially concurrently with such proceedings&#59; (c) if any shareholder or proxy holder votes or takes other action at the meeting by means of remote communication, a record of the vote or other action shall be maintained by the Corporation&#59; and (d) all participants are advised of the means of remote communication and the names of the participants in the meeting are divulged to all participants.</font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Section 2.7.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">List of Shareholders Entitled to Vote.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#160;The officer or agent who has charge of the stock transfer books of the Corporation shall make and certify a complete list, based upon the record date for a meeting of shareholders determined pursuant to Section 5.8 hereof, of the shareholders entitled to vote at such meeting or any adjournment thereof, arranged alphabetically within each class and series, with the address of and the number of shares held by each shareholder. Such list shall be produced at the time and place of the meeting and may be inspected by any shareholder during the entire meeting. If a meeting of shareholders is held solely by means of remote communication, then the list shall be open to the examination of any shareholder during the entire meeting by posting the list on a reasonably accessible electronic network and the information required to access the list shall be provided with the notice of the meeting.</font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Such list shall be prima facie evidence as to who are the shareholders entitled to examine the list or to vote in person or by proxy at the meeting.</font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Section 2.8.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">Adjourned Meetings and Notice Thereof.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#160;Any meeting of shareholders may be adjourned to another time or place, and the Corporation may transact at any adjourned meeting only business that could have been transacted at the original meeting unless notice of the adjourned meeting is given. Notice need not be given of the adjourned meeting if the time and place to which the meeting is adjourned are announced at the meeting at which the adjournment is taken, unless after the adjournment the Board of Directors fixes a new record date for the adjourned meeting. If notice of an adjourned meeting is given, such notice shall be given to each shareholder of record entitled to vote at the adjourned meeting in the manner prescribed in these Bylaws for the giving of notice of meetings. A shareholder or proxy holder may be present and vote at the adjourned meeting by means of a remote communication if he or she was permitted to be present and vote by that means of remote communication in the original meeting notice.</font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Section 2.9.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">Quorum.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#160;At any meeting of shareholders, except as otherwise provided in the MBCA, the holders of record of shares entitled to cast a majority of the votes at a meeting constitute a quorum at the meeting. The shareholders present in person or by proxy at such meeting may continue to do business until adjournment, notwithstanding the withdrawal of enough shareholders to leave less than a quorum. Whether or not a quorum is present, the meeting may be adjourned by a vote of the shares present. When the holders of a class or series of shares are entitled to vote separately on an item of business, this Section 2.9 applies in determining the presence of a quorum of such class or series for transaction of the item of business.</font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Section 2.10.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">Voting&#59; Proxies.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#160;At any meeting of shareholders each outstanding share of stock having voting power shall be entitled to one vote on each matter submitted to vote at such meeting, unless otherwise provided in the Articles of Incorporation. A vote may be cast either orally or in writing and otherwise as provided in these Bylaws. If an action other than the election of directors is to be taken by vote of the shareholders, it shall be authorized by a majority of the votes cast by the holders of shares entitled to vote on the action, unless a greater vote is required by the MBCA. Abstaining from a vote or submitting a ballot marked &#8220;abstain&#8221; with respect to an action is not a vote cast on that action. Except as otherwise provided in the Articles of Incorporation, directors shall be elected by a plurality of the votes cast at an election.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Each shareholder entitled to vote at a meeting of shareholders may authorize another person or persons to act for him or her by proxy. Without limiting the manner in which a shareholder may authorize another person or persons to act for him or her as proxy, the following methods constitute a valid means by which a shareholder may grant authority to another person to act as proxy&#58; (a) the execution of a writing authorizing another person or persons to act for the shareholder as proxy, which may be accomplished by the shareholder or by an authorized officer, director, employee, or agent signing the writing or causing his or her signature to be affixed to the writing by any reasonable means including, but not limited to, facsimile signature&#59; and (b) transmitting or authorizing the transmission of a telegram, cablegram or other means of electronic transmission to the person who will hold the proxy or to a proxy solicitation firm, proxy support service organization or similar agent fully authorized by the person who will hold the proxy to receive that transmission. Any telegram, cablegram or other means of electronic transmission must either set forth or be submitted with information from which it can be determined that the telegram, cablegram or other electronic transmission was authorized by the shareholder. If a telegram, cablegram or other electronic transmission is determined to be valid, the inspectors of election, or, if there are no inspectors, the persons making the determination shall specify the information upon which they relied. No proxy shall be voted or acted upon after three (3) years from its date, unless the proxy provides for a longer period. The authority of the holder of a proxy to act is not revoked by the incompetence or death of the shareholder who executed the proxy unless, before the authority is exercised, written notice of an adjudication of the incompetence or death is received by the officer or agent responsible for maintaining the list of shareholders. A shareholder whose shares are pledged shall be entitled to vote the shares until the shares have been transferred into the name of the pledgee or a nominee of the pledgee. A person holding shares in a representative or fiduciary capacity may vote such shares without a transfer of such shares into such person's name.</font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">In advance of any meeting of shareholders, the Board of Directors may appoint any persons, other than nominees for office, as inspectors of election to act at such meeting or any adjournment thereof. The number of inspectors shall be either one or three. If the Board of Directors so appoints either one or three inspectors, that appointment shall not be altered at the meeting. If inspectors of election are not so appointed, the Chair of the Board, or, in the absence of the Chair of the Board, the Chief Executive Officer or, in the absence of both the Chair and Chief Executive Officer, the President may make such appointment at the meeting. Unless otherwise prescribed by applicable law, the duties of such inspectors shall include&#58; determining the number of shares of stock and the voting power of each share, the shares of stock represented at the meeting, the existence of a quorum, the authenticity, validity and effect of proxies&#59; receiving votes, ballots or consents&#59; hearing and determining all challenges and questions in any way arising in connection with the right to vote&#59; counting and tabulating all votes or consents&#59; determining the result&#59; and such acts as may be proper to conduct the election or vote with fairness to all shareholders.</font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Section 2.11.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">Fixing of Record Dates.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#160;The Board of Directors may fix, in advance, a record date, which shall not be more than sixty (60) nor less than ten (10) days before the date of any meeting of shareholders, nor more than sixty (60) days prior to any other action, for the purpose of determining shareholders entitled to notice of and to vote at such meeting of shareholders or any adjournment thereof, or to express consent or dissent from a proposal without a meeting, or to receive payment or any dividend or allotment of any rights or for the purpose of any other action.</font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">If no record date is fixed by the Board of Directors, the record date for the determination of shareholders entitled to notice of or to vote at a meeting of shareholders shall be the close of business on the day next preceding the day on which notice is given, or if no notice is given, the day next preceding the day on which the meeting is held, and the record date for determining shareholders for any other purpose shall be the close of business on the day on which the Board of Directors adopts the resolution relating thereto. A determination of shareholders of record entitled to notice of or to vote at a meeting of shareholders shall apply to any adjournment of the meeting, unless the Board of Directors fixes a new record date for the adjourned meeting.</font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Section 2.12.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">Conduct of Meetings.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#160;At each meeting of shareholders, the Chair of the Board or, in the absence of the Chair of the Board, the Chief Executive Officer or, in the absence of both the Chair and Chief Executive Officer, the President or such other person designated by the Board of Directors shall preside and act as the chair of the meeting. The chair shall determine the order of business, may adjourn any meeting from time to time and shall have the authority to establish rules for the conduct of the meeting, which may include, without limitation, the following&#58; (i) the establishment of an agenda or order of business for the meeting&#59; (ii) the determination of when the polls shall open and close for any </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">given matter to be voted on at the meeting&#59; (iii) rules and procedures for maintaining order at the meeting and the safety of those present&#59; (iv) limitations on attendance at or participation in the meeting to shareholders of record of the Corporation, their duly authorized and constituted proxies or such other persons as the chair of the meeting shall determine&#59; (v) restrictions on entry to the meeting after the time fixed for the commencement thereof&#59; and (vi) limitations on the time allotted to questions or comments by participants.</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Section 2.13.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">Proxy Access for Director Nominations.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#160;<br><br>(a) Whenever the Board of Directors solicits proxies with respect to the election of directors at an annual meeting of shareholders, subject to the provisions of this Section 2.13, the Corporation shall include in its proxy statement for such annual meeting, in addition to any persons nominated for election by or at the direction of the Board of Directors (or any duly authorized committee thereof), the name, together with the Required Information (as defined below), of any person nominated for election to the Board of Directors by an Eligible Shareholder pursuant to and in accordance with this Section 2.13 (a &#8220;Shareholder Nominee&#8221;). For purposes of this Section 2.13, the &#8220;Required Information&#8221; that the Corporation will include in its proxy statement is (i) the information provided to the Secretary concerning the Shareholder Nominee and the Eligible Shareholder that is required to be disclosed in the Corporation&#8217;s proxy statement pursuant to Section 14 of the Exchange Act and the rules and regulations promulgated thereunder and (ii) if the Eligible Shareholder so elects, a Supporting Statement (as defined in Section 2.13(h)). For the avoidance of doubt, nothing in this Section 2.13 shall limit the Corporation&#8217;s ability to solicit against any Shareholder Nominee or include in its proxy materials the Corporation&#8217;s own statements or other information relating to any Eligible Shareholder or Shareholder Nominee, including any information provided to the Corporation pursuant to this Section 2.13. Subject to the provisions of this Section 2.13, the name of any Shareholder Nominee included in the Corporation&#8217;s proxy statement for an annual meeting of shareholders shall also be set forth on the form of proxy distributed by the Corporation in connection with such annual meeting.<br><br>(b) In addition to any other applicable requirements, for a nomination to be made by an Eligible Shareholder pursuant to this Section 2.13, the Eligible Shareholder must have given timely notice thereof (a &#8220;Notice of Proxy Access Nomination&#8221;) in proper written form to the Secretary and must expressly request in the Notice of Proxy Access Nomination to have such nominee included in the Corporation&#8217;s proxy materials pursuant to this Section 2.13. To be timely, a Notice of Proxy Access Nomination must be received by the Secretary at the principal executive offices of the Corporation not less than one hundred twenty (120) days nor more than one hundred fifty (150) days prior to the anniversary of the date that the Corporation first distributed its proxy statement to shareholders for the immediately preceding annual meeting of shareholders&#59; provided, however, that in the event that no annual meeting was held in the previous year or if the date of the annual meeting is more than thirty (30) days before or more than sixty (60) days after such anniversary date, to be timely, the Notice of Proxy Access Nomination must be received by the Secretary at the principal executive offices of the Corporation not more than one hundred sixty-five (165) days prior to the date of such annual meeting and not later than the close of business on the later of (x) the one hundred thirty-fifth (135th) day prior to the date of such annual meeting or (y) the tenth (10th) day following the day on which public disclosure of the date of the annual meeting was made. In no event shall the adjournment or postponement of an annual meeting, or the public disclosure of such an adjournment or postponement, commence a new time period (or extend any time period) for the giving of a Notice of Proxy Access Nomination pursuant to this Section 2.13.<br><br>(c) The maximum number of Shareholder Nominees nominated by all Eligible Shareholders that will be included in the Corporation&#8217;s proxy materials with respect to an annual meeting of shareholders shall not exceed the greater of (i) two (2) or (ii) twenty percent (20%) of the number of directors in office as of the last day on which a Notice of Proxy Access Nomination may be delivered pursuant to and in accordance with this Section 2.13 (the &#8220;Final Proxy Access Nomination Date&#8221;) or, if such amount is not a whole number, the closest whole number below twenty percent (20%) (such greater number, as it may be adjusted pursuant to this Section 2.13(c), the &#8220;Permitted Number&#8221;). In the event that one or more vacancies for any reason occurs on the Board of Directors after the Final Proxy Access Nomination Date but before the date of the annual meeting and the Board of Directors resolves to reduce the size of the Board of Directors in connection therewith, the Permitted Number shall be calculated based on the number of directors in office as so reduced. In addition, the Permitted Number shall be reduced by (i) the number of individuals who will be included in the Corporation&#8217;s proxy materials as nominees recommended by the Board of Directors pursuant to an agreement, arrangement or understanding with </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">a shareholder or group of shareholders (other than any such agreement, arrangement or understanding entered into in connection with an acquisition of stock from the Corporation by such shareholder or group of shareholders) and (ii) the number of directors in office as of the Final Proxy Access Nomination Date who were included in the Corporation&#8217;s proxy materials as Shareholder Nominees for any of the two (2) preceding annual meetings of shareholders (including any persons counted as Shareholder Nominees pursuant to the immediately succeeding sentence) and whose re-election at the upcoming annual meeting is being recommended by the Board of Directors. For purposes of determining when the Permitted Number has been reached, any individual nominated by an Eligible Shareholder for inclusion in the Corporation&#8217;s proxy materials pursuant to this Section 2.13 whose nomination is subsequently withdrawn or whom the Board of Directors decides to nominate for election to the Board of Directors shall be counted as one of the Shareholder Nominees. Any Eligible Shareholder submitting more than one Shareholder Nominee for inclusion in the Corporation&#8217;s proxy materials pursuant to this Section 2.13 shall rank such Shareholder Nominees based on the order in which the Eligible Shareholder desires such Shareholder Nominees to be selected for inclusion in the Corporation&#8217;s proxy materials in the event that the total number of Shareholder Nominees submitted by Eligible Shareholders pursuant to this Section 2.13 exceeds the Permitted Number. In the event that the number of Shareholder Nominees submitted by Eligible Shareholders pursuant to this Section 2.13 exceeds the Permitted Number, the highest ranking Shareholder Nominee who meets the requirements of this Section 2.13 from each Eligible Shareholder will be selected for inclusion in the Corporation&#8217;s proxy materials until the Permitted Number is reached, going in order of the amount (largest to smallest) of shares of common stock of the Corporation each Eligible Shareholder disclosed as Owned in its Notice of Proxy Access Nomination. If the Permitted Number is not reached after the highest ranking Shareholder Nominee who meets the requirements of this Section 2.13 from each Eligible Shareholder has been selected, then the next highest ranking Shareholder Nominee who meets the requirements of this Section 2.13 from each Eligible Shareholder will be selected for inclusion in the Corporation&#8217;s proxy materials, and this process will continue as many times as necessary, following the same order each time, until the Permitted Number is reached. Notwithstanding anything to the contrary contained in this Section 2.13, the Corporation shall not be required to include any Shareholder Nominees in its proxy materials pursuant to this Section 2.13 for any meeting of shareholders for which the Secretary receives a notice (whether or not subsequently withdrawn) that a shareholder intends to nominate one or more persons for election to the Board of Directors pursuant to clause (b) of the first paragraph of Section 2.3 hereof.<br><br>(d) An &#8220;Eligible Shareholder&#8221; is a shareholder or group of no more than twenty (20) shareholders (counting as one shareholder, for this purpose, any two (2) or more funds that are part of the same Qualifying Fund Group (as defined below)) that (i) has Owned (as defined in Section 2.13(e)) continuously for at least three (3) years (the &#8220;Minimum Holding Period&#8221;) a number of shares of common stock of the Corporation equal to no less than the Required Shares (as defined below), (ii) continues to Own the Required Shares through the date of the annual meeting and (iii) meets all other requirements of this Section 2.13. &#8220;Required Shares&#8221; means a number of shares of common stock of the Corporation that represents at least three percent (3%) of the outstanding shares of common stock of the Corporation as of the date the Notice of Proxy Access Nomination is received at the principal executive offices of the Corporation in accordance with this Section 2.13. A &#8220;Qualifying Fund Group&#8221; means two (2) or more funds that are (i) under common management and investment control, (ii) under common management and funded primarily by the same employer or (iii) a &#8220;group of investment companies&#8221; as such term is defined in Section 12(d)(1)(G)(ii) of the Investment Company Act of 1940, as amended. Whenever the Eligible Shareholder consists of a group of shareholders (including a group of funds that are part of the same Qualifying Fund Group), (i) each provision in this Section 2.13 that requires the Eligible Shareholder to provide any written statements, representations, undertakings, agreements or other instruments or to meet any other conditions shall be deemed to require each shareholder (including each individual fund) that is a member of such group to provide such statements, representations, undertakings, agreements or other instruments and to meet such other conditions (except that the members of such group may aggregate the shares that each member has Owned continuously throughout the Minimum Holding Period in order to meet the three percent (3%) Ownership requirement of the &#8220;Required Shares&#8221; definition) and (ii) a breach of any obligation, agreement or representation under this Section 2.13 by any member of such group shall be deemed a breach by the Eligible Shareholder. No shareholder may be a member of more than one group of shareholders constituting an Eligible Shareholder with respect to any annual meeting.<br><br>(e) For purposes of this Section 2.13, a shareholder shall be deemed to &#8220;Own&#8221; and have &#8220;Ownership&#8221; of only those outstanding shares of common stock of the Corporation as to which the shareholder possesses both (i) the full voting and investment rights pertaining to the shares and (ii) the full </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">economic interest in (including the opportunity for profit from and risk of loss on) such shares&#59; provided that the number of shares calculated in accordance with clauses (i) and (ii) shall not include any shares (A) sold by such shareholder or any of its affiliates in any transaction that has not been settled or closed, (B) borrowed by such shareholder or any of its affiliates for any purposes or purchased by such shareholder or any of its affiliates pursuant to an agreement to resell, or (C) subject to any option, warrant, forward contract, swap, contract of sale, or other derivative or similar instrument or agreement entered into by such shareholder or any of its affiliates, whether any such instrument or agreement is to be settled with shares or with cash based on the notional amount or value of shares of outstanding common stock of the Corporation, in any such case which instrument or agreement has, or is intended to have, the purpose or effect of (1) reducing in any manner, to any extent or at any time in the future, such shareholder&#8217;s or its affiliates&#8217; full right to vote or direct the voting of any such shares and&#47;or (2) hedging, offsetting or altering to any degree any gain or loss realized or realizable from maintaining the full economic ownership of such shares by such shareholder or affiliate. A shareholder shall &#8220;Own&#8221; shares held in the name of a nominee or other intermediary so long as the shareholder retains the right to instruct how the shares are voted with respect to the election of directors and possesses the full economic interest in the shares. A shareholder&#8217;s Ownership of shares shall be deemed to continue during any period in which (x) the shareholder has loaned such shares, provided that the shareholder has the power to recall such loaned shares on five (5) business days&#8217; notice and includes in the Notice of Proxy Access Nomination an agreement that it (A) will promptly recall such loaned shares upon being notified that any of its Shareholder Nominees will be included in the Corporation&#8217;s proxy materials and (B) will continue to hold such recalled shares through the date of the annual meeting or (y) the shareholder has delegated any voting power by means of a proxy, power of attorney or other instrument or arrangement which is revocable at any time by the shareholder. The terms &#8220;Owned,&#8221; &#8220;Owning&#8221; and other variations of the word &#8220;Own&#8221; shall have correlative meanings. Whether outstanding shares of common stock of the Corporation are &#8220;Owned&#8221; for these purposes shall be decided by the Board of Directors.<br><br>(f) To be in proper written form, a Notice of Proxy Access Nomination must set forth or be accompanied by the following&#58;<br></font></div><div style="text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">(i) a statement by the Eligible Shareholder (A) setting forth and certifying as to the number of shares it Owns and has Owned continuously throughout the Minimum Holding Period, (B) agreeing to continue to Own the Required Shares through the date of annual meeting and (C) indicating whether it intends to continue to own the Required Shares for at least one year following the annual meeting&#59;<br></font></div><div style="text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">(ii) one or more written statements from the record holder of the Required Shares (and from each intermediary through which the Required Shares are or have been held during the Minimum Holding Period) verifying that, as of a date within seven (7) calendar days prior to the date the Notice of Proxy Access Nomination is received at the principal executive offices of the Corporation, the Eligible Shareholder Owns, and has Owned continuously throughout the Minimum Holding Period, the Required Shares, and the Eligible Shareholder&#8217;s agreement to provide, within five (5) business days following the later of the record date for the determination of shareholders entitled to receive notice of and to vote at the annual meeting and the date notice of the record date is first publicly disclosed, one or more written statements from the record holder and such intermediaries verifying the Eligible Shareholder&#8217;s continuous Ownership of the Required Shares through the record date&#59;<br></font></div><div style="text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">(iii) a copy of the Schedule 14N that has been or is concurrently being filed with the Securities and Exchange Commission as required by Rule 14a-18 under the Exchange Act&#59;<br></font></div><div style="text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">(iv) the information, representations, agreements and other documents that would be required to be set forth in or included with a shareholder&#8217;s notice of nomination made pursuant to clause (b) of the first paragraph of Section 2.3 hereof&#59;<br></font></div><div style="text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">(v) a representation that the Eligible Shareholder (A) did not acquire, and is not holding, any securities of the Corporation for the purpose or with the intent of changing or influencing control of the Corporation, (B) has not nominated and will not nominate for election to the Board of Directors at the annual meeting any person other than the Shareholder Nominee(s) it is nominating pursuant to this Section 2.13, (C) has not engaged and will not engage in, and has not and will not be a &#8220;participant&#8221; in another person&#8217;s, &#8220;solicitation&#8221; within the meaning of Rule 14a-1(l) under the Exchange Act in support of the election of any individual as a director at the annual meeting other than its Shareholder Nominee(s) or a nominee of the Board of Directors, (D) has not distributed and will not distribute to any </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">shareholder of the Corporation any form of proxy for the annual meeting other than the form distributed by the Corporation, (E) has complied and will comply with all laws, rules and regulations applicable to solicitations and the use, if any, of soliciting material in connection with the annual meeting and (F) has provided and will provide facts, statements and other information in all communications with the Corporation and its shareholders that are or will be true and correct in all material respects and do not and will not omit to state a material fact necessary in order to make the statements made, in light of the circumstances under which they were made, not misleading&#59;<br></font></div><div style="text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">(vi) an undertaking that the Eligible Shareholder agrees to (A) assume all liability stemming from any legal or regulatory violation arising out of the Eligible Shareholder&#8217;s communications with the shareholders of the Corporation or out of the information that the Eligible Shareholder provided to the Corporation, (B) indemnify and hold harmless the Corporation and each of its directors, officers and employees individually against any liability, loss or damages in connection with any threatened or pending action, suit or proceeding, whether legal, administrative or investigative, against the Corporation or any of its directors, officers or employees arising out of any nomination submitted by the Eligible Shareholder pursuant to this Section 2.13 or any solicitation or other activity in connection therewith and (C) file with the Securities and Exchange Commission any solicitation or other communication with the shareholders of the Corporation relating to the meeting at which its Shareholder Nominee(s) will be nominated, regardless of whether any such filing is required under Regulation 14A of the Exchange Act or whether any exemption from filing is available for such solicitation or other communication under Regulation 14A of the Exchange Act&#59;<br></font></div><div style="text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">(vii) in the case of a nomination by an Eligible Shareholder consisting of a group of shareholders, the designation by all group members of one member of the group that is authorized to receive communications, notices and inquiries from the Corporation and to act on behalf of all members of the group with respect to all matters relating to the nomination under this Section 2.13 (including withdrawal of the nomination)&#59; and<br>&#160;</font></div><div style="text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">(viii) in the case of a nomination by an Eligible Shareholder consisting of a group of shareholders in which two (2) or more funds are intended to be treated as one shareholder for purposes of qualifying as an Eligible Shareholder, documentation reasonably satisfactory to the Corporation that demonstrates that the funds are part of the same Qualifying Fund Group.<br><br>(g) In addition to the information required or requested pursuant to Section 2.13(f) or any other provision of these Bylaws, (i) the Corporation may require any proposed Shareholder Nominee to furnish any other information (A) that may reasonably be requested by the Corporation to determine whether the Shareholder Nominee would be independent under the rules and listing standards of the securities exchanges upon which the stock of the Corporation is listed or traded, any applicable rules of the Securities and Exchange Commission or any publicly disclosed standards used by the Board of Directors in determining and disclosing the independence of the Corporation&#8217;s directors (collectively, the &#8220;Independence Standards&#8221;), (B) that could be material to a reasonable shareholder&#8217;s understanding of the independence, or lack thereof, of such Shareholder Nominee or (C) that may reasonably be requested by the Corporation to determine the eligibility of such Shareholder Nominee to be included in the Corporation&#8217;s proxy materials pursuant to this Section 2.13 or to serve as a director of the Corporation, and (ii) the Corporation may require the Eligible Shareholder to furnish any other information that may reasonably be requested by the Corporation to verify the Eligible Shareholder&#8217;s continuous Ownership of the Required Shares throughout the Minimum Holding Period and through the date of the annual meeting.<br><br>(h) For each of its Shareholder Nominees, the Eligible Shareholder may, at its option, provide to the Secretary, at the time the Notice of Proxy Access Nomination is provided, a written statement for inclusion in the Corporation&#8217;s proxy materials, not to exceed five hundred (500) words, in support of such Shareholder Nominee&#8217;s candidacy (a &#8220;Supporting Statement&#8221;). Only one Supporting Statement may be submitted by an Eligible Shareholder (including any group of shareholders together constituting an Eligible Shareholder) in support of each of its Shareholder Nominee(s). Notwithstanding anything to the contrary contained in this Section 2.13, the Corporation may omit from its proxy materials any information or Supporting Statement (or portion thereof) that it, in good faith, believes would violate any applicable law, rule or regulation.<br><br>(i) In the event that any information or communications provided by an Eligible Shareholder or a Shareholder Nominee to the Corporation or its shareholders is not, when provided, or thereafter ceases </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">to be, true and correct in all material respects or omits to state a material fact necessary to make the statements made, in light of the circumstances under which they were made, not misleading, such Eligible Shareholder or Shareholder Nominee, as the case may be, shall promptly notify the Secretary of any such defect and of the information that is required to correct any such defect. Without limiting the foregoing, an Eligible Shareholder shall provide immediate notice to the Corporation if the Eligible Shareholder ceases to Own a number of shares of the Corporation&#8217;s common stock at least equal to the Required Shares prior to the date of the annual meeting. In addition, any person providing any information to the Corporation pursuant to this Section 2.13 shall further update and supplement such information, if necessary, so that all such information shall be true and correct as of the record date for determining the shareholders entitled to receive notice of and to vote at the annual meeting, and such update and supplement shall be delivered to or be mailed and received by the Secretary at the principal executive offices of the Corporation not later than five (5) business days following the later of the record date for the determination of shareholders entitled to receive notice of and to vote at the annual meeting and the date notice of the record date is first publicly disclosed. For the avoidance of doubt, no notification, update or supplement provided pursuant to this Section 2.13(i) or otherwise shall be deemed to cure any defect in any previously provided information or communications or limit the remedies available to the Corporation relating to any such defect (including the right to omit a Shareholder Nominee from its proxy materials pursuant to this Section 2.13).<br><br>(j) Notwithstanding anything to the contrary contained in this Section 2.13, the Corporation shall not be required to include in its proxy materials, pursuant to this Section 2.13, any Shareholder Nominee (i) who would not be an independent director under the Independence Standards, (ii) whose election as a member of the Board of Directors would cause the Corporation to be in violation of these Bylaws, the Articles of Incorporation, the rules and listing standards of the securities exchanges upon which the stock of the Corporation is listed or traded, or any applicable law, rule or regulation, (iii) who is or has been, within the past three (3) years, an officer or director of a competitor, as defined in Section 8 of the Clayton Antitrust Act of 1914, (iv) who is a named subject of a pending criminal proceeding (excluding traffic violations and other minor offenses) or has been convicted in such a criminal proceeding within the past ten (10) years, (v) who is subject to any order of the type specified in Rule 506(d) of Regulation D promulgated under the Securities Act of 1933, as amended, or (vi) who shall have provided any information to the Corporation or its shareholders that was untrue in any material respect or that omitted to state a material fact necessary to make the statements made, in light of the circumstances in which they were made, not misleading.<br><br>(k) Notwithstanding anything to the contrary set forth herein, if (i) a Shareholder Nominee and&#47;or the applicable Eligible Shareholder breaches any of its agreements or representations or fails to comply with any of its obligations under this Section 2.13 or (ii) a Shareholder Nominee otherwise becomes ineligible for inclusion in the Corporation&#8217;s proxy materials pursuant to this Section 2.13, or dies, becomes disabled or otherwise becomes ineligible or unavailable for election at the annual meeting, in each case as determined by the Board of Directors (or any duly authorized committee thereof) or the chair of the annual meeting, (A) the Corporation may omit or, to the extent feasible, remove the information concerning such Shareholder Nominee and the related Supporting Statement from its proxy materials and&#47;or otherwise communicate to its shareholders that such Shareholder Nominee will not be eligible for election at the annual meeting, (B) the Corporation shall not be required to include in its proxy materials any successor or replacement nominee proposed by the applicable Eligible Shareholder or any other Eligible Shareholder and (C) the chair of the annual meeting shall declare such nomination to be invalid and such nomination shall be disregarded, notwithstanding that proxies in respect of such vote may have been received by the Corporation.<br><br>(l) Any Shareholder Nominee who is included in the Corporation&#8217;s proxy materials for a particular annual meeting of shareholders but either (i) withdraws from or becomes ineligible or unavailable for election at the annual meeting, or (ii) does not receive at least twenty-five percent (25%) of the votes cast in favor of such Shareholder Nominee&#8217;s election, will be ineligible to be a Shareholder Nominee pursuant to this Section 2.13 for the next two (2) annual meetings of shareholders. For the avoidance of doubt, the immediately preceding sentence shall not prevent any shareholder from nominating any person to the Board of Directors pursuant to clause (b) of the first paragraph of Section 2.3 hereof.<br><br>(m) Other than Rule 14a-19 under the Exchange Act, this Section 2.13 provides the exclusive method for a shareholder to include nominees for election to the Board of Directors in the Corporation&#8217;s proxy materials.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.75pt solid #b2b4ae;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:11.25pt;padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="margin-bottom:11.25pt;padding-left:2.75pt;padding-right:2.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:18.5pt;font-weight:700;line-height:100%">Article III</font></div></td></tr></table></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:400;line-height:100%">Board of Directors</font></div><div style="margin-bottom:11.25pt"><font><br></font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Section 3.1.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">General Powers.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#160;The business and affairs of the Corporation shall be managed by or under the direction of the Board of Directors except as otherwise provided in the MBCA.</font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Section 3.2.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">Number of Directors.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#160;The Board of Directors of the Corporation shall consist of one or more members. The exact number of directors that shall constitute the whole Board of Directors shall be fixed from time to time by resolution adopted by a majority of the whole Board of Directors. The Board of Directors may, by resolution adopted by a majority of the whole Board of Directors, from time to time change the number of directors constituting the whole Board of Directors, provided, however, that in no event will a decrease in the number of directors shorten the term of any incumbent director.</font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Section 3.3.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">Qualification.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#160;Directors need not be residents of the State of Michigan nor shareholders of the Corporation. In addition, in order to be eligible for election or re-election as a director of the Corporation, a person must deliver to the Secretary at the principal executive offices of the Corporation a written representation and agreement that such person (a) is not and will not become a party to (i) any arrangement or understanding with, and has not given any commitment or assurance to, any person or entity as to how such person, if elected as a director of the Corporation, will act or vote on any issue or question (a &#8220;Voting Commitment&#8221;) that has not been disclosed to the Corporation in such representation and agreement or (ii) any Voting Commitment that could limit or interfere with such person&#8217;s ability to comply, if elected as a director of the Corporation, with such person&#8217;s fiduciary duties under applicable law, (b) is not and will not become a party to any arrangement or understanding with any person or entity other than the Corporation with respect to any direct or indirect compensation, reimbursement or indemnification in connection with such person&#8217;s nomination, candidacy, service or action as a director that has not been disclosed to the Corporation in such representation and agreement, (c) would be in compliance, if elected as a director of the Corporation, and will comply with the Corporation&#8217;s code of conduct, corporate governance guidelines, securities trading policies and any other policies or guidelines of the Corporation applicable to directors and (d) will make such other acknowledgments, enter into such agreements and provide such information as the Board of Directors requires of all directors, including promptly submitting all completed and signed questionnaires required of the Corporation&#8217;s directors.</font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Section 3.4.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">Election.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#160;The directors of the Corporation shall be elected in each year at the annual meeting of shareholders, except as provided in Section 3.7 hereof.</font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Section 3.5.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">Term.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#160;Each director shall hold office until the succeeding annual meeting and until his or her successor is duly elected and qualified or until his or her resignation or removal.</font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Section 3.6.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">Resignation and Removal.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#160;Any director may resign at any time upon written notice to the Corporation. The resignation of any director shall take effect upon receipt of notice thereof or at a later time specified in such notice. Any director may be removed at any time, with or without cause, by the vote of the holders of a majority of the shares entitled to vote at an election of directors.</font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Section 3.7.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">Vacancies.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#160;Vacancies in the Board of Directors and newly created directorships resulting from any increase in the authorized number of directors may be filled by the shareholders or by the Board of Directors. If the directors remaining in office constitute fewer than a quorum, they may fill vacancies by the affirmative vote of a majority of all the directors remaining in office.</font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Section 3.8.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">Regulations.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#160;The Board of Directors may adopt such rules and regulations for the conduct of the business and management of the Corporation that are not inconsistent with the MBCA or the Articles of Incorporation or these Bylaws as the Board of Directors may deem proper.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Section 3.9.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">Annual Meeting of Board of Directors.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#160;An annual meeting of the Board of Directors shall be called and held for the purpose of organization, election of officers and transaction of any other business. If such meeting is held promptly after and at the place specified for the annual meeting of shareholders, no notice of the annual meeting of the Board of Directors need be given. Otherwise such annual meeting shall be held at such time (not more than thirty days after the annual meeting of shareholders) and place as may be specified in a notice of the meeting.</font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Section 3.10.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">Regular Meetings.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#160;Regular meetings of the Board of Directors shall be held at the time and place as shall from time to time be determined by the Board of Directors. After there has been such determination and notice thereof has been given to each member of the Board of Directors, no further notice shall be required for any such regular meeting.</font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Section 3.11.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">Special Meetings.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#160;Special meetings of the Board of Directors may be called from time to time by the Chair of the Board, the Chief Executive Officer, or the President and shall be called by the Chair of the Board or the Secretary upon the written request of a majority of the whole Board of Directors directed to the Chair of the Board or the Secretary. Notice of any special meeting of the Board of Directors, stating the time and place of such special meeting, shall be given to each director. Such notice shall be given personally, by telephone, by overnight courier or by a form of electronic transmission not less than forty-eight (48) hours before the time of the meeting (or on such shorter notice as the person or persons calling such meeting may deem necessary or appropriate in the circumstances).</font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Section 3.12.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">Committees of Directors.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#160;The Board of Directors may designate one or more committees, each committee to consist of one or more of the directors of the Corporation. The Board of Directors may designate one or more directors as alternate members of any committee, who may replace any absent or disqualified member at any meeting of the committee. Each committee and each member thereof shall serve at the pleasure of the Board of Directors.</font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Section 3.13.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">Powers and Duties of Committees.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#160;Any committee, to the extent provided in the resolution or resolutions creating such committee, shall have and may exercise all powers and authority of the Board of Directors in the management of the business and affairs of the Corporation, subject to any limitation by the MBCA or these Bylaws. No such committee shall have the power or authority with regard to amending the Articles of Incorporation (except that a committee may prescribe the relative rights and preferences of the shares of series of preferred stock permitted to be fixed by the Board of Directors in accordance with the Articles of Incorporation), adopting an agreement of merger, conversion, or share exchange, recommending to the shareholders the sale, lease or exchange of all or substantially all of the Corporation&#8217;s property and assets, recommending to the shareholders a dissolution of the Corporation or a revocation of a dissolution, amending these Bylaws or filling vacancies on the Board of Directors or fixing compensation of the directors for serving on the Board of Directors or on a committee thereof and, unless a resolution of the Board of Directors so provides, declaring a distribution or dividend or authorizing the issuance of shares.</font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Each committee may adopt its own rules of procedure and may meet at stated times or on such notice as such committee may determine and, unless otherwise provided in a resolution of the Board of Directors, may designate one or more subcommittees, each of which shall consist of one or more members, to which all or part of the power and authority of the committee may be delegated. Each committee shall keep regular minutes of its proceedings and report the same to the Board of Directors.</font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Section 3.14.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">Quorum and Voting.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#160;A majority of the members of the Board of Directors then in office and, unless the resolution of the Board of Directors establishing the committee provides otherwise, of the members of a committee constitutes a quorum for the transaction of business by the Board of Directors or such committee. A director interested in a contract or transaction may be counted in determining the presence of a quorum at a meeting of the Board of Directors or committee that authorizes the contract or transaction. In the absence of a quorum, a majority of the directors or of a committee present may adjourn a meeting of the Board of Directors or such committee until a quorum shall be present.</font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Members of the Board of Directors or any committee designated by the Board of Directors may participate in a meeting of the Board of Directors or such committee by means of a conference telephone or other means of remote communication through which all persons participating in the meeting can communicate with the other participants, and participation in such a meeting shall constitute presence in person at such meeting.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">The vote of the majority of the directors present at a meeting at which a quorum is present constitutes the action of the Board of Directors or of a committee unless the vote of a greater number is required by the MBCA or, in the case of a committee, the resolution of the Board of Directors establishing the committee&#59; provided, however, that amendment of the Bylaws by the Board requires the vote of not less than a majority of the directors then in office.</font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Section 3.15.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">Action Without Meeting.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#160;Action required or permitted to be taken under authorization voted at a meeting of the Board of Directors or of any committee thereof may be taken without a meeting if, before or after the action, all members of the Board of Directors then in office or of such committee, as the case may be, consent to the action in writing or by electronic transmission. The consents shall be filed with the minutes of proceedings of the Board of Directors or such committee and shall have the same effect as a vote of the Board of Directors or committee for all purposes.</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Section 3.16.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">Director Compensation.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#160;Directors may receive such compensation for service on the Board of Directors as the Board may determine. Members of either standing or special committees may be allowed such compensation as the Board of Directors may determine.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.75pt solid #b2b4ae;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:11.25pt;padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="margin-bottom:11.25pt;padding-left:2.75pt;padding-right:2.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:18.5pt;font-weight:700;line-height:100%">Article IV</font></div></td></tr></table></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:400;line-height:100%">Officers and Chair of the Board</font></div><div style="margin-bottom:11.25pt"><font><br></font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Section 4.1.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">Officers.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#160;The officers of the Corporation shall be appointed by the Board of Directors and shall include a President, a Secretary and a Treasurer. The Board may, in its discretion, appoint any other officers, including without limitation a Chair of the Board, a Chief Executive Officer, a Chief Operating Officer, a Chief Financial Officer, one or more Vice Presidents, Assistant Treasurers, Assistant Secretaries, and any such other officers and agents as it may deem necessary. None of the officers, except the Chair of the Board, if any, need be a director of the Corporation. Any two or more offices may be held by the same person.</font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Section 4.2.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">Election of Officers&#59; Term of Office.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#160;Officers of the Corporation shall be elected annually by the Board of Directors at the annual meeting of the Board of Directors. If any vacancy in any office shall occur or any office shall be newly created, such office may be filled by the Board of Directors. The Board of Directors may delegate to the Chief Executive Officer or the President the power to appoint designated officers. Each officer shall hold office for the term for which he or she is elected or appointed or until his or her successor is duly elected or appointed and qualified or until his or her resignation or removal.</font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Section 4.3.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">Resignation and Removal of Officers.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#160;Any officer of the Corporation may resign at any time upon written notice to the Corporation. The resignation of any officer shall take effect upon receipt by the Corporation of notice thereof or at a later time specified in such notice. An officer of the Corporation may be removed at any time by the Board of Directors with or without cause, but such removal shall be without prejudice to the contract rights, if any, of the officer so removed. The election or appointment of any officer does not itself create contract rights.</font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Section 4.4.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">Chair of the Board.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#160;The Chair of the Board, who may be an officer of the Corporation or may be a non-executive Chair of the Board as determined by the Board of Directors, shall preside at all meetings of shareholders and of the Board of Directors at which he or she is present. The Chair of the Board shall have such other powers and perform such other duties as may be assigned to him or her from time to time by these Bylaws or the Board of Directors.  The Chair of the Board may also use the title Chairman or Chairperson and such titles shall be considered to refer to the Chair of the Board. </font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Section 4.5.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">Chief Executive Officer.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#160;The Chief Executive Officer, subject to the control of the Board of Directors, shall have the final authority over the general policy and business of the Corporation. The Chief Executive Officer shall perform other duties as may be prescribed from time to time by the Board </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">of Directors or these Bylaws. If no Chief Executive Officer is appointed, the duties and powers of the Chief Executive Officer shall be performed by the President.</font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Section 4.6.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">President.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#160;The President shall, in the absence of the Chair of the Board and the Chief Executive Officer, preside at all meetings of shareholders and of the Board of Directors at which he or she is present. The President shall have general supervision over the business of the Corporation. The President shall have all powers and duties usually incident to the office of the President except as specifically limited by a resolution of the Board of Directors. The President shall have such other powers and perform such other duties as may be assigned to him or her from time to time by the Board of Directors or the Chief Executive Officer.</font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Section 4.7.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">Chief Operating Officer.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#160;The Chief Operating Officer shall have general charge, control and supervision over the day-to-day operating activities of the Corporation, subject to such limitations and with such other duties and powers as may be imposed or given by the Board of Directors, the Chief Executive Officer, or the President. If no Chief Operating Officer is appointed, the duties and powers of the Chief Operating Officer shall be performed by the Chief Executive Officer or, if no Chief Executive Officer is appointed, by the President.</font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Section 4.8.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">Vice President.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#160;In the absence or disability of the President or if the office of President be vacant, the Vice Presidents in the order determined by the Board of Directors, or, if no such determination has been made, in the order of their seniority, shall perform the duties and exercise the powers of the President, subject to the right of the Board of Directors at any time to extend or confine such powers and duties or to assign them to others. Any Vice President may have such additional designation in his or her title as the Board of Directors, the Chief Executive Officer, or the President may determine, which may reflect seniority, duties or responsibilities of such Vice President. The Vice Presidents shall generally assist the Chief Executive Officer and the President in such manner as they shall direct. Each Vice President shall have such other powers and perform such other duties as may be assigned to him or her from time to time by the Board of Directors, the Chief Executive Officer, or the President.</font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Section 4.9.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">Secretary.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#160;The Secretary shall act as Secretary of all meetings of shareholders and of the Board of Directors at which he or she is present, shall record all the proceedings of all such meetings in a book to be kept for that purpose, shall have supervision over the giving and service of notices of the Corporation and shall have supervision over the care and custody of the records and seal of the Corporation. The Secretary shall be empowered to affix the corporate seal to documents, the execution of which on behalf of the Corporation under its seal is duly authorized, and when so affixed may attest the same. The Secretary shall have all powers and duties usually incident to the office of Secretary except as specifically limited by a resolution of the Board of Directors. The Secretary shall have such other powers and perform such other duties as may be assigned to him or her from time to time by the Board of Directors, the Chief Executive Officer, or the President.</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Section 4.10.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">Treasurer.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#160;The Treasurer shall have general supervision over the care and custody of the funds and over the receipts and disbursements of the Corporation and shall cause the funds of the Corporation to be deposited in the name of the Corporation in such banks or other depositaries as the Board of Directors may designate. The Treasurer shall have supervision over the care and safekeeping of the securities of the Corporation. The Treasurer shall have all powers and duties usually incident to the office of Treasurer except as specifically limited by a resolution of the Board of Directors. The Treasurer shall have such other powers and perform such other duties as may be assigned to him or her from time to time by the Board of Directors, the Chief Executive Officer, or the President.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.75pt solid #b2b4ae;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:11.25pt;padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="margin-bottom:11.25pt;padding-left:2.75pt;padding-right:2.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:18.5pt;font-weight:700;line-height:100%">Article V</font></div></td></tr></table></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:400;line-height:100%">Capital stock</font></div><div style="margin-bottom:11.25pt"><font><br></font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Section 5.1.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">Issuance of Certificates for Stock.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#160;The shares of the Corporation shall be represented by certificates or, if authorized by the Board of Directors, may be issued without certificates. Authorization to issue shares in uncertificated form shall not affect outstanding shares already represented by a certificate until the certificate is surrendered to the Corporation. Unless otherwise determined by the Board of Directors, each shareholder, upon written request to the Secretary of the Corporation, shall be entitled to a certificate or certificates representing the number of shares held by him or her in the Corporation.</font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Within a reasonable time after the issuance or transfer of uncertificated shares, as long as the same is required by the MBCA, the Corporation shall send to the registered owner thereof a written statement of the designation, relative rights, preferences and limitations of the shares of each class authorized to be issued and the other information required by the MBCA to be set forth in or stated on certificates for stock.</font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Section 5.2.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">Signatures on Stock Certificates.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#160;Certificates for shares of capital stock of the Corporation shall be signed by, or in the name of the Corporation by, the Chair of the Board, the President or a Vice President and also may be signed by the Secretary, the Treasurer, an Assistant Secretary or an Assistant Treasurer. Any of or all the signatures on the certificate may be a facsimile. In case any officer who has signed or whose facsimile signature has been placed upon a certificate ceases to be an officer before such certificate is issued, such certificate may be issued by the Corporation with the same effect as if such signer were such officer at the date of issue.</font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Section 5.3.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">Stock Ledger.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#160;A record of all shares of capital stock issued by the Corporation shall be kept by the Secretary or any other officer or employee of the Corporation designated by the Secretary or by any transfer agent appointed pursuant to Section 5.4 hereof. Such record shall show the name and address of the person in which shares of capital stock are registered, the number of shares registered in such person&#8217;s name, the date of any certificate issued in respect of such shares and, in the case of any certificate that has been cancelled, the date of cancellation.</font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">The Corporation shall be entitled to treat the holder of record of shares of capital stock as shown on the stock ledger as the owner thereof and as the person entitled to receive dividends thereon, to vote such shares, to receive notice of meetings and for all other purposes. The Corporation shall not be bound to recognize any equitable or other claim to or interest in any share of capital stock on the part of any other person whether or not the Corporation shall have express or other notice thereof.</font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Section 5.4.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">Regulations Relating to Transfer.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#160;The Board of Directors may make such rules and regulations as it may deem expedient, not inconsistent with the MBCA, the Articles of Incorporation or these Bylaws, concerning the issuance, transfer and registration of shares of capital stock of the Corporation. The Board of Directors may appoint, or authorize any principal officer to appoint, one or more transfer agents and one or more registrars and may require all certificates for capital stock to bear the signature or signatures of any of them.</font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Section 5.5.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">Transfers.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#160;All transfers of capital stock shall be made on the books of the Corporation only upon delivery to the Corporation or its transfer agent of a written direction of the registered holder of the shares, in person or by such holder&#8217;s attorney lawfully constituted in writing, and, if such shares are certificated, upon surrender of the certificate or certificates representing such shares duly endorsed.</font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Section 5.6.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">Cancellation.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#160;Each certificate for capital stock surrendered to the Corporation for exchange or transfer shall be cancelled and no new certificate or certificates or uncertificated shares shall be </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">issued in exchange for any existing certificate, other than pursuant to Section 5.7, until such existing certificate shall have been cancelled.</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Section 5.7.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">Lost, Destroyed, Stolen and Mutilated Certificates.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#160;In the event that any certificate for shares of capital stock of the Corporation shall be mutilated, the Corporation shall issue a new certificate or uncertificated shares in place of such mutilated certificate. In case any such certificate shall be lost or destroyed the Corporation may issue a new certificate for capital stock or uncertificated shares in the place of any such lost or destroyed certificate. The applicant for any substituted certificate or for uncertificated shares shall surrender any mutilated certificate or, in the case of any lost or destroyed certificate, furnish satisfactory proof of such loss, theft or destruction of such certificate and of the ownership thereof. The Corporation may, in its discretion, require the owner of a lost or destroyed certificate, or his or her representative, to furnish to the Corporation a bond with an acceptable surety or sureties and in such sum as will be sufficient to indemnify the Corporation against any claim that may be made against it on account of the lost or destroyed certificate or the issuance of such new certificate or uncertificated shares in respect thereof.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.75pt solid #b2b4ae;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:11.25pt;padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="margin-bottom:11.25pt;padding-left:2.75pt;padding-right:2.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:18.5pt;font-weight:700;line-height:100%">Article VI</font></div></td></tr></table></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:400;line-height:100%">Indemnification</font></div><div style="margin-bottom:11.25pt"><font><br></font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Section 6.1.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">Indemnification.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#160;The Corporation shall indemnify its directors and certain officers as designated by the Board of Directors from time to time to the fullest extent authorized or permitted by law (as now or hereafter in effect) and such right to indemnification shall continue as to a person who has ceased to be a director or designated officer of the Corporation and shall inure to the benefit of his or her heirs, executors and personal and legal representatives&#59; provided, however, that, except for proceedings to enforce rights to indemnification, the Corporation shall not be obligated to indemnify any director or designated officer (or his or her heirs, executors or personal or legal representatives) in connection with a proceeding (or part thereof) initiated by such person unless such proceeding (or part thereof) was authorized or consented to by the Board of Directors. The right to indemnification conferred by this Section 6.1 shall include the right to be paid by the Corporation, promptly as incurred, the reasonable expenses of defending or otherwise participating in any action, suit or proceeding in advance of its final disposition upon receipt of a written undertaking executed by or on behalf of such director or designated officer to repay the advance if it is ultimately determined that he or she did not meet the standard of conduct, if any, required for the indemnification of a person under the circumstances. The Corporation may, to the extent authorized from time to time by the Board of Directors, provide rights to indemnification and to the advancement of expenses to other officers, employees and agents of the Corporation. The rights to indemnification and to the advancement of expenses conferred in this Section 6.1 shall not be exclusive of any other right that any person may have or hereafter acquire under these Bylaws, the Articles of Incorporation, any statute, agreement, vote of shareholders or disinterested directors or otherwise. Any repeal or modification of this Section 6.1 shall not adversely affect any rights to indemnification and to the advancement of expenses of a director or designated officer of the Corporation existing at the time of such repeal or modification with respect to any acts or omissions occurring prior to such repeal or modification.</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Section 6.2.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">Indemnification Insurance.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#160;The Corporation shall have power to purchase and maintain insurance on behalf of any person who is or was a director, officer, employee or agent of the Corporation, or is or was serving at the request of the Corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against any liability asserted against him or her and incurred by him or her in any such capacity or arising out of his or her status as such, whether or not the Corporation would have the power to indemnify him or her against such liability under applicable law.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.75pt solid #b2b4ae;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:11.25pt;padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="margin-bottom:11.25pt;padding-left:2.75pt;padding-right:2.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:18.5pt;font-weight:700;line-height:100%">Article VII</font></div></td></tr></table></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:400;line-height:100%">Miscellaneous provisions</font></div><div style="margin-bottom:11.25pt"><font><br></font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Section 7.1.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">Corporate Seal.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#160;The seal of the Corporation shall be circular in form with the name of the Corporation and the word Michigan in the circumference and the words &#8220;Corporate Seal&#8221; in the center. The seal may be used by causing it or a facsimile to be affixed, impressed or reproduced in any other manner.</font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Section 7.2.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">Fiscal Year.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#160;The fiscal year of the Corporation shall be from the 1st day of January to the 31st day of December, inclusive, in each year, or such other twelve consecutive months as the Board of Directors may designate.</font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Section 7.3.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">Electronic Transmission.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#160;When used in these Bylaws, the term &#8220;electronic transmission&#8221; shall include any telegram, cablegram, facsimile transmission, communication by electronic mail or other form of communication that does not directly involve the physical transmission of paper, creates a record that may be retained and retrieved by the recipient and may be directly reproduced in paper by the recipient through an automated process.</font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Section 7.4.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">Notices and Communications Generally.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#160;When a notice is required or permitted to be given by these Bylaws in writing, electronic transmission is written notice. When a notice or other communication is permitted by the MBCA to be transmitted electronically, the notice or other communication is given when electronically transmitted to the person entitled to the notice or communication in a manner authorized by such person.</font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">When a notice or communication is given by mail, it shall be mailed, except as otherwise provided in the MBCA, to the person to whom it is directed at the address designated by him or her for that purpose or, if none is designated, at his or her last known address. The notice or communication is given when deposited, with postage thereon prepaid, in a post office or official depository under the exclusive care and custody of the United States postal service. Notice and any other written report, statement or communication required to be given to shareholders shall be deemed to have been given to all shareholders of record who share an address if notice is given or such other report, statement or communication is delivered in accordance with the &#8220;householding&#8221; rules set forth in Rule 14a-3(e) under the Exchange Act and in Section 143 of the MBCA.</font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">When a notice or communication is required to be given to a person by the MBCA, the Articles of Incorporation or these Bylaws or otherwise and communication with the person is then unlawful under a statute of Michigan or the United States or a rule, regulation, proclamation or order issued under any such statute, the giving of the notice or communication to such person is not required and there is no duty to apply for a license or other permission to do so.</font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Section 7.5.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">Waiver of Notice.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#160;Whenever any notice is required to be given under any provision of these Bylaws, a waiver thereof signed by the person or persons entitled to such notice or, in the case of a shareholder, his or her attorney-in-fact or given by electronic transmission, whether before or after the time stated therein for the meeting, shall be deemed equivalent to notice.</font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">A shareholder&#8217;s attendance at a meeting will result in both of the following&#58; (a) waiver of objection to lack of notice or defective notice of the meeting, unless the shareholder at the beginning of the meeting objects to holding the meeting or transacting business at the meeting&#59; and (b) waiver of objection to consideration of a particular matter at the meeting that is not within the purpose or purposes described in the meeting notice, unless the shareholder objects to considering the matter when it is presented.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">A director&#8217;s attendance at or participation in a meeting waives any required notice to the director of the meeting, unless the director at the beginning of the meeting or promptly upon the director&#8217;s arrival, objects to the meeting or the transacting of business at the meeting and does not thereafter vote for or assent to any action taken at the meeting.</font></div><div style="margin-bottom:11.25pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Section 7.6.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">Execution of Instruments, Contracts, etc.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#160;Except as otherwise required by law, the Articles of Incorporation or these Bylaws, any contract, conveyance, lease, power of attorney or other agreement, instrument or document may be executed and delivered in the name and on behalf of the Corporation by such officer or officers or person or persons as from time to time may be designated by the Board of Directors or by such officer or officers of the Corporation authorized by the Board of Directors to make such designation.</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Section 7.7.&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">Amendment of Bylaws.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">&#160;These Bylaws may be amended or repealed or new bylaws may be adopted by the shareholders or by the vote of not less than a majority of the Board of Directors then in office.</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Last Updated November&#47;2022</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.20
<SEQUENCE>3
<FILENAME>ex4xx1231202210k.htm
<DESCRIPTION>EX-4.20
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i4a08a172c4b5421781fb384a8053d161_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">DESCRIPTION OF THE REGISTRANT&#8217;S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Description of Capital Stock</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The following description is a summary of certain terms of the capital stock of Stryker Corporation (&#8220;Stryker&#8221; or the &#8220;Company&#8221;). It does not purport to be complete and is subject in all respects to the applicable provisions of the Michigan Business Corporation Act, as amended, or the MBCA, our Restated Articles of Incorporation, as amended, or our articles, and our By-laws, as amended, or our by-laws. As used in this exhibit, and except where the context otherwise requires, &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221; refer to Stryker Corporation.</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Capital Stock</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Our authorized capital stock consists of (1) 1,000,000,000 shares of common stock, $0.10 par value per share and (2) 500,000 shares of preferred stock, $1.00 par value per share. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Common Stock</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Each share of common stock entitles the holder thereof to one vote for each share held by it of record on each matter submitted to a vote. Other than the election of directors, if an action is to be taken by vote of the shareholders, it will be authorized by a majority of the votes cast by the holders of shares entitled to vote on the action, unless a greater vote is required in our articles or by-laws. Directors are elected by a majority of the votes cast by the holders of shares entitled to vote (and for such purpose, a majority of the votes cast means that the number of shares voted &#8220;for&#8221; a nominee must exceed the number of votes cast &#8220;against&#8221; that nominee)&#894; provided, however, that if as of the record date for a meeting at which directors will be elected, there are more nominees than positions on the board of directors to be filled by election at such meeting, each director shall be elected by a plurality of the votes cast at the election.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Subject to the prior payment or provision therefor of dividends on the preferred stock, if any, holders of the common stock are entitled to receive ratably such dividends, if any, as may be declared from time to time by our Board of Directors out of funds legally available therefor. Holders of our common stock have no conversion, preemptive or other rights to subscribe for any securities of ours, and there are no redemption or sinking fund provisions with respect to such shares. In the event of any liquidation, dissolution or distribution of our assets and after satisfaction of the preferential requirements of the preferred stock, if any, holders of common stock will be entitled to share ratably in the distribution of the remaining assets of the Company available for distribution. The rights, preferences and privileges of holders of common stock are subject to applicable law and the rights of the holders of any shares of preferred stock and any additional classes of stock that we may issue in the future.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Preferred Stock</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Our articles authorize our Board of Directors to issue up to 500,000 shares of preferred stock in one or more series, with such distinctive designation or title and in such number of shares as may be authorized by our Board of Directors. Our Board of Directors is authorized to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">prescribe the relative rights and preferences of each series, and the limitations applicable thereto, including but not limited to the following&#58; (1) the voting powers, full, special, or limited, or no voting powers&#894; (2) the rate, terms and conditions on which dividends will be paid, whether such dividends will be cumulative, and what preference such dividends shall have in relation to the dividends on other series or classes of stock&#894; (3) the rights, terms and conditions, if any, for conversion of preferred stock into shares of other series or classes of stock&#894; (4) any right of the Company to redeem the shares of preferred stock, and the price, time and conditions of redemption, including the provisions for any sinking fund&#894; and (5) the rights of holders of preferred stock in relation to the rights of other series and classes of stock upon the liquidation, dissolution or distribution of our assets. Unless otherwise provided by our Board of Directors, upon redemption or conversion, shares of preferred stock will revert to authorized but unissued shares and may be reissued as shares of any series of preferred stock.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Limitation of Liability</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Our articles provide that, to the full extent authorized or permitted by the MBCA, directors of Stryker will not be personally liable to Stryker or its shareholders for any acts or omissions in such person&#8217;s capacity as a director. Such limitation of liability does not affect the availability of equitable remedies such as injunctive relief or rescission. These provisions will not limit the liability of directors under federal securities laws.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Certain Statutory, Articles and By-law Provisions Affecting Shareholders</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Certain provisions in our articles and by-laws and the MBCA may have the effect of delaying, deferring or preventing a change of control of the Company or may operate only with respect to extraordinary corporate transactions involving the Company.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Business Combination Act</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We are subject to the provisions of Chapter 7A of the MBCA, which provides that business combinations between a Michigan corporation and a beneficial owner of shares entitled to 10% or more of the voting power of such corporation generally require the affirmative vote of 90% of the votes of each class of stock entitled to vote and not less than two-thirds of each class of stock entitled to vote (excluding voting shares owned by such 10% owner). Chapter 7A defines a &#8220;business combination&#8221; to encompass any merger, consolidation, share exchange, sale of assets, stock issue, liquidation, or reclassification of securities involving an interested shareholder or certain affiliates. An &#8220;interested shareholder&#8221; is generally any person who owns 10% or more of the voting shares of the corporation. An &#8220;affiliate&#8221; is a person who directly or indirectly controls, is controlled by, or is under common control with, a specified person. Such requirements do not apply if the transaction satisfies fairness standards, other specified conditions are met and the interested shareholder has been such for at least five years.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Article and By-Law Provisions</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Our articles and by-laws include a number of provisions that may have the effect of encouraging persons considering unsolicited tender offers or other unilateral takeover proposals to negotiate with our Board of Directors rather than pursue non- negotiated takeover attempts. These provisions include an advance notice requirement for director nominations and actions to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">be taken at annual meetings of shareholders and the availability of authorized but unissued blank check preferred stock.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Advance Notice Requirement</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Our by-laws set forth advance notice procedures with regard to shareholder proposals relating to the nomination of candidates for election as directors or new business to be presented at meetings of shareholders. These procedures provide that notice of such shareholder proposals must be timely given in writing to the secretary of Stryker prior to the meeting at which the action is to be taken. Generally, to be timely, notice must be received at the principal executive offices of Stryker not less than 90 days nor more than 120 days prior to the meeting. The advance notice requirement does not give the Board of Directors any power to approve or</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">disapprove shareholder director nominations or proposals but may have the effect of precluding the consideration of certain business at a meeting if the proper notice procedures are not followed.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Special Meetings of Shareholders</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Under our by-laws, special meetings of shareholders may be called by the chair of our Board of Directors, our chief executive officer, our president or by order of our Board of Directors. Our by-laws provide that a special meeting of the shareholders shall be called by the chief executive officer upon written request of one or more record holders of shares of our common stock representing not less than 25% of our issued and outstanding shares of common stock.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Blank Check Preferred Stock</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Our preferred stock could be deemed to have an anti-takeover effect in that, if a hostile takeover situation should arise, shares of preferred stock could be issued to purchasers sympathetic with our management or others in such a way as to render more difficult or to discourage a merger, tender offer, proxy contest, the assumption of control by a holder of a large block of our securities or the removal of incumbent management.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The effects of the issuance of one or more series of the preferred stock on the holders of our common stock could include&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">reduction of the amount otherwise available for payments of dividends on common stock if dividends are payable on the series of preferred stock&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">restrictions on dividends on our common stock if dividends on the series of preferred stock are in arrears&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">dilution of the voting power of our common stock if the series of preferred stock has voting rights, including a possible &#8220;veto&#8221; power if the series of preferred stock has class voting rights&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">dilution of the equity interest of holders of our common stock if the series of preferred stock is convertible, and is converted, into our common stock&#894; and</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">restrictions on the rights of holders of our common stock to share in our assets upon liquidation until satisfaction of any liquidation preference granted to the holders of the series of preferred stock.</font></div><div style="padding-left:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Transfer Agent and Registrar</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The transfer agent and registrar for our common stock is American Stock Transfer &#38; Trust Company, LLC.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Listing</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Our common stock is listed on the New York Stock Exchange under the symbol &#8220;SYK.&#8221;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:138%">Description of Debt Securities&#58;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:138%">1.125% Notes due 2023</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:138%">2.125% Notes due 2027</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:138%">2.625% Notes due 2030</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company previously filed a registration statement on Form S-3 (File No. 333-209526), which was filed with the Securities and Exchange Commission on February 12, 2016 and covers the issuance of the Company&#8217;s 1.125% Notes due 2023 (the &#8220;2023 notes&#8221;), the 2.125% Notes due 2027 (the &#8220;2027 notes&#8221;), and the 2.625% Notes due 2030 (the &#8220;2030 notes&#8221; and together with the 2023 notes, the 2027 notes and the 2030 notes, the &#8220;notes&#8221;). The notes are governed by a base indenture dated January 15, 2010 between the Company and U.S. Bank National Association, as trustee, as supplemented by the applicable supplemental indenture governing a particular series of notes (as so supplemented, the &#8220;Indenture&#8221;). This summary is subject to and qualified in its entirety by reference to all of the provisions of the Indenture and the notes, including definitions of certain terms used in the Indenture and the notes.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">General</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The 2023 notes, the 2027 notes and the 2030 notes were issued as separate series of debt securities under the Indenture. The notes are senior unsecured obligations of ours and rank equally in right of payment with our other existing and future senior unsecured indebtedness. The notes are not secured by any of our assets. Any future claims of our secured lenders with respect to assets securing their loans will be prior to any claim of the holders of the notes with respect to those assets. Holders of secured debt that we have now or may issue in the future may foreclose on the assets securing such debt, reducing the cash flow from the foreclosed property available for payment of unsecured debt, including the notes. Holders of our secured debt also would have priority over unsecured creditors in the event of our bankruptcy, liquidation or similar proceeding to the extent of the value of the collateral securing such debt. The notes are structurally subordinated to all liabilities of our subsidiaries, including trade payables. Because we conduct many of our operations through our subsidiaries, our right to participate in any distribution of the assets of a subsidiary when it winds up its business is subject to the prior claims of the creditors of that subsidiary. This means that your right to payment as a holder of our notes is also subject to the prior claims of these creditors if a subsidiary liquidates or reorganizes or otherwise winds up its business. If we are a creditor of any of our subsidiaries, our right as a creditor would be subordinated to any security interest in the assets of those subsidiaries and any indebtedness of our subsidiaries senior in right of payment to that held by us. </font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Indenture does not limit the amount of notes, unsecured debentures or other evidences of indebtedness that we may issue under the Indenture and provides that notes, unsecured debentures or other evidences of indebtedness may be issued from time to time in one or more series. We may from time to time, without notice to or the consent of the holders of the notes, create and issue additional notes of any series having the same ranking and terms and conditions as the notes of the same series, except for the issue date, the public offering price and, in some cases, the first interest payment date. Any additional notes having such similar terms, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">together with the notes offered of the same series, will constitute a single series of securities under the Indenture. </font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We issued the notes in fully registered book-entry form without coupons and in denominations of &#8364;100,000 and integral multiples of &#8364;1,000 thereafter.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Principal of and interest on the notes are payable, and the notes are transferable or exchangeable, at the office or offices or agency maintained by us for these purposes. Payment of interest on the notes may be made at our option by check mailed to the registered holders thereof.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The 2023 notes, the 2027 notes and the 2030 notes are listed on the New York Stock Exchange under the symbols &#8220;SYK23,&#8221; &#8220;SYK27,&#8221; and &#8220;SYK30,&#8221; respectively. We have no obligation to maintain such listings, and we may delist any series of the notes at any time. </font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">U.S. Bank National Association is registrar and transfer agent for the notes. Upon notice to the trustee, we may change the registrar or transfer agent.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Fixed Rate Notes</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The 2023 notes, 2027 notes and 2030 notes bear interest from the date of issuance, payable annually on November 30 of each year, beginning November 30, 2019, to the persons in whose names such notes are registered at the close of business on the business day (for this purpose, a day on which Clearstream and Euroclear are open for business) immediately preceding the relevant interest payment. Interest on the notes is computed on the basis of the actual number of days in the period for which interest is being calculated and the actual number of days from and including the last date on which interest was paid on the notes, to, but excluding, the next scheduled interest payment date. This payment convention is referred to as Actual&#47;Actual (ICMA) as defined in the rulebook of the International Capital Market Association.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If any interest payment date would otherwise be a day that is not a business day, such interest payment date will be postponed to the next date that is a business day and no interest will accrue on the amounts payable from and after such interest payment date to the next business day. If the maturity date of any series of the notes falls on a day that is not a business day, the related payment of principal, premium, if any, and interest will be made on the next business day as if it were made on the date such payment was due, and no interest will accrue on the amounts so payable for the period from and after such date to the next business day.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Business Day</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For purposes of the notes, a &#8220;business day&#8221; is any day that is not a Saturday, Sunday or other day on which banking institutions in New York City, London or another place of payment on the notes are authorized or required by law to close and on which the Trans-European Automated Real-Time Gross Settlement Express Transfer system (the TARGET2 system), or any successor thereto, is open.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Issuance in euro</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">All payments of interest, premium, if any, and principal, including payments made upon any redemption or repurchase of the notes, will be made in euro&#894; provided that if the euro is unavailable to us due to the imposition of exchange controls or other circumstances beyond our control or if the euro is no longer being used by the then member states of the European Monetary Union that have adopted the euro as their currency or for the settlement of</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">transactions by public institutions of or within the international banking community, then all payments in respect of the notes will be made in U.S. dollars until the euro is again available to us or so used. In such circumstances, the amount payable on any date in euro will be converted into U.S. dollars at the rate mandated by the Board of Governors of the Federal Reserve System as of the close of business on the second business day prior to the relevant payment date or, if the Board of Governors of the Federal Reserve System has not announced a rate of conversion, on the basis of the most recent U.S. dollar&#47;euro exchange rate published in The Wall Street Journal on or prior to the second business day prior to the relevant payment date or, in the event The Wall Street Journal has not published such exchange rate, the rate is determined in our sole discretion on the basis of the most recently available market exchange rate for the euro. Any payment in respect of the notes so made in U.S. dollars do not constitute an Event of Default (as defined in the Indenture). Neither the trustee nor the paying agent shall have any responsibility for any calculation or conversion in connection with the foregoing. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Optional Redemption</font></div><div style="text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We may redeem the notes prior to October 31, 2023 in the case of the 2023 notes, August 31, 2027 in the case of the 2027 notes and August 31, 2030 in the case of the 2030 notes, in whole, at any time, or in part, from time to time, at our option, for cash, at a redemption price equal to the greater of&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:8.01pt">100% of the principal amount of the applicable series of the notes to be redeemed&#894; or</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:8.01pt"> an amount determined by the Quotation Agent (as defined below) equal to the sum of the </font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">present values of the remaining scheduled payments of principal, premium, if any, and interest thereon (not including any portion of such payments of interest accrued to the date of redemption) to October 31, 2023 with respect to the 2023 notes, August 31, 2027 with respect to the 2027 notes and August 31, 2030 with respect to the 2030 notes, discounted to the date of redemption on an annual basis (Actual&#47;Actual (ICMA) at the Comparable Government Bond Rate (as defined below), plus 25 basis points with respect to the 2023 notes, 30 basis points with respect to the 2027 notes and 35 basis points with respect to the 2030 notes, plus accrued and unpaid interest thereon to, but not including, the date of redemption.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">On or after October 31, 2023 in the case of the 2023 notes, August 31, 2027, in the case of the 2027 notes and August 31, 2030, in the case of the 2030 notes, we may redeem the applicable series of the notes, in whole, at any time, or in part, from time to time, at our option, for cash, at a redemption price equal to 100% of the principal amount of such series of the notes, plus accrued and unpaid interest to, but not including, the redemption date.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The principal amount of any note remaining outstanding after a redemption in part shall be &#8364;100,000 or a higher integral multiple of &#8364;1,000. Notwithstanding the foregoing, installments of interest on any series of the notes that are due and payable on interest payment dates falling on or prior to a redemption date will be payable on the interest payment date to the registered holders as of the close of business on the relevant record date.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Comparable </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Government Bond&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means, in relation to any Comparable Government Bond Rate calculation, at the discretion of an independent investment bank selected by us (the &#8220;Quotation Agent&#8221;), a German government bund whose maturity is closest to the par call date, or if such Quotation Agent in its discretion determines that such similar bond is not in issue, such other German government bund as such Quotation Agent may, with the advice of three brokers of, and&#47;or market makers in, German government bunds selected by us, determine to be appropriate for determining the Comparable Government Bond Rate.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Comparable </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Government Bond Rate&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means the price, expressed as a percentage (rounded to three decimal places, with 0.0005 being rounded upwards), at which the gross redemption yield on the notes to be redeemed, if they were to be purchased at such price on the third business day prior to the date fixed for redemption, would be equal to the gross redemption yield on such business day of the Comparable Government Bond on the basis of the middle market price of the Comparable Government Bond prevailing at 11&#58;00 a.m. (London time) on such business day as determined by the Quotation Agent selected by us.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notice of any redemption will be mailed (or, in the case of notes held in book-entry form, be transmitted electronically) at least 10 days but not more than 60 days before the redemption date to each registered holder of the applicable series of the notes to be redeemed. Unless we default in payment of the redemption price, on and after the redemption date, interest will cease to accrue on the applicable series of the notes or portions thereof called for redemption. If less than all of the applicable series of the notes are to be redeemed, the notes to be redeemed will be selected by the trustee in accordance with the standard procedures of the depositary. If the notes to be redeemed are not global notes then held by Euroclear or Clearstream, the trustee will select the notes to be redeemed on a pro rata basis. If the notes are listed on the NYSE or any other national securities exchange, the trustee will select notes in compliance with the requirements of the NYSE or other principal national securities exchange on which the notes are listed. </font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, if less than all of a series of notes are to be redeemed, no notes of such series of a principal amount of &#8364;100,000 or less shall be redeemed in part. If money sufficient to pay the redemption price on the series of notes (or portions thereof) to be redeemed on the redemption date is deposited with the paying agent on or before the redemption date and certain other conditions are satisfied, then on and after such redemption date, interest will cease to accrue on such series of the Fixed Rate Notes (or such portion thereof) called for redemption.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Optional Redemption for Tax Reasons</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The notes of any series may be redeemed at our option in whole, but not in part, on not less than 10 nor more than 60 days&#8217; prior notice, at 100% of the principal amount of such series, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">together with accrued and unpaid interest, if any, to, but excluding, the redemption date if, as a result of any change in, or amendment to, the laws, regulations or rulings of the United States (or any political subdivision or taxing authority thereof or therein having power to tax), or any change in official position regarding application or interpretation of those laws, regulations or rulings (including a holding by a court of competent jurisdiction), which change, amendment, application or interpretation is announced or becomes effective on or after the original issue date with respect to the notes, we become or, based upon a written opinion of independent counsel selected by us, will become obligated to pay additional amounts as described below in &#8220;&#8212;Payment of Additional Amounts.&#8221;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Payment of Additional Amounts</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">All payments of principal, interest, and premium, if any, in respect of the notes will be made free and clear of, and without withholding or deduction for, any present or future taxes, assessments, duties or governmental charges of whatever nature imposed, levied or collected by the United States (or any political subdivision or taxing authority thereof or therein having power to tax), unless such withholding or deduction is required by law or the official interpretation or administration thereof.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We will, subject to the exceptions and limitations set forth below, pay as additional interest in respect of the notes such additional amounts as are necessary in order that the net payment by us of the principal of, premium, if any, and interest in respect of the notes to a holder who is not a United States person (as defined below), after withholding or deduction for any present or future tax, assessment, duties or other governmental charge imposed by the United States (or any political subdivision or taxing authority thereof or therein having power to tax), will not be less than the amount provided in the notes to be then due and payable&#894; provided, however, that the foregoing obligation to pay additional amounts shall not apply&#58;</font></div><div style="text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:8.01pt"> to the extent any tax, assessment or other governmental charge would not have been imposed but for the holder (or the beneficial owner for whose benefit such holder holds such note), or a fiduciary, settlor, beneficiary, member or shareholder of the holder if the holder is an estate, trust, partnership or corporation, or a person holding a power over an estate or trust administered by a fiduciary holder, being considered as&#58;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">being or having been engaged in a trade or business in the United States or having or having had a permanent establishment in the United States&#894;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">having a current or former connection with the United States (other than a connection arising solely as a result of the ownership of the notes, the receipt of any payment in respect of the notes or the enforcement of any rights hereunder), including being or having been a citizen or resident of the United States&#894;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">being or having been a personal holding company, a passive foreign investment company or a controlled foreign corporation for U.S. federal income tax purposes, a foreign tax-exempt organization, or a corporation that has accumulated earnings to avoid U.S. federal income tax&#894;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">being or having been a &#8220;10-percent shareholder&#8221; of the Company as defined in section 871(h)(3) of the United States Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;) or any successor provision&#894; or</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">being a bank receiving payments on an extension of credit made pursuant to a loan agreement entered into in the ordinary course of its trade or business, as described in section 881(c)(3)(A) of the Code or any successor provision&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:8.01pt">to any holder that is not the sole beneficial owner of the notes, or a portion of the notes, or that is a fiduciary, partnership, limited liability company or other fiscally transparent entity, but only to the extent that a beneficial owner with respect to the holder, a beneficiary or settlor with respect to the fiduciary, or a beneficial owner or member of the partnership, limited liability company or other fiscally transparent entity would not have been entitled to the payment of an additional amount had the beneficiary, settlor, beneficial owner or member received directly its beneficial or distributive share of the payment&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:8.01pt">to the extent any tax, assessment or other governmental charge that would not have been imposed but for the failure of the holder or any other person to comply with certification, identification or information reporting requirements concerning the nationality, residence, identity or connection with the United States of the holder or beneficial owner of the notes, if compliance is required by statute, by regulation of the United States or any taxing authority therein or by an applicable income tax treaty to which the United States is a party as a precondition to exemption from such tax, assessment or other governmental charge&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:8.01pt">to any tax, assessment or other governmental charge that is imposed otherwise than by withholding by us or a paying agent from the payment&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:8.01pt">to any tax, assessment or other governmental charge required to be withheld by any paying agent from any payment of principal of or interest on any notes, if such payment can be made without such withholding by any other paying agent&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">6)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:8.01pt">to any estate, inheritance, gift, sales, transfer, wealth, capital gains or personal property tax or similar tax, assessment or other governmental charge, or excise tax imposed on the transfer of notes&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">7)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:8.01pt">to the extent any tax, assessment or other governmental charge would not have been imposed but for the presentation by the holder of any note, where presentation is required, for payment on a date more than 30 days after the date on which payment became due and payable or the date on which payment thereof is duly provided for, whichever occurs later except to the extent that the beneficiary or holder thereof would have been entitled to the payment of additional amounts had such note been presented for payment on any day during such 30-day period&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">8)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:8.01pt">to any tax, assessment or other governmental charge imposed under sections 1471 through 1474 of the Code (or any amended or successor provisions), any current or future </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">regulations or official interpretations thereof, any agreement entered into pursuant to section 1471(b) of the Code or any fiscal or regulatory legislation, rules or practices adopted pursuant to any intergovernmental agreement entered into in connection with the implementation of such sections of the Code, whether currently in effect or as published and amended from time to time&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">9)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:8.01pt">to any tax, assessment or other governmental charge that is imposed or withheld solely by reason of a change in law, regulation, or administrative or judicial interpretation that becomes effective more than 15 days after the payment becomes due or is duly provided for, whichever occurs later&#894; or</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">10)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:2.01pt"> in the case of any combination of the above numbered items. </font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The notes are subject in all cases to any tax, fiscal or other law or regulation or administrative or judicial interpretation applicable to the notes. Except as specifically provided under this heading &#8220;&#8212;Payment of Additional Amounts,&#8221; we are not required to make any payment for any tax, assessment or other governmental charge imposed by any government or a political subdivision or taxing authority of or in any government or political subdivision. </font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">As used under this heading &#8220;&#8212;Payment of Additional Amounts&#8221; and under the heading &#8220;&#8212;Optional Redemption for Tax Reasons,&#8221; the term &#8220;United States&#8221; means the United States of America, its territories and possessions, the states of the United States and the District of Columbia, and the term &#8220;United States person&#8221; means (i) any individual who is a citizen or resident of the United States for U.S. federal income tax purposes, (ii) a corporation, partnership or other entity created or organized in or under the laws of the United States, any state of the United States or the District of Columbia (other than a partnership that is not treated as a United States person for United States federal income tax purposes), (iii) any estate the income of which is subject to U.S. federal income taxation regardless of its source, or (iv) any trust if a United</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">States court can exercise primary supervision over the administration of the trust and one or more United States persons can control all substantial trust decisions, or if a valid election is in place to treat the trust as a United States person.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Repurchase at the Option of Holders Upon Change of Control Repurchase Event</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If a Change of Control Repurchase Event (as defined below) occurs in respect of a series of notes, unless we have exercised our right to redeem the notes of such series as described above under &#8220;&#8212;Optional Redemption,&#8221; we will be required to make an offer (a &#8220;Change of Control Offer&#8221;) to each holder of notes of such series to repurchase all or any part (in minimum denominations of &#8364;100,000 and integral multiples of &#8364;1,000 original principal amount above that amount) of that holder&#8217;s notes at a repurchase price in cash equal to 101% of the aggregate principal amount of notes repurchased plus any accrued and unpaid interest on the notes repurchased to, but not including, the date of such repurchase. Within 30 days following any Change of Control Repurchase Event or, at our option, prior to any Change of Control (as defined below), but after the public announcement of an impending Change of Control, we will mail a notice to each holder, with a copy to the trustee, describing the transaction or transactions that constitute or may constitute the Change of Control Repurchase Event and offering to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">repurchase notes on the payment date specified in the notice, which date will be no earlier than 30 days and no later than 60 days from the date such notice is mailed. The notice shall, if mailed prior to the date of consummation of the Change of Control, state that the offer to purchase is conditioned on the Change of Control Repurchase Event occurring on or prior to the payment date specified in the notice.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We will comply with the requirements of Rule 14e-1 under the Securities Exchange Act of 1934, as amended, or the Exchange Act, and any other securities laws and regulations thereunder, to the extent those laws and regulations are applicable in connection with the repurchase of the notes as a result of a Change of Control Repurchase Event. To the extent that the provisions of any securities laws or regulations conflict with the Change of Control Repurchase Event provisions of the notes, we will comply with the applicable securities laws and regulations and will not be deemed to have breached our obligations under the Change of Control Repurchase Event provisions of the notes by virtue of such conflict.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">On the Change of Control Repurchase Event payment date, we will, to the extent lawful&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">accept for payment all notes or portions of notes (in minimum denominations of &#8364;100,000 and integral multiples of &#8364;1,000 original principal amount above that amount) properly tendered pursuant to our offer&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">deposit with the paying agent an amount equal to the aggregate purchase price in respect of all notes or portions of notes properly tendered&#894; and</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">deliver or cause to be delivered to the trustee for cancellation the notes properly accepted, together with an officers&#8217; certificate stating the aggregate principal amount of notes being repurchased by us.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The paying agent will promptly mail to each holder of notes properly tendered the purchase price for the notes, and the trustee will promptly authenticate and mail (or cause to be transferred by book-entry) to each holder a new note equal in principal amount to any unpurchased portion of any notes surrendered&#894; provided, that each new note will be in minimum denominations of &#8364;100,000 and integral multiples of &#8364;1,000 original principal amount above that amount.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We will not be required to make a Change of Control Offer upon a Change of Control Repurchase Event if (i) a third party makes such an offer in the manner, at the times and otherwise in compliance with the requirements for a Change of Control Offer made by us and such third party purchases all notes properly tendered and not withdrawn under its offer or (ii) we have previously or concurrently mailed a redemption notice with respect to all of the outstanding notes as described under &#8220;Optional Redemption&#8221; above.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If holders of not less than 90% in aggregate principal amount of the outstanding notes of any series validly tender and do not withdraw such notes in a Change of Control Offer and we, or any third party making such an offer in lieu of us as described above, purchases all of the notes of such series validly tendered and not withdrawn by such holders, we or such third party will have the right, upon not less than 10 days nor more than 60 days&#8217; prior notice, provided that such </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">notice is given not more than 30 days following such repurchase pursuant to the Change of Control Offer described above, to redeem all notes of such series that remain outstanding following such purchase on a date specified in such notice (the &#8220;Second Change of Control Payment Date&#8221;) and at a price in cash equal to 101% of the aggregate principal amount of notes of such series repurchased plus any accrued and unpaid interest on the notes repurchased to, but not including, the Second Change of Control Payment Date.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We have no present intention to engage in a transaction involving a Change of Control, although it is possible that we would decide to do so in the future. We could, in the future, enter into certain transactions, including acquisitions, refinancings or other recapitalizations, that would not constitute a Change of Control but that could increase the amount of debt outstanding at such time or otherwise affect our capital structure or credit ratings.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Definitions</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Below Investment Grade Rating Event&#8221; means the notes of such series are rated below Investment Grade by each of the Rating Agencies on any date during the period commencing upon the first public notice of the occurrence of a Change of Control or our intention to effect a Change of Control and ending 60 days following public notice of the occurrence of the related Change of Control (which period shall be extended so long as the rating of the notes of such series is under publicly announced consideration for possible downgrade by any of the Rating Agencies, provided that no such extension shall occur if on such 60th day the notes of such series are rated Investment Grade by at least one of such Rating Agency and are not subject to review for possible downgrade by such Rating Agency)&#894; provided further that a Below Investment Grade Rating Event otherwise arising by virtue of a particular reduction in rating shall not be deemed to have occurred in respect of a particular Change of Control (and thus shall not be deemed a Below Investment Grade Rating Event for purposes of the definition of Change of Control Repurchase Event hereunder) if the Rating Agencies making the reduction in rating to which this definition would otherwise apply do not announce or publicly confirm or inform the trustee in writing at its request that the reduction was the result, in whole or in part, of any event or circumstance comprised of or arising as a result of, or in respect of, the applicable Change of Control (whether or not the applicable Change of Control shall have occurred at the time of the Below Investment Grade Rating Event).</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Change of Control&#8221; means the occurrence of any of the following&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:8.01pt">the direct or indirect sale, transfer, conveyance or other disposition (other than by way of merger or consolidation), in one or a series of related transactions, of all or substantially all of our assets and those of our subsidiaries taken as a whole to any &#8220;person&#8221; (as that term is used in Section 13(d)(3) of the Exchange Act), other than us or one of our subsidiaries&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:8.01pt">the adoption of a plan relating to our liquidation or dissolution&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:8.01pt">the first day on which a majority of the members of our Board of Directors are not Continuing Directors&#894; or</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:8.01pt"> the consummation of any transaction (including, without limitation, any merger or consolidation) the result of which is that any &#8220;person&#8221; (as that term is used in Section 13(d)(3) of the Exchange Act), other than us or one or more of our subsidiaries, becomes the beneficial owner (as defined in Rule 13d-3 of the Exchange Act), directly or indirectly, of more than 50% of the then outstanding number of shares of our Voting Stock.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, a transaction will not be considered to be a Change of Control if (a) we become a direct or indirect wholly-owned subsidiary of a holding company and (b)(i) immediately following that transaction, the direct or indirect holders of the Voting Stock of the holding company are substantially the same as the holders of our Voting Stock immediately prior to that transaction or (ii) immediately following that transaction, no person is the beneficial owner, directly or indirectly, of more than 50% of the Voting Stock of such holding company.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Change of Control Repurchase Event&#8221; means the occurrence of both a Change of Control and a Below Investment Grade Rating Event.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Continuing Directors&#8221; means, as of any date of determination, any member of our Board of Directors who (1) was a member of such Board of Directors on the date of the issuance of the notes&#894; or (2) was nominated for election, elected or appointed to such Board of Directors with the approval of a majority of the Continuing Directors who were members of such Board of Directors at the time of such nomination, election or appointment (either by a specific vote or by approval of our proxy statement in which such member was named as a nominee for election as a director). &#8220;Investment Grade&#8221; means a rating of Baa3 or better by Moody&#8217;s (or its equivalent under any successor rating categories of Moody&#8217;s) and a rating of BBB- or better by S&#38;P (or its equivalent under any successor rating categories of S&#38;P) or the equivalent investment grade credit rating from any additional Rating Agency or Rating Agencies selected by us.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Moody&#8217;s&#8221; means Moody&#8217;s Investors Service Inc., a subsidiary of Moody&#8217;s Corporation, and its successors.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Rating Agency&#8221; means (1) each of Moody&#8217;s and S&#38;P&#894; and (2) if any of Moody&#8217;s or S&#38;P ceases to rate the notes or fails to make a rating of the notes publicly available for reasons outside of our control, a &#8220;nationally recognized statistical rating organization&#8221; within the meaning of Section 3(a)(62) under the Exchange Act, selected by us as a replacement agency for Moody&#8217;s or S&#38;P, or both of them, as the case may be.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;S&#38;P&#8221; means S&#38;P Global Ratings Inc., a division of S&#38;P Global Inc. and its successors.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Voting Stock&#8221; of any specified person as of any date means the capital stock of such person that is at the time entitled to vote generally in the election of the board of directors of such person. The definition of &#8220;Change of Control&#8221; includes a phrase relating to the direct or indirect sale, transfer, conveyance or other disposition of &#8220;all or substantially all&#8221; of our assets and those of our subsidiaries, taken as a whole. Although there is a limited body of case law interpreting </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the phrase &#8220;substantially all,&#8221; there is no precise established definition of the phrase under applicable law. Accordingly, the ability of a holder of notes to require us to repurchase the notes as a result of a sale, transfer, conveyance or other disposition of less than all of our assets and the assets of our subsidiaries, taken as a whole, to another person or group may be uncertain.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Certain Covenants</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Limitation on Liens</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Indenture contains a covenant that we will not, and we will not permit any of our Restricted Subsidiaries to, issue, assume or guarantee any Indebtedness secured by any Mortgage upon any of our Principal Properties or those of any of our Restricted Subsidiaries without equally and ratably securing the notes (and, if we so determine, any other Indebtedness ranking equally with the notes) with such Indebtedness.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This covenant will not prevent us or any of our Restricted Subsidiaries from issuing, assuming or guaranteeing&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">any purchase money mortgage on such Principal Property prior to, simultaneously with or within 180 days after the later of (1) the acquisition or completion of construction or completion of substantial reconstruction, renovation, remodeling, expansion or improvement (each, a substantial improvement&#8221;) of such Principal Property or (2) the placing in operation of such property after the acquisition or completion of any such construction or substantial improvement&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">Mortgages on a Principal Property existing at the time of acquisition, including acquisition through merger or consolidation&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">Mortgages existing on the date of the initial issuance of the notes, Mortgages on assets of a corporation or other business entity existing on the date it becomes a Restricted Subsidiary or is merged or consolidated with us or a Restricted Subsidiary or at the time the corporation or the business entity sells, leases or otherwise disposes of its property as an entirety or substantially as an entirety to us or a Restricted Subsidiary or Mortgages on the assets of a Subsidiary that is newly designated as a Restricted Subsidiary if the Mortgage would have been permitted under the provisions of this paragraph if such Mortgage was created while the Subsidiary was a Restricted Subsidiary&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">Mortgages in favor of us or a Restricted Subsidiary&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">Mortgages for taxes, assessments or governmental charges or levies that are not delinquent or that are being contested in good faith&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">Carriers&#8217;, warehousemen&#8217;s, materialmen&#8217;s, repairmen&#8217;s, mechanic&#8217;s, landlords&#8217; and other similar Mortgages arising in ordinary course of business that are not delinquent or remain payable without penalty or that are being contested in good faith&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">Mortgages (other than any Mortgage imposed by ERISA) consisting of pledges or deposits required in the ordinary course of business in connection with workers&#8217; compensation, unemployment insurance and other social security legislation&#894;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">Easements, rights-of-way, restrictions, encroachments, imperfections and other similar encumbrances affecting real property that, in the aggregate, are not substantial in amount and do not in any case materially detract from the value of the Principal Property subject thereto or materially interfere with the ordinary conduct of our and our Subsidiaries&#8217; business, taken as a whole&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">Mortgages arising by reason of deposits with, or the giving of any form of security to, any governmental agency or anybody created or approved by law or governmental regulation, including any zoning or similar law or right reserved to or vested in any governmental office or agency to control or regulate the use of any real property&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">Mortgages arising from filing Uniform Commercial Code financing statements relating solely to leases&#894; and</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">Mortgages to secure Indebtedness incurred to extend, renew, refinance or replace Indebtedness secured by any Mortgages referred to above, provided that the principal amount of the extended, renewed, refinanced or replaced Indebtedness does not exceed the principal amount of Indebtedness so extended, renewed, refinanced or replaced, plus transaction costs and fees, and that any such Mortgage applies only to the same property or assets subject to the prior permitted Mortgage (and, in the case of real property, improvements).</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Limitations on Sale and Leaseback Transactions</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Indenture contains a covenant that we will not, and will not permit our Restricted Subsidiaries to, enter into any arrangement with any person providing for the leasing by us or any Restricted Subsidiary of any Principal Property owned or acquired thereafter that has been or is to be sold or transferred by us or such Restricted Subsidiary to such person with the intention of taking back a lease of such Principal Property, a &#8220;sale and leaseback transaction,&#8221; without equally and ratably securing the notes (and, if we shall so determine, any other Indebtedness ranking equally with the notes), unless&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">within 180 days after the receipt of the proceeds of the sale or transfer, we or any Restricted Subsidiary apply an amount equal to the greater of the net proceeds of the sale or transfer or the fair value of such Principal Property at the time of such sale or transfer to any (or a combination) of (1) the prepayment or retirement (other than any mandatory prepayment or retirement) of our Senior Funded Debt or (2) the purchase, construction, development, expansion or improvement of other comparable property, subject in each case to credits for voluntary retirements of Senior Funded Debt&#894; or</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">we or such Restricted Subsidiary would be entitled, at the effective date of the sale or transfer, to incur Indebtedness secured by a Mortgage on such Principal Property, in an amount at least equal to the Attributable Debt in respect of the sale and leaseback transaction, without equally and ratably securing the notes pursuant to &#8220;&#8212;Limitation on Liens&#8221; described above.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The foregoing restriction will not apply to&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">any sale and leaseback transaction for a term of not more than three years including renewals&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">any sale and leaseback transaction with respect to a Principal Property if a binding commitment with respect thereto is entered into within three years after the later of (1) the date of the issuance of the notes under the Supplemental Indenture, or (2) the date such Principal Property was acquired&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">any sale and leaseback transaction with respect to a Principal Property if a binding commitment with respect thereto is entered into within 180 days after the later of the date such property was acquired and, if applicable, the date such property was first placed in operation&#894; or</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">any sale and leaseback transaction between us and a Restricted Subsidiary or between Restricted Subsidiaries.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Exception to Limitations for Exempted Debt</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding the limitations in the Indenture on liens and sale and leaseback transactions, we or our Restricted Subsidiaries may, in addition to amounts permitted under such restrictions and without equally and ratably securing the notes, create or assume and renew, extend or replace Mortgages, or enter into sale and leaseback transactions without any obligation to retire any Senior Funded Debt of us or any Restricted Subsidiary, provided that at the time of such creation, assumption, renewal, extension or replacement of a Mortgage or at the time of entering into such sale and leaseback transactions, and after giving effect thereto, Exempted Debt does not exceed 15% of our Consolidated Net Tangible Assets.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Definitions</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For purposes of the Indenture&#58;</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Attributable Debt&#8221; in respect of a sale and leaseback transaction means, at the time of determination, the present value (discounted at the imputed rate of interest of such transaction as determined in good faith by us) of the obligation of the lessee for net rental payments during the remaining term of the lease included in such sale and leaseback transaction (including any period for which such lease has been extended or may, at the option of the lessor, be extended). The term &#8220;net rental payments&#8221; under any lease for any period means the sum of the rental and other payments required to be paid in such period by the lessee thereunder, not including any amounts required to be paid by such lessee (whether or not designated as rental or additional rent) on account of maintenance and repairs, insurance, taxes, assessments, water rates or similar charges required to be paid by such lessee thereunder or any amount required to be paid by lessee thereunder contingent upon the amount of maintenance and repairs, insurance, taxes, assessments, water rates or similar charges. In the case of any lease that is terminable by the lessee upon the payment of a penalty, such net amount shall be the lesser of (x) the net amount determined assuming termination upon the first date such lease may be terminated (in which case the net amount shall also include the amount of the penalty, but shall not include any rent that would be required to be paid under such lease subsequent to the first date upon which it may</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">be so terminated) or (y) the net amount determined assuming no such termination.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Consolidated Net Tangible Assets&#8221; means the total amounts of assets (less depreciation and valuation reserves and other reserves and items deductible from gross book value of specific asset accounts under generally accepted accounting principles) that under generally accepted accounting principles would be included on a consolidated balance sheet of us and our consolidated Restricted Subsidiaries after deducting (1) all current liabilities, excluding current liabilities that could be classified as long-term debt under generally accepted accounting principles and current liabilities that are by their terms extendable or renewable at the obligor&#8217;s option to a time more than 12 months after the time as of which the amount of current liabilities is being computed&#894; (2) investments in Unrestricted Subsidiaries&#894; and (3) all trade names, trademarks, licenses, patents, copyrights and goodwill, organizational and development costs, deferred charges, other than prepaid items such as insurance, taxes, interest, commissions, rents and similar items and tangible assets being amortized, and amortized debt discount and expense, less unamortized premium.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Exempted Debt&#8221; means the sum of the following items outstanding as of the date Exempted Debt is being determined (1) Indebtedness of us and our Restricted Subsidiaries secured by a Mortgage and not permitted to exist under the Indenture and (2) Attributable Debt of us and our Restricted Subsidiaries in respect of all sale and leaseback transactions not permitted under the Indenture.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Funded Debt&#8221; means Indebtedness that matures more than one year from the date of creation, or that is extendable or renewable at the sole option of the obligor so that it may become payable more than one year from such date. Funded Debt does not include (1) obligations created pursuant to leases, (2) any Indebtedness or portion thereof maturing by its terms within one year from the time of any computation of the amount of outstanding</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Funded Debt unless such Indebtedness shall be extendable or renewable at the sole option of the obligor in such manner that it may become payable more than one year from such time, or (3) any Indebtedness for the payment or redemption of which money in the necessary amount shall have been deposited in trust either at or before the maturity date thereof.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Indebtedness&#8221; means any and all of the obligations of a person for money borrowed that in accordance with generally accepted accounting principles would be reflected on the balance sheet of such person as a liability as of the date of which the Indebtedness is to be determined. For the avoidance of doubt, a change in generally accepted accounting principles subsequent to the issue date of the notes shall not be deemed an incurrence of Indebtedness.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Investment&#8221; means any investment in stock, evidences of Indebtedness, loans or advances, however made or acquired, but does not include our account receivable or the accounts receivable of any Restricted Subsidiary arising from transactions in the ordinary course of business, or any evidences of Indebtedness, loans or advance made in connection with the sale to any Subsidiary of our accounts receivable or the accounts receivable of any Restricted Subsidiary arising from transactions in the ordinary course of business.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Mortgage&#8221; means any mortgage, security interest, pledge, lien or other encumbrance.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Principal Property&#8221; means all real property and improvements thereon owned by us or a Restricted Subsidiary, including, without limitation, any manufacturing, warehouse, distribution or research facility, and improvements therein, having a net book value in excess of 2% of Consolidated Net Tangible Assets that is located within the United States, excluding its territories and possessions and Puerto Rico. This term does not include any real</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">property and improvements thereon that our Board of Directors declares by resolution not to be of material importance to the total business conducted by us and our Restricted Subsidiaries taken as a whole.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Restricted Subsidiary&#8221; means a Subsidiary that owns a Principal Property.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Senior Funded Debt&#8221; means all Funded Debt (except Funded Debt, the payment of which is subordinated to the payment of the notes).</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Subsidiary&#8221; means a corporation, partnership or other legal entity of which, in the case of a corporation, more than 50% of the outstanding voting stock is owned, directly or indirectly, by us or by one or more other Subsidiaries, or by us and one or more other Subsidiaries or, in the case of any partnership or other legal entity, more than 50% of the ordinary capital interests is, at the time, directly or indirectly owned or controlled by us or by one or more other Subsidiaries. For the purposes of this definition, &#8220;voting stock&#8221; means the equity interest that ordinarily has voting power for the election of directors, managers or trustees of an entity, or persons performing similar functions, whether at all times or only so long as no senior class of equity</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">interest has such voting power by reason of any contingency.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Unrestricted Subsidiary&#8221; means any Subsidiary other than a Restricted Subsidiary.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Consolidation, Merger and Sale of Assets</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We may consolidate or merge with or into any other corporation, and we may sell or transfer all or substantially all of our assets to another corporation, provided, among other things, that (a) we are the surviving corporation or the corporation formed by or resulting from any such</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">consolidation or merger or the transferee of such assets shall be a corporation organized and existing under the laws of the United States, any state thereof or the District of Columbia and shall expressly assume by supplemental indenture payment of the principal of, and premium, if any, and interest, if any, on the notes issued under the Indenture and the performance and observance of the Indenture and (b) we or such successor corporation shall not immediately thereafter be in default under the Indenture.</font></div><div style="text-indent:36pt"><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Events of Default</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The following events are defined in the Indenture as &#8220;Events of Default&#8221;&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">default in the payment of any installment of interest on any series of notes for 30 days after becoming due&#894;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">default in the payment of principal or premium, if any, of any series of notes when due&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">default in the deposit of any sinking fund payment, when due&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">default in the performance of any other covenant for 90 days after notice, which must be sent by either the trustee or holders of 25% of the principal amount of the notes of the affected series&#894; and</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">certain events of bankruptcy, insolvency or reorganization.</font></div><div><font><br></font></div><div style="text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If an Event of Default occurs and continues with respect to a series of notes, either the trustee or the holders of at least 25% in principal amount of the outstanding notes of such series may declare the entire principal amount of all of such series to be due and payable&#894; provided that, in the case of an Event of Default involving certain events of bankruptcy, insolvency or reorganization, such acceleration is automatic&#894; and, provided further, that after such acceleration, but before a judgment or decree based on acceleration, the holders of a majority in aggregate principal amount of the outstanding notes of that series may, subject to certain conditions, rescind and annul such acceleration if all Events of Default, other than the nonpayment of accelerated principal, have been cured or waived. </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-indent:36pt"><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div style="margin-bottom:10pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Description of Debt Securities&#58;</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:138%">0.250% Notes due 2024</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:138%">0.750% Notes due 2029</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.000 % Notes due 2031</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">The Company has an effective a registration statement on Form S-3 (File No. 333-229539), which was filed with the Securities and Exchange Commission on February 7, 2019 and covers the issuance of the Company&#8217;s 0.250% Notes due 2024 (the &#8220;2024 notes&#8221;), the 0.750% Notes due 2029 (the &#8220;2029 notes&#8221;) and the 1.000% Notes due 2031 (the &#8220;2031 notes&#8221; and together with the 2024 notes, the 2029 notes and the 2031 notes, the &#8220;notes&#8221;). The notes are governed by a base indenture dated January 15, 2010 between the Company and U.S. Bank National Association, as trustee, as supplemented by the applicable supplemental indenture governing a particular series of notes (as so supplemented, the &#8220;Indenture&#8221;). This summary is subject to and qualified in its entirety by reference to all of the provisions of the Indenture and the notes, including definitions of certain terms used in the Indenture and the notes. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:138%">General</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">The notes were issued as separate series of debt securities under the Indenture. The notes are senior unsecured obligations of ours and rank equally in right of payment with our other existing and future senior unsecured indebtedness. The notes are not secured by any of our assets. Any future claims of our secured lenders with respect to assets securing their loans will be prior to any claim of the holders of the notes with respect to those assets. Holders of secured debt that we have now or may issue in the future may foreclose on the assets securing such debt, reducing the cash flow from the foreclosed property available for payment of unsecured debt, including the notes. Holders of our secured debt also would have priority over unsecured creditors in the event of our bankruptcy, liquidation or similar proceeding to the extent of the value of the collateral securing such debt. The notes are structurally subordinated to all liabilities of our subsidiaries, including trade payables. Because we conduct many of our operations through our subsidiaries, our right to participate in any distribution of the assets of a subsidiary when it winds up its business is subject to the prior claims of the creditors of that subsidiary. This means that your right to payment as a holder of our notes is also subject to the prior claims of these creditors if a subsidiary liquidates or reorganizes or otherwise winds up its business. If we are a creditor of any of our subsidiaries, our right as a creditor would be subordinated to any security interest in the assets of those subsidiaries and any indebtedness of our subsidiaries senior in right of payment to that held by us. </font></div><div style="text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">The Indenture does not limit the amount of notes, unsecured debentures or other evidences of indebtedness that we may issue under the Indenture and provides that notes, unsecured debentures or other evidences of indebtedness may be issued from time to time in one or more series. We may from time to time, without notice to or the consent of the holders of the notes, create and issue additional notes of any series having the same ranking and terms and conditions as the notes of the same series, except for the issue date, the public offering price and, in some cases, the first interest payment date. Any additional notes having such similar terms, together with the notes offered of the same series, will constitute a single series of securities under the Indenture. If the additional notes of a series, if any, are not fungible with the notes of that series offered for U.S. federal income tax purposes, the additional notes have a separate CUSIP number.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">We issued the notes in fully registered book-entry form without coupons and in denominations of &#8364;100,000 and integral multiples of &#8364;1,000 thereafter.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">Principal of and interest on the notes are payable, and the notes are transferable or exchangeable, at the office or offices or agency maintained by us for these purposes. Payment of interest on the notes may be made at our option by check mailed to the registered holders thereof.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">The 2024 notes, the 2029 notes and the 2031 notes are listed on the New York Stock Exchange under the symbols &#8220;SYK24A,&#8221; &#8220;SYK29&#8221; and &#8220;SYK31,&#8221; respectively. We have no obligation to maintain such listings, and we may delist any series of the notes at any time.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">Elavon Financial Services DAC is paying agent for the notes. U.S. Bank National Association will is registrar and transfer agent for the notes. Upon notice to the trustee, we may change the paying agent, registrar or transfer agent.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:138%">Interest</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">The 2024 notes and 2031 notes bear interest from the date of issuance, payable annually on December 3 of each year, beginning December 3, 2020, and the 2029 notes bear interest from the date of issuance, payable annually on March 1 of each year, beginning March 1, 2021, to the persons in whose names such notes are registered at the close of business on the business day (for this purpose, a day on which Clearstream and Euroclear are open for business) immediately preceding the relevant interest payment. Interest on the notes is computed on the basis of the actual number of days in the period for which interest is being calculated and the actual number of days from and including the last date on which interest was paid on the notes (or December 3, 2019, if no interest has been paid on the applicable series of notes), to, but excluding, the next scheduled interest payment date. This payment convention is referred to as Actual&#47;Actual (ICMA) as defined in the rulebook of the International Capital Market Association.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">If any interest payment date would otherwise be a day that is not a business day, such interest payment date will be postponed to the next date that is a business day and no interest will accrue on the amounts payable from and after such interest payment date to the next business day. If the maturity date of any series of notes falls on a day that is not a business day, the related payment of principal, premium, if any, and interest will be made on the next business day as if it were made on the date such payment was due, and no interest will accrue on the amounts so payable for the period from and after such date to the next business day.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:138%">Business Day</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">For purposes of the notes, a &#8220;business day&#8221; is any day that is not a Saturday, Sunday or other day on which banking institutions in New York City, London or another place of payment on the notes are authorized or required by law to close and on which the Trans-European Automated Real-Time Gross Settlement Express Transfer system (the TARGET2 system), or any successor thereto, is open.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:138%">Issuance in euro</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">All payments of interest, premium, if any, and principal, including payments made upon any redemption or repurchase of the notes, will be made in euro&#894; provided that if the euro is unavailable to us due to the imposition of exchange controls or other circumstances beyond our control or if the euro is no longer being used by the then member states of the European Monetary Union that have adopted the euro as their currency or for the settlement of transactions by public institutions of or within the international banking community, then all payments in respect of the notes will be made in U.S. dollars until the euro is again available to us or so used. In such circumstances, the amount payable on any date in euro will be converted into U.S. dollars at the rate mandated by the Board of Governors of the Federal Reserve System as of the close of business on the second business day prior to the relevant payment date or, if the Board of Governors of the Federal Reserve System has not announced a rate of conversion, on the basis of the most recent U.S. dollar&#47;euro exchange rate published in The Wall Street Journal on or prior to the second business day prior to the relevant payment date or, in the event The Wall Street Journal has not published such exchange rate, the rate will be determined in our sole discretion on the basis of the most recently available market exchange rate for the euro. Any payment in respect of the notes so made in U.S. dollars will not constitute an Event of Default (as defined in the Indenture). Neither the trustee nor the paying agent shall have any responsibility for any calculation or conversion in connection with the foregoing.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">Investors are subject to foreign exchange risks as to payments of principal, premium, if any, and interest that may have important economic and tax consequences to them. </font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:138%">Optional Redemption</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">We may redeem the notes prior to November 3, 2024 in the case of the 2024 notes, December 1, 2028 in the case of the 2029 notes and September 3, 2031 in the case of the 2031 notes, in whole, at any time, or in part, from time to time, at our option, for cash, at a redemption price equal to the greater of&#58;</font></div><div style="text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:8.01pt">100% of the principal amount of the applicable series of notes to be redeemed&#894; or</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:8.01pt">an amount determined by the Quotation Agent (as defined below) equal to the sum of the present values of the remaining scheduled payments of principal, premium, if any, and interest thereon (not including any portion of such payments of interest accrued to the date of redemption) to November 3, 2024 with respect to the 2024 notes, December 1, 2028 with respect to the 2029 notes and September 3, 2031 with respect to the 2031 notes, discounted to the date of redemption on an annual basis (Actual&#47;Actual (ICMA) at the Comparable Government Bond Rate (as defined below)), plus 15 basis points with respect to the 2024 notes, 20 basis points with respect to the 2029 notes and 25 basis points with respect to the 2031 notes,</font></div><div style="padding-left:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">plus accrued and unpaid interest thereon to, but not including, the date of redemption.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">On or after November 3, 2024 in the case of the 2024 notes, December 1, 2028 in the case of the 2029 notes and September 3, 2031 in the case of the 2031 notes, we may redeem the applicable series of notes, in whole, at any time, or in part, from time to time, at our option, for cash, at a redemption price equal to 100% of the principal amount of such series of notes, plus accrued and unpaid interest to, but not including, the redemption date.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">The principal amount of any note remaining outstanding after a redemption in part shall be &#8364;100,000 or a higher integral multiple of &#8364;1,000. Notwithstanding the foregoing, installments of interest on any series of notes that are due and payable on interest payment dates falling on or prior to a redemption date will be payable on the interest payment date to the registered holders as of the close of business on the relevant record date.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:138%">Comparable Government Bond</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8221; means, in relation to any Comparable Government Bond Rate calculation, at the discretion of an independent investment bank selected by us (the &#8220;Quotation Agent&#8221;), a German government bund whose maturity is closest to the par call date, or if such Quotation Agent in its discretion determines that such similar bond is not in issue, such other German government bund as such Quotation Agent may, with the advice of three brokers of, and&#47;or market makers in, German government bunds selected by us, determine to be appropriate for determining the Comparable Government Bond Rate.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:138%">Comparable Government Bond Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8221; means the price, expressed as a percentage (rounded to three decimal places, with 0.0005 being rounded upwards), at which the gross redemption yield on the notes to be redeemed, if they were to be purchased at such price on the third business day prior to the date fixed for redemption, would be equal to the gross redemption yield on such business day of the Comparable Government Bond on the basis of the middle market price of the Comparable Government Bond prevailing at 11&#58;00 A.M. (London time) on such business day as determined by the Quotation Agent selected by us.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">Notice of any redemption will be sent (or, in the case of notes held in book-entry form, be transmitted electronically) at least 10 days but not more than 60 days before the redemption date to each registered holder of the applicable series of notes to be redeemed. Unless we default in payment of the redemption price, on and after the redemption date, interest will cease to accrue on the applicable series of notes or portions thereof called for redemption. If less than all of the applicable series of notes are to be redeemed, the notes to be redeemed will be selected by the trustee in accordance with the standard procedures of the depositary. If the notes to be redeemed are not global notes then held by Euroclear or Clearstream, the trustee will select the notes to be redeemed on a pro rata basis. If the notes are listed on the NYSE or any other national securities exchange, the trustee will select notes in compliance with the requirements of the NYSE or other principal national securities exchange on which the notes are listed. </font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">Notwithstanding the foregoing, if less than all of a series of notes is to be redeemed, no notes of such series of a principal amount of &#8364;100,000 or less shall be redeemed in part. If money sufficient to pay the redemption price on the series of notes (or portions thereof) to be redeemed on the redemption date is deposited with the paying agent on or before the redemption date and certain other conditions are satisfied, then on and after such redemption date, interest will cease to accrue on such series of notes (or such portion thereof) called for redemption.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:138%">Special Mandatory Redemption</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">If we do not satisfy the minimum tender and other conditions in the Purchase Agreement and consummate the Wright Tender Offer on or prior to February 4, 2021, or if, prior to such date, we notify the trustee in writing that the Purchase Agreement has been terminated (each, a &#8220;Special Mandatory Redemption Event&#8221;), the provisions set forth below will be applicable (other than with respect to the 2029 notes). The 2029 notes will not be subject to the special mandatory redemption and will remain outstanding (unless otherwise redeemed) even if the Wright Tender Offer is not consummated on or prior to February 4, 2021. If a Special Mandatory Redemption Event occurs, we will be required to redeem each series of notes (other than the 2029 notes) in the manner set forth below in whole and not in part at a special mandatory redemption price (the &#8220;Special Mandatory Redemption Price&#8221;) equal to 101% of the aggregate principal amount of such series, plus accrued and unpaid interest, if any, to, but excluding, the Special Mandatory </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">Redemption Date (as defined below) (subject to the right of holders of record on the relevant record date to receive interest due on any interest payment date that is on or prior to the Special Mandatory Redemption Date).</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">Upon the occurrence of a Special Mandatory Redemption Event, we will promptly (but in no event later than ten business days following such Special Mandatory Redemption Event) notify the trustee in writing of such event (such notice to include the officers&#8217; certificate required by the Indenture), and the trustee shall, no later than five business days following receipt of such notice from us, notify the holders of each series of notes (such date of notification to such holders, the &#8220;Redemption Notice Date&#8221;) that all of the outstanding notes will be redeemed at the Special Mandatory Redemption Price on the third business day following the Redemption Notice Date (such date, the &#8220;Special Mandatory Redemption Date&#8221;) automatically and without any further action by the holders of the notes, in each case in accordance with the applicable provisions of the Indenture. At or prior to 12&#58;00 p.m. (New York City time) on the business day immediately preceding the Special Mandatory Redemption Date, we will deposit with the trustee funds sufficient to pay the Special Mandatory Redemption Price for the notes. If such deposit is made as provided above, the notes will cease to bear interest on and after the Special Mandatory Redemption Date.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">If we fail to pay the Special Mandatory Redemption Price, it will be an event of default with respect to each series of notes (other than the 2029 notes) under the Indenture.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:138%">Optional Redemption for Tax Reasons</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">The notes of any series may be redeemed at our option in whole, but not in part, on not less than 10 nor more than 60 days&#8217; prior notice, at 100% of the principal amount of such series together with accrued and unpaid interest, if any, to, but excluding, the redemption date if, as a result of any change in, or amendment to, the laws, regulations or rulings of the United States (or any political subdivision or taxing authority thereof or therein having power to tax), or any change in official position regarding application or interpretation of those laws, regulations or rulings (including a holding by a court of competent jurisdiction), which change, amendment, application or interpretation is announced or becomes effective on or after the original issue date with respect to the notes, we become or, based upon a written opinion of independent counsel selected by us, will become obligated to pay additional amounts as described below in &#8220;&#8212; Payment of Additional Amounts.&#8221;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:138%">Payment of Additional Amounts</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">All payments of principal, interest, and premium, if any, in respect of the notes are will be made free and clear of, and without withholding or deduction for, any present or future taxes, assessments, duties or governmental charges of whatever nature imposed, levied or collected by </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">the United States (or any political subdivision or taxing authority thereof or therein having power to tax), unless such withholding or deduction is required by law or the official interpretation or administration thereof.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">We will, subject to the exceptions and limitations set forth below, pay as additional interest in respect of the notes such additional amounts as are necessary in order that the net payment by us of the principal of, premium, if any, and interest in respect of the notes to a holder who is not a United States person (as defined below), after withholding or deduction for any present or future tax, assessment, duties or other governmental charge imposed by the United States (or any political subdivision or taxing authority thereof or therein having power to tax), will not be less than the amount provided in the notes to be then due and payable&#59; provided, however, that the foregoing obligation to pay additional amounts shall not apply&#58;</font></div><div style="text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:8.01pt">to the extent any tax, assessment or other governmental charge would not have been imposed but for the holder (or the beneficial owner for whose benefit such holder holds such note), or a fiduciary, settlor, beneficiary, member or shareholder of the holder if the holder is an estate, trust, partnership or corporation, or a person holding a power over an estate or trust administered by a fiduciary holder, being considered as&#58;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">being or having been engaged in a trade or business in the United States or having or having had a permanent establishment in the United States&#59;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">having a current or former connection with the United States (other than a connection arising solely as a result of the ownership of the notes, the receipt of any payment in respect of the notes or the enforcement of any rights hereunder), including being or having been a citizen or resident of the United States&#59;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">being or having been a personal holding company, a passive foreign investment company or a controlled foreign corporation for U.S. federal income tax purposes, a foreign tax-exempt organization, or a corporation that has accumulated earnings to avoid U.S. federal income tax&#59;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">being or having been a &#8220;10-percent shareholder&#8221; of the Company as defined in section 871(h)(3) of the United States Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;) or any successor provision&#59; or</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">being a bank receiving payments on an extension of credit made pursuant to a loan agreement entered into in the ordinary course of its trade or business, as described in section 881(c)(3)(A) of the Code or any successor provision&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:8.01pt">to any holder that is not the sole beneficial owner of the notes, or a portion of the notes, or that is a fiduciary, partnership, limited liability company or other fiscally transparent entity, but only to the extent that a beneficial owner with respect to the holder, a beneficiary or settlor with respect to the fiduciary, or a beneficial owner or member of the partnership, limited liability company or other fiscally transparent entity would not have </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">been entitled to the payment of an additional amount had the beneficiary, settlor, beneficial owner or member received directly its beneficial or distributive share of the payment&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:8.01pt">to the extent any tax, assessment or other governmental charge that would not have been imposed but for the failure of the holder or any other person to comply with certification, identification or information reporting requirements concerning the nationality, residence, identity or connection with the United States of the holder or beneficial owner of the notes, if compliance is required by statute, by regulation of the United States or any taxing authority therein or by an applicable income tax treaty to which the United States is a party as a precondition to exemption from such tax, assessment or other governmental charge&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:8.01pt">to any tax, assessment or other governmental charge that is imposed otherwise than by withholding by us or a paying agent from the payment&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:8.01pt">to any tax, assessment or other governmental charge required to be withheld by any paying agent from any payment of principal of or interest on any notes, if such payment can be made without such withholding by any other paying agent&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">6)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:8.01pt">to any estate, inheritance, gift, sales, transfer, wealth, capital gains or personal property tax or similar tax, assessment or other governmental charge, or excise tax imposed on the transfer of notes&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">7)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:8.01pt">to the extent any tax, assessment or other governmental charge would not have been imposed but for the presentation by the holder of any note, where presentation is required, for payment on a date more than 30 days after the date on which payment became due and payable or the date on which payment thereof is duly provided for, whichever occurs later except to the extent that the beneficiary or holder thereof would have been entitled to the payment of additional amounts had such note been presented for payment on any day during such 30-day period&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">8)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:8.01pt">to any tax, assessment or other governmental charge imposed under sections 1471 through 1474 of the Code (or any amended or successor provisions), any current or future regulations or official interpretations thereof, any agreement entered into pursuant to section 1471(b) of the Code or any fiscal or regulatory legislation, rules or practices adopted pursuant to any intergovernmental agreement entered into in connection with the implementation of such sections of the Code, whether currently in effect or as published and amended from time to time&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">9)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:8.01pt">to any tax, assessment or other governmental charge that is imposed or withheld solely by reason of a change in law, regulation, or administrative or judicial interpretation that becomes effective more than 15 days after the payment becomes due or is duly provided for, whichever occurs later&#59; or</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">10)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:2.01pt">in the case of any combination of the above numbered items.  </font></div><div style="padding-left:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">The notes are subject in all cases to any tax, fiscal or other law or regulation or administrative or judicial interpretation applicable to the notes. Except as specifically provided under this heading &#8220;&#8212;Payment of Additional Amounts,&#8221; we are not required to make any payment for any tax, assessment or other governmental charge imposed by any government or a political subdivision or taxing authority of or in any government or political subdivision.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">As used under this heading &#8220;&#8212;Payment of Additional Amounts&#8221; and under the heading &#8220;&#8212;Optional Redemption for Tax Reasons,&#8221; the term &#8220;United States&#8221; means the United States of America, its territories and possessions, the states of the United States and the District of Columbia, and the term &#8220;United States person&#8221; means (i) any individual who is a citizen or resident of the United States for U.S. federal income tax purposes, (ii) a corporation, partnership or other entity created or organized in or under the laws of the United States, any state of the United States or the District of Columbia (other than a partnership that is not treated as a United States person for United States federal income tax purposes), (iii) any estate the income of which is subject to U.S. federal income taxation regardless of its source, or (iv) any trust if a United States court can exercise primary supervision over the administration of the trust and one or more United States persons can control all substantial trust decisions, or if a valid election is in place to treat the trust as a United States person.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Repurchase at the Option of Holders Upon Change of Control Repurchase Event</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">If a Change of Control Repurchase Event (as defined below) occurs in respect of a series of notes, unless we have exercised our right to redeem the notes of such series as described above under &#8220;&#8212;Optional Redemption or &#8220;Optional Redemption for Tax Reasons&#8221; or have been required to redeem the notes as described under &#8220;&#8212;Special Mandatory Redemption&#8221; we will be required to make an offer (a &#8220;Change of Control Offer&#8221;) to each holder of such series of notes to repurchase all or any part (in minimum denominations of &#8364;100,000 and integral multiples of &#8364;1,000 original principal amount above that amount) of that holder&#8217;s notes at a repurchase price in cash equal to 101% of the aggregate principal amount of notes repurchased plus any accrued and unpaid interest on the notes repurchased to, but not including, the date of such repurchase. Within 30 days following any Change of Control Repurchase Event or, at our option, prior to any Change of Control (as defined below), but after the public announcement of an impending Change of Control, we will mail a notice to each holder, with a copy to the trustee, describing the transaction or transactions that constitute or may constitute the Change of Control Repurchase Event and offering to repurchase notes on the payment date specified in the notice, which date will be no earlier than 30 days and no later than 60 days from the date such notice is mailed. The notice will, if mailed prior to the date of consummation of the Change of Control, state that the offer to purchase is conditioned on the Change of Control Repurchase Event occurring on or prior to the payment date specified in the notice.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">We will comply with the requirements of Rule 14e-1 under the Securities Exchange Act of 1934, as amended, or the Exchange Act, and any other securities laws and regulations thereunder, to the extent those laws and regulations are applicable in connection with the repurchase of the notes as a result of a Change of Control Repurchase Event. To the extent that the provisions of any securities laws or regulations conflict with the Change of Control Repurchase Event provisions of the notes, we will comply with the applicable securities laws and regulations and will not be deemed to have breached our obligations under the Change of Control Repurchase Event provisions of the notes by virtue of such conflict.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">On the Change of Control Repurchase Event payment date, we will, to the extent lawful&#58;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">accept for payment all notes or portions of notes (in minimum denominations of &#8364;100,000 and integral multiples of &#8364;1,000 original principal amount above that amount) properly tendered pursuant to our offer&#59;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">deposit with the paying agent an amount equal to the aggregate purchase price in respect of all notes or portions of notes properly tendered&#59; and</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">deliver or cause to be delivered to the trustee for cancellation the notes properly accepted, together with an officers&#8217; certificate stating the aggregate principal amount of notes being repurchased by us.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">The paying agent will promptly mail to each holder of notes properly tendered the purchase price for the notes, and the trustee will promptly authenticate and mail (or cause to be transferred by book-entry) to each holder a new note equal in principal amount to any unpurchased portion of any notes surrendered&#59; provided, that each new note will be in minimum denominations of &#8364;100,000 and integral multiples of &#8364;1,000 original principal amount above that amount.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">We will not be required to make a Change of Control Offer upon a Change of Control Repurchase Event if (i) a third party makes such an offer in the manner, at the times and otherwise in compliance with the requirements for a Change of Control Offer made by us and such third party purchases all notes properly tendered and not withdrawn under its offer or (ii) we have previously or concurrently mailed a redemption notice with respect to all of the outstanding notes as described under &#8220;Optional Redemption&#8221; above.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">If holders of not less than 90% in aggregate principal amount of the outstanding notes of any series validly tender and do not withdraw such notes in a Change of Control Offer and we, or any third party making such an offer in lieu of us as described above, purchases all of the notes of such series validly tendered and not withdrawn by such holders, we or such third party will have the right, upon not less than 10 days nor more than 60 days&#8217; prior notice, provided that such notice is given not more than 30 days following such repurchase pursuant to the Change of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">Control Offer described above, to redeem all notes of such series that remain outstanding following such purchase on a date specified in such notice (the &#8220;Second Change of Control Payment Date&#8221;) and at a price in cash equal to 101% of the aggregate principal amount of notes of such series repurchased plus any accrued and unpaid interest on the notes repurchased to, but not including, the Second Change of Control Payment Date.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">We have no present intention to engage in a transaction involving a Change of Control, although it is possible that we would decide to do so in the future. We could, in the future, enter into certain transactions, including acquisitions, refinancings or other recapitalizations, that would not constitute a Change of Control but that could increase the amount of debt outstanding at such time or otherwise affect our capital structure or credit ratings.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%">Definitions</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8220;Below Investment Grade Rating Event&#8221; means the notes of such series are rated below Investment Grade by each of the Rating Agencies on any date during the period commencing upon the first public notice of the occurrence of a Change of Control or our intention to effect a Change of Control and ending 60 days following public notice of the occurrence of the related Change of Control (which period shall be extended so long as the rating of the notes of such series is under publicly announced consideration for possible downgrade by any of the Rating Agencies, provided that no such extension shall occur if on such 60th day the notes of such series are rated Investment Grade by at least one of such Rating Agency and are not subject to review for possible downgrade by such Rating Agency)&#59; provided further that a Below Investment Grade Rating Event otherwise arising by virtue of a particular reduction in rating shall not be deemed to have occurred in respect of a particular Change of Control (and thus shall not be deemed a Below Investment Grade Rating Event for purposes of the definition of Change of Control Repurchase Event hereunder) if the Rating Agencies making the reduction in rating to which this definition would otherwise apply do not announce or publicly confirm or inform the trustee in writing at its request that the reduction was the result, in whole or in part, of any event or circumstance comprised of or arising as a result of, or in respect of, the applicable Change of Control (whether or not the applicable Change of Control shall have occurred at the time of the Below Investment Grade Rating Event).</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8220;Change of Control&#8221; means the occurrence of any of the following&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:8.01pt">the direct or indirect sale, transfer, conveyance or other disposition (other than by way of merger or consolidation), in one or a series of related transactions, of all or substantially all of our assets and those of our subsidiaries taken as a whole to any &#8220;person&#8221; (as that term is used in Section 13(d)(3) of the Exchange Act), other than us or one of our subsidiaries&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:8.01pt">the adoption of a plan relating to our liquidation or dissolution&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:8.01pt">the first day on which a majority of the members of our Board of Directors are not Continuing Directors&#59; or</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:8.01pt">the consummation of any transaction (including, without limitation, any merger or consolidation) the result of which is that any &#8220;person&#8221; (as that term is used in Section 13(d)(3) of the Exchange Act), other than us or one or more of our subsidiaries, becomes the beneficial owner (as defined in Rule 13d-3 of the Exchange Act), directly or indirectly, of more than 50% of the then outstanding number of shares of our Voting Stock.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">Notwithstanding the foregoing, a transaction will not be considered to be a Change of Control if (a) we become a direct or indirect wholly-owned subsidiary of a holding company and (b)(i) immediately following that transaction, the direct or indirect holders of the Voting Stock of the holding company are substantially the same as the holders of our Voting Stock immediately prior to that transaction or (ii) immediately following that transaction, no person is the beneficial owner, directly or indirectly, of more than 50% of the Voting Stock of such holding company.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8220;Change of Control Repurchase Event&#8221; means the occurrence of both a Change of Control and a Below Investment Grade Rating Event.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8220;Continuing Directors&#8221; means, as of any date of determination, any member of our Board of Directors who (1) was a member of such Board of Directors on the date of the issuance of the notes&#59; or (2) was nominated for election, elected or appointed to such Board of Directors with the approval of a majority of the Continuing Directors who were members of such Board of Directors at the time of such nomination, election or appointment (either by a specific vote or by approval of our proxy statement in which such member was named as a nominee for election as a director).</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8220;Investment Grade&#8221; means a rating of Baa3 or better by Moody&#8217;s (or its equivalent under any successor rating categories of Moody&#8217;s) and a rating of BBB- or better by S&#38;P (or its equivalent under any successor rating categories of S&#38;P) or the equivalent investment grade credit rating from any additional Rating Agency or Rating Agencies selected by us.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8220;Moody&#8217;s&#8221; means Moody&#8217;s Investors Service Inc., a subsidiary of Moody&#8217;s Corporation, and its successors.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8220;Rating Agency&#8221; means (1) each of Moody&#8217;s and S&#38;P&#59; and (2) if any of Moody&#8217;s or S&#38;P ceases to rate the notes or fails to make a rating of the notes publicly available for reasons outside of our control, a &#8220;nationally recognized statistical rating organization&#8221; within the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">meaning of Section 3(a) (62) under the Exchange Act, selected by us as a replacement agency for Moody&#8217;s or S&#38;P, or both of them, as the case may be.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8220;S&#38;P&#8221; means S&#38;P Global Ratings Inc., a division of S&#38;P Global Inc. and its successors.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8220;Voting Stock&#8221; of any specified person as of any date means the capital stock of such person that is at the time entitled to vote generally in the election of the board of directors of such person.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">The definition of &#8220;Change of Control&#8221; includes a phrase relating to the direct or indirect sale, transfer, conveyance or other disposition of &#8220;all or substantially all&#8221; of our assets and those of our subsidiaries, taken as a whole. Although there is a limited body of case law interpreting the phrase &#8220;substantially all,&#8221; there is no precise established definition of the phrase under applicable law. Accordingly, the ability of a holder of notes to require us to repurchase the notes as a result of a sale, transfer, conveyance or other disposition of less than all of our assets and the assets of our subsidiaries, taken as a whole, to another person or group may be uncertain.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:138%">Certain Covenants</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%">Limitation on Liens</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">The Indenture contains a covenant that we will not, and we will not permit any of our Restricted Subsidiaries to, issue, assume or guarantee any Indebtedness secured by any Mortgage upon any of our Principal Properties or those of any of our Restricted Subsidiaries without equally and ratably securing the notes (and, if we so determine, any other Indebtedness ranking equally with the notes) with such Indebtedness.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">This covenant will not prevent us or any of our Restricted Subsidiaries from issuing, assuming or guaranteeing&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">any purchase money mortgage on such Principal Property prior to, simultaneously with or within 180 days after the later of (1) the acquisition or completion of construction or completion of substantial reconstruction, renovation, remodeling, expansion or improvement (each, a &#8220;substantial improvement&#8221;) of such Principal Property or (2) the placing in operation of such property after the acquisition or completion of any such construction or substantial improvement&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">Mortgages on a Principal Property existing at the time of acquisition, including acquisition through merger or consolidation&#59; </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">Mortgages existing on the date of the initial issuance of the notes, Mortgages on assets of a corporation or other business entity existing on the date it becomes a Restricted Subsidiary or is merged or consolidated with us or a Restricted Subsidiary or at the time </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">the corporation or other business entity sells, leases or otherwise disposes of its property as an entirety or substantially as an entirety to us or a Restricted Subsidiary or Mortgages on the assets of a Subsidiary that is newly designated as a Restricted Subsidiary if the Mortgage would have been permitted under the provisions of this paragraph if such Mortgage was created while the Subsidiary was a Restricted Subsidiary&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">Mortgages in favor of us or a Restricted Subsidiary&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">Mortgages for taxes, assessments or governmental charges or levies that are not delinquent or that are being contested in good faith&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">Carriers&#8217;, warehousemen&#8217;s, materialmen&#8217;s, repairmen&#8217;s, mechanic&#8217;s, landlords&#8217; and other similar Mortgages arising in ordinary course of business that are not delinquent or remain payable without penalty or that are being contested in good faith&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">Mortgages (other than any Mortgage imposed by ERISA) consisting of pledges or deposits required in the ordinary course of business in connection with workers&#8217; compensation, unemployment insurance and other social security legislation&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">Easements, rights-of-way, restrictions, encroachments, imperfections and other similar encumbrances affecting real property that, in the aggregate, are not substantial in amount and do not in any case materially detract from the value of the Principal Property subject thereto or materially interfere with the ordinary conduct of our and our Subsidiaries&#8217; business, taken as a whole&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">Mortgages arising by reason of deposits with, or the giving of any form of security to, any governmental agency or anybody created or approved by law or governmental regulation, including any zoning or similar law or right reserved to or vested in any governmental office or agency to control or regulate the use of any real property&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">Mortgages arising from filing Uniform Commercial Code financing statements relating solely to leases&#59; and</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">Mortgages to secure Indebtedness incurred to extend, renew, refinance or replace Indebtedness secured by any Mortgages referred to above, provided that the principal amount of the extended, renewed, refinanced or replaced Indebtedness does not exceed the principal amount of Indebtedness so extended, renewed, refinanced or replaced, plus transaction costs and fees, and that any such Mortgage applies only to the same property or assets subject to the prior permitted Mortgage (and, in the case of real property, improvements).</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:138%">Limitations on Sale and Leaseback Transactions</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">The Indenture contains a covenant that we will not, and will not permit our Restricted Subsidiaries to, enter into any arrangement with any person providing for the leasing by us or any Restricted Subsidiary of any Principal Property owned or acquired thereafter that has been or is to be sold or transferred by us or such Restricted Subsidiary to such person with the intention of taking back a lease of such Principal Property, a &#8220;sale and leaseback transaction,&#8221; without </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">equally and ratably securing the notes (and, if we shall so determine, any other Indebtedness ranking equally with the notes), unless&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">within 180 days after the receipt of the proceeds of the sale or transfer, we or any Restricted Subsidiary apply an amount equal to the greater of the net proceeds of the sale or transfer or the fair value of such Principal Property at the time of such sale or transfer to any (or a combination) of (1) the prepayment or retirement (other than any mandatory prepayment or retirement) of our Senior Funded Debt or (2) the purchase, construction, development, expansion or improvement of other comparable property, subject in each case to credits for voluntary retirements of Senior Funded Debt&#59; or</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">we or such Restricted Subsidiary would be entitled, at the effective date of the sale or transfer, to incur Indebtedness secured by a Mortgage on such Principal Property, in an amount at least equal to the Attributable Debt in respect of the sale and leaseback transaction, without equally and ratably securing the notes pursuant to &#8220;&#8212;Limitation on Liens&#8221; described above.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">The foregoing restriction will not apply to&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">any sale and leaseback transaction for a term of not more than three years including renewals&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">any sale and leaseback transaction with respect to a Principal Property if a binding commitment with respect thereto is entered into within three years after the later of (1) the date of the issuance of the notes under the Supplemental Indenture, or (2) the date such Principal Property was acquired&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">any sale and leaseback transaction with respect to a Principal Property if a binding commitment with respect thereto is entered into within 180 days after the later of the date such property was acquired and, if applicable, the date such property was first placed in operation&#59; or</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">any sale and leaseback transaction between us and a Restricted Subsidiary or between Restricted Subsidiaries.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%">Exception to Limitations for Exempted Debt</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">Notwithstanding the limitations in the Indenture on liens and sale and leaseback transactions, we or our Restricted Subsidiaries may, in addition to amounts permitted under such restrictions and without equally and ratably securing the notes, create or assume and renew, extend or replace Mortgages, or enter into sale and leaseback transactions without any obligation to retire any Senior Funded Debt of us or any Restricted Subsidiary, provided that at the time of such creation, assumption, renewal, extension or replacement of a Mortgage or at the time of entering into such sale and leaseback transactions, and after giving effect thereto, Exempted Debt does not exceed 15% of our Consolidated Net Tangible Assets.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%">Definitions</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">For purposes of the Indenture&#58;</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8220;Attributable Debt&#8221; in respect of a sale and leaseback transaction means, at the time of determination, the present value (discounted at the imputed rate of interest of such transaction as determined in good faith by us) of the obligation of the lessee for net rental payments during the remaining term of the lease included in such sale and leaseback transaction (including any period for which such lease has been extended or may, at the option of the lessor, be extended). The term &#8220;net rental payments&#8221; under any lease for any period means the sum of the rental and other payments required to be paid in such period by the lessee thereunder, not including any amounts required to be paid by such lessee (whether or not designated as rental or additional rent) on account of maintenance and repairs, insurance, taxes, assessments, water rates or similar charges required to be paid by such lessee thereunder or any amount required to be paid by lessee thereunder contingent upon the amount of maintenance and repairs, insurance, taxes, assessments, water rates or similar charges. In the case of any lease that is terminable by the lessee upon the payment of a penalty, such net amount shall be the lesser of (x) the net amount determined assuming termination upon the first date such lease may be terminated (in which case the net amount shall also include the amount of the penalty, but shall not include any rent that would be required to be paid under such lease subsequent to the first date upon which it may be so terminated) or (y) the net amount determined assuming no such termination.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8220;Consolidated Net Tangible Assets&#8221; means the total amounts of assets (less depreciation and valuation reserves and other reserves and items deductible from gross book value of specific asset accounts under generally accepted accounting principles) that under generally accepted accounting principles would be included on a consolidated balance sheet of us and our consolidated Restricted Subsidiaries after deducting (1) all current liabilities, excluding current liabilities that could be classified as long-term debt under generally accepted accounting principles and current liabilities that are by their terms extendable or renewable at the obligor&#8217;s option to a time more than 12 months after the time as of which the amount of current liabilities is being computed&#59; (2) investments in Unrestricted Subsidiaries&#59; and (3) all trade names, trademarks, licenses, patents, copyrights and goodwill, organizational and development costs, deferred charges, other than prepaid items such as insurance, taxes, interest, commissions, rents and similar items and tangible assets being amortized, and amortized debt discount and expense, less unamortized premium.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8220;Exempted Debt&#8221; means the sum of the following items outstanding as of the date Exempted Debt is being determined (1) Indebtedness of us and our Restricted Subsidiaries secured by a Mortgage and not permitted to exist under the Indenture and (2) Attributable Debt </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">of us and our Restricted Subsidiaries in respect of all sale and leaseback transactions not permitted under the Indenture.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8220;Funded Debt&#8221; means Indebtedness that matures more than one year from the date of creation, or that is extendable or renewable at the sole option of the obligor so that it may become payable more than one year from such date. Funded Debt does not include (1) obligations created pursuant to leases, (2) any Indebtedness or portion thereof maturing by its terms within one year from the time of any computation of the amount of outstanding Funded Debt unless such Indebtedness shall be extendable or renewable at the sole option of the obligor in such manner that it may become payable more than one year from such time, or (3) any Indebtedness for the payment or redemption of which money in the necessary amount shall have been deposited in trust either at or before the maturity date thereof.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8220;Indebtedness&#8221; means any and all of the obligations of a person for money borrowed that in accordance with generally accepted accounting principles would be reflected on the balance sheet of such person as a liability as of the date of which the Indebtedness is to be determined. Notwithstanding the foregoing, a change in generally accepted accounting principles subsequent to November 30, 2018 shall not be deemed an incurrence of Indebtedness.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8220;Investment&#8221; means any investment in stock, evidences of Indebtedness, loans or advances, however made or acquired, but does not include our account receivable or the accounts receivable of any Restricted Subsidiary arising from transactions in the ordinary course of business, or any evidences of Indebtedness, loans or advance made in connection with the sale to any Subsidiary of our accounts receivable or the accounts receivable of any Restricted Subsidiary arising from transactions in the ordinary course of business.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8220;Mortgage&#8221; means any mortgage, security interest, pledge, lien or other encumbrance.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8220;Principal Property&#8221; means all real property and improvements thereon owned by us or a Restricted Subsidiary, including, without limitation, any manufacturing, warehouse, distribution or research facility, and improvements therein, having a net book value in excess of 2% of Consolidated Net Tangible Assets that is located within the United States, excluding its territories and possessions and Puerto Rico. This term does not include any real property and improvements thereon that our Board of Directors declares by resolution not to be of material importance to the total business conducted by us and our Restricted Subsidiaries taken as a whole.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8220;Restricted Subsidiary&#8221; means a Subsidiary that owns a Principal Property.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8220;Senior Funded Debt&#8221; means all Funded Debt (except Funded Debt, the payment of which is subordinated to the payment of the notes).</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8220;Subsidiary&#8221; means a corporation, partnership or other legal entity of which, in the case of a corporation, more than 50% of the outstanding voting stock is owned, directly or indirectly, by us or by one or more other Subsidiaries, or by us and one or more other Subsidiaries or, in the case of any partnership or other legal entity, more than 50% of the ordinary capital interests is, at the time, directly or indirectly owned or controlled by us or by one or more other Subsidiaries. For the purposes of this definition, &#8220;voting stock&#8221; means the equity interest that ordinarily has voting power for the election of directors, managers or trustees of an entity, or persons performing similar functions, whether at all times or only so long as no senior class of equity interest has such voting power by reason of any contingency.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8220;Unrestricted Subsidiary&#8221; means any Subsidiary other than a Restricted Subsidiary.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Consolidation, Merger and Sale of Assets</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We may consolidate or merge with or into any other corporation, and we may sell or transfer all or substantially all of our assets to another corporation, provided, among other things, that (a) we are the surviving corporation or the corporation formed by or resulting from any such</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">consolidation or merger or the transferee of such assets shall be a corporation organized and existing under the laws of the United States, any state thereof or the District of Columbia and shall expressly assume by supplemental indenture payment of the principal of, and premium, if any, and interest, if any, on the notes issued under the Indenture and the performance and observance of the Indenture and (b) we or such successor corporation shall not immediately thereafter be in default under the Indenture.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Events of Default</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The following events are defined in the Indenture as &#8220;Events of Default&#8221;&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">default in the payment of any installment of interest on any series of notes for 30 days after becoming due&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">default in the payment of principal or premium, if any, of any series of notes when due&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">default in the deposit of any sinking fund payment, when due&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">default in the performance of any other covenant for 90 days after notice, which must be sent by either the trustee or holders of 25% of the principal amount of the notes of the affected series&#894; and</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">certain events of bankruptcy, insolvency or reorganization.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If an Event of Default occurs and continues with respect to a series of notes, either the trustee or the holders of at least 25% in principal amount of the outstanding notes of such series may declare the entire principal amount of all the notes of such series to be due and payable&#894; provided that, in the case of an Event of Default involving certain events of bankruptcy, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">insolvency or reorganization, such acceleration is automatic&#894; and, provided further, that after such acceleration, but before a judgment or decree based on acceleration, the holders of a majority in aggregate principal amount of the outstanding notes of that series may, subject to certain conditions, rescind and annul such acceleration if all Events of Default, other than the nonpayment of accelerated principal, have been cured or waived. </font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>4
<FILENAME>ex10i2023nqstockoptionawar.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i548e6510261a48ef9d6d8529bae406c9_1"></div><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(i)</font></div></div><div style="padding-left:432.3pt"><font><br></font></div><div style="padding-left:432.3pt"><img alt="image_0a.jpg" src="image_0a.jpg" style="height:34px;margin-bottom:5pt;vertical-align:text-bottom;width:135px"></div><div style="margin-top:5.1pt;padding-left:7.2pt"><font style="color:#ffb500;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:100%">Kevin </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:100%">A. Lobo</font></div><div style="margin-top:5.95pt;padding-left:7.2pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Chair and CEO</font></div><div style="margin-top:6pt;padding-left:7.15pt;padding-right:403.1pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2825 Airview Boulevard Kalamazoo MI 49002 USA P 269 389 7353</font></div><div style="margin-top:0.05pt;padding-left:7.2pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">www.stryker.com</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:5pt;padding-left:5.75pt"><font style="color:#ffb500;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Personal and confidential</font></div><div><font><br></font></div><div style="padding-left:5.75pt;padding-right:430.45pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:232%">February 9, 2023 </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:232%;text-decoration:underline">First Name Last Name</font></div><div style="padding-left:5.75pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Dear First Name&#58;</font></div><div><font><br></font></div><div style="padding-left:5.75pt;padding-right:6.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">I am pleased to inform you that you are one of a select group of individuals receiving a stock option award in 2023. We use these awards to reward performers who we believe will be key contributors to our growth well into the future. The total Award Date Value (ADV) of your award is approximately USD $xx,xxx.</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:5.75pt;padding-right:6.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">We are awarding you a nonstatutory stock option for xxx shares of Stryker Corporation Common Stock at a price of USD $xxx.xx per share. Except as otherwise provided in the Terms and Conditions, you may exercise this option at 20% per year beginning on February 9, 2024, and it will expire on February 8, 2033.</font></div><div><font><br></font></div><div style="padding-left:5.75pt;padding-right:4.9pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:100%">You must &#8220;Accept&#8221; the award online via the UBS One Source web site located at </font><font style="color:#529cdb;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">www.ubs.com&#47;onesource&#47;SYK</font><font style="color:#529cdb;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:100%">between March 1 and March 31, 2023</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The detailed terms of the option are in the Terms and Conditions, any applicable country addendum and the provisions of the Company's 2011 Long- Term Incentive Plan, as Amended and Restated. Those documents, together with the related Prospectus, are available on the UBS One Source web site, and you should read them before accepting the award. In addition, you may be asked to sign the most recent version of Stryker&#8217;s Confidentiality, Intellectual Property, Non-Competition and Non-Solicitation Agreement (&#8220;Non-Compete Agreement&#8221;) in connection with this award. If you are asked to sign the Non-Compete Agreement, it will be emailed to you and you will be asked to sign the document electronically via Adobe Sign by March 31, 2023. The exercisability of the options is conditioned on you having signed the Non-Compete Agreement by March 31, 2023, where permitted by applicable law.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:5.75pt;text-indent:-0.05pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">You can find additional educational materials on the UBS One Source web site in the Resources section, including Stock Option brochure and Stock Option Tax Questions &#38; Answers.</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:5.75pt;padding-right:34.3pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">We are committed to growing talent and want our people to experience rewarding careers at Stryker. Your valuable contributions helped us deliver strong results during a challenging year and I look forward to our continued business growth and success.</font></div><div style="padding-right:34.3pt;text-align:justify"><font><br></font></div><div style="margin-top:10.5pt;padding-left:5.75pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Sincerely,</font></div><div><font><br></font></div><div style="margin-top:10.5pt;padding-left:5.75pt"><img alt="image_1a.jpg" src="image_1a.jpg" style="height:93px;margin-bottom:5pt;vertical-align:text-bottom;width:85px"></div><div style="padding-left:5.75pt;padding-right:445.4pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Kevin A. Lobo Chair and CEO</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i548e6510261a48ef9d6d8529bae406c9_4"></div><hr style="page-break-after:always"><div style="min-height:61.2pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(i)</font></div></div><div style="margin-top:3.8pt;padding-left:170.55pt;padding-right:170.55pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">STRYKER CORPORATION</font></div><div style="margin-top:0.65pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:170.55pt;padding-right:170.55pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">TERMS AND CONDITIONS</font></div><div style="padding-left:38.25pt;padding-right:38.25pt;text-align:center;text-indent:-0.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">RELATING TO NONSTATUTORY STOCK OPTIONS GRANTED PURSUANT TO THE 2011 LONG-TERM INCENTIVE PLAN, AS AMENDED AND RESTATED</font></div><div style="margin-top:13.8pt;padding-left:35.95pt;padding-right:35.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.95pt">The Options to purchase Shares of Stryker Corporation (the &#8220;Company&#8221;) granted to you during 2023 are subject to these Terms and Conditions Relating to Nonstatutory Stock Options Granted Pursuant to the 2011 Long-Term Incentive Plan, as Amended and Restated (the &#8220;Terms and Conditions&#8221;) and all of the terms and conditions of the Stryker Corporation 2011 Long-Term Incentive Plan, as Amended and Restated (the &#8220;2011 Plan&#8221;), which is incorporated herein by reference. In the case of a conflict between these Terms and Conditions and the terms of the 2011 Plan, the provisions of the 2011 Plan will govern. Capitalized terms used but not defined herein have the meaning provided therefor in the 2011 Plan. For purposes of these Terms and Conditions, &#8220;Employer&#8221; means the Company or any Subsidiary that employs you on the applicable date, and &#34;Stock Plan Administrator&#34; means UBS Financial Services Inc. (or any other independent service provider engaged by the Company to assist with the implementation, operation and administration of the 2011 Plan).</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.9pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.95pt">Upon the termination of your employment with your Employer, your right to exercise the Options shall be only as follows&#58;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:35.95pt;padding-right:35.8pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.09pt">If your employment is terminated by reason of Disability (as such term is defined in the 2011 Plan) or death, you, your legal representative or your estate shall have the right, for a period of one (1) year following such termination, to exercise the Options with respect to all or any part of the Shares subject thereto, regardless of whether the right to purchase such Shares had vested on or before the date of your termination by Disability or death.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:35.95pt;padding-right:35.75pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.38pt">If your employment is terminated by reason of Retirement (as such term is defined in the 2011 Plan) prior to the date that your Options become fully vested, you will continue to vest in your Options in accordance with the vesting schedule as set forth in the award letter as if you had continued your employment with your Employer. You (or your estate in the event of your death after your termination by Retirement) shall have the right, at any time on or prior to the 10th anniversary of the grant date, to exercise the vested portion of the Options.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:35.95pt;padding-right:35.7pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.65pt">If you cease to be an Employee for any reason other than those provided in (a) or (b) above, you or your estate (in the event of your death after such termination) may, within the 30-day period following such termination, exercise the Options with respect to only such number of Shares as to which the right of exercise had vested on or before the Termination Date. If you are a resident of or employed in the United States, &#8220;Termination Date&#8221; shall mean the effective date of termination of your employment with</font></div><div style="text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:61.2pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(i)</font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:3.8pt;padding-left:35.95pt;padding-right:35.85pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">your Employer. If you are resident or employed outside of the United States, &#8220;Termination Date&#8221; shall mean the earliest of (i) the date on which notice of termination is provided to you,</font></div><div style="padding-left:35.95pt;padding-right:35.85pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii) the last day of your active service with your Employer, or (iii) the last day on which you are an Employee of your Employer, as determined in each case without including any required advance notice period and irrespective of the status of the termination under local labor or employment laws.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:35.95pt;padding-right:35.75pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.29pt">Notwithstanding the foregoing, the Options shall not be exercisable in whole or in part (i) after the 10th anniversary of the grant date or (ii) except as provided in Section 3(c) hereof or in the event of termination of employment because of Disability, Retirement or death, unless you shall have continued in the employ of the Company or one of its Subsidiaries for one (1) year following the date of grant of the Options.</font></div><div><font><br></font></div><div style="padding-left:35.95pt;padding-right:35.8pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.09pt">Notwithstanding the foregoing, if you are eligible for Retirement but cease to be an Employee for any other reason before you retire, the right to exercise the Options shall be determined as if your employment ceased by reason of Retirement.</font></div><div><font><br></font></div><div style="padding-left:35.95pt;padding-right:35.95pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:23.31pt">If you are both an Employee and a Director, the provisions of this Section 2 shall not apply until such time as you are neither an Employee nor a Director.</font></div><div><font><br></font></div><div style="padding-left:35.95pt;padding-right:35.95pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">The number of Shares subject to the Options and the price to be paid therefor shall be subject to adjustment and the term and exercise dates hereof may be accelerated as follows&#58;</font></div><div><font><br></font></div><div style="padding-left:35.95pt;padding-right:35.7pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.09pt">In the event that the Shares, as presently constituted, shall be changed into or exchanged for a different number or kind of shares of stock or other securities of the Company or of another corporation (whether by reason of merger, consolidation, recapitalization, reclassification, split-up, combination of shares, or otherwise) or if the number of such Shares shall be increased through the payment of a stock dividend or a dividend on the Shares of rights or warrants to purchase securities of the Company shall be made, then there shall be substituted for or added to each Share theretofore subject to the Options the number and kind of shares of stock or other securities into which each outstanding Share shall be so changed, or for which each such Share shall be exchanged, or to which each such Share shall be entitled. The Options shall also be appropriately amended as to price and other terms as may be necessary to reflect the foregoing events. In the event there shall be any other change in the number or kind of the outstanding Shares, or of any stock or other securities into which such Common Stock shall have been exchanged, then if the Committee shall, in its sole discretion, determine that such change equitably requires an adjustment in the Options, such adjustment shall be made in accordance with such determination.</font></div><div><font><br></font></div><div style="padding-left:35.95pt;padding-right:35.9pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.38pt">Fractional Shares resulting from any adjustment in the Options may be settled in cash or otherwise as the Committee shall determine, in its sole discretion. Notice of any adjustment will be given to you and such adjustment (whether or not such notice is given) shall be effective and binding for all purposes hereof.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:61.2pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(i)</font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:3.8pt;padding-left:36pt;padding-right:35.85pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.6pt">The Committee shall have the power to amend the Options to permit the exercise of the Options (and to terminate any unexercised Options) prior to the effectiveness of (i) any disposition of substantially all of the assets of the Company or your Employer, (ii) the shutdown, discontinuance of operations or dissolution of the Company or your Employer, or (iii) the merger or consolidation of the Company or your Employer with or into any other unrelated corporation.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:36pt;padding-right:35.6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt">To exercise the Options, you must complete the on-line exercise procedures as established through the Stock Plan Administrator at </font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">www.ubs.com&#47;onesource&#47;SYK</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> or by telephone at +1 860 727 1515 (or such other direct dial-in number that may be established from time to time). As part of such procedures, you shall be required to specify the number of Shares that you elect to purchase and the date on which such purchase is to be made, and you shall be required to make full payment of the Exercise Price. An Option shall not be deemed to have been exercised (i.e., the exercise date shall not be deemed to have occurred) until the notice of such exercise and payment in full of the Exercise Price are provided. The exercise date will be defined by the New York Stock Exchange (&#8220;NYSE&#8221;) trading hours. If an exercise is completed after the market close or on a weekend, the exercise will be dated the next following trading day.</font></div><div style="margin-top:12.05pt;padding-left:36pt;padding-right:35.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Exercise Price may be paid in such manner as the Committee may specify from time to time in its sole discretion and as established through Stock Plan Administrator, including (but not limited to) the following methods&#58; (i) by a net exercise arrangement pursuant to which the Company will reduce the number of Shares issued upon exercise by the largest whole number of Shares with an aggregate Fair Market Value on the date of purchase sufficient to cover the aggregate Exercise Price&#59; (ii) by a broker-assisted cashless exercise transaction pursuant to which the Stock Plan Administrator loans funds to you to enable you to pay the aggregate Exercise Price and purchase Shares, and then sells a sufficient &#91;whole&#93; number of the purchased Shares on your behalf to enable you to repay the aggregate Exercise Price (with the remaining Shares and&#47;or cash then delivered by Stock Plan Administrator to you) or (iii) cash payment. In cases where you utilize the net exercise arrangement and the Fair Market Value of the number of whole Shares withheld or sold, as applicable, is greater than the aggregate Exercise Price, the Company shall make a cash payment to you equal to the difference as soon as administratively practicable.</font></div><div style="margin-top:11.95pt;padding-left:35.95pt;padding-right:35.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.95pt">If you are resident and&#47;or employed outside of the United States, you agree, as a condition of the grant of the Options, to repatriate all payments attributable to the Shares and&#47;or cash acquired under the 2011 Plan (including, but not limited to, dividends and any proceeds derived from the sale of the Shares acquired pursuant to the Options) if required by and in accordance with local foreign exchange rules and regulations in your country of residence (and country of employment, if different). In addition, you also agree to take any and all actions, and consent to any and all actions taken by the Company and its Subsidiaries, as may be required to allow the Company and its Subsidiaries to comply with local laws, rules and regulations in your country of residence (and country of employment, if different). Finally, you agree to take any and all actions as may be required to comply with your personal legal and tax obligations under local laws, rules and regulations in your country of residence (and country of employment, if different).</font></div><div style="text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:61.2pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(i)</font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:3.8pt;padding-left:36pt;padding-right:35.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt">If you are resident or employed in a country that is a member of the European Union, the grant of the Options and these Terms and Conditions are intended to comply with the age discrimination provisions of the EU Equal Treatment Framework Directive, as implemented into local law (the &#8220;Age Discrimination Rules&#8221;). To the extent that a court or tribunal of competent jurisdiction determines that any provision of these Terms and Conditions is invalid or unenforceable, in whole or in part, under the Age Discrimination Rules, the Company, in its sole discretion, shall have the power and authority to revise or strike such provision to the minimum extent necessary to make it valid and enforceable to the full extent permitted under local law.</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt">Regardless of any action the Company and&#47;or your Employer take with respect to any or all income tax (including U.S. federal, state and local taxes and&#47;or non-U.S. taxes), social insurance, payroll tax, payment on account or other tax-related withholding (&#8220;Tax-Related Items&#8221;), you acknowledge that the ultimate liability for all Tax-Related Items legally due by you is and remains your responsibility and that the Company and your Employer (i) make no representations or undertakings regarding the treatment of any Tax- Related Items in connection with any aspect of the Options, including the grant of the Options, the vesting of the Options, the exercise of the Options, the subsequent sale of any Shares acquired pursuant to the Options and the receipt of any dividends and (ii) do not commit to structure the terms of the grant or any aspect of the Options to reduce or eliminate your liability for Tax-Related Items. Further, if you become subject to taxation in more than one country between the grant date and the date of any relevant taxable or tax withholding event, as applicable, you acknowledge that the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one country.</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Prior to the delivery of Shares upon exercise of your Options, if your country of residence (and&#47;or your country of employment, if different) requires withholding of Tax- Related Items, the Company may withhold a number of whole Shares otherwise issuable upon exercise of the Options that have an aggregate Fair Market Value that the Company, taking into account local requirements and administrative issues, determines in its sole discretion is appropriate to cover withholding for Tax-Related Items with respect to the Shares. The cash equivalent of the Shares withheld will be used to settle the obligation to withhold the Tax-Related Items. In cases where the Fair Market Value of the number of whole Shares withheld at the time of exercise is greater than the amount required to be paid to the relevant government authorities with respect to withholding for Tax-Related Items, the Company shall make a cash payment to you equal to the difference as soon as administratively practicable. In the event that withholding in Shares is prohibited or problematic under applicable law or causes adverse consequences to the Company or your Employer, your Employer may withhold the Tax-Related Items required to be withheld with respect to the Shares (i) from the proceeds of the sale of Shares acquired upon exercise of the Options either through a voluntary sale or through a mandatory sale arranged by the Company (on your behalf pursuant to this authorization without further consent), or (ii) in cash from your regular salary and&#47;or wages or other amounts payable to you. In the event the withholding requirements are not satisfied through the withholding of Shares or through your regular salary and&#47;or wages or any other amounts payable to you by your Employer, no Shares will be issued to you (or your estate) upon exercise of the Options unless and until satisfactory arrangements (as determined by the Board of Directors) have been made by you</font></div><div style="text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:61.2pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(i)</font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:3.8pt;padding-left:36pt;padding-right:35.8pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">with respect to the payment of any Tax-Related Items that the Company or your Employer determines, in its sole discretion, should be withheld or collected with respect to such Options. By accepting these Options, you expressly consent to the withholding of Shares and&#47;or withholding from your regular salary and&#47;or wages or other amounts payable to you as provided for hereunder. All other Tax-Related Items related to the Options and any Shares delivered in payment thereof are your sole responsibility.</font></div><div style="margin-top:12pt;padding-left:36pt;padding-right:35.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt">The Options are intended to be exempt from the requirements of Code Section 409A. The 2011 Plan and these Terms and Conditions shall be administered and interpreted in a manner consistent with this intent. If the Company determines that these Terms and Conditions are subject to Code Section 409A and that it has failed to comply with the requirements of that Section, the Company may, at the Company&#8217;s sole discretion and without your consent, amend these Terms and Conditions to cause them to comply with Code Section 409A or be exempt from Code Section 409A.</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.75pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.95pt">If you were required to sign the &#8220;Stryker Confidentiality, Intellectual Property, Non-Competition and Non-Solicitation Agreement&#8221; or a similar agreement in order to receive the Options or have previously signed such an agreement and you breach any non- competition, non-solicitation or non-disclosure provision or provision as to ownership of inventions contained therein at any time while employed by the Company or a Subsidiary or during the one-year period following termination of employment, any unexercised portion of the Options shall be rescinded and you shall return to the Company all Shares that were acquired upon exercise of the Options that you have not disposed of and the Company shall repay you an amount for each such Share equal to the lesser of the Exercise Price or the Fair Market Value of a Share at such time. Further, you shall pay to the Company an amount equal to the profit realized by you (if any) on all Shares that were acquired upon exercise of the Options that you have disposed of. For purposes of the preceding sentence, the profit shall be the positive difference between the Fair Market Value of the Shares at the time of disposition and the Exercise Price.</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.8pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.31pt">The Options shall be transferable only by will or the laws of descent and distribution and shall be exercisable during your lifetime only by you. If you purport to make any transfer of the Options, except as aforesaid, the Options and all rights thereunder shall terminate immediately.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:36pt;padding-right:35.7pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.31pt">The Options shall not be exercisable in whole or in part, and the Company shall not be obligated to issue any Shares subject to the Options, if such exercise and sale would, in the opinion of counsel for the Company, violate the Securities Act of 1933 or any other U.S. federal, state or non-U.S. statute having similar requirements as it may be in effect at the time. The Options are subject to the further requirement that, if at any time the Board of Directors shall determine in its discretion that the listing or qualification of the Shares subject to the Options under any securities exchange requirements or under any applicable law, or the consent or approval of any governmental regulatory body, is necessary or desirable as a condition of or in connection with the issuance of Shares pursuant to the Options, the Options may not be exercised in whole or in part unless such listing, qualification, consent or approval shall have been effected or obtained free of any conditions not acceptable to the Board of Directors.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i548e6510261a48ef9d6d8529bae406c9_7"></div><hr style="page-break-after:always"><div style="min-height:74.88pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(i)</font></div></div><div style="margin-top:3.8pt;padding-left:36pt;padding-right:35.7pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">12.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.31pt">The grant of the Options shall not confer upon you any right to continue in the employ of your Employer nor limit in any way the right of your Employer to terminate your employment at any time. You shall have no rights as a shareholder of the Company with respect to any Shares issuable upon the exercise of the Options until the date of issuance of such Shares.</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:36pt;padding-right:35.8pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">13.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.31pt">You acknowledge and agree that the 2011 Plan is discretionary in nature and may be amended, cancelled, or terminated by the Company, in its sole discretion, at any time. The grant of the Options under the 2011 Plan is a one-time benefit and does not create any contractual or other right to receive a grant of Options or any other award under the 2011 Plan or other benefits in lieu thereof in the future. Future grants, if any, will be at the sole discretion of the Company, including, but not limited to, the form and timing of any grant, the number of Shares subject to the grant, the vesting provisions and the exercise price. Any amendment, modification or termination of the 2011 Plan shall not constitute a change or impairment of the terms and conditions of your employment with your Employer.</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.7pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">14.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.31pt">Your participation in the 2011 Plan is voluntary. The value of the Options and any other awards granted under the 2011 Plan is an extraordinary item of compensation outside the scope of your employment (and your employment contract, if any). Any grant under the 2011 Plan, including the grant of the Options, is not part of normal or expected compensation for purposes of calculating any severance, resignation, redundancy, end of service payments, bonuses, long-service awards, pension, or retirement benefits or similar payments.</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.31pt">These Terms and Conditions shall bind and inure to the benefit of the Company, its successors and assigns and you and your estate in the event of your death.</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">16.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.31pt">The Options are Nonstatutory Stock Options and shall not be treated as Incentive Stock Options.</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.8pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">17.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.31pt">The Company is located at 2825 Airview Boulevard Kalamazoo, Michigan 49002, U.S.A. and grants Options under the 2011 Plan to employees of the Company and Subsidiaries in its sole discretion. In conjunction with the Company&#8217;s grant of the Options under the 2011 Plan and its ongoing administration of such awards, the Company is providing the following information about its data collection, processing and transfer practices (&#8220;Personal Data Activities&#8221;). In accepting the grant of the Options, you expressly and explicitly consent to the Personal Data Activities as described herein.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:36pt;padding-right:35.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Company collects, processes and uses your personal data, including your name, home address, email address, and telephone number, date of birth, social insurance number or other identification number, salary, citizenship, job title, any Shares or directorships held in the Company, and details of all Options or any other equity compensation awards granted, canceled, exercised, vested, or outstanding in your favor, which the Company receives from you or your Employer. In granting the Options under the Plan, the Company will collect your personal data for purposes of allocating Shares and implementing, administering and managing the 2011 Plan. The Company&#8217;s legal basis for the collection, processing and usage</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i548e6510261a48ef9d6d8529bae406c9_10"></div><hr style="page-break-after:always"><div style="min-height:61.2pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(i)</font></div></div><div style="margin-top:3.8pt;padding-left:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">of your personal data is your consent.</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.75pt;text-align:justify;text-indent:49.5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:7.49pt">The Company transfers your personal data to the Stock Plan Administrator. In the future, the Company may select a different Stock Plan Administrator and share your personal data with another company that serves in a similar manner. The Stock Plan Administrator will open an account for you, if an account is not already in place, to receive and trade Shares acquired under the 2011 Plan. You will be asked to agree on separate terms and data processing practices with the Stock Plan Administrator, which is a condition to your ability to participate in the 2011 Plan.</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.75pt;text-align:justify;text-indent:49.5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:6.78pt">The Company and the Stock Plan Administrator are based in the United States. You should note that your country of residence may have enacted data privacy laws that are different from the United States. The Company&#8217;s legal basis for the transfer of your personal data to the United States is your consent.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:36pt;padding-right:35.85pt;text-align:justify;text-indent:49.5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:8.05pt">Your participation in the 2011 Plan and your grant of consent is purely voluntary. You may deny or withdraw your consent at any time. If you do not consent, or if you withdraw your consent, you may be unable to participate in the 2011 Plan. This would not affect your existing employment or salary&#59; instead, you merely may forfeit the opportunities associated with the 2011 Plan.</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.8pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You may have a number of rights under the data privacy laws in your country of residence. For example, your rights may include the right to (i) request access or copies of personal data the Company processes, (ii) request rectification of incorrect data, (iii) request deletion of data, (iv) place restrictions on processing, (v) lodge complaints with competent authorities in your country or residence, and&#47;or (vi) request a list with the names and addresses of any potential recipients of your personal data. To receive clarification regarding your rights or to exercise your rights, you should contact your local HR manager or the Company&#8217;s Human Resources Department.</font></div><div><font><br></font></div><div style="padding-left:35.95pt;padding-right:35.75pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">18.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.36pt">The grant of the Options is not intended to be a public offering of securities in your country of residence (and country of employment, if different). The Company has not submitted any registration statement, prospectus or other filing(s) with the local securities authorities (unless otherwise required under local law). </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">No employee of the Company is permitted to advise you on whether you should purchase Shares under the 2011 Plan or provide you with any legal, tax or financial advice with respect to the grant of your Options. Investment in Shares involves a degree of risk. Before deciding to purchase Shares pursuant to the Options, you should carefully consider all risk factors and tax considerations relevant to the acquisition of Shares under the 2011 Plan or the disposition of them. Further, you should carefully review all of the materials related to the Options and the 2011 Plan, and you should consult with your personal legal, tax and financial advisors for professional advice in relation to your personal circumstances.</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:36pt;padding-right:35.9pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">19.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.31pt">All questions concerning the construction, validity and interpretation of the Options and the 2011 Plan shall be governed and construed according to the laws of the state of Michigan, without regard to the application of the conflicts of laws provisions thereof. Any</font></div><div style="text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:61.2pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(i)</font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:3.8pt;padding-left:36pt;padding-right:6.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">disputes regarding the Options or the 2011 Plan shall be brought only in the state or federal courts of the state of Michigan.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:36pt;padding-right:35.65pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">20.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.31pt">The Company may, in its sole discretion, decide to deliver any documents related to the Options or other awards granted to you under the 2011 Plan by electronic means. You hereby consent to receive such documents by electronic delivery and agree to participate in the 2011 Plan through an on-line or electronic system established and maintained by the Company or a third party designated by the Company.</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.8pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">21.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.31pt">The invalidity or unenforceability of any provision of the 2011 Plan or these Terms and Conditions shall not affect the validity or enforceability of any other provision of the 2011 Plan or these Terms and Conditions.</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.8pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">22.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.31pt">If you are resident outside of the United States, you acknowledge and agree that it is your express intent that these Terms and Conditions, the 2011 Plan and all other documents, notices and legal proceedings entered into, given or instituted pursuant to the Options be drawn up in English. If you have received these Terms and Conditions, the 2011 Plan or any other documents related to the Options translated into a language other than English and the meaning of the translated version is different than the English version, the English version will control.</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.65pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">23.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.31pt">You acknowledge that, depending on your or your broker's country of residence or where the Shares are listed, you may be subject to insider trading restrictions and&#47;or market abuse laws which may affect your ability to accept, acquire, sell or otherwise dispose of Shares, rights to Shares (e.g., Options) or rights linked to the value of Shares during such times you are considered to have &#8220;inside information&#8221; regarding the Company as defined in the laws or regulations in your country of employment (and country of residence, if different). Local insider trading laws and regulations may prohibit the cancellation or amendment of orders you placed before you possessed inside information. Furthermore, you could be prohibited from (i) disclosing the inside information to any third party (other than on a &#8220;need to know&#8221; basis) and (ii) &#8220;tipping&#8221; third parties or causing them otherwise to buy or sell securities. Third parties include fellow employees. Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under any applicable Company insider trading policy. You acknowledge that it is your responsibility to comply with any restrictions and are advised to speak to your personal advisor on this matter.</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">24.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.26pt">Notwithstanding any provisions of these Terms and Conditions to the contrary, the Options shall be subject to any special terms and conditions for your country of residence (and country of employment, if different) set forth in an addendum to these Terms and Conditions (an &#8220;Addendum&#8221;). Further, if you transfer your residence and&#47;or employment to another country reflected in an Addendum to these Terms and Conditions at the time of transfer, the special terms and conditions for such country will apply to you to the extent the Company determines, in its sole discretion, that the application of such special terms and conditions is necessary or advisable in order to comply with local law, rules and regulations, or to facilitate the operation and administration of the award and the 2011 Plan (or the Company may establish alternative terms and conditions as may be necessary or</font></div><div style="text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:61.2pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(i)</font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:3.8pt;padding-left:36pt;padding-right:23.9pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">advisable to accommodate your transfer). In all circumstances, any applicable Addendum shall constitute part of these Terms and Conditions.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:36pt;padding-right:35.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">25.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.26pt">The Company reserves the right to impose other requirements on the Options, any Shares acquired pursuant to the Options and your participation in the 2011 Plan to the extent the Company determines, in its sole discretion, that such other requirements are necessary or advisable in order to comply with local law, rules and regulations, or to facilitate the operation and administration of the award and the 2011 Plan. Such requirements may include (but are not limited to) requiring you to sign any agreements or undertakings that may be necessary to accomplish the foregoing.</font></div><div><font><br></font></div><div style="padding-left:35.95pt;padding-right:35.6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">26.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:20.31pt">This Section 26 applies only to those persons whom the Company&#8217;s Recoupment Policy applies (the corporate officers elected by the Company&#8217;s Board of Directors other than Assistant Controllers, Assistant Secretaries and Assistant Treasurers)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Notwithstanding any other provision of these Terms and Conditions to the contrary, you acknowledge and agree that your Options, any Shares acquired pursuant thereto and&#47;or any amount received with respect to any sale of such Shares are subject to potential cancellation, recoupment, rescission, payback or other action in accordance with the terms of the Company&#8217;s Recoupment Policy as in effect on the date of grant (a copy of which has been furnished to you) and as the Recoupment Policy may be amended from time to time in order to comply with changes in laws, rules or regulations that are applicable to such Options and Shares. You agree and consent to the Company&#8217;s application, implementation and enforcement of (a) the Recoupment Policy and (b) any provision of applicable law relating to cancellation, recoupment, rescission or payback of compensation and expressly agree that the Company may take such actions as are necessary to effectuate the Recoupment Policy (as applicable to you) or applicable law without further consent or action being required by you. For purposes of the foregoing, you expressly and explicitly authorize the Company to issue instructions, on your behalf, to any brokerage firm and&#47;or third party administrator engaged by the Company to hold your Shares and other amounts acquired under the Plan to re-convey, transfer or otherwise return such Shares and&#47;or other amounts to the Company. In the case of a conflict between these Terms and Conditions and the Recoupment Policy, the terms of the Recoupment Policy shall prevail.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:36pt;padding-right:35.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">27.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:20.26pt">By accepting the grant of Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">you acknowledge that you have read these Terms and Conditions, the Addendum to these Terms and Conditions (as applicable) and the 2011 Plan and specifically accept and agree to the provisions therein.</font></div><div><font><br></font></div><div style="margin-top:11.65pt;padding-left:170.52pt;padding-right:170.52pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">*****************************</font></div><div style="text-align:center"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:61.2pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(i)</font></div></div><div style="text-align:center"><font><br></font></div><div style="margin-top:3.8pt;padding-left:170.55pt;padding-right:170.55pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">STRYKER CORPORATION</font></div><div><font><br></font></div><div style="padding-left:200.35pt;padding-right:189.6pt;text-indent:27pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ADDENDUM TO TERMS AND CONDITIONS</font></div><div style="padding-left:101.05pt;padding-right:48.8pt;text-indent:8pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">RELATING TO NONSTATUTORY STOCK OPTIONS GRANTED PURSUANT TO THE 2011 PLAN, AS AMENDED AND RESTATED</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:35.95pt;padding-right:35.8pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In addition to the terms of the 2011 Plan and the Terms and Conditions, the Options are subject to the following additional terms and conditions (the &#8220;Addendum&#8221;). </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">The information reflected in this Addendum is based on the securities, exchange control and other laws in effect in the respective countries as of December 2022. </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">All capitalized terms as contained in this Addendum shall have the same meaning as set forth in the 2011 Plan and the Terms and Conditions. Pursuant to Section 24 of the Terms and Conditions, if you transfer your residence and&#47;or employment to another country reflected in an Addendum at the time of transfer, the special terms and conditions for such country will apply to you to the extent the Company determines, in its sole discretion, that the application of such terms and conditions is necessary or advisable in order to comply with local law, rules and regulations, or to facilitate the operation and administration of the award and the 2011 Plan (or the Company may establish alternative terms and conditions as may be necessary or advisable to accommodate your transfer).</font></div><div style="text-indent:36pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:36pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Data Privacy Information&#58; European Union (&#8220;EU&#8221;) &#47; European Economic Area (&#8220;EEA&#8221;)</font></div><div style="margin-top:0.05pt;padding-left:36pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#47; Switzerland and the United Kingdom*                                                                                              </font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:5.05pt;padding-left:35.95pt;padding-right:35.8pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">*The below information is for data privacy purposes only and you should determine whether any other special terms and conditions apply to your awards in these jurisdictions.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:36pt;padding-right:35.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Data Privacy</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. If you reside and&#47;or you are employed in the EU &#47; EEA, Switzerland or the United Kingdom the following provision replaces Section 17 of the Terms and Conditions&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.65pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Company is located at 2825 Airview Boulevard Kalamazoo, Michigan 49002, U.S.A. and grants Options under the 2011 Plan to employees of the Company and its Subsidiaries in its sole discretion. You should review the following information about the Company&#8217;s data processing practices.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:36pt;padding-right:35.7pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:34.49pt;text-decoration:underline">Data Collection, Processing and Usage</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Pursuant to applicable data protection laws, you are hereby notified that the Company collects, processes and uses certain personally-identifiable information about you for the legitimate interest of implementing, administering and managing the 2011 Plan and generally administering equity awards&#59; specifically, including your name, home address, email address and telephone number, date of birth, social insurance number or other identification number, salary, citizenship, job title, any Shares or directorships held in the Company, and details of all options or any other awards granted, canceled, exercised, vested, or outstanding in your favor, which the Company receives from you or your Employer. In granting the Options under the 2011 Plan, the Company will collect your personal data for purposes of allocating Shares and</font></div><div style="text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:61.2pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(i)</font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:3.8pt;padding-left:36pt;padding-right:35.85pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">implementing, administering and managing the 2011 Plan. The Company&#8217;s collection, processing, use and transfer of your personal data is necessary for the performance of the Company&#8217;s contractual obligations under the Plan and pursuant to the Company&#8217;s legitimate interest of managing and generally administering employee equity awards. Your refusal to provide personal data would make it impossible for the Company to perform its contractual obligations and may affect your ability to participate in the 2011 Plan. As such, by participating in the 2011 Plan, you voluntarily acknowledge the collection, processing and use of your personal data as described herein.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:36pt;padding-right:35.75pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:33.78pt;text-decoration:underline">Stock Plan Administration Service Provider</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company transfers participant data to the Stock Plan Administrator. In the future, the Company may select a different Stock Plan Administrator and share your data with another company that serves in a similar manner. The Stock Plan Administrator will open an account for you, if an account is not already in place, to receive and trade Shares acquired under the 2011 Plan. You will be asked to agree on separate terms and data processing practices with the Stock Plan Administrator, which is a condition to your ability to participate in the 2011 Plan.</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.7pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:35.05pt;text-decoration:underline">International Data Transfers</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company and the Stock Plan Administrator are based in the United States. The Company can only meet its contractual obligations to you if your personal data is transferred to the United States. The Company&#8217;s legal basis for the transfer of your personal data to the United States is to satisfy its contractual obligations to you and&#47;or its use of the standard data protection clauses adopted by the EU Commission.</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:35.95pt;padding-right:35.85pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:33.74pt;text-decoration:underline">Data Retention</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company will use your personal data only as long as is necessary to implement, administer and manage your participation in the 2011 Plan or as required to comply with legal or regulatory obligations, including under tax and security laws. When the Company no longer needs your personal data, the Company will remove it from its systems. If the Company keeps your data longer, it would be to satisfy legal or regulatory obligations and the Company&#8217;s legal basis would be for compliance with relevant laws or regulations.</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.75pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:34.49pt;text-decoration:underline">Data Subject Rights</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. You may have a number of rights under data privacy laws in your country of residence. For example, your rights may include the right to (i) request access or copies of personal data the Company processes, (ii) request rectification of incorrect data, (iii) request deletion of data, (iv) place restrictions on processing, (v) lodge complaints with competent authorities in your country of residence, and&#47;or (vi) request a list with the names and addresses of any potential recipients of the Participant&#8217;s personal data. To receive clarification regarding your rights or to exercise your rights, you should contact your local HR manager or the Company&#8217;s Human Resources Department.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARGENTINA&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Neither the grant of the Options, nor the issuance of Shares subject to the exercise of the Options, constitutes a public offering in Argentina. The grant of Options pursuant to the 2011 Plan is a private placement and is not subject to any filing or disclosure requirements in Argentina.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:61.2pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(i)</font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:3.8pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">AUSTRALIA&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:35.95pt;padding-right:35.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.95pt;text-decoration:underline">Options Conditioned on Satisfaction of Regulatory Obligations</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. If you are (a) a director of a Subsidiary incorporated in Australia, or (b) a person who is a management-level executive of a Subsidiary incorporated in Australia and who also is a director of a Subsidiary incorporated outside of the Australia, the grant of the Options is conditioned upon satisfaction of the shareholder approval provisions of section 200B of the Corporations Act 2001 (Cth) in Australia.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:36pt;padding-right:35.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The grant of Options is being made under Division 1A, Part 7.12 of the Corporations Act 2001 (Cth). Additional details and terms of the grant are set forth in the ESS Offer Document to Australian Resident Employees, which can be accessed in the library section of the UBS website at &#91;UBS INSERT LINK HERE&#93;. By accepting the Options, you acknowledge and confirm that you have reviewed the Australian ESS Offer Document. In the event of any inconsistency between the Terms and Conditions and the terms set forth in the ESS Offer Document, the terms in the ESS Offer Document will prevail.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">AUSTRIA&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">BELGIUM&#160;&#160;&#160;&#160;</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:5pt;padding-left:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Name&#58;&#160;&#160;&#160;&#160;___________________________&#160;&#160;&#160;&#160;Number of Shares&#58; _____________________</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:5.05pt;padding-left:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Date of Grant&#58; ___________________________&#160;&#160;&#160;&#160;Exercise Price&#58; _____________________</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:5pt;padding-left:36pt;padding-right:35.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Acceptance of Options</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. For the Options to be subject to taxation at the time of grant, you must affirmatively accept the Options in writing within 60 days of the date of grant specified above by signing below and returning this original executed Addendum to&#58;</font></div><div style="margin-top:12pt;padding-left:170.65pt;padding-right:170.65pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Stock Plan Administration Department 2825 Airview Blvd.</font></div><div style="padding-left:170.5pt;padding-right:170.5pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Kalamazoo, Michigan 49002 (U.S.A)</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.9pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">I hereby accept the </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (number) Options granted to me by the Company on the date of grant. I also acknowledge that I have been encouraged to discuss the acceptance of the Options and the applicable tax treatment with a financial and&#47;or tax advisor, and that my decision to accept the Options is made with full knowledge of the applicable consequences.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee Signature&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:5pt;padding-left:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee Printed Name&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:5pt;padding-left:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Date of Acceptance&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:5pt;padding-left:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If you fail to affirmatively accept the Options in writing within 60 days of the date of grant,</font></div><div><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:61.2pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(i)</font></div></div><div><font><br></font></div><div style="margin-top:3.8pt;padding-left:36pt;padding-right:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the Options will not be subject to taxation at the time of grant but instead will be subject to taxation on the date you exercise the Options (or such other treatment as may apply under Belgian tax law at the time of exercise).</font></div><div style="margin-top:11.95pt;padding-left:36pt;padding-right:35.75pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.95pt;text-decoration:underline">Payment of Exercise Price Limited to Cash Payment</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Notwithstanding anything to the contrary in Section 4 of the Terms and Conditions, you shall be permitted to pay the Exercise Price only by means of a cash payment (the net exercise method and the cashless exercise method shall not be permitted).</font></div><div style="margin-top:12pt;padding-left:36pt;padding-right:35.8pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.95pt;text-decoration:underline">Undertaking for Qualifying Options</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. If you are accepting the Options in writing within 60 days of the date of grant and wish to have the Options subject to a lower valuation for Belgium tax purposes pursuant to the article 43, &#167;6 of the Belgian law of 26 March 1999, you may agree and undertake to (a) not exercise the Options before the end of the third calendar year following the calendar year in which the date of grant falls, and (b) not transfer the Options under any circumstances (except on rights your heir might have in the Options upon your death). If you wish to make this undertaking, you must sign below and return this executed Addendum to the address listed above.</font></div><div style="margin-top:12.05pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee Signature&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:5pt;padding-left:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee Printed Name&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">BRAZIL&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:35.95pt;padding-right:35.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.95pt;text-decoration:underline">Labor Law Acknowledgment</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. By accepting the Options, you acknowledge and agree, for all legal purposes, that (a) the benefits provided under the Terms and Conditions and the 2011 Plan are the result of commercial transactions unrelated to your employment&#59;</font></div><div style="padding-left:35.95pt;padding-right:35.85pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b) the Terms and Conditions and the 2011 Plan are not a part of the terms and conditions of your employment&#59; and (c) the income from the Options, if any, is not part of your remuneration from employment.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:36pt;padding-right:35.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Compliance with Law</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. By accepting the Options, you acknowledge and agree to comply with applicable Brazilian laws and to pay any and all applicable taxes associated with the exercise of the Options, the issuance and&#47;or sale of Shares acquired under the 2011 Plan and the receipt of any dividends.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:61.2pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(i)</font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:3.8pt;padding-left:34.5pt;text-align:justify"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">CANADA&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.85pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.95pt;text-decoration:underline">Non-Qualified Securities</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. All or a portion of the Shares subject to your Options may be &#34;non-qualified securities&#34; within the meaning of the </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Income Tax Act </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(Canada). The Company shall provide you with additional information and&#47;or appropriate notification regarding the characterization of the Options for Canadian income tax purposes as may be required by the </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Income Tax Act </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(Canada) and the regulations thereunder.</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">No Exercise by Using Previously Owned Shares</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Notwithstanding anything in Section 4 of the Terms and Conditions to the contrary, if you are resident in Canada, you shall not be permitted to use previously-owned Shares for exercising the Options.</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Termination of Employment</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The following supplements Section 2(c) of the Terms and Conditions as well as any other section required to give effect to the same&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;padding-right:35.8pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In the event of your termination of employment for any reason (other than by reason of death, Disability or Retirement), either by you or by the Employer, with or without cause, your rights to vest or to continue to vest in the Options and receive Shares upon exercise under the 2011 Plan, if any, will terminate as of the actual Termination Date. For this purpose, the &#8220;Termination Date&#8221; shall mean the last day on which you are actively employed by the Employer, and shall not include or be extended by any period following such day during which you are in receipt of or eligible to receive any notice of termination, pay in lieu of notice of termination, severance pay or any other payments or damages, whether arising under statute, contract or at common law.</font></div><div style="margin-top:12pt;padding-left:36pt;padding-right:35.85pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the foregoing, if applicable employment standards legislation explicitly requires continued entitlement to vesting during a statutory notice period, your right to vest in the Options under the 2011 Plan, if any, will terminate effective as of the last day of your minimum statutory notice period, but you will not earn or be entitled to pro-rated vesting if the vesting date falls after the end of your statutory notice period, nor will you be entitled to any compensation for lost vesting.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:36pt;padding-right:35.9pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">BY SIGNING BELOW, YOU ACKNOWLEDGE, UNDERSTAND AND AGREE TO THE PROVISIONS OF THE 2011 PLAN, THE TERMS AND CONDITIONS AND THIS ADDENDUM. PLEASE SIGN AND RETURN THIS ADDENDUM VIA EMAIL NO LATER THAN APRIL 28, 2023 TO </font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">STOCKPLANADMINISTRATION&#64;STRYKER.COM.</font></div><div><font><br></font></div><div style="margin-top:0.15pt;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">___________________________________&#160;&#160;&#160;&#160;            ______________________________</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee Signature&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Employee Name (Printed)</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">_____________________</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Date&#160;&#160;&#160;&#160;</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">COLOMBIA&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.8pt;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.95pt;text-decoration:underline">Nature of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. In addition to the provisions of Section 14 of the Terms and Conditions you acknowledge that, pursuant to Article 128 of the Colombian Labor Code, the 2011</font></div><div><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:61.2pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(i)</font></div></div><div><font><br></font></div><div style="margin-top:3.8pt;padding-left:35.95pt;padding-right:35.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Plan and related benefits do not constitute a component of your &#8220;salary&#8221; for any legal purpose. Therefore, they will not be included and&#47;or considered for purposes of calculating any and all labor benefits, such as legal&#47;fringe benefits, vacations, indemnities, payroll taxes, social insurance contributions and&#47;or any other labor-related amount which may be payable.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:36pt;padding-right:35.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Shares subject to the Options are not and will not be registered in the Colombian registry of publicly traded securities (</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Registro Nacional de Valores y Emisores</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) and therefore the Shares may not be offered to the public in Colombia. Nothing in this document should be construed as the making of a public offer of securities in Colombia.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">COSTA RICA&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">DENMARK&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.8pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.95pt;text-decoration:underline">Treatment of Options upon Termination of Employment</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Notwithstanding any provision in the Terms and Conditions or the Plan to the contrary, unless you are a member of registered management who is not considered a salaried employee, the treatment of the Option upon a termination of employment which is not a result of death shall be governed by Sections 4 and 5 of the Danish Act on Stock Option in Employment Relations. However, if the provisions in the Terms and Conditions or the Plan governing the treatment of the Option upon a termination of employment are more favorable, then the provisions of the Terms and Conditions or the 2011 Plan will govern.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FINLAND&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Withholding of Tax-Related Items</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Notwithstanding anything in Section 5 of the Terms and Conditions to the contrary, if you are a local national of Finland, any Tax- Related Items shall be withheld only in cash from your regular salary&#47;wages or other amounts payable to you in cash or such other withholding methods as may be permitted under the 2011 Plan and allowed under local law.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt;text-align:justify"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FRANCE&#160;&#160;&#160;&#160;</font></div><div style="margin-top:12pt;padding-left:36pt;padding-right:35.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Use of English Language</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. By accepting the Options, you acknowledge and agree that it is your express wish that the Terms and Conditions, this Addendum, as well as all other documents, notices and legal proceedings entered into, given or instituted pursuant to your Option, either directly or indirectly, be drawn up in English.</font></div><div style="margin-top:12pt;padding-left:36pt;padding-right:35.85pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Langue anglaise</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">. En acceptant l'allocation de votre Option, vous reconnaissez et acceptez avoir souhait&#233; que le Termes et Conditions, le pr&#233;sent avenant, ainsi que tous autres documents ex&#233;cut&#233;s, avis donn&#233;s et proc&#233;dures judiciaires intent&#233;es, relatifs, directement ou indirectement, &#224; l'allocation de votre Option, soient r&#233;dig&#233;s en anglais</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:61.2pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(i)</font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:3.8pt;padding-left:36pt;padding-right:23.9pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">BY SIGNING BELOW, YOU ACKNOWLEDGE, UNDERSTAND AND AGREE TO THE PROVISIONS OF THE 2011 PLAN, THE TERMS AND CONDITIONS AND THIS ADDENDUM.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:36pt;padding-right:23.9pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PLEASE SIGN AND RETURN THIS ADDENDUM VIA EMAIL NO LATER THAN APRIL 28, 2023 TO </font><font style="color:#00006e;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">STOCKPLANADMINISTRATION&#64;STRYKER.COM</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.</font></div><div style="margin-top:0.1pt;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">___________________________________&#160;&#160;&#160;&#160; ______________________________</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee Signature&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Employee Name (Printed)</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">_____________________</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Date</font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">GERMANY&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">HONG KONG&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:35.95pt;padding-right:35.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.95pt;text-decoration:underline">Important Notice</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Warning&#58; The contents of the Terms and Conditions, this Addendum, the 2011 Plan, and all other materials pertaining to the Options and&#47;or the 2011 Plan have not been reviewed by any regulatory authority in Hong Kong. You are hereby advised to exercise caution in relation to the offer thereunder. If you have any doubts about any of the contents of the aforesaid materials, you should obtain independent professional advice.</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Lapse of Restrictions</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. If, for any reason, Shares are issued to you within six (6) months of the grant date, you agree that you will not sell or otherwise dispose of any such Shares prior to the six-month anniversary of the grant date.</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Settlement in Shares</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Notwithstanding anything to the contrary in this Addendum, the Terms and Conditions or the 2011 Plan, the Options shall be settled only in Shares (and may not be settled in cash).</font></div><div><font><br></font></div><div style="padding-left:35.95pt;padding-right:35.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.95pt;text-decoration:underline">Nature of the Plan</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company specifically intends that the 2011 Plan will not be treated as an occupational retirement scheme for purposes of the Occupational Retirement Schemes Ordinance (&#8220;ORSO&#8221;). To the extent any court, tribunal or legal&#47;regulatory body in Hong Kong determines that the 2011 Plan constitutes an occupational retirement scheme for the purposes of ORSO, the grant of the Options shall be null and void.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:5.05pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">INDIA&#160;&#160;&#160;&#160;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:36pt;padding-right:35.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Repatriation Requirements</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. You expressly agree to repatriate all sale proceeds and dividends attributable to Shares acquired under the 2011 Plan in accordance with local foreign exchange rules and regulations. Neither the Company, your Employer or any of the Company&#8217;s Subsidiaries shall be liable for any fines or penalties resulting from your failure to comply with applicable laws, rules or regulations.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i548e6510261a48ef9d6d8529bae406c9_13"></div><hr style="page-break-after:always"><div style="min-height:89.28pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(i)</font></div></div><div style="margin-top:3.9pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">IRELAND&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ITALY&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">JAPAN&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">MEXICO&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Commercial Relationship</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. You expressly recognize that your participation in the 2011 Plan and the Company&#8217;s grant of the Options does not constitute an employment relationship between you and the Company. You have been granted the Options as a consequence of the commercial relationship between the Company and the Subsidiary in Mexico that employs you, and the Company&#8217;s Subsidiary in Mexico is your sole employer. Based on the foregoing, (a) you expressly recognize the 2011 Plan and the benefits you may derive from your participation in the 2011 Plan do not establish any rights between you and the Company&#8217;s Subsidiary in Mexico that employs you, (b) the 2011 Plan and the benefits you may derive from your participation in the 2011 Plan are not part of the employment conditions and&#47;or benefits provided by the Company&#8217;s Subsidiary in Mexico that employs you, and (c) any modification or amendment of the 2011 Plan by the Company, or a termination of the 2011 Plan by the Company, shall not constitute a change or impairment of the terms and conditions of your employment with the Company&#8217;s Subsidiary in Mexico that employs you.</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.75pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.95pt;text-decoration:underline">Securities Law Information.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> You expressly recognize and acknowledge that the Company's grant of the Options and the underlying Shares under the Plan have not been registered with the National Register of Securities maintained by the Mexican National Banking and Securities Commission and cannot be offered or sold publicly in Mexico. In addition, the 2011 Plan, the Terms and Conditions and any other document relating to the Options may not be publicly distributed in Mexico. These materials are addressed to you only because of your existing relationship with the Company and these materials should not be reproduced or copied in any form. The offer contained in these materials does not constitute a public offering of securities but rather constitutes a private placement of securities addressed specifically to individuals who are present employees of the Employer in Mexico made in accordance with the provisions of the Mexican Securities Market Law, and any rights under such offering shall not be assigned or transferred.</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.75pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.95pt;text-decoration:underline">Extraordinary Item of Compensation</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. You expressly recognize and acknowledge that your participation in the 2011 Plan is a result of the discretionary and unilateral decision of the Company, as well as your free and voluntary decision to participate</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i548e6510261a48ef9d6d8529bae406c9_16"></div><hr style="page-break-after:always"><div style="min-height:61.2pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(i)</font></div></div><div style="margin-top:3.8pt;padding-left:36pt;padding-right:35.7pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">in the 2011 Plan in accord with the terms and conditions of the 2011 Plan, the Terms and Conditions, and this Addendum. As such, you acknowledge and agree that the Company may, in its sole discretion, amend and&#47;or discontinue your participation in the 2011 Plan at any time and without any liability. The value of the Options is an extraordinary item of compensation outside the scope of your employment contract, if any. The Options are not part of your regular or expected compensation for purposes of calculating any severance, resignation, redundancy, end of service payments, bonuses, long-service awards, pension or retirement benefits, or any similar payments, which are the exclusive obligations of the Company&#8217;s Subsidiary in Mexico that employs you.</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.95pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">BY SIGNING BELOW, YOU ACKNOWLEDGE, UNDERSTAND AND AGREE TO THE PROVISIONS OF THE 2011 PLAN, THE TERMS AND CONDITIONS AND THIS ADDENDUM.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:36pt;padding-right:35.9pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PLEASE SIGN AND RETURN THIS ADDENDUM VIA EMAIL NO LATER THAN APRIL 28, 2023 TO </font><font style="color:#00006e;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">STOCKPLANADMINISTRATION&#64;STRYKER.COM</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.</font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">___________________________________&#160;&#160;&#160;&#160;            ______________________________</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee Signature&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Employee Name (Printed)</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">_____________________</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Date</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">NETHERLANDS&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:35.95pt;padding-right:35.8pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Waiver of Termination Rights</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. As a condition to the grant of the Options, you hereby waive any and all rights to compensation or damages as a result of the termination of your employment with the Company and your Employer for any reason whatsoever, insofar as those rights result or may result from (a) the loss or diminution in value of such rights or entitlements under the 2011 Plan, or (b) you ceasing to have rights under or ceasing to be entitled to any awards under the 2011 Plan as a result of such termination.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">NEW ZEALAND&#160;&#160;&#160;&#160;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:36pt;padding-right:35.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">WARNING</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. You are being offered Options in Stryker Corporation. If the Company runs into financial difficulties and is wound up, you may lose some or all your investment. New Zealand law normally requires people who offer financial products to give information to investors before they invest. This requires those offering financial products to have disclosed information that is important for investors to make an informed decision. The usual rules do not apply to this offer because it is an offer made under the Employee Share Scheme exemption. As a result, you may not be given all the information usually required. You will also have fewer other legal protections for this investment. You should ask questions, read all documents carefully, and seek independent financial advice before accepting the offer. The Company&#8217;s Shares are currently traded on the New York Stock Exchange under the ticker symbol &#8220;SYK&#8221; and Shares acquired under the 2011 Plan may be sold through this exchange. You may end up selling the Shares at a price that is lower than the value of the Shares when you acquired them. The price will depend on the demand for</font></div><div style="text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:61.2pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(i)</font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:3.8pt;padding-left:35.95pt;padding-right:35.8pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the Company's Shares. </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">The Company&#8217;s most recent annual report (which includes the Company&#8217;s financial statements) is available at </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;</font><font style="color:#00006e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">https&#58;&#47;&#47;investors.stryker.com&#47;financial-</font><font style="color:#00006e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#00006e;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">information&#47;sec-filings&#47;default.aspx</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#93;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">. You are entitled to receive a copy of this report, free of charge,&#160;&#160;&#160;&#160;upon&#160;&#160;&#160;&#160;written&#160;&#160;&#160;&#160;request&#160;&#160;&#160;&#160;to&#160;&#160;&#160;&#160;the&#160;&#160;&#160;&#160;Company&#160;&#160;&#160;&#160;at </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">STOCKPLANADMINISTRATION&#64;STRYKER.COM</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">.</font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">POLAND&#160;&#160;&#160;&#160;</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:5pt;padding-left:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PORTUGAL&#160;&#160;&#160;&#160;</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:5pt;padding-left:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PUERTO RICO</font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:5pt;padding-left:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ROMANIA</font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:5.05pt;padding-left:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SINGAPORE</font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:5.05pt;padding-left:36pt;padding-right:35.8pt;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.95pt;text-decoration:underline">Qualifying Person Exemption</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The following provision shall replace Section 18 of the Terms and Conditions&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.7pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The grant of the Options under the 2011 Plan is being made pursuant to the &#8220;Qualifying Person&#8221; exemption&#8221; under section 273(1)(f) of the Securities and Futures Act (Chapter 289, 2006 Ed.) (&#8220;SFA&#8221;). The 2011 Plan has not been lodged or registered as a prospectus with the Monetary Authority of Singapore. You should note that, as a result, the Options are subject to section 257 of the SFA and you will not be able to make (a) any subsequent sale of the Shares in Singapore or (ii) any offer of such subsequent sale of the Shares subject to the Options in Singapore, unless such sale or offer is made pursuant to the exemptions under Part XIII Division (1) Subdivision (4) (other than section 280) of the SFA (Chapter 289, 2006 Ed.).</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:5pt;padding-left:36pt;padding-right:35.75pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.95pt;text-decoration:underline">Director Reporting Notification</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. If you are a director, associate director or shadow director of a Singapore company, you are subject to certain notification requirements under the Singapore Companies Act. Among these requirements is an obligation to notify the Singapore company in writing when you receive an interest (e.g., Options or Shares) in the Company or any related company. In addition, you must notify the Singapore company when you sell Shares (including when you sell Shares acquired upon exercise of the Options). These notifications must be made within two business days of acquiring or disposing of any interest in the Company or any related company. In addition, a notification must be made of Participant&#8217;s interests in the Company or any related company within two business days of becoming a director.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i548e6510261a48ef9d6d8529bae406c9_19"></div><hr style="page-break-after:always"><div style="min-height:89.28pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(i)</font></div></div><div style="margin-top:3.9pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SOUTH AFRICA&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:36pt;padding-right:35.75pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.95pt;text-decoration:underline">Withholding Taxes</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. In addition to the provisions of Section 7 of the Terms and Conditions, you agree to notify your Employer in South Africa of the amount of any gain realized upon exercise of the Options. If you fail to advise the Company of the gain realized upon exercise, you may be liable for a fine. You will be responsible for paying any difference between the actual tax liability and the amount withheld.</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Exchange Control Obligations</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. You are solely responsible for complying with applicable exchange control regulations and rulings (the &#8220;Exchange Control Regulations&#8221;) in South Africa. As the Exchange Control Regulations change frequently and without notice, you should consult your legal advisor prior to the acquisition or sale of Shares under the 2011 Plan to ensure compliance with current Exchange Control Regulations. Neither the Company nor any of its Subsidiaries will be liable for any fines or penalties resulting from your failure to comply with applicable laws.</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:36.95pt;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Securities Law Information and Deemed Acceptance of Options</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Neither the Options nor the underlying Shares shall be publicly offered or listed on any stock exchange in South Africa. The offer is intended to be private pursuant to Section 96 of the Companies Act and is not subject to the supervision of any South African governmental authority. Pursuant to Section 96 of the Companies Act, the Options offer must be finalized on or before the 60th day following the grant date. If you do not want to accept the Options, you are required to decline the Options no later than the 60th day following the grant date. If you do not reject the Options on or before the 60th day following the grant date, you will be deemed to accept the Options.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:5.05pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SOUTH KOREA&#160;&#160;&#160;&#160;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SPAIN&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Acknowledgement of Discretionary Nature of the 2011 Plan&#59; No Vested Rights</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. In accepting the Options, you acknowledge that you consent to participation in the 2011 Plan and have received a copy of the 2011 Plan. You understand that the Company has unilaterally, gratuitously and in its sole discretion granted Options under the 2011 Plan to individuals who may be employees of the Company or its Subsidiaries throughout the world. The decision is a limited decision that is entered into upon the express assumption and condition that any grant will not economically or otherwise bind the Company or any of its Subsidiaries on an ongoing basis. Consequently, you understand that the Options are granted on the assumption and condition that the Options and the Shares acquired upon exercise of the Options shall not become a part of any employment contract (either with the Company or any of its Subsidiaries) and shall not be considered a mandatory benefit, salary for any purposes (including severance compensation) or any other right whatsoever. In addition, you understand that this grant would not be made to you but for the assumptions</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i548e6510261a48ef9d6d8529bae406c9_22"></div><hr style="page-break-after:always"><div style="min-height:61.2pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(i)</font></div></div><div style="margin-top:3.8pt;padding-left:36pt;padding-right:35.8pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and conditions referenced above. Thus, you acknowledge and freely accept that should any or all of the assumptions be mistaken or should any of the conditions not be met for any reason, the Options shall be null and void.</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.8pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You understand and agree that, as a condition of the grant of the Options, any unvested Options as of the date you cease active employment and any vested portion of the Options not exercised within the post-termination exercise period set out in the Terms and Conditions will be forfeited without entitlement to the underlying Shares or to any amount of indemnification in the event of the termination of employment by reason of, but not limited to, (i) material modification of the terms of employment under Article 41 of the Workers&#8217; Statute or (ii) relocation under Article 40 of the Workers&#8217; Statute. You acknowledge that you have read and specifically accept the conditions referred to in the Terms and Conditions regarding the impact of a termination of employment on your Options.</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.95pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">BY SIGNING BELOW, YOU ACKNOWLEDGE, UNDERSTAND AND AGREE TO THE PROVISIONS OF THE 2011 PLAN, THE TERMS AND CONDITIONS AND THIS ADDENDUM.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:36pt;padding-right:35.9pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PLEASE SIGN AND RETURN THIS ADDENDUM VIA EMAIL NO LATER THAN APRIL 28, 2023 TO </font><font style="color:#00006e;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">STOCKPLANADMINISTRATION&#64;STRYKER.COM</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.</font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">___________________________________&#160;&#160;&#160;&#160;            ______________________________</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee Signature&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Employee Name (Printed)</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">_____________________</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Date</font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SWEDEN&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Exercise by Cash Payment Only</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Notwithstanding anything in Section 4 of the Terms and Conditions to the contrary, if you are a local national of Sweden, you may exercise the Options only by means of a cash payment or such other methods as may be permitted under the 2011 Plan and allowed under local law.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:35.95pt;padding-right:35.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.95pt;text-decoration:underline">Withholding of Tax-Related Items</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Notwithstanding anything in the Terms and Conditions to the contrary, if you are a local national of Sweden, any Tax-Related Items shall be withheld only in cash from your regular salary&#47;wages or other amounts payable to you in cash, or such other withholding methods as may be permitted under the 2011 Plan and allowed under local law. Additionally, the Company and&#47;or the Employer may withhold Tax- Related Items from salary in an amount up to the statutory maximum withholding limitations, however, the Company and&#47;or your Employer will not withhold amounts in excess of your statutory maximum withholding limitations.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:5.05pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SWITZERLAND&#160;&#160;&#160;&#160;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:36pt;padding-right:35.85pt;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Neither this document nor any other materials relating to the Options (a) constitutes a prospectus according to articles 35 et seq. of the</font></div><div><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:61.2pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(i)</font></div></div><div><font><br></font></div><div style="margin-top:3.8pt;padding-left:35.95pt;padding-right:35.8pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Swiss Federal Act on Financial Services (&#8220;FinSA&#8221;) (b) may be publicly distributed or otherwise made publicly available in Switzerland to any person other than an employee of the Company or (c) has been or will be filed with, approved or supervised by any Swiss reviewing body according to article 51 FinSA or any Swiss regulatory authority, including the Swiss Financial Market Supervisory Authority (&#34;FINMA&#34;).</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TAIWAN&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Securities Law Notice</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The offer of participation in the 2011 Plan is available only for employees of the Company and its Subsidiaries. The offer of participation in the 2011 Plan is not a public offer of securities by a Taiwanese company.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TURKEY&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Under Turkish law, you are not permitted to sell any Shares acquired under the 2011 Plan within Turkey. The Shares are currently traded on the New York Stock Exchange, which is located outside of Turkey, under the ticker symbol &#8220;SYK&#8221; and the Shares may be sold through this exchange.</font></div><div><font><br></font></div><div style="padding-left:35.95pt;padding-right:35.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.95pt;text-decoration:underline">Financial Intermediary Obligation</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. You acknowledge that any activity related to investments in foreign securities (e.g., the sale of Shares) should be conducted through a bank or financial intermediary institution licensed by the Turkey Capital Markets Board and should be reported to the Turkish Capital Markets Board. You solely are responsible for complying with this requirement and should consult with a personal legal advisor for further information regarding any obligations in this respect.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt;text-align:justify"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">UNITED ARAB EMIRATES&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The offer of the Options is available only for select Employees of the Company </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and its Subsidiaries </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and is in the nature of providing incentives in the United Arab Emirates. The 2011 Plan and the Terms and Conditions are intended for distribution only to such individuals and must not be delivered to, or relied on by any other person. Prospective purchasers of securities should conduct their own due diligence.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:36pt;padding-right:35.65pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Emirates Securities and Commodities Authority has no responsibility for reviewing or verifying any documents in connection with this statement, including the 2011 Plan and the Terms and Conditions, or any other incidental communication materials distributed in connection with the Options. Further, neither the Ministry of Economy nor the Dubai Department of Economic Development has approved this statement nor taken steps to verify the information set out in it, and has no responsibility for it. Residents of the United Arab Emirates who have any questions regarding the contents of the 2011 Plan and the Terms and Conditions should obtain independent advice.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:61.2pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(i)</font></div></div><div style="text-align:justify;text-indent:36pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">UNITED KINGDOM                                                                                                                                    &#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:35.95pt;padding-right:35.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.95pt;text-decoration:underline">No Exercise by Using Existing Shares</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Notwithstanding anything in Section 4 of the Terms and Conditions to the contrary, if you are resident in the United Kingdom, you shall not be permitted to use existing Shares for exercising the Options and paying the Exercise Price.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:36pt;padding-right:35.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Income Tax and Social Insurance Contribution Withholding</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The following provision shall supplement Section 7 of the Terms and Conditions&#58;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:35.95pt;padding-right:35.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Without limitation to Section 7 of the Terms and Conditions, you agree that you are liable for all Tax-Related Items and hereby covenant to pay all such Tax-Related Items, as and when requested by the Company, your Employer or by Her Majesty&#8217;s Revenue and Customs (&#8220;HMRC&#8221;) (or any other tax authority or any other relevant authority). You also agree to indemnify and keep indemnified the Company and your Employer against any Tax- Related Items that they are required to pay or withhold or have paid or will pay to HMRC on your behalf (or any other tax authority or any other relevant authority).</font></div><div><font><br></font></div><div style="padding-left:35.95pt;padding-right:35.8pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Exclusion of Claim</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. You acknowledge and agree that you will have no entitlement to compensation or damages in consequence of the termination of your employment with the Company and the Subsidiary that employs you for any reason whatsoever and whether or not in breach of contract, insofar as any purported claim to such entitlement arises or may arise from your ceasing to have rights under or to be entitled to exercise the Options as a result of such termination of employment (whether the termination is in breach of contract or otherwise), or from the loss or diminution in value of the Options. Upon the grant of the Options, you shall be deemed irrevocably to have waived any such entitlement.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:170.55pt;padding-right:170.55pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">****************************</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>5
<FILENAME>ex10ii2023rsuawardletteran.htm
<DESCRIPTION>EX-10.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i7ffc44fdc039485184c8a3f5e467fbcf_1"></div><div style="min-height:43.2pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="padding-left:432.3pt"><font><br></font></div><div style="padding-left:432.3pt"><img alt="image_0.jpg" src="image_0.jpg" style="height:34px;margin-bottom:5pt;vertical-align:text-bottom;width:135px"></div><div style="margin-top:5.1pt;padding-left:7.4pt"><font style="color:#ffb500;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:100%">Kevin </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:100%">A. Lobo</font></div><div style="margin-top:5.95pt;padding-left:7.4pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Chair and CEO</font></div><div style="margin-top:6pt;padding-left:7.4pt;padding-right:402.85pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2825 Airview Boulevard Kalamazoo MI 49002 USA P 269 389 7353</font></div><div style="margin-top:0.05pt;padding-left:7.4pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">www.stryker.com</font></div><div style="margin-top:4.5pt;padding-left:5.75pt"><font style="color:#ffb500;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Personal and confidential</font></div><div><font><br></font></div><div style="padding-left:5.75pt;padding-right:430.45pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:232%">February 9, 2023 </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:232%;text-decoration:underline">First Name Last Name</font></div><div style="padding-left:5.75pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:117%">Dear First Name&#58;</font></div><div><font><br></font></div><div style="padding-left:5.75pt;padding-right:5.7pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">I am pleased to inform you that you are one of a select group of individuals receiving a restricted stock units (RSUs) award in 2023. We use these awards to reward performers who we believe will be key contributors to our growth well into the future. The total Award Date Value (ADV) of your award is approximately USD $xx,xxx.</font></div><div><font><br></font></div><div style="padding-left:5.75pt;padding-right:13.85pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">You are receiving xx RSUs with respect to Common Stock of Stryker Corporation. Except as otherwise provided in the Terms and Conditions, one-third of these RSUs will vest on March 21 of each of the three years beginning March 21, 2024.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:5.75pt;padding-right:5.7pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:100%">You must &#8220;Accept&#8221; the award online via the UBS One Source web site located at </font><font style="color:#529cdb;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">www.ubs.com&#47;onesource&#47;SYK</font><font style="color:#529cdb;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:100%">between March 1 and March 31, 2023</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The detailed terms of the RSUs are in the Terms and Conditions, any applicable country addendum and the provisions of the Company's 2011 Long- Term Incentive Plan, as Amended and Restated. Those documents, together with the related Prospectus, are available on the UBS One Source web site, and you should read them before accepting the award. In addition, you may be asked to sign the most recent version of Stryker&#8217;s Confidentiality, Intellectual Property, Non-Competition and Non-Solicitation Agreement (&#8220;Non-Compete Agreement&#8221;) in connection with this award. If you are asked to sign the Non-Compete Agreement, it will be emailed to you and you will be asked to sign the document electronically via Adobe Sign by March 31, 2023. The vesting of the RSUs is conditioned on you having signed the Non-Compete Agreement by March 31, 2023, where permitted by applicable law.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:5.75pt;text-indent:-0.05pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">You can find additional educational materials on the UBS One Source web site in the Resources section, including RSU brochure and RSU Tax Questions &#38; Answers.</font></div><div><font><br></font></div><div style="padding-left:5.75pt;padding-right:34.3pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">We are committed to growing talent and want our people to experience rewarding careers at Stryker. Your valuable contributions helped us deliver strong results during a challenging year and I look forward to our continued business growth and success.</font></div><div><font><br></font></div><div style="margin-top:10.55pt;padding-left:5.75pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Sincerely,</font></div><div style="margin-top:10.55pt;padding-left:5.75pt"><img alt="image_1.jpg" src="image_1.jpg" style="height:93px;margin-bottom:5pt;vertical-align:text-bottom;width:85px"></div><div style="margin-top:8.2pt;padding-left:5.75pt;padding-right:445.4pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Kevin A. Lobo Chair and CEO</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i7ffc44fdc039485184c8a3f5e467fbcf_4"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="margin-top:4pt;padding-left:186.3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">STRYKER CORPORATION</font></div><div style="margin-top:0.65pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:185.6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">TERMS AND CONDITIONS</font></div><div style="padding-left:38.3pt;padding-right:30.75pt;text-indent:58.3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">RELATING TO RESTRICTED STOCK UNITS GRANTED PURSUANT TO THE 2011 LONG-TERM INCENTIVE PLAN, AS AMENDED</font></div><div style="padding-left:217.95pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">AND RESTATED</font></div><div style="margin-top:13.8pt;padding-left:35.95pt;padding-right:35.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.05pt">The Restricted Stock Units (&#8220;RSUs&#8221;) with respect to Common Stock of Stryker Corporation (the &#8220;Company&#8221;) granted to you during 2023 are subject to these Terms and Conditions Relating to Restricted Stock Units Granted Pursuant to the 2011 Long-Term Incentive Plan, as Amended and Restated (the &#8220;Terms and Conditions&#8221;) and all of the terms and conditions of the Stryker Corporation 2011 Long-Term Incentive Plan, as Amended and Restated (the &#8220;2011 Plan&#8221;), which is incorporated herein by reference. In the case of a conflict between these Terms and Conditions and the terms of the 2011 Plan, the provisions of the 2011 Plan will govern. Capitalized terms used but not defined herein have the meaning provided therefor in the 2011 Plan. For purposes of these Terms and Conditions, &#8220;Employer&#8221; means the Company or any Subsidiary that employs you on the applicable date, and &#34;Stock Plan Administrator&#34; means UBS Financial Services Inc. (or any other independent service provider engaged by the Company to assist with the implementation, operation and administration of the 2011 Plan).</font></div><div><font><br></font></div><div style="padding-left:35.95pt;padding-right:35.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.95pt">Your right to receive the Shares issuable pursuant to the RSUs shall be only as follows&#58;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:35.95pt;padding-right:35.85pt;text-align:justify;text-indent:70.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.74pt">If you continue to be an Employee, you will receive the Shares underlying the RSUs that have become vested as soon as administratively possible following the vesting date as set forth in the award letter.</font></div><div><font><br></font></div><div style="padding-left:35.95pt;padding-right:35.8pt;text-align:justify;text-indent:70.3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.03pt">If you cease to be an Employee by reason of Disability (as such term is defined in the 2011 Plan or determined under local law) or death prior to the date that your RSUs become fully vested, you or your estate will become fully vested in your RSUs, and you, your legal representative or your estate will receive all of the underlying Shares as soon as administratively practicable following your termination by Disability or death.</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:35.95pt;padding-right:35.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.6pt">If you cease to be an Employee by reason of Retirement (as such term is defined in the 2011 Plan or determined under local law) prior to the date that your RSUs become fully vested, you (or your estate in the event of your death after your termination by Retirement) will continue to vest in your RSUs in accordance with the vesting schedule as set forth in the award letter as if you had continued your employment with your Employer.</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.85pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.19pt">If you cease to be an Employee prior to the date that your RSUs become fully vested for any reason other than those provided in (b) or (c) above, you shall cease vesting in your RSUs effective as of your Termination Date. If you are a resident of or employed in the United States, &#8220;Termination Date&#8221; shall mean the effective date of</font></div><div style="text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:4pt;padding-left:36pt;padding-right:35.85pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">termination of your employment with your Employer. If you are resident or employed outside of the United States, &#8220;Termination Date&#8221; shall mean the earliest of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i) the date on which notice of termination is provided to you, (ii) the last day of your active service with your Employer, or (iii) the last day on which you are an Employee of your Employer, as determined in each case without including any required advance notice period and irrespective of the status of the termination under local labor or employment laws.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:36pt;padding-right:35.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.99pt">Notwithstanding the foregoing, the Company may, in its sole discretion, settle your RSUs in the form of&#58; (i) a cash payment to the extent settlement in Shares (1) is prohibited under local law, (2) would require you, the Company and&#47;or your Employer to obtain the approval of any governmental and&#47;or regulatory body in your country of residence (and country of employment, if different), or (3) is administratively burdensome&#59; or (ii) Shares, but require you to immediately sell such Shares (in which case, the Company shall have the authority to issue sales instructions in relation to such Shares on your behalf).</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.85pt;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt">The number of Shares subject to the RSUs shall be subject to adjustment and the vesting dates hereof may be accelerated as follows&#58;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:36pt;padding-right:35.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.99pt">In the event that the Shares, as presently constituted, shall be changed into or exchanged for a different number or kind of shares of stock or other securities of the Company or of another corporation (whether by reason of merger, consolidation, recapitalization, reclassification, split-up, combination of shares, or otherwise) or if the number of such Shares shall be increased through the payment of a stock dividend or a dividend on the Shares of rights or warrants to purchase securities of the Company shall be made, then there shall be substituted for or added to each Share theretofore subject to the RSUs the number and kind of shares of stock or other securities into which each outstanding Share shall be so changed, or for which each such Share shall be exchanged, or to which each such Share shall be entitled. The other terms of the RSUs shall also be appropriately amended as may be necessary to reflect the foregoing events. In the event there shall be any other change in the number or kind of the outstanding Shares, or of any stock or other securities into which such Shares shall have been exchanged, then if the Committee shall, in its sole discretion, determine that such change equitably requires an adjustment in the RSUs, such adjustment shall be made in accordance with such determination.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:36pt;padding-right:35.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.28pt">Fractional Shares resulting from any adjustment in the RSUs may be settled in cash or otherwise as the Committee shall determine, in its sole discretion. Notice of any adjustment will be given to you and such adjustment (whether or not such notice is given) shall be effective and binding for all purposes hereof.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:36pt;padding-right:35.85pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.55pt">The Committee shall have the power to amend the RSUs to permit the immediate vesting of the RSUs (and to terminate any unvested RSUs) and the distribution of the underlying Shares prior to the effectiveness of (i) any disposition of substantially all of the assets of the Company or your Employer, (ii) the shutdown, discontinuance of operations or dissolution of the Company or your Employer, or (iii) the merger or consolidation of the Company or your Employer with or into any other unrelated corporation.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:4pt;padding-left:36pt;padding-right:35.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt">If you are resident and&#47;or employed outside of the United States, you agree, as a condition of the grant of the RSUs, to repatriate all payments attributable to the Shares and&#47;or cash acquired under the 2011 Plan (including, but not limited to, dividends, dividend equivalents and any proceeds derived from the sale of the Shares acquired pursuant to the RSUs) if required by and in accordance with local foreign exchange rules and regulations in your country of residence (and country of employment, if different). In addition, you also agree to take any and all actions, and consent to any and all actions taken by the Company and its Subsidiaries, as may be required to allow the Company and its Subsidiaries to comply with local laws, rules and regulations in your country of residence (and country of employment, if different). Finally, you agree to take any and all actions as may be required to comply with your personal legal and tax obligations under local laws, rules and regulations in your country of residence (and country of employment, if different).</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:36pt;padding-right:35.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt">If you are resident and&#47;or employed in a country that is a member of the European Union, the grant of the RSUs and these Terms and Conditions are intended to comply with the age discrimination provisions of the EU Equal Treatment Framework Directive, as implemented into local law (the &#8220;Age Discrimination Rules&#8221;). To the extent that a court or tribunal of competent jurisdiction determines that any provision of these Terms and Conditions is invalid or unenforceable, in whole or in part, under the Age Discrimination Rules, the Company, in its sole discretion, shall have the power and authority to revise or strike such provision to the minimum extent necessary to make it valid and enforceable to the full extent permitted under local law.</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:35.95pt;padding-right:35.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.95pt">Regardless of any action the Company and&#47;or your Employer take with respect to any or all income tax (including U.S. federal, state and local taxes and&#47;or non-U.S. taxes), social insurance, payroll tax, payment on account or other tax-related withholding (&#8220;Tax- Related Items&#8221;), you acknowledge that the ultimate liability for all Tax-Related Items legally due by you is and remains your responsibility and that the Company and your Employer (i) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the RSUs, including the grant of the RSUs, the vesting of the RSUs, the subsequent sale of any Shares acquired pursuant to the RSUs and the receipt of any dividends or dividend equivalents and (ii) do not commit to structure the terms of the grant or any aspect of the RSUs to reduce or eliminate your liability for Tax-Related Items. Further, if you become subject to taxation in more than one country between the grant date and the date of any relevant taxable or tax withholding event, as applicable, you acknowledge that your Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one country.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:35.95pt;padding-right:35.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Prior to any taxable event, if your country of residence (and&#47;or your country of employment, if different) requires withholding of Tax-Related Items, the Company shall withhold a number of whole Shares that have an aggregate Fair Market Value that the Company, taking into account local requirements and administrative issues, determines in its sole discretion is appropriate to cover withholding for Tax-Related Items with respect to the Shares. The cash equivalent of the Shares withheld will be used to settle the obligation to withhold the Tax-Related Items. In cases where the Fair Market Value of the number of whole Shares withheld is greater than the amount required to be paid to the relevant</font></div><div style="text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:4pt;padding-left:36pt;padding-right:35.75pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">government authorities with respect to withholding for Tax-Related Items, the Company shall make a cash payment to you equal to the difference as soon as administratively practicable. In the event that withholding in Shares is prohibited or problematic under applicable law or otherwise may trigger adverse consequences to the Company or your Employer, your Employer shall withhold the Tax-Related Items required to be withheld with respect to the Shares in cash from your regular salary and&#47;or wages or other amounts payable to you. In the event the withholding requirements are not satisfied through the withholding of Shares or through your regular salary and&#47;or wages or any other amounts payable to you by your Employer, no Shares will be issued to you (or your estate) unless and until satisfactory arrangements (as determined by the Board of Directors) have been made by you with respect to the payment of any Tax-Related Items that the Company or your Employer determines, in its sole discretion, should be withheld or collected with respect to such RSUs. By accepting these RSUs, you expressly consent to the withholding of Shares and&#47;or withholding from your regular salary and&#47;or wages or other amounts payable to you as provided for hereunder. All other Tax-Related Items related to the RSUs and any Shares delivered in payment thereof are your sole responsibility.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:35.95pt;padding-right:35.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.05pt">The RSUs are intended to be exempt from the requirements of Code Section 409A. The 2011 Plan and these Terms and Conditions shall be administered and interpreted in a manner consistent with this intent. If the Company determines that these Terms and Conditions are subject to Code Section 409A and that it has failed to comply with the requirements of that Section, the Company may, at the Company&#8217;s sole discretion and without your consent, amend these Terms and Conditions to cause them to comply with Code Section 409A or be exempt from Code Section 409A.</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:35.95pt;padding-right:35.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.95pt">If you were required to sign the &#8220;Stryker Confidentiality, Intellectual Property, Non-Competition and Non-Solicitation Agreement&#8221; or a similar agreement in order to receive the RSUs or have previously signed such an agreement and you breach any non-competition, non-solicitation or non-disclosure provision or provision as to ownership of inventions contained therein at any time while employed by the Company or a Subsidiary, or during the one-year period following termination of employment, any unvested RSUs shall be rescinded and you shall return to the Company all Shares that were acquired upon vesting of the RSUs that you have not disposed of. Further, you shall pay to the Company an amount equal to the profit realized by you (if any) on all Shares that were acquired upon vesting of the RSUs that you have disposed of. For purposes of the preceding sentence, the profit shall be the Fair Market Value of the Shares at the time of disposition.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:36pt;padding-right:35.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt">The RSUs shall be transferable only by will or the laws of descent and distribution. If you purport to make any transfer of the RSUs, except as aforesaid, the RSUs and all rights thereunder shall terminate immediately.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:35.95pt;padding-right:35.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.31pt">The RSUs shall not be vested in whole or in part, and the Company shall not be obligated to issue any Shares subject to the RSUs, if such issuance would, in the opinion of counsel for the Company, violate the Securities Act of 1933 or any other U.S. federal, state or non-U.S. statute having similar requirements as it may be in effect at the time. The RSUs are subject to the further requirement that, if at any time the Board of Directors shall determine</font></div><div style="text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:4pt;padding-left:36pt;padding-right:35.8pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">in its discretion that the listing or qualification of the Shares subject to the RSUs under any securities exchange requirements or under any applicable law, or the consent or approval of any governmental regulatory body, is necessary or desirable as a condition of or in connection with the issuance of Shares pursuant to the RSUs, the RSUs may not be vested in whole or in part unless such listing, qualification, consent or approval shall have been effected or obtained free of any conditions not acceptable to the Board of Directors.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:36pt;padding-right:35.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.26pt">The grant of the RSUs shall not confer upon you any right to continue in the employ of your Employer nor limit in any way the right of your Employer to terminate your employment at any time. You shall have no rights as a shareholder of the Company with respect to any Shares issuable upon the vesting of the RSUs until the date of issuance of such Shares.</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">12.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.26pt">You acknowledge and agree that the 2011 Plan is discretionary in nature and may be amended, cancelled, or terminated by the Company, in its sole discretion, at any time. The grant of the RSUs under the 2011 Plan is a one-time benefit and does not create any contractual or other right to receive a grant of RSUs or any other award under the 2011 Plan or other benefits in lieu thereof in the future. Future grants, if any, will be at the sole discretion of the Company, including, but not limited to, the form and timing of any grant, the number of Shares subject to the grant, and the vesting provisions. Any amendment, modification or termination of the 2011 Plan shall not constitute a change or impairment of the terms and conditions of your employment with your Employer.</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:36pt;padding-right:35.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">13.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.26pt">Your participation in the 2011 Plan is voluntary. The value of the RSUs and any other awards granted under the 2011 Plan is an extraordinary item of compensation outside the scope of your employment (and your employment contract, if any). Any grant under the 2011 Plan, including the grant of the RSUs, is not part of normal or expected compensation for purposes of calculating any severance, resignation, redundancy, end of service payments, bonuses, long-service awards, pension, or retirement benefits or similar payments.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:36pt;padding-right:35.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">14.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.26pt">These Terms and Conditions shall bind and inure to the benefit of the Company, its successors and assigns and you and your estate in the event of your death.</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:36pt;padding-right:35.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.26pt">The Company is located at 2825 Airview Boulevard Kalamazoo, Michigan 49002, U.S.A. and grants RSUs under the 2011 Plan to employees of the Company and Subsidiaries in its sole discretion. In conjunction with the Company&#8217;s grant of the RSUs under the 2011 Plan and its ongoing administration of such awards, the Company is providing the following information about its data collection, processing and transfer practices (&#8220;Personal Data Activities&#8221;). In accepting the grant of the RSUs, you expressly and explicitly consent to the Personal Data Activities as described herein.</font></div><div style="margin-top:11.5pt;padding-left:36pt;padding-right:35.85pt;text-align:justify;text-indent:49.5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:7.49pt">The Company collects, processes and uses your personal data, including your name, home address, email address, and telephone number, date of birth, social insurance number or other identification number, salary, citizenship, job title, any Shares or directorships held in the Company, and details of all RSUs or any other equity compensation awards granted, canceled, exercised, vested, or outstanding in your favor, which the</font></div><div style="text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:4pt;padding-left:36pt;padding-right:35.8pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Company receives from you or your Employer. In granting the RSUs under the Plan, the Company will collect your personal data for purposes of allocating Shares and implementing, administering and managing the 2011 Plan. The Company&#8217;s legal basis for the collection, processing and usage of your personal data is your consent.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:35.95pt;padding-right:35.9pt;text-align:justify;text-indent:49.5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:6.83pt">The Company transfers your personal data to the Stock Plan Administrator. In the future, the Company may select a different Stock Plan Administrator and share your personal data with another company that serves in a similar manner. The Stock Plan Administrator will open an account for you, if an account is not already in place, to receive and trade Shares acquired under the 2011 Plan You will be asked to agree on separate terms and data processing practices with the Stock Plan Administrator, which is a condition to your ability to participate in the 2011 Plan.</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.8pt;text-align:justify;text-indent:49.5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:8.05pt">The Company and the Stock Plan Administrator are based in the United States. You should note that your country of residence may have enacted data privacy laws that are different from the United States. The Company&#8217;s legal basis for the transfer of your personal data to the United States is your consent.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:36pt;padding-right:35.9pt;text-align:justify;text-indent:49.5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:6.69pt">Your participation in the 2011 Plan and your grant of consent is purely voluntary. You may deny or withdraw your consent at any time. If you do not consent, or if you withdraw your consent, you may be unable to participate in the 2011 Plan. This would not affect your existing employment or salary&#59; instead, you merely may forfeit the opportunities associated with the 2011 Plan.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:36pt;padding-right:35.8pt;text-align:justify;text-indent:49.5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:7.49pt">You may have a number of rights under the data privacy laws in your country of residence. For example, your rights may include the right to (i) request access or copies of personal data the Company processes, (ii) request rectification of incorrect data, (iii) request deletion of data, (iv) place restrictions on processing, (v) lodge complaints with competent authorities in your country or residence, and&#47;or (vi) request a list with the names and addresses of any potential recipients of your personal data. To receive clarification regarding your rights or to exercise your rights, you should contact your local HR manager or the Company&#8217;s Human Resources Department.</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:36pt;padding-right:35.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">16.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.26pt">The grant of the RSUs is not intended to be a public offering of securities in your country of residence (and country of employment, if different). The Company has not submitted any registration statement, prospectus or other filing(s) with the local securities authorities (unless otherwise required under local law). </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">No employee of the Company is permitted to advise you on whether you should acquire Shares under the 2011 Plan or provide you with any legal, tax or financial advice with respect to the grant of the RSUs. The acquisition of Shares involves certain risks, and you should carefully consider all risk factors and tax considerations relevant to the acquisition of Shares under the 2011 Plan or the disposition of them. Further, you should carefully review all of the materials related to the RSUs and the 2011 Plan, and you should consult with your personal legal, tax and financial advisors for professional advice in relation to your personal circumstances.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:4pt;padding-left:36pt;padding-right:35.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">17.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.26pt">All questions concerning the construction, validity and interpretation of the RSUs and the 2011 Plan shall be governed and construed according to the laws of the state of Michigan, without regard to the application of the conflicts of laws provisions thereof. Any disputes regarding the RSUs or the 2011 Plan shall be brought only in the state or federal courts of the state of Michigan.</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">18.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.26pt">The Company may, in its sole discretion, decide to deliver any documents related to the RSUs or other awards granted to you under the 2011 Plan by electronic means. You hereby consent to receive such documents by electronic delivery and agree to participate in the 2011 Plan through an on-line or electronic system established and maintained by the Company or a third party designated by the Company.</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">19.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.26pt">The invalidity or unenforceability of any provision of the 2011 Plan or these Terms and Conditions shall not affect the validity or enforceability of any other provision of the 2011 Plan or these Terms and Conditions.</font></div><div><font><br></font></div><div style="padding-left:35.95pt;padding-right:35.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">20.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.31pt">If you are resident outside of the United States, you acknowledge and agree that it is your express intent that these Terms and Conditions, the 2011 Plan and all other documents, notices and legal proceedings entered into, given or instituted pursuant to the RSUs be drawn up in English. If you have received these Terms and Conditions, the 2011 Plan or any other documents related to the RSUs translated into a language other than English and the meaning of the translated version is different than the English version, the English version will control.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:36pt;padding-right:35.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">21.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.26pt">You acknowledge that, depending on your or your broker's country of residence or where the Shares are listed, you may be subject to insider trading restrictions and&#47;or market abuse laws which may affect your ability to accept, acquire, sell or otherwise dispose of Shares, rights to Shares (e.g., RSUs) or rights linked to the value of Shares during such times you are considered to have &#8220;inside information&#8221; regarding the Company as defined in the laws or regulations in your country of employment (and country of residence, if different). Local insider trading laws and regulations may prohibit the cancellation or amendment of orders you placed before you possessed inside information. Furthermore, you could be prohibited from (i) disclosing the inside information to any third party (other than on a &#8220;need to know&#8221; basis) and (ii) &#8220;tipping&#8221; third parties or causing them otherwise to buy or sell securities. Third parties include fellow employees. Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under any applicable Company insider trading policy. You acknowledge that it is your responsibility to comply with any restrictions and are advised to speak to your personal advisor on this matter.</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">22.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.26pt">Notwithstanding any provisions of these Terms and Conditions to the contrary, the RSUs shall be subject to any special terms and conditions for your country of residence (and country of employment, if different) set forth in an addendum to these Terms and Conditions (an &#8220;Addendum&#8221;). Further, if you transfer your residence and&#47;or employment to another country reflected in an Addendum to these Terms and Conditions at the time of transfer, the special terms and conditions for such country will apply to you to the extent the</font></div><div style="text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:4pt;padding-left:36pt;padding-right:35.8pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Company determines, in its sole discretion, that the application of such special terms and conditions is necessary or advisable in order to comply with local law, rules and regulations, or to facilitate the operation and administration of the award and the 2011 Plan (or the Company may establish alternative terms and conditions as may be necessary or advisable to accommodate your transfer). In all circumstances, any applicable Addendum shall constitute part of these Terms and Conditions.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:35.95pt;padding-right:35.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">23.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.31pt">The Company reserves the right to impose other requirements on the RSUs, any Shares acquired pursuant to the RSUs and your participation in the 2011 Plan to the extent the Company determines, in its sole discretion, that such other requirements are necessary or advisable in order to comply with local law, rules and regulations, or to facilitate the operation and administration of the award and the 2011 Plan. Such requirements may include (but are not limited to) requiring you to sign any agreements or undertakings that may be necessary to accomplish the foregoing.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:35.95pt;padding-right:35.75pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">24.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:15.81pt">This Section 24 applies only to those persons whom the Company&#8217;s Recoupment Policy applies (the corporate officers elected by the Company&#8217;s Board of Directors other than Assistant Controllers, Assistant Secretaries and Assistant Treasurers). </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding any other provision of these Terms and Conditions to the contrary, you acknowledge and agree that your RSUs, any Shares acquired pursuant thereto and&#47;or any amount received with respect to any sale of such Shares are subject to potential cancellation, recoupment, rescission, payback or other action in accordance with the terms of the Company&#8217;s Recoupment Policy as in effect on the date of grant (a copy of which has been furnished to you) and as the Recoupment Policy may be amended from time to time in order to comply with changes in laws, rules or regulations that are applicable to such RSUs and Shares. You agree and consent to the Company&#8217;s application, implementation and enforcement of (a) the Recoupment Policy and (b) any provision of applicable law relating to cancellation, recoupment, rescission or payback of compensation and expressly agree that the Company may take such actions as are necessary to effectuate the Recoupment Policy (as applicable to you) or applicable law without further consent or action being required by you. For purposes of the foregoing, you expressly and explicitly authorize the Company to issue instructions, on your behalf, to any brokerage firm and&#47;or third party administrator engaged by the Company to hold your Shares and other amounts acquired under the 2011 Plan to re- convey, transfer or otherwise return such Shares and&#47;or other amounts to the Company. In the case of a conflict between these Terms and Conditions and the Recoupment Policy, the terms of the Recoupment Policy shall prevail.</font></div><div style="margin-top:10.9pt;padding-left:36pt;padding-right:35.85pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:124%">25.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:124%;padding-left:15.76pt">By accepting the grant of the RSUs, you acknowledge that you have read these Terms and Conditions, the Addendum to these Terms and Conditions (as applicable) and the 2011 Plan and specifically accept and agree to the provisions therein.</font></div><div><font><br></font></div><div style="margin-top:10.55pt;padding-left:194.32pt;padding-right:194.32pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">***********************</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i7ffc44fdc039485184c8a3f5e467fbcf_7"></div><hr style="page-break-after:always"><div style="min-height:82.08pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="margin-top:4pt;padding-left:194.35pt;padding-right:194.35pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">STRYKER CORPORATION</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:200.35pt;padding-right:189.6pt;text-indent:27pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ADDENDUM TO TERMS AND CONDITIONS</font></div><div style="padding-left:101.05pt;padding-right:68.05pt;text-indent:27.2pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">RELATING TO RESTRICTED STOCK UNITS GRANTED PURSUANT TO THE 2011 PLAN, AS AMENDED AND RESTATED</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.75pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In addition to the terms of the 2011 Plan and the Terms and Conditions, the RSUs are subject to the following additional terms and conditions (the &#8220;Addendum&#8221;). </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">The information reflected in this Addendum is based on the securities, exchange control and other laws in effect in the respective countries as of December 2022. </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">All capitalized terms as contained in this Addendum shall have the same meaning as set forth in the 2011 Plan and the Terms and Conditions. Pursuant to Section 22 of the Terms and Conditions, if you transfer your residence and&#47;or employment to another country reflected in an Addendum at the time of transfer, the special terms and conditions for such country will apply to you to the extent the Company determines, in its sole discretion, that the application of such terms and conditions is necessary or advisable in order to comply with local law, rules and regulations, or to facilitate the operation and administration of the award and the 2011 Plan (or the Company may establish alternative terms and conditions as may be necessary or advisable to accommodate your transfer).</font></div><div style="padding-right:35.75pt;text-align:justify"><font><br></font></div><div style="margin-top:0.05pt;padding-left:36pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Data Privacy Information&#58; European Union (&#8220;EU&#8221;) &#47; European Economic Area (&#8220;EEA&#8221;)</font></div><div style="margin-top:0.05pt;padding-left:36pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#47; Switzerland and the United Kingdom*                                                                                              </font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:5pt;padding-left:36pt;padding-right:35.8pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">*The below information is for data privacy purposes only and you should determine whether any other special terms and conditions apply to your awards in these jurisdictions.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:36pt;padding-right:35.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.  </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Data Privacy</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. If you reside and&#47;or you are employed in the EU &#47; EEA, Switzerland or the United Kingdom the following provision replaces Section 15 of the Terms and Conditions&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.85pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Company is located at 2825 Airview Boulevard Kalamazoo, Michigan 49002, U.S.A. and grants RSUs under the 2011 Plan to employees of the Company and its Subsidiaries in its sole discretion. You should review the following information about the Company&#8217;s data processing practices.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:35.95pt;padding-right:35.75pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:34.54pt;text-decoration:underline">Data Collection, Processing and Usage</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Pursuant to applicable data protection laws, you are hereby notified that the Company collects, processes and uses certain personally-identifiable information about you for the legitimate interest of implementing, administering and managing the 2011 Plan and generally administering equity awards&#59; specifically, including your name, home address, email address and telephone number, date of birth, social insurance number or other identification number, salary, citizenship, job title, any Shares or directorships held in the Company, and details of all options or any other awards granted, canceled, exercised, vested, or outstanding in your favor, which the</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i7ffc44fdc039485184c8a3f5e467fbcf_10"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="margin-top:4pt;padding-left:36pt;padding-right:35.8pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Company receives from you or your Employer. In granting the RSUs under the 2011 Plan, the Company will collect your personal data for purposes of allocating Shares and implementing, administering and managing the 2011 Plan. The Company&#8217;s collection, processing, use and transfer of your personal data is necessary for the performance of the Company&#8217;s contractual obligations under the Plan and pursuant to the Company&#8217;s legitimate interest of managing and generally administering employee equity awards. Your refusal to provide personal data would make it impossible for the Company to perform its contractual obligations and may affect your ability to participate in the 2011 Plan. As such, by participating in the 2011 Plan, you voluntarily acknowledge the collection, processing and use of your personal data as described herein.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:36pt;padding-right:35.85pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:33.78pt;text-decoration:underline">Stock Plan Administration Service Provider</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company transfers participant data to the Stock Plan Administrator. In the future, the Company may select a different Stock Plan Administrator and share your data with another company that serves in a similar manner. The Stock Plan Administrator will open an account for you, if an account is not already in place, to receive and trade Shares acquired under the 2011 Plan. You will be asked to agree on separate terms and data processing practices with the Stock Plan Administrator, which is a condition to your ability to participate in the 2011 Plan.</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.9pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:35.05pt;text-decoration:underline">International Data Transfers</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company and the Stock Plan Administrator are based in the United States. The Company can only meet its contractual obligations to you if your personal data is transferred to the United States. The Company&#8217;s legal basis for the transfer of your personal data to the United States is to satisfy its contractual obligations to you and&#47;or its use of the standard data protection clauses adopted by the EU Commission.</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:36pt;padding-right:35.85pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:33.69pt;text-decoration:underline">Data Retention</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company will use your personal data only as long as is necessary to implement, administer and manage your participation in the 2011 Plan or as required to comply with legal or regulatory obligations, including under tax and security laws. When the Company no longer needs your personal data, the Company will remove it from its systems. If the Company keeps your data longer, it would be to satisfy legal or regulatory obligations and the Company&#8217;s legal basis would be for compliance with relevant laws or regulations.</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.85pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:34.49pt;text-decoration:underline">Data Subject Rights</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. You may have a number of rights under data privacy laws in your country of residence. For example, your rights may include the right to (i) request access or copies of personal data the Company processes, (ii) request rectification of incorrect data, (iii) request deletion of data, (iv) place restrictions on processing, (v) lodge complaints with competent authorities in your country of residence, and&#47;or (vi) request a list with the names and addresses of any potential recipients of the Participant&#8217;s personal data. To receive clarification regarding your rights or to exercise your rights, you should contact your local HR manager or the Company&#8217;s Human Resources Department.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> ARGENTINA&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:36pt;padding-right:35.9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Neither the grant of the RSUs, nor the issuance of Shares subject to the RSUs, constitutes a public offering in Argentina. The grant of RSUs pursuant</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i7ffc44fdc039485184c8a3f5e467fbcf_13"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="margin-top:3pt;padding-left:36pt;padding-right:30.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">to the 2011 Plan is a private placement and is not subject to any filing or disclosure requirements in Argentina.</font></div><div style="padding-right:30.75pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> AUSTRALIA&#160;&#160;&#160;&#160;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:5pt;padding-left:36pt;padding-right:35.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">RSUs Conditioned on Satisfaction of Regulatory Obligations</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. If you are (a) a director of a Subsidiary incorporated in Australia, or (b) a person who is a management-level executive of a Subsidiary incorporated in Australia and who also is a director of a Subsidiary incorporated outside of the Australia, the grant of the RSUs is conditioned upon satisfaction of the shareholder approval provisions of section 200B of the Corporations Act 2001 (Cth) in Australia.</font></div><div><font><br></font></div><div style="padding-left:35.95pt;padding-right:35.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.95pt;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. This grant of RSUs is being made under Division 1A Part 7.12 of the Australian Corporations Act 2001 (Cth). If Shares acquired under the Plan are offered for sale to a person or entity resident in Australia, your offer may be subject to disclosure requirements under Australian law. You should obtain legal advice on any disclosure obligations prior to making any such offer.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> AUSTRIA&#160;&#160;&#160;&#160;</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:5.05pt;padding-left:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">BELGIUM&#160;&#160;&#160;&#160;</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:5pt;padding-left:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> BRAZIL&#160;&#160;&#160;&#160;</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:5pt;padding-left:36pt;padding-right:35.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Labor Law Acknowledgment</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. By accepting the RSUs, you acknowledge and agree, for all legal purposes, that (a) the benefits provided under the Terms and Conditions and the 2011 Plan are the result of commercial transactions unrelated to your employment&#59;</font></div><div style="padding-left:36pt;padding-right:35.9pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b) the Terms and Conditions and the 2011 Plan are not a part of the terms and conditions of your employment&#59; and (c) the income from the RSUs, if any, is not part of your remuneration from employment.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:36pt;padding-right:35.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Compliance with Law</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. By accepting the RSUs, you acknowledge and agree to comply with applicable Brazilian laws and to pay any and all applicable taxes associated with the vesting of the RSUs, the issuance and&#47;or sale of Shares acquired under the 2011 Plan and the receipt of any dividends.</font></div><div style="margin-top:0.55pt;text-indent:36pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> CANADA&#160;&#160;&#160;&#160;</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:5.05pt;padding-left:36pt;padding-right:35.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Settlement in Shares</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Notwithstanding anything to the contrary in the Terms and Conditions or the 2011 Plan, the RSUs shall be settled only in Shares (and may not be settled in cash).</font></div><div><font><br></font></div><div style="padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Termination of Employment</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The following supplements Section 2(b) of the</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i7ffc44fdc039485184c8a3f5e467fbcf_16"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="margin-top:4pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Terms and Conditions as well as any other section required to give effect to the same&#58;</font></div><div style="margin-top:11.95pt;padding-left:35.95pt;padding-right:35.8pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In the event of your termination of employment for any reason (other than by reason of death, Disability or Retirement), either by you or by the Employer, with or without cause, your rights to vest or to continue to vest in the RSUs and receive Shares under the 2011 Plan, if any, will terminate as of the actual Termination Date. For this purpose, the &#8220;Termination Date&#8221; shall mean the last day on which you are actively employed by the Employer, and shall not include or be extended by any period following such day during which you are in receipt of or eligible to receive any notice of termination, pay in lieu of notice of termination, severance pay or any other payments or damages, whether arising under statute, contract or at common law.</font></div><div style="margin-top:12.05pt;padding-left:35.95pt;padding-right:35.8pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the foregoing, if applicable employment standards legislation explicitly requires continued entitlement to vesting during a statutory notice period, your right to vest in the RSUs under the 2011 Plan, if any, will terminate effective as of the last day of your minimum statutory notice period, but you will not earn or be entitled to pro-rated vesting if the vesting date falls after the end of your statutory notice period, nor will you be entitled to any compensation for lost vesting.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:35.95pt;padding-right:35.9pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">BY SIGNING BELOW, YOU ACKNOWLEDGE, UNDERSTAND AND AGREE TO THE PROVISIONS OF THE 2011 PLAN, THE TERMS AND CONDITIONS AND THIS ADDENDUM.</font></div><div><font><br></font></div><div style="padding-left:35.95pt;padding-right:35.9pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PLEASE SIGN AND RETURN THIS ADDENDUM VIA EMAIL NO LATER THAN APRIL 28, 2023 TO </font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">STOCKPLANADMINISTRATION&#64;STRYKER.COM</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.</font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">___________________________________&#160;&#160;&#160;&#160;            ______________________________</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee Signature&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Employee Name (Printed)</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">_____________________</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Date</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> CHILE&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.8pt;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Private Placement</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The following provision shall replace Section 16 of the Terms and Conditions&#58;</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:36pt;padding-right:30.75pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The grant of the RSUs hereunder is not intended to be a public offering of securities in Chile but instead is intended to be a private placement.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:72pt;padding-right:35.8pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:7.57pt">The starting date of the offer will be the grant date, and this offer conforms to General Ruling no. 336 of the Chilean Commission for the Financial Markets (&#8220;CMF&#8221;)&#59;</font></div><div style="margin-top:6pt;padding-left:72pt;padding-right:35.85pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">b)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:6.86pt">The offer deals with securities not registered in the registry of securities or in the registry of foreign securities of the CMF, and therefore such securities are not subject to its oversight&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:4pt;padding-left:72pt;padding-right:35.9pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">c)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:8.13pt">The Company, as the issuer, is not obligated to provide public information in Chile regarding the foreign securities, as such securities are not registered with the CMF&#59; and</font></div><div style="margin-top:5.95pt;padding-left:72pt;padding-right:35.95pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">d)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:6.77pt">The Shares, as foreign securities, shall not be subject to public offering as long as they are not registered with the corresponding registry of securities in Chile.</font></div><div><font><br></font></div><div style="margin-top:9.7pt;padding-left:72pt;padding-right:35.9pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:7.57pt">La fecha de inicio de la oferta ser&#225; el de la fecha de otorgamiento y esta oferta se acoge a la norma de Car&#225;cter General n&#176; 336 de la </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Comisi&#243;n para el Mercado Financiero Chilena (&#8220;CMF&#8221;)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#59;</font></div><div style="margin-top:5.95pt;padding-left:72pt;padding-right:35.85pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">b)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:6.86pt">La oferta versa sobre valores no inscritos en el registro de valores o en el registro de valores extranjeros que lleva la CMF, por lo que tales valores no est&#225;n sujetos a la fiscalizaci&#243;n de &#233;sta&#59;</font></div><div style="margin-top:6.05pt;padding-left:72pt;padding-right:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">c)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:8.13pt">Por tratar de valores no inscritos no existe la obligaci&#243;n por parte del emisor de entregar en chile informaci&#243;n p&#250;blica respecto de esos valores&#59; y</font></div><div style="margin-top:6pt;padding-left:72pt;padding-right:35.8pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">d)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:6.77pt">Esos valores no podr&#225;n ser objeto de oferta p&#250;blica mientras no sean inscritos en el registro de valores correspondiente.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> CHINA&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">RSUs Conditioned on Satisfaction of Regulatory Obligations</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. If you are a People&#8217;s Republic of China (&#8220;PRC&#8221;) national, the grant of the RSUs is conditioned upon the Company securing all necessary approvals from the PRC State Administration of Foreign Exchange to permit the operation of the 2011 Plan and the participation of PRC nationals employed by your Employer, as determined by the Company in its sole discretion.</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Sale of Shares</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Notwithstanding anything to the contrary in the 2011 Plan, upon any termination of employment with your Employer, you shall be required to sell all Shares acquired under the 2011 Plan within such time period as may be established by the PRC State Administration of Foreign Exchange.</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Exchange Control Restrictions</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. You acknowledge and agree that you will be required immediately to repatriate to the PRC the proceeds from the sale of any Shares acquired under the 2011 Plan, as well as any other cash amounts attributable to the Shares acquired under the 2011 Plan (collectively, &#8220;Cash Proceeds&#8221;). Further, you acknowledge and agree that the repatriation of the Cash Proceeds must be effected through a special bank account established by your Employer, the Company or one of its Subsidiaries, and you hereby consent and agree that the Cash Proceeds may be transferred to such account by the Company on your behalf prior to being delivered to you. The Cash Proceeds may be paid to you in U.S. dollars or local currency at the Company&#8217;s discretion. If the Cash Proceeds are paid to you in U.S. dollars, you understand that a U.S. dollar bank account must be established and maintained in China so that the proceeds may be deposited into such account. Additionally, if the Company changes its Stock Plan Administrator, you acknowledge and agree that the Company may transfer any Shares issued under the 2011 Plan to the new</font></div><div style="text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:4pt;padding-left:36pt;padding-right:35.8pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">designated Stock Plan Administrator if necessary for legal or administrative reasons. You agree to sign any documentation necessary to facilitate the transfer. If the Cash Proceeds are paid to you in local currency, you acknowledge and agree that the Company is under no obligation to secure any particular exchange conversion rate and that the Company may face delays in converting the Cash Proceeds to local currency due to exchange control restrictions. You agree to bear any currency fluctuation risk between the time the Shares are sold and the Cash Proceeds are converted into local currency and distributed to you. You further agree to comply with any other requirements that may be imposed by your Employer, the Company and its Subsidiaries in the future in order to facilitate compliance with exchange control requirements in the PRC.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> COLOMBIA&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Nature of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. In addition to the provisions of Section 13 of the Terms and Conditions you acknowledge that, pursuant to Article 128 of the Colombian Labor Code, the 2011 Plan and related benefits do not constitute a component of your &#8220;salary&#8221; for any legal purpose. Therefore, they will not be included and&#47;or considered for purposes of calculating any and all labor benefits, such as legal&#47;fringe benefits, vacations, indemnities, payroll taxes, social insurance contributions and&#47;or any other labor-related amount which may be payable.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:36pt;padding-right:35.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Shares subject to the RSUs are not and will not be registered in the Colombian registry of publicly traded securities (</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Registro Nacional de Valores y Emisores</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) and therefore the Shares may not be offered to the public in Colombia. Nothing in this document should be construed as the making of a public offer of securities in Colombia.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> COSTA RICA&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> DENMARK&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Treatment of RSUs upon Termination of Employment</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Notwithstanding any provision in the Terms and Conditions or the 2011 Plan to the contrary, unless you are a member of registered management who is not considered a salaried employee, the treatment of the RSUs upon a termination of employment which is not a result of death shall be governed by Sections 4 and 5 of the Danish Act on Stock Option in Employment Relations. However, if the provisions in the Terms and Conditions or the Plan governing the treatment of the RSUs upon a termination of employment are more favorable, then the provisions of the Terms and Conditions or the 2011 Plan will govern.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:4pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> FINLAND&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Withholding of Tax-Related Items</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Notwithstanding anything in Section 6 of the Terms and Conditions to the contrary, if you are a local national of Finland, any Tax- Related Items shall be withheld only in cash from your regular salary&#47;wages or other amounts payable to you in cash or such other withholding methods as may be permitted under the 2011 Plan and allowed under local law.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> FRANCE&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Use of English Language</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. By accepting your RSUs, you acknowledge and agree that it is your wish that the Terms and Conditions, this Addendum, as well as all other documents, notices and legal proceedings entered into, given or instituted pursuant to your RSUs, either directly or indirectly, be drawn up in English.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:36pt;padding-right:35.9pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Langue anglaise</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">. En acceptant l'allocation de vos RSUs, vous reconnaissez et acceptez avoir souhait&#233; que le Termes et Conditions, le pr&#233;sent avenant, ainsi que tous autres documents ex&#233;cut&#233;s, avis donn&#233;s et proc&#233;dures judiciaires intent&#233;es, relatifs, directement ou indirectement, &#224; l'allocation de vos RSUs, soient r&#233;dig&#233;s en anglais</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">BY SIGNING BELOW, YOU ACKNOWLEDGE, UNDERSTAND AND AGREE TO THE PROVISIONS OF THE 2011 PLAN, THE TERMS AND CONDITIONS AND THIS ADDENDUM.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:35.95pt;padding-right:30.75pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PLEASE SIGN AND RETURN THIS ADDENDUM VIA EMAIL NO LATER THAN APRIL 28, 2023 TO </font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">STOCKPLANADMINISTRATION&#64;STRYKER.COM</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.</font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">___________________________________&#160;&#160;&#160;&#160;            ______________________________</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee Signature&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Employee Name (Printed)</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">_____________________</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Date              </font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> GERMANY&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div><font><br></font></div><div style="margin-top:4pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> HONG KONG&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Important Notice</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Warning&#58; The contents of the Terms and Conditions, this Addendum, the 2011 Plan, and all other materials pertaining to the RSUs and&#47;or the 2011 Plan have not been reviewed by any regulatory authority in Hong Kong. You are hereby advised to exercise caution in relation to the offer thereunder. If you have any doubts about any of the contents of the aforesaid materials, you should obtain independent professional advice.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:36pt;padding-right:35.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Lapse of Restrictions</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. If, for any reason, Shares are issued to you within six (6) months of the grant date, you agree that you will not sell or otherwise dispose of any such Shares prior to the six-month anniversary of the grant date.</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Settlement in Shares</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Notwithstanding anything to the contrary in this Addendum, the Terms and Conditions or the 2011 Plan, the RSUs shall be settled only in Shares (and may not be settled in cash).</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:41.35pt;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Nature of the Plan</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company specifically intends that the 2011 Plan will not be treated as an occupational retirement scheme for purposes of the Occupational Retirement Schemes Ordinance (&#8220;ORSO&#8221;). To the extent any court, tribunal or legal&#47;regulatory body in Hong Kong determines that the 2011 Plan constitutes an occupational retirement scheme for the purposes of ORSO, the grant of the RSUs shall be null and void.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> INDIA&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:36pt;padding-right:35.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Repatriation Requirements</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. You expressly agree to repatriate all sale proceeds and dividends attributable to Shares acquired under the 2011 Plan in accordance with local foreign exchange rules and regulations. Neither the Company, your Employer or any of the Company&#8217;s Subsidiaries shall be liable for any fines or penalties resulting from your failure to comply with applicable laws, rules or regulations.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> IRELAND&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> ITALY&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:5.05pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> JAPAN&#160;&#160;&#160;&#160;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div><font><br></font></div><div style="margin-top:4pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> MEXICO&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Commercial Relationship</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. You expressly recognize that your participation in the 2011 Plan and the Company&#8217;s grant of the RSUs does not constitute an employment relationship between you and the Company. You have been granted the RSUs as a consequence of the commercial relationship between the Company and the Subsidiary in Mexico that employs you, and the Company&#8217;s Subsidiary in Mexico is your sole employer. Based on the foregoing, (a) you expressly recognize the 2011 Plan and the benefits you may derive from your participation in the 2011 Plan do not establish any rights between you and the Company&#8217;s Subsidiary in Mexico that employs you, (b) the 2011 Plan and the benefits you may derive from your participation in the 2011 Plan are not part of the employment conditions and&#47;or benefits provided by the Company&#8217;s Subsidiary in Mexico that employs you, and (c) any modification or amendment of the 2011 Plan by the Company, or a termination of the 2011 Plan by the Company, shall not constitute a change or impairment of the terms and conditions of your employment with the Company&#8217;s Subsidiary in Mexico that employs you.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:36pt;padding-right:35.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Securities Law Information.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> You expressly recognize and acknowledge that the Company's grant of RSUs and the underlying Shares under the Plan have not been registered with the National Register of Securities maintained by the Mexican National Banking and Securities Commission and cannot be offered or sold publicly in Mexico. In addition, the 2011 Plan, the Terms and Conditions and any other document relating to the RSUs may not be publicly distributed in Mexico. These materials are addressed to you only because of your existing relationship with the Company and these materials should not be reproduced or copied in any form. The offer contained in these materials does not constitute a public offering of securities but rather constitutes a private placement of securities addressed specifically to individuals who are present employees of the Employer in Mexico made in accordance with the provisions of the Mexican Securities Market Law, and any rights under such offering shall not be assigned or transferred.</font></div><div><font><br></font></div><div style="padding-left:35.95pt;padding-right:35.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.95pt;text-decoration:underline">Extraordinary Item of Compensation</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. You expressly recognize and acknowledge that your participation in the 2011 Plan is a result of the discretionary and unilateral decision of the Company, as well as your free and voluntary decision to participate in the 2011 Plan in accord with the terms and conditions of the 2011 Plan, the Terms and Conditions, and this Addendum. As such, you acknowledge and agree that the Company may, in its sole discretion, amend and&#47;or discontinue your participation in the 2011 Plan at any time and without any liability. The value of the RSUs is an extraordinary item of compensation outside the scope of your employment contract, if any. The RSUs are not part of your regular or expected compensation for purposes of calculating any severance, resignation, redundancy, end of service payments, bonuses, long-service awards, pension or retirement benefits, or any similar payments, which are the exclusive obligations of the Company&#8217;s Subsidiary in Mexico that employs you.</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">BY SIGNING BELOW, YOU ACKNOWLEDGE, UNDERSTAND AND AGREE TO THE PROVISIONS OF THE 2011 PLAN, THE TERMS AND CONDITIONS AND THIS ADDENDUM.</font></div><div><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div><font><br></font></div><div style="margin-top:4pt;padding-left:36pt;padding-right:30.75pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PLEASE SIGN AND RETURN THIS ADDENDUM VIA EMAIL NO LATER THAN APRIL 28, 2023 TO </font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">STOCKPLANADMINISTRATION&#64;STRYKER.COM</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.</font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">___________________________________&#160;&#160;&#160;&#160;            ______________________________</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee Signature&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Employee Name (Printed)</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">_____________________</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Date</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> NETHERLANDS&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Waiver of Termination Rights</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. As a condition to the grant of the RSUs, you hereby waive any and all rights to compensation or damages as a result of the termination of your employment with the Company and your Employer for any reason whatsoever, insofar as those rights result or may result from (a) the loss or diminution in value of such rights or entitlements under the 2011 Plan, or (b) you ceasing to have rights under or ceasing to be entitled to any awards under the 2011 Plan as a result of such termination.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:36pt;padding-right:35.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Tax Deferral Upon Retirement</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Unless you otherwise elect by contacting Stryker no later than April 28, 2023, you hereby agree that upon Retirement eligibility, the RSUs shall not become taxable until the date of settlement when Shares are actually delivered or otherwise made available.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:4pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> NEW ZEALAND&#160;&#160;&#160;&#160;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:36pt;padding-right:35.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">WARNING</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. You are being offered RSUs to be settled in the form of shares of Stryker Corporation common stock. If the Company runs into financial difficulties and is wound up, you may lose some or all your investment. New Zealand law normally requires people who offer financial products to give information to investors before they invest. This requires those offering financial products to have disclosed information that is important for investors to make an informed decision. The usual rules do not apply to this offer because it is an offer made under the Employee Share Scheme exemption. As a result, you may not be given all the information usually required. You will also have fewer other legal protections for this investment. You should ask questions, read all documents carefully, and seek independent financial advice before accepting the offer. The Company&#8217;s Shares are currently traded on the New York Stock Exchange under the ticker symbol &#8220;SYK&#8221; and Shares acquired under the 2011 Plan may be sold through this exchange. You may end up selling the Shares at a price that is lower than the value of the Shares when you acquired them. The price will depend on the demand for the Company's Shares. </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">The Company&#8217;s most recent annual report (which includes the Company&#8217;s financial statements) is available at </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">https&#58;&#47;&#47;investors.stryker.com&#47;financial-information&#47;sec-filings&#47;default.aspx</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#93;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">. You are entitled to receive a copy of this report, free of charge, upon written request to the Company at </font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">STOCKPLANADMINISTRATION&#64;STRYKER.COM</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> POLAND&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> PUERTO RICO&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> ROMANIA&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> RUSSIA&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">IMPORTANT EMPLOYEE NOTIFICATION</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. You may be required to repatriate certain cash amounts received with respect to the RSUs to Russia as soon as you intend to use those cash amounts for any purpose, including reinvestment. If the repatriation requirement applies, such funds must initially be credited to you through a foreign currency account at an authorized bank in Russia. After the funds are initially received in Russia, they may be further remitted to foreign banks in accordance with Russian exchange control laws. Under the Directive N 5371-U of the Russian Central Bank (the &#8220;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">CBR</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), the repatriation requirement may not apply in certain cases with respect to cash amounts received in an account that is considered by the CBR to be a foreign brokerage account. Statutory exceptions to the repatriation requirement also may apply. </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">You should contact your personal advisor to ensure compliance with the applicable exchange control requirements prior to</font></div><div style="text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:4pt;padding-left:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">vesting in the RSUs and&#47;or selling the Shares acquired pursuant to the RSUs</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:5.95pt;padding-left:36pt;padding-right:35.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">SECURITIES LAW NOTIFICATION</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The grant of RSUs and the issuance of Shares upon vesting are not intended to be an offering of securities with the Russian Federation, and the Terms and Conditions, the 2011 Plan, this Addendum and all other materials that you receive in connection with the grant of RSUs and your participation in the 2011 Plan (collectively, &#8220;Grant Materials&#8221;) do not constitute advertising or a solicitation within the Russian Federation. In connection with your grant of RSUs, the Company has not submitted any registration statement, prospectus or other filing with the Russian Federal Bank or any other governmental or regulatory body within the Russian Federation, and the Grant Materials expressly may not be used, directly or indirectly, for the purpose of making a securities offering or public circulation of Shares within the Russian Federation. Any Shares acquired under the 2011 Plan will be maintained on your behalf outside of Russia. Moreover, you will not be permitted to sell or otherwise alienate any Shares directly to other Russian legal entities or individuals.</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:36pt;padding-right:35.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">EXCHANGE CONTROL NOTIFICATION</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. You are solely responsible for complying with applicable Russian exchange control regulations. Since the exchange control regulations change frequently and without notice, you should consult your legal advisor prior to the acquisition or sale of Shares under the 2011 Plan to ensure compliance with current regulations. As noted, it is your personal responsibility to comply with Russian exchange control laws, and neither the Company nor any Subsidiary will be liable for any fines or penalties resulting from failure to comply with applicable laws.</font></div><div style="margin-top:11.95pt;padding-left:35.95pt;padding-right:35.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.95pt;text-decoration:underline">ANTI-CORRUPTION NOTIFICATION</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Anti-corruption laws prohibit certain public servants, their spouses and their dependent children from owning any foreign source financial instruments (</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">e</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">g</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">., shares of foreign companies such as the Company). Accordingly, you should inform the Company if you are covered by these laws as this relates to your acquisition of Shares under the 2011 Plan.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt;text-align:justify"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> SINGAPORE&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.9pt;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Qualifying Person Exemption</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The following provision shall replace Section 16 of the Terms and Conditions&#58;</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:36pt;padding-right:35.8pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The grant of the RSUs under the 2011 Plan is being made pursuant to the &#8220;Qualifying Person&#8221; exemption&#8221; under section 273(1)(f) of the Securities and Futures Act (Chapter 289, 2006 Ed.) (&#8220;SFA&#8221;). The 2011 Plan has not been lodged or registered as a prospectus with the Monetary Authority of Singapore. You should note that, as a result, the RSUs are subject to section 257 of the SFA and you will not be able to make (a) any subsequent sale of the Shares in Singapore or (ii) any offer of such subsequent sale of the Shares subject to the RSUs in Singapore, unless such sale or offer is made pursuant to the exemptions under Part XIII Division (1) Subdivision (4) (other than section 280) of the SFA (Chapter 289, 2006 Ed.).</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:36pt;padding-right:35.9pt;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Director Reporting Notification</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. If you are a director, associate director or shadow director of a Singapore company, you are subject to certain notification</font></div><div><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div><font><br></font></div><div style="margin-top:4pt;padding-left:36pt;padding-right:35.8pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">requirements under the Singapore Companies Act. Among these requirements is an obligation to notify the Singapore company in writing when you receive an interest (e.g., RSUs or Shares) in the Company or any related company. In addition, you must notify the Singapore company when you sell Shares (including when you sell Shares acquired at vesting of the Restricted Stock Units). These notifications must be made within two business days of acquiring or disposing of any interest in the Company or any related company. In addition, a notification must be made of Participant&#8217;s interests in the Company or any related company within two business days of becoming a director.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> SOUTH AFRICA&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Withholding Taxes</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. In addition to the provisions of Section 6 of the Terms and Conditions, you agree to notify your Employer in South Africa of the amount of any gain realized upon vesting of the RSUs. If you fail to advise your Employer of the gain realized upon vesting of the RSUs, you may be liable for a fine. You will be responsible for paying any difference between the actual tax liability and the amount withheld.</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Exchange Control Obligations</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. You are solely responsible for complying with applicable exchange control regulations and rulings (the &#8220;Exchange Control Regulations&#8221;) in South Africa. As the Exchange Control Regulations change frequently and without notice, you should consult your legal advisor prior to the acquisition or sale of Shares under the 2011 Plan to ensure compliance with current Exchange Control Regulations. Neither the Company nor any of its Subsidiaries will be liable for any fines or penalties resulting from your failure to comply with applicable laws.</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Securities Law Information and Deemed Acceptance of RSUs</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Neither the RSUs nor the underlying Shares shall be publicly offered or listed on any stock exchange in South Africa. The offer is intended to be private pursuant to Section 96 of the Companies Act and is not subject to the supervision of any South African governmental authority. Pursuant to Section 96 of the Companies Act, the RSU offer must be finalized on or before the 60th day following the grant date. If you do not want to accept the RSUs, you are required to decline the RSUs no later than the 60th day following the grant date. If you do not reject the RSUs on or before the 60th day following the grant date, you will be deemed to accept the RSUs.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:5.05pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> SOUTH KOREA&#160;&#160;&#160;&#160;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div><font><br></font></div><div style="margin-top:4pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> SPAIN&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Acknowledgement of Discretionary Nature of the 2011 Plan&#59; No Vested Rights</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. In accepting the RSUs, you acknowledge that you consent to participation in the 2011 Plan and have received a copy of the 2011 Plan. You understand that the Company has unilaterally, gratuitously and in its sole discretion granted RSUs under the 2011 Plan to individuals who may be employees of the Company or its Subsidiaries throughout the world. The decision is a limited decision that is entered into upon the express assumption and condition that any grant will not economically or otherwise bind the Company or any of its Subsidiaries on an ongoing basis. Consequently, you understand that the RSUs are granted on the assumption and condition that the RSUs and the Shares acquired upon vesting of the RSUs shall not become a part of any employment contract (either with the Company or any of its Subsidiaries) and shall not be considered a mandatory benefit, salary for any purposes (including severance compensation) or any other right whatsoever. In addition, you understand that this grant would not be made to you but for the assumptions and conditions referenced above. Thus, you acknowledge and freely accept that should any or all of the assumptions be mistaken or should any of the conditions not be met for any reason, the RSUs shall be null and void.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:36pt;padding-right:35.85pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You understand and agree that, as a condition of the grant of the RSUs, any unvested RSUs as of the date you cease active employment will be forfeited without entitlement to the underlying Shares or to any amount of indemnification in the event of the termination of employment by reason of, but not limited to, (i) material modification of the terms of employment under Article 41 of the Workers&#8217; Statute or (ii) relocation under Article 40 of the Workers&#8217; Statute. You acknowledge that you have read and specifically accept the conditions referred to in the Terms and Conditions regarding the impact of a termination of employment on your RSUs.</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">BY SIGNING BELOW, YOU ACKNOWLEDGE, UNDERSTAND AND AGREE TO THE PROVISIONS OF THE 2011 PLAN, THE TERMS AND CONDITIONS AND THIS ADDENDUM.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:36pt;padding-right:30.75pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PLEASE SIGN AND RETURN THIS ADDENDUM VIA EMAIL NO LATER THAN APRIL 28, 2023 TO </font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">STOCKPLANADMINISTRATION&#64;STRYKER.COM</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.</font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">___________________________________&#160;&#160;&#160;&#160;            ______________________________</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee Signature&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Employee Name (Printed)</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">_____________________</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Date</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> SWITZERLAND&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Neither this document nor any other materials relating to the RSUs (a) constitutes a prospectus according to articles 35 et seq. of the Swiss Federal Act on Financial Services (&#8220;FinSA&#8221;) (b) may be publicly distributed or otherwise</font></div><div style="text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:4pt;padding-left:36pt;padding-right:35.8pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">made publicly available in Switzerland to any person other than an employee of the Company or (c) has been or will be filed with, approved or supervised by any Swiss reviewing body according to article 51 FinSA or any Swiss regulatory authority, including the Swiss Financial Market Supervisory Authority (&#34;FINMA&#34;).</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> TAIWAN&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Securities Law Notice</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The offer of participation in the 2011 Plan is available only for employees of the Company and its Subsidiaries. The offer of participation in the 2011 Plan is not a public offer of securities by a Taiwanese company.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> THAILAND&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> TURKEY&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Under Turkish law, you are not permitted to sell any Shares acquired under the 2011 Plan within Turkey. The Shares are currently traded on the New York Stock Exchange, which is located outside of Turkey, under the ticker symbol &#8220;SYK&#8221; and the Shares may be sold through this exchange.</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Financial Intermediary Obligation</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. You acknowledge that any activity related to investments in foreign securities (e.g., the sale of Shares) should be conducted through a bank or financial intermediary institution licensed by the Turkey Capital Markets Board and should be reported to the Turkish Capital Markets Board. You solely are responsible for complying with this requirement and should consult with a personal legal advisor for further information regarding any obligations in this respect.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt;text-align:justify"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> UNITED ARAB EMIRATES&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The offer of the RSUs is available only for select Employees of the Company and its Subsidiaries and is in the nature of providing incentives in the United Arab Emirates. The 2011 Plan and the Terms and Conditions are intended for distribution only to such individuals and must not be delivered to, or relied on by any other person. Prospective purchasers of securities should conduct their own due diligence.</font></div><div style="margin-top:12pt;padding-left:36pt;padding-right:35.85pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Emirates Securities and Commodities Authority has no responsibility for reviewing or verifying any documents in connection with this statement, including the 2011 Plan and the Terms and Conditions, or any other incidental communication materials distributed in connection with the RSUs. Further, neither the Ministry of Economy nor the Dubai Department of Economic Development has approved this statement nor taken steps to verify the information set out in it, and has no responsibility for it. Residents of the United Arab Emirates who have any questions regarding the contents of the 2011 Plan and the Terms and Conditions should obtain independent advice.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="text-align:justify;text-indent:36pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> UNITED KINGDOM&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Income Tax and Social Insurance Contribution Withholding</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The following provision shall supplement Section 6 of the Terms and Conditions&#58;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:36pt;padding-right:35.85pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Without limitation to Section 6 of the Terms and Conditions, you agree that you are liable for all Tax-Related Items and hereby covenant to pay all such Tax-Related Items, as and when requested by the Company, your Employer or by Her Majesty&#8217;s Revenue and Customs (&#8220;HMRC&#8221;) (or any other tax authority or any other relevant authority). You also agree to indemnify and keep indemnified the Company and your Employer against any Tax- Related Items that they are required to pay or withhold or have paid or will pay to HMRC on your behalf (or any other tax authority or any other relevant authority).</font></div><div style="margin-top:12.05pt;padding-left:36pt;padding-right:35.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Exclusion of Claim</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. You acknowledge and agree that you will have no entitlement to compensation or damages in consequence of the termination of your employment with the Company and your Employer for any reason whatsoever and whether or not in breach of contract, insofar as any purported claim to such entitlement arises or may arise from your ceasing to have rights under or to be entitled to vest in the RSUs as a result of such termination of employment (whether the termination is in breach of contract or otherwise), or from the loss or diminution in value of the RSUs. Upon the grant of the RSUs, you shall be deemed irrevocably to have waived any such entitlement.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:97.17pt;padding-right:97.17pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">****************************</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>6
<FILENAME>ex10iii2023psuawardlettera.htm
<DESCRIPTION>EX-10.3
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ib579d757a6804f8984567549778ec9d3_1"></div><div style="min-height:90.72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div><font><br></font></div><div style="margin-top:5pt;padding-left:7.35pt;text-align:right"><img alt="image_0b.jpg" src="image_0b.jpg" style="height:34px;margin-bottom:5pt;vertical-align:text-bottom;width:135px"></div><div style="margin-top:5pt;padding-left:7.35pt"><font style="color:#ffb500;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:100%">Kevin </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:100%">A. Lobo</font></div><div style="margin-top:5.9pt;padding-left:7.35pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Chair and CEO</font></div><div style="margin-top:6pt;padding-left:7.35pt;padding-right:398.85pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2825 Airview Boulevard Kalamazoo MI 49002 USA P 269 389 7353</font></div><div style="margin-top:0.05pt;padding-left:7.4pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">www.stryker.com</font></div><div style="margin-top:10pt;padding-left:5.75pt"><font style="color:#ffb500;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Personal and confidential</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5.75pt;padding-right:430.8pt;text-indent:-0.1pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:232%">February 9, 2023 </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:232%;text-decoration:underline">First Name Last Name</font></div><div style="margin-top:0.05pt;padding-left:5.75pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Dear First Name&#58;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:5.75pt;padding-right:8.4pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">I am pleased to inform you that as an SLT member, you are receiving performance stock units (PSUs) award in 2023. We use these awards to reward performers who we believe will be key contributors to our growth well into the future. The total Award Date Value (ADV) of your awards is approximately USD $xx,xxx.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:5.7pt;padding-right:8.4pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">We are awarding you a xxx PSUs. The number of PSUs actually earned will be dependent upon Stryker&#8217;s financial performance during the three-year period ending December 31, 2025. Refer to the Terms and Conditions accompanying the 2023 PSUs award for specific criteria associated with vesting in such award. In order to earn any of the PSUs, you must be continuously employed with Stryker through the vesting date of March 21, 2026 except as otherwise provided in the Terms and Conditions.</font></div><div><font><br></font></div><div style="padding-left:5.65pt;padding-right:5.35pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:700;line-height:100%">You must &#8220;Accept&#8221; both awards online via the UBS One Source web site located at </font><font style="color:#519cdb;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:700;line-height:100%;text-decoration:underline">www.ubs.com&#47;onesource&#47;SYK</font><font style="color:#519cdb;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:700;line-height:100%">between March 1 and March 31, 2023</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">. The detailed terms of the option and PSUs are in the Terms and Conditions, any applicable country addendum and the provisions of the Company's 2011 Long- Term Incentive Plan, as Amended and Restated. Those documents, together with the related Prospectus, are available on the UBS One Source web site, and you should read them before accepting the awards. In addition, you may be asked to sign the most recent version of Stryker&#8217;s Confidentiality, Intellectual Property, Non-Competition and Non- Solicitation Agreement (&#8220;Non-Compete Agreement&#8221;) in connection with these awards. If you are asked to sign the Non-Compete Agreement, it will be emailed to you and you will be asked to sign the document electronically via Adobe Sign by March 31, 2023. The exercisability of the options and vesting of the PSUs is conditioned on you having signed the Non-Compete Agreement by March 31, 2023, where permitted by applicable law.</font></div><div><font><br></font></div><div style="padding-left:5.75pt;padding-right:8.4pt;text-indent:-0.1pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">You can find additional educational materials on the UBS One Source web site in the Resources section, including Stock Option brochure and Stock Option Tax Questions &#38; Answers.</font></div><div><font><br></font></div><div style="padding-left:5.7pt;padding-right:8.4pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Thank you for your efforts in helping us deliver strong results. With your help, I look forward to our continued business growth and success.</font></div><div><font><br></font></div><div style="padding-left:5.7pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">Sincerely,</font></div><div><img alt="imagea.jpg" src="imagea.jpg" style="height:93px;margin-bottom:5pt;vertical-align:text-bottom;width:84px"></div><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Kevin A. Lobo </font></div><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Chair</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:112%">and</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:112%">CEO</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ib579d757a6804f8984567549778ec9d3_4"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="margin-top:4pt;padding-left:186.3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">STRYKER CORPORATION</font></div><div style="margin-top:0.65pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:185.6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">TERMS AND CONDITIONS</font></div><div style="padding-left:38.3pt;padding-right:8.4pt;text-indent:49.65pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">RELATING TO PERFORMANCE STOCK UNITS GRANTED PURSUANT TO THE 2011 LONG-TERM INCENTIVE PLAN, AS AMENDED</font></div><div style="padding-left:217.95pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">AND RESTATED</font></div><div style="margin-top:13.8pt;padding-left:35.95pt;padding-right:29.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.05pt">The Performance Stock Units with respect to Common Stock of Stryker Corporation (the &#8220;Company&#8221;) granted to you during 2023 (the &#8220;PSUs&#8221;) are subject to these Terms and Conditions Relating to Performance Stock Units Granted Pursuant to the 2011 Long-Term Incentive Plan, as Amended and Restated (the &#8220;Terms and Conditions&#8221;) and all of the terms and conditions of the Stryker Corporation 2011 Long-Term Incentive Plan, as Amended and Restated (the &#8220;2011 Plan&#8221;), which is incorporated herein by reference. In the case of a conflict between these Terms and Conditions and the terms of the 2011 Plan, the provisions of the 2011 Plan will govern. Capitalized terms used but not defined herein have the meaning provided therefor in the 2011 Plan. For purposes of these Terms and Conditions, &#8220;Employer&#8221; means the Company or any Subsidiary that employs you on the applicable date, and &#34;Stock Plan Administrator&#34; means UBS Financial Services Inc. (or any other independent service provider engaged by the Company to assist with the implementation, operation and administration of the 2011 Plan).</font></div><div><font><br></font></div><div style="padding-left:35.95pt;padding-right:29.7pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Vesting</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Except as provided in Section 8(a), the vesting of your PSUs is dependent upon your remaining continuously employed with your Employer through March 21, 2026 (the &#8220;Vesting Date&#8221;) as well as upon the Company&#8217;s financial performance during the three-year period ending December 31, 2025 (the &#8220;Performance Period&#8221;). Specifically, the vesting of any of the PSUs is dependent upon attainment of the Threshold Performance Target as set forth in Section 3. If the Threshold Performance Target is attained, then the vesting of 50% of the PSUs (the &#8220;EPS PSUs&#8221;) is dependent on Adjusted EPS Growth as set forth in Section 4, and vesting of the remaining 50% of the PSUs (the &#8220;Sales Growth PSUs&#8221;) is dependent on the Sales Growth Percentile Ranking as set forth in Section 5. The actual number of your PSUs that become vested, if any, shall be determined based on exercise of negative discretion by the Committee in accordance with Sections 4, 5 and 6 below.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:35.95pt;padding-right:29.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.95pt;text-decoration:underline">Threshold Performance Target</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. If the Company&#8217;s Adjusted EPS Growth as of the last day of the Performance Period is less than 2.0%, none of your PSUs shall become vested and all of your PSUs shall be forfeited as of the last day of the Performance Period. If the Company&#8217;s Adjusted EPS Growth as of the last day of the Performance Period is 2.0% or greater (the &#8220;Threshold Performance Target&#8221;) and, except as provided in Section 8(a), you remain in the continuous employment of Stryker through the Vesting Date, you shall become eligible to vest in up to 200% of your PSUs, although the actual number of your PSUs that become vested shall be determined based on exercise of negative discretion by the Committee in accordance with Sections 4, 5 and 6 below.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ib579d757a6804f8984567549778ec9d3_7"></div><hr style="page-break-after:always"><div style="min-height:90.72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="margin-top:9.1pt;padding-left:107.95pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.95pt;text-decoration:underline">Adjusted EPS Growth</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:5pt;padding-left:36pt;padding-right:29.75pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.04pt">If the Threshold Performance Target is attained and, except as provided in Section 8(a), you have remained in the continuous employment of Stryker through the Vesting Date, then subject to Section 6 you shall become vested in the percentage of the EPS PSUs determined based on the Company&#8217;s Adjusted EPS Growth using the table below, applying straight line interpolation rounded down to the nearest whole number of EPS PSUs for Adjusted EPS Growth resulting in vested EPS PSUs between 50% and 100% or between 100% and 200%.</font></div><div><font><br></font></div><div style="padding-left:36.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.004%"><tr><td style="width:1.0%"></td><td style="width:20.982%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.881%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.881%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.932%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:108%">&#60; Minimum</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 6.35pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Minimum</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 6.35pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Target</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 6.4pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Maximum</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.35pt;padding-right:25.9pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:117%">Adjusted EPS Growth</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.35pt;padding-right:4.8pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:117%">Less&#160;&#160;&#160;&#160;than 4.0%</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 6.35pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.0%</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:7.05pt;padding-left:5.35pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.5% - 8.5%</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:7.05pt;padding-left:5.45pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">12% or more</font></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font><br></font></div><div style="padding-left:5.35pt;padding-right:4.75pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Vested&#160;&#160;&#160;&#160;Percent of EPS PSUs</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font><br></font></div><div style="padding-left:5.35pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">0%</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font><br></font></div><div style="padding-left:5.4pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">50%</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font><br></font></div><div style="padding-left:5.4pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">100%</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font><br></font></div><div style="padding-left:5.4pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">200%</font></div></td></tr></table></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Any EPS PSUs that do not become vested in accordance with the foregoing shall be forfeited.</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:29.7pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.33pt">As soon as administratively practicable following the Vesting Date (but in no event later than December 31, 2026), the Company shall issue you the Shares underlying the vested EPS PSUs.</font></div><div><font><br></font></div><div style="padding-left:144pt;text-align:justify;text-indent:-36.1pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.65pt">For purposes of these Terms and Conditions&#58;</font></div><div style="margin-top:5.95pt;padding-left:107.95pt;padding-right:29.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:23.56pt">&#8220;Adjusted EPS&#8221; for a calendar year shall mean the Company&#8217;s diluted net earnings per share for such year as determined under U.S. generally accepted accounting principles (&#8220;GAAP&#8221;) but subject to such adjustments, if any, for non-GAAP financial measures that are reflected in a reconciliation to the GAAP financial statements included in the Company&#8217;s Annual Report on Form 10-K filed with the Securities and Exchange Commission.</font></div><div style="margin-top:6pt;padding-left:107.95pt;padding-right:29.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.23pt">&#8220;Adjusted EPS Growth&#8221; shall mean the sum of the Annual Percentage Change in Adjusted EPS for the three (3) calendar years in the Performance Period divided by three (3).</font></div><div style="margin-top:6.05pt;padding-left:107.95pt;padding-right:29.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.9pt">&#8220;Annual Percentage Change in Adjusted EPS&#8221; for a calendar year shall mean the amount by which the Adjusted EPS for such calendar year has increased or decreased relative to the immediately preceding calendar year, expressed as a positive or negative percentage (depending on whether Adjusted EPS increased or decreased) of the Adjusted EPS for such preceding calendar year.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ib579d757a6804f8984567549778ec9d3_10"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="margin-top:4pt;padding-left:35.95pt;padding-right:29.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.24pt">Notwithstanding anything to the contrary herein, the Committee shall have discretion to make such adjustments to the foregoing metrics as it deems appropriate to reflect the impact of corporate transactions, accounting or tax law changes or extraordinary, unusual, nonrecurring or infrequent items&#59; provided, however, that for purposes of calculating the Threshold Performance Target in Section 3, in no case shall such adjustments have the net aggregate effect of increasing Adjusted EPS Growth.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:107.95pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.95pt;text-decoration:underline">Sales Growth Percentile Ranking</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:5.05pt;padding-left:35.95pt;padding-right:29.75pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.09pt">If the Threshold Performance Target is attained and, except as provided in Section 8(a), you have remained in the continuous employment of Stryker through the Vesting Date, then subject to Section 6 you shall become vested in the percentage of the Sales Growth PSUs based upon the Company&#8217;s Sales Growth Percentile Ranking, as determined using the table below, applying straight line interpolation rounded down to the nearest whole number of Sales Growth PSUs for Sales Growth Percentile Ranking resulting in vested Sales Growth PSUs between 50% and 100% or between 100% and 200%.</font></div><div><font><br></font></div><div style="padding-left:36.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.004%"><tr><td style="width:1.0%"></td><td style="width:20.982%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.881%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.881%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.932%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.35pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:117%">Sales Growth</font></div><div style="padding-left:5.35pt;padding-right:25.9pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:117%">Percentile Ranking</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font><br></font></div><div style="padding-left:5.35pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Below 33</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:8pt;font-weight:400;line-height:100%">rd</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font><br></font></div><div style="padding-left:5.35pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">33</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:8pt;font-weight:400;line-height:100%">rd</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font><br></font></div><div style="padding-left:5.35pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">50</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:8pt;font-weight:400;line-height:100%">th</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font><br></font></div><div style="padding-left:5.4pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">75</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:8pt;font-weight:400;line-height:100%">th </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and Above</font></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font><br></font></div><div style="padding-left:5.35pt;padding-right:12.95pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Vested Percent of Sales Growth PSUs</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font><br></font></div><div style="margin-top:11.7pt;padding-left:5.35pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">0%</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font><br></font></div><div style="margin-top:11.7pt;padding-left:5.4pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">50%</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font><br></font></div><div style="margin-top:8.2pt;padding-left:5.35pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">100%</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font><br></font></div><div style="margin-top:11.7pt;padding-left:5.4pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">200%</font></div></td></tr></table></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:36pt;padding-right:29.9pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Any Sales Growth PSUs that do not become vested in accordance with the foregoing shall be forfeited, and if the Company&#8217;s Average Sales Growth in the Performance Period is equal to or less than zero, all of the Sales Growth PSUs shall be forfeited (irrespective of the Sales Growth Percentile Ranking).</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:36pt;padding-right:29.7pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.33pt">As soon as administratively practicable following the Vesting Date &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(but in no event later than December 31, 2026), the Company shall issue you the Shares underlying the vested Sales Growth PSUs.</font></div><div style="padding-right:29.7pt;text-align:justify;text-indent:89.95pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.6pt">For purposes of these Terms and Conditions and subject to Section 5(d)</font></div><div style="padding-left:0.36pt;text-align:justify;text-indent:0.36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:0.36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">below&#58;</font></div><div style="padding-right:29.7pt;text-align:justify;text-indent:0.36pt"><font><br></font></div><div style="margin-top:6.05pt;padding-left:107.95pt;padding-right:29.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:23.56pt">&#8220;Average Sales Growth&#8221; shall mean, for the Company and each company in the Comparison Group, the sum of the Sales Growth for each Reporting Period ending within the Performance Period divided by three&#59;</font></div><div style="padding-left:71.95pt;padding-right:29.85pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="padding-left:107.95pt;padding-right:29.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.55pt">&#8220;Comparison Group&#8221; shall mean&#58;</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ib579d757a6804f8984567549778ec9d3_16"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="padding-left:216pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9642;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:14.49pt">Abbott Laboratories</font></div><div style="padding-left:216pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9642;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:14.49pt">Agilent Technologies, Inc. </font></div><div style="padding-left:216pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9642;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:14.49pt">Baxter International Inc.</font></div><div style="padding-left:216pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9642;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:14.49pt">Becton, Dickinson and Company</font></div><div style="padding-left:216pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9642;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:14.49pt">Boston Scientific Corporation</font></div><div style="padding-left:216pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9642;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:14.49pt">Danaher Corporation</font></div><div style="padding-left:216pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9642;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:14.49pt">Fresenius Medical Care AG &#38; Co. KGaA</font></div><div style="padding-left:216pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9642;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:14.49pt">GE Healthcare</font></div><div style="padding-left:216pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9642;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:14.49pt">Johnson &#38; Johnson (MedTech)</font></div><div style="padding-left:216pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9642;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:14.49pt">Laboratory Corporation of America Holdings</font></div><div style="padding-left:216pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9642;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:14.49pt">Medtronic plc</font></div><div style="padding-left:216pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9642;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:14.49pt">Quest Diagnostics Incorporated</font></div><div style="padding-left:216pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9642;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:14.49pt">Royal Philips (combined segments of Diagnosis &#38; Treatment and Connected Care)</font></div><div style="padding-left:216pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9642;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:14.49pt">Siemens Healthineers AG</font></div><div style="padding-left:216pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9642;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:14.49pt">Smith &#38; Nephew plc</font></div><div style="padding-left:216pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9642;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:14.49pt">Thermo Fisher Scientific Inc.</font></div><div style="padding-left:216pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9642;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:14.49pt">3M Company (Healthcare)</font></div><div style="padding-left:216pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9642;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:14.49pt">Zimmer Biomet Holdings, Inc.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:107.95pt;padding-right:29.9pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">For purposes of the foregoing, any company for which Sales Growth cannot be calculated for three full annual Reporting Periods ending within the Performance Period shall be excluded.</font></div><div style="margin-top:6.05pt;padding-left:107.95pt;padding-right:29.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.9pt">&#8220;Net Sales&#8221; shall mean, for the Company and each company in the Comparison Group, net sales as publicly reported for the applicable Reporting Period.</font></div><div style="margin-top:5.95pt;padding-left:107.95pt;padding-right:29.6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:17.52pt">&#8220;Reporting Period&#8221; shall mean a calendar year in the case of the Company and each company in the Comparison Group that reports on a calendar year basis, and in the case of any other company in the Comparison Group, the four fiscal quarters that include the last fiscal quarter ending prior to December 31 for which such company has publicly reported prior to the following February 28.</font></div><div style="margin-top:6pt;padding-left:107.95pt;padding-right:29.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.85pt">&#8220;Sales Growth&#8221; for a Reporting Period shall mean the amount by which Net Sales has increased or decreased relative to the immediately preceding Reporting Period, expressed as a positive or negative percentage (depending on whether Net Sales increased or decreased) of the Net Sales for such preceding Reporting Period.</font></div><div style="margin-top:6pt;padding-left:107.95pt;padding-right:29.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(vi)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:17.52pt">&#8220;Sales Growth Percentile Ranking&#8221; shall mean the percentile ranking of the Company&#8217;s Average Sales Growth relative to the Average Sales Growth for each company in the Comparison Group, rounded to the whole nearest percentile. For this purpose, the percentile ranking shall be calculated as 1 &#8211; (Rank-1)&#47;(Total of the Comparison Group plus the Company-1). For example, if the Company ranked 5</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:8pt;font-weight:400;line-height:100%">th </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">out of 19 companies including itself, the percentile rank would be calculated as 1 &#8211; (5-1)&#47;(19-1) or 1 &#8211; (4&#47;18) or 1-0.22 or the 78</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:8pt;font-weight:400;line-height:100%">th </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">percentile.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:4pt;padding-left:72pt;padding-right:29.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.19pt">The Committee may make such revisions and adjustments to each of the items set forth in Sections 5(c)(i)-(vi) as it may determine necessary and appropriate in its discretion.</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:29.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Discretion of the Committee</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Notwithstanding anything in these Terms or Conditions or the 2011 Plan to the contrary, provided that the Threshold Performance Target has been attained, the Committee shall have the power and authority, in its sole and absolute exercise of negative discretion, to reduce or increase the vested PSUs such that the actual earned PSUs will be greater than or less than the vested PSUs, which increase or reduction may be made by taking into account any criteria the Committee deems appropriate&#59; provided further that notwithstanding anything in these Terms or Conditions to the contrary you shall not become vested in more than 200% of your PSUs.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:35.95pt;padding-right:29.7pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. In connection with your PSUs, you shall be entitled to receive all of the cash dividends for which the record date occurs during the period between the commencement of the Performance Period and the Vesting Date with respect to each Share underlying your vested PSUs (&#8220;Dividend Equivalents&#8221;). Dividend Equivalents shall be converted into their equivalent number of additional PSUs rounded down to the nearest whole number of PSUs based on the Fair Market Value of a Share on the Vesting Date, provided, that the maximum number of additional PSUs you may receive upon such conversion shall be equal to 200% of your originally granted PSUs. Such additional PSUs shall be subject to the terms and conditions applicable to the PSUs to which the Dividend Equivalents relate, including, without limitation, the vesting, forfeiture, and payment form and timing provisions contained herein.</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:35.95pt;padding-right:29.8pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">In the event you cease to remain in the continuous employment of the Company or a Subsidiary for the entire period commencing on the grant date and ending on the applicable Vesting Date, your right to receive the Shares issuable pursuant to the PSUs shall be only as follows&#58;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:35.95pt;padding-right:29.75pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.09pt">If you cease to be an Employee prior to the Vesting Date by reason of Disability (as such term is defined in the 2011 Plan), death or Retirement (as such term is defined in the 2011 Plan), you or your estate will become vested on the Vesting Date in a pro- rata portion (determined by dividing (a) the number of days during the Performance Period in which you were an Employee by (b) the total number of days during the Performance Period) of your PSUs based upon the Company&#8217;s Adjusted EPS Growth and Sales Growth Percentile Ranking for the Performance Period as determined pursuant to Sections 3, 4, 5 and 6 of these Terms and Conditions. Any pro rata portion shall be rounded down to the nearest whole number of PSUs. You, your legal representative or your estate will receive all of the underlying Shares attributable to the vested PSUs as soon as administratively practicable following (and in no event more than ninety (90) days after) the Vesting Date.</font></div><div><font><br></font></div><div style="padding-left:35.95pt;padding-right:29.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.07pt">If you cease to be an Employee for any reason other than those provided in (a) above and your Termination Date is prior to the Vesting Date, you shall immediately forfeit all PSUs granted hereunder effective as of your Termination Date. If you are a resident of or employed in the United States, &#8220;Termination Date&#8221; shall mean the</font></div><div style="text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:4pt;padding-left:36pt;padding-right:29.75pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">effective date of termination of your employment with your Employer. If you are resident or employed outside of the United States, &#8220;Termination Date&#8221; shall mean the earliest of (i) the date on which notice of termination is provided to you, (ii) the last day of your active service with your Employer, or (iii) the last day on which you are an Employee of your Employer, as determined in each case without including any required advance notice period and irrespective of the status of the termination under local labor or employment laws.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:35.95pt;padding-right:29.7pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">Notwithstanding the foregoing, the Company may, in its sole discretion, settle the PSUs (and any Dividend Equivalents) in the form of&#58; (i) a cash payment to the extent settlement in Shares (1) is prohibited under local law, (2) would require you, the Company and&#47;or your Employer to obtain the approval of any governmental and&#47;or regulatory body in your country of residence (and country of employment, if different), or (3) is administratively burdensome&#59; or (ii) Shares, but require you to immediately sell such Shares (in which case, the Company shall have the authority to issue sales instructions in relation to such Shares on your behalf).</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:35.95pt;padding-right:29.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.31pt">The number of Shares subject to the PSUs shall be subject to adjustment and the vesting dates hereof may be accelerated as follows&#58;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:35.95pt;padding-right:29.7pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.09pt">In the event that the Shares, as presently constituted, shall be changed into or exchanged for a different number or kind of shares of stock or other securities of the Company or of another corporation (whether by reason of merger, consolidation, recapitalization, reclassification, split-up, combination of shares, or otherwise) or if the number of such Shares shall be increased through the payment of a stock dividend or a dividend on the Shares of rights or warrants to purchase securities of the Company shall be made, then there shall be substituted for or added to each Share theretofore subject to the PSUs the number and kind of shares of stock or other securities into which each outstanding Share shall be so changed, or for which each such Share shall be exchanged, or to which each such Share shall be entitled. The other terms of the PSUs shall also be appropriately amended as may be necessary to reflect the foregoing events. In the event there shall be any other change in the number or kind of the outstanding Shares, or of any stock or other securities into which such Shares shall have been exchanged, then if the Committee shall, in its sole discretion, determine that such change equitably requires an adjustment in the PSUs, such adjustment shall be made in accordance with such determination.</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:35.95pt;padding-right:29.9pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.38pt">Fractional Shares resulting from any adjustment in the PSUs may be settled in cash or otherwise as the Committee shall determine, in its sole discretion. Notice of any adjustment will be given to you and such adjustment (whether or not such notice is given) shall be effective and binding for all purposes hereof.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:35.95pt;padding-right:29.75pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.65pt">The Committee shall have the power to amend the PSUs to permit the immediate vesting of the PSUs (and to terminate any unvested PSUs) and the distribution of the underlying Shares prior to the effectiveness of (i) any disposition of substantially all of the assets of the Company or your Employer, (ii) the shutdown, discontinuance of operations or dissolution of the Company or your Employer, or (iii) the merger or consolidation of the Company or your Employer with or into any other unrelated corporation.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ib579d757a6804f8984567549778ec9d3_19"></div><hr style="page-break-after:always"><div style="min-height:82.08pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="margin-top:4pt;padding-left:35.95pt;padding-right:29.65pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.36pt">If you are resident or employed outside of the United States, you agree, as a condition of the grant of the PSUs, to repatriate all payments attributable to the Shares and&#47;or cash acquired under the 2011 Plan (including, but not limited to, dividends, dividend equivalents and any proceeds derived from the sale of the Shares acquired pursuant to the PSUs) if required by and in accordance with local foreign exchange rules and regulations in your country of residence (and country of employment, if different). In addition, you also agree to take any and all actions, and consent to any and all actions taken by the Company and its Subsidiaries, as may be required to allow the Company and its Subsidiaries to comply with local laws, rules and regulations in your country of residence (and country of employment, if different). Finally, you agree to take any and all actions as may be required to comply with your personal legal and tax obligations under local laws, rules and regulations in your country of residence (and country of employment, if different).</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:36pt;padding-right:29.8pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">12.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.31pt">If you are resident and&#47;or employed in a country that is a member of the European Union, the grant of the PSUs and these Terms and Conditions are intended to comply with the age discrimination provisions of the EU Equal Treatment Framework Directive, as implemented into local law (the &#8220;Age Discrimination Rules&#8221;). To the extent that a court or tribunal of competent jurisdiction determines that any provision of these Terms and Conditions are invalid or unenforceable, in whole or in part, under the Age Discrimination Rules, the Company, in its sole discretion, shall have the power and authority to revise or strike such provision to the minimum extent necessary to make it valid and enforceable to the full extent permitted under local law.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:36pt;padding-right:29.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">13.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.26pt">Regardless of any action the Company and&#47;or your Employer take with respect to any or all income tax (including U.S. federal, state and local taxes or non-U.S. taxes), social insurance, payroll tax, payment on account or other tax-related withholding (&#8220;Tax- Related Items&#8221;), you acknowledge that the ultimate liability for all Tax-Related Items legally due by you is and remains your responsibility and that the Company and your Employer (i) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the PSUs, including the grant of the PSUs, the vesting of the PSUs, the subsequent sale of any Shares acquired pursuant to the PSUs and the receipt of any dividends or dividend equivalents and (ii) do not commit to structure the terms of the grant or any aspect of the PSUs to reduce or eliminate your liability for Tax-Related Items. Further, if you become subject to taxation in more than one country between the grant date and the date of any relevant taxable or tax withholding event, as applicable, you acknowledge that your Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one country.</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:29.75pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Prior to any taxable event, if your country of residence (and&#47;or your country of employment, if different) requires withholding of Tax-Related Items, the Company shall withhold a number of whole Shares that have an aggregate Fair Market Value that the Company, taking into account local requirements and administrative issues, determines in its sole discretion is appropriate to cover withholding for Tax-Related Items with respect to the Shares. The cash equivalent of the Shares withheld will be used to settle the obligation to withhold the Tax-Related Items. In cases where the Fair Market Value of the number of</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ib579d757a6804f8984567549778ec9d3_22"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="margin-top:4pt;padding-left:35.95pt;padding-right:29.75pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">whole Shares withheld is greater than the amount required to be paid to the relevant government authorities with respect to withholding for Tax-Related Items, the Company shall make a cash payment to you equal to the difference as soon as administratively practicable. In the event that withholding in Shares is prohibited or problematic under applicable law or otherwise may trigger adverse consequences to the Company or your Employer, your Employer shall withhold the Tax-Related Items required to be withheld with respect to the Shares in cash from your regular salary and&#47;or wages or other amounts payable to you. In the event the withholding requirements are not satisfied through the withholding of Shares or through your regular salary and&#47;or wages or any other amounts payable to you by your Employer, no Shares will be issued to you (or your estate) unless and until satisfactory arrangements (as determined by the Board of Directors) have been made by you with respect to the payment of any Tax-Related Items that the Company or your Employer determines, in its sole discretion, should be withheld or collected with respect to such PSUs. By accepting these PSUs, you expressly consent to the withholding of Shares and&#47;or withholding from your regular salary and&#47;or wages or other amounts payable to you as provided for hereunder. All other Tax-Related Items related to the PSUs and any Shares delivered in payment thereof are your sole responsibility.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:35.95pt;padding-right:29.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">14.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.05pt">The PSUs are intended to be exempt from the requirements of Code Section 409A. The 2011 Plan and these Terms and Conditions shall be administered and interpreted in a manner consistent with this intent. If the Company determines that these Terms and Conditions are subject to Code Section 409A and that it has failed to comply with the requirements of that Section, the Company may, at the Company&#8217;s sole discretion and without your consent, amend these Terms and Conditions to cause them to comply with Code Section 409A or be exempt from Code Section 409A.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:35.95pt;padding-right:29.8pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.36pt">If you were required to sign the &#8220;Stryker Confidentiality, Intellectual Property, Non-Competition and Non-Solicitation Agreement&#8221; or a similar agreement in order to receive the PSUs or have previously signed such an agreement and you breach any non- competition, non-solicitation or non-disclosure provision or provision as to ownership of inventions contained therein at any time while employed by the Company or a Subsidiary, or during the one-year period following termination of employment, any unvested PSUs shall be rescinded and you shall return to the Company all Shares that were acquired upon vesting of the PSUs that you have not disposed of. Further, you shall pay to the Company an amount equal to the profit realized by you (if any) on all Shares that were acquired upon vesting of the PSUs that you have disposed of. For purposes of the preceding sentence, the profit shall be the Fair Market Value of the Shares at the time of disposition.</font></div><div><font><br></font></div><div style="padding-left:35.95pt;padding-right:29.9pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">16.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.36pt">The PSUs shall be transferable only by will or the laws of descent and distribution. If you shall purport to make any transfer of the PSUs, except as aforesaid, the PSUs and all rights thereunder shall terminate immediately.</font></div><div><font><br></font></div><div style="padding-left:35.95pt;padding-right:29.85pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">17.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.36pt">The PSUs shall not be vested in whole or in part, and the Company shall not be obligated to issue any Shares subject to the PSUs, if such issuance would, in the opinion of counsel for the Company, violate the Securities Act of 1933 or any other U.S. federal, state or</font></div><div style="text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:4pt;padding-left:35.95pt;padding-right:29.75pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">non-U.S. statute having similar requirements as it may be in effect at the time. The PSUs are subject to the further requirement that, if at any time the Board of Directors shall determine in its discretion that the listing or qualification of the Shares subject to the PSUs under any securities exchange requirements or under any applicable law, or the consent or approval of any governmental regulatory body, is necessary or desirable as a condition of or in connection with the issuance of Shares pursuant to the PSUs, the PSUs may not be vested in whole or in part unless such listing, qualification, consent or approval shall have been effected or obtained free of any conditions not acceptable to the Board of Directors.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:36pt;padding-right:29.7pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">18.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.31pt">The grant of the PSUs shall not confer upon you any right to continue in the employ of your Employer nor limit in any way the right of your Employer to terminate your employment at any time. You shall have no rights as a shareholder of the Company with respect to any Shares issuable upon the vesting of the PSUs until the date of issuance of such Shares.</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:29.7pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">19.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.31pt">You acknowledge and agree that the 2011 Plan is discretionary in nature and may be amended, cancelled, or terminated by the Company, in its sole discretion, at any time. The grant of the PSUs under the 2011 Plan is a one-time benefit and does not create any contractual or other right to receive a grant of PSUs or any other award under the 2011 Plan or other benefits in lieu thereof in the future. Future grants, if any, will be at the sole discretion of the Company, including, but not limited to, the form and timing of any grant, the number of Shares subject to the grant, and the vesting provisions. Any amendment, modification or termination of the 2011 Plan shall not constitute a change or impairment of the terms and conditions of your employment with your Employer.</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:36pt;padding-right:29.7pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">20.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.31pt">Your participation in the 2011 Plan is voluntary. The value of the PSUs and any other awards granted under the 2011 Plan is an extraordinary item of compensation outside the scope of your employment (and your employment contract, if any). Any grant under the 2011 Plan, including the grant of the PSUs, is not part of normal or expected compensation for purposes of calculating any severance, resignation, redundancy, end of service payments, bonuses, long-service awards, pension, or retirement benefits or similar payments.</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:30pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">21.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.31pt">These Terms and Conditions shall bind and inure to the benefit of the Company, its successors and assigns and you and your estate in the event of your death.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:36pt;padding-right:29.6pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">22.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.31pt">The Company is located at 2825 Airview Boulevard Kalamazoo, Michigan 49002, U.S.A. and grants PSUs under the 2011 Plan to employees of the Company and Subsidiaries in its sole discretion. In conjunction with the Company&#8217;s grant of the PSUs under the 2011 Plan and its ongoing administration of such awards, the Company is providing the following information about its data collection, processing and transfer practices (&#8220;Personal Data Activities&#8221;). In accepting the grant of the PSUs, you expressly and explicitly consent to the Personal Data Activities as described herein.</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:29.8pt;text-indent:49.5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:7.49pt">The Company collects, processes and uses your personal data, including your name, home address, email address, and telephone number, date of birth, social insurance</font></div><div><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div><font><br></font></div><div style="margin-top:4pt;padding-left:35.95pt;padding-right:29.75pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">number or other identification number, salary, citizenship, job title, any Shares or directorships held in the Company, and details of all PSUs or any other equity compensation awards granted, canceled, exercised, vested, or outstanding in your favor, which the Company receives from you or your Employer. In granting the PSUs under the Plan, the Company will collect your personal data for purposes of allocating Shares and implementing, administering and managing the 2011 Plan. The Company&#8217;s legal basis for the collection, processing and usage of your personal data is your consent.</font></div><div><font><br></font></div><div style="padding-left:35.95pt;padding-right:29.75pt;text-align:justify;text-indent:49.5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:6.83pt">The Company transfers your personal data to the Stock Plan Administrator. In the future, the Company may select a different Stock Plan Administrator and share your personal data with another company that serves in a similar manner. The Stock Plan Administrator will open an account for you, if an account is not already in place, to receive and trade Shares acquired under the 2011 Plan. You will be asked to agree on separate terms and data processing practices with the Stock Plan Administrator, which is a condition to your ability to participate in the 2011 Plan.</font></div><div><font><br></font></div><div style="padding-left:35.95pt;padding-right:29.75pt;text-align:justify;text-indent:49.5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:8.1pt">The Company and the Stock Plan Administrator are based in the United States. You should note that your country of residence may have enacted data privacy laws that are different from the United States. The Company&#8217;s legal basis for the transfer of your personal data to the United States is your consent.</font></div><div><font><br></font></div><div style="padding-left:35.95pt;padding-right:29.85pt;text-align:justify;text-indent:49.5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:6.74pt">Your participation in the 2011 Plan and your grant of consent is purely voluntary. You may deny or withdraw your consent at any time. If you do not consent, or if you withdraw your consent, you may be unable to participate in the 2011 Plan. This would not affect your existing employment or salary&#59; instead, you merely may forfeit the opportunities associated with the 2011 Plan.</font></div><div><font><br></font></div><div style="padding-left:35.95pt;padding-right:29.55pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You may have a number of rights under the data privacy laws in your country of residence. For example, your rights may include the right to (i) request access or copies of personal data the Company processes, (ii) request rectification of incorrect data, (iii) request deletion of data, (iv) place restrictions on processing, (v) lodge complaints with competent authorities in your country or residence, and&#47;or (vi) request a list with the names and addresses of any potential recipients of your personal data. To receive clarification regarding your rights or to exercise your rights, you should contact your local HR manager or the Company&#8217;s Human Resources Department.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:35.95pt;padding-right:29.75pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">23.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.36pt">The grant of the PSUs is not intended to be a public offering of securities in your country of residence (and country of employment, if different). The Company has not submitted any registration statement, prospectus or other filing(s) with the local securities authorities (unless otherwise required under local law). </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">No employee of the Company is permitted to advise you on whether you should acquire Shares under the 2011 Plan or provide you with any legal, tax or financial advice with respect to the grant of the PSUs. The acquisition of Shares involves certain risks, and you should carefully consider all risk factors and tax considerations relevant to the acquisition of Shares under the 2011 Plan or the disposition of them. Further, you should carefully review all of the materials related to the PSUs and the 2011 Plan, and you should consult with</font></div><div style="text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:4pt;padding-left:36pt;padding-right:17pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">your personal legal, tax and financial advisors for professional advice in relation to your personal circumstances.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:36pt;padding-right:29.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">24.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.26pt">All questions concerning the construction, validity and interpretation of the PSUs and the 2011 Plan shall be governed and construed according to the laws of the state of Michigan, without regard to the application of the conflicts of laws provisions thereof. Any disputes regarding the PSUs or the 2011 Plan shall be brought only in the state or federal courts of the state of Michigan.</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:29.65pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">25.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.31pt">The Company may, in its sole discretion, decide to deliver any documents related to the PSUs or other awards granted to you under the 2011 Plan by electronic means. You hereby consent to receive such documents by electronic delivery and agree to participate in the 2011 Plan through an on-line or electronic system established and maintained by the Company or a third party designated by the Company.</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:29.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">26.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.26pt">The invalidity or unenforceability of any provision of the 2011 Plan or these Terms and Conditions shall not affect the validity or enforceability of any other provision of the 2011 Plan or these Terms and Conditions.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:36pt;padding-right:29.75pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">27.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.31pt">If you are resident outside of the United States, you acknowledge and agree that it is your express intent that these Terms and Conditions, the 2011 Plan and all other documents, notices and legal proceedings entered into, given or instituted pursuant to the PSUs be drawn up in English. If you have received these Terms and Conditions, the 2011 Plan or any other documents related to the PSUs translated into a language other than English and the meaning of the translated version is different than the English version, the English version will control.</font></div><div><font><br></font></div><div style="padding-left:35.95pt;padding-right:29.65pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">28.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.36pt">You acknowledge that, depending on your or your broker's country of residence or where the Shares are listed, you may be subject to insider trading restrictions and&#47;or market abuse laws which may affect your ability to accept, acquire, sell or otherwise dispose of Shares, rights to Shares (e.g., PSUs) or rights linked to the value of Shares during such times you are considered to have &#8220;inside information&#8221; regarding the Company as defined in the laws or regulations in your country of employment (and country of residence, if different). Local insider trading laws and regulations may prohibit the cancellation or amendment of orders you placed before you possessed inside information. Furthermore, you could be prohibited from (i) disclosing the inside information to any third party (other than on a &#8220;need to know&#8221; basis) and (ii) &#8220;tipping&#8221; third parties or causing them otherwise to buy or sell securities. Third parties include fellow employees. Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under any applicable Company insider trading policy. You acknowledge that it is your responsibility to comply with any restrictions and are advised to speak to your personal advisor on this matter.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:36pt;padding-right:29.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">29.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.26pt">Notwithstanding any provisions of these Terms and Conditions to the contrary, the PSUs shall be subject to any special terms and conditions for your country of residence (and country of employment, if different) set forth in an addendum to these Terms</font></div><div style="text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:4pt;padding-left:36pt;padding-right:29.8pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and Conditions (an &#8220;Addendum&#8221;). Further, if you transfer your residence and&#47;or employment to another country reflected in an Addendum to these Terms and Conditions at the time of transfer, the special terms and conditions for such country will apply to you to the extent the Company determines, in its sole discretion, that the application of such special terms and conditions is necessary or advisable in order to comply with local law, rules and regulations, or to facilitate the operation and administration of the award and the 2011 Plan (or the Company may establish alternative terms and conditions as may be necessary or advisable to accommodate your transfer). In all circumstances, any applicable Addendum shall constitute part of these Terms and Conditions.</font></div><div><font><br></font></div><div style="padding-left:35.95pt;padding-right:29.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">30.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.31pt">The Company reserves the right to impose other requirements on the PSUs, any Shares acquired pursuant to the PSUs and your participation in the 2011 Plan to the extent the Company determines, in its sole discretion, that such other requirements are necessary or advisable in order to comply with local law, rules and regulations, or to facilitate the operation and administration of the award and the 2011 Plan. Such requirements may include (but are not limited to) requiring you to sign any agreements or undertakings that may be necessary to accomplish the foregoing.</font></div><div><font><br></font></div><div style="padding-left:35.95pt;padding-right:29.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">31.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:20.31pt">This Section 31 applies only to those persons whom the Company&#8217;s Recoupment Policy applies (the corporate officers elected by the Company&#8217;s Board of Directors other than Assistant Controllers, Assistant Secretaries and Assistant Treasurers). </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding any other provision of these Terms and Conditions to the contrary, you acknowledge and agree that your PSUs, any Shares acquired pursuant thereto and&#47;or any amount received with respect to any sale of such Shares are subject to potential cancellation, recoupment, rescission, payback or other action in accordance with the terms of the Company&#8217;s Recoupment Policy as in effect on the date of grant (a copy of which has been furnished to you) and as the Recoupment Policy may be amended from time to time in order to comply with changes in laws, rules or regulations that are applicable to such PSUs and Shares. You agree and consent to the Company&#8217;s application, implementation and enforcement of (a) the Recoupment Policy and (b) any provision of applicable law relating to cancellation, recoupment, rescission or payback of compensation and expressly agree that the Company may take such actions as are necessary to effectuate the Recoupment Policy (as applicable to you) or applicable law without further consent or action being required by you. For purposes of the foregoing, you expressly and explicitly authorize the Company to issue instructions, on your behalf, to any brokerage firm and&#47;or third party administrator engaged by the Company to hold your Shares and other amounts acquired under the 2011 Plan to re- convey, transfer or otherwise return such Shares and&#47;or other amounts to the Company. In the case of a conflict between these Terms and Conditions and the Recoupment Policy, the terms of the Recoupment Policy shall prevail.</font></div><div><font><br></font></div><div style="padding-left:35.95pt;padding-right:29.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">32.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:20.31pt">By accepting the grant of the PSUs, you acknowledge that you have read these Terms and Conditions, the Addendum to these Terms and Conditions (as applicable) and the 2011 Plan and specifically accept and agree to the provisions therein.</font></div><div style="margin-top:4pt;padding-left:2.97pt;padding-right:2.97pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">***********************</font></div><div style="text-align:center"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="text-align:center"><font><br></font></div><div style="margin-top:4pt;padding-left:2.97pt;padding-right:2.97pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">STRYKER CORPORATION</font></div><div><font><br></font></div><div style="padding-left:200.35pt;padding-right:183.6pt;text-indent:27pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ADDENDUM TO TERMS AND CONDITIONS</font></div><div style="padding-left:101.05pt;padding-right:54.85pt;text-indent:20.1pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">RELATING TO PERFORMANCE STOCK UNITS GRANTED PURSUANT TO THE 2011 PLAN, AS AMENDED AND RESTATED</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:35.95pt;padding-right:29.7pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In addition to the terms of the 2011 Plan and the Terms and Conditions, the PSUs are subject to the following additional terms and conditions (the &#8220;Addendum&#8221;). </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">The information reflected in this Addendum is based on the securities, exchange control and other laws in effect in the respective countries as of December 2022. </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">All capitalized terms as contained in this Addendum shall have the same meaning as set forth in the 2011 Plan and the Terms and Conditions. Pursuant to Section 29 of the Terms and Conditions, if you transfer your residence and&#47;or employment to another country reflected in an Addendum at the time of transfer, the special terms and conditions for such country will apply to you to the extent the Company determines, in its sole discretion, that the application of such terms and conditions is necessary or advisable in order to comply with local law, rules and regulations, or to facilitate the operation and administration of the award and the 2011 Plan (or the Company may establish alternative terms and conditions as may be necessary or advisable to accommodate your transfer).</font></div><div style="text-indent:36pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:0.34pt;text-indent:36pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Data Privacy Information&#58; European Union (&#8220;EU&#8221;) &#47; European Economic Area (&#8220;EEA&#8221;)</font></div><div style="margin-top:0.05pt;padding-left:0.34pt;text-indent:36pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#47; Switzerland and the United Kingdom*                                                                                              </font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:5.05pt;padding-left:35.95pt;padding-right:29.8pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">*The below information is for data privacy purposes only and you should determine whether any other special terms and conditions apply to your awards in these jurisdictions.</font></div><div style="padding-left:36pt;padding-right:29.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Data Privacy</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. If you reside and&#47;or you are employed in the EU &#47; EEA, Switzerland or the United Kingdom the following provision replaces Section 22 of the Terms and Conditions&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:29.65pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Company is located at 2825 Airview Boulevard Kalamazoo, Michigan 49002, U.S.A. and grants PSUs under the 2011 Plan to employees of the Company and its Subsidiaries in its sole discretion. You should review the following information about the Company&#8217;s data processing practices.</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:29.7pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:34.49pt;text-decoration:underline">Data Collection, Processing and Usage</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Pursuant to applicable data protection laws, you are hereby notified that the Company collects, processes and uses certain personally-identifiable information about you for the legitimate interest of implementing, administering and managing the 2011 Plan and generally administering equity awards&#59; specifically, including your name, home address, email address and telephone number, date of birth, social insurance number or other identification number, salary, citizenship, job title, any Shares or directorships held in the Company, and details of all options or any other awards granted, canceled, exercised, vested, or outstanding in your favor, which the Company receives from you or your Employer. In granting the PSUs under the 2011 Plan, the Company will collect your personal data for purposes of allocating Shares and implementing,</font></div><div style="text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:4pt;padding-left:35.95pt;padding-right:29.85pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">administering and managing the 2011 Plan. The Company&#8217;s collection, processing, use and transfer of your personal data is necessary for the performance of the Company&#8217;s contractual obligations under the Plan and pursuant to the Company&#8217;s legitimate interest of managing and generally administering employee equity awards. Your refusal to provide personal data would make it impossible for the Company to perform its contractual obligations and may affect your ability to participate in the 2011 Plan. As such, by participating in the 2011 Plan, you voluntarily acknowledge the collection, processing and use of your personal data as described herein.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:36pt;padding-right:29.75pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:33.78pt;text-decoration:underline">Stock Plan Administration Service Provider</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company transfers participant data to the Stock Plan Administrator. In the future, the Company may select a different Stock Plan Administrator and share your data with another company that serves in a similar manner. The Stock Plan Administrator will open an account for you, if an account is not already in place, to receive and trade Shares acquired under the 2011 Plan. You will be asked to agree on separate terms and data processing practices with the Stock Plan Administrator, which is a condition to your ability to participate in the 2011 Plan.</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:29.7pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:35.05pt;text-decoration:underline">International Data Transfers</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company and the Stock Plan Administrator are based in the United States. The Company can only meet its contractual obligations to you if your personal data is transferred to the United States. The Company&#8217;s legal basis for the transfer of your personal data to the United States is to satisfy its contractual obligations to you and&#47;or its use of the standard data protection clauses adopted by the EU Commission.</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:35.95pt;padding-right:29.85pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:33.74pt;text-decoration:underline">Data Retention</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company will use your personal data only as long as is necessary to implement, administer and manage your participation in the 2011 Plan or as required to comply with legal or regulatory obligations, including under tax and security laws. When the Company no longer needs your personal data, the Company will remove it from its systems. If the Company keeps your data longer, it would be to satisfy legal or regulatory obligations and the Company&#8217;s legal basis would be for compliance with relevant laws or regulations.</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:29.75pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:34.49pt;text-decoration:underline">Data Subject Rights</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. You may have a number of rights under data privacy laws in your country of residence. For example, your rights may include the right to (i) request access or copies of personal data the Company processes, (ii) request rectification of incorrect data, (iii) request deletion of data, (iv) place restrictions on processing, (v) lodge complaints with competent authorities in your country of residence, and&#47;or (vi) request a list with the names and addresses of any potential recipients of the Participant&#8217;s personal data. To receive clarification regarding your rights or to exercise your rights, you should contact your local HR manager or the Company&#8217;s Human Resources Department.</font></div><div><font><br></font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARGENTINA&#160;&#160;&#160;&#160;</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div><font><br></font></div><div style="margin-top:4pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">AUSTRALIA&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:35.95pt;padding-right:29.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.95pt;text-decoration:underline">PSUs Conditioned on Satisfaction of Regulatory Obligations</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. If you are (a) a director of a Subsidiary incorporated in Australia, or (b) a person who is a management-level executive of a Subsidiary incorporated in Australia and who also is a director of a Subsidiary incorporated outside of the Australia, the grant of the PSUs is conditioned upon satisfaction of the shareholder approval provisions of section 200B of the Corporations Act 2001 (Cth) in Australia.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:36pt;padding-right:29.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. This grant of PSUs is being made under Division 1A Part 7.12 of the Australian Corporations Act 2001 (Cth). If Shares acquired under the Plan are offered for sale to a person or entity resident in Australia, your offer may be subject to disclosure requirements under Australian law. You should obtain legal advice on any disclosure obligations prior to making any such offer.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">AUSTRIA&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">BELGIUM&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">BRAZIL&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:35.95pt;padding-right:29.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.95pt;text-decoration:underline">Labor Law Acknowledgment</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. By accepting the PSUs, you acknowledge and agree, for all legal purposes, that (a) the benefits provided under the Terms and Conditions and the 2011 Plan are the result of commercial transactions unrelated to your employment&#59;</font></div><div style="padding-left:35.95pt;padding-right:29.85pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b) the Terms and Conditions and the 2011 Plan are not a part of the terms and conditions of your employment&#59; and (c) the income from the PSUs, if any, is not part of your remuneration from employment.</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:29.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Compliance with Law</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. By accepting the PSUs, you acknowledge and agree to comply with applicable Brazilian laws and to pay any and all applicable taxes associated with the vesting of the PSUs, the issuance and&#47;or sale of Shares acquired under the 2011 Plan and the receipt of any dividends.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">CANADA&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:29.85pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.95pt;text-decoration:underline">Settlement in Shares</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Notwithstanding anything to the contrary in the Terms and Conditions or the 2011 Plan, the PSUs shall be settled only in Shares (and may not be settled in cash).</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:29.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Termination of Employment</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The following supplements Section 8(b) of the Terms and Conditions as well as any other section required to give effect to the same&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:4pt;padding-left:36pt;padding-right:29.75pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In the event of your termination of employment for any reason (other than by reason of death, Disability or Retirement), either by you or by the Employer, with or without cause, your rights to vest or to continue to vest in the PSUs and receive Shares under the 2011 Plan, if any, will terminate as of the actual Termination Date. For this purpose, the &#8220;Termination Date&#8221; shall mean the last day on which you are actively employed by the Employer, and shall not include or be extended by any period following such day during which you are in receipt of or eligible to receive any notice of termination, pay in lieu of notice of termination, severance pay or any other payments or damages, whether arising under statute, contract or at common law. Notwithstanding the foregoing, if applicable employment standards legislation explicitly requires continued entitlement to vesting during a statutory notice period, your right to vest in the PSUs under the 2011 Plan, if any, will terminate effective as of the last day of your minimum statutory notice period, but you will not earn or be entitled to pro-rated vesting if the vesting date falls after the end of your statutory notice period, nor will you be entitled to any compensation for lost vesting.</font></div><div style="margin-top:12pt;padding-left:36pt;padding-right:29.95pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">BY SIGNING BELOW, YOU ACKNOWLEDGE, UNDERSTAND AND AGREE TO THE PROVISIONS OF THE 2011 PLAN, THE TERMS AND CONDITIONS AND THIS ADDENDUM.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:36pt;padding-right:29.9pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PLEASE SIGN AND RETURN THIS ADDENDUM VIA EMAIL NO LATER THAN APRIL 28, 2023 TO </font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">STOCKPLANADMINISTRATION&#64;STRYKER.COM</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.</font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">___________________________________&#160;&#160;&#160;&#160;            ______________________________</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee Signature&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Employee Name (Printed)</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">_____________________</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Date</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">CHILE&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:29.85pt;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.95pt;text-decoration:underline">Private Placement</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The following provision shall replace Section 23 of the Terms and Conditions&#58;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:36pt;padding-right:17pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The grant of the PSUs hereunder is not intended to be a public offering of securities in Chile but instead is intended to be a private placement.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:72pt;padding-right:29.85pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:7.57pt">The starting date of the offer will be the grant date, and this offer conforms to General Ruling no. 336 of the Chilean Commission for the Financial Markets (&#8220;CMF&#8221;)&#59;</font></div><div style="margin-top:5.95pt;padding-left:72pt;padding-right:29.7pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">b)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:6.86pt">The offer deals with securities not registered in the registry of securities or in the registry of foreign securities of the CMF, and therefore such securities are not subject to its oversight&#59;</font></div><div style="margin-top:6pt;padding-left:72pt;padding-right:29.7pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">c)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:8.13pt">The Company, as the issuer, is not obligated to provide public information in Chile regarding the foreign securities, as such securities are not registered with the CMF&#59; and</font></div><div style="text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:4pt;padding-left:72pt;padding-right:29.95pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">d)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:6.77pt">The Shares, as foreign securities, shall not be subject to public offering as long as they are not registered with the corresponding registry of securities in Chile.</font></div><div><font><br></font></div><div style="margin-top:9.6pt;padding-left:72pt;padding-right:29.85pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:7.57pt">La fecha de inicio de la oferta ser&#225; el de la fecha de otorgamiento y esta oferta se acoge a la norma de Car&#225;cter General n&#176; 336 de la </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Comisi&#243;n para el Mercado Financiero Chilena (&#8220;CMF&#8221;)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#59;</font></div><div style="margin-top:6.05pt;padding-left:72pt;padding-right:29.8pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">b)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:6.86pt">La oferta versa sobre valores no inscritos en el registro de valores o en el registro de valores extranjeros que lleva la CMF, por lo que tales valores no est&#225;n sujetos a la fiscalizaci&#243;n de &#233;sta&#59;</font></div><div style="margin-top:5.95pt;padding-left:72pt;padding-right:29.8pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">c)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:8.13pt">Por tratar de valores no inscritos no existe la obligaci&#243;n por parte del emisor de entregar en chile informaci&#243;n p&#250;blica respecto de esos valores&#59; y</font></div><div style="margin-top:6.05pt;padding-left:72pt;padding-right:29.85pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">d)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:6.77pt">Esos valores no podr&#225;n ser objeto de oferta p&#250;blica mientras no sean inscritos en el registro de valores correspondiente.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">CHINA&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:36pt;padding-right:29.75pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.95pt;text-decoration:underline">PSUs Conditioned on Satisfaction of Regulatory Obligations</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. If you are a People&#8217;s Republic of China (&#8220;PRC&#8221;) national, the grant of the PSUs is conditioned upon the Company securing all necessary approvals from the PRC State Administration of Foreign Exchange to permit the operation of the 2011 Plan and the participation of PRC nationals employed by your Employer, as determined by the Company in its sole discretion.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:36pt;padding-right:29.75pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.95pt;text-decoration:underline">Sale of Shares</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Notwithstanding anything to the contrary in the 2011 Plan, upon any termination of employment with your Employer, you shall be required to sell all Shares acquired under the 2011 Plan within such time period as may be established by the PRC State Administration of Foreign Exchange.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:35.95pt;padding-right:29.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.95pt;text-decoration:underline">Exchange Control Restrictions</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. You acknowledge and agree that you will be required immediately to repatriate to the PRC the proceeds from the sale of any Shares acquired under the 2011 Plan, as well as any other cash amounts attributable to the Shares acquired under the 2011 Plan (collectively, &#8220;Cash Proceeds&#8221;). Further, you acknowledge and agree that the repatriation of the Cash Proceeds must be effected through a special bank account established by your Employer, the Company or one of its Subsidiaries, and you hereby consent and agree that the Cash Proceeds may be transferred to such account by the Company on your behalf prior to being delivered to you. The Cash Proceeds may be paid to you in U.S. dollars or local currency at the Company&#8217;s discretion. If the Cash Proceeds are paid to you in U.S. dollars, you understand that a U.S. dollar bank account must be established and maintained in China so that the proceeds may be deposited into such account. Additionally, if the Company changes its Stock Plan Administrator, you acknowledge and agree that the Company may transfer any Shares issued under the 2011 Plan to the new designated Stock Plan Administrator if necessary for legal or administrative reasons. You agree to sign any documentation necessary to facilitate the transfer. If the Cash Proceeds are paid to you in local currency, you acknowledge and agree that the Company is under no</font></div><div style="text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:4pt;padding-left:35.95pt;padding-right:29.8pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">obligation to secure any particular exchange conversion rate and that the Company may face delays in converting the Cash Proceeds to local currency due to exchange control restrictions. You agree to bear any currency fluctuation risk between the time the Shares are sold and the Cash Proceeds are converted into local currency and distributed to you. You further agree to comply with any other requirements that may be imposed by your Employer, the Company and its Subsidiaries in the future in order to facilitate compliance with exchange control requirements in the PRC.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">COLOMBIA&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:35.95pt;padding-right:29.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.95pt;text-decoration:underline">Nature of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. In addition to the provisions of Section 20 of the Terms and Conditions you acknowledge that, pursuant to Article 128 of the Colombian Labor Code, the 2011 Plan and related benefits do not constitute a component of your &#8220;salary&#8221; for any legal purpose. Therefore, they will not be included and&#47;or considered for purposes of calculating any and all labor benefits, such as legal&#47;fringe benefits, vacations, indemnities, payroll taxes, social insurance contributions and&#47;or any other labor-related amount which may be payable.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:36pt;padding-right:29.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Shares subject to the PSUs are not and will not be registered in the Colombian registry of publicly traded securities (</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Registro Nacional de Valores y Emisores</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) and therefore the Shares may not be offered to the public in Colombia. Nothing in this document should be construed as the making of a public offer of securities in Colombia.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">COSTA RICA&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">DENMARK&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:29.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Treatment of PSUs upon Termination of Employment</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Notwithstanding any provision in the Terms and Conditions or the 2011 Plan to the contrary, unless you are a member of registered management who is not considered a salaried employee, the treatment of the PSUs upon a termination of employment which is not a result of death shall be governed by Sections 4 and 5 of the Danish Act on Stock Option in Employment Relations. However, if the provisions in the Terms and Conditions or the Plan governing the treatment of the PSUs upon a termination of employment are more favorable, then the provisions of the Terms and Conditions or the 2011 Plan will govern.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FINLAND&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:29.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Withholding of Tax-Related Items</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Notwithstanding anything in Section 13 of the Terms and Conditions to the contrary, if you are a local national of Finland, any Tax- Related Items shall be withheld only in cash from your regular salary&#47;wages or other amounts payable to you in cash or such other withholding methods as may be permitted under the 2011 Plan and allowed under local law.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:4pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FRANCE&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:29.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Use of English Language</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. By accepting your PSUs, you acknowledge and agree that it is your wish that the Terms and Conditions, this Addendum, as well as all other documents, notices and legal proceedings entered into, given or instituted pursuant to your PSUs, either directly or indirectly, be drawn up in English.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:36pt;padding-right:29.9pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Langue anglaise</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">. En acceptant l'allocation de vos PSUs, vous reconnaissez et acceptez avoir souhait&#233; que le Termes et Conditions, le pr&#233;sent avenant, ainsi que tous autres documents ex&#233;cut&#233;s, avis donn&#233;s et proc&#233;dures judiciaires intent&#233;es, relatifs, directement ou indirectement, &#224; l'allocation de vos PSUs, soient r&#233;dig&#233;s en anglais</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">BY SIGNING BELOW, YOU ACKNOWLEDGE, UNDERSTAND AND AGREE TO THE PROVISIONS OF THE 2011 PLAN, THE TERMS AND CONDITIONS AND THIS ADDENDUM.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:36pt;padding-right:17pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PLEASE SIGN AND RETURN THIS ADDENDUM VIA EMAIL NO LATER THAN APRIL 28, 2023 TO </font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">STOCKPLANADMINISTRATION&#64;STRYKER.COM</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.</font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">___________________________________&#160;&#160;&#160;&#160;            ______________________________</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee Signature&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Employee Name (Printed)</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">_____________________</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Date</font></div><div><font><br></font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">GERMANY&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div><font><br></font></div><div style="margin-top:4pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">HONG KONG&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:29.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Importance Notice.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Warning&#58; The contents of the Terms and Conditions, this Addendum, the 2011 Plan, and all other materials pertaining to the PSUs and&#47;or the 2011 Plan have not been reviewed by any regulatory authority in Hong Kong. You are hereby advised to exercise caution in relation to the offer thereunder. If you have any doubts about any of the contents of the aforesaid materials, you should obtain independent professional advice.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:36pt;padding-right:29.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Lapse of Restrictions</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. If, for any reason, Shares are issued to you within six (6) months of the grant date, you agree that you will not sell or otherwise dispose of any such Shares prior to the six-month anniversary of the grant date.</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:29.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Settlement in Shares</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Notwithstanding anything to the contrary in this Addendum, the Terms and Conditions or the 2011 Plan, the PSUs shall be settled only in Shares (and may not be settled in cash).</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:35.5pt;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Nature of the Plan</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company specifically intends that the 2011 Plan will not be treated as an occupational retirement scheme for purposes of the Occupational Retirement Schemes Ordinance (&#8220;ORSO&#8221;). To the extent any court, tribunal or legal&#47;regulatory body in Hong Kong determines that the 2011 Plan constitutes an occupational retirement scheme for the purposes of ORSO, the grant of the PSUs shall be null and void.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">INDIA&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:36pt;padding-right:29.8pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.95pt;text-decoration:underline">Repatriation Requirements</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. You expressly agree to repatriate all sale proceeds and dividends attributable to Shares acquired under the 2011 Plan in accordance with local foreign exchange rules and regulations. Neither the Company, your Employer or any of the Company&#8217;s Subsidiaries shall be liable for any fines or penalties resulting from your failure to comply with applicable laws, rules or regulations.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">IRELAND&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ITALY&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:5.05pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">JAPAN&#160;&#160;&#160;&#160;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div><font><br></font></div><div style="margin-top:4pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">MEXICO&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:29.75pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.95pt;text-decoration:underline">Commercial Relationship</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. You expressly recognize that your participation in the 2011 Plan and the Company&#8217;s grant of the PSUs does not constitute an employment relationship between you and the Company. You have been granted the PSUs as a consequence of the commercial relationship between the Company and the Subsidiary in Mexico that employs you, and the Company&#8217;s Subsidiary in Mexico is your sole employer. Based on the foregoing, (a) you expressly recognize the 2011 Plan and the benefits you may derive from your participation in the 2011 Plan do not establish any rights between you and the Company&#8217;s Subsidiary in Mexico that employs you, (b) the 2011 Plan and the benefits you may derive from your participation in the 2011 Plan are not part of the employment conditions and&#47;or benefits provided by the Company&#8217;s Subsidiary in Mexico that employs you, and (c) any modification or amendment of the 2011 Plan by the Company, or a termination of the 2011 Plan by the Company, shall not constitute a change or impairment of the terms and conditions of your employment with the Company&#8217;s Subsidiary in Mexico that employs you.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:36pt;padding-right:29.75pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.95pt;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. You expressly recognize and acknowledge that the Company's grant of PSUs and the underlying Shares under the Plan have not been registered with the National Register of Securities maintained by the Mexican National Banking and Securities Commission and cannot be offered or sold publicly in Mexico. In addition, the 2011 Plan, the Terms and Conditions and any other document relating to the PSUs may not be publicly distributed in Mexico. These materials are addressed to you only because of your existing relationship with the Company and these materials should not be reproduced or copied in any form. The offer contained in these materials does not constitute a public offering of securities but rather constitutes a private placement of securities addressed specifically to individuals who are present employees of the Employer in Mexico made in accordance with the provisions of the Mexican Securities Market Law, and any rights under such offering shall not be assigned or transferred.</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:29.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Extraordinary Item of Compensation</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. You expressly recognize and acknowledge that your participation in the 2011 Plan is a result of the discretionary and unilateral decision of the Company, as well as your free and voluntary decision to participate in the 2011 Plan in accord with the terms and conditions of the 2011 Plan, the Terms and Conditions, and this Addendum. As such, you acknowledge and agree that the Company may, in its sole discretion, amend and&#47;or discontinue your participation in the 2011 Plan at any time and without any liability. The value of the PSUs is an extraordinary item of compensation outside the scope of your employment contract, if any. The PSUs are not part of your regular or expected compensation for purposes of calculating any severance, resignation, redundancy, end of service payments, bonuses, long-service awards, pension or retirement benefits, or any similar payments, which are the exclusive obligations of the Company&#8217;s Subsidiary in Mexico that employs you.</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">BY SIGNING BELOW, YOU ACKNOWLEDGE, UNDERSTAND AND AGREE TO THE PROVISIONS OF THE 2011 PLAN, THE TERMS AND CONDITIONS AND THIS ADDENDUM.</font></div><div><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div><font><br></font></div><div style="margin-top:4pt;padding-left:36pt;padding-right:17pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PLEASE SIGN AND RETURN THIS ADDENDUM VIA EMAIL NO LATER THAN APRIL 28, 2023 TO </font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">STOCKPLANADMINISTRATION&#64;STRYKER.COM</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.</font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">___________________________________&#160;&#160;&#160;&#160;            ______________________________</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee Signature&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Employee Name (Printed)</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">_____________________</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Date</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">NETHERLANDS&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:35.95pt;padding-right:29.8pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Waiver of Termination Rights</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. As a condition to the grant of the PSUs, you hereby waive any and all rights to compensation or damages as a result of the termination of your employment with the Company and your Employer for any reason whatsoever, insofar as those rights result or may result from (a) the loss or diminution in value of such rights or entitlements under the 2011 Plan, or (b) you ceasing to have rights under or ceasing to be entitled to any awards under the 2011 Plan as a result of such termination.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:36pt;padding-right:29.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Tax Deferral Upon Retirement</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Unless you otherwise elect by contacting Stryker no later than April 28, 2023, you hereby agree that upon Retirement eligibility, the PSUs shall not become taxable until the date of settlement when Shares are actually delivered or otherwise made available.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">NEW ZEALAND&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:35.95pt;padding-right:29.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.95pt;text-decoration:underline">WARNING</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. You are being offered PSUs to be settled in the form of shares of Stryker Corporation common stock. If the Company runs into financial difficulties and is wound up, you may lose some or all your investment. New Zealand law normally requires people who offer financial products to give information to investors before they invest. This requires those offering financial products to have disclosed information that is important for investors to make an informed decision. The usual rules do not apply to this offer because it is an offer made under the Employee Share Scheme exemption. As a result, you may not be given all the information usually required. You will also have fewer other legal protections for this investment. You should ask questions, read all documents carefully, and seek independent financial advice before accepting the offer. The Company&#8217;s Shares are currently traded on the New York Stock Exchange under the ticker symbol &#8220;SYK&#8221; and Shares acquired under the 2011 Plan may be sold through this exchange. You may end up selling the Shares at a price that is lower than the value of the Shares when you acquired them. The price will depend on the demand for the Company's Shares. </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">The Company&#8217;s most recent annual report (which includes the Company&#8217;s financial statements) is available at </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">https&#58;&#47;&#47;investors.stryker.com&#47;financial-information&#47;sec-filings&#47;default.aspx</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">. You are entitled to receive a copy of this report, free of charge, upon written request to the Company at </font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">STOCKPLANADMINISTRATION&#64;STRYKER.COM</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ib579d757a6804f8984567549778ec9d3_25"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="padding-left:34.5pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">POLAND&#160;&#160;&#160;&#160;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:5pt;padding-left:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-top:0.55pt;text-indent:36pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PORTUGAL&#160;&#160;&#160;&#160;</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:5pt;padding-left:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-top:0.55pt;text-indent:36pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PUERTO RICO&#160;&#160;&#160;&#160;</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:5pt;padding-left:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-top:0.55pt;text-indent:36pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ROMANIA</font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:5pt;padding-left:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-top:0.55pt;text-indent:36pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> RUSSIA</font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:5pt;padding-left:36pt;padding-right:29.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">IMPORTANT EMPLOYEE NOTIFICATION</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. You may be required to repatriate certain cash amounts received with respect to the PSUs to Russia as soon as you intend to use those cash amounts for any purpose, including reinvestment. If the repatriation requirement applies, such funds must initially be credited to you through a foreign currency account at an authorized bank in Russia. After the funds are initially received in Russia, they may be further remitted to foreign banks in accordance with Russian exchange control laws. Under the Directive N 5371-U of the Russian Central Bank (the &#8220;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">CBR</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), the repatriation requirement may not apply in certain cases with respect to cash amounts received in an account that is considered by the CBR to be a foreign brokerage account. Statutory exceptions to the repatriation requirement also may apply. </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">You should contact your personal advisor to ensure compliance with the applicable exchange control requirements prior to vesting in the PSUs and&#47;or selling the Shares acquired pursuant to the PSUs</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:5.95pt;padding-left:36pt;padding-right:29.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">SECURITIES LAW NOTIFICATION</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The grant of PSUs and the issuance of Shares upon vesting are not intended to be an offering of securities with the Russian Federation, and the Terms and Conditions, the 2011 Plan, this Addendum and all other materials that you receive in connection with the grant of PSUs and your participation in the 2011 Plan (collectively, &#8220;Grant Materials&#8221;) do not constitute advertising or a solicitation within the Russian Federation. In connection with your grant of PSUs, the Company has not submitted any registration statement, prospectus or other filing with the Russian Federal Bank or any other governmental or regulatory body within the Russian Federation, and the Grant Materials expressly may not be used, directly or indirectly, for the purpose of making a securities offering or public circulation of Shares within the Russian Federation. Any Shares acquired under the 2011 Plan will be maintained on your behalf outside of Russia. Moreover, you will not be permitted to sell or otherwise alienate any Shares directly to other Russian legal entities or individuals.</font></div><div><font><br></font></div><div style="padding-left:108pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.95pt;text-decoration:underline">EXCHANGE CONTROL NOTIFICATION</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;You are solely responsible for</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ib579d757a6804f8984567549778ec9d3_28"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="margin-top:4pt;padding-left:35.95pt;padding-right:29.85pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">complying with applicable Russian exchange control regulations. Since the exchange control regulations change frequently and without notice, you should consult your legal advisor prior to the acquisition or sale of Shares under the 2011 Plan to ensure compliance with current regulations. As noted, it is your personal responsibility to comply with Russian exchange control laws, and neither the Company nor any Subsidiary will be liable for any fines or penalties resulting from failure to comply with applicable laws.</font></div><div style="margin-top:12pt;padding-left:36pt;padding-right:29.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">ANTI-CORRUPTION NOTIFICATION</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Anti-corruption laws prohibit certain public servants, their spouses and their dependent children from owning any foreign source financial instruments (</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">e</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">g</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">., shares of foreign companies such as the Company). Accordingly, you should inform the Company if you are covered by these laws as this relates to your acquisition of Shares under the 2011 Plan.</font></div><div style="margin-top:11.95pt;padding-left:34.5pt;text-align:justify"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SINGAPORE&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:29.8pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.95pt;text-decoration:underline">Qualifying Person Exemption</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The following provision shall replace Section 23 of the Terms and Conditions&#58;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:36pt;padding-right:29.75pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The grant of the PSUs under the 2011 Plan is being made pursuant to the &#8220;Qualifying Person&#8221; exemption&#8221; under section 273(1)(f) of the Securities and Futures Act (Chapter 289, 2006 Ed.) (&#8220;SFA&#8221;). The 2011 Plan has not been lodged or registered as a prospectus with the Monetary Authority of Singapore. You should note that, as a result, the PSUs are subject to section 257 of the SFA and you will not be able to make (a) any subsequent sale of the Shares in Singapore or (ii) any offer of such subsequent sale of the Shares subject to the PSUs in Singapore, unless such sale or offer is made pursuant to the exemptions under Part XIII Division (1) Subdivision (4) (other than section 280) of the SFA (Chapter 289, 2006 Ed.).</font></div><div><font><br></font></div><div style="padding-left:35.95pt;padding-right:29.75pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Director Reporting Notification</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. If you are a director, associate director or shadow director of a Singapore company, you are subject to certain notification requirements under the Singapore Companies Act. Among these requirements is an obligation to notify the Singapore company in writing when you receive an interest (e.g., PSUs or Shares) in the Company or any related company. In addition, you must notify the Singapore company when you sell Shares (including when you sell Shares acquired at vesting of the Performance Stock Units). These notifications must be made within two business days of acquiring or disposing of any interest in the Company or any related company. In addition, a notification must be made of Participant&#8217;s interests in the Company or any related company within two business days of becoming a director.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:34.5pt;text-align:justify"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SOUTH AFRICA&#160;&#160;&#160;&#160;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:36pt;padding-right:29.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Withholding Taxes</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. In addition to the provisions of Section 13 of the Terms and Conditions, you agree to notify your Employer in South Africa of the amount of any gain realized upon vesting of the PSUs. If you fail to advise your Employer of the gain realized upon vesting of the PSUs, you may be liable for a fine. You will be responsible for paying any difference between the actual tax liability and the amount withheld.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:4pt;padding-left:36pt;padding-right:29.6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Exchange Control Obligations</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. You are solely responsible for complying with applicable exchange control regulations and rulings (the &#8220;Exchange Control Regulations&#8221;) in South Africa. As the Exchange Control Regulations change frequently and without notice, you should consult your legal advisor prior to the acquisition or sale of Shares under the 2011 Plan to ensure compliance with current Exchange Control Regulations. Neither the Company nor any of its Subsidiaries will be liable for any fines or penalties resulting from your failure to comply with applicable laws.</font></div><div><font><br></font></div><div style="padding-left:35.95pt;padding-right:29.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.95pt;text-decoration:underline">Securities Law Information and Deemed Acceptance of PSUs</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Neither the PSUs nor the underlying Shares shall be publicly offered or listed on any stock exchange in South Africa. The offer is intended to be private pursuant to Section 96 of the Companies Act and is not subject to the supervision of any South African governmental authority. Pursuant to Section 96 of the Companies Act, the PSU offer must be finalized on or before the 60th day following the grant date. If you do not want to accept the PSUs, you are required to decline the PSUs no later than the 60th day following the grant date. If you do not reject the PSUs on or before the 60th day following the grant date, you will be deemed to accept the PSUs.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SOUTH KOREA&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt;text-align:justify"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SPAIN&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:29.7pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.95pt;text-decoration:underline">Acknowledgement of Discretionary Nature of the 2011 Plan&#59; No Vested Rights</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. In accepting the PSUs, you acknowledge that you consent to participation in the 2011 Plan and have received a copy of the 2011 Plan. You understand that the Company has unilaterally, gratuitously and in its sole discretion granted PSUs under the 2011 Plan to individuals who may be employees of the Company or its Subsidiaries throughout the world. The decision is a limited decision that is entered into upon the express assumption and condition that any grant will not economically or otherwise bind the Company or any of its Subsidiaries on an ongoing basis. Consequently, you understand that the PSUs are granted on the assumption and condition that the PSUs and the Shares acquired upon vesting of the PSUs shall not become a part of any employment contract (either with the Company or any of its Subsidiaries) and shall not be considered a mandatory benefit, salary for any purposes (including severance compensation) or any other right whatsoever. In addition, you understand that this grant would not be made to you but for the assumptions and conditions referenced above. Thus, you acknowledge and freely accept that should any or all of the assumptions be mistaken or should any of the conditions not be met for any reason, the PSUs shall be null and void.</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:29.75pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You understand and agree that, as a condition of the grant of the PSUs, any unvested PSUs as of the date you cease active employment will be forfeited without entitlement to the underlying Shares or to any amount of indemnification in the event of the termination of employment by reason of, but not limited to, (i) material modification of the terms of employment under Article 41 of the Workers&#8217; Statute or (ii) relocation under Article 40 of the Workers&#8217; Statute.  You acknowledge that you have read and specifically accept the</font></div><div style="text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:4pt;padding-left:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">conditions referred to in the Terms and Conditions regarding the impact of a termination of employment on your PSUs.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">BY SIGNING BELOW, YOU ACKNOWLEDGE, UNDERSTAND AND AGREE TO THE PROVISIONS OF THE 2011 PLAN, THE TERMS AND CONDITIONS AND THIS ADDENDUM.</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:36pt;padding-right:17pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PLEASE SIGN AND RETURN THIS ADDENDUM VIA EMAIL NO LATER THAN APRIL 28, 2023 TO </font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">STOCKPLANADMINISTRATION&#64;STRYKER.COM</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.</font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">___________________________________&#160;&#160;&#160;&#160;            ______________________________</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee Signature&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Employee Name (Printed)</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">_____________________</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Date</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SWITZERLAND&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:35.95pt;padding-right:29.7pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Neither this document nor any other materials relating to the RSUs (a) constitutes a prospectus according to articles 35 et seq. of the Swiss Federal Act on Financial Services (&#8220;FinSA&#8221;) (b) may be publicly distributed or otherwise made publicly available in Switzerland to any person other than an employee of the Company or (c) has been or will be filed with, approved or supervised by any Swiss reviewing body according to article 51 FinSA or any Swiss regulatory authority, including the Swiss Financial Market Supervisory Authority (&#8220;FINMA&#8221;).</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:5.05pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TAIWAN&#160;&#160;&#160;&#160;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:36pt;padding-right:29.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Securities Law Notice</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The offer of participation in the 2011 Plan is available only for employees of the Company and its Subsidiaries. The offer of participation in the 2011 Plan is not a public offer of securities by a Taiwanese company.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">THAILAND&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TURKEY&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:36pt;padding-right:29.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Under Turkish law, you are not permitted to sell any Shares acquired under the 2011 Plan within Turkey. The Shares are currently traded on the New York Stock Exchange, which is located outside of Turkey, under the ticker symbol &#8220;SYK&#8221; and the Shares may be sold through this exchange.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:36pt;padding-right:29.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.9pt;text-decoration:underline">Financial Intermediary Obligation</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. You acknowledge that any activity related to investments in foreign securities (e.g., the sale of Shares) should be conducted through a bank or financial intermediary institution licensed by the Turkey Capital Markets Board and</font></div><div style="text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:4pt;padding-left:35.95pt;padding-right:29.8pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">should be reported to the Turkish Capital Markets Board. You solely are responsible for complying with this requirement and should consult with a personal legal advisor for further information regarding any obligations in this respect.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:5pt;padding-left:34.5pt;text-align:justify"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">UNITED ARAB EMIRATES&#160;&#160;&#160;&#160;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:36pt;padding-right:29.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The offer of the PSUs is available only for select Employees of the Company </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and its Subsidiaries </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and is in the nature of providing incentives in the United Arab Emirates. The 2011 Plan and the Terms and Conditions are intended for distribution only to such individuals and must not be delivered to, or relied on by any other person. Prospective purchasers of securities should conduct their own due diligence.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:36pt;padding-right:29.65pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Emirates Securities and Commodities Authority has no responsibility for reviewing or verifying any documents in connection with this statement, including the 2011 Plan and the Terms and Conditions, or any other incidental communication materials distributed in connection with the PSUs. Further, neither the Ministry of Economy nor the Dubai Department of Economic Development has approved this statement nor taken steps to verify the information set out in it, and has no responsibility for it. Residents of the United Arab Emirates who have any questions regarding the contents of the 2011 Plan and the Terms and Conditions should obtain independent advice.</font></div><div style="padding-right:29.65pt;text-align:justify"><font><br></font></div><div style="margin-top:0.45pt;text-indent:36pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">UNITED KINGDOM&#160;&#160;&#160;&#160;                                                                                                                                           </font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:36pt;padding-right:29.95pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.95pt;text-decoration:underline">Income Tax and Social Insurance Contribution Withholding</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The following provision shall supplement Section 13 of the Terms and Conditions&#58;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:35.95pt;padding-right:29.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Without limitation to Section 13 of the Terms and Conditions, you agree that you are liable for all Tax-Related Items and hereby covenant to pay all such Tax-Related Items, as and when requested by the Company, your Employer or by Her Majesty&#8217;s Revenue and Customs (&#8220;HMRC&#8221;) (or any other tax authority or any other relevant authority). You also agree to indemnify and keep indemnified the Company and your Employer against any Tax- Related Items that they are required to pay or withhold or have paid or will pay to HMRC on your behalf (or any other tax authority or any other relevant authority).</font></div><div style="margin-top:12pt;padding-left:36pt;padding-right:29.65pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.95pt;text-decoration:underline">Exclusion of Claim</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. You acknowledge and agree that you will have no entitlement to compensation or damages in consequence of the termination of your employment with the Company and your Employer for any reason whatsoever and whether or not in breach of contract, insofar as any purported claim to such entitlement arises or may arise from your ceasing to have rights under or to be entitled to vest in the PSUs as a result of such termination of employment (whether the termination is in breach of contract or otherwise), or from the loss or diminution in value of the PSUs. Upon the grant of the PSUs, you shall be deemed irrevocably to have waived any such entitlement.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:3pt;padding-right:3pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">****************************</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>7
<FILENAME>ex21i1231202210k.htm
<DESCRIPTION>EX-21.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i45c7f9023d4a411ba49ce55547cdd555_1"></div><div style="min-height:60.75pt;width:100%"><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 21(i)</font></div><div style="text-align:right"><font><br></font></div></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">STRYKER CORPORATION LIST OF SUBSIDIARIES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December&#160;31, 2022</font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.410%"><tr><td style="width:1.0%"></td><td style="width:71.155%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.645%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">Name of Subsidiary</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">State or Country of Incorporation</font></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2Hip Holdings SAS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">France</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Aimago SA</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Switzerland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Alcott Indemnity Company</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Vermont</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Arrinex, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Berchtold + Fritz GmbH</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Berchtold Corporation</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Berchtold GmbH  &#38; Co. KG</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Berchtold Holding Switzerland GmbH</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Switzerland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">BioMimetic Therapeutics USA, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">BioMimetic Therapeutics, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cartiva, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changzhou Orthomed Medical Instrument Company Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">China</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ease Applications, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Florida</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EnMovi, Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Entellus Medical, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Extension, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Indiana</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gauss Surgical, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gongping (Shanghai) Medical Devices Trading Co. Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">China</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GYS Tech, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">HeartSine Technologies Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">HeartSine Technologies, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Howmedica International S. de R.L.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Panama</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Howmedica Osteonics Corp.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - New Jersey</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hyperbranch Medical Technologies, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Imascap SAS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">France</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Imorphics Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Infinity MSD Corp.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Infinity MSF Corp.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">InstruMedics, L.L.C.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Michigan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Invuity, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Jiangsu Chuangyi Medical Instrument Company Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">China</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Jolife AB</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sweden</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">K2M Group Holdings, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">K2M Holdings, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">K2M, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loon Intermediateco, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">MAKO Surgical Corp</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mobius Imaging, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Muka Metal Ticaret ve Sanayi Anaonim Sirketi</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Turkey</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nettrick Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Novadaq Corp.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Novadaq Technologies ULC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">N.V. Stryker SA</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Belgium</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OOO &#34;Stryker&#34;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Russia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Orneo &#214;zel Sa&#287;l&#305;k Hizmetleri Medikal Ticaret Anonim &#350;irketi</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Turkey</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OrthoHelix Surgical Designs, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Orthomed (Hong Kong) Medical Instrument Company Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hong Kong</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OrthoSensor Korea, Ltd</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">South Korea</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Orthosensor, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ortho-Space, Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Israel</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Orthovita, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Pennsylvania</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">P.C. Sweden Holding AB</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sweden</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">PatientSafe Solutions, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Physio-Control (Shanghai) Sales Co., Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">China</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Physio-Control Lebanon Sales Offshore s.a.l.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lebanon</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Physio-Control Manufacturing, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Washington</font></td></tr></table></div><div style="height:38.25pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.75pt;width:100%"><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 21(i)</font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.410%"><tr><td style="width:1.0%"></td><td style="width:71.155%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.645%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">Name of Subsidiary</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">State or Country of Incorporation</font></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Physio-Control Operations Netherlands B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Physio-Control Sales Limited Liability Company</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Russia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Physio-Control, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Washington</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">PTH West, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SafeAir AG </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Switzerland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sage Products Holdings II, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sage Products Holdings III, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sage Products, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SCI Calyx SA</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">France</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Scopis GmbH</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Spirox, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SSI Divestiture, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Massachusetts</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stanmore Implants Worldwide Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stanmore, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Massachusetts</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker (Barbados) Foreign Sales Corporation</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Barbados</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker (Beijing) Healthcare Products Co., Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">China</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker (Shanghai) Healthcare Products Co., Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">China</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker (Suzhou) Medical Technology Co Ltd</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">China</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker (Thailand) Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Thailand</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker AB</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sweden</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Acquisitions B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Australia LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Australia Pty. Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Australia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Austria GmbH</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Austria</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Berchtold B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Beteiligungs GmbH</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Canada Holding ULC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Canada Manufacturing ULC </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Canada ULC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Canadian Management, ULC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Capital B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker China Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hong Kong</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Colombia SAS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Colombia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Communications, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Corporation (Chile) y Compania Limitada</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Chile</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Corporation (Malaysia) Sdn. Bhd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Malaysia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Customs Brokers, LLC </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Czech Republic s.r.o.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Czech Republic</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker do Brasil Ltda</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker EMEA Supply Chain Services B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Employment Company, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Michigan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker European Holdings Co&#246;peratief U.A</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker European Holdings, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker European Operations B.V. </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker European Operations Holdings I B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker European Operations Holdings II B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker European Operations Holdings III B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker European Operations Holdings, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker European Operations Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Far East, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Foreign Acquisitions, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker France SAS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">France</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Funding B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Global Technology Center Private Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">India</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker GmbH</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Switzerland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker GmbH &#38; Co. KG</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Grundst&#252;cks GmbH &#38; Co KG</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Grundst&#252;cks Verwaltungs GmbH</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Germany</font></td></tr></table></div><div style="height:38.25pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.75pt;width:100%"><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 21(i)</font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.410%"><tr><td style="width:1.0%"></td><td style="width:71.155%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.645%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">Name of Subsidiary</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">State or Country of Incorporation</font></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Holdings B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Iberia, S.L. Unipersonal</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Spain</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker IFSC Designated Activity Company</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker India Private Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">India</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker International Acquisitions B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker International Holdings B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Ireland Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Irish Holdings DAC </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Italia S.r.l.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Italy</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Japan K.K.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Japan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Korea Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">South Korea</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Lebanon (Offshore) S.A.L.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lebanon</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Leibinger GmbH &#38; Co. KG</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Luxembourg Sarl</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Luxembourg</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Malta Holdings Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Malta</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Manufacturing Holding Company B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Manufacturing S. de R.L. de C.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mexico</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Mauritius Holding Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mauritius</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Medtech K.K.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Japan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Mexico Holdings B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Mexico SA de CV</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mexico</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Nederland B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker New Zealand Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">New Zealand</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker NV Operations Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Osteonics AG</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Switzerland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Pacific Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hong Kong</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Performance Solutions, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - New Jersey</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Poland Manufacturing sp. z  o. o.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Poland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Poland Services sp. z o.o.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Poland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Polska sp.z.o.o.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Poland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Portugal - Produtos Medicos, Unipessoal, Lda.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Portugal</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Professional Latin America S. de R.L. de C.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mexico</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Puerto Rico Holdings B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Puerto Rico Sales, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Puerto Rico</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Puerto Rico, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Puerto Rico</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Renovation Services, LLC </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Romania SRL</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Romania</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Sales LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Michigan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Servicios Administrativos S.de R.L. de C.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mexico</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Singapore Private Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Singapore</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker South Africa (Proprietary) Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">South Africa</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Spain Medtech Holdings, S.L.U.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Spain</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Spine Sarl</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Switzerland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Spine SAS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">France</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Sustainability Solutions, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Tibbi Cihazlan Sanayi ve Ticaret Limited Sirketi</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Turkey</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Tijuana Operations, S. de R.L. de C.V. </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mexico</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Trauma GmbH</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Turkish Holdings B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker UK Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Unite, Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Bermuda</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Verwaltungs GmbH</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Vietnam Company Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vietnam</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SYK Costa Rica Services Sociedad De Responsabilidad Limitada</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Costa Rica</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Thermedx LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Ohio</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TMG France SAS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">France</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TMJ Solutions, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tornier Orthopedics Ireland Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tornier Pty Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Australia</font></td></tr></table></div><div style="height:38.25pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.75pt;width:100%"><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 21(i)</font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.410%"><tr><td style="width:1.0%"></td><td style="width:71.155%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.645%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">Name of Subsidiary</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">State or Country of Incorporation</font></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tornier SAS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">France</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tornier, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trauson (China) Medical Instrument Company Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">China</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trauson (Hong Kong) Company Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hong Kong</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trauson Holdings (B.V.I.) Company Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">British Virgin Islands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trauson Holdings (Hong Kong) Company Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hong Kong</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trauson Holdings Company Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cayman Islands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TSO3 Corporation</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TSO3 Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vocera Acquisition Corp.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vocera Canada Ltd</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vocera Communications Australia Pty Ltd</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Australia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vocera Communications India Private Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">India</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vocera Communications Middle East FZ - LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United Arab Emirates</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vocera Communications UK Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vocera Communications, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Wright Medical Australia Pty Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Australia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Wright Medical Costa Rica, S.A.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Costa Rica</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Wright Medical Device (Shanghai) Co., Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">China</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Wright Medical Group, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Wright Medical Technology, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Wright Medical UK Ltd</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Wright PacRim, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ZipLine Medical Consulting (Shanghai) Co., Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">China</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ZipLine Medical Hong Kong Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hong Kong</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ZipLine Medical, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stryker Corporation directly or indirectly owns 100% of the outstanding voting securities of each of the above-named subsidiaries, with the exception of any designated by an asterisk (*), which Stryker Corporation directly or indirectly owns a majority of the outstanding voting securities.</font></div><div style="text-align:center"><font><br></font></div><div style="height:38.25pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>8
<FILENAME>ex23i1231202210k.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="iebfb71841f8143bfbfb54d23fb55922a_1"></div><div style="min-height:72pt;width:100%"><div style="padding-left:72pt;text-align:right;text-indent:36pt"><font><br></font></div><div style="padding-left:72pt;text-align:right;text-indent:36pt"><font><br></font></div><div style="padding-left:72pt;text-align:right;text-indent:36pt"><font><br></font></div><div style="padding-left:72pt;text-align:right;text-indent:36pt"><font><br></font></div><div style="padding-left:72pt;text-align:right;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:116%">Exhibit 23(i)</font></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:117%">Consent of Independent Registered Public Accounting Firm</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:117%">We consent to the incorporation by reference in the following Registration Statements&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%;padding-left:10.5pt">Registration Statement (Form S-3 No. 333-262652) of Stryker Corporation, and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:117%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:117%;padding-left:10.5pt">Registration Statement (Form S-8 No. 333-78201) pertaining to the 1998 Stock Option Plan of Stryker Corporation, and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:117%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:117%;padding-left:10.5pt">Registration Statement (Form S-8 No. 333-140961) pertaining to the 2006 Long-Term Incentive Plan of Stryker Corporation, and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:117%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:117%;padding-left:10.5pt">Registration Statements (Form S-8 No. 333-150396 and Form S-8 333-221959) pertaining to the 2008 Employee Stock Purchase Plan of Stryker Corporation, and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:117%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:117%;padding-left:10.5pt">Registration Statements (Form S-8 No. 333-179142 and Form S-8 333-221958) pertaining to the 2011 Long-Term Incentive Plan of Stryker Corporation&#59;</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:117%">of our reports dated February 10, 2023, with respect to the consolidated financial statements and schedule of Stryker Corporation and subsidiaries and the effectiveness of internal control over financial reporting of Stryker Corporation and subsidiaries included in this Annual Report (Form 10-K) for the year ended December 31, 2022.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:116%">&#47;s&#47; Ernst &#38; Young LLP</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:140%">Grand Rapids, Michigan</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:140%">February 10, 2023</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>9
<FILENAME>ex31i1231202210k.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i5c365ebe368342868aae5f875583cc3d_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 31(i)</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 302</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Kevin A. Lobo, certify that&#58; </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.  I have reviewed this Annual Report on Form 10-K for the year ended December&#160;31, 2022 of Stryker Corporation&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.  Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.  Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.  The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)  Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)  Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)  Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)  Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.  The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)  All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)  Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:6.671%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.820%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.209%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 10, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; KEVIN A. LOBO</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kevin A. Lobo</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chair, Chief Executive Officer and President</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>10
<FILENAME>ex31ii1231202210k.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ifcdffa9323cc4dcabae3b1db0c0c072a_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 31(ii)</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 302</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Glenn S. Boehnlein, certify that&#58; </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.  I have reviewed this Annual Report on Form 10-K for the year ended December&#160;31, 2022 of Stryker Corporation&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.  Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.  Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.  The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)  Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)  Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)  Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)  Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.  The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)  All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)  Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:6.671%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.820%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.209%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 10, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; GLENN S. BOEHNLEIN</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Glenn S. Boehnlein</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President, Chief Financial Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>11
<FILENAME>ex32i1231202210k.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i90e7447a1744400a8f0b8d16ddee40d0_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 32(i) </font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350, </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 </font></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Annual Report on Form 10-K of Stryker Corporation (the &#34;Company&#34;) for the year ended December&#160;31, 2022 (the &#34;Report&#34;), I, Kevin A. Lobo, Chair, Chief Executive Officer and President of the Company, certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that&#58; </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:6.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.811%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.342%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 10, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; KEVIN A. LOBO</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kevin A. Lobo</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chair, Chief Executive Officer and President</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>12
<FILENAME>ex32ii1231202210k.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i7938c1004beb4b19ba80e19ffc2f1f65_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 32(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350, </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 </font></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Annual Report on Form 10-K of Stryker Corporation (the &#34;Company&#34;) for the year ended December&#160;31, 2022 (the &#34;Report&#34;), I, Glenn S. Boehnlein, Vice President, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that&#58; </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:6.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.811%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.342%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 10, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; GLENN S. BOEHNLEIN</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Glenn S. Boehnlein</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President, Chief Financial Officer</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>13
<FILENAME>syk-20221231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:2349b3b0-68ea-4cbc-845b-39a36087e2b4,g:780e132c-de96-43a0-a8bf-d2cffc0e012a-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:syk="http://www.stryker.com/20221231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.stryker.com/20221231">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="syk-20221231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="syk-20221231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="syk-20221231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="syk-20221231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="COVERPAGE" roleURI="http://www.stryker.com/role/COVERPAGE">
        <link:definition>0000001 - Document - COVER PAGE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://www.stryker.com/role/AuditInformation">
        <link:definition>0000002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsOfEarnings" roleURI="http://www.stryker.com/role/ConsolidatedStatementsOfEarnings">
        <link:definition>0000003 - Statement - Consolidated Statements Of Earnings</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsOfEarningsParenthetical" roleURI="http://www.stryker.com/role/ConsolidatedStatementsOfEarningsParenthetical">
        <link:definition>0000004 - Statement - Consolidated Statements Of Earnings (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveIncome" roleURI="http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome">
        <link:definition>0000005 - Statement - Consolidated Statements of Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://www.stryker.com/role/ConsolidatedBalanceSheets">
        <link:definition>0000006 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParentheticals" roleURI="http://www.stryker.com/role/ConsolidatedBalanceSheetsParentheticals">
        <link:definition>0000007 - Statement - Consolidated Balance Sheets (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsOfShareholdersEquity" roleURI="http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity">
        <link:definition>0000008 - Statement - Consolidated Statements Of Shareholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsOfCashFlows" roleURI="http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows">
        <link:definition>0000009 - Statement - Consolidated Statements Of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPolicies" roleURI="http://www.stryker.com/role/SignificantAccountingPolicies">
        <link:definition>0000010 - Disclosure - Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognition" roleURI="http://www.stryker.com/role/RevenueRecognition">
        <link:definition>0000011 - Disclosure - Revenue Recognition</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.stryker.com/role/FairValueMeasurements">
        <link:definition>0000012 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstruments" roleURI="http://www.stryker.com/role/DerivativeInstruments">
        <link:definition>0000013 - Disclosure - Derivative Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLossIncomeAOCI" roleURI="http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCI">
        <link:definition>0000014 - Disclosure - Accumulated Other Comprehensive (Loss) Income (AOCI)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Acquisitions" roleURI="http://www.stryker.com/role/Acquisitions">
        <link:definition>0000015 - Disclosure - Acquisitions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesandCommitments" roleURI="http://www.stryker.com/role/ContingenciesandCommitments">
        <link:definition>0000016 - Disclosure - Contingencies and Commitments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssets" roleURI="http://www.stryker.com/role/GoodwillandOtherIntangibleAssets">
        <link:definition>0000017 - Disclosure - Goodwill and Other Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStock" roleURI="http://www.stryker.com/role/CapitalStock">
        <link:definition>0000018 - Disclosure - Capital Stock</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandCreditFacilities" roleURI="http://www.stryker.com/role/DebtandCreditFacilities">
        <link:definition>0000019 - Disclosure - Debt and Credit Facilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.stryker.com/role/IncomeTaxes">
        <link:definition>0000020 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementPlans" roleURI="http://www.stryker.com/role/RetirementPlans">
        <link:definition>0000021 - Disclosure - Retirement Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofQuarterlyDataUnaudited" roleURI="http://www.stryker.com/role/SummaryofQuarterlyDataUnaudited">
        <link:definition>0000022 - Disclosure - Summary of Quarterly Data (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentandGeographicData" roleURI="http://www.stryker.com/role/SegmentandGeographicData">
        <link:definition>0000023 - Disclosure - Segment and Geographic Data</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AssetImpairments" roleURI="http://www.stryker.com/role/AssetImpairments">
        <link:definition>0000024 - Disclosure - Asset Impairments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleIIValuationandQualifyingAccountsNotes" roleURI="http://www.stryker.com/role/ScheduleIIValuationandQualifyingAccountsNotes">
        <link:definition>0000025 - Disclosure - Schedule II Valuation and Qualifying Accounts (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesPolicies" roleURI="http://www.stryker.com/role/SignificantAccountingPoliciesPolicies">
        <link:definition>0000026 - Disclosure - Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionTables" roleURI="http://www.stryker.com/role/RevenueRecognitionTables">
        <link:definition>0000027 - Disclosure - Revenue Recognition (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.stryker.com/role/FairValueMeasurementsTables">
        <link:definition>0000028 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsTables" roleURI="http://www.stryker.com/role/DerivativeInstrumentsTables">
        <link:definition>0000029 - Disclosure - Derivative Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLossIncomeAOCITables" roleURI="http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCITables">
        <link:definition>0000030 - Disclosure - Accumulated Other Comprehensive (Loss) Income (AOCI) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsTables" roleURI="http://www.stryker.com/role/AcquisitionsTables">
        <link:definition>0000031 - Disclosure - Acquisitions (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesandCommitmentsTables" roleURI="http://www.stryker.com/role/ContingenciesandCommitmentsTables">
        <link:definition>0000032 - Disclosure - Contingencies and Commitments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsTables" roleURI="http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsTables">
        <link:definition>0000033 - Disclosure - Goodwill and Other Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStockTables" roleURI="http://www.stryker.com/role/CapitalStockTables">
        <link:definition>0000034 - Disclosure - Capital Stock (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandCreditFacilitiesTables" roleURI="http://www.stryker.com/role/DebtandCreditFacilitiesTables">
        <link:definition>0000035 - Disclosure - Debt and Credit Facilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.stryker.com/role/IncomeTaxesTables">
        <link:definition>0000036 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementPlansTables" roleURI="http://www.stryker.com/role/RetirementPlansTables">
        <link:definition>0000037 - Disclosure - Retirement Plans (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofQuarterlyDataUnauditedTables" roleURI="http://www.stryker.com/role/SummaryofQuarterlyDataUnauditedTables">
        <link:definition>0000038 - Disclosure - Summary of Quarterly Data (Unaudited) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentandGeographicDataTables" roleURI="http://www.stryker.com/role/SegmentandGeographicDataTables">
        <link:definition>0000039 - Disclosure - Segment and Geographic Data (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesDetails" roleURI="http://www.stryker.com/role/SignificantAccountingPoliciesDetails">
        <link:definition>0000040 - Disclosure - Significant Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionNarrativeDetails" roleURI="http://www.stryker.com/role/RevenueRecognitionNarrativeDetails">
        <link:definition>0000041 - Disclosure - Revenue Recognition - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionDisaggregatedSalesAnalysisDetails" roleURI="http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails">
        <link:definition>0000042 - Disclosure - Revenue Recognition - Disaggregated Sales Analysis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionChangesinContractLiabilitiesDetails" roleURI="http://www.stryker.com/role/RevenueRecognitionChangesinContractLiabilitiesDetails">
        <link:definition>0000043 - Disclosure - Revenue Recognition - Changes in Contract Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails" roleURI="http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails">
        <link:definition>0000044 - Disclosure - Fair Value Measurements (Valuation Of Financial Instruments By Pricing Categories) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsAvailableForSaleSecuritiesDetails" roleURI="http://www.stryker.com/role/FairValueMeasurementsAvailableForSaleSecuritiesDetails">
        <link:definition>0000045 - Disclosure - Fair Value Measurements (Available-For-Sale Securities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsNarrativeDetails" roleURI="http://www.stryker.com/role/FairValueMeasurementsNarrativeDetails">
        <link:definition>0000046 - Disclosure - Fair Value Measurements (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsForwardCurrencyExchangeContractsDetails" roleURI="http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails">
        <link:definition>0000047 - Disclosure - Derivative Instruments (Forward Currency Exchange Contracts) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsNarrativeDetails" roleURI="http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails">
        <link:definition>0000048 - Disclosure - Derivative Instruments (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsMovementsoutofOCIDetails" roleURI="http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails">
        <link:definition>0000049 - Disclosure - Derivative Instruments (Movements out of OCI) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails" roleURI="http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails">
        <link:definition>0000050 - Disclosure - Accumulated Other Comprehensive (Loss) Income (AOCI) (Schedule of Amounts Recognized in Other Comprehensive Income (Loss)) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsNarrativeDetails" roleURI="http://www.stryker.com/role/AcquisitionsNarrativeDetails">
        <link:definition>0000051 - Disclosure - Acquisitions (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails" roleURI="http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails">
        <link:definition>0000052 - Disclosure - Acquisitions (Allocation Of The Preliminary Purchase Price To The Acquired Net Assets Of Acquisitions) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesandCommitmentsNarrativeDetails" roleURI="http://www.stryker.com/role/ContingenciesandCommitmentsNarrativeDetails">
        <link:definition>0000053 - Disclosure - Contingencies and Commitments (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesLeaseCostDetails" roleURI="http://www.stryker.com/role/CommitmentsandContingenciesLeaseCostDetails">
        <link:definition>0000054 - Disclosure - Commitments and Contingencies (Lease Cost) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails" roleURI="http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails">
        <link:definition>0000055 - Disclosure - Contingencies and Commitments (Future Purchase Obligations and Minimum Lease Payments) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsGoodwillDetails" roleURI="http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails">
        <link:definition>0000056 - Disclosure - Goodwill and Other Intangible Assets (Goodwill) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails" roleURI="http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails">
        <link:definition>0000057 - Disclosure - Goodwill and Other Intangible Assets (Summary of the Company's Other Intangible Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsEstimatedAmortizationExpenseDetails" roleURI="http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsEstimatedAmortizationExpenseDetails">
        <link:definition>0000058 - Disclosure - Goodwill and Other Intangible Assets (Estimated Amortization Expense) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStockNarrativeDetails" roleURI="http://www.stryker.com/role/CapitalStockNarrativeDetails">
        <link:definition>0000059 - Disclosure - Capital Stock (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStockOptionGrantAssumptionsDetails" roleURI="http://www.stryker.com/role/CapitalStockOptionGrantAssumptionsDetails">
        <link:definition>0000060 - Disclosure - Capital Stock (Option Grant Assumptions) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStockSummaryofStockOptionActivityDetails" roleURI="http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails">
        <link:definition>0000061 - Disclosure - Capital Stock (Summary of Stock Option Activity) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStockSummaryofRSUandPSUActivityDetails" roleURI="http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails">
        <link:definition>0000062 - Disclosure - Capital Stock (Summary of RSU and PSU Activity) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandCreditFacilitiesNarrativeDetails" roleURI="http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails">
        <link:definition>0000063 - Disclosure - Debt and Credit Facilities (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails" roleURI="http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails">
        <link:definition>0000064 - Disclosure - Debt and Credit Facilities (Maturities Of Long-Term Debt Disclosures) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails_1" roleURI="http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails_1">
        <link:definition>0000064 - Disclosure - Debt and Credit Facilities (Maturities Of Long-Term Debt Disclosures) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://www.stryker.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>0000065 - Disclosure - Income Taxes (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails" roleURI="http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails">
        <link:definition>0000066 - Disclosure - Income Taxes (Schedule of Reconciliation of U.S. Statutory Income Tax Rate to Company's Effective Income Tax Rate from Continuing Operations) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetails" roleURI="http://www.stryker.com/role/IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetails">
        <link:definition>0000067 - Disclosure - Income Taxes (Schedule of Earnings before Income Taxes) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofProvisionforIncomeTaxesDetails" roleURI="http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails">
        <link:definition>0000068 - Disclosure - Income Taxes (Schedule of Provision for Income Taxes) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails" roleURI="http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails">
        <link:definition>0000069 - Disclosure - Income Taxes (Schedule of Difference in Income Tax Effects Comprising Company's Deferred Income Tax Assets and Liabilities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails_1" roleURI="http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails_1">
        <link:definition>0000069 - Disclosure - Income Taxes (Schedule of Difference in Income Tax Effects Comprising Company's Deferred Income Tax Assets and Liabilities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofUnresolvedIncomeTaxPositionsDetails" roleURI="http://www.stryker.com/role/IncomeTaxesScheduleofUnresolvedIncomeTaxPositionsDetails">
        <link:definition>0000070 - Disclosure - Income Taxes (Schedule of Unresolved Income Tax Positions) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementPlansScheduleofDefinedContributionPlanDisclosuresDetails" roleURI="http://www.stryker.com/role/RetirementPlansScheduleofDefinedContributionPlanDisclosuresDetails">
        <link:definition>0000071 - Disclosure - Retirement Plans (Schedule of Defined Contribution Plan Disclosures) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails" roleURI="http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails">
        <link:definition>0000072 - Disclosure - Retirement Plans (Schedule of Funded Status and Components of the Amounts Recognized in the Consolidated Balance Sheets and in Accumulated Other Comprehensive Gain (Loss), Before the Effect of Income Taxes) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementPlansScheduleofChangeinBenefitObligationsDetails" roleURI="http://www.stryker.com/role/RetirementPlansScheduleofChangeinBenefitObligationsDetails">
        <link:definition>0000073 - Disclosure - Retirement Plans (Schedule of Change in Benefit Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementPlansChangeinPlanAssetsDetails" roleURI="http://www.stryker.com/role/RetirementPlansChangeinPlanAssetsDetails">
        <link:definition>0000074 - Disclosure - Retirement Plans (Change in Plan Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementPlansScheduleofTargetandActualAllocationofPlanAssetsDetails" roleURI="http://www.stryker.com/role/RetirementPlansScheduleofTargetandActualAllocationofPlanAssetsDetails">
        <link:definition>0000075 - Disclosure - Retirement Plans (Schedule of Target and Actual Allocation of Plan Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails" roleURI="http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails">
        <link:definition>0000076 - Disclosure - Retirement Plans (Schedule of Valuation of the Company's Pension Plan Assets by Pricing Categories) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementPlansNarrativeDetails" roleURI="http://www.stryker.com/role/RetirementPlansNarrativeDetails">
        <link:definition>0000077 - Disclosure - Retirement Plans (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementPlansExpectedBenefitPaymentsDetails" roleURI="http://www.stryker.com/role/RetirementPlansExpectedBenefitPaymentsDetails">
        <link:definition>0000078 - Disclosure - Retirement Plans (Expected Benefit Payments) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofQuarterlyDataUnauditedDetails" roleURI="http://www.stryker.com/role/SummaryofQuarterlyDataUnauditedDetails">
        <link:definition>0000079 - Disclosure - Summary of Quarterly Data (Unaudited) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails" roleURI="http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails">
        <link:definition>0000080 - Disclosure - Segment and Geographic Data (Sales And Other Financial Information By Business Segment) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentandGeographicDataSegmentInformationDetails" roleURI="http://www.stryker.com/role/SegmentandGeographicDataSegmentInformationDetails">
        <link:definition>0000081 - Disclosure - Segment and Geographic Data (Segment Information) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails" roleURI="http://www.stryker.com/role/SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails">
        <link:definition>0000082 - Disclosure - Segment and Geographic Data (Geographic Information on Net Sales and Long-Lived Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AssetImpairmentsDetails" roleURI="http://www.stryker.com/role/AssetImpairmentsDetails">
        <link:definition>0000083 - Disclosure - Asset Impairments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleIIValuationandQualifyingAccountsDetails" roleURI="http://www.stryker.com/role/ScheduleIIValuationandQualifyingAccountsDetails">
        <link:definition>0000084 - Disclosure - Schedule II Valuation and Qualifying Accounts (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="syk_OtherIncomeexpenseMember" abstract="true" name="OtherIncomeexpenseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotes1.125Due2023Member" abstract="true" name="SeniorUnsecuredNotes1.125Due2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_PercentageofServiceRevenueRecognizeoverTime" abstract="false" name="PercentageofServiceRevenueRecognizeoverTime" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="syk_AuditorInformationAbstract" abstract="true" name="AuditorInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="syk_AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" abstract="false" name="AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_SpineMember" abstract="true" name="SpineMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_EndoscopyMember" abstract="true" name="EndoscopyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotes4.375due2044Member" abstract="true" name="SeniorUnsecuredNotes4.375due2044Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_TraumaandExtremitiesMember" abstract="true" name="TraumaandExtremitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_DeferredTaxLiabilitiesDepreciationAndAmortization" abstract="false" name="DeferredTaxLiabilitiesDepreciationAndAmortization" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_CommonAndPreferredStockSharesAuthorized" abstract="false" name="CommonAndPreferredStockSharesAuthorized" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="syk_OrthopaedicsAndSpineMember" abstract="true" name="OrthopaedicsAndSpineMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_Changeinaccrualforrecallexpenses" abstract="false" name="Changeinaccrualforrecallexpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_PureWickMember" abstract="true" name="PureWickMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotes2.900due2050Member" abstract="true" name="SeniorUnsecuredNotes2.900due2050Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_AccruedCompensationMember" abstract="true" name="AccruedCompensationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_MedSurgAndNeurotechnologyMember" abstract="true" name="MedSurgAndNeurotechnologyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotes350Due2026Member" abstract="true" name="SeniorUnsecuredNotes350Due2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_ContractWithCustomerLiabilityNetAdvanceConsiderationReceivedDuringPeriod" abstract="false" name="ContractWithCustomerLiabilityNetAdvanceConsiderationReceivedDuringPeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_SpineReportingUnitMember" abstract="true" name="SpineReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities" abstract="false" name="FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_CapitalExpendituresDuringPeriod" abstract="false" name="CapitalExpendituresDuringPeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_DefinedContributionRetirementPlansCommonStockHeldByCompany" abstract="false" name="DefinedContributionRetirementPlansCommonStockHeldByCompany" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="syk_BusinessCombinationConsiderationTransferredPricePerShare" abstract="false" name="BusinessCombinationConsiderationTransferredPricePerShare" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="syk_OtherForeignCountriesMember" abstract="true" name="OtherForeignCountriesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_CapitalStockAbstract" abstract="true" name="CapitalStockAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="syk_DefinedContributionRetirementPlansCommonStockValueHeldByCompany" abstract="false" name="DefinedContributionRetirementPlansCommonStockValueHeldByCompany" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_InstrumentsMember" abstract="true" name="InstrumentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotes3.375due2025MemberMember" abstract="true" name="SeniorUnsecuredNotes3.375due2025MemberMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized" abstract="false" name="IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotesDueNovember2030Member" abstract="true" name="SeniorUnsecuredNotesDueNovember2030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_WeightedAverageUsedInDeterminationOfProjectedBenefitObligations" abstract="false" name="WeightedAverageUsedInDeterminationOfProjectedBenefitObligations" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="syk_A150ConvertibleNotesMember" abstract="true" name="A150ConvertibleNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_NeuroCranialMember" abstract="true" name="NeuroCranialMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_InProcessRDOtherIntangibleAssetsAndPropertyPlantAndEquipmentMember" abstract="true" name="InProcessRDOtherIntangibleAssetsAndPropertyPlantAndEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotesDueNovember2027Member" abstract="true" name="SeniorUnsecuredNotesDueNovember2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_IncomeTaxExpenseBenefitTaxSettlementReleaseOfAccruedInterest" abstract="false" name="IncomeTaxExpenseBenefitTaxSettlementReleaseOfAccruedInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_MedicalDeviceRegulationsExpense" abstract="false" name="MedicalDeviceRegulationsExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotes3.375due2024Member" abstract="true" name="SeniorUnsecuredNotes3.375due2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_A050ConvertibleNotesMember" abstract="true" name="A050ConvertibleNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_GaussMember" abstract="true" name="GaussMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_PerformanceStockUnitPsusMember" abstract="true" name="PerformanceStockUnitPsusMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotes1.150Due2025Member" abstract="true" name="SeniorUnsecuredNotes1.150Due2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotes0600Due2023Member" abstract="true" name="SeniorUnsecuredNotes0600Due2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_LandBuildingsAndImprovementsGross" abstract="false" name="LandBuildingsAndImprovementsGross" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_HipsMember" abstract="true" name="HipsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_DeferredTaxAssetsResearchAndDevelopmentCapitalization" abstract="false" name="DeferredTaxAssetsResearchAndDevelopmentCapitalization" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_OperatingLossCarryforwardsSubjectToValuationAllowance" abstract="false" name="OperatingLossCarryforwardsSubjectToValuationAllowance" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotes3650Due2028Member" abstract="true" name="SeniorUnsecuredNotes3650Due2028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_TermLoanDueFebruary222025Member" abstract="true" name="TermLoanDueFebruary222025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_RejuvenateABGIIHipRecallCharges" abstract="false" name="RejuvenateABGIIHipRecallCharges" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_TermLoanMember" abstract="true" name="TermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_SaleOfInventorySteppedUpToFairValueAtAcquisition" abstract="false" name="SaleOfInventorySteppedUpToFairValueAtAcquisition" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp" abstract="false" name="PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract" abstract="true" name="ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="syk_GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock" abstract="false" name="GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotesDueNovember2023Member" abstract="true" name="SeniorUnsecuredNotesDueNovember2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_RecallMattersMember" abstract="true" name="RecallMattersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_OtherOrthopaedicsMember" abstract="true" name="OtherOrthopaedicsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_DeferredTaxAssetsDepreciationAndAmortization" abstract="false" name="DeferredTaxAssetsDepreciationAndAmortization" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_MedicalMember" abstract="true" name="MedicalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_BusinessCombinationConsiderationTransferredIncludingConvertibleNotes" abstract="false" name="BusinessCombinationConsiderationTransferredIncludingConvertibleNotes" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotes0.250due2024Member" abstract="true" name="SeniorUnsecuredNotes0.250due2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_VoceraMember" abstract="true" name="VoceraMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_AssetImpairmentsOtherThanGoodwillImpairment" abstract="false" name="AssetImpairmentsOtherThanGoodwillImpairment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_NeurovascularMember" abstract="true" name="NeurovascularMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_KneesMember" abstract="true" name="KneesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotes410Due2043Member" abstract="true" name="SeniorUnsecuredNotes410Due2043Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotes0.750due2029Member" abstract="true" name="SeniorUnsecuredNotes0.750due2029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotes1.000due2031Member" abstract="true" name="SeniorUnsecuredNotes1.000due2031Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_MovementInContractLiabilitiesRollForward" abstract="true" name="MovementInContractLiabilitiesRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="syk_TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany" abstract="false" name="TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="syk_LongLivedAssetsAndIntangibleAssetsMember" abstract="true" name="LongLivedAssetsAndIntangibleAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_CreditAgreementMember" abstract="true" name="CreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotes1.950Due2030Member" abstract="true" name="SeniorUnsecuredNotes1.950Due2030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotes4625Due2046Member" abstract="true" name="SeniorUnsecuredNotes4625Due2046Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotes2.125Due2027Member" abstract="true" name="SeniorUnsecuredNotes2.125Due2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_CustomerAndDistributorRelationshipsMember" abstract="true" name="CustomerAndDistributorRelationshipsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotes2.625Due2030Member" abstract="true" name="SeniorUnsecuredNotes2.625Due2030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>14
<FILENAME>syk-20221231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:2349b3b0-68ea-4cbc-845b-39a36087e2b4,g:780e132c-de96-43a0-a8bf-d2cffc0e012a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.stryker.com/role/ConsolidatedStatementsOfEarnings" xlink:type="simple" xlink:href="syk-20221231.xsd#ConsolidatedStatementsOfEarnings"/>
  <link:calculationLink xlink:role="http://www.stryker.com/role/ConsolidatedStatementsOfEarnings" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_4edbe12e-43f1-4b8b-8645-fef571bdb4d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_cdf33171-50b8-41ff-9748-7bdb37d263b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_4edbe12e-43f1-4b8b-8645-fef571bdb4d9" xlink:to="loc_us-gaap_Revenues_cdf33171-50b8-41ff-9748-7bdb37d263b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_f1555521-46e2-48ef-bbcd-fecaab0b927b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_4edbe12e-43f1-4b8b-8645-fef571bdb4d9" xlink:to="loc_us-gaap_CostOfRevenue_f1555521-46e2-48ef-bbcd-fecaab0b927b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_05a5961e-c0b0-4a34-907c-bda4df758007" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f9536bd6-3c42-47d6-995e-9973bc183a54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_05a5961e-c0b0-4a34-907c-bda4df758007" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f9536bd6-3c42-47d6-995e-9973bc183a54" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_b933b8c2-0aae-4bd4-a87e-dcaf3a5ce5f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_05a5961e-c0b0-4a34-907c-bda4df758007" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_b933b8c2-0aae-4bd4-a87e-dcaf3a5ce5f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_f7ef1c8c-4b01-4bf6-9c19-1f6f32c41ba6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_d11ff7fa-7331-47cf-b75d-511759e2ecc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_f7ef1c8c-4b01-4bf6-9c19-1f6f32c41ba6" xlink:to="loc_us-gaap_GrossProfit_d11ff7fa-7331-47cf-b75d-511759e2ecc1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_3e3393b6-c233-4435-af6b-f1d3aea32fe7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_f7ef1c8c-4b01-4bf6-9c19-1f6f32c41ba6" xlink:to="loc_us-gaap_OperatingExpenses_3e3393b6-c233-4435-af6b-f1d3aea32fe7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a40bf6ae-9987-4f78-8ff6-6279e69d9795" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6a3654c6-7992-4764-afd1-811a4903bff1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a40bf6ae-9987-4f78-8ff6-6279e69d9795" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6a3654c6-7992-4764-afd1-811a4903bff1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_3c64e510-6f63-47f6-b692-497b8808f5a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a40bf6ae-9987-4f78-8ff6-6279e69d9795" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_3c64e510-6f63-47f6-b692-497b8808f5a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_8525e4d2-8b39-44d0-adf7-46195b579eca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_be674517-70f0-4bab-b6da-adc331634e7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_8525e4d2-8b39-44d0-adf7-46195b579eca" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_be674517-70f0-4bab-b6da-adc331634e7e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_b11e581a-998d-43ad-bc84-a42f5be95cfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_8525e4d2-8b39-44d0-adf7-46195b579eca" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_b11e581a-998d-43ad-bc84-a42f5be95cfe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_73002da6-9490-4618-b92a-e103e9666543" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_8525e4d2-8b39-44d0-adf7-46195b579eca" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_73002da6-9490-4618-b92a-e103e9666543" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityAccrualPeriodExpense_4832df68-eb1d-4685-9e7b-408361e0381b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductLiabilityAccrualPeriodExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_8525e4d2-8b39-44d0-adf7-46195b579eca" xlink:to="loc_us-gaap_ProductLiabilityAccrualPeriodExpense_4832df68-eb1d-4685-9e7b-408361e0381b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_ea6e505d-8521-45d4-b6e0-a881dc4d8720" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_8525e4d2-8b39-44d0-adf7-46195b579eca" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_ea6e505d-8521-45d4-b6e0-a881dc4d8720" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_faf4df9c-0ef9-481f-93d0-7fee8979910f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_20a46f26-c095-41cb-b9ae-eff1e415dae0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_faf4df9c-0ef9-481f-93d0-7fee8979910f" xlink:to="loc_us-gaap_OperatingIncomeLoss_20a46f26-c095-41cb-b9ae-eff1e415dae0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_755a58a8-b3b3-4422-b818-515ecc49f15e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_faf4df9c-0ef9-481f-93d0-7fee8979910f" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_755a58a8-b3b3-4422-b818-515ecc49f15e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="syk-20221231.xsd#ConsolidatedStatementsofComprehensiveIncome"/>
  <link:calculationLink xlink:role="http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a3da1ffc-ef27-4503-b7a9-17427bac1e7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_c1f09d48-dcbe-4c04-9cf3-d30aa2966ed1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a3da1ffc-ef27-4503-b7a9-17427bac1e7d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_c1f09d48-dcbe-4c04-9cf3-d30aa2966ed1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_67ae1805-120c-4529-b4e7-454b1ba375b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a3da1ffc-ef27-4503-b7a9-17427bac1e7d" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_67ae1805-120c-4529-b4e7-454b1ba375b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_8aee71bf-5ca1-43ff-9c6c-038635d3258c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a3da1ffc-ef27-4503-b7a9-17427bac1e7d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_8aee71bf-5ca1-43ff-9c6c-038635d3258c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_bd2c2ee8-253e-42fc-9557-6f952e08887d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a3da1ffc-ef27-4503-b7a9-17427bac1e7d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_bd2c2ee8-253e-42fc-9557-6f952e08887d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_8f2328bf-7c63-4dbe-8a1a-4f9001ad2402" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6025e4b3-bb39-478c-a9e7-14baad95ab62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_8f2328bf-7c63-4dbe-8a1a-4f9001ad2402" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6025e4b3-bb39-478c-a9e7-14baad95ab62" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c05d175d-693d-4c9a-b88b-d585664a1555" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_8f2328bf-7c63-4dbe-8a1a-4f9001ad2402" xlink:to="loc_us-gaap_NetIncomeLoss_c05d175d-693d-4c9a-b88b-d585664a1555" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="syk-20221231.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.stryker.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_eebf4ee7-043c-4854-982c-128390e367f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_3d573128-9f82-4ee0-ace3-136467fdef2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_eebf4ee7-043c-4854-982c-128390e367f1" xlink:to="loc_us-gaap_DebtCurrent_3d573128-9f82-4ee0-ace3-136467fdef2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_e137be54-b58e-4514-98dc-cbf382c7defc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_eebf4ee7-043c-4854-982c-128390e367f1" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_e137be54-b58e-4514-98dc-cbf382c7defc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_e3b538f2-0e23-4163-8e97-88d23d504313" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_eebf4ee7-043c-4854-982c-128390e367f1" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_e3b538f2-0e23-4163-8e97-88d23d504313" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRefundLiabilityCurrent_f05e937b-9b89-4759-8a2e-3452867dd84c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRefundLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_eebf4ee7-043c-4854-982c-128390e367f1" xlink:to="loc_us-gaap_CustomerRefundLiabilityCurrent_f05e937b-9b89-4759-8a2e-3452867dd84c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent_d678f99a-7450-4a77-88bd-19bbb16f3bef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_eebf4ee7-043c-4854-982c-128390e367f1" xlink:to="loc_us-gaap_DividendsPayableCurrent_d678f99a-7450-4a77-88bd-19bbb16f3bef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_0d3bd0fa-8600-494e-b4ff-47b99c066f19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_eebf4ee7-043c-4854-982c-128390e367f1" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_0d3bd0fa-8600-494e-b4ff-47b99c066f19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_8963cc6c-e503-457e-ac9e-3f012f6f37d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_eebf4ee7-043c-4854-982c-128390e367f1" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_8963cc6c-e503-457e-ac9e-3f012f6f37d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_dd7ee58d-d95a-4195-8cbe-7669fe9ad01c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_3a4feb8e-00ff-4bf1-b24c-9b34ff28b99d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_dd7ee58d-d95a-4195-8cbe-7669fe9ad01c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_3a4feb8e-00ff-4bf1-b24c-9b34ff28b99d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_ddf7bc42-dd5b-4320-a81c-12ce6e1e3288" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_dd7ee58d-d95a-4195-8cbe-7669fe9ad01c" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_ddf7bc42-dd5b-4320-a81c-12ce6e1e3288" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_2b48f5a0-47a0-4509-96ac-b7a666de379a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_dd7ee58d-d95a-4195-8cbe-7669fe9ad01c" xlink:to="loc_us-gaap_InventoryNet_2b48f5a0-47a0-4509-96ac-b7a666de379a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_12f8c25e-a208-42ac-b1b8-911a7fcc8570" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_dd7ee58d-d95a-4195-8cbe-7669fe9ad01c" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_12f8c25e-a208-42ac-b1b8-911a7fcc8570" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0d93df4a-1f6d-437f-9de5-61a25e6618ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_dd7ee58d-d95a-4195-8cbe-7669fe9ad01c" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0d93df4a-1f6d-437f-9de5-61a25e6618ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_a94be1d8-e645-4ce1-867e-3bd91e9cb52f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_e2c838e5-1d46-4725-817b-d6c1bc6b569d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a94be1d8-e645-4ce1-867e-3bd91e9cb52f" xlink:to="loc_us-gaap_AssetsCurrent_e2c838e5-1d46-4725-817b-d6c1bc6b569d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_73e880ce-e92c-4e15-ba0f-2eb5b27c9ff2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a94be1d8-e645-4ce1-867e-3bd91e9cb52f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_73e880ce-e92c-4e15-ba0f-2eb5b27c9ff2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_13685703-c381-400e-9571-341ae6d1c55d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a94be1d8-e645-4ce1-867e-3bd91e9cb52f" xlink:to="loc_us-gaap_Goodwill_13685703-c381-400e-9571-341ae6d1c55d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_bfb304b7-9f4b-4d6b-bad3-43cf32ad56fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a94be1d8-e645-4ce1-867e-3bd91e9cb52f" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_bfb304b7-9f4b-4d6b-bad3-43cf32ad56fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_83e8ca5e-7b5b-4f9f-9b7b-06ce24715507" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a94be1d8-e645-4ce1-867e-3bd91e9cb52f" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_83e8ca5e-7b5b-4f9f-9b7b-06ce24715507" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_0c1eb043-2319-46f8-ba2c-c2c61722281e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a94be1d8-e645-4ce1-867e-3bd91e9cb52f" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_0c1eb043-2319-46f8-ba2c-c2c61722281e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_1fea5d21-258f-4f6a-b4a3-ac161306680f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_4f6b7f82-b813-439f-bafa-844ddbe0f917" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_1fea5d21-258f-4f6a-b4a3-ac161306680f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_4f6b7f82-b813-439f-bafa-844ddbe0f917" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0d429074-e7c1-4998-8b11-c642c1f480a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_1fea5d21-258f-4f6a-b4a3-ac161306680f" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0d429074-e7c1-4998-8b11-c642c1f480a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_f1225f72-a452-430d-9d79-434a587b2f1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_8c0e2911-1eff-4729-8769-addaccdb5a71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_f1225f72-a452-430d-9d79-434a587b2f1b" xlink:to="loc_us-gaap_Liabilities_8c0e2911-1eff-4729-8769-addaccdb5a71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_46b7184c-5eda-41c9-90f8-0fb41e99f2e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_f1225f72-a452-430d-9d79-434a587b2f1b" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_46b7184c-5eda-41c9-90f8-0fb41e99f2e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_2da09d64-3160-4bcb-bef3-433f855b4def" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_LandBuildingsAndImprovementsGross_5d88d436-e052-4fc5-a38a-928f23604967" xlink:href="syk-20221231.xsd#syk_LandBuildingsAndImprovementsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_2da09d64-3160-4bcb-bef3-433f855b4def" xlink:to="loc_syk_LandBuildingsAndImprovementsGross_5d88d436-e052-4fc5-a38a-928f23604967" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross_dae2b11f-3730-4c30-96d2-1ee7ad88afd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_2da09d64-3160-4bcb-bef3-433f855b4def" xlink:to="loc_us-gaap_MachineryAndEquipmentGross_dae2b11f-3730-4c30-96d2-1ee7ad88afd6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_7f33807a-7614-4972-913d-45e628c128ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_3b6340ad-18a8-43fb-aca8-9c774325b74a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_7f33807a-7614-4972-913d-45e628c128ec" xlink:to="loc_us-gaap_LiabilitiesCurrent_3b6340ad-18a8-43fb-aca8-9c774325b74a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_8aa7d3b6-99ce-4058-8562-742a850344b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_7f33807a-7614-4972-913d-45e628c128ec" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_8aa7d3b6-99ce-4058-8562-742a850344b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_c07c0481-4d7c-41db-83a9-bb9d574368ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_7f33807a-7614-4972-913d-45e628c128ec" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_c07c0481-4d7c-41db-83a9-bb9d574368ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_e073d0a8-babd-4076-917e-847872c3ba9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_7f33807a-7614-4972-913d-45e628c128ec" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_e073d0a8-babd-4076-917e-847872c3ba9a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_a0b56f6f-3966-46e6-896e-ccbcbd1d8b59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_802b3824-548f-475c-96ea-c16308967063" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_a0b56f6f-3966-46e6-896e-ccbcbd1d8b59" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_802b3824-548f-475c-96ea-c16308967063" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_475a53b3-9225-4eb2-8b90-cca8451b0d79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_a0b56f6f-3966-46e6-896e-ccbcbd1d8b59" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_475a53b3-9225-4eb2-8b90-cca8451b0d79" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_5fab4356-e0b9-4513-b925-576eee0ef818" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_a0b56f6f-3966-46e6-896e-ccbcbd1d8b59" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_5fab4356-e0b9-4513-b925-576eee0ef818" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_073f9d7c-0409-4d2a-8177-b258aa3755db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValueOutstanding_d5243341-4ef2-4078-9897-7c4c24d4edf1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValueOutstanding"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_073f9d7c-0409-4d2a-8177-b258aa3755db" xlink:to="loc_us-gaap_CommonStockValueOutstanding_d5243341-4ef2-4078-9897-7c4c24d4edf1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_62d937b2-3d21-49ae-b06f-3df55af4bbe5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_073f9d7c-0409-4d2a-8177-b258aa3755db" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_62d937b2-3d21-49ae-b06f-3df55af4bbe5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_327a3e00-6e26-409e-a517-3ea1148e47c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_073f9d7c-0409-4d2a-8177-b258aa3755db" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_327a3e00-6e26-409e-a517-3ea1148e47c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c1d02584-1c11-4c65-ab8e-1a57aff20aee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_073f9d7c-0409-4d2a-8177-b258aa3755db" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c1d02584-1c11-4c65-ab8e-1a57aff20aee" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="simple" xlink:href="syk-20221231.xsd#ConsolidatedStatementsOfCashFlows"/>
  <link:calculationLink xlink:role="http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_95807c52-2a22-4ac0-b468-b2e29bfe48d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_55afc3a2-f280-40f9-b397-8d9aae04a9d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_95807c52-2a22-4ac0-b468-b2e29bfe48d5" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_55afc3a2-f280-40f9-b397-8d9aae04a9d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_fd9a008e-b1ef-41ac-a525-2d6b8ed6d645" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_95807c52-2a22-4ac0-b468-b2e29bfe48d5" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_fd9a008e-b1ef-41ac-a525-2d6b8ed6d645" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_a520fe93-2704-4b0d-98bb-0b1dea4ad894" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_95807c52-2a22-4ac0-b468-b2e29bfe48d5" xlink:to="loc_us-gaap_PaymentsOfDividends_a520fe93-2704-4b0d-98bb-0b1dea4ad894" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_ba266508-afae-4a4a-9f48-4157e9356832" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_95807c52-2a22-4ac0-b468-b2e29bfe48d5" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_ba266508-afae-4a4a-9f48-4157e9356832" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_5d60a7ff-4ae2-4141-b7c9-2d6d2df7bde4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_95807c52-2a22-4ac0-b468-b2e29bfe48d5" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_5d60a7ff-4ae2-4141-b7c9-2d6d2df7bde4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_77ccf609-60d9-49db-93aa-48119c30882c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_95807c52-2a22-4ac0-b468-b2e29bfe48d5" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_77ccf609-60d9-49db-93aa-48119c30882c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_97c0cff7-f4d0-45a9-b7ed-c2c3341f4ce9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_1be72202-aae9-492a-916a-77913e11f0d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_97c0cff7-f4d0-45a9-b7ed-c2c3341f4ce9" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_1be72202-aae9-492a-916a-77913e11f0d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_Changeinaccrualforrecallexpenses_d436854e-4ae1-4290-bb8f-f3b3ce6986b0" xlink:href="syk-20221231.xsd#syk_Changeinaccrualforrecallexpenses"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_97c0cff7-f4d0-45a9-b7ed-c2c3341f4ce9" xlink:to="loc_syk_Changeinaccrualforrecallexpenses_d436854e-4ae1-4290-bb8f-f3b3ce6986b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_ff35fae7-e52f-453f-9693-baf2a570724f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_97c0cff7-f4d0-45a9-b7ed-c2c3341f4ce9" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_ff35fae7-e52f-453f-9693-baf2a570724f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_9967b9f9-f52a-4b24-a6ad-47f96dc5491c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_97c0cff7-f4d0-45a9-b7ed-c2c3341f4ce9" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_9967b9f9-f52a-4b24-a6ad-47f96dc5491c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_95b60b49-bc3e-41ac-8f36-1938a8f80de2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_97c0cff7-f4d0-45a9-b7ed-c2c3341f4ce9" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_95b60b49-bc3e-41ac-8f36-1938a8f80de2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_e7afaacb-3e4d-45a8-ad45-0f7ab0f6e5f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_97c0cff7-f4d0-45a9-b7ed-c2c3341f4ce9" xlink:to="loc_us-gaap_AdjustmentForAmortization_e7afaacb-3e4d-45a8-ad45-0f7ab0f6e5f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_5384c459-a85b-4e9c-a811-7f3756e64aa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_97c0cff7-f4d0-45a9-b7ed-c2c3341f4ce9" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_5384c459-a85b-4e9c-a811-7f3756e64aa3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_97aea1da-22f5-4a90-bab7-d8e0a2648eb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_97c0cff7-f4d0-45a9-b7ed-c2c3341f4ce9" xlink:to="loc_us-gaap_NetIncomeLoss_97aea1da-22f5-4a90-bab7-d8e0a2648eb9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_4cbc15aa-7b60-4dd1-910a-a2f9f1fe627a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_97c0cff7-f4d0-45a9-b7ed-c2c3341f4ce9" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_4cbc15aa-7b60-4dd1-910a-a2f9f1fe627a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_8f28996a-d44c-43ad-a3bb-aa2a95d8b0b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_97c0cff7-f4d0-45a9-b7ed-c2c3341f4ce9" xlink:to="loc_us-gaap_Depreciation_8f28996a-d44c-43ad-a3bb-aa2a95d8b0b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_6f3ba6d8-f1da-4447-9f79-29085e6b6ce2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_97c0cff7-f4d0-45a9-b7ed-c2c3341f4ce9" xlink:to="loc_us-gaap_ShareBasedCompensation_6f3ba6d8-f1da-4447-9f79-29085e6b6ce2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_628e2211-3ada-43e7-a030-75935c2b8ecc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_97c0cff7-f4d0-45a9-b7ed-c2c3341f4ce9" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_628e2211-3ada-43e7-a030-75935c2b8ecc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_AssetImpairmentsOtherThanGoodwillImpairment_73c66250-d8a7-420b-aa99-006d2688029f" xlink:href="syk-20221231.xsd#syk_AssetImpairmentsOtherThanGoodwillImpairment"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_97c0cff7-f4d0-45a9-b7ed-c2c3341f4ce9" xlink:to="loc_syk_AssetImpairmentsOtherThanGoodwillImpairment_73c66250-d8a7-420b-aa99-006d2688029f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityAccrualPeriodExpense_709040a2-cc6c-483e-b2e2-587c31d919ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductLiabilityAccrualPeriodExpense"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_97c0cff7-f4d0-45a9-b7ed-c2c3341f4ce9" xlink:to="loc_us-gaap_ProductLiabilityAccrualPeriodExpense_709040a2-cc6c-483e-b2e2-587c31d919ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SaleOfInventorySteppedUpToFairValueAtAcquisition_d92cb5eb-92de-4e0a-8cbf-7497443b5b05" xlink:href="syk-20221231.xsd#syk_SaleOfInventorySteppedUpToFairValueAtAcquisition"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_97c0cff7-f4d0-45a9-b7ed-c2c3341f4ce9" xlink:to="loc_syk_SaleOfInventorySteppedUpToFairValueAtAcquisition_d92cb5eb-92de-4e0a-8cbf-7497443b5b05" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_9a5156e6-2602-4742-a8dd-4b0d947221a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_97c0cff7-f4d0-45a9-b7ed-c2c3341f4ce9" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_9a5156e6-2602-4742-a8dd-4b0d947221a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b38f238e-58c3-4471-9353-0a69d14dda58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9c884380-7edc-40ea-a944-04258ac86d0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b38f238e-58c3-4471-9353-0a69d14dda58" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9c884380-7edc-40ea-a944-04258ac86d0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c5ce6cee-d02e-461d-bc6f-6aebaeaeab90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b38f238e-58c3-4471-9353-0a69d14dda58" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c5ce6cee-d02e-461d-bc6f-6aebaeaeab90" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_bbc26ec2-5fc1-4b33-9b62-a7677aeca5e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b38f238e-58c3-4471-9353-0a69d14dda58" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_bbc26ec2-5fc1-4b33-9b62-a7677aeca5e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3a9b53dd-0133-4642-aaef-16d3928ddfd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b38f238e-58c3-4471-9353-0a69d14dda58" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3a9b53dd-0133-4642-aaef-16d3928ddfd1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_72abfb8c-8702-4e3b-9424-e2b7f658cae5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_6817ef98-61d7-4a18-a033-119031dd7687" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_72abfb8c-8702-4e3b-9424-e2b7f658cae5" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_6817ef98-61d7-4a18-a033-119031dd7687" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_79b5f9f3-5de7-4298-9163-dd9800815f90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_72abfb8c-8702-4e3b-9424-e2b7f658cae5" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_79b5f9f3-5de7-4298-9163-dd9800815f90" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_74565374-3d9d-4aa3-adfd-79c5f7f4b6ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_72abfb8c-8702-4e3b-9424-e2b7f658cae5" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_74565374-3d9d-4aa3-adfd-79c5f7f4b6ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_8bee95a8-dbc8-4bcf-98fc-b2380da25e93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_72abfb8c-8702-4e3b-9424-e2b7f658cae5" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_8bee95a8-dbc8-4bcf-98fc-b2380da25e93" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_a42bcdc1-1997-4d6a-9763-9b2da0823b52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_72abfb8c-8702-4e3b-9424-e2b7f658cae5" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_a42bcdc1-1997-4d6a-9763-9b2da0823b52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeInvestingActivities_fa37abb5-b761-4f9e-ab51-7000eeb786f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromHedgeInvestingActivities"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_72abfb8c-8702-4e3b-9424-e2b7f658cae5" xlink:to="loc_us-gaap_ProceedsFromHedgeInvestingActivities_fa37abb5-b761-4f9e-ab51-7000eeb786f3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#DerivativeInstrumentsForwardCurrencyExchangeContractsDetails"/>
  <link:calculationLink xlink:role="http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet_c6db4c8b-3f34-4abb-9969-d741e4992948" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_a103d1c8-8d3a-40bd-aed2-331b62220aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeNet_c6db4c8b-3f34-4abb-9969-d741e4992948" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_a103d1c8-8d3a-40bd-aed2-331b62220aa9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_ac826808-bf6c-4e70-b52f-33e1a52dcb18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeNet_c6db4c8b-3f34-4abb-9969-d741e4992948" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_ac826808-bf6c-4e70-b52f-33e1a52dcb18" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails"/>
  <link:calculationLink xlink:role="http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2925210e-52e6-4cf7-bdbb-10b5c25e3405" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_5d1f1100-5e66-4fff-a8bd-14682aeb1a55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2925210e-52e6-4cf7-bdbb-10b5c25e3405" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_5d1f1100-5e66-4fff-a8bd-14682aeb1a55" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_4838ab55-0239-4082-a1e7-b3c64f80c8d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2925210e-52e6-4cf7-bdbb-10b5c25e3405" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_4838ab55-0239-4082-a1e7-b3c64f80c8d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_f580a758-f84c-4058-9951-24a6461ec123" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2925210e-52e6-4cf7-bdbb-10b5c25e3405" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_f580a758-f84c-4058-9951-24a6461ec123" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_17367e8e-6c84-4d12-94b9-a115bc39a869" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2925210e-52e6-4cf7-bdbb-10b5c25e3405" xlink:to="loc_us-gaap_Goodwill_17367e8e-6c84-4d12-94b9-a115bc39a869" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_89b3105a-50a6-419c-8ce2-62d7f5009516" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2925210e-52e6-4cf7-bdbb-10b5c25e3405" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_89b3105a-50a6-419c-8ce2-62d7f5009516" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_a59a419e-5c49-4a82-a5ac-3f682b0d5fab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2925210e-52e6-4cf7-bdbb-10b5c25e3405" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_a59a419e-5c49-4a82-a5ac-3f682b0d5fab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt_8360f07c-7abf-4e60-9f93-2a803045c62a" xlink:href="syk-20221231.xsd#syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2925210e-52e6-4cf7-bdbb-10b5c25e3405" xlink:to="loc_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt_8360f07c-7abf-4e60-9f93-2a803045c62a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_755133ce-e8a6-42f4-8fb8-c678eac361ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2925210e-52e6-4cf7-bdbb-10b5c25e3405" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_755133ce-e8a6-42f4-8fb8-c678eac361ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_8ac6e19b-2bfd-42d1-8cf8-575037ca1686" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2925210e-52e6-4cf7-bdbb-10b5c25e3405" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_8ac6e19b-2bfd-42d1-8cf8-575037ca1686" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_96495a8c-8d7e-4aba-89f7-bd043d836aaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_5e85d931-6697-44f1-b4a4-bd503e90016c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_96495a8c-8d7e-4aba-89f7-bd043d836aaf" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_5e85d931-6697-44f1-b4a4-bd503e90016c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_3476e900-457e-4b7a-910e-3d0cbacafde1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_96495a8c-8d7e-4aba-89f7-bd043d836aaf" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_3476e900-457e-4b7a-910e-3d0cbacafde1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"/>
  <link:calculationLink xlink:role="http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_3d9cbd54-9263-4dec-92df-595fef4ef52c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebt_8ab6e953-bde4-4f3a-9b0d-a372309e8089" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnsecuredDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_3d9cbd54-9263-4dec-92df-595fef4ef52c" xlink:to="loc_us-gaap_UnsecuredDebt_8ab6e953-bde4-4f3a-9b0d-a372309e8089" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermDebt_48251dde-61bb-4055-9e59-3af286fc1b10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermDebt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_3d9cbd54-9263-4dec-92df-595fef4ef52c" xlink:to="loc_us-gaap_OtherLongTermDebt_48251dde-61bb-4055-9e59-3af286fc1b10" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_d1501ea6-fc01-4471-b05b-48760d31d00e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_3d9cbd54-9263-4dec-92df-595fef4ef52c" xlink:to="loc_us-gaap_LongTermDebt_d1501ea6-fc01-4471-b05b-48760d31d00e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails_1" xlink:type="simple" xlink:href="syk-20221231.xsd#DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails_1"/>
  <link:calculationLink xlink:role="http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_53ae7dd0-aca1-4a09-93ec-0ccbf7ac92e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_163d045d-05a2-419f-ad74-323bdc9f268c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_53ae7dd0-aca1-4a09-93ec-0ccbf7ac92e7" xlink:to="loc_us-gaap_DebtCurrent_163d045d-05a2-419f-ad74-323bdc9f268c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_f80ef1a1-876e-42bf-a7a2-2a0d00356c68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_53ae7dd0-aca1-4a09-93ec-0ccbf7ac92e7" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_f80ef1a1-876e-42bf-a7a2-2a0d00356c68" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails"/>
  <link:calculationLink xlink:role="http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_1f52c960-4559-41bc-992b-6ef358a3ecb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_c1cadb9a-d940-4391-a6fb-88df09cfa53d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_1f52c960-4559-41bc-992b-6ef358a3ecb7" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_c1cadb9a-d940-4391-a6fb-88df09cfa53d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_e502b3ff-cb43-43c0-87e5-0f65e5a7ca0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_1f52c960-4559-41bc-992b-6ef358a3ecb7" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_e502b3ff-cb43-43c0-87e5-0f65e5a7ca0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_a6ec33ef-4278-4ac2-82ff-f8a51a70cdb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_1f52c960-4559-41bc-992b-6ef358a3ecb7" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_a6ec33ef-4278-4ac2-82ff-f8a51a70cdb4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent_ad2d1776-be2c-414d-833c-123b27f37138" xlink:href="syk-20221231.xsd#syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_1f52c960-4559-41bc-992b-6ef358a3ecb7" xlink:to="loc_syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent_ad2d1776-be2c-414d-833c-123b27f37138" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_679f7bc7-05b0-4b1e-a0df-cad62083d7ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_1f52c960-4559-41bc-992b-6ef358a3ecb7" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_679f7bc7-05b0-4b1e-a0df-cad62083d7ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent_2559e1d6-ba5f-42e5-b793-22d8248120b3" xlink:href="syk-20221231.xsd#syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_1f52c960-4559-41bc-992b-6ef358a3ecb7" xlink:to="loc_syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent_2559e1d6-ba5f-42e5-b793-22d8248120b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic_f42dfd8f-2dae-4f5f-9f2a-294aebf0b3a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_1f52c960-4559-41bc-992b-6ef358a3ecb7" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic_f42dfd8f-2dae-4f5f-9f2a-294aebf0b3a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_af3629f9-a350-49fe-9347-5c6b56e0a8c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_1f52c960-4559-41bc-992b-6ef358a3ecb7" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_af3629f9-a350-49fe-9347-5c6b56e0a8c9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.stryker.com/role/IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8b39779c-8652-444c-8628-ce8d4f5f17d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_c818c49f-2918-48de-9573-ccc63c739d11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8b39779c-8652-444c-8628-ce8d4f5f17d9" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_c818c49f-2918-48de-9573-ccc63c739d11" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_5301d972-ea63-41bb-a566-bb904fc73a9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8b39779c-8652-444c-8628-ce8d4f5f17d9" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_5301d972-ea63-41bb-a566-bb904fc73a9c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#IncomeTaxesScheduleofProvisionforIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_9dee1671-b5cc-4885-9e8b-d70856de78c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_77ccd9e3-9c43-44f2-9562-1c7ccc27395e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_9dee1671-b5cc-4885-9e8b-d70856de78c1" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_77ccd9e3-9c43-44f2-9562-1c7ccc27395e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_b12f7701-2603-435a-ac91-2478359cab77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_9dee1671-b5cc-4885-9e8b-d70856de78c1" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_b12f7701-2603-435a-ac91-2478359cab77" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_ada61c2f-a8e5-40ef-a9e4-4098d058d584" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_9dee1671-b5cc-4885-9e8b-d70856de78c1" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_ada61c2f-a8e5-40ef-a9e4-4098d058d584" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_37650ce5-7960-4212-9e6d-7f53e7344336" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_e3fa2fe8-043c-4e9c-8eed-dbacd2d8376a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_37650ce5-7960-4212-9e6d-7f53e7344336" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_e3fa2fe8-043c-4e9c-8eed-dbacd2d8376a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_71c52a27-4222-4ed5-87af-0fa5c025a1f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_37650ce5-7960-4212-9e6d-7f53e7344336" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_71c52a27-4222-4ed5-87af-0fa5c025a1f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_2acd7fd4-c50f-4970-ab50-ba842c3bd06c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_d430969f-fec1-490a-b529-9503cdada85b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_2acd7fd4-c50f-4970-ab50-ba842c3bd06c" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_d430969f-fec1-490a-b529-9503cdada85b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_f239e149-51ae-4557-b062-3d4994f83b1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_2acd7fd4-c50f-4970-ab50-ba842c3bd06c" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_f239e149-51ae-4557-b062-3d4994f83b1f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_e3962838-da9d-4b08-8c5b-1d191da60eb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_2acd7fd4-c50f-4970-ab50-ba842c3bd06c" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_e3962838-da9d-4b08-8c5b-1d191da60eb6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_6dab72ce-146d-433f-a2fe-6e3e366a79f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_968c4892-366d-4a72-b9eb-0c12fd71d69f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_6dab72ce-146d-433f-a2fe-6e3e366a79f6" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_968c4892-366d-4a72-b9eb-0c12fd71d69f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_27f16df5-4103-4989-b4fe-63f58374e44b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_6dab72ce-146d-433f-a2fe-6e3e366a79f6" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_27f16df5-4103-4989-b4fe-63f58374e44b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_533817f2-3b42-452f-9af3-93b00dfeed44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DeferredTaxLiabilitiesDepreciationAndAmortization_6e88a9f6-00fe-41fb-9fbd-62da17199c91" xlink:href="syk-20221231.xsd#syk_DeferredTaxLiabilitiesDepreciationAndAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_533817f2-3b42-452f-9af3-93b00dfeed44" xlink:to="loc_syk_DeferredTaxLiabilitiesDepreciationAndAmortization_6e88a9f6-00fe-41fb-9fbd-62da17199c91" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_f2c9fddd-923b-464e-b38c-f820f763e538" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_533817f2-3b42-452f-9af3-93b00dfeed44" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_f2c9fddd-923b-464e-b38c-f820f763e538" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_6c814978-bddb-4912-80c9-0250f9f9c354" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_26b17c73-f5a3-419d-b56a-8ff3f7674103" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_6c814978-bddb-4912-80c9-0250f9f9c354" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_26b17c73-f5a3-419d-b56a-8ff3f7674103" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_9f039834-2657-4d14-a019-21b37a346abe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_6c814978-bddb-4912-80c9-0250f9f9c354" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_9f039834-2657-4d14-a019-21b37a346abe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_6e6cc509-c4d0-4af7-b401-54ab092b9745" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory_fe9eeab3-968b-4a39-a623-e76161d00e4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_6e6cc509-c4d0-4af7-b401-54ab092b9745" xlink:to="loc_us-gaap_DeferredTaxAssetsInventory_fe9eeab3-968b-4a39-a623-e76161d00e4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_c0e36fe8-1dbc-4a5d-aa3e-3d04f2cc3286" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_6e6cc509-c4d0-4af7-b401-54ab092b9745" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_c0e36fe8-1dbc-4a5d-aa3e-3d04f2cc3286" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_513a022e-8199-446f-be13-f1ecd125d45a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_6e6cc509-c4d0-4af7-b401-54ab092b9745" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_513a022e-8199-446f-be13-f1ecd125d45a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsStateTaxes_5cb4bd72-69d2-4bfe-9e98-6d9dd26ded20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsStateTaxes"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_6e6cc509-c4d0-4af7-b401-54ab092b9745" xlink:to="loc_us-gaap_DeferredTaxAssetsStateTaxes_5cb4bd72-69d2-4bfe-9e98-6d9dd26ded20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_75e45126-271b-4c1a-9db8-e058acb01895" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_6e6cc509-c4d0-4af7-b401-54ab092b9745" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_75e45126-271b-4c1a-9db8-e058acb01895" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_6f983ecd-63f2-4b15-afe5-8dafc4b7d8ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_6e6cc509-c4d0-4af7-b401-54ab092b9745" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_6f983ecd-63f2-4b15-afe5-8dafc4b7d8ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_3163204e-a627-4e3a-a254-fa5128b2e803" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_6e6cc509-c4d0-4af7-b401-54ab092b9745" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_3163204e-a627-4e3a-a254-fa5128b2e803" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DeferredTaxAssetsDepreciationAndAmortization_03edb41d-af14-4043-92df-d96780122e69" xlink:href="syk-20221231.xsd#syk_DeferredTaxAssetsDepreciationAndAmortization"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_6e6cc509-c4d0-4af7-b401-54ab092b9745" xlink:to="loc_syk_DeferredTaxAssetsDepreciationAndAmortization_03edb41d-af14-4043-92df-d96780122e69" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DeferredTaxAssetsResearchAndDevelopmentCapitalization_74795e57-b018-426f-bd99-c0aeab57738b" xlink:href="syk-20221231.xsd#syk_DeferredTaxAssetsResearchAndDevelopmentCapitalization"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_6e6cc509-c4d0-4af7-b401-54ab092b9745" xlink:to="loc_syk_DeferredTaxAssetsResearchAndDevelopmentCapitalization_74795e57-b018-426f-bd99-c0aeab57738b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetInterestCarryforward_1a2dca00-8875-4fd3-8549-3450f27a1502" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetInterestCarryforward"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_6e6cc509-c4d0-4af7-b401-54ab092b9745" xlink:to="loc_us-gaap_DeferredTaxAssetInterestCarryforward_1a2dca00-8875-4fd3-8549-3450f27a1502" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails_1" xlink:type="simple" xlink:href="syk-20221231.xsd#IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_72f01840-0304-4710-9997-7eb46ca1861e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_95859d80-468d-4d29-8223-9c8ef46ea2da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_72f01840-0304-4710-9997-7eb46ca1861e" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_95859d80-468d-4d29-8223-9c8ef46ea2da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_ee6bdc30-0b70-49fc-9ccc-b76768ededf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_72f01840-0304-4710-9997-7eb46ca1861e" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_ee6bdc30-0b70-49fc-9ccc-b76768ededf5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_0b2842c9-e2d3-497b-9e26-337c4c666d16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_af1b8980-316d-4931-affd-2c94e83d16f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_0b2842c9-e2d3-497b-9e26-337c4c666d16" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_af1b8980-316d-4931-affd-2c94e83d16f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_c71f3efa-c5a4-4bd0-b0a7-5bbc8d52f9a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_0b2842c9-e2d3-497b-9e26-337c4c666d16" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_c71f3efa-c5a4-4bd0-b0a7-5bbc8d52f9a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_ad8cd391-1d0a-4a23-acfa-2270fbbe75bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_0b2842c9-e2d3-497b-9e26-337c4c666d16" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_ad8cd391-1d0a-4a23-acfa-2270fbbe75bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_cb014627-6ff0-4147-bc1c-bec9eda2d9ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_0b2842c9-e2d3-497b-9e26-337c4c666d16" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_cb014627-6ff0-4147-bc1c-bec9eda2d9ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_a4aee8f1-979e-4c7e-9c15-3788813b623b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_0b2842c9-e2d3-497b-9e26-337c4c666d16" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_a4aee8f1-979e-4c7e-9c15-3788813b623b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_8211d35b-5220-4efd-8bdd-bbcb0f20df77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_0b2842c9-e2d3-497b-9e26-337c4c666d16" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_8211d35b-5220-4efd-8bdd-bbcb0f20df77" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_8e396658-ec47-45f8-8290-210d24cbd906" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_c5242e23-fd76-4420-8e1f-81ae90b5b142" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_8e396658-ec47-45f8-8290-210d24cbd906" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_c5242e23-fd76-4420-8e1f-81ae90b5b142" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_55779c07-a02e-4eaf-861e-9f267b52f8a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_8e396658-ec47-45f8-8290-210d24cbd906" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_55779c07-a02e-4eaf-861e-9f267b52f8a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax_7b39dc80-d59a-4b7f-8ee7-564ed03992aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_8e396658-ec47-45f8-8290-210d24cbd906" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax_7b39dc80-d59a-4b7f-8ee7-564ed03992aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_a2b65674-13a4-4139-9d0b-14374513611f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_8e396658-ec47-45f8-8290-210d24cbd906" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_a2b65674-13a4-4139-9d0b-14374513611f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax_9d6179a8-82b9-4b5b-a689-7f2e91b755f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_bf6f59ec-7251-420b-8d54-08499e515d60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax_9d6179a8-82b9-4b5b-a689-7f2e91b755f4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_bf6f59ec-7251-420b-8d54-08499e515d60" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_78bbfe1f-9982-4248-b5dc-4e406f7a9ffb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax_9d6179a8-82b9-4b5b-a689-7f2e91b755f4" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_78bbfe1f-9982-4248-b5dc-4e406f7a9ffb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_48ccf77e-3251-43cc-a3cd-b9ec32745cb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_8ffa562d-4ea9-449c-9eba-675f721cfcf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_48ccf77e-3251-43cc-a3cd-b9ec32745cb2" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_8ffa562d-4ea9-449c-9eba-675f721cfcf8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_92b311a5-6126-4442-b86a-ce5ef9200388" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_48ccf77e-3251-43cc-a3cd-b9ec32745cb2" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_92b311a5-6126-4442-b86a-ce5ef9200388" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_fc1302d7-0099-4a9d-895f-e08b701479f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_ddfbd437-3e44-4fa4-b7d9-78d37a6932e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_fc1302d7-0099-4a9d-895f-e08b701479f3" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_ddfbd437-3e44-4fa4-b7d9-78d37a6932e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_43dc8974-3a16-40c3-ad0c-2729952d1462" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_fc1302d7-0099-4a9d-895f-e08b701479f3" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_43dc8974-3a16-40c3-ad0c-2729952d1462" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>15
<FILENAME>syk-20221231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:2349b3b0-68ea-4cbc-845b-39a36087e2b4,g:780e132c-de96-43a0-a8bf-d2cffc0e012a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.stryker.com/role/COVERPAGE" xlink:type="simple" xlink:href="syk-20221231.xsd#COVERPAGE"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/COVERPAGE" xlink:type="extended" id="id036e003b3be406db310c6aa27310ed7_COVERPAGE">
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_7e320a0a-71c5-4850-ae81-64fc69dafec3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_DocumentType_7e320a0a-71c5-4850-ae81-64fc69dafec3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_4d262e5f-b8ab-45f4-bad1-d312291be40f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_DocumentAnnualReport_4d262e5f-b8ab-45f4-bad1-d312291be40f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_6674b51b-5ebe-4bd6-81d6-f7f0d5a7f0fd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_DocumentPeriodEndDate_6674b51b-5ebe-4bd6-81d6-f7f0d5a7f0fd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_21c8a07f-7976-44a4-af85-1f414df95d4d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_CurrentFiscalYearEndDate_21c8a07f-7976-44a4-af85-1f414df95d4d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_8070e601-4f86-40f9-b060-c9c62079a72a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_DocumentTransitionReport_8070e601-4f86-40f9-b060-c9c62079a72a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_5eb4118f-c441-4c13-ab18-a92371d86d5b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_EntityFileNumber_5eb4118f-c441-4c13-ab18-a92371d86d5b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_a580a8b5-5cb1-4ed8-afb1-3410a5b32714" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_EntityRegistrantName_a580a8b5-5cb1-4ed8-afb1-3410a5b32714" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_8188f616-6758-40ad-8cb6-94c30ba442a8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_EntityIncorporationStateCountryCode_8188f616-6758-40ad-8cb6-94c30ba442a8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_4713f962-08d5-49db-ab35-1863047c0a75" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_EntityTaxIdentificationNumber_4713f962-08d5-49db-ab35-1863047c0a75" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_5f4e74a8-f4cd-4c09-994f-120f3915a947" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_EntityAddressAddressLine1_5f4e74a8-f4cd-4c09-994f-120f3915a947" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_cd9ca7c1-20bc-4e61-8463-f0423f756ead" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_EntityAddressCityOrTown_cd9ca7c1-20bc-4e61-8463-f0423f756ead" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_ce7753ee-b2c3-418a-aa50-1d962850f21e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_EntityAddressStateOrProvince_ce7753ee-b2c3-418a-aa50-1d962850f21e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_30e51f3c-afc5-4fa9-bc37-02cd1144530a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_EntityAddressPostalZipCode_30e51f3c-afc5-4fa9-bc37-02cd1144530a" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_0a3d97cf-fb31-44d8-93da-4ba7c828dda6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_CityAreaCode_0a3d97cf-fb31-44d8-93da-4ba7c828dda6" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_5e7e5214-ee3f-4cd9-be70-9bf9ba03e5cd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_LocalPhoneNumber_5e7e5214-ee3f-4cd9-be70-9bf9ba03e5cd" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_0640f308-35d6-489e-b684-f03ce35b9b45" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_Security12bTitle_0640f308-35d6-489e-b684-f03ce35b9b45" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_7e6e5d09-2102-4723-bbea-004253fa098c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_TradingSymbol_7e6e5d09-2102-4723-bbea-004253fa098c" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_523a1b07-0b0d-4669-9508-6fc9c6d8f168" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_SecurityExchangeName_523a1b07-0b0d-4669-9508-6fc9c6d8f168" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12gTitle_ac31d739-f91c-442f-bc51-eef305e22bfe" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_Security12gTitle_ac31d739-f91c-442f-bc51-eef305e22bfe" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_80d28f7d-086b-4e35-abd2-c08dfc28b556" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_80d28f7d-086b-4e35-abd2-c08dfc28b556" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_a73b313c-b31e-43e2-9698-aa67e9982155" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_EntityVoluntaryFilers_a73b313c-b31e-43e2-9698-aa67e9982155" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_f36d1aa2-7b90-4b6a-8e68-a5b5caf44ff0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_EntityCurrentReportingStatus_f36d1aa2-7b90-4b6a-8e68-a5b5caf44ff0" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_9eaa4d4c-6d83-480a-aa1b-a706a012759e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_EntityInteractiveDataCurrent_9eaa4d4c-6d83-480a-aa1b-a706a012759e" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_f1976265-25d2-4e05-9f37-1265adbf3302" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_EntityFilerCategory_f1976265-25d2-4e05-9f37-1265adbf3302" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_db03c3f8-195c-4649-8cfb-598fbd58b511" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_EntityEmergingGrowthCompany_db03c3f8-195c-4649-8cfb-598fbd58b511" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_61a0d187-dc7d-4bec-a65b-ea90b46c0dc5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_EntitySmallBusiness_61a0d187-dc7d-4bec-a65b-ea90b46c0dc5" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_fc06d7c4-c30c-4a9e-8d18-86a574ea865c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_IcfrAuditorAttestationFlag_fc06d7c4-c30c-4a9e-8d18-86a574ea865c" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_e9a73e32-9a44-41aa-80f1-0c65338752ef" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_EntityShellCompany_e9a73e32-9a44-41aa-80f1-0c65338752ef" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_f7d4b646-3ccc-423b-aa32-d9e1aed87c52" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_EntityPublicFloat_f7d4b646-3ccc-423b-aa32-d9e1aed87c52" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_cb6ec521-d9be-4200-9406-d555b5294a1f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_cb6ec521-d9be-4200-9406-d555b5294a1f" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_19fb06ac-20d9-4840-b901-93ac1409f334" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_19fb06ac-20d9-4840-b901-93ac1409f334" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_c1873a14-8d87-4b50-9707-cd41bcc0774c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_AmendmentFlag_c1873a14-8d87-4b50-9707-cd41bcc0774c" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_f80a6ffb-700f-4767-bdec-7750abb5b917" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_DocumentFiscalYearFocus_f80a6ffb-700f-4767-bdec-7750abb5b917" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_7cab567c-ca64-4dc3-9021-57abf3595601" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_DocumentFiscalPeriodFocus_7cab567c-ca64-4dc3-9021-57abf3595601" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_71ff00ec-b3f8-4c05-a199-a7d4bb66bf4c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_EntityCentralIndexKey_71ff00ec-b3f8-4c05-a199-a7d4bb66bf4c" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_5861f118-45c9-45a0-bde3-c58ed346d173" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_EntitiesTable_5861f118-45c9-45a0-bde3-c58ed346d173" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_74cc3a6c-b573-469a-ae01-a975bb79f3f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_5861f118-45c9-45a0-bde3-c58ed346d173" xlink:to="loc_us-gaap_StatementClassOfStockAxis_74cc3a6c-b573-469a-ae01-a975bb79f3f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_74cc3a6c-b573-469a-ae01-a975bb79f3f9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_74cc3a6c-b573-469a-ae01-a975bb79f3f9" xlink:to="loc_us-gaap_ClassOfStockDomain_74cc3a6c-b573-469a-ae01-a975bb79f3f9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_e3eee962-f45a-4e9f-b318-f5b391a26e32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_74cc3a6c-b573-469a-ae01-a975bb79f3f9" xlink:to="loc_us-gaap_ClassOfStockDomain_e3eee962-f45a-4e9f-b318-f5b391a26e32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_7515bd12-2f58-4e0f-9a30-9ce36282478a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_e3eee962-f45a-4e9f-b318-f5b391a26e32" xlink:to="loc_us-gaap_CommonStockMember_7515bd12-2f58-4e0f-9a30-9ce36282478a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes1.125Due2023Member_ebbaf89f-fe44-42bb-9985-51e876e861f8" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotes1.125Due2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_e3eee962-f45a-4e9f-b318-f5b391a26e32" xlink:to="loc_syk_SeniorUnsecuredNotes1.125Due2023Member_ebbaf89f-fe44-42bb-9985-51e876e861f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes0.250due2024Member_1319b061-3057-46c0-9c5e-363f9b9d4720" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotes0.250due2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_e3eee962-f45a-4e9f-b318-f5b391a26e32" xlink:to="loc_syk_SeniorUnsecuredNotes0.250due2024Member_1319b061-3057-46c0-9c5e-363f9b9d4720" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes2.125Due2027Member_e597c2ee-f75f-49c7-bc07-7cfd5b9317f0" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotes2.125Due2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_e3eee962-f45a-4e9f-b318-f5b391a26e32" xlink:to="loc_syk_SeniorUnsecuredNotes2.125Due2027Member_e597c2ee-f75f-49c7-bc07-7cfd5b9317f0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes0.750due2029Member_bd888ccf-0a7f-4f72-84c7-bafcd07bf3c0" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotes0.750due2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_e3eee962-f45a-4e9f-b318-f5b391a26e32" xlink:to="loc_syk_SeniorUnsecuredNotes0.750due2029Member_bd888ccf-0a7f-4f72-84c7-bafcd07bf3c0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes2.625Due2030Member_3dba89c5-4343-4791-8465-e2ad5d3aff2b" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotes2.625Due2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_e3eee962-f45a-4e9f-b318-f5b391a26e32" xlink:to="loc_syk_SeniorUnsecuredNotes2.625Due2030Member_3dba89c5-4343-4791-8465-e2ad5d3aff2b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes1.000due2031Member_f1f49f17-eec1-472b-9ce7-eacccd8d8e9f" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotes1.000due2031Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_e3eee962-f45a-4e9f-b318-f5b391a26e32" xlink:to="loc_syk_SeniorUnsecuredNotes1.000due2031Member_f1f49f17-eec1-472b-9ce7-eacccd8d8e9f" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity" xlink:type="simple" xlink:href="syk-20221231.xsd#ConsolidatedStatementsOfShareholdersEquity"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity" xlink:type="extended" id="icbf3418759024fcebdec8b9abc10b753_ConsolidatedStatementsOfShareholdersEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ff997ef1-2b82-4e2e-a3e5-4a6db591272a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f6244f94-4276-49f5-ab23-d90f43f29ed0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ff997ef1-2b82-4e2e-a3e5-4a6db591272a" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f6244f94-4276-49f5-ab23-d90f43f29ed0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9a84dbef-6ea3-460f-b4c8-10858825686e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f6244f94-4276-49f5-ab23-d90f43f29ed0" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9a84dbef-6ea3-460f-b4c8-10858825686e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_606f6ff2-359a-48ad-8fe1-b9b1ce33e249" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f6244f94-4276-49f5-ab23-d90f43f29ed0" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_606f6ff2-359a-48ad-8fe1-b9b1ce33e249" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_e9862618-1041-48b8-b3e5-555f41358914" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f6244f94-4276-49f5-ab23-d90f43f29ed0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_e9862618-1041-48b8-b3e5-555f41358914" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_820c0716-13ae-4473-9c6c-ee3e0b02f781" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f6244f94-4276-49f5-ab23-d90f43f29ed0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_820c0716-13ae-4473-9c6c-ee3e0b02f781" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2791b8c3-abda-4bea-a7f7-9c8722c7697c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f6244f94-4276-49f5-ab23-d90f43f29ed0" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2791b8c3-abda-4bea-a7f7-9c8722c7697c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_bf3e863e-3116-4bb7-986c-cb740a103de3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f6244f94-4276-49f5-ab23-d90f43f29ed0" xlink:to="loc_us-gaap_NetIncomeLoss_bf3e863e-3116-4bb7-986c-cb740a103de3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCash_e81187d1-feca-487b-9d6d-130c991ee65a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f6244f94-4276-49f5-ab23-d90f43f29ed0" xlink:to="loc_us-gaap_DividendsCash_e81187d1-feca-487b-9d6d-130c991ee65a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_480b2512-26e0-4fb9-9765-37792e8492aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f6244f94-4276-49f5-ab23-d90f43f29ed0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_480b2512-26e0-4fb9-9765-37792e8492aa" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_e1a7c1dc-1581-4db9-9594-e32fdc10e472" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e8ab8767-24e0-47c1-8c65-cf8561fc1cad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_52f3c497-c2f8-4dee-a0b6-cf93083d60bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_ff997ef1-2b82-4e2e-a3e5-4a6db591272a" xlink:to="loc_us-gaap_StatementTable_52f3c497-c2f8-4dee-a0b6-cf93083d60bc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_fe2a4bc7-15ca-400b-9778-422c1179e09b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_52f3c497-c2f8-4dee-a0b6-cf93083d60bc" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_fe2a4bc7-15ca-400b-9778-422c1179e09b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_fe2a4bc7-15ca-400b-9778-422c1179e09b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_fe2a4bc7-15ca-400b-9778-422c1179e09b" xlink:to="loc_us-gaap_EquityComponentDomain_fe2a4bc7-15ca-400b-9778-422c1179e09b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8f502ec4-e79c-491f-adac-2f218c91d9e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_fe2a4bc7-15ca-400b-9778-422c1179e09b" xlink:to="loc_us-gaap_EquityComponentDomain_8f502ec4-e79c-491f-adac-2f218c91d9e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_ef9ddc4b-cafe-42df-ab7c-1e08156051ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8f502ec4-e79c-491f-adac-2f218c91d9e8" xlink:to="loc_us-gaap_CommonStockMember_ef9ddc4b-cafe-42df-ab7c-1e08156051ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_454eaaee-7dd6-48a9-a3fa-81c134a3bbd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8f502ec4-e79c-491f-adac-2f218c91d9e8" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_454eaaee-7dd6-48a9-a3fa-81c134a3bbd3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_cc18df25-b433-4f3b-b762-eec38a68b6c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8f502ec4-e79c-491f-adac-2f218c91d9e8" xlink:to="loc_us-gaap_RetainedEarningsMember_cc18df25-b433-4f3b-b762-eec38a68b6c8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c5af06ab-2ace-4bfe-9a06-aec88dbdea71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8f502ec4-e79c-491f-adac-2f218c91d9e8" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c5af06ab-2ace-4bfe-9a06-aec88dbdea71" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/SignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#SignificantAccountingPoliciesDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/SignificantAccountingPoliciesDetails" xlink:type="extended" id="i08a0787eba134db08738c9fedf85da5a_SignificantAccountingPoliciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_03be6598-6c02-4df0-ae69-d58dccd30423" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTermOfContract_64fce6bf-d85a-48c2-bd77-f4b306bfb82a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_03be6598-6c02-4df0-ae69-d58dccd30423" xlink:to="loc_us-gaap_DerivativeTermOfContract_64fce6bf-d85a-48c2-bd77-f4b306bfb82a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_28a3607a-9d5f-4aff-a2b9-32bb04c60723" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_03be6598-6c02-4df0-ae69-d58dccd30423" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_28a3607a-9d5f-4aff-a2b9-32bb04c60723" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_1656486b-879a-4d0d-bd0f-ca6662f13e3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_03be6598-6c02-4df0-ae69-d58dccd30423" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_1656486b-879a-4d0d-bd0f-ca6662f13e3c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_3c2f5a15-db15-43df-9f67-22633603f714" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_03be6598-6c02-4df0-ae69-d58dccd30423" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_3c2f5a15-db15-43df-9f67-22633603f714" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod_9a011552-ecfa-426a-9f13-6d6cefa28552" xlink:href="syk-20221231.xsd#syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_03be6598-6c02-4df0-ae69-d58dccd30423" xlink:to="loc_syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod_9a011552-ecfa-426a-9f13-6d6cefa28552" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_fd212dd6-2604-475d-8555-4eba0ef6c8be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_03be6598-6c02-4df0-ae69-d58dccd30423" xlink:to="loc_us-gaap_StatementTable_fd212dd6-2604-475d-8555-4eba0ef6c8be" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1d15c004-b75f-4f34-a28b-e4347f7240f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_fd212dd6-2604-475d-8555-4eba0ef6c8be" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1d15c004-b75f-4f34-a28b-e4347f7240f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1d15c004-b75f-4f34-a28b-e4347f7240f6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1d15c004-b75f-4f34-a28b-e4347f7240f6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1d15c004-b75f-4f34-a28b-e4347f7240f6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2c0df6c4-3bce-4c6c-a04e-5e20b1e71b23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1d15c004-b75f-4f34-a28b-e4347f7240f6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2c0df6c4-3bce-4c6c-a04e-5e20b1e71b23" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_13173912-c85d-4fa1-83a9-416050d9e530" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2c0df6c4-3bce-4c6c-a04e-5e20b1e71b23" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_13173912-c85d-4fa1-83a9-416050d9e530" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_b8b5ee78-41f3-48e9-8622-b6443d468a6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2c0df6c4-3bce-4c6c-a04e-5e20b1e71b23" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_b8b5ee78-41f3-48e9-8622-b6443d468a6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_13002b26-a146-4efd-b745-da5c9b24ceb1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_fd212dd6-2604-475d-8555-4eba0ef6c8be" xlink:to="loc_srt_RangeAxis_13002b26-a146-4efd-b745-da5c9b24ceb1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_13002b26-a146-4efd-b745-da5c9b24ceb1_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_13002b26-a146-4efd-b745-da5c9b24ceb1" xlink:to="loc_srt_RangeMember_13002b26-a146-4efd-b745-da5c9b24ceb1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8ac95e2d-7170-41e1-8069-43d4a84d8cda" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_13002b26-a146-4efd-b745-da5c9b24ceb1" xlink:to="loc_srt_RangeMember_8ac95e2d-7170-41e1-8069-43d4a84d8cda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e3252db1-548d-467b-acdf-1e50c7d52a23" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8ac95e2d-7170-41e1-8069-43d4a84d8cda" xlink:to="loc_srt_MinimumMember_e3252db1-548d-467b-acdf-1e50c7d52a23" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8596a6a6-43b1-4639-b5c2-a161c0f75513" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8ac95e2d-7170-41e1-8069-43d4a84d8cda" xlink:to="loc_srt_MaximumMember_8596a6a6-43b1-4639-b5c2-a161c0f75513" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_cb599344-77e3-461c-a4c0-2b03ce63af54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_fd212dd6-2604-475d-8555-4eba0ef6c8be" xlink:to="loc_us-gaap_AwardTypeAxis_cb599344-77e3-461c-a4c0-2b03ce63af54" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cb599344-77e3-461c-a4c0-2b03ce63af54_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_cb599344-77e3-461c-a4c0-2b03ce63af54" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cb599344-77e3-461c-a4c0-2b03ce63af54_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_08e0b3b1-c284-4df9-a327-219db449c706" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_cb599344-77e3-461c-a4c0-2b03ce63af54" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_08e0b3b1-c284-4df9-a327-219db449c706" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_79d02ca2-cb07-45aa-bc87-b7084d2f7f32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_08e0b3b1-c284-4df9-a327-219db449c706" xlink:to="loc_us-gaap_EmployeeStockOptionMember_79d02ca2-cb07-45aa-bc87-b7084d2f7f32" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_f7720e35-37f1-47c6-88c4-9c041e1428c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_08e0b3b1-c284-4df9-a327-219db449c706" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_f7720e35-37f1-47c6-88c4-9c041e1428c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_PerformanceStockUnitPsusMember_841b37c5-40ea-40a3-8a27-ddc06d20d07e" xlink:href="syk-20221231.xsd#syk_PerformanceStockUnitPsusMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_08e0b3b1-c284-4df9-a327-219db449c706" xlink:to="loc_syk_PerformanceStockUnitPsusMember_841b37c5-40ea-40a3-8a27-ddc06d20d07e" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#RevenueRecognitionDisaggregatedSalesAnalysisDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails" xlink:type="extended" id="i2b22d6c80a7c4e3db08574941c9c0279_RevenueRecognitionDisaggregatedSalesAnalysisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_018c54e1-50a6-427a-8001-0ef4a4241f23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_bfa8860d-6e26-4aca-83d1-890f9d6b5cfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_018c54e1-50a6-427a-8001-0ef4a4241f23" xlink:to="loc_us-gaap_Revenues_bfa8860d-6e26-4aca-83d1-890f9d6b5cfb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_136847fa-dd1b-4ab9-8192-c6f0366a61a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_018c54e1-50a6-427a-8001-0ef4a4241f23" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_136847fa-dd1b-4ab9-8192-c6f0366a61a0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_edbb353b-4b59-4f9e-bb7e-6d2d9a5eda02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_136847fa-dd1b-4ab9-8192-c6f0366a61a0" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_edbb353b-4b59-4f9e-bb7e-6d2d9a5eda02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_edbb353b-4b59-4f9e-bb7e-6d2d9a5eda02_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_edbb353b-4b59-4f9e-bb7e-6d2d9a5eda02" xlink:to="loc_us-gaap_SegmentDomain_edbb353b-4b59-4f9e-bb7e-6d2d9a5eda02_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b302e0e4-a7af-4b2a-9d8a-e85be0702ae1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_edbb353b-4b59-4f9e-bb7e-6d2d9a5eda02" xlink:to="loc_us-gaap_SegmentDomain_b302e0e4-a7af-4b2a-9d8a-e85be0702ae1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_MedSurgAndNeurotechnologyMember_bf989450-e30b-4e54-880b-b14e7e26854d" xlink:href="syk-20221231.xsd#syk_MedSurgAndNeurotechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b302e0e4-a7af-4b2a-9d8a-e85be0702ae1" xlink:to="loc_syk_MedSurgAndNeurotechnologyMember_bf989450-e30b-4e54-880b-b14e7e26854d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OrthopaedicsAndSpineMember_c7eab2ca-3be7-401b-bb40-2bf25da8f9be" xlink:href="syk-20221231.xsd#syk_OrthopaedicsAndSpineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b302e0e4-a7af-4b2a-9d8a-e85be0702ae1" xlink:to="loc_syk_OrthopaedicsAndSpineMember_c7eab2ca-3be7-401b-bb40-2bf25da8f9be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_78c1a5cd-6f84-4a3d-9001-c20350bf0374" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_136847fa-dd1b-4ab9-8192-c6f0366a61a0" xlink:to="loc_srt_ProductOrServiceAxis_78c1a5cd-6f84-4a3d-9001-c20350bf0374" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_78c1a5cd-6f84-4a3d-9001-c20350bf0374_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_78c1a5cd-6f84-4a3d-9001-c20350bf0374" xlink:to="loc_srt_ProductsAndServicesDomain_78c1a5cd-6f84-4a3d-9001-c20350bf0374_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d397b703-d2a2-4115-bcc7-105a711b0f4e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_78c1a5cd-6f84-4a3d-9001-c20350bf0374" xlink:to="loc_srt_ProductsAndServicesDomain_d397b703-d2a2-4115-bcc7-105a711b0f4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_InstrumentsMember_c6fa72c4-8cb3-4fbd-ac36-4119c5005fbe" xlink:href="syk-20221231.xsd#syk_InstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d397b703-d2a2-4115-bcc7-105a711b0f4e" xlink:to="loc_syk_InstrumentsMember_c6fa72c4-8cb3-4fbd-ac36-4119c5005fbe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_EndoscopyMember_c14c8f87-fc4b-4c5f-abcb-369eb3f6c596" xlink:href="syk-20221231.xsd#syk_EndoscopyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d397b703-d2a2-4115-bcc7-105a711b0f4e" xlink:to="loc_syk_EndoscopyMember_c14c8f87-fc4b-4c5f-abcb-369eb3f6c596" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_MedicalMember_b794e57b-30e4-4a69-9414-8a9e7c54cde6" xlink:href="syk-20221231.xsd#syk_MedicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d397b703-d2a2-4115-bcc7-105a711b0f4e" xlink:to="loc_syk_MedicalMember_b794e57b-30e4-4a69-9414-8a9e7c54cde6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_NeurovascularMember_5c834867-a691-467b-9eff-d112f5e4733f" xlink:href="syk-20221231.xsd#syk_NeurovascularMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d397b703-d2a2-4115-bcc7-105a711b0f4e" xlink:to="loc_syk_NeurovascularMember_5c834867-a691-467b-9eff-d112f5e4733f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_NeuroCranialMember_bb81fb04-e124-4d94-858f-a220ab1b0ab2" xlink:href="syk-20221231.xsd#syk_NeuroCranialMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d397b703-d2a2-4115-bcc7-105a711b0f4e" xlink:to="loc_syk_NeuroCranialMember_bb81fb04-e124-4d94-858f-a220ab1b0ab2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OtherOrthopaedicsMember_a2d98981-04e7-45a4-99c8-aad0fe8c84da" xlink:href="syk-20221231.xsd#syk_OtherOrthopaedicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d397b703-d2a2-4115-bcc7-105a711b0f4e" xlink:to="loc_syk_OtherOrthopaedicsMember_a2d98981-04e7-45a4-99c8-aad0fe8c84da" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_KneesMember_2543c52d-6e0d-4281-b8cc-a7b5093f0c87" xlink:href="syk-20221231.xsd#syk_KneesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d397b703-d2a2-4115-bcc7-105a711b0f4e" xlink:to="loc_syk_KneesMember_2543c52d-6e0d-4281-b8cc-a7b5093f0c87" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_HipsMember_b5f97c37-f365-4bff-85f5-dfce3eb28027" xlink:href="syk-20221231.xsd#syk_HipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d397b703-d2a2-4115-bcc7-105a711b0f4e" xlink:to="loc_syk_HipsMember_b5f97c37-f365-4bff-85f5-dfce3eb28027" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_TraumaandExtremitiesMember_16fc0755-6072-4f7c-bea9-eb1c02afcdd1" xlink:href="syk-20221231.xsd#syk_TraumaandExtremitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d397b703-d2a2-4115-bcc7-105a711b0f4e" xlink:to="loc_syk_TraumaandExtremitiesMember_16fc0755-6072-4f7c-bea9-eb1c02afcdd1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SpineMember_4a8e2e93-37cd-4532-8875-cc5cf42e4d02" xlink:href="syk-20221231.xsd#syk_SpineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d397b703-d2a2-4115-bcc7-105a711b0f4e" xlink:to="loc_syk_SpineMember_4a8e2e93-37cd-4532-8875-cc5cf42e4d02" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_da22985c-8986-4272-a1b2-0b7a03e383ed" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_136847fa-dd1b-4ab9-8192-c6f0366a61a0" xlink:to="loc_srt_StatementGeographicalAxis_da22985c-8986-4272-a1b2-0b7a03e383ed" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_da22985c-8986-4272-a1b2-0b7a03e383ed_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_da22985c-8986-4272-a1b2-0b7a03e383ed" xlink:to="loc_srt_SegmentGeographicalDomain_da22985c-8986-4272-a1b2-0b7a03e383ed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_db36a17b-0b2a-42bf-a880-cf7ee452c0d6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_da22985c-8986-4272-a1b2-0b7a03e383ed" xlink:to="loc_srt_SegmentGeographicalDomain_db36a17b-0b2a-42bf-a880-cf7ee452c0d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_5d249ad0-cef4-4801-9df1-935e0faa62d6" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_db36a17b-0b2a-42bf-a880-cf7ee452c0d6" xlink:to="loc_country_US_5d249ad0-cef4-4801-9df1-935e0faa62d6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_4bb8b02e-f7ce-458c-90d4-00df662a3e23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_db36a17b-0b2a-42bf-a880-cf7ee452c0d6" xlink:to="loc_us-gaap_NonUsMember_4bb8b02e-f7ce-458c-90d4-00df662a3e23" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails" xlink:type="extended" id="icac57e754ffa4fe9bdfcab4841c328e4_FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_109485ba-a718-4699-8b53-1d1b467e3d6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_29b7d809-8d85-484f-aadc-c1ca6c53f640" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_109485ba-a718-4699-8b53-1d1b467e3d6c" xlink:to="loc_us-gaap_AssetsAbstract_29b7d809-8d85-484f-aadc-c1ca6c53f640" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_2bd89f4d-d9b5-4736-a152-0c5b9fd5c49f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_29b7d809-8d85-484f-aadc-c1ca6c53f640" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_2bd89f4d-d9b5-4736-a152-0c5b9fd5c49f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecuritiesDebt_163364be-3d87-4290-9d71-cc452c1526b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecuritiesDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_29b7d809-8d85-484f-aadc-c1ca6c53f640" xlink:to="loc_us-gaap_TradingSecuritiesDebt_163364be-3d87-4290-9d71-cc452c1526b4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_4228052f-6e6d-4566-9d69-746243b9b209" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_29b7d809-8d85-484f-aadc-c1ca6c53f640" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_4228052f-6e6d-4566-9d69-746243b9b209" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_4566627f-1c43-497b-95a9-53437065d09d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_29b7d809-8d85-484f-aadc-c1ca6c53f640" xlink:to="loc_us-gaap_DerivativeAssets_4566627f-1c43-497b-95a9-53437065d09d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_445ab718-e795-49e0-ad99-f5113ff4fe18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_91d69b8f-19a4-41ac-8fb1-9afdb8452ed5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_29b7d809-8d85-484f-aadc-c1ca6c53f640" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_91d69b8f-19a4-41ac-8fb1-9afdb8452ed5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_578c58f5-dace-421d-b989-8f60baa26862" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_109485ba-a718-4699-8b53-1d1b467e3d6c" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_578c58f5-dace-421d-b989-8f60baa26862" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities_a7550767-a9d4-4cd9-9d0f-3d0890c0894c" xlink:href="syk-20221231.xsd#syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_578c58f5-dace-421d-b989-8f60baa26862" xlink:to="loc_syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities_a7550767-a9d4-4cd9-9d0f-3d0890c0894c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_bc04b0a2-03f3-4416-b1aa-80490840b80f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_578c58f5-dace-421d-b989-8f60baa26862" xlink:to="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_bc04b0a2-03f3-4416-b1aa-80490840b80f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_40160743-0254-43d2-9b0d-1701c34ecd47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_578c58f5-dace-421d-b989-8f60baa26862" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_40160743-0254-43d2-9b0d-1701c34ecd47" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_dde4ca23-d070-4af8-890c-d160e344261a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_40160743-0254-43d2-9b0d-1701c34ecd47" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_dde4ca23-d070-4af8-890c-d160e344261a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_73a3acac-b209-42dd-89d7-f6dc9ba61dc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_40160743-0254-43d2-9b0d-1701c34ecd47" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_73a3acac-b209-42dd-89d7-f6dc9ba61dc0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_72ce0107-885b-441f-8df5-49f3e93071f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_40160743-0254-43d2-9b0d-1701c34ecd47" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_72ce0107-885b-441f-8df5-49f3e93071f8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_02ac63a1-3599-4a18-986f-a072bbc8d654" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_40160743-0254-43d2-9b0d-1701c34ecd47" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_02ac63a1-3599-4a18-986f-a072bbc8d654" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_7aa5e7c7-284e-4b6b-bd41-d8277064d188" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_bfc9f8ae-be7a-4f52-b20c-6b9833b31c30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_578c58f5-dace-421d-b989-8f60baa26862" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_bfc9f8ae-be7a-4f52-b20c-6b9833b31c30" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_483d686d-79ad-4da6-b5c5-3bf1ddcf075e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_109485ba-a718-4699-8b53-1d1b467e3d6c" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_483d686d-79ad-4da6-b5c5-3bf1ddcf075e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0eee0a0f-b253-4638-a798-bd316256a8c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_483d686d-79ad-4da6-b5c5-3bf1ddcf075e" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0eee0a0f-b253-4638-a798-bd316256a8c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0eee0a0f-b253-4638-a798-bd316256a8c5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0eee0a0f-b253-4638-a798-bd316256a8c5" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0eee0a0f-b253-4638-a798-bd316256a8c5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6e976d31-9ab0-4643-ab6e-a0012684eb5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0eee0a0f-b253-4638-a798-bd316256a8c5" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6e976d31-9ab0-4643-ab6e-a0012684eb5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_1b4f5049-a56e-4cb8-8853-4add90a70319" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6e976d31-9ab0-4643-ab6e-a0012684eb5b" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_1b4f5049-a56e-4cb8-8853-4add90a70319" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_66229156-0b76-4c95-b411-7b5146fdb0d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6e976d31-9ab0-4643-ab6e-a0012684eb5b" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_66229156-0b76-4c95-b411-7b5146fdb0d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_91ee3d66-0686-404a-9b59-2919ce565742" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6e976d31-9ab0-4643-ab6e-a0012684eb5b" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_91ee3d66-0686-404a-9b59-2919ce565742" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InformationByCategoryOfDebtSecurityAxis_6dfe06d3-8fb6-4c90-a3f2-6f39255cd3a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InformationByCategoryOfDebtSecurityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_483d686d-79ad-4da6-b5c5-3bf1ddcf075e" xlink:to="loc_us-gaap_InformationByCategoryOfDebtSecurityAxis_6dfe06d3-8fb6-4c90-a3f2-6f39255cd3a6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_6dfe06d3-8fb6-4c90-a3f2-6f39255cd3a6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InformationByCategoryOfDebtSecurityAxis_6dfe06d3-8fb6-4c90-a3f2-6f39255cd3a6" xlink:to="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_6dfe06d3-8fb6-4c90-a3f2-6f39255cd3a6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_49509c03-5823-4d86-a806-3f1f2e71a377" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InformationByCategoryOfDebtSecurityAxis_6dfe06d3-8fb6-4c90-a3f2-6f39255cd3a6" xlink:to="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_49509c03-5823-4d86-a806-3f1f2e71a377" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableforsaleSecuritiesMember_41707456-f56b-466d-ada2-63b8316a641b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableforsaleSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_49509c03-5823-4d86-a806-3f1f2e71a377" xlink:to="loc_us-gaap_AvailableforsaleSecuritiesMember_41707456-f56b-466d-ada2-63b8316a641b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f77a771c-816b-4172-8383-3ef3372c2c17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_483d686d-79ad-4da6-b5c5-3bf1ddcf075e" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f77a771c-816b-4172-8383-3ef3372c2c17" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f77a771c-816b-4172-8383-3ef3372c2c17_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f77a771c-816b-4172-8383-3ef3372c2c17" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f77a771c-816b-4172-8383-3ef3372c2c17_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_153177e9-2298-44be-a27b-49cb5b4d5eb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f77a771c-816b-4172-8383-3ef3372c2c17" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_153177e9-2298-44be-a27b-49cb5b4d5eb3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_ae593854-4d42-49b0-bf52-c55753fccfc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_153177e9-2298-44be-a27b-49cb5b4d5eb3" xlink:to="loc_us-gaap_ForeignExchangeContractMember_ae593854-4d42-49b0-bf52-c55753fccfc0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_f493adc6-96d4-461a-8fe5-7844910357f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_153177e9-2298-44be-a27b-49cb5b4d5eb3" xlink:to="loc_us-gaap_InterestRateSwapMember_f493adc6-96d4-461a-8fe5-7844910357f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_7c4497f3-8069-4eb1-a476-bd2ebacd08ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_483d686d-79ad-4da6-b5c5-3bf1ddcf075e" xlink:to="loc_us-gaap_FinancialInstrumentAxis_7c4497f3-8069-4eb1-a476-bd2ebacd08ec" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7c4497f3-8069-4eb1-a476-bd2ebacd08ec_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_7c4497f3-8069-4eb1-a476-bd2ebacd08ec" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7c4497f3-8069-4eb1-a476-bd2ebacd08ec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_88d5c729-dd61-4283-8235-535fe31d7696" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_7c4497f3-8069-4eb1-a476-bd2ebacd08ec" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_88d5c729-dd61-4283-8235-535fe31d7696" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_dc2acfda-a11a-4745-b856-80cb749c48d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_88d5c729-dd61-4283-8235-535fe31d7696" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_dc2acfda-a11a-4745-b856-80cb749c48d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_387b4dc0-3638-412f-9f57-ef86721ab6a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignGovernmentDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_88d5c729-dd61-4283-8235-535fe31d7696" xlink:to="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_387b4dc0-3638-412f-9f57-ef86721ab6a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_a1ae72ce-e7a5-4edf-9807-77738e210d3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_88d5c729-dd61-4283-8235-535fe31d7696" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_a1ae72ce-e7a5-4edf-9807-77738e210d3c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_2272acc8-3c3e-4f37-850d-6f5f7c5a455f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_88d5c729-dd61-4283-8235-535fe31d7696" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_2272acc8-3c3e-4f37-850d-6f5f7c5a455f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_cb0ca1cb-73ce-42fb-932e-4c6a1cd31977" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_88d5c729-dd61-4283-8235-535fe31d7696" xlink:to="loc_us-gaap_CertificatesOfDepositMember_cb0ca1cb-73ce-42fb-932e-4c6a1cd31977" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended" id="icae29a7d9de747ce8942f14682c30850_FairValueMeasurementsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_aea34714-993a-4264-a9c5-cfeb043218fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesGainLoss_a26d15d6-3026-4ffb-813c-4a01c304abc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_aea34714-993a-4264-a9c5-cfeb043218fc" xlink:to="loc_us-gaap_MarketableSecuritiesGainLoss_a26d15d6-3026-4ffb-813c-4a01c304abc4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_8b67569a-74a3-4eaa-b586-9c00bb8076ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_aea34714-993a-4264-a9c5-cfeb043218fc" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_8b67569a-74a3-4eaa-b586-9c00bb8076ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_9a8fc64e-384b-4854-a3a2-b89a9aab2fa1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_aea34714-993a-4264-a9c5-cfeb043218fc" xlink:to="loc_us-gaap_StatementTable_9a8fc64e-384b-4854-a3a2-b89a9aab2fa1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InformationByCategoryOfDebtSecurityAxis_f33a5dc5-bd49-4b5a-a9ba-9e5cea55421a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InformationByCategoryOfDebtSecurityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_9a8fc64e-384b-4854-a3a2-b89a9aab2fa1" xlink:to="loc_us-gaap_InformationByCategoryOfDebtSecurityAxis_f33a5dc5-bd49-4b5a-a9ba-9e5cea55421a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_f33a5dc5-bd49-4b5a-a9ba-9e5cea55421a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InformationByCategoryOfDebtSecurityAxis_f33a5dc5-bd49-4b5a-a9ba-9e5cea55421a" xlink:to="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_f33a5dc5-bd49-4b5a-a9ba-9e5cea55421a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_8d6e3b52-f889-4cf0-99c3-a213eb9212ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InformationByCategoryOfDebtSecurityAxis_f33a5dc5-bd49-4b5a-a9ba-9e5cea55421a" xlink:to="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_8d6e3b52-f889-4cf0-99c3-a213eb9212ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableforsaleSecuritiesMember_c2f77d82-c484-40c6-b931-9f5aabe181e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableforsaleSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_8d6e3b52-f889-4cf0-99c3-a213eb9212ea" xlink:to="loc_us-gaap_AvailableforsaleSecuritiesMember_c2f77d82-c484-40c6-b931-9f5aabe181e3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#DerivativeInstrumentsForwardCurrencyExchangeContractsDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails" xlink:type="extended" id="ic1208f6659ee47ccbdc92fe9aaad68af_DerivativeInstrumentsForwardCurrencyExchangeContractsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_bfce0046-4b03-4a5a-83e1-f72db7f2b803" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_5c0b1784-c4c4-4872-acbe-b6318cab1c39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_bfce0046-4b03-4a5a-83e1-f72db7f2b803" xlink:to="loc_us-gaap_DerivativeNotionalAmount_5c0b1784-c4c4-4872-acbe-b6318cab1c39" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_addd56c2-99b4-46df-b626-ddd7b90e70b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_bfce0046-4b03-4a5a-83e1-f72db7f2b803" xlink:to="loc_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_addd56c2-99b4-46df-b626-ddd7b90e70b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_0e59d071-4cb9-4c89-9148-7bd7d076688d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_bfce0046-4b03-4a5a-83e1-f72db7f2b803" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_0e59d071-4cb9-4c89-9148-7bd7d076688d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_9743d421-3bce-419e-ad94-acf3401a73c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_bfce0046-4b03-4a5a-83e1-f72db7f2b803" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_9743d421-3bce-419e-ad94-acf3401a73c1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet_2bf7ed47-eb6e-4205-87b4-7978c6ea8248" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_bfce0046-4b03-4a5a-83e1-f72db7f2b803" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeNet_2bf7ed47-eb6e-4205-87b4-7978c6ea8248" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_c5b02f53-3dd7-4abd-9fa2-ba0a71f1e1b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_bfce0046-4b03-4a5a-83e1-f72db7f2b803" xlink:to="loc_us-gaap_DerivativeTable_c5b02f53-3dd7-4abd-9fa2-ba0a71f1e1b4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6fe84c97-75a5-4a16-9a85-053fc689b326" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_c5b02f53-3dd7-4abd-9fa2-ba0a71f1e1b4" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6fe84c97-75a5-4a16-9a85-053fc689b326" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_6fe84c97-75a5-4a16-9a85-053fc689b326_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6fe84c97-75a5-4a16-9a85-053fc689b326" xlink:to="loc_us-gaap_HedgingRelationshipDomain_6fe84c97-75a5-4a16-9a85-053fc689b326_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_9b561d53-1da7-476b-9008-7cb436d5236f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6fe84c97-75a5-4a16-9a85-053fc689b326" xlink:to="loc_us-gaap_HedgingRelationshipDomain_9b561d53-1da7-476b-9008-7cb436d5236f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_e3d0aefb-66f5-4475-b41b-be837dad6536" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_9b561d53-1da7-476b-9008-7cb436d5236f" xlink:to="loc_us-gaap_CashFlowHedgingMember_e3d0aefb-66f5-4475-b41b-be837dad6536" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_f4d64db7-58a5-4a8e-8853-fdfade010b43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_9b561d53-1da7-476b-9008-7cb436d5236f" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_f4d64db7-58a5-4a8e-8853-fdfade010b43" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_3548830e-9862-4e34-b4ba-6833d47b5c6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_c5b02f53-3dd7-4abd-9fa2-ba0a71f1e1b4" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_3548830e-9862-4e34-b4ba-6833d47b5c6d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3548830e-9862-4e34-b4ba-6833d47b5c6d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3548830e-9862-4e34-b4ba-6833d47b5c6d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3548830e-9862-4e34-b4ba-6833d47b5c6d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6ffc88fd-1b0b-46b0-b7ef-ebec44357a33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3548830e-9862-4e34-b4ba-6833d47b5c6d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6ffc88fd-1b0b-46b0-b7ef-ebec44357a33" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_cdbff39d-c4b4-4baf-a54b-73efc6306526" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6ffc88fd-1b0b-46b0-b7ef-ebec44357a33" xlink:to="loc_us-gaap_ForeignExchangeContractMember_cdbff39d-c4b4-4baf-a54b-73efc6306526" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_c4efffad-9592-4a50-8749-56b55ad738ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_c5b02f53-3dd7-4abd-9fa2-ba0a71f1e1b4" xlink:to="loc_us-gaap_HedgingDesignationAxis_c4efffad-9592-4a50-8749-56b55ad738ae" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_c4efffad-9592-4a50-8749-56b55ad738ae_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_c4efffad-9592-4a50-8749-56b55ad738ae" xlink:to="loc_us-gaap_HedgingDesignationDomain_c4efffad-9592-4a50-8749-56b55ad738ae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_cef9cc94-c7c9-4ee9-bf30-5dfb8d0af486" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_c4efffad-9592-4a50-8749-56b55ad738ae" xlink:to="loc_us-gaap_HedgingDesignationDomain_cef9cc94-c7c9-4ee9-bf30-5dfb8d0af486" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_300a42a0-fb3f-4ad2-82db-5b0e9cb1c381" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_cef9cc94-c7c9-4ee9-bf30-5dfb8d0af486" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_300a42a0-fb3f-4ad2-82db-5b0e9cb1c381" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_83e64d95-78ec-4b11-8dcd-e2a0c718762e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_cef9cc94-c7c9-4ee9-bf30-5dfb8d0af486" xlink:to="loc_us-gaap_NondesignatedMember_83e64d95-78ec-4b11-8dcd-e2a0c718762e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_5dedb6d5-2eb3-43df-9c9b-b8508aa707e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_c5b02f53-3dd7-4abd-9fa2-ba0a71f1e1b4" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_5dedb6d5-2eb3-43df-9c9b-b8508aa707e1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_5dedb6d5-2eb3-43df-9c9b-b8508aa707e1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_5dedb6d5-2eb3-43df-9c9b-b8508aa707e1" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_5dedb6d5-2eb3-43df-9c9b-b8508aa707e1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_68d188ca-2788-45f7-b68a-c99c7014f060" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_5dedb6d5-2eb3-43df-9c9b-b8508aa707e1" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_68d188ca-2788-45f7-b68a-c99c7014f060" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember_6b16ce99-06ff-49b2-9ed4-82c1d0da6d27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_68d188ca-2788-45f7-b68a-c99c7014f060" xlink:to="loc_us-gaap_OtherCurrentAssetsMember_6b16ce99-06ff-49b2-9ed4-82c1d0da6d27" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_4419656c-ec01-4da1-bb78-20b9dc423e2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_68d188ca-2788-45f7-b68a-c99c7014f060" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_4419656c-ec01-4da1-bb78-20b9dc423e2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_5004d5d1-82ac-477b-a48a-b525e9cba5ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_68d188ca-2788-45f7-b68a-c99c7014f060" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_5004d5d1-82ac-477b-a48a-b525e9cba5ae" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_5665bb28-3609-42dc-bac1-911ce02fb3fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_68d188ca-2788-45f7-b68a-c99c7014f060" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_5665bb28-3609-42dc-bac1-911ce02fb3fc" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#DerivativeInstrumentsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails" xlink:type="extended" id="if397da5fd5014bdba8a9a17b1da8b322_DerivativeInstrumentsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6e99c2e9-d028-496e-995f-ba8aa7939399" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_cc8f976f-0273-49f7-a02a-8c25932ba652" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6e99c2e9-d028-496e-995f-ba8aa7939399" xlink:to="loc_us-gaap_DerivativeNotionalAmount_cc8f976f-0273-49f7-a02a-8c25932ba652" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeInvestingActivities_0ebb55ab-cbd6-4a10-8a51-46756fb18650" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromHedgeInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6e99c2e9-d028-496e-995f-ba8aa7939399" xlink:to="loc_us-gaap_ProceedsFromHedgeInvestingActivities_0ebb55ab-cbd6-4a10-8a51-46756fb18650" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax_b444f314-8f53-4562-9cb3-8fa7e846dfd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6e99c2e9-d028-496e-995f-ba8aa7939399" xlink:to="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax_b444f314-8f53-4562-9cb3-8fa7e846dfd0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_9da414a9-7148-41ee-b587-8ddd955089c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6e99c2e9-d028-496e-995f-ba8aa7939399" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_9da414a9-7148-41ee-b587-8ddd955089c7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax_cb63feda-15a7-45cf-bcca-2bf3f7c784d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6e99c2e9-d028-496e-995f-ba8aa7939399" xlink:to="loc_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax_cb63feda-15a7-45cf-bcca-2bf3f7c784d5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_f0707021-b9b0-4ee1-8d62-728c0910f802" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6e99c2e9-d028-496e-995f-ba8aa7939399" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_f0707021-b9b0-4ee1-8d62-728c0910f802" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_d8053365-644b-4b0d-a591-e1fcc961a5b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_f0707021-b9b0-4ee1-8d62-728c0910f802" xlink:to="loc_us-gaap_HedgingDesignationAxis_d8053365-644b-4b0d-a591-e1fcc961a5b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_d8053365-644b-4b0d-a591-e1fcc961a5b8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_d8053365-644b-4b0d-a591-e1fcc961a5b8" xlink:to="loc_us-gaap_HedgingDesignationDomain_d8053365-644b-4b0d-a591-e1fcc961a5b8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_7cfac226-21c8-4955-9604-6671d4c0cb4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_d8053365-644b-4b0d-a591-e1fcc961a5b8" xlink:to="loc_us-gaap_HedgingDesignationDomain_7cfac226-21c8-4955-9604-6671d4c0cb4a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_f9d67eeb-c389-4da7-86ce-a261ae515e84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_7cfac226-21c8-4955-9604-6671d4c0cb4a" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_f9d67eeb-c389-4da7-86ce-a261ae515e84" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_fd1d8dfe-1643-4f84-bff8-e5cda482b283" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_f0707021-b9b0-4ee1-8d62-728c0910f802" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_fd1d8dfe-1643-4f84-bff8-e5cda482b283" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_fd1d8dfe-1643-4f84-bff8-e5cda482b283_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_fd1d8dfe-1643-4f84-bff8-e5cda482b283" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_fd1d8dfe-1643-4f84-bff8-e5cda482b283_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_0b55d03f-0d5a-4005-8106-413083186004" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_fd1d8dfe-1643-4f84-bff8-e5cda482b283" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_0b55d03f-0d5a-4005-8106-413083186004" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_dbddcc7f-b847-486d-85b6-073ca9ff1244" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0b55d03f-0d5a-4005-8106-413083186004" xlink:to="loc_us-gaap_ForeignExchangeContractMember_dbddcc7f-b847-486d-85b6-073ca9ff1244" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_36065f69-afcb-4620-ba8a-e80e81a3b49f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0b55d03f-0d5a-4005-8106-413083186004" xlink:to="loc_us-gaap_InterestRateSwapMember_36065f69-afcb-4620-ba8a-e80e81a3b49f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_01892273-e497-41ff-9477-5f7c1b08b2e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmbeddedDerivativeFinancialInstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0b55d03f-0d5a-4005-8106-413083186004" xlink:to="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_01892273-e497-41ff-9477-5f7c1b08b2e5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_45154fcf-2e44-498c-852f-43031aba5faa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_f0707021-b9b0-4ee1-8d62-728c0910f802" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_45154fcf-2e44-498c-852f-43031aba5faa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_45154fcf-2e44-498c-852f-43031aba5faa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_45154fcf-2e44-498c-852f-43031aba5faa" xlink:to="loc_us-gaap_HedgingRelationshipDomain_45154fcf-2e44-498c-852f-43031aba5faa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_5d77f9aa-d08c-4a12-9138-e1f22989517e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_45154fcf-2e44-498c-852f-43031aba5faa" xlink:to="loc_us-gaap_HedgingRelationshipDomain_5d77f9aa-d08c-4a12-9138-e1f22989517e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_00848b82-cdeb-454b-85c6-86eb15e20860" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_5d77f9aa-d08c-4a12-9138-e1f22989517e" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_00848b82-cdeb-454b-85c6-86eb15e20860" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#DerivativeInstrumentsMovementsoutofOCIDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails" xlink:type="extended" id="i2d226d286e764fdd941531579c995240_DerivativeInstrumentsMovementsoutofOCIDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_0149ecff-fd13-4e3f-aa04-1ba96bc6d775" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_de9529d5-737e-4663-86a6-5be966ca77dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_0149ecff-fd13-4e3f-aa04-1ba96bc6d775" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_de9529d5-737e-4663-86a6-5be966ca77dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax_1b0cb987-7047-47c6-9fca-600b5daea766" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_0149ecff-fd13-4e3f-aa04-1ba96bc6d775" xlink:to="loc_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax_1b0cb987-7047-47c6-9fca-600b5daea766" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_13682a78-9f78-411c-a77b-e959e73f7ca3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_0149ecff-fd13-4e3f-aa04-1ba96bc6d775" xlink:to="loc_us-gaap_DerivativeTable_13682a78-9f78-411c-a77b-e959e73f7ca3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_04b36157-ee09-44bb-add9-da991aa7f13c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_13682a78-9f78-411c-a77b-e959e73f7ca3" xlink:to="loc_us-gaap_HedgingDesignationAxis_04b36157-ee09-44bb-add9-da991aa7f13c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_04b36157-ee09-44bb-add9-da991aa7f13c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_04b36157-ee09-44bb-add9-da991aa7f13c" xlink:to="loc_us-gaap_HedgingDesignationDomain_04b36157-ee09-44bb-add9-da991aa7f13c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_a0ecd426-8503-49ef-aa8b-13d908d58793" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_04b36157-ee09-44bb-add9-da991aa7f13c" xlink:to="loc_us-gaap_HedgingDesignationDomain_a0ecd426-8503-49ef-aa8b-13d908d58793" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_c1d0ccbb-a000-4fbe-ab7d-010fcf284eab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_a0ecd426-8503-49ef-aa8b-13d908d58793" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_c1d0ccbb-a000-4fbe-ab7d-010fcf284eab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_df63250e-ac00-408c-9812-3d3055b1e0fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_a0ecd426-8503-49ef-aa8b-13d908d58793" xlink:to="loc_us-gaap_NondesignatedMember_df63250e-ac00-408c-9812-3d3055b1e0fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_ec1b6750-7a3c-42c8-9f0f-5a064231cf72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_13682a78-9f78-411c-a77b-e959e73f7ca3" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_ec1b6750-7a3c-42c8-9f0f-5a064231cf72" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ec1b6750-7a3c-42c8-9f0f-5a064231cf72_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_ec1b6750-7a3c-42c8-9f0f-5a064231cf72" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ec1b6750-7a3c-42c8-9f0f-5a064231cf72_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_aa5bcd79-2e70-489b-a26b-c05381d3f7b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_ec1b6750-7a3c-42c8-9f0f-5a064231cf72" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_aa5bcd79-2e70-489b-a26b-c05381d3f7b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_ec2769fe-13c6-4481-a793-94d4ab30e177" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_aa5bcd79-2e70-489b-a26b-c05381d3f7b6" xlink:to="loc_us-gaap_ForeignExchangeContractMember_ec2769fe-13c6-4481-a793-94d4ab30e177" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_6997e84b-c855-4f65-bd2c-1c6e12e5a65b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_13682a78-9f78-411c-a77b-e959e73f7ca3" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_6997e84b-c855-4f65-bd2c-1c6e12e5a65b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_6997e84b-c855-4f65-bd2c-1c6e12e5a65b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_6997e84b-c855-4f65-bd2c-1c6e12e5a65b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_6997e84b-c855-4f65-bd2c-1c6e12e5a65b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_9eb348b3-635f-46bf-8a9e-5b3a7977b5c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_6997e84b-c855-4f65-bd2c-1c6e12e5a65b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_9eb348b3-635f-46bf-8a9e-5b3a7977b5c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_87f063ca-d212-44cd-9e5a-2f92b96996ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_9eb348b3-635f-46bf-8a9e-5b3a7977b5c8" xlink:to="loc_us-gaap_CostOfSalesMember_87f063ca-d212-44cd-9e5a-2f92b96996ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OtherIncomeexpenseMember_5499bc43-feb1-42ed-bcef-9bbc3f4bdba5" xlink:href="syk-20221231.xsd#syk_OtherIncomeexpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_9eb348b3-635f-46bf-8a9e-5b3a7977b5c8" xlink:to="loc_syk_OtherIncomeexpenseMember_5499bc43-feb1-42ed-bcef-9bbc3f4bdba5" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails" xlink:type="extended" id="i9c15cd9b2ad74fd5939456c27a55bf28_AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_3932cac0-50c4-47d4-9951-25e58f17d578" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_b5c42f00-f919-4029-9353-f1e7e52bc283" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_3932cac0-50c4-47d4-9951-25e58f17d578" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_b5c42f00-f919-4029-9353-f1e7e52bc283" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_0796a299-db68-442e-911b-5a4e2898107c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_b5c42f00-f919-4029-9353-f1e7e52bc283" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_0796a299-db68-442e-911b-5a4e2898107c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_7241f240-2a90-43c7-a3d2-5c88c7619854" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_b5c42f00-f919-4029-9353-f1e7e52bc283" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_7241f240-2a90-43c7-a3d2-5c88c7619854" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_ce02198b-6b52-4134-aa75-bad06d048479" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_b5c42f00-f919-4029-9353-f1e7e52bc283" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_ce02198b-6b52-4134-aa75-bad06d048479" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_8852cc8e-d81e-4295-885f-5f7455007a11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_b5c42f00-f919-4029-9353-f1e7e52bc283" xlink:to="loc_us-gaap_CostOfRevenue_8852cc8e-d81e-4295-885f-5f7455007a11" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_f4a92d62-184f-4f71-af3d-44c829729992" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_b5c42f00-f919-4029-9353-f1e7e52bc283" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_f4a92d62-184f-4f71-af3d-44c829729992" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_fb914912-6ab1-46d8-95b3-981e7798db1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_b5c42f00-f919-4029-9353-f1e7e52bc283" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_fb914912-6ab1-46d8-95b3-981e7798db1f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_24789640-e5da-4883-86ca-ec437154bb7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_b5c42f00-f919-4029-9353-f1e7e52bc283" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_24789640-e5da-4883-86ca-ec437154bb7d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a642ef97-14ba-48fb-9c9d-1c76eb092e8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_212d758a-2e69-4cf0-86b3-c26567bc526c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_3932cac0-50c4-47d4-9951-25e58f17d578" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_212d758a-2e69-4cf0-86b3-c26567bc526c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_3ec0d74a-9da5-4a88-8444-c35bdee29c78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_212d758a-2e69-4cf0-86b3-c26567bc526c" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_3ec0d74a-9da5-4a88-8444-c35bdee29c78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3ec0d74a-9da5-4a88-8444-c35bdee29c78_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3ec0d74a-9da5-4a88-8444-c35bdee29c78" xlink:to="loc_us-gaap_EquityComponentDomain_3ec0d74a-9da5-4a88-8444-c35bdee29c78_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_47294ac7-d18a-4629-aa80-bfc1e362ab10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3ec0d74a-9da5-4a88-8444-c35bdee29c78" xlink:to="loc_us-gaap_EquityComponentDomain_47294ac7-d18a-4629-aa80-bfc1e362ab10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_9136d995-83d7-407b-a79f-cb57c534e461" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_47294ac7-d18a-4629-aa80-bfc1e362ab10" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_9136d995-83d7-407b-a79f-cb57c534e461" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_0dc2df2d-e204-4b90-ae47-b7dcd099510e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_47294ac7-d18a-4629-aa80-bfc1e362ab10" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_0dc2df2d-e204-4b90-ae47-b7dcd099510e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_f79907e2-8e22-4f72-9711-8f9b7e117f16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_47294ac7-d18a-4629-aa80-bfc1e362ab10" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_f79907e2-8e22-4f72-9711-8f9b7e117f16" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_13432443-eb73-4a51-8037-6ce986f27bd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_47294ac7-d18a-4629-aa80-bfc1e362ab10" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_13432443-eb73-4a51-8037-6ce986f27bd0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_4a5cf594-f917-46e0-8941-d50ad1430d94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_212d758a-2e69-4cf0-86b3-c26567bc526c" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_4a5cf594-f917-46e0-8941-d50ad1430d94" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_4a5cf594-f917-46e0-8941-d50ad1430d94_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_4a5cf594-f917-46e0-8941-d50ad1430d94" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_4a5cf594-f917-46e0-8941-d50ad1430d94_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_97a79c6e-3312-4af9-ab53-218cf5b3ee1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_4a5cf594-f917-46e0-8941-d50ad1430d94" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_97a79c6e-3312-4af9-ab53-218cf5b3ee1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_bc8969f8-51d4-48cc-897e-805337d757fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_97a79c6e-3312-4af9-ab53-218cf5b3ee1d" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_bc8969f8-51d4-48cc-897e-805337d757fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_e7cdeb16-6750-41af-883f-aa6c47e017a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_212d758a-2e69-4cf0-86b3-c26567bc526c" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_e7cdeb16-6750-41af-883f-aa6c47e017a9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_e7cdeb16-6750-41af-883f-aa6c47e017a9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_e7cdeb16-6750-41af-883f-aa6c47e017a9" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_e7cdeb16-6750-41af-883f-aa6c47e017a9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_5f0e0475-2015-47e8-b0b4-ecb395aec577" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_e7cdeb16-6750-41af-883f-aa6c47e017a9" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_5f0e0475-2015-47e8-b0b4-ecb395aec577" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_b35a1487-1ca8-430c-92fc-43bd5c85ae85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5f0e0475-2015-47e8-b0b4-ecb395aec577" xlink:to="loc_us-gaap_CostOfSalesMember_b35a1487-1ca8-430c-92fc-43bd5c85ae85" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OtherIncomeexpenseMember_fb47f033-9980-4580-b814-384091d5b732" xlink:href="syk-20221231.xsd#syk_OtherIncomeexpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5f0e0475-2015-47e8-b0b4-ecb395aec577" xlink:to="loc_syk_OtherIncomeexpenseMember_fb47f033-9980-4580-b814-384091d5b732" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/AcquisitionsNarrativeDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#AcquisitionsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/AcquisitionsNarrativeDetails" xlink:type="extended" id="i6343f7d628e54636bc6672c3ac586f89_AcquisitionsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_5afb45dc-d8cb-4729-9918-01a0131fe9a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_aabc0b3c-1417-4186-a5ac-c5e4c2f4cb26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5afb45dc-d8cb-4729-9918-01a0131fe9a4" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_aabc0b3c-1417-4186-a5ac-c5e4c2f4cb26" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_BusinessCombinationConsiderationTransferredPricePerShare_c7bbf855-ef22-44eb-aa9d-e5f8fd8fa266" xlink:href="syk-20221231.xsd#syk_BusinessCombinationConsiderationTransferredPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5afb45dc-d8cb-4729-9918-01a0131fe9a4" xlink:to="loc_syk_BusinessCombinationConsiderationTransferredPricePerShare_c7bbf855-ef22-44eb-aa9d-e5f8fd8fa266" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_BusinessCombinationConsiderationTransferredIncludingConvertibleNotes_5b19ff85-5d8a-4f6c-8efb-9939b4ee0ce1" xlink:href="syk-20221231.xsd#syk_BusinessCombinationConsiderationTransferredIncludingConvertibleNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5afb45dc-d8cb-4729-9918-01a0131fe9a4" xlink:to="loc_syk_BusinessCombinationConsiderationTransferredIncludingConvertibleNotes_5b19ff85-5d8a-4f6c-8efb-9939b4ee0ce1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b6c01ea2-86e5-41fb-8056-607a80e1239e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5afb45dc-d8cb-4729-9918-01a0131fe9a4" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b6c01ea2-86e5-41fb-8056-607a80e1239e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_8ef585f7-921c-413c-bc99-a7b39fd7f024" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5afb45dc-d8cb-4729-9918-01a0131fe9a4" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_8ef585f7-921c-413c-bc99-a7b39fd7f024" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_4de2657e-48de-4084-81f9-d5589f3924ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5afb45dc-d8cb-4729-9918-01a0131fe9a4" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_4de2657e-48de-4084-81f9-d5589f3924ca" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh_53863845-78c7-4ec3-8102-176b88a8ba73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5afb45dc-d8cb-4729-9918-01a0131fe9a4" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh_53863845-78c7-4ec3-8102-176b88a8ba73" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4071d077-bfbc-445b-8c80-e067a8d595cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5afb45dc-d8cb-4729-9918-01a0131fe9a4" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4071d077-bfbc-445b-8c80-e067a8d595cc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_53bc1644-8f7c-4ae7-971c-8c51b505f67a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4071d077-bfbc-445b-8c80-e067a8d595cc" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_53bc1644-8f7c-4ae7-971c-8c51b505f67a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_53bc1644-8f7c-4ae7-971c-8c51b505f67a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_53bc1644-8f7c-4ae7-971c-8c51b505f67a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_53bc1644-8f7c-4ae7-971c-8c51b505f67a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c6ca0116-d9d7-4dca-aef6-b33f856a08a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_53bc1644-8f7c-4ae7-971c-8c51b505f67a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c6ca0116-d9d7-4dca-aef6-b33f856a08a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_VoceraMember_dc1af082-1f7f-455b-a2d5-37c19254c632" xlink:href="syk-20221231.xsd#syk_VoceraMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c6ca0116-d9d7-4dca-aef6-b33f856a08a3" xlink:to="loc_syk_VoceraMember_dc1af082-1f7f-455b-a2d5-37c19254c632" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_GaussMember_cf0c446b-9baa-469c-a0d4-df49d9964d18" xlink:href="syk-20221231.xsd#syk_GaussMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c6ca0116-d9d7-4dca-aef6-b33f856a08a3" xlink:to="loc_syk_GaussMember_cf0c446b-9baa-469c-a0d4-df49d9964d18" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_20374200-5b2d-4105-9441-77073b306e78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4071d077-bfbc-445b-8c80-e067a8d595cc" xlink:to="loc_us-gaap_DebtInstrumentAxis_20374200-5b2d-4105-9441-77073b306e78" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_20374200-5b2d-4105-9441-77073b306e78_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_20374200-5b2d-4105-9441-77073b306e78" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_20374200-5b2d-4105-9441-77073b306e78_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_845f5d8b-ee24-4a42-8be2-e9c80e22da83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_20374200-5b2d-4105-9441-77073b306e78" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_845f5d8b-ee24-4a42-8be2-e9c80e22da83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_A150ConvertibleNotesMember_412d3ca9-f957-4e79-8776-d3d116344c15" xlink:href="syk-20221231.xsd#syk_A150ConvertibleNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_845f5d8b-ee24-4a42-8be2-e9c80e22da83" xlink:to="loc_syk_A150ConvertibleNotesMember_412d3ca9-f957-4e79-8776-d3d116344c15" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_A050ConvertibleNotesMember_eaf8cfe3-ca8a-45a3-ab8e-711c04bcc484" xlink:href="syk-20221231.xsd#syk_A050ConvertibleNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_845f5d8b-ee24-4a42-8be2-e9c80e22da83" xlink:to="loc_syk_A050ConvertibleNotesMember_eaf8cfe3-ca8a-45a3-ab8e-711c04bcc484" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails" xlink:type="extended" id="i4c5698f50c8e4ee597027a7991e4a85a_AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_d0ee08c3-043b-441c-935d-2d0698e7b00c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_fbbacac8-d231-4ae2-8ed2-d035743bbc5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d0ee08c3-043b-441c-935d-2d0698e7b00c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_fbbacac8-d231-4ae2-8ed2-d035743bbc5b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_2fc4a7b1-0e45-4de5-aae3-f13e6c05a74e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d0ee08c3-043b-441c-935d-2d0698e7b00c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_2fc4a7b1-0e45-4de5-aae3-f13e6c05a74e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_2076ee9a-cc81-487a-876b-48241bf0752f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d0ee08c3-043b-441c-935d-2d0698e7b00c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_2076ee9a-cc81-487a-876b-48241bf0752f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_61e1e090-23e1-4d00-9f11-2cefeaef5cb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d0ee08c3-043b-441c-935d-2d0698e7b00c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_61e1e090-23e1-4d00-9f11-2cefeaef5cb9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt_f09ceadd-717f-4b2f-b6af-c8c1e9382a41" xlink:href="syk-20221231.xsd#syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d0ee08c3-043b-441c-935d-2d0698e7b00c" xlink:to="loc_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt_f09ceadd-717f-4b2f-b6af-c8c1e9382a41" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_863b1459-6dcf-4a9b-8ed5-c62f0ef9285c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d0ee08c3-043b-441c-935d-2d0698e7b00c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_863b1459-6dcf-4a9b-8ed5-c62f0ef9285c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_d3d42873-b023-43c7-9145-8d25ff90ba1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d0ee08c3-043b-441c-935d-2d0698e7b00c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_d3d42873-b023-43c7-9145-8d25ff90ba1c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_0a8a4b6e-35ba-4c02-ac56-5c621c65778f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d0ee08c3-043b-441c-935d-2d0698e7b00c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_0a8a4b6e-35ba-4c02-ac56-5c621c65778f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_4a97aaec-cfdf-4674-9be6-7f5f02754a06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d0ee08c3-043b-441c-935d-2d0698e7b00c" xlink:to="loc_us-gaap_Goodwill_4a97aaec-cfdf-4674-9be6-7f5f02754a06" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_4c7b30c2-e216-4505-9425-770211f8b9fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d0ee08c3-043b-441c-935d-2d0698e7b00c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_4c7b30c2-e216-4505-9425-770211f8b9fe" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_c1430f89-efaa-4b68-9b95-2b35607962fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d0ee08c3-043b-441c-935d-2d0698e7b00c" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_c1430f89-efaa-4b68-9b95-2b35607962fc" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_7ecae911-b4c3-4678-b992-c5fc246521e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d0ee08c3-043b-441c-935d-2d0698e7b00c" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_7ecae911-b4c3-4678-b992-c5fc246521e8" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_56c93d65-e2c7-4165-a180-a88147e87cca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d0ee08c3-043b-441c-935d-2d0698e7b00c" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_56c93d65-e2c7-4165-a180-a88147e87cca" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_f090865f-122f-4eb8-b53c-74160c832047" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_56c93d65-e2c7-4165-a180-a88147e87cca" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_f090865f-122f-4eb8-b53c-74160c832047" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f090865f-122f-4eb8-b53c-74160c832047_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f090865f-122f-4eb8-b53c-74160c832047" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f090865f-122f-4eb8-b53c-74160c832047_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8cb47f8a-ed01-4194-b474-c5c876f7d937" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f090865f-122f-4eb8-b53c-74160c832047" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8cb47f8a-ed01-4194-b474-c5c876f7d937" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_VoceraMember_b706ddab-1a89-4505-9f73-caa746d6f8b1" xlink:href="syk-20221231.xsd#syk_VoceraMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8cb47f8a-ed01-4194-b474-c5c876f7d937" xlink:to="loc_syk_VoceraMember_b706ddab-1a89-4505-9f73-caa746d6f8b1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_83bd537f-72e9-4337-93e3-e183cf8739c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_56c93d65-e2c7-4165-a180-a88147e87cca" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_83bd537f-72e9-4337-93e3-e183cf8739c1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_83bd537f-72e9-4337-93e3-e183cf8739c1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_83bd537f-72e9-4337-93e3-e183cf8739c1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_83bd537f-72e9-4337-93e3-e183cf8739c1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6f1a1054-8569-429b-9261-a77dfb820c76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_83bd537f-72e9-4337-93e3-e183cf8739c1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6f1a1054-8569-429b-9261-a77dfb820c76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_CustomerAndDistributorRelationshipsMember_dd47511d-699a-4244-8c64-c6f888f46084" xlink:href="syk-20221231.xsd#syk_CustomerAndDistributorRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6f1a1054-8569-429b-9261-a77dfb820c76" xlink:to="loc_syk_CustomerAndDistributorRelationshipsMember_dd47511d-699a-4244-8c64-c6f888f46084" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_0b66fcc8-c8dd-480a-8f36-7633b939babd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6f1a1054-8569-429b-9261-a77dfb820c76" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_0b66fcc8-c8dd-480a-8f36-7633b939babd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_61f71fa8-b85f-48d1-ac98-aa7bf98130af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6f1a1054-8569-429b-9261-a77dfb820c76" xlink:to="loc_us-gaap_TradeNamesMember_61f71fa8-b85f-48d1-ac98-aa7bf98130af" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/ContingenciesandCommitmentsNarrativeDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#ContingenciesandCommitmentsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/ContingenciesandCommitmentsNarrativeDetails" xlink:type="extended" id="i1bef01a0883a4a519c486e13cb0317ca_ContingenciesandCommitmentsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_018c0c58-e362-4765-bc10-f9a7e8b15171" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyLossInPeriod_698d944e-f011-4e9a-98ab-59821cb35a75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyLossInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_018c0c58-e362-4765-bc10-f9a7e8b15171" xlink:to="loc_us-gaap_LossContingencyLossInPeriod_698d944e-f011-4e9a-98ab-59821cb35a75" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_b317fd74-7190-43d4-beac-e67f339fc19a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_018c0c58-e362-4765-bc10-f9a7e8b15171" xlink:to="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_b317fd74-7190-43d4-beac-e67f339fc19a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_Changeinaccrualforrecallexpenses_4f9a6c62-d3e7-46e4-abd2-7d026fa016ce" xlink:href="syk-20221231.xsd#syk_Changeinaccrualforrecallexpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_018c0c58-e362-4765-bc10-f9a7e8b15171" xlink:to="loc_syk_Changeinaccrualforrecallexpenses_4f9a6c62-d3e7-46e4-abd2-7d026fa016ce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_ede96302-3736-4ff8-b6fc-bbdcd0897b0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_018c0c58-e362-4765-bc10-f9a7e8b15171" xlink:to="loc_us-gaap_OperatingLeaseExpense_ede96302-3736-4ff8-b6fc-bbdcd0897b0f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_d90f6db0-3bba-4c55-bb7a-cdea63be4ded" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_018c0c58-e362-4765-bc10-f9a7e8b15171" xlink:to="loc_us-gaap_LossContingenciesTable_d90f6db0-3bba-4c55-bb7a-cdea63be4ded" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5a2abf3e-6402-40b2-9eff-66aab2e0afa7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_d90f6db0-3bba-4c55-bb7a-cdea63be4ded" xlink:to="loc_srt_RangeAxis_5a2abf3e-6402-40b2-9eff-66aab2e0afa7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5a2abf3e-6402-40b2-9eff-66aab2e0afa7_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_5a2abf3e-6402-40b2-9eff-66aab2e0afa7" xlink:to="loc_srt_RangeMember_5a2abf3e-6402-40b2-9eff-66aab2e0afa7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c123230a-3340-40a0-b540-f83a12262e19" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_5a2abf3e-6402-40b2-9eff-66aab2e0afa7" xlink:to="loc_srt_RangeMember_c123230a-3340-40a0-b540-f83a12262e19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a1e584a3-6091-47cb-9062-f87c4342c951" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c123230a-3340-40a0-b540-f83a12262e19" xlink:to="loc_srt_MinimumMember_a1e584a3-6091-47cb-9062-f87c4342c951" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_27213686-c79d-4d2a-b1b4-009af4eac857" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c123230a-3340-40a0-b540-f83a12262e19" xlink:to="loc_srt_MaximumMember_27213686-c79d-4d2a-b1b4-009af4eac857" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_e3c42281-16e7-4ed4-a86f-9a27f6048198" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_d90f6db0-3bba-4c55-bb7a-cdea63be4ded" xlink:to="loc_srt_LitigationCaseAxis_e3c42281-16e7-4ed4-a86f-9a27f6048198" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_e3c42281-16e7-4ed4-a86f-9a27f6048198_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_e3c42281-16e7-4ed4-a86f-9a27f6048198" xlink:to="loc_srt_LitigationCaseTypeDomain_e3c42281-16e7-4ed4-a86f-9a27f6048198_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_a3afeacf-7e3e-407f-8eb7-aca730c2f382" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_e3c42281-16e7-4ed4-a86f-9a27f6048198" xlink:to="loc_srt_LitigationCaseTypeDomain_a3afeacf-7e3e-407f-8eb7-aca730c2f382" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_PureWickMember_01dc37a2-9415-4ebb-bae2-430f7104a4c7" xlink:href="syk-20221231.xsd#syk_PureWickMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_a3afeacf-7e3e-407f-8eb7-aca730c2f382" xlink:to="loc_syk_PureWickMember_01dc37a2-9415-4ebb-bae2-430f7104a4c7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_RecallMattersMember_ea693ae6-4ba4-4776-aaae-3bcfcbe0d37b" xlink:href="syk-20221231.xsd#syk_RecallMattersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_a3afeacf-7e3e-407f-8eb7-aca730c2f382" xlink:to="loc_syk_RecallMattersMember_ea693ae6-4ba4-4776-aaae-3bcfcbe0d37b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#GoodwillandOtherIntangibleAssetsGoodwillDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails" xlink:type="extended" id="i35e69295bbe34ba88d0f86abe3271c59_GoodwillandOtherIntangibleAssetsGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_a78cb556-acb7-4761-881e-23f882edb6ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e14e0fea-fd54-41df-a885-5db227d2525d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_a78cb556-acb7-4761-881e-23f882edb6ac" xlink:to="loc_us-gaap_Goodwill_e14e0fea-fd54-41df-a885-5db227d2525d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_831f6cd8-3610-4e26-8192-ee687a172967" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_a78cb556-acb7-4761-881e-23f882edb6ac" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_831f6cd8-3610-4e26-8192-ee687a172967" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_7a4779d0-7575-4da4-87e8-ddedfd3c8620" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_a78cb556-acb7-4761-881e-23f882edb6ac" xlink:to="loc_us-gaap_GoodwillRollForward_7a4779d0-7575-4da4-87e8-ddedfd3c8620" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_168d032c-a76b-4fab-ac97-5136c1a82751" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_e0af0836-0d5c-4f88-b92f-3de0fef03c06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_7a4779d0-7575-4da4-87e8-ddedfd3c8620" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_e0af0836-0d5c-4f88-b92f-3de0fef03c06" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_f8e48856-123c-4ab9-9678-d29d9b48fc21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_7a4779d0-7575-4da4-87e8-ddedfd3c8620" xlink:to="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_f8e48856-123c-4ab9-9678-d29d9b48fc21" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_42ef6834-61ce-49a3-bb9e-8a817ab1fd3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_13d17708-60a6-4e4f-bdd6-02742adea2ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_02a6c89b-b329-476f-9906-1094fdf45b1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_a78cb556-acb7-4761-881e-23f882edb6ac" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_02a6c89b-b329-476f-9906-1094fdf45b1d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_558e7b55-239c-4b57-a5f4-25a57fd5de5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_02a6c89b-b329-476f-9906-1094fdf45b1d" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_558e7b55-239c-4b57-a5f4-25a57fd5de5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_558e7b55-239c-4b57-a5f4-25a57fd5de5c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_558e7b55-239c-4b57-a5f4-25a57fd5de5c" xlink:to="loc_us-gaap_SegmentDomain_558e7b55-239c-4b57-a5f4-25a57fd5de5c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ef7139d5-e11c-450b-88aa-121322b998ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_558e7b55-239c-4b57-a5f4-25a57fd5de5c" xlink:to="loc_us-gaap_SegmentDomain_ef7139d5-e11c-450b-88aa-121322b998ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_MedSurgAndNeurotechnologyMember_876d8fd3-c711-4885-9746-29a5f122c504" xlink:href="syk-20221231.xsd#syk_MedSurgAndNeurotechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_ef7139d5-e11c-450b-88aa-121322b998ac" xlink:to="loc_syk_MedSurgAndNeurotechnologyMember_876d8fd3-c711-4885-9746-29a5f122c504" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OrthopaedicsAndSpineMember_c9c6f8be-6d58-46fc-97de-51cb33ebab89" xlink:href="syk-20221231.xsd#syk_OrthopaedicsAndSpineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_ef7139d5-e11c-450b-88aa-121322b998ac" xlink:to="loc_syk_OrthopaedicsAndSpineMember_c9c6f8be-6d58-46fc-97de-51cb33ebab89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_5f7d65fc-cf0c-4cdf-859e-7be83efbeca9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_02a6c89b-b329-476f-9906-1094fdf45b1d" xlink:to="loc_us-gaap_ReportingUnitAxis_5f7d65fc-cf0c-4cdf-859e-7be83efbeca9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_5f7d65fc-cf0c-4cdf-859e-7be83efbeca9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReportingUnitAxis_5f7d65fc-cf0c-4cdf-859e-7be83efbeca9" xlink:to="loc_us-gaap_ReportingUnitDomain_5f7d65fc-cf0c-4cdf-859e-7be83efbeca9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_5b3a7ec0-6952-41db-a730-116ba9205fa1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReportingUnitAxis_5f7d65fc-cf0c-4cdf-859e-7be83efbeca9" xlink:to="loc_us-gaap_ReportingUnitDomain_5b3a7ec0-6952-41db-a730-116ba9205fa1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SpineReportingUnitMember_ebf4ca12-f9b8-459b-83b4-12b1b0be7ce9" xlink:href="syk-20221231.xsd#syk_SpineReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_5b3a7ec0-6952-41db-a730-116ba9205fa1" xlink:to="loc_syk_SpineReportingUnitMember_ebf4ca12-f9b8-459b-83b4-12b1b0be7ce9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails" xlink:type="extended" id="ie29957a64adf44df8d142d5925dae117_GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_8447666a-f534-40e0-a84f-c2bf3fb6717a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_a3a27e8c-475c-49c8-9d3a-5ab592a07a53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_8447666a-f534-40e0-a84f-c2bf3fb6717a" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_a3a27e8c-475c-49c8-9d3a-5ab592a07a53" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_52081e28-c276-4f23-8075-32a9ab9ba683" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_8447666a-f534-40e0-a84f-c2bf3fb6717a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_52081e28-c276-4f23-8075-32a9ab9ba683" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1c6b3491-18c5-4e20-96d9-58e0c4bb56cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_8447666a-f534-40e0-a84f-c2bf3fb6717a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1c6b3491-18c5-4e20-96d9-58e0c4bb56cc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_3c4335ec-680c-4fc6-81ac-151c3afe3426" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_8447666a-f534-40e0-a84f-c2bf3fb6717a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_3c4335ec-680c-4fc6-81ac-151c3afe3426" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_d872b739-fc04-436e-ba8e-5849337c1e33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_8447666a-f534-40e0-a84f-c2bf3fb6717a" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_d872b739-fc04-436e-ba8e-5849337c1e33" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6c205aaf-d164-44b5-9d8c-89c005ca02d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_d872b739-fc04-436e-ba8e-5849337c1e33" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6c205aaf-d164-44b5-9d8c-89c005ca02d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6c205aaf-d164-44b5-9d8c-89c005ca02d3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6c205aaf-d164-44b5-9d8c-89c005ca02d3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6c205aaf-d164-44b5-9d8c-89c005ca02d3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d4530027-4733-422b-bc52-657613adde8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6c205aaf-d164-44b5-9d8c-89c005ca02d3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d4530027-4733-422b-bc52-657613adde8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_16cf9ad8-9ef1-4bcc-86d8-dc9d5dee5eb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d4530027-4733-422b-bc52-657613adde8e" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_16cf9ad8-9ef1-4bcc-86d8-dc9d5dee5eb6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_d3c07a8e-793d-4a7e-a061-3a3ce6e3a2a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d4530027-4733-422b-bc52-657613adde8e" xlink:to="loc_us-gaap_CustomerRelationshipsMember_d3c07a8e-793d-4a7e-a061-3a3ce6e3a2a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_d231fb78-6365-4ec7-8963-c8978ef1c961" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PatentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d4530027-4733-422b-bc52-657613adde8e" xlink:to="loc_us-gaap_PatentsMember_d231fb78-6365-4ec7-8963-c8978ef1c961" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_5f5e1b5d-07d1-4a41-8e2b-36d29228959d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d4530027-4733-422b-bc52-657613adde8e" xlink:to="loc_us-gaap_TrademarksMember_5f5e1b5d-07d1-4a41-8e2b-36d29228959d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_f068ab9a-721e-4a06-a54e-9e8688984223" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d4530027-4733-422b-bc52-657613adde8e" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_f068ab9a-721e-4a06-a54e-9e8688984223" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_5ba4ddcd-6c1d-4f8d-907f-88f855e49c5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d4530027-4733-422b-bc52-657613adde8e" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_5ba4ddcd-6c1d-4f8d-907f-88f855e49c5e" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/CapitalStockNarrativeDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#CapitalStockNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/CapitalStockNarrativeDetails" xlink:type="extended" id="i0f31916c00f7400b9d64244ec485505d_CapitalStockNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f8a4e30a-427a-431c-ad43-c5d891b6c2fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_CommonAndPreferredStockSharesAuthorized_34ca0e16-443d-4eff-a0e1-ab8edf494190" xlink:href="syk-20221231.xsd#syk_CommonAndPreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f8a4e30a-427a-431c-ad43-c5d891b6c2fb" xlink:to="loc_syk_CommonAndPreferredStockSharesAuthorized_34ca0e16-443d-4eff-a0e1-ab8edf494190" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_04152d00-fd59-4092-98e2-664ce2a22d0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f8a4e30a-427a-431c-ad43-c5d891b6c2fb" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_04152d00-fd59-4092-98e2-664ce2a22d0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_cfbe10b2-0dd9-4c32-9fe4-fb2fbe11ccff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f8a4e30a-427a-431c-ad43-c5d891b6c2fb" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_cfbe10b2-0dd9-4c32-9fe4-fb2fbe11ccff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_887ba924-0694-4e12-ab4a-6f479b5f0b16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f8a4e30a-427a-431c-ad43-c5d891b6c2fb" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_887ba924-0694-4e12-ab4a-6f479b5f0b16" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_43889854-9cb0-4dd9-b5de-9ef6cfc2ccfd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f8a4e30a-427a-431c-ad43-c5d891b6c2fb" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_43889854-9cb0-4dd9-b5de-9ef6cfc2ccfd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_eea90d7e-7b1b-45bf-8af0-558b05e95f6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f8a4e30a-427a-431c-ad43-c5d891b6c2fb" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_eea90d7e-7b1b-45bf-8af0-558b05e95f6c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_a157e7b8-50e0-4c19-b2ef-1d9c8536bbc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f8a4e30a-427a-431c-ad43-c5d891b6c2fb" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_a157e7b8-50e0-4c19-b2ef-1d9c8536bbc9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_7d84e4cc-3373-47f6-b64c-e51b4f4400f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f8a4e30a-427a-431c-ad43-c5d891b6c2fb" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_7d84e4cc-3373-47f6-b64c-e51b4f4400f3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_6417f911-8348-4bfd-8447-e6f8e6930013" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f8a4e30a-427a-431c-ad43-c5d891b6c2fb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_6417f911-8348-4bfd-8447-e6f8e6930013" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_3dc043cc-0d54-4a17-b8b7-ac6568b3b6a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f8a4e30a-427a-431c-ad43-c5d891b6c2fb" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_3dc043cc-0d54-4a17-b8b7-ac6568b3b6a7" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_17e9ffa7-9c55-4ae5-ada4-ae39738cccff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f8a4e30a-427a-431c-ad43-c5d891b6c2fb" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_17e9ffa7-9c55-4ae5-ada4-ae39738cccff" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_09b2ceae-aea9-4d62-9eb1-adf9e7f3437e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f8a4e30a-427a-431c-ad43-c5d891b6c2fb" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_09b2ceae-aea9-4d62-9eb1-adf9e7f3437e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_a2fa86d4-88a2-407d-a514-49af981229ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f8a4e30a-427a-431c-ad43-c5d891b6c2fb" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_a2fa86d4-88a2-407d-a514-49af981229ce" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_4551cc74-760c-4ed6-9f84-b6818df6760c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f8a4e30a-427a-431c-ad43-c5d891b6c2fb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_4551cc74-760c-4ed6-9f84-b6818df6760c" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue_1cfe191c-7baf-4b19-8a43-7cdf348eab46" xlink:href="syk-20221231.xsd#syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f8a4e30a-427a-431c-ad43-c5d891b6c2fb" xlink:to="loc_syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue_1cfe191c-7baf-4b19-8a43-7cdf348eab46" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp_b6b1de8a-c9c2-40ed-b96b-8618e6cbd519" xlink:href="syk-20221231.xsd#syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f8a4e30a-427a-431c-ad43-c5d891b6c2fb" xlink:to="loc_syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp_b6b1de8a-c9c2-40ed-b96b-8618e6cbd519" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_a0402944-e85c-4b74-bb42-b84cecdf7244" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f8a4e30a-427a-431c-ad43-c5d891b6c2fb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_a0402944-e85c-4b74-bb42-b84cecdf7244" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_b5884505-3e13-4acd-9823-bd5e7f51e6cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f8a4e30a-427a-431c-ad43-c5d891b6c2fb" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_b5884505-3e13-4acd-9823-bd5e7f51e6cf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_77867ba4-75b6-4b60-989c-0c979a8e6042" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_b5884505-3e13-4acd-9823-bd5e7f51e6cf" xlink:to="loc_us-gaap_AwardTypeAxis_77867ba4-75b6-4b60-989c-0c979a8e6042" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_77867ba4-75b6-4b60-989c-0c979a8e6042_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_77867ba4-75b6-4b60-989c-0c979a8e6042" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_77867ba4-75b6-4b60-989c-0c979a8e6042_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_03aa54ae-b271-4fa9-a12a-f312edfb0115" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_77867ba4-75b6-4b60-989c-0c979a8e6042" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_03aa54ae-b271-4fa9-a12a-f312edfb0115" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_1d018e0a-c1f4-4295-8136-5a65142d2790" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_03aa54ae-b271-4fa9-a12a-f312edfb0115" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_1d018e0a-c1f4-4295-8136-5a65142d2790" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_PerformanceStockUnitPsusMember_e037412d-fdde-4812-a655-14b65a25b3ed" xlink:href="syk-20221231.xsd#syk_PerformanceStockUnitPsusMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_03aa54ae-b271-4fa9-a12a-f312edfb0115" xlink:to="loc_syk_PerformanceStockUnitPsusMember_e037412d-fdde-4812-a655-14b65a25b3ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_d888b99f-ec8d-445e-bcd3-de0f847b4100" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_03aa54ae-b271-4fa9-a12a-f312edfb0115" xlink:to="loc_us-gaap_EmployeeStockMember_d888b99f-ec8d-445e-bcd3-de0f847b4100" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#CapitalStockSummaryofRSUandPSUActivityDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails" xlink:type="extended" id="ica5a0cc9046e4b3f9249307b6ff75133_CapitalStockSummaryofRSUandPSUActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_a3b7997e-83bc-4e89-bea8-286512dc0084" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9487aaad-c54e-457d-86a6-c60f8a686829" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a3b7997e-83bc-4e89-bea8-286512dc0084" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9487aaad-c54e-457d-86a6-c60f8a686829" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7c6ec43c-ddb7-487a-abf2-d2b282f2e504" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9487aaad-c54e-457d-86a6-c60f8a686829" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7c6ec43c-ddb7-487a-abf2-d2b282f2e504" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_6aa2dc94-2d72-472c-a7b6-8a8259fdc580" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9487aaad-c54e-457d-86a6-c60f8a686829" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_6aa2dc94-2d72-472c-a7b6-8a8259fdc580" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_cde1501f-62aa-42fb-9577-b22538ff3e2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9487aaad-c54e-457d-86a6-c60f8a686829" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_cde1501f-62aa-42fb-9577-b22538ff3e2a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_592c0950-c00d-4c39-a3c9-f01c50d19c4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9487aaad-c54e-457d-86a6-c60f8a686829" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_592c0950-c00d-4c39-a3c9-f01c50d19c4b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_bba0b83e-0ac7-4bea-9c46-4d9213955a92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ca376c74-a56d-412d-9e88-9ee9dcd85c6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a3b7997e-83bc-4e89-bea8-286512dc0084" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ca376c74-a56d-412d-9e88-9ee9dcd85c6d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_aad15c90-e142-4abd-ad58-0696d7ca4fe0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ca376c74-a56d-412d-9e88-9ee9dcd85c6d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_aad15c90-e142-4abd-ad58-0696d7ca4fe0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_576b1afa-b631-4b2c-9e17-f7507553e56b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ca376c74-a56d-412d-9e88-9ee9dcd85c6d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_576b1afa-b631-4b2c-9e17-f7507553e56b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_07c7db14-574e-4e54-ae71-9c8faf960d49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ca376c74-a56d-412d-9e88-9ee9dcd85c6d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_07c7db14-574e-4e54-ae71-9c8faf960d49" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_6be4abc4-421a-40cc-b8be-a2a111ed38ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ca376c74-a56d-412d-9e88-9ee9dcd85c6d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_6be4abc4-421a-40cc-b8be-a2a111ed38ab" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e24ea231-c62e-4766-82fe-50ebd2f0262e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_f0516c34-324c-4829-87a1-53eababb2272" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_a3b7997e-83bc-4e89-bea8-286512dc0084" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_f0516c34-324c-4829-87a1-53eababb2272" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_ab67f838-ae07-4af0-a2ac-e0f859518911" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_f0516c34-324c-4829-87a1-53eababb2272" xlink:to="loc_us-gaap_AwardTypeAxis_ab67f838-ae07-4af0-a2ac-e0f859518911" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ab67f838-ae07-4af0-a2ac-e0f859518911_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_ab67f838-ae07-4af0-a2ac-e0f859518911" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ab67f838-ae07-4af0-a2ac-e0f859518911_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1f66595e-ec13-4950-b0a4-0d0a5ed16581" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_ab67f838-ae07-4af0-a2ac-e0f859518911" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1f66595e-ec13-4950-b0a4-0d0a5ed16581" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_853a460d-ae49-4059-b74c-8e8d308381b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1f66595e-ec13-4950-b0a4-0d0a5ed16581" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_853a460d-ae49-4059-b74c-8e8d308381b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_PerformanceStockUnitPsusMember_21a64797-a4a3-4b4f-9e29-77ef09362254" xlink:href="syk-20221231.xsd#syk_PerformanceStockUnitPsusMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1f66595e-ec13-4950-b0a4-0d0a5ed16581" xlink:to="loc_syk_PerformanceStockUnitPsusMember_21a64797-a4a3-4b4f-9e29-77ef09362254" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#DebtandCreditFacilitiesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails" xlink:type="extended" id="i62378a6cce134ea988c2f3e178ef08f8_DebtandCreditFacilitiesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_1ef23136-ce0d-4b63-b16a-ca514c5cbac7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_6230dc78-5631-406f-af95-5002c0fcc70a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1ef23136-ce0d-4b63-b16a-ca514c5cbac7" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_6230dc78-5631-406f-af95-5002c0fcc70a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_f212ede4-c961-451a-a12b-2fc323b29630" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1ef23136-ce0d-4b63-b16a-ca514c5cbac7" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_f212ede4-c961-451a-a12b-2fc323b29630" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_752f232f-6078-4eaf-8dd4-41254cc39221" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1ef23136-ce0d-4b63-b16a-ca514c5cbac7" xlink:to="loc_us-gaap_RepaymentsOfDebt_752f232f-6078-4eaf-8dd4-41254cc39221" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_39f579bb-c19c-49d8-8e9f-cf1af77ecb64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1ef23136-ce0d-4b63-b16a-ca514c5cbac7" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_39f579bb-c19c-49d8-8e9f-cf1af77ecb64" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaper_03462bb9-1c94-4c20-abf1-bf8e29e854e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaper"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1ef23136-ce0d-4b63-b16a-ca514c5cbac7" xlink:to="loc_us-gaap_CommercialPaper_03462bb9-1c94-4c20-abf1-bf8e29e854e4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_3884741d-4a2d-45d0-b37a-1b171149d537" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1ef23136-ce0d-4b63-b16a-ca514c5cbac7" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_3884741d-4a2d-45d0-b37a-1b171149d537" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_8ea594df-025c-4686-874a-e673b0a40b7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1ef23136-ce0d-4b63-b16a-ca514c5cbac7" xlink:to="loc_us-gaap_InterestExpenseDebt_8ea594df-025c-4686-874a-e673b0a40b7e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_10a085b9-9f64-46ae-9558-b4c09bcc9ca0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1ef23136-ce0d-4b63-b16a-ca514c5cbac7" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_10a085b9-9f64-46ae-9558-b4c09bcc9ca0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_a44d36a8-a3a0-4034-a7ee-c922faedb369" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_10a085b9-9f64-46ae-9558-b4c09bcc9ca0" xlink:to="loc_us-gaap_DebtInstrumentAxis_a44d36a8-a3a0-4034-a7ee-c922faedb369" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a44d36a8-a3a0-4034-a7ee-c922faedb369_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_a44d36a8-a3a0-4034-a7ee-c922faedb369" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a44d36a8-a3a0-4034-a7ee-c922faedb369_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_81dd6855-d801-420a-97ed-4a4981a3ec04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_a44d36a8-a3a0-4034-a7ee-c922faedb369" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_81dd6855-d801-420a-97ed-4a4981a3ec04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_TermLoanDueFebruary222025Member_e7feb346-ec04-4717-b4f2-93af081d942b" xlink:href="syk-20221231.xsd#syk_TermLoanDueFebruary222025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_81dd6855-d801-420a-97ed-4a4981a3ec04" xlink:to="loc_syk_TermLoanDueFebruary222025Member_e7feb346-ec04-4717-b4f2-93af081d942b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_CreditAgreementMember_a01937ae-40d5-4d67-86fd-6cd4bf0e192e" xlink:href="syk-20221231.xsd#syk_CreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_81dd6855-d801-420a-97ed-4a4981a3ec04" xlink:to="loc_syk_CreditAgreementMember_a01937ae-40d5-4d67-86fd-6cd4bf0e192e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_7eea64ae-9f5b-488c-a05f-b410e4deffa8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_10a085b9-9f64-46ae-9558-b4c09bcc9ca0" xlink:to="loc_us-gaap_CreditFacilityAxis_7eea64ae-9f5b-488c-a05f-b410e4deffa8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_7eea64ae-9f5b-488c-a05f-b410e4deffa8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_7eea64ae-9f5b-488c-a05f-b410e4deffa8" xlink:to="loc_us-gaap_CreditFacilityDomain_7eea64ae-9f5b-488c-a05f-b410e4deffa8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_6e39c244-11fb-4648-a6e2-94f3ca991f3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_7eea64ae-9f5b-488c-a05f-b410e4deffa8" xlink:to="loc_us-gaap_CreditFacilityDomain_6e39c244-11fb-4648-a6e2-94f3ca991f3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_8c81b0f4-b7d6-4ce4-b3db-b40fca3c4d23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_6e39c244-11fb-4648-a6e2-94f3ca991f3a" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_8c81b0f4-b7d6-4ce4-b3db-b40fca3c4d23" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_878691ae-e5be-420c-aeb3-ee98903eb761" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_10a085b9-9f64-46ae-9558-b4c09bcc9ca0" xlink:to="loc_us-gaap_VariableRateAxis_878691ae-e5be-420c-aeb3-ee98903eb761" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_878691ae-e5be-420c-aeb3-ee98903eb761_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_878691ae-e5be-420c-aeb3-ee98903eb761" xlink:to="loc_us-gaap_VariableRateDomain_878691ae-e5be-420c-aeb3-ee98903eb761_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_92e41938-3815-4b59-8ebe-db25d7af68c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_878691ae-e5be-420c-aeb3-ee98903eb761" xlink:to="loc_us-gaap_VariableRateDomain_92e41938-3815-4b59-8ebe-db25d7af68c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_addce0e2-fb3a-434b-955c-e862d14c384a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_92e41938-3815-4b59-8ebe-db25d7af68c8" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_addce0e2-fb3a-434b-955c-e862d14c384a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails" xlink:type="extended" id="ibbd082ce8e6443038d72e2dcc61f3afa_DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_775cc885-e368-4d3a-8295-970e9964eb2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_29601de4-a487-4531-921f-cade3257ad00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_775cc885-e368-4d3a-8295-970e9964eb2b" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_29601de4-a487-4531-921f-cade3257ad00" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebt_9bcc6cbd-bd97-49c6-970e-36c17bdc6319" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnsecuredDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_775cc885-e368-4d3a-8295-970e9964eb2b" xlink:to="loc_us-gaap_UnsecuredDebt_9bcc6cbd-bd97-49c6-970e-36c17bdc6319" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_b5382716-fca7-4df7-bc79-d77c9e5b2c1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_775cc885-e368-4d3a-8295-970e9964eb2b" xlink:to="loc_us-gaap_LongTermDebt_b5382716-fca7-4df7-bc79-d77c9e5b2c1c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermDebt_fd82090b-928e-4bb8-9a79-1cc115d7d693" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_775cc885-e368-4d3a-8295-970e9964eb2b" xlink:to="loc_us-gaap_OtherLongTermDebt_fd82090b-928e-4bb8-9a79-1cc115d7d693" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_6b816e53-e922-4d27-b7a6-2e8bd64aad48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_775cc885-e368-4d3a-8295-970e9964eb2b" xlink:to="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_6b816e53-e922-4d27-b7a6-2e8bd64aad48" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_b1b64b16-19bd-4b8c-894f-e0268463a646" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_775cc885-e368-4d3a-8295-970e9964eb2b" xlink:to="loc_us-gaap_DebtCurrent_b1b64b16-19bd-4b8c-894f-e0268463a646" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_68746295-3ab4-4393-8c01-333499536761" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_775cc885-e368-4d3a-8295-970e9964eb2b" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_68746295-3ab4-4393-8c01-333499536761" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_fe4def78-663b-478e-8fbf-8eac6c7ec1de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_775cc885-e368-4d3a-8295-970e9964eb2b" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_fe4def78-663b-478e-8fbf-8eac6c7ec1de" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_9481e543-92e5-4e4f-a11d-1fd06afb13ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_775cc885-e368-4d3a-8295-970e9964eb2b" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_9481e543-92e5-4e4f-a11d-1fd06afb13ab" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_9eb0f244-8f5d-4263-933d-4567fa6f497e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_775cc885-e368-4d3a-8295-970e9964eb2b" xlink:to="loc_us-gaap_DebtInstrumentFairValue_9eb0f244-8f5d-4263-933d-4567fa6f497e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable_54b326fc-9372-4ed6-b6fb-2c90e92bbcab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_775cc885-e368-4d3a-8295-970e9964eb2b" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTable_54b326fc-9372-4ed6-b6fb-2c90e92bbcab" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_eb1b5e1b-feb5-46dc-a471-c32da9b23f7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_54b326fc-9372-4ed6-b6fb-2c90e92bbcab" xlink:to="loc_us-gaap_DebtInstrumentAxis_eb1b5e1b-feb5-46dc-a471-c32da9b23f7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_eb1b5e1b-feb5-46dc-a471-c32da9b23f7b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_eb1b5e1b-feb5-46dc-a471-c32da9b23f7b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_eb1b5e1b-feb5-46dc-a471-c32da9b23f7b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1a255442-5407-49ab-8556-b10201e2f11b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_eb1b5e1b-feb5-46dc-a471-c32da9b23f7b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1a255442-5407-49ab-8556-b10201e2f11b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotesDueNovember2023Member_2b459f42-7ce0-411d-96bf-0611911eb826" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotesDueNovember2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1a255442-5407-49ab-8556-b10201e2f11b" xlink:to="loc_syk_SeniorUnsecuredNotesDueNovember2023Member_2b459f42-7ce0-411d-96bf-0611911eb826" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes0600Due2023Member_1e1bb398-92ad-4875-ab34-92881bccfe60" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotes0600Due2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1a255442-5407-49ab-8556-b10201e2f11b" xlink:to="loc_syk_SeniorUnsecuredNotes0600Due2023Member_1e1bb398-92ad-4875-ab34-92881bccfe60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes3.375due2024Member_e043acc3-5602-4b52-990e-1f29a08cfc3f" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotes3.375due2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1a255442-5407-49ab-8556-b10201e2f11b" xlink:to="loc_syk_SeniorUnsecuredNotes3.375due2024Member_e043acc3-5602-4b52-990e-1f29a08cfc3f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes0.250due2024Member_bed9f836-35e1-46e4-8b13-f27bb0cfd40a" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotes0.250due2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1a255442-5407-49ab-8556-b10201e2f11b" xlink:to="loc_syk_SeniorUnsecuredNotes0.250due2024Member_bed9f836-35e1-46e4-8b13-f27bb0cfd40a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes1.150Due2025Member_29fa4fb7-8298-4249-aecd-4baa42804be8" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotes1.150Due2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1a255442-5407-49ab-8556-b10201e2f11b" xlink:to="loc_syk_SeniorUnsecuredNotes1.150Due2025Member_29fa4fb7-8298-4249-aecd-4baa42804be8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes3.375due2025MemberMember_c13ac7f9-5664-4bcc-a4cb-718c86102598" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotes3.375due2025MemberMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1a255442-5407-49ab-8556-b10201e2f11b" xlink:to="loc_syk_SeniorUnsecuredNotes3.375due2025MemberMember_c13ac7f9-5664-4bcc-a4cb-718c86102598" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes350Due2026Member_3313012b-1754-4710-a984-c84179ae31c4" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotes350Due2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1a255442-5407-49ab-8556-b10201e2f11b" xlink:to="loc_syk_SeniorUnsecuredNotes350Due2026Member_3313012b-1754-4710-a984-c84179ae31c4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotesDueNovember2027Member_e516ee36-c8bf-48b6-a6d3-7c62ebf6c59e" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotesDueNovember2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1a255442-5407-49ab-8556-b10201e2f11b" xlink:to="loc_syk_SeniorUnsecuredNotesDueNovember2027Member_e516ee36-c8bf-48b6-a6d3-7c62ebf6c59e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes3650Due2028Member_e6ad99e1-c85e-4c41-8bf5-d925f136305a" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotes3650Due2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1a255442-5407-49ab-8556-b10201e2f11b" xlink:to="loc_syk_SeniorUnsecuredNotes3650Due2028Member_e6ad99e1-c85e-4c41-8bf5-d925f136305a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes0.750due2029Member_73987482-45a2-4e32-aa6a-f9e2eea8eedc" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotes0.750due2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1a255442-5407-49ab-8556-b10201e2f11b" xlink:to="loc_syk_SeniorUnsecuredNotes0.750due2029Member_73987482-45a2-4e32-aa6a-f9e2eea8eedc" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes1.950Due2030Member_9c444366-8756-4853-a2af-44615535cefd" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotes1.950Due2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1a255442-5407-49ab-8556-b10201e2f11b" xlink:to="loc_syk_SeniorUnsecuredNotes1.950Due2030Member_9c444366-8756-4853-a2af-44615535cefd" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotesDueNovember2030Member_ecc35f49-9d23-4aa3-8da0-41d99496d0a0" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotesDueNovember2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1a255442-5407-49ab-8556-b10201e2f11b" xlink:to="loc_syk_SeniorUnsecuredNotesDueNovember2030Member_ecc35f49-9d23-4aa3-8da0-41d99496d0a0" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes1.000due2031Member_37737c38-43b3-458a-8873-9c67de96ae5e" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotes1.000due2031Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1a255442-5407-49ab-8556-b10201e2f11b" xlink:to="loc_syk_SeniorUnsecuredNotes1.000due2031Member_37737c38-43b3-458a-8873-9c67de96ae5e" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes410Due2043Member_f8a51842-7230-4ec4-9241-1ee7d6ab75e2" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotes410Due2043Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1a255442-5407-49ab-8556-b10201e2f11b" xlink:to="loc_syk_SeniorUnsecuredNotes410Due2043Member_f8a51842-7230-4ec4-9241-1ee7d6ab75e2" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes4.375due2044Member_366747b3-8322-4357-8c43-75bce8a42b7e" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotes4.375due2044Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1a255442-5407-49ab-8556-b10201e2f11b" xlink:to="loc_syk_SeniorUnsecuredNotes4.375due2044Member_366747b3-8322-4357-8c43-75bce8a42b7e" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes4625Due2046Member_88c7fa5e-2945-4483-bc02-e8cb1c70bf1d" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotes4625Due2046Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1a255442-5407-49ab-8556-b10201e2f11b" xlink:to="loc_syk_SeniorUnsecuredNotes4625Due2046Member_88c7fa5e-2945-4483-bc02-e8cb1c70bf1d" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes2.900due2050Member_c0a6517a-b659-439c-8bd4-2415de1cd25a" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotes2.900due2050Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1a255442-5407-49ab-8556-b10201e2f11b" xlink:to="loc_syk_SeniorUnsecuredNotes2.900due2050Member_c0a6517a-b659-439c-8bd4-2415de1cd25a" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_TermLoanMember_62f9eefd-f07b-46eb-a1c6-5605d1b438df" xlink:href="syk-20221231.xsd#syk_TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1a255442-5407-49ab-8556-b10201e2f11b" xlink:to="loc_syk_TermLoanMember_62f9eefd-f07b-46eb-a1c6-5605d1b438df" xlink:type="arc" order="17"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended" id="i6c028294892448819fb3d5b87baefc88_IncomeTaxesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_2ac295aa-c30b-4a39-8dc8-5ad8180d333d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_2305a833-163c-4eac-8fed-1a2a39f567b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ac295aa-c30b-4a39-8dc8-5ad8180d333d" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_2305a833-163c-4eac-8fed-1a2a39f567b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_39366344-be2a-4053-a3cd-d663754e8389" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ac295aa-c30b-4a39-8dc8-5ad8180d333d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_39366344-be2a-4053-a3cd-d663754e8389" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized_c9618f5c-48a4-432b-8f6c-3fe0043e03d8" xlink:href="syk-20221231.xsd#syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ac295aa-c30b-4a39-8dc8-5ad8180d333d" xlink:to="loc_syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized_c9618f5c-48a4-432b-8f6c-3fe0043e03d8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_f4da0549-fba9-4c4a-9fe6-9d96fe348dca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ac295aa-c30b-4a39-8dc8-5ad8180d333d" xlink:to="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_f4da0549-fba9-4c4a-9fe6-9d96fe348dca" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_b4704b8d-fc2d-45a4-b96b-d0031e22f42c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ac295aa-c30b-4a39-8dc8-5ad8180d333d" xlink:to="loc_us-gaap_OperatingLossCarryforwards_b4704b8d-fc2d-45a4-b96b-d0031e22f42c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OperatingLossCarryforwardsSubjectToValuationAllowance_0456541f-7a5b-416a-841e-0e58d86ce722" xlink:href="syk-20221231.xsd#syk_OperatingLossCarryforwardsSubjectToValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ac295aa-c30b-4a39-8dc8-5ad8180d333d" xlink:to="loc_syk_OperatingLossCarryforwardsSubjectToValuationAllowance_0456541f-7a5b-416a-841e-0e58d86ce722" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_357e574f-b71e-4851-a3d7-c09884d3a585" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ac295aa-c30b-4a39-8dc8-5ad8180d333d" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_357e574f-b71e-4851-a3d7-c09884d3a585" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardValuationAllowance_1401d225-8a19-476e-a2a2-6c70d3e961b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ac295aa-c30b-4a39-8dc8-5ad8180d333d" xlink:to="loc_us-gaap_TaxCreditCarryforwardValuationAllowance_1401d225-8a19-476e-a2a2-6c70d3e961b2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense_12b89bd7-a231-4d20-8e2d-05c44ee312d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ac295aa-c30b-4a39-8dc8-5ad8180d333d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense_12b89bd7-a231-4d20-8e2d-05c44ee312d4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxSettlements_403a25e9-ea7e-4d88-bd24-d666b3eff1e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ac295aa-c30b-4a39-8dc8-5ad8180d333d" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxSettlements_403a25e9-ea7e-4d88-bd24-d666b3eff1e1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_IncomeTaxExpenseBenefitTaxSettlementReleaseOfAccruedInterest_c0d93bd2-9e3e-4d32-9bab-9f2576f931dd" xlink:href="syk-20221231.xsd#syk_IncomeTaxExpenseBenefitTaxSettlementReleaseOfAccruedInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ac295aa-c30b-4a39-8dc8-5ad8180d333d" xlink:to="loc_syk_IncomeTaxExpenseBenefitTaxSettlementReleaseOfAccruedInterest_c0d93bd2-9e3e-4d32-9bab-9f2576f931dd" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_b96da297-fe40-49a3-aab7-b71b4001a6ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ac295aa-c30b-4a39-8dc8-5ad8180d333d" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_b96da297-fe40-49a3-aab7-b71b4001a6ef" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_2f63d964-e5be-42df-be32-ee5ffdf35960" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_b96da297-fe40-49a3-aab7-b71b4001a6ef" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_2f63d964-e5be-42df-be32-ee5ffdf35960" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_2f63d964-e5be-42df-be32-ee5ffdf35960_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_2f63d964-e5be-42df-be32-ee5ffdf35960" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_2f63d964-e5be-42df-be32-ee5ffdf35960_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_f3163672-897e-4b5e-88d9-27507e2e3583" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_2f63d964-e5be-42df-be32-ee5ffdf35960" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_f3163672-897e-4b5e-88d9-27507e2e3583" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_34aa02ac-e091-4a50-b6ad-9adeba29cf7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_f3163672-897e-4b5e-88d9-27507e2e3583" xlink:to="loc_us-gaap_DomesticCountryMember_34aa02ac-e091-4a50-b6ad-9adeba29cf7c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_e02dc7fe-1166-4c42-b590-a7627ec219fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_f3163672-897e-4b5e-88d9-27507e2e3583" xlink:to="loc_us-gaap_ForeignCountryMember_e02dc7fe-1166-4c42-b590-a7627ec219fe" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails" xlink:type="extended" id="iddb1ec24425c4d54baa128eee0ffe3dd_RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_01d09d31-b2e2-4e62-91f3-83ee47c56b6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract_e49b05bb-0c63-43a8-b2fd-6a5430c1e18d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_01d09d31-b2e2-4e62-91f3-83ee47c56b6d" xlink:to="loc_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract_e49b05bb-0c63-43a8-b2fd-6a5430c1e18d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_b439a1c5-579f-495b-b5df-c62e19fc9a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract_e49b05bb-0c63-43a8-b2fd-6a5430c1e18d" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_b439a1c5-579f-495b-b5df-c62e19fc9a7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_f814633b-8a84-4126-a7dd-515126c1f6dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract_e49b05bb-0c63-43a8-b2fd-6a5430c1e18d" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_f814633b-8a84-4126-a7dd-515126c1f6dc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_6d2171ea-20e5-440e-9a20-eebe34aeaf4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract_e49b05bb-0c63-43a8-b2fd-6a5430c1e18d" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_6d2171ea-20e5-440e-9a20-eebe34aeaf4d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_20fc1482-c22d-4dca-9ad3-0577ae422c47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract_e49b05bb-0c63-43a8-b2fd-6a5430c1e18d" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_20fc1482-c22d-4dca-9ad3-0577ae422c47" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_74b93053-63b8-4ea5-8f22-4e20424f648d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract_e49b05bb-0c63-43a8-b2fd-6a5430c1e18d" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_74b93053-63b8-4ea5-8f22-4e20424f648d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_82ff775d-1622-43f7-bcba-b53fe1b514ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract_e49b05bb-0c63-43a8-b2fd-6a5430c1e18d" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_82ff775d-1622-43f7-bcba-b53fe1b514ae" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_85a10890-1746-4c65-a0bb-b81935a1b325" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_01d09d31-b2e2-4e62-91f3-83ee47c56b6d" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_85a10890-1746-4c65-a0bb-b81935a1b325" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_ba25a107-b0bb-495f-ae3f-3564a82cff05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_85a10890-1746-4c65-a0bb-b81935a1b325" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_ba25a107-b0bb-495f-ae3f-3564a82cff05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ba25a107-b0bb-495f-ae3f-3564a82cff05_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ba25a107-b0bb-495f-ae3f-3564a82cff05" xlink:to="loc_us-gaap_EquityComponentDomain_ba25a107-b0bb-495f-ae3f-3564a82cff05_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b411afb4-055f-4106-ac3a-7ddb989a8a5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ba25a107-b0bb-495f-ae3f-3564a82cff05" xlink:to="loc_us-gaap_EquityComponentDomain_b411afb4-055f-4106-ac3a-7ddb989a8a5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember_868f3c2e-ad9f-477e-9d14-caf4ddbf5ce1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b411afb4-055f-4106-ac3a-7ddb989a8a5d" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember_868f3c2e-ad9f-477e-9d14-caf4ddbf5ce1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_75489b62-94cc-4d8a-86f7-6dcf7cfd905f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_85a10890-1746-4c65-a0bb-b81935a1b325" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_75489b62-94cc-4d8a-86f7-6dcf7cfd905f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_75489b62-94cc-4d8a-86f7-6dcf7cfd905f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_75489b62-94cc-4d8a-86f7-6dcf7cfd905f" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_75489b62-94cc-4d8a-86f7-6dcf7cfd905f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_3a77bae8-c777-49b7-a4d1-6f7903b52218" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_75489b62-94cc-4d8a-86f7-6dcf7cfd905f" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_3a77bae8-c777-49b7-a4d1-6f7903b52218" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_AccruedCompensationMember_9a2aa2b7-8b8a-459e-aa76-ee825739297a" xlink:href="syk-20221231.xsd#syk_AccruedCompensationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3a77bae8-c777-49b7-a4d1-6f7903b52218" xlink:to="loc_syk_AccruedCompensationMember_9a2aa2b7-8b8a-459e-aa76-ee825739297a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_458bba65-aa3d-4588-839e-f5263715457e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3a77bae8-c777-49b7-a4d1-6f7903b52218" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_458bba65-aa3d-4588-839e-f5263715457e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_39a5f2cb-60e2-44a1-97f4-69d35f9f20c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3a77bae8-c777-49b7-a4d1-6f7903b52218" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_39a5f2cb-60e2-44a1-97f4-69d35f9f20c5" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RetirementPlansScheduleofTargetandActualAllocationofPlanAssetsDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#RetirementPlansScheduleofTargetandActualAllocationofPlanAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/RetirementPlansScheduleofTargetandActualAllocationofPlanAssetsDetails" xlink:type="extended" id="i585c5ccba25c44448948317cf4d2dcdc_RetirementPlansScheduleofTargetandActualAllocationofPlanAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9a256c46-354f-4de4-9437-59e3a16b5f41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_f1eff15b-dd08-4e9c-a907-efe5229efc6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9a256c46-354f-4de4-9437-59e3a16b5f41" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_f1eff15b-dd08-4e9c-a907-efe5229efc6b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_5f77694d-fa52-41a0-b570-bf19edb582fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9a256c46-354f-4de4-9437-59e3a16b5f41" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_5f77694d-fa52-41a0-b570-bf19edb582fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_bd0d07b7-0c50-41ae-81bc-2239efdac237" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9a256c46-354f-4de4-9437-59e3a16b5f41" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_bd0d07b7-0c50-41ae-81bc-2239efdac237" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_ac1bcbad-6040-484b-8398-4942b52a7146" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_bd0d07b7-0c50-41ae-81bc-2239efdac237" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_ac1bcbad-6040-484b-8398-4942b52a7146" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_ac1bcbad-6040-484b-8398-4942b52a7146_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_ac1bcbad-6040-484b-8398-4942b52a7146" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_ac1bcbad-6040-484b-8398-4942b52a7146_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_e1a154b4-93fc-4ef2-a58b-29c61db86aaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_ac1bcbad-6040-484b-8398-4942b52a7146" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_e1a154b4-93fc-4ef2-a58b-29c61db86aaa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_8144e584-8b59-43c5-8c3f-0fcbe72d50d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_e1a154b4-93fc-4ef2-a58b-29c61db86aaa" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_8144e584-8b59-43c5-8c3f-0fcbe72d50d8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDebtSecurityMember_faf8baa4-13bb-45f4-9e46-12a193541c50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDebtSecurityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_e1a154b4-93fc-4ef2-a58b-29c61db86aaa" xlink:to="loc_us-gaap_DefinedBenefitPlanDebtSecurityMember_faf8baa4-13bb-45f4-9e46-12a193541c50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestmentsMember_63709efa-92c5-42e6-b48b-2072e758454c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_e1a154b4-93fc-4ef2-a58b-29c61db86aaa" xlink:to="loc_us-gaap_OtherLongTermInvestmentsMember_63709efa-92c5-42e6-b48b-2072e758454c" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails" xlink:type="extended" id="i6de4bad262034527802995525197c888_RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2cddab91-cbe2-4b9d-ac9b-2501a2bca224" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_11d06cd7-e852-4578-b77e-de0df9e496e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2cddab91-cbe2-4b9d-ac9b-2501a2bca224" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_11d06cd7-e852-4578-b77e-de0df9e496e6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_898a39cc-a1f8-4ec7-8786-a0ff2bfe0d8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2cddab91-cbe2-4b9d-ac9b-2501a2bca224" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_898a39cc-a1f8-4ec7-8786-a0ff2bfe0d8c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_15424bcf-bb9c-4e4d-88f1-ba4faf2fa674" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_898a39cc-a1f8-4ec7-8786-a0ff2bfe0d8c" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_15424bcf-bb9c-4e4d-88f1-ba4faf2fa674" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_15424bcf-bb9c-4e4d-88f1-ba4faf2fa674_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_15424bcf-bb9c-4e4d-88f1-ba4faf2fa674" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_15424bcf-bb9c-4e4d-88f1-ba4faf2fa674_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_20314b78-e080-4f40-b365-ca2c8139deb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_15424bcf-bb9c-4e4d-88f1-ba4faf2fa674" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_20314b78-e080-4f40-b365-ca2c8139deb2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_fc89d6f9-0990-4ea3-8b47-68c2350f4353" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_20314b78-e080-4f40-b365-ca2c8139deb2" xlink:to="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_fc89d6f9-0990-4ea3-8b47-68c2350f4353" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_cf31c32e-f290-4761-8547-9339b43a6644" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_20314b78-e080-4f40-b365-ca2c8139deb2" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_cf31c32e-f290-4761-8547-9339b43a6644" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_9a4f4837-c792-4942-badc-a565642fa081" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_20314b78-e080-4f40-b365-ca2c8139deb2" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_9a4f4837-c792-4942-badc-a565642fa081" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember_8449bb6a-da76-48f2-8c2b-223c7a9fbb10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_20314b78-e080-4f40-b365-ca2c8139deb2" xlink:to="loc_us-gaap_OtherDebtSecuritiesMember_8449bb6a-da76-48f2-8c2b-223c7a9fbb10" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8912dfb7-a7ed-4f98-9a32-08153f546d4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_898a39cc-a1f8-4ec7-8786-a0ff2bfe0d8c" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8912dfb7-a7ed-4f98-9a32-08153f546d4d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8912dfb7-a7ed-4f98-9a32-08153f546d4d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8912dfb7-a7ed-4f98-9a32-08153f546d4d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8912dfb7-a7ed-4f98-9a32-08153f546d4d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_091db5e1-7a76-4285-9e39-d1dc400921de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8912dfb7-a7ed-4f98-9a32-08153f546d4d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_091db5e1-7a76-4285-9e39-d1dc400921de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_698c8a14-ddcf-4f91-b584-bfab61541282" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_091db5e1-7a76-4285-9e39-d1dc400921de" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_698c8a14-ddcf-4f91-b584-bfab61541282" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_931194c2-d549-4022-891f-10f2e4d7777c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_091db5e1-7a76-4285-9e39-d1dc400921de" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_931194c2-d549-4022-891f-10f2e4d7777c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_13444dc0-eca6-4741-8024-fef052041c6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_091db5e1-7a76-4285-9e39-d1dc400921de" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_13444dc0-eca6-4741-8024-fef052041c6b" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RetirementPlansNarrativeDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#RetirementPlansNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/RetirementPlansNarrativeDetails" xlink:type="extended" id="i46678ea8ebfb4dbbbc41dc395d1fceea_RetirementPlansNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7182dd0f-122e-42e6-8c10-c6565c44e133" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_fc6314bb-e80c-4e45-bfd4-ea3e50912d30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7182dd0f-122e-42e6-8c10-c6565c44e133" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_fc6314bb-e80c-4e45-bfd4-ea3e50912d30" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_a9f51e31-0c4b-450d-bb40-81e1d96a8089" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7182dd0f-122e-42e6-8c10-c6565c44e133" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_a9f51e31-0c4b-450d-bb40-81e1d96a8089" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e1d68ff5-7b90-4391-b025-bbf4d3b9ca06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7182dd0f-122e-42e6-8c10-c6565c44e133" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e1d68ff5-7b90-4391-b025-bbf4d3b9ca06" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a77d0470-a1fa-4abb-a9fc-81444dbd4e08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e1d68ff5-7b90-4391-b025-bbf4d3b9ca06" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a77d0470-a1fa-4abb-a9fc-81444dbd4e08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a77d0470-a1fa-4abb-a9fc-81444dbd4e08_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a77d0470-a1fa-4abb-a9fc-81444dbd4e08" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a77d0470-a1fa-4abb-a9fc-81444dbd4e08_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c670fb9e-0083-4916-b407-6bc04e6521b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a77d0470-a1fa-4abb-a9fc-81444dbd4e08" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c670fb9e-0083-4916-b407-6bc04e6521b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_52f3a54e-07b3-473a-bd8c-86a98ce4f556" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c670fb9e-0083-4916-b407-6bc04e6521b0" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_52f3a54e-07b3-473a-bd8c-86a98ce4f556" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails" xlink:type="extended" id="i34a363155e3f45f8b2ca61cbb44ca825_SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_5fba2ae6-5edc-41cb-ae03-e9c28b691141" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_90e4a657-760b-4f24-8d9b-ee5bce538cf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5fba2ae6-5edc-41cb-ae03-e9c28b691141" xlink:to="loc_us-gaap_NumberOfReportableSegments_90e4a657-760b-4f24-8d9b-ee5bce538cf8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_b33faee8-291c-4f70-af3d-2b7f0692ba74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5fba2ae6-5edc-41cb-ae03-e9c28b691141" xlink:to="loc_us-gaap_Revenues_b33faee8-291c-4f70-af3d-2b7f0692ba74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_46802d23-6265-42c8-96e1-fed084f85b6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5fba2ae6-5edc-41cb-ae03-e9c28b691141" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_46802d23-6265-42c8-96e1-fed084f85b6c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_97731dd0-dd22-4e58-963c-386d0cc243c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5fba2ae6-5edc-41cb-ae03-e9c28b691141" xlink:to="loc_us-gaap_OperatingIncomeLoss_97731dd0-dd22-4e58-963c-386d0cc243c7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_fe9aab4e-80f0-4a4d-8f3a-375ea511dee4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5fba2ae6-5edc-41cb-ae03-e9c28b691141" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_fe9aab4e-80f0-4a4d-8f3a-375ea511dee4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_457838af-58d5-49b9-b42c-f5d705ab579d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5fba2ae6-5edc-41cb-ae03-e9c28b691141" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_457838af-58d5-49b9-b42c-f5d705ab579d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_5e384b6b-8d1a-440c-a13d-496794c58a35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5fba2ae6-5edc-41cb-ae03-e9c28b691141" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_5e384b6b-8d1a-440c-a13d-496794c58a35" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_bbe628b5-4e49-47a6-bdab-21d2fa0e005c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5fba2ae6-5edc-41cb-ae03-e9c28b691141" xlink:to="loc_us-gaap_RestructuringCosts_bbe628b5-4e49-47a6-bdab-21d2fa0e005c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_7a158444-f7b8-49e3-ad2c-021872013f47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5fba2ae6-5edc-41cb-ae03-e9c28b691141" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_7a158444-f7b8-49e3-ad2c-021872013f47" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_MedicalDeviceRegulationsExpense_4c543d91-bd7e-45a7-a490-93e17e654cc7" xlink:href="syk-20221231.xsd#syk_MedicalDeviceRegulationsExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5fba2ae6-5edc-41cb-ae03-e9c28b691141" xlink:to="loc_syk_MedicalDeviceRegulationsExpense_4c543d91-bd7e-45a7-a490-93e17e654cc7" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_RejuvenateABGIIHipRecallCharges_db5beeeb-6fc7-435e-ace4-5cf809ecfd6f" xlink:href="syk-20221231.xsd#syk_RejuvenateABGIIHipRecallCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5fba2ae6-5edc-41cb-ae03-e9c28b691141" xlink:to="loc_syk_RejuvenateABGIIHipRecallCharges_db5beeeb-6fc7-435e-ace4-5cf809ecfd6f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalFees_3ea34dda-9414-461c-922c-ff303ce15bb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LegalFees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5fba2ae6-5edc-41cb-ae03-e9c28b691141" xlink:to="loc_us-gaap_LegalFees_3ea34dda-9414-461c-922c-ff303ce15bb2" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e4b4f582-42ed-4e09-b743-034007086a26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5fba2ae6-5edc-41cb-ae03-e9c28b691141" xlink:to="loc_us-gaap_NetIncomeLoss_e4b4f582-42ed-4e09-b743-034007086a26" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_923dc468-54d7-461c-a102-b8924450b451" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5fba2ae6-5edc-41cb-ae03-e9c28b691141" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_923dc468-54d7-461c-a102-b8924450b451" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_ce997f0c-06e2-42b9-b25f-ee84b20ef369" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_923dc468-54d7-461c-a102-b8924450b451" xlink:to="loc_srt_ConsolidationItemsAxis_ce997f0c-06e2-42b9-b25f-ee84b20ef369" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_ce997f0c-06e2-42b9-b25f-ee84b20ef369_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_ce997f0c-06e2-42b9-b25f-ee84b20ef369" xlink:to="loc_srt_ConsolidationItemsDomain_ce997f0c-06e2-42b9-b25f-ee84b20ef369_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_48ee6452-b586-416d-93bc-9604d5d6bbeb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_ce997f0c-06e2-42b9-b25f-ee84b20ef369" xlink:to="loc_srt_ConsolidationItemsDomain_48ee6452-b586-416d-93bc-9604d5d6bbeb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_a83651d6-6d92-44e7-a5e4-6556d9be3805" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_48ee6452-b586-416d-93bc-9604d5d6bbeb" xlink:to="loc_us-gaap_OperatingSegmentsMember_a83651d6-6d92-44e7-a5e4-6556d9be3805" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_e5745af7-7fbd-4434-ad94-096cf980f44a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_48ee6452-b586-416d-93bc-9604d5d6bbeb" xlink:to="loc_us-gaap_CorporateNonSegmentMember_e5745af7-7fbd-4434-ad94-096cf980f44a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_104118ad-ffdf-4068-ba5c-4bdb7d627552" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_48ee6452-b586-416d-93bc-9604d5d6bbeb" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_104118ad-ffdf-4068-ba5c-4bdb7d627552" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_bbf2f0d7-b166-4c4c-9cd0-274c8f90bec3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_923dc468-54d7-461c-a102-b8924450b451" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_bbf2f0d7-b166-4c4c-9cd0-274c8f90bec3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_bbf2f0d7-b166-4c4c-9cd0-274c8f90bec3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_bbf2f0d7-b166-4c4c-9cd0-274c8f90bec3" xlink:to="loc_us-gaap_SegmentDomain_bbf2f0d7-b166-4c4c-9cd0-274c8f90bec3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_08419ac3-c6e3-4f3f-b50d-beb356e14b48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_bbf2f0d7-b166-4c4c-9cd0-274c8f90bec3" xlink:to="loc_us-gaap_SegmentDomain_08419ac3-c6e3-4f3f-b50d-beb356e14b48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_MedSurgAndNeurotechnologyMember_35703a95-01d8-467a-8558-41664b274b57" xlink:href="syk-20221231.xsd#syk_MedSurgAndNeurotechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_08419ac3-c6e3-4f3f-b50d-beb356e14b48" xlink:to="loc_syk_MedSurgAndNeurotechnologyMember_35703a95-01d8-467a-8558-41664b274b57" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OrthopaedicsAndSpineMember_8800d62d-9bc2-441a-80bf-d70fbe9640fe" xlink:href="syk-20221231.xsd#syk_OrthopaedicsAndSpineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_08419ac3-c6e3-4f3f-b50d-beb356e14b48" xlink:to="loc_syk_OrthopaedicsAndSpineMember_8800d62d-9bc2-441a-80bf-d70fbe9640fe" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/SegmentandGeographicDataSegmentInformationDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#SegmentandGeographicDataSegmentInformationDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/SegmentandGeographicDataSegmentInformationDetails" xlink:type="extended" id="i7bcf2886ca174998a8ca305d3542b206_SegmentandGeographicDataSegmentInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_2687b3eb-3dbc-4d6b-a386-82ece32aa21d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_80fcfad8-5078-476f-bdfd-4c34cddcb65d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2687b3eb-3dbc-4d6b-a386-82ece32aa21d" xlink:to="loc_us-gaap_Assets_80fcfad8-5078-476f-bdfd-4c34cddcb65d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_CapitalExpendituresDuringPeriod_28c80368-e1d4-451b-b8c6-918deef2457b" xlink:href="syk-20221231.xsd#syk_CapitalExpendituresDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2687b3eb-3dbc-4d6b-a386-82ece32aa21d" xlink:to="loc_syk_CapitalExpendituresDuringPeriod_28c80368-e1d4-451b-b8c6-918deef2457b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e72d75d0-a796-4a90-a2df-2a2fd8cde231" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2687b3eb-3dbc-4d6b-a386-82ece32aa21d" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e72d75d0-a796-4a90-a2df-2a2fd8cde231" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_f3fe1c0c-ee59-4b05-9a8d-5a9b4c5ce840" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e72d75d0-a796-4a90-a2df-2a2fd8cde231" xlink:to="loc_srt_ConsolidationItemsAxis_f3fe1c0c-ee59-4b05-9a8d-5a9b4c5ce840" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_f3fe1c0c-ee59-4b05-9a8d-5a9b4c5ce840_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_f3fe1c0c-ee59-4b05-9a8d-5a9b4c5ce840" xlink:to="loc_srt_ConsolidationItemsDomain_f3fe1c0c-ee59-4b05-9a8d-5a9b4c5ce840_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_1597dfb0-4be0-47a6-a954-0bb9a654eb2b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_f3fe1c0c-ee59-4b05-9a8d-5a9b4c5ce840" xlink:to="loc_srt_ConsolidationItemsDomain_1597dfb0-4be0-47a6-a954-0bb9a654eb2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_45a67cae-fb68-46a0-a575-cc1e83519b63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_1597dfb0-4be0-47a6-a954-0bb9a654eb2b" xlink:to="loc_us-gaap_OperatingSegmentsMember_45a67cae-fb68-46a0-a575-cc1e83519b63" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_b3f80bd2-b6d4-4652-bec0-ede0ba41044b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_1597dfb0-4be0-47a6-a954-0bb9a654eb2b" xlink:to="loc_us-gaap_CorporateNonSegmentMember_b3f80bd2-b6d4-4652-bec0-ede0ba41044b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_9f650b07-330f-4d2e-9a83-04d295cb0c59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e72d75d0-a796-4a90-a2df-2a2fd8cde231" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_9f650b07-330f-4d2e-9a83-04d295cb0c59" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9f650b07-330f-4d2e-9a83-04d295cb0c59_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9f650b07-330f-4d2e-9a83-04d295cb0c59" xlink:to="loc_us-gaap_SegmentDomain_9f650b07-330f-4d2e-9a83-04d295cb0c59_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9c644611-4415-42c0-9f14-4d5c0be00a3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9f650b07-330f-4d2e-9a83-04d295cb0c59" xlink:to="loc_us-gaap_SegmentDomain_9c644611-4415-42c0-9f14-4d5c0be00a3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_MedSurgAndNeurotechnologyMember_16578824-4927-4ca1-b6ab-b6245e62654d" xlink:href="syk-20221231.xsd#syk_MedSurgAndNeurotechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9c644611-4415-42c0-9f14-4d5c0be00a3e" xlink:to="loc_syk_MedSurgAndNeurotechnologyMember_16578824-4927-4ca1-b6ab-b6245e62654d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OrthopaedicsAndSpineMember_04944fea-2d02-406d-8fb7-c688c6092389" xlink:href="syk-20221231.xsd#syk_OrthopaedicsAndSpineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9c644611-4415-42c0-9f14-4d5c0be00a3e" xlink:to="loc_syk_OrthopaedicsAndSpineMember_04944fea-2d02-406d-8fb7-c688c6092389" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails" xlink:type="extended" id="i05f3984acc60436f8c893ff4b35fbf6d_SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_e33c39cd-6234-4259-9886-28dd789b200f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_0606bb31-bccd-439a-b896-e76869ddd5ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e33c39cd-6234-4259-9886-28dd789b200f" xlink:to="loc_us-gaap_Revenues_0606bb31-bccd-439a-b896-e76869ddd5ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_ec17789b-5589-4bab-8485-5c61fa092d9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e33c39cd-6234-4259-9886-28dd789b200f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_ec17789b-5589-4bab-8485-5c61fa092d9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_086dae05-3d39-40c2-b546-4c439af7ec1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e33c39cd-6234-4259-9886-28dd789b200f" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_086dae05-3d39-40c2-b546-4c439af7ec1d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_e67b596f-933e-4404-a3a2-2fc72e2cf7a9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_086dae05-3d39-40c2-b546-4c439af7ec1d" xlink:to="loc_srt_StatementGeographicalAxis_e67b596f-933e-4404-a3a2-2fc72e2cf7a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_e67b596f-933e-4404-a3a2-2fc72e2cf7a9_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_e67b596f-933e-4404-a3a2-2fc72e2cf7a9" xlink:to="loc_srt_SegmentGeographicalDomain_e67b596f-933e-4404-a3a2-2fc72e2cf7a9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_e9742c17-70cb-4183-b46a-59cd008a99e4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_e67b596f-933e-4404-a3a2-2fc72e2cf7a9" xlink:to="loc_srt_SegmentGeographicalDomain_e9742c17-70cb-4183-b46a-59cd008a99e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_a95ebbc8-450a-40b4-88a7-b4e41eee144d" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_e9742c17-70cb-4183-b46a-59cd008a99e4" xlink:to="loc_country_US_a95ebbc8-450a-40b4-88a7-b4e41eee144d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_31009a09-22f6-48dd-b744-a18b9f509254" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EMEAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_e9742c17-70cb-4183-b46a-59cd008a99e4" xlink:to="loc_us-gaap_EMEAMember_31009a09-22f6-48dd-b744-a18b9f509254" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_e6b67446-69d8-44a8-ac26-00393fed9a97" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AsiaPacificMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_e9742c17-70cb-4183-b46a-59cd008a99e4" xlink:to="loc_srt_AsiaPacificMember_e6b67446-69d8-44a8-ac26-00393fed9a97" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OtherForeignCountriesMember_2791b905-6432-49c4-9fd8-45d025226582" xlink:href="syk-20221231.xsd#syk_OtherForeignCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_e9742c17-70cb-4183-b46a-59cd008a99e4" xlink:to="loc_syk_OtherForeignCountriesMember_2791b905-6432-49c4-9fd8-45d025226582" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/AssetImpairmentsDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#AssetImpairmentsDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/AssetImpairmentsDetails" xlink:type="extended" id="i39bca689bffa4dd2be34efb1dfc43cab_AssetImpairmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d6edd491-0837-4e7f-8054-951ab71b948e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_b8d3f45f-1f92-4dec-a1c0-cf006e38b093" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d6edd491-0837-4e7f-8054-951ab71b948e" xlink:to="loc_us-gaap_AssetImpairmentCharges_b8d3f45f-1f92-4dec-a1c0-cf006e38b093" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_fb0ed2d7-033f-49c5-b8b7-d7d5d6be22ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d6edd491-0837-4e7f-8054-951ab71b948e" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_fb0ed2d7-033f-49c5-b8b7-d7d5d6be22ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5eaaa658-dc15-4454-9fe6-5b885324f7ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d6edd491-0837-4e7f-8054-951ab71b948e" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5eaaa658-dc15-4454-9fe6-5b885324f7ed" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_b24789bc-de96-4505-8cbe-859b4ebc0270" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5eaaa658-dc15-4454-9fe6-5b885324f7ed" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_b24789bc-de96-4505-8cbe-859b4ebc0270" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_b24789bc-de96-4505-8cbe-859b4ebc0270_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_b24789bc-de96-4505-8cbe-859b4ebc0270" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_b24789bc-de96-4505-8cbe-859b4ebc0270_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_cc349462-d669-4037-a153-de8c93565833" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_b24789bc-de96-4505-8cbe-859b4ebc0270" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_cc349462-d669-4037-a153-de8c93565833" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_ef1dfc99-716c-4023-a9d9-15513c37bbc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_cc349462-d669-4037-a153-de8c93565833" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_ef1dfc99-716c-4023-a9d9-15513c37bbc9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_8445a8be-8adb-4fce-9b9d-26bfc98f5ce3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5eaaa658-dc15-4454-9fe6-5b885324f7ed" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_8445a8be-8adb-4fce-9b9d-26bfc98f5ce3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_8445a8be-8adb-4fce-9b9d-26bfc98f5ce3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_8445a8be-8adb-4fce-9b9d-26bfc98f5ce3" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_8445a8be-8adb-4fce-9b9d-26bfc98f5ce3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_6a20c79a-ca42-4ec2-9bb1-1bd937b431ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_8445a8be-8adb-4fce-9b9d-26bfc98f5ce3" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_6a20c79a-ca42-4ec2-9bb1-1bd937b431ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember_13fa7c0e-444c-4b0b-84d7-c72ce74c6d1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_6a20c79a-ca42-4ec2-9bb1-1bd937b431ae" xlink:to="loc_us-gaap_GeographicConcentrationRiskMember_13fa7c0e-444c-4b0b-84d7-c72ce74c6d1b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_2c8677f6-7358-4cf3-936e-15312c7a972e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5eaaa658-dc15-4454-9fe6-5b885324f7ed" xlink:to="loc_srt_StatementGeographicalAxis_2c8677f6-7358-4cf3-936e-15312c7a972e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_2c8677f6-7358-4cf3-936e-15312c7a972e_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_2c8677f6-7358-4cf3-936e-15312c7a972e" xlink:to="loc_srt_SegmentGeographicalDomain_2c8677f6-7358-4cf3-936e-15312c7a972e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_a6e8018e-97f0-453e-bfc6-5555e6776c0d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_2c8677f6-7358-4cf3-936e-15312c7a972e" xlink:to="loc_srt_SegmentGeographicalDomain_a6e8018e-97f0-453e-bfc6-5555e6776c0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CN_19bb19b6-c335-41e0-b239-9cde63e77f3b" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CN"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a6e8018e-97f0-453e-bfc6-5555e6776c0d" xlink:to="loc_country_CN_19bb19b6-c335-41e0-b239-9cde63e77f3b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_5e7891af-2e1e-4dce-8e9a-6ae8a9ac441f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5eaaa658-dc15-4454-9fe6-5b885324f7ed" xlink:to="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_5e7891af-2e1e-4dce-8e9a-6ae8a9ac441f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_5e7891af-2e1e-4dce-8e9a-6ae8a9ac441f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_5e7891af-2e1e-4dce-8e9a-6ae8a9ac441f" xlink:to="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_5e7891af-2e1e-4dce-8e9a-6ae8a9ac441f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_769195d9-c16f-4720-af9a-1fbbd994de4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_5e7891af-2e1e-4dce-8e9a-6ae8a9ac441f" xlink:to="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_769195d9-c16f-4720-af9a-1fbbd994de4c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_LongLivedAssetsAndIntangibleAssetsMember_dd3e4512-3cea-4f09-92e6-421dcadcab4f" xlink:href="syk-20221231.xsd#syk_LongLivedAssetsAndIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_769195d9-c16f-4720-af9a-1fbbd994de4c" xlink:to="loc_syk_LongLivedAssetsAndIntangibleAssetsMember_dd3e4512-3cea-4f09-92e6-421dcadcab4f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_InProcessRDOtherIntangibleAssetsAndPropertyPlantAndEquipmentMember_f0262deb-4673-42ce-ba5f-dad722003e6f" xlink:href="syk-20221231.xsd#syk_InProcessRDOtherIntangibleAssetsAndPropertyPlantAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_769195d9-c16f-4720-af9a-1fbbd994de4c" xlink:to="loc_syk_InProcessRDOtherIntangibleAssetsAndPropertyPlantAndEquipmentMember_f0262deb-4673-42ce-ba5f-dad722003e6f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/ScheduleIIValuationandQualifyingAccountsDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#ScheduleIIValuationandQualifyingAccountsDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/ScheduleIIValuationandQualifyingAccountsDetails" xlink:type="extended" id="i3d5d37f83a3c40dda849a42aa3d1314d_ScheduleIIValuationandQualifyingAccountsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_b03eabbb-5478-450a-b4dd-ce7d63aef5a1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_346c1083-5695-48e9-837d-82124804804f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_b03eabbb-5478-450a-b4dd-ce7d63aef5a1" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_346c1083-5695-48e9-837d-82124804804f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_9d99e16b-575b-4f5e-a20e-5f9183eca450" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_b03eabbb-5478-450a-b4dd-ce7d63aef5a1" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_9d99e16b-575b-4f5e-a20e-5f9183eca450" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_95cf4cc9-3ba3-4903-a9b0-11fd6c6c9dee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_b03eabbb-5478-450a-b4dd-ce7d63aef5a1" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_95cf4cc9-3ba3-4903-a9b0-11fd6c6c9dee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesAdjustments_04faf5ca-4407-481e-8eb2-f696ae0a7bac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_b03eabbb-5478-450a-b4dd-ce7d63aef5a1" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesAdjustments_04faf5ca-4407-481e-8eb2-f696ae0a7bac" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_0d180333-16c4-40d8-9759-fde81a1b5416" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_8caaf076-bdf5-4142-9ff1-251dcaf75154" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_b03eabbb-5478-450a-b4dd-ce7d63aef5a1" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_8caaf076-bdf5-4142-9ff1-251dcaf75154" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_abbaa9a0-9a51-48a7-9c81-f33751b4325e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_8caaf076-bdf5-4142-9ff1-251dcaf75154" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_abbaa9a0-9a51-48a7-9c81-f33751b4325e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_abbaa9a0-9a51-48a7-9c81-f33751b4325e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_abbaa9a0-9a51-48a7-9c81-f33751b4325e" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_abbaa9a0-9a51-48a7-9c81-f33751b4325e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_9f701060-def0-480f-83c6-84f0d62b63dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_abbaa9a0-9a51-48a7-9c81-f33751b4325e" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_9f701060-def0-480f-83c6-84f0d62b63dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForNotesReceivableMember_2d777d12-d9e0-4eec-8d04-f5d4d67fd244" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForNotesReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_9f701060-def0-480f-83c6-84f0d62b63dd" xlink:to="loc_us-gaap_AllowanceForNotesReceivableMember_2d777d12-d9e0-4eec-8d04-f5d4d67fd244" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="loc_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>16
<FILENAME>syk-20221231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:2349b3b0-68ea-4cbc-845b-39a36087e2b4,g:780e132c-de96-43a0-a8bf-d2cffc0e012a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_GeographicConcentrationRiskMember_1beda7bd-e6a5-4805-9c14-291cba635387_terseLabel_en-US" xlink:label="lab_us-gaap_GeographicConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Concentration Risk</link:label>
    <link:label id="lab_us-gaap_GeographicConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_GeographicConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicConcentrationRiskMember" xlink:to="lab_us-gaap_GeographicConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_d37ad876-cb1c-4c6f-abb0-52288872db74_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_c12a390f-40f8-4fa5-996c-88b416cb197e_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due in one year or less</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_QuarterlyFinancialDataAbstract_10823abd-bd22-40dc-b63b-e2ff1d8b954a_terseLabel_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialDataAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly Financial Data [Abstract]</link:label>
    <link:label id="lab_us-gaap_QuarterlyFinancialDataAbstract_label_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialDataAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly Financial Data [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialDataAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_QuarterlyFinancialDataAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_QuarterlyFinancialDataAbstract" xlink:to="lab_us-gaap_QuarterlyFinancialDataAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4529dfe4-ddca-4dd8-a0d9-3a60dfd51941_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_d21ec439-ec74-46cb-bffc-d6b725d66391_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_31223d61-bda8-432e-8c83-b678196ac7fd_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_2fb1a4c5-1f21-4a1d-aff1-2759877f8e44_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Translation</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_681ab8f8-cf35-4167-90ea-576fcd7d919f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent deferred income tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_001f2067-143a-42e3-bc40-bec0112756a3_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock_6c816e17-0532-45f7-ba1e-7463b237a3ef_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan Disclosures</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanDisclosuresTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock" xlink:to="lab_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh_45188f15-33f2-4581-9223-a16d287618a1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future milestone payments</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Range of Outcomes, Contingent Consideration, Liability, Value, High</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_MedicalMember_c527fc51-c2d1-4eab-ba93-d774488a8387_terseLabel_en-US" xlink:label="lab_syk_MedicalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical</link:label>
    <link:label id="lab_syk_MedicalMember_label_en-US" xlink:label="lab_syk_MedicalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical [Member]</link:label>
    <link:label id="lab_syk_MedicalMember_documentation_en-US" xlink:label="lab_syk_MedicalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_MedicalMember" xlink:href="syk-20221231.xsd#syk_MedicalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_MedicalMember" xlink:to="lab_syk_MedicalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_2f3ff65e-c802-4a32-b4e8-98ba7b8a6a45_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment:</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_8d98dbef-1e8e-4444-8e88-4e8c877e2678_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax expense (benefit):</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_82342812-a98c-4e34-90dc-b10feb93082f_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_c09efd4b-708c-4f72-a34d-0dc3f9980891_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_bded3e32-385b-43ac-9490-cc3290feb1b9_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_551637df-57be-4113-9460-2de351fc881e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_39a0c71d-2083-4ced-b827-b57e7c143046_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax_59096be0-dd94-430d-af0d-d274e9b39e45_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior service cost and transition amount</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_24d6e4a6-25a3-4535-b9b8-9d6edbcbb21e_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_e09b68bf-c2a7-43e4-a725-98cf3cbe4af6_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_50ff8a00-0eac-45dd-a213-6c311fccdf01_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_07f81b25-fc15-4087-8930-6e5b19776b1b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_2a339230-f612-4e1b-8348-0e43674c2a77_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of senior unsecured notes</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyLossInPeriod_91c985e5-4d17-48ad-b971-3f9bf551540a_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyLossInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charges during period</link:label>
    <link:label id="lab_us-gaap_LossContingencyLossInPeriod_label_en-US" xlink:label="lab_us-gaap_LossContingencyLossInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Loss in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyLossInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyLossInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyLossInPeriod" xlink:to="lab_us-gaap_LossContingencyLossInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_d1e4ffb7-7ee7-4072-962b-14df708acae3_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uncollectible Amounts Written Off, Net of Recoveries</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNetAbstract_ea60763c-0509-4872-94d4-5f02cac066ef_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories:</link:label>
    <link:label id="lab_us-gaap_InventoryNetAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNetAbstract" xlink:to="lab_us-gaap_InventoryNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_92f01556-d54b-43ba-a95e-5b7c5f355849_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency exchange forward contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SpineReportingUnitMember_f8e0eab2-cf42-4eb7-905b-ebc0aaaadeec_terseLabel_en-US" xlink:label="lab_syk_SpineReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Spine Reporting Unit</link:label>
    <link:label id="lab_syk_SpineReportingUnitMember_label_en-US" xlink:label="lab_syk_SpineReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Spine Reporting Unit [Member]</link:label>
    <link:label id="lab_syk_SpineReportingUnitMember_documentation_en-US" xlink:label="lab_syk_SpineReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Spine Reporting Unit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SpineReportingUnitMember" xlink:href="syk-20221231.xsd#syk_SpineReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SpineReportingUnitMember" xlink:to="lab_syk_SpineReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ca224519-cc64-4966-8b4d-72a999a90a13_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_c42a74a4-ab86-4e5c-b29d-b1614de3c567_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_1f2266b8-5bec-4dd6-a518-490c6e935f21_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other investing, net</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_f92044e3-8d8a-482b-8627-23d946a2351d_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_d6a6e3e3-63d0-4f2a-a306-90759c48f800_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_fa73c6b2-2247-4ec1-b3f0-c62463a26cf2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_d0707c8d-c804-41e7-8233-9a26d204cdef_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred income tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_4b871400-2016-43a8-8e8d-5e911c1019d4_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average discount rate</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_ff658f0b-4fc3-4e4e-86d1-9a576f1caaf3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stated interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_fe9600ba-9d7c-45c8-b3bf-c28a592a3999_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales of marketable securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_e9455761-2a74-457a-ac76-77acc462ea2f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statute of limitations expirations and other</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentAssetsMember_f3b3537c-04cf-4216-a67a-e5c745a83b1b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentAssetsMember" xlink:to="lab_us-gaap_OtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_88cc4f5e-75a2-48f4-a847-7bc465fedf94_verboseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_b76ddcbc-64d8-4d08-ba6c-0ae7242ffe5c_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic benefit cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_97f6d3c0-6b35-476a-92d5-dc4107fe0a01_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Axis]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_430a2e05-8f40-4223-8b96-bdcfd3fb9c0c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allocation Of The Preliminary Purchase Price To The Acquired Net Assets Of Acquisitions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCountryMember_8bde9474-2af6-4724-9820-a780ecadbc85_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_3cea4cb2-eeb7-42da-860c-202cbbcd5c23_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebt" xlink:to="lab_us-gaap_RepaymentsOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_c0048a3f-8f85-4132-8f3f-873477361eb7_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States state and local</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_ec774545-1dd4-44eb-b8c0-8188b9018f87_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency exchange forward contracts</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contracts, Liability, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:to="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_8c649b16-f06e-4101-986f-5250018d8b6e_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_6445fba0-dac4-47a9-9ddb-ff5a88def5a0_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_583565ef-7de3-4147-976b-e54ea50f4533_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_713e2d24-4db9-444d-8b11-08e1ab99f87e_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_8ea6b971-75c7-4fcc-8b9a-4f9ce88dd5b0_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anti-dilutive shares excluded from calculation of dilutive employee stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_66fefe28-dc8c-48c9-b9c8-d29e49690f97_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsMember" xlink:to="lab_us-gaap_OtherIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_e35b81f8-bc1d-46c8-aa71-37c9edc88e65_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of prior service cost and transition amount</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Prior Service Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_1cf0aa20-2aed-448a-a3bc-85b4b63ec6b2_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Equity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember" xlink:to="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_4b8cc8ca-4e52-433b-a6fa-c6034fdf8d96_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_1765bba3-9033-45f0-a1a9-af0b198a4080_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_33291fbc-6914-43df-87d1-7b8835577ff5_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_e9344610-dd4b-453a-baa5-76df0f81b73a_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_436ccc29-8b37-49ef-8944-c1ea7d69f9fd_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets measured at fair value</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_35f5a1c8-74af-4680-b32b-b4836d897720_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increases related to current year income tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyEstimateOfPossibleLoss_30e1325f-cdbe-4ca1-bca1-5c2a7bc0b018_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of possible loss</link:label>
    <link:label id="lab_us-gaap_LossContingencyEstimateOfPossibleLoss_label_en-US" xlink:label="lab_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Estimate of Possible Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:to="lab_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_dacc7c47-01e1-4f0f-a020-0efc4dd142ed_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unresolved Income Tax Positions</link:label>
    <link:label id="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Income Tax Contingencies [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfIncomeTaxContingenciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:to="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12gTitle_97ef5fc8-84b7-404a-bc0a-cdea2ec5d60b_terseLabel_en-US" xlink:label="lab_dei_Security12gTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(g) Security</link:label>
    <link:label id="lab_dei_Security12gTitle_label_en-US" xlink:label="lab_dei_Security12gTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(g) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12gTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12gTitle" xlink:to="lab_dei_Security12gTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_1ece5f3e-4cc7-47cf-9963-d4a0adb4a0a2_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_b53a0dbf-a753-4674-ae50-07b0b280fb96_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent_183474fe-2cb1-4bf4-944e-475e5cc4b605_terseLabel_en-US" xlink:label="lab_syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intellectual property transfers</link:label>
    <link:label id="lab_syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent_label_en-US" xlink:label="lab_syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Transfer Of Intellectual Property, Percent</link:label>
    <link:label id="lab_syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent_documentation_en-US" xlink:label="lab_syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Transfer Of Intellectual Property, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent" xlink:href="syk-20221231.xsd#syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent" xlink:to="lab_syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_b76a0618-025e-4b75-9718-194ecdb7c3bf_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_896e8cc7-2903-418d-909b-cba8fe3d4e63_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental cash flow disclosure:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c0389791-b7ac-4abc-ad21-81abd435d182_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price, Cancelled or forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_efd44ec4-b040-4ee2-8fa2-972b880db17e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes4625Due2046Member_42d4a719-39a0-4a1b-9c28-d77694be1e4a_terseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes4625Due2046Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 4.625% due 2046</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes4625Due2046Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes4625Due2046Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 4.625% due 2046 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes4625Due2046Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes4625Due2046Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 4.625% due 2046</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes4625Due2046Member" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotes4625Due2046Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes4625Due2046Member" xlink:to="lab_syk_SeniorUnsecuredNotes4625Due2046Member" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes2.625Due2030Member_31901f92-cec0-4e7a-9d10-4c1ba9d8994c_terseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes2.625Due2030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.625% Notes due 2030</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes2.625Due2030Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes2.625Due2030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes, 2.625% Due 2030 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes2.625Due2030Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes2.625Due2030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes, 2.625% Due 2030</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes2.625Due2030Member" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotes2.625Due2030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes2.625Due2030Member" xlink:to="lab_syk_SeniorUnsecuredNotes2.625Due2030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_28f62652-89f8-4a8f-b819-b1dc579e9282_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_ec554d28-f613-40d5-97ca-28d1121ef5fa_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValueOutstanding_e6d9e47b-065d-4481-b96a-a7878d04cc64_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.10 par value</link:label>
    <link:label id="lab_us-gaap_CommonStockValueOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValueOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValueOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValueOutstanding" xlink:to="lab_us-gaap_CommonStockValueOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_bb6acef3-4878-4599-bfc8-d1e6f883234b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_8b72bb64-d411-4393-a3ef-05a13c076789_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Level 1)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_24db962b-b597-418e-b405-3da09617ca3f_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undistributed earnings</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Undistributed Foreign Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes3650Due2028Member_cfd78f02-cb3b-4c6e-abfc-b6462744d0bc_terseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes3650Due2028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 3.650% due 2028</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes3650Due2028Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes3650Due2028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 3.650% due 2028 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes3650Due2028Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes3650Due2028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 3.650% due 2028 [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes3650Due2028Member" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotes3650Due2028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes3650Due2028Member" xlink:to="lab_syk_SeniorUnsecuredNotes3650Due2028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_59d917f1-073f-41c3-b56a-0a691875c0fb_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plans</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_ff13f78f-d75d-484b-b379-e5d960217b1f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_96e8e306-b270-44b1-9184-32a88135f72d_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average remaining contractual term, Options outstanding at December 31 (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_e5cce657-c306-4c4f-92e3-7f1987a48b5e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized prior service credit</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, Prior Service Cost (Credit), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_10d64a25-40df-4d0c-8a7e-3cd7ded59efc_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_944098aa-e3b1-4110-ac36-0146b2dd9e63_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial (gains) losses</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:to="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_f1288749-336e-4a5f-8e50-1d09795935c6_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_ae5ffbcf-6fd9-4af1-9df4-774b5551ec74_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements of income tax audits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_37973545-edb0-4f38-9200-91991702a63e_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCosts_9ee3d4e3-9db7-43e8-ab4e-879ee4d02bdf_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring-related and other charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCosts_label_en-US" xlink:label="lab_us-gaap_RestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCosts" xlink:to="lab_us-gaap_RestructuringCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_22acf2dd-7323-40c7-abd9-3acfbac7442e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liabilities, current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_d05c6378-e55d-47f1-a1d0-075c3ae8d9d2_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency exchange forward contracts</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_7ab0d6b4-9da2-4020-8b09-84081820409e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swap asset</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_PureWickMember_27448397-0321-4b47-ad34-8caae634a808_terseLabel_en-US" xlink:label="lab_syk_PureWickMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PureWick</link:label>
    <link:label id="lab_syk_PureWickMember_label_en-US" xlink:label="lab_syk_PureWickMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PureWick [Member]</link:label>
    <link:label id="lab_syk_PureWickMember_documentation_en-US" xlink:label="lab_syk_PureWickMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PureWick</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_PureWickMember" xlink:href="syk-20221231.xsd#syk_PureWickMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_PureWickMember" xlink:to="lab_syk_PureWickMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_d1be773f-c002-4f95-bb21-ea6166249d2a_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_354c0e6a-89a7-467e-8b65-8085f5cc9462_verboseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-process research and development</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_210ba249-5d08-43cf-98ff-dff7fe7e6444_negatedLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_7bd3f7e1-1198-4c0f-9421-6a000cf11beb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Stock [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_d6e5ad6a-75b5-46f6-a01e-bb995e89b10b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Cancelled or forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_920b2704-370a-4041-9aa1-2baea1e4a438_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDebtSecurityMember_deb94848-f791-4904-ad6f-938388e5cb13_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDebtSecurityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDebtSecurityMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDebtSecurityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Debt Security [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDebtSecurityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDebtSecurityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDebtSecurityMember" xlink:to="lab_us-gaap_DefinedBenefitPlanDebtSecurityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_df9afa2c-a822-4bc1-8a46-bbc2fe193893_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_PerformanceStockUnitPsusMember_e7135bbf-4575-48dd-9296-6690185aa8e4_verboseLabel_en-US" xlink:label="lab_syk_PerformanceStockUnitPsusMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Stock Units (PSUs)</link:label>
    <link:label id="lab_syk_PerformanceStockUnitPsusMember_bd34ec0d-dc4b-44b0-b15e-8f88bf9a40c9_terseLabel_en-US" xlink:label="lab_syk_PerformanceStockUnitPsusMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Stock Units (PSUs)</link:label>
    <link:label id="lab_syk_PerformanceStockUnitPsusMember_label_en-US" xlink:label="lab_syk_PerformanceStockUnitPsusMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Stock Unit (PSUs) [Member]</link:label>
    <link:label id="lab_syk_PerformanceStockUnitPsusMember_documentation_en-US" xlink:label="lab_syk_PerformanceStockUnitPsusMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Stock Unit (PSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_PerformanceStockUnitPsusMember" xlink:href="syk-20221231.xsd#syk_PerformanceStockUnitPsusMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_PerformanceStockUnitPsusMember" xlink:to="lab_syk_PerformanceStockUnitPsusMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_0178f433-2a5f-424e-ad94-5e99e57e2102_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, excluding current maturities</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_464445b4-7f1e-45e6-933d-f9394f3033b8_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear_e1f384d2-7573-492d-b11f-e9bebec998c8_terseLabel_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear_label_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recorded Unconditional Purchase Obligation, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear" xlink:to="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CertificatesOfDepositMember_5662ff0c-5c7b-4e25-9aa1-0f2871561526_terseLabel_en-US" xlink:label="lab_us-gaap_CertificatesOfDepositMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates of deposit</link:label>
    <link:label id="lab_us-gaap_CertificatesOfDepositMember_label_en-US" xlink:label="lab_us-gaap_CertificatesOfDepositMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates of Deposit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CertificatesOfDepositMember" xlink:to="lab_us-gaap_CertificatesOfDepositMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_ee184c74-4e46-42ca-9418-847a0cd8c8c1_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_519484f3-9d7f-455e-946d-1e7097f0c5f0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average remaining lease term (years)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_deab590a-ca0f-4ecd-9ac5-1a946a6ceefc_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_97a406ce-c1e7-4cd1-8dac-d36b20e07653_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_efc29395-b0bf-467c-9bd5-c35dcbe60907_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Expected Benefit Payments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Expected Benefit Payments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract_4b39dffb-412e-4465-8ad4-7da9b1e42a24_terseLabel_en-US" xlink:label="lab_syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustments Out of Accumulated Other Comprehensive Income (AOCI) [Abstract]</link:label>
    <link:label id="lab_syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract_label_en-US" xlink:label="lab_syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustments Out of Accumulated Other Comprehensive Income (AOCI) [Abstract]</link:label>
    <link:label id="lab_syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract_documentation_en-US" xlink:label="lab_syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustments Out of Accumulated Other Comprehensive Income (AOCI) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract" xlink:href="syk-20221231.xsd#syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract" xlink:to="lab_syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock_7bc10dbf-4013-41a5-9841-605685ca4531_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Accumulated Postemployment Benefit Obligations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Projected Benefit Obligations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_A150ConvertibleNotesMember_e448aead-9b00-4990-9be2-d84eda735176_terseLabel_en-US" xlink:label="lab_syk_A150ConvertibleNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.50% Convertible Notes</link:label>
    <link:label id="lab_syk_A150ConvertibleNotesMember_label_en-US" xlink:label="lab_syk_A150ConvertibleNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.50% Convertible Notes [Member]</link:label>
    <link:label id="lab_syk_A150ConvertibleNotesMember_documentation_en-US" xlink:label="lab_syk_A150ConvertibleNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.50% Convertible Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_A150ConvertibleNotesMember" xlink:href="syk-20221231.xsd#syk_A150ConvertibleNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_A150ConvertibleNotesMember" xlink:to="lab_syk_A150ConvertibleNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_b869bb86-b606-42be-9bdc-a2e684ca8c1c_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6c3e6840-9678-48a8-bd2e-71bf32f251ab_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_0daad04d-c822-4c28-86bf-9a523bda5af0_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue_e7977bd2-5cc6-4f33-b421-dd519c796466_terseLabel_en-US" xlink:label="lab_syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares vested during the period</link:label>
    <link:label id="lab_syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue_label_en-US" xlink:label="lab_syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Fair Value</link:label>
    <link:label id="lab_syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue_documentation_en-US" xlink:label="lab_syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue" xlink:href="syk-20221231.xsd#syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue" xlink:to="lab_syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_4e104d70-1ed6-4f9f-9452-357d89c1ed37_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_591eceee-7ec3-436b-bcc4-50c735c6d4c4_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale marketable securities:</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_421c2a79-1cca-44d1-b9a2-36d8384727a1_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current income tax expense (benefit):</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_81582dfc-649a-407f-bc3d-f7478a9f3739_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:to="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_3d94b21b-94fe-45db-8aa1-facd1e95a32c_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_6bbeabda-64d2-44d2-bca3-98aacb02d1cd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise&#160;Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_f6d3b00b-e0f5-498b-aa3c-3db4e2624024_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SOFR</link:label>
    <link:label id="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_label_en-US" xlink:label="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:to="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_bf597c12-f0a0-4210-a60d-5f3f773ffad4_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment useful life</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_4873482a-b429-40c5-8d6d-e7589416a9b8_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_b7af26ff-2be5-4f19-97a0-8ffeaf953d6a_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Net Periodic Pension Cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_6952f75d-345c-468f-b2c4-77eb817fb840_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_1a40efaf-e8d6-4b4f-a82d-2a08b90d5439_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6ec1d9f8-b1cc-4cf4-9190-f31ab8166f5d_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_OperatingLossCarryforwardsSubjectToValuationAllowance_4812da2d-a0bd-42a4-8127-990b4d5da158_terseLabel_en-US" xlink:label="lab_syk_OperatingLossCarryforwardsSubjectToValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards, subject to full valuation allowance</link:label>
    <link:label id="lab_syk_OperatingLossCarryforwardsSubjectToValuationAllowance_label_en-US" xlink:label="lab_syk_OperatingLossCarryforwardsSubjectToValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards, Subject to Valuation Allowance</link:label>
    <link:label id="lab_syk_OperatingLossCarryforwardsSubjectToValuationAllowance_documentation_en-US" xlink:label="lab_syk_OperatingLossCarryforwardsSubjectToValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards, Subject to Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OperatingLossCarryforwardsSubjectToValuationAllowance" xlink:href="syk-20221231.xsd#syk_OperatingLossCarryforwardsSubjectToValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_OperatingLossCarryforwardsSubjectToValuationAllowance" xlink:to="lab_syk_OperatingLossCarryforwardsSubjectToValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_80d5be07-dd19-4cab-8c39-354645822d25_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant date fair value, Outstanding at January 1 (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_ab3a7fa2-8543-4b0c-81eb-305832a62fa8_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant date fair value, Outstanding at December 31 (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_57d4d216-593d-40b4-8846-44013b0f719e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_b50bd505-cb49-4cf3-a0ba-b14ced1688ca_verboseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_fc19163f-b735-474e-b017-cf88344e05a4_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt And Credit Facilities</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_5fe09605-da5a-4f48-a0e5-37a1a86adbf7_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_2d6e62de-3e45-4fd1-addf-3d64af24a9e0_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_374f7103-5647-4a96-b6e9-61ca62e91b5f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax (benefit) expense</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_cb3d2eb2-0e3a-4e85-aa87-73d9b37d1de0_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_1863d6f8-e73d-4549-bc67-230f007ffa52_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_0637e8ac-fea0-4095-b027-01ded217d838_periodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning fair value of plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_e373791f-e9d2-4877-932e-4b3ee73f13b3_periodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending fair value of plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets for Plan Benefits, Defined Benefit Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:to="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_40bdc583-7921-4570-ad0b-d2d0b632304f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decreases related to prior year income tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_e8194d19-2438-489a-8080-ad0803b0dce4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Allocation of Plan Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Allocation of Plan Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_9591bb70-77a9-4a3c-b23f-29e8faff8360_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_829cc4c4-80a7-49a3-8596-dce56c499021_terseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed technology</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_642d5ce1-6143-48d1-b138-f07cac1f11c2_verboseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed technologies</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_label_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:to="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_db774bbc-8772-40cc-997d-d0d2f4d79ab6_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_3aa73186-52ca-4ea4-bcc3-0ab0198a6e0e_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_b1c95692-29d0-48c8-b7bd-c357119752b9_terseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax liabilities:</link:label>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Deferred Tax Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_ff854a8f-6e9f-4a15-94a8-d533f329c0da_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_f6dadb2e-74fd-4b31-a17c-d65c340f95eb_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_0a36acdf-dcef-4c86-aafa-97465c1150c2_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_3f114322-973c-4931-90f5-b6246195573a_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Contract Liabilities</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_ef90eb39-0ee6-46a6-919e-58e3fbd24a7f_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock_1b462bea-d2d1-48ea-989c-db5aa9bee9fd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Costs of Retirement Plans</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Costs of Retirement Plans [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_7bccd3ea-df96-4dc9-bd73-a89aa5d55cab_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_a86773fd-1f37-4178-8912-a13a6a2bf37b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_e42e5d37-3442-439e-bca1-4b9bd766cb62_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_10397193-e7ea-47dc-a4db-ffbeb8cba95d_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_AssetImpairmentsOtherThanGoodwillImpairment_a4b06c4f-f54e-4020-b683-09a0437a10d5_terseLabel_en-US" xlink:label="lab_syk_AssetImpairmentsOtherThanGoodwillImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset impairments</link:label>
    <link:label id="lab_syk_AssetImpairmentsOtherThanGoodwillImpairment_label_en-US" xlink:label="lab_syk_AssetImpairmentsOtherThanGoodwillImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairments, Other Than Goodwill Impairment</link:label>
    <link:label id="lab_syk_AssetImpairmentsOtherThanGoodwillImpairment_documentation_en-US" xlink:label="lab_syk_AssetImpairmentsOtherThanGoodwillImpairment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairments, Other Than Goodwill Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_AssetImpairmentsOtherThanGoodwillImpairment" xlink:href="syk-20221231.xsd#syk_AssetImpairmentsOtherThanGoodwillImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_AssetImpairmentsOtherThanGoodwillImpairment" xlink:to="lab_syk_AssetImpairmentsOtherThanGoodwillImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_a260aa14-8949-4838-b5e0-4de3a8937030_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings per share of common stock:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_d7ee2c14-976b-4a1b-812f-401b02255b05_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock_17ae372a-6fd3-449d-a82f-109035e30fd1_terseLabel_en-US" xlink:label="lab_syk_GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Intangibles and Long-Lived Asset Impairment Tests</link:label>
    <link:label id="lab_syk_GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_syk_GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Long-Lived Assets Impairment Tests Policy [Policy Text Block]</link:label>
    <link:label id="lab_syk_GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_syk_GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Long-Lived Assets Impairment Tests Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock" xlink:href="syk-20221231.xsd#syk_GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock" xlink:to="lab_syk_GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_4a68d990-60f3-47b6-93d2-3a89bb57d39d_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Employer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:to="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_4c3610a3-8f40-4066-b1ae-60cc1f40c6bc_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swap</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_BusinessCombinationConsiderationTransferredIncludingConvertibleNotes_66f478c7-4123-4f41-a396-85c05a4ac45b_terseLabel_en-US" xlink:label="lab_syk_BusinessCombinationConsiderationTransferredIncludingConvertibleNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price of acquisitions, including convertible notes</link:label>
    <link:label id="lab_syk_BusinessCombinationConsiderationTransferredIncludingConvertibleNotes_label_en-US" xlink:label="lab_syk_BusinessCombinationConsiderationTransferredIncludingConvertibleNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Including Convertible Notes</link:label>
    <link:label id="lab_syk_BusinessCombinationConsiderationTransferredIncludingConvertibleNotes_documentation_en-US" xlink:label="lab_syk_BusinessCombinationConsiderationTransferredIncludingConvertibleNotes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Including Convertible Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_BusinessCombinationConsiderationTransferredIncludingConvertibleNotes" xlink:href="syk-20221231.xsd#syk_BusinessCombinationConsiderationTransferredIncludingConvertibleNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_BusinessCombinationConsiderationTransferredIncludingConvertibleNotes" xlink:to="lab_syk_BusinessCombinationConsiderationTransferredIncludingConvertibleNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_228760b7-1610-4298-9669-b64ff95e4900_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price, Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_094b6d6c-62c4-4ee2-aed3-dd5b640e2b15_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_e586174c-cc08-4ba2-88df-d676707747a5_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_22f984bd-f9e6-4350-a557-e95cdfe0ddac_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, debt</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAbstract_fb9cb3b8-dfcc-4cf8-bd7d-6852864705c6_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Unclassified [Abstract]</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAbstract_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Unclassified [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAbstract" xlink:to="lab_us-gaap_LongTermDebtAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_32b7b259-c5ce-4088-890d-f0986775c9c1_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_010a002c-5f5b-43b1-9d79-cf2a8e6f8f97_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate and asset-backed debt securities</link:label>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-Backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetBackedSecuritiesMember" xlink:to="lab_us-gaap_AssetBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_34a2da7a-75ae-42a4-ab31-86962ce82ca9_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5eeee3b0-7c41-48b6-924e-50b87ebbe5ab_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9f62b19e-73fd-4d8b-8f53-ca58bb91e3f4_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (loss) before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_dd3fa4ff-df25-4e51-9b76-108321f102cb_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign income tax at rates other than 21%</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_2e55905b-15f6-424a-a644-70285f7b13c4_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_5ee0b783-0761-4cf5-8b8c-9b1e4b95d21a_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_38e6bb6a-b0be-4405-a031-056a9b0ae330_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_026b2e0b-b30d-4a8a-a9da-723e13cc6ddd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_394a1c0b-a541-47ae-bb2f-cd6edc98a5a2_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_51e5179f-b09f-47d7-9f05-95d06f42d411_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other noncurrent liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_50b88005-93ba-4a8f-8e57-7ff400784081_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value Assumptions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_b8478830-d542-4828-8f3a-426fcd5ae2d3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_3e63c70d-675f-4128-946e-e98112aacbef_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_13470b56-5ecb-4cee-9ae6-4d35c4c33d76_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Provision for Income Taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_6c3f0ce1-5afc-4fbe-8263-7cb8d9fdfb0c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dbb2273f-bd8e-4109-a072-03c397f654e3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Award [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_16b19f7d-b0bf-479b-b2a1-4f4f4dd5e079_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation cost not yet recognized, period for recognized</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_b23b84b4-3cc8-4911-9363-9a3bafe3eade_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average remaining contractual term, Exercisable at December 31 (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_87c5e2c1-c025-4bcc-bdd5-3cc256f2c30e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyTable" xlink:to="lab_us-gaap_IncomeTaxContingencyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_abf854a7-46d8-4807-800c-859e5ce24ff7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of the Company's Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_f7c01242-1af6-4bb4-be7d-9414de819ef5_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:to="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductLiabilityAccrualPeriodExpense_8a75ae7a-2bec-4c76-9cc8-d0bf4ecaa84b_terseLabel_en-US" xlink:label="lab_us-gaap_ProductLiabilityAccrualPeriodExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recall charges, net</link:label>
    <link:label id="lab_us-gaap_ProductLiabilityAccrualPeriodExpense_label_en-US" xlink:label="lab_us-gaap_ProductLiabilityAccrualPeriodExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability Accrual, Period Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityAccrualPeriodExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductLiabilityAccrualPeriodExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductLiabilityAccrualPeriodExpense" xlink:to="lab_us-gaap_ProductLiabilityAccrualPeriodExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_NeuroCranialMember_da72d496-41c9-43c1-84ee-689fd4b0a157_terseLabel_en-US" xlink:label="lab_syk_NeuroCranialMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Neuro Cranial</link:label>
    <link:label id="lab_syk_NeuroCranialMember_label_en-US" xlink:label="lab_syk_NeuroCranialMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Neuro Cranial [Member]</link:label>
    <link:label id="lab_syk_NeuroCranialMember_documentation_en-US" xlink:label="lab_syk_NeuroCranialMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Neuro Cranial</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_NeuroCranialMember" xlink:href="syk-20221231.xsd#syk_NeuroCranialMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_NeuroCranialMember" xlink:to="lab_syk_NeuroCranialMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_c5c8244b-a78d-40a8-b3fa-663a42258284_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_d6bdbb06-af4d-496b-8002-59ab3c6879c9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradingSecuritiesDebt_dc777437-7858-4886-89f4-c2ccd668ad78_terseLabel_en-US" xlink:label="lab_us-gaap_TradingSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading marketable securities</link:label>
    <link:label id="lab_us-gaap_TradingSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_TradingSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecuritiesDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradingSecuritiesDebt" xlink:to="lab_us-gaap_TradingSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_a16d034a-3eaa-4b97-8fb3-c085e69a3605_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_30fdbc7e-9eca-44ef-8801-3b72a939ad9a_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_label_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentHedgingMember" xlink:to="lab_us-gaap_NetInvestmentHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_b1353e65-8b96-4b32-9f08-dbdd4c786948_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_5fc5414b-54a8-449b-93ae-daa1f350310d_terseLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_6012a9d1-8082-4a9e-a5ff-9e94b120b12d_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_292d31d3-d965-48e9-8f62-9d2950d43e91_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_OtherIncomeexpenseMember_55464483-0f58-4331-adb9-66473f04db25_terseLabel_en-US" xlink:label="lab_syk_OtherIncomeexpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_syk_OtherIncomeexpenseMember_12f3c414-87bf-453f-9184-1e71c45f8cc9_verboseLabel_en-US" xlink:label="lab_syk_OtherIncomeexpenseMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income) expense, net</link:label>
    <link:label id="lab_syk_OtherIncomeexpenseMember_label_en-US" xlink:label="lab_syk_OtherIncomeexpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income (expense) [Member]</link:label>
    <link:label id="lab_syk_OtherIncomeexpenseMember_documentation_en-US" xlink:label="lab_syk_OtherIncomeexpenseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income (expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OtherIncomeexpenseMember" xlink:href="syk-20221231.xsd#syk_OtherIncomeexpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_OtherIncomeexpenseMember" xlink:to="lab_syk_OtherIncomeexpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_country_CN_a3c230d0-1ea9-4feb-8008-d8ea6a612ff2_terseLabel_en-US" xlink:label="lab_country_CN" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CHINA</link:label>
    <link:label id="lab_country_CN_label_en-US" xlink:label="lab_country_CN" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CHINA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_CN" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CN"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CN" xlink:to="lab_country_CN" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_b3fa285d-1dc4-4ada-932e-b3e050a375a8_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued expenses</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent_cfe2ed93-aa22-4374-bccc-35d2d9580a99_terseLabel_en-US" xlink:label="lab_syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax related to repatriation of foreign earnings</link:label>
    <link:label id="lab_syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent_label_en-US" xlink:label="lab_syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Earnings Repatriation, Percent</link:label>
    <link:label id="lab_syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent_documentation_en-US" xlink:label="lab_syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Earnings Repatriation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent" xlink:href="syk-20221231.xsd#syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent" xlink:to="lab_syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_aaeacc19-bce2-49f1-a61c-c39932850043_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_5e0e117a-4ac6-45c9-a6b2-b95456e5e085_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_8559ce14-5ab8-483f-b797-bedea8c91fce_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised during period, exercise price range, upper range limit</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PatentsMember_f6c3651b-0bce-4972-85c8-d34ab5e94657_terseLabel_en-US" xlink:label="lab_us-gaap_PatentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents</link:label>
    <link:label id="lab_us-gaap_PatentsMember_label_en-US" xlink:label="lab_us-gaap_PatentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PatentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PatentsMember" xlink:to="lab_us-gaap_PatentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_98d0289c-98a9-47ec-b4b8-add63dcba1eb_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Statement Translation</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_8d2ecccb-2d80-4492-9217-e07caef80ef7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits paid</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_59b73e02-a13c-4383-9922-761f4ead8f25_verboseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_TermLoanMember_a913a947-73a6-49cb-b07a-bb0ab8c06530_terseLabel_en-US" xlink:label="lab_syk_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan</link:label>
    <link:label id="lab_syk_TermLoanMember_label_en-US" xlink:label="lab_syk_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan [Member]</link:label>
    <link:label id="lab_syk_TermLoanMember_documentation_en-US" xlink:label="lab_syk_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_TermLoanMember" xlink:href="syk-20221231.xsd#syk_TermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_TermLoanMember" xlink:to="lab_syk_TermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_a451d430-3031-4685-905d-9ba92a4fbe34_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_4e3b5093-7907-4fbc-a6ef-56e7afc93c9b_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plans</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EMEAMember_f053c0c4-b8c6-487e-8e81-5712e3f13eda_terseLabel_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe, Middle East, Africa</link:label>
    <link:label id="lab_us-gaap_EMEAMember_label_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMEA [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EMEAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EMEAMember" xlink:to="lab_us-gaap_EMEAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_4df49bcc-f6ae-42ac-b537-762574bbdf83_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedges</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:to="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_dffcdf63-eae6-4363-8e8e-f75d74175140_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum lease payments</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_dd330b18-f011-4f21-b573-7cb79c04fee0_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total shareholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9f4e30d4-b2f3-4019-9f82-fdd93fc9a280_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_7cce6719-ed3f-465d-8c34-56b4038bf0c0_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_e65ef425-af04-4013-9470-084b33cc16a8_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange impact</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_4272deec-b34b-4b8f-9790-1565bfe0fea4_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss and other credit carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_63eb107c-3935-430e-9d1b-9a445034215b_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_Changeinaccrualforrecallexpenses_f1d891b7-65b0-4f7c-9c60-bb197331eeb6_terseLabel_en-US" xlink:label="lab_syk_Changeinaccrualforrecallexpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recall-related payments</link:label>
    <link:label id="lab_syk_Changeinaccrualforrecallexpenses_label_en-US" xlink:label="lab_syk_Changeinaccrualforrecallexpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in accrual for recall expenses</link:label>
    <link:label id="lab_syk_Changeinaccrualforrecallexpenses_documentation_en-US" xlink:label="lab_syk_Changeinaccrualforrecallexpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in accrual for recall expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_Changeinaccrualforrecallexpenses" xlink:href="syk-20221231.xsd#syk_Changeinaccrualforrecallexpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_Changeinaccrualforrecallexpenses" xlink:to="lab_syk_Changeinaccrualforrecallexpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_4465415b-67c9-473e-bdfb-084bbbc88d51_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028-2032</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_DeferredTaxLiabilitiesDepreciationAndAmortization_4208ccf7-3564-4c94-a65d-b4d2f42b2fb0_negatedTerseLabel_en-US" xlink:label="lab_syk_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_syk_DeferredTaxLiabilitiesDepreciationAndAmortization_label_en-US" xlink:label="lab_syk_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities Depreciation And Amortization</link:label>
    <link:label id="lab_syk_DeferredTaxLiabilitiesDepreciationAndAmortization_documentation_en-US" xlink:label="lab_syk_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities Depreciation And Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:href="syk-20221231.xsd#syk_DeferredTaxLiabilitiesDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:to="lab_syk_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_8bc49b17-612d-4291-8e50-698d3f4e5637_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_9a07b287-1825-4a06-af5d-039e33469f89_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_7b542926-76e1-4c74-a2bb-d7fc5ccf788c_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_3e20955d-f257-4a46-aae1-928271b261cc_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract_3d66a174-ed65-4582-9fee-c6a942ba5e2e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Information about Plan Assets [Abstract]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Information about Plan Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_1c537638-091a-4ecf-9412-fd805fa8ea77_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss) before Reclassifications, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_f2138697-09f1-4a69-88ee-cfd8ee76ace9_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_999f0e13-ab9f-4cc7-9e2f-2deae042fa68_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4e5a8703-5cc1-47ea-a2be-942ef65d12f4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_4463ddfa-2bf9-40f9-a921-6cc73c6c79cd_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_9453f2bd-0aeb-45a6-be15-0f3e9eed22e0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_01f815f9-b25c-4207-b70a-cbae967a7d14_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_c44623c1-fe3d-46b0-8cc7-e311a6c1af6b_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_0e1e0788-24a3-4869-8a2e-1e89fa4c095f_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_b39a1049-a2c2-45a9-9e46-bd057a2c7f38_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Trade, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableTradeCurrent" xlink:to="lab_us-gaap_AccountsPayableTradeCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_1fe3169a-fda7-4b52-a9b3-e8210fe56c52_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_2fac42db-9481-470d-a93d-5b897850d53f_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_8b5c0bd8-7d16-453c-8cdc-6ff3416fba6a_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research, development and engineering expenses</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_e9893c19-cb76-4fbb-9982-2c64fd6f399c_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increases related to prior year income tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_dd89f845-62a8-4083-8828-e0b692f11244_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_43d527ba-04ae-4d93-b429-35391588d403_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_522ef7b6-0d2e-417e-af0f-474f97d0c0b1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_b718d760-e1dd-4a18-8237-aa981abfe18c_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs)</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_94aa3a5c-3fed-4e61-9320-619fb01e47e1_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs)</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInformationLineItems_1d5938dc-0996-47c4-ae03-91af8986da3f_terseLabel_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:label id="lab_dei_EntityInformationLineItems_label_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationLineItems" xlink:to="lab_dei_EntityInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e3c2e62d-bba2-43e3-bca3-c382679e00aa_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax, percent</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_f089c6dc-0891-4646-84b1-111f0d3ab41b_totalLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_9058fc5c-4bc5-4fc2-9397-f64f7292bfa9_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_5973a957-6c30-4de5-8850-fe0e7f23476e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated future employer contributions in next fiscal year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_abc84048-a3c6-4cdc-ab53-d0d24abb2d0f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Options expected to vest (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_b2fb7273-1f60-41ee-983a-7113d7bb64d5_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_15520080-f0a2-4626-a810-c15fba2044b3_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale marketable securities</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_36aa73ae-4ea1-4aec-8920-a3ebe9691154_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_d877843e-4d67-4592-bc3e-ba1ae380302b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Fair Value of Plan Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Fair Value of Plan Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRefundLiabilityCurrent_4c3c9717-641c-41fd-9fcc-0373e67d73a0_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRefundLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued product liabilities</link:label>
    <link:label id="lab_us-gaap_CustomerRefundLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_CustomerRefundLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Refund Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRefundLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRefundLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRefundLiabilityCurrent" xlink:to="lab_us-gaap_CustomerRefundLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_f1d1a9ec-a6b3-422b-8491-4c0e58d9f816_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Curtailment gain</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_74667257-dec7-4e9c-a5ad-d01d9e07cbe6_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price, net of cash acquired of $281</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_235ce764-d9d7-47b3-9367-d2e888f9e1be_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_692827e1-1e5a-4040-8e47-222b03b33527_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_9566fc28-2894-451f-bd04-990ddfc207c3_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk (as a percent)</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_413f42a8-36d5-40dc-b175-c0cd41805d2b_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_4eaffbd6-fd56-42ca-9790-9e5a6e0bd5c7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_27fd11b3-365f-4a49-a219-3444af500966_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction of contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_3d012142-02eb-445f-8c6b-45108e890290_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment operating income</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_5935c42b-d0aa-4c1c-9edc-ef786a0922ac_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States state and local</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_5054f046-b6e8-48d8-ba3d-f43c3850f462_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_fe3e9320-518b-4325-806b-1dd0d22374e2_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Cash and Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_733d5d3b-9a96-4162-a6c4-1d4f4fb1dda5_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_3d666b08-ea34-43df-a877-b0b2ff3b7049_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_7aee8f76-64ec-43f1-827b-da50d4e0852c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_2c9a74a6-7d18-4d56-b966-b82ac887b0bc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in the Net Carrying Amount of Goodwill by Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_fb206594-d206-4a82-9427-7d55cd352516_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for interest on debt</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_931144a7-312b-45db-8a05-7aeb59fe9161_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net earnings per share of common stock (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_06883577-8727-4497-ab97-0923ed74d103_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_a34dc443-811c-4043-be51-56eee99eb464_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount_8d4a6f61-8ec2-4515-b7f5-acef8b1204a8_totalLabel_en-US" xlink:label="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt</link:label>
    <link:label id="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount_label_en-US" xlink:label="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Long-Term and Short-Term, Combined Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:to="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_A050ConvertibleNotesMember_ccc531dc-29d7-481c-a54a-244972bdd227_terseLabel_en-US" xlink:label="lab_syk_A050ConvertibleNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.50% Convertible Notes</link:label>
    <link:label id="lab_syk_A050ConvertibleNotesMember_label_en-US" xlink:label="lab_syk_A050ConvertibleNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.50% Convertible Notes [Member]</link:label>
    <link:label id="lab_syk_A050ConvertibleNotesMember_documentation_en-US" xlink:label="lab_syk_A050ConvertibleNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.50% Convertible Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_A050ConvertibleNotesMember" xlink:href="syk-20221231.xsd#syk_A050ConvertibleNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_A050ConvertibleNotesMember" xlink:to="lab_syk_A050ConvertibleNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_19e9f91a-c0bc-45ef-bdcc-22cf09ac1eef_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_96d35269-649c-4062-ac31-85219bd1d01b_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plans</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes410Due2043Member_01e9a54e-01d0-4771-87fd-d1857bb017c0_verboseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes410Due2043Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 4.10% due 2043</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes410Due2043Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes410Due2043Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 4.10% due 2043 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes410Due2043Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes410Due2043Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 4.10% due 2043 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes410Due2043Member" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotes410Due2043Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes410Due2043Member" xlink:to="lab_syk_SeniorUnsecuredNotes410Due2043Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_5c60c8bd-1f0f-4186-a583-02cd73942f4e_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_d9be00bf-665a-46ea-a5de-4f45c00a0521_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract_26b2583e-67c8-40c5-8923-a1102856bd7b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used in Calculations [Abstract]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used in Calculations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany_1f058d32-f9c9-4aeb-9431-16043d8a1cdd_terseLabel_en-US" xlink:label="lab_syk_TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stryker common stock held by plan, value as a percentage of total plan assets</link:label>
    <link:label id="lab_syk_TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany_label_en-US" xlink:label="lab_syk_TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Percentage of Defined Contribution Retirement Plan Assets Value Held by Company</link:label>
    <link:label id="lab_syk_TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany_documentation_en-US" xlink:label="lab_syk_TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Percentage of Defined Contribution Retirement Plan Assets Value Held by Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany" xlink:href="syk-20221231.xsd#syk_TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany" xlink:to="lab_syk_TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_3ff26bd7-b51b-4bcb-949c-d25bb9bec764_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_ae237304-e3e3-483d-a800-89f6ba31dc83_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseCurrent" xlink:to="lab_us-gaap_PrepaidExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_83fb88b8-14f8-4ae1-b16a-1f79164e1db6_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax credit carryforward, amount</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:to="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_PercentageofServiceRevenueRecognizeoverTime_4b63e976-6620-4135-bfc6-87868935b73e_terseLabel_en-US" xlink:label="lab_syk_PercentageofServiceRevenueRecognizeoverTime" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of sales recognized as services over time (less than)</link:label>
    <link:label id="lab_syk_PercentageofServiceRevenueRecognizeoverTime_label_en-US" xlink:label="lab_syk_PercentageofServiceRevenueRecognizeoverTime" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of Service Revenue Recognize over Time</link:label>
    <link:label id="lab_syk_PercentageofServiceRevenueRecognizeoverTime_documentation_en-US" xlink:label="lab_syk_PercentageofServiceRevenueRecognizeoverTime" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of Service Revenue Recognize over Time</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_PercentageofServiceRevenueRecognizeoverTime" xlink:href="syk-20221231.xsd#syk_PercentageofServiceRevenueRecognizeoverTime"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_PercentageofServiceRevenueRecognizeoverTime" xlink:to="lab_syk_PercentageofServiceRevenueRecognizeoverTime" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_bf7306a5-66ae-428b-89c2-5a74bb3cfbc9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant date fair value, Cancelled (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_e779c693-1a7b-4acb-9885-52b4ee99b057_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_999107b6-b9a1-48fd-a7e6-e4cfebb381a3_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_9fc2891d-d543-423f-8564-3bd2696496e8_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_5fe045a0-1b52-4e74-bf9c-6b6317cf97b8_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_73888e4d-a01e-48a1-a1b5-2e81c135c30e_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a65909b9-bcc2-4b09-95bd-335c07a1ba1a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_DeferredTaxAssetsResearchAndDevelopmentCapitalization_09cbbe23-5fc2-4266-bdef-ef11cacf6152_terseLabel_en-US" xlink:label="lab_syk_DeferredTaxAssetsResearchAndDevelopmentCapitalization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development capitalization</link:label>
    <link:label id="lab_syk_DeferredTaxAssetsResearchAndDevelopmentCapitalization_label_en-US" xlink:label="lab_syk_DeferredTaxAssetsResearchAndDevelopmentCapitalization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Research And Development Capitalization</link:label>
    <link:label id="lab_syk_DeferredTaxAssetsResearchAndDevelopmentCapitalization_documentation_en-US" xlink:label="lab_syk_DeferredTaxAssetsResearchAndDevelopmentCapitalization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Research And Development Capitalization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DeferredTaxAssetsResearchAndDevelopmentCapitalization" xlink:href="syk-20221231.xsd#syk_DeferredTaxAssetsResearchAndDevelopmentCapitalization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_DeferredTaxAssetsResearchAndDevelopmentCapitalization" xlink:to="lab_syk_DeferredTaxAssetsResearchAndDevelopmentCapitalization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_cd9d7c3b-e174-4037-9396-5cfefbb69000_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0291693c-30d8-4c29-bf6c-377abba8ca9d_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_b373daf6-786c-4e1d-85c9-9f3e6bec14dc_terseLabel_en-US" xlink:label="lab_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Embedded Derivative Financial Instruments</link:label>
    <link:label id="lab_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_label_en-US" xlink:label="lab_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Embedded Derivative Financial Instruments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmbeddedDerivativeFinancialInstrumentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember" xlink:to="lab_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_AuditorInformationAbstract_label_en-US" xlink:label="lab_syk_AuditorInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Information [Abstract]</link:label>
    <link:label id="lab_syk_AuditorInformationAbstract_documentation_en-US" xlink:label="lab_syk_AuditorInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_AuditorInformationAbstract" xlink:href="syk-20221231.xsd#syk_AuditorInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_AuditorInformationAbstract" xlink:to="lab_syk_AuditorInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_831c6e10-9bac-4a0a-973f-4d8f269b2627_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividends_875af459-b349-45a1-9f34-301a838fe5f1_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of dividends</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividends_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividends" xlink:to="lab_us-gaap_PaymentsOfDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_571e4cf6-b70f-4d57-b284-9dafd04e565a_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_03d3b160-2147-4701-804f-8b4c27eacf54_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableforsaleSecuritiesMember_79113b9c-76ac-4e1c-ac16-55db4f4bbcf7_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableforsaleSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale marketable securities:</link:label>
    <link:label id="lab_us-gaap_AvailableforsaleSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_AvailableforsaleSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-Sale Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableforsaleSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableforsaleSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableforsaleSecuritiesMember" xlink:to="lab_us-gaap_AvailableforsaleSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax_11f208f8-09eb-471a-b94e-8f64d5359602_terseLabel_en-US" xlink:label="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After-tax gain (loss) recognized in AOCI related to designated net investment hedges</link:label>
    <link:label id="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax_label_en-US" xlink:label="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Derivative Used in Net Investment Hedge, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" xlink:to="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_84c56331-605f-4c17-92b2-700cd8ede8ff_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, $.10 Par Value</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_4445e73d-18da-496f-9ef6-9d68de3ec56a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_b7e4c62e-3d3e-4319-8a1e-5e664b54fe40_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under stock compensation and benefit plans</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_de8f0bce-b7af-47c8-beeb-66586c6d0bed_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_565a2132-f24a-46fe-a02d-b954596f1c67_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaper_aa28b9b2-1148-4d77-b094-3c3aa6b81e45_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaper" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaper_label_en-US" xlink:label="lab_us-gaap_CommercialPaper" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaper" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaper"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaper" xlink:to="lab_us-gaap_CommercialPaper" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_8a2f59d1-43d3-401f-a7e2-f3207e98077b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_a026d4b4-cf1b-4ab7-a231-50cfa4affd58_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_03d3fe1e-badd-457a-ae31-564e4ef51954_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_52065036-96d9-474d-9038-9d6213fc43b8_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesPolicy_600c7316-9f35-4f0d-81d9-9e26955a8dfc_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesPolicy_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesPolicy" xlink:to="lab_us-gaap_MarketableSecuritiesPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_e57b2113-d4b1-453b-be04-7b78bbf97830_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_949c3c48-4913-42d8-aa3f-94e26522ff33_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant date fair value, Vested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes1.125Due2023Member_4352d2ac-9b67-42e0-a66b-88d1a4f8996e_terseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes1.125Due2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.125% Notes due 2023</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes1.125Due2023Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes1.125Due2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes, 1.125% Due 2023 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes1.125Due2023Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes1.125Due2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes, 1.125% Due 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes1.125Due2023Member" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotes1.125Due2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes1.125Due2023Member" xlink:to="lab_syk_SeniorUnsecuredNotes1.125Due2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_811da802-d610-44ba-b0e5-e950fcbd2ce4_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_b1728844-2dbd-47cd-8bca-44d3fe116f06_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense and penalties included in other income (expense), net</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_c9611a6d-962b-47b5-b3d6-243c5de5bb1e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liabilities, noncurrent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_f6b71b5f-fce3-40e4-af77-091b07aa6d2e_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total recognized in OCI</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_MedicalDeviceRegulationsExpense_613b6377-f20a-4219-bd72-b8466c13d019_negatedTerseLabel_en-US" xlink:label="lab_syk_MedicalDeviceRegulationsExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical device regulations</link:label>
    <link:label id="lab_syk_MedicalDeviceRegulationsExpense_label_en-US" xlink:label="lab_syk_MedicalDeviceRegulationsExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Device Regulations Expense</link:label>
    <link:label id="lab_syk_MedicalDeviceRegulationsExpense_documentation_en-US" xlink:label="lab_syk_MedicalDeviceRegulationsExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Device Regulations Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_MedicalDeviceRegulationsExpense" xlink:href="syk-20221231.xsd#syk_MedicalDeviceRegulationsExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_MedicalDeviceRegulationsExpense" xlink:to="lab_syk_MedicalDeviceRegulationsExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_ee9d915f-c341-436d-bb63-d040f5fd4da6_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan expense</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:to="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_f05ae2b8-0692-4b3b-985b-8d51e45dd53a_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_96b8260c-4329-4411-a434-7791e253e102_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Domain]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromHedgeInvestingActivities_b3ff0e77-5833-43ff-9192-4acf3c6c2561_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromHedgeInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from settlement of net investment hedges</link:label>
    <link:label id="lab_us-gaap_ProceedsFromHedgeInvestingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromHedgeInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Hedge, Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromHedgeInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromHedgeInvestingActivities" xlink:to="lab_us-gaap_ProceedsFromHedgeInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_3d0e0bc9-ec0b-4b03-bbc0-49ec85fc5dba_negatedLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in estimate</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_980c8f9b-a958-4242-8026-d1165a5d7160_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_94dd2c63-d13b-4def-8726-a50b4efa5d2f_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impaired Long-Lived Assets Held and Used, Asset Name [Domain]</link:label>
    <link:label id="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_label_en-US" xlink:label="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impaired Long-Lived Assets Held and Used, Asset Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain" xlink:to="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_21fa15b5-38ef-4037-9f7b-de3b48ed5b44_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, less allowance of $154 ($167 in 2021)</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_900af629-7aab-4916-9983-95c0024be461_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of marketable securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_8b41a802-3572-4b79-9d01-a1fe3ccf11d0_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksMember_c8954370-ba3c-4432-8b91-94da29b418b2_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks</link:label>
    <link:label id="lab_us-gaap_TrademarksMember_label_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksMember" xlink:to="lab_us-gaap_TrademarksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_25ae9b5b-9fcd-4c06-9672-8ffaf1e2594b_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_b69fe70c-e263-4638-8ae7-b11f54bc8dd1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price, Exercisable at December 31 (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_3cc00db4-3f1b-40fc-9329-6ed6ab13cc84_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_0941da8b-cd44-45e6-8eab-31cd0519ca0a_terseLabel_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_label_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain" xlink:to="lab_us-gaap_PlanAssetCategoriesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d2cd0e42-c611-4712-8cbc-08d5b28d61dc_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_af098b1a-5511-479a-af0f-e9b4ce35c5b9_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForNotesReceivableMember_554df2eb-bd4a-4b75-9818-ce73304dc073_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForNotesReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Allowance, Notes Receivable</link:label>
    <link:label id="lab_us-gaap_AllowanceForNotesReceivableMember_label_en-US" xlink:label="lab_us-gaap_AllowanceForNotesReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Allowance, Notes Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForNotesReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForNotesReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForNotesReceivableMember" xlink:to="lab_us-gaap_AllowanceForNotesReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2391eb2f-04a1-49c6-bc3b-931c10b85434_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Nonvested at January 1 (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_702993a3-3067-4250-9b54-b0e7ccedbecf_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Nonvested at December 31 (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_94c59743-828c-4dea-aa51-e8687679aedb_verboseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_70654afa-ac3c-4f45-a9df-90fc75706318_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income) expense, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_0090d206-d6ed-49f1-953e-6433148ac244_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_c85bf9bf-5623-432d-b58b-5c29929bc1b0_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_52e81fc2-5cf0-4eab-8777-08966f6842aa_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_6b881b62-793c-4ce9-86f7-b62fb8829683_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes1.000due2031Member_e95f4787-cd9f-4cb7-a721-1573a4494b6a_verboseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes1.000due2031Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.000% Notes due 2031</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes1.000due2031Member_d8d71c7c-e389-4c4a-837c-d12a0bcb3b01_terseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes1.000due2031Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 1.000% due 2031</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes1.000due2031Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes1.000due2031Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 1.000% due 2031 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes1.000due2031Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes1.000due2031Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 1.000% due 2031 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes1.000due2031Member" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotes1.000due2031Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes1.000due2031Member" xlink:to="lab_syk_SeniorUnsecuredNotes1.000due2031Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_7afade19-61cf-48b3-a818-f2d569844b32_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_LongLivedAssetsAndIntangibleAssetsMember_6e78cdd0-da01-4ef5-9707-27de06b7b325_terseLabel_en-US" xlink:label="lab_syk_LongLivedAssetsAndIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Assets and Intangible Assets</link:label>
    <link:label id="lab_syk_LongLivedAssetsAndIntangibleAssetsMember_label_en-US" xlink:label="lab_syk_LongLivedAssetsAndIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Assets and Intangible Assets [Member]</link:label>
    <link:label id="lab_syk_LongLivedAssetsAndIntangibleAssetsMember_documentation_en-US" xlink:label="lab_syk_LongLivedAssetsAndIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Assets and Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_LongLivedAssetsAndIntangibleAssetsMember" xlink:href="syk-20221231.xsd#syk_LongLivedAssetsAndIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_LongLivedAssetsAndIntangibleAssetsMember" xlink:to="lab_syk_LongLivedAssetsAndIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_35317c5b-b32f-4a61-aa36-2394a112b8a4_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current income tax expense</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_70ac424f-5d77-4206-bf42-3376dfeab5d2_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_12cf7cc2-c1b9-46b0-80a4-a65095cc9c05_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Investments, Including Marketable Securities and Investments Held at Cost, Categories of Investments [Domain]</link:label>
    <link:label id="lab_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_0ce906ee-189c-491f-8294-2e138aa6c384_terseLabel_en-US" xlink:label="lab_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other than Temporary Impairment, Credit Losses Recognized in Earnings, Categories of Investments [Domain]</link:label>
    <link:label id="lab_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_label_en-US" xlink:label="lab_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other than Temporary Impairment, Credit Losses Recognized in Earnings, Categories of Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain" xlink:to="lab_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_eea9af2f-7bb4-48c0-9952-a5b699fab031_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_93da5d56-ea7a-4ac5-83eb-2d4ab74139f3_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Loss) Income (AOCI)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_42b57d17-2ed3-4e88-8457-e9289e666e5c_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_27bf9149-8298-4083-8145-f16513951e9c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price, Options expected to vest (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_c6ebbfaa-9dc4-4c62-a748-f9e1d53802c9_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseExpense" xlink:to="lab_us-gaap_OperatingLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_f03fa852-1bab-416a-8430-a8ea6ba0fb5f_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_c682830d-c909-4ed8-a521-82956db5a065_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCountryMember_e8d1ae18-c7de-4da9-ad98-afc0a5803204_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember" xlink:to="lab_us-gaap_ForeignCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_82fc68c9-473d-4c30-93d7-08d5e4a489fa_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_3a0461fa-939e-49a5-b6ce-3505d9c1c2b7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Stock Option Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_175a0dde-a94f-43bf-9db8-4740fdb77827_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_8569c363-9f9e-4535-9bb7-dc7b2521c452_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment net earnings (loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInventory_9a41277c-15bc-481e-b5b0-e7ddceb90ec5_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInventory_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsInventory" xlink:to="lab_us-gaap_DeferredTaxAssetsInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_c3d35254-077b-47b2-a077-d2623f6a44de_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of RSU and PSU Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_c1a38346-3121-4f85-ad6b-c4419fc408b4_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeNet_edbfe2bb-7209-4a92-994b-4614d61c1283_totalLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, fair value, net</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Fair Value, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_f697b673-cb6c-4102-bd86-4c13697e1cc7_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements Not Yet Adopted and Accounting Pronouncements Recently Adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_3a128624-4986-48f8-ae91-9207d62b9fce_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized_a9903172-6f02-4f83-87a2-7f1973d95ea0_terseLabel_en-US" xlink:label="lab_syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforward recognized</link:label>
    <link:label id="lab_syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized_label_en-US" xlink:label="lab_syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense (benefit), Portion of Net Operating Loss Carryforward Recognized</link:label>
    <link:label id="lab_syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized_documentation_en-US" xlink:label="lab_syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense (benefit), Portion of Net Operating Loss Carryforward Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized" xlink:href="syk-20221231.xsd#syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized" xlink:to="lab_syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes3.375due2025MemberMember_c4be10f1-5b4d-4306-a92e-7a9060907c16_terseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes3.375due2025MemberMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 3.375% due 2025</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes3.375due2025MemberMember_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes3.375due2025MemberMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 3.375% due 2025 [Member] [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes3.375due2025MemberMember_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes3.375due2025MemberMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 3.375% due 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes3.375due2025MemberMember" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotes3.375due2025MemberMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes3.375due2025MemberMember" xlink:to="lab_syk_SeniorUnsecuredNotes3.375due2025MemberMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_c400daf6-d340-457c-9a8d-fdc496907f3c_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance, shares</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_dab8e87e-7d59-4465-b2ed-f42b16ee9309_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance, shares</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_fae442b3-f566-4f7d-8700-c64edffed261_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_2f83dc4f-290b-42c8-9031-78c2251df13e_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_1e08af3e-b489-46a7-a3c0-ccec4702da1a_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_71faf5d7-43de-490d-bf4c-df9fcbb936f5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes4.375due2044Member_1f8fb335-9d7b-41fe-92cd-98369f33257f_terseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes4.375due2044Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 4.375% due 2044</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes4.375due2044Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes4.375due2044Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 4.375% due 2044 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes4.375due2044Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes4.375due2044Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 4.375% due 2044 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes4.375due2044Member" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotes4.375due2044Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes4.375due2044Member" xlink:to="lab_syk_SeniorUnsecuredNotes4.375due2044Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_504842a9-7320-415c-bc89-c3e07945b958_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities measured at fair value</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_ee899b63-dae5-48f2-822c-071dfec47664_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_926f776f-b01f-4b78-9a1a-d73682596862_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual return</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_cc750417-72de-487e-ba33-fdbb6739b770_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net earnings to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_9fad4133-90f4-43fa-ad7f-4d76082dbce7_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_219ecc77-3115-4612-a757-eedc9151f2d8_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_fa8da5f7-ca5e-4d24-8d96-9eab9752310c_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_b7e1cfc0-b371-43c0-a206-60d8da537a4c_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember_84774780-03cb-403f-bd02-28b18f315526_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Net Prior Service Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Net Prior Service Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_77232bcd-0e03-4fa5-beb7-06d77790f4c3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent liabilities&#8212;Other liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_2093f2c5-c68d-42e6-ba72-77c463731e44_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less valuation allowances</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_a99afb36-f6d2-403b-b257-f0b703721bfd_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_DeferredTaxAssetsDepreciationAndAmortization_13bb8501-3a82-44d3-b73d-acb1fb0ff881_terseLabel_en-US" xlink:label="lab_syk_DeferredTaxAssetsDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_syk_DeferredTaxAssetsDepreciationAndAmortization_label_en-US" xlink:label="lab_syk_DeferredTaxAssetsDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Depreciation And Amortization</link:label>
    <link:label id="lab_syk_DeferredTaxAssetsDepreciationAndAmortization_documentation_en-US" xlink:label="lab_syk_DeferredTaxAssetsDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Depreciation And Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DeferredTaxAssetsDepreciationAndAmortization" xlink:href="syk-20221231.xsd#syk_DeferredTaxAssetsDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_DeferredTaxAssetsDepreciationAndAmortization" xlink:to="lab_syk_DeferredTaxAssetsDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_8f5610eb-f2a4-4ebf-8a15-4f758a250de9_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par per share</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_c3ddffc7-a3c0-4063-9dca-a4f18e83628e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_f3c3ee71-d572-4027-a067-e34dff7f91fd_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_13edf614-c248-4547-a074-dcf5cf80d74d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_3552c6d1-770d-4192-96b3-9e36c70e7d6e_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_dabd0c3f-83e3-4f8a-8577-a6fe7941af10_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States federal</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_OtherOrthopaedicsMember_64fb040d-526f-4503-8041-6114c4c8f08e_terseLabel_en-US" xlink:label="lab_syk_OtherOrthopaedicsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_syk_OtherOrthopaedicsMember_label_en-US" xlink:label="lab_syk_OtherOrthopaedicsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Orthopaedics [Member]</link:label>
    <link:label id="lab_syk_OtherOrthopaedicsMember_documentation_en-US" xlink:label="lab_syk_OtherOrthopaedicsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Orthopaedics</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OtherOrthopaedicsMember" xlink:href="syk-20221231.xsd#syk_OtherOrthopaedicsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_OtherOrthopaedicsMember" xlink:to="lab_syk_OtherOrthopaedicsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_bf6c270a-7e8b-460f-af54-17cf2c69c70d_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_0dc70ab8-9f3c-4bdb-a807-3a1e4e4a3666_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_260ad9e2-1e53-4817-bb97-187f34ef686e_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_bb686856-3281-461c-9f81-bf040bcf36f8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value of options exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_aba6ad10-af84-4e01-8741-5f9f6324466d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_65c19a1b-b257-4542-8b06-89cbb79b2ad1_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes0.250due2024Member_592870d2-ac8d-4d9a-a6a8-25d7e780b094_verboseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes0.250due2024Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.250% Notes due 2024</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes0.250due2024Member_8c2b6dc7-08b3-4924-b64c-beeb012414a4_terseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes0.250due2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 0.250% due 2024</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes0.250due2024Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes0.250due2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 0.250% due 2024 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes0.250due2024Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes0.250due2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 0.250% due 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes0.250due2024Member" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotes0.250due2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes0.250due2024Member" xlink:to="lab_syk_SeniorUnsecuredNotes0.250due2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_56799400-5b8b-44c6-bd63-6b6567b4ef94_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less allowance for depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_64676a34-6114-4cbd-be33-d22ffed951c8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liability</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Subject to Master Netting Arrangement, before Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_9f51ed31-57ad-4455-83db-50e4a76411fe_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected option life (years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_KneesMember_8510a974-0f8b-48d6-bef5-41bbf7f7e209_terseLabel_en-US" xlink:label="lab_syk_KneesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Knees</link:label>
    <link:label id="lab_syk_KneesMember_label_en-US" xlink:label="lab_syk_KneesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Knees [Member]</link:label>
    <link:label id="lab_syk_KneesMember_documentation_en-US" xlink:label="lab_syk_KneesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Knees [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_KneesMember" xlink:href="syk-20221231.xsd#syk_KneesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_KneesMember" xlink:to="lab_syk_KneesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOptionTextBlock_377a23b0-84f3-4ffc-a751-2ef98ebda06a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueOptionTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueOptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Option [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOptionTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOptionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOptionTextBlock" xlink:to="lab_us-gaap_FairValueOptionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_e25ac8e8-7230-490e-81a2-204138ecc9e1_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear_0eae72b5-dfbe-4894-9f90-0fa467005563_terseLabel_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear_label_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recorded Unconditional Purchase Obligation, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear" xlink:to="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_6f71fed9-e1b8-41fc-8f16-7c43199a5203_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and Improvements</link:label>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_label_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and Building Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:to="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_81b03fd3-2153-4742-b9bb-da26c9cffe35_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes0600Due2023Member_18e434b5-9358-497e-8183-59913634a0fa_terseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes0600Due2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 0.600% due 2023</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes0600Due2023Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes0600Due2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 0.600% due 2023 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes0600Due2023Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes0600Due2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 0.600% due 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes0600Due2023Member" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotes0600Due2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes0600Due2023Member" xlink:to="lab_syk_SeniorUnsecuredNotes0600Due2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes350Due2026Member_87d56f04-e575-4732-8304-4ea956d20d0e_terseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes350Due2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 3.50% due 2026</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes350Due2026Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes350Due2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 3.50% due 2026 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes350Due2026Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes350Due2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 3.50% due 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes350Due2026Member" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotes350Due2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes350Due2026Member" xlink:to="lab_syk_SeniorUnsecuredNotes350Due2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_7f055647-f8ee-444a-8fbf-39f216269ce1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_75904a93-1f43-490b-a30f-91c30d7270f1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_ContractWithCustomerLiabilityNetAdvanceConsiderationReceivedDuringPeriod_4ff4758d-fdeb-4dd1-b6b5-fbad96785ac7_terseLabel_en-US" xlink:label="lab_syk_ContractWithCustomerLiabilityNetAdvanceConsiderationReceivedDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net advance consideration received during the period</link:label>
    <link:label id="lab_syk_ContractWithCustomerLiabilityNetAdvanceConsiderationReceivedDuringPeriod_label_en-US" xlink:label="lab_syk_ContractWithCustomerLiabilityNetAdvanceConsiderationReceivedDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Net Advance Consideration Received During Period</link:label>
    <link:label id="lab_syk_ContractWithCustomerLiabilityNetAdvanceConsiderationReceivedDuringPeriod_documentation_en-US" xlink:label="lab_syk_ContractWithCustomerLiabilityNetAdvanceConsiderationReceivedDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Net Advance Consideration Received During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_ContractWithCustomerLiabilityNetAdvanceConsiderationReceivedDuringPeriod" xlink:href="syk-20221231.xsd#syk_ContractWithCustomerLiabilityNetAdvanceConsiderationReceivedDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_ContractWithCustomerLiabilityNetAdvanceConsiderationReceivedDuringPeriod" xlink:to="lab_syk_ContractWithCustomerLiabilityNetAdvanceConsiderationReceivedDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts_7f227e9a-65d6-47ed-bb94-c9b184a24ad0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition and integration-related charges</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Integration Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue_3d43a5d6-c6de-4290-bd86-f48f26039df8_verboseLabel_en-US" xlink:label="lab_syk_AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after one year through three years</link:label>
    <link:label id="lab_syk_AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue_label_en-US" xlink:label="lab_syk_AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available for sale Securities, Debt Maturities, After One Through Three Years, Fair Value</link:label>
    <link:label id="lab_syk_AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue_documentation_en-US" xlink:label="lab_syk_AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This item represents the fair value of debt securities which are expected to mature after one through three years of the balance sheet date and which are categorized neither as held-to-maturity nor trading securities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" xlink:href="syk-20221231.xsd#syk_AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" xlink:to="lab_syk_AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_8294477a-1fc0-4ddd-b71c-3c438bb8a0d3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant date fair value, Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AsiaPacificMember_21b1ef6e-dded-46c5-bc8c-54258d986961_terseLabel_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific</link:label>
    <link:label id="lab_srt_AsiaPacificMember_label_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AsiaPacificMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AsiaPacificMember" xlink:to="lab_srt_AsiaPacificMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_bfc435b6-e379-4f6b-9b46-1349912108b3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_09f34df2-59cd-4845-9351-4569ee3abc5b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_5ca905d4-921a-48e8-a324-cdf04e828199_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_41cb612d-ca65-4609-9195-8fa6c404204f_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flow hedge gain (loss) to be reclassified within twelve months</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedge Gain (Loss) to be Reclassified within 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:to="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_589600a3-b6dc-4078-abc9-131ceae46348_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value, Exercisable at December 31</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_RejuvenateABGIIHipRecallCharges_16425a6a-98b3-4d5d-a2d8-94bd31404505_negatedLabel_en-US" xlink:label="lab_syk_RejuvenateABGIIHipRecallCharges" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recall-related matters</link:label>
    <link:label id="lab_syk_RejuvenateABGIIHipRecallCharges_label_en-US" xlink:label="lab_syk_RejuvenateABGIIHipRecallCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rejuvenate / ABG II Hip Recall Charges</link:label>
    <link:label id="lab_syk_RejuvenateABGIIHipRecallCharges_documentation_en-US" xlink:label="lab_syk_RejuvenateABGIIHipRecallCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rejuvenate / ABG II Hip Recall Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_RejuvenateABGIIHipRecallCharges" xlink:href="syk-20221231.xsd#syk_RejuvenateABGIIHipRecallCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_RejuvenateABGIIHipRecallCharges" xlink:to="lab_syk_RejuvenateABGIIHipRecallCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_3e0eb5e3-e126-4d06-b19d-95b6f1490ef4_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4de49c5f-b98f-432b-9acb-50ba9cd7cd5f_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at beginning of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9f6a7d73-10b6-47b3-a68d-322f67a92109_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at end of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_7011ffd3-db17-47de-b9cc-3c8dc333cab6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial statement translation</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_cadf8fd4-4d20-408a-9dbb-a28da41b6759_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_fdcf96fe-c402-48d5-908b-8ed78252d299_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies and Commitments</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_LandBuildingsAndImprovementsGross_10aab6a7-e260-4681-a016-aa5343a1bf5b_terseLabel_en-US" xlink:label="lab_syk_LandBuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land, buildings and improvements</link:label>
    <link:label id="lab_syk_LandBuildingsAndImprovementsGross_label_en-US" xlink:label="lab_syk_LandBuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land, Buildings and Improvements, Gross</link:label>
    <link:label id="lab_syk_LandBuildingsAndImprovementsGross_documentation_en-US" xlink:label="lab_syk_LandBuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land, Buildings and Improvements, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_LandBuildingsAndImprovementsGross" xlink:href="syk-20221231.xsd#syk_LandBuildingsAndImprovementsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_LandBuildingsAndImprovementsGross" xlink:to="lab_syk_LandBuildingsAndImprovementsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_002548a2-eb41-42e7-a828-ee69dd3964cf_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_7e999613-caa4-44cb-a82e-ca4dcc75cc00_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of long-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_cedc5bf7-261a-48a1-8ea0-744fdd3be3e9_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Curtailment gain</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Curtailment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" xlink:to="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_f493a799-4b12-471d-ab4c-cfe5d313786e_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average remaining contractual term, Options expected to vest (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_CapitalExpendituresDuringPeriod_6edde230-f5f6-4682-8fc0-d74d4c4102bd_terseLabel_en-US" xlink:label="lab_syk_CapitalExpendituresDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures During Period</link:label>
    <link:label id="lab_syk_CapitalExpendituresDuringPeriod_label_en-US" xlink:label="lab_syk_CapitalExpendituresDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures During Period</link:label>
    <link:label id="lab_syk_CapitalExpendituresDuringPeriod_documentation_en-US" xlink:label="lab_syk_CapitalExpendituresDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_CapitalExpendituresDuringPeriod" xlink:href="syk-20221231.xsd#syk_CapitalExpendituresDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_CapitalExpendituresDuringPeriod" xlink:to="lab_syk_CapitalExpendituresDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_817c2bae-5959-4d2c-9e77-ad4bc7e1b37c_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency transaction gains (losses)</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_1ed7dc93-5834-40f0-bdb9-47a9ff2bbce4_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_419175fb-e8ac-4706-ba07-2361b2b2caf8_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_cd27b0df-e285-4871-a755-15242e786392_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_214b7ab5-25bb-4a89-8e7a-f542979f8993_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0319b48f-6b2a-467e-8f6d-27a8900d1af0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_53f1cbb0-0bce-4ec5-bfa6-ddfa4d2193bb_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_608c7c18-951f-4407-8d8a-e1fd68cab504_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible asset, useful life</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_10e415f6-fded-4e02-8513-8367e1957add_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_3a626db2-e4db-4464-beed-dbf1a2e5fb55_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_34631dd6-05dc-4bbc-9af6-e713a96acc25_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:to="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_bf9cac9a-be89-45e7-b659-7bf911e11837_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_0a24bc44-c4de-414e-a6fa-96e57a3841e0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_aaf02b12-8732-47e5-8703-6b7c67cb4fdd_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_53c03df9-a835-43cb-8640-632bfb84043a_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_3394a589-480d-4963-8053-8bc2ffad608a_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions and adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes2.125Due2027Member_b5dc79fd-b3e1-402d-8b97-0dbda2d71e24_terseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes2.125Due2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.125% Notes due 2027</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes2.125Due2027Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes2.125Due2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes, 2.125% Due 2027 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes2.125Due2027Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes2.125Due2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes, 2.125% Due 2027 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes2.125Due2027Member" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotes2.125Due2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes2.125Due2027Member" xlink:to="lab_syk_SeniorUnsecuredNotes2.125Due2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_TraumaandExtremitiesMember_958e1566-8731-4ebb-8d54-72b91dd5d932_terseLabel_en-US" xlink:label="lab_syk_TraumaandExtremitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trauma and Extremities</link:label>
    <link:label id="lab_syk_TraumaandExtremitiesMember_label_en-US" xlink:label="lab_syk_TraumaandExtremitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trauma and Extremities [Member]</link:label>
    <link:label id="lab_syk_TraumaandExtremitiesMember_documentation_en-US" xlink:label="lab_syk_TraumaandExtremitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trauma and Extremities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_TraumaandExtremitiesMember" xlink:href="syk-20221231.xsd#syk_TraumaandExtremitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_TraumaandExtremitiesMember" xlink:to="lab_syk_TraumaandExtremitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_c700f08b-0e26-41d5-903a-4b7a95bde216_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and Other Financial Information by Business Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_181f223e-4354-42c6-9e6c-9b00d3794735_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_8bb8952b-b276-4a46-8745-dacf2704557c_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligationFiscalYearMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase obligations</link:label>
    <link:label id="lab_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_label_en-US" xlink:label="lab_us-gaap_PurchaseObligationFiscalYearMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligation, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationFiscalYearMaturityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PurchaseObligationFiscalYearMaturityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligationFiscalYearMaturityAbstract" xlink:to="lab_us-gaap_PurchaseObligationFiscalYearMaturityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_5cd86a8b-0744-4824-b629-d1cb9d19e672_terseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax assets:</link:label>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Deferred Tax Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_da5dc35c-fc79-4a4b-b6d7-93506f443d22_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_a0e73615-f702-4b69-afa1-2a1354d9e90d_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_36b7623f-c701-4295-9600-2e1ba44eaf8a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_b60ab74e-4556-484d-b3b7-67db09c44212_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other noncurrent assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_fdf5993f-166e-436b-a26b-045468fa20a9_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_00f1bbb0-9fc2-40cd-8372-167062d588d9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_30f07a87-f002-4a2d-be6a-c3ea401f3a4f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Exercisable at December 31 (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_74c6e6d9-88dc-4df8-bdb8-6057e41bbe17_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_cfff15e4-6fcf-4556-b4cd-0ee06b74a5b7_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange</link:label>
    <link:label id="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Translation and Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_HipsMember_14f4a37b-dc9f-41ee-9ea5-17c20f3bdc49_terseLabel_en-US" xlink:label="lab_syk_HipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hips</link:label>
    <link:label id="lab_syk_HipsMember_label_en-US" xlink:label="lab_syk_HipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hips [Member]</link:label>
    <link:label id="lab_syk_HipsMember_documentation_en-US" xlink:label="lab_syk_HipsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hips [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_HipsMember" xlink:href="syk-20221231.xsd#syk_HipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_HipsMember" xlink:to="lab_syk_HipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_e2b7433c-f4f8-48ab-beb9-8ea5e06715a6_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_74f6634a-9acd-4892-ba8b-4199e7db6c17_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States federal statutory rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes1.150Due2025Member_fe8082dd-b018-41d9-bc7a-16f0fce6d5f8_terseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes1.150Due2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes, 1.150% Due 2025</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes1.150Due2025Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes1.150Due2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes, 1.150% Due 2025 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes1.150Due2025Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes1.150Due2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes, 1.150% Due 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes1.150Due2025Member" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotes1.150Due2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes1.150Due2025Member" xlink:to="lab_syk_SeniorUnsecuredNotes1.150Due2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_d21d143e-2e19-49e7-98d6-2362dfe03872_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charged&#160;to Costs &amp; Expenses</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_OrthopaedicsAndSpineMember_82ee18b7-0ab9-4fdf-8575-8a665e7a51b6_terseLabel_en-US" xlink:label="lab_syk_OrthopaedicsAndSpineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Orthopaedics and Spine</link:label>
    <link:label id="lab_syk_OrthopaedicsAndSpineMember_label_en-US" xlink:label="lab_syk_OrthopaedicsAndSpineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Orthopaedics and Spine [Member]</link:label>
    <link:label id="lab_syk_OrthopaedicsAndSpineMember_documentation_en-US" xlink:label="lab_syk_OrthopaedicsAndSpineMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Orthopaedics and Spine</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OrthopaedicsAndSpineMember" xlink:href="syk-20221231.xsd#syk_OrthopaedicsAndSpineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_OrthopaedicsAndSpineMember" xlink:to="lab_syk_OrthopaedicsAndSpineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_6164f9e5-410e-4600-9ba2-9597d51ede77_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3c20bf67-003a-4307-b78f-244e67d62b3f_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Options outstanding at January 1 (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_20ec8751-d536-4825-870b-205ba8f4c093_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Options outstanding at December 31 (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_c55fbec4-83b1-432f-961d-acbd683868bf_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_AccruedCompensationMember_068a09b6-dd47-4e32-8935-5a59ad3e1947_terseLabel_en-US" xlink:label="lab_syk_AccruedCompensationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Compensation</link:label>
    <link:label id="lab_syk_AccruedCompensationMember_label_en-US" xlink:label="lab_syk_AccruedCompensationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Compensation [Member]</link:label>
    <link:label id="lab_syk_AccruedCompensationMember_documentation_en-US" xlink:label="lab_syk_AccruedCompensationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Compensation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_AccruedCompensationMember" xlink:href="syk-20221231.xsd#syk_AccruedCompensationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_AccruedCompensationMember" xlink:to="lab_syk_AccruedCompensationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_e30d165c-33fe-4edd-9de6-a10653ba299f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_5ccbc089-e0a6-461b-8f0a-1b9f1a9267ef_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets:</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_2774fa8a-e36b-4f2c-8823-e18227311829_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net actuarial gain (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_RecallMattersMember_1b92579c-a5cf-446a-97d7-3b3666afe0fb_terseLabel_en-US" xlink:label="lab_syk_RecallMattersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recall Matters</link:label>
    <link:label id="lab_syk_RecallMattersMember_label_en-US" xlink:label="lab_syk_RecallMattersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recall Matters [Member]</link:label>
    <link:label id="lab_syk_RecallMattersMember_documentation_en-US" xlink:label="lab_syk_RecallMattersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recall Matters</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_RecallMattersMember" xlink:href="syk-20221231.xsd#syk_RecallMattersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_RecallMattersMember" xlink:to="lab_syk_RecallMattersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_269e0663-018c-4cf5-8fec-d3cbc75eef00_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_1032f8f9-d0e0-4e4d-bcda-ccceff3b8c3e_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States state and local income taxes, less federal deduction</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities_0ed82f1b-3b96-462f-a964-e126826227c6_verboseLabel_en-US" xlink:label="lab_syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation arrangements</link:label>
    <link:label id="lab_syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities_label_en-US" xlink:label="lab_syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Liabilities Measured On Recurring Basis Deferred Compensation Plan Liabilities</link:label>
    <link:label id="lab_syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities_documentation_en-US" xlink:label="lab_syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Deferred Compensation Plan Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities" xlink:href="syk-20221231.xsd#syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities" xlink:to="lab_syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_36d97170-5c52-4a03-9fd6-7c08ef917edf_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_eff29040-5329-45f7-8883-eaff3809797a_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_8d5fc030-9140-4a57-be68-2d4e642d83f8_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_1ce43ec7-f144-4b93-8bc8-aacd80e25d36_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Property, Plant &amp; Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitiesTable_4693752b-900d-437c-bfbe-f11f42d687dd_terseLabel_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:label id="lab_dei_EntitiesTable_label_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitiesTable" xlink:to="lab_dei_EntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_InProcessRDOtherIntangibleAssetsAndPropertyPlantAndEquipmentMember_f7b12130-22e8-4851-8d1a-59b2187b7cbe_terseLabel_en-US" xlink:label="lab_syk_InProcessRDOtherIntangibleAssetsAndPropertyPlantAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-Process R&amp;D, Other Intangible Assets and Property, Plant and Equipment</link:label>
    <link:label id="lab_syk_InProcessRDOtherIntangibleAssetsAndPropertyPlantAndEquipmentMember_label_en-US" xlink:label="lab_syk_InProcessRDOtherIntangibleAssetsAndPropertyPlantAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-Process R&amp;D, Other Intangible Assets and Property, Plant and Equipment [Member]</link:label>
    <link:label id="lab_syk_InProcessRDOtherIntangibleAssetsAndPropertyPlantAndEquipmentMember_documentation_en-US" xlink:label="lab_syk_InProcessRDOtherIntangibleAssetsAndPropertyPlantAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-Process R&amp;D, Other Intangible Assets and Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_InProcessRDOtherIntangibleAssetsAndPropertyPlantAndEquipmentMember" xlink:href="syk-20221231.xsd#syk_InProcessRDOtherIntangibleAssetsAndPropertyPlantAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_InProcessRDOtherIntangibleAssetsAndPropertyPlantAndEquipmentMember" xlink:to="lab_syk_InProcessRDOtherIntangibleAssetsAndPropertyPlantAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_02ab445d-dc20-42b2-b8e7-c3340255d23e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_957e205b-a91f-4b56-9629-b0c12fbb1fec_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_6c7a46dd-838b-4de3-9774-9bc712a2f404_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Amortization Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationTextBlock_fa861cde-a888-4b9e-976b-47e37add6a04_terseLabel_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Quarterly Data (Unaudited)</link:label>
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationTextBlock_label_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly Financial Information [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_QuarterlyFinancialInformationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:to="lab_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_86f08eda-09d9-4e74-8d74-e1fa1e4191b2_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Option</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_71463b28-dc42-48a0-acaf-d39ce111d41c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension plans</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_ca51040d-85ff-484d-bbe0-9bd31a3894d2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected stock price volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_1cc3e5c4-efb8-45d7-8a9f-2e42d657c1e1_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, allowance</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_0833f30f-653b-4fcb-b3af-cfa35f01c29e_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_a27fa228-12a9-413a-9ddb-5cb484e05e2a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Cancelled (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetInterestCarryforward_280b95b7-e624-48b4-9bfa-9a10f40ae786_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetInterestCarryforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International interest expense carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetInterestCarryforward_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetInterestCarryforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Interest Carryforward</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetInterestCarryforward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetInterestCarryforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetInterestCarryforward" xlink:to="lab_us-gaap_DeferredTaxAssetInterestCarryforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_f74735c1-f564-417e-9283-fe4355d1bc49_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_4853a943-dcd8-43b0-9829-85a1cd667b2d_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardValuationAllowance_1121f175-3e36-47cd-974b-a80d05294959_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax credit carryforward, valuation allowance</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardValuationAllowance_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardValuationAllowance" xlink:to="lab_us-gaap_TaxCreditCarryforwardValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_994ca4e7-e90a-4dbf-8259-080c23147833_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_0437f454-c876-4355-bcf5-59af2a8c25e0_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_bca61cef-6fb5-4a97-a039-da15352145ee_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_a59a5a69-fd41-4685-9243-8f2a22d71c20_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_83d6877e-705f-4d47-8eed-a26c06d17471_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d7c57e27-a956-4856-85a3-4df1926abb69_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Beginning of Period</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b1929bcb-b9f6-4d33-a20a-02ae5dd4c415_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), End of Period</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination_6e0ddeda-1393-4a43-a961-3093af19d306_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liabilities acquired</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade_0711bcae-3e0a-408f-9103-289d730d9c02_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable, Trade</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanCurtailments_2c4e19ad-55a9-403c-aa4e-6fabff6bbe69_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanCurtailments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Curtailment gain</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanCurtailments_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanCurtailments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Curtailment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCurtailments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanCurtailments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanCurtailments" xlink:to="lab_us-gaap_DefinedBenefitPlanCurtailments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_a3e27ba9-9a2a-47ee-880a-b431152724cf_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-Term Rate of Return on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a99f778f-25dc-48b7-8585-1eb13c162b08_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_0d6c2c53-a9a9-4ab5-8e26-4f7326f74eaf_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_7f6d8582-5623-4abd-b9fa-7c90dee778e6_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_d906f9cc-64d7-4d50-a240-5181e01a0b46_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_e0148505-774a-41bc-815a-7b672cdf1dc1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for income taxes, net of refunds</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_VoceraMember_5a28dff0-9a6e-454c-bf24-ccd4cdae1568_terseLabel_en-US" xlink:label="lab_syk_VoceraMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vocera</link:label>
    <link:label id="lab_syk_VoceraMember_label_en-US" xlink:label="lab_syk_VoceraMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vocera [Member]</link:label>
    <link:label id="lab_syk_VoceraMember_documentation_en-US" xlink:label="lab_syk_VoceraMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vocera</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_VoceraMember" xlink:href="syk-20221231.xsd#syk_VoceraMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_VoceraMember" xlink:to="lab_syk_VoceraMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_c5d7c959-fb1e-4dbc-835d-c6980056713c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognized from beginning of year contract liabilities</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_de00359c-04d4-4967-bfd5-39b7f2a4704e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_e8f89012-1121-49f8-ad86-90b20b244482_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_b509f6bf-efd7-40e4-a7a8-edadc350b9ab_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_CreditAgreementMember_151066ad-8eb4-48d7-8350-93831974a002_terseLabel_en-US" xlink:label="lab_syk_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement</link:label>
    <link:label id="lab_syk_CreditAgreementMember_label_en-US" xlink:label="lab_syk_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement [Member]</link:label>
    <link:label id="lab_syk_CreditAgreementMember_documentation_en-US" xlink:label="lab_syk_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_CreditAgreementMember" xlink:href="syk-20221231.xsd#syk_CreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_CreditAgreementMember" xlink:to="lab_syk_CreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_2b3db8fa-d905-4669-b6db-ecef885c3e1e_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Stock</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_f7059bd1-878e-4df9-9d88-948281efc8af_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared per share of common stock (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_693667ec-4909-4115-b40b-b04890b43932_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued under the ESPP</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_782226b4-438b-4d08-b834-84b87092a4dc_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_a691edb9-1650-42f5-9e18-5343f0744739_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesPolicyTextBlock_509b434f-fc42-4d85-b5bc-b52eda52d7d9_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales</link:label>
    <link:label id="lab_us-gaap_CostOfSalesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Service [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesPolicyTextBlock" xlink:to="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_0321fd6a-9abd-4bd4-ad6d-cf244be64d9c_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax_6190ba8f-05f8-404c-84b3-27be7bc1f408_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total recognized in net periodic benefit cost and OCI</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_df809adc-b806-4a0e-bc99-8edde393d3cc_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation cost not yet recognized</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b07cee58-dcf9-4b37-b1c3-70c844411b7e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock_cac37089-a30b-42c7-8780-f553880cd968_terseLabel_en-US" xlink:label="lab_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future Purchase Obligations and Minimum Lease Payments</link:label>
    <link:label id="lab_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock_label_en-US" xlink:label="lab_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Obligation, Fiscal Year Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock" xlink:to="lab_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_6c1bf177-355a-4274-9374-57abcea70f57_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual plan asset allocations</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Actual Allocation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:to="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLongTermDebt_042741ef-2639-4de7-8132-598f9ef60c63_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term debt</link:label>
    <link:label id="lab_us-gaap_OtherLongTermDebt_label_en-US" xlink:label="lab_us-gaap_OtherLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLongTermDebt" xlink:to="lab_us-gaap_OtherLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_8f549cc8-3af4-48d2-82ce-654bcc6884e5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value, Options outstanding at December 31</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_1666191f-0825-4cdd-be73-714d2faf5ed3_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_291bc1a7-ccc6-456b-b13e-4c749ae52384_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_5b85a030-f26d-49a6-a28a-e628e8ae950c_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_5e1a4bf2-69cc-4578-9f5b-48b1fe58c063_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes2.900due2050Member_92eeae2b-976b-43c0-8297-22d90064c573_terseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes2.900due2050Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes, 2.900% due 2050</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes2.900due2050Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes2.900due2050Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes, 2.900% due 2050 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes2.900due2050Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes2.900due2050Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes, 2.900% due 2050 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes2.900due2050Member" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotes2.900due2050Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes2.900due2050Member" xlink:to="lab_syk_SeniorUnsecuredNotes2.900due2050Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnsecuredDebt_6cadcda7-c749-487a-88c2-7d7b9381773b_terseLabel_en-US" xlink:label="lab_us-gaap_UnsecuredDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured debt</link:label>
    <link:label id="lab_us-gaap_UnsecuredDebt_label_en-US" xlink:label="lab_us-gaap_UnsecuredDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnsecuredDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnsecuredDebt" xlink:to="lab_us-gaap_UnsecuredDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_5dc0a9a8-87af-4381-9fab-eb07fb046618_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_e6c967d9-9f68-4641-b809-360c804cbf4c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:to="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReportingUnitAxis_109efd27-d5b8-4b33-be11-ab4212057ded_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Axis]</link:label>
    <link:label id="lab_us-gaap_ReportingUnitAxis_label_en-US" xlink:label="lab_us-gaap_ReportingUnitAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitAxis" xlink:to="lab_us-gaap_ReportingUnitAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_38c4f2f9-f4e6-426a-ada0-6415bb5ddf4e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:to="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_da902a9a-4dd3-46b6-9081-21e80b2c82b6_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_19cdc649-1cc4-47c7-9633-89a7b9d74346_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under stock compensation and benefit plans, shares</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_0dc19849-d5dd-4472-bf16-febe257d4055_verboseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States agency debt securities</link:label>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Agencies Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_71fb677c-73b0-403f-8317-0d36fff0cdb7_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment and Geographic Data</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_5fa0ecab-5a67-4435-ab31-a05b7d266d78_periodStartLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance&#160;at Beginning of Period</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_8ad55570-7a85-4245-aef7-c9d84fda448a_periodEndLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at End of Period</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_d5d4534d-327e-40d5-95d5-3b7af1e6e3eb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InformationByCategoryOfDebtSecurityAxis_b1993cfe-de8e-4330-863b-b2a619e27920_verboseLabel_en-US" xlink:label="lab_us-gaap_InformationByCategoryOfDebtSecurityAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Gain (Loss) on Investments, Including Marketable Securities and Investments Held at Cost, Reported Amounts, by Category [Axis]</link:label>
    <link:label id="lab_us-gaap_InformationByCategoryOfDebtSecurityAxis_9cd03cfc-9640-462f-8398-6488b84969fb_terseLabel_en-US" xlink:label="lab_us-gaap_InformationByCategoryOfDebtSecurityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Security Category [Axis]</link:label>
    <link:label id="lab_us-gaap_InformationByCategoryOfDebtSecurityAxis_label_en-US" xlink:label="lab_us-gaap_InformationByCategoryOfDebtSecurityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Security Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InformationByCategoryOfDebtSecurityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InformationByCategoryOfDebtSecurityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InformationByCategoryOfDebtSecurityAxis" xlink:to="lab_us-gaap_InformationByCategoryOfDebtSecurityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SpineMember_dee0acfc-f9cf-4254-bb84-d7dc6e71719c_terseLabel_en-US" xlink:label="lab_syk_SpineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Spine</link:label>
    <link:label id="lab_syk_SpineMember_label_en-US" xlink:label="lab_syk_SpineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Spine [Member]</link:label>
    <link:label id="lab_syk_SpineMember_documentation_en-US" xlink:label="lab_syk_SpineMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Spine [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SpineMember" xlink:href="syk-20221231.xsd#syk_SpineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SpineMember" xlink:to="lab_syk_SpineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_5dddeb17-344c-44bc-ab07-d4d05f390f78_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_276a17da-cc0a-4cfe-a488-914ae34bd6ed_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gains (losses) on designated hedges</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_707d4405-90e6-4af7-aa32-f62b83af856c_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and shareholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_OtherForeignCountriesMember_c96755fc-1744-44c6-9208-080037663eee_terseLabel_en-US" xlink:label="lab_syk_OtherForeignCountriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other foreign countries</link:label>
    <link:label id="lab_syk_OtherForeignCountriesMember_label_en-US" xlink:label="lab_syk_OtherForeignCountriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other foreign countries [Member]</link:label>
    <link:label id="lab_syk_OtherForeignCountriesMember_documentation_en-US" xlink:label="lab_syk_OtherForeignCountriesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other foreign countries [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OtherForeignCountriesMember" xlink:href="syk-20221231.xsd#syk_OtherForeignCountriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_OtherForeignCountriesMember" xlink:to="lab_syk_OtherForeignCountriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_93c3a0e4-8959-4e01-96d0-cd87c22a8fb2_verboseLabel_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States treasury debt securities</link:label>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasurySecuritiesMember" xlink:to="lab_us-gaap_USTreasurySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_a57b7479-96a6-46df-9a4d-de03612e8b43_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price, Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_fb55c9e7-d015-4055-9d37-ae4023f386ec_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits paid</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_23975b61-139f-4c5c-a65e-aab0651557c4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_8144cef4-7e25-4039-b71c-d2ed5b59aef2_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average shares outstanding (in millions):</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes1.950Due2030Member_9302d712-9308-4a41-9aa9-8d811f56a101_terseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes1.950Due2030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes, 1.950% Due 2030</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes1.950Due2030Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes1.950Due2030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes, 1.950% Due 2030 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes1.950Due2030Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes1.950Due2030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes, 1.950% Due 2030 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes1.950Due2030Member" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotes1.950Due2030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes1.950Due2030Member" xlink:to="lab_syk_SeniorUnsecuredNotes1.950Due2030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_e83ac3b6-b141-4988-b3a4-4b5798313573_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_d40bc5b7-a58e-4af8-b0ed-65405a83a997_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value, Options expected to vest</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentChargesTextBlock_bfe0bbdb-fa52-4f1b-ba9b-f9be32cb0689_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentChargesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairments</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentChargesTextBlock_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentChargesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentChargesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentChargesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentChargesTextBlock" xlink:to="lab_us-gaap_AssetImpairmentChargesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotesDueNovember2023Member_c3b6fdc4-6238-4ef3-8791-9527a626f9fd_verboseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotesDueNovember2023Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes, 1.125%, due 2023</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotesDueNovember2023Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotesDueNovember2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes, Due November 2023 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotesDueNovember2023Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotesDueNovember2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes, Due November 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotesDueNovember2023Member" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotesDueNovember2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotesDueNovember2023Member" xlink:to="lab_syk_SeniorUnsecuredNotesDueNovember2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_a3b9860d-59d0-4957-aa6d-e0fed868864c_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_4f96338a-2dcf-4797-bf93-7afc686f4547_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_9a14225b-474f-44a3-856c-01f723ac7c50_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale Securities</link:label>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Classified by Contractual Maturity Date [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_3d5e375a-5364-4b75-9deb-cf8145a504b3_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_274362bb-9224-4671-bddb-4efe07d097e1_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_3865da06-e08b-467f-96b1-2e22aa05be88_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NatureOfOperations_f7fc76d4-5f55-46a0-9167-c6b60432a5cb_terseLabel_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Operations</link:label>
    <link:label id="lab_us-gaap_NatureOfOperations_label_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Operations [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NatureOfOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations" xlink:to="lab_us-gaap_NatureOfOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear_3c5b943b-39af-4052-9963-1e36670ea78f_terseLabel_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear_label_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recorded Unconditional Purchase Obligation, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear" xlink:to="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_65914cca-d3d5-4208-9b44-a8f60a3062e3_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_MovementInContractLiabilitiesRollForward_53d11957-c2de-46be-9623-55d9451ba6d3_terseLabel_en-US" xlink:label="lab_syk_MovementInContractLiabilitiesRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Movement In Contract Liabilities [Roll Forward]</link:label>
    <link:label id="lab_syk_MovementInContractLiabilitiesRollForward_label_en-US" xlink:label="lab_syk_MovementInContractLiabilitiesRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Movement In Contract Liabilities [Roll Forward]</link:label>
    <link:label id="lab_syk_MovementInContractLiabilitiesRollForward_documentation_en-US" xlink:label="lab_syk_MovementInContractLiabilitiesRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Movement In Contract Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_MovementInContractLiabilitiesRollForward" xlink:href="syk-20221231.xsd#syk_MovementInContractLiabilitiesRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_MovementInContractLiabilitiesRollForward" xlink:to="lab_syk_MovementInContractLiabilitiesRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e2521ccd-5f58-4b9a-a296-4f68192e6ee6_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_a6b27da7-408a-4df9-8bd7-7605baa48bbf_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_bc854a5e-94b3-4158-af27-36ea2628239f_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_1508c3f1-415e-47b7-af8e-16d455bc0b67_verboseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_CapitalStockAbstract_7b14d79f-03cc-40a0-a6f8-f0a9964544b5_terseLabel_en-US" xlink:label="lab_syk_CapitalStockAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Stock [Abstract]</link:label>
    <link:label id="lab_syk_CapitalStockAbstract_label_en-US" xlink:label="lab_syk_CapitalStockAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Stock [Abstract]</link:label>
    <link:label id="lab_syk_CapitalStockAbstract_documentation_en-US" xlink:label="lab_syk_CapitalStockAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Stock [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_CapitalStockAbstract" xlink:href="syk-20221231.xsd#syk_CapitalStockAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_CapitalStockAbstract" xlink:to="lab_syk_CapitalStockAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_BusinessCombinationConsiderationTransferredPricePerShare_68fc7128-f40e-47c6-9b01-6e6c963cb591_terseLabel_en-US" xlink:label="lab_syk_BusinessCombinationConsiderationTransferredPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration transferred, price per share (in dollars per share)</link:label>
    <link:label id="lab_syk_BusinessCombinationConsiderationTransferredPricePerShare_label_en-US" xlink:label="lab_syk_BusinessCombinationConsiderationTransferredPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Price Per Share</link:label>
    <link:label id="lab_syk_BusinessCombinationConsiderationTransferredPricePerShare_documentation_en-US" xlink:label="lab_syk_BusinessCombinationConsiderationTransferredPricePerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_BusinessCombinationConsiderationTransferredPricePerShare" xlink:href="syk-20221231.xsd#syk_BusinessCombinationConsiderationTransferredPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_BusinessCombinationConsiderationTransferredPricePerShare" xlink:to="lab_syk_BusinessCombinationConsiderationTransferredPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_e0e953cc-1a91-4f66-999f-82dc9bd222c9_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_63d1330a-2ac9-4c2b-ac8c-b2184b63b7da_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based payment expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_3275dfe3-3b4c-4d20-a02c-dd7c61d294b6_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_47098389-af31-4064-9ec5-e7b8a2f0aa47_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_05c00cab-c94c-4794-89fb-8c4080cadec7_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price, Options outstanding at January 1 (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_63bddf59-fa9f-49eb-98b1-23771cecebd8_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price, Options outstanding at December 31 (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_8aa6b917-d230-4e0c-b8ff-38426c6ca567_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Target plan asset allocations</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Target Allocation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_798823a1-d2c4-43be-9dbe-a174a7a6e8c6_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average life of intangible assets</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_80f271ac-4ad9-4bc5-8852-91eae294f260_verboseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Amortization Period (Years)</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_4f515162-01d6-4f10-9091-07fde32115be_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_39ee3cab-40d6-47ee-aa5e-e9677e6b5c35_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_6c2b1642-c18a-4051-988b-0d5e5df3780c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Quarterly Data</link:label>
    <link:label id="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly Financial Information [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaterialReconcilingItemsMember_5ee0ba44-b589-4c44-a6a9-598bf040b2ec_terseLabel_en-US" xlink:label="lab_us-gaap_MaterialReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reconciling Items</link:label>
    <link:label id="lab_us-gaap_MaterialReconcilingItemsMember_label_en-US" xlink:label="lab_us-gaap_MaterialReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reconciling Items [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaterialReconcilingItemsMember" xlink:to="lab_us-gaap_MaterialReconcilingItemsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_b070a36e-0e6e-44f6-bb4d-431d0bfd2b2f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest and penalties</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Penalties and Interest Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:to="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_ec06dea8-d3dc-4275-83a2-bb59e52153b9_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_b0ca4c25-d153-4fd5-ba86-de2b8b5db7d2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock_fb3e060c-28ac-4b15-b9cf-ef5e6ff1c7e0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Information on Net Sales and Long-Lived Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock" xlink:to="lab_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_6db40828-df41-4b8e-9c99-5556d3736577_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear_958dcaef-713c-487d-a70e-4a88b43eade0_terseLabel_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear_label_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recorded Unconditional Purchase Obligation, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear" xlink:to="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_c4f2d0f0-c45b-400d-a5f2-6531c6dada37_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_19b01295-b446-4725-b8ef-774c6a320953_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_b55b1b34-b1cb-46e4-9e5c-1b4eb4eb81f3_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Service Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:to="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtCurrent_439e78f5-175d-472d-a8e7-661864675bcc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current maturities of debt</link:label>
    <link:label id="lab_us-gaap_DebtCurrent_label_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtCurrent" xlink:to="lab_us-gaap_DebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_0a1c0fa7-b053-4564-8b35-bbaa8f5d0677_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital shares reserved for future issuance</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_0fbac02c-96f1-43f9-bf01-c05437a3dd14_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_45bf0fb4-e261-4899-909c-bfc2fa73c197_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Level 3)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_dd297b88-c2d2-430f-9cf1-cd9ed45d39bf_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_149a0762-3d1d-4652-877c-4423fcf126b4_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_3d4301ad-8e26-43ad-8b49-9c295f64bb03_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotesDueNovember2030Member_cd9e8004-9dd4-4d26-94d5-b2d80718578e_verboseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotesDueNovember2030Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes, 2.625% due 2030</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotesDueNovember2030Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotesDueNovember2030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes, Due November 2030 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotesDueNovember2030Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotesDueNovember2030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes, Due November 2030 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotesDueNovember2030Member" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotesDueNovember2030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotesDueNovember2030Member" xlink:to="lab_syk_SeniorUnsecuredNotesDueNovember2030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_MedSurgAndNeurotechnologyMember_6b4850af-3bcb-4e5e-8ded-496abd263451_terseLabel_en-US" xlink:label="lab_syk_MedSurgAndNeurotechnologyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MedSurg and Neurotechnology</link:label>
    <link:label id="lab_syk_MedSurgAndNeurotechnologyMember_label_en-US" xlink:label="lab_syk_MedSurgAndNeurotechnologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MedSurg and Neurotechnology [Member]</link:label>
    <link:label id="lab_syk_MedSurgAndNeurotechnologyMember_documentation_en-US" xlink:label="lab_syk_MedSurgAndNeurotechnologyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MedSurg and Neurotechnology</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_MedSurgAndNeurotechnologyMember" xlink:href="syk-20221231.xsd#syk_MedSurgAndNeurotechnologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_MedSurgAndNeurotechnologyMember" xlink:to="lab_syk_MedSurgAndNeurotechnologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_aee7d41e-e708-45d1-8730-d087a92890bd_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange impact</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_db0c5767-5297-44d9-81f3-56afbd9e999e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_598ed6fe-be04-4145-8d95-e225792fc7b1_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work in process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_1462159e-f97b-457c-868c-bc2cf79896f7_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_8ef5ba2a-5d5e-48b7-a5b9-db88cae5790b_terseLabel_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Acquired from Acquisition</link:label>
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_label_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Acquired from Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAcquiredFromAcquisition" xlink:to="lab_us-gaap_CashAcquiredFromAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_1056e915-77ae-4c4d-aef8-c5586d870563_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_a77143dd-4b42-4224-9651-a618a57afc34_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_c0a640f1-0cd4-422b-a4e2-c4ff374db410_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognized net actuarial loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_ab10ac07-54b4-4609-bfb1-245f590c3052_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Axis]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:to="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_032f6046-c08f-416c-84ff-bcc5c5f39f56_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt_0d67dbe0-b6f1-45b9-ba29-f43f4592104b_negatedTerseLabel_en-US" xlink:label="lab_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt_label_en-US" xlink:label="lab_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Debt</link:label>
    <link:label id="lab_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt_documentation_en-US" xlink:label="lab_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt" xlink:href="syk-20221231.xsd#syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt" xlink:to="lab_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_f2c0370d-4a98-4ea7-b983-0b7c08965b1d_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_6b022cfe-5707-405f-9f56-375a96b9f153_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognized actuarial loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_6036437b-c131-4085-b3e6-dfc4df290dcc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for taxes from withheld shares</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_5faa21a5-3dc9-44b5-b732-273ba8d199bc_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities &amp; shareholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes0.750due2029Member_da32dbb0-d1bd-4301-b980-f93edc0d717b_verboseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes0.750due2029Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.750% Notes due 2029</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes0.750due2029Member_a1bddad0-9c1e-435f-8d39-70538fbec709_terseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes0.750due2029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 0.750% due 2029</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes0.750due2029Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes0.750due2029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 0.750% due 2029 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes0.750due2029Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes0.750due2029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 0.750% due 2029 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes0.750due2029Member" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotes0.750due2029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes0.750due2029Member" xlink:to="lab_syk_SeniorUnsecuredNotes0.750due2029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_48a37136-05ce-43c6-b0fb-75cbbef44dc0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Difference in Income Tax Effects Comprising Company's Deferred Income Tax Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_GaussMember_54554133-9c54-4fa1-b56c-4f8064934478_terseLabel_en-US" xlink:label="lab_syk_GaussMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gauss</link:label>
    <link:label id="lab_syk_GaussMember_label_en-US" xlink:label="lab_syk_GaussMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gauss [Member]</link:label>
    <link:label id="lab_syk_GaussMember_documentation_en-US" xlink:label="lab_syk_GaussMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gauss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_GaussMember" xlink:href="syk-20221231.xsd#syk_GaussMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_GaussMember" xlink:to="lab_syk_GaussMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_123ae2ef-2fde-4f75-898a-744d069249b9_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Materials and supplies</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials and Supplies, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_TermLoanDueFebruary222025Member_bb9ab4c6-8f7b-4831-ad29-d9d19aa5d734_terseLabel_en-US" xlink:label="lab_syk_TermLoanDueFebruary222025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Due February 22, 2025</link:label>
    <link:label id="lab_syk_TermLoanDueFebruary222025Member_label_en-US" xlink:label="lab_syk_TermLoanDueFebruary222025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Due February 22, 2025 [Member]</link:label>
    <link:label id="lab_syk_TermLoanDueFebruary222025Member_documentation_en-US" xlink:label="lab_syk_TermLoanDueFebruary222025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Due February 22, 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_TermLoanDueFebruary222025Member" xlink:href="syk-20221231.xsd#syk_TermLoanDueFebruary222025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_TermLoanDueFebruary222025Member" xlink:to="lab_syk_TermLoanDueFebruary222025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_0335eed1-e7ea-414f-a6b7-45507f633e76_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_IncomeTaxExpenseBenefitTaxSettlementReleaseOfAccruedInterest_1055e7f7-5dc6-4efc-95f2-7055cfaee1ef_negatedTerseLabel_en-US" xlink:label="lab_syk_IncomeTaxExpenseBenefitTaxSettlementReleaseOfAccruedInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax settlement, release of accrued interest</link:label>
    <link:label id="lab_syk_IncomeTaxExpenseBenefitTaxSettlementReleaseOfAccruedInterest_label_en-US" xlink:label="lab_syk_IncomeTaxExpenseBenefitTaxSettlementReleaseOfAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit), Tax Settlement, Release Of Accrued Interest</link:label>
    <link:label id="lab_syk_IncomeTaxExpenseBenefitTaxSettlementReleaseOfAccruedInterest_documentation_en-US" xlink:label="lab_syk_IncomeTaxExpenseBenefitTaxSettlementReleaseOfAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit), Tax Settlement, Release Of Accrued Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_IncomeTaxExpenseBenefitTaxSettlementReleaseOfAccruedInterest" xlink:href="syk-20221231.xsd#syk_IncomeTaxExpenseBenefitTaxSettlementReleaseOfAccruedInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_IncomeTaxExpenseBenefitTaxSettlementReleaseOfAccruedInterest" xlink:to="lab_syk_IncomeTaxExpenseBenefitTaxSettlementReleaseOfAccruedInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_4dffac92-6e82-450c-b48d-4b807de7b171_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining shares authorized to be repurchased</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_da818c5a-4f62-461d-b211-3320e7302a53_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_288219d5-35fc-4cf0-b41c-b3b2306eaca1_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_5d2f55f4-66cd-4f17-a311-6fd823648d9a_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred income tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_59731957-0357-4cff-84c0-65c9e2dc5e78_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_a192921a-4842-4962-985c-94497e0a44b0_terseLabel_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_label_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:to="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_d9f0f885-a279-49c5-a257-adfc4c600dc8_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_a9d332ae-e150-4806-87e4-955b27eca42b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax_f696ea96-e892-444c-8aee-f6e5302f5006_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment hedges expected to be reclassified to cost of sales and other income (expense)</link:label>
    <link:label id="lab_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax_5f6f0d19-a991-47d1-856b-445fc8d77bbc_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives used in Net Investment Hedge, Gain (Loss), Reclassified to Earnings, Net of Tax</link:label>
    <link:label id="lab_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax_label_en-US" xlink:label="lab_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives used in Net Investment Hedge, Gain (Loss), Reclassified to Earnings, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax" xlink:to="lab_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_8d74c318-d8f8-4adb-ab8d-47f6b3d1aae9_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Level 2)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_fcc33854-b895-4580-a772-ffe0eae7eb63_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Level 2)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_0b261209-8474-476f-a391-7cb5dfe91c8f_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_8c1585a2-df20-45c5-9a95-3a2818be4647_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_77a9b23a-a847-46a2-92c1-214d1f810142_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangibles, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_71191e32-a778-428d-a7fa-cb24e51d6aa3_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net earnings per share of common stock (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense_434169eb-f832-42f3-b67b-43363ffbdd3c_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits, interest on income tax expense</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Interest on Income Taxes Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_12bb528e-f8d6-4190-8dcf-64e63b649212_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product-related liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_8c6508d2-6cf5-4a0a-8d1f-0cdc64d93037_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending accumulated benefit obligations</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_e067ce0f-c95d-426c-833b-c3676fc3be45_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear_2e38e972-e3ef-4093-a403-244e6397981f_terseLabel_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear_label_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recorded Unconditional Purchase Obligation, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear" xlink:to="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f2acfd5b-69bc-4075-9f8e-fcf29031c65c_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_1e2f9de7-8b81-4f13-b381-84402bd76ffe_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_5034ffdc-8732-48c0-9a0c-ae4c3ac96f15_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic_275bcb8b-3e36-483f-960c-be6919aa0af2_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States federal audit settlement</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Settlement, Domestic, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_203859c0-7f35-4bc1-85d7-21940aea05fe_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_18e68a4e-ff0e-4220-8ed4-327b6e0159fb_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReportingUnitDomain_daad5a12-a93b-4b86-ae69-64887e558e4a_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Domain]</link:label>
    <link:label id="lab_us-gaap_ReportingUnitDomain_label_en-US" xlink:label="lab_us-gaap_ReportingUnitDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitDomain" xlink:to="lab_us-gaap_ReportingUnitDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCash_ee4208d3-adfc-452b-aad3-bfe4bddbb91d_negatedLabel_en-US" xlink:label="lab_us-gaap_DividendsCash" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends declared</link:label>
    <link:label id="lab_us-gaap_DividendsCash_label_en-US" xlink:label="lab_us-gaap_DividendsCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCash" xlink:to="lab_us-gaap_DividendsCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_bd721465-34d7-44b2-be4f-006c39db88ff_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_e06717f6-ab13-479d-93ac-2af453063711_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation_ac0e928d-1c73-4ccf-84d2-a45d67a2ddf1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Foreign Currency Translation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_a8efa238-9125-4b4a-a585-7a003020daf1_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning uncertain tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_c02a3ccd-00b1-4d19-a345-6394153e7b01_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending uncertain tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_615e3dc9-4492-4830-ad23-e1060d1bb317_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred income tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_9ea8285d-233c-4287-8d66-23b796860191_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_657a7533-7605-4e4f-923d-ba76fbee5142_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate debt securities</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_74747ac1-c63f-4a84-960b-a4a00f2a8d0b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_963b4bdd-4a53-46cc-ba23-7a1c77ff5f75_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer Benchmark</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_08ca323a-1edf-49dc-814d-f797da2aa9c7_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_label_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentForAmortization" xlink:to="lab_us-gaap_AdjustmentForAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_043da6d0-647f-4286-a4d5-d5523489c1e1_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative asset</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Subject to Master Netting Arrangement, before Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignGovernmentDebtSecuritiesMember_ae585c0f-7d97-4ebe-bd5a-5ab3ffbe5e5d_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignGovernmentDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign government debt securities</link:label>
    <link:label id="lab_us-gaap_ForeignGovernmentDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_ForeignGovernmentDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Security, Government, Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignGovernmentDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember" xlink:to="lab_us-gaap_ForeignGovernmentDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_8ee67076-7a7c-42ef-9b7f-4b358d087729_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised during period, exercise price range, lower range limit</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_e26bc340-0249-40b5-adc5-fd8823560540_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_WeightedAverageUsedInDeterminationOfProjectedBenefitObligations_f797978a-5281-48cb-acca-2e312367a7d4_terseLabel_en-US" xlink:label="lab_syk_WeightedAverageUsedInDeterminationOfProjectedBenefitObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average discount rate used to determine projected benefit obligations</link:label>
    <link:label id="lab_syk_WeightedAverageUsedInDeterminationOfProjectedBenefitObligations_label_en-US" xlink:label="lab_syk_WeightedAverageUsedInDeterminationOfProjectedBenefitObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Used in the Determination of the Projected Benefit Obligations</link:label>
    <link:label id="lab_syk_WeightedAverageUsedInDeterminationOfProjectedBenefitObligations_documentation_en-US" xlink:label="lab_syk_WeightedAverageUsedInDeterminationOfProjectedBenefitObligations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Used in the Determination of the Projected Benefit Obligations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_WeightedAverageUsedInDeterminationOfProjectedBenefitObligations" xlink:href="syk-20221231.xsd#syk_WeightedAverageUsedInDeterminationOfProjectedBenefitObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_WeightedAverageUsedInDeterminationOfProjectedBenefitObligations" xlink:to="lab_syk_WeightedAverageUsedInDeterminationOfProjectedBenefitObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenue_954067f3-ddeb-4234-8c7c-c80690365faf_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfRevenue_label_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenue" xlink:to="lab_us-gaap_CostOfRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_70d7f0b6-a9b7-49d7-a765-7eb6a1039be7_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other financing, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_c3051e5a-37ac-476d-8bd1-e4efdb491a15_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liabilities</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_cb29dc47-5a72-41e1-b177-8738950c1883_periodStartLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning contract liabilities</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_ffd651ce-3c13-4bcf-ae0f-e09357cd214d_periodEndLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending contract liabilities</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_bcfa9a60-f47e-42fe-973d-d1b62316f488_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_91000e27-ad9d-486c-a664-caacfad1e184_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds and payments on short-term borrowings, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repayments of) Short-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_03ff8cb9-e200-475d-acf0-ccc61fd65e41_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_abe6961a-865e-4cea-803f-fbbd349fbdf9_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_8d5884c2-5049-4267-b9b7-a967b0020fd0_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_a1d4ee41-0462-41f4-9287-41f409c68642_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_9687a2b0-63b0-4fe7-ba5c-0a7fcfbe917a_verboseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowing capacity on existing facilities</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_4cbb09ff-b5f8-4614-93a3-843e376d52cc_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_495d05c3-8edb-4f7f-8ff7-48f5f6ae7456_terseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade name</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_39e71510-4abc-4620-a23c-38717a4f0d2b_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_b8db2980-2863-480c-81e5-7fd42403aeb5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_95f6b0d7-e742-4572-ad20-e6bfce962c97_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense funded with Stryker common stock</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Discretionary Contribution Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_a43ce3cd-58fd-4145-a61f-dee25236175b_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities Of Long-Term Debt Disclosures</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_ce17a38b-e6a0-45a8-b2a6-52f87d21d6d2_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentMember" xlink:to="lab_us-gaap_MachineryAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_6e9d7e13-43ce-4006-8e51-9098965ce576_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLongTermInvestmentsMember_b53b39bd-c08a-4583-af32-a7c24394be8a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLongTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherLongTermInvestmentsMember_label_en-US" xlink:label="lab_us-gaap_OtherLongTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-Term Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLongTermInvestmentsMember" xlink:to="lab_us-gaap_OtherLongTermInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_1a4fcf13-0024-4837-b6b1-de29baeb34a3_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_52bf6352-6047-47bf-8939-a0e189fd05a1_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funded status</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Funded (Unfunded) Status of Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:to="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnamortizedDebtIssuanceExpense_93e2e64c-1f3f-4939-b924-b5fe3dd32e12_verboseLabel_en-US" xlink:label="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized debt issuance costs</link:label>
    <link:label id="lab_us-gaap_UnamortizedDebtIssuanceExpense_label_en-US" xlink:label="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized Debt Issuance Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnamortizedDebtIssuanceExpense" xlink:to="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear_07a9757a-7888-47f4-b23c-1595b8ad5758_terseLabel_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear_label_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recorded Unconditional Purchase Obligation, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear" xlink:to="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_28c6f84d-1cfa-4b2f-958d-d9c10ee3cd19_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other noncurrent assets</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:to="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_CommonAndPreferredStockSharesAuthorized_108e47b7-2b81-407f-9493-2ef76bd489f9_terseLabel_en-US" xlink:label="lab_syk_CommonAndPreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common and Preferred Stock, shares authorized (in shares)</link:label>
    <link:label id="lab_syk_CommonAndPreferredStockSharesAuthorized_label_en-US" xlink:label="lab_syk_CommonAndPreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common And Preferred Stock, Shares Authorized</link:label>
    <link:label id="lab_syk_CommonAndPreferredStockSharesAuthorized_documentation_en-US" xlink:label="lab_syk_CommonAndPreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common And Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_CommonAndPreferredStockSharesAuthorized" xlink:href="syk-20221231.xsd#syk_CommonAndPreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_CommonAndPreferredStockSharesAuthorized" xlink:to="lab_syk_CommonAndPreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_InstrumentsMember_867d351a-dadc-4e37-9995-3fc74b0b21cd_terseLabel_en-US" xlink:label="lab_syk_InstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Instruments</link:label>
    <link:label id="lab_syk_InstrumentsMember_label_en-US" xlink:label="lab_syk_InstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Instruments [Member]</link:label>
    <link:label id="lab_syk_InstrumentsMember_documentation_en-US" xlink:label="lab_syk_InstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Instruments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_InstrumentsMember" xlink:href="syk-20221231.xsd#syk_InstrumentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_InstrumentsMember" xlink:to="lab_syk_InstrumentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_3ba27d44-e20b-41b2-b05b-0c0673f4c808_terseLabel_en-US" xlink:label="lab_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum term</link:label>
    <link:label id="lab_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_label_en-US" xlink:label="lab_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Remaining Maturity of Foreign Currency Derivatives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1" xlink:to="lab_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_29adcc18-35aa-4701-a026-cc1aada80295_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impaired Long-Lived Assets Held and Used by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impaired Long-Lived Assets Held and Used by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis" xlink:to="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_3f498d7e-380b-499e-9e27-9dbf12ddd63f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTable_ad6c75fb-da07-4384-836f-e79ba0468361_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-term Debt [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-Term Debt [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable" xlink:to="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_70678d8d-ad4f-4e8a-8341-165b27cb4996_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Disaggregated Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_bb0a15cb-af51-4df6-aa74-ffc5e825f797_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred income tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionAbstract_06424b91-84c0-43b2-8fb1-ba87ef4d7b17_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionAbstract" xlink:to="lab_us-gaap_RevenueRecognitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesAdjustments_31335691-f1fe-451e-a10f-8ea7d598943c_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Changes in Foreign Currency Exchange Rates</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesAdjustments_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Increase (Decrease) Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesAdjustments" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableCurrent_e2ccf1f4-a551-4f3c-90a5-2c74858bfc49_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend payable</link:label>
    <link:label id="lab_us-gaap_DividendsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableCurrent" xlink:to="lab_us-gaap_DividendsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_330e8d18-98f1-481e-9c4e-8f7b479663aa_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Plan Participant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_95a57cdb-6e21-4fca-872b-2fb3dff5f4a6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized net actuarial gain (loss)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes3.375due2024Member_c9a8a23d-4097-40dc-8325-b90465982df8_terseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes3.375due2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 3.375% due 2024</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes3.375due2024Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes3.375due2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 3.375% due 2024 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes3.375due2024Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes3.375due2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 3.375% due 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes3.375due2024Member" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotes3.375due2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes3.375due2024Member" xlink:to="lab_syk_SeniorUnsecuredNotes3.375due2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_5e83f207-02fe-4311-af3e-31315e2274e7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Reconciliation of U.S. Statutory Income Tax Rate to Company's Effective Income Tax Rate from Continuing Operations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_af3f33a1-9b9f-494a-95af-ea18917f37cd_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_ffe41ff0-e33a-4d6b-aa0b-1caed55bcd99_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of dilutive employee stock compensation (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted, Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_b189e598-5f73-446d-b479-aee34b34a1ce_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_3d8a1b0f-8169-4af3-ab0b-a81fcbaa9041_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesGainLoss_b36f757f-7233-460e-b6e7-620adf3aeee9_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities, gain (loss)</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesGainLoss_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesGainLoss" xlink:to="lab_us-gaap_MarketableSecuritiesGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_f348a703-7875-4abd-a203-943ac0447625_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research, Development and Engineering Expenses</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_18cca304-4a5f-4c9f-8628-c910a8a474c5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7f1b0a27-3291-48b0-9721-68a569273bdf_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_a39437bb-5e0f-490a-889d-0adbb726f4c5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate purchase price of acquisitions</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_DefinedContributionRetirementPlansCommonStockHeldByCompany_25deedd8-72e5-4b4b-b214-86aab3cd0484_terseLabel_en-US" xlink:label="lab_syk_DefinedContributionRetirementPlansCommonStockHeldByCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stryker common stock held by plan, shares</link:label>
    <link:label id="lab_syk_DefinedContributionRetirementPlansCommonStockHeldByCompany_label_en-US" xlink:label="lab_syk_DefinedContributionRetirementPlansCommonStockHeldByCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Retirement Plans Common Stock Held by Company</link:label>
    <link:label id="lab_syk_DefinedContributionRetirementPlansCommonStockHeldByCompany_documentation_en-US" xlink:label="lab_syk_DefinedContributionRetirementPlansCommonStockHeldByCompany" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Retirement Plans Common Stock Held by Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DefinedContributionRetirementPlansCommonStockHeldByCompany" xlink:href="syk-20221231.xsd#syk_DefinedContributionRetirementPlansCommonStockHeldByCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_DefinedContributionRetirementPlansCommonStockHeldByCompany" xlink:to="lab_syk_DefinedContributionRetirementPlansCommonStockHeldByCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_DefinedContributionRetirementPlansCommonStockValueHeldByCompany_549fe5b5-4410-4a41-8f7d-b4c8c7498f3f_terseLabel_en-US" xlink:label="lab_syk_DefinedContributionRetirementPlansCommonStockValueHeldByCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stryker common stock held by plan, amount</link:label>
    <link:label id="lab_syk_DefinedContributionRetirementPlansCommonStockValueHeldByCompany_label_en-US" xlink:label="lab_syk_DefinedContributionRetirementPlansCommonStockValueHeldByCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Retirement Plans Common Stock Value Held by Company</link:label>
    <link:label id="lab_syk_DefinedContributionRetirementPlansCommonStockValueHeldByCompany_documentation_en-US" xlink:label="lab_syk_DefinedContributionRetirementPlansCommonStockValueHeldByCompany" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Retirement Plans Common Stock Value Held by Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DefinedContributionRetirementPlansCommonStockValueHeldByCompany" xlink:href="syk-20221231.xsd#syk_DefinedContributionRetirementPlansCommonStockValueHeldByCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_DefinedContributionRetirementPlansCommonStockValueHeldByCompany" xlink:to="lab_syk_DefinedContributionRetirementPlansCommonStockValueHeldByCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsStateTaxes_712aa164-b565-4701-ba77-07c7567d601b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsStateTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsStateTaxes_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsStateTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, State Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsStateTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsStateTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsStateTaxes" xlink:to="lab_us-gaap_DeferredTaxAssetsStateTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_EndoscopyMember_77dcd5e8-eaeb-44ea-a9c0-76381161789a_terseLabel_en-US" xlink:label="lab_syk_EndoscopyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Endoscopy</link:label>
    <link:label id="lab_syk_EndoscopyMember_label_en-US" xlink:label="lab_syk_EndoscopyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Endoscopy [Member]</link:label>
    <link:label id="lab_syk_EndoscopyMember_documentation_en-US" xlink:label="lab_syk_EndoscopyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Endoscopy [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_EndoscopyMember" xlink:href="syk-20221231.xsd#syk_EndoscopyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_EndoscopyMember" xlink:to="lab_syk_EndoscopyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_c06c85cb-13de-427a-b3a4-2999e2e5a94c_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_d76881f0-7c1d-451d-8fc1-cc08bfdb7d2d_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LegalFees_606720f3-daa3-4868-9aec-088638aef070_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LegalFees" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regulatory and legal matters</link:label>
    <link:label id="lab_us-gaap_LegalFees_label_en-US" xlink:label="lab_us-gaap_LegalFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalFees" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LegalFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LegalFees" xlink:to="lab_us-gaap_LegalFees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_3361ae8f-52b5-4184-b8e4-dd581c2d4f2c_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_CustomerAndDistributorRelationshipsMember_99c4b396-56b5-4c11-a001-bf9a043850b1_terseLabel_en-US" xlink:label="lab_syk_CustomerAndDistributorRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer and distributor relationships</link:label>
    <link:label id="lab_syk_CustomerAndDistributorRelationshipsMember_label_en-US" xlink:label="lab_syk_CustomerAndDistributorRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer and Distributor Relationships [Member]</link:label>
    <link:label id="lab_syk_CustomerAndDistributorRelationshipsMember_documentation_en-US" xlink:label="lab_syk_CustomerAndDistributorRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer and Distributor Relationships</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_CustomerAndDistributorRelationshipsMember" xlink:href="syk-20221231.xsd#syk_CustomerAndDistributorRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_CustomerAndDistributorRelationshipsMember" xlink:to="lab_syk_CustomerAndDistributorRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_0964a64d-f886-4376-9680-d514a2c88e92_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_NeurovascularMember_1b2621c7-9a06-4fdb-8d2b-2661d817de56_terseLabel_en-US" xlink:label="lab_syk_NeurovascularMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Neurovascular</link:label>
    <link:label id="lab_syk_NeurovascularMember_label_en-US" xlink:label="lab_syk_NeurovascularMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Neurovascular [Member]</link:label>
    <link:label id="lab_syk_NeurovascularMember_documentation_en-US" xlink:label="lab_syk_NeurovascularMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Neurovascular</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_NeurovascularMember" xlink:href="syk-20221231.xsd#syk_NeurovascularMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_NeurovascularMember" xlink:to="lab_syk_NeurovascularMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_fb763e28-c453-465f-ba4a-07465dfa68ac_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_edc2f06a-32f7-4e18-a318-1293b3802654_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherDebtSecuritiesMember_ff524dc7-3c8c-4333-877f-db53ab234bca_terseLabel_en-US" xlink:label="lab_us-gaap_OtherDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_OtherDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Debt Obligations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherDebtSecuritiesMember" xlink:to="lab_us-gaap_OtherDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_fed45daf-3759-485e-acb1-b9e9a1094383_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxSettlements_bd24937c-c161-41eb-a574-986ac5e93c48_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxSettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax settlement amount</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxSettlements_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Settlement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxSettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxSettlements" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_61ab2c42-d568-4c9e-ae71-025ad832a630_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_95227a79-482f-4424-9746-aad29daa53a7_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_47e2ae7a-29b4-4e56-bc51-e929e95e6f64_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a9754e7b-e489-4b82-b32a-d850ffc99cfe_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average fair value per share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_65b918c6-5528-46b6-b0f2-bf6fa9309fe1_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_ef34e495-9716-441a-8436-6104d9c844ad_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other noncurrent liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod_742f5bba-b224-4edd-988c-b75026eca6c5_terseLabel_en-US" xlink:label="lab_syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance period</link:label>
    <link:label id="lab_syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod_label_en-US" xlink:label="lab_syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Performance Period</link:label>
    <link:label id="lab_syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod_documentation_en-US" xlink:label="lab_syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Performance Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod" xlink:href="syk-20221231.xsd#syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod" xlink:to="lab_syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_0baff068-3d0d-4aa9-b420-460ffc3a0857_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset impairments</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_48055a07-8005-4f4c-bc32-09200c426241_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentGross_6c5b2754-bfc2-4310-b7fd-3fdd938a5333_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and equipment</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentGross" xlink:to="lab_us-gaap_MachineryAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_66ce1fe6-8907-405e-a684-82d6f0c0aada_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTermOfContract_45af6161-6e0e-4033-b1a1-9ba574cd21ce_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative term (up to)</link:label>
    <link:label id="lab_us-gaap_DerivativeTermOfContract_label_en-US" xlink:label="lab_us-gaap_DerivativeTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTermOfContract" xlink:to="lab_us-gaap_DerivativeTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_75eeb9c4-942a-4098-be78-dd5626ed8849_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_7e830a3f-0fea-4f73-ab1d-409dadef852b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit obligations</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_9e191f9d-626b-4b03-a62d-f1353b26a0a4_periodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning projected benefit obligations</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_f064bb1e-43fd-41b4-b6ea-02bc449d5b20_periodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending projected benefit obligations</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotesDueNovember2027Member_e61fe6ed-0551-4e15-9a31-6a7c08579a2e_verboseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotesDueNovember2027Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes,2.125%, due 2027</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotesDueNovember2027Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotesDueNovember2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes, Due November 2027 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotesDueNovember2027Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotesDueNovember2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes, Due November 2027 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotesDueNovember2027Member" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotesDueNovember2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotesDueNovember2027Member" xlink:to="lab_syk_SeniorUnsecuredNotesDueNovember2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SaleOfInventorySteppedUpToFairValueAtAcquisition_d9b5e4ef-d6b5-4e0e-aa24-4c7f029903c9_terseLabel_en-US" xlink:label="lab_syk_SaleOfInventorySteppedUpToFairValueAtAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of inventory stepped up to fair value at acquisition</link:label>
    <link:label id="lab_syk_SaleOfInventorySteppedUpToFairValueAtAcquisition_label_en-US" xlink:label="lab_syk_SaleOfInventorySteppedUpToFairValueAtAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Inventory, Stepped-Up to Fair Value at Acquisition</link:label>
    <link:label id="lab_syk_SaleOfInventorySteppedUpToFairValueAtAcquisition_documentation_en-US" xlink:label="lab_syk_SaleOfInventorySteppedUpToFairValueAtAcquisition" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Inventory, Stepped-Up to Fair Value at Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SaleOfInventorySteppedUpToFairValueAtAcquisition" xlink:href="syk-20221231.xsd#syk_SaleOfInventorySteppedUpToFairValueAtAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SaleOfInventorySteppedUpToFairValueAtAcquisition" xlink:to="lab_syk_SaleOfInventorySteppedUpToFairValueAtAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_1d787e6e-606f-4edd-a888-7f0680b4f311_verboseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_43cb8044-4948-4abb-85d7-e8886c2e1bc6_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp_6485dd6a-08d0-4bd8-8bfe-e33eafc8f9c4_terseLabel_en-US" xlink:label="lab_syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of closing stock price under ESPP</link:label>
    <link:label id="lab_syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp_label_en-US" xlink:label="lab_syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of Closing Stock Price Represents Purchase Price Under ESPP</link:label>
    <link:label id="lab_syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp_documentation_en-US" xlink:label="lab_syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of Closing Stock Price Represents Purchase Price Under ESPP</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp" xlink:href="syk-20221231.xsd#syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp" xlink:to="lab_syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>17
<FILENAME>syk-20221231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:2349b3b0-68ea-4cbc-845b-39a36087e2b4,g:780e132c-de96-43a0-a8bf-d2cffc0e012a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.stryker.com/role/COVERPAGE" xlink:type="simple" xlink:href="syk-20221231.xsd#COVERPAGE"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/COVERPAGE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_7d5942e0-772c-4170-bab5-50b9b2d16d1a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_5861f118-45c9-45a0-bde3-c58ed346d173" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d5942e0-772c-4170-bab5-50b9b2d16d1a" xlink:to="loc_dei_EntitiesTable_5861f118-45c9-45a0-bde3-c58ed346d173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_74cc3a6c-b573-469a-ae01-a975bb79f3f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_5861f118-45c9-45a0-bde3-c58ed346d173" xlink:to="loc_us-gaap_StatementClassOfStockAxis_74cc3a6c-b573-469a-ae01-a975bb79f3f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_e3eee962-f45a-4e9f-b318-f5b391a26e32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_74cc3a6c-b573-469a-ae01-a975bb79f3f9" xlink:to="loc_us-gaap_ClassOfStockDomain_e3eee962-f45a-4e9f-b318-f5b391a26e32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_7515bd12-2f58-4e0f-9a30-9ce36282478a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_e3eee962-f45a-4e9f-b318-f5b391a26e32" xlink:to="loc_us-gaap_CommonStockMember_7515bd12-2f58-4e0f-9a30-9ce36282478a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes1.125Due2023Member_ebbaf89f-fe44-42bb-9985-51e876e861f8" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotes1.125Due2023Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_e3eee962-f45a-4e9f-b318-f5b391a26e32" xlink:to="loc_syk_SeniorUnsecuredNotes1.125Due2023Member_ebbaf89f-fe44-42bb-9985-51e876e861f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes0.250due2024Member_1319b061-3057-46c0-9c5e-363f9b9d4720" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotes0.250due2024Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_e3eee962-f45a-4e9f-b318-f5b391a26e32" xlink:to="loc_syk_SeniorUnsecuredNotes0.250due2024Member_1319b061-3057-46c0-9c5e-363f9b9d4720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes2.125Due2027Member_e597c2ee-f75f-49c7-bc07-7cfd5b9317f0" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotes2.125Due2027Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_e3eee962-f45a-4e9f-b318-f5b391a26e32" xlink:to="loc_syk_SeniorUnsecuredNotes2.125Due2027Member_e597c2ee-f75f-49c7-bc07-7cfd5b9317f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes0.750due2029Member_bd888ccf-0a7f-4f72-84c7-bafcd07bf3c0" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotes0.750due2029Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_e3eee962-f45a-4e9f-b318-f5b391a26e32" xlink:to="loc_syk_SeniorUnsecuredNotes0.750due2029Member_bd888ccf-0a7f-4f72-84c7-bafcd07bf3c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes2.625Due2030Member_3dba89c5-4343-4791-8465-e2ad5d3aff2b" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotes2.625Due2030Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_e3eee962-f45a-4e9f-b318-f5b391a26e32" xlink:to="loc_syk_SeniorUnsecuredNotes2.625Due2030Member_3dba89c5-4343-4791-8465-e2ad5d3aff2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes1.000due2031Member_f1f49f17-eec1-472b-9ce7-eacccd8d8e9f" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotes1.000due2031Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_e3eee962-f45a-4e9f-b318-f5b391a26e32" xlink:to="loc_syk_SeniorUnsecuredNotes1.000due2031Member_f1f49f17-eec1-472b-9ce7-eacccd8d8e9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_5861f118-45c9-45a0-bde3-c58ed346d173" xlink:to="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_7e320a0a-71c5-4850-ae81-64fc69dafec3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_DocumentType_7e320a0a-71c5-4850-ae81-64fc69dafec3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_4d262e5f-b8ab-45f4-bad1-d312291be40f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_DocumentAnnualReport_4d262e5f-b8ab-45f4-bad1-d312291be40f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_6674b51b-5ebe-4bd6-81d6-f7f0d5a7f0fd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_DocumentPeriodEndDate_6674b51b-5ebe-4bd6-81d6-f7f0d5a7f0fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_21c8a07f-7976-44a4-af85-1f414df95d4d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_CurrentFiscalYearEndDate_21c8a07f-7976-44a4-af85-1f414df95d4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_8070e601-4f86-40f9-b060-c9c62079a72a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_DocumentTransitionReport_8070e601-4f86-40f9-b060-c9c62079a72a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_5eb4118f-c441-4c13-ab18-a92371d86d5b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_EntityFileNumber_5eb4118f-c441-4c13-ab18-a92371d86d5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_a580a8b5-5cb1-4ed8-afb1-3410a5b32714" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_EntityRegistrantName_a580a8b5-5cb1-4ed8-afb1-3410a5b32714" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_8188f616-6758-40ad-8cb6-94c30ba442a8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_EntityIncorporationStateCountryCode_8188f616-6758-40ad-8cb6-94c30ba442a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_4713f962-08d5-49db-ab35-1863047c0a75" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_EntityTaxIdentificationNumber_4713f962-08d5-49db-ab35-1863047c0a75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_5f4e74a8-f4cd-4c09-994f-120f3915a947" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_EntityAddressAddressLine1_5f4e74a8-f4cd-4c09-994f-120f3915a947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_cd9ca7c1-20bc-4e61-8463-f0423f756ead" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_EntityAddressCityOrTown_cd9ca7c1-20bc-4e61-8463-f0423f756ead" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_ce7753ee-b2c3-418a-aa50-1d962850f21e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_EntityAddressStateOrProvince_ce7753ee-b2c3-418a-aa50-1d962850f21e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_30e51f3c-afc5-4fa9-bc37-02cd1144530a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_EntityAddressPostalZipCode_30e51f3c-afc5-4fa9-bc37-02cd1144530a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_0a3d97cf-fb31-44d8-93da-4ba7c828dda6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_CityAreaCode_0a3d97cf-fb31-44d8-93da-4ba7c828dda6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_5e7e5214-ee3f-4cd9-be70-9bf9ba03e5cd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_LocalPhoneNumber_5e7e5214-ee3f-4cd9-be70-9bf9ba03e5cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_0640f308-35d6-489e-b684-f03ce35b9b45" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_Security12bTitle_0640f308-35d6-489e-b684-f03ce35b9b45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_7e6e5d09-2102-4723-bbea-004253fa098c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_TradingSymbol_7e6e5d09-2102-4723-bbea-004253fa098c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_523a1b07-0b0d-4669-9508-6fc9c6d8f168" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_SecurityExchangeName_523a1b07-0b0d-4669-9508-6fc9c6d8f168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12gTitle_ac31d739-f91c-442f-bc51-eef305e22bfe" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_Security12gTitle_ac31d739-f91c-442f-bc51-eef305e22bfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_80d28f7d-086b-4e35-abd2-c08dfc28b556" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_80d28f7d-086b-4e35-abd2-c08dfc28b556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_a73b313c-b31e-43e2-9698-aa67e9982155" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_EntityVoluntaryFilers_a73b313c-b31e-43e2-9698-aa67e9982155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_f36d1aa2-7b90-4b6a-8e68-a5b5caf44ff0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_EntityCurrentReportingStatus_f36d1aa2-7b90-4b6a-8e68-a5b5caf44ff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_9eaa4d4c-6d83-480a-aa1b-a706a012759e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_EntityInteractiveDataCurrent_9eaa4d4c-6d83-480a-aa1b-a706a012759e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_f1976265-25d2-4e05-9f37-1265adbf3302" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_EntityFilerCategory_f1976265-25d2-4e05-9f37-1265adbf3302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_db03c3f8-195c-4649-8cfb-598fbd58b511" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_EntityEmergingGrowthCompany_db03c3f8-195c-4649-8cfb-598fbd58b511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_61a0d187-dc7d-4bec-a65b-ea90b46c0dc5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_EntitySmallBusiness_61a0d187-dc7d-4bec-a65b-ea90b46c0dc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_fc06d7c4-c30c-4a9e-8d18-86a574ea865c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_IcfrAuditorAttestationFlag_fc06d7c4-c30c-4a9e-8d18-86a574ea865c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_e9a73e32-9a44-41aa-80f1-0c65338752ef" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_EntityShellCompany_e9a73e32-9a44-41aa-80f1-0c65338752ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_f7d4b646-3ccc-423b-aa32-d9e1aed87c52" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_EntityPublicFloat_f7d4b646-3ccc-423b-aa32-d9e1aed87c52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_cb6ec521-d9be-4200-9406-d555b5294a1f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_cb6ec521-d9be-4200-9406-d555b5294a1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_19fb06ac-20d9-4840-b901-93ac1409f334" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_19fb06ac-20d9-4840-b901-93ac1409f334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_c1873a14-8d87-4b50-9707-cd41bcc0774c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_AmendmentFlag_c1873a14-8d87-4b50-9707-cd41bcc0774c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_f80a6ffb-700f-4767-bdec-7750abb5b917" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_DocumentFiscalYearFocus_f80a6ffb-700f-4767-bdec-7750abb5b917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_7cab567c-ca64-4dc3-9021-57abf3595601" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_DocumentFiscalPeriodFocus_7cab567c-ca64-4dc3-9021-57abf3595601" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_71ff00ec-b3f8-4c05-a199-a7d4bb66bf4c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_72006eb7-e2bd-44bc-ba88-832053675c41" xlink:to="loc_dei_EntityCentralIndexKey_71ff00ec-b3f8-4c05-a199-a7d4bb66bf4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/AuditInformation" xlink:type="simple" xlink:href="syk-20221231.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_syk_AuditorInformationAbstract_03402cc2-2e23-4d52-8e94-de618fd2be63" xlink:href="syk-20221231.xsd#syk_AuditorInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_fd57fbd9-30d1-4c66-8ebf-986700a93137" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_AuditorInformationAbstract_03402cc2-2e23-4d52-8e94-de618fd2be63" xlink:to="loc_dei_AuditorFirmId_fd57fbd9-30d1-4c66-8ebf-986700a93137" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_e0baf24a-8a1b-4d5b-814c-f0d9f6567499" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_AuditorInformationAbstract_03402cc2-2e23-4d52-8e94-de618fd2be63" xlink:to="loc_dei_AuditorName_e0baf24a-8a1b-4d5b-814c-f0d9f6567499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_40078a65-de98-4432-90fc-e47302e9d8fc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_AuditorInformationAbstract_03402cc2-2e23-4d52-8e94-de618fd2be63" xlink:to="loc_dei_AuditorLocation_40078a65-de98-4432-90fc-e47302e9d8fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/ConsolidatedStatementsOfEarnings" xlink:type="simple" xlink:href="syk-20221231.xsd#ConsolidatedStatementsOfEarnings"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/ConsolidatedStatementsOfEarnings" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_190a51b8-bb15-4dcf-9520-a07b86d644cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_e70431b3-404b-4179-8423-9da492837db7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_190a51b8-bb15-4dcf-9520-a07b86d644cb" xlink:to="loc_us-gaap_Revenues_e70431b3-404b-4179-8423-9da492837db7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_4a5031a7-e2e2-4645-85c2-ede837a2e51e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_190a51b8-bb15-4dcf-9520-a07b86d644cb" xlink:to="loc_us-gaap_CostOfRevenue_4a5031a7-e2e2-4645-85c2-ede837a2e51e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_33df5ac3-cd90-439c-b684-271a82667227" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_190a51b8-bb15-4dcf-9520-a07b86d644cb" xlink:to="loc_us-gaap_GrossProfit_33df5ac3-cd90-439c-b684-271a82667227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_cacc9c2b-6d61-4666-9aae-2dbafecc9ae0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_190a51b8-bb15-4dcf-9520-a07b86d644cb" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_cacc9c2b-6d61-4666-9aae-2dbafecc9ae0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_8e5866e6-1476-45a3-ac98-38f8380ec823" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_190a51b8-bb15-4dcf-9520-a07b86d644cb" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_8e5866e6-1476-45a3-ac98-38f8380ec823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityAccrualPeriodExpense_b34e9d4f-2c69-48b4-acc3-0fdbe130333b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductLiabilityAccrualPeriodExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_190a51b8-bb15-4dcf-9520-a07b86d644cb" xlink:to="loc_us-gaap_ProductLiabilityAccrualPeriodExpense_b34e9d4f-2c69-48b4-acc3-0fdbe130333b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_db9a7b2e-e8a6-46d8-b69e-8e85c1c3224f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_190a51b8-bb15-4dcf-9520-a07b86d644cb" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_db9a7b2e-e8a6-46d8-b69e-8e85c1c3224f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_de5a8a2e-c77c-4dc5-b14d-d487fe6e0de1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_190a51b8-bb15-4dcf-9520-a07b86d644cb" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_de5a8a2e-c77c-4dc5-b14d-d487fe6e0de1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_ad990d70-df2b-4b36-a653-e5951c4e3525" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_190a51b8-bb15-4dcf-9520-a07b86d644cb" xlink:to="loc_us-gaap_OperatingExpenses_ad990d70-df2b-4b36-a653-e5951c4e3525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_95834333-4b33-4fa2-a977-72c2ff07c483" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_190a51b8-bb15-4dcf-9520-a07b86d644cb" xlink:to="loc_us-gaap_OperatingIncomeLoss_95834333-4b33-4fa2-a977-72c2ff07c483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_31561b47-13e4-4ec0-b95e-cc2cd4027fc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_190a51b8-bb15-4dcf-9520-a07b86d644cb" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_31561b47-13e4-4ec0-b95e-cc2cd4027fc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0d286906-813c-4631-9792-85d6b6bd596d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_190a51b8-bb15-4dcf-9520-a07b86d644cb" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0d286906-813c-4631-9792-85d6b6bd596d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_d36544ce-18aa-4498-ac6f-217553f0ff14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_190a51b8-bb15-4dcf-9520-a07b86d644cb" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_d36544ce-18aa-4498-ac6f-217553f0ff14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_9c294435-1928-49c1-9421-e55adaf39ea3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_190a51b8-bb15-4dcf-9520-a07b86d644cb" xlink:to="loc_us-gaap_NetIncomeLoss_9c294435-1928-49c1-9421-e55adaf39ea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_b9de006a-7033-4381-8821-d7ed511b3792" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_190a51b8-bb15-4dcf-9520-a07b86d644cb" xlink:to="loc_us-gaap_EarningsPerShareAbstract_b9de006a-7033-4381-8821-d7ed511b3792" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_c1bf1281-434a-4c2f-b616-b642d691a812" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b9de006a-7033-4381-8821-d7ed511b3792" xlink:to="loc_us-gaap_EarningsPerShareBasic_c1bf1281-434a-4c2f-b616-b642d691a812" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_62a42506-5027-4c57-b27c-aea1600714a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b9de006a-7033-4381-8821-d7ed511b3792" xlink:to="loc_us-gaap_EarningsPerShareDiluted_62a42506-5027-4c57-b27c-aea1600714a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_cd1c5856-796b-4caf-93b8-974592023c0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_190a51b8-bb15-4dcf-9520-a07b86d644cb" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_cd1c5856-796b-4caf-93b8-974592023c0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6ee153a0-1250-4656-ab9c-765fb57574b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_cd1c5856-796b-4caf-93b8-974592023c0b" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6ee153a0-1250-4656-ab9c-765fb57574b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_3d8fe519-9324-43be-9e1b-baf74c97959b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_cd1c5856-796b-4caf-93b8-974592023c0b" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_3d8fe519-9324-43be-9e1b-baf74c97959b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1a565ae2-c6c9-4d35-beef-a0d7774fef68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_cd1c5856-796b-4caf-93b8-974592023c0b" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1a565ae2-c6c9-4d35-beef-a0d7774fef68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/ConsolidatedStatementsOfEarningsParenthetical" xlink:type="simple" xlink:href="syk-20221231.xsd#ConsolidatedStatementsOfEarningsParenthetical"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/ConsolidatedStatementsOfEarningsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_6d4e85b0-b5c8-4a8b-8a02-22e58b10d8a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_76d7c0a5-244a-4007-b3cb-9668c9ab5a6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6d4e85b0-b5c8-4a8b-8a02-22e58b10d8a2" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_76d7c0a5-244a-4007-b3cb-9668c9ab5a6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="syk-20221231.xsd#ConsolidatedStatementsofComprehensiveIncome"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_9f5e7618-64da-44d6-ae50-6c3434cd511d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_87305616-d489-4ec7-b170-8a19762d146c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_9f5e7618-64da-44d6-ae50-6c3434cd511d" xlink:to="loc_us-gaap_NetIncomeLoss_87305616-d489-4ec7-b170-8a19762d146c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_40f48222-7c7c-446e-900c-a577de1d2b70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_9f5e7618-64da-44d6-ae50-6c3434cd511d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_40f48222-7c7c-446e-900c-a577de1d2b70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_ded45da9-41d2-4981-9a6f-9295fcc2994b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_40f48222-7c7c-446e-900c-a577de1d2b70" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_ded45da9-41d2-4981-9a6f-9295fcc2994b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_c1a5bd4f-412b-4bbb-9392-6e599333c8e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_40f48222-7c7c-446e-900c-a577de1d2b70" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_c1a5bd4f-412b-4bbb-9392-6e599333c8e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_1b861266-c4f3-44fa-9c7d-ae2584f9016b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_40f48222-7c7c-446e-900c-a577de1d2b70" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_1b861266-c4f3-44fa-9c7d-ae2584f9016b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_c11ffb8e-7c4b-4cea-b5c2-d12e52b85b97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_40f48222-7c7c-446e-900c-a577de1d2b70" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_c11ffb8e-7c4b-4cea-b5c2-d12e52b85b97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c16eedc1-9600-4c2b-98da-8fad3b67bfb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_40f48222-7c7c-446e-900c-a577de1d2b70" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c16eedc1-9600-4c2b-98da-8fad3b67bfb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_125cdbf9-ca03-4283-98aa-47fcde63543c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_9f5e7618-64da-44d6-ae50-6c3434cd511d" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_125cdbf9-ca03-4283-98aa-47fcde63543c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="syk-20221231.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_2b0f3658-240e-4beb-a4ce-8cc4e6da6fe5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_0cfdb0f9-48e5-47fb-b1f4-0a21db514618" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2b0f3658-240e-4beb-a4ce-8cc4e6da6fe5" xlink:to="loc_us-gaap_AssetsAbstract_0cfdb0f9-48e5-47fb-b1f4-0a21db514618" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_b5727c51-625a-4e0f-a253-4945acf530f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0cfdb0f9-48e5-47fb-b1f4-0a21db514618" xlink:to="loc_us-gaap_AssetsCurrentAbstract_b5727c51-625a-4e0f-a253-4945acf530f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0d1b91d8-40b1-471a-ba82-d6bf71386b20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_b5727c51-625a-4e0f-a253-4945acf530f9" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0d1b91d8-40b1-471a-ba82-d6bf71386b20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_551adecd-e659-4b57-9bd7-ad60ae229ca8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_b5727c51-625a-4e0f-a253-4945acf530f9" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_551adecd-e659-4b57-9bd7-ad60ae229ca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_34c6af03-4733-44af-939c-08f3e3152849" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_b5727c51-625a-4e0f-a253-4945acf530f9" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_34c6af03-4733-44af-939c-08f3e3152849" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract_cffcf2e5-cde8-4bec-9f44-cc8ff8a12250" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNetAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_b5727c51-625a-4e0f-a253-4945acf530f9" xlink:to="loc_us-gaap_InventoryNetAbstract_cffcf2e5-cde8-4bec-9f44-cc8ff8a12250" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_8af512ef-6518-42d4-95b7-d01c38f4da2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_cffcf2e5-cde8-4bec-9f44-cc8ff8a12250" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_8af512ef-6518-42d4-95b7-d01c38f4da2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_ee7ce63a-b070-4876-a2ba-0c1be28ca1be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_cffcf2e5-cde8-4bec-9f44-cc8ff8a12250" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_ee7ce63a-b070-4876-a2ba-0c1be28ca1be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_c341a0ec-3824-4e4a-a7a6-d46c50ef870e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_cffcf2e5-cde8-4bec-9f44-cc8ff8a12250" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_c341a0ec-3824-4e4a-a7a6-d46c50ef870e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_44fc7160-0ced-45a3-9bda-9548909f540a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_cffcf2e5-cde8-4bec-9f44-cc8ff8a12250" xlink:to="loc_us-gaap_InventoryNet_44fc7160-0ced-45a3-9bda-9548909f540a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_ac196d45-ddc9-47da-ac2e-46c8d3690196" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_b5727c51-625a-4e0f-a253-4945acf530f9" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_ac196d45-ddc9-47da-ac2e-46c8d3690196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_60245c22-033c-492b-8871-03697e766e8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_b5727c51-625a-4e0f-a253-4945acf530f9" xlink:to="loc_us-gaap_AssetsCurrent_60245c22-033c-492b-8871-03697e766e8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_6ba1d7e5-d3c3-4217-8a02-6a8bdb8e730d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0cfdb0f9-48e5-47fb-b1f4-0a21db514618" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAbstract_6ba1d7e5-d3c3-4217-8a02-6a8bdb8e730d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_LandBuildingsAndImprovementsGross_a3b46fee-0de8-4801-87c5-9a2116521d78" xlink:href="syk-20221231.xsd#syk_LandBuildingsAndImprovementsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_6ba1d7e5-d3c3-4217-8a02-6a8bdb8e730d" xlink:to="loc_syk_LandBuildingsAndImprovementsGross_a3b46fee-0de8-4801-87c5-9a2116521d78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross_d2936592-043d-40eb-a431-bfb0c1ccc50a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_6ba1d7e5-d3c3-4217-8a02-6a8bdb8e730d" xlink:to="loc_us-gaap_MachineryAndEquipmentGross_d2936592-043d-40eb-a431-bfb0c1ccc50a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_800ed1c3-1e21-4a1f-ae67-f7f3c7abfdbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_6ba1d7e5-d3c3-4217-8a02-6a8bdb8e730d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_800ed1c3-1e21-4a1f-ae67-f7f3c7abfdbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_eeb3858a-83ac-4614-a95e-325e8e4f43c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_6ba1d7e5-d3c3-4217-8a02-6a8bdb8e730d" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_eeb3858a-83ac-4614-a95e-325e8e4f43c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_4aaf19f8-e2c4-45d5-9c14-9d3427e9067a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_6ba1d7e5-d3c3-4217-8a02-6a8bdb8e730d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_4aaf19f8-e2c4-45d5-9c14-9d3427e9067a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_bd62280b-aed3-4392-a65e-032d70a2bd6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0cfdb0f9-48e5-47fb-b1f4-0a21db514618" xlink:to="loc_us-gaap_Goodwill_bd62280b-aed3-4392-a65e-032d70a2bd6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_602b3387-bad8-436d-ac29-05175ece1484" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0cfdb0f9-48e5-47fb-b1f4-0a21db514618" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_602b3387-bad8-436d-ac29-05175ece1484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_4c035646-087e-4ca3-bca1-7976d78b4bda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0cfdb0f9-48e5-47fb-b1f4-0a21db514618" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_4c035646-087e-4ca3-bca1-7976d78b4bda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_8cc23f12-9e66-4da7-9672-f8dcf3819855" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0cfdb0f9-48e5-47fb-b1f4-0a21db514618" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_8cc23f12-9e66-4da7-9672-f8dcf3819855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_cfad16e9-235d-48a3-899b-94e7267cdccf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0cfdb0f9-48e5-47fb-b1f4-0a21db514618" xlink:to="loc_us-gaap_Assets_cfad16e9-235d-48a3-899b-94e7267cdccf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_29012920-d7db-4751-8672-d480feddac18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2b0f3658-240e-4beb-a4ce-8cc4e6da6fe5" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_29012920-d7db-4751-8672-d480feddac18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_cac423d3-6f95-44a5-822b-91bc89470f7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_29012920-d7db-4751-8672-d480feddac18" xlink:to="loc_us-gaap_LiabilitiesAbstract_cac423d3-6f95-44a5-822b-91bc89470f7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_3c7e4168-87cf-4cc5-ba70-93cb98a08c93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_cac423d3-6f95-44a5-822b-91bc89470f7d" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_3c7e4168-87cf-4cc5-ba70-93cb98a08c93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_ed5059cf-94ef-4dda-9001-cb350030c8f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3c7e4168-87cf-4cc5-ba70-93cb98a08c93" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_ed5059cf-94ef-4dda-9001-cb350030c8f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_eaea5165-0223-454c-bc03-f59ccb2bf786" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3c7e4168-87cf-4cc5-ba70-93cb98a08c93" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_eaea5165-0223-454c-bc03-f59ccb2bf786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_0e1725c3-c46b-4066-a6fa-e658d80efd79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3c7e4168-87cf-4cc5-ba70-93cb98a08c93" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_0e1725c3-c46b-4066-a6fa-e658d80efd79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent_113bbf09-37a0-4268-a6a1-b3a8c007a440" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3c7e4168-87cf-4cc5-ba70-93cb98a08c93" xlink:to="loc_us-gaap_DividendsPayableCurrent_113bbf09-37a0-4268-a6a1-b3a8c007a440" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRefundLiabilityCurrent_d9ecaaaf-adb3-4be5-9455-d67a972cac49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRefundLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3c7e4168-87cf-4cc5-ba70-93cb98a08c93" xlink:to="loc_us-gaap_CustomerRefundLiabilityCurrent_d9ecaaaf-adb3-4be5-9455-d67a972cac49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_63cc5f94-4ffd-4e9d-b746-18207d17b57d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3c7e4168-87cf-4cc5-ba70-93cb98a08c93" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_63cc5f94-4ffd-4e9d-b746-18207d17b57d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_b8ef9bcc-a225-4949-ad55-3197b4b00693" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3c7e4168-87cf-4cc5-ba70-93cb98a08c93" xlink:to="loc_us-gaap_DebtCurrent_b8ef9bcc-a225-4949-ad55-3197b4b00693" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_16572917-3cf3-40bc-8dc7-02563638da1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3c7e4168-87cf-4cc5-ba70-93cb98a08c93" xlink:to="loc_us-gaap_LiabilitiesCurrent_16572917-3cf3-40bc-8dc7-02563638da1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_b1e97ece-5184-48e4-99c1-be53a2c33493" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_cac423d3-6f95-44a5-822b-91bc89470f7d" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_b1e97ece-5184-48e4-99c1-be53a2c33493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_bac46fe3-f24e-42c6-8c20-85a000ca527a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_cac423d3-6f95-44a5-822b-91bc89470f7d" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_bac46fe3-f24e-42c6-8c20-85a000ca527a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_e392636c-c0c1-4e5b-8493-03192dc81760" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_cac423d3-6f95-44a5-822b-91bc89470f7d" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_e392636c-c0c1-4e5b-8493-03192dc81760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_4ae191bf-010b-430c-af7c-9e8d57da29e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_cac423d3-6f95-44a5-822b-91bc89470f7d" xlink:to="loc_us-gaap_Liabilities_4ae191bf-010b-430c-af7c-9e8d57da29e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_45b34ea1-cd76-4a14-aa5b-bdc87d459dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_29012920-d7db-4751-8672-d480feddac18" xlink:to="loc_us-gaap_StockholdersEquityAbstract_45b34ea1-cd76-4a14-aa5b-bdc87d459dd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValueOutstanding_45398c29-b77b-451a-9580-c13a2056029d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValueOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_45b34ea1-cd76-4a14-aa5b-bdc87d459dd8" xlink:to="loc_us-gaap_CommonStockValueOutstanding_45398c29-b77b-451a-9580-c13a2056029d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_5663550b-de85-4b64-82e1-9bb9edae56b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_45b34ea1-cd76-4a14-aa5b-bdc87d459dd8" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_5663550b-de85-4b64-82e1-9bb9edae56b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_7d9a8782-ba50-42a8-b935-ccaa9a371384" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_45b34ea1-cd76-4a14-aa5b-bdc87d459dd8" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_7d9a8782-ba50-42a8-b935-ccaa9a371384" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c0c4b947-1461-456f-8845-db07d9611f2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_45b34ea1-cd76-4a14-aa5b-bdc87d459dd8" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c0c4b947-1461-456f-8845-db07d9611f2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_81b84988-1f6c-4dbf-a518-7d43fcbd43a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_45b34ea1-cd76-4a14-aa5b-bdc87d459dd8" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_81b84988-1f6c-4dbf-a518-7d43fcbd43a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_3eb266df-e341-4562-9438-23c16a66ea7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_29012920-d7db-4751-8672-d480feddac18" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_3eb266df-e341-4562-9438-23c16a66ea7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_daca83ab-db9f-4506-9ab6-47f8816bff03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2b0f3658-240e-4beb-a4ce-8cc4e6da6fe5" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_daca83ab-db9f-4506-9ab6-47f8816bff03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/ConsolidatedBalanceSheetsParentheticals" xlink:type="simple" xlink:href="syk-20221231.xsd#ConsolidatedBalanceSheetsParentheticals"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/ConsolidatedBalanceSheetsParentheticals" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_75636d90-b8a3-4e77-9e45-0677facb9141" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_219218f0-a465-4ff5-bbaa-a331f1d8e404" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_75636d90-b8a3-4e77-9e45-0677facb9141" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_219218f0-a465-4ff5-bbaa-a331f1d8e404" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_e70e1fc6-cefc-4cf1-996e-0c64fb3288e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_75636d90-b8a3-4e77-9e45-0677facb9141" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_e70e1fc6-cefc-4cf1-996e-0c64fb3288e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity" xlink:type="simple" xlink:href="syk-20221231.xsd#ConsolidatedStatementsOfShareholdersEquity"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_05334123-88df-4875-abe7-30b6b2434bc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_52f3c497-c2f8-4dee-a0b6-cf93083d60bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_05334123-88df-4875-abe7-30b6b2434bc1" xlink:to="loc_us-gaap_StatementTable_52f3c497-c2f8-4dee-a0b6-cf93083d60bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_fe2a4bc7-15ca-400b-9778-422c1179e09b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_52f3c497-c2f8-4dee-a0b6-cf93083d60bc" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_fe2a4bc7-15ca-400b-9778-422c1179e09b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8f502ec4-e79c-491f-adac-2f218c91d9e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_fe2a4bc7-15ca-400b-9778-422c1179e09b" xlink:to="loc_us-gaap_EquityComponentDomain_8f502ec4-e79c-491f-adac-2f218c91d9e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_ef9ddc4b-cafe-42df-ab7c-1e08156051ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8f502ec4-e79c-491f-adac-2f218c91d9e8" xlink:to="loc_us-gaap_CommonStockMember_ef9ddc4b-cafe-42df-ab7c-1e08156051ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_454eaaee-7dd6-48a9-a3fa-81c134a3bbd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8f502ec4-e79c-491f-adac-2f218c91d9e8" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_454eaaee-7dd6-48a9-a3fa-81c134a3bbd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_cc18df25-b433-4f3b-b762-eec38a68b6c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8f502ec4-e79c-491f-adac-2f218c91d9e8" xlink:to="loc_us-gaap_RetainedEarningsMember_cc18df25-b433-4f3b-b762-eec38a68b6c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c5af06ab-2ace-4bfe-9a06-aec88dbdea71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8f502ec4-e79c-491f-adac-2f218c91d9e8" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c5af06ab-2ace-4bfe-9a06-aec88dbdea71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ff997ef1-2b82-4e2e-a3e5-4a6db591272a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_52f3c497-c2f8-4dee-a0b6-cf93083d60bc" xlink:to="loc_us-gaap_StatementLineItems_ff997ef1-2b82-4e2e-a3e5-4a6db591272a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f6244f94-4276-49f5-ab23-d90f43f29ed0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ff997ef1-2b82-4e2e-a3e5-4a6db591272a" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f6244f94-4276-49f5-ab23-d90f43f29ed0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9a84dbef-6ea3-460f-b4c8-10858825686e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f6244f94-4276-49f5-ab23-d90f43f29ed0" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9a84dbef-6ea3-460f-b4c8-10858825686e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_606f6ff2-359a-48ad-8fe1-b9b1ce33e249" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f6244f94-4276-49f5-ab23-d90f43f29ed0" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_606f6ff2-359a-48ad-8fe1-b9b1ce33e249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_e9862618-1041-48b8-b3e5-555f41358914" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f6244f94-4276-49f5-ab23-d90f43f29ed0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_e9862618-1041-48b8-b3e5-555f41358914" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_820c0716-13ae-4473-9c6c-ee3e0b02f781" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f6244f94-4276-49f5-ab23-d90f43f29ed0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_820c0716-13ae-4473-9c6c-ee3e0b02f781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2791b8c3-abda-4bea-a7f7-9c8722c7697c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f6244f94-4276-49f5-ab23-d90f43f29ed0" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2791b8c3-abda-4bea-a7f7-9c8722c7697c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_bf3e863e-3116-4bb7-986c-cb740a103de3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f6244f94-4276-49f5-ab23-d90f43f29ed0" xlink:to="loc_us-gaap_NetIncomeLoss_bf3e863e-3116-4bb7-986c-cb740a103de3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCash_e81187d1-feca-487b-9d6d-130c991ee65a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCash"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f6244f94-4276-49f5-ab23-d90f43f29ed0" xlink:to="loc_us-gaap_DividendsCash_e81187d1-feca-487b-9d6d-130c991ee65a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_480b2512-26e0-4fb9-9765-37792e8492aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f6244f94-4276-49f5-ab23-d90f43f29ed0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_480b2512-26e0-4fb9-9765-37792e8492aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_e1a7c1dc-1581-4db9-9594-e32fdc10e472" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f6244f94-4276-49f5-ab23-d90f43f29ed0" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_e1a7c1dc-1581-4db9-9594-e32fdc10e472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e8ab8767-24e0-47c1-8c65-cf8561fc1cad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f6244f94-4276-49f5-ab23-d90f43f29ed0" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e8ab8767-24e0-47c1-8c65-cf8561fc1cad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="simple" xlink:href="syk-20221231.xsd#ConsolidatedStatementsOfCashFlows"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_9493c598-e093-4e3e-b6df-70eced359ce2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_699e188e-9e8c-4407-90b9-68269baa0b2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_9493c598-e093-4e3e-b6df-70eced359ce2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_699e188e-9e8c-4407-90b9-68269baa0b2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b60e1a99-c570-4a9d-827c-213dd68eca1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_699e188e-9e8c-4407-90b9-68269baa0b2c" xlink:to="loc_us-gaap_NetIncomeLoss_b60e1a99-c570-4a9d-827c-213dd68eca1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9aedc5bd-b0fb-4a4d-806c-06d33591605a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_699e188e-9e8c-4407-90b9-68269baa0b2c" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9aedc5bd-b0fb-4a4d-806c-06d33591605a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_1d4dcbb1-2a9a-457d-8ecc-47ecade56ac1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9aedc5bd-b0fb-4a4d-806c-06d33591605a" xlink:to="loc_us-gaap_Depreciation_1d4dcbb1-2a9a-457d-8ecc-47ecade56ac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_3b44d3a0-05a5-48d4-9931-858e8473b01d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9aedc5bd-b0fb-4a4d-806c-06d33591605a" xlink:to="loc_us-gaap_AdjustmentForAmortization_3b44d3a0-05a5-48d4-9931-858e8473b01d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_66035290-54e3-4a37-a11d-075b5a0aaf04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9aedc5bd-b0fb-4a4d-806c-06d33591605a" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_66035290-54e3-4a37-a11d-075b5a0aaf04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_AssetImpairmentsOtherThanGoodwillImpairment_169c7d69-e3b1-4346-9761-b0b54ca722a6" xlink:href="syk-20221231.xsd#syk_AssetImpairmentsOtherThanGoodwillImpairment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9aedc5bd-b0fb-4a4d-806c-06d33591605a" xlink:to="loc_syk_AssetImpairmentsOtherThanGoodwillImpairment_169c7d69-e3b1-4346-9761-b0b54ca722a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_1dddd8ba-7c4a-4d08-be99-54e763fde897" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9aedc5bd-b0fb-4a4d-806c-06d33591605a" xlink:to="loc_us-gaap_ShareBasedCompensation_1dddd8ba-7c4a-4d08-be99-54e763fde897" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityAccrualPeriodExpense_da5fe37b-7d64-4c74-8f27-715478cb10d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductLiabilityAccrualPeriodExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9aedc5bd-b0fb-4a4d-806c-06d33591605a" xlink:to="loc_us-gaap_ProductLiabilityAccrualPeriodExpense_da5fe37b-7d64-4c74-8f27-715478cb10d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SaleOfInventorySteppedUpToFairValueAtAcquisition_8b6b4ce5-598f-4219-901b-43d5f476c942" xlink:href="syk-20221231.xsd#syk_SaleOfInventorySteppedUpToFairValueAtAcquisition"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9aedc5bd-b0fb-4a4d-806c-06d33591605a" xlink:to="loc_syk_SaleOfInventorySteppedUpToFairValueAtAcquisition_8b6b4ce5-598f-4219-901b-43d5f476c942" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_3e3284f4-980d-4e67-8f28-95d9fb023a1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9aedc5bd-b0fb-4a4d-806c-06d33591605a" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_3e3284f4-980d-4e67-8f28-95d9fb023a1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0dbc74b8-fa4c-4959-b5b7-f9b4ba3f0bcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9aedc5bd-b0fb-4a4d-806c-06d33591605a" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0dbc74b8-fa4c-4959-b5b7-f9b4ba3f0bcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_2b9b74a2-d3e7-4b6a-a778-285e624efedf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0dbc74b8-fa4c-4959-b5b7-f9b4ba3f0bcd" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_2b9b74a2-d3e7-4b6a-a778-285e624efedf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_f33df04a-3f57-4ef6-b827-789f7667f3f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0dbc74b8-fa4c-4959-b5b7-f9b4ba3f0bcd" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_f33df04a-3f57-4ef6-b827-789f7667f3f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_7bdc9ebc-ea57-4d41-a7f7-8514de8fc0d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0dbc74b8-fa4c-4959-b5b7-f9b4ba3f0bcd" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_7bdc9ebc-ea57-4d41-a7f7-8514de8fc0d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_712bdea3-e171-496b-b139-ea2af6722ca3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0dbc74b8-fa4c-4959-b5b7-f9b4ba3f0bcd" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_712bdea3-e171-496b-b139-ea2af6722ca3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_Changeinaccrualforrecallexpenses_792fa532-1ba2-436e-88b5-033d4dc0f058" xlink:href="syk-20221231.xsd#syk_Changeinaccrualforrecallexpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0dbc74b8-fa4c-4959-b5b7-f9b4ba3f0bcd" xlink:to="loc_syk_Changeinaccrualforrecallexpenses_792fa532-1ba2-436e-88b5-033d4dc0f058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_99e0a0d0-9442-481b-b5c9-e64d5e3150a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0dbc74b8-fa4c-4959-b5b7-f9b4ba3f0bcd" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_99e0a0d0-9442-481b-b5c9-e64d5e3150a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_fea81be3-c0e4-49e0-8bd7-1d07dc222200" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0dbc74b8-fa4c-4959-b5b7-f9b4ba3f0bcd" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_fea81be3-c0e4-49e0-8bd7-1d07dc222200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_caed4127-80e2-4c31-b1b7-f66f25033a82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_699e188e-9e8c-4407-90b9-68269baa0b2c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_caed4127-80e2-4c31-b1b7-f66f25033a82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f6e6ae33-36ea-4f32-8082-afb3c58270aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_9493c598-e093-4e3e-b6df-70eced359ce2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f6e6ae33-36ea-4f32-8082-afb3c58270aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_c41aa9e7-75ec-44dd-8fd3-94b5b58961e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f6e6ae33-36ea-4f32-8082-afb3c58270aa" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_c41aa9e7-75ec-44dd-8fd3-94b5b58961e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_96de508d-90b5-4bba-abd5-943ffaa5873c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f6e6ae33-36ea-4f32-8082-afb3c58270aa" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_96de508d-90b5-4bba-abd5-943ffaa5873c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_ef4da37f-55dd-4b33-b2a6-3adcccb37689" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f6e6ae33-36ea-4f32-8082-afb3c58270aa" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_ef4da37f-55dd-4b33-b2a6-3adcccb37689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_76375d4c-ca51-4f59-83de-d704ce8a8b0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f6e6ae33-36ea-4f32-8082-afb3c58270aa" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_76375d4c-ca51-4f59-83de-d704ce8a8b0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeInvestingActivities_c9253df4-b06e-4587-8f16-2d34e5bd8906" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromHedgeInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f6e6ae33-36ea-4f32-8082-afb3c58270aa" xlink:to="loc_us-gaap_ProceedsFromHedgeInvestingActivities_c9253df4-b06e-4587-8f16-2d34e5bd8906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_7a9673da-4cf3-4ed2-add9-5dd13dffbfbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f6e6ae33-36ea-4f32-8082-afb3c58270aa" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_7a9673da-4cf3-4ed2-add9-5dd13dffbfbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_fcd08f44-3dbf-47bd-90bc-95867d059724" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f6e6ae33-36ea-4f32-8082-afb3c58270aa" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_fcd08f44-3dbf-47bd-90bc-95867d059724" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_cf36f143-7326-4304-be3a-41fa63624560" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_9493c598-e093-4e3e-b6df-70eced359ce2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_cf36f143-7326-4304-be3a-41fa63624560" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_f107f285-7cff-41c7-bb2d-2b6358467d4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_cf36f143-7326-4304-be3a-41fa63624560" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_f107f285-7cff-41c7-bb2d-2b6358467d4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_9a0bdbe0-d9d0-4c3a-9d31-57098b122b61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_cf36f143-7326-4304-be3a-41fa63624560" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_9a0bdbe0-d9d0-4c3a-9d31-57098b122b61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_835a95fc-89f6-4f74-ab73-a23c540a4fbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_cf36f143-7326-4304-be3a-41fa63624560" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_835a95fc-89f6-4f74-ab73-a23c540a4fbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_cf0ef2bc-d379-4953-b3df-2817f83ba3f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_cf36f143-7326-4304-be3a-41fa63624560" xlink:to="loc_us-gaap_PaymentsOfDividends_cf0ef2bc-d379-4953-b3df-2817f83ba3f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_f7ddf072-7899-4640-b023-a8a11f6b6355" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_cf36f143-7326-4304-be3a-41fa63624560" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_f7ddf072-7899-4640-b023-a8a11f6b6355" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_dde35290-0b02-47fa-a440-cc2b51bd3232" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_cf36f143-7326-4304-be3a-41fa63624560" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_dde35290-0b02-47fa-a440-cc2b51bd3232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3a686fef-46aa-4774-94c7-c93200b6085e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_cf36f143-7326-4304-be3a-41fa63624560" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3a686fef-46aa-4774-94c7-c93200b6085e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_bca30565-8735-4428-9e5c-69f8bca5f4c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_9493c598-e093-4e3e-b6df-70eced359ce2" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_bca30565-8735-4428-9e5c-69f8bca5f4c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_798dcf93-bf9a-4fcf-8389-26551dfa4b7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_9493c598-e093-4e3e-b6df-70eced359ce2" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_798dcf93-bf9a-4fcf-8389-26551dfa4b7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1c663b57-7719-46fd-af49-0499a4cb369b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_9493c598-e093-4e3e-b6df-70eced359ce2" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1c663b57-7719-46fd-af49-0499a4cb369b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_109ba224-c957-490b-aa5b-196136abc2f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_9493c598-e093-4e3e-b6df-70eced359ce2" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_109ba224-c957-490b-aa5b-196136abc2f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_4ccc3a05-54ac-436c-b930-79185b36dfa7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_9493c598-e093-4e3e-b6df-70eced359ce2" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_4ccc3a05-54ac-436c-b930-79185b36dfa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_fa28a61e-f722-47b7-8dc6-b1880c069fa2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_4ccc3a05-54ac-436c-b930-79185b36dfa7" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_fa28a61e-f722-47b7-8dc6-b1880c069fa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_cf3cf0a4-b253-49da-acba-25afb16d1346" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_4ccc3a05-54ac-436c-b930-79185b36dfa7" xlink:to="loc_us-gaap_InterestPaidNet_cf3cf0a4-b253-49da-acba-25afb16d1346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/SignificantAccountingPolicies" xlink:type="simple" xlink:href="syk-20221231.xsd#SignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/SignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_1c2933c2-a17f-44ce-866a-648594c82dc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_eac7b5d2-1227-40cb-8ec1-dc9e016f7a5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1c2933c2-a17f-44ce-866a-648594c82dc4" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_eac7b5d2-1227-40cb-8ec1-dc9e016f7a5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RevenueRecognition" xlink:type="simple" xlink:href="syk-20221231.xsd#RevenueRecognition"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/RevenueRecognition" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionAbstract_5e7110c8-d01e-4bb0-9db5-a399a2aa9eb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_f2bd0690-b1f4-4850-9896-8a35926791c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRecognitionAbstract_5e7110c8-d01e-4bb0-9db5-a399a2aa9eb5" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_f2bd0690-b1f4-4850-9896-8a35926791c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="syk-20221231.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_5ed9c0e7-5283-4a95-9a20-5fc8b099e851" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_5913c19b-150e-4ab7-8592-5757ec964684" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_5ed9c0e7-5283-4a95-9a20-5fc8b099e851" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_5913c19b-150e-4ab7-8592-5757ec964684" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/DerivativeInstruments" xlink:type="simple" xlink:href="syk-20221231.xsd#DerivativeInstruments"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/DerivativeInstruments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_13688fb9-fdad-4c28-9581-50ee6bae481a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_ac4e9721-2a50-499b-829f-23ef6447cbf6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_13688fb9-fdad-4c28-9581-50ee6bae481a" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_ac4e9721-2a50-499b-829f-23ef6447cbf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCI" xlink:type="simple" xlink:href="syk-20221231.xsd#AccumulatedOtherComprehensiveLossIncomeAOCI"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCI" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract_4b56ff98-652e-41be-b1ac-b85b65d5b3ea" xlink:href="syk-20221231.xsd#syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_d793e009-f599-4cb6-bec5-a02977c590cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract_4b56ff98-652e-41be-b1ac-b85b65d5b3ea" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_d793e009-f599-4cb6-bec5-a02977c590cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/Acquisitions" xlink:type="simple" xlink:href="syk-20221231.xsd#Acquisitions"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/Acquisitions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_8ce6097b-72ad-4cd2-b3d1-3746b1a3a56d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_8fe3982e-c942-44ab-9694-9e96d441f05f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_8ce6097b-72ad-4cd2-b3d1-3746b1a3a56d" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_8fe3982e-c942-44ab-9694-9e96d441f05f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/ContingenciesandCommitments" xlink:type="simple" xlink:href="syk-20221231.xsd#ContingenciesandCommitments"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/ContingenciesandCommitments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_24171a43-45f5-4212-bf0b-a8308ced845e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_691d700e-9afd-468e-af7e-8d2d4a8b5d8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_24171a43-45f5-4212-bf0b-a8308ced845e" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_691d700e-9afd-468e-af7e-8d2d4a8b5d8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/GoodwillandOtherIntangibleAssets" xlink:type="simple" xlink:href="syk-20221231.xsd#GoodwillandOtherIntangibleAssets"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/GoodwillandOtherIntangibleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_3e944b8d-a66c-46a4-97ec-b08a4f6976cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_7c2b3255-62d9-4e79-b0df-7f4fad77e1a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_3e944b8d-a66c-46a4-97ec-b08a4f6976cd" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_7c2b3255-62d9-4e79-b0df-7f4fad77e1a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/CapitalStock" xlink:type="simple" xlink:href="syk-20221231.xsd#CapitalStock"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/CapitalStock" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_syk_CapitalStockAbstract_8886e1c1-ca32-4da9-ae41-e220583ba5eb" xlink:href="syk-20221231.xsd#syk_CapitalStockAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_0e0bbdad-d0eb-4e6e-aa97-5e1db5e882a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_CapitalStockAbstract_8886e1c1-ca32-4da9-ae41-e220583ba5eb" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_0e0bbdad-d0eb-4e6e-aa97-5e1db5e882a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/DebtandCreditFacilities" xlink:type="simple" xlink:href="syk-20221231.xsd#DebtandCreditFacilities"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/DebtandCreditFacilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAbstract_a70fd16f-5657-47a6-ba20-9a95cd83bfa2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_3cdcd883-6ac9-46c2-b535-3cd5f8ebabc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtAbstract_a70fd16f-5657-47a6-ba20-9a95cd83bfa2" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_3cdcd883-6ac9-46c2-b535-3cd5f8ebabc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/IncomeTaxes" xlink:type="simple" xlink:href="syk-20221231.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_142d6d93-9a54-4835-8fa6-e46c76e56058" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_50d2289c-a264-432d-90be-4b9b5ed317ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_142d6d93-9a54-4835-8fa6-e46c76e56058" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_50d2289c-a264-432d-90be-4b9b5ed317ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RetirementPlans" xlink:type="simple" xlink:href="syk-20221231.xsd#RetirementPlans"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/RetirementPlans" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_3b31225f-6590-439c-8413-123a2b055610" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_9e166bd0-599b-4b11-b8ae-9023fd610469" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_3b31225f-6590-439c-8413-123a2b055610" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_9e166bd0-599b-4b11-b8ae-9023fd610469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/SummaryofQuarterlyDataUnaudited" xlink:type="simple" xlink:href="syk-20221231.xsd#SummaryofQuarterlyDataUnaudited"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/SummaryofQuarterlyDataUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialDataAbstract_30c8b2c4-68fb-4623-8d7b-2b3685e76cd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_QuarterlyFinancialDataAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationTextBlock_ea1ff667-7e6e-43aa-9ffe-1e90535bbbc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_QuarterlyFinancialInformationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialDataAbstract_30c8b2c4-68fb-4623-8d7b-2b3685e76cd8" xlink:to="loc_us-gaap_QuarterlyFinancialInformationTextBlock_ea1ff667-7e6e-43aa-9ffe-1e90535bbbc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/SegmentandGeographicData" xlink:type="simple" xlink:href="syk-20221231.xsd#SegmentandGeographicData"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/SegmentandGeographicData" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_00a14d79-ac74-401f-a950-b684c687b22f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_8574dd28-7bb2-4b95-98be-4d782ea441b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_00a14d79-ac74-401f-a950-b684c687b22f" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_8574dd28-7bb2-4b95-98be-4d782ea441b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/AssetImpairments" xlink:type="simple" xlink:href="syk-20221231.xsd#AssetImpairments"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/AssetImpairments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_01a81b36-e409-4c10-9d12-847075643b31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentChargesTextBlock_1df21632-a2b4-496b-ba0d-a1d26560dee2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentChargesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_01a81b36-e409-4c10-9d12-847075643b31" xlink:to="loc_us-gaap_AssetImpairmentChargesTextBlock_1df21632-a2b4-496b-ba0d-a1d26560dee2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/ScheduleIIValuationandQualifyingAccountsNotes" xlink:type="simple" xlink:href="syk-20221231.xsd#ScheduleIIValuationandQualifyingAccountsNotes"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/ScheduleIIValuationandQualifyingAccountsNotes" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.stryker.com/role/SignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="syk-20221231.xsd#SignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/SignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_02231369-a649-433c-88e2-267a115b608a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations_fb5e4521-2db2-42df-8954-c85508a304b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NatureOfOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_02231369-a649-433c-88e2-267a115b608a" xlink:to="loc_us-gaap_NatureOfOperations_fb5e4521-2db2-42df-8954-c85508a304b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_2e3f597f-fe23-4ee3-ad06-7bc7aa30d5c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_02231369-a649-433c-88e2-267a115b608a" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_2e3f597f-fe23-4ee3-ad06-7bc7aa30d5c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_1a465736-35eb-4f08-89ec-7b1f6113723b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_02231369-a649-433c-88e2-267a115b608a" xlink:to="loc_us-gaap_UseOfEstimates_1a465736-35eb-4f08-89ec-7b1f6113723b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_bfce67b5-3b4b-4108-99da-b16001f87d31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_02231369-a649-433c-88e2-267a115b608a" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_bfce67b5-3b4b-4108-99da-b16001f87d31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesPolicyTextBlock_026c14aa-9096-47d3-af97-754b626bbcd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_02231369-a649-433c-88e2-267a115b608a" xlink:to="loc_us-gaap_CostOfSalesPolicyTextBlock_026c14aa-9096-47d3-af97-754b626bbcd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_13459161-222d-40e7-bcad-ca7ebbb35c32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_02231369-a649-433c-88e2-267a115b608a" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_13459161-222d-40e7-bcad-ca7ebbb35c32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_77c81d8a-78d1-4879-ac61-0787201c32bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_02231369-a649-433c-88e2-267a115b608a" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_77c81d8a-78d1-4879-ac61-0787201c32bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_3842524f-c42d-4e9b-a92e-2ab8a0f49432" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_02231369-a649-433c-88e2-267a115b608a" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_3842524f-c42d-4e9b-a92e-2ab8a0f49432" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_f924de59-27fc-4dca-9011-4cf40a864f8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_02231369-a649-433c-88e2-267a115b608a" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_f924de59-27fc-4dca-9011-4cf40a864f8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy_30fe6f69-122d-476b-82b9-7b329c5b4387" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesPolicy"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_02231369-a649-433c-88e2-267a115b608a" xlink:to="loc_us-gaap_MarketableSecuritiesPolicy_30fe6f69-122d-476b-82b9-7b329c5b4387" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_6c216858-0d27-4703-b414-16f292114204" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_02231369-a649-433c-88e2-267a115b608a" xlink:to="loc_us-gaap_ReceivablesPolicyTextBlock_6c216858-0d27-4703-b414-16f292114204" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_32d15195-20ca-4a02-9d5c-eac78d809967" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_02231369-a649-433c-88e2-267a115b608a" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_32d15195-20ca-4a02-9d5c-eac78d809967" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOptionTextBlock_26e27551-d8c5-47ef-b648-2c8ebb5a0e18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOptionTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_02231369-a649-433c-88e2-267a115b608a" xlink:to="loc_us-gaap_FairValueOptionTextBlock_26e27551-d8c5-47ef-b648-2c8ebb5a0e18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_3df2a9e3-f54c-465a-a976-6501467abdea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_02231369-a649-433c-88e2-267a115b608a" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_3df2a9e3-f54c-465a-a976-6501467abdea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_f08d75b4-20e2-4aae-a905-396d3dae8673" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_02231369-a649-433c-88e2-267a115b608a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_f08d75b4-20e2-4aae-a905-396d3dae8673" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_150b8a5f-3127-493f-a7cc-0e032952b3f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_02231369-a649-433c-88e2-267a115b608a" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_150b8a5f-3127-493f-a7cc-0e032952b3f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock_54ecdbee-bc68-4680-b257-3918c5cfb73f" xlink:href="syk-20221231.xsd#syk_GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_02231369-a649-433c-88e2-267a115b608a" xlink:to="loc_syk_GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock_54ecdbee-bc68-4680-b257-3918c5cfb73f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_156f0f35-f592-4acb-af86-dee5b19ebc5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_02231369-a649-433c-88e2-267a115b608a" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_156f0f35-f592-4acb-af86-dee5b19ebc5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_541cbe43-2d84-414e-b88f-2da66784e70e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_02231369-a649-433c-88e2-267a115b608a" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_541cbe43-2d84-414e-b88f-2da66784e70e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_24b9638e-f668-4f02-8a0f-bb63cb82020e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_02231369-a649-433c-88e2-267a115b608a" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_24b9638e-f668-4f02-8a0f-bb63cb82020e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RevenueRecognitionTables" xlink:type="simple" xlink:href="syk-20221231.xsd#RevenueRecognitionTables"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/RevenueRecognitionTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionAbstract_c13e7d65-c76f-4a64-acae-192ff3ce17dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_00c14168-a3ce-444f-be30-120d3598cf28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRecognitionAbstract_c13e7d65-c76f-4a64-acae-192ff3ce17dd" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_00c14168-a3ce-444f-be30-120d3598cf28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_a2954a1e-7ad2-40a8-9dbc-5f6222b497a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRecognitionAbstract_c13e7d65-c76f-4a64-acae-192ff3ce17dd" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_a2954a1e-7ad2-40a8-9dbc-5f6222b497a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="syk-20221231.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_ba21d627-ea12-4e9c-9335-e598c8877aeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_18aca846-f655-497d-82c9-23d333f3fe89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_ba21d627-ea12-4e9c-9335-e598c8877aeb" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_18aca846-f655-497d-82c9-23d333f3fe89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_ac487da4-b39f-4783-87f3-994b898ae534" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_ba21d627-ea12-4e9c-9335-e598c8877aeb" xlink:to="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_ac487da4-b39f-4783-87f3-994b898ae534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/DerivativeInstrumentsTables" xlink:type="simple" xlink:href="syk-20221231.xsd#DerivativeInstrumentsTables"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/DerivativeInstrumentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_889628c6-f76b-47d3-ac7c-bcab266f368a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_990fc760-b7e4-4c32-92be-9f1e960d038e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_889628c6-f76b-47d3-ac7c-bcab266f368a" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_990fc760-b7e4-4c32-92be-9f1e960d038e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_f80b50b2-2b1e-442b-a7be-36c0c402c71d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_889628c6-f76b-47d3-ac7c-bcab266f368a" xlink:to="loc_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_f80b50b2-2b1e-442b-a7be-36c0c402c71d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCITables" xlink:type="simple" xlink:href="syk-20221231.xsd#AccumulatedOtherComprehensiveLossIncomeAOCITables"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCITables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract_7de1b276-2c5d-427a-81e4-2ed2afb35dec" xlink:href="syk-20221231.xsd#syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_cab6ff52-d59b-4343-98f4-d022bb8accae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract_7de1b276-2c5d-427a-81e4-2ed2afb35dec" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_cab6ff52-d59b-4343-98f4-d022bb8accae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/AcquisitionsTables" xlink:type="simple" xlink:href="syk-20221231.xsd#AcquisitionsTables"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/AcquisitionsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_33ee9420-ea19-48de-bb4a-ab0cf7a1cd97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_be590a51-b524-44ed-a92b-b25d6ccbff65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_33ee9420-ea19-48de-bb4a-ab0cf7a1cd97" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_be590a51-b524-44ed-a92b-b25d6ccbff65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/ContingenciesandCommitmentsTables" xlink:type="simple" xlink:href="syk-20221231.xsd#ContingenciesandCommitmentsTables"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/ContingenciesandCommitmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d3ed6a63-5c19-42f1-b6f7-205580efe057" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_69a6022c-1ff8-4ec1-a0bd-038ab7fc38c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d3ed6a63-5c19-42f1-b6f7-205580efe057" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_69a6022c-1ff8-4ec1-a0bd-038ab7fc38c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock_2a61a865-17f3-440d-850a-f43a3ffaff73" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d3ed6a63-5c19-42f1-b6f7-205580efe057" xlink:to="loc_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock_2a61a865-17f3-440d-850a-f43a3ffaff73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsTables" xlink:type="simple" xlink:href="syk-20221231.xsd#GoodwillandOtherIntangibleAssetsTables"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_4bba26a7-b9a0-4b23-a0dd-53ce1f9ec4ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_272473c6-3030-4fe6-9dbe-bc5fa2da05c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_4bba26a7-b9a0-4b23-a0dd-53ce1f9ec4ea" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_272473c6-3030-4fe6-9dbe-bc5fa2da05c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_c5bffdb8-d131-4880-b04e-9b0de5ad00ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_4bba26a7-b9a0-4b23-a0dd-53ce1f9ec4ea" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_c5bffdb8-d131-4880-b04e-9b0de5ad00ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_01b954a4-edd0-42fc-b55c-7d4b103f873e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_4bba26a7-b9a0-4b23-a0dd-53ce1f9ec4ea" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_01b954a4-edd0-42fc-b55c-7d4b103f873e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/CapitalStockTables" xlink:type="simple" xlink:href="syk-20221231.xsd#CapitalStockTables"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/CapitalStockTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_syk_CapitalStockAbstract_3494dff0-b2b2-4c4f-ad50-63cc864f0a44" xlink:href="syk-20221231.xsd#syk_CapitalStockAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_1dd6e662-b030-4c77-8140-4dfe66ea69ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_CapitalStockAbstract_3494dff0-b2b2-4c4f-ad50-63cc864f0a44" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_1dd6e662-b030-4c77-8140-4dfe66ea69ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_9aed5722-b18d-4a0d-b015-fa252ae80e41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_CapitalStockAbstract_3494dff0-b2b2-4c4f-ad50-63cc864f0a44" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_9aed5722-b18d-4a0d-b015-fa252ae80e41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_e36fd336-7a7a-4557-9833-a4e02767c7b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_CapitalStockAbstract_3494dff0-b2b2-4c4f-ad50-63cc864f0a44" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_e36fd336-7a7a-4557-9833-a4e02767c7b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/DebtandCreditFacilitiesTables" xlink:type="simple" xlink:href="syk-20221231.xsd#DebtandCreditFacilitiesTables"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/DebtandCreditFacilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAbstract_d8992c31-696d-4339-b1c1-180ca2a520dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_f4205129-86e8-44e5-b11a-2ae974553ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtAbstract_d8992c31-696d-4339-b1c1-180ca2a520dc" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_f4205129-86e8-44e5-b11a-2ae974553ca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="syk-20221231.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_4b2527f9-396e-47c7-87a7-e93386315c6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_fa0cb210-b00c-40cc-88ff-2e00d5871828" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4b2527f9-396e-47c7-87a7-e93386315c6a" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_fa0cb210-b00c-40cc-88ff-2e00d5871828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_95a9dcae-839a-4446-8df4-2da265646596" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4b2527f9-396e-47c7-87a7-e93386315c6a" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_95a9dcae-839a-4446-8df4-2da265646596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_b4bb2c95-bf12-4c24-bb2c-4892073f1024" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4b2527f9-396e-47c7-87a7-e93386315c6a" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_b4bb2c95-bf12-4c24-bb2c-4892073f1024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_c2b561af-7b72-4ef6-93bd-ce86228c1917" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfIncomeTaxContingenciesTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4b2527f9-396e-47c7-87a7-e93386315c6a" xlink:to="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_c2b561af-7b72-4ef6-93bd-ce86228c1917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RetirementPlansTables" xlink:type="simple" xlink:href="syk-20221231.xsd#RetirementPlansTables"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/RetirementPlansTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_d176c280-094e-4e74-b0bb-dbeb185bdbee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock_0a7c53aa-2184-458c-908f-2fcfb805b120" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanDisclosuresTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_d176c280-094e-4e74-b0bb-dbeb185bdbee" xlink:to="loc_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock_0a7c53aa-2184-458c-908f-2fcfb805b120" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock_70e4c70a-1c6b-4437-94b0-a6f3d39e11ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_d176c280-094e-4e74-b0bb-dbeb185bdbee" xlink:to="loc_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock_70e4c70a-1c6b-4437-94b0-a6f3d39e11ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_8a549622-5923-4986-a556-49c85470b83e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_d176c280-094e-4e74-b0bb-dbeb185bdbee" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_8a549622-5923-4986-a556-49c85470b83e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock_6f3517a1-f0c9-4784-9b4a-969aa614b282" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_d176c280-094e-4e74-b0bb-dbeb185bdbee" xlink:to="loc_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock_6f3517a1-f0c9-4784-9b4a-969aa614b282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_fc12e305-664b-41d1-8a4f-f6c1f395a528" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_d176c280-094e-4e74-b0bb-dbeb185bdbee" xlink:to="loc_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_fc12e305-664b-41d1-8a4f-f6c1f395a528" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_370ea6c6-8acc-4093-93e0-490e164e8282" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_d176c280-094e-4e74-b0bb-dbeb185bdbee" xlink:to="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_370ea6c6-8acc-4093-93e0-490e164e8282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_a06710b7-383f-4a65-a9e3-fd8a1943bc2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_d176c280-094e-4e74-b0bb-dbeb185bdbee" xlink:to="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_a06710b7-383f-4a65-a9e3-fd8a1943bc2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/SummaryofQuarterlyDataUnauditedTables" xlink:type="simple" xlink:href="syk-20221231.xsd#SummaryofQuarterlyDataUnauditedTables"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/SummaryofQuarterlyDataUnauditedTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialDataAbstract_7829fddc-7259-4aaa-a641-db3408217a45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_QuarterlyFinancialDataAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_7befb13f-c837-45a8-a50d-9fc4339db3d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialDataAbstract_7829fddc-7259-4aaa-a641-db3408217a45" xlink:to="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_7befb13f-c837-45a8-a50d-9fc4339db3d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/SegmentandGeographicDataTables" xlink:type="simple" xlink:href="syk-20221231.xsd#SegmentandGeographicDataTables"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/SegmentandGeographicDataTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_5aebb947-5fde-499a-a686-8a4486f5d0f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_7d37b8d0-e19b-48a8-a46a-bcf1d95b455e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_5aebb947-5fde-499a-a686-8a4486f5d0f4" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_7d37b8d0-e19b-48a8-a46a-bcf1d95b455e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_7fb781de-0195-433c-a735-613f15293c41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_5aebb947-5fde-499a-a686-8a4486f5d0f4" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_7fb781de-0195-433c-a735-613f15293c41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock_9a84b48c-2d35-45e7-96a1-19aa89048f3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_5aebb947-5fde-499a-a686-8a4486f5d0f4" xlink:to="loc_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock_9a84b48c-2d35-45e7-96a1-19aa89048f3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/SignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#SignificantAccountingPoliciesDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/SignificantAccountingPoliciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_5957cb1b-af03-46db-bec4-cf6f461819c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_fd212dd6-2604-475d-8555-4eba0ef6c8be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5957cb1b-af03-46db-bec4-cf6f461819c6" xlink:to="loc_us-gaap_StatementTable_fd212dd6-2604-475d-8555-4eba0ef6c8be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1d15c004-b75f-4f34-a28b-e4347f7240f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_fd212dd6-2604-475d-8555-4eba0ef6c8be" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1d15c004-b75f-4f34-a28b-e4347f7240f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2c0df6c4-3bce-4c6c-a04e-5e20b1e71b23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1d15c004-b75f-4f34-a28b-e4347f7240f6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2c0df6c4-3bce-4c6c-a04e-5e20b1e71b23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_13173912-c85d-4fa1-83a9-416050d9e530" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2c0df6c4-3bce-4c6c-a04e-5e20b1e71b23" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_13173912-c85d-4fa1-83a9-416050d9e530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_b8b5ee78-41f3-48e9-8622-b6443d468a6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2c0df6c4-3bce-4c6c-a04e-5e20b1e71b23" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_b8b5ee78-41f3-48e9-8622-b6443d468a6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_13002b26-a146-4efd-b745-da5c9b24ceb1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_fd212dd6-2604-475d-8555-4eba0ef6c8be" xlink:to="loc_srt_RangeAxis_13002b26-a146-4efd-b745-da5c9b24ceb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8ac95e2d-7170-41e1-8069-43d4a84d8cda" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_13002b26-a146-4efd-b745-da5c9b24ceb1" xlink:to="loc_srt_RangeMember_8ac95e2d-7170-41e1-8069-43d4a84d8cda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e3252db1-548d-467b-acdf-1e50c7d52a23" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8ac95e2d-7170-41e1-8069-43d4a84d8cda" xlink:to="loc_srt_MinimumMember_e3252db1-548d-467b-acdf-1e50c7d52a23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8596a6a6-43b1-4639-b5c2-a161c0f75513" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8ac95e2d-7170-41e1-8069-43d4a84d8cda" xlink:to="loc_srt_MaximumMember_8596a6a6-43b1-4639-b5c2-a161c0f75513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_cb599344-77e3-461c-a4c0-2b03ce63af54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_fd212dd6-2604-475d-8555-4eba0ef6c8be" xlink:to="loc_us-gaap_AwardTypeAxis_cb599344-77e3-461c-a4c0-2b03ce63af54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_08e0b3b1-c284-4df9-a327-219db449c706" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_cb599344-77e3-461c-a4c0-2b03ce63af54" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_08e0b3b1-c284-4df9-a327-219db449c706" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_79d02ca2-cb07-45aa-bc87-b7084d2f7f32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_08e0b3b1-c284-4df9-a327-219db449c706" xlink:to="loc_us-gaap_EmployeeStockOptionMember_79d02ca2-cb07-45aa-bc87-b7084d2f7f32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_f7720e35-37f1-47c6-88c4-9c041e1428c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_08e0b3b1-c284-4df9-a327-219db449c706" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_f7720e35-37f1-47c6-88c4-9c041e1428c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_PerformanceStockUnitPsusMember_841b37c5-40ea-40a3-8a27-ddc06d20d07e" xlink:href="syk-20221231.xsd#syk_PerformanceStockUnitPsusMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_08e0b3b1-c284-4df9-a327-219db449c706" xlink:to="loc_syk_PerformanceStockUnitPsusMember_841b37c5-40ea-40a3-8a27-ddc06d20d07e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_03be6598-6c02-4df0-ae69-d58dccd30423" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_fd212dd6-2604-475d-8555-4eba0ef6c8be" xlink:to="loc_us-gaap_StatementLineItems_03be6598-6c02-4df0-ae69-d58dccd30423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTermOfContract_64fce6bf-d85a-48c2-bd77-f4b306bfb82a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTermOfContract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_03be6598-6c02-4df0-ae69-d58dccd30423" xlink:to="loc_us-gaap_DerivativeTermOfContract_64fce6bf-d85a-48c2-bd77-f4b306bfb82a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_28a3607a-9d5f-4aff-a2b9-32bb04c60723" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_03be6598-6c02-4df0-ae69-d58dccd30423" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_28a3607a-9d5f-4aff-a2b9-32bb04c60723" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_1656486b-879a-4d0d-bd0f-ca6662f13e3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_03be6598-6c02-4df0-ae69-d58dccd30423" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_1656486b-879a-4d0d-bd0f-ca6662f13e3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_3c2f5a15-db15-43df-9f67-22633603f714" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_03be6598-6c02-4df0-ae69-d58dccd30423" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_3c2f5a15-db15-43df-9f67-22633603f714" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod_9a011552-ecfa-426a-9f13-6d6cefa28552" xlink:href="syk-20221231.xsd#syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_03be6598-6c02-4df0-ae69-d58dccd30423" xlink:to="loc_syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod_9a011552-ecfa-426a-9f13-6d6cefa28552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RevenueRecognitionNarrativeDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#RevenueRecognitionNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/RevenueRecognitionNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionAbstract_5744d70c-b4e3-49d1-81b7-d15081748596" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_PercentageofServiceRevenueRecognizeoverTime_fb75e16e-3050-414b-9b35-3cc773dffdf8" xlink:href="syk-20221231.xsd#syk_PercentageofServiceRevenueRecognizeoverTime"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRecognitionAbstract_5744d70c-b4e3-49d1-81b7-d15081748596" xlink:to="loc_syk_PercentageofServiceRevenueRecognizeoverTime_fb75e16e-3050-414b-9b35-3cc773dffdf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_07410744-b51b-43ab-903a-79fbe7511ea7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRecognitionAbstract_5744d70c-b4e3-49d1-81b7-d15081748596" xlink:to="loc_us-gaap_ContractWithCustomerLiability_07410744-b51b-43ab-903a-79fbe7511ea7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#RevenueRecognitionDisaggregatedSalesAnalysisDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionAbstract_10bac5d4-3c4e-499d-adf6-03723ae35ba7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_136847fa-dd1b-4ab9-8192-c6f0366a61a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRecognitionAbstract_10bac5d4-3c4e-499d-adf6-03723ae35ba7" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_136847fa-dd1b-4ab9-8192-c6f0366a61a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_edbb353b-4b59-4f9e-bb7e-6d2d9a5eda02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_136847fa-dd1b-4ab9-8192-c6f0366a61a0" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_edbb353b-4b59-4f9e-bb7e-6d2d9a5eda02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b302e0e4-a7af-4b2a-9d8a-e85be0702ae1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_edbb353b-4b59-4f9e-bb7e-6d2d9a5eda02" xlink:to="loc_us-gaap_SegmentDomain_b302e0e4-a7af-4b2a-9d8a-e85be0702ae1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_MedSurgAndNeurotechnologyMember_bf989450-e30b-4e54-880b-b14e7e26854d" xlink:href="syk-20221231.xsd#syk_MedSurgAndNeurotechnologyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b302e0e4-a7af-4b2a-9d8a-e85be0702ae1" xlink:to="loc_syk_MedSurgAndNeurotechnologyMember_bf989450-e30b-4e54-880b-b14e7e26854d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OrthopaedicsAndSpineMember_c7eab2ca-3be7-401b-bb40-2bf25da8f9be" xlink:href="syk-20221231.xsd#syk_OrthopaedicsAndSpineMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b302e0e4-a7af-4b2a-9d8a-e85be0702ae1" xlink:to="loc_syk_OrthopaedicsAndSpineMember_c7eab2ca-3be7-401b-bb40-2bf25da8f9be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_78c1a5cd-6f84-4a3d-9001-c20350bf0374" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_136847fa-dd1b-4ab9-8192-c6f0366a61a0" xlink:to="loc_srt_ProductOrServiceAxis_78c1a5cd-6f84-4a3d-9001-c20350bf0374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d397b703-d2a2-4115-bcc7-105a711b0f4e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_78c1a5cd-6f84-4a3d-9001-c20350bf0374" xlink:to="loc_srt_ProductsAndServicesDomain_d397b703-d2a2-4115-bcc7-105a711b0f4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_InstrumentsMember_c6fa72c4-8cb3-4fbd-ac36-4119c5005fbe" xlink:href="syk-20221231.xsd#syk_InstrumentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d397b703-d2a2-4115-bcc7-105a711b0f4e" xlink:to="loc_syk_InstrumentsMember_c6fa72c4-8cb3-4fbd-ac36-4119c5005fbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_EndoscopyMember_c14c8f87-fc4b-4c5f-abcb-369eb3f6c596" xlink:href="syk-20221231.xsd#syk_EndoscopyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d397b703-d2a2-4115-bcc7-105a711b0f4e" xlink:to="loc_syk_EndoscopyMember_c14c8f87-fc4b-4c5f-abcb-369eb3f6c596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_MedicalMember_b794e57b-30e4-4a69-9414-8a9e7c54cde6" xlink:href="syk-20221231.xsd#syk_MedicalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d397b703-d2a2-4115-bcc7-105a711b0f4e" xlink:to="loc_syk_MedicalMember_b794e57b-30e4-4a69-9414-8a9e7c54cde6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_NeurovascularMember_5c834867-a691-467b-9eff-d112f5e4733f" xlink:href="syk-20221231.xsd#syk_NeurovascularMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d397b703-d2a2-4115-bcc7-105a711b0f4e" xlink:to="loc_syk_NeurovascularMember_5c834867-a691-467b-9eff-d112f5e4733f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_NeuroCranialMember_bb81fb04-e124-4d94-858f-a220ab1b0ab2" xlink:href="syk-20221231.xsd#syk_NeuroCranialMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d397b703-d2a2-4115-bcc7-105a711b0f4e" xlink:to="loc_syk_NeuroCranialMember_bb81fb04-e124-4d94-858f-a220ab1b0ab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OtherOrthopaedicsMember_a2d98981-04e7-45a4-99c8-aad0fe8c84da" xlink:href="syk-20221231.xsd#syk_OtherOrthopaedicsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d397b703-d2a2-4115-bcc7-105a711b0f4e" xlink:to="loc_syk_OtherOrthopaedicsMember_a2d98981-04e7-45a4-99c8-aad0fe8c84da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_KneesMember_2543c52d-6e0d-4281-b8cc-a7b5093f0c87" xlink:href="syk-20221231.xsd#syk_KneesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d397b703-d2a2-4115-bcc7-105a711b0f4e" xlink:to="loc_syk_KneesMember_2543c52d-6e0d-4281-b8cc-a7b5093f0c87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_HipsMember_b5f97c37-f365-4bff-85f5-dfce3eb28027" xlink:href="syk-20221231.xsd#syk_HipsMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d397b703-d2a2-4115-bcc7-105a711b0f4e" xlink:to="loc_syk_HipsMember_b5f97c37-f365-4bff-85f5-dfce3eb28027" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_TraumaandExtremitiesMember_16fc0755-6072-4f7c-bea9-eb1c02afcdd1" xlink:href="syk-20221231.xsd#syk_TraumaandExtremitiesMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d397b703-d2a2-4115-bcc7-105a711b0f4e" xlink:to="loc_syk_TraumaandExtremitiesMember_16fc0755-6072-4f7c-bea9-eb1c02afcdd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SpineMember_4a8e2e93-37cd-4532-8875-cc5cf42e4d02" xlink:href="syk-20221231.xsd#syk_SpineMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d397b703-d2a2-4115-bcc7-105a711b0f4e" xlink:to="loc_syk_SpineMember_4a8e2e93-37cd-4532-8875-cc5cf42e4d02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_da22985c-8986-4272-a1b2-0b7a03e383ed" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_136847fa-dd1b-4ab9-8192-c6f0366a61a0" xlink:to="loc_srt_StatementGeographicalAxis_da22985c-8986-4272-a1b2-0b7a03e383ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_db36a17b-0b2a-42bf-a880-cf7ee452c0d6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_da22985c-8986-4272-a1b2-0b7a03e383ed" xlink:to="loc_srt_SegmentGeographicalDomain_db36a17b-0b2a-42bf-a880-cf7ee452c0d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_5d249ad0-cef4-4801-9df1-935e0faa62d6" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_db36a17b-0b2a-42bf-a880-cf7ee452c0d6" xlink:to="loc_country_US_5d249ad0-cef4-4801-9df1-935e0faa62d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_4bb8b02e-f7ce-458c-90d4-00df662a3e23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_db36a17b-0b2a-42bf-a880-cf7ee452c0d6" xlink:to="loc_us-gaap_NonUsMember_4bb8b02e-f7ce-458c-90d4-00df662a3e23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_018c54e1-50a6-427a-8001-0ef4a4241f23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_136847fa-dd1b-4ab9-8192-c6f0366a61a0" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_018c54e1-50a6-427a-8001-0ef4a4241f23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_bfa8860d-6e26-4aca-83d1-890f9d6b5cfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_018c54e1-50a6-427a-8001-0ef4a4241f23" xlink:to="loc_us-gaap_Revenues_bfa8860d-6e26-4aca-83d1-890f9d6b5cfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RevenueRecognitionChangesinContractLiabilitiesDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#RevenueRecognitionChangesinContractLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/RevenueRecognitionChangesinContractLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_9eba3e14-e3d4-4568-b367-caccc68ce83c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_MovementInContractLiabilitiesRollForward_03032700-7a58-4ea9-bbbd-a0f4166880a1" xlink:href="syk-20221231.xsd#syk_MovementInContractLiabilitiesRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_9eba3e14-e3d4-4568-b367-caccc68ce83c" xlink:to="loc_syk_MovementInContractLiabilitiesRollForward_03032700-7a58-4ea9-bbbd-a0f4166880a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_0c1a1254-67a6-4b00-8a35-885fa44db9ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_MovementInContractLiabilitiesRollForward_03032700-7a58-4ea9-bbbd-a0f4166880a1" xlink:to="loc_us-gaap_ContractWithCustomerLiability_0c1a1254-67a6-4b00-8a35-885fa44db9ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_caa1f42c-4b8c-4b43-8df3-c4c7ab14e467" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_MovementInContractLiabilitiesRollForward_03032700-7a58-4ea9-bbbd-a0f4166880a1" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_caa1f42c-4b8c-4b43-8df3-c4c7ab14e467" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination_390b5e74-9280-4062-8f20-79df51b3fb3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_MovementInContractLiabilitiesRollForward_03032700-7a58-4ea9-bbbd-a0f4166880a1" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination_390b5e74-9280-4062-8f20-79df51b3fb3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_ContractWithCustomerLiabilityNetAdvanceConsiderationReceivedDuringPeriod_c7409f17-9b4e-471f-ab0b-4a3202488228" xlink:href="syk-20221231.xsd#syk_ContractWithCustomerLiabilityNetAdvanceConsiderationReceivedDuringPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_MovementInContractLiabilitiesRollForward_03032700-7a58-4ea9-bbbd-a0f4166880a1" xlink:to="loc_syk_ContractWithCustomerLiabilityNetAdvanceConsiderationReceivedDuringPeriod_c7409f17-9b4e-471f-ab0b-4a3202488228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_419d2fc9-1565-4bfe-8ec6-dfa39ddc34fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_MovementInContractLiabilitiesRollForward_03032700-7a58-4ea9-bbbd-a0f4166880a1" xlink:to="loc_us-gaap_ContractWithCustomerLiability_419d2fc9-1565-4bfe-8ec6-dfa39ddc34fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_5f5dbdf1-3ce3-4eb9-bd48-fe7db7c20c9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_483d686d-79ad-4da6-b5c5-3bf1ddcf075e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_5f5dbdf1-3ce3-4eb9-bd48-fe7db7c20c9b" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_483d686d-79ad-4da6-b5c5-3bf1ddcf075e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0eee0a0f-b253-4638-a798-bd316256a8c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_483d686d-79ad-4da6-b5c5-3bf1ddcf075e" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0eee0a0f-b253-4638-a798-bd316256a8c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6e976d31-9ab0-4643-ab6e-a0012684eb5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0eee0a0f-b253-4638-a798-bd316256a8c5" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6e976d31-9ab0-4643-ab6e-a0012684eb5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_1b4f5049-a56e-4cb8-8853-4add90a70319" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6e976d31-9ab0-4643-ab6e-a0012684eb5b" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_1b4f5049-a56e-4cb8-8853-4add90a70319" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_66229156-0b76-4c95-b411-7b5146fdb0d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6e976d31-9ab0-4643-ab6e-a0012684eb5b" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_66229156-0b76-4c95-b411-7b5146fdb0d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_91ee3d66-0686-404a-9b59-2919ce565742" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6e976d31-9ab0-4643-ab6e-a0012684eb5b" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_91ee3d66-0686-404a-9b59-2919ce565742" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InformationByCategoryOfDebtSecurityAxis_6dfe06d3-8fb6-4c90-a3f2-6f39255cd3a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InformationByCategoryOfDebtSecurityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_483d686d-79ad-4da6-b5c5-3bf1ddcf075e" xlink:to="loc_us-gaap_InformationByCategoryOfDebtSecurityAxis_6dfe06d3-8fb6-4c90-a3f2-6f39255cd3a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_49509c03-5823-4d86-a806-3f1f2e71a377" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InformationByCategoryOfDebtSecurityAxis_6dfe06d3-8fb6-4c90-a3f2-6f39255cd3a6" xlink:to="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_49509c03-5823-4d86-a806-3f1f2e71a377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableforsaleSecuritiesMember_41707456-f56b-466d-ada2-63b8316a641b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableforsaleSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_49509c03-5823-4d86-a806-3f1f2e71a377" xlink:to="loc_us-gaap_AvailableforsaleSecuritiesMember_41707456-f56b-466d-ada2-63b8316a641b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f77a771c-816b-4172-8383-3ef3372c2c17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_483d686d-79ad-4da6-b5c5-3bf1ddcf075e" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f77a771c-816b-4172-8383-3ef3372c2c17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_153177e9-2298-44be-a27b-49cb5b4d5eb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f77a771c-816b-4172-8383-3ef3372c2c17" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_153177e9-2298-44be-a27b-49cb5b4d5eb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_ae593854-4d42-49b0-bf52-c55753fccfc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_153177e9-2298-44be-a27b-49cb5b4d5eb3" xlink:to="loc_us-gaap_ForeignExchangeContractMember_ae593854-4d42-49b0-bf52-c55753fccfc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_f493adc6-96d4-461a-8fe5-7844910357f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_153177e9-2298-44be-a27b-49cb5b4d5eb3" xlink:to="loc_us-gaap_InterestRateSwapMember_f493adc6-96d4-461a-8fe5-7844910357f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_7c4497f3-8069-4eb1-a476-bd2ebacd08ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_483d686d-79ad-4da6-b5c5-3bf1ddcf075e" xlink:to="loc_us-gaap_FinancialInstrumentAxis_7c4497f3-8069-4eb1-a476-bd2ebacd08ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_88d5c729-dd61-4283-8235-535fe31d7696" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_7c4497f3-8069-4eb1-a476-bd2ebacd08ec" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_88d5c729-dd61-4283-8235-535fe31d7696" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_dc2acfda-a11a-4745-b856-80cb749c48d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_88d5c729-dd61-4283-8235-535fe31d7696" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_dc2acfda-a11a-4745-b856-80cb749c48d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_387b4dc0-3638-412f-9f57-ef86721ab6a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignGovernmentDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_88d5c729-dd61-4283-8235-535fe31d7696" xlink:to="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_387b4dc0-3638-412f-9f57-ef86721ab6a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_a1ae72ce-e7a5-4edf-9807-77738e210d3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_88d5c729-dd61-4283-8235-535fe31d7696" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_a1ae72ce-e7a5-4edf-9807-77738e210d3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_2272acc8-3c3e-4f37-850d-6f5f7c5a455f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_88d5c729-dd61-4283-8235-535fe31d7696" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_2272acc8-3c3e-4f37-850d-6f5f7c5a455f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_cb0ca1cb-73ce-42fb-932e-4c6a1cd31977" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_88d5c729-dd61-4283-8235-535fe31d7696" xlink:to="loc_us-gaap_CertificatesOfDepositMember_cb0ca1cb-73ce-42fb-932e-4c6a1cd31977" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_109485ba-a718-4699-8b53-1d1b467e3d6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_483d686d-79ad-4da6-b5c5-3bf1ddcf075e" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_109485ba-a718-4699-8b53-1d1b467e3d6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_29b7d809-8d85-484f-aadc-c1ca6c53f640" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_109485ba-a718-4699-8b53-1d1b467e3d6c" xlink:to="loc_us-gaap_AssetsAbstract_29b7d809-8d85-484f-aadc-c1ca6c53f640" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_2bd89f4d-d9b5-4736-a152-0c5b9fd5c49f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_29b7d809-8d85-484f-aadc-c1ca6c53f640" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_2bd89f4d-d9b5-4736-a152-0c5b9fd5c49f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecuritiesDebt_163364be-3d87-4290-9d71-cc452c1526b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecuritiesDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_29b7d809-8d85-484f-aadc-c1ca6c53f640" xlink:to="loc_us-gaap_TradingSecuritiesDebt_163364be-3d87-4290-9d71-cc452c1526b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_4228052f-6e6d-4566-9d69-746243b9b209" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_29b7d809-8d85-484f-aadc-c1ca6c53f640" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_4228052f-6e6d-4566-9d69-746243b9b209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_4566627f-1c43-497b-95a9-53437065d09d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_29b7d809-8d85-484f-aadc-c1ca6c53f640" xlink:to="loc_us-gaap_DerivativeAssets_4566627f-1c43-497b-95a9-53437065d09d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_445ab718-e795-49e0-ad99-f5113ff4fe18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_29b7d809-8d85-484f-aadc-c1ca6c53f640" xlink:to="loc_us-gaap_DerivativeAssets_445ab718-e795-49e0-ad99-f5113ff4fe18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_91d69b8f-19a4-41ac-8fb1-9afdb8452ed5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_29b7d809-8d85-484f-aadc-c1ca6c53f640" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_91d69b8f-19a4-41ac-8fb1-9afdb8452ed5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_578c58f5-dace-421d-b989-8f60baa26862" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_109485ba-a718-4699-8b53-1d1b467e3d6c" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_578c58f5-dace-421d-b989-8f60baa26862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities_a7550767-a9d4-4cd9-9d0f-3d0890c0894c" xlink:href="syk-20221231.xsd#syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_578c58f5-dace-421d-b989-8f60baa26862" xlink:to="loc_syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities_a7550767-a9d4-4cd9-9d0f-3d0890c0894c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_bc04b0a2-03f3-4416-b1aa-80490840b80f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_578c58f5-dace-421d-b989-8f60baa26862" xlink:to="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_bc04b0a2-03f3-4416-b1aa-80490840b80f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_40160743-0254-43d2-9b0d-1701c34ecd47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_578c58f5-dace-421d-b989-8f60baa26862" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_40160743-0254-43d2-9b0d-1701c34ecd47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_dde4ca23-d070-4af8-890c-d160e344261a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_40160743-0254-43d2-9b0d-1701c34ecd47" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_dde4ca23-d070-4af8-890c-d160e344261a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_73a3acac-b209-42dd-89d7-f6dc9ba61dc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_40160743-0254-43d2-9b0d-1701c34ecd47" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_73a3acac-b209-42dd-89d7-f6dc9ba61dc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_72ce0107-885b-441f-8df5-49f3e93071f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_40160743-0254-43d2-9b0d-1701c34ecd47" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_72ce0107-885b-441f-8df5-49f3e93071f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_02ac63a1-3599-4a18-986f-a072bbc8d654" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_40160743-0254-43d2-9b0d-1701c34ecd47" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_02ac63a1-3599-4a18-986f-a072bbc8d654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_7aa5e7c7-284e-4b6b-bd41-d8277064d188" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_40160743-0254-43d2-9b0d-1701c34ecd47" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_7aa5e7c7-284e-4b6b-bd41-d8277064d188" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_bfc9f8ae-be7a-4f52-b20c-6b9833b31c30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_578c58f5-dace-421d-b989-8f60baa26862" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_bfc9f8ae-be7a-4f52-b20c-6b9833b31c30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/FairValueMeasurementsAvailableForSaleSecuritiesDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#FairValueMeasurementsAvailableForSaleSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/FairValueMeasurementsAvailableForSaleSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_679b1def-cbc1-4a2f-b7d3-a30c14105c93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_18beef46-cdcb-4b38-985d-1c3ba3c44a82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_679b1def-cbc1-4a2f-b7d3-a30c14105c93" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_18beef46-cdcb-4b38-985d-1c3ba3c44a82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue_d9602c04-b026-453f-aeca-eeff26947779" xlink:href="syk-20221231.xsd#syk_AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_679b1def-cbc1-4a2f-b7d3-a30c14105c93" xlink:to="loc_syk_AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue_d9602c04-b026-453f-aeca-eeff26947779" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_7efaa126-9c5d-4d77-993c-88ada781ff81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_9a8fc64e-384b-4854-a3a2-b89a9aab2fa1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_7efaa126-9c5d-4d77-993c-88ada781ff81" xlink:to="loc_us-gaap_StatementTable_9a8fc64e-384b-4854-a3a2-b89a9aab2fa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InformationByCategoryOfDebtSecurityAxis_f33a5dc5-bd49-4b5a-a9ba-9e5cea55421a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InformationByCategoryOfDebtSecurityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_9a8fc64e-384b-4854-a3a2-b89a9aab2fa1" xlink:to="loc_us-gaap_InformationByCategoryOfDebtSecurityAxis_f33a5dc5-bd49-4b5a-a9ba-9e5cea55421a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_8d6e3b52-f889-4cf0-99c3-a213eb9212ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InformationByCategoryOfDebtSecurityAxis_f33a5dc5-bd49-4b5a-a9ba-9e5cea55421a" xlink:to="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_8d6e3b52-f889-4cf0-99c3-a213eb9212ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableforsaleSecuritiesMember_c2f77d82-c484-40c6-b931-9f5aabe181e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableforsaleSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_8d6e3b52-f889-4cf0-99c3-a213eb9212ea" xlink:to="loc_us-gaap_AvailableforsaleSecuritiesMember_c2f77d82-c484-40c6-b931-9f5aabe181e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_aea34714-993a-4264-a9c5-cfeb043218fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_9a8fc64e-384b-4854-a3a2-b89a9aab2fa1" xlink:to="loc_us-gaap_StatementLineItems_aea34714-993a-4264-a9c5-cfeb043218fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesGainLoss_a26d15d6-3026-4ffb-813c-4a01c304abc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesGainLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_aea34714-993a-4264-a9c5-cfeb043218fc" xlink:to="loc_us-gaap_MarketableSecuritiesGainLoss_a26d15d6-3026-4ffb-813c-4a01c304abc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_8b67569a-74a3-4eaa-b586-9c00bb8076ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_aea34714-993a-4264-a9c5-cfeb043218fc" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_8b67569a-74a3-4eaa-b586-9c00bb8076ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#DerivativeInstrumentsForwardCurrencyExchangeContractsDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_9e3bb8ff-a5d6-4149-a19c-04f67e45a1e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_c5b02f53-3dd7-4abd-9fa2-ba0a71f1e1b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_9e3bb8ff-a5d6-4149-a19c-04f67e45a1e3" xlink:to="loc_us-gaap_DerivativeTable_c5b02f53-3dd7-4abd-9fa2-ba0a71f1e1b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6fe84c97-75a5-4a16-9a85-053fc689b326" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_c5b02f53-3dd7-4abd-9fa2-ba0a71f1e1b4" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6fe84c97-75a5-4a16-9a85-053fc689b326" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_9b561d53-1da7-476b-9008-7cb436d5236f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6fe84c97-75a5-4a16-9a85-053fc689b326" xlink:to="loc_us-gaap_HedgingRelationshipDomain_9b561d53-1da7-476b-9008-7cb436d5236f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_e3d0aefb-66f5-4475-b41b-be837dad6536" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_9b561d53-1da7-476b-9008-7cb436d5236f" xlink:to="loc_us-gaap_CashFlowHedgingMember_e3d0aefb-66f5-4475-b41b-be837dad6536" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_f4d64db7-58a5-4a8e-8853-fdfade010b43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_9b561d53-1da7-476b-9008-7cb436d5236f" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_f4d64db7-58a5-4a8e-8853-fdfade010b43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_3548830e-9862-4e34-b4ba-6833d47b5c6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_c5b02f53-3dd7-4abd-9fa2-ba0a71f1e1b4" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_3548830e-9862-4e34-b4ba-6833d47b5c6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6ffc88fd-1b0b-46b0-b7ef-ebec44357a33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3548830e-9862-4e34-b4ba-6833d47b5c6d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6ffc88fd-1b0b-46b0-b7ef-ebec44357a33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_cdbff39d-c4b4-4baf-a54b-73efc6306526" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6ffc88fd-1b0b-46b0-b7ef-ebec44357a33" xlink:to="loc_us-gaap_ForeignExchangeContractMember_cdbff39d-c4b4-4baf-a54b-73efc6306526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_c4efffad-9592-4a50-8749-56b55ad738ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_c5b02f53-3dd7-4abd-9fa2-ba0a71f1e1b4" xlink:to="loc_us-gaap_HedgingDesignationAxis_c4efffad-9592-4a50-8749-56b55ad738ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_cef9cc94-c7c9-4ee9-bf30-5dfb8d0af486" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_c4efffad-9592-4a50-8749-56b55ad738ae" xlink:to="loc_us-gaap_HedgingDesignationDomain_cef9cc94-c7c9-4ee9-bf30-5dfb8d0af486" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_300a42a0-fb3f-4ad2-82db-5b0e9cb1c381" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_cef9cc94-c7c9-4ee9-bf30-5dfb8d0af486" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_300a42a0-fb3f-4ad2-82db-5b0e9cb1c381" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_83e64d95-78ec-4b11-8dcd-e2a0c718762e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_cef9cc94-c7c9-4ee9-bf30-5dfb8d0af486" xlink:to="loc_us-gaap_NondesignatedMember_83e64d95-78ec-4b11-8dcd-e2a0c718762e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_5dedb6d5-2eb3-43df-9c9b-b8508aa707e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_c5b02f53-3dd7-4abd-9fa2-ba0a71f1e1b4" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_5dedb6d5-2eb3-43df-9c9b-b8508aa707e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_68d188ca-2788-45f7-b68a-c99c7014f060" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_5dedb6d5-2eb3-43df-9c9b-b8508aa707e1" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_68d188ca-2788-45f7-b68a-c99c7014f060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember_6b16ce99-06ff-49b2-9ed4-82c1d0da6d27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_68d188ca-2788-45f7-b68a-c99c7014f060" xlink:to="loc_us-gaap_OtherCurrentAssetsMember_6b16ce99-06ff-49b2-9ed4-82c1d0da6d27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_4419656c-ec01-4da1-bb78-20b9dc423e2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_68d188ca-2788-45f7-b68a-c99c7014f060" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_4419656c-ec01-4da1-bb78-20b9dc423e2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_5004d5d1-82ac-477b-a48a-b525e9cba5ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_68d188ca-2788-45f7-b68a-c99c7014f060" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_5004d5d1-82ac-477b-a48a-b525e9cba5ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_5665bb28-3609-42dc-bac1-911ce02fb3fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_68d188ca-2788-45f7-b68a-c99c7014f060" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_5665bb28-3609-42dc-bac1-911ce02fb3fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_bfce0046-4b03-4a5a-83e1-f72db7f2b803" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_c5b02f53-3dd7-4abd-9fa2-ba0a71f1e1b4" xlink:to="loc_us-gaap_DerivativeLineItems_bfce0046-4b03-4a5a-83e1-f72db7f2b803" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_5c0b1784-c4c4-4872-acbe-b6318cab1c39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_bfce0046-4b03-4a5a-83e1-f72db7f2b803" xlink:to="loc_us-gaap_DerivativeNotionalAmount_5c0b1784-c4c4-4872-acbe-b6318cab1c39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_addd56c2-99b4-46df-b626-ddd7b90e70b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_bfce0046-4b03-4a5a-83e1-f72db7f2b803" xlink:to="loc_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_addd56c2-99b4-46df-b626-ddd7b90e70b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_0e59d071-4cb9-4c89-9148-7bd7d076688d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_bfce0046-4b03-4a5a-83e1-f72db7f2b803" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_0e59d071-4cb9-4c89-9148-7bd7d076688d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_9743d421-3bce-419e-ad94-acf3401a73c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_bfce0046-4b03-4a5a-83e1-f72db7f2b803" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_9743d421-3bce-419e-ad94-acf3401a73c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet_2bf7ed47-eb6e-4205-87b4-7978c6ea8248" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_bfce0046-4b03-4a5a-83e1-f72db7f2b803" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeNet_2bf7ed47-eb6e-4205-87b4-7978c6ea8248" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#DerivativeInstrumentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_7752bc35-8ff9-4769-8510-021e615e6da8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_f0707021-b9b0-4ee1-8d62-728c0910f802" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_7752bc35-8ff9-4769-8510-021e615e6da8" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_f0707021-b9b0-4ee1-8d62-728c0910f802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_d8053365-644b-4b0d-a591-e1fcc961a5b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_f0707021-b9b0-4ee1-8d62-728c0910f802" xlink:to="loc_us-gaap_HedgingDesignationAxis_d8053365-644b-4b0d-a591-e1fcc961a5b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_7cfac226-21c8-4955-9604-6671d4c0cb4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_d8053365-644b-4b0d-a591-e1fcc961a5b8" xlink:to="loc_us-gaap_HedgingDesignationDomain_7cfac226-21c8-4955-9604-6671d4c0cb4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_f9d67eeb-c389-4da7-86ce-a261ae515e84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_7cfac226-21c8-4955-9604-6671d4c0cb4a" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_f9d67eeb-c389-4da7-86ce-a261ae515e84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_fd1d8dfe-1643-4f84-bff8-e5cda482b283" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_f0707021-b9b0-4ee1-8d62-728c0910f802" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_fd1d8dfe-1643-4f84-bff8-e5cda482b283" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_0b55d03f-0d5a-4005-8106-413083186004" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_fd1d8dfe-1643-4f84-bff8-e5cda482b283" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_0b55d03f-0d5a-4005-8106-413083186004" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_dbddcc7f-b847-486d-85b6-073ca9ff1244" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0b55d03f-0d5a-4005-8106-413083186004" xlink:to="loc_us-gaap_ForeignExchangeContractMember_dbddcc7f-b847-486d-85b6-073ca9ff1244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_36065f69-afcb-4620-ba8a-e80e81a3b49f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0b55d03f-0d5a-4005-8106-413083186004" xlink:to="loc_us-gaap_InterestRateSwapMember_36065f69-afcb-4620-ba8a-e80e81a3b49f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_01892273-e497-41ff-9477-5f7c1b08b2e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmbeddedDerivativeFinancialInstrumentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0b55d03f-0d5a-4005-8106-413083186004" xlink:to="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_01892273-e497-41ff-9477-5f7c1b08b2e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_45154fcf-2e44-498c-852f-43031aba5faa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_f0707021-b9b0-4ee1-8d62-728c0910f802" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_45154fcf-2e44-498c-852f-43031aba5faa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_5d77f9aa-d08c-4a12-9138-e1f22989517e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_45154fcf-2e44-498c-852f-43031aba5faa" xlink:to="loc_us-gaap_HedgingRelationshipDomain_5d77f9aa-d08c-4a12-9138-e1f22989517e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_00848b82-cdeb-454b-85c6-86eb15e20860" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_5d77f9aa-d08c-4a12-9138-e1f22989517e" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_00848b82-cdeb-454b-85c6-86eb15e20860" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6e99c2e9-d028-496e-995f-ba8aa7939399" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_f0707021-b9b0-4ee1-8d62-728c0910f802" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6e99c2e9-d028-496e-995f-ba8aa7939399" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_cc8f976f-0273-49f7-a02a-8c25932ba652" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6e99c2e9-d028-496e-995f-ba8aa7939399" xlink:to="loc_us-gaap_DerivativeNotionalAmount_cc8f976f-0273-49f7-a02a-8c25932ba652" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeInvestingActivities_0ebb55ab-cbd6-4a10-8a51-46756fb18650" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromHedgeInvestingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6e99c2e9-d028-496e-995f-ba8aa7939399" xlink:to="loc_us-gaap_ProceedsFromHedgeInvestingActivities_0ebb55ab-cbd6-4a10-8a51-46756fb18650" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax_b444f314-8f53-4562-9cb3-8fa7e846dfd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6e99c2e9-d028-496e-995f-ba8aa7939399" xlink:to="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax_b444f314-8f53-4562-9cb3-8fa7e846dfd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_9da414a9-7148-41ee-b587-8ddd955089c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6e99c2e9-d028-496e-995f-ba8aa7939399" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_9da414a9-7148-41ee-b587-8ddd955089c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax_cb63feda-15a7-45cf-bcca-2bf3f7c784d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6e99c2e9-d028-496e-995f-ba8aa7939399" xlink:to="loc_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax_cb63feda-15a7-45cf-bcca-2bf3f7c784d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#DerivativeInstrumentsMovementsoutofOCIDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2e7aa86d-cb7e-4ff9-a1ec-8cafd66afe81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_13682a78-9f78-411c-a77b-e959e73f7ca3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2e7aa86d-cb7e-4ff9-a1ec-8cafd66afe81" xlink:to="loc_us-gaap_DerivativeTable_13682a78-9f78-411c-a77b-e959e73f7ca3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_04b36157-ee09-44bb-add9-da991aa7f13c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_13682a78-9f78-411c-a77b-e959e73f7ca3" xlink:to="loc_us-gaap_HedgingDesignationAxis_04b36157-ee09-44bb-add9-da991aa7f13c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_a0ecd426-8503-49ef-aa8b-13d908d58793" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_04b36157-ee09-44bb-add9-da991aa7f13c" xlink:to="loc_us-gaap_HedgingDesignationDomain_a0ecd426-8503-49ef-aa8b-13d908d58793" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_c1d0ccbb-a000-4fbe-ab7d-010fcf284eab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_a0ecd426-8503-49ef-aa8b-13d908d58793" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_c1d0ccbb-a000-4fbe-ab7d-010fcf284eab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_df63250e-ac00-408c-9812-3d3055b1e0fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_a0ecd426-8503-49ef-aa8b-13d908d58793" xlink:to="loc_us-gaap_NondesignatedMember_df63250e-ac00-408c-9812-3d3055b1e0fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_ec1b6750-7a3c-42c8-9f0f-5a064231cf72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_13682a78-9f78-411c-a77b-e959e73f7ca3" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_ec1b6750-7a3c-42c8-9f0f-5a064231cf72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_aa5bcd79-2e70-489b-a26b-c05381d3f7b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_ec1b6750-7a3c-42c8-9f0f-5a064231cf72" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_aa5bcd79-2e70-489b-a26b-c05381d3f7b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_ec2769fe-13c6-4481-a793-94d4ab30e177" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_aa5bcd79-2e70-489b-a26b-c05381d3f7b6" xlink:to="loc_us-gaap_ForeignExchangeContractMember_ec2769fe-13c6-4481-a793-94d4ab30e177" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_6997e84b-c855-4f65-bd2c-1c6e12e5a65b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_13682a78-9f78-411c-a77b-e959e73f7ca3" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_6997e84b-c855-4f65-bd2c-1c6e12e5a65b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_9eb348b3-635f-46bf-8a9e-5b3a7977b5c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_6997e84b-c855-4f65-bd2c-1c6e12e5a65b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_9eb348b3-635f-46bf-8a9e-5b3a7977b5c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_87f063ca-d212-44cd-9e5a-2f92b96996ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_9eb348b3-635f-46bf-8a9e-5b3a7977b5c8" xlink:to="loc_us-gaap_CostOfSalesMember_87f063ca-d212-44cd-9e5a-2f92b96996ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OtherIncomeexpenseMember_5499bc43-feb1-42ed-bcef-9bbc3f4bdba5" xlink:href="syk-20221231.xsd#syk_OtherIncomeexpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_9eb348b3-635f-46bf-8a9e-5b3a7977b5c8" xlink:to="loc_syk_OtherIncomeexpenseMember_5499bc43-feb1-42ed-bcef-9bbc3f4bdba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_0149ecff-fd13-4e3f-aa04-1ba96bc6d775" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_13682a78-9f78-411c-a77b-e959e73f7ca3" xlink:to="loc_us-gaap_DerivativeLineItems_0149ecff-fd13-4e3f-aa04-1ba96bc6d775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_de9529d5-737e-4663-86a6-5be966ca77dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_0149ecff-fd13-4e3f-aa04-1ba96bc6d775" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_de9529d5-737e-4663-86a6-5be966ca77dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax_1b0cb987-7047-47c6-9fca-600b5daea766" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_0149ecff-fd13-4e3f-aa04-1ba96bc6d775" xlink:to="loc_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax_1b0cb987-7047-47c6-9fca-600b5daea766" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract_12340054-1200-4cf0-9675-4349c0e18eca" xlink:href="syk-20221231.xsd#syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_212d758a-2e69-4cf0-86b3-c26567bc526c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract_12340054-1200-4cf0-9675-4349c0e18eca" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_212d758a-2e69-4cf0-86b3-c26567bc526c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_3ec0d74a-9da5-4a88-8444-c35bdee29c78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_212d758a-2e69-4cf0-86b3-c26567bc526c" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_3ec0d74a-9da5-4a88-8444-c35bdee29c78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_47294ac7-d18a-4629-aa80-bfc1e362ab10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3ec0d74a-9da5-4a88-8444-c35bdee29c78" xlink:to="loc_us-gaap_EquityComponentDomain_47294ac7-d18a-4629-aa80-bfc1e362ab10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_9136d995-83d7-407b-a79f-cb57c534e461" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_47294ac7-d18a-4629-aa80-bfc1e362ab10" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_9136d995-83d7-407b-a79f-cb57c534e461" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_0dc2df2d-e204-4b90-ae47-b7dcd099510e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_47294ac7-d18a-4629-aa80-bfc1e362ab10" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_0dc2df2d-e204-4b90-ae47-b7dcd099510e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_f79907e2-8e22-4f72-9711-8f9b7e117f16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_47294ac7-d18a-4629-aa80-bfc1e362ab10" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_f79907e2-8e22-4f72-9711-8f9b7e117f16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_13432443-eb73-4a51-8037-6ce986f27bd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_47294ac7-d18a-4629-aa80-bfc1e362ab10" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_13432443-eb73-4a51-8037-6ce986f27bd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_4a5cf594-f917-46e0-8941-d50ad1430d94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_212d758a-2e69-4cf0-86b3-c26567bc526c" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_4a5cf594-f917-46e0-8941-d50ad1430d94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_97a79c6e-3312-4af9-ab53-218cf5b3ee1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_4a5cf594-f917-46e0-8941-d50ad1430d94" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_97a79c6e-3312-4af9-ab53-218cf5b3ee1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_bc8969f8-51d4-48cc-897e-805337d757fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_97a79c6e-3312-4af9-ab53-218cf5b3ee1d" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_bc8969f8-51d4-48cc-897e-805337d757fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_e7cdeb16-6750-41af-883f-aa6c47e017a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_212d758a-2e69-4cf0-86b3-c26567bc526c" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_e7cdeb16-6750-41af-883f-aa6c47e017a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_5f0e0475-2015-47e8-b0b4-ecb395aec577" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_e7cdeb16-6750-41af-883f-aa6c47e017a9" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_5f0e0475-2015-47e8-b0b4-ecb395aec577" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_b35a1487-1ca8-430c-92fc-43bd5c85ae85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5f0e0475-2015-47e8-b0b4-ecb395aec577" xlink:to="loc_us-gaap_CostOfSalesMember_b35a1487-1ca8-430c-92fc-43bd5c85ae85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OtherIncomeexpenseMember_fb47f033-9980-4580-b814-384091d5b732" xlink:href="syk-20221231.xsd#syk_OtherIncomeexpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5f0e0475-2015-47e8-b0b4-ecb395aec577" xlink:to="loc_syk_OtherIncomeexpenseMember_fb47f033-9980-4580-b814-384091d5b732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_3932cac0-50c4-47d4-9951-25e58f17d578" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_212d758a-2e69-4cf0-86b3-c26567bc526c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_3932cac0-50c4-47d4-9951-25e58f17d578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_b5c42f00-f919-4029-9353-f1e7e52bc283" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_3932cac0-50c4-47d4-9951-25e58f17d578" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_b5c42f00-f919-4029-9353-f1e7e52bc283" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_0796a299-db68-442e-911b-5a4e2898107c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_b5c42f00-f919-4029-9353-f1e7e52bc283" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_0796a299-db68-442e-911b-5a4e2898107c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_7241f240-2a90-43c7-a3d2-5c88c7619854" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_b5c42f00-f919-4029-9353-f1e7e52bc283" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_7241f240-2a90-43c7-a3d2-5c88c7619854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_ce02198b-6b52-4134-aa75-bad06d048479" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_b5c42f00-f919-4029-9353-f1e7e52bc283" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_ce02198b-6b52-4134-aa75-bad06d048479" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_8852cc8e-d81e-4295-885f-5f7455007a11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_b5c42f00-f919-4029-9353-f1e7e52bc283" xlink:to="loc_us-gaap_CostOfRevenue_8852cc8e-d81e-4295-885f-5f7455007a11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_f4a92d62-184f-4f71-af3d-44c829729992" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_b5c42f00-f919-4029-9353-f1e7e52bc283" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_f4a92d62-184f-4f71-af3d-44c829729992" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_fb914912-6ab1-46d8-95b3-981e7798db1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_b5c42f00-f919-4029-9353-f1e7e52bc283" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_fb914912-6ab1-46d8-95b3-981e7798db1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_24789640-e5da-4883-86ca-ec437154bb7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_b5c42f00-f919-4029-9353-f1e7e52bc283" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_24789640-e5da-4883-86ca-ec437154bb7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a642ef97-14ba-48fb-9c9d-1c76eb092e8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_b5c42f00-f919-4029-9353-f1e7e52bc283" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a642ef97-14ba-48fb-9c9d-1c76eb092e8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/AcquisitionsNarrativeDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#AcquisitionsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/AcquisitionsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_15667d45-bc00-4c6d-ba0c-47591b217981" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4071d077-bfbc-445b-8c80-e067a8d595cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_15667d45-bc00-4c6d-ba0c-47591b217981" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4071d077-bfbc-445b-8c80-e067a8d595cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_53bc1644-8f7c-4ae7-971c-8c51b505f67a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4071d077-bfbc-445b-8c80-e067a8d595cc" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_53bc1644-8f7c-4ae7-971c-8c51b505f67a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c6ca0116-d9d7-4dca-aef6-b33f856a08a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_53bc1644-8f7c-4ae7-971c-8c51b505f67a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c6ca0116-d9d7-4dca-aef6-b33f856a08a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_VoceraMember_dc1af082-1f7f-455b-a2d5-37c19254c632" xlink:href="syk-20221231.xsd#syk_VoceraMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c6ca0116-d9d7-4dca-aef6-b33f856a08a3" xlink:to="loc_syk_VoceraMember_dc1af082-1f7f-455b-a2d5-37c19254c632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_GaussMember_cf0c446b-9baa-469c-a0d4-df49d9964d18" xlink:href="syk-20221231.xsd#syk_GaussMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c6ca0116-d9d7-4dca-aef6-b33f856a08a3" xlink:to="loc_syk_GaussMember_cf0c446b-9baa-469c-a0d4-df49d9964d18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_20374200-5b2d-4105-9441-77073b306e78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4071d077-bfbc-445b-8c80-e067a8d595cc" xlink:to="loc_us-gaap_DebtInstrumentAxis_20374200-5b2d-4105-9441-77073b306e78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_845f5d8b-ee24-4a42-8be2-e9c80e22da83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_20374200-5b2d-4105-9441-77073b306e78" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_845f5d8b-ee24-4a42-8be2-e9c80e22da83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_A150ConvertibleNotesMember_412d3ca9-f957-4e79-8776-d3d116344c15" xlink:href="syk-20221231.xsd#syk_A150ConvertibleNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_845f5d8b-ee24-4a42-8be2-e9c80e22da83" xlink:to="loc_syk_A150ConvertibleNotesMember_412d3ca9-f957-4e79-8776-d3d116344c15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_A050ConvertibleNotesMember_eaf8cfe3-ca8a-45a3-ab8e-711c04bcc484" xlink:href="syk-20221231.xsd#syk_A050ConvertibleNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_845f5d8b-ee24-4a42-8be2-e9c80e22da83" xlink:to="loc_syk_A050ConvertibleNotesMember_eaf8cfe3-ca8a-45a3-ab8e-711c04bcc484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_5afb45dc-d8cb-4729-9918-01a0131fe9a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4071d077-bfbc-445b-8c80-e067a8d595cc" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_5afb45dc-d8cb-4729-9918-01a0131fe9a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_aabc0b3c-1417-4186-a5ac-c5e4c2f4cb26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5afb45dc-d8cb-4729-9918-01a0131fe9a4" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_aabc0b3c-1417-4186-a5ac-c5e4c2f4cb26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_BusinessCombinationConsiderationTransferredPricePerShare_c7bbf855-ef22-44eb-aa9d-e5f8fd8fa266" xlink:href="syk-20221231.xsd#syk_BusinessCombinationConsiderationTransferredPricePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5afb45dc-d8cb-4729-9918-01a0131fe9a4" xlink:to="loc_syk_BusinessCombinationConsiderationTransferredPricePerShare_c7bbf855-ef22-44eb-aa9d-e5f8fd8fa266" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_BusinessCombinationConsiderationTransferredIncludingConvertibleNotes_5b19ff85-5d8a-4f6c-8efb-9939b4ee0ce1" xlink:href="syk-20221231.xsd#syk_BusinessCombinationConsiderationTransferredIncludingConvertibleNotes"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5afb45dc-d8cb-4729-9918-01a0131fe9a4" xlink:to="loc_syk_BusinessCombinationConsiderationTransferredIncludingConvertibleNotes_5b19ff85-5d8a-4f6c-8efb-9939b4ee0ce1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b6c01ea2-86e5-41fb-8056-607a80e1239e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5afb45dc-d8cb-4729-9918-01a0131fe9a4" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b6c01ea2-86e5-41fb-8056-607a80e1239e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_8ef585f7-921c-413c-bc99-a7b39fd7f024" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5afb45dc-d8cb-4729-9918-01a0131fe9a4" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_8ef585f7-921c-413c-bc99-a7b39fd7f024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_4de2657e-48de-4084-81f9-d5589f3924ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5afb45dc-d8cb-4729-9918-01a0131fe9a4" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_4de2657e-48de-4084-81f9-d5589f3924ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh_53863845-78c7-4ec3-8102-176b88a8ba73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5afb45dc-d8cb-4729-9918-01a0131fe9a4" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh_53863845-78c7-4ec3-8102-176b88a8ba73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_5ad8c505-cf4e-4a72-9413-390cd0d4218c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_56c93d65-e2c7-4165-a180-a88147e87cca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_5ad8c505-cf4e-4a72-9413-390cd0d4218c" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_56c93d65-e2c7-4165-a180-a88147e87cca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_f090865f-122f-4eb8-b53c-74160c832047" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_56c93d65-e2c7-4165-a180-a88147e87cca" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_f090865f-122f-4eb8-b53c-74160c832047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8cb47f8a-ed01-4194-b474-c5c876f7d937" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f090865f-122f-4eb8-b53c-74160c832047" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8cb47f8a-ed01-4194-b474-c5c876f7d937" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_VoceraMember_b706ddab-1a89-4505-9f73-caa746d6f8b1" xlink:href="syk-20221231.xsd#syk_VoceraMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8cb47f8a-ed01-4194-b474-c5c876f7d937" xlink:to="loc_syk_VoceraMember_b706ddab-1a89-4505-9f73-caa746d6f8b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_83bd537f-72e9-4337-93e3-e183cf8739c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_56c93d65-e2c7-4165-a180-a88147e87cca" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_83bd537f-72e9-4337-93e3-e183cf8739c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6f1a1054-8569-429b-9261-a77dfb820c76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_83bd537f-72e9-4337-93e3-e183cf8739c1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6f1a1054-8569-429b-9261-a77dfb820c76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_CustomerAndDistributorRelationshipsMember_dd47511d-699a-4244-8c64-c6f888f46084" xlink:href="syk-20221231.xsd#syk_CustomerAndDistributorRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6f1a1054-8569-429b-9261-a77dfb820c76" xlink:to="loc_syk_CustomerAndDistributorRelationshipsMember_dd47511d-699a-4244-8c64-c6f888f46084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_0b66fcc8-c8dd-480a-8f36-7633b939babd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6f1a1054-8569-429b-9261-a77dfb820c76" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_0b66fcc8-c8dd-480a-8f36-7633b939babd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_61f71fa8-b85f-48d1-ac98-aa7bf98130af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6f1a1054-8569-429b-9261-a77dfb820c76" xlink:to="loc_us-gaap_TradeNamesMember_61f71fa8-b85f-48d1-ac98-aa7bf98130af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_d0ee08c3-043b-441c-935d-2d0698e7b00c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_56c93d65-e2c7-4165-a180-a88147e87cca" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_d0ee08c3-043b-441c-935d-2d0698e7b00c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_fbbacac8-d231-4ae2-8ed2-d035743bbc5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d0ee08c3-043b-441c-935d-2d0698e7b00c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_fbbacac8-d231-4ae2-8ed2-d035743bbc5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_2fc4a7b1-0e45-4de5-aae3-f13e6c05a74e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d0ee08c3-043b-441c-935d-2d0698e7b00c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_2fc4a7b1-0e45-4de5-aae3-f13e6c05a74e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_2076ee9a-cc81-487a-876b-48241bf0752f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d0ee08c3-043b-441c-935d-2d0698e7b00c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_2076ee9a-cc81-487a-876b-48241bf0752f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_61e1e090-23e1-4d00-9f11-2cefeaef5cb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d0ee08c3-043b-441c-935d-2d0698e7b00c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_61e1e090-23e1-4d00-9f11-2cefeaef5cb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt_f09ceadd-717f-4b2f-b6af-c8c1e9382a41" xlink:href="syk-20221231.xsd#syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d0ee08c3-043b-441c-935d-2d0698e7b00c" xlink:to="loc_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt_f09ceadd-717f-4b2f-b6af-c8c1e9382a41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_863b1459-6dcf-4a9b-8ed5-c62f0ef9285c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d0ee08c3-043b-441c-935d-2d0698e7b00c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_863b1459-6dcf-4a9b-8ed5-c62f0ef9285c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_d3d42873-b023-43c7-9145-8d25ff90ba1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d0ee08c3-043b-441c-935d-2d0698e7b00c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_d3d42873-b023-43c7-9145-8d25ff90ba1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_0a8a4b6e-35ba-4c02-ac56-5c621c65778f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d0ee08c3-043b-441c-935d-2d0698e7b00c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_0a8a4b6e-35ba-4c02-ac56-5c621c65778f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_4a97aaec-cfdf-4674-9be6-7f5f02754a06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d0ee08c3-043b-441c-935d-2d0698e7b00c" xlink:to="loc_us-gaap_Goodwill_4a97aaec-cfdf-4674-9be6-7f5f02754a06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_4c7b30c2-e216-4505-9425-770211f8b9fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d0ee08c3-043b-441c-935d-2d0698e7b00c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_4c7b30c2-e216-4505-9425-770211f8b9fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_c1430f89-efaa-4b68-9b95-2b35607962fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d0ee08c3-043b-441c-935d-2d0698e7b00c" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_c1430f89-efaa-4b68-9b95-2b35607962fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_7ecae911-b4c3-4678-b992-c5fc246521e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d0ee08c3-043b-441c-935d-2d0698e7b00c" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_7ecae911-b4c3-4678-b992-c5fc246521e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/ContingenciesandCommitmentsNarrativeDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#ContingenciesandCommitmentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/ContingenciesandCommitmentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ccfc1bea-4604-406c-8298-2b20ebc51079" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_d90f6db0-3bba-4c55-bb7a-cdea63be4ded" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ccfc1bea-4604-406c-8298-2b20ebc51079" xlink:to="loc_us-gaap_LossContingenciesTable_d90f6db0-3bba-4c55-bb7a-cdea63be4ded" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5a2abf3e-6402-40b2-9eff-66aab2e0afa7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_d90f6db0-3bba-4c55-bb7a-cdea63be4ded" xlink:to="loc_srt_RangeAxis_5a2abf3e-6402-40b2-9eff-66aab2e0afa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c123230a-3340-40a0-b540-f83a12262e19" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_5a2abf3e-6402-40b2-9eff-66aab2e0afa7" xlink:to="loc_srt_RangeMember_c123230a-3340-40a0-b540-f83a12262e19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a1e584a3-6091-47cb-9062-f87c4342c951" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c123230a-3340-40a0-b540-f83a12262e19" xlink:to="loc_srt_MinimumMember_a1e584a3-6091-47cb-9062-f87c4342c951" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_27213686-c79d-4d2a-b1b4-009af4eac857" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c123230a-3340-40a0-b540-f83a12262e19" xlink:to="loc_srt_MaximumMember_27213686-c79d-4d2a-b1b4-009af4eac857" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_e3c42281-16e7-4ed4-a86f-9a27f6048198" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_d90f6db0-3bba-4c55-bb7a-cdea63be4ded" xlink:to="loc_srt_LitigationCaseAxis_e3c42281-16e7-4ed4-a86f-9a27f6048198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_a3afeacf-7e3e-407f-8eb7-aca730c2f382" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_e3c42281-16e7-4ed4-a86f-9a27f6048198" xlink:to="loc_srt_LitigationCaseTypeDomain_a3afeacf-7e3e-407f-8eb7-aca730c2f382" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_PureWickMember_01dc37a2-9415-4ebb-bae2-430f7104a4c7" xlink:href="syk-20221231.xsd#syk_PureWickMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_a3afeacf-7e3e-407f-8eb7-aca730c2f382" xlink:to="loc_syk_PureWickMember_01dc37a2-9415-4ebb-bae2-430f7104a4c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_RecallMattersMember_ea693ae6-4ba4-4776-aaae-3bcfcbe0d37b" xlink:href="syk-20221231.xsd#syk_RecallMattersMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_a3afeacf-7e3e-407f-8eb7-aca730c2f382" xlink:to="loc_syk_RecallMattersMember_ea693ae6-4ba4-4776-aaae-3bcfcbe0d37b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_018c0c58-e362-4765-bc10-f9a7e8b15171" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_d90f6db0-3bba-4c55-bb7a-cdea63be4ded" xlink:to="loc_us-gaap_StatementLineItems_018c0c58-e362-4765-bc10-f9a7e8b15171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyLossInPeriod_698d944e-f011-4e9a-98ab-59821cb35a75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyLossInPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_018c0c58-e362-4765-bc10-f9a7e8b15171" xlink:to="loc_us-gaap_LossContingencyLossInPeriod_698d944e-f011-4e9a-98ab-59821cb35a75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_b317fd74-7190-43d4-beac-e67f339fc19a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_018c0c58-e362-4765-bc10-f9a7e8b15171" xlink:to="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_b317fd74-7190-43d4-beac-e67f339fc19a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_Changeinaccrualforrecallexpenses_4f9a6c62-d3e7-46e4-abd2-7d026fa016ce" xlink:href="syk-20221231.xsd#syk_Changeinaccrualforrecallexpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_018c0c58-e362-4765-bc10-f9a7e8b15171" xlink:to="loc_syk_Changeinaccrualforrecallexpenses_4f9a6c62-d3e7-46e4-abd2-7d026fa016ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_ede96302-3736-4ff8-b6fc-bbdcd0897b0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_018c0c58-e362-4765-bc10-f9a7e8b15171" xlink:to="loc_us-gaap_OperatingLeaseExpense_ede96302-3736-4ff8-b6fc-bbdcd0897b0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/CommitmentsandContingenciesLeaseCostDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#CommitmentsandContingenciesLeaseCostDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/CommitmentsandContingenciesLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_58ffd85c-0aeb-4b9f-aad2-bbf1298f54f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_b4c7e532-88fa-45ca-8ce1-1ce637209979" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_58ffd85c-0aeb-4b9f-aad2-bbf1298f54f0" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_b4c7e532-88fa-45ca-8ce1-1ce637209979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_7e37a458-5781-45a8-aa51-3c96ed9c01b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_58ffd85c-0aeb-4b9f-aad2-bbf1298f54f0" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_7e37a458-5781-45a8-aa51-3c96ed9c01b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_2e58daa6-d56a-4dde-a8d7-092301daaf5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_58ffd85c-0aeb-4b9f-aad2-bbf1298f54f0" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_2e58daa6-d56a-4dde-a8d7-092301daaf5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_1cd42b6b-f024-4aa3-8483-00245babc23c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_58ffd85c-0aeb-4b9f-aad2-bbf1298f54f0" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_1cd42b6b-f024-4aa3-8483-00245babc23c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_09e959dc-3bae-41cc-aba2-4859e11922fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_58ffd85c-0aeb-4b9f-aad2-bbf1298f54f0" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_09e959dc-3bae-41cc-aba2-4859e11922fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_8d4172f5-86c2-4823-9783-e8108d9d9bf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_58ffd85c-0aeb-4b9f-aad2-bbf1298f54f0" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_8d4172f5-86c2-4823-9783-e8108d9d9bf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_d7d28dbb-03c2-49b9-8a7c-c51bea1dab4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_58ffd85c-0aeb-4b9f-aad2-bbf1298f54f0" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_d7d28dbb-03c2-49b9-8a7c-c51bea1dab4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_e0a076fe-f946-47df-8db9-9064526e066d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_58ffd85c-0aeb-4b9f-aad2-bbf1298f54f0" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_e0a076fe-f946-47df-8db9-9064526e066d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c127de34-b103-40c0-b254-12865d74db22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_477cb9b2-4e77-47ca-ae1c-d3ab939ca029" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c127de34-b103-40c0-b254-12865d74db22" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_477cb9b2-4e77-47ca-ae1c-d3ab939ca029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_220ad85c-12da-4241-9ffd-6ac5db0c7688" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c127de34-b103-40c0-b254-12865d74db22" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_220ad85c-12da-4241-9ffd-6ac5db0c7688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_cab69105-434d-4881-a558-4fc176a1c145" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c127de34-b103-40c0-b254-12865d74db22" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_cab69105-434d-4881-a558-4fc176a1c145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_11036dd5-4ea4-4e69-8324-7712669e5dac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c127de34-b103-40c0-b254-12865d74db22" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_11036dd5-4ea4-4e69-8324-7712669e5dac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_a0403171-c0fb-4213-91bc-954618ab1f0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c127de34-b103-40c0-b254-12865d74db22" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_a0403171-c0fb-4213-91bc-954618ab1f0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_d56ef8ea-c865-4fb3-8304-45bde24e88ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c127de34-b103-40c0-b254-12865d74db22" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_d56ef8ea-c865-4fb3-8304-45bde24e88ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_dfcb3e3e-d452-423a-8f88-bb0838c9d1b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PurchaseObligationFiscalYearMaturityAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c127de34-b103-40c0-b254-12865d74db22" xlink:to="loc_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_dfcb3e3e-d452-423a-8f88-bb0838c9d1b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear_9fd93074-f4c6-4f38-85f6-101dabcc87d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_dfcb3e3e-d452-423a-8f88-bb0838c9d1b7" xlink:to="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear_9fd93074-f4c6-4f38-85f6-101dabcc87d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear_d54f0fc3-a786-4455-b9d7-e6944bbf0fc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_dfcb3e3e-d452-423a-8f88-bb0838c9d1b7" xlink:to="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear_d54f0fc3-a786-4455-b9d7-e6944bbf0fc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear_d21010de-3758-4295-b4d9-4300ea9e5141" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_dfcb3e3e-d452-423a-8f88-bb0838c9d1b7" xlink:to="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear_d21010de-3758-4295-b4d9-4300ea9e5141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear_11aad1d9-21f5-4785-8c87-d2e55a9298b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_dfcb3e3e-d452-423a-8f88-bb0838c9d1b7" xlink:to="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear_11aad1d9-21f5-4785-8c87-d2e55a9298b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear_2de0baa6-8cff-4ba4-a657-b37131fc88d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_dfcb3e3e-d452-423a-8f88-bb0838c9d1b7" xlink:to="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear_2de0baa6-8cff-4ba4-a657-b37131fc88d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear_5765e790-4eff-4faa-8b82-d08a586aa324" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_dfcb3e3e-d452-423a-8f88-bb0838c9d1b7" xlink:to="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear_5765e790-4eff-4faa-8b82-d08a586aa324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_e4f6217d-4d08-44c9-accd-b023c115fe8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c127de34-b103-40c0-b254-12865d74db22" xlink:to="loc_us-gaap_LeasesAbstract_e4f6217d-4d08-44c9-accd-b023c115fe8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_261832d4-759c-4ff8-887a-2fa0594cb89c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e4f6217d-4d08-44c9-accd-b023c115fe8c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_261832d4-759c-4ff8-887a-2fa0594cb89c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_30a71983-db5a-403c-8b81-1000a18e7a17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e4f6217d-4d08-44c9-accd-b023c115fe8c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_30a71983-db5a-403c-8b81-1000a18e7a17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_77f66553-1c57-4770-8013-b19476a1447d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e4f6217d-4d08-44c9-accd-b023c115fe8c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_77f66553-1c57-4770-8013-b19476a1447d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_4c162910-3e95-4efd-870a-081f7747e8c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e4f6217d-4d08-44c9-accd-b023c115fe8c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_4c162910-3e95-4efd-870a-081f7747e8c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_21b77006-841b-4637-9306-f6da995ee702" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e4f6217d-4d08-44c9-accd-b023c115fe8c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_21b77006-841b-4637-9306-f6da995ee702" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0dc75fac-9a3e-40b9-ac98-7f8f3ce5d490" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e4f6217d-4d08-44c9-accd-b023c115fe8c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0dc75fac-9a3e-40b9-ac98-7f8f3ce5d490" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#GoodwillandOtherIntangibleAssetsGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c79a50d4-b385-4b69-81cc-05e11c10bf7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_02a6c89b-b329-476f-9906-1094fdf45b1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c79a50d4-b385-4b69-81cc-05e11c10bf7d" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_02a6c89b-b329-476f-9906-1094fdf45b1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_558e7b55-239c-4b57-a5f4-25a57fd5de5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_02a6c89b-b329-476f-9906-1094fdf45b1d" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_558e7b55-239c-4b57-a5f4-25a57fd5de5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ef7139d5-e11c-450b-88aa-121322b998ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_558e7b55-239c-4b57-a5f4-25a57fd5de5c" xlink:to="loc_us-gaap_SegmentDomain_ef7139d5-e11c-450b-88aa-121322b998ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_MedSurgAndNeurotechnologyMember_876d8fd3-c711-4885-9746-29a5f122c504" xlink:href="syk-20221231.xsd#syk_MedSurgAndNeurotechnologyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_ef7139d5-e11c-450b-88aa-121322b998ac" xlink:to="loc_syk_MedSurgAndNeurotechnologyMember_876d8fd3-c711-4885-9746-29a5f122c504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OrthopaedicsAndSpineMember_c9c6f8be-6d58-46fc-97de-51cb33ebab89" xlink:href="syk-20221231.xsd#syk_OrthopaedicsAndSpineMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_ef7139d5-e11c-450b-88aa-121322b998ac" xlink:to="loc_syk_OrthopaedicsAndSpineMember_c9c6f8be-6d58-46fc-97de-51cb33ebab89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_5f7d65fc-cf0c-4cdf-859e-7be83efbeca9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_02a6c89b-b329-476f-9906-1094fdf45b1d" xlink:to="loc_us-gaap_ReportingUnitAxis_5f7d65fc-cf0c-4cdf-859e-7be83efbeca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_5b3a7ec0-6952-41db-a730-116ba9205fa1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitAxis_5f7d65fc-cf0c-4cdf-859e-7be83efbeca9" xlink:to="loc_us-gaap_ReportingUnitDomain_5b3a7ec0-6952-41db-a730-116ba9205fa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SpineReportingUnitMember_ebf4ca12-f9b8-459b-83b4-12b1b0be7ce9" xlink:href="syk-20221231.xsd#syk_SpineReportingUnitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_5b3a7ec0-6952-41db-a730-116ba9205fa1" xlink:to="loc_syk_SpineReportingUnitMember_ebf4ca12-f9b8-459b-83b4-12b1b0be7ce9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_a78cb556-acb7-4761-881e-23f882edb6ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_02a6c89b-b329-476f-9906-1094fdf45b1d" xlink:to="loc_us-gaap_GoodwillLineItems_a78cb556-acb7-4761-881e-23f882edb6ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e14e0fea-fd54-41df-a885-5db227d2525d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_a78cb556-acb7-4761-881e-23f882edb6ac" xlink:to="loc_us-gaap_Goodwill_e14e0fea-fd54-41df-a885-5db227d2525d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_831f6cd8-3610-4e26-8192-ee687a172967" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_a78cb556-acb7-4761-881e-23f882edb6ac" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_831f6cd8-3610-4e26-8192-ee687a172967" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_7a4779d0-7575-4da4-87e8-ddedfd3c8620" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_a78cb556-acb7-4761-881e-23f882edb6ac" xlink:to="loc_us-gaap_GoodwillRollForward_7a4779d0-7575-4da4-87e8-ddedfd3c8620" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_168d032c-a76b-4fab-ac97-5136c1a82751" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_7a4779d0-7575-4da4-87e8-ddedfd3c8620" xlink:to="loc_us-gaap_Goodwill_168d032c-a76b-4fab-ac97-5136c1a82751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_e0af0836-0d5c-4f88-b92f-3de0fef03c06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_7a4779d0-7575-4da4-87e8-ddedfd3c8620" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_e0af0836-0d5c-4f88-b92f-3de0fef03c06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_f8e48856-123c-4ab9-9678-d29d9b48fc21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_7a4779d0-7575-4da4-87e8-ddedfd3c8620" xlink:to="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_f8e48856-123c-4ab9-9678-d29d9b48fc21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_42ef6834-61ce-49a3-bb9e-8a817ab1fd3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_7a4779d0-7575-4da4-87e8-ddedfd3c8620" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_42ef6834-61ce-49a3-bb9e-8a817ab1fd3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_13d17708-60a6-4e4f-bdd6-02742adea2ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_7a4779d0-7575-4da4-87e8-ddedfd3c8620" xlink:to="loc_us-gaap_Goodwill_13d17708-60a6-4e4f-bdd6-02742adea2ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d7cd0dbc-0bfe-4c88-a705-b247681db41f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_a4f621f8-cf31-4d6a-ab92-2a273e5e0605" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d7cd0dbc-0bfe-4c88-a705-b247681db41f" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_a4f621f8-cf31-4d6a-ab92-2a273e5e0605" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_d872b739-fc04-436e-ba8e-5849337c1e33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d7cd0dbc-0bfe-4c88-a705-b247681db41f" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_d872b739-fc04-436e-ba8e-5849337c1e33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6c205aaf-d164-44b5-9d8c-89c005ca02d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_d872b739-fc04-436e-ba8e-5849337c1e33" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6c205aaf-d164-44b5-9d8c-89c005ca02d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d4530027-4733-422b-bc52-657613adde8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6c205aaf-d164-44b5-9d8c-89c005ca02d3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d4530027-4733-422b-bc52-657613adde8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_16cf9ad8-9ef1-4bcc-86d8-dc9d5dee5eb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d4530027-4733-422b-bc52-657613adde8e" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_16cf9ad8-9ef1-4bcc-86d8-dc9d5dee5eb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_d3c07a8e-793d-4a7e-a061-3a3ce6e3a2a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d4530027-4733-422b-bc52-657613adde8e" xlink:to="loc_us-gaap_CustomerRelationshipsMember_d3c07a8e-793d-4a7e-a061-3a3ce6e3a2a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_d231fb78-6365-4ec7-8963-c8978ef1c961" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PatentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d4530027-4733-422b-bc52-657613adde8e" xlink:to="loc_us-gaap_PatentsMember_d231fb78-6365-4ec7-8963-c8978ef1c961" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_5f5e1b5d-07d1-4a41-8e2b-36d29228959d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d4530027-4733-422b-bc52-657613adde8e" xlink:to="loc_us-gaap_TrademarksMember_5f5e1b5d-07d1-4a41-8e2b-36d29228959d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_f068ab9a-721e-4a06-a54e-9e8688984223" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d4530027-4733-422b-bc52-657613adde8e" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_f068ab9a-721e-4a06-a54e-9e8688984223" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_5ba4ddcd-6c1d-4f8d-907f-88f855e49c5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d4530027-4733-422b-bc52-657613adde8e" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_5ba4ddcd-6c1d-4f8d-907f-88f855e49c5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_8447666a-f534-40e0-a84f-c2bf3fb6717a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_d872b739-fc04-436e-ba8e-5849337c1e33" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_8447666a-f534-40e0-a84f-c2bf3fb6717a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_a3a27e8c-475c-49c8-9d3a-5ab592a07a53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_8447666a-f534-40e0-a84f-c2bf3fb6717a" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_a3a27e8c-475c-49c8-9d3a-5ab592a07a53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_52081e28-c276-4f23-8075-32a9ab9ba683" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_8447666a-f534-40e0-a84f-c2bf3fb6717a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_52081e28-c276-4f23-8075-32a9ab9ba683" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1c6b3491-18c5-4e20-96d9-58e0c4bb56cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_8447666a-f534-40e0-a84f-c2bf3fb6717a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1c6b3491-18c5-4e20-96d9-58e0c4bb56cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_3c4335ec-680c-4fc6-81ac-151c3afe3426" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_8447666a-f534-40e0-a84f-c2bf3fb6717a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_3c4335ec-680c-4fc6-81ac-151c3afe3426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsEstimatedAmortizationExpenseDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#GoodwillandOtherIntangibleAssetsEstimatedAmortizationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsEstimatedAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8b5061d4-807c-438b-97d3-8bdae8f0b138" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_4d9b422d-54d9-4626-930a-72eb6b20092e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8b5061d4-807c-438b-97d3-8bdae8f0b138" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_4d9b422d-54d9-4626-930a-72eb6b20092e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_2350af49-febe-4768-984c-3584c81ed3e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8b5061d4-807c-438b-97d3-8bdae8f0b138" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_2350af49-febe-4768-984c-3584c81ed3e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_950391b6-5652-4a9f-bd0a-41b7ebd06e44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8b5061d4-807c-438b-97d3-8bdae8f0b138" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_950391b6-5652-4a9f-bd0a-41b7ebd06e44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_40373223-25f0-49cc-bd1e-34072b422444" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8b5061d4-807c-438b-97d3-8bdae8f0b138" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_40373223-25f0-49cc-bd1e-34072b422444" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_ce5c4d7a-7915-47f9-bef9-d7694aba3999" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8b5061d4-807c-438b-97d3-8bdae8f0b138" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_ce5c4d7a-7915-47f9-bef9-d7694aba3999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/CapitalStockNarrativeDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#CapitalStockNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/CapitalStockNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_syk_CapitalStockAbstract_91ef47fd-2148-4d35-af9e-023050acc880" xlink:href="syk-20221231.xsd#syk_CapitalStockAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_b5884505-3e13-4acd-9823-bd5e7f51e6cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_CapitalStockAbstract_91ef47fd-2148-4d35-af9e-023050acc880" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_b5884505-3e13-4acd-9823-bd5e7f51e6cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_77867ba4-75b6-4b60-989c-0c979a8e6042" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_b5884505-3e13-4acd-9823-bd5e7f51e6cf" xlink:to="loc_us-gaap_AwardTypeAxis_77867ba4-75b6-4b60-989c-0c979a8e6042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_03aa54ae-b271-4fa9-a12a-f312edfb0115" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_77867ba4-75b6-4b60-989c-0c979a8e6042" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_03aa54ae-b271-4fa9-a12a-f312edfb0115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_1d018e0a-c1f4-4295-8136-5a65142d2790" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_03aa54ae-b271-4fa9-a12a-f312edfb0115" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_1d018e0a-c1f4-4295-8136-5a65142d2790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_PerformanceStockUnitPsusMember_e037412d-fdde-4812-a655-14b65a25b3ed" xlink:href="syk-20221231.xsd#syk_PerformanceStockUnitPsusMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_03aa54ae-b271-4fa9-a12a-f312edfb0115" xlink:to="loc_syk_PerformanceStockUnitPsusMember_e037412d-fdde-4812-a655-14b65a25b3ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_d888b99f-ec8d-445e-bcd3-de0f847b4100" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_03aa54ae-b271-4fa9-a12a-f312edfb0115" xlink:to="loc_us-gaap_EmployeeStockMember_d888b99f-ec8d-445e-bcd3-de0f847b4100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f8a4e30a-427a-431c-ad43-c5d891b6c2fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_b5884505-3e13-4acd-9823-bd5e7f51e6cf" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f8a4e30a-427a-431c-ad43-c5d891b6c2fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_CommonAndPreferredStockSharesAuthorized_34ca0e16-443d-4eff-a0e1-ab8edf494190" xlink:href="syk-20221231.xsd#syk_CommonAndPreferredStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f8a4e30a-427a-431c-ad43-c5d891b6c2fb" xlink:to="loc_syk_CommonAndPreferredStockSharesAuthorized_34ca0e16-443d-4eff-a0e1-ab8edf494190" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_04152d00-fd59-4092-98e2-664ce2a22d0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f8a4e30a-427a-431c-ad43-c5d891b6c2fb" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_04152d00-fd59-4092-98e2-664ce2a22d0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_cfbe10b2-0dd9-4c32-9fe4-fb2fbe11ccff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f8a4e30a-427a-431c-ad43-c5d891b6c2fb" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_cfbe10b2-0dd9-4c32-9fe4-fb2fbe11ccff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_887ba924-0694-4e12-ab4a-6f479b5f0b16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f8a4e30a-427a-431c-ad43-c5d891b6c2fb" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_887ba924-0694-4e12-ab4a-6f479b5f0b16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_43889854-9cb0-4dd9-b5de-9ef6cfc2ccfd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f8a4e30a-427a-431c-ad43-c5d891b6c2fb" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_43889854-9cb0-4dd9-b5de-9ef6cfc2ccfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_eea90d7e-7b1b-45bf-8af0-558b05e95f6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f8a4e30a-427a-431c-ad43-c5d891b6c2fb" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_eea90d7e-7b1b-45bf-8af0-558b05e95f6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_a157e7b8-50e0-4c19-b2ef-1d9c8536bbc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f8a4e30a-427a-431c-ad43-c5d891b6c2fb" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_a157e7b8-50e0-4c19-b2ef-1d9c8536bbc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_7d84e4cc-3373-47f6-b64c-e51b4f4400f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f8a4e30a-427a-431c-ad43-c5d891b6c2fb" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_7d84e4cc-3373-47f6-b64c-e51b4f4400f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_6417f911-8348-4bfd-8447-e6f8e6930013" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f8a4e30a-427a-431c-ad43-c5d891b6c2fb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_6417f911-8348-4bfd-8447-e6f8e6930013" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_3dc043cc-0d54-4a17-b8b7-ac6568b3b6a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f8a4e30a-427a-431c-ad43-c5d891b6c2fb" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_3dc043cc-0d54-4a17-b8b7-ac6568b3b6a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_17e9ffa7-9c55-4ae5-ada4-ae39738cccff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f8a4e30a-427a-431c-ad43-c5d891b6c2fb" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_17e9ffa7-9c55-4ae5-ada4-ae39738cccff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_09b2ceae-aea9-4d62-9eb1-adf9e7f3437e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f8a4e30a-427a-431c-ad43-c5d891b6c2fb" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_09b2ceae-aea9-4d62-9eb1-adf9e7f3437e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_a2fa86d4-88a2-407d-a514-49af981229ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f8a4e30a-427a-431c-ad43-c5d891b6c2fb" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_a2fa86d4-88a2-407d-a514-49af981229ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_4551cc74-760c-4ed6-9f84-b6818df6760c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f8a4e30a-427a-431c-ad43-c5d891b6c2fb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_4551cc74-760c-4ed6-9f84-b6818df6760c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue_1cfe191c-7baf-4b19-8a43-7cdf348eab46" xlink:href="syk-20221231.xsd#syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f8a4e30a-427a-431c-ad43-c5d891b6c2fb" xlink:to="loc_syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue_1cfe191c-7baf-4b19-8a43-7cdf348eab46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp_b6b1de8a-c9c2-40ed-b96b-8618e6cbd519" xlink:href="syk-20221231.xsd#syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f8a4e30a-427a-431c-ad43-c5d891b6c2fb" xlink:to="loc_syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp_b6b1de8a-c9c2-40ed-b96b-8618e6cbd519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_a0402944-e85c-4b74-bb42-b84cecdf7244" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f8a4e30a-427a-431c-ad43-c5d891b6c2fb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_a0402944-e85c-4b74-bb42-b84cecdf7244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/CapitalStockOptionGrantAssumptionsDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#CapitalStockOptionGrantAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/CapitalStockOptionGrantAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_syk_CapitalStockAbstract_d42c38c2-6788-4375-843a-dbeadd545864" xlink:href="syk-20221231.xsd#syk_CapitalStockAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ddd4b73e-6bfe-43c8-b61f-136872fd7eca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_CapitalStockAbstract_d42c38c2-6788-4375-843a-dbeadd545864" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ddd4b73e-6bfe-43c8-b61f-136872fd7eca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_67fe7621-549d-4bf0-b328-12ad748a1e84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_CapitalStockAbstract_d42c38c2-6788-4375-843a-dbeadd545864" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_67fe7621-549d-4bf0-b328-12ad748a1e84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_c980e512-5c0d-46c8-a229-f70e9835baaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_CapitalStockAbstract_d42c38c2-6788-4375-843a-dbeadd545864" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_c980e512-5c0d-46c8-a229-f70e9835baaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_974d24fa-6e2b-4ffb-988f-abbf249a3860" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_CapitalStockAbstract_d42c38c2-6788-4375-843a-dbeadd545864" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_974d24fa-6e2b-4ffb-988f-abbf249a3860" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_ee00eda3-1f2f-4fe8-8d81-d93f7edd548e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_CapitalStockAbstract_d42c38c2-6788-4375-843a-dbeadd545864" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_ee00eda3-1f2f-4fe8-8d81-d93f7edd548e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#CapitalStockSummaryofStockOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_syk_CapitalStockAbstract_02ac7fbd-bd1f-4524-bb19-410b7c610443" xlink:href="syk-20221231.xsd#syk_CapitalStockAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_9fcf1811-8ecb-407b-a523-d5a221695ee7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_CapitalStockAbstract_02ac7fbd-bd1f-4524-bb19-410b7c610443" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_9fcf1811-8ecb-407b-a523-d5a221695ee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_15a5a07f-12b2-47ad-bc07-41f2a33c0885" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_9fcf1811-8ecb-407b-a523-d5a221695ee7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_15a5a07f-12b2-47ad-bc07-41f2a33c0885" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_a111f461-85a0-43bc-85e0-e44a5c6b12e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_9fcf1811-8ecb-407b-a523-d5a221695ee7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_a111f461-85a0-43bc-85e0-e44a5c6b12e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_f381add0-e5a6-4c8f-b146-34f3a47cf709" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_9fcf1811-8ecb-407b-a523-d5a221695ee7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_f381add0-e5a6-4c8f-b146-34f3a47cf709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_67f21253-e573-48cd-9047-caf7a8c56b64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_9fcf1811-8ecb-407b-a523-d5a221695ee7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_67f21253-e573-48cd-9047-caf7a8c56b64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_ef91ebed-2604-478c-abaa-6d009782fade" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_9fcf1811-8ecb-407b-a523-d5a221695ee7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_ef91ebed-2604-478c-abaa-6d009782fade" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_a06a256a-2933-4f37-9eda-777d1b14e816" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_CapitalStockAbstract_02ac7fbd-bd1f-4524-bb19-410b7c610443" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_a06a256a-2933-4f37-9eda-777d1b14e816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_4d0f9f98-27c8-4796-a084-5733ac134467" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_CapitalStockAbstract_02ac7fbd-bd1f-4524-bb19-410b7c610443" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_4d0f9f98-27c8-4796-a084-5733ac134467" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e955f616-5b51-4e66-8314-2356e4c907ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_CapitalStockAbstract_02ac7fbd-bd1f-4524-bb19-410b7c610443" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e955f616-5b51-4e66-8314-2356e4c907ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_ede18f1e-477a-4bfb-8463-f3f87595d5fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e955f616-5b51-4e66-8314-2356e4c907ae" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_ede18f1e-477a-4bfb-8463-f3f87595d5fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_41460b1b-649c-403f-a150-9a45be61d77b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e955f616-5b51-4e66-8314-2356e4c907ae" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_41460b1b-649c-403f-a150-9a45be61d77b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_ba920e49-11ac-42cc-afde-1974fc9d071a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e955f616-5b51-4e66-8314-2356e4c907ae" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_ba920e49-11ac-42cc-afde-1974fc9d071a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_3287be95-1802-4c69-ad80-b499edebd265" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e955f616-5b51-4e66-8314-2356e4c907ae" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_3287be95-1802-4c69-ad80-b499edebd265" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0e65fa82-d6fe-4e2b-b86a-ba448be81958" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e955f616-5b51-4e66-8314-2356e4c907ae" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0e65fa82-d6fe-4e2b-b86a-ba448be81958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_87ff949d-07c1-4c87-ac85-4c947423c82d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_CapitalStockAbstract_02ac7fbd-bd1f-4524-bb19-410b7c610443" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_87ff949d-07c1-4c87-ac85-4c947423c82d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_23f64162-ec25-48ba-9481-a797709bdf87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_CapitalStockAbstract_02ac7fbd-bd1f-4524-bb19-410b7c610443" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_23f64162-ec25-48ba-9481-a797709bdf87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_15e0b794-146a-4a06-a3cc-d81680b0c6fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_CapitalStockAbstract_02ac7fbd-bd1f-4524-bb19-410b7c610443" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_15e0b794-146a-4a06-a3cc-d81680b0c6fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_56709f5f-6c26-4fa4-b0ff-7e436b29cb9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_15e0b794-146a-4a06-a3cc-d81680b0c6fd" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_56709f5f-6c26-4fa4-b0ff-7e436b29cb9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_32ec9496-2fcc-472f-a90e-ed4154fd52b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_15e0b794-146a-4a06-a3cc-d81680b0c6fd" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_32ec9496-2fcc-472f-a90e-ed4154fd52b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_3d122dab-8824-4677-ab78-4f48dc92a5fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_15e0b794-146a-4a06-a3cc-d81680b0c6fd" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_3d122dab-8824-4677-ab78-4f48dc92a5fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_ab5441c4-6ec1-46ac-bc8d-1d093db22f77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_15e0b794-146a-4a06-a3cc-d81680b0c6fd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_ab5441c4-6ec1-46ac-bc8d-1d093db22f77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_77d21e86-7676-41a1-84f3-7584e3082fab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_15e0b794-146a-4a06-a3cc-d81680b0c6fd" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_77d21e86-7676-41a1-84f3-7584e3082fab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_b2897e9e-4751-47f5-bf59-688487b479b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_15e0b794-146a-4a06-a3cc-d81680b0c6fd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_b2897e9e-4751-47f5-bf59-688487b479b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#CapitalStockSummaryofRSUandPSUActivityDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_syk_CapitalStockAbstract_1734b087-c88d-4534-84c3-9682e9b2c4c6" xlink:href="syk-20221231.xsd#syk_CapitalStockAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_f0516c34-324c-4829-87a1-53eababb2272" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_CapitalStockAbstract_1734b087-c88d-4534-84c3-9682e9b2c4c6" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_f0516c34-324c-4829-87a1-53eababb2272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_ab67f838-ae07-4af0-a2ac-e0f859518911" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_f0516c34-324c-4829-87a1-53eababb2272" xlink:to="loc_us-gaap_AwardTypeAxis_ab67f838-ae07-4af0-a2ac-e0f859518911" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1f66595e-ec13-4950-b0a4-0d0a5ed16581" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_ab67f838-ae07-4af0-a2ac-e0f859518911" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1f66595e-ec13-4950-b0a4-0d0a5ed16581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_853a460d-ae49-4059-b74c-8e8d308381b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1f66595e-ec13-4950-b0a4-0d0a5ed16581" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_853a460d-ae49-4059-b74c-8e8d308381b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_PerformanceStockUnitPsusMember_21a64797-a4a3-4b4f-9e29-77ef09362254" xlink:href="syk-20221231.xsd#syk_PerformanceStockUnitPsusMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1f66595e-ec13-4950-b0a4-0d0a5ed16581" xlink:to="loc_syk_PerformanceStockUnitPsusMember_21a64797-a4a3-4b4f-9e29-77ef09362254" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_a3b7997e-83bc-4e89-bea8-286512dc0084" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_f0516c34-324c-4829-87a1-53eababb2272" xlink:to="loc_us-gaap_ClassOfStockLineItems_a3b7997e-83bc-4e89-bea8-286512dc0084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9487aaad-c54e-457d-86a6-c60f8a686829" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a3b7997e-83bc-4e89-bea8-286512dc0084" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9487aaad-c54e-457d-86a6-c60f8a686829" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7c6ec43c-ddb7-487a-abf2-d2b282f2e504" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9487aaad-c54e-457d-86a6-c60f8a686829" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7c6ec43c-ddb7-487a-abf2-d2b282f2e504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_6aa2dc94-2d72-472c-a7b6-8a8259fdc580" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9487aaad-c54e-457d-86a6-c60f8a686829" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_6aa2dc94-2d72-472c-a7b6-8a8259fdc580" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_cde1501f-62aa-42fb-9577-b22538ff3e2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9487aaad-c54e-457d-86a6-c60f8a686829" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_cde1501f-62aa-42fb-9577-b22538ff3e2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_592c0950-c00d-4c39-a3c9-f01c50d19c4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9487aaad-c54e-457d-86a6-c60f8a686829" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_592c0950-c00d-4c39-a3c9-f01c50d19c4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_bba0b83e-0ac7-4bea-9c46-4d9213955a92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9487aaad-c54e-457d-86a6-c60f8a686829" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_bba0b83e-0ac7-4bea-9c46-4d9213955a92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ca376c74-a56d-412d-9e88-9ee9dcd85c6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a3b7997e-83bc-4e89-bea8-286512dc0084" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ca376c74-a56d-412d-9e88-9ee9dcd85c6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_aad15c90-e142-4abd-ad58-0696d7ca4fe0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ca376c74-a56d-412d-9e88-9ee9dcd85c6d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_aad15c90-e142-4abd-ad58-0696d7ca4fe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_576b1afa-b631-4b2c-9e17-f7507553e56b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ca376c74-a56d-412d-9e88-9ee9dcd85c6d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_576b1afa-b631-4b2c-9e17-f7507553e56b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_07c7db14-574e-4e54-ae71-9c8faf960d49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ca376c74-a56d-412d-9e88-9ee9dcd85c6d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_07c7db14-574e-4e54-ae71-9c8faf960d49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_6be4abc4-421a-40cc-b8be-a2a111ed38ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ca376c74-a56d-412d-9e88-9ee9dcd85c6d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_6be4abc4-421a-40cc-b8be-a2a111ed38ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e24ea231-c62e-4766-82fe-50ebd2f0262e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ca376c74-a56d-412d-9e88-9ee9dcd85c6d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e24ea231-c62e-4766-82fe-50ebd2f0262e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#DebtandCreditFacilitiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAbstract_2e76043b-ac3f-4905-ab1e-fcf852b3ce85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_10a085b9-9f64-46ae-9558-b4c09bcc9ca0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtAbstract_2e76043b-ac3f-4905-ab1e-fcf852b3ce85" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_10a085b9-9f64-46ae-9558-b4c09bcc9ca0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_a44d36a8-a3a0-4034-a7ee-c922faedb369" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_10a085b9-9f64-46ae-9558-b4c09bcc9ca0" xlink:to="loc_us-gaap_DebtInstrumentAxis_a44d36a8-a3a0-4034-a7ee-c922faedb369" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_81dd6855-d801-420a-97ed-4a4981a3ec04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_a44d36a8-a3a0-4034-a7ee-c922faedb369" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_81dd6855-d801-420a-97ed-4a4981a3ec04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_TermLoanDueFebruary222025Member_e7feb346-ec04-4717-b4f2-93af081d942b" xlink:href="syk-20221231.xsd#syk_TermLoanDueFebruary222025Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_81dd6855-d801-420a-97ed-4a4981a3ec04" xlink:to="loc_syk_TermLoanDueFebruary222025Member_e7feb346-ec04-4717-b4f2-93af081d942b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_CreditAgreementMember_a01937ae-40d5-4d67-86fd-6cd4bf0e192e" xlink:href="syk-20221231.xsd#syk_CreditAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_81dd6855-d801-420a-97ed-4a4981a3ec04" xlink:to="loc_syk_CreditAgreementMember_a01937ae-40d5-4d67-86fd-6cd4bf0e192e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_7eea64ae-9f5b-488c-a05f-b410e4deffa8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_10a085b9-9f64-46ae-9558-b4c09bcc9ca0" xlink:to="loc_us-gaap_CreditFacilityAxis_7eea64ae-9f5b-488c-a05f-b410e4deffa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_6e39c244-11fb-4648-a6e2-94f3ca991f3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_7eea64ae-9f5b-488c-a05f-b410e4deffa8" xlink:to="loc_us-gaap_CreditFacilityDomain_6e39c244-11fb-4648-a6e2-94f3ca991f3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_8c81b0f4-b7d6-4ce4-b3db-b40fca3c4d23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_6e39c244-11fb-4648-a6e2-94f3ca991f3a" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_8c81b0f4-b7d6-4ce4-b3db-b40fca3c4d23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_878691ae-e5be-420c-aeb3-ee98903eb761" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_10a085b9-9f64-46ae-9558-b4c09bcc9ca0" xlink:to="loc_us-gaap_VariableRateAxis_878691ae-e5be-420c-aeb3-ee98903eb761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_92e41938-3815-4b59-8ebe-db25d7af68c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_878691ae-e5be-420c-aeb3-ee98903eb761" xlink:to="loc_us-gaap_VariableRateDomain_92e41938-3815-4b59-8ebe-db25d7af68c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_addce0e2-fb3a-434b-955c-e862d14c384a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_92e41938-3815-4b59-8ebe-db25d7af68c8" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_addce0e2-fb3a-434b-955c-e862d14c384a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_1ef23136-ce0d-4b63-b16a-ca514c5cbac7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_10a085b9-9f64-46ae-9558-b4c09bcc9ca0" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_1ef23136-ce0d-4b63-b16a-ca514c5cbac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_6230dc78-5631-406f-af95-5002c0fcc70a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1ef23136-ce0d-4b63-b16a-ca514c5cbac7" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_6230dc78-5631-406f-af95-5002c0fcc70a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_f212ede4-c961-451a-a12b-2fc323b29630" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1ef23136-ce0d-4b63-b16a-ca514c5cbac7" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_f212ede4-c961-451a-a12b-2fc323b29630" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_752f232f-6078-4eaf-8dd4-41254cc39221" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1ef23136-ce0d-4b63-b16a-ca514c5cbac7" xlink:to="loc_us-gaap_RepaymentsOfDebt_752f232f-6078-4eaf-8dd4-41254cc39221" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_39f579bb-c19c-49d8-8e9f-cf1af77ecb64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1ef23136-ce0d-4b63-b16a-ca514c5cbac7" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_39f579bb-c19c-49d8-8e9f-cf1af77ecb64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaper_03462bb9-1c94-4c20-abf1-bf8e29e854e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaper"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1ef23136-ce0d-4b63-b16a-ca514c5cbac7" xlink:to="loc_us-gaap_CommercialPaper_03462bb9-1c94-4c20-abf1-bf8e29e854e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_3884741d-4a2d-45d0-b37a-1b171149d537" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1ef23136-ce0d-4b63-b16a-ca514c5cbac7" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_3884741d-4a2d-45d0-b37a-1b171149d537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_8ea594df-025c-4686-874a-e673b0a40b7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_1ef23136-ce0d-4b63-b16a-ca514c5cbac7" xlink:to="loc_us-gaap_InterestExpenseDebt_8ea594df-025c-4686-874a-e673b0a40b7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAbstract_15040f88-b8ee-4ce5-a6ce-464e40b6b014" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable_54b326fc-9372-4ed6-b6fb-2c90e92bbcab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtAbstract_15040f88-b8ee-4ce5-a6ce-464e40b6b014" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTable_54b326fc-9372-4ed6-b6fb-2c90e92bbcab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_eb1b5e1b-feb5-46dc-a471-c32da9b23f7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_54b326fc-9372-4ed6-b6fb-2c90e92bbcab" xlink:to="loc_us-gaap_DebtInstrumentAxis_eb1b5e1b-feb5-46dc-a471-c32da9b23f7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1a255442-5407-49ab-8556-b10201e2f11b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_eb1b5e1b-feb5-46dc-a471-c32da9b23f7b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1a255442-5407-49ab-8556-b10201e2f11b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotesDueNovember2023Member_2b459f42-7ce0-411d-96bf-0611911eb826" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotesDueNovember2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1a255442-5407-49ab-8556-b10201e2f11b" xlink:to="loc_syk_SeniorUnsecuredNotesDueNovember2023Member_2b459f42-7ce0-411d-96bf-0611911eb826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes0600Due2023Member_1e1bb398-92ad-4875-ab34-92881bccfe60" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotes0600Due2023Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1a255442-5407-49ab-8556-b10201e2f11b" xlink:to="loc_syk_SeniorUnsecuredNotes0600Due2023Member_1e1bb398-92ad-4875-ab34-92881bccfe60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes3.375due2024Member_e043acc3-5602-4b52-990e-1f29a08cfc3f" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotes3.375due2024Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1a255442-5407-49ab-8556-b10201e2f11b" xlink:to="loc_syk_SeniorUnsecuredNotes3.375due2024Member_e043acc3-5602-4b52-990e-1f29a08cfc3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes0.250due2024Member_bed9f836-35e1-46e4-8b13-f27bb0cfd40a" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotes0.250due2024Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1a255442-5407-49ab-8556-b10201e2f11b" xlink:to="loc_syk_SeniorUnsecuredNotes0.250due2024Member_bed9f836-35e1-46e4-8b13-f27bb0cfd40a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes1.150Due2025Member_29fa4fb7-8298-4249-aecd-4baa42804be8" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotes1.150Due2025Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1a255442-5407-49ab-8556-b10201e2f11b" xlink:to="loc_syk_SeniorUnsecuredNotes1.150Due2025Member_29fa4fb7-8298-4249-aecd-4baa42804be8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes3.375due2025MemberMember_c13ac7f9-5664-4bcc-a4cb-718c86102598" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotes3.375due2025MemberMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1a255442-5407-49ab-8556-b10201e2f11b" xlink:to="loc_syk_SeniorUnsecuredNotes3.375due2025MemberMember_c13ac7f9-5664-4bcc-a4cb-718c86102598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes350Due2026Member_3313012b-1754-4710-a984-c84179ae31c4" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotes350Due2026Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1a255442-5407-49ab-8556-b10201e2f11b" xlink:to="loc_syk_SeniorUnsecuredNotes350Due2026Member_3313012b-1754-4710-a984-c84179ae31c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotesDueNovember2027Member_e516ee36-c8bf-48b6-a6d3-7c62ebf6c59e" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotesDueNovember2027Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1a255442-5407-49ab-8556-b10201e2f11b" xlink:to="loc_syk_SeniorUnsecuredNotesDueNovember2027Member_e516ee36-c8bf-48b6-a6d3-7c62ebf6c59e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes3650Due2028Member_e6ad99e1-c85e-4c41-8bf5-d925f136305a" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotes3650Due2028Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1a255442-5407-49ab-8556-b10201e2f11b" xlink:to="loc_syk_SeniorUnsecuredNotes3650Due2028Member_e6ad99e1-c85e-4c41-8bf5-d925f136305a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes0.750due2029Member_73987482-45a2-4e32-aa6a-f9e2eea8eedc" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotes0.750due2029Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1a255442-5407-49ab-8556-b10201e2f11b" xlink:to="loc_syk_SeniorUnsecuredNotes0.750due2029Member_73987482-45a2-4e32-aa6a-f9e2eea8eedc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes1.950Due2030Member_9c444366-8756-4853-a2af-44615535cefd" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotes1.950Due2030Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1a255442-5407-49ab-8556-b10201e2f11b" xlink:to="loc_syk_SeniorUnsecuredNotes1.950Due2030Member_9c444366-8756-4853-a2af-44615535cefd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotesDueNovember2030Member_ecc35f49-9d23-4aa3-8da0-41d99496d0a0" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotesDueNovember2030Member"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1a255442-5407-49ab-8556-b10201e2f11b" xlink:to="loc_syk_SeniorUnsecuredNotesDueNovember2030Member_ecc35f49-9d23-4aa3-8da0-41d99496d0a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes1.000due2031Member_37737c38-43b3-458a-8873-9c67de96ae5e" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotes1.000due2031Member"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1a255442-5407-49ab-8556-b10201e2f11b" xlink:to="loc_syk_SeniorUnsecuredNotes1.000due2031Member_37737c38-43b3-458a-8873-9c67de96ae5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes410Due2043Member_f8a51842-7230-4ec4-9241-1ee7d6ab75e2" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotes410Due2043Member"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1a255442-5407-49ab-8556-b10201e2f11b" xlink:to="loc_syk_SeniorUnsecuredNotes410Due2043Member_f8a51842-7230-4ec4-9241-1ee7d6ab75e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes4.375due2044Member_366747b3-8322-4357-8c43-75bce8a42b7e" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotes4.375due2044Member"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1a255442-5407-49ab-8556-b10201e2f11b" xlink:to="loc_syk_SeniorUnsecuredNotes4.375due2044Member_366747b3-8322-4357-8c43-75bce8a42b7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes4625Due2046Member_88c7fa5e-2945-4483-bc02-e8cb1c70bf1d" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotes4625Due2046Member"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1a255442-5407-49ab-8556-b10201e2f11b" xlink:to="loc_syk_SeniorUnsecuredNotes4625Due2046Member_88c7fa5e-2945-4483-bc02-e8cb1c70bf1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes2.900due2050Member_c0a6517a-b659-439c-8bd4-2415de1cd25a" xlink:href="syk-20221231.xsd#syk_SeniorUnsecuredNotes2.900due2050Member"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1a255442-5407-49ab-8556-b10201e2f11b" xlink:to="loc_syk_SeniorUnsecuredNotes2.900due2050Member_c0a6517a-b659-439c-8bd4-2415de1cd25a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_TermLoanMember_62f9eefd-f07b-46eb-a1c6-5605d1b438df" xlink:href="syk-20221231.xsd#syk_TermLoanMember"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1a255442-5407-49ab-8556-b10201e2f11b" xlink:to="loc_syk_TermLoanMember_62f9eefd-f07b-46eb-a1c6-5605d1b438df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_775cc885-e368-4d3a-8295-970e9964eb2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_54b326fc-9372-4ed6-b6fb-2c90e92bbcab" xlink:to="loc_us-gaap_StatementLineItems_775cc885-e368-4d3a-8295-970e9964eb2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_29601de4-a487-4531-921f-cade3257ad00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_775cc885-e368-4d3a-8295-970e9964eb2b" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_29601de4-a487-4531-921f-cade3257ad00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebt_9bcc6cbd-bd97-49c6-970e-36c17bdc6319" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnsecuredDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_775cc885-e368-4d3a-8295-970e9964eb2b" xlink:to="loc_us-gaap_UnsecuredDebt_9bcc6cbd-bd97-49c6-970e-36c17bdc6319" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_b5382716-fca7-4df7-bc79-d77c9e5b2c1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_775cc885-e368-4d3a-8295-970e9964eb2b" xlink:to="loc_us-gaap_LongTermDebt_b5382716-fca7-4df7-bc79-d77c9e5b2c1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermDebt_fd82090b-928e-4bb8-9a79-1cc115d7d693" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_775cc885-e368-4d3a-8295-970e9964eb2b" xlink:to="loc_us-gaap_OtherLongTermDebt_fd82090b-928e-4bb8-9a79-1cc115d7d693" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_6b816e53-e922-4d27-b7a6-2e8bd64aad48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_775cc885-e368-4d3a-8295-970e9964eb2b" xlink:to="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_6b816e53-e922-4d27-b7a6-2e8bd64aad48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_b1b64b16-19bd-4b8c-894f-e0268463a646" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_775cc885-e368-4d3a-8295-970e9964eb2b" xlink:to="loc_us-gaap_DebtCurrent_b1b64b16-19bd-4b8c-894f-e0268463a646" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_68746295-3ab4-4393-8c01-333499536761" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_775cc885-e368-4d3a-8295-970e9964eb2b" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_68746295-3ab4-4393-8c01-333499536761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_fe4def78-663b-478e-8fbf-8eac6c7ec1de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_775cc885-e368-4d3a-8295-970e9964eb2b" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_fe4def78-663b-478e-8fbf-8eac6c7ec1de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_9481e543-92e5-4e4f-a11d-1fd06afb13ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_775cc885-e368-4d3a-8295-970e9964eb2b" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_9481e543-92e5-4e4f-a11d-1fd06afb13ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_9eb0f244-8f5d-4263-933d-4567fa6f497e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_775cc885-e368-4d3a-8295-970e9964eb2b" xlink:to="loc_us-gaap_DebtInstrumentFairValue_9eb0f244-8f5d-4263-933d-4567fa6f497e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails_1" xlink:type="simple" xlink:href="syk-20221231.xsd#DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails_1"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.stryker.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_33bf2beb-a592-4b23-8acc-39328082925c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_b96da297-fe40-49a3-aab7-b71b4001a6ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_33bf2beb-a592-4b23-8acc-39328082925c" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_b96da297-fe40-49a3-aab7-b71b4001a6ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_2f63d964-e5be-42df-be32-ee5ffdf35960" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_b96da297-fe40-49a3-aab7-b71b4001a6ef" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_2f63d964-e5be-42df-be32-ee5ffdf35960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_f3163672-897e-4b5e-88d9-27507e2e3583" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_2f63d964-e5be-42df-be32-ee5ffdf35960" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_f3163672-897e-4b5e-88d9-27507e2e3583" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_34aa02ac-e091-4a50-b6ad-9adeba29cf7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_f3163672-897e-4b5e-88d9-27507e2e3583" xlink:to="loc_us-gaap_DomesticCountryMember_34aa02ac-e091-4a50-b6ad-9adeba29cf7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_e02dc7fe-1166-4c42-b590-a7627ec219fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_f3163672-897e-4b5e-88d9-27507e2e3583" xlink:to="loc_us-gaap_ForeignCountryMember_e02dc7fe-1166-4c42-b590-a7627ec219fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_2ac295aa-c30b-4a39-8dc8-5ad8180d333d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_b96da297-fe40-49a3-aab7-b71b4001a6ef" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_2ac295aa-c30b-4a39-8dc8-5ad8180d333d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_2305a833-163c-4eac-8fed-1a2a39f567b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ac295aa-c30b-4a39-8dc8-5ad8180d333d" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_2305a833-163c-4eac-8fed-1a2a39f567b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_39366344-be2a-4053-a3cd-d663754e8389" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ac295aa-c30b-4a39-8dc8-5ad8180d333d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_39366344-be2a-4053-a3cd-d663754e8389" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized_c9618f5c-48a4-432b-8f6c-3fe0043e03d8" xlink:href="syk-20221231.xsd#syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ac295aa-c30b-4a39-8dc8-5ad8180d333d" xlink:to="loc_syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized_c9618f5c-48a4-432b-8f6c-3fe0043e03d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_f4da0549-fba9-4c4a-9fe6-9d96fe348dca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ac295aa-c30b-4a39-8dc8-5ad8180d333d" xlink:to="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_f4da0549-fba9-4c4a-9fe6-9d96fe348dca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_b4704b8d-fc2d-45a4-b96b-d0031e22f42c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ac295aa-c30b-4a39-8dc8-5ad8180d333d" xlink:to="loc_us-gaap_OperatingLossCarryforwards_b4704b8d-fc2d-45a4-b96b-d0031e22f42c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OperatingLossCarryforwardsSubjectToValuationAllowance_0456541f-7a5b-416a-841e-0e58d86ce722" xlink:href="syk-20221231.xsd#syk_OperatingLossCarryforwardsSubjectToValuationAllowance"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ac295aa-c30b-4a39-8dc8-5ad8180d333d" xlink:to="loc_syk_OperatingLossCarryforwardsSubjectToValuationAllowance_0456541f-7a5b-416a-841e-0e58d86ce722" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_357e574f-b71e-4851-a3d7-c09884d3a585" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ac295aa-c30b-4a39-8dc8-5ad8180d333d" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_357e574f-b71e-4851-a3d7-c09884d3a585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardValuationAllowance_1401d225-8a19-476e-a2a2-6c70d3e961b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardValuationAllowance"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ac295aa-c30b-4a39-8dc8-5ad8180d333d" xlink:to="loc_us-gaap_TaxCreditCarryforwardValuationAllowance_1401d225-8a19-476e-a2a2-6c70d3e961b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense_12b89bd7-a231-4d20-8e2d-05c44ee312d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ac295aa-c30b-4a39-8dc8-5ad8180d333d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense_12b89bd7-a231-4d20-8e2d-05c44ee312d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxSettlements_403a25e9-ea7e-4d88-bd24-d666b3eff1e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxSettlements"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ac295aa-c30b-4a39-8dc8-5ad8180d333d" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxSettlements_403a25e9-ea7e-4d88-bd24-d666b3eff1e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_IncomeTaxExpenseBenefitTaxSettlementReleaseOfAccruedInterest_c0d93bd2-9e3e-4d32-9bab-9f2576f931dd" xlink:href="syk-20221231.xsd#syk_IncomeTaxExpenseBenefitTaxSettlementReleaseOfAccruedInterest"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ac295aa-c30b-4a39-8dc8-5ad8180d333d" xlink:to="loc_syk_IncomeTaxExpenseBenefitTaxSettlementReleaseOfAccruedInterest_c0d93bd2-9e3e-4d32-9bab-9f2576f931dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_d39ae1ac-7ddb-4c39-a8fb-3720512b9ae1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_ca8b48cc-b0b9-4c53-950c-61376c21ba1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d39ae1ac-7ddb-4c39-a8fb-3720512b9ae1" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_ca8b48cc-b0b9-4c53-950c-61376c21ba1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_66121f05-7c19-4e3f-a284-c42eca813ef3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d39ae1ac-7ddb-4c39-a8fb-3720512b9ae1" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_66121f05-7c19-4e3f-a284-c42eca813ef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_9c96b10c-270c-46f1-aa51-2638f706be75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d39ae1ac-7ddb-4c39-a8fb-3720512b9ae1" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_9c96b10c-270c-46f1-aa51-2638f706be75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent_296f1dfc-f5ee-4e02-b4e4-279d73bcbf68" xlink:href="syk-20221231.xsd#syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d39ae1ac-7ddb-4c39-a8fb-3720512b9ae1" xlink:to="loc_syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent_296f1dfc-f5ee-4e02-b4e4-279d73bcbf68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent_fcfa41af-dd7e-4ef7-88b4-9228b40204aa" xlink:href="syk-20221231.xsd#syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d39ae1ac-7ddb-4c39-a8fb-3720512b9ae1" xlink:to="loc_syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent_fcfa41af-dd7e-4ef7-88b4-9228b40204aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic_77a5061c-2e82-4c16-a2cc-ed4fb8f9f334" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d39ae1ac-7ddb-4c39-a8fb-3720512b9ae1" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic_77a5061c-2e82-4c16-a2cc-ed4fb8f9f334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_78035fa2-b537-4c19-be8a-70fc5f18d391" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d39ae1ac-7ddb-4c39-a8fb-3720512b9ae1" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_78035fa2-b537-4c19-be8a-70fc5f18d391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_891ba43f-06fe-48b7-9c71-e78259c374eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d39ae1ac-7ddb-4c39-a8fb-3720512b9ae1" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_891ba43f-06fe-48b7-9c71-e78259c374eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e28bad9e-8157-40b1-bfb4-e00212f279ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d39ae1ac-7ddb-4c39-a8fb-3720512b9ae1" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e28bad9e-8157-40b1-bfb4-e00212f279ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_6a4c8d96-26be-4e21-9c35-90f5f2d0d771" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_179cf9d4-ca41-49cf-a1b2-4fd6e07b34a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6a4c8d96-26be-4e21-9c35-90f5f2d0d771" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_179cf9d4-ca41-49cf-a1b2-4fd6e07b34a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_85ba5008-1192-47ed-9fb9-516a365b253b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6a4c8d96-26be-4e21-9c35-90f5f2d0d771" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_85ba5008-1192-47ed-9fb9-516a365b253b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3ac1b341-7a47-4d47-9a0b-62e73cac941a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6a4c8d96-26be-4e21-9c35-90f5f2d0d771" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3ac1b341-7a47-4d47-9a0b-62e73cac941a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#IncomeTaxesScheduleofProvisionforIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_9800cf9f-6b5c-4e3a-a00a-29e93ebc2b5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_18adffc8-97ee-4411-92dd-463be2eab0d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9800cf9f-6b5c-4e3a-a00a-29e93ebc2b5d" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_18adffc8-97ee-4411-92dd-463be2eab0d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_3c1e988a-8056-42a8-8c70-632157b3dfdd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_18adffc8-97ee-4411-92dd-463be2eab0d6" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_3c1e988a-8056-42a8-8c70-632157b3dfdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_4365423d-749f-4e11-bbd8-41ef58b89437" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_18adffc8-97ee-4411-92dd-463be2eab0d6" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_4365423d-749f-4e11-bbd8-41ef58b89437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_72c6710c-d0e8-4fb6-a3ad-5e6821011721" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_18adffc8-97ee-4411-92dd-463be2eab0d6" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_72c6710c-d0e8-4fb6-a3ad-5e6821011721" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_189097c0-4828-4a49-a426-cd94e7037dc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_18adffc8-97ee-4411-92dd-463be2eab0d6" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_189097c0-4828-4a49-a426-cd94e7037dc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_b820bcde-a017-4f0a-8e60-e28bafa84e76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9800cf9f-6b5c-4e3a-a00a-29e93ebc2b5d" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_b820bcde-a017-4f0a-8e60-e28bafa84e76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_c771ecc2-447e-4ea0-ac31-3c795d8c72b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_b820bcde-a017-4f0a-8e60-e28bafa84e76" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_c771ecc2-447e-4ea0-ac31-3c795d8c72b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_e565aec1-6ff4-4351-a005-af1be81178f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_b820bcde-a017-4f0a-8e60-e28bafa84e76" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_e565aec1-6ff4-4351-a005-af1be81178f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_2ee3cd2a-41bc-4f97-9173-d24b3305eb39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_b820bcde-a017-4f0a-8e60-e28bafa84e76" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_2ee3cd2a-41bc-4f97-9173-d24b3305eb39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_9ebff334-801b-4be2-8e91-7134e44ffa57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_b820bcde-a017-4f0a-8e60-e28bafa84e76" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_9ebff334-801b-4be2-8e91-7134e44ffa57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_d4501738-aafc-4a73-9e95-bf18da839f3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9800cf9f-6b5c-4e3a-a00a-29e93ebc2b5d" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_d4501738-aafc-4a73-9e95-bf18da839f3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_a8cfe37b-b557-467b-ac16-eaf77e61ce68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_9b7f5700-75ba-46ad-8c2c-e37c20c5b643" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a8cfe37b-b557-467b-ac16-eaf77e61ce68" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_9b7f5700-75ba-46ad-8c2c-e37c20c5b643" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory_2a058610-ad59-4e37-be6c-98023746479a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_9b7f5700-75ba-46ad-8c2c-e37c20c5b643" xlink:to="loc_us-gaap_DeferredTaxAssetsInventory_2a058610-ad59-4e37-be6c-98023746479a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_f627c7cb-4e09-43b9-8087-f8422d50ead1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_9b7f5700-75ba-46ad-8c2c-e37c20c5b643" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_f627c7cb-4e09-43b9-8087-f8422d50ead1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_afaa4f68-6ee7-425f-9297-a370a2b784e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_9b7f5700-75ba-46ad-8c2c-e37c20c5b643" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_afaa4f68-6ee7-425f-9297-a370a2b784e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DeferredTaxAssetsDepreciationAndAmortization_ebec75d6-18ad-42ec-a8b1-4444e75cf69d" xlink:href="syk-20221231.xsd#syk_DeferredTaxAssetsDepreciationAndAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_9b7f5700-75ba-46ad-8c2c-e37c20c5b643" xlink:to="loc_syk_DeferredTaxAssetsDepreciationAndAmortization_ebec75d6-18ad-42ec-a8b1-4444e75cf69d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsStateTaxes_de56e4b7-a84b-4722-9403-151b3acfbfc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsStateTaxes"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_9b7f5700-75ba-46ad-8c2c-e37c20c5b643" xlink:to="loc_us-gaap_DeferredTaxAssetsStateTaxes_de56e4b7-a84b-4722-9403-151b3acfbfc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_25bb7fb3-2621-4f1b-a282-61154726b2bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_9b7f5700-75ba-46ad-8c2c-e37c20c5b643" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_25bb7fb3-2621-4f1b-a282-61154726b2bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DeferredTaxAssetsResearchAndDevelopmentCapitalization_8ff922b1-9449-45ce-a599-94399e6f6280" xlink:href="syk-20221231.xsd#syk_DeferredTaxAssetsResearchAndDevelopmentCapitalization"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_9b7f5700-75ba-46ad-8c2c-e37c20c5b643" xlink:to="loc_syk_DeferredTaxAssetsResearchAndDevelopmentCapitalization_8ff922b1-9449-45ce-a599-94399e6f6280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetInterestCarryforward_8fb793e0-201d-43bf-a975-362661c03ed7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetInterestCarryforward"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_9b7f5700-75ba-46ad-8c2c-e37c20c5b643" xlink:to="loc_us-gaap_DeferredTaxAssetInterestCarryforward_8fb793e0-201d-43bf-a975-362661c03ed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_ea37998f-1b3c-45d2-92b4-d224bc9e44e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_9b7f5700-75ba-46ad-8c2c-e37c20c5b643" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_ea37998f-1b3c-45d2-92b4-d224bc9e44e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_a5c6ec81-9387-4643-9309-d074c108d09a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_9b7f5700-75ba-46ad-8c2c-e37c20c5b643" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_a5c6ec81-9387-4643-9309-d074c108d09a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_e1dbf540-9e81-4d04-b551-5590d1b64f43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_9b7f5700-75ba-46ad-8c2c-e37c20c5b643" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_e1dbf540-9e81-4d04-b551-5590d1b64f43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_e912ab08-49ea-4347-8a2c-98672683b3f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_9b7f5700-75ba-46ad-8c2c-e37c20c5b643" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_e912ab08-49ea-4347-8a2c-98672683b3f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_c5280cdd-7605-4e2c-aa75-a1083b23c7e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_9b7f5700-75ba-46ad-8c2c-e37c20c5b643" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_c5280cdd-7605-4e2c-aa75-a1083b23c7e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_e1dcd83e-37cb-4c4d-bb3a-7d41a17dc3e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a8cfe37b-b557-467b-ac16-eaf77e61ce68" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_e1dcd83e-37cb-4c4d-bb3a-7d41a17dc3e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DeferredTaxLiabilitiesDepreciationAndAmortization_b3954e24-86ca-4293-9575-b6964993ea2a" xlink:href="syk-20221231.xsd#syk_DeferredTaxLiabilitiesDepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_e1dcd83e-37cb-4c4d-bb3a-7d41a17dc3e5" xlink:to="loc_syk_DeferredTaxLiabilitiesDepreciationAndAmortization_b3954e24-86ca-4293-9575-b6964993ea2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_d153ca38-d602-4ee6-9fd1-06d3ff926ddc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_e1dcd83e-37cb-4c4d-bb3a-7d41a17dc3e5" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_d153ca38-d602-4ee6-9fd1-06d3ff926ddc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_4bd2f0b6-d71d-4ec8-8382-99c72b0f68bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_e1dcd83e-37cb-4c4d-bb3a-7d41a17dc3e5" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_4bd2f0b6-d71d-4ec8-8382-99c72b0f68bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_b4f13c70-27a2-4e73-91df-c0b9f160d60f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a8cfe37b-b557-467b-ac16-eaf77e61ce68" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_b4f13c70-27a2-4e73-91df-c0b9f160d60f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_5a92dd91-a9f0-4783-98a7-9e44f351133b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a8cfe37b-b557-467b-ac16-eaf77e61ce68" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_5a92dd91-a9f0-4783-98a7-9e44f351133b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_dbd373ff-1887-4d13-a70b-ff3254b942cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a8cfe37b-b557-467b-ac16-eaf77e61ce68" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_dbd373ff-1887-4d13-a70b-ff3254b942cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails_1" xlink:type="simple" xlink:href="syk-20221231.xsd#IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails_1"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.stryker.com/role/IncomeTaxesScheduleofUnresolvedIncomeTaxPositionsDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#IncomeTaxesScheduleofUnresolvedIncomeTaxPositionsDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/IncomeTaxesScheduleofUnresolvedIncomeTaxPositionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_af06c3e5-1887-43f6-984f-c2f8633137c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_7acb8b85-4e00-474f-bd0e-ca56080d86b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_af06c3e5-1887-43f6-984f-c2f8633137c9" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_7acb8b85-4e00-474f-bd0e-ca56080d86b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_48c24ddb-1d34-4d31-a1ae-18b8f87a1081" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_7acb8b85-4e00-474f-bd0e-ca56080d86b5" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_48c24ddb-1d34-4d31-a1ae-18b8f87a1081" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_d892c69c-fe2c-476f-98c8-e3a5da80a284" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_7acb8b85-4e00-474f-bd0e-ca56080d86b5" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_d892c69c-fe2c-476f-98c8-e3a5da80a284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_d6dfd8f3-c031-45be-87fd-4d16e0716bb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_7acb8b85-4e00-474f-bd0e-ca56080d86b5" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_d6dfd8f3-c031-45be-87fd-4d16e0716bb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_eefb870c-78d8-4a75-b918-27b924c8c756" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_7acb8b85-4e00-474f-bd0e-ca56080d86b5" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_eefb870c-78d8-4a75-b918-27b924c8c756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_8ff0b991-117f-4e71-bf38-61fce61f6fca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_7acb8b85-4e00-474f-bd0e-ca56080d86b5" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_8ff0b991-117f-4e71-bf38-61fce61f6fca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_dcd350f3-846f-4875-8efb-27248eff43bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_7acb8b85-4e00-474f-bd0e-ca56080d86b5" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_dcd350f3-846f-4875-8efb-27248eff43bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation_ce102885-ca90-4dfc-83f5-461ec4043439" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_7acb8b85-4e00-474f-bd0e-ca56080d86b5" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation_ce102885-ca90-4dfc-83f5-461ec4043439" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_4a85fd7a-0432-4420-a5d0-4a388287a021" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_7acb8b85-4e00-474f-bd0e-ca56080d86b5" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_4a85fd7a-0432-4420-a5d0-4a388287a021" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RetirementPlansScheduleofDefinedContributionPlanDisclosuresDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#RetirementPlansScheduleofDefinedContributionPlanDisclosuresDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/RetirementPlansScheduleofDefinedContributionPlanDisclosuresDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e4d8c41b-98c4-4025-b237-bfc43bb7e55e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_af60fb0c-55d5-4310-8e64-b3dfc3ea27c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e4d8c41b-98c4-4025-b237-bfc43bb7e55e" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_af60fb0c-55d5-4310-8e64-b3dfc3ea27c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_41c30fab-d865-4a8e-9a94-46504cbd141e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e4d8c41b-98c4-4025-b237-bfc43bb7e55e" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_41c30fab-d865-4a8e-9a94-46504cbd141e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DefinedContributionRetirementPlansCommonStockValueHeldByCompany_ca8cf27f-7f27-43fe-8f9e-4908617d013a" xlink:href="syk-20221231.xsd#syk_DefinedContributionRetirementPlansCommonStockValueHeldByCompany"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e4d8c41b-98c4-4025-b237-bfc43bb7e55e" xlink:to="loc_syk_DefinedContributionRetirementPlansCommonStockValueHeldByCompany_ca8cf27f-7f27-43fe-8f9e-4908617d013a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DefinedContributionRetirementPlansCommonStockHeldByCompany_1fcc8da3-1355-48ab-917a-9b4b21b9b038" xlink:href="syk-20221231.xsd#syk_DefinedContributionRetirementPlansCommonStockHeldByCompany"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e4d8c41b-98c4-4025-b237-bfc43bb7e55e" xlink:to="loc_syk_DefinedContributionRetirementPlansCommonStockHeldByCompany_1fcc8da3-1355-48ab-917a-9b4b21b9b038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany_4f2cd311-ba7a-42bf-b32c-cf0b97541d12" xlink:href="syk-20221231.xsd#syk_TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e4d8c41b-98c4-4025-b237-bfc43bb7e55e" xlink:to="loc_syk_TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany_4f2cd311-ba7a-42bf-b32c-cf0b97541d12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_9a7b5e37-3dd0-496c-9087-a74431a6b0d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_e8bdb1b6-3734-484b-94a0-999038b448d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_9a7b5e37-3dd0-496c-9087-a74431a6b0d1" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_e8bdb1b6-3734-484b-94a0-999038b448d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_fd3ee094-37cf-4a5a-be9b-5dda68b9e978" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_e8bdb1b6-3734-484b-94a0-999038b448d6" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_fd3ee094-37cf-4a5a-be9b-5dda68b9e978" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_c976bce1-53ef-4ee1-a1e1-eeb3c08cb32b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_e8bdb1b6-3734-484b-94a0-999038b448d6" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_c976bce1-53ef-4ee1-a1e1-eeb3c08cb32b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_b36a3ae9-a2cc-42a4-a94e-17f657db8fea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_e8bdb1b6-3734-484b-94a0-999038b448d6" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_b36a3ae9-a2cc-42a4-a94e-17f657db8fea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_7ccb8372-b52b-485f-9243-63c7256fccaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_e8bdb1b6-3734-484b-94a0-999038b448d6" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_7ccb8372-b52b-485f-9243-63c7256fccaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_870e12c0-b2a9-4db7-9238-438d869dac32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_e8bdb1b6-3734-484b-94a0-999038b448d6" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_870e12c0-b2a9-4db7-9238-438d869dac32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_b8fcdb78-3c67-498e-8f24-042ace8547c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_e8bdb1b6-3734-484b-94a0-999038b448d6" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_b8fcdb78-3c67-498e-8f24-042ace8547c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_773df29a-7aa1-43f6-8e67-2700ddf2f9a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_e8bdb1b6-3734-484b-94a0-999038b448d6" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_773df29a-7aa1-43f6-8e67-2700ddf2f9a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_805630f8-fc92-4c81-abea-72133794dcb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_9a7b5e37-3dd0-496c-9087-a74431a6b0d1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_805630f8-fc92-4c81-abea-72133794dcb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_70c7ac31-77e8-4600-bab7-ff9c88f4fc49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_9a7b5e37-3dd0-496c-9087-a74431a6b0d1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_70c7ac31-77e8-4600-bab7-ff9c88f4fc49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax_1b4c0b26-6a51-45cc-ac7c-6a69de605db7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_9a7b5e37-3dd0-496c-9087-a74431a6b0d1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax_1b4c0b26-6a51-45cc-ac7c-6a69de605db7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_5da89bfc-c2a8-4637-8065-af8cc0dd2e02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_9a7b5e37-3dd0-496c-9087-a74431a6b0d1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_5da89bfc-c2a8-4637-8065-af8cc0dd2e02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_907b110b-c93c-4323-98a1-f9c9ed3603c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_9a7b5e37-3dd0-496c-9087-a74431a6b0d1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_907b110b-c93c-4323-98a1-f9c9ed3603c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax_947a2a8c-776f-4e4d-8515-33c18a1c9fc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_9a7b5e37-3dd0-496c-9087-a74431a6b0d1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax_947a2a8c-776f-4e4d-8515-33c18a1c9fc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract_18b880e6-dd37-45cd-9c04-b3dc3ea8883c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_9a7b5e37-3dd0-496c-9087-a74431a6b0d1" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract_18b880e6-dd37-45cd-9c04-b3dc3ea8883c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_55be0d0e-6791-49d3-9241-1ac22e49c8aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract_18b880e6-dd37-45cd-9c04-b3dc3ea8883c" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_55be0d0e-6791-49d3-9241-1ac22e49c8aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_727f467d-084b-4202-b664-df34f9e11b5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract_18b880e6-dd37-45cd-9c04-b3dc3ea8883c" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_727f467d-084b-4202-b664-df34f9e11b5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_c617898d-fd29-493b-9786-885b181af2d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract_18b880e6-dd37-45cd-9c04-b3dc3ea8883c" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_c617898d-fd29-493b-9786-885b181af2d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_WeightedAverageUsedInDeterminationOfProjectedBenefitObligations_95023a3c-6ef3-4740-be4e-07f4b342ae21" xlink:href="syk-20221231.xsd#syk_WeightedAverageUsedInDeterminationOfProjectedBenefitObligations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract_18b880e6-dd37-45cd-9c04-b3dc3ea8883c" xlink:to="loc_syk_WeightedAverageUsedInDeterminationOfProjectedBenefitObligations_95023a3c-6ef3-4740-be4e-07f4b342ae21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_85a10890-1746-4c65-a0bb-b81935a1b325" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_9a7b5e37-3dd0-496c-9087-a74431a6b0d1" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_85a10890-1746-4c65-a0bb-b81935a1b325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_ba25a107-b0bb-495f-ae3f-3564a82cff05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_85a10890-1746-4c65-a0bb-b81935a1b325" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_ba25a107-b0bb-495f-ae3f-3564a82cff05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b411afb4-055f-4106-ac3a-7ddb989a8a5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ba25a107-b0bb-495f-ae3f-3564a82cff05" xlink:to="loc_us-gaap_EquityComponentDomain_b411afb4-055f-4106-ac3a-7ddb989a8a5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember_868f3c2e-ad9f-477e-9d14-caf4ddbf5ce1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b411afb4-055f-4106-ac3a-7ddb989a8a5d" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember_868f3c2e-ad9f-477e-9d14-caf4ddbf5ce1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_75489b62-94cc-4d8a-86f7-6dcf7cfd905f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_85a10890-1746-4c65-a0bb-b81935a1b325" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_75489b62-94cc-4d8a-86f7-6dcf7cfd905f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_3a77bae8-c777-49b7-a4d1-6f7903b52218" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_75489b62-94cc-4d8a-86f7-6dcf7cfd905f" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_3a77bae8-c777-49b7-a4d1-6f7903b52218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_AccruedCompensationMember_9a2aa2b7-8b8a-459e-aa76-ee825739297a" xlink:href="syk-20221231.xsd#syk_AccruedCompensationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3a77bae8-c777-49b7-a4d1-6f7903b52218" xlink:to="loc_syk_AccruedCompensationMember_9a2aa2b7-8b8a-459e-aa76-ee825739297a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_458bba65-aa3d-4588-839e-f5263715457e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3a77bae8-c777-49b7-a4d1-6f7903b52218" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_458bba65-aa3d-4588-839e-f5263715457e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_39a5f2cb-60e2-44a1-97f4-69d35f9f20c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3a77bae8-c777-49b7-a4d1-6f7903b52218" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_39a5f2cb-60e2-44a1-97f4-69d35f9f20c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_01d09d31-b2e2-4e62-91f3-83ee47c56b6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_85a10890-1746-4c65-a0bb-b81935a1b325" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_01d09d31-b2e2-4e62-91f3-83ee47c56b6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract_e49b05bb-0c63-43a8-b2fd-6a5430c1e18d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_01d09d31-b2e2-4e62-91f3-83ee47c56b6d" xlink:to="loc_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract_e49b05bb-0c63-43a8-b2fd-6a5430c1e18d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_b439a1c5-579f-495b-b5df-c62e19fc9a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract_e49b05bb-0c63-43a8-b2fd-6a5430c1e18d" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_b439a1c5-579f-495b-b5df-c62e19fc9a7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_f814633b-8a84-4126-a7dd-515126c1f6dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract_e49b05bb-0c63-43a8-b2fd-6a5430c1e18d" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_f814633b-8a84-4126-a7dd-515126c1f6dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_6d2171ea-20e5-440e-9a20-eebe34aeaf4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract_e49b05bb-0c63-43a8-b2fd-6a5430c1e18d" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_6d2171ea-20e5-440e-9a20-eebe34aeaf4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_20fc1482-c22d-4dca-9ad3-0577ae422c47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract_e49b05bb-0c63-43a8-b2fd-6a5430c1e18d" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_20fc1482-c22d-4dca-9ad3-0577ae422c47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_74b93053-63b8-4ea5-8f22-4e20424f648d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract_e49b05bb-0c63-43a8-b2fd-6a5430c1e18d" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_74b93053-63b8-4ea5-8f22-4e20424f648d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_82ff775d-1622-43f7-bcba-b53fe1b514ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract_e49b05bb-0c63-43a8-b2fd-6a5430c1e18d" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_82ff775d-1622-43f7-bcba-b53fe1b514ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RetirementPlansScheduleofChangeinBenefitObligationsDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#RetirementPlansScheduleofChangeinBenefitObligationsDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/RetirementPlansScheduleofChangeinBenefitObligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f08b58d2-4519-4cee-9be4-e54c2b1bcd3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_7583d94e-974f-42dd-81c3-b9ae37fde6ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f08b58d2-4519-4cee-9be4-e54c2b1bcd3a" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_7583d94e-974f-42dd-81c3-b9ae37fde6ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_66fe7f66-4b44-4796-9e14-ea4063582d24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_7583d94e-974f-42dd-81c3-b9ae37fde6ef" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_66fe7f66-4b44-4796-9e14-ea4063582d24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_fc35c7cf-d11b-4f6e-9edb-9491c2fe7044" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_7583d94e-974f-42dd-81c3-b9ae37fde6ef" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_fc35c7cf-d11b-4f6e-9edb-9491c2fe7044" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_94737f62-5af0-4705-84eb-bc47f2ddb76c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_7583d94e-974f-42dd-81c3-b9ae37fde6ef" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_94737f62-5af0-4705-84eb-bc47f2ddb76c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_4740916a-5558-4ee5-a68d-544b10ca2c90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_7583d94e-974f-42dd-81c3-b9ae37fde6ef" xlink:to="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_4740916a-5558-4ee5-a68d-544b10ca2c90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_304c25e2-06fb-4934-a912-f0f8bbd3cd26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_7583d94e-974f-42dd-81c3-b9ae37fde6ef" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_304c25e2-06fb-4934-a912-f0f8bbd3cd26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_ec67a3d9-5f0f-4051-9fd8-a175f7732ee2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_7583d94e-974f-42dd-81c3-b9ae37fde6ef" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_ec67a3d9-5f0f-4051-9fd8-a175f7732ee2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCurtailments_64e20fb7-d2da-4b8b-96ea-d56e031c4ac5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanCurtailments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_7583d94e-974f-42dd-81c3-b9ae37fde6ef" xlink:to="loc_us-gaap_DefinedBenefitPlanCurtailments_64e20fb7-d2da-4b8b-96ea-d56e031c4ac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_7d2a5774-b36e-4a4c-8ea6-483cddfcbc6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_7583d94e-974f-42dd-81c3-b9ae37fde6ef" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_7d2a5774-b36e-4a4c-8ea6-483cddfcbc6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_806a6225-e836-4613-a0a3-e3fdcae96042" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_7583d94e-974f-42dd-81c3-b9ae37fde6ef" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_806a6225-e836-4613-a0a3-e3fdcae96042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_e9a36657-d4b1-4d50-9c4e-18fe2ea960cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f08b58d2-4519-4cee-9be4-e54c2b1bcd3a" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_e9a36657-d4b1-4d50-9c4e-18fe2ea960cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RetirementPlansChangeinPlanAssetsDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#RetirementPlansChangeinPlanAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/RetirementPlansChangeinPlanAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e9b39809-ae5d-4b96-9e31-60815d794e6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_4b5e4cb7-c5cd-493b-b61b-0dffe0a2d18e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e9b39809-ae5d-4b96-9e31-60815d794e6e" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_4b5e4cb7-c5cd-493b-b61b-0dffe0a2d18e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_09b0f926-2500-46bb-82cf-7ab411461581" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_4b5e4cb7-c5cd-493b-b61b-0dffe0a2d18e" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_09b0f926-2500-46bb-82cf-7ab411461581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_a228636d-06e5-436a-979b-9ebf2ab15a01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_4b5e4cb7-c5cd-493b-b61b-0dffe0a2d18e" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_a228636d-06e5-436a-979b-9ebf2ab15a01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_2880687d-79a4-48f0-8162-a619536a8df3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_4b5e4cb7-c5cd-493b-b61b-0dffe0a2d18e" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_2880687d-79a4-48f0-8162-a619536a8df3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_5dcc81b2-fd80-4442-9f65-3d3917e2f3e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_4b5e4cb7-c5cd-493b-b61b-0dffe0a2d18e" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_5dcc81b2-fd80-4442-9f65-3d3917e2f3e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_00ef04f1-677f-4b82-b6eb-0bc74756b806" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_4b5e4cb7-c5cd-493b-b61b-0dffe0a2d18e" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_00ef04f1-677f-4b82-b6eb-0bc74756b806" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_8393d89b-dc0d-4e3e-b9ab-1e8c3935939c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_4b5e4cb7-c5cd-493b-b61b-0dffe0a2d18e" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_8393d89b-dc0d-4e3e-b9ab-1e8c3935939c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_2d045f13-9e87-47f3-903f-c2bad3091de4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_4b5e4cb7-c5cd-493b-b61b-0dffe0a2d18e" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_2d045f13-9e87-47f3-903f-c2bad3091de4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RetirementPlansScheduleofTargetandActualAllocationofPlanAssetsDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#RetirementPlansScheduleofTargetandActualAllocationofPlanAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/RetirementPlansScheduleofTargetandActualAllocationofPlanAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_3c2ebf98-5c41-4669-830c-5a8ed8f4b82f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_bd0d07b7-0c50-41ae-81bc-2239efdac237" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_3c2ebf98-5c41-4669-830c-5a8ed8f4b82f" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_bd0d07b7-0c50-41ae-81bc-2239efdac237" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_ac1bcbad-6040-484b-8398-4942b52a7146" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_bd0d07b7-0c50-41ae-81bc-2239efdac237" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_ac1bcbad-6040-484b-8398-4942b52a7146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_e1a154b4-93fc-4ef2-a58b-29c61db86aaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_ac1bcbad-6040-484b-8398-4942b52a7146" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_e1a154b4-93fc-4ef2-a58b-29c61db86aaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_8144e584-8b59-43c5-8c3f-0fcbe72d50d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_e1a154b4-93fc-4ef2-a58b-29c61db86aaa" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_8144e584-8b59-43c5-8c3f-0fcbe72d50d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDebtSecurityMember_faf8baa4-13bb-45f4-9e46-12a193541c50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDebtSecurityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_e1a154b4-93fc-4ef2-a58b-29c61db86aaa" xlink:to="loc_us-gaap_DefinedBenefitPlanDebtSecurityMember_faf8baa4-13bb-45f4-9e46-12a193541c50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestmentsMember_63709efa-92c5-42e6-b48b-2072e758454c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermInvestmentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_e1a154b4-93fc-4ef2-a58b-29c61db86aaa" xlink:to="loc_us-gaap_OtherLongTermInvestmentsMember_63709efa-92c5-42e6-b48b-2072e758454c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9a256c46-354f-4de4-9437-59e3a16b5f41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_bd0d07b7-0c50-41ae-81bc-2239efdac237" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9a256c46-354f-4de4-9437-59e3a16b5f41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_f1eff15b-dd08-4e9c-a907-efe5229efc6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9a256c46-354f-4de4-9437-59e3a16b5f41" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_f1eff15b-dd08-4e9c-a907-efe5229efc6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_5f77694d-fa52-41a0-b570-bf19edb582fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9a256c46-354f-4de4-9437-59e3a16b5f41" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_5f77694d-fa52-41a0-b570-bf19edb582fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_8f065394-7f78-445a-87d1-540f95856187" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_898a39cc-a1f8-4ec7-8786-a0ff2bfe0d8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_8f065394-7f78-445a-87d1-540f95856187" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_898a39cc-a1f8-4ec7-8786-a0ff2bfe0d8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_15424bcf-bb9c-4e4d-88f1-ba4faf2fa674" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_898a39cc-a1f8-4ec7-8786-a0ff2bfe0d8c" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_15424bcf-bb9c-4e4d-88f1-ba4faf2fa674" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_20314b78-e080-4f40-b365-ca2c8139deb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_15424bcf-bb9c-4e4d-88f1-ba4faf2fa674" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_20314b78-e080-4f40-b365-ca2c8139deb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_fc89d6f9-0990-4ea3-8b47-68c2350f4353" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_20314b78-e080-4f40-b365-ca2c8139deb2" xlink:to="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_fc89d6f9-0990-4ea3-8b47-68c2350f4353" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_cf31c32e-f290-4761-8547-9339b43a6644" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_20314b78-e080-4f40-b365-ca2c8139deb2" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_cf31c32e-f290-4761-8547-9339b43a6644" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_9a4f4837-c792-4942-badc-a565642fa081" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_20314b78-e080-4f40-b365-ca2c8139deb2" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_9a4f4837-c792-4942-badc-a565642fa081" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember_8449bb6a-da76-48f2-8c2b-223c7a9fbb10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_20314b78-e080-4f40-b365-ca2c8139deb2" xlink:to="loc_us-gaap_OtherDebtSecuritiesMember_8449bb6a-da76-48f2-8c2b-223c7a9fbb10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8912dfb7-a7ed-4f98-9a32-08153f546d4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_898a39cc-a1f8-4ec7-8786-a0ff2bfe0d8c" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8912dfb7-a7ed-4f98-9a32-08153f546d4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_091db5e1-7a76-4285-9e39-d1dc400921de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8912dfb7-a7ed-4f98-9a32-08153f546d4d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_091db5e1-7a76-4285-9e39-d1dc400921de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_698c8a14-ddcf-4f91-b584-bfab61541282" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_091db5e1-7a76-4285-9e39-d1dc400921de" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_698c8a14-ddcf-4f91-b584-bfab61541282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_931194c2-d549-4022-891f-10f2e4d7777c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_091db5e1-7a76-4285-9e39-d1dc400921de" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_931194c2-d549-4022-891f-10f2e4d7777c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_13444dc0-eca6-4741-8024-fef052041c6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_091db5e1-7a76-4285-9e39-d1dc400921de" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_13444dc0-eca6-4741-8024-fef052041c6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2cddab91-cbe2-4b9d-ac9b-2501a2bca224" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_898a39cc-a1f8-4ec7-8786-a0ff2bfe0d8c" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2cddab91-cbe2-4b9d-ac9b-2501a2bca224" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_11d06cd7-e852-4578-b77e-de0df9e496e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_2cddab91-cbe2-4b9d-ac9b-2501a2bca224" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_11d06cd7-e852-4578-b77e-de0df9e496e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RetirementPlansNarrativeDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#RetirementPlansNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/RetirementPlansNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_5aea7a21-800d-414c-8668-823f1f8a4d10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e1d68ff5-7b90-4391-b025-bbf4d3b9ca06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_5aea7a21-800d-414c-8668-823f1f8a4d10" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e1d68ff5-7b90-4391-b025-bbf4d3b9ca06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a77d0470-a1fa-4abb-a9fc-81444dbd4e08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e1d68ff5-7b90-4391-b025-bbf4d3b9ca06" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a77d0470-a1fa-4abb-a9fc-81444dbd4e08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c670fb9e-0083-4916-b407-6bc04e6521b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a77d0470-a1fa-4abb-a9fc-81444dbd4e08" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c670fb9e-0083-4916-b407-6bc04e6521b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_52f3a54e-07b3-473a-bd8c-86a98ce4f556" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c670fb9e-0083-4916-b407-6bc04e6521b0" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_52f3a54e-07b3-473a-bd8c-86a98ce4f556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7182dd0f-122e-42e6-8c10-c6565c44e133" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e1d68ff5-7b90-4391-b025-bbf4d3b9ca06" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7182dd0f-122e-42e6-8c10-c6565c44e133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_fc6314bb-e80c-4e45-bfd4-ea3e50912d30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7182dd0f-122e-42e6-8c10-c6565c44e133" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_fc6314bb-e80c-4e45-bfd4-ea3e50912d30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_a9f51e31-0c4b-450d-bb40-81e1d96a8089" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7182dd0f-122e-42e6-8c10-c6565c44e133" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_a9f51e31-0c4b-450d-bb40-81e1d96a8089" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RetirementPlansExpectedBenefitPaymentsDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#RetirementPlansExpectedBenefitPaymentsDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/RetirementPlansExpectedBenefitPaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_7dcf3ef9-a8ef-4252-a110-9bf1f4e72a07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_da79e0e6-29df-4cbe-81bc-e375c14f18a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_7dcf3ef9-a8ef-4252-a110-9bf1f4e72a07" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_da79e0e6-29df-4cbe-81bc-e375c14f18a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_4188ef77-5027-4ebb-bf4f-04b4337382fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_7dcf3ef9-a8ef-4252-a110-9bf1f4e72a07" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_4188ef77-5027-4ebb-bf4f-04b4337382fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_a94dfb72-aee6-40f5-9ff7-2c39e34077e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_7dcf3ef9-a8ef-4252-a110-9bf1f4e72a07" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_a94dfb72-aee6-40f5-9ff7-2c39e34077e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_82647fcb-a270-4028-9b24-7b540146a104" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_7dcf3ef9-a8ef-4252-a110-9bf1f4e72a07" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_82647fcb-a270-4028-9b24-7b540146a104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_52d38458-3219-4115-91e8-14419a089251" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_7dcf3ef9-a8ef-4252-a110-9bf1f4e72a07" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_52d38458-3219-4115-91e8-14419a089251" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_22018ad1-fd9d-4638-a09f-25da07d08041" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_7dcf3ef9-a8ef-4252-a110-9bf1f4e72a07" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_22018ad1-fd9d-4638-a09f-25da07d08041" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/SummaryofQuarterlyDataUnauditedDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#SummaryofQuarterlyDataUnauditedDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/SummaryofQuarterlyDataUnauditedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialDataAbstract_5793e569-cc37-4563-b4c3-7d71f5bec67b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_QuarterlyFinancialDataAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_acb68791-7d91-4625-a691-ccc11778e846" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialDataAbstract_5793e569-cc37-4563-b4c3-7d71f5bec67b" xlink:to="loc_us-gaap_Revenues_acb68791-7d91-4625-a691-ccc11778e846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_bafa7caf-de58-4ee2-a540-7ee8b05a1c89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialDataAbstract_5793e569-cc37-4563-b4c3-7d71f5bec67b" xlink:to="loc_us-gaap_GrossProfit_bafa7caf-de58-4ee2-a540-7ee8b05a1c89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_be3f432a-7918-4c91-a2dd-b4681735a95a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialDataAbstract_5793e569-cc37-4563-b4c3-7d71f5bec67b" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_be3f432a-7918-4c91-a2dd-b4681735a95a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_146f5253-527f-4bd4-b786-7d570790938a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialDataAbstract_5793e569-cc37-4563-b4c3-7d71f5bec67b" xlink:to="loc_us-gaap_NetIncomeLoss_146f5253-527f-4bd4-b786-7d570790938a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_2099fa21-235b-4c09-948a-7b34f6f77140" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialDataAbstract_5793e569-cc37-4563-b4c3-7d71f5bec67b" xlink:to="loc_us-gaap_EarningsPerShareBasic_2099fa21-235b-4c09-948a-7b34f6f77140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_b4507303-6227-4ed8-abad-f7827c32a317" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialDataAbstract_5793e569-cc37-4563-b4c3-7d71f5bec67b" xlink:to="loc_us-gaap_EarningsPerShareDiluted_b4507303-6227-4ed8-abad-f7827c32a317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_07af569f-8360-4fe0-8da6-216d79213a67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialDataAbstract_5793e569-cc37-4563-b4c3-7d71f5bec67b" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_07af569f-8360-4fe0-8da6-216d79213a67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_ff5d8e7a-2bf6-494d-8ea2-544700078822" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_fc500059-daf0-497a-8d56-c869011fd399" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ff5d8e7a-2bf6-494d-8ea2-544700078822" xlink:to="loc_us-gaap_NumberOfReportableSegments_fc500059-daf0-497a-8d56-c869011fd399" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_923dc468-54d7-461c-a102-b8924450b451" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ff5d8e7a-2bf6-494d-8ea2-544700078822" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_923dc468-54d7-461c-a102-b8924450b451" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_ce997f0c-06e2-42b9-b25f-ee84b20ef369" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_923dc468-54d7-461c-a102-b8924450b451" xlink:to="loc_srt_ConsolidationItemsAxis_ce997f0c-06e2-42b9-b25f-ee84b20ef369" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_48ee6452-b586-416d-93bc-9604d5d6bbeb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_ce997f0c-06e2-42b9-b25f-ee84b20ef369" xlink:to="loc_srt_ConsolidationItemsDomain_48ee6452-b586-416d-93bc-9604d5d6bbeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_a83651d6-6d92-44e7-a5e4-6556d9be3805" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_48ee6452-b586-416d-93bc-9604d5d6bbeb" xlink:to="loc_us-gaap_OperatingSegmentsMember_a83651d6-6d92-44e7-a5e4-6556d9be3805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_e5745af7-7fbd-4434-ad94-096cf980f44a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_48ee6452-b586-416d-93bc-9604d5d6bbeb" xlink:to="loc_us-gaap_CorporateNonSegmentMember_e5745af7-7fbd-4434-ad94-096cf980f44a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_104118ad-ffdf-4068-ba5c-4bdb7d627552" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_48ee6452-b586-416d-93bc-9604d5d6bbeb" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_104118ad-ffdf-4068-ba5c-4bdb7d627552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_bbf2f0d7-b166-4c4c-9cd0-274c8f90bec3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_923dc468-54d7-461c-a102-b8924450b451" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_bbf2f0d7-b166-4c4c-9cd0-274c8f90bec3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_08419ac3-c6e3-4f3f-b50d-beb356e14b48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_bbf2f0d7-b166-4c4c-9cd0-274c8f90bec3" xlink:to="loc_us-gaap_SegmentDomain_08419ac3-c6e3-4f3f-b50d-beb356e14b48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_MedSurgAndNeurotechnologyMember_35703a95-01d8-467a-8558-41664b274b57" xlink:href="syk-20221231.xsd#syk_MedSurgAndNeurotechnologyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_08419ac3-c6e3-4f3f-b50d-beb356e14b48" xlink:to="loc_syk_MedSurgAndNeurotechnologyMember_35703a95-01d8-467a-8558-41664b274b57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OrthopaedicsAndSpineMember_8800d62d-9bc2-441a-80bf-d70fbe9640fe" xlink:href="syk-20221231.xsd#syk_OrthopaedicsAndSpineMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_08419ac3-c6e3-4f3f-b50d-beb356e14b48" xlink:to="loc_syk_OrthopaedicsAndSpineMember_8800d62d-9bc2-441a-80bf-d70fbe9640fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_5fba2ae6-5edc-41cb-ae03-e9c28b691141" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_923dc468-54d7-461c-a102-b8924450b451" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_5fba2ae6-5edc-41cb-ae03-e9c28b691141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_90e4a657-760b-4f24-8d9b-ee5bce538cf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5fba2ae6-5edc-41cb-ae03-e9c28b691141" xlink:to="loc_us-gaap_NumberOfReportableSegments_90e4a657-760b-4f24-8d9b-ee5bce538cf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_b33faee8-291c-4f70-af3d-2b7f0692ba74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5fba2ae6-5edc-41cb-ae03-e9c28b691141" xlink:to="loc_us-gaap_Revenues_b33faee8-291c-4f70-af3d-2b7f0692ba74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_46802d23-6265-42c8-96e1-fed084f85b6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5fba2ae6-5edc-41cb-ae03-e9c28b691141" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_46802d23-6265-42c8-96e1-fed084f85b6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_97731dd0-dd22-4e58-963c-386d0cc243c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5fba2ae6-5edc-41cb-ae03-e9c28b691141" xlink:to="loc_us-gaap_OperatingIncomeLoss_97731dd0-dd22-4e58-963c-386d0cc243c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_fe9aab4e-80f0-4a4d-8f3a-375ea511dee4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5fba2ae6-5edc-41cb-ae03-e9c28b691141" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_fe9aab4e-80f0-4a4d-8f3a-375ea511dee4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_457838af-58d5-49b9-b42c-f5d705ab579d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5fba2ae6-5edc-41cb-ae03-e9c28b691141" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_457838af-58d5-49b9-b42c-f5d705ab579d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_5e384b6b-8d1a-440c-a13d-496794c58a35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5fba2ae6-5edc-41cb-ae03-e9c28b691141" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_5e384b6b-8d1a-440c-a13d-496794c58a35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_bbe628b5-4e49-47a6-bdab-21d2fa0e005c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCosts"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5fba2ae6-5edc-41cb-ae03-e9c28b691141" xlink:to="loc_us-gaap_RestructuringCosts_bbe628b5-4e49-47a6-bdab-21d2fa0e005c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_7a158444-f7b8-49e3-ad2c-021872013f47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5fba2ae6-5edc-41cb-ae03-e9c28b691141" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_7a158444-f7b8-49e3-ad2c-021872013f47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_MedicalDeviceRegulationsExpense_4c543d91-bd7e-45a7-a490-93e17e654cc7" xlink:href="syk-20221231.xsd#syk_MedicalDeviceRegulationsExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5fba2ae6-5edc-41cb-ae03-e9c28b691141" xlink:to="loc_syk_MedicalDeviceRegulationsExpense_4c543d91-bd7e-45a7-a490-93e17e654cc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_RejuvenateABGIIHipRecallCharges_db5beeeb-6fc7-435e-ace4-5cf809ecfd6f" xlink:href="syk-20221231.xsd#syk_RejuvenateABGIIHipRecallCharges"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5fba2ae6-5edc-41cb-ae03-e9c28b691141" xlink:to="loc_syk_RejuvenateABGIIHipRecallCharges_db5beeeb-6fc7-435e-ace4-5cf809ecfd6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalFees_3ea34dda-9414-461c-922c-ff303ce15bb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LegalFees"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5fba2ae6-5edc-41cb-ae03-e9c28b691141" xlink:to="loc_us-gaap_LegalFees_3ea34dda-9414-461c-922c-ff303ce15bb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e4b4f582-42ed-4e09-b743-034007086a26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_5fba2ae6-5edc-41cb-ae03-e9c28b691141" xlink:to="loc_us-gaap_NetIncomeLoss_e4b4f582-42ed-4e09-b743-034007086a26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/SegmentandGeographicDataSegmentInformationDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#SegmentandGeographicDataSegmentInformationDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/SegmentandGeographicDataSegmentInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_3194a9c2-743b-4864-9001-4170d8e4ca2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e72d75d0-a796-4a90-a2df-2a2fd8cde231" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_3194a9c2-743b-4864-9001-4170d8e4ca2b" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e72d75d0-a796-4a90-a2df-2a2fd8cde231" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_f3fe1c0c-ee59-4b05-9a8d-5a9b4c5ce840" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e72d75d0-a796-4a90-a2df-2a2fd8cde231" xlink:to="loc_srt_ConsolidationItemsAxis_f3fe1c0c-ee59-4b05-9a8d-5a9b4c5ce840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_1597dfb0-4be0-47a6-a954-0bb9a654eb2b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_f3fe1c0c-ee59-4b05-9a8d-5a9b4c5ce840" xlink:to="loc_srt_ConsolidationItemsDomain_1597dfb0-4be0-47a6-a954-0bb9a654eb2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_45a67cae-fb68-46a0-a575-cc1e83519b63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_1597dfb0-4be0-47a6-a954-0bb9a654eb2b" xlink:to="loc_us-gaap_OperatingSegmentsMember_45a67cae-fb68-46a0-a575-cc1e83519b63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_b3f80bd2-b6d4-4652-bec0-ede0ba41044b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_1597dfb0-4be0-47a6-a954-0bb9a654eb2b" xlink:to="loc_us-gaap_CorporateNonSegmentMember_b3f80bd2-b6d4-4652-bec0-ede0ba41044b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_9f650b07-330f-4d2e-9a83-04d295cb0c59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e72d75d0-a796-4a90-a2df-2a2fd8cde231" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_9f650b07-330f-4d2e-9a83-04d295cb0c59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9c644611-4415-42c0-9f14-4d5c0be00a3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9f650b07-330f-4d2e-9a83-04d295cb0c59" xlink:to="loc_us-gaap_SegmentDomain_9c644611-4415-42c0-9f14-4d5c0be00a3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_MedSurgAndNeurotechnologyMember_16578824-4927-4ca1-b6ab-b6245e62654d" xlink:href="syk-20221231.xsd#syk_MedSurgAndNeurotechnologyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9c644611-4415-42c0-9f14-4d5c0be00a3e" xlink:to="loc_syk_MedSurgAndNeurotechnologyMember_16578824-4927-4ca1-b6ab-b6245e62654d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OrthopaedicsAndSpineMember_04944fea-2d02-406d-8fb7-c688c6092389" xlink:href="syk-20221231.xsd#syk_OrthopaedicsAndSpineMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9c644611-4415-42c0-9f14-4d5c0be00a3e" xlink:to="loc_syk_OrthopaedicsAndSpineMember_04944fea-2d02-406d-8fb7-c688c6092389" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_2687b3eb-3dbc-4d6b-a386-82ece32aa21d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e72d75d0-a796-4a90-a2df-2a2fd8cde231" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_2687b3eb-3dbc-4d6b-a386-82ece32aa21d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_80fcfad8-5078-476f-bdfd-4c34cddcb65d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2687b3eb-3dbc-4d6b-a386-82ece32aa21d" xlink:to="loc_us-gaap_Assets_80fcfad8-5078-476f-bdfd-4c34cddcb65d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_CapitalExpendituresDuringPeriod_28c80368-e1d4-451b-b8c6-918deef2457b" xlink:href="syk-20221231.xsd#syk_CapitalExpendituresDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2687b3eb-3dbc-4d6b-a386-82ece32aa21d" xlink:to="loc_syk_CapitalExpendituresDuringPeriod_28c80368-e1d4-451b-b8c6-918deef2457b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_3dfcf138-74d4-4ef9-b912-373a94c8d0f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_086dae05-3d39-40c2-b546-4c439af7ec1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_3dfcf138-74d4-4ef9-b912-373a94c8d0f6" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_086dae05-3d39-40c2-b546-4c439af7ec1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_e67b596f-933e-4404-a3a2-2fc72e2cf7a9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_086dae05-3d39-40c2-b546-4c439af7ec1d" xlink:to="loc_srt_StatementGeographicalAxis_e67b596f-933e-4404-a3a2-2fc72e2cf7a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_e9742c17-70cb-4183-b46a-59cd008a99e4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_e67b596f-933e-4404-a3a2-2fc72e2cf7a9" xlink:to="loc_srt_SegmentGeographicalDomain_e9742c17-70cb-4183-b46a-59cd008a99e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_a95ebbc8-450a-40b4-88a7-b4e41eee144d" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_e9742c17-70cb-4183-b46a-59cd008a99e4" xlink:to="loc_country_US_a95ebbc8-450a-40b4-88a7-b4e41eee144d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_31009a09-22f6-48dd-b744-a18b9f509254" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EMEAMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_e9742c17-70cb-4183-b46a-59cd008a99e4" xlink:to="loc_us-gaap_EMEAMember_31009a09-22f6-48dd-b744-a18b9f509254" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_e6b67446-69d8-44a8-ac26-00393fed9a97" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AsiaPacificMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_e9742c17-70cb-4183-b46a-59cd008a99e4" xlink:to="loc_srt_AsiaPacificMember_e6b67446-69d8-44a8-ac26-00393fed9a97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OtherForeignCountriesMember_2791b905-6432-49c4-9fd8-45d025226582" xlink:href="syk-20221231.xsd#syk_OtherForeignCountriesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_e9742c17-70cb-4183-b46a-59cd008a99e4" xlink:to="loc_syk_OtherForeignCountriesMember_2791b905-6432-49c4-9fd8-45d025226582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_e33c39cd-6234-4259-9886-28dd789b200f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_086dae05-3d39-40c2-b546-4c439af7ec1d" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_e33c39cd-6234-4259-9886-28dd789b200f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_0606bb31-bccd-439a-b896-e76869ddd5ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e33c39cd-6234-4259-9886-28dd789b200f" xlink:to="loc_us-gaap_Revenues_0606bb31-bccd-439a-b896-e76869ddd5ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_ec17789b-5589-4bab-8485-5c61fa092d9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e33c39cd-6234-4259-9886-28dd789b200f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_ec17789b-5589-4bab-8485-5c61fa092d9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/AssetImpairmentsDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#AssetImpairmentsDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/AssetImpairmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_2b99adf2-3822-4545-8c6a-d1615556d52f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5eaaa658-dc15-4454-9fe6-5b885324f7ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_2b99adf2-3822-4545-8c6a-d1615556d52f" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5eaaa658-dc15-4454-9fe6-5b885324f7ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_b24789bc-de96-4505-8cbe-859b4ebc0270" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5eaaa658-dc15-4454-9fe6-5b885324f7ed" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_b24789bc-de96-4505-8cbe-859b4ebc0270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_cc349462-d669-4037-a153-de8c93565833" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_b24789bc-de96-4505-8cbe-859b4ebc0270" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_cc349462-d669-4037-a153-de8c93565833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_ef1dfc99-716c-4023-a9d9-15513c37bbc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_cc349462-d669-4037-a153-de8c93565833" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_ef1dfc99-716c-4023-a9d9-15513c37bbc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_8445a8be-8adb-4fce-9b9d-26bfc98f5ce3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5eaaa658-dc15-4454-9fe6-5b885324f7ed" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_8445a8be-8adb-4fce-9b9d-26bfc98f5ce3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_6a20c79a-ca42-4ec2-9bb1-1bd937b431ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_8445a8be-8adb-4fce-9b9d-26bfc98f5ce3" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_6a20c79a-ca42-4ec2-9bb1-1bd937b431ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember_13fa7c0e-444c-4b0b-84d7-c72ce74c6d1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_6a20c79a-ca42-4ec2-9bb1-1bd937b431ae" xlink:to="loc_us-gaap_GeographicConcentrationRiskMember_13fa7c0e-444c-4b0b-84d7-c72ce74c6d1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_2c8677f6-7358-4cf3-936e-15312c7a972e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5eaaa658-dc15-4454-9fe6-5b885324f7ed" xlink:to="loc_srt_StatementGeographicalAxis_2c8677f6-7358-4cf3-936e-15312c7a972e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_a6e8018e-97f0-453e-bfc6-5555e6776c0d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_2c8677f6-7358-4cf3-936e-15312c7a972e" xlink:to="loc_srt_SegmentGeographicalDomain_a6e8018e-97f0-453e-bfc6-5555e6776c0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CN_19bb19b6-c335-41e0-b239-9cde63e77f3b" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CN"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a6e8018e-97f0-453e-bfc6-5555e6776c0d" xlink:to="loc_country_CN_19bb19b6-c335-41e0-b239-9cde63e77f3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_5e7891af-2e1e-4dce-8e9a-6ae8a9ac441f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5eaaa658-dc15-4454-9fe6-5b885324f7ed" xlink:to="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_5e7891af-2e1e-4dce-8e9a-6ae8a9ac441f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_769195d9-c16f-4720-af9a-1fbbd994de4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_5e7891af-2e1e-4dce-8e9a-6ae8a9ac441f" xlink:to="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_769195d9-c16f-4720-af9a-1fbbd994de4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_LongLivedAssetsAndIntangibleAssetsMember_dd3e4512-3cea-4f09-92e6-421dcadcab4f" xlink:href="syk-20221231.xsd#syk_LongLivedAssetsAndIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_769195d9-c16f-4720-af9a-1fbbd994de4c" xlink:to="loc_syk_LongLivedAssetsAndIntangibleAssetsMember_dd3e4512-3cea-4f09-92e6-421dcadcab4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_InProcessRDOtherIntangibleAssetsAndPropertyPlantAndEquipmentMember_f0262deb-4673-42ce-ba5f-dad722003e6f" xlink:href="syk-20221231.xsd#syk_InProcessRDOtherIntangibleAssetsAndPropertyPlantAndEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_769195d9-c16f-4720-af9a-1fbbd994de4c" xlink:to="loc_syk_InProcessRDOtherIntangibleAssetsAndPropertyPlantAndEquipmentMember_f0262deb-4673-42ce-ba5f-dad722003e6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d6edd491-0837-4e7f-8054-951ab71b948e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5eaaa658-dc15-4454-9fe6-5b885324f7ed" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d6edd491-0837-4e7f-8054-951ab71b948e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_b8d3f45f-1f92-4dec-a1c0-cf006e38b093" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d6edd491-0837-4e7f-8054-951ab71b948e" xlink:to="loc_us-gaap_AssetImpairmentCharges_b8d3f45f-1f92-4dec-a1c0-cf006e38b093" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_fb0ed2d7-033f-49c5-b8b7-d7d5d6be22ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d6edd491-0837-4e7f-8054-951ab71b948e" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_fb0ed2d7-033f-49c5-b8b7-d7d5d6be22ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/ScheduleIIValuationandQualifyingAccountsDetails" xlink:type="simple" xlink:href="syk-20221231.xsd#ScheduleIIValuationandQualifyingAccountsDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/ScheduleIIValuationandQualifyingAccountsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_67f459ab-6be6-4d1a-906f-be324425c058" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_8caaf076-bdf5-4142-9ff1-251dcaf75154" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_67f459ab-6be6-4d1a-906f-be324425c058" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_8caaf076-bdf5-4142-9ff1-251dcaf75154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_abbaa9a0-9a51-48a7-9c81-f33751b4325e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_8caaf076-bdf5-4142-9ff1-251dcaf75154" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_abbaa9a0-9a51-48a7-9c81-f33751b4325e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_9f701060-def0-480f-83c6-84f0d62b63dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_abbaa9a0-9a51-48a7-9c81-f33751b4325e" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_9f701060-def0-480f-83c6-84f0d62b63dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForNotesReceivableMember_2d777d12-d9e0-4eec-8d04-f5d4d67fd244" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForNotesReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_9f701060-def0-480f-83c6-84f0d62b63dd" xlink:to="loc_us-gaap_AllowanceForNotesReceivableMember_2d777d12-d9e0-4eec-8d04-f5d4d67fd244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_b03eabbb-5478-450a-b4dd-ce7d63aef5a1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_8caaf076-bdf5-4142-9ff1-251dcaf75154" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_b03eabbb-5478-450a-b4dd-ce7d63aef5a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_346c1083-5695-48e9-837d-82124804804f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_b03eabbb-5478-450a-b4dd-ce7d63aef5a1" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_346c1083-5695-48e9-837d-82124804804f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_9d99e16b-575b-4f5e-a20e-5f9183eca450" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_b03eabbb-5478-450a-b4dd-ce7d63aef5a1" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_9d99e16b-575b-4f5e-a20e-5f9183eca450" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_95cf4cc9-3ba3-4903-a9b0-11fd6c6c9dee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_b03eabbb-5478-450a-b4dd-ce7d63aef5a1" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_95cf4cc9-3ba3-4903-a9b0-11fd6c6c9dee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesAdjustments_04faf5ca-4407-481e-8eb2-f696ae0a7bac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesAdjustments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_b03eabbb-5478-450a-b4dd-ce7d63aef5a1" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesAdjustments_04faf5ca-4407-481e-8eb2-f696ae0a7bac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_0d180333-16c4-40d8-9759-fde81a1b5416" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_b03eabbb-5478-450a-b4dd-ce7d63aef5a1" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_0d180333-16c4-40d8-9759-fde81a1b5416" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>image_0.jpg
<TEXT>
begin 644 image_0.jpg
MB5!.1PT*&@H    -24A$4@   L(   "V" (   !<7'QP   _@$E$051X7NV=
M!U04U]O_?^>?V%!$0$3 0A,I]EZPE\2NL?<6>R^QQ1)[-_;>:ZRQQ]YB[#$6
M[*+203K((OU_9=_DL,\#N#-W9G8'GL_YG/?\WIR9YWOG[MP[S\*R_B^-4 ,F
M_^];"875"4*UX-M;M+ T01!Z\#_X'PBC!&]Y/,+J!*%:\.TM6EB:( @]H#9"
M'> MCT=8G2!4"[Z]10M+$P2A!]1&J .\Y?$(JQ.$:L&WMVAA:8(@](#:"'6
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M?O_NW?-GS^_=N7OIPL7C1X_MWK%S_9JU*Y<M9TW#PKGS?OEYQI2)/XT9/F)
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M&7<S:B/4 9XT'F%U X$')E2Y%YX6MB.O7[NV3X^>GC5J2?)34QB0!?A$3F&
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M$DZT+OA<H2JSFQE7&Y$FQ<3E&.'42 U.Y!%6-Q!X8$)59N$9MHU(DV*B@#!
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MW+%M^^Z=NL")U@6?*U1E=K.,6YE4NQFU$8H*YTYO<"D>874#@0<F5&46GI&
M+Y]3&) U^%Q^8898<&75"2^)CX:UZWI6KUG6WM&RH"G.(@7)YM"EM$.=JM7K
MU:P-)UH7?*Y0U;N;2=!&I$DQ@[E'.'?Z@>OP"*L;"#PPH:IWX8D 7SZG,"!K
M\+G\P@RQX,IJ%%X5!^Z.SJ[VCG:65F;Y"N @4I!LA[$V,[<O;NMH6P).M"[X
M7*&J=S>3IHU(DV(2<X]P[O0 %^$15C<0>&!"5>_"$P>> 1YA]:S!YW(* SC
MQ=4HO"H./)S*N#DXE2A:S(S['Z8B"WV;EVTR%B:%F'"B=<'G"E6]NYED;42:
M%/.8>X1S]S5P!1YA=0.!!R94]2X\<> 9X!0&9 $^D5,8P $NKE+AA8FEL6?]
M^C5KNSHXT2\U)%';23#A1.N"3Q2J>G<S*=N(-"FF,O<(YRY;\.D\PNH& @],
MJ.I=>.+ ,\ I#,@,?!:_,(,#7%R]PFL31?=.73JV;5^]8F5K^HBEI,*)U@4?
M+U3U[F82MQ%I4LQF[A'.7=;@<WF$U0T$'IA0U;OPQ(%G@%,8D!GX+$YA !^X
MOGJ%UR:*\:/'C!@RM+%G??J#3WX+?9O7O$!!MLFPG@Q.M"[X7*&J=S>3OHU(
MDV)"<XEPXK(&G\LCK&X@\,"$JMZ%)QH\"3S"ZIF!S^(4!O"!ZZM:>'G"6;IP
M\=Q9O[1OU;IT<?KZ*5[9#F-C;NE<LK1+:0<XT;K@<X6JWMU,EC8B38HYS0W"
M6<L:?"Z/L+J!P ,3JGH7GFCP)' * W3!Q_,+,_C ]54MO#SA[-ZQ<^.Z];V[
M=7<J41+7)P5I7J"@HUW):N4KUJQ4!4ZT+OA<H:IW-Y.KC4B38EISO'#*L@:?
MRR.L;B#PP(2JWH4G&CP)G,( 7?#Q_,(,/G!]M0NO4"!G3YT^=. WMB+8&VA<
MG!2DE:E915?W%DV:M?W^*_^B'CY7J.K=S61L(]*DF-D<+YRR+, G\@BK&P@\
M,*&J=^'Q@.>!1UA=%WP\IS" &QRA=N$5"N3N[3N7SE^8,'JLFZ,S+DX*TL;"
MTK-ZS;X]>@[N/P!.M"[X7*&J=S>3MXU(DV)R<[9POK( G\@CK&X@\,"$JMZ%
MQP.>!TYA0 ;PP9S" &YPA +*':U[B<)X\>PYZR2F_339P]D%5Q9AP6_RV!4M
MYE'&I7K%RC4J5<E5-JW?<%"__O/GS%FZ*(?\TUQR('L;D2;%_.9@X61E 3Z1
M1UC=0."!"56]"X\'/ ^<PH!_P4?R"S.XP1%RJT!TANL3C)^?G]=3K]DS9I9W
M<<6516B:)U_-2E4&].[[\^0I,Z9.F_7S]-SCHGD+=FS==N;4Z?/GSL&)U@7/
MFU#5NYLIT49HP;-&:H4SE1GX+!YA=0.!!R94]2X\'O \< H#_@4?R2D,D *<
M(K?*I&=,$41D9.3[]^\7S9M?T<T=EQ4A:R,ZMFFW<=WZ:U>N_GG]QJV;?^4>
M[]^]]_+%BP#_@*"@(#C1NN!Y$ZIZ=S/EV@@ GL1<*YR:S,!G\0BK&P@\,*&J
M=^%Q@J>"1UC]7_"1G,( *< IL@KC91L C-&;3Y\^!?C[+UVXJ)*;!RXK0K;*
MNG7LM&?GKG_^?OCLJ=>;UV_>OLDMOG_W+B@P*"(B(BHJ"DZT+GC>A*K>W<Q@
M;41&\(3F*N%T9 8^BT=8W4#@@0E5O0N/$SP5G,* =/!AG,( *< I\@FST\&'
M225,TH^DI*2/(2$KEBRM[%X.UQ0A6V6]NW4_>NCP.V_OH,! ]D"-SC7$QL9J
M-)J$=.!$ZX+G3:CJW<V,HHU0'?@.X!%6SPQ\%H^PNH'  Q.J>A<>)W@J.(4!
MBD1( @Z221B< 7RP),(8_4A-38T(#U^S<E6M*M7,"Q0TS9L?5Q8D6V4].W?Y
M;=_^-Z]>AX:&)B<GPTA"BGM O;L9M1$BP3<!C[ Z I_"(ZQN(/# A*K>A<</
MG@T>876IZYMD%B$).$@F87 &\,%2"9/T@+41D9&1VS9O:=6LN8-MB6+<_[*&
M:9Y\K-3B^0LN_''N]<M7B8F),)*0XAY0[VY&;81(\$W (ZR.P*?P"*L;"#PP
MH:IWX?&#9X-3A>M+!0Z20YB*P*=()4S2@YCHZ -[]_7NVKV*1_E2UKQ?B<W:
M",_J-8</&KQY_88[MV[':S0PCY#B!E#O;D9MA$CP3< CK([ I_ (JQL(/#"A
MJG?A\8-G@U-9ZX/B$H*S)!=&9@8^2RIADA[$QL:>.G%BPIBQS1LV=G-T+O1M
M7EQ6?]GI'LXN+9LVFSQ^PIF3IV)C8E)34V%DK@?/FU#5NYM1&R$2?!-P"@-T
MP<?S"*L;"#PPH:IWX4D"GA >Y:ML(N<MA[.D%>9E#3Y7*F'2U]#$Q5V]?&7)
M@D6]NW:O5KXB9QMA\N7+'(NZ.CAU;--VU[;MD>$1*<G)U$D \*0)5;V[&;41
MXL'W 8^PNB[X>!YA=0.!!R94]2X\2< 3PJ-\E4WDO.5PEH3"L&S!ITLE3/H:
M\?'Q#^[?W[5]Q_C18QK4KL/?1IBD_TRBBD?YI0L7^?KX:.(T24E),#5W@V=,
MJ.K=S:B-$ ^^#WB$U77!Q_,(JQL(/#"AJG?A20*>$$X5J"PY.$M"8=C7P!6D
M$B9ER^?/GY]Y>9T\?F+.S%G?-6ILFB<?+BA"5P?'80,''=Q_X,&]^\%!P:GI
MP.S<"IXNH:IW-Z,V0CSX/N 15M<%'\\CK&X@\,"$JMZ%)PEX0CB5J7*&(4L/
MCI-*F*0'N(A4PJ1L24Q(>.?][L_K-U:O6-FN12NIVH@25M;-&C0:/6S$KFT[
MGCWU2DE)H3;B/_!T"56]NQFU$>+!]P&G," #^& >874#@0<F5/4N/*G <\*C
M'#5-9+[?<)PDPAB]P:6D$B9E35)24G!P\#.O9[MW[.S>L;-9O@*2_%[#RM2L
MO(MKL_H-ITSXZ?BQW]^_?Q\>%O[5[V7*)>#I$JIZ=S-J(\2#[P-.84 &\,$\
MPNH& @],J.I=>%*!YX1'.6J:R'R_X3A^8880<#6IA$E9DYR<'!T='1@0</K$
MR8%]^EH6*LQ6"G\G89;?I$318JX.3NU:M/IY\M3]>_<]N'<_*O(KWQ*=2\#3
M)53U[F;41H@'WP><PH ,X(-YA-4-!!Z84-6[\*0"SPFGDM>$(Y8:G,@I#! .
MKBF5,"EKDI*2XN/C;][X<_2PX=9FYD7RF_"W$2;I'[0TS9.OK+WC=XV;CAHZ
M_-"!@X$!@?2KC30I7G3U[F;41H@'WP><PH ,X(,YA0&& (]*J.I=>!*"I\6H
MA,.5&IS(*0P0!2XKB3 F:U)24E@G\>RIU^H5O[9KT:I:^8IVEE:XH#CMBA:K
MZ.K>LFGSF=-^/G7BI-?3I\%!02GIP''D&O L"56]NQFU$>+!]P&G," #^&!.
M88 AP*,2JGH7GH3@:3$JX7"E!B?R"*N+!5>62IB4->RA[N_G?_Z/<RN6+NO5
MM;N[<QE<39SF!0K:6A1U<W3NT+K-M$F3]^[:_?#!WPD)"<E)2;GV)Q-XEH2J
MWMV,V@CQX/N 4QB0 7PPIS# $.!1"56]"T]"\+08CW"L,H!#10M+\X'K2R5,
MRIKHZ.C7KU[?N'9]]HR9]6K4,LMO(M5?;9BD-Q/E75Q;-&TV<=RX0P=^>^_M
M'1P4%!49J=%H$A,3<]O?<>#Y$:IZ=S-J(\2#[P-.84 &\,&<P@!#@$<E5/4N
M/&G!,V,DPH'*  X5+2S-!ZXOE3 I:^+CXS^&?'S[YLWF#1L[M^O@5*)4<7-+
MJ3H)T[SY2UG;5'!U_ZYQD\$#!BZ<,W?WCIU7+EUZ_NQ94&!@PN>$7/4[#CP_
M0E7O;D9MA'CP?< I#,@ /IA?F*$X>$A"5>_"DQ8\,T8B'*@,X%#1PM+<X BI
MA$E9P![DB8F)&HWFU/$3(X<,JU6E&NLDS/*;X((B+/A-'K-\!2P+FMI96CF7
M+%7>Q;57UV[+%BT^>^KTLZ=//\7&)B<GI^::3@+/CU#5NYM1&R$2?!/P"S,R
M@ ^61!BC+'@\0E7OPI,6/#/&(!RE/.!<T<+2W. (J81)7^/>G;MK5JX:V+MO
MW6HUBA8JC MR6NC;O,P:%2OW[=%SWB^S=V[==NG\^0?W[KU^^2HH,# L-#0Z
M*CHN+N[SY\^LK6'M1<[[006>$Z&J=S>C-D(D^";@%V9D !\LH3!,*?!(A*K>
MA2<M>&:,03A*><"YHH6EI0"G2"5,RA9?'Y^;-VYL7K^A1Z<N$O[)1D99&V%O
M8UNM?,7F#1MW:?_#H'[]Y\R<M6?GKNM7KCY\\/?;UV\"_/W#PL)B8V/CX^.3
M<MR',?&$"%6]NQFU$2+!-P&_,",#^&#)A9'R@\<@5/4N/,G!DV-PX1#E >>*
M%I:6 IPBE3 I6Q(2$F*BH__Y^^^I/TUR*E&RX#=Y<$&I9/U$D?PF%B:%ZE2M
M/G+PT,T;-OY^Y.C-&W\^??+D_;MW(2$AD9&1<7%QVA]+*$#JOQ_VE+5QP?,@
M5/7N9M1&B '? 9((8S* #Y9/F"T;.%JHZEUXDH,GQ^#"(<H#SA4M+"T1.$@J
M85+6)"4FQFLTWF_>;%RWKF/;=E4\RK-5@PM*)5N8K)-PM7?\KF'C@7WZCATQ
M<OJ4J0OGSEN^9.G:E:LVKEN_9>.F'5NV[MZQ<]_N/?OW[-V_5RZ/'3YR\\:-
MUR]?A00'QWV*@_,B'7@2A*K>W>Q_^&)(0PE?G S@@U4AO Q=\/%"5>_"DQP\
M.885CD\V<+1H86F)P$%2"9.R)B4EA;TO_Q@2\L?I,_-FS^G6L5-%5W=<4"JU
M'Y6P*FQF;V/GX>Q2R<VC6H6*M2I7K5.M1KV:M1O4KM.PCF>3>O6_;]RTS7<M
MVK5LQ>S0JK4<]NG>8\F"A6=/G7[Z^$GHQX]P7J0#3X)0U;N;41MA1,(7)P/X
M8%4(+T,7?+Q0U;OPY #/CP&%@Y,-'"U:6%HZ<)94PJ1LB8V-??+H\?%CQZ9/
MF=;8LYY9O@)2_?&G"%F?86Y2R+J(A8U%4::M/)9W*3NX_X"=6[?=NGG3W\\/
MSHATX L4JGIW,VHCC$CXXF0 'ZP*X67H@H\7JGH7GAS@^3&@<'"R@:-%"TM+
M!\Z22IB4+9\_?PX,"'CZY,G639N[_M#1SM*J:/J_VH7+*B.+9IV$1;J6A4SE
MT*6T??]>O;=NW'3S^@T_'U\X(]*!KTZHZMW-J(TP(N&+DP%\L"J$EZ$+/EZH
MZEUX<H#GQU#"D<D)3A<M+"TI.$XJ85+6?/D:B80$C49S\?R%D4.&N91V8)U$
M$8F^1D*<VE]_R*=]<=M>7;MM7+?^^M5K/A]\X(Q(![XTH:IW-Z,VPHB$+TX&
M\,&J$%Z&+OAXH:IWX<D!GA]#"4<F)SA=M+"TU.!$280Q7R,U-?7Q/X_6KES5
MHW.7.M6JVUH4Q35SC*6LB_?LW'7CVO77KERE-D(FJ(TP(N&+DP%\L"J$EZ$+
M/EZHZEUX,H&GR"#"8<D)3A<M+"TU.%$J85+6I*;C[^=W[<J5S>LW].O9JVQI
M!UPPQTAMA )0&V%$PA?G7_"1:A%>B2[X>*&J=^')!)XBY85CDAD\ -'"TC*
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MLGUQ6[;ZF*9Y\FDM]&U>(_SD!+41"D!MA(&%+TBVX-.-7'@!NN#CA:K>A:<
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7Y/\#53@5D2,T^/0     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>image_0a.jpg
<TEXT>
begin 644 image_0a.jpg
MB5!.1PT*&@H    -24A$4@   L(   "V" (   !<7'QP   _@$E$051X7NV=
M!U04U]O_?^>?V%!$0$3 0A,I]EZPE\2NL?<6>R^QQ1)[-_;>:ZRQQ]YB[#$6
M[*+203K((OU_9=_DL,\#N#-W9G8'GL_YG/?\WIR9YWOG[MP[S\*R_B^-4 ,F
M_^];"875"4*UX-M;M+ T01!Z\#_X'PBC!&]Y/,+J!*%:\.TM6EB:( @]H#9"
M'> MCT=8G2!4"[Z]10M+$P2A!]1&J .\Y?$(JQ.$:L&WMVAA:8(@](#:"'6
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M?O_NW?-GS^_=N7OIPL7C1X_MWK%S_9JU*Y<M9TW#PKGS?OEYQI2)/XT9/F)
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M&7<S:B/4 9XT'F%U X$')E2Y%YX6MB.O7[NV3X^>GC5J2?)34QB0!?A$3F&
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M$DZT+OA<H2JSFQE7&Y$FQ<3E&.'42 U.Y!%6-Q!X8$)59N$9MHU(DV*B@#!
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MW+%M^^Z=NL")U@6?*U1E=K.,6YE4NQFU$8H*YTYO<"D>874#@0<F5&46GI&
M+Y]3&) U^%Q^8898<&75"2^)CX:UZWI6KUG6WM&RH"G.(@7)YM"EM$.=JM7K
MU:P-)UH7?*Y0U;N;2=!&I$DQ@[E'.'?Z@>OP"*L;"#PPH:IWX8D 7SZG,"!K
M\+G\P@RQX,IJ%%X5!^Z.SJ[VCG:65F;Y"N @4I!LA[$V,[<O;NMH6P).M"[X
M7*&J=S>3IHU(DV(2<X]P[O0 %^$15C<0>&!"5>_"$P>> 1YA]:S!YW(* SC
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M!UPPQTAMA )0&V%$PA?G7_"1:A%>B2[X>*&J=^')!)XBY85CDAD\ -'"TC*
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MLGUQ6[;ZF*9Y\FDM]&U>(_SD!+41"D!MA(&%+TBVX-.-7'@!NN#CA:K>A:<
M>+KD$V8K"!Z,:&%II< CD4J8)):4E!36200&!K)5MF'-VCDS9HX9/K)?S]X]
M.G7YH77;%DV:-:A=IUJ%BF7M'6TMBYH7*&@\'Z&@-D(!J(TPL/ %^1JX@C$+
M1Z\+/EZHZEUXRH!G3"9AL(+@P8@6EE80/!BIA$FBT/XAJ$:C"0H,?/GBQ?V[
M]ZY<NGSB]^-[=^UF7<7\.7/&C1S5NVNW)I[UW9V<BQ>QL# I9"0_F: V0@&H
MC3"D\-40 JYFA,)!ZX*/%ZIZ%YXRX!F30YBJ+'@\HH6E%00/1BIA$C>LI8B/
MCX^,C SP#WCQ_/G=VW?.GCJ]:]OV)0L6CAD^HG.[]HWJ>-:I6KUJN0J5W#S*
MEW4M5Z:LJX-3F5+V]C9V)8H6LS8SMRQHJMB/*ZB-4 !J(PP@?!$XP,6-2CA<
M7?#Q0E7OPE,&/&-R"%.5!8]'M+"TLN#Q2"5,XH.U$4E)21J-)CK]TY>^/CZL
MF7AP[][5RY>/'SVV>\?.#6O6KE[QZ[)%BQ?,GO/+S].G3)PX:NBP ;W[=&K;
MOEF#AC4J5G8I[<":"64^2T%MA )0&Z&<<.XE!<<9@W"4NN#CA:K>A:<,>,;D
M$*8J"QZ/:&%I9<'CD4J8Q 'K(;3_-R4E)9F1E)28F)CP^3/K*N+BXF)B8J*B
MHL+#PD*"@P/] [S?OGWRZ-&MFW^=/'YBY[;MB^<O'#UL!&LFZE2MKOV$)K41
M&57O;D9MA.S"*5<0/!B%A0/2!1\O5/4N/ 7 TR6',%5Q\)!$"TLK#AZ25,(D
M.?GRXXK$Q,_Q\1'AX;X^/L^\O*Y=O7KDX*$UOZZ:-'X">ZC7KUG;4:GOQ*0V
M0@'^!_\#01 Y KQ/R2%,)0@BET%M!$'D3/ C7PYA*D$0N0QJ(PA"4?"36+W"
M:R,((O=!;01!* I^&*M7>&T$0>0^J(T@"$7!#V/U"J^-((C<![41!*$H^&&L
M4N&%$021*Z$V@B 4!3^/52J\,((@<B741A"$HN#GL1J%5T401&Z%V@B"4!3\
M2%:=\)((@LC%4!M!$(J"G\JJ$UX201"Y&&HC"$)1\%-97<+K(0@B=T-M!$$H
M"GXPJTMX/01!Y&ZHC2 (1<$/9A4)+X8@B%P/M1$$H2CXV:P6X940!$%0&T$0
M"H,?SVH17@E!$ 2U$02A,/CQK KA91 $0:1#;01!* I^0AN_\!H(@B#^A=H(
M@E 4_) V<N$%$ 1!9(#:"()0%/R<-F;AZ F"('2A-H(@% 4_JHU6.'2"( @$
MM1$$H2CX:6V<PG$3!$%D!K41!*$H^(%MA,)!$P1!9 &U$02A*/B9;6S"$1,$
M060-M1$$H2CXL6U4PN$2!$%D"[41!*$H^,EM#,)1$@1!Z >U$02A*/@1;ECA
M^ B"((1 ;01!* I^D!M$."R"( A14!M!$(J"G^A*"D=#$ 3!![41!$$0!$&(
7Y/\#53@5D2,T^/0     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>image_0b.jpg
<TEXT>
begin 644 image_0b.jpg
MB5!.1PT*&@H    -24A$4@   L(   "V" 8   #3/NLG    "7!(67,  $SE
M  !,Y0%USO"5   \PTE$051XG.V=!9@51_KU]_MV-YLE>' =W%T''5P&=]<(
M!'=W)[B[AP1W#QJ"!@W!)1!\@(%A<'G__59R9P<R7&[/=%=5WSF_YSG/[F8#
MM[JZ^KSG]BWY!P%@DO_^OW]*$0# F< ?  !.X1^J&P"<!X(P , =\ < @%-
M$ :F01 & +@#_@  < H(PL T",(  '? 'P  3@%!&)@&01@ X [X P# *2 (
M ],@" , W %_   X!01A8!H$80" .^ /  "G@" ,3(,@# !P!_P! . 4$(2!
M:1"$ 0#N@#\  )P"@C P#8(P , =\ < @%- $ :F01 & +@#_@  < H(PL T
M",(  '? 'P  3@%!&)@&01@ X [X P# *2 ( ],@" , W %_   X!01A8!H$
M80" .^ /  "G@" ,3(,@# !P!_P! . 4$(2!:1"$ 0#N@#\  )P"@C P#8(P
M , =\ < @%- $ :F01 & +@#_@  < H(PL T",(  '? 'P  3@%!&)@&01@
MX [X P# *2 ( ],@" , W %_   X!01A8!H$80" .^ /  "G@" ,3(,@# !P
M!_P! . 4$(2!:1"$ 0#N@#\  )P"@C P#8(P , =\ < @%- $ :F01 & +@#
M_@  < H(PL T",(  '? 'P  3@%!&)@&01@ X [X P# *2 ( ],@" , W %_
M   X!01A8!H$80" .^ /  "G@" ,3(,@# !P!_P! . 4$(2!:1"$ 0#N@#\
M )P"@C P#8(P , =\ < @%- $ :F01 & +@#_@  < K*@O#1(T<^** W",(
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M&)_-.Q<L6?P]_7KR) 7<#8C0/?66.M.A=5LJ4;B(\84F#L6-_N=T%_%VV*)
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MR0B '#C$5F+&EVA>L%2Y;'FQV,V_9&DJ7Z*4>)O;ML4WXI<G%B\JX\,G>-H
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M_7KU,M5F;_4AV:'-2>W6H0T?4\LOOK2L3\UR\\8-6KQPH=A!P<\( +S@R<X
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M]E)WR/1:E\R^_3/#\J5+J6SQDE*",,]%KE>S%O7KU9OFSII#.[?OH'FSY]"
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M%UYX$9IK*[4M&S=1E_8=J501/[&]&;^=C?Z?_]IRR(8[\=MAWM>8ITPDBY>
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M\8E5    [ =!& "@%:I#J X"   @!P1A (!6J ZAJG7[UBW5MP   "(-",(
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2&QCOBWTW     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>image_1.jpg
<TEXT>
begin 644 image_1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" $E 0H# 2(  A$! Q$!_\0
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M;:-HD79M51@*.@':@ ARP9B,$X^O2IAP*14"  =*=0 4444 %%%% !2&EHI
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MZ5QG[3D\'BN/PE\,AJ7V6_\ &.JQ)):&)G%YIMNRS7T;,!A08E*G)&0<#J*
M/DS2O!'B'Q/8>"3J6HQIXX^.?BRV\6:NDB'_ $+0[%!<1VS*/O!5,:[N!F3V
MK])+9513M&U>PKY(^$Y'Q0_;?\?^(+8Q3^%?AOI%MX4T98"!#%<S*)+H*1_$
MH4(0>@(':OKM%&S@Y'J* 'T444 %%%% !1110 4444 %-*@G-.I,T ,\E V0
MH!)R<#K39B4B; W8[9_G3R^.G/\ 2O./CI\6M,^#GP_USQ%?2G[1:Z=<75M:
MQJ6DF:-,\#T&1GVH \'_ &8_B!HP\1_'_P"(^N3II=G?>,&TR*ZG)(DCM80L
M:KQDG[V*Y<2>//V^->6*6UNO 7P6TJ_+BYAG(N]?5>"K#<-L9]"IJC^Q/^S]
MJ7Q,^$FGZ_\ %"\LO%.@:CJ:>)O#EG!(Q6WD8LTC2*RXSN;'_ 17W;96T5O%
MY42+&B\!$&%4>BCL* ,CP'X%T/X=>%K'P_X>TRVTK2;.,)%;VL:HHP.2=H )
M/<]ZZ%1@4#I2T %%%% !24M0SOM5N57"YR3T]S[4 2EO2EK!\%^*;/QGX9T[
M7;$3)9W\(N(5N8]DFP\@D9...:W1TH 6BBB@ HHHH :>M?(O[#\['XM_M.0&
M) D?CN0K,H^9R4/!^F/UKZZ:OC[]B=F'QY_:H@.U%3QDC!4/ )C?GZD 4 ?6
M.MZE;:/I\U]>3I;6MK&T\T\A^2.-5)9F]@.:^%OV0?!E_P#M%?M#>,OVF==>
M;^R1<3Z1X-T^?YT6V0")KA<DE#@< !<M(YJ'_@II\9+NWU+P1\%;.[DTVP\8
MG[5KVH6V[[1!8K,H_=X.,?+)NR&^5>E>B_L*^(_A)X7M/$'PC^&?BK6?%1\.
MA+^[N-3!\IFE 5S;G:H";@<K@?,Q- 'UG!*# K+C!'!Q@=:^6=2^)UA<_%'X
MP?$O5H8XM ^%6F2Z'I]RW+/>F(37I7@D-S;Q#'J<DYP/4OVD?C5:_ ;X3:QX
MEF)GU20"PT:R\MG>\U*4%;>(*".K8)Y& K<BOC[]ICPOJOPY_8L^'7P7N%%Y
M\1/B3K=M:ZGO(9I;R:X6\O#YHP/EE:) QS\F!SC- 'T)_P $\O ;>$OV8O#>
MJ7H+Z[XI>7Q'J5Q*H\R6:X8MDGKPFP#/.!^%?3(&!6;X=T>V\/Z)I^EV8Q9V
M-O':P=.(T4*O3CH!TK3H **** "BBB@ I*9*6V-L^]CC-0KYI49ZXYH M444
MPN03QP.] #BP7J<5!<2!8W8X*J"<DX%<=\4?C!X0^$ND1WWBSQ!8Z)%-*L$*
MW4JJ\LAZ*JD@L:^79/'OQ4_;,&JZ5X1LI_AK\-S,EL^MZI"WVN]5'5Y/+3;@
M)(AVYW=J /5/BU^TE-I=Y?\ ASX;:0/&WB^V0MLM!YUM:N20HE*ME3U/->->
M)OAGXD^&O['OC?Q9\4=1B\0^-K?1-0D$#-NM[)[ACE$P > 0,'/ Z]Z^H_@[
M\"_"?P4TAK3PW8"W>=56ZN7),EP5)PS9)YY/3UKR7_@H5K#P? F/PW9N3J'B
M[6;'1(XHQN=T>4&0!>XVJV<>M 'I_P"S!H6G^'OV>_AYI^EV]S:V$.BVQBAN
M_P#6IE Q!_$G\*]3"@'/>L_0=/31](LM/C'[NU@C@4@8&%4*/Y5HT %%%% !
M1110 5XO^UYX5\9^.O@'XK\.^ IH(?$6J0)9J;C.TPNX689P<'9NP0,CUKVB
MD*@__6H ^&O@]K/BO]D+Q]=?#;Q)JTOB[P8]C;W]OJ=S*6N=/5F$ @5<+NC7
M"\X[]:^Y(V#(I'((R#6#XG\(Z1XI6./5=/@OT1E*>8OS*0P88/;D _A6\B[5
MQ0 ZBBB@ HHI.E "-GG&,^_2OA/]G?XC>%O@GXS_ &H_%/C#6;?1-.D\=2HA
MNI0C3E(BRK$IY=B&/ Z\5]C?$?QM8_#KP+X@\4:@K266CV,M]+&GWF5%+8'N
M<8K\P_V1/V;HOVU?$GBCXE_%*XFO/#C:H]U8^'XY2L<C3YD;?(N#A5*KCV_&
M@#H/VB_VV_!%[\4_"6O>'OA@WCLWOAY9?[2N@_G+9/*S&&.-'(61&C?<<'J!
MQDBNE_9N_:(_9D^'^G?$KQMX+T>[\*>)=/TLRW6F:Q=%;B]1%4B*W1I6'S2!
M<@#.6R<<BONOP%\-/#'PTT/3=(\-:+;Z5IMA";:TA0LWDQLVXJ&<EB"3ZU^>
M7[?7P^\%?%OXLW?B&>ZMO#OAKP'I)F\1:[Y0VZK=S2KY5A"P.'N-D;'!(QO'
M;F@#JOV9_B%XV_;/^.FFW'C]].@TKX<HGB*'3-,384O[H.EI',>23%&LC8SR
M6YS79_&:Y_X6+_P4M^"WA(1-+:>$-&N_$-SN;Y2[K(J,/<.L7IU'M6'^Q;JG
MAK]G'X22>.OB!JUKH&K?%7Q"+G3X+U@DPMFW+:*RL1\NU7?=TPZCN#6U^RE>
M0?%?]NK]H?XA1117>GZ1]D\+Z9?HX9 (QMG",ORL&>(-GT(I@?<:=2<YI](!
MBEJ>H!1113 **** "BBB@".254!RP4@9Y/0>OTKY@^-/[6%YG4O#'P2T27XG
M>/XI/L4R:<";+2G8#][-<;3&2NX?)NZCFM_]MKP;\3?'/P5NM-^$][=67BC[
M7#(_V.[%K++;?,)$60D 9XXKY=_9W_83^/\ X*\"WNF?\+0@^&QO+LW=PFFV
M[75Y.7 W%[A)E&X'/&T\T >T?"3]D"Y\7+8^+?V@+H^.?'BR+<QV<\O^A:>R
M *H2.-_+8< ]",U]8Z?IUKIEI%:V=O%;6\("1Q1)M5 .P Z"OB+_ (8/^-$=
MU+=V_P"U3XO\[81'NBFP>.-P\_FN:U_]G']L'X>M:7'A;XS2>/6$+M+;:B[V
MP1NH&&F;<?Q% 'Z&?*37R3^UOI]QXW_:&_9U\+V=TT2Q:_/K=PL:[ODMXP<G
MT'45\X^)/VY_VF_V<+ZTL?BI\,M*O;9(OM,MW$65GA!V[O-BD=%)/][\JZ[X
M#?M:^"/VI?VO_"'BC9/X8U#2O#M[81Z7>70DA>:25""C[%RQ5B/>@#]%8\9;
MDYSR*?4:2@L1P".H[U(.GI0 M%%% !12$XIHD#="&^E #Z*2EH 3 S12T4 %
M%%% !1132VW.>@[T@,O7]&L_$-C<:5J-K#>:=>PO;SVTPW)*C*0RD>F*_)SX
M+_&?Q%^PS\4?C7HUIX*USQK\-['66M(S9>8L&G2J=Z!FV.$'E$CDCA!ZU^KW
MB;Q+IWA71+[6=4NX['3;&(S7-W)DK$@Y)./\].M?GW^RWJFO?M _$GX[Z/X>
MN;&V^&^H>+1J-[J%S;M+<7:R*5:V5"R@!ECW;F'  XYJ@,[Q_P#\%/O$'Q:T
M*/PY\#O &LZIXIU.T_>W4&^5].=A@;0(BK8YY)4<]JK?L[_\$^_B-XSCMW^/
M^L78\*V5T+N'P<UV)(]0N IQ-<21."#\Q7!R<'&:_0'P/\+?"7PWM+6#P[X:
MTS1UAMQ;B>TLXXY74<?,ZJ"<]\UUY('E@C&2!M';O_A4]0/A'XA_ SP]^T9\
M;OB%XF\9 3_#?X<Z3+X>T[2TW6\4-U';)-/.NQE.(_,(  P/)&/2N+_X(Z_$
MBTM_"WBWX?ZA9_8-<:Y7Q%:7$Z&.74K-U6$R#(!<(T:C<,Y,A'8UU_QA\4-\
M$_V$_BKK>HWA&N>-]=UF.WDB)!,EW=R1+@C. L,>3D]%(KQ#7?&E[\(]&_9X
M^,WP\\'R:CH_A3PM;^'M<N"RVR7BW4(CACE. S?OS(2<$!MN2-V!0'ZS),K+
MD,I X)S3]X]1^=? ?CK]I[]J_P"$^EW6N:[\$]"O- AN$WO:W1>:)6&2,)*2
M>?EW;< ]J][_ &9_VLO#WQY\*:9=WD</A;Q7=RS0R>&[NYWS(R,1E254MD $
M #O[5/4#Z"'-+3(W#KQQ3Z8!1110 4444 -,:D$$9![&C8..Y'?O3J* $VBD
MV '.*=10!1U"SBO8I(9T2:%OO1R+N5AZ$'@CVK\Z?'W[.'A_]K[XG?'6VT'3
M=,\/>(?#<EGI>C:G: 1)]H4>8S2; 2#E=N0!C K]'+N9;:&6:1@J1J7)/
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M 'R:_0_ (Y%8V@^'-.\-6*6&DZ;;:781DLEI9Q+%$A8DL0J@ 9))/N36R.E
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M^-)T:UT.S@L+"SM[&PMXQ%#:VT82.-!V51P![5<M(FCB56/(&"?7WJ=1M&*
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M)],^-+RG+-\2=6.".VR"OJA@3T.*^0?^":]U>7_@'XHWMU*)5N?B%J[H^.6
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MH'@S1%']G:3;B%788:5^K2-R?F8DF@#N8N(UR<GN?>GT@X%+0 4444 %%%%
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M_,>:Z?DAGR=VT8&0<$Y/>OH-0 ..!4<4(BZ8QZ@5+TH 6BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** $Q2T44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !124
MP29D*9&0,XH DHI*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J(0*LC/SN;@T44 2T444
C%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>image_1a.jpg
<TEXT>
begin 644 image_1a.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" $E 0H# 2(  A$! Q$!_\0
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M;:-HD79M51@*.@':@ ARP9B,$X^O2IAP*14"  =*=0 4444 %%%% !2&EHI
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MZ5QG[3D\'BN/PE\,AJ7V6_\ &.JQ)):&)G%YIMNRS7T;,!A08E*G)&0<#J*
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M=,\/>(?#<EGI>C:G: 1)]H4>8S2; 2#E=N0!C K]'+N9;:&6:1@J1J7)/
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M 'R:_0_ (Y%8V@^'-.\-6*6&DZ;;:781DLEI9Q+%$A8DL0J@ 9))/N36R.E
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M^-)T:UT.S@L+"SM[&PMXQ%#:VT82.-!V51P![5<M(FCB56/(&"?7WJ=1M&*
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M)],^-+RG+-\2=6.".VR"OJA@3T.*^0?^":]U>7_@'XHWMU*)5N?B%J[H^.6
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MH'@S1%']G:3;B%788:5^K2-R?F8DF@#N8N(UR<GN?>GT@X%+0 4444 %%%%
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M_,>:Z?DAGR=VT8&0<$Y/>OH-0 ..!4<4(BZ8QZ@5+TH 6BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** $Q2T44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !124
MP29D*9&0,XH DHI*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J(0*LC/SN;@T44 2T444
C%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>imagea.jpg
<TEXT>
begin 644 imagea.jpg
MB5!.1PT*&@H    -24A$4@   (4   "2" 8   !K"0D?     7-21T( KLX<
MZ0    1G04U!  "QCPO\804    )<$A9<P  %Q$  !<1 <HF\S\  ": 241!
M5'A>[=T'F&Q%\39P^ 3Y"P9$$:\118(!5#""@(@*!A#,@2"("0,BYH"8441
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M>%6]5"FUR<HF"*Y9Z)HBX'I3][U"T7Z/<!,$V5FO>,4K*JWH"XT$QAH*KTW
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M:-NO7=ID)*>-_8*ZPA]3%A?<>\>M[[3OJ\IS%?$;,0L&Y^:;;UZGW!C"!IL
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M"(5POM$_':'(E,'6\KM]UE18VOE^H"]"@2#;Y>0BZM@<#P'YU%F 88)<<@Z
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M@QD+!8.-)4\]V]\AI3]_,#L(]3Q;Q.BS"SX:8E!M4[_IPKJ*_RT7/9T,RXJ
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M2$W1[B0?82)6.*$@#%X;8'?72%-,CA52*.P9'6F+J;%"VA0C#;$DE/+_ <9
2EB3Y>S5B     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>syk-20221231_g1.jpg
<TEXT>
begin 644 syk-20221231_g1.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_[@ .061O8F4 9      !_^$-M$5X:68
M $U- "H    (  <!$@ #     0 !   !&@ %     0   &(!&P %     0
M &H!*  #     0 "   !,0 "    )    '(!,@ "    %    ):':0 $
M 0   *H   $N  K\@   )Q  "OR    G$$%D;V)E(%!H;W1O<VAO<"!#0R R
M,#$U("A-86-I;G1O<V@I #(P,34Z,#DZ,C@@,3$Z-3DZ,S<   >0 P "
M%    020!  "    %    1B2D0 "     S P  "2D@ "     S P  "@ 0 #
M     ?__  "@ @ $     0   N2@ P $     0   ,@     ,C Q-3HP-SHQ
M-B Q,CHP,3HP,  R,#$U.C W.C$V(#$R.C Q.C P      8! P #     0 &
M   !&@ %     0   7P!&P %     0   80!*  #     0 "   " 0 $
M 0   8P" @ $     0  #"          2     $   !(     ?_8_^T #$%D
M;V)E7T--  +_[@ .061O8F4 9(     !_]L A  ," @("0@,"0D,$0L*"Q$5
M#PP,#Q48$Q,5$Q,8$0P,# P,#!$,# P,# P,# P,# P,# P,# P,# P,# P,
M# P, 0T+"PT.#1 .#A 4#@X.%!0.#@X.%!$,# P,#!$1# P,# P,$0P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1"  K * # 2(  A$! Q$!_]T
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MW;6;BWWN^BQ>+9G^-7Z[=1S7'ICQB5:FO%HI9<0T'3U'WU7/L>UOTWL]*O\
MX*M)3[DDO"?^?W^,[_N1?_[!T_\ O*E_S^_QG?\ <B__ -@Z?_>5)3O?63Z\
M?6C!^O[^CXN;Z> ,G&K%/I5'VV-H=8WU'U.M]WJ/_P (O6%\S9_5.LY76CU+
M.<X]5]2MY>ZMK';V!C:?T#6,9]%E?^#79=!^NW^,3(Z[T[&S;[CBW9=%60UV
M+4P>F^QC+6N>W'8YGL=^\DI]G27B/UB_QB_73"^L74L'$Z@6T49=U5%?H4.(
M:VQS*V;G4.>[V_O*DW_&A]?:+&/NS=[09].S'I#71RT[*:[/\QZ2GWM)>4];
M_P 8?U@S/JC@_6#H]XP+JLAV%U.AM;+6FPL;=3=5]HKN=71M9_GW>C^F]+U%
MU/\ BT^LV9]8OJ^Z[J-@MSL:]]-KX:TN:0VZJPUU-8QGML]'Z'^!24]:O//\
M:OUKZ_\ 5Z[IK>D97V9N0VXVCTZ[-Q8:MG\_7;M^F[Z*H?XS/K[UWH_7V=-Z
M+EC'930UV2!778?4>7/#7>O7;MVT>D_V_P"D6-_C//43TKZLOZI:Z[/LQK;,
ME[FM80^ST+34:Z6LK;Z._P!'Z/YB2GU;ZK9N3G_5SIN;EO\ 5R<C'KLML@-E
MSA+G;6!K&_V5JKB\/ZSX/U8_Q=]+ZAECU'G%J9C8[3#K;"WVLG\QC?I6V_X.
MO_26;*G\M]3?K-_C!^MG6C0SJ)Q\"H^IF65T4176XG912ZVBS]+9'IT>KZG^
ME_2^DDI]=27GOU[_ ,:+>AY3ND]&K9DY]8C)OLDUU./%36M+?7OV_P Y[_3I
M_P"%L]6NGBA]?/\ &:[&/46WWG#$SD#$J]$:_P"E^S>DDI]W27GGU$_QI-ZU
MDLZ3UMM>/G60,;(9+:[7?Z%[7%WHY#O\'_@K_P";_16>E7=2_P :'US^LO0>
MOX^'TG,^S8]F(RUS/2J?+S9?6YVZ^JU_T*F)*?4$EX$?\9G^,%K=YZ@X-T.X
MXU$:\?\ :=>B?XN/K_?]9O6Z?U%C&=0QJQ:+*P0VVL$5O>YGN;78RQU>_P#,
M?ZOZ.M)3_]#OOK;TN_J_U;ZCT['UOOI<*6R!N>W])77N<6M;ZCV;/<O#_JG]
M;.H?4W/RR,1EMEH]&^F\%EC'5N/MW?SE>U_\[4O7_K-_C#Z)]6>H,Z?U"G)?
M<^IMP=2QCF[7.?6!-EU3MWZ+]U<UF_XRO\7'4+?7S^C695T >K=BX[WP.&[W
MW.=M24YO_CX=3_\ *NC_ +<?_<NB^J?^-CI_7,ZOIN?C?L_*O(9CO#]]5CS_
M (+<6UNIL?\ X%OZ3U/])]#?CCZ]?XJ9_P#$_P#^R6-_Z57"VOQ^J_6YKOJ_
MCNPZLK+K^Q42 6$N;M=[3LJ_2?I=C'>GC_0^A6DIV_KB3_XZKS.HR\.#\&8R
M]T7@_P#C#?;T[_&+D9ME1<UEF-D5M,M#VLKI^B^#^?4^K>O0>G_XW/JUU#/Q
ML"C'S&W9EU=%9?76&AUCFU,+RW(=[-SO<DI\XL__ "JC_P!/C?\ VZ"]A^NO
M0;_K#]7,GI>+Z3<FTUNI?=(:TLL98]VYC+7L=Z+;*_8S\]>/6?\ Y51_Z?&_
M^W07OR2GS;IG^+OJG3OJ7UWI&<^F^_, OQ1C.<Z;*1ZM3/TM=/\ .6UL8L+_
M !*]4&/US,Z8]P#,Z@/9/)LH,M8W_K-V0_\ ZVO9E\\=<;E?5#ZZ9PP-M3\:
MRW[-I(;5DUN],-_E,QLG;_QB2D[!_P \?\8NOZ:C.S2=?:3BU'=M_K?8*%T_
M^/+^D='_ *F1^6A5_P#$GTKUNJYW5GB6XE3::I'Y]QW.>QW[U=5.QW_'JQ_C
MR_I'1_ZF1^6A)3YYU/K.?U-F)5E/FG H9C8M31#&,8 W=M_TMSF[[K/S_P#B
MV55L]P_Q>7]&K^I6/?TFO:RMCG9;)!L.2T?K/K.;^>_:WTMW_:;[.L7HWU!Z
M;U#_ !;LQ:&@9_4:V9K<E^A^T!KCCL<[W?H*VV/Q_P#B[K[?YVQ<M_BO^L5O
M0/K#9T3J.ZK&SW_9[:[ 1Z62T^G5N9!V[W_JMW_6_5_F$E/)X'5&4]9;U3J6
M.WJGZ1UUU%SB&VV.W.W71._],[U7U_0N_F[/T:[T?X[^H 0.E4@#@>H[_P B
MN:ZOT[J/U$^M@>VMME=+W68;K6[Z[J'[F;+-S1N=Z3_1O_T=O\W_ (*U=MC_
M .-7ZCOI8[)Z/95<0/48RFBQH/@RUUE+GM_ZU6DI\RZIU2K*ZN_J?3\9O3"Y
M[;64T..VNQL$OH,,]/\ 2-]5K/\ !_F+J/\ &WE?;.M],RR-OVCI=%NWPWV9
M#X_Z2](^JO7OJI]:_M8Z=TX5C#]/U?M%%39]7U-FSTW7?Z%^[<O/O\=0 ^M.
M( ( P*P /^.RDE/JN%C_ &SZJX^*0U_VC 946O\ HG?2&19]+V>[W+D?\7W^
M+SK?U8ZW9U#/NQK*;,9](;0^QSMSGU6"1932W;^B_>7;="_Y#Z=_X5I_\]L5
MY)3_ /_1ZSZS_P"+OHGUGZ@SJ&?=DUW,J;2&T/K:W:US[ 8LIM=N_2_O+)_\
M97ZJ_P#<K/\ ^W*O_>9=^DDI\_\ _&5^JO\ W*S_ /MRK_WE6]]7?J#]6_J[
M:,C!H=9F-!#<J]V^P C:[T]&55>WV[JJF/71))*<7ZQ_5#H7UDK:.IT;K:QM
MJR*SLM8"9AKQ[7M_D6LLK6#T_P#Q1?5KI^?C9]&3FNNQ+J[ZP^RHM+JW-M8'
MAN.UVS<W]Y=PDDIY!W^+'H#OK!^W_7R_M?VL9VS?7Z?J"S[1LV^AZGI;_P#A
M?[:Z])))3Y[_ (PO\8?6/JOUJGI^#1C6U6XS;W.O:\NW.LNJ@>G;4W9MI_=7
MF/UB^L'4?K;U>K*NQJVY;V,QJZL5CIL.YWI^QSKK++GNM]/_ +;8O6_KK_RK
M5_XFOYAO_+G])^G;_-?]U/W/^&]=2^I?]/M_\3?T/^\/^>_Z[_P22F_]0/JW
M9]7/JY3AY C,N<<C+ (<!8\-;Z8<WV_HJF55NV>SU-ZE]:OJ/TGZU/QG]1MR
M*CB!XK%#F-!W["[?ZM5W^C71))*:G2NG4=+Z=C=.QW.=3B5MJK=807%K1M&\
MM:QN[^PN:Z[_ (KOJWUSJ=W4\A^3CWY$&UN.ZMK"X#;ZFRRFWWO_ ,(NP224
MYN=]7^E]3Z;7TWJM7[0IK:UOJ7_SI<T;?7]:KTG5WO\ \)93Z2Y2W_$Q]4WV
M.>V[-J:3I6RRLM']7U*+'_YSUWJ22GG_ *J?4KI7U4^U?LZV^W[9Z?J?:',=
M'I>ILV>E53_IG[E7^M'^+SHOUGZA7U#J%V37;52*&MH<QK=K766AQ]6FYV_=
M<[\Y=0DDI#B8U>)BTXM9)KQZVU,+M26L 8W=Q[O:C)))*?_9_^T5=%!H;W1O
M<VAO<" S+C  .$))300$       L' %:  ,;)4<< @   @  ' (W  @R,#$U
M,#<Q-AP"/  +,3(P,3 P*S P,# X0DE-!"4      ! #%M'!JU@13,IV2@$W
M68,&.$))300Z      #E    $     $       MP<FEN=$]U='!U=     4
M    4'-T4V)O;VP!     $EN=&5E;G5M     $EN=&4     0VQR;0    ]P
M<FEN=%-I>'1E96Y":71B;V]L      MP<FEN=&5R3F%M951%6%0    !
M   /<')I;G10<F]O9E-E='5P3V)J8P    P 4 !R &\ ;P!F "  4P!E '0
M=0!P       *<')O;V93971U<     $     0FQT;F5N=6T    ,8G5I;'1I
M;E!R;V]F    "7!R;V]F0TU92P X0DE-!#L      BT    0     0
M$G!R:6YT3W5T<'5T3W!T:6]N<P   !<     0W!T;F)O;VP      $-L8G)B
M;V]L      !29W--8F]O;       0W)N0V)O;VP      $-N=$-B;V]L
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M8W)O<%)E8W1";W1T;VUL;VYG          QC<F]P4F5C=$QE9G1L;VYG
M      UC<F]P4F5C=%)I9VAT;&]N9P         +8W)O<%)E8W14;W!L;VYG
M       X0DE- ^T      !  2     $  0!(     0 !.$))300F       .
M             #^    X0DE-! T       0    >.$))3009       $
M'CA"24T#\P      "0           0 X0DE-)Q        H  0         !
M.$))30/U      !( "]F9@ ! &QF9@ &       ! "]F9@ ! *&9F@ &
M   ! #(    ! %H    &       ! #4    ! "T    &       !.$))30/X
M      !P  #_____________________________ ^@     ____________
M_________________P/H     /____________________________\#Z
M  #_____________________________ ^@  #A"24T$"       $     $
M  )    "0      X0DE-!!X       0     .$))300:      -=    !@
M            R    N0    4 ', = !R 'D :P!E '( 7P!L &\ 9P!O #(
M,  Q #4 7P!W &4 8@    $                          0
M   "Y    ,@                      0                         0
M     0       &YU;&P    "    !F)O=6YD<T]B:F,    !        4F-T
M,0    0     5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M
M;&]N9P   ,@     4F=H=&QO;F<   +D    !G-L:6-E<U9L3',    !3V)J
M8P    $       5S;&EC90   !(    '<VQI8V5)1&QO;F<         !V=R
M;W5P241L;VYG          9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@
M  UA=71O1V5N97)A=&5D     %1Y<&5E;G5M    "D53;&EC951Y<&4
M26UG(     9B;W5N9'-/8FIC     0       %)C=#$    $     %1O<"!L
M;VYG          !,969T;&]N9P          0G1O;6QO;F<   #(     %)G
M:'1L;VYG   "Y     -U<FQ415A4     0       &YU;&Q415A4     0
M     $US9V5415A4     0      !F%L=%1A9U1%6%0    !       .8V5L
M;%1E>'1)<TA434QB;V]L 0    AC96QL5&5X=%1%6%0    !       ):&]R
M>D%L:6=N96YU;0    ]%4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV
M97)T06QI9VYE;G5M    #T53;&EC959E<G1!;&EG;@    =D969A=6QT
M"V)G0V]L;W)4>7!E96YU;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE
M    "71O<$]U='-E=&QO;F<         "FQE9G1/=71S971L;VYG
M  QB;W1T;VU/=71S971L;VYG          MR:6=H=$]U='-E=&QO;F<
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M_P#8.G_WE24[WUD^O'UHP?K^_H^+F^G@#)QJQ3Z51]MC:'6-]1]3K?=ZC_\
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MSGL=^]753L=_QZL?X\OZ1T?^ID?EH24^>=3ZSG]39B593YIP*&8V+4T0QC&
M-W;?]+<YN^ZS\_\ XME5;/</\7E_1J_J5CW])KVLK8YV6R0;#DM'ZSZSF_GO
MVM]+=_VF^SK%Z-]0>F]0_P 6[,6AH&?U&MF:W)?H?M :XX['.]WZ"MMC\?\
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M &\ <P!H &\ <    !< 00!D &\ 8@!E "  4 !H &\ = !O ', : !O '
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M P,# P,# P/_P  1" #( N0# 1$  A$! Q$!_\0 'P    8" P$
M    !P@&!00) PH" 0 +_\0 M1   @$#! $# P(# P,"!@EU 0(#!!$%$@8A
M!Q,B  @Q%$$R(Q4)44(6820S%U)Q@1ABD25#H;'P)C1R"AG!T34GX5,V@O&2
MHD14<T5&-T=C*%565QJRPM+B\F2#=).$9:.SP]/C*3AF\W4J.3I(24I865IG
M:&EJ=G=X>7J%AH>(B8J4E9:7F)F:I*6FIZBIJK2UMK>XN;K$Q<;'R,G*U-76
MU]C9VN3EYN?HZ>KT]?;W^/GZ_\0 'P$   8# 0$!            !@4$ P<"
M" $)  H+_\0 M1$  @$# @0$ P4$! 0&!@5M 0(#$00A$@4Q!@ B$T%1!S)A
M%'$(0H$CD152H6(6,PFQ),'10W+P%^&"-"624QAC1/&BLB8U&50V160G"G.#
MDT9TPM+B\E5E=58WA(6CL\/3X_,I&I2DM,34Y/25I;7%U>7U*$=79CAVAI:F
MML;6YO9G=X>7I[?'U^?W2%AH>(B8J+C(V.CX.4E9:7F)F:FYR=GI^2HZ2EIJ
M>HJ:JKK*VNKZ_]T ! !=_]H # ,!  (1 Q$ /P#?X]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=?_]#?X]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]UJ2_\*J_YG'SA_EM[1^$^4^%O=O\ H8KNW-Q]\T'8
M4_\ HVZB[$_O!2;+QG4U1MJ+Q=K[!WU#B?X;-N:N.JA6F:;SVE+A(PGNO=:;
M_P#T%'?SU_\ O.;_ -EF^'G_ -S[[]U[KW_04=_/7_[SF_\ 99OAY_\ <^^_
M=>ZM._DF_P __P#FX?+G^:/\1OCG\AOEG_I!Z:[/WAO#%;YV=_H'^,^U/XY0
M8KJO?FY*"#^\.R.F=M;JQG@S6%IIM5'74[MX]#$QLZM[KW7TK/?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7R*-X_\*?OYYF*W=NG%T'S
M@\%#C=QYR@HH/]EI^($OAI*/)U5/31>6;H"2:3QPQ@:G9F-KDD\^_=>Z3G_0
M4=_/7_[SF_\ 99OAY_\ <^^_=>Z]_P!!1W\]?_O.;_V6;X>?_<^^_=>Z^B9_
MPGO^7'R%^</\KCI7Y&?*/L'_ $G]R[MWAW-BMP[Q_NILC97\0H-J=J;IVW@(
M/[O=>;:VEM6D^PPN-AAU04,;RZ-<A>0LQ]U[JZ[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U__T=_CW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW6AE_PN
M/_X\+^6__P"'?\HO_=-T1[]U[KYZGOW7NO>_=>ZN^_X3>_\ ;[7X$?\ B0.P
M?_?(=H>_=>Z^QU[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z^!MV#_P ?[O?_ ,._<O\ [N:WW[KW20]^Z]U[W[KW7UNO^$G_ /VY*^.7
M_B0/D1_[^_>_OW7NMC[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U__TM_CW[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW6AE_PN/_X\+^6__P"'?\HO_=-T
M1[]U[KYZGOW7NO>_=>ZN^_X3>_\ ;[7X$?\ B0.P?_?(=H>_=>Z^QU[]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z^!MV#_P ?[O?_ ,._
M<O\ [N:WW[KW20]^Z]U[W[KW7UNO^$G_ /VY*^.7_B0/D1_[^_>_OW7NMC[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U__T]_CW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW6AE_PN/_X\+^6__P"'?\HO_=-T1[]U[KYZGOW7NO>_=>ZN
M^_X3>_\ ;[7X$?\ B0.P?_?(=H>_=>Z^QU[]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z^!MV#_P ?[O?_ ,._<O\ [N:WW[KW20]^Z]U[
MW[KW7UNO^$G_ /VY*^.7_B0/D1_[^_>_OW7NMC[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U__U-_CW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]TC]]=A; ZNVW7;R[,WQL
M_KK:&,"G);JWUN;"[1VWCPP8J:[.;@K<?BZ0,%-O)*M['W[KW54_9_\ PH#_
M )-/4-;44&[/Y@G1F3J*5Y(YCUG/NSNJFUQFSB&NZ:VQOVBJ1?Z&.1P?Q?W[
MKW0$_P#04;_(H_[SF_\ 99OF'_\ <^^_=>Z]_P!!1W\BC_O.;_V6;YA__<^^
M_=>Z]_T%'?R*/^\YO_99OF'_ /<^^_=>Z]_T%'?R*/\ O.;_ -EF^8?_ -S[
M[]U[KW_04=_(H_[SF_\ 99OF'_\ <^^_=>Z]_P!!1W\BC_O.;_V6;YA__<^^
M_=>Z]_T%'?R*/^\YO_99OF'_ /<^^_=>Z]_T%'?R*/\ O.;_ -EF^8?_ -S[
M[]U[KW_04=_(H_[SF_\ 99OF'_\ <^^_=>Z]_P!!1W\BC_O.;_V6;YA__<^^
M_=>Z]_T%'?R*/^\YO_99OF'_ /<^^_=>ZU)?^%5?\U;X$_S)-H_"?%_"WOC_
M $SUW4>X^^:_L*#_ $7]S==_W?I-Z8SJ:GVU+Y>U^N]BPY;^)3;9KAIH6J6A
M\%Y0@>,O[KW6F_[]U[KWOW7NK3OY)OR/Z8^(W\T?XC?(SY#;R_T?=-=8;PWA
ME=\[Q_N[NO=?\#H,KU7OS;=!/_=[9&#W+NK)^?-9JFATT=#4.ODUL!&KLONO
M=?2L_P"@H[^11_WG-_[+-\P__N???NO=>_Z"COY%'_><W_LLWS#_ /N???NO
M=>_Z"COY%'_><W_LLWS#_P#N???NO=>_Z"COY%'_ 'G-_P"RS?,/_P"Y]]^Z
M]U<-\9?DSTA\QNC=A_)+XX;V_P!(O2W9E/G*K9&\_P"[>[MH_P ;@VYN?-;-
MS+_W=WW@-L;KQOV>Y-NUE-:KH:<R>'R1AHG1V]U[HL'S@_FS?R_?Y;^?V#M?
MYG]_?Z&L[VAA\UG]BT/^BONOL/\ CF)V]6T6.S%7]SU3UQOFCQGV=9D(4\=9
M)3RR:[HK*&(]U[HC'_04=_(H_P"\YO\ V6;YA_\ W/OOW7NO?]!1W\BC_O.;
M_P!EF^8?_P!S[[]U[KW_ $%'?R*/^\YO_99OF'_]S[[]U[KW_04=_(H_[SF_
M]EF^8?\ ]S[[]U[KW_04=_(H_P"\YO\ V6;YA_\ W/OOW7NLD7_"HG^15-(D
M2?.>,,[!5,OQK^7T$8)_U<T_0$<4:_XLP ]^Z]T;7I?^=A_*;[_K:3&=9_/S
MXVU.7KW6/'X3>>_*7JC.Y&=R E+CL)VO#LG+5]8]^(887E(!.FP/OW7NK.Z&
MNHLG1TN1QM92Y#'U]/#5T-?0U$571UE)41K+3U5+50/)!44\\3AD=&*LI!!(
M]^Z]U*]^Z]U[W[KW5,'?O_"A/^4'\7NY.POC]WQ\M*KK_M[JK<,^UM^;.J_C
MQ\J,S+@\W3PP5+4Z9C;72&:V]EZ6:EJ8IH*JAJZFDJ(9$DBE=&#'W7N@@_Z"
MCOY%'_><W_LLWS#_ /N???NO=>_Z"COY%'_><W_LLWS#_P#N???NO=#5\=?^
M% W\H?Y8=U; ^._0?R\IM[]P=HY6IP>Q-IU71_R2V5%GLO2XK(9J3'KN7?W3
MNUMI8^IEH,7,85JZ^#[B8+#%KFDCC?W7NKE/?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U6)\U?YRG\MG^7=V9M[IWYB?)2FZB[*W3LBA['PFUH^JN\.Q*JIV7DLYGM
MMX_.5%9U5UGOC%XR.LS6UZ^&.&JGAJ6^V9Q'H*LWNO=$\_Z"COY%'_><W_LL
MWS#_ /N???NO=>_Z"COY%'_><W_LLWS#_P#N???NO=2*3_A4'_(RKZJFH:'Y
MNSUE;6U$-)1TE+\8/F/45-555$BPT]-301?'MY9YYY7"HB@LS$ "Y]^Z]U?H
MCB1$D4,%=5=0Z/$X# , \<BI)&P!Y5@&!X(O[]U[KX''8/\ Q_N]_P#P[]R_
M^[FM]^Z]TD/?NO=>]^Z]U];K_A)__P!N2OCE_P") ^1'_O[][^_=>ZV/O?NO
M=>]^Z]U[W[KW17OEY\T?C!\#.GZKOKY:]N87ISJRESN'VPFX<IB]R[CKLGN/
M/RR1XO!;>VGLK";EWEN?+314\U0\&.Q]5+!14T]5*$IJ>:6/W7NJHO\ H*._
MD4?]YS?^RS?,/_[GWW[KW7O^@H[^11_WG-_[+-\P_P#[GWW[KW7O^@H[^11_
MWG-_[+-\P_\ [GWW[KW2BVA_PI?_ )*/8&Z]M;$V/\Q,QNW>>\\]B-K;3VMM
M[XK?,S+9[<>Y,]7P8O"X/"XNB^/,U7D<IE<C51P00Q*TDLKJJ@D^_=>ZO:5@
MZJXU ,H8!E9& 87&I'"NC6/((!'Y]^Z]UR]^Z]U[W[KW7O?NO=(/L;M3K#I[
M;53O/MSL?8?5NSZ(Z:S=?8V[]O;(VU2-I9[5.=W-D<9BX#H0GU2C@$^_=>ZJ
M)[>_X48_R7.EJFJH-R?._K/=.1IC(B4O4.W^QN[*:KEC)!CI<]U/LS>&UR'(
M],CUR0L/H_(]^Z]T2W-?\*]_Y.&*J7@H=V?(;<D2OI%9A>B\I!32#G]Q%W%F
M\!5A./[42MS]/K;W7NEELK_A6?\ R5]UU,-/F^[^U.MTE.DU>]?C_P!HUE-"
M20!YO]'V#WW4 &_U6-@!];>_=>ZM)^/'\V/^6M\K*NAQ70OS:^.^^=QY1XX\
M;LN7L3#[1[!R#R6TK1=>;XDVUOBIY8 Z,>VEB ;$@>_=>ZL)]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=5.?+G^>/_*W^"7<^3^/?RK^4'^BSM_#X/ ;DR.T
M?]"GR(WQ]MA=ST7\0P=9_'^N.I-W[8F^^H_7XXZUI8OI(J-Q[]U[HLG_ $%'
M?R*/^\YO_99OF'_]S[[]U[KW_04=_(H_[SF_]EF^8?\ ]S[[]U[KW_04=_(H
M_P"\YO\ V6;YA_\ W/OOW7NO?]!1W\BC_O.;_P!EF^8?_P!S[[]U[KW_ $%'
M?R*/^\YO_99OF'_]S[[]U[J70_\ "H#^1=D*J*DI_G321RS,%1Z[XZ_+7&4H
M)(4&6MR70U)10+<\EY% ')-O?NO='IZ'_FR_RT?DU746(Z2^<?QKWGN+)/%'
MC=H2=H[<VMOG(23,%C2AV+O*KV]N^L<N0I$=$Q5F -B0#[KW5A7OW7NO>_=>
MZ][]U[KWOW7NO>_=>Z__U=_CW[KW7O?NO=>]^Z]U[W[KW35G<[A-KX3,;FW-
MF<5MW;FWL7D,YG]P9W(4F)PF#PN)I):_*9C,96OFIZ'&8O&T,$DU1432)%#$
MC.[!03[]U[K0E_FX?\+ *S"9W=/0_P#*MQN%KDQ<]9A,W\O]]X*+-4%760LT
M,\W1G7>:@.,KJ*FF6T6>W'3U--5C7X,4T/@K9/=>ZT<OD)\I_DC\L=YU'87R
M6[R[1[QWA/+/)%F.R=Y9O=!QB5#ZWHL!0Y&KEQFV\2G BHL?#34D* +'&J@
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M!72[E[SJ7W_CZ7*PZ5:+)[;V3E,1AI48:T_AH5O4#[]U[JZ3W[KW7P-NP?\
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M,=/245%1PI3TM)2T\2K%!34T$:HB* JJH %A[]U[J7[]U[KX&W8/_'^[W_\
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M*NT'6>V]UT\R)ZU^^B)(# /[KW7TVO?NO=>]^Z]U\#;L'_C_ '>__AW[E_\
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M#'+;4D4]1M&E9U'#&-2?TCW[KW7S,_?NO=>]^Z]T?_\ E._]O3?Y:?\ XO\
M_#?_ ."*ZY]^Z]U]OGW[KW7O?NO=?__2W^/?NO=>]^Z]U[W[KW53W\\[X[9'
MY3?RD_G3U%A*"3*;C?I/)=D;8QM/#YZ[);EZ0S.&[JPF)QB#UG(YNOV E%"
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MMCRD.W^F4D:]K#2TRC^O/OW7NOGD>_=>Z][]U[J[[_A-[_V^U^!'_B0.P?\
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M@GR%5-)'!$K"-?=>Z'W_ *#5OYIO_/@_@!_Z*SY%?_=5>_=>Z]_T&K?S3?\
MGP?P _\ 16?(K_[JKW[KW7O^@U;^:;_SX/X ?^BL^17_ -U5[]U[KW_0:M_-
M-_Y\'\ /_16?(K_[JKW[KW7O^@U;^:;_ ,^#^ '_ **SY%?_ '57OW7NO?\
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M8W;@-[8A:;.X2II,I0&'<&VJ25C%(ID1"C75F!]U[JCO_H$S_DI_\^([0_\
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M7[O=(F-'M[M3O;:L\X12L=3O':/7F7I(B]M2M-%L68@ V(C-_H/?NO=?.O\
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MH::HG8RSSIL3?=;3[RI@TQNE/1;KHJ&%#HB@1 H7W7NJ+>S_ /A$K\Y,/6U
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MQL__ -";"_\ U;[]U[KW^D/8'_/<;/\ _0FPO_U;[]U[KW^D/8'_ #W&S_\
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MX]OXF+)XRGC1YJC-X:DIH]"U4Q/NO=?)#]^Z]U[W[KW7O?NO=?1)_P"$<O\
M-%_OEL/>7\K_ +=W%Y-R];4^<[6^+M5E*J\V4Z^KZ]J_L_JZBDG9!)4;-W!D
M#G\=3J99Y:')Y&P2GQR@>Z]UO7^_=>ZK-_FF_P J_P"./\UWX[UG2O=] <#O
M# '(9CI?NO!XZEJM\=/[RJZ>*)LEBC-)3?QK:V;^UAAS>#FFCI<K31H0\%7!
M1UE+[KW7R1OYCG\L+Y8_RO.ZJOJ#Y+['FI,;D:BOFZT[;V]%6Y#JOMS 4<B
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MY961F5E*LI*LK AE8&Q5@;$$$<CW[KW77OW7NO>_=>Z][]U[KWOW7NOL,_\
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M?]K#Y*__  5W=_OW7NM@[W[KW7O?NO=>]^Z]U\G3_A7+_P!OF^S/_$(="?\
MO&^_=>ZUDO?NO=>]^Z]UN.?\(H?^WDOR5_\ %']W_P#O^>@/?NO=?3<]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=?_3W^/?NO=% ^:O
MP*^)W\Q+JS =*?,7JG_3!UEM?L#%=I8+;7]^>R>O_L=]X3;FZMIXS._QGJW>
M.R=P5/VVW][92G^UFJY*-_NM;Q-)'$\?NO=5@?\ 0+C_ "*/^\&?_9F?F'_]
MT%[]U[KW_0+C_(H_[P9_]F9^8?\ ]T%[]U[KW_0+C_(H_P"\&?\ V9GYA_\
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M23R?!B%7D8LRT_R1^7=)""?^.=/2]^PT\2_X*H'OW7NL/_0+C_(H_P"\&?\
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JW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>syk-20221231_g2.jpg
<TEXT>
begin 644 syk-20221231_g2.jpg
M_]C_X  02D9)1@ ! 0$ ;0!N  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" (/ ]4# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#Y_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MFQ_^2:]NHH \1_X:+\1?]$/^(7_?FQ_^2:/^&B_$7_1#_B%_WYL?_DFO;J*
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MR])K5\[3Z,IPRGV(!J_X@\'Z%XJTZ>PUC1[+4[.9#')#=0*ZE2,$<CBOS/\
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M21(8VDD94C4%F9C@ #J2:^6_BA_P4:^%/P_UR;0M(?4_'6N0L4>U\.6WGHC
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MR*'Q=X+\7>#H96"B\O;#,*Y/5B2IQ] 3[5]:>"O'GAWXC:%!K/AG6+36],F
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MK,*%A2(-P"R*KD^K?B?J?4?#VEZO9O:7VFVEW:NI5H9H5="",$8(H Y3X/\
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M>+;VVDM&UJVO+Z&"08*0N"8Q]-N*_0G]IGP1)\1_@#X[\.0IYD]]I4R1KWW
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M>"?^NNH?^EL]?3] /<^'?^"NO_)N>@_]C%#_ .D]Q7UW\,?^2<^&?^P=;_\
MHL5\B?\ !77_ )-ST'_L8H?_ $GN*^N_AC_R3GPS_P!@ZW_]%B@.A^7GQIUS
MQ+9_\%.=3U7PUX9'C#7]-FMY+/2'F\H2>7:QJ#N[8'-?47_#3'[3G_1N$?\
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M!:_.[_@E?JD.F_$/X[>'[AO+U%M52Y6%N&*1S7".<>QD3\Z_1&@&>2_M:?\
M)L_Q,_[ -U_Z :\6_P""5O\ R:S#_P!A:Z_]EKM/^"A'CR#P/^RKXS5V_P!(
MUB :3;J#\Q:8[<@>PS7&?\$K_P#DUN'_ +"]U_[+0'0^F_B=X L/BG\/M?\
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M9_\ HT4 MSWO]FE0O[.GPN &!_PB^F?^DL=>DUYO^S7_ ,FZ_"[_ +%;2_\
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M*^P_@7\$/#?[/WP]L/"7AFW*6T WSW4@'G7<Q^]+(1U8_D!@# %>@T4 >?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@#E_B/\ $OPW\)?"L_B3Q7J<>D:+!)'%)=2@
ME59V"J./4D"O+--_;J^!^L:C:V-IX\L9KJYD6&*,(^69C@#IZUZ]XT\"^'_B
M-H$NA^)]'L]=TB5TDDLK^$2Q,RL&4E3QD$ CZ5^;'[>GPE\&?"OXW?!J'P?X
M9TSPW%=7B-.NFVRPB4B88+;1S0-'ZB4444""BBB@ JI!JUC=7!@AO()9AG,:
M2 MQUXS5NOA[]F_]A/Q=\&_VF-5^(^IZ_IE[I5W-J$BVMNCB4">1G4$DXX!Y
MH ^X:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]1?L]_'30OVAOACI?BW1)5!F41WMH3\]I< #S(F'L>A[@@C@UZ50!^>'Q$^
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O@
M;XI_\$T]8\:?&7Q!X@T7QE9Z1X,UW5[?5[[0WAD+R2(=[YQ\I)=YB/3S#7WS
M10,@L;*'3;&WM+=/+M[>-8HT_NJH  _(5/110(^&_P!J'_@GGKWQI^,6J^-O
M"OC&S\-1:Q9+::A:7$4A,N%V-]WC#+U![U]=_"SP':_"_P"&_AKPG9[6@T?3
MX;/S%&!(R( S_5F!;\:ZFB@85Y'^T7^S#X,_:8\,PZ9XHMI(KRT+-8ZI:G;<
M6K$<X/=3QE3P<"O7**!'P?H?P&_:Q^ =JND> ?'VD>-/#<7RVMGK8'F01C[J
MAI/N_1>*T+WX6_M@_&"S?2/%/CC0? 6BS?)<G1D5KET/#!9(^1D$\'BON"B@
M=SQW]F_]EKP;^S)X=N;#PW%+=:C?%6O]7O#NN+DCH"?X5&20HXR2>]>Q444"
M"J.N:)8^)-'O=*U.VCO-/O(6@N+>5<K(C#!!'TJ]10!\$R?L._%/]G7Q9?:W
M^SQXXBM=,ON;C0-< D3@G:,M\K@ \,WS#)KHK/1?VU_%G_$NU#6?"/A&VE'E
MRZE#%'/(JGJ5"Y(;T/8U]J44#N?&WB+_ ()X6=U\%O&6@67B>;5?B#XJDM9-
M1\7:_NEDD$5Q',4 '*J2G0=2!GI5/X._LG_M _"*W\/:+8_&'1QX2TN=2^F1
MZ>^7AW9= Q]>?SK[5HH"Y\K_ !:^!O[0WC+Q;XAE\.?%_2]$\*Z@SI;Z5-I[
MN\,++@H6'7O7D'PB_8(^.OP)L+^R\$?&#1=&MKYTDN$73Y7WLH(4\^@)K]!Z
M* N<#\$O#'C;PCX%BT_Q_P")K?Q9XB6=W?4K:$Q(T9QM7:?3G\ZZCQ7X5TKQ
MOX;U'0=<LHM1TG4(&M[FUF&5D1A@@UK44"/A&X_8-^(GP'\1W.N?L]?$1]&M
MK@[KC0=;S+"^/NC)X? [OS6G';?MPZHOV&6Y\':2K_(VI!89"H_O;!7VW10.
MY\E? _\ 8/3PK\1H?B5\3O%MU\1?'D1+Q2W&?LL#X(5D#<G:"<9X'&*^M:**
M!!1110!Y)^T7^S+X-_:8\*PZ3XHMWCNK1F>QU.U.VXM688.T]U.!E3P<#TKY
MF\/? G]K3]G^T&B^ O'&C>-/#,1VVMKK( D@C'109/N_1>*^]**!GQ?'\&?V
MH?C;:MI/Q(\?:;X'\,R_+=6OAB-?MEPA&"OFKP%(X(/K5;XY?\$\)O%>D_#C
M2_ASK]CX4LO!T3B)K^)YI)9FD,AE)7JQ8DG/K7VS10%SY[^!?PL^.?@_QR^H
M?$3XH:=XO\/FTDB&G6MDT+"8LA23)[ !AC_:KCOBS^SY^T/X\UOQ1!I?QATG
M3?"6K>;!%I4VGNS1VTB;&C+#KP6Y]Z^M:* /@?X6_L2_M!_!?PVV@^#_ (S:
M+I.E-,UP8%TZ1_G;[QR:^Q?@_P"'_%GA?X?Z;IOC?7X?$_B6$R?:=4MXC&DN
M78KA3TPI _"NSHH \4_:$^'?Q=\<7NCR?#/X@V7@F"WC<7D=W:-,9V)&TC'3
M S7S#I_[ GQSTKXK7WQ)M?B_HD7C*]!6?41I\N7!14(V]/NJH_"OT)HH"YY7
M^S_X*^)/@G0=1M_B5XSM?&FHS3A[:YM+<PB*/!RI!Z\UZI110(^8/VM_V1=5
M^//BKPCXO\'^(K;PGXNT))8/[0N(V?S(6!VJ-O0@O)_WU75_L>_LTI^R_P#"
MU_#L^H1ZOK-Y>27M_?Q*521R JJN>=H51U[LU>Z44#"J>L:/8^(=)N],U.TB
MOM/O(F@N+:= R2HPPRL#U!%7**!'PKK7_!/_ ,8_"'Q=<^)OV?/B!+X3\_YI
MM#U)FDMY,'(3/1A[/TK0BC_;CO,6;S>#;$'Y3J6V!\?[6P5]M44#N?(/PJ_8
M-FD^(%M\1?C3XLF^)'C2WD62VB;<+&V*G*;4;DA220IX! (KZ9^(VCZ_KO@;
M6=/\*ZK%H7B"XMFCL=1FC+I;R$?*Y4=0*Z6B@1^?OQ6_81^//QNL=,M/&?QA
MT36+?39S<VJMI\B>7(0 3QUX%>R?!_X*_M!>#_&NC77BWXN:9XA\+6@VW&EP
M6#1O*@7"@,>F#C\J^GJ*!W/.OCMX3\>>,O!,=A\._%5OX/U\7:2MJ%U 94,(
M5@R;1W)*G/\ LU\@>+?V#?CQXZ\>:!XRUOXPZ+>>(]"97T^\_L^13"58,#@<
M'Y@#7Z"44 >$_L__  U^,_@GQ%J=U\2OB18>--+FMECM;6TLVA:&7=DN2>HQ
MQ7NU%% @HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **^3OV6?VL_$GQ^^.OQ
M'\,ZCIECI6C>&_,AMH[<EY)&2X,>]F('4#H..:^L: "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "O,OCM\?M"_9^T&PU;7M/U;4;>\N#;
MQII%K]H=6QG+#(P/>O3:CFMXKA0)8DE Y =0?YT ?,_PU_X*"?#KXH?$C1O
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M\!?COX=_:)\"MXK\+QWD6F"[DL]M]$(Y-Z!2> 3Q\X[UZ/7QG_P2?_Y-7?\
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M/B?X,_\ !0_5?$?P:\5^*_%F@6LOB&TU:+1M%T'1MQFU&ZD0E8P#DG!!)(Z
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M -A]?_0&K[[H&SXC_P""N?\ R;#8_P#8?M__ $7+7U9\'?\ DD7@?_L!V/\
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M/"?^"3__ ":NW_8>NO\ T7#7V97QG_P2?_Y-7;_L.W7_ *+AK[,H&]S\[O\
M@D__ ,ACXN?]A%/ZU^B-?G5_P2SGCTGX@?&+0+F18]2BOA(;=CA]H8J3CV(K
MW+]M#]H#Q9\(?$?PKT#P5<69U?Q-J_V:YM9H?.D-N&CR0H((X+\^Q]* ZGU'
M7YD?\$[O^3W_ (Q_]@^\_P#2Z"OTWK\R/^"=_'[<'QD_[!]Y_P"ET% (_3>N
M1^+O_)+?%O\ V"[G_P!%M775R/Q<!/PM\6X&?^)7<_\ HMJ!'QK_ ,$>_P#D
MB'BS_L-_^V\54?\ @L1:W#?"WP1<*#]F75I(V]-Y@<K^BM5[_@CV#_PH_P 6
M''']N?\ MO%7T+^VA\"7_:"^ >N>'K.,2:Y:[=1TL'O<1@_)]70N@]W%!74]
M'^$MQ#=?##PI-;X,#Z9;E,=,>6*ZROB[_@G9^T_I_C+X?VOPR\3W4>E>.?#(
M^P):7A\N2[A0[5*ANKKT9>O?&*^T:"0HKXW_ ."B'[1TW@7P79_#SP3JKCXB
M>)+F*WCBT]LSVL);[QQDJS';@>@8]*^GOA7H-_X7^&_AO2M5O+B_U2VL(EN[
MBZ;=(\VT%\GO\Q(_"@#XL^,W[1OQ+_:-^.5[\&/@;>#P_;:29!K7B1R,E5P&
M*M@E$!(4;?F9B.5%:VC_ /!+NSUB%9_'WQ:\9>(]2?YII+6[\I"?0>;YI_6O
M+/V =4M/A+^UY\5/"'BVXCTO7+XS16SWC;#.XG#^6I/4E>1Z[>.:_3J@H^)=
M6_X);?"W2='O;J#Q9XZMVMX'EW)JL(^ZI//[CVK@?^"0T<4-Q\9(X'>6!+RQ
M6.20Y9E!NP"3W)&,U]/_ +7/QPC^&/P[N-#T79J?COQ&#IFD:1"0\S/("&E9
M!R$52237S!_P2%TN;0YOC)IUPP>>RO+"VE93D%T-VI(/U!H#H?HQ7YX?\% ^
M?VP/V=\_\_"?^E<=?H?7YX_\% @?^&P?V=N/^7E/_2N.@2/T.KPG]NBWGNOV
M2_B5%; F8Z<I&WK@31D_H#7NU8WC+PM9^./">L>']07=9:G:R6LO&<*ZD9'N
M,Y_"@1^6G[$_[,GQ(^+GP8?7?!_QIO\ P'I?]J7%N^DVMK(Z>:JQEI,K,HRP
M*]NPYKWS_AA3XY?]'.:Q_P" ,W_R17 ?L4_$Y/V0?BQXN^!?Q(E_L2SN;[[3
MH^IW1V6[,> 2YXVR)M^?H&0@]:_2*VNH;RWCGMY8YX)%#))&P96!Z$$<$4%,
M^'/^&%/CE_T<YK'_ ( S?_)%='^SC^PGXD^"_P =I?B7X@^)?_"97]Q936EP
MLNG-%+,7\L!FD,K9P(P,8]*^H?B%\1/#WPM\*WWB'Q-JEOI6F6D;.TMPX4N0
M,[5'5F/8#)KYF_84^*WQ&_: UKQ]X_\ $6I7*>!)[]K7P[I,D,:+&H9BQR%R
MVU3&N<D;@_I0(^O:***!#)O]4_\ NFOS=_X)O7$,?[57QWA<CSI+B0Q^N!>3
M[OYBOTBDYC<#DX-?CE^SC\0KKX._M:^/_'-PKGPIIVL7-CKSHI8P07-U(J3%
M1V1H^3VW4%+8_9"BJ&AZ_IOB?2[?4M(O[?4]/N%#Q7-K*)(W!]"#3/$7B32_
M"6CW.JZUJ%OI>FVR&2:ZNI B(H&3R?ITH)/SX_X*8;;O]H'X&65N,ZE)/E-O
M7:;A /UKO_\ @K1;SM^S=83(";>+6K?S?3G.W]<UXS\)]=N?VX/V^H?&HM)Q
MX(\''S[,LA"HL1S!N/(W/(%8KGI7W5^U%\&8_CW\$/$GA E5O+B'SK*1NB7*
M<QG\^/QH*/CGX*_L:_%_Q9\)O">LZ-^T/J>AZ7?:=%/;Z;#9RLELC+GRP1.
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MLO\ Y$H_X4EJ7_15O'G_ (%67_R)7J-% 'EW_"DM2_Z*MX\_\"K+_P"1*/\
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MLO\ Y$H_X4EJ7_15O'G_ (%67_R)7J-% 'EW_"DM2_Z*MX\_\"K+_P"1*/\
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M_DY3X*_]<=:_]%VU &]_PI+4O^BK>//_  *LO_D2C_A26I?]%6\>?^!5E_\
M(E>HT4 >7?\ "DM2_P"BK>//_ JR_P#D2C_A26I?]%6\>?\ @59?_(E>HT4
M>7?\*2U+_HJWCS_P*LO_ )$H_P"%):E_T5;QY_X%67_R)7J-% 'EW_"DM2_Z
M*MX\_P# JR_^1*/^%):E_P!%6\>?^!5E_P#(E>HT4 >7?\*2U+_HJWCS_P "
MK+_Y$H_X4EJ7_15O'G_@59?_ ")7J-% 'EW_  I+4O\ HJWCS_P*LO\ Y$H_
MX4EJ7_15O'G_ (%67_R)7J-% 'EW_"DM2_Z*MX\_\"K+_P"1*/\ A26I?]%6
M\>?^!5E_\B5ZC10!Y=_PI+4O^BK>//\ P*LO_D2C_A26I?\ 15O'G_@59?\
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M% &S_P *3U+_ **MX\_\"K+_ .1*/^%):E_T5;QY_P"!5E_\B5ZA2T >7?\
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M]:7_ .D,=>W5XC\(_P#DXCXX?]?6E_\ I#'0![=1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 5XHG_)YEU_V(EO\ ^E]Q7M=>*)_R>9=?]B);_P#I?<4 >UT444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 5XA\5O^3E/@K_UQUK_ -%VU>WUXA\5O^3E/@K_ -<=:_\ 1=M0
M![?1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %>*_MB?\D US_K\TW_TN@KVJO%?VQ/^2 :Y_P!?FF_^
MET% 'M-+24M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M"HYH8[B,QRQK*AY*NH(XY'!J2B@ HHHH **** "BBB@ HHHH **** "BBB@
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M([4 0_\ !,WPGXP7X-^'=:_X3+_BD!+<K_PC?V&/[V,!O.QOZX.,]J\WTO\
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MR[%B)' )&. >!BK^D?&[5O%'[+8^)=E_9^FZQ;Z3)J-[:W,;RPQ20J6FA(#
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M]* /6J*\R'[2'PZ7Q)%H+>)%^VR78T]+C['.+-[GIY(N=GDE\\;=_7CK7IM
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M\#W7@O\ :&^#_AS1O$6G^%-/TGPA-IVCWVK:<MW 9XVC5T16DC E,8C.0V<
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MX6\80#R+B1+6,GR9MVY0\3(HR,9!Q7V=8V-OIEG#:6D$=M:PH(XX8E"JB@8
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ML>2J,D;!E5=O%?7^H>"=!U6\>\NM'LI[UO\ EXD@5I/;YL9KQ'P=X!\7^ ?
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)BB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>syk-20221231_g3.jpg
<TEXT>
begin 644 syk-20221231_g3.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_!3GX4?$GQ9JEQKO@[X-+9W)NKV5FL[R/2/$@E"%F)4K(N,C!^0&D_X*,_\
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M[JFJ:%X2\,V6E:/J6MW:SWEU;00K'')-(J('D90"S!5!)S@5^/7Q \%_$/\
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MQ \-_P#!P!^W7XO\1>!=9L-)U:_0Z5JE[IDL5M>#[:3F*1E"R<<_*30!Y_\
M$GX5:3\'?^#H_P#9-_9 T?Q'KFI^"_#_ .RTWAL6FM:FTKZA:6VA^);57NB@
M1)97CB4NX5<MR . .C_X-N_'OC+]CW]L[]JC_@CE\:?&-]>3^ ?%<GBGP1<Z
MU>,\MQI9,<$DQ:0Y"O;/I4X4<#SI#ZD[O[3?PZ^(-]_P=^_L[?$>Q\"ZS-X>
MLO@C?07FO1:9*UE!*=/\3@(\X78K9D08)!RZ^HKQ'_@Z ^!?[3W[+G[;/@G_
M (*1_L3^#M:O=4\?_#77/A_XV/A_2)[IHGDL9K6.YD6$$AVMKS]VQX5]-B..
M,$ ROV,M9\8_MZ7O_!2__@L#JOB'4Y/#3?#;Q?X-^%&;N00QVT6CRMYT:9VQ
MRI9V^F_,HSFZEYY.?D__ ()M_"+_ ((+_%7]D/P[XW_X*%_\%.?BUX(^*UU=
M7ZZ_X;T3Q'<K;6T27<J6S*!IEQR\"Q.?WK<L>G0?L;^SQ^PWJ?[$W_!MAXI_
M9GA\,3GQ;=_LZ>*-2\2V,%LSW,VMZCI-U<30;5&7>-Y5ME &2(4&*_./_@DA
M^WU_P3__ &-_V$O"G[/W[8W_  1K^*_COX@:/>ZG+J_B:T_9XTK5([E)[Z>:
M!1<7T\<[[(I(TPR +MP,@ T ?LS_ ,$B/A+^R3\(/V%?"^D_L.?&CQ)\0?AI
MJ=[J&HZ!XK\57QN+N\+W4D<P+-;P-M6:.1 #&"-O<8-?E?\ \'*=A\%/&7_!
M;#]G#X8_M4?'37? 'PLUCX;NOC+7]$ULV3V<(O-1*R!RDBJ3(L:Y,;<''N/U
MG_X)F_M4? W]KG]F"W^(/[.G[-WBOX4>%-,UNZTFQ\&^+O!UMH4]N\>R9Y([
M2UEDC2)VG)# C<V\D9Y/Y[_\%<?V<8OCY_P<@?LC6'Q ^ Z^-/ +^"9K?Q-#
MK/A?^TM'8";57$=T)(WA(W>6P63OM/I0!U7_  1S_86_X(I^%?VNXOC%_P $
M]O\ @H7\0?BIXT\(Z%=S7/A_5_'4-_9Q6EPGV5YI8EL82<&8!2'X8@X-?G5^
MQ]^SO\1/VP?^#=C]J77= \4:U<>+/A?\<I_&&@W$>HS>=Y-EIMM]LA#!MQ0V
M<MTP0<%T3C(!']%7P2_8O_8[_9GUZ[\4_LX?LG?#3X?ZGJ%I]DO]2\$>!-/T
MJ>Y@W!_*DDM849TW*K;22,J#C(K\T?\ @T:^$?BSPS^Q3\</!WQ?^&NIZ9%J
M_P 9;X/IOB'2);?[9:R:;:(WR2J-\;#<I."#R* )OV@/^"Q3ZS_P:W0?MDVG
MBPKX]\:>!H? #3I/MG_X2*0MIM],ISE)!%%=WJ=\!".H-?#_ /P55_9FO_V)
M_P#@DC^PC\&?BYX]U_1+G7_%]WK/Q2U6'4IDO('U%+6XN5=AN)>V@E$(^5A_
MHXX/?D_V?/\ @FG^UE>?\%2]"_X(L>./!'B";]GSX?\ [1FH^/IK^^TB<V-[
MIT=I%)"7N&'ED3V4$, 52<27LG<DU]Y_\'<GA;Q)J^C?LP>*=,^$>O\ C'2_
M#OQ2NM0\0Z7H&@/J+O9QK:/(C1@%3O5&4!R%8\$XS0!X%\&?V.O^#7GQC\8/
M"GA'X7_\%<OC=J_B75?$MC9^'=*?Q1< 7M]+<(EO =VBJN'D9%Y91\W)'6OW
M[\4>&= \:^&=1\&^*]*AO]+U:QFLM2L;A<QW%O*A22-AW5E8@^QK\>M!_P""
MW'_!'OPQKEEXE\,_\$)/C5IVI:==QW.GZA8_LP>'X9[6>-@\<L<B7H9'5@&#
M @@@$'(K]DZ /P-^&_[:7CS_ (->OVL_C=^QI^T;)XB\8_!_Q=H-YXU_9]U&
M]GEN7EOPA6'3WE.2@D*+;3N?N/;12A LY)Z?]G#]C3X^?#K_ ((B?M6_\%._
MVPO%&KW7QJ^/_P +M=UU%N[F5&T#1YHGN((HH]W^CM.Q28HN-D:VT>%,; ^H
M_P#!V7\'/$?Q8\-_LPCPQ\++[Q*]G\9-FH?8-#>\,%G(D/FK)L1ML3;%W _*
M=@SG K[B_P""RF@:QXA_X)0_M!>&_"^B7-]>W7PFUB&RL+"V:669S;.%1$0$
ML3T  S0!^!'[ ?P6_P"#?+XD_LA^#/&_[<W_  5(^+W@_P"*U_:W+>+_  WI
M'B2Y6VLI5NYTA5 -*GP&@6%S^]?ECTZ#]UOV5?%O[&?_  3P_P""0]K\6_@+
M\7-?\:?!OP-X,U?Q/HOBCQ-?^=?ZM;//<WI4R-#"6=YI&AC4QJ>8UP3R?R?_
M ."87_!1;_@G'^RG^PE\/OV?OVJ_^"+?Q9\9_$#PY97D7B/Q-;?LYZ1J,=\\
ME]<31L+B\N(YY=L4D:9= 1LP,@ GUK_@L#^U[K7_  40_P""<WP._8G_ .">
MW[*_Q \!Z?\ 'CXDQZ->^'=<\!C3/[ TG3[Z.-1<P6;R0VD$EY)!,K;P#':2
MD@#H ?*7_!*W]HK]L#]C3_@H#\"?^"EW[6?C6]D\ _MJ:[XDTO5UNKF7R+.2
M?5!&DK*[%(4%VUK,C8&+?S-ORY-?9G_!X)=V)L?V6/#WB3Q[J'ASP_J_Q.OK
M3Q)J>GZF;1H+%Q8K-*9/NKLC9VW,"!C)!KS#_@HQ_P &VW[?/A[_ ()Y7FFM
M_P %4M=^+NB?!/P\-6\"?"A_A2E@H2QMS&8K6:/49G21;7S=BB-S(RJN,L&&
M%_P4T^(OQ=_X*4_L1?\ !/7XE^/_ ('^)=4UX_$8Z5\5=&O_  O<.R75O+86
MMW+=0M'\D-P(VG&X;2DV,G!H \3_ ."DWP9_X)<?L,_![1OC+_P2+_X*Z_$[
MQ5\;(/%UA#H6@:+\2XM7-U"[-O.+&VB,;*0I&YRKY\LHWF C^DK]G[6?B3XC
M^ W@CQ#\9M(&G^,+_P (Z;<>*[!8]@MM2>UC:ZBVC[NV8NN.V*_'?_@L+_P3
M'\2?\$K_ -H#P#_P6*_X)&? #3K3_A%-4@LOB9\+/#N@"6RNK620*MU!:HC>
M2C@^1*85!C9H9D"LLCU^P'[.'QU\*_M-_ CPI\??!6FZC9:;XKT6&_AT_6+)
M[>[LF88DMIXG *2Q2!XW'3<AP2,$@';4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 445^&7_!;GQ]_P7K_ ."5
M_P 'KK]K:V_X*U6>M>&->^)0T70_"6G_  OTB*;3H+F.\N8%::6U?S!'';",
MD\L2#GK0!^YM%?G1\'=8_P""C7_!,O\ 9_\ B5^WA_P4Y_X*'V?QM\":!\-&
MU+2O"&F>!++1YX]19X6@ GAB7<TA86X#94-,&(XKYN_9,\,_\'(/_!67X+1?
MM[>'_P#@HSX9^!'A_P 4RW%U\-OAYIO@V"Y@:T25DC>=VB:18G9#M>4W#LOS
M[0K*I /VHHK\H?\ @G9_P4-_X**_\% ?A5\??^"9_P 5_B9HGPI_:V^#MY!9
MQ?$>PT&"ZL[NW2^2.:\^QLIA9\1M&2JK&Z7D,B(O('S;XQ^('_!PEX0_X*Y>
M%/\ @DQ/_P %B+*?6?%7@J3Q'#XR3X4:.+:WC2WO)O):#[+O9B+-AN#8^<<<
M4 ?OA17S/\/O%_QR_P""=W_!._Q+\6?^"B?[2MK\4_$7P_T75]=U_P 8V>AP
M:4+^WC\R6"U2")502;=D*X&69AU)K\S?^" W_!:;_@H3\:?V[-,_9_\ ^"E7
MCB2[T?XZ^ +CQ/\ !=;K1+*R2$P7=V D)MX8V:*6*UO0OFL[$VD6/]9E@#]R
MJ*_-C_@K_P#M^?M;?LM_\%0OV*OV=?@3\6?["\&_%OQY_9WQ"T?^P;"Z_M6V
M_M+38?+\VX@DE@_=W$R[H7C;Y\YR 1^D] !17SS_ ,%9/C3\3OV<_P#@FS\:
M?CI\&/%+Z)XK\+> ;W4- U:.VBF:TN8URD@29'C;'HRD>U?F7^Q]X/\ ^#CS
M]K_]@?PU^WEX$_X+0^&-'@\0>'[S5[;P[XC^&.CQI;K;2SQE)KD63(JDP9+%
M-H5LGIR ?MU17XE^"/\ @N)^VY\?_P#@V6^+O[>UMXHMO"_QC^&WC33O#,?C
M'2=$MO*OMVJZ(&NEMIHY(%=[;47A=0FT,K.H3*A>H_98^ W_  <&_M0?LS_#
M_P#:1L/^"\_AC1(/'O@S3?$$.CWGPFT:26Q6\MHYQ [" !F02;20!DCH* /V
M,HK\\_VL_P!D[_@MO=?"WPEXK^!G_!7/1_#$W@[X6)'X]F;X7Z==?\)1K4!N
M)IM2C\R%A;K+&84$:X5?+R!R:^2_^"(7C3_@O%_P4]^$FB?MBZS_ ,%9K/3?
M".D?$C^S/$'@N_\ AAI,DVIVMHUK-<1B>&V3R_-BF:,$<J><T ?N!17YI_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/PS\8R-X:\$W>IVQA.JC[1;.9%7INCAL;=I!D[7N@N20V-7XV?\ *Y?\(/\
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M7QUX*\-_#?QI^Q'\*]6\/^#8+F'PEHNH^!;&:UT:.XE\Z=+6)XBL"R2?.P0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@>%/#6EZGX6'@JQU,Z&FF:7/=6L&KS7^]Q;2B\GN,V_D/MF+>:Q7%>L>)_\
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M .U>X_V=I_\ SXP_]^A7B/\ P3W_ .2)ZM_V/>L_^E)KW2@"'^SM/_Y\8?\
MOT*/[.T__GQA_P"_0J:B@"'^SM/_ .?&'_OT*R?!MK:SZ5(\]M&Y%W* 70$X
MW=*W*Q_ _P#R")?^OV;_ -"H TO[.T__ )\8?^_0H_L[3_\ GQA_[]"IJ* (
M?[.T_P#Y\8?^_0H_L[3_ /GQA_[]"IJ* (?[.T__ )\8?^_0H_L[3_\ GQA_
M[]"IJ* (?[.T_P#Y\8?^_0H_L[3_ /GQA_[]"IJ* ,CQ99VD/AN\EAM8T982
M594 (JY86%BUC"S641)B4DF,<\5!XQ_Y%B]_ZX&KFG?\@^#_ *XK_(4 ']G:
M?_SXP_\ ?H4?V=I__/C#_P!^A4U% $/]G:?_ ,^,/_?H4?V=I_\ SXP_]^A4
MU% $/]G:?_SXP_\ ?H4?V=I__/C#_P!^A4U% $/]G:?_ ,^,/_?H4?V=I_\
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M )%B]_ZX&KFG?\@^#_KBO\A5/QC_ ,BQ>_\ 7 U<T[_D'P?]<5_D* )J***
M"BBB@ HHHH **** ,?Q+_P A?1_^OT_^@FMBL?Q+_P A?1_^OT_^@FMB@ HH
MHH **** "BBB@ HHHH Q[+_D=[W_ *\HOYFMBL>R_P"1WO?^O*+^9K8H ***
M* "BBB@ HHHH **** ,?P/\ \@B7_K]F_P#0JV*Q_ __ "")?^OV;_T*MB@
MHHHH **** "BBB@ K-\8_P#(L7O_ %P-:59OC'_D6+W_ *X&@"YIW_(/@_ZX
MK_(5-4.G?\@^#_KBO\A4U !1110 4444 %%%% !1110 4444 %%%% !1110
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M1_PDNK_]"A>_]]+6Q10!C_\ "2ZO_P!"A>_]]+1_PDNK_P#0H7O_ 'TM;%%
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M2/\ GYO?_ MJ/^$'TC_GYO?_  +:@";QC_R+%[_UP-7-._Y!\'_7%?Y"N?\
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MENKA/BSKJZWX=U&XF=IG9(;J>.Y@9V=BEOI]S!$"W$#\"OK>OCC]F[_@A_\
ML4_![QG'\:OC!X4N_BW\0ENY[FT\0_$O4)=8M]#$LS2BUTRSN"UO901%ML6V
M/S%"K\_' !N?\$W_ /@IA?\ _!0$ZW_9_P"S9XOTG0M(YTGXHKI5Q#X6\4Q9
M4"33I-0BM;QR<DE#;%$VD><_!;ZKI%544(B@ #  '2EH ***^.H_VMOVSKO_
M (*S>#?V</&?PNT[P5\)=<\'>,I]$BN=0M[W5O$UQI-SI<2ZG+Y09;*U87O[
MB$2>:X9WF5#Y<:@'V+17YC>//^"D_BSQ7^V!\8O VK?\%,K+X*^%/!?Q2MO!
M?ANQF^# UFR61-.T\SSW^KO']FL3)?W%S%&MQ+'Q%QQ@UZY\4/C+^W%^T3\>
M/C_HG[*?Q_TOP!H_[/L-CINDZ7<^#K75(_&&ORZ1%JTT=])/^\@LUCN;6W"V
MQCEW-+(9" J4 ?;M%><_L@?M V'[5_[*?PW_ &F]-TG^SXO'_@C2]?\ [.+[
MOLC75K',\&[^+8SLF>^W->C4 %%9/CKQ#JGA3PC?^(]$\*W>N7=I 9(-)L64
M3739'R(6XS]?2O(?^&L/C9_T8_X[_P# JV_^*H /^">__)$]6_['O6?_ $I-
M>Z5\X?\ !/'Q3K,OP-U*5_!=\C/XTU5V0LN4+3;BI]U)*GW4U[O_ ,)+J_\
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MQ$U=#N-]XVU-KB(-WQ;Q[(BOLZOCUKJ^J82C_&K*_:"YG]^D?N;.?Z]CJ_\
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M*** "BBB@ HHHH *S?&/_(L7O_7 UI5F^,?^18O?^N!H N:=_P @^#_KBO\
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MM_V/>L_^E)KW2@ HHHH *Q_ _P#R")?^OV;_ -"K8K'\#_\ ((E_Z_9O_0J
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M[Z%&;(O=<N8B D"?+;"1)963:B,OCC]G?XLM^U3^T9\>_P!EK_@I?H_@C6=
M\*>&M+U/PL/!5CJ9T--,TN>ZM8-7FO\ >XMI1>3W&;?R'VS%O-8KBO6/$_\
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MLAZ3/XAA^)7[0WBN?X@>*4.Z"34XPNGZ><YVVUJ/D4 ]V!R0& 4U[* % 50
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MK8HH Q_^$EU?_H4+W_OI:/\ A)=7_P"A0O?^^EK8HH Q_P#A)=7_ .A0O?\
MOI:/^$EU?_H4+W_OI:V** ,?_A)=7_Z%"]_[Z6C_ (275_\ H4+W_OI:V**
M.4M=<U%?%-U=+X;N6=[:-6@#+N4 GDUI_P#"2ZO_ -"A>_\ ?2T67_([WO\
MUY1?S-;% &/_ ,)+J_\ T*%[_P!]+1_PDNK_ /0H7O\ WTM;%% &/_PDNK_]
M"A>_]]+1_P )+J__ $*%[_WTM;%% &/_ ,)+J_\ T*%[_P!]+1_PDNK_ /0H
M7O\ WTM;%% &/_PDNK_]"A>_]]+1_P )+J__ $*%[_WTM;%% '*>%=<U&UTZ
M2.'PW<S@W,C%T9< ENGX5I_\)+J__0H7O_?2T>!_^01+_P!?LW_H5;% &/\
M\)+J_P#T*%[_ -]+1_PDNK_]"A>_]]+6Q10!C_\ "2ZO_P!"A>_]]+1_PDNK
M_P#0H7O_ 'TM;%% &/\ \)+J_P#T*%[_ -]+1_PDNK_]"A>_]]+6Q10!C_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MJ*\%_P"'=7P/_P"AN\=_^%?/1_P[J^!__0W>._\ PKYZ />J*\%_X=U? _\
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M*\%_X=U? _\ Z&[QW_X5\]'_  [J^!__ $-WCO\ \*^>@#WJBO!?^'=7P/\
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M7AMBKO%=?9K&:_GD:5%*0PI;6\LAFE9(_N+NW2(K<+^SQ_P4._8U_:L\8R>
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M/1;[2K];.5BL=VMM?P0RRV[,-HG16C)P-V2* /7:*** "BBB@ HHHH ****
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MR\,:WXN\;> 9[G0[&\T:]T^XL+/3HK:&9KC2YX8[";)^U32RI.LGFC 5<?\
M8@\1_#3_ ()]?LP?MP>*/A7X"T_2/#_PP^._B.?PSX8TJU$<)>#POH)MK.)%
MZM+-LC'=GDY)))K[2_9U_91_9[_9.\/:CX:_9_\ AG:>'X=9U W^MW0N)KJ\
MU.ZVA/.NKJY>2>Y<* H:5V(4 # &*9J'[)/[.NI^'O$WA2\^&%H=.\9^-[7Q
M?XIM8[F=%U/6K>6SEBNY=K@L0VGV>8_]6ZPA65E9@P!\6?\ !1/_ ()[_![P
ME_P0RUGPO\8_#(\2>)/@M^SMK\NEW5[?3-:C7Y-(+7>JO;!Q!-=&X266.:1&
M:%II#$4+L3N_MIV7Q!\=_M*?L9?"_P#9]\2Z9X4^)T&E^(/$?A_QQXELC?Z5
M8Z;;:1:VFHV<FG!HFOYKA-0AV+'/;O$(7D\S */]O?%'X8^ _C5\-]=^$/Q2
M\-0:SX;\3:3<:9KVDW)81WEI/&8Y8F*D-AD8@X(//6N5^.O[(?[.'[2W@W1O
M ?QK^%EGK-AX<NDN?#L@N9[6[TF9(S&);6ZMW2>W?RR4+1R*64D'(.* /GS_
M ((Z6^M>#;#]H#X,_$>]@U;X@^&OV@-4N?B+XLTHA=,\0:EJ%C8WZ7-I"%'V
M)5M9[:![0M(T4D#;I92Y<_9=<;\"/V>_@M^S'\/X_A=\!OAWI_AK0TNYKN2T
ML58M<7,S;I;B:5RTD\SMRTLC,[8&6.!794 <7\?OV?/A1^U!\-;GX._&[P[+
MK/AB_N89=3T9=1GMH;]8G$BPS^0Z&:!F4;X6)CD VNK*2I^*?^">#_LF?#G_
M ((G^&/&O[5ECH=C\._ 7C?Q)K>S4+<_9;*>Q\:ZE+8^5#$,R2+<) (855B\
MGEHJ,2%/Z%5XYXX_X)^?L<_$C]GFW_90\:_ O3+[X>6FM2:M;^%FNKA($O7N
MIKMIMR2!RQN)Y9>6P&?(' P ?+]WXG^._AV#XS?\%I/C!\,+KP/J<7P7?PG\
M$_A=J,:?VM]C%R]U:3:L 2L=]>ZA+;(EH"1;1D(Y,CR!?2_!7[/WAWX+?#;1
M/V3/V2?BG\._#7[1W@WX(:)I4OBWQ3X2?5[PZ$DTJ?:)(DGMWECEODNY QD9
M%F=W>-\[6ZSX<_\ !);_ ()Y_"6_EU+X>?LX6>FRSW.GSS[-=U&197L=0MM2
MM=ZR7#*RI=V=M-M(*L8@&#*2#V?[1_[#/[*G[6VJ:7K_ ,??A%;:UJFC6LUK
MINL6VHW6GWL5K,09;;[39RQ2M Y4%H68QL1DJ: /C/\ 94^ /[.G[3W_  0R
M\/\ @KXD_"N6_P!-^%6E>*+.+2+[Q!+>:;J&N:1<:C9RZB?*6&&_MWN8I;F%
M)(C%&73:@:)2-SP0?^%B?\$LOV&_V3;;]XWQ5T#X=6^LP#OHFE:+;Z[J&_TC
MEBTU;1CW^W*O5A7W%X8^"_PG\$_"2W^ W@OX?:5I'@RTT8Z3:>&M+M%M[2"R
M*&,P)''@*I4D<8/)/7FLSPI^S1\#? ][X$O_  I\/[>R?X9>%)O#7@1(KF8Q
MZ/I<L=I&]O&A<JV4L;5 [AG58R P#N& /DO]OC]FKX+^$?\ @HC^RY^TWI'@
MX-X[\6_'Y-/U;Q%>WDUQ,EC!X.UU8[.W$KLMI;EHUE:&$(DDN97#.=U87Q/L
MOCI^S]^T]^UGXC^#G@CX:_$;P[\2=(TS4_&NL:S\0K>QN/AU)!X=CLS#K-HT
M4DLUBUK#]LB$?SE99EV@,)*^Y_'7P@^&OQ,U_P +>*/'?A*WU+4/!6NG6?"U
MU.S!M.OS;3VIG3:0"WD7,\?S9&)#QG!'G7QU_P""=O[%O[2_Q#'Q4^./P"TK
M7]<>R@L[^YFN;B&/5+:!VDAM[Z&&1(M0B1F8K'<I*B[B ,$T <M_P1UL_&=A
M_P $J/V=[3Q^+@:HGP?T'S5N\^:L1LHC"K9Y!$7EC!Y&,&OI*F6]O!:0):VL
M"111($CCC4*J*!@  = !VI] '%_'[]GSX4?M0?#6Y^#OQN\.RZSX8O[F&74]
M&749[:&_6)Q(L,_D.AF@9E&^%B8Y -KJRDJ?BG_@G@_[)GPY_P"")_ACQK^U
M98Z'8_#OP%XW\2:WLU"W/V6RGL?&NI2V/E0Q#,DBW"0"&%58O)Y:*C$A3^A5
M>.>./^"?G['/Q(_9YM_V4/&OP+TR^^'EIK4FK6_A9KJX2!+U[J:[:;<D@<L;
MB>67EL!GR!P, 'R_=^)_COX=@^,W_!:3XP?#"Z\#ZG%\%W\)_!/X7:C&G]K?
M8Q<O=6DVK $K'?7NH2VR): D6T9".3(\@7TOP5^S]X=^"WPVT3]DS]DGXI_#
MOPU^T=X-^"&B:5+XM\4^$GU>\.A)-*GVB2))[=Y8Y;Y+N0,9&19G=WC?.UNL
M^'/_  26_P"">?PEOY=2^'G[.%GILL]SI\\^S7=1D65['4+;4K7>LEPRLJ7=
MG;3;2"K&(!@RD@]G^T?^PS^RI^UMJFEZ_P#'WX16VM:IHUK-:Z;K%MJ-UI][
M%:S$&6V^TV<L4K0.5!:%F,;$9*F@#XS_ &5/@#^SI^T]_P $,O#_ (*^)/PK
MEO\ 3?A5I7BBSBTB^\02WFFZAKFD7&HV<NHGREAAO[=[F*6YA22(Q1ETVH&B
M4C<\$'_A8G_!++]AO]DVV_>-\5= ^'5OK, [Z)I6BV^NZAO](Y8M-6T8]_MR
MKU85]Q>&/@O\)_!/PDM_@-X+^'VE:1X,M-&.DVGAK2[1;>T@LBAC,"1QX"J5
M)'&#R3UYK,\*?LT? WP/>^!+_P *?#^WLG^&7A2;PUX$2*YF,>CZ7+':1O;Q
MH7*ME+&U0.X9U6,@, [A@#X__:QT'PI^U$?B=_P2E_8/^'EC:KXYUFYN/VE/
MB6EMNTOPH-2"27R!FR+W7+F#:([=.+<.DLK1A41KG[/6D?#_ ,-?M%?M\Z'\
M4F@^Q6+>'8=0_M20,/\ A%T\$VJP[R_6'>-2R3P7\_/.ZO3/%?\ P1=_X)C>
M-O&FN_$3Q-^REIEQK7B;6KG5]>OUUS4HVO;ZXD,DT[A+D#>[L22!7;?&[_@G
M+^Q/^T=X@TWQ3\:?V?\ 2M<O],T:+2(YY+JYA^UZ=$^^.QNUAE1;ZV5\L(+D
M2Q@LQV_,V0# _P""0H\8C_@EA^SN/'HN!JH^#7AWSQ=Y\W9_9\/E[\\[O+V9
MSSGKS7T74=K:VMC:QV5E;1PPPQA(88D"JB@8"@#@ #@ 5)0!\(_\'!_[-7P7
M^)W_  3Q^(WQU^(7@T:QXB\">#YCX0EO[R9[;2YIKFW62YCMB_D?:=GR+.4,
MB*65&4,P/LW[:?QM^!'[,?CKPE\6YO@Y<>/?CAKFGW_A?X0^$=!4-J^L><T%
MQ=P1,Y\NTM%,%O+<WDF(X8XP68DJC^R?%_X0?#7X^?#75_@]\8/"5OKOAG7K
M;[/J^D7;,([J+<&VL4(;&Y0>".E><?M-_P#!.K]B_P#;)\8:3X__ &E_@58^
M*M9T+3Y+'2-0N=1NX'M;=WWO&OD3(,,V">,G ]!0!\O6'[+GC_X3_#?X:?LF
M_%_7],U/QW^T3^TO/\2?BY;Z!&RZ99Q6;_V_>6MJ'&]K19=/TNP+-\TQNF=@
M/-8#*_X*M6_@S4_V$OB%\5?V6_%WP\;X0>"OB'<^(/V@/!&D:2;/5?%6KZ;K
M5O<ZC:1ZGO*6-XUQ;@/NM9)9I-JK+%N#5]@_ 3]@?]D?]F#5].UWX%_!VWT&
MZTBVU.#3)$U2\N!;)J#6+7NU9YG4-*=-LLMC<!  " S!LOQC_P $T?V%/'_Q
MFE^/OC#]G#1+[Q-<ZQ!JU_+)+<"SOM1@"B&]N;%9!:7-RFQ-L\L32 HI#948
M /G[_@K+^SU\$]>\6_ +]KZ[\#27'CAOVC/AAI6F:OJ]Q/))I5@_B*VD>&W@
MD<Q6CR%OWK1HKR;55V8(H'I?Q1\/>!_VD?\ @H7JO@KXFVUI>>!OA'\"[U/$
ML%_-Y=J][XGF>!Q*^1M,6FZ3<ACD;8]4R3\PQ]#?$SX0?#7XR6.D:;\3?"5O
MK$&@^)+#Q!I$=RS 6NI64ZSVMRNTCYHY55QG(R.0:QM<_9B^!7B72_B-HNO>
M (;NU^+<9C^(D4UY.?[9C.GQ:=Y;'S,QQ_984BV1[%^\V-SNS 'RE\&-*/\
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M%\8[6Y?P#JWA_P 4V=]?1S1VOVJ"'5;$%3IC740/DEI) KE8Y_(<LJ\E9_\
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M#^YTKX;2>/="UC5]2M+J/5-"ANA:W,LD=L[M:S12/$3"Q8E) <@@K7(>$_\
M@JQ!XJU?X!RV/[,GB.ZT/]I6&XN/AAJ6G:[8-/%;16IOC)J4-Q) MJS6(:Y6
M.&6X8B-X^) JL ?7%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% 'SU_P %5/V7OBW^VK^P1\1?V4?@
MK=^'+37/'6C+IL6H^*=2N+:TLT,T;M(3!;SNY"H0%VC)(^85ZEIWP]U#QA\
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M1)ML/, CW@F7:6&W<WZ#44 ?(_QN^&'Q+^%W[9]]_P %+?BQ<>!]*^'/@O\
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MJZ/2*Q?&?Q$\$?#RR74/&GB6UT^.0D1"=_GDQUVH,LV/8&N1_P"&I/AY_P!
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !#^"GQ%B\4:)H5Y-9ZIJ.BV%S/'#<PG$UN-L>7EC/#QJ"Z9&X#(J_\  /\
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MS.CS,$QOVDJ>2M?^";OP,M=3BTL:]XA;P/;?$AO'EI\,&FM?[$AUXW!O/M
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M8>*I/$WBGX,Z=XGA7PIJ.KRN))KAH#;FXC2:0"26".=893\KHT9,9]M_::^
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MZ_"3]F_]H+]N']A+]L?]B7X/_#KPTUM\0/VRO']G>>-/%6N>7::)$NNP327
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M?=5^/WQ3\8>)_$4^O_""Y^&OB#PSJ+V(TK4M"N)3-.LL<5HDHE>0DETE4#)
M4#BO>** /D3X<_\ !(?PAX U'X0R7?[8OQEU_3O@3K,MY\,-)UO4='=-+MWL
MI;'["\L>FI-=0BVF>(&=WE5%54D0!MVG\&?^"3?PA^ ?Q@U#QM\,OCU\5;#P
M-J'BN7Q/_P *3'B>$^%+;5Y)_M+3PP_9_M$<?VD?:!;"?R/,Y*%<*/JBB@#Y
MO^*?_!,OX5_&#P'8>&O%OQC\?KXATOXJI\0=.^(UE<Z9%K]MK"$K$$G%@8A
MD&VU$?E?\>T:0L608/T796\MI90VL][+<O'$J/<SA \I P78(JJ">IV@#)X
M'%2T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
61110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631657679520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COVER PAGE - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-13149<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">STRYKER CORP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">MI<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">38-1239739<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2825 Airview Boulevard,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Kalamazoo,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MI<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">49002<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(269)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">385-2600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12gTitle', window );">Title of 12(g) Security</a></td>
<td class="text">None<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 70,965,162,853<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">378,831,249<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text">Portions of the proxy statement to be filed with the U.S. Securities and Exchange Commission relating to the 2023 Annual Meeting of Shareholders (the 2023 proxy statement) are incorporated by reference into Part III.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000310764<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock, $.10 Par Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $.10 Par Value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SYK<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=syk_SeniorUnsecuredNotes1.125Due2023Member', window );">1.125% Notes due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.125% Notes due 2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SYK23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=syk_SeniorUnsecuredNotes0.250due2024Member', window );">0.250% Notes due 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.250% Notes due 2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SYK24A<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=syk_SeniorUnsecuredNotes2.125Due2027Member', window );">2.125% Notes due 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">2.125% Notes due 2027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SYK27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=syk_SeniorUnsecuredNotes0.750due2029Member', window );">0.750% Notes due 2029</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.750% Notes due 2029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SYK29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=syk_SeniorUnsecuredNotes2.625Due2030Member', window );">2.625% Notes due 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">2.625% Notes due 2030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SYK30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=syk_SeniorUnsecuredNotes1.000due2031Member', window );">1.000% Notes due 2031</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.000% Notes due 2031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SYK31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12gTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(g) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection g<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12gTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=syk_SeniorUnsecuredNotes1.125Due2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=syk_SeniorUnsecuredNotes1.125Due2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=syk_SeniorUnsecuredNotes0.250due2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=syk_SeniorUnsecuredNotes0.250due2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=syk_SeniorUnsecuredNotes2.125Due2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=syk_SeniorUnsecuredNotes2.125Due2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=syk_SeniorUnsecuredNotes0.750due2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=syk_SeniorUnsecuredNotes0.750due2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=syk_SeniorUnsecuredNotes2.625Due2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=syk_SeniorUnsecuredNotes2.625Due2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=syk_SeniorUnsecuredNotes1.000due2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=syk_SeniorUnsecuredNotes1.000due2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631666018032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_AuditorInformationAbstract', window );"><strong>Auditor Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">42<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Ernst&#160;& Young LLP<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Grand Rapids, Michigan<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_AuditorInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Auditor Information</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_AuditorInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631661341296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements Of Earnings - USD ($)<br> $ in Thousands, shares in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="nump">$ 18,449,000<span></span>
</td>
<td class="nump">$ 17,108,000<span></span>
</td>
<td class="nump">$ 14,351,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of sales</a></td>
<td class="nump">6,871,000<span></span>
</td>
<td class="nump">6,140,000<span></span>
</td>
<td class="nump">5,294,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">11,578,000<span></span>
</td>
<td class="nump">10,968,000<span></span>
</td>
<td class="nump">9,057,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research, development and engineering expenses</a></td>
<td class="nump">1,454,000<span></span>
</td>
<td class="nump">1,235,000<span></span>
</td>
<td class="nump">984,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">6,455,000<span></span>
</td>
<td class="nump">6,427,000<span></span>
</td>
<td class="nump">5,361,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductLiabilityAccrualPeriodExpense', window );">Recall charges, net</a></td>
<td class="num">(15,000)<span></span>
</td>
<td class="nump">103,000<span></span>
</td>
<td class="nump">17,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">627,000<span></span>
</td>
<td class="nump">619,000<span></span>
</td>
<td class="nump">472,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="nump">216,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">8,737,000<span></span>
</td>
<td class="nump">8,384,000<span></span>
</td>
<td class="nump">6,834,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">2,841,000<span></span>
</td>
<td class="nump">2,584,000<span></span>
</td>
<td class="nump">2,223,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="num">(158,000)<span></span>
</td>
<td class="num">(303,000)<span></span>
</td>
<td class="num">(269,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings before income taxes</a></td>
<td class="nump">2,683,000<span></span>
</td>
<td class="nump">2,281,000<span></span>
</td>
<td class="nump">1,954,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income taxes</a></td>
<td class="nump">325,000<span></span>
</td>
<td class="nump">287,000<span></span>
</td>
<td class="nump">355,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings</a></td>
<td class="nump">$ 2,358,000<span></span>
</td>
<td class="nump">$ 1,994,000<span></span>
</td>
<td class="nump">$ 1,599,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net earnings per share of common stock:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net earnings per share of common stock (in dollars per share)</a></td>
<td class="nump">$ 6.23<span></span>
</td>
<td class="nump">$ 5.29<span></span>
</td>
<td class="nump">$ 4.26<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net earnings per share of common stock (in dollars per share)</a></td>
<td class="nump">$ 6.17<span></span>
</td>
<td class="nump">$ 5.21<span></span>
</td>
<td class="nump">$ 4.20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted-average shares outstanding (in millions):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">378.2<span></span>
</td>
<td class="nump">377.0<span></span>
</td>
<td class="nump">375.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Effect of dilutive employee stock compensation (in shares)</a></td>
<td class="nump">4.0<span></span>
</td>
<td class="nump">5.3<span></span>
</td>
<td class="nump">4.8<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">382.2<span></span>
</td>
<td class="nump">382.3<span></span>
</td>
<td class="nump">380.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductLiabilityAccrualPeriodExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of loss reported during the period pertaining to product liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductLiabilityAccrualPeriodExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631757238816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements Of Earnings (Parenthetical) - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive shares excluded from calculation of dilutive employee stock options (in shares)</a></td>
<td class="nump">4.3<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631657411360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Income - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings</a></td>
<td class="nump">$ 2,358<span></span>
</td>
<td class="nump">$ 1,994<span></span>
</td>
<td class="nump">$ 1,599<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss), net of tax</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Marketable securities</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Pension plans</a></td>
<td class="nump">186<span></span>
</td>
<td class="nump">104<span></span>
</td>
<td class="num">(80)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Unrealized gains (losses) on designated hedges</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="num">(57)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Financial statement translation</a></td>
<td class="nump">113<span></span>
</td>
<td class="nump">469<span></span>
</td>
<td class="num">(414)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income (loss), net of tax</a></td>
<td class="nump">310<span></span>
</td>
<td class="nump">626<span></span>
</td>
<td class="num">(551)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income</a></td>
<td class="nump">$ 2,668<span></span>
</td>
<td class="nump">$ 2,620<span></span>
</td>
<td class="nump">$ 1,048<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631660484272">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 1,844<span></span>
</td>
<td class="nump">$ 2,944<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="nump">84<span></span>
</td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, less allowance of $154 ($167 in 2021)</a></td>
<td class="nump">3,565<span></span>
</td>
<td class="nump">3,022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNetAbstract', window );"><strong>Inventories:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves', window );">Materials and supplies</a></td>
<td class="nump">1,006<span></span>
</td>
<td class="nump">691<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work in process</a></td>
<td class="nump">348<span></span>
</td>
<td class="nump">264<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">2,641<span></span>
</td>
<td class="nump">2,359<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventories</a></td>
<td class="nump">3,995<span></span>
</td>
<td class="nump">3,314<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">787<span></span>
</td>
<td class="nump">662<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">10,275<span></span>
</td>
<td class="nump">10,017<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_LandBuildingsAndImprovementsGross', window );">Land, buildings and improvements</a></td>
<td class="nump">1,739<span></span>
</td>
<td class="nump">1,656<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MachineryAndEquipmentGross', window );">Machinery and equipment</a></td>
<td class="nump">4,066<span></span>
</td>
<td class="nump">3,842<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property, plant and equipment</a></td>
<td class="nump">5,805<span></span>
</td>
<td class="nump">5,498<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less allowance for depreciation</a></td>
<td class="nump">2,835<span></span>
</td>
<td class="nump">2,665<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">2,970<span></span>
</td>
<td class="nump">2,833<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">14,880<span></span>
</td>
<td class="nump">12,918<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangibles, net</a></td>
<td class="nump">4,885<span></span>
</td>
<td class="nump">4,840<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Noncurrent deferred income tax assets</a></td>
<td class="nump">1,410<span></span>
</td>
<td class="nump">1,760<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other noncurrent assets</a></td>
<td class="nump">2,464<span></span>
</td>
<td class="nump">2,263<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">36,884<span></span>
</td>
<td class="nump">34,631<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Accounts payable</a></td>
<td class="nump">1,413<span></span>
</td>
<td class="nump">1,129<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation</a></td>
<td class="nump">1,149<span></span>
</td>
<td class="nump">1,092<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income taxes</a></td>
<td class="nump">292<span></span>
</td>
<td class="nump">192<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrent', window );">Dividend payable</a></td>
<td class="nump">284<span></span>
</td>
<td class="nump">263<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CustomerRefundLiabilityCurrent', window );">Accrued product liabilities</a></td>
<td class="nump">230<span></span>
</td>
<td class="nump">401<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Accrued expenses and other liabilities</a></td>
<td class="nump">1,744<span></span>
</td>
<td class="nump">1,465<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Current maturities of debt</a></td>
<td class="nump">1,191<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">6,303<span></span>
</td>
<td class="nump">4,549<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, excluding current maturities</a></td>
<td class="nump">11,857<span></span>
</td>
<td class="nump">12,472<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesNoncurrent', window );">Income taxes</a></td>
<td class="nump">641<span></span>
</td>
<td class="nump">913<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other noncurrent liabilities</a></td>
<td class="nump">1,467<span></span>
</td>
<td class="nump">1,820<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">20,268<span></span>
</td>
<td class="nump">19,754<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders' equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValueOutstanding', window );">Common stock, $0.10 par value</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">2,034<span></span>
</td>
<td class="nump">1,890<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">14,765<span></span>
</td>
<td class="nump">13,480<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(221)<span></span>
</td>
<td class="num">(531)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total shareholders' equity</a></td>
<td class="nump">16,616<span></span>
</td>
<td class="nump">14,877<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities &amp; shareholders' equity</a></td>
<td class="nump">$ 36,884<span></span>
</td>
<td class="nump">$ 34,631<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_LandBuildingsAndImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Land, Buildings and Improvements, Gross</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_LandBuildingsAndImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of all classes of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares exclude common shares repurchased by the entity and held as treasury shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CustomerRefundLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Current regulatory liabilities generally represent obligations to make refunds to customers for various reasons including overpayment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CustomerRefundLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. This amount is net of valuation reserves and adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MachineryAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MachineryAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126905020&amp;loc=d3e5879-108316<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631666032432">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parentheticals) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Accounts receivable, allowance</a></td>
<td class="nump">$ 154<span></span>
</td>
<td class="nump">$ 167<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631657338464">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements Of Shareholders' Equity - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss)</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37<span></span>
</td>
<td class="nump">$ 1,628<span></span>
</td>
<td class="nump">$ 11,748<span></span>
</td>
<td class="num">$ (606)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance, shares at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">374.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under stock compensation and benefit plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="num">(29)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under stock compensation and benefit plans, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings</a></td>
<td class="nump">$ 1,599<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,599<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCash', window );">Cash dividends declared</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(885)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(551)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(551)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance, shares at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">376.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Dec. 31, 2020</a></td>
<td class="nump">13,084<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
<td class="nump">1,741<span></span>
</td>
<td class="nump">12,462<span></span>
</td>
<td class="num">(1,157)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under stock compensation and benefit plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(22)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under stock compensation and benefit plans, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">171<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings</a></td>
<td class="nump">1,994<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,994<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCash', window );">Cash dividends declared</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(976)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">626<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">626<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance, shares at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">377.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Dec. 31, 2021</a></td>
<td class="nump">14,877<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
<td class="nump">1,890<span></span>
</td>
<td class="nump">13,480<span></span>
</td>
<td class="num">(531)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under stock compensation and benefit plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(24)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under stock compensation and benefit plans, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">168<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings</a></td>
<td class="nump">2,358<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,358<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCash', window );">Cash dividends declared</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,073)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">310<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance, shares at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">378.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Dec. 31, 2022</a></td>
<td class="nump">$ 16,616<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
<td class="nump">$ 2,034<span></span>
</td>
<td class="nump">$ 14,765<span></span>
</td>
<td class="num">$ (221)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631661158272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements Of Cash Flows - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings</a></td>
<td class="nump">$ 2,358<span></span>
</td>
<td class="nump">$ 1,994<span></span>
</td>
<td class="nump">$ 1,599<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net earnings to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">371<span></span>
</td>
<td class="nump">371<span></span>
</td>
<td class="nump">340<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization of intangible assets</a></td>
<td class="nump">627<span></span>
</td>
<td class="nump">619<span></span>
</td>
<td class="nump">472<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="nump">216<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_AssetImpairmentsOtherThanGoodwillImpairment', window );">Asset impairments</a></td>
<td class="nump">54<span></span>
</td>
<td class="nump">264<span></span>
</td>
<td class="nump">215<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">168<span></span>
</td>
<td class="nump">171<span></span>
</td>
<td class="nump">142<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductLiabilityAccrualPeriodExpense', window );">Recall charges, net</a></td>
<td class="num">(15)<span></span>
</td>
<td class="nump">103<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_SaleOfInventorySteppedUpToFairValueAtAcquisition', window );">Sale of inventory stepped up to fair value at acquisition</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">266<span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax (benefit) expense</a></td>
<td class="nump">58<span></span>
</td>
<td class="num">(237)<span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(579)<span></span>
</td>
<td class="num">(377)<span></span>
</td>
<td class="nump">354<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(762)<span></span>
</td>
<td class="num">(189)<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade', window );">Accounts payable</a></td>
<td class="nump">290<span></span>
</td>
<td class="nump">329<span></span>
</td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses and other liabilities</a></td>
<td class="nump">328<span></span>
</td>
<td class="nump">315<span></span>
</td>
<td class="num">(54)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_Changeinaccrualforrecallexpenses', window );">Recall-related payments</a></td>
<td class="num">(157)<span></span>
</td>
<td class="num">(221)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income taxes</a></td>
<td class="num">(238)<span></span>
</td>
<td class="num">(98)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other, net</a></td>
<td class="num">(107)<span></span>
</td>
<td class="num">(47)<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">2,624<span></span>
</td>
<td class="nump">3,263<span></span>
</td>
<td class="nump">3,277<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisitions, net of cash acquired</a></td>
<td class="num">(2,563)<span></span>
</td>
<td class="num">(339)<span></span>
</td>
<td class="num">(4,222)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchases of marketable securities</a></td>
<td class="num">(52)<span></span>
</td>
<td class="num">(49)<span></span>
</td>
<td class="num">(54)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Proceeds from sales of marketable securities</a></td>
<td class="nump">43<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="nump">61<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property, plant and equipment</a></td>
<td class="num">(588)<span></span>
</td>
<td class="num">(525)<span></span>
</td>
<td class="num">(487)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromHedgeInvestingActivities', window );">Proceeds from settlement of net investment hedges</a></td>
<td class="nump">197<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other investing, net</a></td>
<td class="nump">39<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(2,924)<span></span>
</td>
<td class="num">(859)<span></span>
</td>
<td class="num">(4,701)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt', window );">Proceeds and payments on short-term borrowings, net</a></td>
<td class="num">(375)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from issuance of long-term debt</a></td>
<td class="nump">1,500<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">3,292<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Payments on long-term debt</a></td>
<td class="num">(653)<span></span>
</td>
<td class="num">(1,151)<span></span>
</td>
<td class="num">(2,297)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Payments of dividends</a></td>
<td class="num">(1,051)<span></span>
</td>
<td class="num">(950)<span></span>
</td>
<td class="num">(863)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Cash paid for taxes from withheld shares</a></td>
<td class="num">(122)<span></span>
</td>
<td class="num">(114)<span></span>
</td>
<td class="num">(110)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other financing, net</a></td>
<td class="num">(48)<span></span>
</td>
<td class="num">(148)<span></span>
</td>
<td class="num">(27)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="num">(749)<span></span>
</td>
<td class="num">(2,365)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash and cash equivalents</a></td>
<td class="num">(51)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Change in cash and cash equivalents</a></td>
<td class="num">(1,100)<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="num">(1,394)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at beginning of year</a></td>
<td class="nump">2,944<span></span>
</td>
<td class="nump">2,943<span></span>
</td>
<td class="nump">4,337<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at end of year</a></td>
<td class="nump">1,844<span></span>
</td>
<td class="nump">2,944<span></span>
</td>
<td class="nump">2,943<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental cash flow disclosure:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash paid for income taxes, net of refunds</a></td>
<td class="nump">505<span></span>
</td>
<td class="nump">622<span></span>
</td>
<td class="nump">323<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest on debt</a></td>
<td class="nump">$ 324<span></span>
</td>
<td class="nump">$ 325<span></span>
</td>
<td class="nump">$ 304<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_AssetImpairmentsOtherThanGoodwillImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset Impairments, Other Than Goodwill Impairment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_AssetImpairmentsOtherThanGoodwillImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_Changeinaccrualforrecallexpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in accrual for recall expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_Changeinaccrualforrecallexpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_SaleOfInventorySteppedUpToFairValueAtAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale of Inventory, Stepped-Up to Fair Value at Acquisition</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_SaleOfInventorySteppedUpToFairValueAtAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableTrade</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromHedgeInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow for a financial contract that meets the hedge criteria as either a cash flow hedge, fair value hedge, or hedge of a net investment in a foreign operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 27<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3581-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromHedgeInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductLiabilityAccrualPeriodExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of loss reported during the period pertaining to product liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductLiabilityAccrualPeriodExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631666833552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Significant Accounting Policies</a></td>
<td class="text">SIGNIFICANT ACCOUNTING POLICIES<div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Nature of Operations: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stryker (the "Company," "we," "us," or "our") is one of the world's leading medical technology companies and, together with its customers, is driven to make healthcare better. The Company offers innovative products and services in Medical and Surgical, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Our products include surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling, emergency medical equipment and intensive care disposable products; clinical communication and workflow solutions; neurosurgical and neurovascular devices; implants used in joint replacement and trauma surgeries; Mako Robotic-Arm Assisted technology; spinal devices; as well as other products used in a variety of medical specialties.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Basis of Presentation and Consolidation: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Consolidated Financial Statements include the Company and its subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation. We have no material interests in variable interest entities and none that require consolidation. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Use of Estimates: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with accounting principles generally accepted in the United States (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities on the date of the financial statements and the reported amounts of net sales and expenses in the reporting period. Actual results could differ from those estimates.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Revenue Recognition: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sales are recognized as the performance obligations to deliver products or services are satisfied and are recorded based on the amount of consideration we expect to receive in exchange for satisfying the performance obligations. Our sales are recognized primarily when we transfer control to the customer, which can be on the date of shipment, the date of receipt by the customer or, for most Orthopaedics products, when we have received a purchase order and appropriate notification the product has been used or implanted. Products and services are primarily transferred to customers at a point in time, with some transfers of services taking place over time.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sales represent the amount of consideration we expect to receive from customers in exchange for transferring products and services. Net sales exclude sales, value added and other taxes we collect from customers. Other costs to obtain and fulfill contracts are generally expensed as incurred due to the short-term nature of most of our sales. We extend terms of payment to our customers based on commercially reasonable terms for the markets of our customers, while also considering their credit quality.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A provision for estimated sales returns, discounts and rebates is recognized as a reduction of sales in the same period that the sales are recognized. Our estimate of the provision for sales returns has been established based on contract terms with our customers and historical business practices and current trends. Shipping and handling costs charged to customers are included in net sales.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Cost of Sales: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cost of sales is primarily comprised of direct materials and supplies consumed in the manufacture of product, as well as manufacturing labor, depreciation expense and direct overhead expense necessary to acquire and convert the purchased materials and supplies into finished product. Cost of </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">sales also includes the cost to distribute products to customers, inbound freight costs, warehousing costs and other shipping and handling activity.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Research, Development and Engineering Expenses: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Research, development and engineering costs are charged to expense as incurred. Costs include research, development and engineering activities relating to the development of new products, improvement of existing products, technical support of products and compliance with governmental regulations for the protection of customers and patients. Costs primarily consist of salaries, wages, consulting and depreciation and maintenance of research facilities and equipment.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Selling, General and Administrative Expenses: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Selling, general and administrative expense is primarily comprised of selling expenses, marketing expenses, administrative and other indirect overhead costs, amortization of loaner instrumentation, depreciation and amortization expense of non-manufacturing assets and other miscellaneous operating items. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Currency Translation: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Financial statements of subsidiaries outside the United States generally are measured using the local currency as the functional currency. Adjustments to translate those statements into United States Dollars are recorded in other comprehensive income (OCI). Transactional exchange gains and losses are included in other income (expense), net.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Cash Equivalents: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Highly liquid investments with remaining stated maturities of three months or less when purchased or other money market instruments that are redeemable upon demand are considered cash equivalents and recorded at cost.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Marketable Securities: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Marketable securities consist of marketable debt securities, certificates of deposit and mutual funds. Mutual funds are acquired to offset changes in certain liabilities related to deferred compensation arrangements and are expected to be used to settle these liabilities and are recognized in other noncurrent assets. Pursuant to our investment policy, all individual marketable security investments must have a minimum credit quality of single A (Standard&#160;&amp; Poor&#8217;s and Fitch) and A2 (Moody&#8217;s Corporation) at the time of acquisition, while the overall portfolio of marketable securities must maintain a minimum average credit quality of double A (Standard&#160;&amp; Poor&#8217;s and Fitch) or Aa (Moody&#8217;s Corporation). In the event of a rating downgrade below the minimum credit quality subsequent to purchase, the marketable security investment is evaluated to determine the appropriate action to take to minimize the overall risk to our marketable security investment portfolio. Our marketable securities are classified as available-for-sale and trading securities. Investments in trading securities represent participant-directed investments of deferred employee compensation.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Accounts Receivable: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable consists of trade and other miscellaneous receivables. An allowance is maintained for doubtful accounts for estimated losses in the collection of accounts receivable. Estimates are made regarding the ability of customers to make required payments based on historical credit experience, current market conditions and expected credit losses. Accounts receivable are written off when all reasonable collection efforts are exhausted.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Inventories: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost or net realizable value, with cost generally determined using the first-in, first-out (FIFO) cost method. For excess and obsolete inventory resulting from the potential inability to sell specific products at prices in excess of current carrying costs, reserves are maintained to reduce current carrying cost to net realizable value.</span></div><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Financial Instruments:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Our financial instruments consist of cash, cash equivalents, marketable securities, accounts receivable, other investments, accounts payable, debt and foreign currency exchange contracts. The carrying value of our financial instruments, with the exception of our senior unsecured notes, approximates fair value on December&#160;31, 2022 and 2021. Refer to Notes 3 and 10 for further details. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">All marketable securities are recognized at fair value. Adjustments to the fair value of marketable securities that are classified as available-for-sale are recognized as increases or decreases, net of income taxes, within accumulated other comprehensive income (AOCI) in shareholders&#8217; equity and adjustments to the fair value of marketable securities that are classified as trading are recognized in earnings. The amortized cost of marketable debt securities is adjusted for amortization of premiums and discounts to maturity computed under the effective interest method. Such amortization and interest and realized gains and losses are included in other income (expense), net. The cost of securities sold is determined by the specific identification method.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We review declines in the fair value of our investments classified as available-for-sale to determine whether the decline in fair value is a result of credit loss or other factors. Impairments of available-for-sale marketable debt securities related to credit loss are included in earnings and impairments related to other factors are recognized within AOCI.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Derivatives:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> All derivatives are recognized at fair value and reported on a gross basis. We enter into forward currency exchange contracts to mitigate the impact of currency fluctuations on transactions denominated in nonfunctional currencies, thereby limiting our risk that would otherwise result from changes in exchange rates. The periods of the forward currency exchange contracts correspond to the periods of the exposed transactions, with realized gains and losses included in the measurement and recording of transactions denominated in the nonfunctional currencies. All forward currency exchange contracts are recorded at their fair value each period.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Forward currency exchange contracts designated as cash flow hedges are designed to hedge the variability of cash flows associated with forecasted transactions denominated in a foreign currency that will take place in the future. These nonfunctional currency exposures principally relate to forecasted intercompany sales and purchases of manufactured products and generally have maturities up to eighteen months. Changes in value of derivatives designated as cash flow hedges are recorded in AOCI on the Consolidated Balance Sheets until earnings are affected by the variability of the underlying cash flows. At that time, the applicable amount of gain or loss from the derivative instrument that is deferred in shareholders&#8217; equity is reclassified into earnings and is included in cost of goods sold in the Consolidated Statements of Earnings. Cash flows associated with these hedges are included in cash from operations in the same category as the cash flows from the items being hedged.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Forward currency exchange contracts are used to offset our exposure to the change in value of specific foreign currency denominated assets and liabilities, primarily intercompany payables and receivables. These derivatives are not designated as hedges and, therefore, changes in the value of these forward contracts are recognized in earnings, thereby offsetting the current earnings effect of the related changes in value of foreign currency denominated assets and liabilities. The estimated fair value of our forward currency exchange contracts represents the </span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">measurement of the contracts at month-end spot rates as adjusted by current forward points. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">From time to time, we designate derivative and non-derivative financial instruments as net investment hedges of our investments in certain international subsidiaries. For derivative instruments that are designated and qualify as a net investment hedge, the effective portion of the derivative's gain or loss is recognized in OCI and reported as a component of AOCI. We have elected to use the spot method to assess effectiveness for our derivatives designated as net investment hedges. Accordingly, the change in fair value attributable to changes in the spot rate is recorded in AOCI. We exclude the spot-forward difference from the assessment of hedge effectiveness and amortize this amount separately on a straight-line basis over the term of the forward contracts. This amortization is recognized in other income (expense), net.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">From time to time, we designate forward starting interest rate derivative instruments as cash flow hedges to manage the exposure to interest rate volatility with regard to future issuance and refinancing of debt. Changes in value of derivatives designated as cash flow hedges are recorded in AOCI on the Consolidated Balance Sheets until earnings are affected by the variability of the underlying cash flows. At that time, the applicable amount of gain or loss from the derivative instrument that is deferred in shareholders&#8217; equity is reclassified into earnings and is included in interest expense within other income (expense), net in the Consolidated Statements of Earnings. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Interest rate derivative instruments designated as fair value hedges have been used in the past to manage the exposure to interest rate movements and to reduce borrowing costs by converting fixed-rate debt into floating-rate debt. Under these agreements, we agree to exchange, at specified intervals, the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional principal amount. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Property, Plant and Equipment:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Property, plant and equipment is stated at cost. Depreciation is generally computed by the straight-line method over the estimated useful lives of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzEzMjA2_7c8fdcfc-54e2-4b81-91c7-7404bca5b6f4">three</span> to 30 years for buildings and improvements and <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzEzMjU2_a5156acf-7357-4ad7-88ef-00f8b1876f98">three</span> to 15 years for machinery and equipment.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Goodwill and Other Intangible Assets:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Goodwill represents the excess of purchase price over fair value of tangible net assets of acquired businesses at the acquisition date, after amounts allocated to other identifiable intangible assets. Factors that contribute to the recognition of goodwill include synergies that are specific to our business and not available to other market participants and are expected to increase net sales and profits; acquisition of a talented workforce; cost savings opportunities; the strategic benefit of expanding our presence in core and adjacent markets; and diversifying our product portfolio.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair values of other identifiable intangible assets acquired in a business combination are primarily determined using the income approach. Other intangible assets include, but are not limited to, developed technology, customer and distributor relationships (which reflect expected continued customer or distributor patronage) and trademarks and patents. Intangible assets with determinable useful lives are amortized on a straight-line basis over their estimated useful lives of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzE0NDEx_42bfd4f4-7388-4875-97fa-bc119a8ba2cf">four</span> to 40 years. Certain acquired trade names are considered to have indefinite lives and are not amortized, but are assessed annually for potential impairment as described below.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In some of our acquisitions, we acquire in-process research and development (IPRD) intangible assets. For acquisitions accounted for as business combinations IPRD is considered to </span></div></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">be an indefinite-lived intangible asset until the research is completed (then it becomes a determinable-lived intangible asset) or determined to have no future use (then it is impaired). For asset acquisitions IPRD is expensed immediately unless there is an alternative future use.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Goodwill, Intangibles and Long-Lived Asset Impairment Tests:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> We perform our annual impairment test for goodwill as of October 31 each year. We consider qualitative indicators of the fair value of a reporting unit when it is unlikely that a reporting unit has impaired goodwill and periodically corroborate that assessment with quantitative information. In certain circumstances, we may also utilize a discounted cash flow analysis that requires certain assumptions and estimates be made regarding market conditions and our future profitability. Indefinite-lived intangible assets are also tested at least annually for impairment by comparing the individual carrying values to the fair value.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We review long-lived assets for indicators of impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. The evaluation is performed at the lowest level of identifiable cash flows. Undiscounted cash flows expected to be generated by the related assets are estimated over the asset's useful life based on updated projections. If the evaluation indicates that the carrying amount of the asset may not be recoverable, any potential impairment is measured based upon the fair value of the related asset or asset group as determined by an appropriate market appraisal or other valuation technique. Assets classified as held for sale are recorded at the lower of carrying amount or fair value less costs to sell.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Share-Based Compensation:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Share-based compensation is in the form of stock options, restricted stock units (RSUs) and performance stock units (PSUs). Stock options are granted under long-term incentive plans to certain key employees and non-employee directors at an exercise price not less than the fair market value of the underlying common stock, which is the quoted closing price of our common stock on the day prior to the date of grant. The options are granted for periods of up to 10 years and become exercisable in varying installments.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We grant RSUs to key employees and non-employee directors and PSUs to certain key employees under our long-term incentive plans. The fair value of RSUs is determined based on the number of shares granted and the quoted closing price of our common stock on the date of grant, adjusted for the fact that RSUs do not include anticipated dividends. RSUs generally vest in one-third increments over a three-year period and are settled in stock. PSUs are earned over a three-year performance cycle and vest in March of the year following the end of that performance cycle. The number of PSUs that will ultimately be earned is based on our performance relative to pre-established goals in that three-year performance cycle. The fair value of PSUs is determined based on the quoted closing price of our common stock on the day of grant.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Compensation expense is recognized in the Consolidated Statements of Earnings based on the estimated fair value of the awards on the grant date. Compensation expense recognized reflects an estimate of the number of awards expected to vest after taking into consideration an estimate of award forfeitures based on actual experience and is recognized on a straight-line basis over the requisite service period, which is generally the period required to obtain full vesting. Management expectations related to the achievement of performance goals associated with PSU grants is assessed regularly and that assessment is used to </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">determine whether PSU grants are expected to vest. If performance-based milestones related to PSU grants are not met or not expected to be met, any compensation expense recognized associated with such grants will be reversed.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Income Taxes:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Deferred income tax assets and liabilities are determined based on differences between financial reporting and income tax bases of assets and liabilities and are measured using the enacted income tax rates in effect for the years in which the differences are expected to reverse. Deferred income tax benefits generally represent the change in net deferred income tax assets and liabilities in the year. Other amounts result from adjustments related to acquisitions and foreign currency as appropriate.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We operate in multiple income tax jurisdictions both within the United States and internationally. Accordingly, management must determine the appropriate allocation of income to each of these jurisdictions based on current interpretations of complex income tax regulations. Income tax authorities in these jurisdictions regularly perform audits of our income tax filings. Income tax audits associated with the allocation of this income and other complex issues, including inventory transfer pricing and cost sharing, product royalty and foreign branch arrangements, may require an extended period of time to resolve and may result in significant income tax adjustments if changes to the income allocation are required between jurisdictions with different income tax rates.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">New Accounting Pronouncements Not Yet Adopted</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In September 2022 the Financial Accounting Standards Board issued ASU 2022-04, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Liabilities - Supplier Finance Programs: Disclosure of Supplier Finance Program Obligations</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, which requires entities that utilize supplier finance programs in connection with the purchase of goods and services to disclose information about the key terms of the programs, a rollforward of the obligations under the programs and where those obligations are presented in the balance sheet. The new disclosure requirements are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. Currently our obligations under these programs are not material.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Accounting Pronouncements Recently Adopted </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On January 1, 2022 we adopted ASU 2021-08, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations: Accounting for Contract Assets and Contract Liabilities from Contracts with Customers</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. This update requires an entity to recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Accounting Standards Codification 606, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. The adoption of this update did not have a material impact on our Consolidated Financial Statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631666818848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionAbstract', window );"><strong>Revenue Recognition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue Recognition</a></td>
<td class="text">REVENUE RECOGNITION<div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We disaggregate our net sales by product line and geographic location for each of our segments as we believe it best depicts how the nature, amount, timing and certainty of our net sales and cash flows are affected by economic factors.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Products and services are primarily transferred to customers at a point in time, with some transfers of services taking place over time. In 2022 less than 10% of our sales were recognized as services transferred over time. Refer to Note 1 for further discussion on our revenue recognition policies. </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.259%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Segment Net Sales</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">MedSurg and Neurotechnology:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Instruments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,279&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,111&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,863&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Endoscopy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,763&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,031&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,607&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,524&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neurovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">973&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neuro Cranial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,376&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,214&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">972&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">277&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,611</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,538</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,345</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Orthopaedics and Spine:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Knees</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,848&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Hips</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,342&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Trauma and Extremities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,807&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,664&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,722&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Spine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,047&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">475&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">464&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,838</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,570</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,006</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">18,449</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">17,108</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14,351</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.259%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">United States Net Sales</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">MedSurg and Neurotechnology:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Instruments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,810&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,637&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,471&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Endoscopy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,914&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,408&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,422&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,007&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,910&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neurovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">446&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">451&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neuro Cranial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">988&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">801&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">273&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,024</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,026</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,218</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Orthopaedics and Spine:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Knees</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,493&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,351&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Hips</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">896&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">822&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">777&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Trauma and Extremities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,035&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,866&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Spine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">836&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">831&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">764&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">425&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">387&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,614</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,295</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,237</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13,638</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12,321</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,455</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.259%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">International Net Sales</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">MedSurg and Neurotechnology:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Instruments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">469&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">474&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">392&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Endoscopy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">509&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">471&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">609&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">614&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neurovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">754&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">737&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">592&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neuro Cranial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,587</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,512</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,127</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Orthopaedics and Spine:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Knees</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">504&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">497&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Hips</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">517&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Trauma and Extremities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">772&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">798&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">583&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Spine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,224</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,275</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,769</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,811</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,787</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,896</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">MedSurg and Neurotechnology</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">MedSurg and Neurotechnology products include surgical equipment and navigation systems (Instruments), endoscopic and communications systems (Endoscopy), patient handling, emergency medical equipment, intensive care disposable products and clinical communication and workflow solutions (Medical), minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke (Neurovascular), a comprehensive line of products for traditional brain and open skull based surgical procedures; orthobiologic and biosurgery </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">products, including synthetic bone grafts and vertebral augmentation products (Neuro Cranial) and other medical device products used in a variety of medical specialties. Substantially all MedSurg and Neurotechnology sales are recognized when a purchase order has been received and control has transferred. For certain Endoscopy, Instruments and Medical services, we may recognize sales over time as we satisfy performance obligations that may include an obligation to complete installation, provide training and perform ongoing services, generally performed within one year.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Orthopaedics and Spine</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Orthopaedics and Spine products consist primarily of implants used in hip and knee joint replacements and trauma and extremity surgeries, and cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies. Substantially all Orthopaedics sales are recognized when we have received a purchase order and appropriate notification the product has been used or implanted. Substantially all Spine sales are recognized when a purchase order has been received and control has transferred. For certain Orthopaedic products in the "other" category, we recognize sales at a point in time, as well as over time for performance obligations that may include an obligation to complete installation and provide training and ongoing services. Performance obligations are generally satisfied within one year.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Contract Assets and Liabilities </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The nature of our products and services do not generally give rise to contract assets as we typically do not incur costs to fulfill a contract before a product or service is provided to a customer. Our costs to obtain contracts are typically in the form of sales commissions paid to employees or third-party agents. Certain sales commissions paid to employees prior to recognition of sales are recorded as contract assets. We expense sales commissions associated with obtaining a contract at the time of the sale or as incurred as the amortization period is generally less than one year. These costs have been presented within selling, general and administrative expenses. On December&#160;31, 2022 contract assets recorded in our Consolidated Balance Sheets were not significant.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our contract liabilities arise as a result of consideration received from customers at inception of contracts for certain businesses or where the timing of billing for services precedes satisfaction of our performance obligations. We generally satisfy performance obligations within one year from the contract inception date. Our contract liabilities were $741 and $529 on December&#160;31, 2022 and 2021. Changes in contract liabilities during the year were as follows:</span></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.658%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.142%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Beginning contract liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">529</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Revenue recognized from beginning of year contract liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(329)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Contract liabilities acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net advance consideration received during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">461&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Ending contract liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">741</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631666818848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">FAIR VALUE MEASUREMENTS Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Financial assets and liabilities carried at fair value are classified in their entirety based on the lowest level of input and disclosed in one of the following three categories:<div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:12.693%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:85.107%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Quoted market prices in active markets for identical assets or liabilities.</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Observable market-based inputs or unobservable inputs that are corroborated by market data.</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level 3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unobservable inputs reflecting our assumptions or external inputs from active markets.</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Use of observable market data, when available, is required in making fair value measurements. When inputs used fall within different levels of the hierarchy, the level within which the fair value measurement is categorized is based on the lowest level input that is significant to the fair value measurement. We determine fair value for Level 1 instruments using exchange-traded prices for identical instruments. We determine fair value of Level 2 instruments using exchange-traded prices of similar instruments, where available, or utilizing other observable inputs that take into account our credit risk and that of our counterparties. Foreign currency exchange contracts and interest rate hedges, when outstanding, are included in Level 2 and are primarily valued using standard calculations and models that use readily observable market data as their basis. Our Level 3 liabilities are comprised of contingent consideration arising from recently completed acquisitions. We determine fair value of these Level 3 liabilities using a discounted cash flow technique. Significant unobservable inputs were used in our assessment of fair value, including assumptions regarding future business results, discount rates, discount periods and probability assessments based on the likelihood of reaching various targets. We remeasure the fair value of our assets and liabilities each reporting period. We record the changes in fair value within selling, general and administrative expense.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the third quarter 2022 we determined that certain commercial and regulatory milestones related to technology acquired in the purchase of Mobius Imaging and Cardan Robotics were no longer probable of being achieved and recorded a $110 reduction in the fair value of contingent consideration reflected in selling, general and administrative expenses.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.141%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.142%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Assets Measured at Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,844&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,944&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Trading marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 1 - Assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,010</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,137</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Available-for-sale marketable securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Corporate and asset-backed debt securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign government debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States agency debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States treasury debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total available-for-sale marketable securities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign currency exchange forward contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 2 - Assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">203</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">287</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,213</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,424</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.141%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.142%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Liabilities Measured at Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deferred compensation arrangements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 1 - Liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">166</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">193</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign currency exchange forward contracts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 2 - Liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">102</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">17</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Contingent consideration:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Beginning</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">393&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in estimate </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(137)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(148)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Ending</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 3 - Liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">121</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">306</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total liabilities measured at fair value</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">389</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">516</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.141%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.142%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Fair Value of Available for Sale Securities by Maturity</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Due in one year or less</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Due after one year through three years</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On December&#160;31, 2022 the aggregate difference between the cost and fair value of available-for-sale marketable securities was nominal. Interest and marketable securities income was $94, $68 and $102 in 2022, 2021 and 2020, which was recorded in other income (expense), net.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our investments in available-for-sale marketable securities had a minimum credit quality rating of A2 (Moody's), A (Standard &amp; Poor's) and A (Fitch). We do not plan to sell the investments, and it is not more likely than not that we will be required to sell the investments before recovery of their amortized cost basis, which may be maturity.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631786229568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Derivative Instruments</a></td>
<td class="text">DERIVATIVE INSTRUMENTS<div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We use operational and economic hedges, foreign currency exchange forward contracts, net investment hedges (both derivative and non-derivative financial instruments) and interest rate derivative instruments to manage the impact of currency exchange and interest rate fluctuations on earnings, cash flow and equity. We do not enter into derivative instruments for speculative purposes. We are exposed to potential credit loss in the event of nonperformance by counterparties on our outstanding derivative instruments but do not anticipate nonperformance by any of our counterparties. Should a counterparty default, our maximum loss exposure is the asset balance of the instrument. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Foreign Currency Hedges</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.805%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.805%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.805%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.661%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cash Flow</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Investment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-Designated</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross notional amount</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,053</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,598</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,417</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,068</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Maximum term in years</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.9</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other noncurrent assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(79)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other noncurrent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total fair value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">73</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(70)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">17</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross notional amount</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">973</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,266</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,512</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,751</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Maximum term in years</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.9</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other noncurrent assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total fair value</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">104</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">82</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">195</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We had &#8364;1.5&#160;billion and &#8364;2.0&#160;billion at December 31, 2022 and 2021 in certain forward currency contracts designated as net investment hedges to hedge a portion of our investments in certain of our entities with functional currencies denominated in Euros. In addition to these derivative financial instruments designated as net investment hedges, we had &#8364;4.4&#160;billion at December 31, 2022 and 2021 of senior unsecured notes designated as net investment hedges to selectively hedge portions of our investment in certain international subsidiaries. The currency effects of our Euro-denominated senior unsecured notes are reflected in AOCI within shareholders' equity where they offset gains and losses recorded on our net investment in international subsidiaries.</span></div><div style="margin-bottom:3pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In 2022 we settled certain foreign currency forward contracts designated as net investment hedges resulting in cash proceeds of $197. The amounts in AOCI related to settled net investment </span></div><div style="margin-bottom:3pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">hedges will remain in AOCI until the hedged investment is either sold or substantially liquidated.</span></div><div style="margin-bottom:3pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The total after-tax gain (loss) recognized in OCI related to designated net investment hedges was $321 in 2022.</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"/><td style="width:28.871%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:37.804%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.274%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.274%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.277%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Net Currency Exchange Rate Gains (Losses)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Derivative Instrument</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Recorded in:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash Flow</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cost of sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net Investment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Non-Designated</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">63</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">20</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pretax gains (losses) on derivatives designated as cash flow hedges of $32 and net investment hedges of $34 recorded in AOCI are expected to be reclassified to cost of sales and other income (expense), net in earnings within 12 months as of December&#160;31, 2022. This cash flow hedge reclassification is primarily due to the sale of inventory that includes previously hedged purchases. A component of the AOCI amounts related to net investment hedges is reclassified over the life of the hedge instruments as we elected to exclude the initial value of the component related to the spot-forward difference from the effectiveness assessment. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Interest Rate Hedges</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pretax gains of $5 recorded in AOCI related to other interest rate hedges closed in conjunction with debt issuances are expected to be reclassified to other income (expense), net in earnings within 12 months of December&#160;31, 2022. The cash flow effect of interest rate hedges is recorded in cash flow from operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI https://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631666878576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive (Loss) Income (AOCI)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract', window );"><strong>Reclassification Adjustments Out of Accumulated Other Comprehensive Income (AOCI) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Accumulated Other Comprehensive (Loss) Income (AOCI)</a></td>
<td class="text">ACCUMULATED OTHER COMPREHENSIVE (LOSS) INCOME (AOCI)<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"/><td style="width:26.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.326%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.868%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.868%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.902%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.871%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Marketable Securities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pension Plans</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Hedges</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Financial Statement Translation</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(259)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(10)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(885)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1,157)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">OCI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">551&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">724&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(101)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Reclassifications to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net OCI</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">469&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">626&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(155)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">40</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(416)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(531)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">OCI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">539&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(173)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Reclassifications to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net OCI</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">310&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">31</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">52</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(303)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(221)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reclassification Adjustments Out of Accumulated Other Comprehensive Income (AOCI) [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI https://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631774483904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Acquisitions</a></td>
<td class="text">ACQUISITIONS<div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We acquire stock in companies and various assets that continue to support our capital deployment and product development strategies. The aggregate purchase price of our acquisitions, net of cash acquired was $2,563 and $393 in 2022 and 2021. </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In February 2022 we completed the acquisition of Vocera for $79.25 per share, or an aggregate purchase price of $2.6&#160;billion, net of cash acquired ($3.0&#160;billion including convertible notes). Vocera is a leader in the digital care coordination and communication category. Vocera is part of our Medical business within MedSurg and Neurotechnology. Goodwill attributable to the acquisition reflects the strategic benefits of expanding our </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">presence in adjacent markets, diversifying our product portfolio, advancing innovations and accelerating our digital aspirations. This goodwill is not deductible for tax purposes</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During 2022 note holders elected to redeem the 1.50% and 0.50% convertible notes assumed in the Vocera acquisition for $101 and $324. These repayments are classified as financing activities in the Consolidated Statements of Cash Flows.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Share-based awards for Vocera employees vested upon our acquisition and a charge of $132 was recorded in selling, general and administrative expenses in 2022.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Purchase price allocations for our significant acquisitions are:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.486%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.878%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Purchase Price Allocation of Acquired Net Assets</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Vocera</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Tangible assets acquired:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deferred income tax assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(425)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deferred income tax liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(182)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(115)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Intangible assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Customer and distributor relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">550&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Trade name</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,328&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Purchase price, net of cash acquired of $281</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,563</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Weighted average life of intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13</span></td><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our allocation of the Vocera purchase price to intangible assets and residual goodwill is preliminary. These amounts are subject to review and potential change during the measurement period, which will extend to February 2023. The subsequent adjustment of the preliminary amounts may be material.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In September 2021 we completed the acquisition of Gauss Surgical, Inc. (Gauss) for $120 in cash and up to $40 in future milestone payments. Gauss is a medical device company that has developed Triton, an artificial intelligence-enabled platform for real-time monitoring of blood loss during surgery. Gauss is part of our Instruments business within MedSurg and Neurotechnology. Goodwill attributable to the acquisition is not deductible for tax purposes. The purchase price allocations for Gauss and other 2021 acquisitions were finalized in 2022 without material adjustments.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI https://asc.fasb.org/topic&amp;trid=2303972<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4946-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631668721904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies and Commitments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Contingencies and Commitments</a></td>
<td class="text">CONTINGENCIES AND COMMITMENTSWe are involved in various ongoing proceedings, legal actions and claims arising in the normal course of business, including proceedings related to product, labor, intellectual property and other matters, the most significant of which are more fully described below. The outcomes of these matters will generally not be known for prolonged periods of time. In certain of the legal proceedings the claimants seek damages as well as other compensatory and equitable relief that could result in the payment of significant claims and settlements and/or the imposition of injunctions or other equitable relief. For legal matters for which management had sufficient information to reasonably estimate our future obligations, a liability representing management's best estimate of the probable loss, or the minimum of the range of probable losses when a best estimate within the range is not known, is recorded. The estimates are based on consultation with legal counsel, previous settlement experience and settlement strategies. If actual outcomes are less favorable than those estimated by management, additional expense may be incurred, which could unfavorably affect future <div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">operating results. We are self-insured for certain claims and expenses. The ultimate cost to us with respect to product liability claims could be materially different than the amount of the current estimates and accruals and could have a material adverse effect on our financial position, results of operations and cash flows.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In April 2022 the United States District Court for the District of Delaware issued a judgment following a jury verdict in favor of PureWick Corporation (PureWick) for its 2019 complaint seeking patent infringement damages related to our PrimaFit and PrimoFit products. The court awarded damages and we recorded charges of $28 in March 2022. In June 2022 PureWick filed a motion to seek enhancement of the judgment and if successful, the judgment could total approximately $100 and include an injunction against future sales. We intend to appeal the outcome of this case. In 2022 PureWick filed additional patent infringement claims related to our PrimaFit products.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Recall Matters</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In June 2012 we voluntarily recalled our Rejuvenate and ABG II Modular-Neck hip stems and terminated global distribution of these hip products. Product liability lawsuits relating to this voluntary recall have been filed against us. In November 2014 we entered into a settlement agreement to compensate eligible United States patients who had revision surgery prior to November 3, 2014 and in December 2016 the settlement program was extended to patients who had revision surgery prior to December 19, 2016. In September 2020 we entered into a second settlement agreement to compensate eligible United States patients who had revision surgery prior to September 9, 2020. There are remaining lawsuits that we will continue to defend against. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In August 2016 and May 2018 we voluntarily recalled certain lot-specific sizes and offsets of LFIT Anatomic CoCr V40 Femoral Heads. Product liability lawsuits and claims relating to this voluntary recall have been filed against us. In November 2018 we entered into a settlement agreement to resolve a significant number of claims and lawsuits related to the recalls. In April 2022 we executed a second agreement to resolve a significant number of claims and lawsuits related to the recalls. The specific terms of the settlement agreement, including the financial terms, are confidential. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">With the acquisition of Wright Medical Group N.V. (Wright) in November 2020, we are responsible for certain product liability claims, primarily related to certain hip products sold by Wright prior to its 2014 divestiture of the OrthoRecon business. We will continue to evaluate each claim and the possible loss we may incur.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">We have incurred, and expect to incur in the future, costs associated with the defense and settlement of these matters. In 2022 we made payments of $157, primarily related to LFIT femoral heads and Wright hip products. Based on the information that has been received, we have estimated the remaining range of probable loss related to these recall matters to be approximately $213 to $347. We have recorded reserves representing the remaining minimum of the range of probable loss. The final outcomes of these matters are dependent on many factors that are difficult to predict. Accordingly, the ultimate cost related to these matters may be materially different than the amount of our current estimate and accruals and could have a material adverse effect on our results of operations and cash flows.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Leases</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">We lease various manufacturing, warehousing and distribution facilities, administrative and sales offices as well as equipment </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">under operating leases. We evaluate our contracts to identify leases, which is generally if there is an identified asset and we have the right to direct the use of and obtain substantially all of the economic benefit from the use of the identified asset. Certain of our lease agreements contain rent escalation clauses (including index-based escalations), rent holidays, capital improvement funding or other lease incentives. We recognize our minimum rental expense on a straight-line basis over the term of the lease beginning with the date of initial control of the asset. Right-of-use assets are recorded in Other noncurrent assets on our Consolidated Balance Sheets. Current and noncurrent lease liabilities are recorded in Accrued expenses and other liabilities and Other noncurrent liabilities, respectively.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have made certain significant assumptions and judgments when recording leases. For all asset classes, we elected to not recognize a right-of-use asset and lease liability for short-term leases and not separate non-lease components from lease components to which they relate and have accounted for the combined lease and non-lease components as a single lease component. The determination of the discount rate used in a lease is our incremental borrowing rate which is based on what we would normally pay to borrow on a collateralized basis over a similar term an amount equal to the lease payments.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.850%"><tr><td style="width:1.0%"/><td style="width:58.493%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.376%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.253%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.378%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzItMC0xLTEtNzIxNTE_9731ce2e-d82a-4967-b042-db8cc99630f8"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzItMC0xLTEtNzIxNTE_f24b63f9-9795-4048-881d-72c0ef014936">Right-of-use assets</span></span> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">419&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzMtMC0xLTEtNzIxNTE_4a79c8d2-7e9e-4a69-8e7c-3f2c45ccd096"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzMtMC0xLTEtNzIxNTE_582bcc35-c25f-4f59-a914-b85367fcbaf4">Lease liabilities, current</span></span> </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzQtMC0xLTEtNzIxNTE_3e00ae6d-1860-4511-a971-3c7d349014a4"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzQtMC0xLTEtNzIxNTE_b077084d-a166-4834-a410-c652caa7aed3">Lease liabilities, noncurrent</span></span> </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">310&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other information:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Weighted-average remaining lease term (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5.5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;text-indent:-0.01pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5.4</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Weighted-average discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease expense totaled $149, $133, and $130 in 2022, 2021 and 2020.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Future Obligations</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have purchase commitments for materials, supplies, services and property, plant and equipment as part of the normal course of business. In addition, we lease various manufacturing, warehousing and distribution facilities, administrative and sales offices as well as equipment under operating leases. Refer to Note 10 for more information on the debt obligations.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.945%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2027</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Thereafter</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Debt repayments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,208&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,450&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,250&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6,300&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Purchase obligations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,595&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Minimum lease payments</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631757834000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Other Intangible Assets</a></td>
<td class="text">GOODWILL AND OTHER INTANGIBLE ASSETS<div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We performed our annual impairment test for goodwill as of October 31, 2022 and determined that the carrying value of the Spine reporting unit exceeded its fair value. As a result an impairment charge of $216 was recognized in the Goodwill impairment line in the Consolidated Statements of Earnings in 2022. As of December&#160;31, 2022 goodwill of the Spine reporting unit is $1,002 after the impairment charge.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We estimated the fair value of the Spine reporting unit using a discounted cash flow analysis. Significant inputs to the analysis include assumptions for future revenue growth and operating margin. The analysis also included a rate to discount the estimated future cash flow projections to their present value, based on the reporting unit&#8217;s estimated weighted average cost of capital. The impairment charge for the Spine reporting unit was primarily driven by the slower than anticipated recovery of surgery volumes as we emerge from the COVID-19 pandemic, the competitive pressures in the spine market and rising interest rates in the current macroeconomic environment.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">For our other reporting units, we considered qualitative indicators of impairment as it was considered more likely than not that the fair values of those reporting units exceeded their respective carrying values. No impairment was identified for those reporting units in 2022. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Future changes in the judgments, assumptions and estimates that are used in our impairment testing for goodwill, including discount and tax rates and future cash flow projections, could result in significantly different estimates of the fair values. A significant reduction in the estimated fair values could result in impairment charges that could materially affect our results of operations.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.681%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.612%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.407%"/><td style="width:0.1%"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Changes in the Net Carrying Value of Goodwill by Segment</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">MedSurg and Neurotechnology</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Orthopaedics and Spine</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,459</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,319</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12,778</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Additions and adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign exchange</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(129)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,669</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,249</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12,918</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Goodwill impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(216)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(216)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Additions and adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign exchange</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(88)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,935</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,945</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14,880</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.440%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.888%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.141%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.888%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.143%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Summary of Other Intangible Assets</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted Average Amortization Period (Years)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Less<br/>Accumulated<br/>Amortization</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Developed technologies</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5,440&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,363&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,077&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5,326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,956&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Customer relationships</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,847&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,322&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,525&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,324&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Patents</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Trademarks</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">425&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">415&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">199&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">In-process research and development</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,181</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,296</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,885</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,542</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,702</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,840</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"/><td style="width:19.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.787%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Estimated Amortization Expense</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2027</span></td></tr><tr><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">620&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">588&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">510&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">490&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI https://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631672670144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Stock<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_CapitalStockAbstract', window );"><strong>Capital Stock [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Capital Stock</a></td>
<td class="text">CAPITAL STOCK<div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The aggregate number of shares of all classes of stock which we are authorized to issue is up to 1,000,500,000, divided into two classes consisting of 500,000 shares of $1 par value preferred stock and 1,000,000,000 shares of common stock with a par value of $0.10. No shares of preferred stock were outstanding on December&#160;31, 2022.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We made no repurchases of shares in 2022. The manner, timing and amount of repurchases are determined by management based on an evaluation of market conditions, stock price and other factors and are subject to regulatory considerations. Purchases are made from time-to-time in the open market, in privately negotiated transactions or otherwise. On December&#160;31, </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2022 the total dollar value of shares that could be purchased under our authorized repurchase program was $1,033.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Shares reserved for future compensation grants of our common stock were 23 million and 25 million&#160;on December&#160;31, 2022 and 2021. </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Stock Options</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We measure the cost of employee stock options based on the grant-date fair value and recognize that cost using the straight-line method over the period in which a recipient is required to provide services in exchange for the options, typically the vesting period. The weighted-average fair value per share of options is estimated on the date of grant using the Black-Scholes option pricing model. </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.060%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.555%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.555%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.558%"/><td style="width:0.1%"/></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Option Value and Assumptions</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Weighted-average fair value per share</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">68.08&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">53.35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">39.34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Assumptions:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expected stock price volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">27.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">26.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expected option life (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5.8</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The risk-free interest rate for periods within the expected life of options granted is based on the United States Treasury yield curve in effect at the time of grant. Expected stock price volatility is based on the historical volatility of our stock. The expected option life, representing the period of time that options granted are expected to be outstanding, is based on historical option exercise and employee termination data. </span></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"/><td style="width:22.819%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.479%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.173%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.513%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.196%"/><td style="width:0.1%"/></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">2022 Stock Option Activity</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares <br/>(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise&#160;Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted-Average<br/>Remaining<br/>Term (in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>&#160;Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Outstanding January&#160;1</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">150.17</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">248.36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">102.85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Canceled or forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">220.16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Outstanding December&#160;31</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">168.80</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">925.3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Exercisable December&#160;31</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">131.38&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">819.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Options expected to vest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">222.62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">102.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The aggregate intrinsic value of options, which represents the cumulative difference between the fair market value of the underlying common stock and the option exercise prices, exercised was $218, $253, and $258 in 2022, 2021 and 2020. Exercise prices for options outstanding ranged from $64.01 to $270.94 on December&#160;31, 2022. On December&#160;31, 2022 there was $111 of unrecognized compensation cost related to nonvested stock options granted under the long-term incentive plans; that cost is expected to be recognized over the weighted-average period of approximately 1.6 years.</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"><tr><td style="width:1.0%"/><td style="width:40.807%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.460%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.245%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.460%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.245%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.217%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.245%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.221%"/><td style="width:0.1%"/></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Restricted Stock Units (RSUs) and Performance Stock Units (PSUs) Activity</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares<br/>(in&#160;millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted Average<br/>Grant&#160;Date Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">RSUs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">PSUs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">RSUs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">PSUs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nonvested on January 1</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">0.7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">0.2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">213.16</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">210.73</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">239.76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">237.17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">204.62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">179.35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Canceled or forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">225.83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">179.35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nonvested on December 31</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">0.7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">0.2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">232.02</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">234.70</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On December&#160;31, 2022 there was $72 of unrecognized compensation cost related to nonvested RSUs. That cost is expected to be recognized as expense over the weighted-average period of approximately one year. The weighted-average grant date fair value per share of RSUs granted was $239.76 and $230.61 in 2022 and 2021. The fair value of RSUs and PSUs vested in 2022 was $75 and $14. On December&#160;31, 2022 there was $18 of unrecognized compensation cost related to nonvested PSUs; the cost is expected to be recognized as expense over the weighted-average period of approximately one year. </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Employee Stock Purchase Plans (ESPP)</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Employees may participate in our ESPP provided they meet certain eligibility requirements. The purchase price for our common stock under the terms of the ESPP is defined as 95% of the closing stock price on the last trading day of a purchase period. We issued 221,387 and 183,964 shares under the ESPP in 2022 and 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_CapitalStockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capital Stock [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_CapitalStockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631668597120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt and Credit Facilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAbstract', window );"><strong>Long-Term Debt, Unclassified [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt And Credit Facilities</a></td>
<td class="text">DEBT AND CREDIT FACILITIES<div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have lines of credit issued by various financial institutions that are available to fund our day-to-day operating needs. Certain of our credit facilities require us to comply with financial and other covenants. We were in compliance with all covenants on December&#160;31, 2022. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In February 2022 we entered into a $1.5&#160;billion term loan agreement that matures on February 22, 2025 and bears interest at a base rate based on the Term Secured Overnight Financing Rate (SOFR) plus 0.725%. In 2022 we repaid $650 on the term loan.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In 2022 our Board of Directors approved an increase to the maximum amount of commercial paper that can be outstanding from $1,500 to $2,250.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">On December&#160;31, 2022 there were no borrowings outstanding under our credit facility or commercial paper program which allows for maturities up to 397 days from the date of issuance.</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"><tr><td style="width:0.1%"/><td style="width:2.401%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.616%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.245%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.865%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.460%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.245%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.463%"/><td style="width:0.1%"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Summary of Total Debt</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Due</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Senior unsecured notes:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.125%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">November 30, 2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">585&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">622&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.600%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 1, 2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.375%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">May 15, 2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">596&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">593&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.250%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 3, 2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">903&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">958&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.150%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 15, 2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">647&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">645&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.375%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">November 1, 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">748&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">748&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.500%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 15, 2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">995&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">994&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.125%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">November 30, 2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">795&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">845&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.650%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 7, 2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">597&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">597&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.750%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 1, 2029</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">848&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">901&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.950%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 15, 2030</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">991&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">990&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.625%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">November 30, 2030</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">684&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">727&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.000%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 3, 2031</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">790&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">840&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.100%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">April 1, 2043</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">392&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">392&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.375%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">May 15, 2044</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">396&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.625%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 15, 2046</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">983&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">982&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.900%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 15, 2050</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">642&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">642&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Term loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13,048</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12,479</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Less current maturities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,191&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11,857</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12,472</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="15" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Unamortized debt issuance costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Borrowing capacity on existing facilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value of senior unsecured notes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10,910&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13,391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>The fair value of the senior unsecured notes was estimated using quoted interest rates, maturities and amounts of borrowings based on quoted active market prices and yields that took into account the underlying terms of the debt instruments. Substantially all of our debt is classified within Level 2 of the fair value hierarchy.Interest expense, including required fees incurred on outstanding debt and credit facilities that were included in other income (expense), net, totaled $337, $337, and $315 in 2022, 2021 and 2020.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631668597120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">INCOME TAXES <div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our effective tax rate was 12.1%, 12.6% and 18.2% for 2022, 2021 and 2020. The effective income tax rate for 2022 decreased due to the effective settlement of the United States federal income tax audit for years 2014 through 2018 and the reversal of deferred income tax on undistributed earnings of foreign subsidiaries. In addition, the effective income tax rates for 2022, 2021 and 2020 reflect the continued lower effective income tax rates as a result of our European operations, the tax effect related to the transfers of intellectual property between tax jurisdictions, the tax effect of future remittances of the undistributed earnings of foreign subsidiaries and certain discrete tax items. </span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.259%"/><td style="width:0.1%"/></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Effective Income Tax Rate Reconciliation</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">United States federal statutory rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">21.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">21.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">21.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States state and local income taxes, less federal deduction</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign income tax at rates other than 21%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Tax related to repatriation of foreign earnings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Intellectual property transfers</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States federal audit settlement</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Goodwill impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Effective income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12.6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">18.2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.259%"/><td style="width:0.1%"/></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Earnings Before Income Taxes&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">407&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">433&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,276&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,848&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,715&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,683</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,281</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,954</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.259%"/><td style="width:0.1%"/></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Components of Income Tax Expense (Benefit)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Current income tax expense (benefit):</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States federal</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States state and local</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">272&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total current income tax expense</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">267</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">524</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">307</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Deferred income tax expense (benefit):</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States federal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(179)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States state and local</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(30)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(23)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(25)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">267&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(132)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total deferred income tax expense (benefit)</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">58</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(237)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">48</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total income tax expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">325</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">287</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">355</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Interest and penalties included in other income (expense), net were income of $71 in 2022, and expense of ($23) and ($35) in 2021 and 2020. The United States federal deferred income tax benefit (expense) includes the utilization of net operating loss carryforwards of $56, $283 and $41 in 2022, 2021 and 2020.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.463%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.545%"/><td style="width:0.1%"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Deferred Income Tax Assets and Liabilities</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Deferred income tax assets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">513&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Product-related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">501&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,038&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">State income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Research and development capitalization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">International interest expense carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net operating loss and other credit carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">191&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total deferred income tax assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,712</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,861</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Less valuation allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(285)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(164)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net deferred income tax assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,427</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,697</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Deferred income tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,037)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(891)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Undistributed earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(114)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total deferred income tax liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1,084)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1,005)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net deferred income tax assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,343</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,692</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reported as:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Noncurrent deferred income tax assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,410&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,760&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Noncurrent liabilities&#8212;Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,343</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,692</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accrued interest and penalties were $66 and $150 on December&#160;31, 2022 and 2021 which were reported in accrued expenses and other liabilities and other noncurrent liabilities.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net operating loss carryforwards totaling $544 with $155 being subject to a full valuation allowance on December&#160;31, 2022 are available to reduce future taxable earnings of certain domestic and foreign subsidiaries. United States loss carryforwards of $377 begin to expire in 2023. International loss carryforwards of $167 begin to expire in 2023; however, some have no expiration. We also have tax credit carryforwards of $133 with $91 being subject to a full valuation allowance. The credits with a full valuation allowance begin to expire in 2023. We do not anticipate generating income tax in excess of the non-expiring credits in the foreseeable future.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">The Tax Cuts and Jobs Act (the Act) was enacted in 2017 in the United States. We recorded a one-time transition tax on earnings of certain foreign subsidiaries that were previously deferred. The Act also subjects a United States shareholder to tax on Global Intangible Low-Taxed Income (GILTI) earned by certain foreign subsidiaries. We have elected to account for GILTI tax in the year the tax is incurred.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">We recorded deferred income tax on undistributed earnings of foreign subsidiaries not determined to be indefinitely reinvested. Determination of the total amount of unrecognized deferred income tax on undistributed earnings of foreign subsidiaries is not practicable.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.750%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.258%"/><td style="width:0.1%"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Uncertain Income Tax Positions</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Beginning uncertain tax positions</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">444</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">457</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Increases related to current year income tax positions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Increases related to prior year income tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Decreases related to prior year income tax positions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(178)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(18)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Settlements of income tax audits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Statute of limitations expirations and other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Ending uncertain tax positions</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">286</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">444</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reported as:</span></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Noncurrent liabilities&#8212;Income taxes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">444&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our income tax expense would have been reduced by $289 and $445 in 2022 and 2021 had these uncertain income tax positions been favorably resolved. It is reasonably possible that the amount of unrecognized tax benefits will significantly change due </span></div>to one or more of the following events in the next 12 months: expiring statutes, audit activity, tax payments, competent authority proceedings related to transfer pricing or final decisions in matters that are the subject of controversy in various taxing jurisdictions in which we operate, including inventory transfer pricing, cost sharing, product royalty and foreign branch arrangements. We are not able to reasonably estimate the amount or the future periods in which changes in unrecognized tax benefits may be resolved. Interest and penalties incurred associated with uncertain tax positions are included in other income (expense), net.In the normal course of business, income tax authorities in various income tax jurisdictions both within the United States and internationally conduct routine audits of our income tax returns filed in prior years.&#160;These audits are generally designed to determine if individual income tax authorities are in agreement with our interpretations of complex income tax regulations regarding the allocation of income to the various income tax jurisdictions. Income tax expense in 2022 decreased $162 due to the effective settlement of the United States federal income tax audit for years 2014 through 2018. In addition, 2022 other income (expense), net includes a benefit of $50 related to the release of accrued interest associated with this settlement. Income tax years are open from 2019 through the current year for the United States federal jurisdiction. Income tax years open for our other major jurisdictions range from 2007 through the current year.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631672670144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement Plans<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Retirement Plans</a></td>
<td class="text">RETIREMENT PLANS<div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Defined Contribution Plans</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We provide certain employees with defined contribution plans and other types of retirement plans. A portion of our retirement plan expense under the defined contribution plans is funded with Stryker common stock. The use of Stryker common stock represents a non-cash operating activity that is not reflected in our Consolidated Statements of Cash Flows.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"/><td style="width:61.436%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.430%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Plan expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expense funded with Stryker common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Stryker common stock held by plan:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dollar amount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">522&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">542&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Shares (in millions)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Value as a percentage of total plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Defined Benefit Plans</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain of our subsidiaries have both funded and unfunded defined benefit pension plans covering some or all of their employees. The majority of our defined benefit pension plans have projected benefit obligations in excess of plan assets.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Discount Rate</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The discount rates were selected using a hypothetical portfolio of high quality bonds on December 31 that would provide the necessary cash flows to match our projected benefit payments. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Expected Return on Plan Assets</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The expected return on plan assets is determined by applying the target allocation in each asset category of plan investments to the anticipated return for each asset category based on historical and projected returns. </span></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"/><td style="width:61.436%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.430%"/><td style="width:0.1%"/></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Components of Net Periodic Pension Cost</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net periodic benefit cost:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(72)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization of prior service credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Recognized actuarial loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Curtailment gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net periodic benefit cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(59)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(74)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(70)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Changes in assets and benefit obligations recognized in OCI:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net actuarial gain (loss)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(117)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Recognized net actuarial loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Prior service credit and transition amount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Curtailment gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total recognized in other comprehensive income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">252</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">138</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(105)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total recognized in net periodic benefit cost and OCI</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">193</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">64</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(175)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted-average rates used to determine net periodic benefit cost:</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Weighted-average discount rate used to determine projected benefit obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The actuarial gain (loss) for all pension plans was primarily related to a change in the discount rate used to measure the benefit obligations of those plans.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Investment Strategy</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The investment strategy for our defined benefit pension plans is to meet the liabilities of the plans as they fall due and to maximize the return on invested assets within appropriate risk tolerances.</span></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.474%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">420&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">543&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Benefit obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(673)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,036)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Funded status</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(253)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(493)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reported as:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Noncurrent assets&#8212;other assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Current liabilities&#8212;accrued compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Noncurrent liabilities&#8212;other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(271)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(491)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pre-tax amounts recognized in AOCI:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Unrecognized net actuarial gain (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(215)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Unrecognized prior service credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">44</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(208)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.474%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change in Benefit Obligations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Beginning projected benefit obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,036</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,118</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign exchange impact</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Employee contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Actuarial (gains) losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(354)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Curtailment gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Ending projected benefit obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">673</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,036</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Ending accumulated benefit obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">645</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">987</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.474%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change in Plan Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Beginning fair value of plan assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">543</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">522</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Actual return</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(109)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Employee contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign exchange impact</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Ending fair value of plan assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">420</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">543</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"/><td style="width:33.770%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.649%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.649%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.652%"/><td style="width:0.1%"/></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Allocation of Plan Assets</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023 Target</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022 Actual</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021 Actual</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.329%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.220%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.220%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.220%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.511%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Valuation of Plan Assets </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Corporate debt securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">46</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">319</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">55</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">420</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">55</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">389</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">99</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">543</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our Level 3 pension plan assets consist primarily of guaranteed investment contracts with insurance companies. The insurance contracts guarantee us principal repayment and a fixed rate of return. The $44 decrease in Level 3 pension plan assets is primarily driven by the change in the corresponding pension liability. We expect to contribute $19 to our defined benefit pension plans in 2023.</span></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"><tr><td style="width:1.0%"/><td style="width:15.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.535%"/><td style="width:0.1%"/></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Estimated Future Benefit Payments</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2027</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2028-2032</span></td></tr><tr><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI https://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631672476112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Quarterly Data (Unaudited)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialDataAbstract', window );"><strong>Quarterly Financial Data [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationTextBlock', window );">Summary of Quarterly Data (Unaudited)</a></td>
<td class="text">SUMMARY OF QUARTERLY DATA (UNAUDITED)<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.031%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.368%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022 Quarters</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Mar 31</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Jun&#160;30</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Sep 30</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dec 31</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,275</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,493</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,479</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,202</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,734&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,782&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,236&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Earnings (loss) before income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">386&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">720&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">816&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">761&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net earnings (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">323</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">656</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">816</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">563</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net earnings (loss) per share of common stock:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dividends declared per share of common stock</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.695&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.695&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.695&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021 Quarters</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Mar 31</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Jun&#160;30</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Sep 30</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dec 31</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,953</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,294</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,160</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,701</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,509&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,772&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,045&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">757&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">302</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">592</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">438</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">662</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net earnings per share of common stock:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dividends declared per share of common stock</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.630&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.630&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.630&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.695&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialDataAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialDataAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -URI https://asc.fasb.org/topic&amp;trid=2126967<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=126900988&amp;loc=SL124452896-108306<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631672673664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment and Geographic Data<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment and Geographic Data</a></td>
<td class="text">SEGMENT AND GEOGRAPHIC DATA<div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We segregate our operations into two reportable business segments: (i) MedSurg and Neurotechnology and (ii) Orthopaedics and Spine which aligns to our internal reporting structure and how the Company manages its businesses.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Corporate and Other category shown in the table below includes corporate and administration, corporate initiatives and share-based compensation, which includes compensation related to employee stock options, restricted stock units and performance stock unit grants and director stock options and restricted stock unit grants.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.693%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.693%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.694%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Segment Results</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedSurg and Neurotechnology</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10,611&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9,538&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8,345&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Orthopaedics and Spine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,838&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,570&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6,006&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">18,449</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">17,108</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14,351</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedSurg and Neurotechnology</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">540&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">496&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Orthopaedics and Spine</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">614&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">629&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">458&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Segment depreciation and amortization </span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,154</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,147</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">954</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Corporate and Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total depreciation and amortization</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,278</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,272</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,076</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedSurg and Neurotechnology</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,737&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,807&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Orthopaedics and Spine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,588&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Segment operating income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,033</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,987</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,002</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Items not allocated to segments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Corporate and Other</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(649)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(605)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(503)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisition and integration-related charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(585)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(242)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(627)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(619)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(472)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Restructuring-related and other charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(349)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(386)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(458)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Goodwill impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(216)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medical device regulations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(140)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(107)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Recall-related matters</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(103)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Regulatory and legal matters</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated operating income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,841</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,584</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,223</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.693%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.693%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.694%"/><td style="width:0.1%"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Segment Assets and Capital Spending</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedSurg and Neurotechnology</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18,283&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15,218&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15,250&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Orthopaedics and Spine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17,295&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18,149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18,090&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total segment assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">35,578</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">33,367</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">33,340</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Corporate and Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,306&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,264&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">990&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">36,884</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">34,631</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">34,330</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Purchases of property, plant and equipment:</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedSurg and Neurotechnology</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">197&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Orthopaedics and Spine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total segment purchases of property, plant and equipment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">348</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">362</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">342</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Corporate and Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total purchases of property, plant and equipment</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">588</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">525</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">487</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We measure the financial results of our reportable segments using an internal performance measure that excludes acquisition and integration-related charges, restructuring-related and other charges, goodwill impairment, reserves for certain product recall matters and reserves for certain legal and regulatory matters. Identifiable assets are those assets used exclusively in the operations of each business segment or allocated when used jointly. Corporate assets are principally property, plant and equipment, and noncurrent assets. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The countries in which we have local revenue generating operations have been combined into the following geographic areas: the United States (including Puerto Rico); Europe, Middle East, Africa; Asia Pacific; and other foreign countries, which include Canada and countries in the Latin American region. Net sales are reported based on the geographic area of the Stryker location where the sales to the customer originated. </span></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.750%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.842%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.842%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.842%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.846%"/><td style="width:0.1%"/></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Geographic Information</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Sales</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Property, Plant and Equipment</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13,638&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12,321&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10,455&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,791&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,717&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Europe, Middle East, Africa</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,299&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,818&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">995&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">941&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,885&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,973&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,630&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other countries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">578&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">515&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">448&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">18,449</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">17,108</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14,351</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,970</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,833</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631657452848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Asset Impairments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentChargesTextBlock', window );">Asset Impairments</a></td>
<td class="text">ASSET IMPAIRMENTS<div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The government in China has launched regional and national programs for volume-based procurement (VBP) of high-value medical consumables to reduce healthcare costs. Each VBP program has specific requirements to award contracts to the lowest bidders who are able to satisfy the quality and quantity requirements. The successful bidders may be guaranteed sales volume for certain products, while unsuccessful bidders may lose unit sales volume. The prices required for a successful bid have negatively impact our affected commercial operations in China, including those for joint replacement, trauma and certain neurovascular products. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As a result of the outcome of certain regional programs for our trauma products and the national VBP program for hips and knees we recorded charges of $105 to impair certain long-lived and intangible assets in 2021. These charges were included in selling, general and administrative expenses. The national VBP program for spine products took place in the third quarter of 2022 and we were unsuccessful in our bid. As a result we are exiting the spine business in China. Related asset impairments recognized in 2022 were not significant and we do not expect any significant impairments related to future VBP programs. Our business in China represented approximately 2.4% of our revenues for the year ended December&#160;31, 2022.</span></div>In addition to asset impairments in connection with VBP program results, we recognized asset impairments of $47 in 2022 for long-lived and intangible assets primarily as a result of the exit of certain product lines.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentChargesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the details of the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value. Disclosure may also include a description of the impaired asset and facts and circumstances leading to the impairment, amount of the impairment loss and where the loss is located in the income statement, method(s) for determining fair value, and the segment in which the impaired asset is reported.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentChargesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631657394128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Nature of Operations</a></td>
<td class="text">Stryker (the "Company," "we," "us," or "our") is one of the world's leading medical technology companies and, together with its customers, is driven to make healthcare better. The Company offers innovative products and services in Medical and Surgical, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Our products include surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling, emergency medical equipment and intensive care disposable products; clinical communication and workflow solutions; neurosurgical and neurovascular devices; implants used in joint replacement and trauma surgeries; Mako Robotic-Arm Assisted technology; spinal devices; as well as other products used in a variety of medical specialties.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Basis of Presentation and Consolidation</a></td>
<td class="text">The Consolidated Financial Statements include the Company and its subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation. We have no material interests in variable interest entities and none that require consolidation.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text">The preparation of financial statements in conformity with accounting principles generally accepted in the United States (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities on the date of the financial statements and the reported amounts of net sales and expenses in the reporting period. Actual results could differ from those estimates.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text">Sales are recognized as the performance obligations to deliver products or services are satisfied and are recorded based on the amount of consideration we expect to receive in exchange for satisfying the performance obligations. Our sales are recognized primarily when we transfer control to the customer, which can be on the date of shipment, the date of receipt by the customer or, for most Orthopaedics products, when we have received a purchase order and appropriate notification the product has been used or implanted. Products and services are primarily transferred to customers at a point in time, with some transfers of services taking place over time.<div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sales represent the amount of consideration we expect to receive from customers in exchange for transferring products and services. Net sales exclude sales, value added and other taxes we collect from customers. Other costs to obtain and fulfill contracts are generally expensed as incurred due to the short-term nature of most of our sales. We extend terms of payment to our customers based on commercially reasonable terms for the markets of our customers, while also considering their credit quality.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A provision for estimated sales returns, discounts and rebates is recognized as a reduction of sales in the same period that the sales are recognized. Our estimate of the provision for sales returns has been established based on contract terms with our customers and historical business practices and current trends. Shipping and handling costs charged to customers are included in net sales.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfSalesPolicyTextBlock', window );">Cost of Sales</a></td>
<td class="text">Cost of sales is primarily comprised of direct materials and supplies consumed in the manufacture of product, as well as manufacturing labor, depreciation expense and direct overhead expense necessary to acquire and convert the purchased materials and supplies into finished product. Cost of sales also includes the cost to distribute products to customers, inbound freight costs, warehousing costs and other shipping and handling activity.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research, Development and Engineering Expenses</a></td>
<td class="text">Research, development and engineering costs are charged to expense as incurred. Costs include research, development and engineering activities relating to the development of new products, improvement of existing products, technical support of products and compliance with governmental regulations for the protection of customers and patients. Costs primarily consist of salaries, wages, consulting and depreciation and maintenance of research facilities and equipment.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock', window );">Selling, General and Administrative Expenses</a></td>
<td class="text">Selling, general and administrative expense is primarily comprised of selling expenses, marketing expenses, administrative and other indirect overhead costs, amortization of loaner instrumentation, depreciation and amortization expense of non-manufacturing assets and other miscellaneous operating items.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Currency Translation</a></td>
<td class="text">Financial statements of subsidiaries outside the United States generally are measured using the local currency as the functional currency. Adjustments to translate those statements into United States Dollars are recorded in other comprehensive income (OCI). Transactional exchange gains and losses are included in other income (expense), net.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash Equivalents</a></td>
<td class="text">Highly liquid investments with remaining stated maturities of three months or less when purchased or other money market instruments that are redeemable upon demand are considered cash equivalents and recorded at cost.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesPolicy', window );">Marketable Securities</a></td>
<td class="text">Marketable securities consist of marketable debt securities, certificates of deposit and mutual funds. Mutual funds are acquired to offset changes in certain liabilities related to deferred compensation arrangements and are expected to be used to settle these liabilities and are recognized in other noncurrent assets. Pursuant to our investment policy, all individual marketable security investments must have a minimum credit quality of single A (Standard&#160;&amp; Poor&#8217;s and Fitch) and A2 (Moody&#8217;s Corporation) at the time of acquisition, while the overall portfolio of marketable securities must maintain a minimum average credit quality of double A (Standard&#160;&amp; Poor&#8217;s and Fitch) or Aa (Moody&#8217;s Corporation). In the event of a rating downgrade below the minimum credit quality subsequent to purchase, the marketable security investment is evaluated to determine the appropriate action to take to minimize the overall risk to our marketable security investment portfolio. Our marketable securities are classified as available-for-sale and trading securities. Investments in trading securities represent participant-directed investments of deferred employee compensation.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Accounts Receivable</a></td>
<td class="text">Accounts receivable consists of trade and other miscellaneous receivables. An allowance is maintained for doubtful accounts for estimated losses in the collection of accounts receivable. Estimates are made regarding the ability of customers to make required payments based on historical credit experience, current market conditions and expected credit losses. Accounts receivable are written off when all reasonable collection efforts are exhausted.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text">Inventories are stated at the lower of cost or net realizable value, with cost generally determined using the first-in, first-out (FIFO) cost method. For excess and obsolete inventory resulting from the potential inability to sell specific products at prices in excess of current carrying costs, reserves are maintained to reduce current carrying cost to net realizable value.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOptionTextBlock', window );">Financial Instruments</a></td>
<td class="text">Our financial instruments consist of cash, cash equivalents, marketable securities, accounts receivable, other investments, accounts payable, debt and foreign currency exchange contracts. The carrying value of our financial instruments, with the exception of our senior unsecured notes, approximates fair value on December&#160;31, 2022 and 2021. Refer to Notes 3 and 10 for further details. <div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">All marketable securities are recognized at fair value. Adjustments to the fair value of marketable securities that are classified as available-for-sale are recognized as increases or decreases, net of income taxes, within accumulated other comprehensive income (AOCI) in shareholders&#8217; equity and adjustments to the fair value of marketable securities that are classified as trading are recognized in earnings. The amortized cost of marketable debt securities is adjusted for amortization of premiums and discounts to maturity computed under the effective interest method. Such amortization and interest and realized gains and losses are included in other income (expense), net. The cost of securities sold is determined by the specific identification method.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We review declines in the fair value of our investments classified as available-for-sale to determine whether the decline in fair value is a result of credit loss or other factors. Impairments of available-for-sale marketable debt securities related to credit loss are included in earnings and impairments related to other factors are recognized within AOCI.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivatives</a></td>
<td class="text">All derivatives are recognized at fair value and reported on a gross basis. We enter into forward currency exchange contracts to mitigate the impact of currency fluctuations on transactions denominated in nonfunctional currencies, thereby limiting our risk that would otherwise result from changes in exchange rates. The periods of the forward currency exchange contracts correspond to the periods of the exposed transactions, with realized gains and losses included in the measurement and recording of transactions denominated in the nonfunctional currencies. All forward currency exchange contracts are recorded at their fair value each period.<div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Forward currency exchange contracts designated as cash flow hedges are designed to hedge the variability of cash flows associated with forecasted transactions denominated in a foreign currency that will take place in the future. These nonfunctional currency exposures principally relate to forecasted intercompany sales and purchases of manufactured products and generally have maturities up to eighteen months. Changes in value of derivatives designated as cash flow hedges are recorded in AOCI on the Consolidated Balance Sheets until earnings are affected by the variability of the underlying cash flows. At that time, the applicable amount of gain or loss from the derivative instrument that is deferred in shareholders&#8217; equity is reclassified into earnings and is included in cost of goods sold in the Consolidated Statements of Earnings. Cash flows associated with these hedges are included in cash from operations in the same category as the cash flows from the items being hedged.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Forward currency exchange contracts are used to offset our exposure to the change in value of specific foreign currency denominated assets and liabilities, primarily intercompany payables and receivables. These derivatives are not designated as hedges and, therefore, changes in the value of these forward contracts are recognized in earnings, thereby offsetting the current earnings effect of the related changes in value of foreign currency denominated assets and liabilities. The estimated fair value of our forward currency exchange contracts represents the </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">measurement of the contracts at month-end spot rates as adjusted by current forward points. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">From time to time, we designate derivative and non-derivative financial instruments as net investment hedges of our investments in certain international subsidiaries. For derivative instruments that are designated and qualify as a net investment hedge, the effective portion of the derivative's gain or loss is recognized in OCI and reported as a component of AOCI. We have elected to use the spot method to assess effectiveness for our derivatives designated as net investment hedges. Accordingly, the change in fair value attributable to changes in the spot rate is recorded in AOCI. We exclude the spot-forward difference from the assessment of hedge effectiveness and amortize this amount separately on a straight-line basis over the term of the forward contracts. This amortization is recognized in other income (expense), net.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">From time to time, we designate forward starting interest rate derivative instruments as cash flow hedges to manage the exposure to interest rate volatility with regard to future issuance and refinancing of debt. Changes in value of derivatives designated as cash flow hedges are recorded in AOCI on the Consolidated Balance Sheets until earnings are affected by the variability of the underlying cash flows. At that time, the applicable amount of gain or loss from the derivative instrument that is deferred in shareholders&#8217; equity is reclassified into earnings and is included in interest expense within other income (expense), net in the Consolidated Statements of Earnings. </span></div>Interest rate derivative instruments designated as fair value hedges have been used in the past to manage the exposure to interest rate movements and to reduce borrowing costs by converting fixed-rate debt into floating-rate debt. Under these agreements, we agree to exchange, at specified intervals, the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional principal amount.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text">Property, plant and equipment is stated at cost. Depreciation is generally computed by the straight-line method over the estimated useful lives of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzEzMjA2_7c8fdcfc-54e2-4b81-91c7-7404bca5b6f4">three</span> to 30 years for buildings and improvements and <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzEzMjU2_a5156acf-7357-4ad7-88ef-00f8b1876f98">three</span> to 15 years for machinery and equipment.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Goodwill and Other Intangible Assets</a></td>
<td class="text">Goodwill represents the excess of purchase price over fair value of tangible net assets of acquired businesses at the acquisition date, after amounts allocated to other identifiable intangible assets. Factors that contribute to the recognition of goodwill include synergies that are specific to our business and not available to other market participants and are expected to increase net sales and profits; acquisition of a talented workforce; cost savings opportunities; the strategic benefit of expanding our presence in core and adjacent markets; and diversifying our product portfolio.<div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair values of other identifiable intangible assets acquired in a business combination are primarily determined using the income approach. Other intangible assets include, but are not limited to, developed technology, customer and distributor relationships (which reflect expected continued customer or distributor patronage) and trademarks and patents. Intangible assets with determinable useful lives are amortized on a straight-line basis over their estimated useful lives of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzE0NDEx_42bfd4f4-7388-4875-97fa-bc119a8ba2cf">four</span> to 40 years. Certain acquired trade names are considered to have indefinite lives and are not amortized, but are assessed annually for potential impairment as described below.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In some of our acquisitions, we acquire in-process research and development (IPRD) intangible assets. For acquisitions accounted for as business combinations IPRD is considered to </span></div>be an indefinite-lived intangible asset until the research is completed (then it becomes a determinable-lived intangible asset) or determined to have no future use (then it is impaired). For asset acquisitions IPRD is expensed immediately unless there is an alternative future use.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock', window );">Goodwill, Intangibles and Long-Lived Asset Impairment Tests</a></td>
<td class="text">We perform our annual impairment test for goodwill as of October 31 each year. We consider qualitative indicators of the fair value of a reporting unit when it is unlikely that a reporting unit has impaired goodwill and periodically corroborate that assessment with quantitative information. In certain circumstances, we may also utilize a discounted cash flow analysis that requires certain assumptions and estimates be made regarding market conditions and our future profitability. Indefinite-lived intangible assets are also tested at least annually for impairment by comparing the individual carrying values to the fair value.We review long-lived assets for indicators of impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. The evaluation is performed at the lowest level of identifiable cash flows. Undiscounted cash flows expected to be generated by the related assets are estimated over the asset's useful life based on updated projections. If the evaluation indicates that the carrying amount of the asset may not be recoverable, any potential impairment is measured based upon the fair value of the related asset or asset group as determined by an appropriate market appraisal or other valuation technique. Assets classified as held for sale are recorded at the lower of carrying amount or fair value less costs to sell.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-Based Compensation</a></td>
<td class="text">hare-based compensation is in the form of stock options, restricted stock units (RSUs) and performance stock units (PSUs). Stock options are granted under long-term incentive plans to certain key employees and non-employee directors at an exercise price not less than the fair market value of the underlying common stock, which is the quoted closing price of our common stock on the day prior to the date of grant. The options are granted for periods of up to 10 years and become exercisable in varying installments.<div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We grant RSUs to key employees and non-employee directors and PSUs to certain key employees under our long-term incentive plans. The fair value of RSUs is determined based on the number of shares granted and the quoted closing price of our common stock on the date of grant, adjusted for the fact that RSUs do not include anticipated dividends. RSUs generally vest in one-third increments over a three-year period and are settled in stock. PSUs are earned over a three-year performance cycle and vest in March of the year following the end of that performance cycle. The number of PSUs that will ultimately be earned is based on our performance relative to pre-established goals in that three-year performance cycle. The fair value of PSUs is determined based on the quoted closing price of our common stock on the day of grant.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Compensation expense is recognized in the Consolidated Statements of Earnings based on the estimated fair value of the awards on the grant date. Compensation expense recognized reflects an estimate of the number of awards expected to vest after taking into consideration an estimate of award forfeitures based on actual experience and is recognized on a straight-line basis over the requisite service period, which is generally the period required to obtain full vesting. Management expectations related to the achievement of performance goals associated with PSU grants is assessed regularly and that assessment is used to </span></div>determine whether PSU grants are expected to vest. If performance-based milestones related to PSU grants are not met or not expected to be met, any compensation expense recognized associated with such grants will be reversed.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text">Deferred income tax assets and liabilities are determined based on differences between financial reporting and income tax bases of assets and liabilities and are measured using the enacted income tax rates in effect for the years in which the differences are expected to reverse. Deferred income tax benefits generally represent the change in net deferred income tax assets and liabilities in the year. Other amounts result from adjustments related to acquisitions and foreign currency as appropriate.We operate in multiple income tax jurisdictions both within the United States and internationally. Accordingly, management must determine the appropriate allocation of income to each of these jurisdictions based on current interpretations of complex income tax regulations. Income tax authorities in these jurisdictions regularly perform audits of our income tax filings. Income tax audits associated with the allocation of this income and other complex issues, including inventory transfer pricing and cost sharing, product royalty and foreign branch arrangements, may require an extended period of time to resolve and may result in significant income tax adjustments if changes to the income allocation are required between jurisdictions with different income tax rates.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Pronouncements Not Yet Adopted and Accounting Pronouncements Recently Adopted</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">New Accounting Pronouncements Not Yet Adopted</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In September 2022 the Financial Accounting Standards Board issued ASU 2022-04, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Liabilities - Supplier Finance Programs: Disclosure of Supplier Finance Program Obligations</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, which requires entities that utilize supplier finance programs in connection with the purchase of goods and services to disclose information about the key terms of the programs, a rollforward of the obligations under the programs and where those obligations are presented in the balance sheet. The new disclosure requirements are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. Currently our obligations under these programs are not material.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Accounting Pronouncements Recently Adopted </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On January 1, 2022 we adopted ASU 2021-08, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations: Accounting for Contract Assets and Contract Liabilities from Contracts with Customers</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. This update requires an entity to recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Accounting Standards Codification 606, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. The adoption of this update did not have a material impact on our Consolidated Financial Statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Goodwill and Long-Lived Assets Impairment Tests Policy [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfSalesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cost of product sold and service rendered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 705<br> -URI https://asc.fasb.org/topic&amp;trid=2122478<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfSalesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41675-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOptionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a company's election to apply the fair value option for measurement and reporting of eligible financial assets and liabilities (as defined), as well as certain other eligible items (as defined) included in the statement of financial position, whether such option is elected for a single eligible item or a group of similar eligible items and is in addition to other disclosures concerning fair value which the company may be required to provide. Such disclosure might be expected to include: (1) for items included in the statement of financial position: (a) the reasons for electing a fair value option for each eligible item or group of similar eligible items; (b) if the fair value option is elected for some but not all eligible items within a group of similar eligible items: (i) a description of those similar items and the reasons for partial election and (ii) information of how the group of similar items relates to individual balance sheet line items; (c) for each line item in the statement of financial position that includes an item or items for which the fair value option has been elected: (i) information of how each line item in the statement of financial position relates to major categories of assets and liabilities presented in accordance with other fair value disclosures and (ii) the aggregate carrying amount of ineligible items included in each line item in the balance sheet, if any; (d) the difference between the aggregate fair value and the aggregate unpaid principal balance (assuming contractual principal amounts and fair value option elected) of: (i) loans and long-term receivables (other than securities otherwise reported at fair value) and (ii) long-term debt instruments; (e) for loans held as assets for which the fair value option has been elected: (i) the aggregate fair value of loans that are 90 days or more past due, (ii) if the policy is to recognize interest income separately from other changes in fair value, the aggregate fair value of loans in nonaccrual status, and (iii) the difference between the aggregate fair value and the aggregate unpaid principal balance for loans that are 90 days or more past due, in nonaccrual status, or both; (f) for investments that would have been accounted for under the equity method if the entity had not chosen to apply the fair value option, the information required for such investments, if material either individually or in the aggregate; (2) for items included in the income statement: (a) the amounts of gains and losses from fair value changes included in earnings and in which line in the income statement those gains and losses are reported whether or not combined with gains and losses from items required to be accounted for at fair value; (b) a description of how interest and dividends are measured and where they are reported in the income statement; (c) for loans and other receivables held as assets: (i) the estimated amount of gains or losses included in earnings attributable to changes in instrument-specific credit risk and (ii) how the gains or losses attributable to changes in instrument-specific credit risk were determined; (d) for liabilities with fair values that have been significantly affected during the reporting period by changes in the instrument-specific credit risk: (i) the estimated amount of gains and losses from fair value changes included in earnings that are attributable to changes in the instrument-specific credit risk, (ii) qualitative information about the reasons for those changes, and (iii) how the gains and losses attributable to changes in instrument-specific credit risk were determined; and (3) certain other disclosures as required or determined to be provided.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14217-108612<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -URI https://asc.fasb.org/topic&amp;trid=2134543<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOptionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI https://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI https://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 330<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6471895&amp;loc=d3e55923-109411<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126900757&amp;loc=d3e543-108305<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment classified as marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=d3e62652-112803<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5033-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10178-111534<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10149-111534<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -URI https://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631672618352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionAbstract', window );"><strong>Revenue Recognition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of Disaggregated Revenue</a></td>
<td class="text"><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.259%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Segment Net Sales</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">MedSurg and Neurotechnology:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Instruments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,279&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,111&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,863&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Endoscopy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,763&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,031&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,607&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,524&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neurovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">973&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neuro Cranial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,376&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,214&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">972&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">277&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,611</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,538</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,345</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Orthopaedics and Spine:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Knees</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,848&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Hips</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,342&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Trauma and Extremities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,807&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,664&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,722&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Spine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,047&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">475&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">464&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,838</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,570</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,006</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">18,449</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">17,108</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14,351</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.259%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">United States Net Sales</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">MedSurg and Neurotechnology:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Instruments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,810&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,637&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,471&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Endoscopy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,914&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,408&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,422&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,007&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,910&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neurovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">446&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">451&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neuro Cranial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">988&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">801&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">273&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,024</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,026</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,218</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Orthopaedics and Spine:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Knees</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,493&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,351&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Hips</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">896&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">822&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">777&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Trauma and Extremities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,035&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,866&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Spine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">836&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">831&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">764&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">425&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">387&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,614</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,295</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,237</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13,638</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12,321</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,455</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.259%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">International Net Sales</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">MedSurg and Neurotechnology:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Instruments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">469&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">474&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">392&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Endoscopy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">509&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">471&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">609&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">614&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neurovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">754&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">737&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">592&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neuro Cranial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,587</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,512</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,127</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Orthopaedics and Spine:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Knees</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">504&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">497&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Hips</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">517&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Trauma and Extremities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">772&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">798&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">583&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Spine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,224</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,275</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,769</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,811</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,787</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,896</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Changes in Contract Liabilities</a></td>
<td class="text">Changes in contract liabilities during the year were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.658%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.142%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Beginning contract liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">529</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Revenue recognized from beginning of year contract liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(329)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Contract liabilities acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net advance consideration received during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">461&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Ending contract liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">741</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631672542944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</a></td>
<td class="text"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.141%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.142%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Assets Measured at Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,844&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,944&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Trading marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 1 - Assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,010</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,137</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Available-for-sale marketable securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Corporate and asset-backed debt securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign government debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States agency debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States treasury debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total available-for-sale marketable securities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign currency exchange forward contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 2 - Assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">203</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">287</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,213</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,424</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.141%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.142%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Liabilities Measured at Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deferred compensation arrangements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 1 - Liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">166</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">193</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign currency exchange forward contracts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 2 - Liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">102</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">17</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Contingent consideration:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Beginning</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">393&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in estimate </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(137)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(148)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Ending</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 3 - Liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">121</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">306</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total liabilities measured at fair value</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">389</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">516</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Available-for-sale Securities</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.141%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.142%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Fair Value of Available for Sale Securities by Maturity</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Due in one year or less</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Due after one year through three years</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631672764464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.805%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.805%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.805%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.661%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cash Flow</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Investment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-Designated</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross notional amount</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,053</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,598</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,417</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,068</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Maximum term in years</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.9</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other noncurrent assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(79)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other noncurrent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total fair value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">73</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(70)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">17</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross notional amount</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">973</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,266</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,512</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,751</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Maximum term in years</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.9</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other noncurrent assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total fair value</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">104</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">82</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">195</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"/><td style="width:28.871%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:37.804%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.274%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.274%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.277%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Net Currency Exchange Rate Gains (Losses)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Derivative Instrument</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Recorded in:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash Flow</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cost of sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net Investment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Non-Designated</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">63</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">20</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative instruments (including nonderivative instruments that are designated and qualify as hedging instruments) of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631672516640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive (Loss) Income (AOCI) (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract', window );"><strong>Reclassification Adjustments Out of Accumulated Other Comprehensive Income (AOCI) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"/><td style="width:26.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.326%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.868%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.868%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.902%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.871%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Marketable Securities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pension Plans</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Hedges</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Financial Statement Translation</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(259)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(10)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(885)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1,157)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">OCI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">551&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">724&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(101)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Reclassifications to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net OCI</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">469&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">626&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(155)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">40</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(416)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(531)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">OCI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">539&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(173)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Reclassifications to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net OCI</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">310&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">31</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">52</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(303)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(221)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reclassification Adjustments Out of Accumulated Other Comprehensive Income (AOCI) [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631657331120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Allocation Of The Preliminary Purchase Price To The Acquired Net Assets Of Acquisitions</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Purchase price allocations for our significant acquisitions are:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.486%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.878%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Purchase Price Allocation of Acquired Net Assets</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Vocera</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Tangible assets acquired:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deferred income tax assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(425)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deferred income tax liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(182)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(115)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Intangible assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Customer and distributor relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">550&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Trade name</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,328&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Purchase price, net of cash acquired of $281</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,563</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Weighted average life of intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13</span></td><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1486-128463<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631665966672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies and Commitments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Lease, Cost</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.850%"><tr><td style="width:1.0%"/><td style="width:58.493%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.376%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.253%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.378%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzItMC0xLTEtNzIxNTE_9731ce2e-d82a-4967-b042-db8cc99630f8"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzItMC0xLTEtNzIxNTE_f24b63f9-9795-4048-881d-72c0ef014936">Right-of-use assets</span></span> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">419&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzMtMC0xLTEtNzIxNTE_4a79c8d2-7e9e-4a69-8e7c-3f2c45ccd096"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzMtMC0xLTEtNzIxNTE_582bcc35-c25f-4f59-a914-b85367fcbaf4">Lease liabilities, current</span></span> </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzQtMC0xLTEtNzIxNTE_3e00ae6d-1860-4511-a971-3c7d349014a4"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzQtMC0xLTEtNzIxNTE_b077084d-a166-4834-a410-c652caa7aed3">Lease liabilities, noncurrent</span></span> </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">310&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other information:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Weighted-average remaining lease term (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5.5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;text-indent:-0.01pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5.4</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Weighted-average discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock', window );">Future Purchase Obligations and Minimum Lease Payments</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.945%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2027</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Thereafter</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Debt repayments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,208&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,450&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,250&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6,300&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Purchase obligations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,595&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Minimum lease payments</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of contractual obligation by timing of payment due. Includes, but is not limited to, long-term debt obligation, lease obligation, and purchase obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 303<br> -Paragraph (a)<br> -Subparagraph (5)<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631665710096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Changes in the Net Carrying Amount of Goodwill by Segment</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.681%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.612%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.407%"/><td style="width:0.1%"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Changes in the Net Carrying Value of Goodwill by Segment</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">MedSurg and Neurotechnology</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Orthopaedics and Spine</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,459</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,319</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12,778</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Additions and adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign exchange</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(129)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,669</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,249</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12,918</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Goodwill impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(216)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(216)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Additions and adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign exchange</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(88)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,935</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,945</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14,880</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Summary of the Company's Other Intangible Assets</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.440%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.888%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.141%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.888%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.143%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Summary of Other Intangible Assets</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted Average Amortization Period (Years)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Less<br/>Accumulated<br/>Amortization</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Developed technologies</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5,440&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,363&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,077&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5,326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,956&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Customer relationships</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,847&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,322&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,525&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,324&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Patents</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Trademarks</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">425&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">415&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">199&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">In-process research and development</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,181</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,296</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,885</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,542</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,702</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,840</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Estimated Amortization Expense</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"/><td style="width:19.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.787%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Estimated Amortization Expense</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2027</span></td></tr><tr><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">620&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">588&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">510&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">490&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=SL108378252-109267<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631664576704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Stock (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_CapitalStockAbstract', window );"><strong>Capital Stock [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Fair Value Assumptions</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.060%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.555%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.555%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.558%"/><td style="width:0.1%"/></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Option Value and Assumptions</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Weighted-average fair value per share</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">68.08&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">53.35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">39.34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Assumptions:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expected stock price volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">27.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">26.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expected option life (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5.8</span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary of Stock Option Activity</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"/><td style="width:22.819%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.479%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.173%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.513%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.196%"/><td style="width:0.1%"/></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">2022 Stock Option Activity</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares <br/>(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise&#160;Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted-Average<br/>Remaining<br/>Term (in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>&#160;Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Outstanding January&#160;1</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">150.17</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">248.36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">102.85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Canceled or forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">220.16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Outstanding December&#160;31</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">168.80</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">925.3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Exercisable December&#160;31</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">131.38&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">819.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Options expected to vest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">222.62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">102.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock', window );">Summary of RSU and PSU Activity</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"><tr><td style="width:1.0%"/><td style="width:40.807%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.460%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.245%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.460%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.245%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.217%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.245%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.221%"/><td style="width:0.1%"/></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Restricted Stock Units (RSUs) and Performance Stock Units (PSUs) Activity</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares<br/>(in&#160;millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted Average<br/>Grant&#160;Date Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">RSUs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">PSUs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">RSUs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">PSUs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nonvested on January 1</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">0.7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">0.2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">213.16</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">210.73</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">239.76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">237.17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">204.62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">179.35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Canceled or forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">225.83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">179.35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nonvested on December 31</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">0.7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">0.2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">232.02</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">234.70</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_CapitalStockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capital Stock [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_CapitalStockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631665698528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt and Credit Facilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAbstract', window );"><strong>Long-Term Debt, Unclassified [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Maturities Of Long-Term Debt Disclosures</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"><tr><td style="width:0.1%"/><td style="width:2.401%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.616%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.245%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.865%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.460%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.245%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.463%"/><td style="width:0.1%"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Summary of Total Debt</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Due</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Senior unsecured notes:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.125%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">November 30, 2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">585&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">622&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.600%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 1, 2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.375%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">May 15, 2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">596&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">593&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.250%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 3, 2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">903&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">958&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.150%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 15, 2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">647&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">645&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.375%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">November 1, 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">748&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">748&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.500%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 15, 2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">995&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">994&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.125%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">November 30, 2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">795&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">845&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.650%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 7, 2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">597&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">597&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.750%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 1, 2029</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">848&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">901&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.950%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 15, 2030</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">991&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">990&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.625%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">November 30, 2030</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">684&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">727&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.000%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 3, 2031</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">790&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">840&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.100%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">April 1, 2043</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">392&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">392&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.375%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">May 15, 2044</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">396&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.625%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 15, 2046</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">983&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">982&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.900%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 15, 2050</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">642&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">642&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Term loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13,048</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12,479</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Less current maturities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,191&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11,857</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12,472</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="15" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Unamortized debt issuance costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Borrowing capacity on existing facilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value of senior unsecured notes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10,910&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13,391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631671849808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Reconciliation of U.S. Statutory Income Tax Rate to Company's Effective Income Tax Rate from Continuing Operations</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.259%"/><td style="width:0.1%"/></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Effective Income Tax Rate Reconciliation</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">United States federal statutory rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">21.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">21.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">21.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States state and local income taxes, less federal deduction</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign income tax at rates other than 21%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Tax related to repatriation of foreign earnings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Intellectual property transfers</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States federal audit settlement</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Goodwill impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Effective income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12.6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">18.2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Provision for Income Taxes</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.259%"/><td style="width:0.1%"/></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Earnings Before Income Taxes&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">407&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">433&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,276&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,848&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,715&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,683</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,281</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,954</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.259%"/><td style="width:0.1%"/></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Components of Income Tax Expense (Benefit)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Current income tax expense (benefit):</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States federal</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States state and local</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">272&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total current income tax expense</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">267</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">524</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">307</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Deferred income tax expense (benefit):</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States federal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(179)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States state and local</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(30)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(23)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(25)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">267&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(132)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total deferred income tax expense (benefit)</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">58</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(237)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">48</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total income tax expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">325</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">287</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">355</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Difference in Income Tax Effects Comprising Company's Deferred Income Tax Assets and Liabilities</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.463%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.545%"/><td style="width:0.1%"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Deferred Income Tax Assets and Liabilities</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Deferred income tax assets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">513&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Product-related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">501&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,038&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">State income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Research and development capitalization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">International interest expense carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net operating loss and other credit carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">191&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total deferred income tax assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,712</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,861</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Less valuation allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(285)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(164)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net deferred income tax assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,427</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,697</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Deferred income tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,037)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(891)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Undistributed earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(114)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total deferred income tax liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1,084)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1,005)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net deferred income tax assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,343</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,692</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reported as:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Noncurrent deferred income tax assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,410&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,760&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Noncurrent liabilities&#8212;Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,343</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,692</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock', window );">Schedule of Unresolved Income Tax Positions</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.750%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.258%"/><td style="width:0.1%"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Uncertain Income Tax Positions</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Beginning uncertain tax positions</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">444</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">457</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Increases related to current year income tax positions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Increases related to prior year income tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Decreases related to prior year income tax positions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(178)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(18)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Settlements of income tax audits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Statute of limitations expirations and other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Ending uncertain tax positions</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">286</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">444</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reported as:</span></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Noncurrent liabilities&#8212;Income taxes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">444&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfIncomeTaxContingenciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631657685280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement Plans (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock', window );">Defined Contribution Plan Disclosures</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"/><td style="width:61.436%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.430%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Plan expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expense funded with Stryker common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Stryker common stock held by plan:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dollar amount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">522&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">542&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Shares (in millions)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Value as a percentage of total plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock', window );">Schedule of Costs of Retirement Plans</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"/><td style="width:61.436%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.430%"/><td style="width:0.1%"/></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Components of Net Periodic Pension Cost</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net periodic benefit cost:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(72)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization of prior service credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Recognized actuarial loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Curtailment gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net periodic benefit cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(59)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(74)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(70)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Changes in assets and benefit obligations recognized in OCI:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net actuarial gain (loss)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(117)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Recognized net actuarial loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Prior service credit and transition amount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Curtailment gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total recognized in other comprehensive income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">252</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">138</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(105)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total recognized in net periodic benefit cost and OCI</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">193</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">64</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(175)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted-average rates used to determine net periodic benefit cost:</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Weighted-average discount rate used to determine projected benefit obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock', window );">Schedule of Defined Benefit Plans Disclosures</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.474%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">420&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">543&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Benefit obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(673)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,036)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Funded status</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(253)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(493)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reported as:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Noncurrent assets&#8212;other assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Current liabilities&#8212;accrued compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Noncurrent liabilities&#8212;other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(271)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(491)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pre-tax amounts recognized in AOCI:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Unrecognized net actuarial gain (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(215)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Unrecognized prior service credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">44</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(208)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock', window );">Schedule of Changes in Accumulated Postemployment Benefit Obligations</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.474%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change in Benefit Obligations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Beginning projected benefit obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,036</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,118</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign exchange impact</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Employee contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Actuarial (gains) losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(354)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Curtailment gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Ending projected benefit obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">673</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,036</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Ending accumulated benefit obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">645</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">987</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock', window );">Schedule of Changes in Fair Value of Plan Assets</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.474%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change in Plan Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Beginning fair value of plan assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">543</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">522</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Actual return</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(109)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Employee contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign exchange impact</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Ending fair value of plan assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">420</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">543</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.329%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.220%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.220%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.220%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.511%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Valuation of Plan Assets </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Corporate debt securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">46</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">319</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">55</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">420</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">55</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">389</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">99</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">543</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock', window );">Schedule of Allocation of Plan Assets</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"/><td style="width:33.770%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.649%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.649%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.652%"/><td style="width:0.1%"/></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Allocation of Plan Assets</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023 Target</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022 Actual</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021 Actual</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock', window );">Schedule of Expected Benefit Payments</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"><tr><td style="width:1.0%"/><td style="width:15.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.535%"/><td style="width:0.1%"/></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Estimated Future Benefit Payments</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2027</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2028-2032</span></td></tr><tr><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of defined contribution pension plans or defined contribution other postretirement plans, separately for pension plans and other postretirement benefit plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans. This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(5)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of beginning and ending balances of the fair value of plan assets of pension plans and/or other employee benefit plans showing separately, if applicable, the effects during the period attributable to each of the following: actual return on plan assets, foreign currency exchange rate changes, contributions by the employer, contributions by plan participants, benefits paid, business combinations, divestitures, and settlements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in the benefit obligation of pension plans and/or other employee benefit plans from the beginning to the end of the period, showing separately, if applicable, the effects of the following: service cost, interest cost, contributions by plan participants, actuarial gains and losses, foreign currency exchange rate changes, benefits paid, plan amendments, business combinations, divestitures, curtailments, settlements, and special and contractual termination benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the costs related to the various types of retirement plans including defined benefit pension plan cost, defined contribution plan cost, other postretirement benefit plan cost, and net periodic benefit cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of one or more of the entity's defined benefit pension plans or one or more other defined benefit postretirement plans, separately for pension plans and other postretirement benefit plans including the entity's schedule of fair value of plan assets for defined benefit or other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2439-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2410-114920<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2417-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631672507232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Quarterly Data (Unaudited) (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialDataAbstract', window );"><strong>Quarterly Financial Data [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock', window );">Summary of Quarterly Data</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.031%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.368%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022 Quarters</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Mar 31</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Jun&#160;30</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Sep 30</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dec 31</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,275</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,493</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,479</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,202</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,734&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,782&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,236&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Earnings (loss) before income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">386&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">720&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">816&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">761&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net earnings (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">323</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">656</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">816</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">563</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net earnings (loss) per share of common stock:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dividends declared per share of common stock</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.695&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.695&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.695&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021 Quarters</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Mar 31</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Jun&#160;30</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Sep 30</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dec 31</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,953</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,294</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,160</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,701</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,509&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,772&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,045&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">757&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">302</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">592</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">438</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">662</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net earnings per share of common stock:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dividends declared per share of common stock</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.630&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.630&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.630&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.695&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialDataAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialDataAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126900988&amp;loc=d3e1280-108306<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631664613584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment and Geographic Data (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock', window );">Reconciliation of Operating Profit (Loss) from Segments to Consolidated</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.693%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.693%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.694%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Segment Results</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedSurg and Neurotechnology</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10,611&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9,538&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8,345&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Orthopaedics and Spine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,838&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,570&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6,006&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">18,449</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">17,108</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14,351</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedSurg and Neurotechnology</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">540&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">496&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Orthopaedics and Spine</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">614&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">629&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">458&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Segment depreciation and amortization </span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,154</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,147</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">954</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Corporate and Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total depreciation and amortization</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,278</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,272</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,076</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedSurg and Neurotechnology</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,737&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,807&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Orthopaedics and Spine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,588&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Segment operating income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,033</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,987</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,002</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Items not allocated to segments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Corporate and Other</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(649)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(605)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(503)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisition and integration-related charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(585)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(242)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(627)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(619)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(472)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Restructuring-related and other charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(349)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(386)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(458)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Goodwill impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(216)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medical device regulations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(140)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(107)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Recall-related matters</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(103)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Regulatory and legal matters</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated operating income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,841</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,584</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,223</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Sales and Other Financial Information by Business Segment</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.693%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.693%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.694%"/><td style="width:0.1%"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Segment Assets and Capital Spending</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedSurg and Neurotechnology</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18,283&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15,218&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15,250&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Orthopaedics and Spine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17,295&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18,149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18,090&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total segment assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">35,578</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">33,367</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">33,340</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Corporate and Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,306&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,264&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">990&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">36,884</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">34,631</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">34,330</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Purchases of property, plant and equipment:</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedSurg and Neurotechnology</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">197&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Orthopaedics and Spine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total segment purchases of property, plant and equipment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">348</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">362</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">342</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Corporate and Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total purchases of property, plant and equipment</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">588</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">525</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">487</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock', window );">Geographic Information on Net Sales and Long-Lived Assets</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.750%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.842%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.842%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.842%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.846%"/><td style="width:0.1%"/></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Geographic Information</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Sales</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Property, Plant and Equipment</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13,638&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12,321&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10,455&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,791&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,717&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Europe, Middle East, Africa</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,299&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,818&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">995&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">941&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,885&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,973&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,630&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other countries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">578&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">515&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">448&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">18,449</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">17,108</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14,351</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,970</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,833</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the names of foreign countries in which material long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets are located, and amount of such long-lived assets located in that country or foreign geographic area.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631662468480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeTermOfContract', window );">Derivative term (up to)</a></td>
<td class="text">18 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod', window );">Performance period</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=syk_PerformanceStockUnitPsusMember', window );">Performance Stock Units (PSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, useful life</a></td>
<td class="text">4 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, useful life</a></td>
<td class="text">40 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Building and Improvements | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Building and Improvements | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment useful life</a></td>
<td class="text">30 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and Equipment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and Equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment useful life</a></td>
<td class="text">15 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Performance Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period the derivative contract is outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=syk_PerformanceStockUnitPsusMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=syk_PerformanceStockUnitPsusMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631664511440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionAbstract', window );"><strong>Revenue Recognition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_PercentageofServiceRevenueRecognizeoverTime', window );">Percentage of sales recognized as services over time (less than)</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract liabilities</a></td>
<td class="nump">$ 741<span></span>
</td>
<td class="nump">$ 529<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_PercentageofServiceRevenueRecognizeoverTime">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of Service Revenue Recognize over Time</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_PercentageofServiceRevenueRecognizeoverTime</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631651477376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition - Disaggregated Sales Analysis (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="nump">$ 5,202,000<span></span>
</td>
<td class="nump">$ 4,479,000<span></span>
</td>
<td class="nump">$ 4,493,000<span></span>
</td>
<td class="nump">$ 4,275,000<span></span>
</td>
<td class="nump">$ 4,701,000<span></span>
</td>
<td class="nump">$ 4,160,000<span></span>
</td>
<td class="nump">$ 4,294,000<span></span>
</td>
<td class="nump">$ 3,953,000<span></span>
</td>
<td class="nump">$ 18,449,000<span></span>
</td>
<td class="nump">$ 17,108,000<span></span>
</td>
<td class="nump">$ 14,351,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,638,000<span></span>
</td>
<td class="nump">12,321,000<span></span>
</td>
<td class="nump">10,455,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,811,000<span></span>
</td>
<td class="nump">4,787,000<span></span>
</td>
<td class="nump">3,896,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,611,000<span></span>
</td>
<td class="nump">9,538,000<span></span>
</td>
<td class="nump">8,345,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,024,000<span></span>
</td>
<td class="nump">7,026,000<span></span>
</td>
<td class="nump">6,218,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,587,000<span></span>
</td>
<td class="nump">2,512,000<span></span>
</td>
<td class="nump">2,127,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology | Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,279,000<span></span>
</td>
<td class="nump">2,111,000<span></span>
</td>
<td class="nump">1,863,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology | Instruments | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,810,000<span></span>
</td>
<td class="nump">1,637,000<span></span>
</td>
<td class="nump">1,471,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology | Instruments | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">469,000<span></span>
</td>
<td class="nump">474,000<span></span>
</td>
<td class="nump">392,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology | Endoscopy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,423,000<span></span>
</td>
<td class="nump">2,141,000<span></span>
</td>
<td class="nump">1,763,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology | Endoscopy | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,914,000<span></span>
</td>
<td class="nump">1,670,000<span></span>
</td>
<td class="nump">1,408,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology | Endoscopy | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">509,000<span></span>
</td>
<td class="nump">471,000<span></span>
</td>
<td class="nump">355,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,031,000<span></span>
</td>
<td class="nump">2,607,000<span></span>
</td>
<td class="nump">2,524,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology | Medical | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,422,000<span></span>
</td>
<td class="nump">2,007,000<span></span>
</td>
<td class="nump">1,910,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology | Medical | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">609,000<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="nump">614,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology | Neurovascular</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="nump">1,188,000<span></span>
</td>
<td class="nump">973,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology | Neurovascular | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">446,000<span></span>
</td>
<td class="nump">451,000<span></span>
</td>
<td class="nump">381,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology | Neurovascular | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">754,000<span></span>
</td>
<td class="nump">737,000<span></span>
</td>
<td class="nump">592,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology | Neuro Cranial</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,376,000<span></span>
</td>
<td class="nump">1,214,000<span></span>
</td>
<td class="nump">972,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology | Neuro Cranial | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,135,000<span></span>
</td>
<td class="nump">988,000<span></span>
</td>
<td class="nump">801,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology | Neuro Cranial | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">241,000<span></span>
</td>
<td class="nump">226,000<span></span>
</td>
<td class="nump">171,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">302,000<span></span>
</td>
<td class="nump">277,000<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology | Other | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">297,000<span></span>
</td>
<td class="nump">273,000<span></span>
</td>
<td class="nump">247,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology | Other | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember', window );">Orthopaedics and Spine</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,838,000<span></span>
</td>
<td class="nump">7,570,000<span></span>
</td>
<td class="nump">6,006,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember', window );">Orthopaedics and Spine | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,614,000<span></span>
</td>
<td class="nump">5,295,000<span></span>
</td>
<td class="nump">4,237,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember', window );">Orthopaedics and Spine | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,224,000<span></span>
</td>
<td class="nump">2,275,000<span></span>
</td>
<td class="nump">1,769,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember', window );">Orthopaedics and Spine | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">475,000<span></span>
</td>
<td class="nump">549,000<span></span>
</td>
<td class="nump">464,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember', window );">Orthopaedics and Spine | Other | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">354,000<span></span>
</td>
<td class="nump">425,000<span></span>
</td>
<td class="nump">387,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember', window );">Orthopaedics and Spine | Other | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">121,000<span></span>
</td>
<td class="nump">124,000<span></span>
</td>
<td class="nump">77,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember', window );">Orthopaedics and Spine | Knees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,997,000<span></span>
</td>
<td class="nump">1,848,000<span></span>
</td>
<td class="nump">1,567,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember', window );">Orthopaedics and Spine | Knees | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,493,000<span></span>
</td>
<td class="nump">1,351,000<span></span>
</td>
<td class="nump">1,170,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember', window );">Orthopaedics and Spine | Knees | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">504,000<span></span>
</td>
<td class="nump">497,000<span></span>
</td>
<td class="nump">397,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember', window );">Orthopaedics and Spine | Hips</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,413,000<span></span>
</td>
<td class="nump">1,342,000<span></span>
</td>
<td class="nump">1,206,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember', window );">Orthopaedics and Spine | Hips | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">896,000<span></span>
</td>
<td class="nump">822,000<span></span>
</td>
<td class="nump">777,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember', window );">Orthopaedics and Spine | Hips | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">517,000<span></span>
</td>
<td class="nump">520,000<span></span>
</td>
<td class="nump">429,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember', window );">Orthopaedics and Spine | Trauma and Extremities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,807,000<span></span>
</td>
<td class="nump">2,664,000<span></span>
</td>
<td class="nump">1,722,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember', window );">Orthopaedics and Spine | Trauma and Extremities | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,035,000<span></span>
</td>
<td class="nump">1,866,000<span></span>
</td>
<td class="nump">1,139,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember', window );">Orthopaedics and Spine | Trauma and Extremities | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">772,000<span></span>
</td>
<td class="nump">798,000<span></span>
</td>
<td class="nump">583,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember', window );">Orthopaedics and Spine | Spine</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,146,000<span></span>
</td>
<td class="nump">1,167,000<span></span>
</td>
<td class="nump">1,047,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember', window );">Orthopaedics and Spine | Spine | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">836,000<span></span>
</td>
<td class="nump">831,000<span></span>
</td>
<td class="nump">764,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember', window );">Orthopaedics and Spine | Spine | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 310,000<span></span>
</td>
<td class="nump">$ 336,000<span></span>
</td>
<td class="nump">$ 283,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=syk_InstrumentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=syk_InstrumentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=syk_EndoscopyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=syk_EndoscopyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=syk_MedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=syk_MedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=syk_NeurovascularMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=syk_NeurovascularMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=syk_NeuroCranialMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=syk_NeuroCranialMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=syk_OtherOrthopaedicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=syk_OtherOrthopaedicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=syk_KneesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=syk_KneesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=syk_HipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=syk_HipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=syk_TraumaandExtremitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=syk_TraumaandExtremitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=syk_SpineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=syk_SpineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631657682624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition - Changes in Contract Liabilities (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_MovementInContractLiabilitiesRollForward', window );"><strong>Movement In Contract Liabilities [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Beginning contract liabilities</a></td>
<td class="nump">$ 529<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized from beginning of year contract liabilities</a></td>
<td class="num">(329)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination', window );">Contract liabilities acquired</a></td>
<td class="nump">80<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_ContractWithCustomerLiabilityNetAdvanceConsiderationReceivedDuringPeriod', window );">Net advance consideration received during the period</a></td>
<td class="nump">461<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Ending contract liabilities</a></td>
<td class="nump">$ 741<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_ContractWithCustomerLiabilityNetAdvanceConsiderationReceivedDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Liability, Net Advance Consideration Received During Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_ContractWithCustomerLiabilityNetAdvanceConsiderationReceivedDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_MovementInContractLiabilitiesRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Movement In Contract Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_MovementInContractLiabilitiesRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration from customer has been received or is due, from business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631662196112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Valuation Of Financial Instruments By Pricing Categories) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Available-for-sale marketable securities:</a></td>
<td class="nump">$ 84<span></span>
</td>
<td class="nump">$ 75<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value</a></td>
<td class="nump">2,213<span></span>
</td>
<td class="nump">3,424<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract', window );"><strong>Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value</a></td>
<td class="nump">389<span></span>
</td>
<td class="nump">516<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">(Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Available-for-sale marketable securities</a></td>
<td class="nump">1,844<span></span>
</td>
<td class="nump">2,944<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradingSecuritiesDebt', window );">Trading marketable securities</a></td>
<td class="nump">166<span></span>
</td>
<td class="nump">193<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value</a></td>
<td class="nump">2,010<span></span>
</td>
<td class="nump">3,137<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities', window );">Deferred compensation arrangements</a></td>
<td class="nump">166<span></span>
</td>
<td class="nump">193<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract', window );"><strong>Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value</a></td>
<td class="nump">166<span></span>
</td>
<td class="nump">193<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">(Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value</a></td>
<td class="nump">203<span></span>
</td>
<td class="nump">287<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract', window );"><strong>Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value</a></td>
<td class="nump">102<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">(Level 2) | Foreign currency exchange forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Foreign currency exchange forward contracts</a></td>
<td class="nump">119<span></span>
</td>
<td class="nump">212<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Interest rate swap asset</a></td>
<td class="nump">119<span></span>
</td>
<td class="nump">212<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign currency exchange forward contracts</a></td>
<td class="nump">102<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">(Level 2) | Available-for-sale marketable securities:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Available-for-sale marketable securities:</a></td>
<td class="nump">84<span></span>
</td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">(Level 2) | Available-for-sale marketable securities: | Corporate and asset-backed debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Available-for-sale marketable securities:</a></td>
<td class="nump">42<span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">(Level 2) | Available-for-sale marketable securities: | Foreign government debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Available-for-sale marketable securities:</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">(Level 2) | Available-for-sale marketable securities: | United States agency debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Available-for-sale marketable securities:</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">(Level 2) | Available-for-sale marketable securities: | United States treasury debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Available-for-sale marketable securities:</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">(Level 2) | Available-for-sale marketable securities: | Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Available-for-sale marketable securities:</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">(Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract', window );"><strong>Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Beginning</a></td>
<td class="nump">306<span></span>
</td>
<td class="nump">393<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Additions</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">62<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease', window );">Change in estimate</a></td>
<td class="num">(137)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements', window );">Settlements</a></td>
<td class="num">(49)<span></span>
</td>
<td class="num">(148)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Ending</a></td>
<td class="nump">121<span></span>
</td>
<td class="nump">306<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value</a></td>
<td class="nump">$ 121<span></span>
</td>
<td class="nump">$ 306<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Liabilities Measured on Recurring Basis, Deferred Compensation Plan Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradingSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in net income (trading).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradingSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InformationByCategoryOfDebtSecurityAxis=us-gaap_AvailableforsaleSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InformationByCategoryOfDebtSecurityAxis=us-gaap_AvailableforsaleSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignGovernmentDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ForeignGovernmentDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631665700032">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements (Available-For-Sale Securities) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Due in one year or less</a></td>
<td class="nump">$ 53<span></span>
</td>
<td class="nump">$ 36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue', window );">Due after one year through three years</a></td>
<td class="nump">$ 31<span></span>
</td>
<td class="nump">$ 39<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the fair value of debt securities which are expected to mature after one through three years of the balance sheet date and which are categorized neither as held-to-maturity nor trading securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631657634544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesGainLoss', window );">Marketable securities, gain (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 94<span></span>
</td>
<td class="nump">$ 68<span></span>
</td>
<td class="nump">$ 102<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1', window );">Reduction of contingent consideration</a></td>
<td class="nump">$ 110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of right to a contingent consideration asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized and realized gain (loss) on investment in marketable security, including other-than-temporary impairment (OTTI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631656765936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments (Forward Currency Exchange Contracts) (Details) - Foreign currency exchange forward contracts<br> $ in Millions, &#8364; in Billions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="nump">$ 6,068<span></span>
</td>
<td class="nump">$ 8,751<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1', window );">Maximum term</a></td>
<td class="text">3 years 10 months 24 days<span></span>
</td>
<td class="text">4 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Derivative, fair value, net</a></td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">$ 195<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Other noncurrent assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset</a></td>
<td class="nump">90<span></span>
</td>
<td class="nump">66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liability</a></td>
<td class="num">(85)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Other noncurrent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liability</a></td>
<td class="num">(17)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Not Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="nump">3,417<span></span>
</td>
<td class="nump">5,512<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Derivative, fair value, net</a></td>
<td class="num">(70)<span></span>
</td>
<td class="nump">82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Not Designated as Hedging Instrument | Other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Not Designated as Hedging Instrument | Other noncurrent assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Not Designated as Hedging Instrument | Other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liability</a></td>
<td class="num">(79)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Not Designated as Hedging Instrument | Other noncurrent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="nump">1,053<span></span>
</td>
<td class="nump">973<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Derivative, fair value, net</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Designated as Hedging Instrument | Other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Designated as Hedging Instrument | Other noncurrent assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Designated as Hedging Instrument | Other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liability</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Designated as Hedging Instrument | Other noncurrent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liability</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="nump">1,598<span></span>
</td>
<td class="nump">2,266<span></span>
</td>
<td class="nump">&#8364; 1.5<span></span>
</td>
<td class="nump">&#8364; 2.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Derivative, fair value, net</a></td>
<td class="nump">73<span></span>
</td>
<td class="nump">104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Designated as Hedging Instrument | Other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Designated as Hedging Instrument | Other noncurrent assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset</a></td>
<td class="nump">89<span></span>
</td>
<td class="nump">65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Designated as Hedging Instrument | Other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Designated as Hedging Instrument | Other noncurrent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liability</a></td>
<td class="num">$ (16)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of the assets less the liabilities of a derivative or group of derivatives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum amount of time remaining before foreign currency exchange rate derivatives mature or expire, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631657146736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments (Narrative) (Details)<br> $ in Millions, &#8364; in Billions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromHedgeInvestingActivities', window );">Proceeds from settlement of net investment hedges</a></td>
<td class="nump">$ 197<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign currency exchange forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">6,068<span></span>
</td>
<td class="nump">8,751<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Foreign currency exchange forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax', window );">After-tax gain (loss) recognized in AOCI related to designated net investment hedges</a></td>
<td class="nump">321<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths', window );">Cash flow hedge gain (loss) to be reclassified within twelve months</a></td>
<td class="nump">32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax', window );">Net investment hedges expected to be reclassified to cost of sales and other income (expense)</a></td>
<td class="nump">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Foreign currency exchange forward contracts | Net Investment Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">1,598<span></span>
</td>
<td class="nump">$ 2,266<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1.5<span></span>
</td>
<td class="nump">&#8364; 2.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Interest rate swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths', window );">Cash flow hedge gain (loss) to be reclassified within twelve months</a></td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Embedded Derivative Financial Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 4.4<span></span>
</td>
<td class="nump">&#8364; 4.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification from other comprehensive income (loss) to earnings from the sale or complete or substantially complete liquidation of an investment in a foreign entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromHedgeInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow for a financial contract that meets the hedge criteria as either a cash flow hedge, fair value hedge, or hedge of a net investment in a foreign operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 27<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3581-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromHedgeInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification from accumulated other comprehensive income (AOCI) of gain (loss) from increase (decrease) in fair value of net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998896-113959<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_EmbeddedDerivativeFinancialInstrumentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_EmbeddedDerivativeFinancialInstrumentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631657427616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments (Movements out of OCI) (Details) - Foreign currency exchange forward contracts - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign currency transaction gains (losses)</a></td>
<td class="nump">$ 63<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign currency transaction gains (losses)</a></td>
<td class="nump">23<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax', window );">Derivatives used in Net Investment Hedge, Gain (Loss), Reclassified to Earnings, Net of Tax</a></td>
<td class="nump">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Other income (expense), net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign currency transaction gains (losses)</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument | Other income (expense), net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign currency transaction gains (losses)</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="num">$ (10)<span></span>
</td>
<td class="num">$ (13)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification from other comprehensive income (loss) to earnings from the sale or complete or substantially complete liquidation of an investment in a foreign entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30226-110892<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=126980362&amp;loc=d3e28228-110885<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=syk_OtherIncomeexpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=syk_OtherIncomeexpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631656394432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive (Loss) Income (AOCI) (Schedule of Amounts Recognized in Other Comprehensive Income (Loss)) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Beginning of Period</a></td>
<td class="num">$ (531)<span></span>
</td>
<td class="num">$ (1,157)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">OCI</a></td>
<td class="nump">539<span></span>
</td>
<td class="nump">724<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Income taxes</a></td>
<td class="num">(173)<span></span>
</td>
<td class="num">(101)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of sales</a></td>
<td class="nump">6,871<span></span>
</td>
<td class="nump">6,140<span></span>
</td>
<td class="nump">$ 5,294<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other (income) expense, net</a></td>
<td class="num">(158)<span></span>
</td>
<td class="num">(303)<span></span>
</td>
<td class="num">(269)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income taxes</a></td>
<td class="nump">325<span></span>
</td>
<td class="nump">287<span></span>
</td>
<td class="nump">355<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">310<span></span>
</td>
<td class="nump">626<span></span>
</td>
<td class="num">(551)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), End of Period</a></td>
<td class="num">(221)<span></span>
</td>
<td class="num">(531)<span></span>
</td>
<td class="num">(1,157)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Reclassification out of Accumulated Other Comprehensive Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income taxes</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">310<span></span>
</td>
<td class="nump">626<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Reclassification out of Accumulated Other Comprehensive Income | Cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of sales</a></td>
<td class="num">(23)<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Reclassification out of Accumulated Other Comprehensive Income | Other (income) expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other (income) expense, net</a></td>
<td class="num">(36)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember', window );">Marketable Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Beginning of Period</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">OCI</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Income taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), End of Period</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember', window );">Marketable Securities | Reclassification out of Accumulated Other Comprehensive Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember', window );">Marketable Securities | Reclassification out of Accumulated Other Comprehensive Income | Cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of sales</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember', window );">Marketable Securities | Reclassification out of Accumulated Other Comprehensive Income | Other (income) expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other (income) expense, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Pension Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Beginning of Period</a></td>
<td class="num">(155)<span></span>
</td>
<td class="num">(259)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">OCI</a></td>
<td class="nump">244<span></span>
</td>
<td class="nump">123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Income taxes</a></td>
<td class="num">(64)<span></span>
</td>
<td class="num">(32)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), End of Period</a></td>
<td class="nump">31<span></span>
</td>
<td class="num">(155)<span></span>
</td>
<td class="num">(259)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Pension Plans | Reclassification out of Accumulated Other Comprehensive Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income taxes</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">186<span></span>
</td>
<td class="nump">104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Pension Plans | Reclassification out of Accumulated Other Comprehensive Income | Cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of sales</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Pension Plans | Reclassification out of Accumulated Other Comprehensive Income | Other (income) expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other (income) expense, net</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Beginning of Period</a></td>
<td class="nump">40<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">OCI</a></td>
<td class="nump">43<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Income taxes</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), End of Period</a></td>
<td class="nump">52<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Hedges | Reclassification out of Accumulated Other Comprehensive Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income taxes</a></td>
<td class="num">(4)<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Hedges | Reclassification out of Accumulated Other Comprehensive Income | Cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of sales</a></td>
<td class="num">(23)<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Hedges | Reclassification out of Accumulated Other Comprehensive Income | Other (income) expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other (income) expense, net</a></td>
<td class="num">(5)<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Financial Statement Translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Beginning of Period</a></td>
<td class="num">(416)<span></span>
</td>
<td class="num">(885)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">OCI</a></td>
<td class="nump">253<span></span>
</td>
<td class="nump">551<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Income taxes</a></td>
<td class="num">(110)<span></span>
</td>
<td class="num">(54)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), End of Period</a></td>
<td class="num">(303)<span></span>
</td>
<td class="num">(416)<span></span>
</td>
<td class="num">$ (885)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Financial Statement Translation | Reclassification out of Accumulated Other Comprehensive Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income taxes</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">113<span></span>
</td>
<td class="nump">469<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Financial Statement Translation | Reclassification out of Accumulated Other Comprehensive Income | Cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of sales</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Financial Statement Translation | Reclassification out of Accumulated Other Comprehensive Income | Other (income) expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other (income) expense, net</a></td>
<td class="num">$ (39)<span></span>
</td>
<td class="num">$ (35)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AOCIAttributableToParentNetOfTaxRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=syk_OtherIncomeexpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=syk_OtherIncomeexpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631651267216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions (Narrative) (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Nov. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Aggregate purchase price of acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,563<span></span>
</td>
<td class="nump">$ 393<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">653<span></span>
</td>
<td class="nump">$ 1,151<span></span>
</td>
<td class="nump">$ 2,297<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=syk_VoceraMember', window );">Vocera</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Aggregate purchase price of acquisitions</a></td>
<td class="nump">$ 2,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_BusinessCombinationConsiderationTransferredPricePerShare', window );">Consideration transferred, price per share (in dollars per share)</a></td>
<td class="nump">$ 79.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_BusinessCombinationConsiderationTransferredIncludingConvertibleNotes', window );">Purchase price of acquisitions, including convertible notes</a></td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based payment expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=syk_VoceraMember', window );">Vocera | 1.50% Convertible Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=syk_VoceraMember', window );">Vocera | 0.50% Convertible Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 324<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=syk_GaussMember', window );">Gauss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Aggregate purchase price of acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh', window );">Future milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_BusinessCombinationConsiderationTransferredIncludingConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Including Convertible Notes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_BusinessCombinationConsiderationTransferredIncludingConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_BusinessCombinationConsiderationTransferredPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Price Per Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_BusinessCombinationConsiderationTransferredPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of any change recognized during the period in the high-end of the estimated range of outcomes (undiscounted) of a liability assumed in a business combination arising from an item of contingent consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=syk_VoceraMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=syk_VoceraMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_A150ConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_A150ConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_A050ConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_A050ConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=syk_GaussMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=syk_GaussMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631657707424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions (Allocation Of The Preliminary Purchase Price To The Acquired Net Assets Of Acquisitions) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 14,880<span></span>
</td>
<td class="nump">$ 12,918<span></span>
</td>
<td class="nump">$ 12,778<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average life of intangible assets</a></td>
<td class="text">14 years<span></span>
</td>
<td class="text">14 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average life of intangible assets</a></td>
<td class="text">14 years<span></span>
</td>
<td class="text">13 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=syk_VoceraMember', window );">Vocera</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="nump">$ 33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets', window );">Deferred income tax assets</a></td>
<td class="nump">73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventory</a></td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="nump">92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt', window );">Debt</a></td>
<td class="num">(425)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred income tax liabilities</a></td>
<td class="num">(182)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther', window );">Other liabilities</a></td>
<td class="num">(115)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">2,328<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Purchase price, net of cash acquired of $281</a></td>
<td class="nump">$ 2,563<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average life of intangible assets</a></td>
<td class="text">13 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Cash Acquired from Acquisition</a></td>
<td class="nump">$ 281<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=syk_VoceraMember', window );">Vocera | Customer and distributor relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets:</a></td>
<td class="nump">550<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=syk_VoceraMember', window );">Vocera | Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets:</a></td>
<td class="nump">178<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=syk_VoceraMember', window );">Vocera | Trade name</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets:</a></td>
<td class="nump">$ 18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Debt</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAcquiredFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAcquiredFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=syk_VoceraMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=syk_VoceraMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=syk_CustomerAndDistributorRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=syk_CustomerAndDistributorRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631656319680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies and Commitments (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_Changeinaccrualforrecallexpenses', window );">Recall-related payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (157)<span></span>
</td>
<td class="num">$ (221)<span></span>
</td>
<td class="num">$ (17)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Lease expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">149<span></span>
</td>
<td class="nump">$ 133<span></span>
</td>
<td class="nump">$ 130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=syk_PureWickMember', window );">PureWick</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyLossInPeriod', window );">Charges during period</a></td>
<td class="nump">$ 28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyEstimateOfPossibleLoss', window );">Estimate of possible loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Recall Matters</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyEstimateOfPossibleLoss', window );">Estimate of possible loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">213<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Recall Matters</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyEstimateOfPossibleLoss', window );">Estimate of possible loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 347<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_Changeinaccrualforrecallexpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in accrual for recall expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_Changeinaccrualforrecallexpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyEstimateOfPossibleLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124440162&amp;loc=d3e12021-110248<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyEstimateOfPossibleLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyLossInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of loss pertaining to the specified contingency that was charged against earnings in the period, including the effects of revisions in previously reported estimates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyLossInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=syk_PureWickMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=syk_PureWickMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=syk_RecallMattersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=syk_RecallMattersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631662185200">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies (Lease Cost) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets</a></td>
<td class="nump">$ 473<span></span>
</td>
<td class="nump">$ 419<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Lease liabilities, current</a></td>
<td class="nump">121<span></span>
</td>
<td class="nump">112<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Lease liabilities, noncurrent</a></td>
<td class="nump">$ 357<span></span>
</td>
<td class="nump">$ 310<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term (years)</a></td>
<td class="text">5 years 6 months<span></span>
</td>
<td class="text">5 years 4 months 24 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate</a></td>
<td class="nump">3.22%<span></span>
</td>
<td class="nump">2.86%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Other Assets, Noncurrent<span></span>
</td>
<td class="text">Other Assets, Noncurrent<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]</a></td>
<td class="text">Other Liabilities, Current<span></span>
</td>
<td class="text">Other Liabilities, Current<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]</a></td>
<td class="text">Other noncurrent liabilities<span></span>
</td>
<td class="text">Other noncurrent liabilities<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes noncurrent operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes operating lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631665540320">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Contingencies and Commitments (Future Purchase Obligations and Minimum Lease Payments) (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 1,208<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2024</a></td>
<td class="nump">1,450<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2025</a></td>
<td class="nump">2,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2026</a></td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2027</a></td>
<td class="nump">750<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">Thereafter</a></td>
<td class="nump">6,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PurchaseObligationFiscalYearMaturityAbstract', window );"><strong>Purchase obligations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear', window );">2023</a></td>
<td class="nump">1,595<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear', window );">2024</a></td>
<td class="nump">68<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear', window );">2025</a></td>
<td class="nump">53<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear', window );">2026</a></td>
<td class="nump">56<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear', window );">2027</a></td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear', window );">Thereafter</a></td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Minimum lease payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">126<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">96<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">73<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">54<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2027</a></td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">$ 76<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationFiscalYearMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationFiscalYearMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of recorded unconditional purchase obligation maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25383-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of recorded unconditional purchase obligation to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25383-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of recorded unconditional purchase obligation to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25383-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of recorded unconditional purchase obligation to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25383-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of recorded unconditional purchase obligation to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25383-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of recorded unconditional purchase obligation to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25383-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631651310976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Goodwill) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 14,880<span></span>
</td>
<td class="nump">$ 12,918<span></span>
</td>
<td class="nump">$ 12,778<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="nump">216<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Beginning balance</a></td>
<td class="nump">12,918<span></span>
</td>
<td class="nump">12,778<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Additions and adjustments</a></td>
<td class="nump">2,320<span></span>
</td>
<td class="nump">282<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Foreign exchange</a></td>
<td class="num">(142)<span></span>
</td>
<td class="num">(142)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="num">(216)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Ending balance</a></td>
<td class="nump">14,880<span></span>
</td>
<td class="nump">12,918<span></span>
</td>
<td class="nump">12,778<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReportingUnitAxis=syk_SpineReportingUnitMember', window );">Spine Reporting Unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">1,002<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Ending balance</a></td>
<td class="nump">1,002<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">7,935<span></span>
</td>
<td class="nump">5,669<span></span>
</td>
<td class="nump">5,459<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Beginning balance</a></td>
<td class="nump">5,669<span></span>
</td>
<td class="nump">5,459<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Additions and adjustments</a></td>
<td class="nump">2,320<span></span>
</td>
<td class="nump">223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Foreign exchange</a></td>
<td class="num">(54)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Ending balance</a></td>
<td class="nump">7,935<span></span>
</td>
<td class="nump">5,669<span></span>
</td>
<td class="nump">5,459<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember', window );">Orthopaedics and Spine</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">6,945<span></span>
</td>
<td class="nump">7,249<span></span>
</td>
<td class="nump">7,319<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="nump">216<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Beginning balance</a></td>
<td class="nump">7,249<span></span>
</td>
<td class="nump">7,319<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Additions and adjustments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Foreign exchange</a></td>
<td class="num">(88)<span></span>
</td>
<td class="num">(129)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="num">(216)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Ending balance</a></td>
<td class="nump">$ 6,945<span></span>
</td>
<td class="nump">$ 7,249<span></span>
</td>
<td class="nump">$ 7,319<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e961-128460<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=syk_SpineReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=syk_SpineReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631671663472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Summary of the Company's Other Intangible Assets) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="nump">$ 216<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted Average Amortization Period (Years)</a></td>
<td class="text">14 years<span></span>
</td>
<td class="text">14 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 9,181<span></span>
</td>
<td class="nump">$ 8,542<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less Accumulated Amortization</a></td>
<td class="nump">4,296<span></span>
</td>
<td class="nump">3,702<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 4,885<span></span>
</td>
<td class="nump">$ 4,840<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed technologies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted Average Amortization Period (Years)</a></td>
<td class="text">14 years<span></span>
</td>
<td class="text">13 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 5,440<span></span>
</td>
<td class="nump">$ 5,326<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less Accumulated Amortization</a></td>
<td class="nump">2,363<span></span>
</td>
<td class="nump">1,956<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 3,077<span></span>
</td>
<td class="nump">$ 3,370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted Average Amortization Period (Years)</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 2,847<span></span>
</td>
<td class="nump">$ 2,324<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less Accumulated Amortization</a></td>
<td class="nump">1,322<span></span>
</td>
<td class="nump">1,174<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 1,525<span></span>
</td>
<td class="nump">$ 1,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted Average Amortization Period (Years)</a></td>
<td class="text">11 years<span></span>
</td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 343<span></span>
</td>
<td class="nump">$ 343<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less Accumulated Amortization</a></td>
<td class="nump">297<span></span>
</td>
<td class="nump">286<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 46<span></span>
</td>
<td class="nump">$ 57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted Average Amortization Period (Years)</a></td>
<td class="text">16 years<span></span>
</td>
<td class="text">16 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 425<span></span>
</td>
<td class="nump">$ 415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less Accumulated Amortization</a></td>
<td class="nump">220<span></span>
</td>
<td class="nump">199<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">205<span></span>
</td>
<td class="nump">216<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">In-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less Accumulated Amortization</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 21<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted Average Amortization Period (Years)</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">9 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 105<span></span>
</td>
<td class="nump">$ 105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less Accumulated Amortization</a></td>
<td class="nump">94<span></span>
</td>
<td class="nump">87<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631661355328">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Estimated Amortization Expense) (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 620<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2024</a></td>
<td class="nump">588<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2025</a></td>
<td class="nump">568<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2026</a></td>
<td class="nump">510<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2027</a></td>
<td class="nump">$ 490<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631657146112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Stock (Narrative) (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Capital Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_CommonAndPreferredStockSharesAuthorized', window );">Common and Preferred Stock, shares authorized (in shares)</a></td>
<td class="nump">1,000,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par per share</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized (in shares)</a></td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Remaining shares authorized to be repurchased</a></td>
<td class="nump">$ 1,033<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Capital shares reserved for future issuance</a></td>
<td class="nump">23,000,000<span></span>
</td>
<td class="nump">25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Aggregate intrinsic value of options exercised</a></td>
<td class="nump">$ 218<span></span>
</td>
<td class="nump">$ 253<span></span>
</td>
<td class="nump">$ 258<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Options exercised during period, exercise price range, lower range limit</a></td>
<td class="nump">$ 64.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Options exercised during period, exercise price range, upper range limit</a></td>
<td class="nump">$ 270.94<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Compensation cost not yet recognized</a></td>
<td class="nump">$ 111<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Compensation cost not yet recognized, period for recognized</a></td>
<td class="text">1 year 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Capital Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Compensation cost not yet recognized</a></td>
<td class="nump">$ 72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Compensation cost not yet recognized, period for recognized</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value, Granted (in dollars per share)</a></td>
<td class="nump">$ 239.76<span></span>
</td>
<td class="nump">$ 230.61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue', window );">Shares vested during the period</a></td>
<td class="nump">$ 75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=syk_PerformanceStockUnitPsusMember', window );">Performance Stock Units (PSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Capital Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Compensation cost not yet recognized</a></td>
<td class="nump">$ 18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Compensation cost not yet recognized, period for recognized</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value, Granted (in dollars per share)</a></td>
<td class="nump">$ 237.17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue', window );">Shares vested during the period</a></td>
<td class="nump">$ 14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">Employee Stock Purchase Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Capital Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp', window );">Percentage of closing stock price under ESPP</a></td>
<td class="nump">95.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Shares issued under the ESPP</a></td>
<td class="nump">221,387<span></span>
</td>
<td class="nump">183,964<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_CommonAndPreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common And Preferred Stock, Shares Authorized</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_CommonAndPreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of Closing Stock Price Represents Purchase Price Under ESPP</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement By Share Based Payment Award Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=syk_PerformanceStockUnitPsusMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=syk_PerformanceStockUnitPsusMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631665400192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Stock (Option Grant Assumptions) (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_CapitalStockAbstract', window );"><strong>Capital Stock [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average fair value per share</a></td>
<td class="nump">$ 68.08<span></span>
</td>
<td class="nump">$ 53.35<span></span>
</td>
<td class="nump">$ 39.34<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">1.80%<span></span>
</td>
<td class="nump">0.80%<span></span>
</td>
<td class="nump">1.40%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.20%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected stock price volatility</a></td>
<td class="nump">27.00%<span></span>
</td>
<td class="nump">26.90%<span></span>
</td>
<td class="nump">18.90%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected option life (years)</a></td>
<td class="text">5 years 10 months 24 days<span></span>
</td>
<td class="text">5 years 10 months 24 days<span></span>
</td>
<td class="text">5 years 9 months 18 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_CapitalStockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capital Stock [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_CapitalStockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631656645040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Stock (Summary of Stock Option Activity) (Details)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Shares, Options outstanding at January 1 (in shares) | shares</a></td>
<td class="nump">12.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Shares, Granted (in shares) | shares</a></td>
<td class="nump">1.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Shares, Exercised (in shares) | shares</a></td>
<td class="num">(1.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Shares, Cancelled or forfeited (in shares) | shares</a></td>
<td class="num">(0.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Shares, Options outstanding at December 31 (in shares) | shares</a></td>
<td class="nump">12.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Shares, Exercisable at December 31 (in shares) | shares</a></td>
<td class="nump">7.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Shares, Options expected to vest (in shares) | shares</a></td>
<td class="nump">4.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise&#160;Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price, Options outstanding at January 1 (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 150.17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">248.36<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, Exercised (in dollars per share) | $ / shares</a></td>
<td class="nump">102.85<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, Cancelled or forfeited (in dollars per share) | $ / shares</a></td>
<td class="nump">220.16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price, Options outstanding at December 31 (in dollars per share) | $ / shares</a></td>
<td class="nump">168.80<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted average exercise price, Exercisable at December 31 (in dollars per share) | $ / shares</a></td>
<td class="nump">131.38<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price, Options expected to vest (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 222.62<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted-average remaining contractual term, Options outstanding at December 31 (in years)</a></td>
<td class="text">5 years 4 months 24 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted-average remaining contractual term, Exercisable at December 31 (in years)</a></td>
<td class="text">3 years 1 month 6 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Weighted-average remaining contractual term, Options expected to vest (in years)</a></td>
<td class="text">7 years 8 months 12 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value, Options outstanding at December 31 | $</a></td>
<td class="nump">$ 925.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate intrinsic value, Exercisable at December 31 | $</a></td>
<td class="nump">819.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Aggregate intrinsic value, Options expected to vest | $</a></td>
<td class="nump">$ 102.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631657049936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Stock (Summary of RSU and PSU Activity) (Details) - $ / shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Shares, Nonvested at January 1 (in shares)</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Shares, Granted (in shares)</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Shares, Vested (in shares)</a></td>
<td class="num">(0.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Shares, Cancelled (in shares)</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Shares, Nonvested at December 31 (in shares)</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value, Outstanding at January 1 (in dollars per share)</a></td>
<td class="nump">$ 213.16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value, Granted (in dollars per share)</a></td>
<td class="nump">239.76<span></span>
</td>
<td class="nump">$ 230.61<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value, Vested (in dollars per share)</a></td>
<td class="nump">204.62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value, Cancelled (in dollars per share)</a></td>
<td class="nump">225.83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value, Outstanding at December 31 (in dollars per share)</a></td>
<td class="nump">$ 232.02<span></span>
</td>
<td class="nump">$ 213.16<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=syk_PerformanceStockUnitPsusMember', window );">Performance Stock Units (PSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Shares, Nonvested at January 1 (in shares)</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Shares, Granted (in shares)</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Shares, Vested (in shares)</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Shares, Cancelled (in shares)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Shares, Nonvested at December 31 (in shares)</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value, Outstanding at January 1 (in dollars per share)</a></td>
<td class="nump">$ 210.73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value, Granted (in dollars per share)</a></td>
<td class="nump">237.17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value, Vested (in dollars per share)</a></td>
<td class="nump">179.35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value, Cancelled (in dollars per share)</a></td>
<td class="nump">179.35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value, Outstanding at December 31 (in dollars per share)</a></td>
<td class="nump">$ 234.70<span></span>
</td>
<td class="nump">$ 210.73<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=syk_PerformanceStockUnitPsusMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=syk_PerformanceStockUnitPsusMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631656646672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt and Credit Facilities (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommercialPaper', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense, debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">337,000,000<span></span>
</td>
<td class="nump">$ 337,000,000<span></span>
</td>
<td class="nump">$ 315,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_TermLoanDueFebruary222025Member', window );">Term Loan Due February 22, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt face amount</a></td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">650,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_TermLoanDueFebruary222025Member', window );">Term Loan Due February 22, 2025 | SOFR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">0.725%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_CreditAgreementMember', window );">Credit Agreement | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,250,000,000<span></span>
</td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of short-term borrowings using unsecured obligations issued by banks, corporations and other borrowers to investors. The maturities of these money market securities generally do not exceed 270 days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_TermLoanDueFebruary222025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_TermLoanDueFebruary222025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_CreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_CreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631657201984">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt and Credit Facilities (Maturities Of Long-Term Debt Disclosures) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLongTermDebt', window );">Other long-term debt</a></td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtLongtermAndShorttermCombinedAmount', window );">Total debt</a></td>
<td class="nump">13,048<span></span>
</td>
<td class="nump">12,479<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Current maturities of debt</a></td>
<td class="nump">1,191<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Total long-term debt</a></td>
<td class="nump">11,857<span></span>
</td>
<td class="nump">12,472<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnamortizedDebtIssuanceExpense', window );">Unamortized debt issuance costs</a></td>
<td class="nump">52<span></span>
</td>
<td class="nump">62<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Borrowing capacity on existing facilities</a></td>
<td class="nump">2,162<span></span>
</td>
<td class="nump">2,162<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Fair value of senior unsecured notes</a></td>
<td class="nump">$ 10,910<span></span>
</td>
<td class="nump">13,391<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotesDueNovember2023Member', window );">Senior Unsecured Notes, 1.125%, due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">1.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Unsecured debt</a></td>
<td class="nump">$ 585<span></span>
</td>
<td class="nump">622<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes0600Due2023Member', window );">Senior Unsecured Notes 0.600% due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">0.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Unsecured debt</a></td>
<td class="nump">$ 599<span></span>
</td>
<td class="nump">598<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes3.375due2024Member', window );">Senior Unsecured Notes 3.375% due 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">3.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Unsecured debt</a></td>
<td class="nump">$ 596<span></span>
</td>
<td class="nump">593<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes0.250due2024Member', window );">Senior Unsecured Notes 0.250% due 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Unsecured debt</a></td>
<td class="nump">$ 903<span></span>
</td>
<td class="nump">958<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes1.150Due2025Member', window );">Senior Unsecured Notes, 1.150% Due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">1.15%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Unsecured debt</a></td>
<td class="nump">$ 647<span></span>
</td>
<td class="nump">645<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes3.375due2025MemberMember', window );">Senior Unsecured Notes 3.375% due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">3.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Unsecured debt</a></td>
<td class="nump">$ 748<span></span>
</td>
<td class="nump">748<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes350Due2026Member', window );">Senior Unsecured Notes 3.50% due 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Unsecured debt</a></td>
<td class="nump">$ 995<span></span>
</td>
<td class="nump">994<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotesDueNovember2027Member', window );">Senior Unsecured Notes,2.125%, due 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">2.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Unsecured debt</a></td>
<td class="nump">$ 795<span></span>
</td>
<td class="nump">845<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes3650Due2028Member', window );">Senior Unsecured Notes 3.650% due 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">3.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Unsecured debt</a></td>
<td class="nump">$ 597<span></span>
</td>
<td class="nump">597<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes0.750due2029Member', window );">Senior Unsecured Notes 0.750% due 2029</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Unsecured debt</a></td>
<td class="nump">$ 848<span></span>
</td>
<td class="nump">901<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes1.950Due2030Member', window );">Senior Unsecured Notes, 1.950% Due 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">1.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Unsecured debt</a></td>
<td class="nump">$ 991<span></span>
</td>
<td class="nump">990<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotesDueNovember2030Member', window );">Senior Unsecured Notes, 2.625% due 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">2.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Unsecured debt</a></td>
<td class="nump">$ 684<span></span>
</td>
<td class="nump">727<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes1.000due2031Member', window );">Senior Unsecured Notes 1.000% due 2031</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Unsecured debt</a></td>
<td class="nump">$ 790<span></span>
</td>
<td class="nump">840<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes410Due2043Member', window );">Senior Unsecured Notes 4.10% due 2043</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">4.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Unsecured debt</a></td>
<td class="nump">$ 392<span></span>
</td>
<td class="nump">392<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes4.375due2044Member', window );">Senior Unsecured Notes 4.375% due 2044</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">4.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Unsecured debt</a></td>
<td class="nump">$ 396<span></span>
</td>
<td class="nump">395<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes4625Due2046Member', window );">Senior Unsecured Notes 4.625% due 2046</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Unsecured debt</a></td>
<td class="nump">$ 983<span></span>
</td>
<td class="nump">982<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes2.900due2050Member', window );">Senior Unsecured Notes, 2.900% due 2050</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">2.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Unsecured debt</a></td>
<td class="nump">$ 642<span></span>
</td>
<td class="nump">642<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_TermLoanMember', window );">Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 850<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtLongtermAndShorttermCombinedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the aggregate of total long-term debt, including current maturities and short-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtLongtermAndShorttermCombinedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnamortizedDebtIssuanceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnamortizedDebtIssuanceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnsecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of uncollateralized debt obligations (with maturities initially due after one year or beyond the operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnsecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotesDueNovember2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotesDueNovember2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes0600Due2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes0600Due2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes3.375due2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes3.375due2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes0.250due2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes0.250due2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes1.150Due2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes1.150Due2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes3.375due2025MemberMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes3.375due2025MemberMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes350Due2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes350Due2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotesDueNovember2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotesDueNovember2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes3650Due2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes3650Due2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes0.750due2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes0.750due2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes1.950Due2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes1.950Due2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotesDueNovember2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotesDueNovember2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes1.000due2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes1.000due2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes410Due2043Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes410Due2043Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes4.375due2044Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes4.375due2044Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes4625Due2046Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes4625Due2046Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes2.900due2050Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes2.900due2050Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631661292000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax, percent</a></td>
<td class="nump">12.10%<span></span>
</td>
<td class="nump">12.60%<span></span>
</td>
<td class="nump">18.20%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense', window );">Interest expense and penalties included in other income (expense), net</a></td>
<td class="nump">$ 71<span></span>
</td>
<td class="num">$ (23)<span></span>
</td>
<td class="num">$ (35)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized', window );">Net operating loss carryforward recognized</a></td>
<td class="nump">56<span></span>
</td>
<td class="nump">283<span></span>
</td>
<td class="nump">$ 41<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued', window );">Accrued interest and penalties</a></td>
<td class="nump">66<span></span>
</td>
<td class="nump">150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">544<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_OperatingLossCarryforwardsSubjectToValuationAllowance', window );">Operating loss carryforwards, subject to full valuation allowance</a></td>
<td class="nump">155<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforward, amount</a></td>
<td class="nump">133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardValuationAllowance', window );">Tax credit carryforward, valuation allowance</a></td>
<td class="nump">91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense', window );">Unrecognized tax benefits, interest on income tax expense</a></td>
<td class="nump">289<span></span>
</td>
<td class="nump">$ 445<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxSettlements', window );">Tax settlement amount</a></td>
<td class="nump">162<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_IncomeTaxExpenseBenefitTaxSettlementReleaseOfAccruedInterest', window );">Tax settlement, release of accrued interest</a></td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">377<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_ForeignCountryMember', window );">Foreign Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">$ 167<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_IncomeTaxExpenseBenefitTaxSettlementReleaseOfAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Tax Expense (Benefit), Tax Settlement, Release Of Accrued Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_IncomeTaxExpenseBenefitTaxSettlementReleaseOfAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income tax expense (benefit), Portion of Net Operating Loss Carryforward Recognized</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_OperatingLossCarryforwardsSubjectToValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Loss Carryforwards, Subject to Valuation Allowance</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_OperatingLossCarryforwardsSubjectToValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income tax settlements. Including, but not limited to, domestic tax settlement, foreign tax settlement, state and local tax settlement, and other tax settlements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from tax credit carryforwards for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense for an underpayment of income taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631665503168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Schedule of Reconciliation of U.S. Statutory Income Tax Rate to Company's Effective Income Tax Rate from Continuing Operations) (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">United States federal statutory rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">United States state and local income taxes, less federal deduction</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">2.70%<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Foreign income tax at rates other than 21%</a></td>
<td class="num">(4.10%)<span></span>
</td>
<td class="num">(6.90%)<span></span>
</td>
<td class="num">(3.30%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent', window );">Tax related to repatriation of foreign earnings</a></td>
<td class="num">(2.40%)<span></span>
</td>
<td class="nump">1.40%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent', window );">Intellectual property transfers</a></td>
<td class="nump">0.10%<span></span>
</td>
<td class="num">(2.30%)<span></span>
</td>
<td class="num">(1.40%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic', window );">United States federal audit settlement</a></td>
<td class="num">(6.10%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses', window );">Goodwill impairment</a></td>
<td class="nump">1.70%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other</a></td>
<td class="num">(0.10%)<span></span>
</td>
<td class="num">(3.30%)<span></span>
</td>
<td class="num">(1.20%)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">12.10%<span></span>
</td>
<td class="nump">12.60%<span></span>
</td>
<td class="nump">18.20%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Foreign Earnings Repatriation, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Transfer Of Intellectual Property, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to impairment loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to domestic income tax settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631665537872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Schedule of Earnings before Income Taxes) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 407<span></span>
</td>
<td class="nump">$ 433<span></span>
</td>
<td class="nump">$ 239<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,276<span></span>
</td>
<td class="nump">1,848<span></span>
</td>
<td class="nump">1,715<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings before income taxes</a></td>
<td class="nump">$ 761<span></span>
</td>
<td class="nump">$ 816<span></span>
</td>
<td class="nump">$ 720<span></span>
</td>
<td class="nump">$ 386<span></span>
</td>
<td class="nump">$ 757<span></span>
</td>
<td class="nump">$ 495<span></span>
</td>
<td class="nump">$ 662<span></span>
</td>
<td class="nump">$ 367<span></span>
</td>
<td class="nump">$ 2,683<span></span>
</td>
<td class="nump">$ 2,281<span></span>
</td>
<td class="nump">$ 1,954<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631661229472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Schedule of Provision for Income Taxes) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current income tax expense (benefit):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">United States federal</a></td>
<td class="num">$ (76)<span></span>
</td>
<td class="nump">$ 155<span></span>
</td>
<td class="nump">$ 80<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">United States state and local</a></td>
<td class="nump">64<span></span>
</td>
<td class="nump">97<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">International</a></td>
<td class="nump">279<span></span>
</td>
<td class="nump">272<span></span>
</td>
<td class="nump">207<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current income tax expense</a></td>
<td class="nump">267<span></span>
</td>
<td class="nump">524<span></span>
</td>
<td class="nump">307<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred income tax expense (benefit):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">United States federal</a></td>
<td class="num">(179)<span></span>
</td>
<td class="num">(82)<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">United States state and local</a></td>
<td class="num">(30)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
<td class="num">(25)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">International</a></td>
<td class="nump">267<span></span>
</td>
<td class="num">(132)<span></span>
</td>
<td class="nump">72<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total deferred income tax expense (benefit)</a></td>
<td class="nump">58<span></span>
</td>
<td class="num">(237)<span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total income tax expense</a></td>
<td class="nump">$ 325<span></span>
</td>
<td class="nump">$ 287<span></span>
</td>
<td class="nump">$ 355<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631651344976">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes (Schedule of Difference in Income Tax Effects Comprising Company's Deferred Income Tax Assets and Liabilities) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract', window );"><strong>Deferred income tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInventory', window );">Inventories</a></td>
<td class="nump">$ 516<span></span>
</td>
<td class="nump">$ 513<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves', window );">Product-related liabilities</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther', window );">Other accrued expenses</a></td>
<td class="nump">155<span></span>
</td>
<td class="nump">501<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_DeferredTaxAssetsDepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">1,038<span></span>
</td>
<td class="nump">1,194<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsStateTaxes', window );">State income taxes</a></td>
<td class="nump">153<span></span>
</td>
<td class="nump">128<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Share-based compensation</a></td>
<td class="nump">73<span></span>
</td>
<td class="nump">63<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_DeferredTaxAssetsResearchAndDevelopmentCapitalization', window );">Research and development capitalization</a></td>
<td class="nump">204<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetInterestCarryforward', window );">International interest expense carryforwards</a></td>
<td class="nump">135<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss and other credit carryforwards</a></td>
<td class="nump">247<span></span>
</td>
<td class="nump">232<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">165<span></span>
</td>
<td class="nump">191<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred income tax assets</a></td>
<td class="nump">2,712<span></span>
</td>
<td class="nump">2,861<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less valuation allowances</a></td>
<td class="num">(285)<span></span>
</td>
<td class="num">(164)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Net deferred income tax assets</a></td>
<td class="nump">2,427<span></span>
</td>
<td class="nump">2,697<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract', window );"><strong>Deferred income tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_DeferredTaxLiabilitiesDepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="num">(1,037)<span></span>
</td>
<td class="num">(891)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings', window );">Undistributed earnings</a></td>
<td class="num">(47)<span></span>
</td>
<td class="num">(114)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred income tax liabilities</a></td>
<td class="num">(1,084)<span></span>
</td>
<td class="num">(1,005)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred income tax assets</a></td>
<td class="nump">1,343<span></span>
</td>
<td class="nump">1,692<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Noncurrent deferred income tax assets</a></td>
<td class="nump">1,410<span></span>
</td>
<td class="nump">1,760<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Noncurrent liabilities&#8212;Other liabilities</a></td>
<td class="num">$ (67)<span></span>
</td>
<td class="num">$ (68)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_DeferredTaxAssetsDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Depreciation And Amortization</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_DeferredTaxAssetsDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_DeferredTaxAssetsResearchAndDevelopmentCapitalization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Research And Development Capitalization</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_DeferredTaxAssetsResearchAndDevelopmentCapitalization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_DeferredTaxLiabilitiesDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities Depreciation And Amortization</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_DeferredTaxLiabilitiesDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetInterestCarryforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible interest carryforward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetInterestCarryforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsStateTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from state taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsStateTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves and accruals, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from undistributed earnings of subsidiary and other recognized entity not within country of domicile. Includes, but is not limited to, other basis differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631661249120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Schedule of Unresolved Income Tax Positions) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Beginning uncertain tax positions</a></td>
<td class="nump">$ 444<span></span>
</td>
<td class="nump">$ 457<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Increases related to current year income tax positions</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Increases related to prior year income tax positions</a></td>
<td class="nump">34<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Decreases related to prior year income tax positions</a></td>
<td class="num">(178)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities', window );">Settlements of income tax audits</a></td>
<td class="num">(13)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Statute of limitations expirations and other</a></td>
<td class="num">(6)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation', window );">Foreign currency translation</a></td>
<td class="num">(12)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Ending uncertain tax positions</a></td>
<td class="nump">$ 286<span></span>
</td>
<td class="nump">$ 444<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from foreign currency translation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631651253712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement Plans (Schedule of Defined Contribution Plan Disclosures) (Details) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Plan expense</a></td>
<td class="nump">$ 305<span></span>
</td>
<td class="nump">$ 259<span></span>
</td>
<td class="nump">$ 235<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount', window );">Expense funded with Stryker common stock</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_DefinedContributionRetirementPlansCommonStockValueHeldByCompany', window );">Stryker common stock held by plan, amount</a></td>
<td class="nump">$ 522<span></span>
</td>
<td class="nump">$ 582<span></span>
</td>
<td class="nump">$ 542<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_DefinedContributionRetirementPlansCommonStockHeldByCompany', window );">Stryker common stock held by plan, shares</a></td>
<td class="nump">2.1<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany', window );">Stryker common stock held by plan, value as a percentage of total plan assets</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_DefinedContributionRetirementPlansCommonStockHeldByCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Contribution Retirement Plans Common Stock Held by Company</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_DefinedContributionRetirementPlansCommonStockHeldByCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_DefinedContributionRetirementPlansCommonStockValueHeldByCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Contribution Retirement Plans Common Stock Value Held by Company</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_DefinedContributionRetirementPlansCommonStockValueHeldByCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total Percentage of Defined Contribution Retirement Plan Assets Value Held by Company</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanCostRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanCostRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of discretionary contributions made by an employer to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631656730080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement Plans (Schedule of Funded Status and Components of the Amounts Recognized in the Consolidated Balance Sheets and in Accumulated Other Comprehensive Gain (Loss), Before the Effect of Income Taxes) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract', window );"><strong>Components of Net Periodic Pension Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="num">$ (56)<span></span>
</td>
<td class="num">$ (72)<span></span>
</td>
<td class="num">$ (63)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="num">(10)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit', window );">Amortization of prior service cost and transition amount</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Recognized actuarial loss</a></td>
<td class="num">(9)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments', window );">Curtailment gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost</a></td>
<td class="num">(59)<span></span>
</td>
<td class="num">(74)<span></span>
</td>
<td class="num">(70)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax', window );">Net actuarial gain (loss)</a></td>
<td class="nump">244<span></span>
</td>
<td class="nump">132<span></span>
</td>
<td class="num">(117)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax', window );">Recognized net actuarial loss</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax', window );">Prior service cost and transition amount</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax', window );">Curtailment gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent', window );">Total recognized in OCI</a></td>
<td class="nump">252<span></span>
</td>
<td class="nump">138<span></span>
</td>
<td class="num">(105)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax', window );">Total recognized in net periodic benefit cost and OCI</a></td>
<td class="nump">$ 193<span></span>
</td>
<td class="nump">$ 64<span></span>
</td>
<td class="num">$ (175)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract', window );"><strong>Defined Benefit Plan, Assumptions Used in Calculations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate', window );">Discount rate</a></td>
<td class="nump">1.10%<span></span>
</td>
<td class="nump">0.80%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected return on plan assets</a></td>
<td class="nump">3.10%<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="nump">2.90%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease', window );">Expected return on plan assets</a></td>
<td class="nump">2.60%<span></span>
</td>
<td class="nump">2.60%<span></span>
</td>
<td class="nump">2.90%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_WeightedAverageUsedInDeterminationOfProjectedBenefitObligations', window );">Weighted-average discount rate used to determine projected benefit obligations</a></td>
<td class="nump">3.30%<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
<td class="nump">0.80%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract', window );"><strong>Defined Benefit Plan, Information about Plan Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 420<span></span>
</td>
<td class="nump">$ 543<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligations</a></td>
<td class="num">(673)<span></span>
</td>
<td class="num">(1,036)<span></span>
</td>
<td class="num">$ (1,118)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded status</a></td>
<td class="num">(253)<span></span>
</td>
<td class="num">(493)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax', window );">Total</a></td>
<td class="nump">44<span></span>
</td>
<td class="num">(208)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=syk_AccruedCompensationMember', window );">Accrued Compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract', window );"><strong>Defined Benefit Plan, Information about Plan Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded status</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember', window );">Other noncurrent assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract', window );"><strong>Defined Benefit Plan, Information about Plan Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded status</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember', window );">Other noncurrent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract', window );"><strong>Defined Benefit Plan, Information about Plan Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded status</a></td>
<td class="num">(271)<span></span>
</td>
<td class="num">(491)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember', window );">Accumulated Defined Benefit Plans Adjustment, Net Prior Service Attributable to Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract', window );"><strong>Defined Benefit Plan, Information about Plan Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax', window );">Unrecognized net actuarial gain (loss)</a></td>
<td class="nump">33<span></span>
</td>
<td class="num">(215)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax', window );">Unrecognized prior service credit</a></td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_WeightedAverageUsedInDeterminationOfProjectedBenefitObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Used in the Determination of the Projected Benefit Obligations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_WeightedAverageUsedInDeterminationOfProjectedBenefitObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of accumulated other comprehensive (income) loss for cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(5)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(5)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2919-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFundedStatusOfPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit from event reducing expected years of future service of present employees or eliminating accrual of defined benefits for some or all future services of present employees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(7)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(7)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (j)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of increase (decrease) to other comprehensive income from settlement and curtailment gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL34724391-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=syk_AccruedCompensationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=syk_AccruedCompensationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631661229712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement Plans (Schedule of Change in Benefit Obligations (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward', window );"><strong>Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Beginning projected benefit obligations</a></td>
<td class="nump">$ 1,036<span></span>
</td>
<td class="nump">$ 1,118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">56<span></span>
</td>
<td class="nump">72<span></span>
</td>
<td class="nump">$ 63<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation', window );">Foreign exchange impact</a></td>
<td class="num">(56)<span></span>
</td>
<td class="num">(70)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant', window );">Employee contributions</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial (gains) losses</a></td>
<td class="num">(354)<span></span>
</td>
<td class="num">(71)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanCurtailments', window );">Curtailment gain</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(23)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Benefits paid</a></td>
<td class="num">(24)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Ending projected benefit obligations</a></td>
<td class="nump">673<span></span>
</td>
<td class="nump">1,036<span></span>
</td>
<td class="nump">$ 1,118<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation', window );">Ending accumulated benefit obligations</a></td>
<td class="nump">$ 645<span></span>
</td>
<td class="nump">$ 987<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActuarialGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActuarialGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(6)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contributions received by defined benefit plan from participant which increase benefit obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanCurtailments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of (increase) decrease in benefit obligation of defined benefit plan from event reducing expected years of future service of present employees or eliminating accrual of benefits for some or all future services of present employees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(10)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanCurtailments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(5)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631662476384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement Plans (Change in Plan Assets) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent', window );">Beginning fair value of plan assets</a></td>
<td class="nump">$ 543<span></span>
</td>
<td class="nump">$ 522<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Actual return</a></td>
<td class="num">(109)<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Employer contributions</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant', window );">Employee contributions</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss', window );">Foreign exchange impact</a></td>
<td class="num">(24)<span></span>
</td>
<td class="num">(29)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid', window );">Benefits paid</a></td>
<td class="num">(14)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent', window );">Ending fair value of plan assets</a></td>
<td class="nump">$ 420<span></span>
</td>
<td class="nump">$ 543<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(5)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contributions received by defined benefit plan from participant which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631665600560">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Retirement Plans (Schedule of Target and Actual Allocation of Plan Assets) (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Target plan asset allocations</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Actual plan asset allocations</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember', window );">Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Target plan asset allocations</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Actual plan asset allocations</a></td>
<td class="nump">27.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanDebtSecurityMember', window );">Debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Target plan asset allocations</a></td>
<td class="nump">41.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Actual plan asset allocations</a></td>
<td class="nump">38.00%<span></span>
</td>
<td class="nump">41.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherLongTermInvestmentsMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Target plan asset allocations</a></td>
<td class="nump">34.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Actual plan asset allocations</a></td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">36.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of target investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of actual investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanDebtSecurityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanDebtSecurityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherLongTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherLongTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631662373344">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Retirement Plans (Schedule of Valuation of the Company's Pension Plan Assets by Pricing Categories) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 420<span></span>
</td>
<td class="nump">$ 543<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">(Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">46<span></span>
</td>
<td class="nump">55<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">(Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">319<span></span>
</td>
<td class="nump">389<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">(Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">55<span></span>
</td>
<td class="nump">99<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember', window );">Cash and cash equivalents | (Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember', window );">Cash and cash equivalents | (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember', window );">Cash and cash equivalents | (Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember', window );">Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">120<span></span>
</td>
<td class="nump">147<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember', window );">Equity securities | (Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember', window );">Equity securities | (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">99<span></span>
</td>
<td class="nump">119<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember', window );">Equity securities | (Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">153<span></span>
</td>
<td class="nump">204<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities | (Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities | (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">151<span></span>
</td>
<td class="nump">202<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities | (Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherDebtSecuritiesMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">129<span></span>
</td>
<td class="nump">171<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherDebtSecuritiesMember', window );">Other | (Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherDebtSecuritiesMember', window );">Other | (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">69<span></span>
</td>
<td class="nump">68<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherDebtSecuritiesMember', window );">Other | (Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 55<span></span>
</td>
<td class="nump">$ 99<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631672965424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement Plans (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Actual return</a></td>
<td class="num">$ (109)<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">(Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Actual return</a></td>
<td class="num">(44)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear', window );">Estimated future employer contributions in next fiscal year</a></td>
<td class="nump">$ 19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution expected to be received by defined benefit plan from employer in next fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631657634416">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Retirement Plans (Expected Benefit Payments) (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 22<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo', window );">2024</a></td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree', window );">2025</a></td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour', window );">2026</a></td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive', window );">2027</a></td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter', window );">2028-2032</a></td>
<td class="nump">$ 146<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631657143600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Quarterly Data (Unaudited) (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialDataAbstract', window );"><strong>Quarterly Financial Data [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="nump">$ 5,202,000<span></span>
</td>
<td class="nump">$ 4,479,000<span></span>
</td>
<td class="nump">$ 4,493,000<span></span>
</td>
<td class="nump">$ 4,275,000<span></span>
</td>
<td class="nump">$ 4,701,000<span></span>
</td>
<td class="nump">$ 4,160,000<span></span>
</td>
<td class="nump">$ 4,294,000<span></span>
</td>
<td class="nump">$ 3,953,000<span></span>
</td>
<td class="nump">$ 18,449,000<span></span>
</td>
<td class="nump">$ 17,108,000<span></span>
</td>
<td class="nump">$ 14,351,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">3,236,000<span></span>
</td>
<td class="nump">2,782,000<span></span>
</td>
<td class="nump">2,826,000<span></span>
</td>
<td class="nump">2,734,000<span></span>
</td>
<td class="nump">3,045,000<span></span>
</td>
<td class="nump">2,642,000<span></span>
</td>
<td class="nump">2,772,000<span></span>
</td>
<td class="nump">2,509,000<span></span>
</td>
<td class="nump">11,578,000<span></span>
</td>
<td class="nump">10,968,000<span></span>
</td>
<td class="nump">9,057,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings (loss) before income taxes</a></td>
<td class="nump">761,000<span></span>
</td>
<td class="nump">816,000<span></span>
</td>
<td class="nump">720,000<span></span>
</td>
<td class="nump">386,000<span></span>
</td>
<td class="nump">757,000<span></span>
</td>
<td class="nump">495,000<span></span>
</td>
<td class="nump">662,000<span></span>
</td>
<td class="nump">367,000<span></span>
</td>
<td class="nump">2,683,000<span></span>
</td>
<td class="nump">2,281,000<span></span>
</td>
<td class="nump">1,954,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings (loss)</a></td>
<td class="nump">$ 563,000<span></span>
</td>
<td class="nump">$ 816,000<span></span>
</td>
<td class="nump">$ 656,000<span></span>
</td>
<td class="nump">$ 323,000<span></span>
</td>
<td class="nump">$ 662,000<span></span>
</td>
<td class="nump">$ 438,000<span></span>
</td>
<td class="nump">$ 592,000<span></span>
</td>
<td class="nump">$ 302,000<span></span>
</td>
<td class="nump">$ 2,358,000<span></span>
</td>
<td class="nump">$ 1,994,000<span></span>
</td>
<td class="nump">$ 1,599,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net earnings per share of common stock (in dollars per share)</a></td>
<td class="nump">$ 1.48<span></span>
</td>
<td class="nump">$ 2.16<span></span>
</td>
<td class="nump">$ 1.73<span></span>
</td>
<td class="nump">$ 0.86<span></span>
</td>
<td class="nump">$ 1.75<span></span>
</td>
<td class="nump">$ 1.17<span></span>
</td>
<td class="nump">$ 1.57<span></span>
</td>
<td class="nump">$ 0.80<span></span>
</td>
<td class="nump">$ 6.23<span></span>
</td>
<td class="nump">$ 5.29<span></span>
</td>
<td class="nump">$ 4.26<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net earnings per share of common stock (in dollars per share)</a></td>
<td class="nump">1.47<span></span>
</td>
<td class="nump">2.14<span></span>
</td>
<td class="nump">1.72<span></span>
</td>
<td class="nump">0.84<span></span>
</td>
<td class="nump">1.73<span></span>
</td>
<td class="nump">1.14<span></span>
</td>
<td class="nump">1.55<span></span>
</td>
<td class="nump">0.79<span></span>
</td>
<td class="nump">$ 6.17<span></span>
</td>
<td class="nump">$ 5.21<span></span>
</td>
<td class="nump">$ 4.20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared per share of common stock (in dollars per share)</a></td>
<td class="nump">$ 0.750<span></span>
</td>
<td class="nump">$ 0.695<span></span>
</td>
<td class="nump">$ 0.695<span></span>
</td>
<td class="nump">$ 0.695<span></span>
</td>
<td class="nump">$ 0.695<span></span>
</td>
<td class="nump">$ 0.630<span></span>
</td>
<td class="nump">$ 0.630<span></span>
</td>
<td class="nump">$ 0.630<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialDataAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialDataAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631650932960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment and Geographic Data (Sales And Other Financial Information By Business Segment) (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="nump">$ 5,202,000<span></span>
</td>
<td class="nump">$ 4,479,000<span></span>
</td>
<td class="nump">$ 4,493,000<span></span>
</td>
<td class="nump">$ 4,275,000<span></span>
</td>
<td class="nump">$ 4,701,000<span></span>
</td>
<td class="nump">$ 4,160,000<span></span>
</td>
<td class="nump">$ 4,294,000<span></span>
</td>
<td class="nump">$ 3,953,000<span></span>
</td>
<td class="nump">$ 18,449,000<span></span>
</td>
<td class="nump">$ 17,108,000<span></span>
</td>
<td class="nump">$ 14,351,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,278,000<span></span>
</td>
<td class="nump">1,272,000<span></span>
</td>
<td class="nump">1,076,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Segment net earnings (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,841,000<span></span>
</td>
<td class="nump">2,584,000<span></span>
</td>
<td class="nump">2,223,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(627,000)<span></span>
</td>
<td class="num">(619,000)<span></span>
</td>
<td class="num">(472,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(216,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings (loss)</a></td>
<td class="nump">$ 563,000<span></span>
</td>
<td class="nump">$ 816,000<span></span>
</td>
<td class="nump">$ 656,000<span></span>
</td>
<td class="nump">$ 323,000<span></span>
</td>
<td class="nump">$ 662,000<span></span>
</td>
<td class="nump">$ 438,000<span></span>
</td>
<td class="nump">$ 592,000<span></span>
</td>
<td class="nump">$ 302,000<span></span>
</td>
<td class="nump">2,358,000<span></span>
</td>
<td class="nump">1,994,000<span></span>
</td>
<td class="nump">1,599,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,611,000<span></span>
</td>
<td class="nump">9,538,000<span></span>
</td>
<td class="nump">8,345,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember', window );">Orthopaedics and Spine</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,838,000<span></span>
</td>
<td class="nump">7,570,000<span></span>
</td>
<td class="nump">6,006,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(216,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,154,000<span></span>
</td>
<td class="nump">1,147,000<span></span>
</td>
<td class="nump">954,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Segment operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,033,000<span></span>
</td>
<td class="nump">4,987,000<span></span>
</td>
<td class="nump">4,002,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | MedSurg and Neurotechnology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,611,000<span></span>
</td>
<td class="nump">9,538,000<span></span>
</td>
<td class="nump">8,345,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">540,000<span></span>
</td>
<td class="nump">518,000<span></span>
</td>
<td class="nump">496,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Segment net earnings (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,737,000<span></span>
</td>
<td class="nump">2,807,000<span></span>
</td>
<td class="nump">2,414,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Orthopaedics and Spine</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,838,000<span></span>
</td>
<td class="nump">7,570,000<span></span>
</td>
<td class="nump">6,006,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">614,000<span></span>
</td>
<td class="nump">629,000<span></span>
</td>
<td class="nump">458,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Segment net earnings (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,296,000<span></span>
</td>
<td class="nump">2,180,000<span></span>
</td>
<td class="nump">1,588,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">124,000<span></span>
</td>
<td class="nump">125,000<span></span>
</td>
<td class="nump">122,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember', window );">Segment Reconciling Items</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Segment operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(649,000)<span></span>
</td>
<td class="num">(605,000)<span></span>
</td>
<td class="num">(503,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationIntegrationRelatedCosts', window );">Acquisition and integration-related charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(150,000)<span></span>
</td>
<td class="num">(585,000)<span></span>
</td>
<td class="num">(242,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(627,000)<span></span>
</td>
<td class="num">(619,000)<span></span>
</td>
<td class="num">(472,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Restructuring-related and other charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(349,000)<span></span>
</td>
<td class="num">(386,000)<span></span>
</td>
<td class="num">(458,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(216,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_MedicalDeviceRegulationsExpense', window );">Medical device regulations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(140,000)<span></span>
</td>
<td class="num">(107,000)<span></span>
</td>
<td class="num">(81,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_RejuvenateABGIIHipRecallCharges', window );">Recall-related matters</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="num">(103,000)<span></span>
</td>
<td class="num">(17,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LegalFees', window );">Regulatory and legal matters</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(76,000)<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="num">(6,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,841,000<span></span>
</td>
<td class="nump">$ 2,584,000<span></span>
</td>
<td class="nump">$ 2,223,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_MedicalDeviceRegulationsExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Medical Device Regulations Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_MedicalDeviceRegulationsExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_RejuvenateABGIIHipRecallCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Rejuvenate / ABG II Hip Recall Charges</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_RejuvenateABGIIHipRecallCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationIntegrationRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationIntegrationRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4613673-111683<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631656371920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment and Geographic Data (Segment Information) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">$ 36,884<span></span>
</td>
<td class="nump">$ 34,631<span></span>
</td>
<td class="nump">$ 34,330<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_CapitalExpendituresDuringPeriod', window );">Capital Expenditures During Period</a></td>
<td class="nump">588<span></span>
</td>
<td class="nump">525<span></span>
</td>
<td class="nump">487<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">35,578<span></span>
</td>
<td class="nump">33,367<span></span>
</td>
<td class="nump">33,340<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_CapitalExpendituresDuringPeriod', window );">Capital Expenditures During Period</a></td>
<td class="nump">348<span></span>
</td>
<td class="nump">362<span></span>
</td>
<td class="nump">342<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | MedSurg and Neurotechnology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">18,283<span></span>
</td>
<td class="nump">15,218<span></span>
</td>
<td class="nump">15,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_CapitalExpendituresDuringPeriod', window );">Capital Expenditures During Period</a></td>
<td class="nump">173<span></span>
</td>
<td class="nump">197<span></span>
</td>
<td class="nump">192<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Orthopaedics and Spine</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">17,295<span></span>
</td>
<td class="nump">18,149<span></span>
</td>
<td class="nump">18,090<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_CapitalExpendituresDuringPeriod', window );">Capital Expenditures During Period</a></td>
<td class="nump">175<span></span>
</td>
<td class="nump">165<span></span>
</td>
<td class="nump">150<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">1,306<span></span>
</td>
<td class="nump">1,264<span></span>
</td>
<td class="nump">990<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_syk_CapitalExpendituresDuringPeriod', window );">Capital Expenditures During Period</a></td>
<td class="nump">$ 240<span></span>
</td>
<td class="nump">$ 163<span></span>
</td>
<td class="nump">$ 145<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_CapitalExpendituresDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capital Expenditures During Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_CapitalExpendituresDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631651302960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment and Geographic Data (Geographic Information on Net Sales and Long-Lived Assets) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="nump">$ 5,202,000<span></span>
</td>
<td class="nump">$ 4,479,000<span></span>
</td>
<td class="nump">$ 4,493,000<span></span>
</td>
<td class="nump">$ 4,275,000<span></span>
</td>
<td class="nump">$ 4,701,000<span></span>
</td>
<td class="nump">$ 4,160,000<span></span>
</td>
<td class="nump">$ 4,294,000<span></span>
</td>
<td class="nump">$ 3,953,000<span></span>
</td>
<td class="nump">$ 18,449,000<span></span>
</td>
<td class="nump">$ 17,108,000<span></span>
</td>
<td class="nump">$ 14,351,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Net Property, Plant &amp; Equipment</a></td>
<td class="nump">2,970,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,833,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,970,000<span></span>
</td>
<td class="nump">2,833,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,638,000<span></span>
</td>
<td class="nump">12,321,000<span></span>
</td>
<td class="nump">10,455,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Net Property, Plant &amp; Equipment</a></td>
<td class="nump">1,791,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,717,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,791,000<span></span>
</td>
<td class="nump">1,717,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember', window );">Europe, Middle East, Africa</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,348,000<span></span>
</td>
<td class="nump">2,299,000<span></span>
</td>
<td class="nump">1,818,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Net Property, Plant &amp; Equipment</a></td>
<td class="nump">995,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">941,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">995,000<span></span>
</td>
<td class="nump">941,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember', window );">Asia Pacific</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,885,000<span></span>
</td>
<td class="nump">1,973,000<span></span>
</td>
<td class="nump">1,630,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Net Property, Plant &amp; Equipment</a></td>
<td class="nump">76,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76,000<span></span>
</td>
<td class="nump">76,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=syk_OtherForeignCountriesMember', window );">Other foreign countries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">578,000<span></span>
</td>
<td class="nump">515,000<span></span>
</td>
<td class="nump">$ 448,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Net Property, Plant &amp; Equipment</a></td>
<td class="nump">$ 108,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 99,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 108,000<span></span>
</td>
<td class="nump">$ 99,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_EMEAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaPacificMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=syk_OtherForeignCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=syk_OtherForeignCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631665476448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Asset Impairments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis=syk_LongLivedAssetsAndIntangibleAssetsMember', window );">Long-Lived Assets and Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Asset impairments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 105<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis=syk_InProcessRDOtherIntangibleAssetsAndPropertyPlantAndEquipmentMember', window );">In-Process R&amp;D, Other Intangible Assets and Property, Plant and Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Asset impairments</a></td>
<td class="nump">$ 47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Revenue from Contract with Customer Benchmark | Geographic Concentration Risk | CHINA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk (as a percent)</a></td>
<td class="nump">2.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis=syk_LongLivedAssetsAndIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis=syk_LongLivedAssetsAndIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis=syk_InProcessRDOtherIntangibleAssetsAndPropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis=syk_InProcessRDOtherIntangibleAssetsAndPropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CN">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CN</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139631657746016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule II Valuation and Qualifying Accounts (Details) - SEC Schedule, 12-09, Allowance, Notes Receivable - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsDisclosureLineItems', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance&#160;at Beginning of Period</a></td>
<td class="nump">$ 167<span></span>
</td>
<td class="nump">$ 131<span></span>
</td>
<td class="nump">$ 88<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Charged&#160;to Costs &amp; Expenses</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">61<span></span>
</td>
<td class="nump">65<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Uncollectible Amounts Written Off, Net of Recoveries</a></td>
<td class="nump">52<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesAdjustments', window );">Effect of Changes in Foreign Currency Exchange Rates</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at End of Period</a></td>
<td class="nump">$ 154<span></span>
</td>
<td class="nump">$ 167<span></span>
</td>
<td class="nump">$ 131<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in valuation and qualifying accounts and reserves from adjustment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column B))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column E))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column D))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForNotesReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForNotesReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>syk-20221231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2022"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:syk="http://www.stryker.com/20221231"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="syk-20221231.xsd" xlink:type="simple"/>
    <context id="i767af96f95ca4aee85700946429afb87_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if231cb99329846998fbe0b34abe79ea7_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7dd02fbab10d4e00b5bcd9c2dedb8209_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syk:SeniorUnsecuredNotes1.125Due2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i71648630b05f40fba5ebd37a3211f4b4_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syk:SeniorUnsecuredNotes0.250due2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic78b7239217245f9b7ba422e50d29a35_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syk:SeniorUnsecuredNotes2.125Due2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic1174c5b8346493d97c292962b5734e9_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syk:SeniorUnsecuredNotes0.750due2029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ied914c836e1441c7890112782c149468_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syk:SeniorUnsecuredNotes2.625Due2030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iaa9f50c457574b7daccc82821729b9e5_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syk:SeniorUnsecuredNotes1.000due2031Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i28ee37853fb34f8596d0f60ff923f553_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ia86e7290435746bc83636123dd097ec2_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6192daadf4b64fcd96cda7971eb2051f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3dd203be44e24244894ceb5a74354945_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4006898201a7425fb94bc2294d0b0392_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i576cd39821c64afe9e29c4e4b0a645cc_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0b7dcd3a92534102aafd86a58bd12396_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i176c600905174175b724a109ca220959_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3b9d8d8eefe34b4f8f369cfda156c6e2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ida5e85091b7148e19fbf01b77d79492c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3e9fecf68eab4b96910415c71a11f0f0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i41ce397bfa0541e29e021952f1d0010a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9ba0930c6af2497b925e9c5d6155812a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9d9e19fe61e242fd8263057ff7c25299_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if2881079343842a19318fe837350c64d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i63b9f6da76294d1a9a151cff381a2952_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i46dac7583cde41d8a83d606ac118cd95_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ieec3502c9db549fea81e263b3f2c2a92_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i94825bd2fefe45ddabf26724a368310b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i795f6d2070234daa91b8880b8539c9c8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1c2a71ba269549d1ae308a0a70bc7f3a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id9d8bd5dcacb4d8d812c9d60d5f7f768_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i517940432d6242d3b90448a4cdb7932b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0a6c70e8449a4b4ea94bebf9dff36ff6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icad1df1351fd4afe9e2355bb6693a77d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1895b0971f404a2dad14c28b8302a8ea_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibe9a125a8f4f4a4b9275e4e42854e3f3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i339c16bfef17406a8c4a7d11ac15a147_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id755d6c5467d4b40bdce4ebfa9392650_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie37658dfd9f847b59178e8bc31697fd2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i98963cf23d234ec1ac275e66bcfd76dc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idd06d67e889a491bb0c3d598c1a2047c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id98b4736a0a349b09845650ad3f9c399_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia81297125f074a4291d33c550b8d6a47_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2a548a74fc5c4c9cb418b21cd08ceca3_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia886c987bacc41c694724a58b11edae4_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6a82af02b4f44599ac62c2a47c8eeeb2_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="idbfae01100bf43918ee77d14424aebd2_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i708148310e2c45b79502852cc7ddd42d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="icb6424572e1a40e48c885f2c92dfe789_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8117cc9161634207825ffb3719f67191_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">syk:PerformanceStockUnitPsusMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib40edc6b554f484e81172008a1b935cd_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:InstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5cd09663d2064e428131942655918cc4_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:InstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if10d0627114c4a58a2be1e34e4b5625d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:InstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic0cc5548a8984d22bd046caa3043eb0b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:EndoscopyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5020782036574b31a5831f83949362a4_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:EndoscopyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3b9f3564aca841c3ae0ea79a17077a20_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:EndoscopyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8e819fe7e1d840638447a95eff013b31_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if4e6f58b0e9f477f87313ee9043d9e30_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7f101fadf7674ec28a0116a48b22b520_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib17c6235040048e8ae37d408059878aa_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeurovascularMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ief7335a3982a47459171c93ed23a8f47_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeurovascularMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2be681678ea4436faff2709791d5137f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeurovascularMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic5f7fd67d1c1485c9f7691e9a1809a38_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeuroCranialMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia4ec9d69bf524a148549268e0c42215d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeuroCranialMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iadd844730bb54ab2a251db4875dd0cc2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeuroCranialMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4b975aad2ca64d32a11f0b1aa57d74bc_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i98f3442517e54ff18879b74015965f7b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i264f9d32cf56445f819b9231bed80ef2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i953031f47dfd4ab48296f976c579f48f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="idac1c88764c44335aba1807e0a6c5920_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i62d3222aba4540cdb06bcf65a6a3bfd2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6ecee5a3b59948519fdbfa67f9373a2b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:KneesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i474cb49aa2d24434a691b5420651c447_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:KneesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4c6154902bf04aeeb004c9e54c981d28_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:KneesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if4b19248ed5d4294b50748ae4ea4aee0_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:HipsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i269eeb7c7e4141e8bf2d3c9c447f3e98_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:HipsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id675a2fbf95744c4be3290137773c281_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:HipsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if9b5b615c9924c07a819ee875818589c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:TraumaandExtremitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i013403153cd64c79a7f3a8634e364ea1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:TraumaandExtremitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6c5b695e084e4496a0671e329ae3381e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:TraumaandExtremitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4d0108479d3b484d80725dc2c041ad97_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:SpineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib0fdc7482bea448a93867fd96f5dcbac_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:SpineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i331257e825de49c58489bfb866ddce44_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:SpineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i666cd5b0c83c456bae79773bcf7f03e1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1801afd3ee7f4dfaac31a549f6ae0482_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie6aca02c723d4fb4ace6192cccb9de77_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i59e41efd1cf44cedb5a90caceaa03aff_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i383cf58c47f8466aaa98e0e267a0ec66_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if132773438c747ef8b1fe48831a7e72d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9ed4ee29f6714ea69ad3fad40ed030cb_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:InstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5d7fbd10640d4d3dbb9a7da83fdc93c2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:InstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id09fcf99189f4b1998d8d9734940d624_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:InstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i98867d5b69f347a49e32704030d048c1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:EndoscopyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i08e13185dfad49da800a2a08a9f432a1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:EndoscopyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i27792d541a2c4696a01a98be72919963_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:EndoscopyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5cea099951df4ff7bbdc41425b5529b6_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i543a25a9f1ec4250931a708a947c22f0_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="idc72c4be0f714dff82bfbdceba60770f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iaefd465e33384342bb74bc7d62b86fcb_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeurovascularMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6601ea0a52494abfb803a90cb4cac08b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeurovascularMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia5206b2de2164734afce54d5a8ff985d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeurovascularMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ifff0fc2d089c44d3aa2f9d5df4e83ff4_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeuroCranialMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic1f97bfe9b3544df927161980c8b37e7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeuroCranialMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i62b4c459d2c147fcb0cfa4526e86d72b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeuroCranialMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i663246eda49749d997c0d746cabbb4ee_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia6a66c36657d43f4a75ef31f2507e955_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia0a11a2714074a598220e8541795a994_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i46e1cd337be44b57b9b1d332b129f69c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7d04a4d184e54baaa0500525454dce8a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie649374514094ad1a1d1a16c42b218da_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6078ad8012384f338b9a92a484d14c65_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:KneesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i797fa079f8f54e3a9a6da8545bed4ed3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:KneesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2dd6e330b6ad41d9b7422a4b7e00bf79_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:KneesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i235f0602f0b049698f8ebba9516a25f6_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:HipsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i71a3f354032646189f007311bac60024_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:HipsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie56858cf83c046b994c5c997f9f03e4d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:HipsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idf66a24721c449dabc5abd76d714c686_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:TraumaandExtremitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic219c45e9bad4e20b8083e43a0aeb4eb_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:TraumaandExtremitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if5a1567757054e22a14abcfa4521d1d8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:TraumaandExtremitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if21f6d50ec354218a38c8290af16e623_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:SpineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia8b02a7bd5e949d7bf3a6197a4b398c0_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:SpineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5586d2399af142dabc67a9bee22f6a8a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:SpineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia1758ceab8dc4cba84c860bf0c70ec7e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i323b04cbc9d248b1b1d4d71d946c7fa3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie50bbe6a5e6d46d4a93975ba9d0688c8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i53c57bd651fd45a185259d088cd6d65c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ifc1a1dbfa4b940c183d1a894a442e7dc_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib5e99b74e17b4087a5567c9b9b9bc240_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iaff1db63800141a4a0f466e4edd07697_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2c40ed4f092642e6ae3512f7b314ae33_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia16521f0e141452ca6e75ab7d3a68848_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i483d950410414fe59ab9e2fa4d84d5df_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:InstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i63a90fa6e8e148b19df1238fd6a1f7c2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:InstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1dc8e759d5044d0aaa1f41483df1232a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:InstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iae1685480e7f4fcbbb1e5f05830d684d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:EndoscopyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia1df304d4eb44faf833fe1d888e9f579_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:EndoscopyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3e65f49264c64a349b9d521fc9f4b8f9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:EndoscopyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i30234a3281d14003a6892b71356e9d0a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if70a16dd5e6945bf9c6e8cf9b8788075_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3fe26adfdbc545c99ea371ee84ab0982_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5018938caadf49a898cc06c5f84bc191_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeurovascularMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id25f8772d4b14bb897d5701f19e7d4f1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeurovascularMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia4b3fca57c9545df8ece61f69e1e1fdc_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeurovascularMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia7c37ca29a884860a690d73964155c6e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeuroCranialMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i57807bf2142f4f7faa936c1cacf88c52_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeuroCranialMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i82f610c3881d4092950ff3ee3559f332_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeuroCranialMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i69286e78969c425b95fb1a1af5a7ffee_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="idded536d0af14e3a827698652b7ec361_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ife69af0daf204c34b24444fefcdc4593_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6e1d87a1079040de8d74635a08480d51_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4f994fa175e14f7fbb0230508d4017b7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i90fb567d63414192b40cf0ac5a8561bb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3c5ee2c8d6a245409c7113431408c137_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:KneesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1521748c0f8b464492226525de5d7eab_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:KneesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1cc4e6c8bedd45858a7ca12a5301a3ae_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:KneesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i502050c566d846e2a9eebc8d4f42d251_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:HipsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i087a6044fb0f4d06ab4771d7a6615b22_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:HipsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i78a574b38eb84b4e9ddbdec1b8422bb5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:HipsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9848e15d5e03446e85be30206896834a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:TraumaandExtremitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i09f67744858942b2ade6faf4e7109a1e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:TraumaandExtremitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie7dbd5a4933a46c3880c5c627cb44975_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:TraumaandExtremitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if21ff3221f9e4f94b678fa254a2b6165_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:SpineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i111c61299cd54de1a129bb3bb7c82c44_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:SpineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ibb4bfa7f666a42c694d9c69757624555_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:SpineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib088580a0b7f4d77b2ec885ae6c1c459_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4da717909f6849eb981891e24024b2a9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i584907bcc13a4da3b2f67d81b5e349e3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i322205428fdb4dd1b9ee8eb34e18bbf1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if7c8e07052dd4d1c91726191ed386ac8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i17bfdc6681b54daf82fee40a6fb5aa86_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iaab182c6b3bb44d086bbe15590d6e157_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8c358267d06c4c30bddf69fbbdad3c82_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ide98561cf401454c96fa8600baf5b8f9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iec7ff50d4aea4a64b1a222ed6cddad1e_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia2d532877fe14293a0c7af8376dd383a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icb345be38a2145ec8f2df1b4c28dc6d4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib9f7092c7cfe4497bab25e1f403f24c9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i684697892eef43b0a398f7e1d3644140_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib50e1688c3054d648339c3791063d5da_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7b0b881c3cc645c8a20d828cc3a3ab1f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if6cd00f7e2984a7197f65f6758fc8f77_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6da21472d42444c2a5f87b4170b8a18a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6b2fac2f3fc9459ab4c0932e6ed5c5b6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1bfd9b18ac254aea9b31268dda67d715_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idba6690bc56542ebab849eb8e0a831d0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic30c4a9be3cb4b41aca184361c77845a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic08aa5d78620463481ca8783fa037ecb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2cfe6ff3822e44e4ae63056b2596b8ae_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i27d980565f3148fe831139d2e7a16efb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3861b631300548c2ab44cbbf58d07920_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5847988c48e945ff89b5383f616f507c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5e94767eea5f4452a8497953475e7b32_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i33ec7e34209e4d64ba95fe5eb1edee60_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1061b720f0314243956e705d577b0331_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i555016f434ae4cd48b50f24fbe1586b3_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0f534a107f4d40bb987de62c5eca2398_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6d64b78c8a794c42aa5ea20736299864_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iaec94f18ada042fabb7f1ebdc25a07d4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8d27f73c86aa47cba1db7a41f08807cd_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibf36006040a941c9932b2b52a950a31a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5f5265baf4a34824aa6bfc4b935f0cc6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i18c253d682754db68c1f963844f236c0_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i502841656af74f0abcbfa0b5b4d5edde_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8f7602ed300f40099fb5e3d0ccea433c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if623c08c13104816b3eec3b501299d90_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icc0b84fb75164adf807974c23c81f865_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1f5c13561a6441838aa726a95c450a0a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibd8e471ce1d84cd0b7332d1e15689be0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic862e33128874fba9c59da29a661709c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4ed382ff805947e282a6b64d016d24f4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i871ebfa1e7e24e09bd4a205545a24e83_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id3f7b3b320914b9dae575c52b5fe8b56_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i50af63eb8b4d4347af19a411f82385bc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i30db394dfc2a41a8b8826988775431cb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibad6a6771ef34df3ae26b4bf524b94cf_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie01905fa5e254373b0ff7bd6859daf50_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7984d6aa73d346b396014350b01a0a8b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i442c41e773ba4c8393f770f45cac23e6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i21b19e56e61b4c329c04eac6cfc4cd58_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id60b785d2b584ee1be26545ea0a1b66f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if244473f9960480abc9486fac01737d2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7e1acc8de3644b2583b558aed3472970_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i526560b9237b4753b4d62b8c0ac70ad0_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iebcaf79884c44374aed5e2028c2ef520_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i36b9ed429956467a99e25dcfa90149c9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2c812d2135a0456199da61bf38ed7721_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id55223eafacf499d89f879372cbf9597_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0b3bc6f133044291a549410c3cf66f4d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5b39e27e21304ce894cab7826e32ac09_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iebe1f9b479ea44f69f1c26a1d8bc2fd8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i785da713e5504f1cac04a1e0354dfa48_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie029123d930d43c8a47136e8b7c03300_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4ed5e0163a634738abd15b3643a5c3f5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0b2e6b2fb13e405d95f685da59183e93_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idf0622bdb40c4cbd87d21f3c67334c2a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7e8c5b89171143fbbff1d92557f393af_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if5dc0a291f3a4f67bfac579e681b910f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icd05c426dad44fd5b836e9f3d2fa90e5_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3dca98f754544fae91bc2be4aa0d5f9c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5fa607b61e244bc0b9d78c50a056da63_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i858bf63c159847d6b3ed57f57eb1ff65_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i900a7f9055784544a570f4f177f0f2f7_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i35651c99f68b487cb5cb0aaf787aa0ed_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie8ba1cabf909458ba3e5abe497e0b36d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2cccc96d34764cf58cc915568b1e6270_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iae3102b5052e4f9792a88230869505ae_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id329aed50c074920944be6fd7b940cf8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic804fede9d9b48fca7326ace0f6cda8a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic3133dd3e2174a0fab3f99c31f3a1c0c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i073bfd5a955943a1910ed816f9ae5c27_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i618987c1cdac4e83bae6d50a1ddc1358_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i30d00fa7ea3a436494f1bd7ba5373101_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib2acfbbc785a4dcba1e0d80a471cf36e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i99212e6414ed4182be360bb4600e1593_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i989cd3b1dfc14409946f1bd46844917f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2e70ca42855942a5a650f69045393b9b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i976b214a31df4949b83c93e6da795727_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i64382fff96cc4d37a1272abc8d08a5b1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="idf0ef3bec3594225be5f4136d591a70a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if03ac61671704ce4b4624fc35057af34_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if4546ff3df1c4906be5936247a46f7b0_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie42d6abca47642698150701f8b361b9f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie6d6069512b142969a9bd9af9461da85_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8301b5b781954e5cab4cec0d280848d8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i56560a3d5b6f482fb1362de4ae05404a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie342040266664c0697ed0bb113671458_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1c613d72567b4a16a99b20a430597575_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4b467ba124624433b5dde0c999c6d48c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i20d1fb9afb38451ca9e6cb8fe56983f4_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib1dd8a1332a14539a8a3ec1b816d046a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i709e6e037bfd466aa715d869eb7ef424_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i03590bf15d844678bd0f164d99ca4949_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0519930af2964fea9f28a898c17d838f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia02e7e1cc90e4e87a48f39f4f3e33376_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1917a31882a249a2adf69310c998c7de_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i99ab40e0eb8d45a9abce0e0cd3109e0c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i27e420a9891e411095e99eaeb5a2021a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4e9f0e75f256464eb07e962100d56a05_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i823914fb5eb4408998556e61e5fe9f04_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6b23b51f78e64690aca64f7624b9d18b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i31974aa90e594af395bc99e745210e04_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ibf37d1b5ba934c02852349cf34dae000_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic4624597685941fb98a05555c8d17182_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib8820c2b08814387afe9320dfdf9b54a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8e1908513627494bb6e9fc5eebd933fa_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i102b956e06124e8aa1a5792f644f35dc_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="icecc44177f9c4483aaa2d013aef04666_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8053af52dacf4e0a9c8f9dcfbcc32961_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8a65bdddfec44880a63f89575a6757b0_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6d20d404d8984a96b12853bc045fd7e1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i181aa9e6db8d4da6a8f9d5751bc9b195_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if5a208a660784ecd8fafc1ab3b4650ae_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7d21dceba0df4948b9211257ad5aa554_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6796554675ff4f1f973d3c595bd3e499_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic99004e7285a44e0a449ff60ca2c5433_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6766e2f3ba404e94b97b133b143443ec_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i09ab23df9d8d46d6b99f210842561aad_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1ce78b990cc3435b974774303b8f1500_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id36e8e59f17a4fd2b1810524c32bdb32_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iedb144142fe44106a0298139475b1b7e_D20220201-20220228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:VoceraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-01</startDate>
            <endDate>2022-02-28</endDate>
        </period>
    </context>
    <context id="if643644842344c0ab2e0d9a12b06b426_I20201130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:VoceraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:A150ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-30</instant>
        </period>
    </context>
    <context id="i22182f50ad11452dba95524874b934aa_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:VoceraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:A050ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2c9e3c188be94e4c980232bc3fbcb14b_D20201101-20201130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:VoceraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:A150ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2020-11-30</endDate>
        </period>
    </context>
    <context id="i89f1c0806ea84da2867f98aea716c643_D20201201-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:VoceraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:A050ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0eadaeefb6b844b7bcb7e34005c139af_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:VoceraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0e2ff09ffaf04bd7b9e7b8d473abbcb6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:VoceraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i101c3d1a12034ac38fe2e5f8c0168405_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:VoceraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">syk:CustomerAndDistributorRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic19a68dc4f2647639ab8a2956791d892_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:VoceraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie1d22140738841ca90e737fe8f886088_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:VoceraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4889250342a0437bb3b31f671106d385_D20210901-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:GaussMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i771ee623eaf644bbb46406b9ab01d509_D20220301-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">syk:PureWickMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ifc3a04258fee41d5854dbca8209b7188_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">syk:PureWickMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ieaab15c857b047cb895f5e84a16ec8e5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">syk:RecallMattersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5bcc369cedab4f869853e6b7824ab18f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">syk:RecallMattersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia066883b5f184c74a8299f3acdca8fc6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">syk:SpineReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i99398de802564a348fcf815e890ee556_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i66bd7e5d901d4e1ba0db77e7d94fe17f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic886ff9d842041ae963fe57a90894324_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2984e4fb7f95431db5d16c82e29be4ae_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i249998c655604f398e1944b84271a97b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iaf16c26d2de44c14872459c255d8e314_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib35db1f319504c6ea1b123bab6945625_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i82108a7656a74aa1ba61a08ab02857ce_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icb79db6333c349f3923f8d6854ee0198_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7267f78ac6824fc7b4d41470e9de6320_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i616a24284ffb4103824360aa36bae0d7_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic6769f38cd4f4dbe805725de19af7ac7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7705b5434d5d4d54a9a81030e299a394_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7803940663364a5c97229c2f0f778b60_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0d7b307071314b9b90794e54e6a0095f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id47b79ebee3845f3b4c19c471642577f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i53d447ff0f8a4e76984a7d915abea8ee_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie7a556e07b064f9e94a25653076cc521_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifb5f69c7b49241dfb194a09187e3c17c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i29eb6be58138460d98a6d32e536dd9e2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2a84ea92e53146cc99a4bd1d326471a9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iaaf6d5d43b13406a9b3c80676ac72655_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i305db0433c34417b92b5c6dbeea5f263_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9538fc60a2cf48fe973a5ff07071a757_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icfee61742ac544ed9c226764b8dc1c9e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1626fc828d9642beb146389e00b7d1aa_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iaaf12506ce6349e290da46b1889b2f07_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib2ed7e2a97b147f5a5e2f0cb1a1b8bdc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i568e131aeee143118e9dfb0c69d84d35_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i76d037e2508d493fb9c5c79f64d84deb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">syk:PerformanceStockUnitPsusMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8910a4c2b7d74f3fb6c50af1f492e5a0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie6221c941312452b8581e8a9deb3ac6a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">syk:PerformanceStockUnitPsusMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3f212fe7e7364a549804bccdf2f81667_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic1b406c0949449359e921c7191771a27_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6d3d3f84201a45599e436e212113af2a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i105ea3d2ed224740a6a5bfb85f70a5e2_I20220228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:TermLoanDueFebruary222025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-28</instant>
        </period>
    </context>
    <context id="ibaa4215050f640eda208f1aaca9866a2_D20220201-20220228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:TermLoanDueFebruary222025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-01</startDate>
            <endDate>2022-02-28</endDate>
        </period>
    </context>
    <context id="i2854c59895d84a0383a8b9cde207fe65_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:TermLoanDueFebruary222025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i89795855715a44adb779c848669d4ad1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i64f47956dd0f44a5985d1c8aa38b28cc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic31b7c04d93e4f11bdf14d0d9b0aad34_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotesDueNovember2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic02d163166494d6f94e0bd14a160bf17_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotesDueNovember2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i808ca3fe28c44ce78c70e8cfba12ca6e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes0600Due2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i15d5d81e0cbe495ebd1b69e9445e539d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes0600Due2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i86a207f857004a4ca1e3d7fed25c46b2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes3.375due2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i60b7b81e39cd453c88fb43773dc15431_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes3.375due2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2a78ebbcbe3e4dcf9d2beb2467073be6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes0.250due2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibdf8e8ff01d04f45a825b8e390068345_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes0.250due2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i035cd0b8f658462394a986d81f43d40e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes1.150Due2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i145b85c88ec4481b842411a5bb47e395_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes1.150Due2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i108518ce09f84a519f3962310c1ed597_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes3.375due2025MemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia21862c342c44911bef866b8e514369b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes3.375due2025MemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i572a1adc5855495dbbba16f658625569_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes350Due2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i54a412d21e93418fb2e9f285ffe87359_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes350Due2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i23d883af8da240e0b193f0fe43f8fbb8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotesDueNovember2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5156547d31f84feabfdeab3c39626aba_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotesDueNovember2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i31b266ec9bca421caa681746ca0a9c57_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes3650Due2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i430f0c280b194413b7ab95bbebb3398f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes3650Due2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3ad767f11d7d42f088c022b95d7ed747_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes0.750due2029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic0bccfa8780e4d148e971bf570bdb5c4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes0.750due2029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3bbbaa43580143a18111b7f7460a8613_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes1.950Due2030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i10299326fcbd4cab9365281e63e32023_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes1.950Due2030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i39597499ab164dd79f0aa42aa4d4a453_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotesDueNovember2030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if06b8b9ac7554a2bb66792f8bc6ae5ec_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotesDueNovember2030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i83cf0776e2f74e6bb340c1c44d9c4873_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes1.000due2031Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i188acddc79bd49c9a2dd28df60de44d3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes1.000due2031Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib1be77f0f83e44f2a4a4070a55aa9cf1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes410Due2043Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib936df3bfdbb4791a87fadc6fbd30cdf_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes410Due2043Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idf00788f9e364a80a3fab4c2aee1223b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes4.375due2044Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6ebc69fb1cb1488c9aebf005afdcf234_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes4.375due2044Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0d645bb615244a36b00b94de383a4937_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes4625Due2046Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ied6226864dea487e92398c823ac01c59_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes4625Due2046Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2c8be8bcd82a4fbbbf309cf8da292a70_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes2.900due2050Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if5c498b0b83c4ce0a21003147411b100_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes2.900due2050Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i097ff20722bb47a2b7d2385fd5c8093b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if1b7a9d52e504b799c8afe34dbd39ccb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8e50f83f7596461c955c6b530bef94eb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia7a76123b7f64330919b0f229f73daa6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic116179f0d574741a8ce9a0151e5f880_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i054f5c7fa9df497fafb3f4d6748a7c59_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id8603ec155204c1e91b9af77be41b5ec_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">syk:AccruedCompensationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id0aab17a929c4fdf94f5c9f278870a98_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">syk:AccruedCompensationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic37ff66ffd7045788387e658a219637c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iafd18aa56bd8454499c7770cf7cae651_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id79a9c944a1046b6aaca9c9fb9f6bebe_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5af6528a025a4ecc83f861806bda8793_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i58b96ce29b8a42aea4c5893906463ce3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0e072f5fbda04e4ca99129d167dfe999_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1683d20c41d847f185c1386f0f3dc4c4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanDebtSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibe98d7ecbed04b7286e7baabd289cc71_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanDebtSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i779788123a93436181d9161accb7424e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherLongTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i561834c74eee46c8bba248e767b8abd2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherLongTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic638fcfdbb6a416d92b8a3b7c9c78967_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id537c1a6699e44bd890ba7e54ef23a6d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1a7ea0b36abd4a6cb52f66b4b312169e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic4059183a5b54d6798538edc19c050cf_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8522801ceae048788c0fce97e5d37ab5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6eb65c14e5914f63978a0d0069999ab8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2cc1146a58874a6eb8ef302951c2aecd_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5df6f1a799424f859f0ab765aa4d61d1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ica6e290960a44739ba644626546b3852_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5a0b0ee47ce04183ad042932b91b34ce_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic5010ff9bb614d35ae3367ed2df39f6b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1eaacfb68128466f93e71b1251c20bea_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4ffb4a3bde3947f88266050517970e80_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib3d6dbee4de64017afe0c8e13e01299a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib19f498ef30f4326a72ede1108304255_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i34080018fa394c35b4a7f8033b8e1796_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i210fd2367de749efa9a2e625851d0bd8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iaa8b9dcdddf64372b0059d96cea46c50_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia6bb811c5e3d4e62aa7eb329cbe0c9b7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iee87b668135841238e75f21caf1cda6f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icd8cfa9e07864166b0bc1f6192348149_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib37f5d53c40e4ad5af1d22e367b1ff8c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3ecf88ddf1cd4958a23d17b1f094f7d0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5a8294b0f5d74e708266fe817d78a47a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5570209ef64543bfba07e2abea804238_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7f7e6cbe52c44cb79b943e8593f46867_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i848d92fcbcf64897bfd1cc126a3aa1a9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibade722fea764961b1d9d387629073e2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia6c76d2fefcd444b82889ab47088a661_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7dfe7c27f3e347c2825a7b6348357a60_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8beea1d5ee1f4b6081ce02f6910e2cab_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7d0292cedd974224858a44410249e5e0_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i05c365347626469281b193639de4b1a1_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib1975d811d9f4de7bc2dc66e567577a2_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i06d24da15c2a4301868cb2cf91cc084f_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i28ee17ac872e4181a4e2ee167127995d_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6b8d2fac04db45dda920f25320d94772_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i47bbb5ea95dc45349b14191d69f1c992_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i49c69f29d3694f059d9bf2a004976b17_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i60771115f5654e2ba9c33e5226dec383_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6324e0271e4c436692bbcb9e623fc2e8_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i81c6954ba7174d4d90e932296c08e140_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i378661c47c334191b9979c19bbafc9b1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9f531e84880c46bbbe92b1c8ce7c31a6_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie984aa38d0f0495d8a86b02fb27192a6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib3f309c92d20420689d59a657fb1d10b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i90ea3f9a188b4371a80590a32f3162a6_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i95cdabbaebc1412494ff81e987370623_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="idba55220993f4de4874efcaf00cabe63_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic8e39c420c4d438997d9ba32c31cd4a4_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if20e557008044e5fb9d0332c0e98ca51_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5cccfcfd1f224a4e8c544848a6c32027_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8fc2a97b3bea475a937cf78e3d486fb9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0025a70b3c024f7ead4a7871ca53fd09_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2dd3298582d043a884e887664abad745_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibd7588c5ae9148c78b08f844142d9e5f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i715d57ade67c48388266154e58153628_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if13c14f2e2cb47afbc845ae42bcab920_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i29115a5568cc447b9a3b7fc6da47a4c0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4aef5c47c71047fe98565c8a3de0fb4a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9d0d6ebb9d7845e3a21c28c263da57f5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i33ba2adb3bd4472c8913fc71b0db21bd_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i07d6396dc54146d6aee48aa19fc60e02_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icf905d3d98e04a87989918e7e14042cb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i32ee708de8b14883887f6bab85af5750_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic8163b2c12c64eeaab735b00242896b8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if2968c9c4a80487baea572af89e9b685_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic5182e3f5e754340a7c52da0e4f360ec_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic5147ef358704bf8901cba0f588770d3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3272d42ee7e948fbb68b77a14396aa85_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i33d7288e19cb441d99394153a6e748b6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i78278663438d4595a6f4289bf181420b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i83b775090133468ca2cef1c982a32a0c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i10ac7111c8bc45da98d1f4aa86d42db5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4879614c45bc4f1a9d1ba8afae2d3a18_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ida0ef91d6b564bd5942bcd3208562cde_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1b32b057330540a1b4c98f8a0860c359_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">syk:OtherForeignCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i63f67a9dc38243c0bc739802cfd40502_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">syk:OtherForeignCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5b61af8b172d4c17bf0aaddfbae515ae_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">syk:OtherForeignCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i05478418b05443d89b6397fa59b450bc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">syk:OtherForeignCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6c78e2c8fe11461fa0a6bbdff48c2aad_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">syk:OtherForeignCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id9dcd044683643db85814ccb7429b46b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ImpairedLongLivedAssetsHeldAndUsedByTypeAxis">syk:LongLivedAssetsAndIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if6f51256944449edba93c596bb051076_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i86612b3448fd4cf8a845faec1531511e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ImpairedLongLivedAssetsHeldAndUsedByTypeAxis">syk:InProcessRDOtherIntangibleAssetsAndPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0a67a3c2c8da44f8b02b124c5c7e4f00_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForNotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icad1710138264073bfe29669fd2b4227_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForNotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i558ca518d7ef47a69b7c90dd2d54b4c0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForNotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibb94cefe14cf4d4ca3781d438a3518be_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForNotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i318eeab7dffd46df8caadd99e8f388be_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForNotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia3f2576e657245638084e8d8a7407dfb_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForNotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5211b3936fb24755baa1b6cb7bb0a9ad_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForNotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="rate">
        <measure>utr:Rate</measure>
    </unit>
    <unit id="segment">
        <measure>syk:segment</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN180L2ZyYWc6NWZlYmRlY2E4N2RjNDRkZWFiMjM4NjExNGE0ZmNkY2MvdGFibGU6NDc1ZjQ5NzZmYjE5NDE1NWI4NDg4ZjVlN2JiZWQ2MjcvdGFibGVyYW5nZTo0NzVmNDk3NmZiMTk0MTU1Yjg0ODhmNWU3YmJlZDYyN180LTEtMS0xLTcyMTUx_1c3d425b-3669-427d-9f48-8809b7ef928e">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN180L2ZyYWc6NWZlYmRlY2E4N2RjNDRkZWFiMjM4NjExNGE0ZmNkY2MvdGFibGU6NDc1ZjQ5NzZmYjE5NDE1NWI4NDg4ZjVlN2JiZWQ2MjcvdGFibGVyYW5nZTo0NzVmNDk3NmZiMTk0MTU1Yjg0ODhmNWU3YmJlZDYyN182LTEtMS0xLTcyMTUx_5e468ebe-d275-4602-9d34-b49338793089">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN180L2ZyYWc6NWZlYmRlY2E4N2RjNDRkZWFiMjM4NjExNGE0ZmNkY2MvdGFibGU6NDc1ZjQ5NzZmYjE5NDE1NWI4NDg4ZjVlN2JiZWQ2MjcvdGFibGVyYW5nZTo0NzVmNDk3NmZiMTk0MTU1Yjg0ODhmNWU3YmJlZDYyN183LTEtMS0xLTcyMTUx_4b1d02cb-e181-40f5-b84c-62f2b286433a">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN180L2ZyYWc6NWZlYmRlY2E4N2RjNDRkZWFiMjM4NjExNGE0ZmNkY2MvdGFibGU6NDc1ZjQ5NzZmYjE5NDE1NWI4NDg4ZjVlN2JiZWQ2MjcvdGFibGVyYW5nZTo0NzVmNDk3NmZiMTk0MTU1Yjg0ODhmNWU3YmJlZDYyN18xMC0xLTEtMS03MjE1MQ_88d38d9d-9844-4c0a-b55f-dffee7cc23b1">0000310764</dei:EntityCentralIndexKey>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xNzU3L2ZyYWc6Zjc0NzkwN2Q4Y2JkNDE4NzkzNDM1YzE3Zjc1ODcyYjcvdGFibGU6YTNiNGJiNGFlNjc4NDA4NzgwZGQxOWQwYWEzMjhkNGIvdGFibGVyYW5nZTphM2I0YmI0YWU2Nzg0MDg3ODBkZDE5ZDBhYTMyOGQ0Yl8xLTMtMS0xLTgzOTU4_8d3f547a-d93d-402e-9fd7-968e0ff96aac"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xNzU3L2ZyYWc6Zjc0NzkwN2Q4Y2JkNDE4NzkzNDM1YzE3Zjc1ODcyYjcvdGFibGU6YTNiNGJiNGFlNjc4NDA4NzgwZGQxOWQwYWEzMjhkNGIvdGFibGVyYW5nZTphM2I0YmI0YWU2Nzg0MDg3ODBkZDE5ZDBhYTMyOGQ0Yl8xLTUtMS0xLTgzOTYw_7acb3598-407c-4acb-8817-f84cad4d62df"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="id98b4736a0a349b09845650ad3f9c399_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzEzMjA2_7c8fdcfc-54e2-4b81-91c7-7404bca5b6f4">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i2a548a74fc5c4c9cb418b21cd08ceca3_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzEzMjU2_a5156acf-7357-4ad7-88ef-00f8b1876f98">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i6a82af02b4f44599ac62c2a47c8eeeb2_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzE0NDEx_42bfd4f4-7388-4875-97fa-bc119a8ba2cf">P4Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzItMC0xLTEtNzIxNTE_9731ce2e-d82a-4967-b042-db8cc99630f8">http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent</us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzItMC0xLTEtNzIxNTE_f24b63f9-9795-4048-881d-72c0ef014936">http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent</us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzMtMC0xLTEtNzIxNTE_4a79c8d2-7e9e-4a69-8e7c-3f2c45ccd096">http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzMtMC0xLTEtNzIxNTE_582bcc35-c25f-4f59-a914-b85367fcbaf4">http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzQtMC0xLTEtNzIxNTE_3e00ae6d-1860-4511-a971-3c7d349014a4">http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent</us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzQtMC0xLTEtNzIxNTE_b077084d-a166-4834-a410-c652caa7aed3">http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent</us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <dei:DocumentType
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGV4dHJlZ2lvbjowOTk1YjY4YTRjNjU0MDNjOGU4Yjc5NWY5NTNhYjA1Y18yNzcx_d6237cc0-6901-440d-8b65-be5d996a1577">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6NGNlNTUwZWY5YTQ0NGFlYmE1NTIxNmY5OWUyMDY4ZDEvdGFibGVyYW5nZTo0Y2U1NTBlZjlhNDQ0YWViYTU1MjE2Zjk5ZTIwNjhkMV8wLTAtMS0xLTcyMTUx_cb87db42-8a71-443a-b6e9-a22fd6e7896e">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGV4dHJlZ2lvbjowOTk1YjY4YTRjNjU0MDNjOGU4Yjc5NWY5NTNhYjA1Y18xMTk_12607b16-fdfa-4c08-8c20-efd07c701ed5">2022-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGV4dHJlZ2lvbjowOTk1YjY4YTRjNjU0MDNjOGU4Yjc5NWY5NTNhYjA1Y18xMTk_99da9a8d-da21-4361-b371-6f451da9f20c">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6OTM5MjI4NDcyZmM3NGU1OTljOTk0ZjQxOGIyMWQ2Y2QvdGFibGVyYW5nZTo5MzkyMjg0NzJmYzc0ZTU5OWM5OTRmNDE4YjIxZDZjZF8wLTAtMS0xLTcyMTUx_06d9836f-cc70-4fe2-9505-16518d98ef4e">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGV4dHJlZ2lvbjowOTk1YjY4YTRjNjU0MDNjOGU4Yjc5NWY5NTNhYjA1Y18yNzcy_40df68c0-a40a-40ec-96be-64f75b535cf4">001-13149</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGV4dHJlZ2lvbjowOTk1YjY4YTRjNjU0MDNjOGU4Yjc5NWY5NTNhYjA1Y18yNzY1_818be3b1-af31-42f9-a6e7-f3c4410a3293">STRYKER CORP</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6MWQwOTM3NThmNTA4NGQ3MTllMWY5NzNlYTM1OGM0NjYvdGFibGVyYW5nZToxZDA5Mzc1OGY1MDg0ZDcxOWUxZjk3M2VhMzU4YzQ2Nl8wLTAtMS0xLTcyMTUx_41b4633d-0747-4923-8604-612f7b00ac88">MI</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6MWQwOTM3NThmNTA4NGQ3MTllMWY5NzNlYTM1OGM0NjYvdGFibGVyYW5nZToxZDA5Mzc1OGY1MDg0ZDcxOWUxZjk3M2VhMzU4YzQ2Nl8wLTYtMS0xLTcyMTUx_855bad6f-3131-4888-a2de-6b6d240c00b3">38-1239739</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6MWQwOTM3NThmNTA4NGQ3MTllMWY5NzNlYTM1OGM0NjYvdGFibGVyYW5nZToxZDA5Mzc1OGY1MDg0ZDcxOWUxZjk3M2VhMzU4YzQ2Nl8zLTAtMS0xLTcyMTUx_a2f0ec1e-6cf4-455e-a60b-51111fca40f5">2825 Airview Boulevard,</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6MWQwOTM3NThmNTA4NGQ3MTllMWY5NzNlYTM1OGM0NjYvdGFibGVyYW5nZToxZDA5Mzc1OGY1MDg0ZDcxOWUxZjk3M2VhMzU4YzQ2Nl8zLTItMS0xLTcyMTUx_7761f481-3a75-4ff9-88b0-a9a5909287be">Kalamazoo,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6MWQwOTM3NThmNTA4NGQ3MTllMWY5NzNlYTM1OGM0NjYvdGFibGVyYW5nZToxZDA5Mzc1OGY1MDg0ZDcxOWUxZjk3M2VhMzU4YzQ2Nl8zLTQtMS0xLTcyMTUx_9854618b-9794-43e0-9749-d77c04f5c57f">MI</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6MWQwOTM3NThmNTA4NGQ3MTllMWY5NzNlYTM1OGM0NjYvdGFibGVyYW5nZToxZDA5Mzc1OGY1MDg0ZDcxOWUxZjk3M2VhMzU4YzQ2Nl8zLTYtMS0xLTcyMTUx_659a5e0d-5ab0-444e-a35f-ae5f09831b3b">49002</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6MWQwOTM3NThmNTA4NGQ3MTllMWY5NzNlYTM1OGM0NjYvdGFibGVyYW5nZToxZDA5Mzc1OGY1MDg0ZDcxOWUxZjk3M2VhMzU4YzQ2Nl82LTMtMS0xLTcyMTUx_78e3f465-2e67-46d2-a023-01ddb9ca023f">(269)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6MWQwOTM3NThmNTA4NGQ3MTllMWY5NzNlYTM1OGM0NjYvdGFibGVyYW5nZToxZDA5Mzc1OGY1MDg0ZDcxOWUxZjk3M2VhMzU4YzQ2Nl82LTQtMS0xLTcyMTUx_676e12a7-711c-4073-938e-faab2b0e1c9a">385-2600</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="if231cb99329846998fbe0b34abe79ea7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6MDM0YzgyODcyODgwNGE5N2E1MDcwNmE5MWEzYmU2ODcvdGFibGVyYW5nZTowMzRjODI4NzI4ODA0YTk3YTUwNzA2YTkxYTNiZTY4N18yLTAtMS0xLTcyMTUx_215cacc8-2998-4d77-a1c6-abbe47434698">Common Stock, $.10 Par Value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="if231cb99329846998fbe0b34abe79ea7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6MDM0YzgyODcyODgwNGE5N2E1MDcwNmE5MWEzYmU2ODcvdGFibGVyYW5nZTowMzRjODI4NzI4ODA0YTk3YTUwNzA2YTkxYTNiZTY4N18yLTEtMS0xLTcyMTUx_54682d5c-64d2-4f45-a769-dda147953619">SYK</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="if231cb99329846998fbe0b34abe79ea7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6MDM0YzgyODcyODgwNGE5N2E1MDcwNmE5MWEzYmU2ODcvdGFibGVyYW5nZTowMzRjODI4NzI4ODA0YTk3YTUwNzA2YTkxYTNiZTY4N18yLTItMS0xLTcyMTUx_def3958f-0222-4f4f-b81a-5c986e34fb85">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i7dd02fbab10d4e00b5bcd9c2dedb8209_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6MDM0YzgyODcyODgwNGE5N2E1MDcwNmE5MWEzYmU2ODcvdGFibGVyYW5nZTowMzRjODI4NzI4ODA0YTk3YTUwNzA2YTkxYTNiZTY4N18zLTAtMS0xLTcyMTUx_d1fd8fce-0a50-4973-b02a-1c265159e32e">1.125% Notes due 2023</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i7dd02fbab10d4e00b5bcd9c2dedb8209_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6MDM0YzgyODcyODgwNGE5N2E1MDcwNmE5MWEzYmU2ODcvdGFibGVyYW5nZTowMzRjODI4NzI4ODA0YTk3YTUwNzA2YTkxYTNiZTY4N18zLTEtMS0xLTcyMTUx_012487ac-8f87-4908-8b8c-14f9d1810ddb">SYK23</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i7dd02fbab10d4e00b5bcd9c2dedb8209_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6MDM0YzgyODcyODgwNGE5N2E1MDcwNmE5MWEzYmU2ODcvdGFibGVyYW5nZTowMzRjODI4NzI4ODA0YTk3YTUwNzA2YTkxYTNiZTY4N18zLTItMS0xLTcyMTUx_89d1ea8e-e974-4604-a9cf-2e638a1bc739">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i71648630b05f40fba5ebd37a3211f4b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6MDM0YzgyODcyODgwNGE5N2E1MDcwNmE5MWEzYmU2ODcvdGFibGVyYW5nZTowMzRjODI4NzI4ODA0YTk3YTUwNzA2YTkxYTNiZTY4N180LTAtMS0xLTcyMTUx_a83ca036-cfc7-4f00-9eb1-bd5b5735e855">0.250% Notes due 2024</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i71648630b05f40fba5ebd37a3211f4b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6MDM0YzgyODcyODgwNGE5N2E1MDcwNmE5MWEzYmU2ODcvdGFibGVyYW5nZTowMzRjODI4NzI4ODA0YTk3YTUwNzA2YTkxYTNiZTY4N180LTEtMS0xLTcyMTUx_106f0422-e74a-402b-84a5-bb897dd4265c">SYK24A</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i71648630b05f40fba5ebd37a3211f4b4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6MDM0YzgyODcyODgwNGE5N2E1MDcwNmE5MWEzYmU2ODcvdGFibGVyYW5nZTowMzRjODI4NzI4ODA0YTk3YTUwNzA2YTkxYTNiZTY4N180LTItMS0xLTcyMTUx_19c3ed47-c685-4653-88c3-0f8884a7ff80">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ic78b7239217245f9b7ba422e50d29a35_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6MDM0YzgyODcyODgwNGE5N2E1MDcwNmE5MWEzYmU2ODcvdGFibGVyYW5nZTowMzRjODI4NzI4ODA0YTk3YTUwNzA2YTkxYTNiZTY4N181LTAtMS0xLTcyMTUx_af296770-c46b-46c9-b1df-f871f7cc27bf">2.125% Notes due 2027</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ic78b7239217245f9b7ba422e50d29a35_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6MDM0YzgyODcyODgwNGE5N2E1MDcwNmE5MWEzYmU2ODcvdGFibGVyYW5nZTowMzRjODI4NzI4ODA0YTk3YTUwNzA2YTkxYTNiZTY4N181LTEtMS0xLTcyMTUx_7fd0ebaf-0fe3-4bcc-b392-8d4f8662d3fa">SYK27</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ic78b7239217245f9b7ba422e50d29a35_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6MDM0YzgyODcyODgwNGE5N2E1MDcwNmE5MWEzYmU2ODcvdGFibGVyYW5nZTowMzRjODI4NzI4ODA0YTk3YTUwNzA2YTkxYTNiZTY4N181LTItMS0xLTcyMTUx_25b0880f-d8b8-440f-90e1-ea67cf6aa6fa">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ic1174c5b8346493d97c292962b5734e9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6MDM0YzgyODcyODgwNGE5N2E1MDcwNmE5MWEzYmU2ODcvdGFibGVyYW5nZTowMzRjODI4NzI4ODA0YTk3YTUwNzA2YTkxYTNiZTY4N182LTAtMS0xLTcyMTUx_62ccc67a-e4ff-4735-9b6d-cd8d167a75f3">0.750% Notes due 2029</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ic1174c5b8346493d97c292962b5734e9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6MDM0YzgyODcyODgwNGE5N2E1MDcwNmE5MWEzYmU2ODcvdGFibGVyYW5nZTowMzRjODI4NzI4ODA0YTk3YTUwNzA2YTkxYTNiZTY4N182LTEtMS0xLTcyMTUx_1da3ec07-20b1-4c69-bc4e-baa55845acb9">SYK29</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ic1174c5b8346493d97c292962b5734e9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6MDM0YzgyODcyODgwNGE5N2E1MDcwNmE5MWEzYmU2ODcvdGFibGVyYW5nZTowMzRjODI4NzI4ODA0YTk3YTUwNzA2YTkxYTNiZTY4N182LTItMS0xLTcyMTUx_411d72f7-b4b7-4ab8-ac61-ca78d2a8c500">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ied914c836e1441c7890112782c149468_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6MDM0YzgyODcyODgwNGE5N2E1MDcwNmE5MWEzYmU2ODcvdGFibGVyYW5nZTowMzRjODI4NzI4ODA0YTk3YTUwNzA2YTkxYTNiZTY4N183LTAtMS0xLTcyMTUx_a21c7e94-0fa4-4bcf-bcee-4eb1731d5bfa">2.625% Notes due 2030</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ied914c836e1441c7890112782c149468_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6MDM0YzgyODcyODgwNGE5N2E1MDcwNmE5MWEzYmU2ODcvdGFibGVyYW5nZTowMzRjODI4NzI4ODA0YTk3YTUwNzA2YTkxYTNiZTY4N183LTEtMS0xLTcyMTUx_d1316cc5-2035-491d-a54c-46a89e20b942">SYK30</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ied914c836e1441c7890112782c149468_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6MDM0YzgyODcyODgwNGE5N2E1MDcwNmE5MWEzYmU2ODcvdGFibGVyYW5nZTowMzRjODI4NzI4ODA0YTk3YTUwNzA2YTkxYTNiZTY4N183LTItMS0xLTcyMTUx_b9a29487-a0e7-4306-beb0-e89a124d46fe">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="iaa9f50c457574b7daccc82821729b9e5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6MDM0YzgyODcyODgwNGE5N2E1MDcwNmE5MWEzYmU2ODcvdGFibGVyYW5nZTowMzRjODI4NzI4ODA0YTk3YTUwNzA2YTkxYTNiZTY4N184LTAtMS0xLTcyMTUx_c3eabdcd-5d22-45e0-a952-e0ac858866cb">1.000% Notes due 2031</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="iaa9f50c457574b7daccc82821729b9e5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6MDM0YzgyODcyODgwNGE5N2E1MDcwNmE5MWEzYmU2ODcvdGFibGVyYW5nZTowMzRjODI4NzI4ODA0YTk3YTUwNzA2YTkxYTNiZTY4N184LTEtMS0xLTcyMTUx_c26e0b3b-cfcd-4f2e-8f25-3bff9c4f2dea">SYK31</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="iaa9f50c457574b7daccc82821729b9e5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6MDM0YzgyODcyODgwNGE5N2E1MDcwNmE5MWEzYmU2ODcvdGFibGVyYW5nZTowMzRjODI4NzI4ODA0YTk3YTUwNzA2YTkxYTNiZTY4N184LTItMS0xLTcyMTUx_2bd14f59-aeb8-4ee9-8449-98e5dba7b3f7">NYSE</dei:SecurityExchangeName>
    <dei:Security12gTitle
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGV4dHJlZ2lvbjowOTk1YjY4YTRjNjU0MDNjOGU4Yjc5NWY5NTNhYjA1Y18yNzY2_f613461f-82ef-4db9-966a-5ad74044c980">None</dei:Security12gTitle>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGV4dHJlZ2lvbjowOTk1YjY4YTRjNjU0MDNjOGU4Yjc5NWY5NTNhYjA1Y181NDk3NTU4MjQ0MTE_2d326c1f-e704-46a7-8a12-da074978cba4">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGV4dHJlZ2lvbjowOTk1YjY4YTRjNjU0MDNjOGU4Yjc5NWY5NTNhYjA1Y18yNzcz_1c908f23-963f-4674-9c99-75e20613dd00">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGV4dHJlZ2lvbjowOTk1YjY4YTRjNjU0MDNjOGU4Yjc5NWY5NTNhYjA1Y181NDk3NTU4MjQ0MTM_78bb1356-7a8c-47cc-9dc9-26e297ff385a">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGV4dHJlZ2lvbjowOTk1YjY4YTRjNjU0MDNjOGU4Yjc5NWY5NTNhYjA1Y18yNzc1_8aa63953-c8a3-4377-8785-913a72e51c67">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6ZjdiNTNmNjgzMDEwNDA0ZDkyN2VmMzg1MThhNWVmODcvdGFibGVyYW5nZTpmN2I1M2Y2ODMwMTA0MDRkOTI3ZWYzODUxOGE1ZWY4N18wLTAtMS0xLTcyMTUx_0e5a81b8-4bd0-4cdb-a5cc-53c5ae77fcd2">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntityEmergingGrowthCompany
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6ZjdiNTNmNjgzMDEwNDA0ZDkyN2VmMzg1MThhNWVmODcvdGFibGVyYW5nZTpmN2I1M2Y2ODMwMTA0MDRkOTI3ZWYzODUxOGE1ZWY4N18wLTUtMS0xLTcyMTUx_6393563b-c9f7-414b-abac-bd3cadf7c710">false</dei:EntityEmergingGrowthCompany>
    <dei:EntitySmallBusiness
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGFibGU6ZjdiNTNmNjgzMDEwNDA0ZDkyN2VmMzg1MThhNWVmODcvdGFibGVyYW5nZTpmN2I1M2Y2ODMwMTA0MDRkOTI3ZWYzODUxOGE1ZWY4N18xLTMtMS0xLTcyMTUx_4ad23bfa-b238-4f26-831f-4a0b993203c6">false</dei:EntitySmallBusiness>
    <dei:IcfrAuditorAttestationFlag
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGV4dHJlZ2lvbjowOTk1YjY4YTRjNjU0MDNjOGU4Yjc5NWY5NTNhYjA1Y18yNzY4_6b931c0e-6a83-4000-9660-96a04a79346f">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGV4dHJlZ2lvbjowOTk1YjY4YTRjNjU0MDNjOGU4Yjc5NWY5NTNhYjA1Y18yNzcw_c954886f-bb6e-4dbe-9437-262282260167">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="i28ee37853fb34f8596d0f60ff923f553_I20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGV4dHJlZ2lvbjowOTk1YjY4YTRjNjU0MDNjOGU4Yjc5NWY5NTNhYjA1Y18yNDE1_3a620ef8-38a0-4438-89f4-f0b2580f7a03"
      unitRef="usd">70965162853</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="ia86e7290435746bc83636123dd097ec2_I20230131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGV4dHJlZ2lvbjowOTk1YjY4YTRjNjU0MDNjOGU4Yjc5NWY5NTNhYjA1Y18yNDM2_79b7cf66-307d-41aa-9f6d-9ca5c7e78f98"
      unitRef="shares">378831249</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xL2ZyYWc6MDk5NWI2OGE0YzY1NDAzYzhlOGI3OTVmOTUzYWIwNWMvdGV4dHJlZ2lvbjowOTk1YjY4YTRjNjU0MDNjOGU4Yjc5NWY5NTNhYjA1Y18yNzY5_ca4507d0-64c9-4e3b-a979-e76c5ca6c263">Portions of the proxy statement to be filed with the U.S. Securities and Exchange Commission relating to the 2023 Annual Meeting of Shareholders (the 2023 proxy statement) are incorporated by reference into Part III.</dei:DocumentsIncorporatedByReferenceTextBlock>
    <dei:AuditorFirmId
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183L2ZyYWc6YjE4NzY4NTg4ZDFmNGYyNjhlZjk4ZTk3YTlkNDBhZjMvdGFibGU6YjU2MjA1MzBlOWIzNGUxNmE4MGFlZTE4MjhjN2VjMzkvdGFibGVyYW5nZTpiNTYyMDUzMGU5YjM0ZTE2YTgwYWVlMTgyOGM3ZWMzOV8xNC0xLTEtMS03MjE1MS90ZXh0cmVnaW9uOmZiYTBjZDUyNzUzZDRlYmU5MzRhN2E1ODZlODE3M2I5Xzcx_2e730fbb-9694-4666-bb14-b6ab7f62c4f5">42</dei:AuditorFirmId>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN182Ny9mcmFnOmQ0NWFiNjFmYjMyZjRjMTc4NWRhMjkwYzczOGFkYzY4L3RleHRyZWdpb246ZDQ1YWI2MWZiMzJmNGMxNzg1ZGEyOTBjNzM4YWRjNjhfNzY5NjU4MTQzMjQ2MA_c03e4d83-80f7-4923-9b6e-33741caac327"
      unitRef="usd">216000000</us-gaap:GoodwillImpairmentLoss>
    <dei:AuditorName
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183Ni9mcmFnOmQ2OGU5MjdjY2E4NDRjMzk5NjRkYjRjMzNjODhiOTI2L3RleHRyZWdpb246ZDY4ZTkyN2NjYTg0NGMzOTk2NGRiNGMzM2M4OGI5MjZfMzY1MQ_19202f6e-4d31-48fe-9b7e-263667e8acbb">Ernst&#160;&amp; Young LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183Ni9mcmFnOmQ2OGU5MjdjY2E4NDRjMzk5NjRkYjRjMzNjODhiOTI2L3RleHRyZWdpb246ZDY4ZTkyN2NjYTg0NGMzOTk2NGRiNGMzM2M4OGI5MjZfMzY1Mg_c4ebacd7-ad01-4c90-be6b-d5dafbd62f48">Grand Rapids, Michigan</dei:AuditorLocation>
    <us-gaap:Revenues
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMS0xLTEtMS03MjE1MQ_b555fe4c-5fa9-46d1-863d-217fca4a23fc"
      unitRef="usd">18449000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMS0zLTEtMS03MjE1MQ_443dc4dc-ff44-4add-9720-a2442753ce00"
      unitRef="usd">17108000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMS01LTEtMS03MjE1MQ_f069d865-13a0-4d28-abc6-27db37b83465"
      unitRef="usd">14351000000</us-gaap:Revenues>
    <us-gaap:CostOfRevenue
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMi0xLTEtMS03MjE1MQ_259ba803-3c75-43c7-86bc-84594ace92c1"
      unitRef="usd">6871000000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMi0zLTEtMS03MjE1MQ_5fa923ae-b3db-42d7-b122-e567dc080084"
      unitRef="usd">6140000000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMi01LTEtMS03MjE1MQ_ac74550b-d41f-44d1-baf2-09c0685d102e"
      unitRef="usd">5294000000</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMy0xLTEtMS03MjE1MQ_b490513a-f969-4f4e-91ef-a5f6820a8386"
      unitRef="usd">11578000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMy0zLTEtMS03MjE1MQ_51bdf7ac-1655-46df-8d86-37c60b8bde5a"
      unitRef="usd">10968000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMy01LTEtMS03MjE1MQ_c417d975-fd6f-49b2-a201-3b69a60dc7b7"
      unitRef="usd">9057000000</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfNC0xLTEtMS03MjE1MQ_64bc1d29-af2e-4336-8e7b-014883c4dd64"
      unitRef="usd">1454000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfNC0zLTEtMS03MjE1MQ_8f872cbe-a3b5-4d4c-9851-0b6aed5ca7f7"
      unitRef="usd">1235000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfNC01LTEtMS03MjE1MQ_a9b31509-30ab-4aff-95c6-71ceaac0ce0b"
      unitRef="usd">984000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfNS0xLTEtMS03MjE1MQ_83c7f965-4d19-4c1f-a56b-74cf4317a003"
      unitRef="usd">6455000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfNS0zLTEtMS03MjE1MQ_23c9624c-0646-44c6-bf12-be8a49862d89"
      unitRef="usd">6427000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfNS01LTEtMS03MjE1MQ_f1fc44b6-4a23-41c8-bd4b-625b6dae4a09"
      unitRef="usd">5361000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ProductLiabilityAccrualPeriodExpense
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfNi0xLTEtMS03MjE1MQ_98aee8da-f6fa-403d-bb2d-bc25c46787ba"
      unitRef="usd">-15000000</us-gaap:ProductLiabilityAccrualPeriodExpense>
    <us-gaap:ProductLiabilityAccrualPeriodExpense
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfNi0zLTEtMS03MjE1MQ_850f513e-d46f-4b3a-ac45-782cdecdee4c"
      unitRef="usd">103000000</us-gaap:ProductLiabilityAccrualPeriodExpense>
    <us-gaap:ProductLiabilityAccrualPeriodExpense
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfNi01LTEtMS03MjE1MQ_be0d72cc-0d5b-462e-9f6c-1da73b54e99b"
      unitRef="usd">17000000</us-gaap:ProductLiabilityAccrualPeriodExpense>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfNy0xLTEtMS03MjE1MQ_97e5e167-43a4-4a16-ac33-93b74a1e69d6"
      unitRef="usd">627000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfNy0zLTEtMS03MjE1MQ_68d13eb8-4b73-477e-8a4c-8dd493a85cfb"
      unitRef="usd">619000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfNy01LTEtMS03MjE1MQ_5125f134-e044-4793-ba75-dfb7ddb94f7c"
      unitRef="usd">472000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfOC0xLTEtMS03NTk5MA_c03e4d83-80f7-4923-9b6e-33741caac327"
      unitRef="usd">216000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfOC0zLTEtMS03NjAxOQ_0930ee2b-1687-4b2a-8799-b0ed7e049750"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfOC01LTEtMS03NjAyNw_fdac06a2-fd50-4e82-b733-8152f371213a"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:OperatingExpenses
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfOC0xLTEtMS03MjE1MQ_80012d91-e90b-4deb-ab98-7c53efbdb773"
      unitRef="usd">8737000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfOC0zLTEtMS03MjE1MQ_ff5a2b1e-6696-4324-8acb-9415e701f669"
      unitRef="usd">8384000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfOC01LTEtMS03MjE1MQ_d9bbbba4-df5b-4739-a00c-660854710a6c"
      unitRef="usd">6834000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfOS0xLTEtMS03MjE1MQ_651c8ef9-1a19-419b-aa55-927cd13f58db"
      unitRef="usd">2841000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfOS0zLTEtMS03MjE1MQ_06bbc172-e21c-469d-b1a8-4352ac4fba04"
      unitRef="usd">2584000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfOS01LTEtMS03MjE1MQ_ddfe70f1-c621-4e25-bfae-ec534ee48780"
      unitRef="usd">2223000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMTAtMS0xLTEtNzIxNTE_4c1d742f-05d9-4f27-922d-5a0de8878983"
      unitRef="usd">-158000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMTAtMy0xLTEtNzIxNTE_6a13d98b-17c2-4abf-8451-babc7e435178"
      unitRef="usd">-303000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMTAtNS0xLTEtNzIxNTE_5698ed1b-0c11-489b-9e42-f90414a6f4e2"
      unitRef="usd">-269000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMTEtMS0xLTEtNzIxNTE_aa01200c-0278-49c9-a4e5-45b24b4a06a8"
      unitRef="usd">2683000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMTEtMy0xLTEtNzIxNTE_4395f7a1-98ed-4e35-9071-4b57e71a9b57"
      unitRef="usd">2281000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMTEtNS0xLTEtNzIxNTE_60b5d50a-da48-41b5-9251-77f05341bf39"
      unitRef="usd">1954000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMTItMS0xLTEtNzIxNTE_2854ae5f-328c-4e89-a828-496d4b2bfd21"
      unitRef="usd">325000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMTItMy0xLTEtNzIxNTE_f5408d94-1665-427d-8b7b-20061133a772"
      unitRef="usd">287000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMTItNS0xLTEtNzIxNTE_2c07f271-544e-4aa6-b3ba-fedfe510fc18"
      unitRef="usd">355000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMTMtMS0xLTEtNzIxNTE_351a2f4f-8080-40a7-ae55-6f750ac81398"
      unitRef="usd">2358000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMTMtMy0xLTEtNzIxNTE_0be39e12-0e45-4c4d-825e-69a297b933c6"
      unitRef="usd">1994000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMTMtNS0xLTEtNzIxNTE_ebc15db0-2e15-49b8-a53b-3a84cd3da855"
      unitRef="usd">1599000000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMTYtMS0xLTEtNzIxNTE_994baef6-88d7-4a5f-b39b-2d534a242948"
      unitRef="usdPerShare">6.23</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMTYtMy0xLTEtNzIxNTE_ab3fa1de-c844-41a1-b36c-d4cc88062afe"
      unitRef="usdPerShare">5.29</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMTYtNS0xLTEtNzIxNTE_79442e76-af0a-47ef-9189-08bf481f55e6"
      unitRef="usdPerShare">4.26</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMTctMS0xLTEtNzIxNTE_cd0c48ac-0c86-439a-835e-af9cacbba4a2"
      unitRef="usdPerShare">6.17</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMTctMy0xLTEtNzIxNTE_d1a6dcde-415b-4adb-9a50-a273ea9870af"
      unitRef="usdPerShare">5.21</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMTctNS0xLTEtNzIxNTE_520f28b6-8050-428b-b1a2-20657ef47204"
      unitRef="usdPerShare">4.20</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMjAtMS0xLTEtNzIxNTE_4ad1c9ae-5b9b-4be2-aea9-9fd5d20db9e2"
      unitRef="shares">378200000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMjAtMy0xLTEtNzIxNTE_86ec3f75-94f9-42c1-9982-a64fff919958"
      unitRef="shares">377000000.0</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMjAtNS0xLTEtNzIxNTE_66421e7f-8ecb-4f76-a1f1-ad302f4e32f2"
      unitRef="shares">375500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMjEtMS0xLTEtNzIxNTE_fd7edcc7-b808-400c-ae25-f3c33c2929da"
      unitRef="shares">4000000.0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMjEtMy0xLTEtNzIxNTE_d6ead0f8-8cae-4896-84cf-9b29509e2e05"
      unitRef="shares">5300000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMjEtNS0xLTEtNzIxNTE_bb0a7889-5385-4f53-b994-d7760cd57f20"
      unitRef="shares">4800000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMjItMS0xLTEtNzIxNTE_5a3afa46-9ec0-4b30-87af-e1c9c6e3f455"
      unitRef="shares">382200000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMjItMy0xLTEtNzIxNTE_73f6803f-29a4-4420-86ad-22f70e49d34c"
      unitRef="shares">382300000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RhYmxlOjI3MjBiYWE5MjZlMzRkZDc4MmQxYmJiN2VkMjUyMDI4L3RhYmxlcmFuZ2U6MjcyMGJhYTkyNmUzNGRkNzgyZDFiYmI3ZWQyNTIwMjhfMjItNS0xLTEtNzIxNTE_36ea811d-b5a6-47e6-8903-f8b0a8d646b0"
      unitRef="shares">380300000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN183OS9mcmFnOjY4ODYxOTE4MDEwODQ5OWJiMjVkYWRhNmEyYjgwNjMyL3RleHRyZWdpb246Njg4NjE5MTgwMTA4NDk5YmIyNWRhZGE2YTJiODA2MzJfNTQ5NzU1ODE0MTgx_c87e47f7-3c7e-4073-b4ee-770a1cb6a490"
      unitRef="shares">4300000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:NetIncomeLoss
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184Mi9mcmFnOjdjN2MwNmQ0OTQxNjQwMWQ4MTA4NTQwN2E2NGI2MWYxL3RhYmxlOjkyMjc2MmJkZmYzNzQ0MGRhZjk1ZDc3OGY3YjFkZjYwL3RhYmxlcmFuZ2U6OTIyNzYyYmRmZjM3NDQwZGFmOTVkNzc4ZjdiMWRmNjBfMS0xLTEtMS03MjE1MQ_351a2f4f-8080-40a7-ae55-6f750ac81398"
      unitRef="usd">2358000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184Mi9mcmFnOjdjN2MwNmQ0OTQxNjQwMWQ4MTA4NTQwN2E2NGI2MWYxL3RhYmxlOjkyMjc2MmJkZmYzNzQ0MGRhZjk1ZDc3OGY3YjFkZjYwL3RhYmxlcmFuZ2U6OTIyNzYyYmRmZjM3NDQwZGFmOTVkNzc4ZjdiMWRmNjBfMS0zLTEtMS03MjE1MQ_0be39e12-0e45-4c4d-825e-69a297b933c6"
      unitRef="usd">1994000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184Mi9mcmFnOjdjN2MwNmQ0OTQxNjQwMWQ4MTA4NTQwN2E2NGI2MWYxL3RhYmxlOjkyMjc2MmJkZmYzNzQ0MGRhZjk1ZDc3OGY3YjFkZjYwL3RhYmxlcmFuZ2U6OTIyNzYyYmRmZjM3NDQwZGFmOTVkNzc4ZjdiMWRmNjBfMS01LTEtMS03MjE1MQ_ebc15db0-2e15-49b8-a53b-3a84cd3da855"
      unitRef="usd">1599000000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184Mi9mcmFnOjdjN2MwNmQ0OTQxNjQwMWQ4MTA4NTQwN2E2NGI2MWYxL3RhYmxlOjkyMjc2MmJkZmYzNzQ0MGRhZjk1ZDc3OGY3YjFkZjYwL3RhYmxlcmFuZ2U6OTIyNzYyYmRmZjM3NDQwZGFmOTVkNzc4ZjdiMWRmNjBfMy0xLTEtMS03MjE1MQ_2f11bfe6-aea6-4f15-b76d-318cb5b229f5"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184Mi9mcmFnOjdjN2MwNmQ0OTQxNjQwMWQ4MTA4NTQwN2E2NGI2MWYxL3RhYmxlOjkyMjc2MmJkZmYzNzQ0MGRhZjk1ZDc3OGY3YjFkZjYwL3RhYmxlcmFuZ2U6OTIyNzYyYmRmZjM3NDQwZGFmOTVkNzc4ZjdiMWRmNjBfMy0zLTEtMS03MjE1MQ_41cfaa5f-a70f-4d37-becf-71f8735df63e"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184Mi9mcmFnOjdjN2MwNmQ0OTQxNjQwMWQ4MTA4NTQwN2E2NGI2MWYxL3RhYmxlOjkyMjc2MmJkZmYzNzQ0MGRhZjk1ZDc3OGY3YjFkZjYwL3RhYmxlcmFuZ2U6OTIyNzYyYmRmZjM3NDQwZGFmOTVkNzc4ZjdiMWRmNjBfMy01LTEtMS03MjE1MQ_98e377e0-192f-4e26-a358-996ec21109eb"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184Mi9mcmFnOjdjN2MwNmQ0OTQxNjQwMWQ4MTA4NTQwN2E2NGI2MWYxL3RhYmxlOjkyMjc2MmJkZmYzNzQ0MGRhZjk1ZDc3OGY3YjFkZjYwL3RhYmxlcmFuZ2U6OTIyNzYyYmRmZjM3NDQwZGFmOTVkNzc4ZjdiMWRmNjBfNC0xLTEtMS03MjE1MQ_01076189-dfd6-45d2-b2b5-c474d5aa144e"
      unitRef="usd">-186000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184Mi9mcmFnOjdjN2MwNmQ0OTQxNjQwMWQ4MTA4NTQwN2E2NGI2MWYxL3RhYmxlOjkyMjc2MmJkZmYzNzQ0MGRhZjk1ZDc3OGY3YjFkZjYwL3RhYmxlcmFuZ2U6OTIyNzYyYmRmZjM3NDQwZGFmOTVkNzc4ZjdiMWRmNjBfNC0zLTEtMS03MjE1MQ_d6d94609-3031-4c2b-88c8-6f8895630749"
      unitRef="usd">-104000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184Mi9mcmFnOjdjN2MwNmQ0OTQxNjQwMWQ4MTA4NTQwN2E2NGI2MWYxL3RhYmxlOjkyMjc2MmJkZmYzNzQ0MGRhZjk1ZDc3OGY3YjFkZjYwL3RhYmxlcmFuZ2U6OTIyNzYyYmRmZjM3NDQwZGFmOTVkNzc4ZjdiMWRmNjBfNC01LTEtMS03MjE1MQ_acc1c5fa-634c-448a-ae7e-93b4be3dc327"
      unitRef="usd">80000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184Mi9mcmFnOjdjN2MwNmQ0OTQxNjQwMWQ4MTA4NTQwN2E2NGI2MWYxL3RhYmxlOjkyMjc2MmJkZmYzNzQ0MGRhZjk1ZDc3OGY3YjFkZjYwL3RhYmxlcmFuZ2U6OTIyNzYyYmRmZjM3NDQwZGFmOTVkNzc4ZjdiMWRmNjBfNS0xLTEtMS03MjE1MQ_facc957e-8de0-423f-a465-0967075eaa92"
      unitRef="usd">12000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184Mi9mcmFnOjdjN2MwNmQ0OTQxNjQwMWQ4MTA4NTQwN2E2NGI2MWYxL3RhYmxlOjkyMjc2MmJkZmYzNzQ0MGRhZjk1ZDc3OGY3YjFkZjYwL3RhYmxlcmFuZ2U6OTIyNzYyYmRmZjM3NDQwZGFmOTVkNzc4ZjdiMWRmNjBfNS0zLTEtMS03MjE1MQ_2cb639c9-907e-4a15-8605-a2baf3639b34"
      unitRef="usd">50000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184Mi9mcmFnOjdjN2MwNmQ0OTQxNjQwMWQ4MTA4NTQwN2E2NGI2MWYxL3RhYmxlOjkyMjc2MmJkZmYzNzQ0MGRhZjk1ZDc3OGY3YjFkZjYwL3RhYmxlcmFuZ2U6OTIyNzYyYmRmZjM3NDQwZGFmOTVkNzc4ZjdiMWRmNjBfNS01LTEtMS03MjE1MQ_bee50e43-c896-485b-b40f-553a2f1df261"
      unitRef="usd">-57000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184Mi9mcmFnOjdjN2MwNmQ0OTQxNjQwMWQ4MTA4NTQwN2E2NGI2MWYxL3RhYmxlOjkyMjc2MmJkZmYzNzQ0MGRhZjk1ZDc3OGY3YjFkZjYwL3RhYmxlcmFuZ2U6OTIyNzYyYmRmZjM3NDQwZGFmOTVkNzc4ZjdiMWRmNjBfNi0xLTEtMS03MjE1MQ_858ab52f-0880-4705-a137-1ff8e9e290d5"
      unitRef="usd">113000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184Mi9mcmFnOjdjN2MwNmQ0OTQxNjQwMWQ4MTA4NTQwN2E2NGI2MWYxL3RhYmxlOjkyMjc2MmJkZmYzNzQ0MGRhZjk1ZDc3OGY3YjFkZjYwL3RhYmxlcmFuZ2U6OTIyNzYyYmRmZjM3NDQwZGFmOTVkNzc4ZjdiMWRmNjBfNi0zLTEtMS03MjE1MQ_e0c4a17a-16b3-41ea-b500-596376321f3c"
      unitRef="usd">469000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184Mi9mcmFnOjdjN2MwNmQ0OTQxNjQwMWQ4MTA4NTQwN2E2NGI2MWYxL3RhYmxlOjkyMjc2MmJkZmYzNzQ0MGRhZjk1ZDc3OGY3YjFkZjYwL3RhYmxlcmFuZ2U6OTIyNzYyYmRmZjM3NDQwZGFmOTVkNzc4ZjdiMWRmNjBfNi01LTEtMS03MjE1MQ_674fd48e-777d-422f-af80-9aec52ec5b48"
      unitRef="usd">-414000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184Mi9mcmFnOjdjN2MwNmQ0OTQxNjQwMWQ4MTA4NTQwN2E2NGI2MWYxL3RhYmxlOjkyMjc2MmJkZmYzNzQ0MGRhZjk1ZDc3OGY3YjFkZjYwL3RhYmxlcmFuZ2U6OTIyNzYyYmRmZjM3NDQwZGFmOTVkNzc4ZjdiMWRmNjBfNy0xLTEtMS03MjE1MQ_798bedf8-2977-47df-a246-8f9e390cb2a0"
      unitRef="usd">310000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184Mi9mcmFnOjdjN2MwNmQ0OTQxNjQwMWQ4MTA4NTQwN2E2NGI2MWYxL3RhYmxlOjkyMjc2MmJkZmYzNzQ0MGRhZjk1ZDc3OGY3YjFkZjYwL3RhYmxlcmFuZ2U6OTIyNzYyYmRmZjM3NDQwZGFmOTVkNzc4ZjdiMWRmNjBfNy0zLTEtMS03MjE1MQ_1919325a-e979-4b19-a953-909eee46cdd3"
      unitRef="usd">626000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184Mi9mcmFnOjdjN2MwNmQ0OTQxNjQwMWQ4MTA4NTQwN2E2NGI2MWYxL3RhYmxlOjkyMjc2MmJkZmYzNzQ0MGRhZjk1ZDc3OGY3YjFkZjYwL3RhYmxlcmFuZ2U6OTIyNzYyYmRmZjM3NDQwZGFmOTVkNzc4ZjdiMWRmNjBfNy01LTEtMS03MjE1MQ_cca45acc-2d33-43c1-988c-5ef9946fc489"
      unitRef="usd">-551000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184Mi9mcmFnOjdjN2MwNmQ0OTQxNjQwMWQ4MTA4NTQwN2E2NGI2MWYxL3RhYmxlOjkyMjc2MmJkZmYzNzQ0MGRhZjk1ZDc3OGY3YjFkZjYwL3RhYmxlcmFuZ2U6OTIyNzYyYmRmZjM3NDQwZGFmOTVkNzc4ZjdiMWRmNjBfOC0xLTEtMS03MjE1MQ_b8e519a2-8ccc-4de8-9d9a-7f58d340415f"
      unitRef="usd">2668000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184Mi9mcmFnOjdjN2MwNmQ0OTQxNjQwMWQ4MTA4NTQwN2E2NGI2MWYxL3RhYmxlOjkyMjc2MmJkZmYzNzQ0MGRhZjk1ZDc3OGY3YjFkZjYwL3RhYmxlcmFuZ2U6OTIyNzYyYmRmZjM3NDQwZGFmOTVkNzc4ZjdiMWRmNjBfOC0zLTEtMS03MjE1MQ_2c503df9-61df-4a3a-ad67-72c5a56476e3"
      unitRef="usd">2620000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184Mi9mcmFnOjdjN2MwNmQ0OTQxNjQwMWQ4MTA4NTQwN2E2NGI2MWYxL3RhYmxlOjkyMjc2MmJkZmYzNzQ0MGRhZjk1ZDc3OGY3YjFkZjYwL3RhYmxlcmFuZ2U6OTIyNzYyYmRmZjM3NDQwZGFmOTVkNzc4ZjdiMWRmNjBfOC01LTEtMS03MjE1MQ_a98ebdaf-6d7c-4f88-83b3-b2c9595ed06a"
      unitRef="usd">1048000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMy0xLTEtMS03MjE1MQ_ac7c6b3a-f893-4411-ac17-f85a839db211"
      unitRef="usd">1844000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMy0zLTEtMS03MjE1MQ_1832490f-ae19-4564-8b91-0af2b1b82942"
      unitRef="usd">2944000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfNC0xLTEtMS03MjE1MQ_ea0c8a15-63a6-439a-a074-f28352c134ff"
      unitRef="usd">84000000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfNC0zLTEtMS03MjE1MQ_27bca679-4a9f-4dbb-9e84-e7f8e547a498"
      unitRef="usd">75000000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfNS0wLTEtMS03MjE1MS90ZXh0cmVnaW9uOjc5Zjk5NjczNmNlMDQzYzA5MzEyZjc4MmRlN2I4ZjI1XzQz_57373350-bdb3-49ea-a483-2b8fbc473541"
      unitRef="usd">154000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfNS0wLTEtMS03MjE1MS90ZXh0cmVnaW9uOjc5Zjk5NjczNmNlMDQzYzA5MzEyZjc4MmRlN2I4ZjI1XzQ3_7cda816d-b6e4-4fb2-8034-4308e1eccd8f"
      unitRef="usd">167000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfNS0xLTEtMS03MjE1MQ_96f8b0b5-f942-42be-9703-b2e52c77afb9"
      unitRef="usd">3565000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfNS0zLTEtMS03MjE1MQ_0f44641a-188e-4121-bd18-150d53ad34e7"
      unitRef="usd">3022000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfNy0xLTEtMS03MjE1MQ_61266958-e093-45fb-a7b2-55c35f76d323"
      unitRef="usd">1006000000</us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves>
    <us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfNy0zLTEtMS03MjE1MQ_c34111f8-a7c4-496e-aba2-e32395214a34"
      unitRef="usd">691000000</us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfOC0xLTEtMS03MjE1MQ_d3fcc133-2c07-43c1-b1bf-01d8c9077b68"
      unitRef="usd">348000000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfOC0zLTEtMS03MjE1MQ_c8648028-85c3-4e5b-abec-4bb3781cf5ac"
      unitRef="usd">264000000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfOS0xLTEtMS03MjE1MQ_94e49021-2d19-41f2-8e2b-9836ee5ea0fb"
      unitRef="usd">2641000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfOS0zLTEtMS03MjE1MQ_6ac36e47-e62f-491c-b48d-b7971c5b5abb"
      unitRef="usd">2359000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMTAtMS0xLTEtNzIxNTE_5b37cbd8-834c-4af2-88d4-765994f5b8c5"
      unitRef="usd">3995000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMTAtMy0xLTEtNzIxNTE_7b77b0c2-5c00-499a-89b3-23420ea06422"
      unitRef="usd">3314000000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMTEtMS0xLTEtNzIxNTE_fb470084-a0be-4120-8118-c5bdd49431d4"
      unitRef="usd">787000000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMTEtMy0xLTEtNzIxNTE_acf1a8ee-80bb-4b79-b46d-1b77184ba633"
      unitRef="usd">662000000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMTItMS0xLTEtNzIxNTE_8a62c189-4b85-4f51-accc-ba234d2757fa"
      unitRef="usd">10275000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMTItMy0xLTEtNzIxNTE_c6907258-77cd-41cd-9c02-5fccf8a5cc17"
      unitRef="usd">10017000000</us-gaap:AssetsCurrent>
    <syk:LandBuildingsAndImprovementsGross
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMTQtMS0xLTEtNzIxNTE_51fb4ecc-1971-4d8e-8cba-b930268aa973"
      unitRef="usd">1739000000</syk:LandBuildingsAndImprovementsGross>
    <syk:LandBuildingsAndImprovementsGross
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMTQtMy0xLTEtNzIxNTE_c1906ebf-93d9-4688-bd74-7229a6cdb33c"
      unitRef="usd">1656000000</syk:LandBuildingsAndImprovementsGross>
    <us-gaap:MachineryAndEquipmentGross
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMTUtMS0xLTEtNzIxNTE_59fdb635-7176-424b-9b9a-61b3dba80a4e"
      unitRef="usd">4066000000</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:MachineryAndEquipmentGross
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMTUtMy0xLTEtNzIxNTE_d0883260-be0d-48c7-875a-d3e70638d8ce"
      unitRef="usd">3842000000</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMTYtMS0xLTEtNzIxNTE_7d58f98d-89c2-42dd-9562-41008d0d2398"
      unitRef="usd">5805000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMTYtMy0xLTEtNzIxNTE_3458da59-0d07-41a4-a6e7-e12816eea31e"
      unitRef="usd">5498000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMTctMS0xLTEtNzIxNTE_2340c4a7-5eaa-4230-b6d0-7949cba951d5"
      unitRef="usd">2835000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMTctMy0xLTEtNzIxNTE_e7bf7715-cf7f-4a39-9d5a-2a5c899a04cd"
      unitRef="usd">2665000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMTgtMS0xLTEtNzIxNTE_3597c982-99cc-4dea-aea6-e04aadae891b"
      unitRef="usd">2970000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMTgtMy0xLTEtNzIxNTE_14af34cb-62e3-4437-84fb-b9bc80fd8b8d"
      unitRef="usd">2833000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMTktMS0xLTEtNzIxNTE_fc64257a-48a0-472a-98db-cf81b1bbbe56"
      unitRef="usd">14880000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMTktMy0xLTEtNzIxNTE_6e98818c-82a1-4226-ab43-79bcdc6d23b5"
      unitRef="usd">12918000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMjAtMS0xLTEtNzIxNTE_54eb39c8-45b8-4341-9aa2-748af8a83411"
      unitRef="usd">4885000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMjAtMy0xLTEtNzIxNTE_4d205b4d-cb6c-42fd-83d3-71c2ef79b496"
      unitRef="usd">4840000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMjEtMS0xLTEtNzIxNTE_9d535bee-3f71-45b0-8c0b-4702a52b0520"
      unitRef="usd">1410000000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMjEtMy0xLTEtNzIxNTE_66897cb0-f0ca-4fc5-aee0-9434ca22e9d8"
      unitRef="usd">1760000000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMjItMS0xLTEtNzIxNTE_05d1f27a-b8db-44f0-a372-46fd401ad7ad"
      unitRef="usd">2464000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMjItMy0xLTEtNzIxNTE_9e5e348a-afd8-48e8-abca-a2181be8ddbc"
      unitRef="usd">2263000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMjMtMS0xLTEtNzIxNTE_6e4c11b7-a73e-4c83-8938-e3137937342c"
      unitRef="usd">36884000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMjMtMy0xLTEtNzIxNTE_117e79d5-7a46-470c-a49c-6ed38eded1a1"
      unitRef="usd">34631000000</us-gaap:Assets>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMjctMS0xLTEtNzIxNTE_76ba9ac8-7a66-4d39-b972-b543be950c00"
      unitRef="usd">1413000000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMjctMy0xLTEtNzIxNTE_e9a7a2fd-dfbc-455b-b420-71211d8da855"
      unitRef="usd">1129000000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMjgtMS0xLTEtNzIxNTE_0bb8e9b0-d6ad-4d26-98ac-67f85b6be36e"
      unitRef="usd">1149000000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMjgtMy0xLTEtNzIxNTE_57c577cf-02e4-4237-a51f-ca738e273eaa"
      unitRef="usd">1092000000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMjktMS0xLTEtNzIxNTE_905ef566-cba0-4300-a6ac-66dd8bfa217e"
      unitRef="usd">292000000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMjktMy0xLTEtNzIxNTE_96e2685e-0c2c-4a00-bdf7-f2bd7dc98006"
      unitRef="usd">192000000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:DividendsPayableCurrent
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMzAtMS0xLTEtNzIxNTE_80fd027f-c748-4c81-8199-0c7bb9d045a0"
      unitRef="usd">284000000</us-gaap:DividendsPayableCurrent>
    <us-gaap:DividendsPayableCurrent
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMzAtMy0xLTEtNzIxNTE_8cc57a9c-2921-41ab-a60f-09cfa26ce44e"
      unitRef="usd">263000000</us-gaap:DividendsPayableCurrent>
    <us-gaap:CustomerRefundLiabilityCurrent
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMzEtMS0xLTEtNzIxNTE_1dd6a40d-ae4e-4dba-a097-cf1217007814"
      unitRef="usd">230000000</us-gaap:CustomerRefundLiabilityCurrent>
    <us-gaap:CustomerRefundLiabilityCurrent
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMzEtMy0xLTEtNzIxNTE_e7fb4b3d-f52c-4a93-a80c-1019b66d01dc"
      unitRef="usd">401000000</us-gaap:CustomerRefundLiabilityCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMzItMS0xLTEtNzIxNTE_aae6f10c-9f7d-43c7-917e-844495974068"
      unitRef="usd">1744000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMzItMy0xLTEtNzIxNTE_ca3b8696-25a8-4b9b-bb22-54b27f3dd8d8"
      unitRef="usd">1465000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:DebtCurrent
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMzMtMS0xLTEtNzIxNTE_ffce4d42-47eb-4e7d-b247-cee0411af29b"
      unitRef="usd">1191000000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMzMtMy0xLTEtNzIxNTE_fbdf0ff2-3f1f-4e35-9c5f-fc008d102890"
      unitRef="usd">7000000</us-gaap:DebtCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMzQtMS0xLTEtNzIxNTE_6f0d66bc-b78e-495b-8d85-4787abb19bcc"
      unitRef="usd">6303000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMzQtMy0xLTEtNzIxNTE_f613887d-19a9-44a4-8c3a-9ebf46eac561"
      unitRef="usd">4549000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMzUtMS0xLTEtNzIxNTE_67abafda-dc64-4a93-ad68-1357ed45d16b"
      unitRef="usd">11857000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMzUtMy0xLTEtNzIxNTE_360239c6-2639-48be-9462-bad9141d61c1"
      unitRef="usd">12472000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:AccruedIncomeTaxesNoncurrent
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMzYtMS0xLTEtNzIxNTE_ac24b42e-0eb7-4cf8-ba7f-b62e2c8abbb1"
      unitRef="usd">641000000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:AccruedIncomeTaxesNoncurrent
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMzYtMy0xLTEtNzIxNTE_fc8e5d18-f4aa-4310-9388-14b67b56f45f"
      unitRef="usd">913000000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMzctMS0xLTEtNzIxNTE_095a9847-a4db-487c-afd1-35108d4cc3ac"
      unitRef="usd">1467000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMzctMy0xLTEtNzIxNTE_ee3e3c26-1257-4b5e-a327-a0a67d6c121d"
      unitRef="usd">1820000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMzgtMS0xLTEtNzIxNTE_517fac13-165e-4583-8ba9-b767ce5c921d"
      unitRef="usd">20268000000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfMzgtMy0xLTEtNzIxNTE_a9f0242f-1a86-4e08-9aa3-1e92b27cd565"
      unitRef="usd">19754000000</us-gaap:Liabilities>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfNDAtMC0xLTEtNzIxNTEvdGV4dHJlZ2lvbjo4ZGMwM2NmYzIzOTA0MDgyYjY0N2NkM2VlMGY4Njg3ZF8xOA_1b0c9bed-17af-47bc-a062-146054209b99"
      unitRef="usdPerShare">0.10</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfNDAtMC0xLTEtNzIxNTEvdGV4dHJlZ2lvbjo4ZGMwM2NmYzIzOTA0MDgyYjY0N2NkM2VlMGY4Njg3ZF8xOA_40cfa560-3397-4764-939e-4a94034752a3"
      unitRef="usdPerShare">0.10</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockValueOutstanding
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfNDAtMS0xLTEtNzIxNTE_5d00b83e-8058-4c62-ad23-626dfd9a8b80"
      unitRef="usd">38000000</us-gaap:CommonStockValueOutstanding>
    <us-gaap:CommonStockValueOutstanding
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfNDAtMy0xLTEtNzIxNTE_2d5f1222-777d-432a-86bd-d55db4876cdc"
      unitRef="usd">38000000</us-gaap:CommonStockValueOutstanding>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfNDEtMS0xLTEtNzIxNTE_53d18a3f-3500-47fa-b52a-652d825b0d99"
      unitRef="usd">2034000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfNDEtMy0xLTEtNzIxNTE_bd9e8a2c-4141-488c-bae0-e4e41dbc4d39"
      unitRef="usd">1890000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfNDItMS0xLTEtNzIxNTE_700d4cc4-69dd-403f-a6d6-939aff16ff41"
      unitRef="usd">14765000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfNDItMy0xLTEtNzIxNTE_e1523b0c-87fb-4961-836b-d96515063751"
      unitRef="usd">13480000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfNDMtMS0xLTEtNzIxNTE_1c563c7f-f45c-4f6b-8e45-65b7964f1c46"
      unitRef="usd">-221000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfNDMtMy0xLTEtNzIxNTE_7bae69b9-29a6-4db9-8b19-1a68a9b56c52"
      unitRef="usd">-531000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfNDYtMS0xLTEtNzIxNTE_985e3838-5aa1-4cd1-95b2-d942ee14248e"
      unitRef="usd">16616000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfNDYtMy0xLTEtNzIxNTE_59a693d9-7524-4934-bc5d-25bf84441b40"
      unitRef="usd">14877000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfNDctMS0xLTEtNzIxNTE_ddef6483-8084-4bd1-a419-1e52e3a47a36"
      unitRef="usd">36884000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN184NS9mcmFnOjY5NjI3ZWZhMzQxNDQyNDRhNzRkNTZmNmRkOGZiZWEzL3RhYmxlOjhjZGMxYTY1ZTNiZjQ3YWFhZjdjNDE0YTJmNDM3NGE2L3RhYmxlcmFuZ2U6OGNkYzFhNjVlM2JmNDdhYWFmN2M0MTRhMmY0Mzc0YTZfNDctMy0xLTEtNzIxNTE_eb679e01-e524-49d4-b763-3d67055833a4"
      unitRef="usd">34631000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i3dd203be44e24244894ceb5a74354945_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMy0xLTEtMS03MjE1MQ_18db9f8d-878e-4a34-a62b-5d6aa0e0fc93"
      unitRef="shares">377500000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3dd203be44e24244894ceb5a74354945_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMy0yLTEtMS03MjE1MQ_d951f8b8-7dfb-44c4-a491-f5ff5af84a1c"
      unitRef="usd">38000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i4006898201a7425fb94bc2294d0b0392_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMy00LTEtMS03MjE1MQ_26e3f0ae-4548-4741-a550-080a5c42d9a7"
      unitRef="shares">376100000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4006898201a7425fb94bc2294d0b0392_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMy01LTEtMS03MjE1MQ_f591afc5-9f07-43dc-b593-e2737f4f0c37"
      unitRef="usd">38000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i576cd39821c64afe9e29c4e4b0a645cc_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMy03LTEtMS03MjE1MQ_f19335c2-1616-4c84-8a9c-5e1411f843bf"
      unitRef="shares">374500000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i576cd39821c64afe9e29c4e4b0a645cc_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMy04LTEtMS03MjE1MQ_8b2b7c3b-1c81-4421-a580-bb825286d1c0"
      unitRef="usd">37000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i0b7dcd3a92534102aafd86a58bd12396_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfNC0xLTEtMS03MjE1MQ_7625c60e-660e-4982-8731-01b0742cca5d"
      unitRef="shares">1200000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i0b7dcd3a92534102aafd86a58bd12396_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfNC0yLTEtMS03MjE1MQ_70e2998e-fc73-4f65-b65e-d6b6cb6a62f9"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i176c600905174175b724a109ca220959_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfNC00LTEtMS03MjE1MQ_d20f92f6-0d58-46e1-8b5d-1f994f67d295"
      unitRef="shares">1400000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i176c600905174175b724a109ca220959_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfNC01LTEtMS03MjE1MQ_b4c000fc-e82b-42d4-8b38-122ed1bfdc62"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i3b9d8d8eefe34b4f8f369cfda156c6e2_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfNC03LTEtMS03MjE1MQ_891286e8-aec0-4754-9725-3e808ef61421"
      unitRef="shares">1600000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i3b9d8d8eefe34b4f8f369cfda156c6e2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfNC04LTEtMS03MjE1MQ_7d1af928-5a3a-4fef-baab-6cc1f2a1af59"
      unitRef="usd">1000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ida5e85091b7148e19fbf01b77d79492c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfNi0xLTEtMS03MjE1MQ_5e257342-816c-4122-996f-ec6f5935eca3"
      unitRef="shares">378700000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ida5e85091b7148e19fbf01b77d79492c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfNi0yLTEtMS03MjE1MQ_e23c0ede-ec2f-401d-b33f-1e1100451f04"
      unitRef="usd">38000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i3dd203be44e24244894ceb5a74354945_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfNi00LTEtMS03MjE1MQ_9027c435-3e09-4360-bdcf-73b6d6d66f19"
      unitRef="shares">377500000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3dd203be44e24244894ceb5a74354945_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfNi01LTEtMS03MjE1MQ_1b64b15d-435e-4dcf-8eea-d1f5b000a6c3"
      unitRef="usd">38000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i4006898201a7425fb94bc2294d0b0392_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfNi03LTEtMS03MjE1MQ_e162391a-2c94-400e-841e-91d880c1d6f3"
      unitRef="shares">376100000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4006898201a7425fb94bc2294d0b0392_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfNi04LTEtMS03MjE1MQ_36228421-cec5-44cb-8599-b3881c78836b"
      unitRef="usd">38000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3e9fecf68eab4b96910415c71a11f0f0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfOC0yLTEtMS03MjE1MQ_c7247456-f6ba-485e-a94a-da501f4f93a2"
      unitRef="usd">1890000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i41ce397bfa0541e29e021952f1d0010a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfOC01LTEtMS03MjE1MQ_544bff86-968e-446f-aad0-13f92a6cc110"
      unitRef="usd">1741000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9ba0930c6af2497b925e9c5d6155812a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfOC04LTEtMS03MjE1MQ_15237111-5ebe-4a14-a915-471a9883e455"
      unitRef="usd">1628000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i9d9e19fe61e242fd8263057ff7c25299_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfOS0yLTEtMS03MjE1MQ_6789fdc0-9ddb-4dea-9626-d0185a9daca7"
      unitRef="usd">-24000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="if2881079343842a19318fe837350c64d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfOS01LTEtMS03MjE1MQ_3357acbb-1140-4498-b17d-1b71cbbe46cb"
      unitRef="usd">-22000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i63b9f6da76294d1a9a151cff381a2952_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfOS04LTEtMS03MjE1MQ_dad1381a-0ec1-4134-9073-ee393c80ae7f"
      unitRef="usd">-29000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i9d9e19fe61e242fd8263057ff7c25299_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMTEtMi0xLTEtNzIxNTE_8e284020-b06c-4404-abfa-3bee29742e39"
      unitRef="usd">168000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="if2881079343842a19318fe837350c64d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMTEtNS0xLTEtNzIxNTE_17602e2f-73f2-4b81-a5ea-e12b7aa1b279"
      unitRef="usd">171000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i63b9f6da76294d1a9a151cff381a2952_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMTEtOC0xLTEtNzIxNTE_7f3fb941-f5e9-43ba-93f1-49a566480e6d"
      unitRef="usd">142000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i46dac7583cde41d8a83d606ac118cd95_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMTItMi0xLTEtNzIxNTE_75bf21a5-1a28-4365-b8be-710dd15b1aa5"
      unitRef="usd">2034000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3e9fecf68eab4b96910415c71a11f0f0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMTItNS0xLTEtNzIxNTE_5d2e7149-f7e9-42e9-84b1-fb16ad47fb0e"
      unitRef="usd">1890000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i41ce397bfa0541e29e021952f1d0010a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMTItOC0xLTEtNzIxNTE_fa0a12fc-11c5-4c74-8e4c-80ce7afa85dc"
      unitRef="usd">1741000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ieec3502c9db549fea81e263b3f2c2a92_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMTQtMi0xLTEtNzIxNTE_8f6cf2f3-32a6-4776-8fff-caffd39b60a0"
      unitRef="usd">13480000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i94825bd2fefe45ddabf26724a368310b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMTQtNS0xLTEtNzIxNTE_87b5df8d-0133-4fef-82a6-b8f037ddaaa7"
      unitRef="usd">12462000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i795f6d2070234daa91b8880b8539c9c8_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMTQtOC0xLTEtNzIxNTE_4c5385e9-2501-4a02-a0e4-6284f15ee6b4"
      unitRef="usd">11748000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i1c2a71ba269549d1ae308a0a70bc7f3a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMTYtMi0xLTEtNzIxNTE_75701729-2eb0-4568-92b7-607b267131f2"
      unitRef="usd">2358000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="id9d8bd5dcacb4d8d812c9d60d5f7f768_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMTYtNS0xLTEtNzIxNTE_05eeb41b-c343-4d00-9313-080f59d5f70c"
      unitRef="usd">1994000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i517940432d6242d3b90448a4cdb7932b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMTYtOC0xLTEtNzIxNTE_268b811c-c592-47a2-864f-6a73da192d1c"
      unitRef="usd">1599000000</us-gaap:NetIncomeLoss>
    <us-gaap:DividendsCash
      contextRef="i1c2a71ba269549d1ae308a0a70bc7f3a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMTgtMi0xLTEtNzIxNTE_a18ce1ed-6fe5-49f3-af66-659135921cf8"
      unitRef="usd">1073000000</us-gaap:DividendsCash>
    <us-gaap:DividendsCash
      contextRef="id9d8bd5dcacb4d8d812c9d60d5f7f768_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMTgtNS0xLTEtNzIxNTE_7710272e-fd50-4e02-b713-391be6590855"
      unitRef="usd">976000000</us-gaap:DividendsCash>
    <us-gaap:DividendsCash
      contextRef="i517940432d6242d3b90448a4cdb7932b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMTgtOC0xLTEtNzIxNTE_b37f6ee1-0996-4aec-80dd-67cc0ad3b204"
      unitRef="usd">885000000</us-gaap:DividendsCash>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0a6c70e8449a4b4ea94bebf9dff36ff6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMTktMi0xLTEtNzIxNTE_ee53849f-1038-4259-9db0-683e371b4d06"
      unitRef="usd">14765000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ieec3502c9db549fea81e263b3f2c2a92_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMTktNS0xLTEtNzIxNTE_1d0a43a5-a671-4bb3-9d8f-0344a19aaba5"
      unitRef="usd">13480000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i94825bd2fefe45ddabf26724a368310b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMTktOC0xLTEtNzIxNTE_ecd075be-8c46-4619-b7ef-19fc8bcb596a"
      unitRef="usd">12462000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icad1df1351fd4afe9e2355bb6693a77d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMjEtMi0xLTEtNzIxNTE_f241b383-84dc-4628-a65b-a4c7787d15db"
      unitRef="usd">-531000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1895b0971f404a2dad14c28b8302a8ea_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMjEtNS0xLTEtNzIxNTE_58fb04f1-1936-4ba5-af6d-65efcd419d44"
      unitRef="usd">-1157000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibe9a125a8f4f4a4b9275e4e42854e3f3_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMjEtOC0xLTEtNzIxNTE_b21b093e-5628-4d87-b74d-cd6a66c00c12"
      unitRef="usd">-606000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMjItMi0xLTEtNzIxNTE_798bedf8-2977-47df-a246-8f9e390cb2a0"
      unitRef="usd">310000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i339c16bfef17406a8c4a7d11ac15a147_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMjItNS0xLTEtNzIxNTE_5da24b91-5cd2-4212-8a33-67be27e1a32f"
      unitRef="usd">626000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id755d6c5467d4b40bdce4ebfa9392650_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMjItOC0xLTEtNzIxNTE_85a38c5d-89e7-42eb-a3c7-6e006b3a0914"
      unitRef="usd">-551000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie37658dfd9f847b59178e8bc31697fd2_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMjMtMi0xLTEtNzIxNTE_35dc01b4-4d13-43c0-a9a9-b5ae5805dd1b"
      unitRef="usd">-221000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icad1df1351fd4afe9e2355bb6693a77d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMjMtNS0xLTEtNzIxNTE_bf1091ee-563d-4962-995d-2b9c43be20a5"
      unitRef="usd">-531000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1895b0971f404a2dad14c28b8302a8ea_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMjMtOC0xLTEtNzIxNTE_46738cd8-9ee8-4142-b8c0-37ce3a0ab24d"
      unitRef="usd">-1157000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMzItMi0xLTEtNzIxNTE_e8a734e0-34ec-4dc5-b8e8-0f9960a575bb"
      unitRef="usd">16616000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMzItNS0xLTEtNzIxNTE_904994ea-d3ce-4e30-8d3a-28250d4505b4"
      unitRef="usd">14877000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i98963cf23d234ec1ac275e66bcfd76dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185MS9mcmFnOjQ0ODM1ZTUzZTI4OTQyMjg5Y2I5YmIzMjNlOWU3YjM0L3RhYmxlOmEzOWJmZTdlODU4ZjQ1ZjhiM2FmOWExNjI2NDNhNjllL3RhYmxlcmFuZ2U6YTM5YmZlN2U4NThmNDVmOGIzYWY5YTE2MjY0M2E2OWVfMzItOC0xLTEtNzIxNTE_3a57b493-8af1-4374-935c-1d334ae82d4c"
      unitRef="usd">13084000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMi0xLTEtMS03MjE1MQ_34d76a0a-124e-4f86-99b2-d4e67d11f50f"
      unitRef="usd">2358000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMi0zLTEtMS03MjE1MQ_92a4c0c3-86ba-4c5d-b8c6-b535d49284d1"
      unitRef="usd">1994000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMi01LTEtMS03MjE1MQ_a681a79f-2ec9-41bb-aa11-db42e8819313"
      unitRef="usd">1599000000</us-gaap:NetIncomeLoss>
    <us-gaap:Depreciation
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfNC0xLTEtMS03MjE1MQ_f837fa97-3a20-4ba7-8f18-6c5b8ecb7acf"
      unitRef="usd">371000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfNC0zLTEtMS03MjE1MQ_23aa35a6-126f-49e1-a5ab-d04d293b37d8"
      unitRef="usd">371000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfNC01LTEtMS03MjE1MQ_c1e00327-8059-4243-acda-43abf76e00c4"
      unitRef="usd">340000000</us-gaap:Depreciation>
    <us-gaap:AdjustmentForAmortization
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfNS0xLTEtMS03MjE1MQ_e4c3a76e-050c-4e5d-8d32-4a2922c8cbca"
      unitRef="usd">627000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfNS0zLTEtMS03MjE1MQ_984c06f4-a24a-495f-806e-b40a39f0b29b"
      unitRef="usd">619000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfNS01LTEtMS03MjE1MQ_1bf7ec10-0d35-4f9b-ba15-fbbc7b52832c"
      unitRef="usd">472000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfNi0xLTEtMS04MDk0OQ_ff6ac74c-87b7-4633-bbe2-649e3835064a"
      unitRef="usd">216000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfNi0zLTEtMS04MDk0OQ_96542535-bda9-44b4-b26b-a03326863c3f"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfNi01LTEtMS04MDk0OQ_c8a99f86-870d-45c6-a23d-d1f317db731b"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <syk:AssetImpairmentsOtherThanGoodwillImpairment
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfNi0xLTEtMS03MjE1MQ_a48135e5-a33b-4992-87a7-3da4f6366bf3"
      unitRef="usd">54000000</syk:AssetImpairmentsOtherThanGoodwillImpairment>
    <syk:AssetImpairmentsOtherThanGoodwillImpairment
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfNi0zLTEtMS03MjE1MQ_c5fb4e2a-0ff7-4e65-90c3-15714c25b1b8"
      unitRef="usd">264000000</syk:AssetImpairmentsOtherThanGoodwillImpairment>
    <syk:AssetImpairmentsOtherThanGoodwillImpairment
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfNi01LTEtMS03MjE1MQ_1f40f66d-2933-4b32-9e32-c0bdf1e3cc9e"
      unitRef="usd">215000000</syk:AssetImpairmentsOtherThanGoodwillImpairment>
    <us-gaap:ShareBasedCompensation
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfNy0xLTEtMS03MjE1MQ_4a518645-87e2-4368-b2a6-66c0c4780f1f"
      unitRef="usd">168000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfNy0zLTEtMS03MjE1MQ_c7f67012-5fb3-4ac6-b4ec-6e64d42f6da4"
      unitRef="usd">171000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfNy01LTEtMS03MjE1MQ_bd4d500f-f7c8-453e-b8fd-b9a1716ac138"
      unitRef="usd">142000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ProductLiabilityAccrualPeriodExpense
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfOC0xLTEtMS03MjE1MQ_01d3419d-e728-4345-938d-aaa5b41acc42"
      unitRef="usd">-15000000</us-gaap:ProductLiabilityAccrualPeriodExpense>
    <us-gaap:ProductLiabilityAccrualPeriodExpense
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfOC0zLTEtMS03MjE1MQ_eee76380-5345-45da-8808-a03c5c6e6e3a"
      unitRef="usd">103000000</us-gaap:ProductLiabilityAccrualPeriodExpense>
    <us-gaap:ProductLiabilityAccrualPeriodExpense
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfOC01LTEtMS03MjE1MQ_8503b70c-3f4d-469d-9edd-4cb2c99ef0de"
      unitRef="usd">17000000</us-gaap:ProductLiabilityAccrualPeriodExpense>
    <syk:SaleOfInventorySteppedUpToFairValueAtAcquisition
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfOS0xLTEtMS03MjE1MQ_81530a1b-663e-4b65-9e5f-b116dfe7ccfb"
      unitRef="usd">12000000</syk:SaleOfInventorySteppedUpToFairValueAtAcquisition>
    <syk:SaleOfInventorySteppedUpToFairValueAtAcquisition
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfOS0zLTEtMS03MjE1MQ_dafbe0c2-c349-4a70-95f5-74331083385c"
      unitRef="usd">266000000</syk:SaleOfInventorySteppedUpToFairValueAtAcquisition>
    <syk:SaleOfInventorySteppedUpToFairValueAtAcquisition
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfOS01LTEtMS03MjE1MQ_da67dcd8-7e2b-4a66-ad1b-82265344ad26"
      unitRef="usd">48000000</syk:SaleOfInventorySteppedUpToFairValueAtAcquisition>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMTAtMS0xLTEtNzIxNTE_cfd7ee9f-eb44-438d-a6d0-afbb8c593e2c"
      unitRef="usd">58000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMTAtMy0xLTEtNzIxNTE_443919a9-4784-4136-bcd4-79addae32c26"
      unitRef="usd">-237000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMTAtNS0xLTEtNzIxNTE_ecdfaed9-a8c4-4346-b120-ae184d425c3b"
      unitRef="usd">48000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMTItMS0xLTEtNzIxNTE_235eb6ba-d506-48b2-89cc-4ae3132505fc"
      unitRef="usd">579000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMTItMy0xLTEtNzIxNTE_53b751e9-4989-4d23-95b7-fd924c604995"
      unitRef="usd">377000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMTItNS0xLTEtNzIxNTE_594ae58f-1a02-447c-b7c8-fcd5d322266b"
      unitRef="usd">-354000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMTMtMS0xLTEtNzIxNTE_b0b3269b-b131-4d9d-821f-f461774744ef"
      unitRef="usd">762000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMTMtMy0xLTEtNzIxNTE_8adecee7-07b4-4b82-9fcd-dd19755bc5b0"
      unitRef="usd">189000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMTMtNS0xLTEtNzIxNTE_ca5cfa8c-0ed4-443e-a233-6132b2ca3d2e"
      unitRef="usd">-27000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMTQtMS0xLTEtNzIxNTE_f78fa08d-33b1-4e66-9d6e-0f9d5a81a650"
      unitRef="usd">290000000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMTQtMy0xLTEtNzIxNTE_3de29d5b-c420-4bf7-8c8a-54007e199733"
      unitRef="usd">329000000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMTQtNS0xLTEtNzIxNTE_dfaf43a4-2c3c-4132-874f-753e407c466c"
      unitRef="usd">100000000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMTUtMS0xLTEtNzIxNTE_11ac4640-2a1b-497c-b721-90b916e097d7"
      unitRef="usd">328000000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMTUtMy0xLTEtNzIxNTE_74301246-2701-4855-a97a-3530865f75f3"
      unitRef="usd">315000000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMTUtNS0xLTEtNzIxNTE_177efcbc-a715-4d59-82b7-b56f3c91af1f"
      unitRef="usd">-54000000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <syk:Changeinaccrualforrecallexpenses
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMTYtMS0xLTEtNzIxNTE_1df7fde0-5d3c-4bb9-a6f9-11178e63f439"
      unitRef="usd">-157000000</syk:Changeinaccrualforrecallexpenses>
    <syk:Changeinaccrualforrecallexpenses
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMTYtMy0xLTEtNzIxNTE_8a61a9f2-d189-4d21-afa2-50a8628e7874"
      unitRef="usd">-221000000</syk:Changeinaccrualforrecallexpenses>
    <syk:Changeinaccrualforrecallexpenses
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMTYtNS0xLTEtNzIxNTE_6c7ea30b-f974-40b1-8e0d-a96519e19f12"
      unitRef="usd">-17000000</syk:Changeinaccrualforrecallexpenses>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMTctMS0xLTEtNzIxNTE_bc8a626f-0149-4b75-b158-dabde09eda4e"
      unitRef="usd">-238000000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMTctMy0xLTEtNzIxNTE_e5ffd952-a7bd-4a90-8d1f-363d04b952cd"
      unitRef="usd">-98000000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMTctNS0xLTEtNzIxNTE_db5b3b7d-e7be-4484-b17f-0b6660438bb0"
      unitRef="usd">-16000000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMTgtMS0xLTEtNzIxNTE_a3ebccf0-671c-41dd-b7bf-d0888bb533fc"
      unitRef="usd">107000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMTgtMy0xLTEtNzIxNTE_e7bd7c41-c96c-4c26-b83a-3b135d4cb2b9"
      unitRef="usd">47000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMTgtNS0xLTEtNzIxNTE_ba746b95-13f0-4ff7-98e5-bc75942d5b62"
      unitRef="usd">-2000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMTktMS0xLTEtNzIxNTE_1127a8fc-9d3f-4e03-bc41-5e31b26055c5"
      unitRef="usd">2624000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMTktMy0xLTEtNzIxNTE_525e028c-7d6c-4029-8465-573502ddc614"
      unitRef="usd">3263000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMTktNS0xLTEtNzIxNTE_8f27eea4-54ae-484b-9b06-f6b268881647"
      unitRef="usd">3277000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMjEtMS0xLTEtNzIxNTE_645f0245-90c5-48e1-bd3f-6bf7816ca670"
      unitRef="usd">2563000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMjEtMy0xLTEtNzIxNTE_a384c956-cc09-44cd-8737-a664024b04b1"
      unitRef="usd">339000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMjEtNS0xLTEtNzIxNTE_4963e75b-0b29-4b65-9e7b-5ae386b53148"
      unitRef="usd">4222000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMjItMS0xLTEtNzIxNTE_ad6f5778-654f-464f-a56f-285c8f8e33ba"
      unitRef="usd">52000000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMjItMy0xLTEtNzIxNTE_eaf8bb44-309d-4bb2-bef1-f65f64ed022e"
      unitRef="usd">49000000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMjItNS0xLTEtNzIxNTE_c7fd2d87-f23e-4287-9c53-ea7bc4245296"
      unitRef="usd">54000000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMjMtMS0xLTEtNzIxNTE_aa27b9a8-dde0-472c-b64e-ba63d52d3116"
      unitRef="usd">43000000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMjMtMy0xLTEtNzIxNTE_d3edeadf-f7b0-4294-bbef-26ae22e7c7b6"
      unitRef="usd">55000000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMjMtNS0xLTEtNzIxNTE_2721c736-b86f-4f9c-8850-3c79d75313a4"
      unitRef="usd">61000000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMjQtMS0xLTEtNzIxNTE_6806fea7-aaf9-42fc-9c5a-cac2094c109d"
      unitRef="usd">588000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMjQtMy0xLTEtNzIxNTE_7f757a88-d83d-4ca5-930a-6acc2062482a"
      unitRef="usd">525000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMjQtNS0xLTEtNzIxNTE_d0eb0b53-fa4a-458d-ae7a-e46820456f11"
      unitRef="usd">487000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromHedgeInvestingActivities
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMjUtMS0xLTEtNzgzODY_6672e980-96c6-422f-bd2a-b74991891d72"
      unitRef="usd">197000000</us-gaap:ProceedsFromHedgeInvestingActivities>
    <us-gaap:ProceedsFromHedgeInvestingActivities
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMjUtMy0xLTEtNzc5Mjc_4db67178-3a43-450c-a89d-43bab4790ec9"
      unitRef="usd">0</us-gaap:ProceedsFromHedgeInvestingActivities>
    <us-gaap:ProceedsFromHedgeInvestingActivities
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMjUtNS0xLTEtNzc5Mjc_dbe9e6b0-b680-48af-bea0-6ec81d875c66"
      unitRef="usd">0</us-gaap:ProceedsFromHedgeInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMjUtMS0xLTEtNzIxNTE_d100904a-6ff8-4b23-a9d4-3e53400f6997"
      unitRef="usd">-39000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMjUtMy0xLTEtNzIxNTE_0aff94d8-f220-4239-944d-7029fa8dbec5"
      unitRef="usd">1000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMjUtNS0xLTEtNzIxNTE_2501e33e-9747-4142-97fb-fdd10ae68fac"
      unitRef="usd">-1000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMjYtMS0xLTEtNzIxNTE_a8ce523e-f883-4ebf-8666-455ba7fe0b0f"
      unitRef="usd">-2924000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMjYtMy0xLTEtNzIxNTE_73c80da5-fe81-4e65-9e0c-112b028e869d"
      unitRef="usd">-859000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMjYtNS0xLTEtNzIxNTE_131b5222-775d-4327-ba99-7252d8895d61"
      unitRef="usd">-4701000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMjgtMS0xLTEtNzIxNTE_9dd9ea21-e759-4f22-98ee-97036d4f591d"
      unitRef="usd">-375000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMjgtMy0xLTEtNzIxNTE_2b453f9d-9d6e-43df-ad4c-4b99a5f32357"
      unitRef="usd">-7000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMjgtNS0xLTEtNzIxNTE_3feedead-b682-43b9-a4ba-af8f18ecaa24"
      unitRef="usd">-6000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMjktMS0xLTEtNzIxNTE_7523b81d-4cb8-4862-bf32-6efb19fbfaba"
      unitRef="usd">1500000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMjktMy0xLTEtNzIxNTE_391ae2ce-4ad8-4027-8e2d-d87715095e11"
      unitRef="usd">5000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMjktNS0xLTEtNzIxNTE_34582d8a-18bd-4fe8-9af3-a3f83bc8cc2b"
      unitRef="usd">3292000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMzAtMS0xLTEtNzIxNTE_a415ef8e-269d-40d2-b60d-f2dc6dbd739a"
      unitRef="usd">653000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMzAtMy0xLTEtNzIxNTE_122b2585-88d7-4929-a197-dcb5169483aa"
      unitRef="usd">1151000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMzAtNS0xLTEtNzIxNTE_ebcc515b-ee0f-4cdb-8c2d-46ee5d71d6ad"
      unitRef="usd">2297000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:PaymentsOfDividends
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMzEtMS0xLTEtNzIxNTE_08ec27a9-ccb3-4408-a714-63cc09b86efa"
      unitRef="usd">1051000000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMzEtMy0xLTEtNzIxNTE_30e72d2c-106c-4650-b296-76bc0b83350f"
      unitRef="usd">950000000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMzEtNS0xLTEtNzIxNTE_e3a4686a-2fb6-4273-9cf9-7e25a972f624"
      unitRef="usd">863000000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMzMtMS0xLTEtNzIxNTE_1f565360-44cf-4373-b095-ac4c03ac5c4f"
      unitRef="usd">122000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMzMtMy0xLTEtNzIxNTE_d842eb86-8805-44bc-b6bd-56253c17bd74"
      unitRef="usd">114000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMzMtNS0xLTEtNzIxNTE_7844bae7-1715-47bc-9bb3-830f33ca3c71"
      unitRef="usd">110000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMzUtMS0xLTEtNzIxNTE_f51a2a1e-a184-4d78-a916-d2ca89cac19a"
      unitRef="usd">-48000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMzUtMy0xLTEtNzIxNTE_4fe94f53-b659-4dd8-a2fa-afa780931efb"
      unitRef="usd">-148000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMzUtNS0xLTEtNzIxNTE_6925e62e-e2d1-43e7-b1f9-b12c50b149d5"
      unitRef="usd">-27000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMzYtMS0xLTEtNzIxNTE_d85a790a-a5c3-4cde-a39f-abaf7097658b"
      unitRef="usd">-749000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMzYtMy0xLTEtNzIxNTE_65c6ca2b-54f2-4ffc-a795-8baea03ba305"
      unitRef="usd">-2365000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMzYtNS0xLTEtNzIxNTE_49a529d0-3c02-4ee8-aeeb-31eff175fdfe"
      unitRef="usd">-11000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMzctMS0xLTEtNzIxNTE_6bf34dc8-5d5b-49be-b2b1-e8d7d4e6bd44"
      unitRef="usd">-51000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMzctMy0xLTEtNzIxNTE_f2cf052b-9918-48ac-b605-e1a741331abb"
      unitRef="usd">-38000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMzctNS0xLTEtNzIxNTE_e14c9af1-c471-49a4-a51c-572958ce3989"
      unitRef="usd">41000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMzgtMS0xLTEtNzIxNTE_71ae5112-bebf-4dda-b055-04e3fbf9254d"
      unitRef="usd">-1100000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMzgtMy0xLTEtNzIxNTE_2a5d5d07-c7cc-4dcd-8ce4-6bbdb67ba5ea"
      unitRef="usd">1000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMzgtNS0xLTEtNzIxNTE_642b5d2c-344c-471c-a6f1-ddea387b0c3a"
      unitRef="usd">-1394000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMzktMS0xLTEtNzIxNTE_540ef410-9ce7-4bd5-bbe8-cf09fb6e1712"
      unitRef="usd">2944000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i98963cf23d234ec1ac275e66bcfd76dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMzktMy0xLTEtNzIxNTE_eb9844cd-f395-4c80-831d-2e32d6fd0e86"
      unitRef="usd">2943000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="idd06d67e889a491bb0c3d598c1a2047c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfMzktNS0xLTEtNzIxNTE_2142fb04-852f-4fb7-9621-1c1a1222f433"
      unitRef="usd">4337000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfNDAtMS0xLTEtNzIxNTE_f47059a4-5685-43f9-ad2b-1ab7ff49d42b"
      unitRef="usd">1844000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfNDAtMy0xLTEtNzIxNTE_f6cad0e7-f783-4f56-b394-a90ba1ec34ca"
      unitRef="usd">2944000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i98963cf23d234ec1ac275e66bcfd76dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfNDAtNS0xLTEtNzIxNTE_ccb31a23-bd02-45bc-8efa-1d59fcb662b2"
      unitRef="usd">2943000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfNDMtMS0xLTEtNzIxNTE_8eaccb41-5199-4d1c-9661-0acda6ea6275"
      unitRef="usd">505000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfNDMtMy0xLTEtNzIxNTE_eb53fb6c-151c-4131-b74b-c20326189c39"
      unitRef="usd">622000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfNDMtNS0xLTEtNzIxNTE_2114964c-6457-4851-b69a-7f107cffba28"
      unitRef="usd">323000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfNDQtMS0xLTEtNzIxNTE_ac882f66-1b04-455b-be73-cc13bf7b782c"
      unitRef="usd">324000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfNDQtMy0xLTEtNzIxNTE_b926b9a1-5704-41d0-8807-f68ef90de63e"
      unitRef="usd">325000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN185NC9mcmFnOjAwZjJmYTVkNDI3ZDQ4MWRiOWMwY2JkMDBlNDQ1MTVlL3RhYmxlOjk4MWU3N2U4YzJhODQ4MDZhZTk3NzhmYTQ3ZjVhNjZlL3RhYmxlcmFuZ2U6OTgxZTc3ZThjMmE4NDgwNmFlOTc3OGZhNDdmNWE2NmVfNDQtNS0xLTEtNzIxNTE_883a2eb0-9784-40b4-991f-609c6cc62885"
      unitRef="usd">304000000</us-gaap:InterestPaidNet>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzIwODI0_3fbab5d3-177e-4d8b-aa0d-6f0b86b58d9d">SIGNIFICANT ACCOUNTING POLICIES&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Nature of Operations: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Stryker (the "Company," "we," "us," or "our") is one of the world's leading medical technology companies and, together with its customers, is driven to make healthcare better. The Company offers innovative products and services in Medical and Surgical, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Our products include surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling, emergency medical equipment and intensive care disposable products; clinical communication and workflow solutions; neurosurgical and neurovascular devices; implants used in joint replacement and trauma surgeries; Mako Robotic-Arm Assisted technology; spinal devices; as well as other products used in a variety of medical specialties.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Basis of Presentation and Consolidation: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Consolidated Financial Statements include the Company and its subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation. We have no material interests in variable interest entities and none that require consolidation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Use of Estimates: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with accounting principles generally accepted in the United States (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities on the date of the financial statements and the reported amounts of net sales and expenses in the reporting period. Actual results could differ from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Revenue Recognition: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Sales are recognized as the performance obligations to deliver products or services are satisfied and are recorded based on the amount of consideration we expect to receive in exchange for satisfying the performance obligations. Our sales are recognized primarily when we transfer control to the customer, which can be on the date of shipment, the date of receipt by the customer or, for most Orthopaedics products, when we have received a purchase order and appropriate notification the product has been used or implanted. Products and services are primarily transferred to customers at a point in time, with some transfers of services taking place over time.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Sales represent the amount of consideration we expect to receive from customers in exchange for transferring products and services. Net sales exclude sales, value added and other taxes we collect from customers. Other costs to obtain and fulfill contracts are generally expensed as incurred due to the short-term nature of most of our sales. We extend terms of payment to our customers based on commercially reasonable terms for the markets of our customers, while also considering their credit quality.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A provision for estimated sales returns, discounts and rebates is recognized as a reduction of sales in the same period that the sales are recognized. Our estimate of the provision for sales returns has been established based on contract terms with our customers and historical business practices and current trends. Shipping and handling costs charged to customers are included in net sales.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Cost of Sales: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Cost of sales is primarily comprised of direct materials and supplies consumed in the manufacture of product, as well as manufacturing labor, depreciation expense and direct overhead expense necessary to acquire and convert the purchased materials and supplies into finished product. Cost of &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;sales also includes the cost to distribute products to customers, inbound freight costs, warehousing costs and other shipping and handling activity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Research, Development and Engineering Expenses: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Research, development and engineering costs are charged to expense as incurred. Costs include research, development and engineering activities relating to the development of new products, improvement of existing products, technical support of products and compliance with governmental regulations for the protection of customers and patients. Costs primarily consist of salaries, wages, consulting and depreciation and maintenance of research facilities and equipment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Selling, General and Administrative Expenses: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Selling, general and administrative expense is primarily comprised of selling expenses, marketing expenses, administrative and other indirect overhead costs, amortization of loaner instrumentation, depreciation and amortization expense of non-manufacturing assets and other miscellaneous operating items. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Currency Translation: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Financial statements of subsidiaries outside the United States generally are measured using the local currency as the functional currency. Adjustments to translate those statements into United States Dollars are recorded in other comprehensive income (OCI). Transactional exchange gains and losses are included in other income (expense), net.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Cash Equivalents: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Highly liquid investments with remaining stated maturities of three months or less when purchased or other money market instruments that are redeemable upon demand are considered cash equivalents and recorded at cost.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Marketable Securities: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Marketable securities consist of marketable debt securities, certificates of deposit and mutual funds. Mutual funds are acquired to offset changes in certain liabilities related to deferred compensation arrangements and are expected to be used to settle these liabilities and are recognized in other noncurrent assets. Pursuant to our investment policy, all individual marketable security investments must have a minimum credit quality of single A (Standard&#160;&amp;amp; Poor&#x2019;s and Fitch) and A2 (Moody&#x2019;s Corporation) at the time of acquisition, while the overall portfolio of marketable securities must maintain a minimum average credit quality of double A (Standard&#160;&amp;amp; Poor&#x2019;s and Fitch) or Aa (Moody&#x2019;s Corporation). In the event of a rating downgrade below the minimum credit quality subsequent to purchase, the marketable security investment is evaluated to determine the appropriate action to take to minimize the overall risk to our marketable security investment portfolio. Our marketable securities are classified as available-for-sale and trading securities. Investments in trading securities represent participant-directed investments of deferred employee compensation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Accounts Receivable: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Accounts receivable consists of trade and other miscellaneous receivables. An allowance is maintained for doubtful accounts for estimated losses in the collection of accounts receivable. Estimates are made regarding the ability of customers to make required payments based on historical credit experience, current market conditions and expected credit losses. Accounts receivable are written off when all reasonable collection efforts are exhausted.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Inventories: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Inventories are stated at the lower of cost or net realizable value, with cost generally determined using the first-in, first-out (FIFO) cost method. For excess and obsolete inventory resulting from the potential inability to sell specific products at prices in excess of current carrying costs, reserves are maintained to reduce current carrying cost to net realizable value.&lt;/span&gt;&lt;/div&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.333%"&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Financial Instruments:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Our financial instruments consist of cash, cash equivalents, marketable securities, accounts receivable, other investments, accounts payable, debt and foreign currency exchange contracts. The carrying value of our financial instruments, with the exception of our senior unsecured notes, approximates fair value on December&#160;31, 2022 and 2021. Refer to Notes 3 and 10 for further details. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;All marketable securities are recognized at fair value. Adjustments to the fair value of marketable securities that are classified as available-for-sale are recognized as increases or decreases, net of income taxes, within accumulated other comprehensive income (AOCI) in shareholders&#x2019; equity and adjustments to the fair value of marketable securities that are classified as trading are recognized in earnings. The amortized cost of marketable debt securities is adjusted for amortization of premiums and discounts to maturity computed under the effective interest method. Such amortization and interest and realized gains and losses are included in other income (expense), net. The cost of securities sold is determined by the specific identification method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We review declines in the fair value of our investments classified as available-for-sale to determine whether the decline in fair value is a result of credit loss or other factors. Impairments of available-for-sale marketable debt securities related to credit loss are included in earnings and impairments related to other factors are recognized within AOCI.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Derivatives:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; All derivatives are recognized at fair value and reported on a gross basis. We enter into forward currency exchange contracts to mitigate the impact of currency fluctuations on transactions denominated in nonfunctional currencies, thereby limiting our risk that would otherwise result from changes in exchange rates. The periods of the forward currency exchange contracts correspond to the periods of the exposed transactions, with realized gains and losses included in the measurement and recording of transactions denominated in the nonfunctional currencies. All forward currency exchange contracts are recorded at their fair value each period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Forward currency exchange contracts designated as cash flow hedges are designed to hedge the variability of cash flows associated with forecasted transactions denominated in a foreign currency that will take place in the future. These nonfunctional currency exposures principally relate to forecasted intercompany sales and purchases of manufactured products and generally have maturities up to eighteen months. Changes in value of derivatives designated as cash flow hedges are recorded in AOCI on the Consolidated Balance Sheets until earnings are affected by the variability of the underlying cash flows. At that time, the applicable amount of gain or loss from the derivative instrument that is deferred in shareholders&#x2019; equity is reclassified into earnings and is included in cost of goods sold in the Consolidated Statements of Earnings. Cash flows associated with these hedges are included in cash from operations in the same category as the cash flows from the items being hedged.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Forward currency exchange contracts are used to offset our exposure to the change in value of specific foreign currency denominated assets and liabilities, primarily intercompany payables and receivables. These derivatives are not designated as hedges and, therefore, changes in the value of these forward contracts are recognized in earnings, thereby offsetting the current earnings effect of the related changes in value of foreign currency denominated assets and liabilities. The estimated fair value of our forward currency exchange contracts represents the &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"/&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.334%"&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;measurement of the contracts at month-end spot rates as adjusted by current forward points. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;From time to time, we designate derivative and non-derivative financial instruments as net investment hedges of our investments in certain international subsidiaries. For derivative instruments that are designated and qualify as a net investment hedge, the effective portion of the derivative's gain or loss is recognized in OCI and reported as a component of AOCI. We have elected to use the spot method to assess effectiveness for our derivatives designated as net investment hedges. Accordingly, the change in fair value attributable to changes in the spot rate is recorded in AOCI. We exclude the spot-forward difference from the assessment of hedge effectiveness and amortize this amount separately on a straight-line basis over the term of the forward contracts. This amortization is recognized in other income (expense), net.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;From time to time, we designate forward starting interest rate derivative instruments as cash flow hedges to manage the exposure to interest rate volatility with regard to future issuance and refinancing of debt. Changes in value of derivatives designated as cash flow hedges are recorded in AOCI on the Consolidated Balance Sheets until earnings are affected by the variability of the underlying cash flows. At that time, the applicable amount of gain or loss from the derivative instrument that is deferred in shareholders&#x2019; equity is reclassified into earnings and is included in interest expense within other income (expense), net in the Consolidated Statements of Earnings. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Interest rate derivative instruments designated as fair value hedges have been used in the past to manage the exposure to interest rate movements and to reduce borrowing costs by converting fixed-rate debt into floating-rate debt. Under these agreements, we agree to exchange, at specified intervals, the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional principal amount. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Property, Plant and Equipment:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Property, plant and equipment is stated at cost. Depreciation is generally computed by the straight-line method over the estimated useful lives of &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzEzMjA2_7c8fdcfc-54e2-4b81-91c7-7404bca5b6f4"&gt;three&lt;/span&gt; to 30 years for buildings and improvements and &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzEzMjU2_a5156acf-7357-4ad7-88ef-00f8b1876f98"&gt;three&lt;/span&gt; to 15 years for machinery and equipment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Goodwill and Other Intangible Assets:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Goodwill represents the excess of purchase price over fair value of tangible net assets of acquired businesses at the acquisition date, after amounts allocated to other identifiable intangible assets. Factors that contribute to the recognition of goodwill include synergies that are specific to our business and not available to other market participants and are expected to increase net sales and profits; acquisition of a talented workforce; cost savings opportunities; the strategic benefit of expanding our presence in core and adjacent markets; and diversifying our product portfolio.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The fair values of other identifiable intangible assets acquired in a business combination are primarily determined using the income approach. Other intangible assets include, but are not limited to, developed technology, customer and distributor relationships (which reflect expected continued customer or distributor patronage) and trademarks and patents. Intangible assets with determinable useful lives are amortized on a straight-line basis over their estimated useful lives of &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzE0NDEx_42bfd4f4-7388-4875-97fa-bc119a8ba2cf"&gt;four&lt;/span&gt; to 40 years. Certain acquired trade names are considered to have indefinite lives and are not amortized, but are assessed annually for potential impairment as described below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In some of our acquisitions, we acquire in-process research and development (IPRD) intangible assets. For acquisitions accounted for as business combinations IPRD is considered to &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;be an indefinite-lived intangible asset until the research is completed (then it becomes a determinable-lived intangible asset) or determined to have no future use (then it is impaired). For asset acquisitions IPRD is expensed immediately unless there is an alternative future use.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Goodwill, Intangibles and Long-Lived Asset Impairment Tests:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; We perform our annual impairment test for goodwill as of October 31 each year. We consider qualitative indicators of the fair value of a reporting unit when it is unlikely that a reporting unit has impaired goodwill and periodically corroborate that assessment with quantitative information. In certain circumstances, we may also utilize a discounted cash flow analysis that requires certain assumptions and estimates be made regarding market conditions and our future profitability. Indefinite-lived intangible assets are also tested at least annually for impairment by comparing the individual carrying values to the fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We review long-lived assets for indicators of impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. The evaluation is performed at the lowest level of identifiable cash flows. Undiscounted cash flows expected to be generated by the related assets are estimated over the asset's useful life based on updated projections. If the evaluation indicates that the carrying amount of the asset may not be recoverable, any potential impairment is measured based upon the fair value of the related asset or asset group as determined by an appropriate market appraisal or other valuation technique. Assets classified as held for sale are recorded at the lower of carrying amount or fair value less costs to sell.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Share-Based Compensation:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Share-based compensation is in the form of stock options, restricted stock units (RSUs) and performance stock units (PSUs). Stock options are granted under long-term incentive plans to certain key employees and non-employee directors at an exercise price not less than the fair market value of the underlying common stock, which is the quoted closing price of our common stock on the day prior to the date of grant. The options are granted for periods of up to 10 years and become exercisable in varying installments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We grant RSUs to key employees and non-employee directors and PSUs to certain key employees under our long-term incentive plans. The fair value of RSUs is determined based on the number of shares granted and the quoted closing price of our common stock on the date of grant, adjusted for the fact that RSUs do not include anticipated dividends. RSUs generally vest in one-third increments over a three-year period and are settled in stock. PSUs are earned over a three-year performance cycle and vest in March of the year following the end of that performance cycle. The number of PSUs that will ultimately be earned is based on our performance relative to pre-established goals in that three-year performance cycle. The fair value of PSUs is determined based on the quoted closing price of our common stock on the day of grant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Compensation expense is recognized in the Consolidated Statements of Earnings based on the estimated fair value of the awards on the grant date. Compensation expense recognized reflects an estimate of the number of awards expected to vest after taking into consideration an estimate of award forfeitures based on actual experience and is recognized on a straight-line basis over the requisite service period, which is generally the period required to obtain full vesting. Management expectations related to the achievement of performance goals associated with PSU grants is assessed regularly and that assessment is used to &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;determine whether PSU grants are expected to vest. If performance-based milestones related to PSU grants are not met or not expected to be met, any compensation expense recognized associated with such grants will be reversed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Income Taxes:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Deferred income tax assets and liabilities are determined based on differences between financial reporting and income tax bases of assets and liabilities and are measured using the enacted income tax rates in effect for the years in which the differences are expected to reverse. Deferred income tax benefits generally represent the change in net deferred income tax assets and liabilities in the year. Other amounts result from adjustments related to acquisitions and foreign currency as appropriate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We operate in multiple income tax jurisdictions both within the United States and internationally. Accordingly, management must determine the appropriate allocation of income to each of these jurisdictions based on current interpretations of complex income tax regulations. Income tax authorities in these jurisdictions regularly perform audits of our income tax filings. Income tax audits associated with the allocation of this income and other complex issues, including inventory transfer pricing and cost sharing, product royalty and foreign branch arrangements, may require an extended period of time to resolve and may result in significant income tax adjustments if changes to the income allocation are required between jurisdictions with different income tax rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;New Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In September 2022 the Financial Accounting Standards Board issued ASU 2022-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Liabilities - Supplier Finance Programs: Disclosure of Supplier Finance Program Obligations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;, which requires entities that utilize supplier finance programs in connection with the purchase of goods and services to disclose information about the key terms of the programs, a rollforward of the obligations under the programs and where those obligations are presented in the balance sheet. The new disclosure requirements are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. Currently our obligations under these programs are not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Accounting Pronouncements Recently Adopted &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On January 1, 2022 we adopted ASU 2021-08, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations: Accounting for Contract Assets and Contract Liabilities from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;. This update requires an entity to recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Accounting Standards Codification 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;. The adoption of this update did not have a material impact on our Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:NatureOfOperations
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzIwODcy_b7e2822c-ce23-4b43-a9fc-e58f98337425">Stryker (the "Company," "we," "us," or "our") is one of the world's leading medical technology companies and, together with its customers, is driven to make healthcare better. The Company offers innovative products and services in Medical and Surgical, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Our products include surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling, emergency medical equipment and intensive care disposable products; clinical communication and workflow solutions; neurosurgical and neurovascular devices; implants used in joint replacement and trauma surgeries; Mako Robotic-Arm Assisted technology; spinal devices; as well as other products used in a variety of medical specialties.</us-gaap:NatureOfOperations>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzIwODUy_53a0022b-26bb-4084-b6c1-7da2a9760352">The Consolidated Financial Statements include the Company and its subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation. We have no material interests in variable interest entities and none that require consolidation.</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzIwOTgw_0755a046-361c-42bc-98f7-7cc7bd1cfc36">The preparation of financial statements in conformity with accounting principles generally accepted in the United States (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities on the date of the financial statements and the reported amounts of net sales and expenses in the reporting period. Actual results could differ from those estimates.</us-gaap:UseOfEstimates>
    <us-gaap:RevenueRecognitionPolicyTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzIwOTM4_9098fbf1-8537-483e-b86c-01c5875ee3a1">Sales are recognized as the performance obligations to deliver products or services are satisfied and are recorded based on the amount of consideration we expect to receive in exchange for satisfying the performance obligations. Our sales are recognized primarily when we transfer control to the customer, which can be on the date of shipment, the date of receipt by the customer or, for most Orthopaedics products, when we have received a purchase order and appropriate notification the product has been used or implanted. Products and services are primarily transferred to customers at a point in time, with some transfers of services taking place over time.&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Sales represent the amount of consideration we expect to receive from customers in exchange for transferring products and services. Net sales exclude sales, value added and other taxes we collect from customers. Other costs to obtain and fulfill contracts are generally expensed as incurred due to the short-term nature of most of our sales. We extend terms of payment to our customers based on commercially reasonable terms for the markets of our customers, while also considering their credit quality.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A provision for estimated sales returns, discounts and rebates is recognized as a reduction of sales in the same period that the sales are recognized. Our estimate of the provision for sales returns has been established based on contract terms with our customers and historical business practices and current trends. Shipping and handling costs charged to customers are included in net sales.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:CostOfSalesPolicyTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzIwODg3_c09fb818-7838-492d-8457-6244ff168e9b">Cost of sales is primarily comprised of direct materials and supplies consumed in the manufacture of product, as well as manufacturing labor, depreciation expense and direct overhead expense necessary to acquire and convert the purchased materials and supplies into finished product. Cost of sales also includes the cost to distribute products to customers, inbound freight costs, warehousing costs and other shipping and handling activity.</us-gaap:CostOfSalesPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzIwOTY3_34411c06-4459-425c-b848-5c861a3d4b38">Research, development and engineering costs are charged to expense as incurred. Costs include research, development and engineering activities relating to the development of new products, improvement of existing products, technical support of products and compliance with governmental regulations for the protection of customers and patients. Costs primarily consist of salaries, wages, consulting and depreciation and maintenance of research facilities and equipment.</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzIwODkz_f6b6bd34-e297-45eb-a8c8-0411e2de55a4">Selling, general and administrative expense is primarily comprised of selling expenses, marketing expenses, administrative and other indirect overhead costs, amortization of loaner instrumentation, depreciation and amortization expense of non-manufacturing assets and other miscellaneous operating items.</us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzIwODM5_618aca1d-3d31-4ada-9d1c-11b8695f14cf">Financial statements of subsidiaries outside the United States generally are measured using the local currency as the functional currency. Adjustments to translate those statements into United States Dollars are recorded in other comprehensive income (OCI). Transactional exchange gains and losses are included in other income (expense), net.</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzIwODYx_58270ab3-ce8b-49b1-b47e-cccf1566b74f">Highly liquid investments with remaining stated maturities of three months or less when purchased or other money market instruments that are redeemable upon demand are considered cash equivalents and recorded at cost.</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:MarketableSecuritiesPolicy
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzIwODk0_614beac8-d894-4291-9e6f-1256d6fe9366">Marketable securities consist of marketable debt securities, certificates of deposit and mutual funds. Mutual funds are acquired to offset changes in certain liabilities related to deferred compensation arrangements and are expected to be used to settle these liabilities and are recognized in other noncurrent assets. Pursuant to our investment policy, all individual marketable security investments must have a minimum credit quality of single A (Standard&#160;&amp;amp; Poor&#x2019;s and Fitch) and A2 (Moody&#x2019;s Corporation) at the time of acquisition, while the overall portfolio of marketable securities must maintain a minimum average credit quality of double A (Standard&#160;&amp;amp; Poor&#x2019;s and Fitch) or Aa (Moody&#x2019;s Corporation). In the event of a rating downgrade below the minimum credit quality subsequent to purchase, the marketable security investment is evaluated to determine the appropriate action to take to minimize the overall risk to our marketable security investment portfolio. Our marketable securities are classified as available-for-sale and trading securities. Investments in trading securities represent participant-directed investments of deferred employee compensation.</us-gaap:MarketableSecuritiesPolicy>
    <us-gaap:ReceivablesPolicyTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzIwOTcy_743cbae1-c85e-4c4a-a614-ff553a4368d4">Accounts receivable consists of trade and other miscellaneous receivables. An allowance is maintained for doubtful accounts for estimated losses in the collection of accounts receivable. Estimates are made regarding the ability of customers to make required payments based on historical credit experience, current market conditions and expected credit losses. Accounts receivable are written off when all reasonable collection efforts are exhausted.</us-gaap:ReceivablesPolicyTextBlock>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzIwODY5_1b4c2e66-a0e0-4240-b740-c8b7510d5e2b">Inventories are stated at the lower of cost or net realizable value, with cost generally determined using the first-in, first-out (FIFO) cost method. For excess and obsolete inventory resulting from the potential inability to sell specific products at prices in excess of current carrying costs, reserves are maintained to reduce current carrying cost to net realizable value.</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:FairValueOptionTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzIwODQ0_9ee629ec-c44e-4d2e-b942-560769f5f299">Our financial instruments consist of cash, cash equivalents, marketable securities, accounts receivable, other investments, accounts payable, debt and foreign currency exchange contracts. The carrying value of our financial instruments, with the exception of our senior unsecured notes, approximates fair value on December&#160;31, 2022 and 2021. Refer to Notes 3 and 10 for further details. &lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;All marketable securities are recognized at fair value. Adjustments to the fair value of marketable securities that are classified as available-for-sale are recognized as increases or decreases, net of income taxes, within accumulated other comprehensive income (AOCI) in shareholders&#x2019; equity and adjustments to the fair value of marketable securities that are classified as trading are recognized in earnings. The amortized cost of marketable debt securities is adjusted for amortization of premiums and discounts to maturity computed under the effective interest method. Such amortization and interest and realized gains and losses are included in other income (expense), net. The cost of securities sold is determined by the specific identification method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We review declines in the fair value of our investments classified as available-for-sale to determine whether the decline in fair value is a result of credit loss or other factors. Impairments of available-for-sale marketable debt securities related to credit loss are included in earnings and impairments related to other factors are recognized within AOCI.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueOptionTextBlock>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzIwOTUw_e46ddb00-5000-4912-8ed0-97317814ae08">All derivatives are recognized at fair value and reported on a gross basis. We enter into forward currency exchange contracts to mitigate the impact of currency fluctuations on transactions denominated in nonfunctional currencies, thereby limiting our risk that would otherwise result from changes in exchange rates. The periods of the forward currency exchange contracts correspond to the periods of the exposed transactions, with realized gains and losses included in the measurement and recording of transactions denominated in the nonfunctional currencies. All forward currency exchange contracts are recorded at their fair value each period.&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Forward currency exchange contracts designated as cash flow hedges are designed to hedge the variability of cash flows associated with forecasted transactions denominated in a foreign currency that will take place in the future. These nonfunctional currency exposures principally relate to forecasted intercompany sales and purchases of manufactured products and generally have maturities up to eighteen months. Changes in value of derivatives designated as cash flow hedges are recorded in AOCI on the Consolidated Balance Sheets until earnings are affected by the variability of the underlying cash flows. At that time, the applicable amount of gain or loss from the derivative instrument that is deferred in shareholders&#x2019; equity is reclassified into earnings and is included in cost of goods sold in the Consolidated Statements of Earnings. Cash flows associated with these hedges are included in cash from operations in the same category as the cash flows from the items being hedged.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Forward currency exchange contracts are used to offset our exposure to the change in value of specific foreign currency denominated assets and liabilities, primarily intercompany payables and receivables. These derivatives are not designated as hedges and, therefore, changes in the value of these forward contracts are recognized in earnings, thereby offsetting the current earnings effect of the related changes in value of foreign currency denominated assets and liabilities. The estimated fair value of our forward currency exchange contracts represents the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;measurement of the contracts at month-end spot rates as adjusted by current forward points. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;From time to time, we designate derivative and non-derivative financial instruments as net investment hedges of our investments in certain international subsidiaries. For derivative instruments that are designated and qualify as a net investment hedge, the effective portion of the derivative's gain or loss is recognized in OCI and reported as a component of AOCI. We have elected to use the spot method to assess effectiveness for our derivatives designated as net investment hedges. Accordingly, the change in fair value attributable to changes in the spot rate is recorded in AOCI. We exclude the spot-forward difference from the assessment of hedge effectiveness and amortize this amount separately on a straight-line basis over the term of the forward contracts. This amortization is recognized in other income (expense), net.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;From time to time, we designate forward starting interest rate derivative instruments as cash flow hedges to manage the exposure to interest rate volatility with regard to future issuance and refinancing of debt. Changes in value of derivatives designated as cash flow hedges are recorded in AOCI on the Consolidated Balance Sheets until earnings are affected by the variability of the underlying cash flows. At that time, the applicable amount of gain or loss from the derivative instrument that is deferred in shareholders&#x2019; equity is reclassified into earnings and is included in interest expense within other income (expense), net in the Consolidated Statements of Earnings. &lt;/span&gt;&lt;/div&gt;Interest rate derivative instruments designated as fair value hedges have been used in the past to manage the exposure to interest rate movements and to reduce borrowing costs by converting fixed-rate debt into floating-rate debt. Under these agreements, we agree to exchange, at specified intervals, the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional principal amount.</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:DerivativeTermOfContract
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzU0OTc1NTgzOTY3Mg_9e390694-4b05-4324-a329-723feacb1965">P18M</us-gaap:DerivativeTermOfContract>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzIwODI4_d9118dfc-2d46-4130-90fd-b11158e55dd8">Property, plant and equipment is stated at cost. Depreciation is generally computed by the straight-line method over the estimated useful lives of &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzEzMjA2_7c8fdcfc-54e2-4b81-91c7-7404bca5b6f4"&gt;three&lt;/span&gt; to 30 years for buildings and improvements and &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzEzMjU2_a5156acf-7357-4ad7-88ef-00f8b1876f98"&gt;three&lt;/span&gt; to 15 years for machinery and equipment.</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ia81297125f074a4291d33c550b8d6a47_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzEzMjEy_d8c99370-4373-474e-97af-5086b91d16cb">P30Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ia886c987bacc41c694724a58b11edae4_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzEzMjYy_b708859d-f730-4f72-913c-b5550d5a079e">P15Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzIwODQy_9567199b-b5c9-4d6b-8946-d536595174ab">Goodwill represents the excess of purchase price over fair value of tangible net assets of acquired businesses at the acquisition date, after amounts allocated to other identifiable intangible assets. Factors that contribute to the recognition of goodwill include synergies that are specific to our business and not available to other market participants and are expected to increase net sales and profits; acquisition of a talented workforce; cost savings opportunities; the strategic benefit of expanding our presence in core and adjacent markets; and diversifying our product portfolio.&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The fair values of other identifiable intangible assets acquired in a business combination are primarily determined using the income approach. Other intangible assets include, but are not limited to, developed technology, customer and distributor relationships (which reflect expected continued customer or distributor patronage) and trademarks and patents. Intangible assets with determinable useful lives are amortized on a straight-line basis over their estimated useful lives of &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzE0NDEx_42bfd4f4-7388-4875-97fa-bc119a8ba2cf"&gt;four&lt;/span&gt; to 40 years. Certain acquired trade names are considered to have indefinite lives and are not amortized, but are assessed annually for potential impairment as described below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In some of our acquisitions, we acquire in-process research and development (IPRD) intangible assets. For acquisitions accounted for as business combinations IPRD is considered to &lt;/span&gt;&lt;/div&gt;be an indefinite-lived intangible asset until the research is completed (then it becomes a determinable-lived intangible asset) or determined to have no future use (then it is impaired). For asset acquisitions IPRD is expensed immediately unless there is an alternative future use.</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="idbfae01100bf43918ee77d14424aebd2_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzE0NDE3_b98354b6-5a33-47c1-bd2f-05f7a5eabea1">P40Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <syk:GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzIwOTQy_6d797982-1acd-4467-b598-8485c0e97bce">We perform our annual impairment test for goodwill as of October 31 each year. We consider qualitative indicators of the fair value of a reporting unit when it is unlikely that a reporting unit has impaired goodwill and periodically corroborate that assessment with quantitative information. In certain circumstances, we may also utilize a discounted cash flow analysis that requires certain assumptions and estimates be made regarding market conditions and our future profitability. Indefinite-lived intangible assets are also tested at least annually for impairment by comparing the individual carrying values to the fair value.We review long-lived assets for indicators of impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. The evaluation is performed at the lowest level of identifiable cash flows. Undiscounted cash flows expected to be generated by the related assets are estimated over the asset's useful life based on updated projections. If the evaluation indicates that the carrying amount of the asset may not be recoverable, any potential impairment is measured based upon the fair value of the related asset or asset group as determined by an appropriate market appraisal or other valuation technique. Assets classified as held for sale are recorded at the lower of carrying amount or fair value less costs to sell.</syk:GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzIwODIx_ee9ef58e-ff93-4d9b-bd98-6e3a1a213a9b">hare-based compensation is in the form of stock options, restricted stock units (RSUs) and performance stock units (PSUs). Stock options are granted under long-term incentive plans to certain key employees and non-employee directors at an exercise price not less than the fair market value of the underlying common stock, which is the quoted closing price of our common stock on the day prior to the date of grant. The options are granted for periods of up to 10 years and become exercisable in varying installments.&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We grant RSUs to key employees and non-employee directors and PSUs to certain key employees under our long-term incentive plans. The fair value of RSUs is determined based on the number of shares granted and the quoted closing price of our common stock on the date of grant, adjusted for the fact that RSUs do not include anticipated dividends. RSUs generally vest in one-third increments over a three-year period and are settled in stock. PSUs are earned over a three-year performance cycle and vest in March of the year following the end of that performance cycle. The number of PSUs that will ultimately be earned is based on our performance relative to pre-established goals in that three-year performance cycle. The fair value of PSUs is determined based on the quoted closing price of our common stock on the day of grant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Compensation expense is recognized in the Consolidated Statements of Earnings based on the estimated fair value of the awards on the grant date. Compensation expense recognized reflects an estimate of the number of awards expected to vest after taking into consideration an estimate of award forfeitures based on actual experience and is recognized on a straight-line basis over the requisite service period, which is generally the period required to obtain full vesting. Management expectations related to the achievement of performance goals associated with PSU grants is assessed regularly and that assessment is used to &lt;/span&gt;&lt;/div&gt;determine whether PSU grants are expected to vest. If performance-based milestones related to PSU grants are not met or not expected to be met, any compensation expense recognized associated with such grants will be reversed.</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i708148310e2c45b79502852cc7ddd42d_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzE3MDAw_9a7f558c-81bb-4206-89ee-6fdf4581784e">P10Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <syk:SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod
      contextRef="icb6424572e1a40e48c885f2c92dfe789_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzIwODIy_8d393fce-70da-4f4f-9459-e24ce575fc0c">P3Y</syk:SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i8117cc9161634207825ffb3719f67191_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzIwODU3_3b36a885-64c2-4f9f-888d-aadf36e4129d">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i8117cc9161634207825ffb3719f67191_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzIwOTM1_04c1bf88-6bbb-4e28-9a6b-73b1471f39a8">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzIwOTE2_308c4ecf-2c52-4209-8b26-6b70f08a934d">Deferred income tax assets and liabilities are determined based on differences between financial reporting and income tax bases of assets and liabilities and are measured using the enacted income tax rates in effect for the years in which the differences are expected to reverse. Deferred income tax benefits generally represent the change in net deferred income tax assets and liabilities in the year. Other amounts result from adjustments related to acquisitions and foreign currency as appropriate.We operate in multiple income tax jurisdictions both within the United States and internationally. Accordingly, management must determine the appropriate allocation of income to each of these jurisdictions based on current interpretations of complex income tax regulations. Income tax authorities in these jurisdictions regularly perform audits of our income tax filings. Income tax audits associated with the allocation of this income and other complex issues, including inventory transfer pricing and cost sharing, product royalty and foreign branch arrangements, may require an extended period of time to resolve and may result in significant income tax adjustments if changes to the income allocation are required between jurisdictions with different income tax rates.</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDAvZnJhZzozMzM5NjQyNGIwZjc0MDE4OTBhYjNlNjNmOWJjZDRmYS90ZXh0cmVnaW9uOjMzMzk2NDI0YjBmNzQwMTg5MGFiM2U2M2Y5YmNkNGZhXzIwODY1_2c7b9c88-bf86-447b-a2ff-3dce201f5b20">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;New Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In September 2022 the Financial Accounting Standards Board issued ASU 2022-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Liabilities - Supplier Finance Programs: Disclosure of Supplier Finance Program Obligations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;, which requires entities that utilize supplier finance programs in connection with the purchase of goods and services to disclose information about the key terms of the programs, a rollforward of the obligations under the programs and where those obligations are presented in the balance sheet. The new disclosure requirements are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. Currently our obligations under these programs are not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Accounting Pronouncements Recently Adopted &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On January 1, 2022 we adopted ASU 2021-08, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations: Accounting for Contract Assets and Contract Liabilities from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;. This update requires an entity to recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Accounting Standards Codification 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;. The adoption of this update did not have a material impact on our Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90ZXh0cmVnaW9uOjhmZjc1ZjcxODE5OTRhNjBiNWZjMDhmOTI5ODQxZDhmXzM2ODc_db873c25-ef42-4289-972b-8fc543d8753d">REVENUE RECOGNITION&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We disaggregate our net sales by product line and geographic location for each of our segments as we believe it best depicts how the nature, amount, timing and certainty of our net sales and cash flows are affected by economic factors.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Products and services are primarily transferred to customers at a point in time, with some transfers of services taking place over time. In 2022 less than 10% of our sales were recognized as services transferred over time. Refer to Note 1 for further discussion on our revenue recognition policies. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.259%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Segment Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;MedSurg and Neurotechnology:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Endoscopy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Medical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Neurovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Neuro Cranial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10,611&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,538&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,345&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Orthopaedics and Spine:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Knees&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Hips&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Trauma and Extremities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Spine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,838&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,570&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,006&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;18,449&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;17,108&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;14,351&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.259%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;United States Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;MedSurg and Neurotechnology:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Endoscopy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Medical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Neurovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Neuro Cranial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,024&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,026&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,218&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Orthopaedics and Spine:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Knees&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Hips&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Trauma and Extremities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Spine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,614&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,295&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,237&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;13,638&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12,321&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10,455&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.259%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;International Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;MedSurg and Neurotechnology:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Endoscopy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Medical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Neurovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Neuro Cranial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,587&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,512&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,127&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Orthopaedics and Spine:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Knees&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Hips&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Trauma and Extremities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Spine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,224&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,275&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,769&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,811&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,787&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,896&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;MedSurg and Neurotechnology&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;MedSurg and Neurotechnology products include surgical equipment and navigation systems (Instruments), endoscopic and communications systems (Endoscopy), patient handling, emergency medical equipment, intensive care disposable products and clinical communication and workflow solutions (Medical), minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke (Neurovascular), a comprehensive line of products for traditional brain and open skull based surgical procedures; orthobiologic and biosurgery &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;products, including synthetic bone grafts and vertebral augmentation products (Neuro Cranial) and other medical device products used in a variety of medical specialties. Substantially all MedSurg and Neurotechnology sales are recognized when a purchase order has been received and control has transferred. For certain Endoscopy, Instruments and Medical services, we may recognize sales over time as we satisfy performance obligations that may include an obligation to complete installation, provide training and perform ongoing services, generally performed within one year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Orthopaedics and Spine&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Orthopaedics and Spine products consist primarily of implants used in hip and knee joint replacements and trauma and extremity surgeries, and cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies. Substantially all Orthopaedics sales are recognized when we have received a purchase order and appropriate notification the product has been used or implanted. Substantially all Spine sales are recognized when a purchase order has been received and control has transferred. For certain Orthopaedic products in the "other" category, we recognize sales at a point in time, as well as over time for performance obligations that may include an obligation to complete installation and provide training and ongoing services. Performance obligations are generally satisfied within one year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contract Assets and Liabilities &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The nature of our products and services do not generally give rise to contract assets as we typically do not incur costs to fulfill a contract before a product or service is provided to a customer. Our costs to obtain contracts are typically in the form of sales commissions paid to employees or third-party agents. Certain sales commissions paid to employees prior to recognition of sales are recorded as contract assets. We expense sales commissions associated with obtaining a contract at the time of the sale or as incurred as the amortization period is generally less than one year. These costs have been presented within selling, general and administrative expenses. On December&#160;31, 2022 contract assets recorded in our Consolidated Balance Sheets were not significant.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Our contract liabilities arise as a result of consideration received from customers at inception of contracts for certain businesses or where the timing of billing for services precedes satisfaction of our performance obligations. We generally satisfy performance obligations within one year from the contract inception date. Our contract liabilities were $741 and $529 on December&#160;31, 2022 and 2021. Changes in contract liabilities during the year were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.658%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.142%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Beginning contract liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;529&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Revenue recognized from beginning of year contract liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(329)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Contract liabilities acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net advance consideration received during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Ending contract liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;741&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <syk:PercentageofServiceRevenueRecognizeoverTime
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90ZXh0cmVnaW9uOjhmZjc1ZjcxODE5OTRhNjBiNWZjMDhmOTI5ODQxZDhmXzQyMw_52e530e3-5663-46ff-a4dc-f58ace831ad3"
      unitRef="number">0.10</syk:PercentageofServiceRevenueRecognizeoverTime>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90ZXh0cmVnaW9uOjhmZjc1ZjcxODE5OTRhNjBiNWZjMDhmOTI5ODQxZDhmXzM2ODQ_dc21e7f4-65d4-44ac-aade-25196b70ee82">&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.259%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Segment Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;MedSurg and Neurotechnology:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Endoscopy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Medical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Neurovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Neuro Cranial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10,611&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,538&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,345&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Orthopaedics and Spine:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Knees&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Hips&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Trauma and Extremities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Spine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,838&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,570&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,006&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;18,449&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;17,108&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;14,351&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.259%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;United States Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;MedSurg and Neurotechnology:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Endoscopy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Medical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Neurovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Neuro Cranial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,024&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,026&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,218&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Orthopaedics and Spine:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Knees&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Hips&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Trauma and Extremities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Spine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,614&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,295&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,237&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;13,638&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12,321&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10,455&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.259%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;International Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;MedSurg and Neurotechnology:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Endoscopy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Medical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Neurovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Neuro Cranial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,587&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,512&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,127&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Orthopaedics and Spine:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Knees&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Hips&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Trauma and Extremities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Spine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,224&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,275&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,769&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,811&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,787&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,896&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:Revenues
      contextRef="ib40edc6b554f484e81172008a1b935cd_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzItMS0xLTEtNzIxNTE_c6334990-c99b-46f8-9b89-0ac72a415d65"
      unitRef="usd">2279000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5cd09663d2064e428131942655918cc4_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzItMy0xLTEtNzIxNTE_ea93c57c-b177-4260-8a8d-5e745f215415"
      unitRef="usd">2111000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if10d0627114c4a58a2be1e34e4b5625d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzItNS0xLTEtNzIxNTE_1b1817a3-239b-42b2-81e2-198ab1a9168e"
      unitRef="usd">1863000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic0cc5548a8984d22bd046caa3043eb0b_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzMtMS0xLTEtNzIxNTE_3aca6a56-5ab0-492c-bfad-01ded993b802"
      unitRef="usd">2423000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5020782036574b31a5831f83949362a4_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzMtMy0xLTEtNzIxNTE_f0f54b6b-d725-440d-b136-89af8611b2ed"
      unitRef="usd">2141000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3b9f3564aca841c3ae0ea79a17077a20_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzMtNS0xLTEtNzIxNTE_4253f8a2-f3cc-4ad7-b67a-92304c03108d"
      unitRef="usd">1763000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8e819fe7e1d840638447a95eff013b31_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzQtMS0xLTEtNzIxNTE_dd8df677-f700-41b8-b1ae-504dfb26386c"
      unitRef="usd">3031000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if4e6f58b0e9f477f87313ee9043d9e30_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzQtMy0xLTEtNzIxNTE_d91705d6-f96f-4843-b553-4d2e47e54329"
      unitRef="usd">2607000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7f101fadf7674ec28a0116a48b22b520_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzQtNS0xLTEtNzIxNTE_bcbeba57-8bea-45de-b026-7b8a456e65a2"
      unitRef="usd">2524000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib17c6235040048e8ae37d408059878aa_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzUtMS0xLTEtNzIxNTE_d0193144-2c78-4995-a64a-6754dde71c79"
      unitRef="usd">1200000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ief7335a3982a47459171c93ed23a8f47_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzUtMy0xLTEtNzIxNTE_b4014421-97f0-45c0-81c7-e0183c1f75d7"
      unitRef="usd">1188000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2be681678ea4436faff2709791d5137f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzUtNS0xLTEtNzIxNTE_070dc4b0-aa99-4d46-8a01-88570af77788"
      unitRef="usd">973000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic5f7fd67d1c1485c9f7691e9a1809a38_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzYtMS0xLTEtNzIxNTE_5acbca02-25d1-4a46-a45e-e1b53d26acf6"
      unitRef="usd">1376000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia4ec9d69bf524a148549268e0c42215d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzYtMy0xLTEtNzIxNTE_7ac6c695-c329-49d2-b9d0-22e3b336a9ac"
      unitRef="usd">1214000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iadd844730bb54ab2a251db4875dd0cc2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzYtNS0xLTEtNzIxNTE_9de8337e-7163-48c9-9322-6f4c99078530"
      unitRef="usd">972000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4b975aad2ca64d32a11f0b1aa57d74bc_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzctMS0xLTEtNzIxNTE_82b252e1-e152-41f3-9a88-22555d4ea98f"
      unitRef="usd">302000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i98f3442517e54ff18879b74015965f7b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzctMy0xLTEtNzIxNTE_7f64489b-626a-4a3e-b408-9bf21054906e"
      unitRef="usd">277000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i264f9d32cf56445f819b9231bed80ef2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzctNS0xLTEtNzIxNTE_e2569573-4829-4105-a4d4-ffb4f0352b09"
      unitRef="usd">250000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i953031f47dfd4ab48296f976c579f48f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzgtMS0xLTEtNzIxNTE_dbf12ce4-9280-4722-a08f-1b812cb23b9e"
      unitRef="usd">10611000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idac1c88764c44335aba1807e0a6c5920_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzgtMy0xLTEtNzIxNTE_a54a36a7-fe6c-48c9-9171-97850bb527a5"
      unitRef="usd">9538000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i62d3222aba4540cdb06bcf65a6a3bfd2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzgtNS0xLTEtNzIxNTE_f066b807-6130-4102-b382-ac8111479f4a"
      unitRef="usd">8345000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6ecee5a3b59948519fdbfa67f9373a2b_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzEwLTEtMS0xLTcyMTUx_7941c549-babe-4a66-912b-6bcfd84f7408"
      unitRef="usd">1997000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i474cb49aa2d24434a691b5420651c447_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzEwLTMtMS0xLTcyMTUx_d0fca103-0e9c-4ff4-8325-2295959fc2dc"
      unitRef="usd">1848000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4c6154902bf04aeeb004c9e54c981d28_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzEwLTUtMS0xLTcyMTUx_62a77144-ef27-4f68-ab0a-cc4181721bd8"
      unitRef="usd">1567000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if4b19248ed5d4294b50748ae4ea4aee0_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzExLTEtMS0xLTcyMTUx_3942b7b4-e366-48c4-98eb-61eadbd092ce"
      unitRef="usd">1413000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i269eeb7c7e4141e8bf2d3c9c447f3e98_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzExLTMtMS0xLTcyMTUx_40be2205-f8e0-4d49-a7c2-8f77e5c480ce"
      unitRef="usd">1342000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id675a2fbf95744c4be3290137773c281_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzExLTUtMS0xLTcyMTUx_5a39463c-25b5-49d8-bb2b-653e424ed65e"
      unitRef="usd">1206000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if9b5b615c9924c07a819ee875818589c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzEyLTEtMS0xLTcyMTUx_5fcfa395-b769-410c-b60e-c372aed9e32e"
      unitRef="usd">2807000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i013403153cd64c79a7f3a8634e364ea1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzEyLTMtMS0xLTcyMTUx_6437d6ce-ebfc-4840-8deb-450fa5bb0c39"
      unitRef="usd">2664000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6c5b695e084e4496a0671e329ae3381e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzEyLTUtMS0xLTcyMTUx_4d83dc16-f63d-40c1-903b-12c69ab6840e"
      unitRef="usd">1722000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4d0108479d3b484d80725dc2c041ad97_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzEzLTEtMS0xLTcyMTUx_19448a4f-7069-49e1-be9b-38ff3a8906b6"
      unitRef="usd">1146000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib0fdc7482bea448a93867fd96f5dcbac_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzEzLTMtMS0xLTcyMTUx_94dc5750-d89d-488d-aae1-08f8899caf23"
      unitRef="usd">1167000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i331257e825de49c58489bfb866ddce44_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzEzLTUtMS0xLTcyMTUx_2d9330fe-597d-425b-a923-6f9502347926"
      unitRef="usd">1047000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i666cd5b0c83c456bae79773bcf7f03e1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzE0LTEtMS0xLTcyMTUx_e826129c-6313-4f0e-b232-afabcc414a57"
      unitRef="usd">475000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1801afd3ee7f4dfaac31a549f6ae0482_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzE0LTMtMS0xLTcyMTUx_8638e178-8298-4d29-849d-f48059ef8f25"
      unitRef="usd">549000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie6aca02c723d4fb4ace6192cccb9de77_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzE0LTUtMS0xLTcyMTUx_00173c80-cf8e-4546-89c9-17975bc8760c"
      unitRef="usd">464000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i59e41efd1cf44cedb5a90caceaa03aff_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzE1LTEtMS0xLTcyMTUx_c861346f-d0e7-4949-9d73-5b58ef48c45f"
      unitRef="usd">7838000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i383cf58c47f8466aaa98e0e267a0ec66_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzE1LTMtMS0xLTcyMTUx_48e072ce-850f-4f55-9743-c97875064869"
      unitRef="usd">7570000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if132773438c747ef8b1fe48831a7e72d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzE1LTUtMS0xLTcyMTUx_4f17f97d-03f6-43c8-b447-bee112934316"
      unitRef="usd">6006000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzE2LTEtMS0xLTcyMTUx_4fa2bb08-7c0c-46ce-9b71-3fae3c8b0268"
      unitRef="usd">18449000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzE2LTMtMS0xLTcyMTUx_d6d89122-6065-4298-8c5a-1ed0399aa9c2"
      unitRef="usd">17108000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTplNDkyMGJhNjdkNTA0YWJlOWYyNDZhYTNiNWJhZTM2YS90YWJsZXJhbmdlOmU0OTIwYmE2N2Q1MDRhYmU5ZjI0NmFhM2I1YmFlMzZhXzE2LTUtMS0xLTcyMTUx_47c0fd33-46cb-4dcd-8083-36f6cf78d0ce"
      unitRef="usd">14351000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9ed4ee29f6714ea69ad3fad40ed030cb_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzItMS0xLTEtNzIxNTE_344ae307-0f2d-4911-ad6f-7c9728fcf500"
      unitRef="usd">1810000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5d7fbd10640d4d3dbb9a7da83fdc93c2_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzItMy0xLTEtNzIxNTE_97644be2-8a0a-4e0e-b4a6-0893d1912038"
      unitRef="usd">1637000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id09fcf99189f4b1998d8d9734940d624_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzItNS0xLTEtNzIxNTE_ea41bb92-7a40-40d4-b418-2ce34da3fa7b"
      unitRef="usd">1471000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i98867d5b69f347a49e32704030d048c1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzMtMS0xLTEtNzIxNTE_0ad1aba0-1616-46dd-be71-4887d1f9e064"
      unitRef="usd">1914000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i08e13185dfad49da800a2a08a9f432a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzMtMy0xLTEtNzIxNTE_5e4a8407-252e-42bf-8c4b-ded9791482b2"
      unitRef="usd">1670000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i27792d541a2c4696a01a98be72919963_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzMtNS0xLTEtNzIxNTE_672b86c6-d1fd-4b79-9b19-1bc2aefaf5bd"
      unitRef="usd">1408000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5cea099951df4ff7bbdc41425b5529b6_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzQtMS0xLTEtNzIxNTE_050406ae-3056-4492-90dd-d78689360196"
      unitRef="usd">2422000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i543a25a9f1ec4250931a708a947c22f0_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzQtMy0xLTEtNzIxNTE_ff8c7751-737a-4fd5-89be-d6187b876db4"
      unitRef="usd">2007000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idc72c4be0f714dff82bfbdceba60770f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzQtNS0xLTEtNzIxNTE_40141f12-ee5f-4357-84ac-d663b5b86782"
      unitRef="usd">1910000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iaefd465e33384342bb74bc7d62b86fcb_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzUtMS0xLTEtNzIxNTE_09ff3e1e-406b-4f96-bca3-eb67ef2abe17"
      unitRef="usd">446000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6601ea0a52494abfb803a90cb4cac08b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzUtMy0xLTEtNzIxNTE_b66a6d17-45e6-4a4d-9c5e-84208149aa41"
      unitRef="usd">451000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia5206b2de2164734afce54d5a8ff985d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzUtNS0xLTEtNzIxNTE_d1a0d510-b876-4e6d-be27-2776e9c60962"
      unitRef="usd">381000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ifff0fc2d089c44d3aa2f9d5df4e83ff4_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzYtMS0xLTEtNzIxNTE_1e28a57a-a60a-4638-ac3f-fc72da9dae4a"
      unitRef="usd">1135000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic1f97bfe9b3544df927161980c8b37e7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzYtMy0xLTEtNzIxNTE_59551ffd-c118-4f0a-a163-05ceb7e0f46f"
      unitRef="usd">988000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i62b4c459d2c147fcb0cfa4526e86d72b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzYtNS0xLTEtNzIxNTE_d7b924f7-787c-4b8e-9233-d729cbfce381"
      unitRef="usd">801000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i663246eda49749d997c0d746cabbb4ee_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzctMS0xLTEtNzIxNTE_afdf8939-83d9-4724-984b-7cb4a47b5a70"
      unitRef="usd">297000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia6a66c36657d43f4a75ef31f2507e955_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzctMy0xLTEtNzIxNTE_23dff8dc-18e3-4f3e-a0a2-f7a965afabb9"
      unitRef="usd">273000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia0a11a2714074a598220e8541795a994_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzctNS0xLTEtNzIxNTE_a8d82abf-4bef-413f-a10c-4e3095f55bbe"
      unitRef="usd">247000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i46e1cd337be44b57b9b1d332b129f69c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzgtMS0xLTEtNzIxNTE_3de4c389-ff24-45d7-816d-fdcbe32e80d2"
      unitRef="usd">8024000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7d04a4d184e54baaa0500525454dce8a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzgtMy0xLTEtNzIxNTE_61b42c10-bcc0-4298-a669-8ef767133fbd"
      unitRef="usd">7026000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie649374514094ad1a1d1a16c42b218da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzgtNS0xLTEtNzIxNTE_dac7d7c5-b4e2-41e0-832a-1a6eebd6c7ee"
      unitRef="usd">6218000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6078ad8012384f338b9a92a484d14c65_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzEwLTEtMS0xLTcyMTUx_843b1f2e-6b2c-4281-972a-f3d5dacd5f88"
      unitRef="usd">1493000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i797fa079f8f54e3a9a6da8545bed4ed3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzEwLTMtMS0xLTcyMTUx_d7b1536b-4dbb-4ad2-9e28-fd5284124039"
      unitRef="usd">1351000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2dd6e330b6ad41d9b7422a4b7e00bf79_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzEwLTUtMS0xLTcyMTUx_3f6c6c89-8160-4829-a350-87c3ae59eab4"
      unitRef="usd">1170000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i235f0602f0b049698f8ebba9516a25f6_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzExLTEtMS0xLTcyMTUx_64d1b031-c2cb-4685-9fc0-a46e98f59ca0"
      unitRef="usd">896000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i71a3f354032646189f007311bac60024_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzExLTMtMS0xLTcyMTUx_214d5479-f033-49b2-8191-3560dd2bc3ef"
      unitRef="usd">822000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie56858cf83c046b994c5c997f9f03e4d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzExLTUtMS0xLTcyMTUx_abb983f8-55d3-494e-a436-5a7f1107fc55"
      unitRef="usd">777000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idf66a24721c449dabc5abd76d714c686_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzEyLTEtMS0xLTcyMTUx_c9b63d5c-c404-4f1e-83c8-911bf2e874f7"
      unitRef="usd">2035000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic219c45e9bad4e20b8083e43a0aeb4eb_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzEyLTMtMS0xLTcyMTUx_14e4c5b3-dc02-4905-a894-e1042b8cab07"
      unitRef="usd">1866000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if5a1567757054e22a14abcfa4521d1d8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzEyLTUtMS0xLTcyMTUx_ff633685-5938-47d8-aeb5-be408b47d902"
      unitRef="usd">1139000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if21f6d50ec354218a38c8290af16e623_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzEzLTEtMS0xLTcyMTUx_049adfef-ac5a-420a-b933-757d4aa82830"
      unitRef="usd">836000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia8b02a7bd5e949d7bf3a6197a4b398c0_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzEzLTMtMS0xLTcyMTUx_e29d6f40-9c08-46ae-bea7-ef94a0ed64c7"
      unitRef="usd">831000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5586d2399af142dabc67a9bee22f6a8a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzEzLTUtMS0xLTcyMTUx_f5987821-7c38-4505-a06d-a43ed4d2b5ca"
      unitRef="usd">764000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia1758ceab8dc4cba84c860bf0c70ec7e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzE0LTEtMS0xLTcyMTUx_32821223-c836-4125-b2bf-3fc4b31dde0e"
      unitRef="usd">354000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i323b04cbc9d248b1b1d4d71d946c7fa3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzE0LTMtMS0xLTcyMTUx_fd7efef0-c725-445a-8ba4-5e16df93a668"
      unitRef="usd">425000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie50bbe6a5e6d46d4a93975ba9d0688c8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzE0LTUtMS0xLTcyMTUx_8d49ba56-6c88-4b1d-a9a9-b3f3a3b4c29b"
      unitRef="usd">387000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i53c57bd651fd45a185259d088cd6d65c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzE1LTEtMS0xLTcyMTUx_df1e6488-7f20-4b98-98aa-7c7402a8e758"
      unitRef="usd">5614000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ifc1a1dbfa4b940c183d1a894a442e7dc_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzE1LTMtMS0xLTcyMTUx_2c20a29b-634c-4403-a3d6-74c85e18f68c"
      unitRef="usd">5295000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib5e99b74e17b4087a5567c9b9b9bc240_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzE1LTUtMS0xLTcyMTUx_b206da9e-cb7a-4d83-a1b8-e80131680fed"
      unitRef="usd">4237000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iaff1db63800141a4a0f466e4edd07697_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzE2LTEtMS0xLTcyMTUx_0d62c0f9-3efc-4075-805d-271beca85304"
      unitRef="usd">13638000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2c40ed4f092642e6ae3512f7b314ae33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzE2LTMtMS0xLTcyMTUx_79892389-745f-4438-bac3-71e690e646b7"
      unitRef="usd">12321000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia16521f0e141452ca6e75ab7d3a68848_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTpkN2YwZWZjOTFlMDg0MzRmYjA4YjNjNzdjZTE5NDM3NS90YWJsZXJhbmdlOmQ3ZjBlZmM5MWUwODQzNGZiMDhiM2M3N2NlMTk0Mzc1XzE2LTUtMS0xLTcyMTUx_d28317ce-dae1-47cb-8374-005c73d1ebf8"
      unitRef="usd">10455000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i483d950410414fe59ab9e2fa4d84d5df_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzItMS0xLTEtNzIxNTE_81df82f9-1f9e-4d82-8471-b83cf310228d"
      unitRef="usd">469000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i63a90fa6e8e148b19df1238fd6a1f7c2_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzItMy0xLTEtNzIxNTE_1d020557-a31e-44c8-9899-828c55973002"
      unitRef="usd">474000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1dc8e759d5044d0aaa1f41483df1232a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzItNS0xLTEtNzIxNTE_75577910-d6fd-4861-a85a-9201b0dc9ee8"
      unitRef="usd">392000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iae1685480e7f4fcbbb1e5f05830d684d_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzMtMS0xLTEtNzIxNTE_d9a64f7c-bbfa-4b88-86bb-0b4b8426a91c"
      unitRef="usd">509000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia1df304d4eb44faf833fe1d888e9f579_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzMtMy0xLTEtNzIxNTE_9a774e1f-a48f-44cc-abcc-940779043cfd"
      unitRef="usd">471000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3e65f49264c64a349b9d521fc9f4b8f9_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzMtNS0xLTEtNzIxNTE_5659a6e6-61a1-4dac-99da-d769f0f206ad"
      unitRef="usd">355000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i30234a3281d14003a6892b71356e9d0a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzQtMS0xLTEtNzIxNTE_bbc69fc6-c0ff-4a02-9246-adf9b05d7317"
      unitRef="usd">609000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if70a16dd5e6945bf9c6e8cf9b8788075_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzQtMy0xLTEtNzIxNTE_f89a8dbc-65e8-4915-879d-98c2517e1ddd"
      unitRef="usd">600000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3fe26adfdbc545c99ea371ee84ab0982_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzQtNS0xLTEtNzIxNTE_a75872f6-0274-4502-a25d-8eab999a94c4"
      unitRef="usd">614000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5018938caadf49a898cc06c5f84bc191_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzUtMS0xLTEtNzIxNTE_abc80db1-695f-4d52-8e9e-8d0528c89b0c"
      unitRef="usd">754000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id25f8772d4b14bb897d5701f19e7d4f1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzUtMy0xLTEtNzIxNTE_6cb0099d-4b21-40f2-b34a-9fd9e1b97152"
      unitRef="usd">737000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia4b3fca57c9545df8ece61f69e1e1fdc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzUtNS0xLTEtNzIxNTE_3380e73e-00e3-418c-8f9f-4a6ea6b0e78b"
      unitRef="usd">592000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia7c37ca29a884860a690d73964155c6e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzYtMS0xLTEtNzIxNTE_6f8fc26c-a0e3-4e4c-ad99-2e79dd1418c3"
      unitRef="usd">241000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i57807bf2142f4f7faa936c1cacf88c52_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzYtMy0xLTEtNzIxNTE_48d43700-4da0-412f-ab36-8e341c55bbb4"
      unitRef="usd">226000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i82f610c3881d4092950ff3ee3559f332_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzYtNS0xLTEtNzIxNTE_705db25e-d814-4e7a-866b-30d1ff21f9dd"
      unitRef="usd">171000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i69286e78969c425b95fb1a1af5a7ffee_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzctMS0xLTEtNzIxNTE_0ca76517-cbb7-4a25-a43c-a0956d135fd3"
      unitRef="usd">5000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idded536d0af14e3a827698652b7ec361_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzctMy0xLTEtNzIxNTE_7bf0904b-a119-467d-8698-a44303fe9a4a"
      unitRef="usd">4000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ife69af0daf204c34b24444fefcdc4593_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzctNS0xLTEtNzIxNTE_a8b618b3-fdf9-43c9-968f-c6de03f4cba0"
      unitRef="usd">3000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6e1d87a1079040de8d74635a08480d51_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzgtMS0xLTEtNzIxNTE_1a881d87-4a43-43a9-82ef-a841385ea065"
      unitRef="usd">2587000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4f994fa175e14f7fbb0230508d4017b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzgtMy0xLTEtNzIxNTE_61dd214c-6c45-488c-b06b-13ecc1cf97fe"
      unitRef="usd">2512000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i90fb567d63414192b40cf0ac5a8561bb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzgtNS0xLTEtNzIxNTE_1b995daa-d2ee-49b2-98af-495a481d20a8"
      unitRef="usd">2127000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3c5ee2c8d6a245409c7113431408c137_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzEwLTEtMS0xLTcyMTUx_ebf5e8ee-7021-4c19-83a3-ff994a377c33"
      unitRef="usd">504000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1521748c0f8b464492226525de5d7eab_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzEwLTMtMS0xLTcyMTUx_898fe2e2-e736-4266-a602-7c52a2172565"
      unitRef="usd">497000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1cc4e6c8bedd45858a7ca12a5301a3ae_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzEwLTUtMS0xLTcyMTUx_a6882970-528f-419d-b513-2b0b990b5d30"
      unitRef="usd">397000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i502050c566d846e2a9eebc8d4f42d251_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzExLTEtMS0xLTcyMTUx_8316a876-60ed-41e5-9fd4-e87a2cdbe689"
      unitRef="usd">517000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i087a6044fb0f4d06ab4771d7a6615b22_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzExLTMtMS0xLTcyMTUx_125de2e8-6728-4368-a070-d5acdb6e6392"
      unitRef="usd">520000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i78a574b38eb84b4e9ddbdec1b8422bb5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzExLTUtMS0xLTcyMTUx_3359f0e0-29db-45d6-b8b1-c4fba55c2820"
      unitRef="usd">429000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9848e15d5e03446e85be30206896834a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzEyLTEtMS0xLTcyMTUx_8ddc9d5c-40db-451e-80b3-3046cb652fff"
      unitRef="usd">772000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i09f67744858942b2ade6faf4e7109a1e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzEyLTMtMS0xLTcyMTUx_dfb2d0ce-545c-4d5c-852a-aca61de8d89e"
      unitRef="usd">798000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie7dbd5a4933a46c3880c5c627cb44975_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzEyLTUtMS0xLTcyMTUx_d183d016-b2c9-400b-a707-2d9bbdf1516d"
      unitRef="usd">583000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if21ff3221f9e4f94b678fa254a2b6165_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzEzLTEtMS0xLTcyMTUx_cc25bbe0-d6df-4767-9045-5de0a061d0d1"
      unitRef="usd">310000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i111c61299cd54de1a129bb3bb7c82c44_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzEzLTMtMS0xLTcyMTUx_60f45500-cbd8-4a40-99b8-76da28edcb1b"
      unitRef="usd">336000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibb4bfa7f666a42c694d9c69757624555_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzEzLTUtMS0xLTcyMTUx_9a9f53fd-1412-4ba5-81ff-016c10000cf4"
      unitRef="usd">283000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib088580a0b7f4d77b2ec885ae6c1c459_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzE0LTEtMS0xLTcyMTUx_ac305b03-506c-4dee-8f3e-825472f43894"
      unitRef="usd">121000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4da717909f6849eb981891e24024b2a9_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzE0LTMtMS0xLTcyMTUx_c00a3ec6-d53b-4e12-8b05-64842c9f4744"
      unitRef="usd">124000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i584907bcc13a4da3b2f67d81b5e349e3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzE0LTUtMS0xLTcyMTUx_1d410e61-baca-44fe-8d00-8bb147f2efe9"
      unitRef="usd">77000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i322205428fdb4dd1b9ee8eb34e18bbf1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzE1LTEtMS0xLTcyMTUx_c423736d-bd34-4817-be4f-586ff4ecaeb4"
      unitRef="usd">2224000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if7c8e07052dd4d1c91726191ed386ac8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzE1LTMtMS0xLTcyMTUx_a35ac656-fee2-4927-885a-39a232051222"
      unitRef="usd">2275000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i17bfdc6681b54daf82fee40a6fb5aa86_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzE1LTUtMS0xLTcyMTUx_65000e89-bb1c-47ee-aed0-fd1d58afff65"
      unitRef="usd">1769000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iaab182c6b3bb44d086bbe15590d6e157_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzE2LTEtMS0xLTcyMTUx_687d63e1-92a0-429a-86aa-79f9041d5860"
      unitRef="usd">4811000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8c358267d06c4c30bddf69fbbdad3c82_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzE2LTMtMS0xLTcyMTUx_7c3500cc-be3a-4b55-b7a6-4de0aa9f2561"
      unitRef="usd">4787000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ide98561cf401454c96fa8600baf5b8f9_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZToyMDRhZjdiMTE0YzQ0ZWJmYjkxNzc1MjRlYTQxMWVjOC90YWJsZXJhbmdlOjIwNGFmN2IxMTRjNDRlYmZiOTE3NzUyNGVhNDExZWM4XzE2LTUtMS0xLTcyMTUx_e5225743-568b-4c68-b53b-9d200ee11726"
      unitRef="usd">3896000000</us-gaap:Revenues>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90ZXh0cmVnaW9uOjhmZjc1ZjcxODE5OTRhNjBiNWZjMDhmOTI5ODQxZDhmXzMyOTg1MzQ4ODcxNzY_4d3e9ab8-5fca-470b-9087-155594ff6045"
      unitRef="usd">741000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90ZXh0cmVnaW9uOjhmZjc1ZjcxODE5OTRhNjBiNWZjMDhmOTI5ODQxZDhmXzMyOTg1MzQ4ODcxODA_30d32f03-21f9-4988-9fa3-a10947eceb75"
      unitRef="usd">529000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90ZXh0cmVnaW9uOjhmZjc1ZjcxODE5OTRhNjBiNWZjMDhmOTI5ODQxZDhmXzU0OTc1NTgxNzc0Mw_3b6416cb-94af-4852-b2ad-ca5d2a4459a8">Changes in contract liabilities during the year were as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.658%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.142%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Beginning contract liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;529&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Revenue recognized from beginning of year contract liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(329)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Contract liabilities acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net advance consideration received during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Ending contract liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;741&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTo3ZmRiYmI4MzA5ZDE0ZGQ0OTBkYjFlMWVmYzgyODZjMC90YWJsZXJhbmdlOjdmZGJiYjgzMDlkMTRkZDQ5MGRiMWUxZWZjODI4NmMwXzEtMS0xLTEtODQ2MjQ_30d32f03-21f9-4988-9fa3-a10947eceb75"
      unitRef="usd">529000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTo3ZmRiYmI4MzA5ZDE0ZGQ0OTBkYjFlMWVmYzgyODZjMC90YWJsZXJhbmdlOjdmZGJiYjgzMDlkMTRkZDQ5MGRiMWUxZWZjODI4NmMwXzItMS0xLTEtODQ2NTU_97436309-a881-4033-985c-0f9500dcc5b4"
      unitRef="usd">329000000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTo3ZmRiYmI4MzA5ZDE0ZGQ0OTBkYjFlMWVmYzgyODZjMC90YWJsZXJhbmdlOjdmZGJiYjgzMDlkMTRkZDQ5MGRiMWUxZWZjODI4NmMwXzMtMS0xLTEtODQ2NTU_07e3ca05-8a02-4312-94d2-73a38d79976d"
      unitRef="usd">80000000</us-gaap:ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination>
    <syk:ContractWithCustomerLiabilityNetAdvanceConsiderationReceivedDuringPeriod
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTo3ZmRiYmI4MzA5ZDE0ZGQ0OTBkYjFlMWVmYzgyODZjMC90YWJsZXJhbmdlOjdmZGJiYjgzMDlkMTRkZDQ5MGRiMWUxZWZjODI4NmMwXzQtMS0xLTEtODQ2NTU_aa28e3e4-22e0-4179-92f9-98652b2b0058"
      unitRef="usd">461000000</syk:ContractWithCustomerLiabilityNetAdvanceConsiderationReceivedDuringPeriod>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDMvZnJhZzo4ZmY3NWY3MTgxOTk0YTYwYjVmYzA4ZjkyOTg0MWQ4Zi90YWJsZTo3ZmRiYmI4MzA5ZDE0ZGQ0OTBkYjFlMWVmYzgyODZjMC90YWJsZXJhbmdlOjdmZGJiYjgzMDlkMTRkZDQ5MGRiMWUxZWZjODI4NmMwXzUtMS0xLTEtODQ2OTA_4d3e9ab8-5fca-470b-9087-155594ff6045"
      unitRef="usd">741000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90ZXh0cmVnaW9uOjE1MmJmZDZhNWExZTQ1ZDg5NzQxZWY4MWNkYWQzYWZmXzI2NzE_79dcc376-2f31-473f-b054-55d5ba5f2043">FAIR VALUE MEASUREMENTS Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Financial assets and liabilities carried at fair value are classified in their entirety based on the lowest level of input and disclosed in one of the following three categories:&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.693%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.107%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Quoted market prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Observable market-based inputs or unobservable inputs that are corroborated by market data.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Unobservable inputs reflecting our assumptions or external inputs from active markets.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Use of observable market data, when available, is required in making fair value measurements. When inputs used fall within different levels of the hierarchy, the level within which the fair value measurement is categorized is based on the lowest level input that is significant to the fair value measurement. We determine fair value for Level 1 instruments using exchange-traded prices for identical instruments. We determine fair value of Level 2 instruments using exchange-traded prices of similar instruments, where available, or utilizing other observable inputs that take into account our credit risk and that of our counterparties. Foreign currency exchange contracts and interest rate hedges, when outstanding, are included in Level 2 and are primarily valued using standard calculations and models that use readily observable market data as their basis. Our Level 3 liabilities are comprised of contingent consideration arising from recently completed acquisitions. We determine fair value of these Level 3 liabilities using a discounted cash flow technique. Significant unobservable inputs were used in our assessment of fair value, including assumptions regarding future business results, discount rates, discount periods and probability assessments based on the likelihood of reaching various targets. We remeasure the fair value of our assets and liabilities each reporting period. We record the changes in fair value within selling, general and administrative expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;During the third quarter 2022 we determined that certain commercial and regulatory milestones related to technology acquired in the purchase of Mobius Imaging and Cardan Robotics were no longer probable of being achieved and recorded a $110 reduction in the fair value of contingent consideration reflected in selling, general and administrative expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.417%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.141%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.142%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Assets Measured at Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Trading marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 1 - Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,010&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,137&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Available-for-sale marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Corporate and asset-backed debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Foreign government debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States agency debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States treasury debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Total available-for-sale marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 2 - Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;203&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;287&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total assets measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,213&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,424&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.417%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.141%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.142%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Liabilities Measured at Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Deferred compensation arrangements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 1 - Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;166&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;193&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 2 - Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;102&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;17&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Contingent consideration:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Beginning&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Change in estimate &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(137)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(148)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Ending&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 3 - Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;121&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;306&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total liabilities measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;389&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;516&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.417%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.141%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.142%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Fair Value of Available for Sale Securities by Maturity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Due in one year or less&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Due after one year through three years&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On December&#160;31, 2022 the aggregate difference between the cost and fair value of available-for-sale marketable securities was nominal. Interest and marketable securities income was $94, $68 and $102 in 2022, 2021 and 2020, which was recorded in other income (expense), net.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Our investments in available-for-sale marketable securities had a minimum credit quality rating of A2 (Moody's), A (Standard &amp;amp; Poor's) and A (Fitch). We do not plan to sell the investments, and it is not more likely than not that we will be required to sell the investments before recovery of their amortized cost basis, which may be maturity.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
      contextRef="iec7ff50d4aea4a64b1a222ed6cddad1e_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90ZXh0cmVnaW9uOjE1MmJmZDZhNWExZTQ1ZDg5NzQxZWY4MWNkYWQzYWZmXzM4NDgyOTA3MDAzMTM_a86370d0-1fd6-4c51-922c-8a220dcee5bd"
      unitRef="usd">-110000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90ZXh0cmVnaW9uOjE1MmJmZDZhNWExZTQ1ZDg5NzQxZWY4MWNkYWQzYWZmXzI2NjY_476b42d1-2ac8-4885-a165-625721ff2487">&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.417%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.141%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.142%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Assets Measured at Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Trading marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 1 - Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,010&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,137&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Available-for-sale marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Corporate and asset-backed debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Foreign government debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States agency debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States treasury debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Total available-for-sale marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 2 - Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;203&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;287&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total assets measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,213&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,424&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.417%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.141%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.142%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Liabilities Measured at Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Deferred compensation arrangements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 1 - Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;166&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;193&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 2 - Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;102&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;17&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Contingent consideration:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Beginning&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Change in estimate &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(137)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(148)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Ending&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 3 - Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;121&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;306&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total liabilities measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;389&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;516&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ia2d532877fe14293a0c7af8376dd383a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTo0MGZhNDNmN2E3NWI0YjUwYTQzODA3ZWIxZDRhZTVhZS90YWJsZXJhbmdlOjQwZmE0M2Y3YTc1YjRiNTBhNDM4MDdlYjFkNGFlNWFlXzItMS0xLTEtNzIxNTE_dc865eb2-07ca-4636-bdec-3f3c415c49f1"
      unitRef="usd">1844000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="icb345be38a2145ec8f2df1b4c28dc6d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTo0MGZhNDNmN2E3NWI0YjUwYTQzODA3ZWIxZDRhZTVhZS90YWJsZXJhbmdlOjQwZmE0M2Y3YTc1YjRiNTBhNDM4MDdlYjFkNGFlNWFlXzItMi0xLTEtNzIxNTE_92b01e25-3d82-4634-a914-8a982e9a9393"
      unitRef="usd">2944000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:TradingSecuritiesDebt
      contextRef="ia2d532877fe14293a0c7af8376dd383a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTo0MGZhNDNmN2E3NWI0YjUwYTQzODA3ZWIxZDRhZTVhZS90YWJsZXJhbmdlOjQwZmE0M2Y3YTc1YjRiNTBhNDM4MDdlYjFkNGFlNWFlXzMtMS0xLTEtNzIxNTE_342b85ee-416c-44a1-a05c-a0f02f75d2c2"
      unitRef="usd">166000000</us-gaap:TradingSecuritiesDebt>
    <us-gaap:TradingSecuritiesDebt
      contextRef="icb345be38a2145ec8f2df1b4c28dc6d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTo0MGZhNDNmN2E3NWI0YjUwYTQzODA3ZWIxZDRhZTVhZS90YWJsZXJhbmdlOjQwZmE0M2Y3YTc1YjRiNTBhNDM4MDdlYjFkNGFlNWFlXzMtMi0xLTEtNzIxNTE_1b24ef11-b01a-4a88-b82d-a65bb99531f5"
      unitRef="usd">193000000</us-gaap:TradingSecuritiesDebt>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ia2d532877fe14293a0c7af8376dd383a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTo0MGZhNDNmN2E3NWI0YjUwYTQzODA3ZWIxZDRhZTVhZS90YWJsZXJhbmdlOjQwZmE0M2Y3YTc1YjRiNTBhNDM4MDdlYjFkNGFlNWFlXzQtMS0xLTEtNzIxNTE_c5b8f592-adc9-4224-843d-580cee4507bd"
      unitRef="usd">2010000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="icb345be38a2145ec8f2df1b4c28dc6d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTo0MGZhNDNmN2E3NWI0YjUwYTQzODA3ZWIxZDRhZTVhZS90YWJsZXJhbmdlOjQwZmE0M2Y3YTc1YjRiNTBhNDM4MDdlYjFkNGFlNWFlXzQtMi0xLTEtNzIxNTE_731bc5af-498d-4766-8a74-825316437153"
      unitRef="usd">3137000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="ib9f7092c7cfe4497bab25e1f403f24c9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTo0MGZhNDNmN2E3NWI0YjUwYTQzODA3ZWIxZDRhZTVhZS90YWJsZXJhbmdlOjQwZmE0M2Y3YTc1YjRiNTBhNDM4MDdlYjFkNGFlNWFlXzYtMS0xLTEtNzIxNTE_a81547c2-cd29-4106-8532-474731130c54"
      unitRef="usd">42000000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i684697892eef43b0a398f7e1d3644140_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTo0MGZhNDNmN2E3NWI0YjUwYTQzODA3ZWIxZDRhZTVhZS90YWJsZXJhbmdlOjQwZmE0M2Y3YTc1YjRiNTBhNDM4MDdlYjFkNGFlNWFlXzYtMi0xLTEtNzIxNTE_6b9d05ad-b46b-4a60-9335-ac044611c373"
      unitRef="usd">48000000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="ib50e1688c3054d648339c3791063d5da_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTo0MGZhNDNmN2E3NWI0YjUwYTQzODA3ZWIxZDRhZTVhZS90YWJsZXJhbmdlOjQwZmE0M2Y3YTc1YjRiNTBhNDM4MDdlYjFkNGFlNWFlXzctMS0xLTEtNzIxNTE_e561d128-2fb3-4b9b-9608-cbf85c305e9e"
      unitRef="usd">1000000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i7b0b881c3cc645c8a20d828cc3a3ab1f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTo0MGZhNDNmN2E3NWI0YjUwYTQzODA3ZWIxZDRhZTVhZS90YWJsZXJhbmdlOjQwZmE0M2Y3YTc1YjRiNTBhNDM4MDdlYjFkNGFlNWFlXzctMi0xLTEtNzIxNTE_dd4809fb-5171-4243-a59f-56e9dde3d3f2"
      unitRef="usd">2000000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="if6cd00f7e2984a7197f65f6758fc8f77_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTo0MGZhNDNmN2E3NWI0YjUwYTQzODA3ZWIxZDRhZTVhZS90YWJsZXJhbmdlOjQwZmE0M2Y3YTc1YjRiNTBhNDM4MDdlYjFkNGFlNWFlXzgtMS0xLTEtNzIxNTE_d3591e7c-b50d-4e7f-a9d8-7bbba109f727"
      unitRef="usd">3000000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i6da21472d42444c2a5f87b4170b8a18a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTo0MGZhNDNmN2E3NWI0YjUwYTQzODA3ZWIxZDRhZTVhZS90YWJsZXJhbmdlOjQwZmE0M2Y3YTc1YjRiNTBhNDM4MDdlYjFkNGFlNWFlXzgtMi0xLTEtNzIxNTE_1bdee13f-67c2-42dc-9246-1548fc18008c"
      unitRef="usd">5000000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i6b2fac2f3fc9459ab4c0932e6ed5c5b6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTo0MGZhNDNmN2E3NWI0YjUwYTQzODA3ZWIxZDRhZTVhZS90YWJsZXJhbmdlOjQwZmE0M2Y3YTc1YjRiNTBhNDM4MDdlYjFkNGFlNWFlXzktMS0xLTEtNzIxNTE_3273dc60-2c5c-4c3d-b1bd-e83929af5014"
      unitRef="usd">36000000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i1bfd9b18ac254aea9b31268dda67d715_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTo0MGZhNDNmN2E3NWI0YjUwYTQzODA3ZWIxZDRhZTVhZS90YWJsZXJhbmdlOjQwZmE0M2Y3YTc1YjRiNTBhNDM4MDdlYjFkNGFlNWFlXzktMi0xLTEtNzIxNTE_d1ba3062-0d8a-4653-9028-d0d8d5e46b51"
      unitRef="usd">19000000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="idba6690bc56542ebab849eb8e0a831d0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTo0MGZhNDNmN2E3NWI0YjUwYTQzODA3ZWIxZDRhZTVhZS90YWJsZXJhbmdlOjQwZmE0M2Y3YTc1YjRiNTBhNDM4MDdlYjFkNGFlNWFlXzEwLTEtMS0xLTcyMTUx_21d0e8d9-aa1a-4c98-8977-3156709fb8db"
      unitRef="usd">2000000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="ic30c4a9be3cb4b41aca184361c77845a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTo0MGZhNDNmN2E3NWI0YjUwYTQzODA3ZWIxZDRhZTVhZS90YWJsZXJhbmdlOjQwZmE0M2Y3YTc1YjRiNTBhNDM4MDdlYjFkNGFlNWFlXzEwLTItMS0xLTcyMTUx_32c24fe9-2780-4197-a631-828eb308f61d"
      unitRef="usd">1000000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="ic08aa5d78620463481ca8783fa037ecb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTo0MGZhNDNmN2E3NWI0YjUwYTQzODA3ZWIxZDRhZTVhZS90YWJsZXJhbmdlOjQwZmE0M2Y3YTc1YjRiNTBhNDM4MDdlYjFkNGFlNWFlXzExLTEtMS0xLTcyMTUx_97fc29a6-ea91-4db8-88b4-8c856b617c9f"
      unitRef="usd">84000000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i2cfe6ff3822e44e4ae63056b2596b8ae_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTo0MGZhNDNmN2E3NWI0YjUwYTQzODA3ZWIxZDRhZTVhZS90YWJsZXJhbmdlOjQwZmE0M2Y3YTc1YjRiNTBhNDM4MDdlYjFkNGFlNWFlXzExLTItMS0xLTcyMTUx_75a8a678-5cc9-438c-b620-d6d61b9f3316"
      unitRef="usd">75000000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:DerivativeAssets
      contextRef="i27d980565f3148fe831139d2e7a16efb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTo0MGZhNDNmN2E3NWI0YjUwYTQzODA3ZWIxZDRhZTVhZS90YWJsZXJhbmdlOjQwZmE0M2Y3YTc1YjRiNTBhNDM4MDdlYjFkNGFlNWFlXzEyLTEtMS0xLTcyMTUx_5e5d0267-7088-4db5-a3e4-88a99311bb0f"
      unitRef="usd">119000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i3861b631300548c2ab44cbbf58d07920_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTo0MGZhNDNmN2E3NWI0YjUwYTQzODA3ZWIxZDRhZTVhZS90YWJsZXJhbmdlOjQwZmE0M2Y3YTc1YjRiNTBhNDM4MDdlYjFkNGFlNWFlXzEyLTItMS0xLTcyMTUx_24b1a8ab-52f1-4804-89bd-e03b9503db9f"
      unitRef="usd">212000000</us-gaap:DerivativeAssets>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i5847988c48e945ff89b5383f616f507c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTo0MGZhNDNmN2E3NWI0YjUwYTQzODA3ZWIxZDRhZTVhZS90YWJsZXJhbmdlOjQwZmE0M2Y3YTc1YjRiNTBhNDM4MDdlYjFkNGFlNWFlXzE0LTEtMS0xLTcyMTUx_db9c7e47-4f5d-49bd-9b24-52ec983f736a"
      unitRef="usd">203000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i5e94767eea5f4452a8497953475e7b32_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTo0MGZhNDNmN2E3NWI0YjUwYTQzODA3ZWIxZDRhZTVhZS90YWJsZXJhbmdlOjQwZmE0M2Y3YTc1YjRiNTBhNDM4MDdlYjFkNGFlNWFlXzE0LTItMS0xLTcyMTUx_b118893c-7328-4f2a-a34c-469cff6d7866"
      unitRef="usd">287000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTo0MGZhNDNmN2E3NWI0YjUwYTQzODA3ZWIxZDRhZTVhZS90YWJsZXJhbmdlOjQwZmE0M2Y3YTc1YjRiNTBhNDM4MDdlYjFkNGFlNWFlXzE1LTEtMS0xLTcyMTUx_401effa8-d5b4-4fef-9413-3e3f3cdb199d"
      unitRef="usd">2213000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTo0MGZhNDNmN2E3NWI0YjUwYTQzODA3ZWIxZDRhZTVhZS90YWJsZXJhbmdlOjQwZmE0M2Y3YTc1YjRiNTBhNDM4MDdlYjFkNGFlNWFlXzE1LTItMS0xLTcyMTUx_a9194564-8deb-4ee1-9cf6-0adb784b27da"
      unitRef="usd">3424000000</us-gaap:AssetsFairValueDisclosure>
    <syk:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities
      contextRef="ia2d532877fe14293a0c7af8376dd383a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTpmYjEzY2UzYjkwOTg0MDY0YTJmZDJhMTc4MmIwZjM5MS90YWJsZXJhbmdlOmZiMTNjZTNiOTA5ODQwNjRhMmZkMmExNzgyYjBmMzkxXzItMS0xLTEtNzIxNTE_2dd2c440-254b-4a3a-87d9-c312b3030d83"
      unitRef="usd">166000000</syk:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities>
    <syk:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities
      contextRef="icb345be38a2145ec8f2df1b4c28dc6d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTpmYjEzY2UzYjkwOTg0MDY0YTJmZDJhMTc4MmIwZjM5MS90YWJsZXJhbmdlOmZiMTNjZTNiOTA5ODQwNjRhMmZkMmExNzgyYjBmMzkxXzItMi0xLTEtNzIxNTE_f3093555-ee9b-4ab8-9b11-a002317329d0"
      unitRef="usd">193000000</syk:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ia2d532877fe14293a0c7af8376dd383a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTpmYjEzY2UzYjkwOTg0MDY0YTJmZDJhMTc4MmIwZjM5MS90YWJsZXJhbmdlOmZiMTNjZTNiOTA5ODQwNjRhMmZkMmExNzgyYjBmMzkxXzMtMS0xLTEtNzIxNTE_dacd82ec-194a-4a7b-a3ef-72325aefadfc"
      unitRef="usd">166000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="icb345be38a2145ec8f2df1b4c28dc6d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTpmYjEzY2UzYjkwOTg0MDY0YTJmZDJhMTc4MmIwZjM5MS90YWJsZXJhbmdlOmZiMTNjZTNiOTA5ODQwNjRhMmZkMmExNzgyYjBmMzkxXzMtMi0xLTEtNzIxNTE_4d7fa849-83e5-4884-a85c-de0b88691481"
      unitRef="usd">193000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i27d980565f3148fe831139d2e7a16efb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTpmYjEzY2UzYjkwOTg0MDY0YTJmZDJhMTc4MmIwZjM5MS90YWJsZXJhbmdlOmZiMTNjZTNiOTA5ODQwNjRhMmZkMmExNzgyYjBmMzkxXzQtMS0xLTEtNzIxNTE_e5e1de1d-0858-4401-a4ea-ff50bd52f34e"
      unitRef="usd">102000000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i3861b631300548c2ab44cbbf58d07920_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTpmYjEzY2UzYjkwOTg0MDY0YTJmZDJhMTc4MmIwZjM5MS90YWJsZXJhbmdlOmZiMTNjZTNiOTA5ODQwNjRhMmZkMmExNzgyYjBmMzkxXzQtMi0xLTEtNzIxNTE_b6fdbd19-dbe5-47fe-8aeb-1707cb1338fd"
      unitRef="usd">17000000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i5847988c48e945ff89b5383f616f507c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTpmYjEzY2UzYjkwOTg0MDY0YTJmZDJhMTc4MmIwZjM5MS90YWJsZXJhbmdlOmZiMTNjZTNiOTA5ODQwNjRhMmZkMmExNzgyYjBmMzkxXzYtMS0xLTEtNzIxNTE_26e4a714-43fa-4e64-8196-777b2c576472"
      unitRef="usd">102000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i5e94767eea5f4452a8497953475e7b32_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTpmYjEzY2UzYjkwOTg0MDY0YTJmZDJhMTc4MmIwZjM5MS90YWJsZXJhbmdlOmZiMTNjZTNiOTA5ODQwNjRhMmZkMmExNzgyYjBmMzkxXzYtMi0xLTEtNzIxNTE_a975a368-730b-476a-b8ee-c12c37ca313f"
      unitRef="usd">17000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i33ec7e34209e4d64ba95fe5eb1edee60_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTpmYjEzY2UzYjkwOTg0MDY0YTJmZDJhMTc4MmIwZjM5MS90YWJsZXJhbmdlOmZiMTNjZTNiOTA5ODQwNjRhMmZkMmExNzgyYjBmMzkxXzgtMS0xLTEtNzIxNTE_ad714375-f59a-494c-a0e2-5861b391b903"
      unitRef="usd">306000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i1061b720f0314243956e705d577b0331_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTpmYjEzY2UzYjkwOTg0MDY0YTJmZDJhMTc4MmIwZjM5MS90YWJsZXJhbmdlOmZiMTNjZTNiOTA5ODQwNjRhMmZkMmExNzgyYjBmMzkxXzgtMi0xLTEtNzIxNTE_9ff6575d-8309-449a-ba65-bf81cd4efb55"
      unitRef="usd">393000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="i555016f434ae4cd48b50f24fbe1586b3_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTpmYjEzY2UzYjkwOTg0MDY0YTJmZDJhMTc4MmIwZjM5MS90YWJsZXJhbmdlOmZiMTNjZTNiOTA5ODQwNjRhMmZkMmExNzgyYjBmMzkxXzktMS0xLTEtNzIxNTE_bdfb4caf-cc6a-4616-ae0c-20685ab42654"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="i0f534a107f4d40bb987de62c5eca2398_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTpmYjEzY2UzYjkwOTg0MDY0YTJmZDJhMTc4MmIwZjM5MS90YWJsZXJhbmdlOmZiMTNjZTNiOTA5ODQwNjRhMmZkMmExNzgyYjBmMzkxXzktMi0xLTEtNzIxNTE_aceb7e44-7023-4d2c-b75f-c16c11daf5a9"
      unitRef="usd">62000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
      contextRef="i555016f434ae4cd48b50f24fbe1586b3_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTpmYjEzY2UzYjkwOTg0MDY0YTJmZDJhMTc4MmIwZjM5MS90YWJsZXJhbmdlOmZiMTNjZTNiOTA5ODQwNjRhMmZkMmExNzgyYjBmMzkxXzEwLTEtMS0xLTcyMTUx_165a9379-1e91-4636-bafe-0738f70b808e"
      unitRef="usd">137000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
      contextRef="i0f534a107f4d40bb987de62c5eca2398_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTpmYjEzY2UzYjkwOTg0MDY0YTJmZDJhMTc4MmIwZjM5MS90YWJsZXJhbmdlOmZiMTNjZTNiOTA5ODQwNjRhMmZkMmExNzgyYjBmMzkxXzEwLTItMS0xLTcyMTUx_ec03c2f1-b4e4-4031-baba-aae94e4821cc"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="i555016f434ae4cd48b50f24fbe1586b3_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTpmYjEzY2UzYjkwOTg0MDY0YTJmZDJhMTc4MmIwZjM5MS90YWJsZXJhbmdlOmZiMTNjZTNiOTA5ODQwNjRhMmZkMmExNzgyYjBmMzkxXzExLTEtMS0xLTcyMTUx_48404d31-e71b-4f73-b930-150d55f91ba3"
      unitRef="usd">49000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="i0f534a107f4d40bb987de62c5eca2398_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTpmYjEzY2UzYjkwOTg0MDY0YTJmZDJhMTc4MmIwZjM5MS90YWJsZXJhbmdlOmZiMTNjZTNiOTA5ODQwNjRhMmZkMmExNzgyYjBmMzkxXzExLTItMS0xLTcyMTUx_95813df9-82da-4784-aa93-59fe47cd8d09"
      unitRef="usd">148000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i6d64b78c8a794c42aa5ea20736299864_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTpmYjEzY2UzYjkwOTg0MDY0YTJmZDJhMTc4MmIwZjM5MS90YWJsZXJhbmdlOmZiMTNjZTNiOTA5ODQwNjRhMmZkMmExNzgyYjBmMzkxXzEyLTEtMS0xLTcyMTUx_537ffb17-4111-4fd3-9e2b-50dfda3b4360"
      unitRef="usd">121000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i33ec7e34209e4d64ba95fe5eb1edee60_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTpmYjEzY2UzYjkwOTg0MDY0YTJmZDJhMTc4MmIwZjM5MS90YWJsZXJhbmdlOmZiMTNjZTNiOTA5ODQwNjRhMmZkMmExNzgyYjBmMzkxXzEyLTItMS0xLTcyMTUx_91211ade-120d-4a48-adb8-9abf542b17f7"
      unitRef="usd">306000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i6d64b78c8a794c42aa5ea20736299864_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTpmYjEzY2UzYjkwOTg0MDY0YTJmZDJhMTc4MmIwZjM5MS90YWJsZXJhbmdlOmZiMTNjZTNiOTA5ODQwNjRhMmZkMmExNzgyYjBmMzkxXzEzLTEtMS0xLTcyMTUx_4f097198-95a1-4289-a43c-caa6073809bf"
      unitRef="usd">121000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i33ec7e34209e4d64ba95fe5eb1edee60_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTpmYjEzY2UzYjkwOTg0MDY0YTJmZDJhMTc4MmIwZjM5MS90YWJsZXJhbmdlOmZiMTNjZTNiOTA5ODQwNjRhMmZkMmExNzgyYjBmMzkxXzEzLTItMS0xLTcyMTUx_a9ec5099-09d5-4830-9d58-6ae38b0857ca"
      unitRef="usd">306000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTpmYjEzY2UzYjkwOTg0MDY0YTJmZDJhMTc4MmIwZjM5MS90YWJsZXJhbmdlOmZiMTNjZTNiOTA5ODQwNjRhMmZkMmExNzgyYjBmMzkxXzE0LTEtMS0xLTcyMTUx_898ea437-927f-4ea2-bc73-5d48438dc465"
      unitRef="usd">389000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTpmYjEzY2UzYjkwOTg0MDY0YTJmZDJhMTc4MmIwZjM5MS90YWJsZXJhbmdlOmZiMTNjZTNiOTA5ODQwNjRhMmZkMmExNzgyYjBmMzkxXzE0LTItMS0xLTcyMTUx_ca123cf3-5458-4067-a369-3a07fb23016e"
      unitRef="usd">516000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90ZXh0cmVnaW9uOjE1MmJmZDZhNWExZTQ1ZDg5NzQxZWY4MWNkYWQzYWZmXzI2ODA_345942d6-00d0-4482-8889-80e6c61346f9">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.417%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.141%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.142%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Fair Value of Available for Sale Securities by Maturity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Due in one year or less&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Due after one year through three years&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTpkMzEzYjQyZGNjMGY0NDMyOGZiMjJlNjhmMjE4MWRkMy90YWJsZXJhbmdlOmQzMTNiNDJkY2MwZjQ0MzI4ZmIyMmU2OGYyMTgxZGQzXzItMS0xLTEtNzIxNTE_44bdef4c-c114-4bc2-a89e-0b2eb0efba4b"
      unitRef="usd">53000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTpkMzEzYjQyZGNjMGY0NDMyOGZiMjJlNjhmMjE4MWRkMy90YWJsZXJhbmdlOmQzMTNiNDJkY2MwZjQ0MzI4ZmIyMmU2OGYyMTgxZGQzXzItMi0xLTEtNzIxNTE_0326a2c4-f1dd-40c7-850a-4c411ecc2ca4"
      unitRef="usd">36000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <syk:AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTpkMzEzYjQyZGNjMGY0NDMyOGZiMjJlNjhmMjE4MWRkMy90YWJsZXJhbmdlOmQzMTNiNDJkY2MwZjQ0MzI4ZmIyMmU2OGYyMTgxZGQzXzMtMS0xLTEtNzIxNTE_cf6dad9e-4ba2-4e0b-b4a4-2d47aacb20cc"
      unitRef="usd">31000000</syk:AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue>
    <syk:AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90YWJsZTpkMzEzYjQyZGNjMGY0NDMyOGZiMjJlNjhmMjE4MWRkMy90YWJsZXJhbmdlOmQzMTNiNDJkY2MwZjQ0MzI4ZmIyMmU2OGYyMTgxZGQzXzMtMi0xLTEtNzIxNTE_3c9c2c2f-27ee-4544-9365-d51c34e7fc86"
      unitRef="usd">39000000</syk:AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue>
    <us-gaap:MarketableSecuritiesGainLoss
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90ZXh0cmVnaW9uOjE1MmJmZDZhNWExZTQ1ZDg5NzQxZWY4MWNkYWQzYWZmXzM4NDgyOTA3MDA0MDI_29e9025d-d6f2-49cb-980e-4d0da3a0c053"
      unitRef="usd">94000000</us-gaap:MarketableSecuritiesGainLoss>
    <us-gaap:MarketableSecuritiesGainLoss
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90ZXh0cmVnaW9uOjE1MmJmZDZhNWExZTQ1ZDg5NzQxZWY4MWNkYWQzYWZmXzM4NDgyOTA3MDA0MTE_144bf492-beb0-49dc-a397-6bf894a4c6ec"
      unitRef="usd">68000000</us-gaap:MarketableSecuritiesGainLoss>
    <us-gaap:MarketableSecuritiesGainLoss
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDYvZnJhZzoxNTJiZmQ2YTVhMWU0NWQ4OTc0MWVmODFjZGFkM2FmZi90ZXh0cmVnaW9uOjE1MmJmZDZhNWExZTQ1ZDg5NzQxZWY4MWNkYWQzYWZmXzM4NDgyOTA3MDA0MjA_ea24ca27-732f-485d-88c2-1f0b97feee64"
      unitRef="usd">102000000</us-gaap:MarketableSecuritiesGainLoss>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90ZXh0cmVnaW9uOjRkYjAxMWE4ZTNkNzQ4ZWFhNTQwMTYzM2ExOGUxNDdhXzI4MTU_962ea0ca-4606-4c28-a503-ac0b0189e5d3">DERIVATIVE INSTRUMENTS&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We use operational and economic hedges, foreign currency exchange forward contracts, net investment hedges (both derivative and non-derivative financial instruments) and interest rate derivative instruments to manage the impact of currency exchange and interest rate fluctuations on earnings, cash flow and equity. We do not enter into derivative instruments for speculative purposes. We are exposed to potential credit loss in the event of nonperformance by counterparties on our outstanding derivative instruments but do not anticipate nonperformance by any of our counterparties. Should a counterparty default, our maximum loss exposure is the asset balance of the instrument. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Foreign Currency Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.661%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net Investment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Non-Designated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Gross notional amount&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,053&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,598&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,417&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,068&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Maximum term in years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair value:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other noncurrent assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(79)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(85)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other noncurrent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;14&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;73&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;17&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Gross notional amount&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;973&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,266&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,512&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,751&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Maximum term in years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair value:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other noncurrent assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;104&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;82&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;195&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:1pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We had &#x20ac;1.5&#160;billion and &#x20ac;2.0&#160;billion at December 31, 2022 and 2021 in certain forward currency contracts designated as net investment hedges to hedge a portion of our investments in certain of our entities with functional currencies denominated in Euros. In addition to these derivative financial instruments designated as net investment hedges, we had &#x20ac;4.4&#160;billion at December 31, 2022 and 2021 of senior unsecured notes designated as net investment hedges to selectively hedge portions of our investment in certain international subsidiaries. The currency effects of our Euro-denominated senior unsecured notes are reflected in AOCI within shareholders' equity where they offset gains and losses recorded on our net investment in international subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:1pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In 2022 we settled certain foreign currency forward contracts designated as net investment hedges resulting in cash proceeds of $197. The amounts in AOCI related to settled net investment &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:1pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;hedges will remain in AOCI until the hedged investment is either sold or substantially liquidated.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:1pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The total after-tax gain (loss) recognized in OCI related to designated net investment hedges was $321 in 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.804%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.277%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Net Currency Exchange Rate Gains (Losses)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Derivative Instrument&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Recorded in:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net Investment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Non-Designated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;63&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;13&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;20&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:1pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Pretax gains (losses) on derivatives designated as cash flow hedges of $32 and net investment hedges of $34 recorded in AOCI are expected to be reclassified to cost of sales and other income (expense), net in earnings within 12 months as of December&#160;31, 2022. This cash flow hedge reclassification is primarily due to the sale of inventory that includes previously hedged purchases. A component of the AOCI amounts related to net investment hedges is reclassified over the life of the hedge instruments as we elected to exclude the initial value of the component related to the spot-forward difference from the effectiveness assessment. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Interest Rate Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Pretax gains of $5 recorded in AOCI related to other interest rate hedges closed in conjunction with debt issuances are expected to be reclassified to other income (expense), net in earnings within 12 months of December&#160;31, 2022. The cash flow effect of interest rate hedges is recorded in cash flow from operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90ZXh0cmVnaW9uOjRkYjAxMWE4ZTNkNzQ4ZWFhNTQwMTYzM2ExOGUxNDdhXzI4Mjc_79a2a07d-0063-4a32-88ee-96950798e98d">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.661%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net Investment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Non-Designated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Gross notional amount&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,053&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,598&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,417&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,068&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Maximum term in years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair value:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other noncurrent assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(79)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(85)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other noncurrent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;14&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;73&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;17&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Gross notional amount&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;973&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,266&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,512&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,751&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Maximum term in years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair value:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other noncurrent assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;104&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;82&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;195&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="iaec94f18ada042fabb7f1ebdc25a07d4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzEtMS0xLTEtNzIxNTE_df398ff5-fe06-4179-8e1b-e81b2010cb5f"
      unitRef="usd">1053000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i8d27f73c86aa47cba1db7a41f08807cd_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzEtMi0xLTEtNzIxNTE_fb1f1a7f-7e2a-4203-a46a-61f3bd1327a3"
      unitRef="usd">1598000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ibf36006040a941c9932b2b52a950a31a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzEtMy0xLTEtNzIxNTE_2e97c798-bdcb-43ee-b4a8-e717109d28d5"
      unitRef="usd">3417000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i5f5265baf4a34824aa6bfc4b935f0cc6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzEtNC0xLTEtNzIxNTE_2bdf6a1a-880f-434e-a341-86e282549426"
      unitRef="usd">6068000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:MaximumRemainingMaturityOfForeignCurrencyDerivatives1
      contextRef="i18c253d682754db68c1f963844f236c0_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzItNC0xLTEtNzIxNTE_cdef0303-e5f5-43c5-b7de-c38223583600">P3Y10M24D</us-gaap:MaximumRemainingMaturityOfForeignCurrencyDerivatives1>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i502841656af74f0abcbfa0b5b4d5edde_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzQtMS0xLTEtNzIxNTE_71ef0416-059e-4331-988f-bbffe59aaf5d"
      unitRef="usd">20000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i8f7602ed300f40099fb5e3d0ccea433c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzQtMi0xLTEtNzIxNTE_20932be0-1221-4f8d-b143-7aa374f0a956"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="if623c08c13104816b3eec3b501299d90_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzQtMy0xLTEtNzIxNTE_abe94c71-546b-4f0f-994e-d555e7525a96"
      unitRef="usd">9000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="icc0b84fb75164adf807974c23c81f865_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzQtNC0xLTEtNzIxNTE_2b188503-cb26-4cc8-99a4-446c2f6f9832"
      unitRef="usd">29000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i1f5c13561a6441838aa726a95c450a0a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzUtMS0xLTEtNzIxNTE_17300859-9a59-4602-abd2-d67d0d45ce03"
      unitRef="usd">1000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ibd8e471ce1d84cd0b7332d1e15689be0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzUtMi0xLTEtNzIxNTE_1287fed3-6c82-4a62-b13a-c7e6df939128"
      unitRef="usd">89000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ic862e33128874fba9c59da29a661709c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzUtMy0xLTEtNzIxNTE_c5219b4d-8765-4370-a8b8-359659fac7b2"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i4ed382ff805947e282a6b64d016d24f4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzUtNC0xLTEtNzIxNTE_f50e1fbf-a12c-4541-89e3-92344523033d"
      unitRef="usd">90000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i871ebfa1e7e24e09bd4a205545a24e83_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzYtMS0xLTEtNzIxNTE_b8ff077a-8cda-43ae-9b6b-1d40603ad51a"
      unitRef="usd">6000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="id3f7b3b320914b9dae575c52b5fe8b56_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzYtMi0xLTEtNzIxNTE_05dc1e43-46a4-4859-912e-d7171ecf1d4d"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i50af63eb8b4d4347af19a411f82385bc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzYtMy0xLTEtNzIxNTE_5a8654f8-655f-42c3-bb7a-4bf2a149cf5a"
      unitRef="usd">79000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i30db394dfc2a41a8b8826988775431cb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzYtNC0xLTEtNzIxNTE_79e59cec-706c-4f00-81a5-0d1f05f34022"
      unitRef="usd">85000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ibad6a6771ef34df3ae26b4bf524b94cf_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzctMS0xLTEtNzIxNTE_31f524cb-352a-4ceb-b59b-7596bb360458"
      unitRef="usd">1000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ie01905fa5e254373b0ff7bd6859daf50_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzctMi0xLTEtNzIxNTE_ab406a5b-2b17-4254-a5a3-c2c6fe06d508"
      unitRef="usd">16000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i7984d6aa73d346b396014350b01a0a8b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzctMy0xLTEtNzIxNTE_51e3cff5-d6e5-454f-9ff7-3257674edfe0"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i442c41e773ba4c8393f770f45cac23e6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzctNC0xLTEtNzIxNTE_bba3c279-b4b9-40ce-abb4-883407e03d8f"
      unitRef="usd">17000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="iaec94f18ada042fabb7f1ebdc25a07d4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzgtMS0xLTEtNzIxNTE_1c0e9c00-9e52-459f-b888-cccb7ad4098d"
      unitRef="usd">14000000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i8d27f73c86aa47cba1db7a41f08807cd_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzgtMi0xLTEtNzIxNTE_7ac1397b-6d05-4174-8744-43e7b568a770"
      unitRef="usd">73000000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="ibf36006040a941c9932b2b52a950a31a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzgtMy0xLTEtNzIxNTE_8802f9e3-dc39-43f5-8580-49d6335a5136"
      unitRef="usd">-70000000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i5f5265baf4a34824aa6bfc4b935f0cc6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzgtNC0xLTEtNzIxNTE_0db6fb59-2401-4252-abaa-5a934a6fe4d6"
      unitRef="usd">17000000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i21b19e56e61b4c329c04eac6cfc4cd58_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzEwLTEtMS0xLTcyMTUx_bf5d8a59-e4fb-4b4e-bb66-c443c48994d4"
      unitRef="usd">973000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="id60b785d2b584ee1be26545ea0a1b66f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzEwLTItMS0xLTcyMTUx_fdb0ac26-8ea9-4e24-a0c5-237f44acbbcc"
      unitRef="usd">2266000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="if244473f9960480abc9486fac01737d2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzEwLTMtMS0xLTcyMTUx_f8fd6d0c-64e7-406a-8de6-30732e2051fb"
      unitRef="usd">5512000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i7e1acc8de3644b2583b558aed3472970_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzEwLTQtMS0xLTcyMTUx_aa2d3817-08bf-45b7-8ab7-79df0c77de9e"
      unitRef="usd">8751000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:MaximumRemainingMaturityOfForeignCurrencyDerivatives1
      contextRef="i526560b9237b4753b4d62b8c0ac70ad0_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzExLTQtMS0xLTcyMTUx_81ab0792-2992-46a0-95f9-b3974d0cd8db">P4Y10M24D</us-gaap:MaximumRemainingMaturityOfForeignCurrencyDerivatives1>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="iebcaf79884c44374aed5e2028c2ef520_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzEzLTEtMS0xLTcyMTUx_ee63a813-6ae9-4f72-9e41-689847530b28"
      unitRef="usd">15000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i36b9ed429956467a99e25dcfa90149c9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzEzLTItMS0xLTcyMTUx_6a174f4a-fe36-4379-b0f2-43b97966de15"
      unitRef="usd">39000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i2c812d2135a0456199da61bf38ed7721_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzEzLTMtMS0xLTcyMTUx_828ee807-84f1-4ec8-a018-1fad0cf2abd4"
      unitRef="usd">92000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="id55223eafacf499d89f879372cbf9597_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzEzLTQtMS0xLTcyMTUx_ba98b1b4-c1ac-4537-8b4e-01d1814e05f6"
      unitRef="usd">146000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i0b3bc6f133044291a549410c3cf66f4d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzE0LTEtMS0xLTcyMTUx_4380d9e8-f4c0-499f-8310-35764499dfb8"
      unitRef="usd">1000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i5b39e27e21304ce894cab7826e32ac09_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzE0LTItMS0xLTcyMTUx_524ac928-1a99-4437-95c4-2d86b6594ac9"
      unitRef="usd">65000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="iebe1f9b479ea44f69f1c26a1d8bc2fd8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzE0LTMtMS0xLTcyMTUx_492c07ae-e60b-40f0-993d-5d175c757b23"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i785da713e5504f1cac04a1e0354dfa48_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzE0LTQtMS0xLTcyMTUx_414a2515-bdb4-4991-ae9d-414718c63321"
      unitRef="usd">66000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ie029123d930d43c8a47136e8b7c03300_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzE1LTEtMS0xLTcyMTUx_158a3998-1eed-487e-a370-1dca58f5b2c7"
      unitRef="usd">7000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i4ed5e0163a634738abd15b3643a5c3f5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzE1LTItMS0xLTcyMTUx_257e3d70-db01-413e-826c-227c248e2369"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i0b2e6b2fb13e405d95f685da59183e93_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzE1LTMtMS0xLTcyMTUx_5bda8100-ed34-4e2b-923e-3f1cc4c58e8e"
      unitRef="usd">10000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="idf0622bdb40c4cbd87d21f3c67334c2a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzE1LTQtMS0xLTcyMTUx_c56cdab5-7d06-4edd-b9f1-5ff3fdaf50b7"
      unitRef="usd">17000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i21b19e56e61b4c329c04eac6cfc4cd58_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzE3LTEtMS0xLTcyMTUx_920ffb70-f609-45c7-aff3-d852597024ce"
      unitRef="usd">9000000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="id60b785d2b584ee1be26545ea0a1b66f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzE3LTItMS0xLTcyMTUx_ba8ae946-1898-4661-97a9-a5f06b4a8833"
      unitRef="usd">104000000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="if244473f9960480abc9486fac01737d2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzE3LTMtMS0xLTcyMTUx_cade87a2-dcfd-4991-bbb1-71bdf7f02738"
      unitRef="usd">82000000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i7e1acc8de3644b2583b558aed3472970_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpkYTk2NWE3ZDE0NTM0MWQ1ODYxYzM0YTVjNzMzYmI5ZS90YWJsZXJhbmdlOmRhOTY1YTdkMTQ1MzQxZDU4NjFjMzRhNWM3MzNiYjllXzE3LTQtMS0xLTcyMTUx_c81edf03-739c-4b8b-a694-c00d4368f13a"
      unitRef="usd">195000000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i8d27f73c86aa47cba1db7a41f08807cd_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90ZXh0cmVnaW9uOjRkYjAxMWE4ZTNkNzQ4ZWFhNTQwMTYzM2ExOGUxNDdhXzc1MQ_98aa627f-d57c-4379-8c54-22dd7da16b69"
      unitRef="eur">1500000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="id60b785d2b584ee1be26545ea0a1b66f_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90ZXh0cmVnaW9uOjRkYjAxMWE4ZTNkNzQ4ZWFhNTQwMTYzM2ExOGUxNDdhXzc1OA_cd2b16f6-72bd-4bb3-b098-0abba35e220c"
      unitRef="eur">2000000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i7e8c5b89171143fbbff1d92557f393af_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90ZXh0cmVnaW9uOjRkYjAxMWE4ZTNkNzQ4ZWFhNTQwMTYzM2ExOGUxNDdhXzEwNzM_9a5134e8-fd0e-406a-bd10-b6b1ad1ea99c"
      unitRef="eur">4400000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="if5dc0a291f3a4f67bfac579e681b910f_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90ZXh0cmVnaW9uOjRkYjAxMWE4ZTNkNzQ4ZWFhNTQwMTYzM2ExOGUxNDdhXzEwNzM_e5641b95-a186-4c04-919d-27825ba28555"
      unitRef="eur">4400000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:ProceedsFromHedgeInvestingActivities
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90ZXh0cmVnaW9uOjRkYjAxMWE4ZTNkNzQ4ZWFhNTQwMTYzM2ExOGUxNDdhXzQzOTgwNDY1MTQwODA_85981c9c-79af-4b65-b561-2e86b1cae470"
      unitRef="usd">197000000</us-gaap:ProceedsFromHedgeInvestingActivities>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax
      contextRef="icd05c426dad44fd5b836e9f3d2fa90e5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90ZXh0cmVnaW9uOjRkYjAxMWE4ZTNkNzQ4ZWFhNTQwMTYzM2ExOGUxNDdhXzE1NjA_9b76fec0-f59f-4745-85c1-d37ae24c74d7"
      unitRef="usd">321000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax>
    <us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90ZXh0cmVnaW9uOjRkYjAxMWE4ZTNkNzQ4ZWFhNTQwMTYzM2ExOGUxNDdhXzI4MjQ_0a3d550a-9daa-4461-9be6-64178e32927c">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.804%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.277%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Net Currency Exchange Rate Gains (Losses)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Derivative Instrument&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Recorded in:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net Investment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Non-Designated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;63&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;13&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;20&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i3dca98f754544fae91bc2be4aa0d5f9c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpiNWQ5MDk5ODQ5OGY0N2YxYWMwZGMyODg3N2EwNDJhMS90YWJsZXJhbmdlOmI1ZDkwOTk4NDk4ZjQ3ZjFhYzBkYzI4ODc3YTA0MmExXzItMi0xLTEtNzIxNTE_cd8b0fa7-5f5d-462e-8451-a8571a4a97a4"
      unitRef="usd">23000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i5fa607b61e244bc0b9d78c50a056da63_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpiNWQ5MDk5ODQ5OGY0N2YxYWMwZGMyODg3N2EwNDJhMS90YWJsZXJhbmdlOmI1ZDkwOTk4NDk4ZjQ3ZjFhYzBkYzI4ODc3YTA0MmExXzItMy0xLTEtNzIxNTE_d425365d-005c-49c9-9bba-21e4f92b98ab"
      unitRef="usd">-12000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i858bf63c159847d6b3ed57f57eb1ff65_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpiNWQ5MDk5ODQ5OGY0N2YxYWMwZGMyODg3N2EwNDJhMS90YWJsZXJhbmdlOmI1ZDkwOTk4NDk4ZjQ3ZjFhYzBkYzI4ODc3YTA0MmExXzItNC0xLTEtNzIxNTE_21cbe8b3-87b6-4abf-bf81-f1122249b820"
      unitRef="usd">5000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i900a7f9055784544a570f4f177f0f2f7_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpiNWQ5MDk5ODQ5OGY0N2YxYWMwZGMyODg3N2EwNDJhMS90YWJsZXJhbmdlOmI1ZDkwOTk4NDk4ZjQ3ZjFhYzBkYzI4ODc3YTA0MmExXzMtMi0xLTEtNzIxNTE_931841a3-2eef-426a-9326-ad1daa5f9807"
      unitRef="usd">39000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i35651c99f68b487cb5cb0aaf787aa0ed_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpiNWQ5MDk5ODQ5OGY0N2YxYWMwZGMyODg3N2EwNDJhMS90YWJsZXJhbmdlOmI1ZDkwOTk4NDk4ZjQ3ZjFhYzBkYzI4ODc3YTA0MmExXzMtMy0xLTEtNzIxNTE_c6953ba9-2cc2-4daf-a83b-2fb904f40865"
      unitRef="usd">35000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="ie8ba1cabf909458ba3e5abe497e0b36d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpiNWQ5MDk5ODQ5OGY0N2YxYWMwZGMyODg3N2EwNDJhMS90YWJsZXJhbmdlOmI1ZDkwOTk4NDk4ZjQ3ZjFhYzBkYzI4ODc3YTA0MmExXzMtNC0xLTEtNzIxNTE_f4234636-935d-4a3b-b6cc-78691a275bfd"
      unitRef="usd">28000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i2cccc96d34764cf58cc915568b1e6270_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpiNWQ5MDk5ODQ5OGY0N2YxYWMwZGMyODg3N2EwNDJhMS90YWJsZXJhbmdlOmI1ZDkwOTk4NDk4ZjQ3ZjFhYzBkYzI4ODc3YTA0MmExXzQtMi0xLTEtNzIxNTE_c0b8e7f4-45cc-48db-b040-269ffddd5e0a"
      unitRef="usd">1000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="iae3102b5052e4f9792a88230869505ae_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpiNWQ5MDk5ODQ5OGY0N2YxYWMwZGMyODg3N2EwNDJhMS90YWJsZXJhbmdlOmI1ZDkwOTk4NDk4ZjQ3ZjFhYzBkYzI4ODc3YTA0MmExXzQtMy0xLTEtNzIxNTE_a87394f9-2f52-4b29-b4c6-98b369a1b7c9"
      unitRef="usd">-10000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="id329aed50c074920944be6fd7b940cf8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpiNWQ5MDk5ODQ5OGY0N2YxYWMwZGMyODg3N2EwNDJhMS90YWJsZXJhbmdlOmI1ZDkwOTk4NDk4ZjQ3ZjFhYzBkYzI4ODc3YTA0MmExXzQtNC0xLTEtNzIxNTE_e3e0dabf-05b5-4781-91c4-0d7b2ba8bd6f"
      unitRef="usd">-13000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i18c253d682754db68c1f963844f236c0_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpiNWQ5MDk5ODQ5OGY0N2YxYWMwZGMyODg3N2EwNDJhMS90YWJsZXJhbmdlOmI1ZDkwOTk4NDk4ZjQ3ZjFhYzBkYzI4ODc3YTA0MmExXzUtMi0xLTEtNzIxNTE_8aec15a8-4371-473e-ab8e-3dfb1d23d2c4"
      unitRef="usd">63000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i526560b9237b4753b4d62b8c0ac70ad0_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpiNWQ5MDk5ODQ5OGY0N2YxYWMwZGMyODg3N2EwNDJhMS90YWJsZXJhbmdlOmI1ZDkwOTk4NDk4ZjQ3ZjFhYzBkYzI4ODc3YTA0MmExXzUtMy0xLTEtNzIxNTE_1420ac94-2fd8-4993-bfc8-2151dfde4951"
      unitRef="usd">13000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="ic804fede9d9b48fca7326ace0f6cda8a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90YWJsZTpiNWQ5MDk5ODQ5OGY0N2YxYWMwZGMyODg3N2EwNDJhMS90YWJsZXJhbmdlOmI1ZDkwOTk4NDk4ZjQ3ZjFhYzBkYzI4ODc3YTA0MmExXzUtNC0xLTEtNzIxNTE_1e082db8-03aa-487d-b375-0765c649f601"
      unitRef="usd">20000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
      contextRef="icd05c426dad44fd5b836e9f3d2fa90e5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90ZXh0cmVnaW9uOjRkYjAxMWE4ZTNkNzQ4ZWFhNTQwMTYzM2ExOGUxNDdhXzE2Mzc_bc01207c-36db-4f3e-8ebb-f720a029266f"
      unitRef="usd">32000000</us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths>
    <us-gaap:DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax
      contextRef="icd05c426dad44fd5b836e9f3d2fa90e5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90ZXh0cmVnaW9uOjRkYjAxMWE4ZTNkNzQ4ZWFhNTQwMTYzM2ExOGUxNDdhXzE2Njk_a4cb33de-1b8d-4189-a11d-69a0d6660dff"
      unitRef="usd">34000000</us-gaap:DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax>
    <us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
      contextRef="ic3133dd3e2174a0fab3f99c31f3a1c0c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMDkvZnJhZzo0ZGIwMTFhOGUzZDc0OGVhYTU0MDE2MzNhMThlMTQ3YS90ZXh0cmVnaW9uOjRkYjAxMWE4ZTNkNzQ4ZWFhNTQwMTYzM2ExOGUxNDdhXzI1MzE_ff672fd4-a2f1-41ab-a164-5af4f627e349"
      unitRef="usd">5000000</us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90ZXh0cmVnaW9uOjgyMTdkZGIxNGNkMjQxODE4YjM3NGMyNjZlYTcxOTZmXzgx_1bf6bc85-9bf8-47d7-a60d-72c3568f02a8">ACCUMULATED OTHER COMPREHENSIVE (LOSS) INCOME (AOCI)&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.868%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.868%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.902%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Marketable Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Pension Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Financial Statement Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(259)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(885)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(1,157)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;OCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(101)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Reclassifications to:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net OCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(155)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;40&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(416)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(531)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;OCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(64)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(110)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(173)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Reclassifications to:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net OCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;31&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;52&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(303)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(221)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90ZXh0cmVnaW9uOjgyMTdkZGIxNGNkMjQxODE4YjM3NGMyNjZlYTcxOTZmXzgw_2e6534f9-1e34-4c05-8a48-cac2149ff996">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.868%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.868%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.902%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Marketable Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Pension Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Financial Statement Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(259)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(885)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(1,157)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;OCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(101)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Reclassifications to:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net OCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(155)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;40&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(416)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(531)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;OCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(64)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(110)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(173)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Reclassifications to:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net OCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;31&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;52&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(303)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(221)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i073bfd5a955943a1910ed816f9ae5c27_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzEtMS0xLTEtNzIxNTE_0e5f1325-a96f-4e32-9101-5182f25f053e"
      unitRef="usd">-3000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i618987c1cdac4e83bae6d50a1ddc1358_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzEtMi0xLTEtNzIxNTE_983410ad-c8fb-4cfb-b451-57db30907764"
      unitRef="usd">-259000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i30d00fa7ea3a436494f1bd7ba5373101_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzEtMy0xLTEtNzIxNTE_e965a266-1456-4e02-8020-d81a8c56d425"
      unitRef="usd">-10000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ib2acfbbc785a4dcba1e0d80a471cf36e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzEtNC0xLTEtNzIxNTE_9b366b0d-7b36-4297-8d1d-913905bfd284"
      unitRef="usd">-885000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i98963cf23d234ec1ac275e66bcfd76dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzEtNS0xLTEtNzIxNTE_548d54b8-9a72-46fb-93e4-02da60c6739f"
      unitRef="usd">-1157000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i99212e6414ed4182be360bb4600e1593_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzItMS0xLTEtNzIxNTE_511a7a2a-9d35-425f-9d3c-213c6b25c153"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i989cd3b1dfc14409946f1bd46844917f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzItMi0xLTEtNzIxNTE_e3067750-b7b4-4dcb-92ea-6d7bfe1f6502"
      unitRef="usd">123000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i2e70ca42855942a5a650f69045393b9b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzItMy0xLTEtNzIxNTE_240bdb75-4cc5-4a20-a3e2-39ea1fbf33c9"
      unitRef="usd">46000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i976b214a31df4949b83c93e6da795727_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzItNC0xLTEtNzIxNTE_eace840a-99ec-47e1-82e4-b0ea578a335c"
      unitRef="usd">551000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzItNS0xLTEtNzIxNTE_ea00a1f3-b07e-4b46-b90b-2652a54dbf1b"
      unitRef="usd">724000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i99212e6414ed4182be360bb4600e1593_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzMtMS0xLTEtNzIxNTE_483a5434-0ab8-478a-8322-f807c6ad7561"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i989cd3b1dfc14409946f1bd46844917f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzMtMi0xLTEtNzIxNTE_b123be6a-7a26-40eb-aeea-7c65f0aefcc6"
      unitRef="usd">-32000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i2e70ca42855942a5a650f69045393b9b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzMtMy0xLTEtNzIxNTE_68a923ab-717e-4443-aa82-16d95b8f328f"
      unitRef="usd">-15000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i976b214a31df4949b83c93e6da795727_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzMtNC0xLTEtNzIxNTE_af5a3ef1-98c0-4caa-8cb4-8dd5840619b2"
      unitRef="usd">-54000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzMtNS0xLTEtNzIxNTE_faff60eb-b32b-4845-b023-61623a7a1011"
      unitRef="usd">-101000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:CostOfRevenue
      contextRef="i64382fff96cc4d37a1272abc8d08a5b1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzUtMS0xLTEtNzIxNTE_5e3574cb-e5f5-4a4c-b175-444c913eb0ec"
      unitRef="usd">0</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="idf0ef3bec3594225be5f4136d591a70a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzUtMi0xLTEtNzIxNTE_616efb54-8786-4df1-afc7-7a816ad71402"
      unitRef="usd">0</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="if03ac61671704ce4b4624fc35057af34_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzUtMy0xLTEtNzIxNTE_12b96986-aa1b-4ad4-b88b-c9f3c9878758"
      unitRef="usd">12000000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="if4546ff3df1c4906be5936247a46f7b0_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzUtNC0xLTEtNzIxNTE_ed7b9570-101e-42ae-9829-77c4148007c1"
      unitRef="usd">0</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="ie42d6abca47642698150701f8b361b9f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzUtNS0xLTEtNzIxNTE_c7cde32f-7ece-41d8-aa1c-a9a94f20d312"
      unitRef="usd">12000000</us-gaap:CostOfRevenue>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ie6d6069512b142969a9bd9af9461da85_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzYtMS0xLTEtNzIxNTE_a9f5d768-e994-43a3-be81-5a4c54faab8d"
      unitRef="usd">0</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i8301b5b781954e5cab4cec0d280848d8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzYtMi0xLTEtNzIxNTE_4972ee75-9cb0-4e01-8f5c-0891051c8c73"
      unitRef="usd">15000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i56560a3d5b6f482fb1362de4ae05404a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzYtMy0xLTEtNzIxNTE_901428c5-54ef-4bd5-8fe0-6c932276813f"
      unitRef="usd">6000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ie342040266664c0697ed0bb113671458_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzYtNC0xLTEtNzIxNTE_c3f80899-7b74-4b1f-95e7-675a2efd0860"
      unitRef="usd">-35000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i1c613d72567b4a16a99b20a430597575_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzYtNS0xLTEtNzIxNTE_de41c577-7f33-4c94-9baf-22c68d84fbb7"
      unitRef="usd">-14000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i4b467ba124624433b5dde0c999c6d48c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzctMS0xLTEtNzIxNTE_87be343b-fee2-4061-a7e2-93d53f29fa74"
      unitRef="usd">-1000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i20d1fb9afb38451ca9e6cb8fe56983f4_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzctMi0xLTEtNzIxNTE_1078b840-49f8-4758-b3ec-d5301b7e6aa7"
      unitRef="usd">-2000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ib1dd8a1332a14539a8a3ec1b816d046a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzctMy0xLTEtNzIxNTE_556f8dc2-8ad2-4a3c-97d9-ec0d653131f2"
      unitRef="usd">1000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i709e6e037bfd466aa715d869eb7ef424_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzctNC0xLTEtNzIxNTE_3d1a2c4f-e61b-4b4a-94c2-338c51644cbf"
      unitRef="usd">7000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i03590bf15d844678bd0f164d99ca4949_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzctNS0xLTEtNzIxNTE_723773df-a3dd-4fb8-8410-1af5640ee941"
      unitRef="usd">5000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i4b467ba124624433b5dde0c999c6d48c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzgtMS0xLTEtNzIxNTE_d4a05321-3278-432a-a7f1-d3bf03976e83"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i20d1fb9afb38451ca9e6cb8fe56983f4_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzgtMi0xLTEtNzIxNTE_75b92b46-b35a-4ac9-8cdd-cf93dce85bc6"
      unitRef="usd">104000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib1dd8a1332a14539a8a3ec1b816d046a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzgtMy0xLTEtNzIxNTE_1a203216-f710-427e-b8c8-58e1a91c9a72"
      unitRef="usd">50000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i709e6e037bfd466aa715d869eb7ef424_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzgtNC0xLTEtNzIxNTE_ef23720c-c73f-4752-9718-05e4b54305cc"
      unitRef="usd">469000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i03590bf15d844678bd0f164d99ca4949_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzgtNS0xLTEtNzIxNTE_eabb6e34-671f-457e-b8f2-f615d8d6c0f3"
      unitRef="usd">626000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i0519930af2964fea9f28a898c17d838f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzktMS0xLTEtNzIxNTE_d06d2b1d-7fd4-4c6e-bbf5-a947443e4921"
      unitRef="usd">0</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ia02e7e1cc90e4e87a48f39f4f3e33376_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzktMi0xLTEtNzIxNTE_933625bf-931d-4d91-a9b5-00e7e82d3f66"
      unitRef="usd">-155000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i1917a31882a249a2adf69310c998c7de_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzktMy0xLTEtNzIxNTE_e11e86fa-bfe5-4c08-98ef-eb27e8258148"
      unitRef="usd">40000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i99ab40e0eb8d45a9abce0e0cd3109e0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzktNC0xLTEtNzIxNTE_b9ce8826-356f-4279-b620-7db6438676c2"
      unitRef="usd">-416000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzktNS0xLTEtNzIxNTE_1d377e82-1f7c-4eef-93d2-c77160e53e15"
      unitRef="usd">-531000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i27e420a9891e411095e99eaeb5a2021a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzEwLTEtMS0xLTcyMTUx_a49b2641-22c4-422b-924f-0fa6fdc2e67d"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i4e9f0e75f256464eb07e962100d56a05_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzEwLTItMS0xLTcyMTUx_8f94292e-e286-4b5c-bb4e-a108eddcd9d7"
      unitRef="usd">244000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i823914fb5eb4408998556e61e5fe9f04_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzEwLTMtMS0xLTcyMTUx_455f7e3f-9bf4-433b-a5b2-5bf5fb6e5fb2"
      unitRef="usd">43000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i6b23b51f78e64690aca64f7624b9d18b_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzEwLTQtMS0xLTcyMTUx_304d0659-473b-4870-b4f0-ef13fcc52d64"
      unitRef="usd">253000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzEwLTUtMS0xLTcyMTUx_3b8b85c2-697a-4f12-81a1-6c9cb3db05cf"
      unitRef="usd">539000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i27e420a9891e411095e99eaeb5a2021a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzExLTEtMS0xLTcyMTUx_bb6e38a2-697b-4c1e-afea-0f9c6f14463a"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i4e9f0e75f256464eb07e962100d56a05_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzExLTItMS0xLTcyMTUx_e639100e-cac7-42f9-a1a5-dc218499ff3e"
      unitRef="usd">-64000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i823914fb5eb4408998556e61e5fe9f04_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzExLTMtMS0xLTcyMTUx_a393288b-376f-4929-91b0-8efeb57c4b83"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i6b23b51f78e64690aca64f7624b9d18b_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzExLTQtMS0xLTcyMTUx_cd3a18fb-5aa0-4262-9a0d-a0ef9a61a3a6"
      unitRef="usd">-110000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzExLTUtMS0xLTcyMTUx_fe6d30da-3705-43b0-a018-b6cab7e78cf4"
      unitRef="usd">-173000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:CostOfRevenue
      contextRef="i31974aa90e594af395bc99e745210e04_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzEzLTEtMS0xLTcyMTUx_5f62abab-f622-4983-9bda-0c7e80c6baf9"
      unitRef="usd">0</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="ibf37d1b5ba934c02852349cf34dae000_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzEzLTItMS0xLTcyMTUx_8b9c785c-b7b4-4281-b4a5-6d43f9f50869"
      unitRef="usd">0</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="ic4624597685941fb98a05555c8d17182_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzEzLTMtMS0xLTcyMTUx_9fe2577a-06bb-4b76-ab33-3292f24f845b"
      unitRef="usd">-23000000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="ib8820c2b08814387afe9320dfdf9b54a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzEzLTQtMS0xLTcyMTUx_34569407-5a23-46ee-8061-5d7bd98b1e80"
      unitRef="usd">0</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i8e1908513627494bb6e9fc5eebd933fa_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzEzLTUtMS0xLTcyMTUx_3c8655e9-a1dc-435d-bde7-cfa278ac863c"
      unitRef="usd">-23000000</us-gaap:CostOfRevenue>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i102b956e06124e8aa1a5792f644f35dc_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzE0LTEtMS0xLTcyMTUx_a8ba9f09-bd82-4903-b7c3-40ad58d71ec4"
      unitRef="usd">0</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="icecc44177f9c4483aaa2d013aef04666_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzE0LTItMS0xLTcyMTUx_61f75200-a8a5-45e2-9aae-9da9847e5b39"
      unitRef="usd">8000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i8053af52dacf4e0a9c8f9dcfbcc32961_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzE0LTMtMS0xLTcyMTUx_e37373c3-8be1-46fe-a1e4-54583ab9ddb1"
      unitRef="usd">-5000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i8a65bdddfec44880a63f89575a6757b0_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzE0LTQtMS0xLTcyMTUx_1bf19b50-ad90-48c6-9f2e-3fc700b3a401"
      unitRef="usd">-39000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i6d20d404d8984a96b12853bc045fd7e1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzE0LTUtMS0xLTcyMTUx_aee4e133-2d3f-40a3-b6b3-4ad6d7027433"
      unitRef="usd">-36000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i181aa9e6db8d4da6a8f9d5751bc9b195_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzE1LTEtMS0xLTcyMTUx_b60a736b-6630-4101-bb88-c194b2de15f8"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if5a208a660784ecd8fafc1ab3b4650ae_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzE1LTItMS0xLTcyMTUx_b6b29e49-e6ff-4e7c-bcb7-6cb82bc871ce"
      unitRef="usd">-2000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i7d21dceba0df4948b9211257ad5aa554_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzE1LTMtMS0xLTcyMTUx_ba44d9bd-26a5-41ce-8edb-40d07c7d153f"
      unitRef="usd">-4000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i6796554675ff4f1f973d3c595bd3e499_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzE1LTQtMS0xLTcyMTUx_ab4ab914-0a5b-409a-a3ef-ad604f939a48"
      unitRef="usd">9000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ic99004e7285a44e0a449ff60ca2c5433_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzE1LTUtMS0xLTcyMTUx_c5da1f65-5957-4d84-a75d-6169dbb6707e"
      unitRef="usd">3000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i181aa9e6db8d4da6a8f9d5751bc9b195_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzE2LTEtMS0xLTcyMTUx_ed4addd2-5b70-4c64-9868-e8706601a4bf"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if5a208a660784ecd8fafc1ab3b4650ae_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzE2LTItMS0xLTcyMTUx_5e303abe-bf62-4d28-807d-193291fce92b"
      unitRef="usd">186000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i7d21dceba0df4948b9211257ad5aa554_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzE2LTMtMS0xLTcyMTUx_aa6c7c5d-ccbf-4033-a361-c16046b17bcd"
      unitRef="usd">12000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6796554675ff4f1f973d3c595bd3e499_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzE2LTQtMS0xLTcyMTUx_a0c5c798-f9ff-4956-994e-c4762fbdc3fc"
      unitRef="usd">113000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic99004e7285a44e0a449ff60ca2c5433_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzE2LTUtMS0xLTcyMTUx_5e23ed03-9d87-4919-8791-2df0c3effb3d"
      unitRef="usd">310000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i6766e2f3ba404e94b97b133b143443ec_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzE3LTEtMS0xLTcyMTUx_7b465dc2-0075-49e2-b97c-47f18f9275b1"
      unitRef="usd">-1000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i09ab23df9d8d46d6b99f210842561aad_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzE3LTItMS0xLTcyMTUx_4bd14903-be52-43a8-83f8-a51eb90108a7"
      unitRef="usd">31000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i1ce78b990cc3435b974774303b8f1500_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzE3LTMtMS0xLTcyMTUx_27f892f2-c9ed-4ef0-a9d4-b8a110ff814a"
      unitRef="usd">52000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="id36e8e59f17a4fd2b1810524c32bdb32_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzE3LTQtMS0xLTcyMTUx_691a81ed-0a05-4c83-ad40-dbf28df5016a"
      unitRef="usd">-303000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTIvZnJhZzo4MjE3ZGRiMTRjZDI0MTgxOGIzNzRjMjY2ZWE3MTk2Zi90YWJsZTowMjQzYjFkYTBhNmI0NjcxYTNmYjFiNmM0YmJiMTk5MC90YWJsZXJhbmdlOjAyNDNiMWRhMGE2YjQ2NzFhM2ZiMWI2YzRiYmIxOTkwXzE3LTUtMS0xLTcyMTUx_4a736a1f-8e7e-4dd1-a081-1c3478c9d251"
      unitRef="usd">-221000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTUvZnJhZzo4NDYwZTAzYzhlZjg0Y2I1YjhkZWQyMjI2ZWIxNDE5Yi90ZXh0cmVnaW9uOjg0NjBlMDNjOGVmODRjYjViOGRlZDIyMjZlYjE0MTliXzMyNzA_7e185176-000f-44dd-a12a-4625fd51d288">ACQUISITIONS&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We acquire stock in companies and various assets that continue to support our capital deployment and product development strategies. The aggregate purchase price of our acquisitions, net of cash acquired was $2,563 and $393 in 2022 and 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In February 2022 we completed the acquisition of Vocera for $79.25 per share, or an aggregate purchase price of $2.6&#160;billion, net of cash acquired ($3.0&#160;billion including convertible notes). Vocera is a leader in the digital care coordination and communication category. Vocera is part of our Medical business within MedSurg and Neurotechnology. Goodwill attributable to the acquisition reflects the strategic benefits of expanding our &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;presence in adjacent markets, diversifying our product portfolio, advancing innovations and accelerating our digital aspirations. This goodwill is not deductible for tax purposes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;During 2022 note holders elected to redeem the 1.50% and 0.50% convertible notes assumed in the Vocera acquisition for $101 and $324. These repayments are classified as financing activities in the Consolidated Statements of Cash Flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Share-based awards for Vocera employees vested upon our acquisition and a charge of $132 was recorded in selling, general and administrative expenses in 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Purchase price allocations for our significant acquisitions are:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.486%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.878%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Purchase Price Allocation of Acquired Net Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Vocera&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Tangible assets acquired:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Deferred income tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(425)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Deferred income tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(182)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(115)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Customer and distributor relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Purchase price, net of cash acquired of $281&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,563&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Weighted average life of intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Our allocation of the Vocera purchase price to intangible assets and residual goodwill is preliminary. These amounts are subject to review and potential change during the measurement period, which will extend to February 2023. The subsequent adjustment of the preliminary amounts may be material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In September 2021 we completed the acquisition of Gauss Surgical, Inc. (Gauss) for $120 in cash and up to $40 in future milestone payments. Gauss is a medical device company that has developed Triton, an artificial intelligence-enabled platform for real-time monitoring of blood loss during surgery. Gauss is part of our Instruments business within MedSurg and Neurotechnology. Goodwill attributable to the acquisition is not deductible for tax purposes. The purchase price allocations for Gauss and other 2021 acquisitions were finalized in 2022 without material adjustments.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTUvZnJhZzo4NDYwZTAzYzhlZjg0Y2I1YjhkZWQyMjI2ZWIxNDE5Yi90ZXh0cmVnaW9uOjg0NjBlMDNjOGVmODRjYjViOGRlZDIyMjZlYjE0MTliXzIzNQ_025d2895-649c-439c-8120-92a5dda32159"
      unitRef="usd">2563000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTUvZnJhZzo4NDYwZTAzYzhlZjg0Y2I1YjhkZWQyMjI2ZWIxNDE5Yi90ZXh0cmVnaW9uOjg0NjBlMDNjOGVmODRjYjViOGRlZDIyMjZlYjE0MTliXzI0Mg_71500055-f8e0-4940-b2a1-7e42e82798c4"
      unitRef="usd">393000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <syk:BusinessCombinationConsiderationTransferredPricePerShare
      contextRef="iedb144142fe44106a0298139475b1b7e_D20220201-20220228"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTUvZnJhZzo4NDYwZTAzYzhlZjg0Y2I1YjhkZWQyMjI2ZWIxNDE5Yi90ZXh0cmVnaW9uOjg0NjBlMDNjOGVmODRjYjViOGRlZDIyMjZlYjE0MTliXzEwOTk1MTE2MzExNDk_ff9655a1-1ad9-4338-923e-d33a1dbb4b53"
      unitRef="usdPerShare">79.25</syk:BusinessCombinationConsiderationTransferredPricePerShare>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="iedb144142fe44106a0298139475b1b7e_D20220201-20220228"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTUvZnJhZzo4NDYwZTAzYzhlZjg0Y2I1YjhkZWQyMjI2ZWIxNDE5Yi90ZXh0cmVnaW9uOjg0NjBlMDNjOGVmODRjYjViOGRlZDIyMjZlYjE0MTliXzEwOTk1MTE2MzExOTg_8742e467-f48f-4d6c-80b3-830f7a392f51"
      unitRef="usd">2600000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <syk:BusinessCombinationConsiderationTransferredIncludingConvertibleNotes
      contextRef="iedb144142fe44106a0298139475b1b7e_D20220201-20220228"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTUvZnJhZzo4NDYwZTAzYzhlZjg0Y2I1YjhkZWQyMjI2ZWIxNDE5Yi90ZXh0cmVnaW9uOjg0NjBlMDNjOGVmODRjYjViOGRlZDIyMjZlYjE0MTliXzEwOTk1MTE2MzEyMjU_2dd71086-309c-40d3-9a5b-7cb11b160f01"
      unitRef="usd">3000000000</syk:BusinessCombinationConsiderationTransferredIncludingConvertibleNotes>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if643644842344c0ab2e0d9a12b06b426_I20201130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTUvZnJhZzo4NDYwZTAzYzhlZjg0Y2I1YjhkZWQyMjI2ZWIxNDE5Yi90ZXh0cmVnaW9uOjg0NjBlMDNjOGVmODRjYjViOGRlZDIyMjZlYjE0MTliXzExOTI_a683eb5a-5cc1-448c-bcc8-8a285f83205c"
      unitRef="rate">0.0150</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i22182f50ad11452dba95524874b934aa_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTUvZnJhZzo4NDYwZTAzYzhlZjg0Y2I1YjhkZWQyMjI2ZWIxNDE5Yi90ZXh0cmVnaW9uOjg0NjBlMDNjOGVmODRjYjViOGRlZDIyMjZlYjE0MTliXzExOTk_3ffde49a-bede-4fbc-8c1f-f1074522b0e6"
      unitRef="rate">0.0050</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i2c9e3c188be94e4c980232bc3fbcb14b_D20201101-20201130"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTUvZnJhZzo4NDYwZTAzYzhlZjg0Y2I1YjhkZWQyMjI2ZWIxNDE5Yi90ZXh0cmVnaW9uOjg0NjBlMDNjOGVmODRjYjViOGRlZDIyMjZlYjE0MTliXzMyNjY_0e813f62-1fe5-4c3f-9af8-e08780f35d47"
      unitRef="usd">101000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i89f1c0806ea84da2867f98aea716c643_D20201201-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTUvZnJhZzo4NDYwZTAzYzhlZjg0Y2I1YjhkZWQyMjI2ZWIxNDE5Yi90ZXh0cmVnaW9uOjg0NjBlMDNjOGVmODRjYjViOGRlZDIyMjZlYjE0MTliXzEyNjU_6449566b-53f1-4760-9d28-1dd84de760b9"
      unitRef="usd">324000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i0eadaeefb6b844b7bcb7e34005c139af_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTUvZnJhZzo4NDYwZTAzYzhlZjg0Y2I1YjhkZWQyMjI2ZWIxNDE5Yi90ZXh0cmVnaW9uOjg0NjBlMDNjOGVmODRjYjViOGRlZDIyMjZlYjE0MTliXzg3OTYwOTMwMjc1Mzc_c480121a-fae0-4e0f-8c18-d4356c45cc97"
      unitRef="usd">132000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTUvZnJhZzo4NDYwZTAzYzhlZjg0Y2I1YjhkZWQyMjI2ZWIxNDE5Yi90ZXh0cmVnaW9uOjg0NjBlMDNjOGVmODRjYjViOGRlZDIyMjZlYjE0MTliXzMyNzQ_a902e96c-69fd-4def-a93e-e4ed152c255c">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Purchase price allocations for our significant acquisitions are:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.486%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.878%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Purchase Price Allocation of Acquired Net Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Vocera&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Tangible assets acquired:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Deferred income tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(425)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Deferred income tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(182)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(115)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Customer and distributor relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Purchase price, net of cash acquired of $281&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,563&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Weighted average life of intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="i0e2ff09ffaf04bd7b9e7b8d473abbcb6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTUvZnJhZzo4NDYwZTAzYzhlZjg0Y2I1YjhkZWQyMjI2ZWIxNDE5Yi90YWJsZTo3M2E2NGRiYzk4NGI0YjBiYmJmZTdkNTQ3NDUzNmY3ZC90YWJsZXJhbmdlOjczYTY0ZGJjOTg0YjRiMGJiYmZlN2Q1NDc0NTM2ZjdkXzMtMi0xLTEtNzIxNTE_95bdaa85-29fb-4556-a848-806448e5249f"
      unitRef="usd">33000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="i0e2ff09ffaf04bd7b9e7b8d473abbcb6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTUvZnJhZzo4NDYwZTAzYzhlZjg0Y2I1YjhkZWQyMjI2ZWIxNDE5Yi90YWJsZTo3M2E2NGRiYzk4NGI0YjBiYmJmZTdkNTQ3NDUzNmY3ZC90YWJsZXJhbmdlOjczYTY0ZGJjOTg0YjRiMGJiYmZlN2Q1NDc0NTM2ZjdkXzQtMi0xLTEtODM0NTA_abe24ae6-994f-4489-bc17-1114ed36e82e"
      unitRef="usd">13000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets
      contextRef="i0e2ff09ffaf04bd7b9e7b8d473abbcb6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTUvZnJhZzo4NDYwZTAzYzhlZjg0Y2I1YjhkZWQyMjI2ZWIxNDE5Yi90YWJsZTo3M2E2NGRiYzk4NGI0YjBiYmJmZTdkNTQ3NDUzNmY3ZC90YWJsZXJhbmdlOjczYTY0ZGJjOTg0YjRiMGJiYmZlN2Q1NDc0NTM2ZjdkXzQtMi0xLTEtNzIxNTE_f14a478d-576f-4ff5-94e0-e1ce5766d830"
      unitRef="usd">73000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="i0e2ff09ffaf04bd7b9e7b8d473abbcb6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTUvZnJhZzo4NDYwZTAzYzhlZjg0Y2I1YjhkZWQyMjI2ZWIxNDE5Yi90YWJsZTo3M2E2NGRiYzk4NGI0YjBiYmJmZTdkNTQ3NDUzNmY3ZC90YWJsZXJhbmdlOjczYTY0ZGJjOTg0YjRiMGJiYmZlN2Q1NDc0NTM2ZjdkXzYtMi0xLTEtNzIxNTE_f0d6449b-58a0-4f69-83fa-71616a2447cf"
      unitRef="usd">92000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <syk:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt
      contextRef="i0e2ff09ffaf04bd7b9e7b8d473abbcb6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTUvZnJhZzo4NDYwZTAzYzhlZjg0Y2I1YjhkZWQyMjI2ZWIxNDE5Yi90YWJsZTo3M2E2NGRiYzk4NGI0YjBiYmJmZTdkNTQ3NDUzNmY3ZC90YWJsZXJhbmdlOjczYTY0ZGJjOTg0YjRiMGJiYmZlN2Q1NDc0NTM2ZjdkXzctMi0xLTEtNzIxNTE_61606f54-d612-498b-bb9d-e10213954823"
      unitRef="usd">425000000</syk:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i0e2ff09ffaf04bd7b9e7b8d473abbcb6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTUvZnJhZzo4NDYwZTAzYzhlZjg0Y2I1YjhkZWQyMjI2ZWIxNDE5Yi90YWJsZTo3M2E2NGRiYzk4NGI0YjBiYmJmZTdkNTQ3NDUzNmY3ZC90YWJsZXJhbmdlOjczYTY0ZGJjOTg0YjRiMGJiYmZlN2Q1NDc0NTM2ZjdkXzgtMi0xLTEtNzIxNTE_a824dade-cc3b-4079-83c3-048a70b7e10d"
      unitRef="usd">182000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="i0e2ff09ffaf04bd7b9e7b8d473abbcb6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTUvZnJhZzo4NDYwZTAzYzhlZjg0Y2I1YjhkZWQyMjI2ZWIxNDE5Yi90YWJsZTo3M2E2NGRiYzk4NGI0YjBiYmJmZTdkNTQ3NDUzNmY3ZC90YWJsZXJhbmdlOjczYTY0ZGJjOTg0YjRiMGJiYmZlN2Q1NDc0NTM2ZjdkXzEwLTItMS0xLTcyMTUx_f979bce3-fc11-4d44-a0a9-26e516d867b9"
      unitRef="usd">115000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i101c3d1a12034ac38fe2e5f8c0168405_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTUvZnJhZzo4NDYwZTAzYzhlZjg0Y2I1YjhkZWQyMjI2ZWIxNDE5Yi90YWJsZTo3M2E2NGRiYzk4NGI0YjBiYmJmZTdkNTQ3NDUzNmY3ZC90YWJsZXJhbmdlOjczYTY0ZGJjOTg0YjRiMGJiYmZlN2Q1NDc0NTM2ZjdkXzEyLTItMS0xLTcyMTUx_9e736e55-f124-4b80-8fa6-7d5f3e212083"
      unitRef="usd">550000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ic19a68dc4f2647639ab8a2956791d892_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTUvZnJhZzo4NDYwZTAzYzhlZjg0Y2I1YjhkZWQyMjI2ZWIxNDE5Yi90YWJsZTo3M2E2NGRiYzk4NGI0YjBiYmJmZTdkNTQ3NDUzNmY3ZC90YWJsZXJhbmdlOjczYTY0ZGJjOTg0YjRiMGJiYmZlN2Q1NDc0NTM2ZjdkXzEzLTItMS0xLTcyMTUx_0d80ec08-ea95-47d9-a8ba-f54d0ace5776"
      unitRef="usd">178000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ie1d22140738841ca90e737fe8f886088_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTUvZnJhZzo4NDYwZTAzYzhlZjg0Y2I1YjhkZWQyMjI2ZWIxNDE5Yi90YWJsZTo3M2E2NGRiYzk4NGI0YjBiYmJmZTdkNTQ3NDUzNmY3ZC90YWJsZXJhbmdlOjczYTY0ZGJjOTg0YjRiMGJiYmZlN2Q1NDc0NTM2ZjdkXzE0LTItMS0xLTcyMTUx_1854ea8b-2f73-4ee8-a171-a58c2189e744"
      unitRef="usd">18000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:Goodwill
      contextRef="i0e2ff09ffaf04bd7b9e7b8d473abbcb6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTUvZnJhZzo4NDYwZTAzYzhlZjg0Y2I1YjhkZWQyMjI2ZWIxNDE5Yi90YWJsZTo3M2E2NGRiYzk4NGI0YjBiYmJmZTdkNTQ3NDUzNmY3ZC90YWJsZXJhbmdlOjczYTY0ZGJjOTg0YjRiMGJiYmZlN2Q1NDc0NTM2ZjdkXzE2LTItMS0xLTcyMTUx_ed8d6e0a-be3a-49a2-b661-945a0c92ef71"
      unitRef="usd">2328000000</us-gaap:Goodwill>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="i0eadaeefb6b844b7bcb7e34005c139af_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTUvZnJhZzo4NDYwZTAzYzhlZjg0Y2I1YjhkZWQyMjI2ZWIxNDE5Yi90YWJsZTo3M2E2NGRiYzk4NGI0YjBiYmJmZTdkNTQ3NDUzNmY3ZC90YWJsZXJhbmdlOjczYTY0ZGJjOTg0YjRiMGJiYmZlN2Q1NDc0NTM2ZjdkXzE3LTAtMS0xLTcyMTUxL3RleHRyZWdpb246MDkwZDlmOWZhZTFhNGFkZmJiOTAyZDQzMjgxNjI0MDBfMTA5OTUxMTYyNzgzMA_a333a478-77d0-4391-8368-fbbe17574542"
      unitRef="usd">281000000</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i0e2ff09ffaf04bd7b9e7b8d473abbcb6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTUvZnJhZzo4NDYwZTAzYzhlZjg0Y2I1YjhkZWQyMjI2ZWIxNDE5Yi90YWJsZTo3M2E2NGRiYzk4NGI0YjBiYmJmZTdkNTQ3NDUzNmY3ZC90YWJsZXJhbmdlOjczYTY0ZGJjOTg0YjRiMGJiYmZlN2Q1NDc0NTM2ZjdkXzE3LTItMS0xLTcyMTUx_ceceee4b-1de2-4297-b999-5a757f42ad84"
      unitRef="usd">2563000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i0eadaeefb6b844b7bcb7e34005c139af_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTUvZnJhZzo4NDYwZTAzYzhlZjg0Y2I1YjhkZWQyMjI2ZWIxNDE5Yi90YWJsZTo3M2E2NGRiYzk4NGI0YjBiYmJmZTdkNTQ3NDUzNmY3ZC90YWJsZXJhbmdlOjczYTY0ZGJjOTg0YjRiMGJiYmZlN2Q1NDc0NTM2ZjdkXzE4LTItMS0xLTcyMTUx_9dac117d-0aa3-4b7d-a06f-d3b1d4599782">P13Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i4889250342a0437bb3b31f671106d385_D20210901-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTUvZnJhZzo4NDYwZTAzYzhlZjg0Y2I1YjhkZWQyMjI2ZWIxNDE5Yi90ZXh0cmVnaW9uOjg0NjBlMDNjOGVmODRjYjViOGRlZDIyMjZlYjE0MTliXzU0OTc1NTgyMzE2MQ_fbbdfd47-d235-4b38-9b16-83f133fd667a"
      unitRef="usd">120000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh
      contextRef="i4889250342a0437bb3b31f671106d385_D20210901-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTUvZnJhZzo4NDYwZTAzYzhlZjg0Y2I1YjhkZWQyMjI2ZWIxNDE5Yi90ZXh0cmVnaW9uOjg0NjBlMDNjOGVmODRjYjViOGRlZDIyMjZlYjE0MTliXzU0OTc1NTgyMzE3MA_4f251aa1-d8f2-40aa-8cfc-6d00fa7a52b8"
      unitRef="usd">40000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90ZXh0cmVnaW9uOjg1ZTMyMWZhOTM4YjQ3OGI5MDMzZmY1ZGM3ZDQ2NTg3XzYyNjg_8cef3d33-73bf-4fa7-8999-2c22b0fb4388">CONTINGENCIES AND COMMITMENTSWe are involved in various ongoing proceedings, legal actions and claims arising in the normal course of business, including proceedings related to product, labor, intellectual property and other matters, the most significant of which are more fully described below. The outcomes of these matters will generally not be known for prolonged periods of time. In certain of the legal proceedings the claimants seek damages as well as other compensatory and equitable relief that could result in the payment of significant claims and settlements and/or the imposition of injunctions or other equitable relief. For legal matters for which management had sufficient information to reasonably estimate our future obligations, a liability representing management's best estimate of the probable loss, or the minimum of the range of probable losses when a best estimate within the range is not known, is recorded. The estimates are based on consultation with legal counsel, previous settlement experience and settlement strategies. If actual outcomes are less favorable than those estimated by management, additional expense may be incurred, which could unfavorably affect future &lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;operating results. We are self-insured for certain claims and expenses. The ultimate cost to us with respect to product liability claims could be materially different than the amount of the current estimates and accruals and could have a material adverse effect on our financial position, results of operations and cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In April 2022 the United States District Court for the District of Delaware issued a judgment following a jury verdict in favor of PureWick Corporation (PureWick) for its 2019 complaint seeking patent infringement damages related to our PrimaFit and PrimoFit products. The court awarded damages and we recorded charges of $28 in March 2022. In June 2022 PureWick filed a motion to seek enhancement of the judgment and if successful, the judgment could total approximately $100 and include an injunction against future sales. We intend to appeal the outcome of this case. In 2022 PureWick filed additional patent infringement claims related to our PrimaFit products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Recall Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In June 2012 we voluntarily recalled our Rejuvenate and ABG II Modular-Neck hip stems and terminated global distribution of these hip products. Product liability lawsuits relating to this voluntary recall have been filed against us. In November 2014 we entered into a settlement agreement to compensate eligible United States patients who had revision surgery prior to November 3, 2014 and in December 2016 the settlement program was extended to patients who had revision surgery prior to December 19, 2016. In September 2020 we entered into a second settlement agreement to compensate eligible United States patients who had revision surgery prior to September 9, 2020. There are remaining lawsuits that we will continue to defend against. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In August 2016 and May 2018 we voluntarily recalled certain lot-specific sizes and offsets of LFIT Anatomic CoCr V40 Femoral Heads. Product liability lawsuits and claims relating to this voluntary recall have been filed against us. In November 2018 we entered into a settlement agreement to resolve a significant number of claims and lawsuits related to the recalls. In April 2022 we executed a second agreement to resolve a significant number of claims and lawsuits related to the recalls. The specific terms of the settlement agreement, including the financial terms, are confidential. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;With the acquisition of Wright Medical Group N.V. (Wright) in November 2020, we are responsible for certain product liability claims, primarily related to certain hip products sold by Wright prior to its 2014 divestiture of the OrthoRecon business. We will continue to evaluate each claim and the possible loss we may incur.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;We have incurred, and expect to incur in the future, costs associated with the defense and settlement of these matters. In 2022 we made payments of $157, primarily related to LFIT femoral heads and Wright hip products. Based on the information that has been received, we have estimated the remaining range of probable loss related to these recall matters to be approximately $213 to $347. We have recorded reserves representing the remaining minimum of the range of probable loss. The final outcomes of these matters are dependent on many factors that are difficult to predict. Accordingly, the ultimate cost related to these matters may be materially different than the amount of our current estimate and accruals and could have a material adverse effect on our results of operations and cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;We lease various manufacturing, warehousing and distribution facilities, administrative and sales offices as well as equipment &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;under operating leases. We evaluate our contracts to identify leases, which is generally if there is an identified asset and we have the right to direct the use of and obtain substantially all of the economic benefit from the use of the identified asset. Certain of our lease agreements contain rent escalation clauses (including index-based escalations), rent holidays, capital improvement funding or other lease incentives. We recognize our minimum rental expense on a straight-line basis over the term of the lease beginning with the date of initial control of the asset. Right-of-use assets are recorded in Other noncurrent assets on our Consolidated Balance Sheets. Current and noncurrent lease liabilities are recorded in Accrued expenses and other liabilities and Other noncurrent liabilities, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We have made certain significant assumptions and judgments when recording leases. For all asset classes, we elected to not recognize a right-of-use asset and lease liability for short-term leases and not separate non-lease components from lease components to which they relate and have accounted for the combined lease and non-lease components as a single lease component. The determination of the discount rate used in a lease is our incremental borrowing rate which is based on what we would normally pay to borrow on a collateralized basis over a similar term an amount equal to the lease payments.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.850%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.493%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.253%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzItMC0xLTEtNzIxNTE_9731ce2e-d82a-4967-b042-db8cc99630f8"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzItMC0xLTEtNzIxNTE_f24b63f9-9795-4048-881d-72c0ef014936"&gt;Right-of-use assets&lt;/span&gt;&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzMtMC0xLTEtNzIxNTE_4a79c8d2-7e9e-4a69-8e7c-3f2c45ccd096"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzMtMC0xLTEtNzIxNTE_582bcc35-c25f-4f59-a914-b85367fcbaf4"&gt;Lease liabilities, current&lt;/span&gt;&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzQtMC0xLTEtNzIxNTE_3e00ae6d-1860-4511-a971-3c7d349014a4"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzQtMC0xLTEtNzIxNTE_b077084d-a166-4834-a410-c652caa7aed3"&gt;Lease liabilities, noncurrent&lt;/span&gt;&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other information:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining lease term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;text-indent:-0.01pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Operating lease expense totaled $149, $133, and $130 in 2022, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Future Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We have purchase commitments for materials, supplies, services and property, plant and equipment as part of the normal course of business. In addition, we lease various manufacturing, warehousing and distribution facilities, administrative and sales offices as well as equipment under operating leases. Refer to Note 10 for more information on the debt obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.945%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Debt repayments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Purchase obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LossContingencyLossInPeriod
      contextRef="i771ee623eaf644bbb46406b9ab01d509_D20220301-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90ZXh0cmVnaW9uOjg1ZTMyMWZhOTM4YjQ3OGI5MDMzZmY1ZGM3ZDQ2NTg3XzEwOTk1MTE2MzczNzE_63922709-de40-4635-b611-673a4078d588"
      unitRef="usd">28000000</us-gaap:LossContingencyLossInPeriod>
    <us-gaap:LossContingencyEstimateOfPossibleLoss
      contextRef="ifc3a04258fee41d5854dbca8209b7188_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90ZXh0cmVnaW9uOjg1ZTMyMWZhOTM4YjQ3OGI5MDMzZmY1ZGM3ZDQ2NTg3XzEwOTk1MTE2Mzc1MjE_6d14096a-553b-4c44-ab8e-2e0d0bb24145"
      unitRef="usd">100000000</us-gaap:LossContingencyEstimateOfPossibleLoss>
    <syk:Changeinaccrualforrecallexpenses
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90ZXh0cmVnaW9uOjg1ZTMyMWZhOTM4YjQ3OGI5MDMzZmY1ZGM3ZDQ2NTg3XzM4NDgyOTA3MTA2NzU_1df7fde0-5d3c-4bb9-a6f9-11178e63f439"
      unitRef="usd">-157000000</syk:Changeinaccrualforrecallexpenses>
    <us-gaap:LossContingencyEstimateOfPossibleLoss
      contextRef="ieaab15c857b047cb895f5e84a16ec8e5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90ZXh0cmVnaW9uOjg1ZTMyMWZhOTM4YjQ3OGI5MDMzZmY1ZGM3ZDQ2NTg3XzM4MzY_79e33eb9-97d5-4441-b83c-6261c35e243d"
      unitRef="usd">213000000</us-gaap:LossContingencyEstimateOfPossibleLoss>
    <us-gaap:LossContingencyEstimateOfPossibleLoss
      contextRef="i5bcc369cedab4f869853e6b7824ab18f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90ZXh0cmVnaW9uOjg1ZTMyMWZhOTM4YjQ3OGI5MDMzZmY1ZGM3ZDQ2NTg3XzM4NDI_3f6c4b20-d32a-401e-888a-4ce1bf02d7d2"
      unitRef="usd">347000000</us-gaap:LossContingencyEstimateOfPossibleLoss>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90ZXh0cmVnaW9uOjg1ZTMyMWZhOTM4YjQ3OGI5MDMzZmY1ZGM3ZDQ2NTg3XzYyNzY_5b0275d3-8e0e-489c-87d8-ab65e24d5711">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.850%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.493%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.253%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzItMC0xLTEtNzIxNTE_9731ce2e-d82a-4967-b042-db8cc99630f8"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzItMC0xLTEtNzIxNTE_f24b63f9-9795-4048-881d-72c0ef014936"&gt;Right-of-use assets&lt;/span&gt;&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzMtMC0xLTEtNzIxNTE_4a79c8d2-7e9e-4a69-8e7c-3f2c45ccd096"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzMtMC0xLTEtNzIxNTE_582bcc35-c25f-4f59-a914-b85367fcbaf4"&gt;Lease liabilities, current&lt;/span&gt;&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzQtMC0xLTEtNzIxNTE_3e00ae6d-1860-4511-a971-3c7d349014a4"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzQtMC0xLTEtNzIxNTE_b077084d-a166-4834-a410-c652caa7aed3"&gt;Lease liabilities, noncurrent&lt;/span&gt;&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other information:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining lease term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;text-indent:-0.01pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzItMS0xLTEtNzIxNTE_50b75d19-362e-4626-baeb-ab66f0368c7c"
      unitRef="usd">473000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzItMy0xLTEtNzIxNTE_98edeb58-c934-4b41-9812-55903ea89688"
      unitRef="usd">419000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzMtMS0xLTEtNzIxNTE_f31c4d56-9221-4518-8857-2dfb9c135057"
      unitRef="usd">121000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzMtMy0xLTEtNzIxNTE_c42aca32-ebcc-4752-bc62-1b9e2bde144e"
      unitRef="usd">112000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzQtMS0xLTEtNzIxNTE_6494d2f3-477c-4ab7-b031-760b5cb56353"
      unitRef="usd">357000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzQtMy0xLTEtNzIxNTE_76fa510a-5c17-439f-bb19-57a0a4e66af3"
      unitRef="usd">310000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzktMS0xLTEtNzIxNTE_8ff95868-390b-43b8-9da2-f16d0ede6a7f">P5Y6M</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzktMy0xLTEtNzIxNTE_91dde324-226b-4c34-907f-d0da9d75a5ee">P5Y4M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzExLTEtMS0xLTcyMTUx_f1dce60b-59bf-41a3-a075-d914a08099c7"
      unitRef="number">0.0322</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTozMGIyNTkxMDMzY2U0MTIzYjZiY2ViMjgyZDIwNDAwMC90YWJsZXJhbmdlOjMwYjI1OTEwMzNjZTQxMjNiNmJjZWIyODJkMjA0MDAwXzExLTMtMS0xLTcyMTUx_b3b0e52e-8bdc-4822-915c-138cb0de7619"
      unitRef="number">0.0286</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseExpense
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90ZXh0cmVnaW9uOjg1ZTMyMWZhOTM4YjQ3OGI5MDMzZmY1ZGM3ZDQ2NTg3XzM4NDgyOTA3MTA2Mzg_27b73ee3-78b0-4cec-b9aa-c20ba8c23aa0"
      unitRef="usd">149000000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90ZXh0cmVnaW9uOjg1ZTMyMWZhOTM4YjQ3OGI5MDMzZmY1ZGM3ZDQ2NTg3XzM4NDgyOTA3MTA2NDY_22625487-1204-43c3-b28e-44271cb814e6"
      unitRef="usd">133000000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90ZXh0cmVnaW9uOjg1ZTMyMWZhOTM4YjQ3OGI5MDMzZmY1ZGM3ZDQ2NTg3XzM4NDgyOTA3MTA2NTA_45af8567-1566-4422-ba9d-baefc68916fc"
      unitRef="usd">130000000</us-gaap:OperatingLeaseExpense>
    <srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90ZXh0cmVnaW9uOjg1ZTMyMWZhOTM4YjQ3OGI5MDMzZmY1ZGM3ZDQ2NTg3XzYyNjc_70aa996f-a9b1-4915-8694-d921044a8422">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.945%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Debt repayments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Purchase obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTpiNWU3ZjZjNjAwOTQ0ZDkwYjJlNWQ5MmJjMmUwMTAxMC90YWJsZXJhbmdlOmI1ZTdmNmM2MDA5NDRkOTBiMmU1ZDkyYmMyZTAxMDEwXzItMS0xLTEtNzIxNTE_d8d4597f-8f71-4f16-8361-5dfa2b31e1ba"
      unitRef="usd">1208000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTpiNWU3ZjZjNjAwOTQ0ZDkwYjJlNWQ5MmJjMmUwMTAxMC90YWJsZXJhbmdlOmI1ZTdmNmM2MDA5NDRkOTBiMmU1ZDkyYmMyZTAxMDEwXzItMi0xLTEtNzIxNTE_6f14647e-97ea-4805-b9d2-5782ff4a8b7d"
      unitRef="usd">1450000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTpiNWU3ZjZjNjAwOTQ0ZDkwYjJlNWQ5MmJjMmUwMTAxMC90YWJsZXJhbmdlOmI1ZTdmNmM2MDA5NDRkOTBiMmU1ZDkyYmMyZTAxMDEwXzItMy0xLTEtNzIxNTE_471eb099-1800-4c9b-96d2-783a245eae4a"
      unitRef="usd">2250000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTpiNWU3ZjZjNjAwOTQ0ZDkwYjJlNWQ5MmJjMmUwMTAxMC90YWJsZXJhbmdlOmI1ZTdmNmM2MDA5NDRkOTBiMmU1ZDkyYmMyZTAxMDEwXzItNC0xLTEtNzIxNTE_72acc67a-ea64-404e-913a-71cea81226ad"
      unitRef="usd">1000000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTpiNWU3ZjZjNjAwOTQ0ZDkwYjJlNWQ5MmJjMmUwMTAxMC90YWJsZXJhbmdlOmI1ZTdmNmM2MDA5NDRkOTBiMmU1ZDkyYmMyZTAxMDEwXzItNS0xLTEtNzIxNTE_70c144de-1ad6-46e9-927c-2d9957bf6b5c"
      unitRef="usd">750000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTpiNWU3ZjZjNjAwOTQ0ZDkwYjJlNWQ5MmJjMmUwMTAxMC90YWJsZXJhbmdlOmI1ZTdmNmM2MDA5NDRkOTBiMmU1ZDkyYmMyZTAxMDEwXzItNi0xLTEtNzIxNTE_4ad883fc-e4db-4a29-b7ee-8426b7a41c17"
      unitRef="usd">6300000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:RecordedUnconditionalPurchaseObligationDueWithinOneYear
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTpiNWU3ZjZjNjAwOTQ0ZDkwYjJlNWQ5MmJjMmUwMTAxMC90YWJsZXJhbmdlOmI1ZTdmNmM2MDA5NDRkOTBiMmU1ZDkyYmMyZTAxMDEwXzMtMS0xLTEtNzIxNTE_212101b4-ba5f-4846-98fc-1d495a933f92"
      unitRef="usd">1595000000</us-gaap:RecordedUnconditionalPurchaseObligationDueWithinOneYear>
    <us-gaap:RecordedUnconditionalPurchaseObligationDueInSecondYear
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTpiNWU3ZjZjNjAwOTQ0ZDkwYjJlNWQ5MmJjMmUwMTAxMC90YWJsZXJhbmdlOmI1ZTdmNmM2MDA5NDRkOTBiMmU1ZDkyYmMyZTAxMDEwXzMtMi0xLTEtNzIxNTE_66365457-7dc4-4ce6-b388-0167f3195b83"
      unitRef="usd">68000000</us-gaap:RecordedUnconditionalPurchaseObligationDueInSecondYear>
    <us-gaap:RecordedUnconditionalPurchaseObligationDueInThirdYear
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTpiNWU3ZjZjNjAwOTQ0ZDkwYjJlNWQ5MmJjMmUwMTAxMC90YWJsZXJhbmdlOmI1ZTdmNmM2MDA5NDRkOTBiMmU1ZDkyYmMyZTAxMDEwXzMtMy0xLTEtNzIxNTE_08c601c6-8664-49e7-825b-face2470bbe9"
      unitRef="usd">53000000</us-gaap:RecordedUnconditionalPurchaseObligationDueInThirdYear>
    <us-gaap:RecordedUnconditionalPurchaseObligationDueInFourthYear
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTpiNWU3ZjZjNjAwOTQ0ZDkwYjJlNWQ5MmJjMmUwMTAxMC90YWJsZXJhbmdlOmI1ZTdmNmM2MDA5NDRkOTBiMmU1ZDkyYmMyZTAxMDEwXzMtNC0xLTEtNzIxNTE_56243b6a-35cf-4946-b718-485f442e2628"
      unitRef="usd">56000000</us-gaap:RecordedUnconditionalPurchaseObligationDueInFourthYear>
    <us-gaap:RecordedUnconditionalPurchaseObligationDueInFifthYear
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTpiNWU3ZjZjNjAwOTQ0ZDkwYjJlNWQ5MmJjMmUwMTAxMC90YWJsZXJhbmdlOmI1ZTdmNmM2MDA5NDRkOTBiMmU1ZDkyYmMyZTAxMDEwXzMtNS0xLTEtNzIxNTE_3fd1d662-3bb4-4ebf-959d-a71fb0679f6b"
      unitRef="usd">59000000</us-gaap:RecordedUnconditionalPurchaseObligationDueInFifthYear>
    <us-gaap:RecordedUnconditionalPurchaseObligationDueAfterFifthYear
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTpiNWU3ZjZjNjAwOTQ0ZDkwYjJlNWQ5MmJjMmUwMTAxMC90YWJsZXJhbmdlOmI1ZTdmNmM2MDA5NDRkOTBiMmU1ZDkyYmMyZTAxMDEwXzMtNi0xLTEtNzIxNTE_44b070a2-5edc-48cc-ac70-aab9100590a6"
      unitRef="usd">14000000</us-gaap:RecordedUnconditionalPurchaseObligationDueAfterFifthYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTpiNWU3ZjZjNjAwOTQ0ZDkwYjJlNWQ5MmJjMmUwMTAxMC90YWJsZXJhbmdlOmI1ZTdmNmM2MDA5NDRkOTBiMmU1ZDkyYmMyZTAxMDEwXzQtMS0xLTEtNzIxNTE_2e573eb0-d6ee-4516-a171-85d6a242d067"
      unitRef="usd">126000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTpiNWU3ZjZjNjAwOTQ0ZDkwYjJlNWQ5MmJjMmUwMTAxMC90YWJsZXJhbmdlOmI1ZTdmNmM2MDA5NDRkOTBiMmU1ZDkyYmMyZTAxMDEwXzQtMi0xLTEtNzIxNTE_26c6ffc2-4218-4e4f-80e3-5494fafc3351"
      unitRef="usd">96000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTpiNWU3ZjZjNjAwOTQ0ZDkwYjJlNWQ5MmJjMmUwMTAxMC90YWJsZXJhbmdlOmI1ZTdmNmM2MDA5NDRkOTBiMmU1ZDkyYmMyZTAxMDEwXzQtMy0xLTEtNzIxNTE_72145c84-3baa-41ef-9f34-5bf725421603"
      unitRef="usd">73000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTpiNWU3ZjZjNjAwOTQ0ZDkwYjJlNWQ5MmJjMmUwMTAxMC90YWJsZXJhbmdlOmI1ZTdmNmM2MDA5NDRkOTBiMmU1ZDkyYmMyZTAxMDEwXzQtNC0xLTEtNzIxNTE_343d4510-5643-4b13-8d43-b9a3409a1b9f"
      unitRef="usd">54000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTpiNWU3ZjZjNjAwOTQ0ZDkwYjJlNWQ5MmJjMmUwMTAxMC90YWJsZXJhbmdlOmI1ZTdmNmM2MDA5NDRkOTBiMmU1ZDkyYmMyZTAxMDEwXzQtNS0xLTEtNzIxNTE_b4affd28-9ca2-47b8-8471-72894f288f8f"
      unitRef="usd">41000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMTgvZnJhZzo4NWUzMjFmYTkzOGI0NzhiOTAzM2ZmNWRjN2Q0NjU4Ny90YWJsZTpiNWU3ZjZjNjAwOTQ0ZDkwYjJlNWQ5MmJjMmUwMTAxMC90YWJsZXJhbmdlOmI1ZTdmNmM2MDA5NDRkOTBiMmU1ZDkyYmMyZTAxMDEwXzQtNi0xLTEtNzIxNTE_d620cdb4-08f3-47ff-a21a-81f351d956cb"
      unitRef="usd">76000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90ZXh0cmVnaW9uOjc5YjQ2OTE1MzQzZjRiNDI4ZmFlMjNjNGQwZWYzZjFjXzE4MA_692977af-ab66-4200-8398-ee332e6a211a">GOODWILL AND OTHER INTANGIBLE ASSETS&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We performed our annual impairment test for goodwill as of October 31, 2022 and determined that the carrying value of the Spine reporting unit exceeded its fair value. As a result an impairment charge of $216 was recognized in the Goodwill impairment line in the Consolidated Statements of Earnings in 2022. As of December&#160;31, 2022 goodwill of the Spine reporting unit is $1,002 after the impairment charge.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We estimated the fair value of the Spine reporting unit using a discounted cash flow analysis. Significant inputs to the analysis include assumptions for future revenue growth and operating margin. The analysis also included a rate to discount the estimated future cash flow projections to their present value, based on the reporting unit&#x2019;s estimated weighted average cost of capital. The impairment charge for the Spine reporting unit was primarily driven by the slower than anticipated recovery of surgery volumes as we emerge from the COVID-19 pandemic, the competitive pressures in the spine market and rising interest rates in the current macroeconomic environment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;For our other reporting units, we considered qualitative indicators of impairment as it was considered more likely than not that the fair values of those reporting units exceeded their respective carrying values. No impairment was identified for those reporting units in 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Future changes in the judgments, assumptions and estimates that are used in our impairment testing for goodwill, including discount and tax rates and future cash flow projections, could result in significantly different estimates of the fair values. A significant reduction in the estimated fair values could result in impairment charges that could materially affect our results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.681%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.612%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.407%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Changes in the Net Carrying Value of Goodwill by Segment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;MedSurg and Neurotechnology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Orthopaedics and Spine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,459&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,319&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12,778&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Additions and adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Foreign exchange&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(129)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,669&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,249&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12,918&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Goodwill impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(216)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(216)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Additions and adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Foreign exchange&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(88)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,935&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,945&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;14,880&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.440%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.141%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.143%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Summary of Other Intangible Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Weighted Average Amortization Period (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Less&lt;br/&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Developed technologies&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;16&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;16&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,181&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,296&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,885&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,542&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,702&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,840&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.787%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Estimated Amortization Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90ZXh0cmVnaW9uOjc5YjQ2OTE1MzQzZjRiNDI4ZmFlMjNjNGQwZWYzZjFjXzc2OTY1ODE0MDgwNzM_c03e4d83-80f7-4923-9b6e-33741caac327"
      unitRef="usd">216000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:Goodwill
      contextRef="ia066883b5f184c74a8299f3acdca8fc6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90ZXh0cmVnaW9uOjc5YjQ2OTE1MzQzZjRiNDI4ZmFlMjNjNGQwZWYzZjFjXzYwNDczMTM5NjY1MjU_637fd543-f8f1-47d9-9ae2-e86e849277c3"
      unitRef="usd">1002000000</us-gaap:Goodwill>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90ZXh0cmVnaW9uOjc5YjQ2OTE1MzQzZjRiNDI4ZmFlMjNjNGQwZWYzZjFjXzE4Nw_52fc8999-0c15-4609-82fb-021dce7cb18c">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.681%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.612%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.407%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Changes in the Net Carrying Value of Goodwill by Segment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;MedSurg and Neurotechnology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Orthopaedics and Spine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,459&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,319&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12,778&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Additions and adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Foreign exchange&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(129)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,669&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,249&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12,918&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Goodwill impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(216)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(216)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Additions and adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Foreign exchange&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(88)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,935&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,945&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;14,880&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i99398de802564a348fcf815e890ee556_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTowNGI0Zjk1Y2MyMWY0OTdiYTRkZmMxNjYyM2YwZmU4Zi90YWJsZXJhbmdlOjA0YjRmOTVjYzIxZjQ5N2JhNGRmYzE2NjIzZjBmZThmXzItMS0xLTEtNzIxNTE_09671d1b-1895-4714-849f-12fb3688b56c"
      unitRef="usd">5459000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i66bd7e5d901d4e1ba0db77e7d94fe17f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTowNGI0Zjk1Y2MyMWY0OTdiYTRkZmMxNjYyM2YwZmU4Zi90YWJsZXJhbmdlOjA0YjRmOTVjYzIxZjQ5N2JhNGRmYzE2NjIzZjBmZThmXzItMi0xLTEtNzIxNTE_41247353-08fb-4ad2-abe9-85d6f4dcdee6"
      unitRef="usd">7319000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i98963cf23d234ec1ac275e66bcfd76dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTowNGI0Zjk1Y2MyMWY0OTdiYTRkZmMxNjYyM2YwZmU4Zi90YWJsZXJhbmdlOjA0YjRmOTVjYzIxZjQ5N2JhNGRmYzE2NjIzZjBmZThmXzItMy0xLTEtNzIxNTE_a351f07b-353e-4ef9-9941-1e6026e4d7a7"
      unitRef="usd">12778000000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="idac1c88764c44335aba1807e0a6c5920_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTowNGI0Zjk1Y2MyMWY0OTdiYTRkZmMxNjYyM2YwZmU4Zi90YWJsZXJhbmdlOjA0YjRmOTVjYzIxZjQ5N2JhNGRmYzE2NjIzZjBmZThmXzMtMS0xLTEtNzIxNTE_48ec5b26-368e-430a-aa72-306325a7aa58"
      unitRef="usd">223000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i383cf58c47f8466aaa98e0e267a0ec66_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTowNGI0Zjk1Y2MyMWY0OTdiYTRkZmMxNjYyM2YwZmU4Zi90YWJsZXJhbmdlOjA0YjRmOTVjYzIxZjQ5N2JhNGRmYzE2NjIzZjBmZThmXzMtMi0xLTEtNzIxNTE_6fbb80d4-9a34-4df5-833b-58e66846660b"
      unitRef="usd">59000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTowNGI0Zjk1Y2MyMWY0OTdiYTRkZmMxNjYyM2YwZmU4Zi90YWJsZXJhbmdlOjA0YjRmOTVjYzIxZjQ5N2JhNGRmYzE2NjIzZjBmZThmXzMtMy0xLTEtNzIxNTE_fd86fd70-a521-47f0-a4ab-1962cef78459"
      unitRef="usd">282000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="idac1c88764c44335aba1807e0a6c5920_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTowNGI0Zjk1Y2MyMWY0OTdiYTRkZmMxNjYyM2YwZmU4Zi90YWJsZXJhbmdlOjA0YjRmOTVjYzIxZjQ5N2JhNGRmYzE2NjIzZjBmZThmXzQtMS0xLTEtNzIxNTE_ea6a3f42-3dc9-48b9-bab5-6ad79554f7e3"
      unitRef="usd">-13000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i383cf58c47f8466aaa98e0e267a0ec66_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTowNGI0Zjk1Y2MyMWY0OTdiYTRkZmMxNjYyM2YwZmU4Zi90YWJsZXJhbmdlOjA0YjRmOTVjYzIxZjQ5N2JhNGRmYzE2NjIzZjBmZThmXzQtMi0xLTEtNzIxNTE_9f95e3dd-f195-4729-afb4-2f51d030a42b"
      unitRef="usd">-129000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTowNGI0Zjk1Y2MyMWY0OTdiYTRkZmMxNjYyM2YwZmU4Zi90YWJsZXJhbmdlOjA0YjRmOTVjYzIxZjQ5N2JhNGRmYzE2NjIzZjBmZThmXzQtMy0xLTEtNzIxNTE_d365a50d-1d84-4026-a02e-9eb67be12805"
      unitRef="usd">-142000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:Goodwill
      contextRef="ic886ff9d842041ae963fe57a90894324_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTowNGI0Zjk1Y2MyMWY0OTdiYTRkZmMxNjYyM2YwZmU4Zi90YWJsZXJhbmdlOjA0YjRmOTVjYzIxZjQ5N2JhNGRmYzE2NjIzZjBmZThmXzUtMS0xLTEtNzIxNTE_e4009029-d728-446d-b8a4-f944d573e937"
      unitRef="usd">5669000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i2984e4fb7f95431db5d16c82e29be4ae_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTowNGI0Zjk1Y2MyMWY0OTdiYTRkZmMxNjYyM2YwZmU4Zi90YWJsZXJhbmdlOjA0YjRmOTVjYzIxZjQ5N2JhNGRmYzE2NjIzZjBmZThmXzUtMi0xLTEtNzIxNTE_b425ec94-35fa-4316-9b82-eb17268f0a6f"
      unitRef="usd">7249000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTowNGI0Zjk1Y2MyMWY0OTdiYTRkZmMxNjYyM2YwZmU4Zi90YWJsZXJhbmdlOjA0YjRmOTVjYzIxZjQ5N2JhNGRmYzE2NjIzZjBmZThmXzUtMy0xLTEtNzIxNTE_ce6870e0-7f9e-4697-8895-2cad9391529c"
      unitRef="usd">12918000000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i953031f47dfd4ab48296f976c579f48f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTowNGI0Zjk1Y2MyMWY0OTdiYTRkZmMxNjYyM2YwZmU4Zi90YWJsZXJhbmdlOjA0YjRmOTVjYzIxZjQ5N2JhNGRmYzE2NjIzZjBmZThmXzctMS0xLTEtODE4ODU_17dd00fb-664d-4d95-80ee-cafb9d89b83d"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i59e41efd1cf44cedb5a90caceaa03aff_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTowNGI0Zjk1Y2MyMWY0OTdiYTRkZmMxNjYyM2YwZmU4Zi90YWJsZXJhbmdlOjA0YjRmOTVjYzIxZjQ5N2JhNGRmYzE2NjIzZjBmZThmXzctMi0xLTEtODE4ODU_1f16f444-bcf6-46d2-83c2-10e0fb83de2b"
      unitRef="usd">216000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTowNGI0Zjk1Y2MyMWY0OTdiYTRkZmMxNjYyM2YwZmU4Zi90YWJsZXJhbmdlOjA0YjRmOTVjYzIxZjQ5N2JhNGRmYzE2NjIzZjBmZThmXzctMy0xLTEtODE4ODU_c18be369-bf88-4299-a72c-8ab208a1f1b0"
      unitRef="usd">216000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i953031f47dfd4ab48296f976c579f48f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTowNGI0Zjk1Y2MyMWY0OTdiYTRkZmMxNjYyM2YwZmU4Zi90YWJsZXJhbmdlOjA0YjRmOTVjYzIxZjQ5N2JhNGRmYzE2NjIzZjBmZThmXzYtMS0xLTEtNzIxNTE_59563cab-8870-4f6c-99af-bf5ab5ba3898"
      unitRef="usd">2320000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i59e41efd1cf44cedb5a90caceaa03aff_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTowNGI0Zjk1Y2MyMWY0OTdiYTRkZmMxNjYyM2YwZmU4Zi90YWJsZXJhbmdlOjA0YjRmOTVjYzIxZjQ5N2JhNGRmYzE2NjIzZjBmZThmXzYtMi0xLTEtNzIxNTE_1c3d896f-1089-4609-8b49-ffd3d4e9c450"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTowNGI0Zjk1Y2MyMWY0OTdiYTRkZmMxNjYyM2YwZmU4Zi90YWJsZXJhbmdlOjA0YjRmOTVjYzIxZjQ5N2JhNGRmYzE2NjIzZjBmZThmXzYtMy0xLTEtNzIxNTE_8ba497b3-746c-4add-941e-d09338f91046"
      unitRef="usd">2320000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i953031f47dfd4ab48296f976c579f48f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTowNGI0Zjk1Y2MyMWY0OTdiYTRkZmMxNjYyM2YwZmU4Zi90YWJsZXJhbmdlOjA0YjRmOTVjYzIxZjQ5N2JhNGRmYzE2NjIzZjBmZThmXzctMS0xLTEtNzIxNTE_957e442c-716c-4846-b6de-c2e508ef1358"
      unitRef="usd">-54000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i59e41efd1cf44cedb5a90caceaa03aff_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTowNGI0Zjk1Y2MyMWY0OTdiYTRkZmMxNjYyM2YwZmU4Zi90YWJsZXJhbmdlOjA0YjRmOTVjYzIxZjQ5N2JhNGRmYzE2NjIzZjBmZThmXzctMi0xLTEtNzIxNTE_d818bbb0-16ff-4b68-860e-35c54a3375a6"
      unitRef="usd">-88000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTowNGI0Zjk1Y2MyMWY0OTdiYTRkZmMxNjYyM2YwZmU4Zi90YWJsZXJhbmdlOjA0YjRmOTVjYzIxZjQ5N2JhNGRmYzE2NjIzZjBmZThmXzctMy0xLTEtNzIxNTE_317a9406-8cde-4445-8115-79e862f607c9"
      unitRef="usd">-142000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:Goodwill
      contextRef="i249998c655604f398e1944b84271a97b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTowNGI0Zjk1Y2MyMWY0OTdiYTRkZmMxNjYyM2YwZmU4Zi90YWJsZXJhbmdlOjA0YjRmOTVjYzIxZjQ5N2JhNGRmYzE2NjIzZjBmZThmXzgtMS0xLTEtNzIxNTE_6f3afe92-f2e8-4a10-960b-330627d5e824"
      unitRef="usd">7935000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="iaf16c26d2de44c14872459c255d8e314_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTowNGI0Zjk1Y2MyMWY0OTdiYTRkZmMxNjYyM2YwZmU4Zi90YWJsZXJhbmdlOjA0YjRmOTVjYzIxZjQ5N2JhNGRmYzE2NjIzZjBmZThmXzgtMi0xLTEtNzIxNTE_8bdf9d18-132f-4847-a0dd-5f5b4c29606c"
      unitRef="usd">6945000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTowNGI0Zjk1Y2MyMWY0OTdiYTRkZmMxNjYyM2YwZmU4Zi90YWJsZXJhbmdlOjA0YjRmOTVjYzIxZjQ5N2JhNGRmYzE2NjIzZjBmZThmXzgtMy0xLTEtNzIxNTE_e325a3d5-005f-4a5e-8253-ecb8ce65f6f8"
      unitRef="usd">14880000000</us-gaap:Goodwill>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90ZXh0cmVnaW9uOjc5YjQ2OTE1MzQzZjRiNDI4ZmFlMjNjNGQwZWYzZjFjXzE5NQ_d2d403a6-cad1-44ed-8c5b-24e4042fc9ed">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.440%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.141%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.143%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Summary of Other Intangible Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Weighted Average Amortization Period (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Less&lt;br/&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Developed technologies&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;16&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;16&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,181&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,296&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,885&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,542&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,702&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,840&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ib35db1f319504c6ea1b123bab6945625_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzMtMS0xLTEtNzIxNTE_8359760c-9363-433b-8e34-df6b0db0261b">P14Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i82108a7656a74aa1ba61a08ab02857ce_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzMtMi0xLTEtNzIxNTE_1aa08396-7417-4bfc-9a48-23a5dd31d32e"
      unitRef="usd">5440000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i82108a7656a74aa1ba61a08ab02857ce_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzMtMy0xLTEtNzIxNTE_dc5b6b97-1af0-4210-a8a7-4ed42f465e45"
      unitRef="usd">2363000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i82108a7656a74aa1ba61a08ab02857ce_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzMtNC0xLTEtNzIxNTE_c285dacc-21ae-4417-b416-830242b02dbb"
      unitRef="usd">3077000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="icb79db6333c349f3923f8d6854ee0198_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzQtMS0xLTEtNzIxNTE_5b3350c7-7d55-46a9-ad1e-1b2544c46c53">P13Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i7267f78ac6824fc7b4d41470e9de6320_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzQtMi0xLTEtNzIxNTE_38de429c-676e-4c9d-a250-0bd43e91f631"
      unitRef="usd">5326000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i7267f78ac6824fc7b4d41470e9de6320_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzQtMy0xLTEtNzIxNTE_03f9705d-6191-441f-ae62-94c43de205a4"
      unitRef="usd">1956000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i7267f78ac6824fc7b4d41470e9de6320_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzQtNC0xLTEtNzIxNTE_2fbc4901-c690-49d2-8dd6-91aabbc258f2"
      unitRef="usd">3370000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i616a24284ffb4103824360aa36bae0d7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzYtMS0xLTEtNzIxNTE_6fbb7cfd-753d-4b8a-88df-da63738e0042">P15Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ic6769f38cd4f4dbe805725de19af7ac7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzYtMi0xLTEtNzIxNTE_c5e67cbc-abdd-4645-a301-f4943329ef63"
      unitRef="usd">2847000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic6769f38cd4f4dbe805725de19af7ac7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzYtMy0xLTEtNzIxNTE_857c5896-9cf4-42dd-aea0-dcdd213234a9"
      unitRef="usd">1322000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ic6769f38cd4f4dbe805725de19af7ac7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzYtNC0xLTEtNzIxNTE_bbfd6ce9-e030-4ed9-9500-21514a8101db"
      unitRef="usd">1525000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i7705b5434d5d4d54a9a81030e299a394_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzctMS0xLTEtNzIxNTE_fdcb7a86-6132-45eb-beaf-4b2ddbf3c923">P15Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i7803940663364a5c97229c2f0f778b60_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzctMi0xLTEtNzIxNTE_cab67830-2a85-4230-9eac-7c2eb8c7d576"
      unitRef="usd">2324000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i7803940663364a5c97229c2f0f778b60_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzctMy0xLTEtNzIxNTE_7a43b4d1-4d0e-434c-b795-11c6f37249b7"
      unitRef="usd">1174000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i7803940663364a5c97229c2f0f778b60_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzctNC0xLTEtNzIxNTE_c3e3ae82-e2c6-410b-88da-63363e66162e"
      unitRef="usd">1150000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i0d7b307071314b9b90794e54e6a0095f_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzktMS0xLTEtNzIxNTE_a29207e0-7b7d-4e4c-a66b-c58679b71ca8">P11Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="id47b79ebee3845f3b4c19c471642577f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzktMi0xLTEtNzIxNTE_dff0ec85-b341-4115-b73b-6e17c07e2e4f"
      unitRef="usd">343000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="id47b79ebee3845f3b4c19c471642577f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzktMy0xLTEtNzIxNTE_3f2289e0-4c8a-40ea-b08d-1f4d587cddca"
      unitRef="usd">297000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="id47b79ebee3845f3b4c19c471642577f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzktNC0xLTEtNzIxNTE_1a01985e-bbbc-41bf-8d01-d7016cbfcbd9"
      unitRef="usd">46000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i53d447ff0f8a4e76984a7d915abea8ee_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzEwLTEtMS0xLTcyMTUx_92dff02e-fa3e-471d-a250-06770c6cf2a4">P12Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ie7a556e07b064f9e94a25653076cc521_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzEwLTItMS0xLTcyMTUx_7f798e11-89e7-41df-b553-3ef702e7ba41"
      unitRef="usd">343000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ie7a556e07b064f9e94a25653076cc521_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzEwLTMtMS0xLTcyMTUx_8211422a-115e-4f0e-acdb-ea6a3b1ad550"
      unitRef="usd">286000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ie7a556e07b064f9e94a25653076cc521_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzEwLTQtMS0xLTcyMTUx_4e072f6d-a4da-4165-bce8-b6a6f512f803"
      unitRef="usd">57000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ifb5f69c7b49241dfb194a09187e3c17c_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzEyLTEtMS0xLTcyMTUx_66d4188e-6769-43b2-8325-9731867391d2">P16Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i29eb6be58138460d98a6d32e536dd9e2_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzEyLTItMS0xLTcyMTUx_fae3d496-d9c7-4c1c-8b2a-fbbf8a2b0703"
      unitRef="usd">425000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i29eb6be58138460d98a6d32e536dd9e2_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzEyLTMtMS0xLTcyMTUx_dd1b9370-25fa-405d-9bbc-d8e3e0d93466"
      unitRef="usd">220000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i29eb6be58138460d98a6d32e536dd9e2_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzEyLTQtMS0xLTcyMTUx_4bc7149e-da48-4f65-b1fe-a6a846a48172"
      unitRef="usd">205000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i2a84ea92e53146cc99a4bd1d326471a9_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzEzLTEtMS0xLTcyMTUx_379129f7-08c2-4d3e-96a4-a538aa13bdbf">P16Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="iaaf6d5d43b13406a9b3c80676ac72655_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzEzLTItMS0xLTcyMTUx_eda3b5c7-9d79-45e5-a82c-a5d30d2dd1bd"
      unitRef="usd">415000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iaaf6d5d43b13406a9b3c80676ac72655_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzEzLTMtMS0xLTcyMTUx_7a3c4481-1a7f-462f-9991-613edf62a7c9"
      unitRef="usd">199000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="iaaf6d5d43b13406a9b3c80676ac72655_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzEzLTQtMS0xLTcyMTUx_cd42a1cc-6386-424b-9a66-7530370fdc2b"
      unitRef="usd">216000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i305db0433c34417b92b5c6dbeea5f263_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzE1LTItMS0xLTcyMTUx_3568ab24-cea5-4e1e-8e5b-55bf09d048c6"
      unitRef="usd">21000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i305db0433c34417b92b5c6dbeea5f263_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzE1LTMtMS0xLTcyMTUx_6433e99d-5644-4c24-a955-a3fc5a06ae87"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i305db0433c34417b92b5c6dbeea5f263_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzE1LTQtMS0xLTcyMTUx_e3d6da47-8dfc-46e0-b9af-62fb9f40c7d3"
      unitRef="usd">21000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i9538fc60a2cf48fe973a5ff07071a757_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzE2LTItMS0xLTcyMTUx_1c232ff6-2ca3-4adb-b48f-67a05c67a8a2"
      unitRef="usd">29000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i9538fc60a2cf48fe973a5ff07071a757_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzE2LTMtMS0xLTcyMTUx_e5e02235-0b6f-4c74-9500-9695a60084c2"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i9538fc60a2cf48fe973a5ff07071a757_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzE2LTQtMS0xLTcyMTUx_4773566b-d42f-4648-8082-49a62dcfc142"
      unitRef="usd">29000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="icfee61742ac544ed9c226764b8dc1c9e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzE4LTEtMS0xLTcyMTUx_be90e19e-dafd-46a3-9914-15800bdf7d14">P6Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i1626fc828d9642beb146389e00b7d1aa_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzE4LTItMS0xLTcyMTUx_e923c374-cfa1-47a2-8a31-fc2a47a62d17"
      unitRef="usd">105000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i1626fc828d9642beb146389e00b7d1aa_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzE4LTMtMS0xLTcyMTUx_8402dfd2-ca86-4a2f-af5c-c48f0a093b39"
      unitRef="usd">94000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i1626fc828d9642beb146389e00b7d1aa_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzE4LTQtMS0xLTcyMTUx_ef82c77b-2834-4fd0-938c-09a26df7aa13"
      unitRef="usd">11000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="iaaf12506ce6349e290da46b1889b2f07_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzE5LTEtMS0xLTcyMTUx_0ae1bb79-5e06-4328-8532-31d45dc8d8b9">P9Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ib2ed7e2a97b147f5a5e2f0cb1a1b8bdc_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzE5LTItMS0xLTcyMTUx_79deee27-1158-410a-a256-86752cf67966"
      unitRef="usd">105000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ib2ed7e2a97b147f5a5e2f0cb1a1b8bdc_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzE5LTMtMS0xLTcyMTUx_4721b625-c731-4da0-8653-79862b7729f0"
      unitRef="usd">87000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ib2ed7e2a97b147f5a5e2f0cb1a1b8bdc_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzE5LTQtMS0xLTcyMTUx_a0f84eb8-adb8-4d42-a9b5-1215cd1cde5c"
      unitRef="usd">18000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzIxLTEtMS0xLTcyMTUx_66ed4ec9-66c0-4934-ba62-2de7840df130">P14Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzIxLTItMS0xLTcyMTUx_b88479f4-b8af-4a68-baf1-1f3e4112df8c"
      unitRef="usd">9181000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzIxLTMtMS0xLTcyMTUx_d3640849-170c-46ac-9337-f385f387b2c7"
      unitRef="usd">4296000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzIxLTQtMS0xLTcyMTUx_2f0838fa-e4ba-4842-8ad5-8652977f88bc"
      unitRef="usd">4885000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzIyLTEtMS0xLTcyMTUx_1847cc38-db60-4122-82f0-2e50e06b4c69">P14Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzIyLTItMS0xLTcyMTUx_8a6e47b1-9c85-44fb-bb37-6869f9089fd3"
      unitRef="usd">8542000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzIyLTMtMS0xLTcyMTUx_11554282-564c-4505-aa5f-26eb77afb14a"
      unitRef="usd">3702000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTo1YWY3NGEwY2VkMTQ0ODhlYmFiODg3YTIwM2M5ODFjYi90YWJsZXJhbmdlOjVhZjc0YTBjZWQxNDQ4OGViYWI4ODdhMjAzYzk4MWNiXzIyLTQtMS0xLTcyMTUx_7d6345fc-2114-4140-b1a9-b928587def89"
      unitRef="usd">4840000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90ZXh0cmVnaW9uOjc5YjQ2OTE1MzQzZjRiNDI4ZmFlMjNjNGQwZWYzZjFjXzE3OA_64f45b04-c84c-454f-a097-6abeb054b4aa">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.787%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Estimated Amortization Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTowOWMxMjViY2Q3YzQ0ZjM0OWZlOWVmNTYzMDllNmMwMi90YWJsZXJhbmdlOjA5YzEyNWJjZDdjNDRmMzQ5ZmU5ZWY1NjMwOWU2YzAyXzItMC0xLTEtNzIxNTE_6f59ea4f-5616-4bda-8a25-991bd01a2378"
      unitRef="usd">620000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTowOWMxMjViY2Q3YzQ0ZjM0OWZlOWVmNTYzMDllNmMwMi90YWJsZXJhbmdlOjA5YzEyNWJjZDdjNDRmMzQ5ZmU5ZWY1NjMwOWU2YzAyXzItMS0xLTEtNzIxNTE_7ac52c72-aa94-4526-9189-ab7157d37235"
      unitRef="usd">588000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTowOWMxMjViY2Q3YzQ0ZjM0OWZlOWVmNTYzMDllNmMwMi90YWJsZXJhbmdlOjA5YzEyNWJjZDdjNDRmMzQ5ZmU5ZWY1NjMwOWU2YzAyXzItMi0xLTEtNzIxNTE_44cc1953-0b2f-48e1-8bc9-51d3ab130f30"
      unitRef="usd">568000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTowOWMxMjViY2Q3YzQ0ZjM0OWZlOWVmNTYzMDllNmMwMi90YWJsZXJhbmdlOjA5YzEyNWJjZDdjNDRmMzQ5ZmU5ZWY1NjMwOWU2YzAyXzItMy0xLTEtNzIxNTE_acc82ddb-9234-4d73-81d3-4776fb91ca23"
      unitRef="usd">510000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjEvZnJhZzo3OWI0NjkxNTM0M2Y0YjQyOGZhZTIzYzRkMGVmM2YxYy90YWJsZTowOWMxMjViY2Q3YzQ0ZjM0OWZlOWVmNTYzMDllNmMwMi90YWJsZXJhbmdlOjA5YzEyNWJjZDdjNDRmMzQ5ZmU5ZWY1NjMwOWU2YzAyXzItNC0xLTEtNzIxNTE_6ffd5f4e-2db8-4470-9e94-aabf8060989f"
      unitRef="usd">490000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzMxNDA_44dd1f89-095b-435c-a7c9-d92540f9b284">CAPITAL STOCK&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The aggregate number of shares of all classes of stock which we are authorized to issue is up to 1,000,500,000, divided into two classes consisting of 500,000 shares of $1 par value preferred stock and 1,000,000,000 shares of common stock with a par value of $0.10. No shares of preferred stock were outstanding on December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We made no repurchases of shares in 2022. The manner, timing and amount of repurchases are determined by management based on an evaluation of market conditions, stock price and other factors and are subject to regulatory considerations. Purchases are made from time-to-time in the open market, in privately negotiated transactions or otherwise. On December&#160;31, &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2022 the total dollar value of shares that could be purchased under our authorized repurchase program was $1,033.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Shares reserved for future compensation grants of our common stock were 23 million and 25 million&#160;on December&#160;31, 2022 and 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We measure the cost of employee stock options based on the grant-date fair value and recognize that cost using the straight-line method over the period in which a recipient is required to provide services in exchange for the options, typically the vesting period. The weighted-average fair value per share of options is estimated on the date of grant using the Black-Scholes option pricing model. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.060%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.555%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.555%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Option Value and Assumptions&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Weighted-average fair value per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;68.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;53.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;39.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Assumptions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Expected stock price volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;27.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;26.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Expected option life (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The risk-free interest rate for periods within the expected life of options granted is based on the United States Treasury yield curve in effect at the time of grant. Expected stock price volatility is based on the historical volatility of our stock. The expected option life, representing the period of time that options granted are expected to be outstanding, is based on historical option exercise and employee termination data. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.819%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.479%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.173%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.513%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.196%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="24" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;2022 Stock Option Activity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Shares &lt;br/&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Exercise&#160;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Remaining&lt;br/&gt;Term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Outstanding January&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12.1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;150.17&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;248.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;102.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Canceled or forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;220.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Outstanding December&#160;31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12.1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;168.80&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;925.3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Exercisable December&#160;31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;131.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;819.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Options expected to vest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;222.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;102.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The aggregate intrinsic value of options, which represents the cumulative difference between the fair market value of the underlying common stock and the option exercise prices, exercised was $218, $253, and $258 in 2022, 2021 and 2020. Exercise prices for options outstanding ranged from $64.01 to $270.94 on December&#160;31, 2022. On December&#160;31, 2022 there was $111 of unrecognized compensation cost related to nonvested stock options granted under the long-term incentive plans; that cost is expected to be recognized over the weighted-average period of approximately 1.6 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.460%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.460%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.217%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Restricted Stock Units (RSUs) and Performance Stock Units (PSUs) Activity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Shares&lt;br/&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Grant&#160;Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;PSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;PSUs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Nonvested on January 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;0.7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;0.2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;213.16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;210.73&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;239.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;237.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;204.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;179.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Canceled or forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;225.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;179.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Nonvested on December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;0.7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;0.2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;232.02&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;234.70&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On December&#160;31, 2022 there was $72 of unrecognized compensation cost related to nonvested RSUs. That cost is expected to be recognized as expense over the weighted-average period of approximately one year. The weighted-average grant date fair value per share of RSUs granted was $239.76 and $230.61 in 2022 and 2021. The fair value of RSUs and PSUs vested in 2022 was $75 and $14. On December&#160;31, 2022 there was $18 of unrecognized compensation cost related to nonvested PSUs; the cost is expected to be recognized as expense over the weighted-average period of approximately one year. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Employee Stock Purchase Plans (ESPP)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Employees may participate in our ESPP provided they meet certain eligibility requirements. The purchase price for our common stock under the terms of the ESPP is defined as 95% of the closing stock price on the last trading day of a purchase period. We issued 221,387 and 183,964 shares under the ESPP in 2022 and 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <syk:CommonAndPreferredStockSharesAuthorized
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzEyNQ_eb893227-df7e-446a-ad0f-8d7baffceae1"
      unitRef="shares">1000500000</syk:CommonAndPreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzE2OA_c3467406-c8c1-4638-89c7-5a0e2f1bde19"
      unitRef="shares">500000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzE4MQ_0633215f-3058-411b-9532-a5bffa28dbdd"
      unitRef="usdPerShare">1</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzIxNA_06c5be7e-ef80-4684-bdb8-40e1176f8b0a"
      unitRef="shares">1000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzI2MA_6e28b085-aabe-4ffb-a6b7-4e4656bcbe04"
      unitRef="usdPerShare">0.10</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzI2NA_255282ee-b5fa-43b1-bae8-78d63974a0e4"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzc2Nw_880025e7-a8df-44a8-9769-9cb74ae913dd"
      unitRef="usd">1033000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzg0Mw_242abf8d-3e0c-4eb9-b010-42d03f4dc4d6"
      unitRef="shares">23000000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzg1OA_f8ebcdf3-cf55-41d1-bb3f-fc6efc6fc33d"
      unitRef="shares">25000000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzMxMzE_fc9537d3-8519-435f-b994-99198b3317f3">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.060%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.555%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.555%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Option Value and Assumptions&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Weighted-average fair value per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;68.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;53.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;39.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Assumptions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Expected stock price volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;27.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;26.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Expected option life (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTpkZjdjOWFkMzFiODY0MDNlOGM4MDE1Y2UyMDVhOThlZS90YWJsZXJhbmdlOmRmN2M5YWQzMWI4NjQwM2U4YzgwMTVjZTIwNWE5OGVlXzItMS0xLTEtNzIxNTE_627e8f32-6163-4d42-8319-60949bcdce55"
      unitRef="usdPerShare">68.08</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTpkZjdjOWFkMzFiODY0MDNlOGM4MDE1Y2UyMDVhOThlZS90YWJsZXJhbmdlOmRmN2M5YWQzMWI4NjQwM2U4YzgwMTVjZTIwNWE5OGVlXzItMy0xLTEtNzIxNTE_4a4755b3-da82-459a-b021-1ba006b7557d"
      unitRef="usdPerShare">53.35</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTpkZjdjOWFkMzFiODY0MDNlOGM4MDE1Y2UyMDVhOThlZS90YWJsZXJhbmdlOmRmN2M5YWQzMWI4NjQwM2U4YzgwMTVjZTIwNWE5OGVlXzItNS0xLTEtNzIxNTE_aacb38c6-6cdd-489b-bbae-af160594f8c0"
      unitRef="usdPerShare">39.34</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTpkZjdjOWFkMzFiODY0MDNlOGM4MDE1Y2UyMDVhOThlZS90YWJsZXJhbmdlOmRmN2M5YWQzMWI4NjQwM2U4YzgwMTVjZTIwNWE5OGVlXzQtMS0xLTEtNzIxNTE_3ea34bd9-27de-4cfd-b42a-f39c14a079a7"
      unitRef="number">0.018</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTpkZjdjOWFkMzFiODY0MDNlOGM4MDE1Y2UyMDVhOThlZS90YWJsZXJhbmdlOmRmN2M5YWQzMWI4NjQwM2U4YzgwMTVjZTIwNWE5OGVlXzQtMy0xLTEtNzIxNTE_bd56e752-8da3-4627-bb91-8280e24ef61c"
      unitRef="number">0.008</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTpkZjdjOWFkMzFiODY0MDNlOGM4MDE1Y2UyMDVhOThlZS90YWJsZXJhbmdlOmRmN2M5YWQzMWI4NjQwM2U4YzgwMTVjZTIwNWE5OGVlXzQtNS0xLTEtNzIxNTE_d659b758-e323-49a6-b04d-19f06a0688de"
      unitRef="number">0.014</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTpkZjdjOWFkMzFiODY0MDNlOGM4MDE1Y2UyMDVhOThlZS90YWJsZXJhbmdlOmRmN2M5YWQzMWI4NjQwM2U4YzgwMTVjZTIwNWE5OGVlXzUtMS0xLTEtNzIxNTE_ea0a8c36-90dd-4f2c-bb09-df5a554dd0c7"
      unitRef="number">0.010</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTpkZjdjOWFkMzFiODY0MDNlOGM4MDE1Y2UyMDVhOThlZS90YWJsZXJhbmdlOmRmN2M5YWQzMWI4NjQwM2U4YzgwMTVjZTIwNWE5OGVlXzUtMy0xLTEtNzIxNTE_d0591de0-0133-4ebf-a5d1-aa3485c19f59"
      unitRef="number">0.012</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTpkZjdjOWFkMzFiODY0MDNlOGM4MDE1Y2UyMDVhOThlZS90YWJsZXJhbmdlOmRmN2M5YWQzMWI4NjQwM2U4YzgwMTVjZTIwNWE5OGVlXzUtNS0xLTEtNzIxNTE_8f5cef7a-f583-499b-a07b-aa28f089b42a"
      unitRef="number">0.010</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTpkZjdjOWFkMzFiODY0MDNlOGM4MDE1Y2UyMDVhOThlZS90YWJsZXJhbmdlOmRmN2M5YWQzMWI4NjQwM2U4YzgwMTVjZTIwNWE5OGVlXzYtMS0xLTEtNzIxNTE_08ca54e4-e937-4fcf-b8f8-a34dac9d911d"
      unitRef="number">0.270</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTpkZjdjOWFkMzFiODY0MDNlOGM4MDE1Y2UyMDVhOThlZS90YWJsZXJhbmdlOmRmN2M5YWQzMWI4NjQwM2U4YzgwMTVjZTIwNWE5OGVlXzYtMy0xLTEtNzIxNTE_9759abb1-2599-4883-999b-8b02d8cbabc1"
      unitRef="number">0.269</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTpkZjdjOWFkMzFiODY0MDNlOGM4MDE1Y2UyMDVhOThlZS90YWJsZXJhbmdlOmRmN2M5YWQzMWI4NjQwM2U4YzgwMTVjZTIwNWE5OGVlXzYtNS0xLTEtNzIxNTE_3b591fa7-5c31-404c-a52f-3c27cec6cf1d"
      unitRef="number">0.189</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTpkZjdjOWFkMzFiODY0MDNlOGM4MDE1Y2UyMDVhOThlZS90YWJsZXJhbmdlOmRmN2M5YWQzMWI4NjQwM2U4YzgwMTVjZTIwNWE5OGVlXzctMS0xLTEtNzIxNTE_0dc4e224-b35d-4bcb-b1ed-a34120a74a88">P5Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTpkZjdjOWFkMzFiODY0MDNlOGM4MDE1Y2UyMDVhOThlZS90YWJsZXJhbmdlOmRmN2M5YWQzMWI4NjQwM2U4YzgwMTVjZTIwNWE5OGVlXzctMy0xLTEtNzIxNTE_37440adc-0ae0-4f64-a397-0c9d0bf001b0">P5Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTpkZjdjOWFkMzFiODY0MDNlOGM4MDE1Y2UyMDVhOThlZS90YWJsZXJhbmdlOmRmN2M5YWQzMWI4NjQwM2U4YzgwMTVjZTIwNWE5OGVlXzctNS0xLTEtNzIxNTE_85c15c8d-ccb3-4213-8b6a-3bfaab422b78">P5Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzMxMzQ_04ac0e8e-2bfb-42ab-b30b-947e0f6d8c97">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.819%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.479%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.173%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.513%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.196%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="24" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;2022 Stock Option Activity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Shares &lt;br/&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Exercise&#160;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Remaining&lt;br/&gt;Term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Outstanding January&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12.1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;150.17&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;248.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;102.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Canceled or forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;220.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Outstanding December&#160;31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12.1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;168.80&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;925.3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Exercisable December&#160;31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;131.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;819.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Options expected to vest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;222.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;102.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTo0MmVjMzUwOTZiM2Y0MTU2OGQ1ZDA4ODM0YmYzMzgxNi90YWJsZXJhbmdlOjQyZWMzNTA5NmIzZjQxNTY4ZDVkMDg4MzRiZjMzODE2XzItMS0xLTEtNzIxNTE_6957f917-6100-48fd-b196-bf55595f78db"
      unitRef="shares">12100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTo0MmVjMzUwOTZiM2Y0MTU2OGQ1ZDA4ODM0YmYzMzgxNi90YWJsZXJhbmdlOjQyZWMzNTA5NmIzZjQxNTY4ZDVkMDg4MzRiZjMzODE2XzItMy0xLTEtNzIxNTE_99f8fa5a-d174-4bab-9442-254a12fee409"
      unitRef="usdPerShare">150.17</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTo0MmVjMzUwOTZiM2Y0MTU2OGQ1ZDA4ODM0YmYzMzgxNi90YWJsZXJhbmdlOjQyZWMzNTA5NmIzZjQxNTY4ZDVkMDg4MzRiZjMzODE2XzMtMS0xLTEtNzIxNTE_e12c4e14-0b9e-4533-97e3-8fb9f34b10ea"
      unitRef="shares">1900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTo0MmVjMzUwOTZiM2Y0MTU2OGQ1ZDA4ODM0YmYzMzgxNi90YWJsZXJhbmdlOjQyZWMzNTA5NmIzZjQxNTY4ZDVkMDg4MzRiZjMzODE2XzMtMy0xLTEtNzIxNTE_9558acbd-8316-4821-946a-21c7490a60ac"
      unitRef="usdPerShare">248.36</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTo0MmVjMzUwOTZiM2Y0MTU2OGQ1ZDA4ODM0YmYzMzgxNi90YWJsZXJhbmdlOjQyZWMzNTA5NmIzZjQxNTY4ZDVkMDg4MzRiZjMzODE2XzQtMS0xLTEtNzIxNTE_04a9e41e-6a41-457d-a6a1-4303c69fd46c"
      unitRef="shares">1500000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTo0MmVjMzUwOTZiM2Y0MTU2OGQ1ZDA4ODM0YmYzMzgxNi90YWJsZXJhbmdlOjQyZWMzNTA5NmIzZjQxNTY4ZDVkMDg4MzRiZjMzODE2XzQtMy0xLTEtNzIxNTE_52936ccc-f6de-44ef-885f-e7661b08d282"
      unitRef="usdPerShare">102.85</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTo0MmVjMzUwOTZiM2Y0MTU2OGQ1ZDA4ODM0YmYzMzgxNi90YWJsZXJhbmdlOjQyZWMzNTA5NmIzZjQxNTY4ZDVkMDg4MzRiZjMzODE2XzUtMS0xLTEtNzIxNTE_ccea0bc6-e3a0-470b-9f41-88be47457462"
      unitRef="shares">400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTo0MmVjMzUwOTZiM2Y0MTU2OGQ1ZDA4ODM0YmYzMzgxNi90YWJsZXJhbmdlOjQyZWMzNTA5NmIzZjQxNTY4ZDVkMDg4MzRiZjMzODE2XzUtMy0xLTEtNzIxNTE_f07b04b3-ef1b-4f5c-9c54-16ed7ce6919e"
      unitRef="usdPerShare">220.16</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTo0MmVjMzUwOTZiM2Y0MTU2OGQ1ZDA4ODM0YmYzMzgxNi90YWJsZXJhbmdlOjQyZWMzNTA5NmIzZjQxNTY4ZDVkMDg4MzRiZjMzODE2XzYtMS0xLTEtNzIxNTE_d40f67e6-82f8-4a92-8025-f5b7af7cc78b"
      unitRef="shares">12100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTo0MmVjMzUwOTZiM2Y0MTU2OGQ1ZDA4ODM0YmYzMzgxNi90YWJsZXJhbmdlOjQyZWMzNTA5NmIzZjQxNTY4ZDVkMDg4MzRiZjMzODE2XzYtMy0xLTEtNzIxNTE_6adedb9e-3158-4b16-b6cc-c3902db211ad"
      unitRef="usdPerShare">168.80</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTo0MmVjMzUwOTZiM2Y0MTU2OGQ1ZDA4ODM0YmYzMzgxNi90YWJsZXJhbmdlOjQyZWMzNTA5NmIzZjQxNTY4ZDVkMDg4MzRiZjMzODE2XzYtNS0xLTEtNzIxNTE_9266f6fe-6a44-4809-8719-715954bed63f">P5Y4M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTo0MmVjMzUwOTZiM2Y0MTU2OGQ1ZDA4ODM0YmYzMzgxNi90YWJsZXJhbmdlOjQyZWMzNTA5NmIzZjQxNTY4ZDVkMDg4MzRiZjMzODE2XzYtNy0xLTEtNzIxNTE_1fd6ccb7-3476-4664-8fbb-c24d01be7cab"
      unitRef="usd">925300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTo0MmVjMzUwOTZiM2Y0MTU2OGQ1ZDA4ODM0YmYzMzgxNi90YWJsZXJhbmdlOjQyZWMzNTA5NmIzZjQxNTY4ZDVkMDg4MzRiZjMzODE2XzctMS0xLTEtNzIxNTE_f6148dc7-59a8-41de-80d0-dee5cc4780fc"
      unitRef="shares">7200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTo0MmVjMzUwOTZiM2Y0MTU2OGQ1ZDA4ODM0YmYzMzgxNi90YWJsZXJhbmdlOjQyZWMzNTA5NmIzZjQxNTY4ZDVkMDg4MzRiZjMzODE2XzctMy0xLTEtNzIxNTE_320cdcd8-564b-4ca3-b0e6-d62dcf469a63"
      unitRef="usdPerShare">131.38</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTo0MmVjMzUwOTZiM2Y0MTU2OGQ1ZDA4ODM0YmYzMzgxNi90YWJsZXJhbmdlOjQyZWMzNTA5NmIzZjQxNTY4ZDVkMDg4MzRiZjMzODE2XzctNS0xLTEtNzIxNTE_cfeb04c7-598e-4a6e-ac67-116bdd017b1c">P3Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTo0MmVjMzUwOTZiM2Y0MTU2OGQ1ZDA4ODM0YmYzMzgxNi90YWJsZXJhbmdlOjQyZWMzNTA5NmIzZjQxNTY4ZDVkMDg4MzRiZjMzODE2XzctNy0xLTEtNzIxNTE_b4682d2d-8dcb-4d1c-89f6-af83b92ebe94"
      unitRef="usd">819200000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTo0MmVjMzUwOTZiM2Y0MTU2OGQ1ZDA4ODM0YmYzMzgxNi90YWJsZXJhbmdlOjQyZWMzNTA5NmIzZjQxNTY4ZDVkMDg4MzRiZjMzODE2XzgtMS0xLTEtNzIxNTE_130a2fa7-0e7f-474b-aa41-e2f89a338384"
      unitRef="shares">4400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTo0MmVjMzUwOTZiM2Y0MTU2OGQ1ZDA4ODM0YmYzMzgxNi90YWJsZXJhbmdlOjQyZWMzNTA5NmIzZjQxNTY4ZDVkMDg4MzRiZjMzODE2XzgtMy0xLTEtNzIxNTE_778c4531-03e0-4541-a4af-9c5f55b2673f"
      unitRef="usdPerShare">222.62</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTo0MmVjMzUwOTZiM2Y0MTU2OGQ1ZDA4ODM0YmYzMzgxNi90YWJsZXJhbmdlOjQyZWMzNTA5NmIzZjQxNTY4ZDVkMDg4MzRiZjMzODE2XzgtNS0xLTEtNzIxNTE_9ea0b8cd-5d47-48e5-b44b-fd345b905fb2">P7Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTo0MmVjMzUwOTZiM2Y0MTU2OGQ1ZDA4ODM0YmYzMzgxNi90YWJsZXJhbmdlOjQyZWMzNTA5NmIzZjQxNTY4ZDVkMDg4MzRiZjMzODE2XzgtNy0xLTEtNzIxNTE_0418f460-112c-401e-bf5a-263d3728c398"
      unitRef="usd">102500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzE5MjU_6dc0aba8-bdf1-4448-ad7b-acebbe7f139a"
      unitRef="usd">218000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzE5Mjk_f3a4bea7-9358-4a61-95fe-8fab486c2ca6"
      unitRef="usd">253000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzE5Mzc_2973d659-a071-4e6c-a6df-27f6754f8130"
      unitRef="usd">258000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzIwMTA_673fd089-d47b-4fcd-9324-a1e5a5e1c6f7"
      unitRef="usdPerShare">64.01</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzIwMTY_ff6f0f19-77bb-498d-897c-e4109c26dc04"
      unitRef="usdPerShare">270.94</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzIwNDI_56fa46b8-bab3-4591-9625-d016783a1012"
      unitRef="usd">111000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzIyNDg_00e38356-1b09-4576-b004-daf91cf62e42">P1Y7M6D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzMxNDg_554b6530-9939-4c63-9bc1-362bce432513">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.460%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.460%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.217%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Restricted Stock Units (RSUs) and Performance Stock Units (PSUs) Activity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Shares&lt;br/&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Grant&#160;Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;PSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;PSUs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Nonvested on January 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;0.7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;0.2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;213.16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;210.73&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;239.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;237.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;204.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;179.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Canceled or forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;225.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;179.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Nonvested on December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;0.7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;0.2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;232.02&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;234.70&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i568e131aeee143118e9dfb0c69d84d35_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTozNGY3ZWUzNzVjMTU0NGJhYWE2YzdiZjhhMjc0MjRjYy90YWJsZXJhbmdlOjM0ZjdlZTM3NWMxNTQ0YmFhYTZjN2JmOGEyNzQyNGNjXzMtMS0xLTEtNzIxNTE_c1a022f0-fcf6-4840-80f8-8f82959ae530"
      unitRef="shares">700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i76d037e2508d493fb9c5c79f64d84deb_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTozNGY3ZWUzNzVjMTU0NGJhYWE2YzdiZjhhMjc0MjRjYy90YWJsZXJhbmdlOjM0ZjdlZTM3NWMxNTQ0YmFhYTZjN2JmOGEyNzQyNGNjXzMtMy0xLTEtNzIxNTE_0973b0c2-1bf6-4c84-bc9f-f3e64ce4811a"
      unitRef="shares">200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i568e131aeee143118e9dfb0c69d84d35_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTozNGY3ZWUzNzVjMTU0NGJhYWE2YzdiZjhhMjc0MjRjYy90YWJsZXJhbmdlOjM0ZjdlZTM3NWMxNTQ0YmFhYTZjN2JmOGEyNzQyNGNjXzMtNS0xLTEtNzIxNTE_34b5e956-4764-45ba-84b6-1e24d56527ad"
      unitRef="usdPerShare">213.16</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i76d037e2508d493fb9c5c79f64d84deb_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTozNGY3ZWUzNzVjMTU0NGJhYWE2YzdiZjhhMjc0MjRjYy90YWJsZXJhbmdlOjM0ZjdlZTM3NWMxNTQ0YmFhYTZjN2JmOGEyNzQyNGNjXzMtNy0xLTEtNzIxNTE_bca1f711-2438-4c34-8f82-eeb77af0baa6"
      unitRef="usdPerShare">210.73</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="icb6424572e1a40e48c885f2c92dfe789_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTozNGY3ZWUzNzVjMTU0NGJhYWE2YzdiZjhhMjc0MjRjYy90YWJsZXJhbmdlOjM0ZjdlZTM3NWMxNTQ0YmFhYTZjN2JmOGEyNzQyNGNjXzQtMS0xLTEtNzIxNTE_33812f6d-fff1-4991-a86e-395377c66d4b"
      unitRef="shares">400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i8117cc9161634207825ffb3719f67191_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTozNGY3ZWUzNzVjMTU0NGJhYWE2YzdiZjhhMjc0MjRjYy90YWJsZXJhbmdlOjM0ZjdlZTM3NWMxNTQ0YmFhYTZjN2JmOGEyNzQyNGNjXzQtMy0xLTEtNzIxNTE_fa7fa064-5feb-4387-b8f9-32e27e95e4fb"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="icb6424572e1a40e48c885f2c92dfe789_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTozNGY3ZWUzNzVjMTU0NGJhYWE2YzdiZjhhMjc0MjRjYy90YWJsZXJhbmdlOjM0ZjdlZTM3NWMxNTQ0YmFhYTZjN2JmOGEyNzQyNGNjXzQtNS0xLTEtNzIxNTE_e75f35e8-974c-4846-b5b1-6c008d8ad04a"
      unitRef="usdPerShare">239.76</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i8117cc9161634207825ffb3719f67191_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTozNGY3ZWUzNzVjMTU0NGJhYWE2YzdiZjhhMjc0MjRjYy90YWJsZXJhbmdlOjM0ZjdlZTM3NWMxNTQ0YmFhYTZjN2JmOGEyNzQyNGNjXzQtNy0xLTEtNzIxNTE_92bad318-49ba-4494-af15-dbc1b7a48132"
      unitRef="usdPerShare">237.17</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="icb6424572e1a40e48c885f2c92dfe789_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTozNGY3ZWUzNzVjMTU0NGJhYWE2YzdiZjhhMjc0MjRjYy90YWJsZXJhbmdlOjM0ZjdlZTM3NWMxNTQ0YmFhYTZjN2JmOGEyNzQyNGNjXzUtMS0xLTEtNzIxNTE_55f95196-6101-4615-9ec3-269fbebe3f64"
      unitRef="shares">300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i8117cc9161634207825ffb3719f67191_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTozNGY3ZWUzNzVjMTU0NGJhYWE2YzdiZjhhMjc0MjRjYy90YWJsZXJhbmdlOjM0ZjdlZTM3NWMxNTQ0YmFhYTZjN2JmOGEyNzQyNGNjXzUtMy0xLTEtNzIxNTE_04cf8999-fb1e-4713-b8de-3f2b14f876b6"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="icb6424572e1a40e48c885f2c92dfe789_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTozNGY3ZWUzNzVjMTU0NGJhYWE2YzdiZjhhMjc0MjRjYy90YWJsZXJhbmdlOjM0ZjdlZTM3NWMxNTQ0YmFhYTZjN2JmOGEyNzQyNGNjXzUtNS0xLTEtNzIxNTE_629cd269-11d2-4463-9fe3-d1276c3431b1"
      unitRef="usdPerShare">204.62</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i8117cc9161634207825ffb3719f67191_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTozNGY3ZWUzNzVjMTU0NGJhYWE2YzdiZjhhMjc0MjRjYy90YWJsZXJhbmdlOjM0ZjdlZTM3NWMxNTQ0YmFhYTZjN2JmOGEyNzQyNGNjXzUtNy0xLTEtNzIxNTE_6ce51dfa-744b-4afc-b664-8543ca48f08e"
      unitRef="usdPerShare">179.35</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="icb6424572e1a40e48c885f2c92dfe789_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTozNGY3ZWUzNzVjMTU0NGJhYWE2YzdiZjhhMjc0MjRjYy90YWJsZXJhbmdlOjM0ZjdlZTM3NWMxNTQ0YmFhYTZjN2JmOGEyNzQyNGNjXzYtMS0xLTEtNzIxNTE_830d3780-8349-4322-b9ef-34d5598bf9e3"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i8117cc9161634207825ffb3719f67191_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTozNGY3ZWUzNzVjMTU0NGJhYWE2YzdiZjhhMjc0MjRjYy90YWJsZXJhbmdlOjM0ZjdlZTM3NWMxNTQ0YmFhYTZjN2JmOGEyNzQyNGNjXzYtMy0xLTEtNzIxNTE_16ab5986-94be-4ffd-b414-96254771274f"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="icb6424572e1a40e48c885f2c92dfe789_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTozNGY3ZWUzNzVjMTU0NGJhYWE2YzdiZjhhMjc0MjRjYy90YWJsZXJhbmdlOjM0ZjdlZTM3NWMxNTQ0YmFhYTZjN2JmOGEyNzQyNGNjXzYtNS0xLTEtNzIxNTE_7d44218d-0e78-4126-8864-d14af234bfa6"
      unitRef="usdPerShare">225.83</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i8117cc9161634207825ffb3719f67191_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTozNGY3ZWUzNzVjMTU0NGJhYWE2YzdiZjhhMjc0MjRjYy90YWJsZXJhbmdlOjM0ZjdlZTM3NWMxNTQ0YmFhYTZjN2JmOGEyNzQyNGNjXzYtNy0xLTEtNzIxNTE_822f4b74-b5aa-4d59-900e-2d93d9618c6b"
      unitRef="usdPerShare">179.35</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i8910a4c2b7d74f3fb6c50af1f492e5a0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTozNGY3ZWUzNzVjMTU0NGJhYWE2YzdiZjhhMjc0MjRjYy90YWJsZXJhbmdlOjM0ZjdlZTM3NWMxNTQ0YmFhYTZjN2JmOGEyNzQyNGNjXzctMS0xLTEtNzIxNTE_f78fbebc-3a29-4d0a-a3fb-aa1640ec3fb7"
      unitRef="shares">700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ie6221c941312452b8581e8a9deb3ac6a_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTozNGY3ZWUzNzVjMTU0NGJhYWE2YzdiZjhhMjc0MjRjYy90YWJsZXJhbmdlOjM0ZjdlZTM3NWMxNTQ0YmFhYTZjN2JmOGEyNzQyNGNjXzctMy0xLTEtNzIxNTE_adc5497f-401f-4ba0-a067-f5a16c84cedf"
      unitRef="shares">200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i8910a4c2b7d74f3fb6c50af1f492e5a0_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTozNGY3ZWUzNzVjMTU0NGJhYWE2YzdiZjhhMjc0MjRjYy90YWJsZXJhbmdlOjM0ZjdlZTM3NWMxNTQ0YmFhYTZjN2JmOGEyNzQyNGNjXzctNS0xLTEtNzIxNTE_15c76154-215c-4299-aa1c-13395b2a6425"
      unitRef="usdPerShare">232.02</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ie6221c941312452b8581e8a9deb3ac6a_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90YWJsZTozNGY3ZWUzNzVjMTU0NGJhYWE2YzdiZjhhMjc0MjRjYy90YWJsZXJhbmdlOjM0ZjdlZTM3NWMxNTQ0YmFhYTZjN2JmOGEyNzQyNGNjXzctNy0xLTEtNzIxNTE_2d539ebc-0323-4a67-8e07-0d64be8cbe16"
      unitRef="usdPerShare">234.70</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i8910a4c2b7d74f3fb6c50af1f492e5a0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzIyNzA_d468fcce-e2c8-482c-a5f9-8336587fd9ac"
      unitRef="usd">72000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="icb6424572e1a40e48c885f2c92dfe789_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzI0MzQ_7af961c3-a24f-4806-a4c5-5d50b25cce5b">P1Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="icb6424572e1a40e48c885f2c92dfe789_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzI1MTE_2226477d-ae9f-48a7-a51a-068f53aac8f0"
      unitRef="usdPerShare">239.76</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i3f212fe7e7364a549804bccdf2f81667_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzI1MTg_ce8e21d1-829b-4092-93f0-a568b645ce25"
      unitRef="usdPerShare">230.61</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <syk:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue
      contextRef="icb6424572e1a40e48c885f2c92dfe789_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzI1ODQ_5a290433-dd73-4f90-88d6-5defb46b5062"
      unitRef="usd">75000000</syk:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue>
    <syk:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue
      contextRef="i8117cc9161634207825ffb3719f67191_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzI1OTE_501c7c98-33df-43e5-9708-db8847d930fb"
      unitRef="usd">14000000</syk:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="ie6221c941312452b8581e8a9deb3ac6a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzI2MTE_3ceebfb6-2213-4454-8b75-e60ceb900635"
      unitRef="usd">18000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i8117cc9161634207825ffb3719f67191_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzI3NzQ_5a88bb35-8b4c-490b-9276-9f23f39c7bd7">P1Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <syk:PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp
      contextRef="ic1b406c0949449359e921c7191771a27_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzI5ODk_03190f67-11e8-4681-87bf-82b4f12aaec6"
      unitRef="number">0.95</syk:PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="ic1b406c0949449359e921c7191771a27_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzMwNzU_7e3a977a-0595-43a7-b9b6-98de80fcfcff"
      unitRef="shares">221387</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="i6d3d3f84201a45599e436e212113af2a_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjQvZnJhZzozNDQyMzMzOWEwMmQ0Mzc1OTQwMmM4ZjhiZDY4NDkyZi90ZXh0cmVnaW9uOjM0NDIzMzM5YTAyZDQzNzU5NDAyYzhmOGJkNjg0OTJmXzMwODI_880961af-8fd6-4c29-a0fa-022304a030aa"
      unitRef="shares">183964</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90ZXh0cmVnaW9uOmQ3NGM1OGM3ZmZlODQ4OWFhNWJhMDc0ZjJmN2NhMTI4XzE2OTQ_69088723-39da-4be6-839b-8bbfd5aaa4b1">DEBT AND CREDIT FACILITIES&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We have lines of credit issued by various financial institutions that are available to fund our day-to-day operating needs. Certain of our credit facilities require us to comply with financial and other covenants. We were in compliance with all covenants on December&#160;31, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In February 2022 we entered into a $1.5&#160;billion term loan agreement that matures on February 22, 2025 and bears interest at a base rate based on the Term Secured Overnight Financing Rate (SOFR) plus 0.725%. In 2022 we repaid $650 on the term loan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In 2022 our Board of Directors approved an increase to the maximum amount of commercial paper that can be outstanding from $1,500 to $2,250.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;On December&#160;31, 2022 there were no borrowings outstanding under our credit facility or commercial paper program which allows for maturities up to 397 days from the date of issuance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"&gt;&lt;tr&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.616%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.865%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.460%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.463%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Summary of Total Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Due&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Senior unsecured notes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.125%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;November 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.600%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.375%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;May 15, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.250%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 3, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.150%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 15, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.375%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;November 1, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.500%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;March 15, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.125%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;November 30, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.650%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;March 7, 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.750%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;March 1, 2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.950%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 15, 2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.625%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;November 30, 2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.000%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 3, 2031&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4.100%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;April 1, 2043&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4.375%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;May 15, 2044&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4.625%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;March 15, 2046&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.900%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 15, 2050&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Term loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;13,048&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12,479&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Less current maturities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;11,857&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12,472&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Unamortized debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Borrowing capacity on existing facilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Fair value of senior unsecured notes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The fair value of the senior unsecured notes was estimated using quoted interest rates, maturities and amounts of borrowings based on quoted active market prices and yields that took into account the underlying terms of the debt instruments. Substantially all of our debt is classified within Level 2 of the fair value hierarchy.Interest expense, including required fees incurred on outstanding debt and credit facilities that were included in other income (expense), net, totaled $337, $337, and $315 in 2022, 2021 and 2020.</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i105ea3d2ed224740a6a5bfb85f70a5e2_I20220228"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90ZXh0cmVnaW9uOmQ3NGM1OGM3ZmZlODQ4OWFhNWJhMDc0ZjJmN2NhMTI4XzEwOTk1MTE2MzAyNDg_9e5d7e21-2e70-46b8-9bec-634df33fd327"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ibaa4215050f640eda208f1aaca9866a2_D20220201-20220228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90ZXh0cmVnaW9uOmQ3NGM1OGM3ZmZlODQ4OWFhNWJhMDc0ZjJmN2NhMTI4XzEwOTk1MTE2MzAyNjk_6361070a-947a-44f4-a388-40fdafad8dff"
      unitRef="number">0.00725</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:RepaymentsOfDebt
      contextRef="i2854c59895d84a0383a8b9cde207fe65_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90ZXh0cmVnaW9uOmQ3NGM1OGM3ZmZlODQ4OWFhNWJhMDc0ZjJmN2NhMTI4XzEwOTk1MTE2MzAyODI_2323488c-333a-4b67-95e8-fecac707f47c"
      unitRef="usd">650000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i89795855715a44adb779c848669d4ad1_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90ZXh0cmVnaW9uOmQ3NGM1OGM3ZmZlODQ4OWFhNWJhMDc0ZjJmN2NhMTI4XzYwNDczMTM5NTU4OTc_7b9753a0-0bf9-410b-a16c-6221dd2acd02"
      unitRef="usd">1500000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i64f47956dd0f44a5985d1c8aa38b28cc_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90ZXh0cmVnaW9uOmQ3NGM1OGM3ZmZlODQ4OWFhNWJhMDc0ZjJmN2NhMTI4XzEwOTk1MTE2Mjk4NjQ_3452994c-f6ee-4e43-8014-84a9072ade85"
      unitRef="usd">2250000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:CommercialPaper
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90ZXh0cmVnaW9uOmQ3NGM1OGM3ZmZlODQ4OWFhNWJhMDc0ZjJmN2NhMTI4XzkxMg_b366a7a8-e168-4ad4-a039-a02c6e276542"
      unitRef="usd">0</us-gaap:CommercialPaper>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90ZXh0cmVnaW9uOmQ3NGM1OGM3ZmZlODQ4OWFhNWJhMDc0ZjJmN2NhMTI4XzE2OTk_4513416f-f3ef-43c3-a3ee-17c930563975">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"&gt;&lt;tr&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.616%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.865%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.460%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.463%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Summary of Total Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Due&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Senior unsecured notes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.125%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;November 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.600%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.375%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;May 15, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.250%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 3, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.150%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 15, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.375%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;November 1, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.500%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;March 15, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.125%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;November 30, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.650%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;March 7, 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.750%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;March 1, 2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.950%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 15, 2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.625%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;November 30, 2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.000%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 3, 2031&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4.100%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;April 1, 2043&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4.375%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;May 15, 2044&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4.625%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;March 15, 2046&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.900%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 15, 2050&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Term loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;13,048&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12,479&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Less current maturities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;11,857&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12,472&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Unamortized debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Borrowing capacity on existing facilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Fair value of senior unsecured notes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic31b7c04d93e4f11bdf14d0d9b0aad34_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzQtMS0xLTEtNzIxNTE_9e53bbda-e90e-4fc1-84d2-b0c23be1ed19"
      unitRef="number">0.01125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebt
      contextRef="ic31b7c04d93e4f11bdf14d0d9b0aad34_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzQtNS0xLTEtNzIxNTE_efe71a19-2122-42f7-8800-f00f589638d7"
      unitRef="usd">585000000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt
      contextRef="ic02d163166494d6f94e0bd14a160bf17_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzQtNy0xLTEtNzIxNTE_bfd7e77b-5e07-43ff-bec4-8d7a753a108e"
      unitRef="usd">622000000</us-gaap:UnsecuredDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i808ca3fe28c44ce78c70e8cfba12ca6e_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzUtMS0xLTEtNzIxNTE_b36d93b8-6c06-4023-8be0-8a1710960992"
      unitRef="number">0.00600</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebt
      contextRef="i808ca3fe28c44ce78c70e8cfba12ca6e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzUtNS0xLTEtNzIxNTE_1d7e24ff-7851-451f-bef3-59a303719e14"
      unitRef="usd">599000000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt
      contextRef="i15d5d81e0cbe495ebd1b69e9445e539d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzUtNy0xLTEtNzIxNTE_0046b7e1-29e2-4ea9-8260-c34b8a1255c6"
      unitRef="usd">598000000</us-gaap:UnsecuredDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i86a207f857004a4ca1e3d7fed25c46b2_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzYtMS0xLTEtNzIxNTE_478ff2f5-33c3-42ec-9cb0-d4158ad8e876"
      unitRef="number">0.03375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebt
      contextRef="i86a207f857004a4ca1e3d7fed25c46b2_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzYtNS0xLTEtNzIxNTE_67a797aa-7a84-4aea-8f38-178766fcaea9"
      unitRef="usd">596000000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt
      contextRef="i60b7b81e39cd453c88fb43773dc15431_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzYtNy0xLTEtNzIxNTE_3285e1d7-a7ef-419b-98a0-9ff17d8b0eb2"
      unitRef="usd">593000000</us-gaap:UnsecuredDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2a78ebbcbe3e4dcf9d2beb2467073be6_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzctMS0xLTEtNzIxNTE_43b25e0e-7b44-4ed2-ba17-07ad8e5f61e7"
      unitRef="number">0.00250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebt
      contextRef="i2a78ebbcbe3e4dcf9d2beb2467073be6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzctNS0xLTEtNzIxNTE_c54d37e1-fdfd-43d8-b4a5-b41b7a61b3ee"
      unitRef="usd">903000000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt
      contextRef="ibdf8e8ff01d04f45a825b8e390068345_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzctNy0xLTEtNzIxNTE_44edc09f-1d49-4847-b29d-3b281000911c"
      unitRef="usd">958000000</us-gaap:UnsecuredDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i035cd0b8f658462394a986d81f43d40e_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzgtMS0xLTEtNzIxNTE_7afccd03-395f-4732-a43d-12ab5ebb7b50"
      unitRef="number">0.01150</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebt
      contextRef="i035cd0b8f658462394a986d81f43d40e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzgtNS0xLTEtNzIxNTE_ff163c8c-a61d-4b35-a582-718676ffc32b"
      unitRef="usd">647000000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt
      contextRef="i145b85c88ec4481b842411a5bb47e395_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzgtNy0xLTEtNzIxNTE_37e2557d-35fb-47f5-9126-bea11fe16964"
      unitRef="usd">645000000</us-gaap:UnsecuredDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i108518ce09f84a519f3962310c1ed597_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzktMS0xLTEtNzIxNTE_c4ab10ad-3fb8-461f-b8d0-ef6fac084c58"
      unitRef="number">0.03375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebt
      contextRef="i108518ce09f84a519f3962310c1ed597_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzktNS0xLTEtNzIxNTE_33264b0d-db06-4e89-af64-bf173970579c"
      unitRef="usd">748000000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt
      contextRef="ia21862c342c44911bef866b8e514369b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzktNy0xLTEtNzIxNTE_d5b1d8eb-3f90-43c4-a5a3-83957f0f8ff4"
      unitRef="usd">748000000</us-gaap:UnsecuredDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i572a1adc5855495dbbba16f658625569_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzEwLTEtMS0xLTcyMTUx_a2cd4f0f-fc82-4023-8824-53e9ab55ccc3"
      unitRef="number">0.03500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebt
      contextRef="i572a1adc5855495dbbba16f658625569_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzEwLTUtMS0xLTcyMTUx_962f59ad-f875-4713-abc9-22d145b9445c"
      unitRef="usd">995000000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt
      contextRef="i54a412d21e93418fb2e9f285ffe87359_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzEwLTctMS0xLTcyMTUx_44ea9dae-62cd-466c-a81d-1e8d9b4943f1"
      unitRef="usd">994000000</us-gaap:UnsecuredDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i23d883af8da240e0b193f0fe43f8fbb8_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzExLTEtMS0xLTcyMTUx_d5e6944c-9c8b-4b89-a9c1-2191d167cbb3"
      unitRef="number">0.02125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebt
      contextRef="i23d883af8da240e0b193f0fe43f8fbb8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzExLTUtMS0xLTcyMTUx_3d214e2b-3d0f-40f3-a9d2-8b9ad3bae2dc"
      unitRef="usd">795000000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt
      contextRef="i5156547d31f84feabfdeab3c39626aba_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzExLTctMS0xLTcyMTUx_3e8cee71-f1b3-4a78-a48c-bd6c101cd41a"
      unitRef="usd">845000000</us-gaap:UnsecuredDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i31b266ec9bca421caa681746ca0a9c57_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzEyLTEtMS0xLTcyMTUx_cfc266c6-04f1-4e70-9484-d01d7ebf8919"
      unitRef="number">0.03650</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebt
      contextRef="i31b266ec9bca421caa681746ca0a9c57_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzEyLTUtMS0xLTcyMTUx_87343814-84b6-4f3c-969d-d3dcf1a11c30"
      unitRef="usd">597000000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt
      contextRef="i430f0c280b194413b7ab95bbebb3398f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzEyLTctMS0xLTcyMTUx_d2b91778-0e15-42d8-8104-5996d93a6225"
      unitRef="usd">597000000</us-gaap:UnsecuredDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3ad767f11d7d42f088c022b95d7ed747_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzEzLTEtMS0xLTcyMTUx_35590164-60f8-4a34-979b-691c25baee25"
      unitRef="number">0.00750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebt
      contextRef="i3ad767f11d7d42f088c022b95d7ed747_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzEzLTUtMS0xLTcyMTUx_f87b9433-6b54-431e-951c-458d2a535cc6"
      unitRef="usd">848000000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt
      contextRef="ic0bccfa8780e4d148e971bf570bdb5c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzEzLTctMS0xLTcyMTUx_e1645bec-6460-42dd-9a03-8fec7f9ab20c"
      unitRef="usd">901000000</us-gaap:UnsecuredDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3bbbaa43580143a18111b7f7460a8613_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzE0LTEtMS0xLTcyMTUx_fb5919cf-4c85-4161-bd76-627c59f72580"
      unitRef="number">0.01950</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebt
      contextRef="i3bbbaa43580143a18111b7f7460a8613_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzE0LTUtMS0xLTcyMTUx_d3181d34-6bd7-492f-b62b-29cf7a110f98"
      unitRef="usd">991000000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt
      contextRef="i10299326fcbd4cab9365281e63e32023_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzE0LTctMS0xLTcyMTUx_1be0d0e7-c869-43e6-872a-25ca303329db"
      unitRef="usd">990000000</us-gaap:UnsecuredDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i39597499ab164dd79f0aa42aa4d4a453_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzE1LTEtMS0xLTcyMTUx_4089bc14-538a-4fd3-b6e7-fb4113ad9ea5"
      unitRef="number">0.02625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebt
      contextRef="i39597499ab164dd79f0aa42aa4d4a453_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzE1LTUtMS0xLTcyMTUx_c33759c6-e28c-4b40-aa48-af5c658b9fbf"
      unitRef="usd">684000000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt
      contextRef="if06b8b9ac7554a2bb66792f8bc6ae5ec_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzE1LTctMS0xLTcyMTUx_ee6a5004-6e74-4d7b-9905-8802c078aad7"
      unitRef="usd">727000000</us-gaap:UnsecuredDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i83cf0776e2f74e6bb340c1c44d9c4873_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzE2LTEtMS0xLTcyMTUx_28f00a18-dbbf-44ae-9bdd-fafcf6799335"
      unitRef="number">0.01000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebt
      contextRef="i83cf0776e2f74e6bb340c1c44d9c4873_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzE2LTUtMS0xLTcyMTUx_d2c4d5a2-95f1-42b3-83b4-33f2bd13b71d"
      unitRef="usd">790000000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt
      contextRef="i188acddc79bd49c9a2dd28df60de44d3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzE2LTctMS0xLTcyMTUx_2789c0e4-e82f-4987-8ef7-adcdd33bef13"
      unitRef="usd">840000000</us-gaap:UnsecuredDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib1be77f0f83e44f2a4a4070a55aa9cf1_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzE3LTEtMS0xLTcyMTUx_fa0381d6-864f-4156-840f-a1ed25ee387b"
      unitRef="number">0.04100</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebt
      contextRef="ib1be77f0f83e44f2a4a4070a55aa9cf1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzE3LTUtMS0xLTcyMTUx_4562032f-6918-41aa-bfc0-ff635fadd34e"
      unitRef="usd">392000000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt
      contextRef="ib936df3bfdbb4791a87fadc6fbd30cdf_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzE3LTctMS0xLTcyMTUx_d89a3efe-224d-40c3-af1e-984eb9132df7"
      unitRef="usd">392000000</us-gaap:UnsecuredDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="idf00788f9e364a80a3fab4c2aee1223b_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzE4LTEtMS0xLTcyMTUx_bc910f70-3e7e-4aca-87c1-0fcd1c6da9de"
      unitRef="number">0.04375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebt
      contextRef="idf00788f9e364a80a3fab4c2aee1223b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzE4LTUtMS0xLTcyMTUx_7b8054a8-cf81-42e5-8760-062d89399037"
      unitRef="usd">396000000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt
      contextRef="i6ebc69fb1cb1488c9aebf005afdcf234_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzE4LTctMS0xLTcyMTUx_2a3cab82-32c8-4bc5-be8d-c1ba13a09274"
      unitRef="usd">395000000</us-gaap:UnsecuredDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0d645bb615244a36b00b94de383a4937_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzE5LTEtMS0xLTcyMTUx_d2814b8b-b1fc-4c70-80b6-b03dac722801"
      unitRef="number">0.04625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebt
      contextRef="i0d645bb615244a36b00b94de383a4937_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzE5LTUtMS0xLTcyMTUx_5cdab1ca-a5bd-4f4b-bc02-2597bc06e547"
      unitRef="usd">983000000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt
      contextRef="ied6226864dea487e92398c823ac01c59_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzE5LTctMS0xLTcyMTUx_c23268d6-0764-4a0f-86ff-cc56337c56cf"
      unitRef="usd">982000000</us-gaap:UnsecuredDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2c8be8bcd82a4fbbbf309cf8da292a70_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzIwLTEtMS0xLTcyMTUx_d22a4e56-b4a1-4249-a26a-c6d8c95fbd1a"
      unitRef="number">0.02900</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebt
      contextRef="i2c8be8bcd82a4fbbbf309cf8da292a70_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzIwLTUtMS0xLTcyMTUx_5ca4d87e-f300-4c42-a38e-d041561d562a"
      unitRef="usd">642000000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt
      contextRef="if5c498b0b83c4ce0a21003147411b100_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzIwLTctMS0xLTcyMTUx_fd06a227-031b-4280-8395-36cdac59162b"
      unitRef="usd">642000000</us-gaap:UnsecuredDebt>
    <us-gaap:LongTermDebt
      contextRef="i097ff20722bb47a2b7d2385fd5c8093b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzIxLTUtMS0xLTcyMTUx_98f2a3c1-81ef-4540-99d9-08e3bbe6fd68"
      unitRef="usd">850000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="if1b7a9d52e504b799c8afe34dbd39ccb_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzIxLTctMS0xLTcyMTUx_7a315063-d54a-4832-9b45-1a859ab546aa"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:OtherLongTermDebt
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzIzLTUtMS0xLTcyMTUx_aa8312c0-aa53-4815-8bed-c945e37a3933"
      unitRef="usd">7000000</us-gaap:OtherLongTermDebt>
    <us-gaap:OtherLongTermDebt
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzIzLTctMS0xLTcyMTUx_e6a6fc32-700f-426c-ac3a-af98a9160995"
      unitRef="usd">10000000</us-gaap:OtherLongTermDebt>
    <us-gaap:DebtLongtermAndShorttermCombinedAmount
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzI0LTUtMS0xLTcyMTUx_1fcf2d28-73f0-4701-83c7-9bb460430e5c"
      unitRef="usd">13048000000</us-gaap:DebtLongtermAndShorttermCombinedAmount>
    <us-gaap:DebtLongtermAndShorttermCombinedAmount
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzI0LTctMS0xLTcyMTUx_63b92b58-359d-4856-902b-ae55eddf5b6c"
      unitRef="usd">12479000000</us-gaap:DebtLongtermAndShorttermCombinedAmount>
    <us-gaap:DebtCurrent
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzI1LTUtMS0xLTcyMTUx_64481554-72a3-403c-b67f-a30eefe7bca9"
      unitRef="usd">1191000000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzI1LTctMS0xLTcyMTUx_1401369c-6678-4c80-8fae-449e679af533"
      unitRef="usd">7000000</us-gaap:DebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzI2LTUtMS0xLTcyMTUx_34543841-ea1c-4ca2-87c5-cd5b0c218f17"
      unitRef="usd">11857000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzI2LTctMS0xLTcyMTUx_5f68fccc-ae10-4f1d-84cf-aff9f85dcb61"
      unitRef="usd">12472000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzI4LTUtMS0xLTcyMTUx_993b6c4e-b601-46c1-93e8-76b6c23e0d7d"
      unitRef="usd">52000000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzI4LTctMS0xLTcyMTUx_614dc9d6-de14-4566-99ed-9d3bb9b5758b"
      unitRef="usd">62000000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzI5LTUtMS0xLTcyMTUx_e77aaf2a-7335-4386-b2ed-0a2cdb4386ec"
      unitRef="usd">2162000000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzI5LTctMS0xLTcyMTUx_1e977fd6-d095-4ddf-bc13-d0fca726edc0"
      unitRef="usd">2162000000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzMwLTUtMS0xLTcyMTUx_ebccde91-ca8a-42f8-86e2-b8928cc6eb50"
      unitRef="usd">10910000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90YWJsZTpmOThhMTg1YjcxZGE0YjNlOGY1MjIzZWM4MTVlYzA0MS90YWJsZXJhbmdlOmY5OGExODViNzFkYTRiM2U4ZjUyMjNlYzgxNWVjMDQxXzMwLTctMS0xLTcyMTUx_f78723a8-dfec-45a7-a460-57ced7112a47"
      unitRef="usd">13391000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:InterestExpenseDebt
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90ZXh0cmVnaW9uOmQ3NGM1OGM3ZmZlODQ4OWFhNWJhMDc0ZjJmN2NhMTI4XzE2NjA_624f5f66-4675-43d4-bd25-2a4fc5ed2291"
      unitRef="usd">337000000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90ZXh0cmVnaW9uOmQ3NGM1OGM3ZmZlODQ4OWFhNWJhMDc0ZjJmN2NhMTI4XzE2NjQ_50836bae-acfe-4c11-b899-9f434f09caed"
      unitRef="usd">337000000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMjcvZnJhZzpkNzRjNThjN2ZmZTg0ODlhYTViYTA3NGYyZjdjYTEyOC90ZXh0cmVnaW9uOmQ3NGM1OGM3ZmZlODQ4OWFhNWJhMDc0ZjJmN2NhMTI4XzE2NzI_f411ac96-6706-443a-821d-e3eeb080daf9"
      unitRef="usd">315000000</us-gaap:InterestExpenseDebt>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90ZXh0cmVnaW9uOmU3ZWQ4YWYyMzA4NDQxODdiZThlNGNkYTNkMGQ3M2U4XzQxNDA_2a2ff8fc-d970-4a2f-bd46-f371d3e0ab0f">INCOME TAXES &lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Our effective tax rate was 12.1%, 12.6% and 18.2% for 2022, 2021 and 2020. The effective income tax rate for 2022 decreased due to the effective settlement of the United States federal income tax audit for years 2014 through 2018 and the reversal of deferred income tax on undistributed earnings of foreign subsidiaries. In addition, the effective income tax rates for 2022, 2021 and 2020 reflect the continued lower effective income tax rates as a result of our European operations, the tax effect related to the transfers of intellectual property between tax jurisdictions, the tax effect of future remittances of the undistributed earnings of foreign subsidiaries and certain discrete tax items. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.259%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Effective Income Tax Rate Reconciliation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;United States federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;21.0&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;21.0&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;21.0&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States state and local income taxes, less federal deduction&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Foreign income tax at rates other than 21%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Tax related to repatriation of foreign earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Intellectual property transfers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States federal audit settlement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Goodwill impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Effective income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12.1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12.6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;18.2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.259%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Earnings Before Income Taxes&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,683&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,281&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,954&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.259%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Components of Income Tax Expense (Benefit)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Current income tax expense (benefit):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States state and local&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total current income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;267&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;524&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;307&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Deferred income tax expense (benefit):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(82)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States state and local&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(132)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total deferred income tax expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;58&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(237)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;48&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;325&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;287&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;355&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Interest and penalties included in other income (expense), net were income of $71 in 2022, and expense of ($23) and ($35) in 2021 and 2020. The United States federal deferred income tax benefit (expense) includes the utilization of net operating loss carryforwards of $56, $283 and $41 in 2022, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.463%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Deferred Income Tax Assets and Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Deferred income tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Product-related liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;State income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Research and development capitalization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;International interest expense carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net operating loss and other credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total deferred income tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,712&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,861&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Less valuation allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(285)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(164)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net deferred income tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,427&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,697&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Deferred income tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,037)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(891)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Undistributed earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total deferred income tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(1,084)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(1,005)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net deferred income tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,343&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,692&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Reported as:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Noncurrent deferred income tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Noncurrent liabilities&#x2014;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(67)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(68)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,343&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,692&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Accrued interest and penalties were $66 and $150 on December&#160;31, 2022 and 2021 which were reported in accrued expenses and other liabilities and other noncurrent liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Net operating loss carryforwards totaling $544 with $155 being subject to a full valuation allowance on December&#160;31, 2022 are available to reduce future taxable earnings of certain domestic and foreign subsidiaries. United States loss carryforwards of $377 begin to expire in 2023. International loss carryforwards of $167 begin to expire in 2023; however, some have no expiration. We also have tax credit carryforwards of $133 with $91 being subject to a full valuation allowance. The credits with a full valuation allowance begin to expire in 2023. We do not anticipate generating income tax in excess of the non-expiring credits in the foreseeable future.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;The Tax Cuts and Jobs Act (the Act) was enacted in 2017 in the United States. We recorded a one-time transition tax on earnings of certain foreign subsidiaries that were previously deferred. The Act also subjects a United States shareholder to tax on Global Intangible Low-Taxed Income (GILTI) earned by certain foreign subsidiaries. We have elected to account for GILTI tax in the year the tax is incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;We recorded deferred income tax on undistributed earnings of foreign subsidiaries not determined to be indefinitely reinvested. Determination of the total amount of unrecognized deferred income tax on undistributed earnings of foreign subsidiaries is not practicable.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.750%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.258%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Uncertain Income Tax Positions&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Beginning uncertain tax positions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;444&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;457&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Increases related to current year income tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Increases related to prior year income tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Decreases related to prior year income tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(178)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Settlements of income tax audits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Statute of limitations expirations and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Ending uncertain tax positions&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;286&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;444&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Reported as:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Noncurrent liabilities&#x2014;Income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Our income tax expense would have been reduced by $289 and $445 in 2022 and 2021 had these uncertain income tax positions been favorably resolved. It is reasonably possible that the amount of unrecognized tax benefits will significantly change due &lt;/span&gt;&lt;/div&gt;to one or more of the following events in the next 12 months: expiring statutes, audit activity, tax payments, competent authority proceedings related to transfer pricing or final decisions in matters that are the subject of controversy in various taxing jurisdictions in which we operate, including inventory transfer pricing, cost sharing, product royalty and foreign branch arrangements. We are not able to reasonably estimate the amount or the future periods in which changes in unrecognized tax benefits may be resolved. Interest and penalties incurred associated with uncertain tax positions are included in other income (expense), net.In the normal course of business, income tax authorities in various income tax jurisdictions both within the United States and internationally conduct routine audits of our income tax returns filed in prior years.&#160;These audits are generally designed to determine if individual income tax authorities are in agreement with our interpretations of complex income tax regulations regarding the allocation of income to the various income tax jurisdictions. Income tax expense in 2022 decreased $162 due to the effective settlement of the United States federal income tax audit for years 2014 through 2018. In addition, 2022 other income (expense), net includes a benefit of $50 related to the release of accrued interest associated with this settlement. Income tax years are open from 2019 through the current year for the United States federal jurisdiction. Income tax years open for our other major jurisdictions range from 2007 through the current year.</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90ZXh0cmVnaW9uOmU3ZWQ4YWYyMzA4NDQxODdiZThlNGNkYTNkMGQ3M2U4XzU2_89d0162b-e8be-491e-8dac-e6644333cdbd"
      unitRef="number">0.121</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90ZXh0cmVnaW9uOmU3ZWQ4YWYyMzA4NDQxODdiZThlNGNkYTNkMGQ3M2U4XzYw_8d103b7d-51a4-41c8-9c67-d7245f80a7e0"
      unitRef="number">0.126</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90ZXh0cmVnaW9uOmU3ZWQ4YWYyMzA4NDQxODdiZThlNGNkYTNkMGQ3M2U4XzY3_53da14f5-3b1f-4caf-8b9b-721612658736"
      unitRef="number">0.182</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90ZXh0cmVnaW9uOmU3ZWQ4YWYyMzA4NDQxODdiZThlNGNkYTNkMGQ3M2U4XzQxMTQ_44495174-7868-4564-b575-8fe0ef8f4544">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.259%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Effective Income Tax Rate Reconciliation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;United States federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;21.0&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;21.0&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;21.0&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States state and local income taxes, less federal deduction&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Foreign income tax at rates other than 21%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Tax related to repatriation of foreign earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Intellectual property transfers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States federal audit settlement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Goodwill impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Effective income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12.1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12.6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;18.2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZToyMmVmZGUxMjIxMTY0MTg0YjE2MTlmNTRjODZkOTc1Yy90YWJsZXJhbmdlOjIyZWZkZTEyMjExNjQxODRiMTYxOWY1NGM4NmQ5NzVjXzItMS0xLTEtNzIxNTE_66ae6f99-36bb-42b4-8afd-f1b0119bbfa7"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZToyMmVmZGUxMjIxMTY0MTg0YjE2MTlmNTRjODZkOTc1Yy90YWJsZXJhbmdlOjIyZWZkZTEyMjExNjQxODRiMTYxOWY1NGM4NmQ5NzVjXzItMy0xLTEtNzIxNTE_f1f201ca-6d26-42eb-a134-60c32fb5a97e"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZToyMmVmZGUxMjIxMTY0MTg0YjE2MTlmNTRjODZkOTc1Yy90YWJsZXJhbmdlOjIyZWZkZTEyMjExNjQxODRiMTYxOWY1NGM4NmQ5NzVjXzItNS0xLTEtNzIxNTE_f49f9fe6-e0f7-4853-a63a-aba0ff2583e1"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZToyMmVmZGUxMjIxMTY0MTg0YjE2MTlmNTRjODZkOTc1Yy90YWJsZXJhbmdlOjIyZWZkZTEyMjExNjQxODRiMTYxOWY1NGM4NmQ5NzVjXzMtMS0xLTEtNzIxNTE_5e2cec9a-8b2d-4aee-9332-ce3c61865d11"
      unitRef="number">0.020</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZToyMmVmZGUxMjIxMTY0MTg0YjE2MTlmNTRjODZkOTc1Yy90YWJsZXJhbmdlOjIyZWZkZTEyMjExNjQxODRiMTYxOWY1NGM4NmQ5NzVjXzMtMy0xLTEtNzIxNTE_182e230e-f033-4d74-add5-af06e1f403b5"
      unitRef="number">0.027</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZToyMmVmZGUxMjIxMTY0MTg0YjE2MTlmNTRjODZkOTc1Yy90YWJsZXJhbmdlOjIyZWZkZTEyMjExNjQxODRiMTYxOWY1NGM4NmQ5NzVjXzMtNS0xLTEtNzIxNTE_477b45b5-633f-44fd-bd9e-038fdf699b91"
      unitRef="number">0.001</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZToyMmVmZGUxMjIxMTY0MTg0YjE2MTlmNTRjODZkOTc1Yy90YWJsZXJhbmdlOjIyZWZkZTEyMjExNjQxODRiMTYxOWY1NGM4NmQ5NzVjXzQtMS0xLTEtNzIxNTE_cc16d36e-90c4-42e7-b5fd-8aaad6d6fc9a"
      unitRef="number">-0.041</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZToyMmVmZGUxMjIxMTY0MTg0YjE2MTlmNTRjODZkOTc1Yy90YWJsZXJhbmdlOjIyZWZkZTEyMjExNjQxODRiMTYxOWY1NGM4NmQ5NzVjXzQtMy0xLTEtNzIxNTE_a4dbc2c9-e93b-4d3b-9434-501b1f80b334"
      unitRef="number">-0.069</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZToyMmVmZGUxMjIxMTY0MTg0YjE2MTlmNTRjODZkOTc1Yy90YWJsZXJhbmdlOjIyZWZkZTEyMjExNjQxODRiMTYxOWY1NGM4NmQ5NzVjXzQtNS0xLTEtNzIxNTE_c6a9cfde-4828-4ee1-9f74-1950c5c931db"
      unitRef="number">-0.033</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <syk:EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZToyMmVmZGUxMjIxMTY0MTg0YjE2MTlmNTRjODZkOTc1Yy90YWJsZXJhbmdlOjIyZWZkZTEyMjExNjQxODRiMTYxOWY1NGM4NmQ5NzVjXzUtMS0xLTEtNzIxNTE_bb9e1b8a-3127-4b86-82d9-ac49cc7031ec"
      unitRef="number">-0.024</syk:EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent>
    <syk:EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZToyMmVmZGUxMjIxMTY0MTg0YjE2MTlmNTRjODZkOTc1Yy90YWJsZXJhbmdlOjIyZWZkZTEyMjExNjQxODRiMTYxOWY1NGM4NmQ5NzVjXzUtMy0xLTEtNzIxNTE_69fa017d-da9f-49b4-aaa2-3f47ded6fd43"
      unitRef="number">0.014</syk:EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent>
    <syk:EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZToyMmVmZGUxMjIxMTY0MTg0YjE2MTlmNTRjODZkOTc1Yy90YWJsZXJhbmdlOjIyZWZkZTEyMjExNjQxODRiMTYxOWY1NGM4NmQ5NzVjXzUtNS0xLTEtNzIxNTE_3dbf9c61-59d4-4fc6-8c8e-2f092946db1c"
      unitRef="number">0.030</syk:EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent>
    <syk:EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZToyMmVmZGUxMjIxMTY0MTg0YjE2MTlmNTRjODZkOTc1Yy90YWJsZXJhbmdlOjIyZWZkZTEyMjExNjQxODRiMTYxOWY1NGM4NmQ5NzVjXzYtMS0xLTEtNzIxNTE_38c283d6-265e-4b57-9a9c-ba0c6ff0913d"
      unitRef="number">0.001</syk:EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent>
    <syk:EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZToyMmVmZGUxMjIxMTY0MTg0YjE2MTlmNTRjODZkOTc1Yy90YWJsZXJhbmdlOjIyZWZkZTEyMjExNjQxODRiMTYxOWY1NGM4NmQ5NzVjXzYtMy0xLTEtNzIxNTE_b9a9d51e-735f-4df8-8186-97b630bb8d07"
      unitRef="number">-0.023</syk:EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent>
    <syk:EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZToyMmVmZGUxMjIxMTY0MTg0YjE2MTlmNTRjODZkOTc1Yy90YWJsZXJhbmdlOjIyZWZkZTEyMjExNjQxODRiMTYxOWY1NGM4NmQ5NzVjXzYtNS0xLTEtNzIxNTE_e795eac9-82a3-43f8-941a-f6d2bad4b045"
      unitRef="number">-0.014</syk:EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZToyMmVmZGUxMjIxMTY0MTg0YjE2MTlmNTRjODZkOTc1Yy90YWJsZXJhbmdlOjIyZWZkZTEyMjExNjQxODRiMTYxOWY1NGM4NmQ5NzVjXzctMS0xLTEtODMzODg_4f992ec0-a709-4e09-9da6-c032b4621061"
      unitRef="number">-0.061</us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZToyMmVmZGUxMjIxMTY0MTg0YjE2MTlmNTRjODZkOTc1Yy90YWJsZXJhbmdlOjIyZWZkZTEyMjExNjQxODRiMTYxOWY1NGM4NmQ5NzVjXzctMy0xLTEtODMzODg_0c32ed41-b315-4795-8d47-c2bbdbb59b3f"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZToyMmVmZGUxMjIxMTY0MTg0YjE2MTlmNTRjODZkOTc1Yy90YWJsZXJhbmdlOjIyZWZkZTEyMjExNjQxODRiMTYxOWY1NGM4NmQ5NzVjXzctNS0xLTEtODMzODg_d9051363-b283-4591-b094-f8a9a7578341"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZToyMmVmZGUxMjIxMTY0MTg0YjE2MTlmNTRjODZkOTc1Yy90YWJsZXJhbmdlOjIyZWZkZTEyMjExNjQxODRiMTYxOWY1NGM4NmQ5NzVjXzgtMS0xLTEtODMzOTY_17dbe23a-4a68-4ff7-860e-d615ea248df9"
      unitRef="number">0.017</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZToyMmVmZGUxMjIxMTY0MTg0YjE2MTlmNTRjODZkOTc1Yy90YWJsZXJhbmdlOjIyZWZkZTEyMjExNjQxODRiMTYxOWY1NGM4NmQ5NzVjXzgtMy0xLTEtODMzOTY_b6daf3b7-b934-4471-afa4-820462808a63"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZToyMmVmZGUxMjIxMTY0MTg0YjE2MTlmNTRjODZkOTc1Yy90YWJsZXJhbmdlOjIyZWZkZTEyMjExNjQxODRiMTYxOWY1NGM4NmQ5NzVjXzgtNS0xLTEtODMzOTY_335e6ab4-4e53-4f6a-835b-48f50383b041"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZToyMmVmZGUxMjIxMTY0MTg0YjE2MTlmNTRjODZkOTc1Yy90YWJsZXJhbmdlOjIyZWZkZTEyMjExNjQxODRiMTYxOWY1NGM4NmQ5NzVjXzctMS0xLTEtNzIxNTE_2f24e818-1fab-4e6d-811d-a71ea7179d02"
      unitRef="number">-0.001</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZToyMmVmZGUxMjIxMTY0MTg0YjE2MTlmNTRjODZkOTc1Yy90YWJsZXJhbmdlOjIyZWZkZTEyMjExNjQxODRiMTYxOWY1NGM4NmQ5NzVjXzctMy0xLTEtNzIxNTE_816ed039-aff6-43f4-be63-f1239d1212d5"
      unitRef="number">-0.033</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZToyMmVmZGUxMjIxMTY0MTg0YjE2MTlmNTRjODZkOTc1Yy90YWJsZXJhbmdlOjIyZWZkZTEyMjExNjQxODRiMTYxOWY1NGM4NmQ5NzVjXzctNS0xLTEtNzIxNTE_dfac3f4e-51c7-4c23-964c-0af3f5144544"
      unitRef="number">-0.012</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZToyMmVmZGUxMjIxMTY0MTg0YjE2MTlmNTRjODZkOTc1Yy90YWJsZXJhbmdlOjIyZWZkZTEyMjExNjQxODRiMTYxOWY1NGM4NmQ5NzVjXzgtMS0xLTEtNzIxNTE_95447fee-a3d3-441c-983c-037d3f2cb24b"
      unitRef="number">0.121</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZToyMmVmZGUxMjIxMTY0MTg0YjE2MTlmNTRjODZkOTc1Yy90YWJsZXJhbmdlOjIyZWZkZTEyMjExNjQxODRiMTYxOWY1NGM4NmQ5NzVjXzgtMy0xLTEtNzIxNTE_ea9f88c3-ffef-4d8b-8516-c7f465c88b46"
      unitRef="number">0.126</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZToyMmVmZGUxMjIxMTY0MTg0YjE2MTlmNTRjODZkOTc1Yy90YWJsZXJhbmdlOjIyZWZkZTEyMjExNjQxODRiMTYxOWY1NGM4NmQ5NzVjXzgtNS0xLTEtNzIxNTE_64a7e672-2193-4e6c-b622-4ce85624071e"
      unitRef="number">0.182</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90ZXh0cmVnaW9uOmU3ZWQ4YWYyMzA4NDQxODdiZThlNGNkYTNkMGQ3M2U4XzQxNDE_a342e4ab-7c6e-49fe-a1c9-c0582535caed">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.259%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Earnings Before Income Taxes&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,683&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,281&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,954&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.259%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Components of Income Tax Expense (Benefit)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Current income tax expense (benefit):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States state and local&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total current income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;267&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;524&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;307&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Deferred income tax expense (benefit):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(82)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States state and local&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(132)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total deferred income tax expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;58&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(237)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;48&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;325&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;287&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;355&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTpiNzU0NjE5YWZjODg0MjVjOTU0Y2I2NzUyNjhkMDRmOC90YWJsZXJhbmdlOmI3NTQ2MTlhZmM4ODQyNWM5NTRjYjY3NTI2OGQwNGY4XzItMS0xLTEtNzIxNTE_dd92b245-adcd-47d3-adf5-4e4cb2d0d12b"
      unitRef="usd">407000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTpiNzU0NjE5YWZjODg0MjVjOTU0Y2I2NzUyNjhkMDRmOC90YWJsZXJhbmdlOmI3NTQ2MTlhZmM4ODQyNWM5NTRjYjY3NTI2OGQwNGY4XzItMy0xLTEtNzIxNTE_6ba92c5f-c35a-462b-a714-cdc8541baeae"
      unitRef="usd">433000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTpiNzU0NjE5YWZjODg0MjVjOTU0Y2I2NzUyNjhkMDRmOC90YWJsZXJhbmdlOmI3NTQ2MTlhZmM4ODQyNWM5NTRjYjY3NTI2OGQwNGY4XzItNS0xLTEtNzIxNTE_24294128-3ad3-4305-814a-4efc27f96e58"
      unitRef="usd">239000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTpiNzU0NjE5YWZjODg0MjVjOTU0Y2I2NzUyNjhkMDRmOC90YWJsZXJhbmdlOmI3NTQ2MTlhZmM4ODQyNWM5NTRjYjY3NTI2OGQwNGY4XzMtMS0xLTEtNzIxNTE_e290fb16-d338-4929-ab89-ffbd5479c78e"
      unitRef="usd">2276000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTpiNzU0NjE5YWZjODg0MjVjOTU0Y2I2NzUyNjhkMDRmOC90YWJsZXJhbmdlOmI3NTQ2MTlhZmM4ODQyNWM5NTRjYjY3NTI2OGQwNGY4XzMtMy0xLTEtNzIxNTE_aa13e124-3c8b-4284-b4cf-1d25da29e050"
      unitRef="usd">1848000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTpiNzU0NjE5YWZjODg0MjVjOTU0Y2I2NzUyNjhkMDRmOC90YWJsZXJhbmdlOmI3NTQ2MTlhZmM4ODQyNWM5NTRjYjY3NTI2OGQwNGY4XzMtNS0xLTEtNzIxNTE_0070993d-d952-4c43-aec3-602c5c5a34bc"
      unitRef="usd">1715000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTpiNzU0NjE5YWZjODg0MjVjOTU0Y2I2NzUyNjhkMDRmOC90YWJsZXJhbmdlOmI3NTQ2MTlhZmM4ODQyNWM5NTRjYjY3NTI2OGQwNGY4XzQtMS0xLTEtNzIxNTE_0c2b71c9-220b-4aa1-b0ac-f6f686e7d340"
      unitRef="usd">2683000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTpiNzU0NjE5YWZjODg0MjVjOTU0Y2I2NzUyNjhkMDRmOC90YWJsZXJhbmdlOmI3NTQ2MTlhZmM4ODQyNWM5NTRjYjY3NTI2OGQwNGY4XzQtMy0xLTEtNzIxNTE_84a9400e-2476-4082-93f0-d07dca975375"
      unitRef="usd">2281000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTpiNzU0NjE5YWZjODg0MjVjOTU0Y2I2NzUyNjhkMDRmOC90YWJsZXJhbmdlOmI3NTQ2MTlhZmM4ODQyNWM5NTRjYjY3NTI2OGQwNGY4XzQtNS0xLTEtNzIxNTE_8cc27292-0f01-4944-9de9-09a5174aa807"
      unitRef="usd">1954000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTozNjFmOWMzZDRhN2I0ZGM2ODEyNWFmNzk5ZTkxZmIyNy90YWJsZXJhbmdlOjM2MWY5YzNkNGE3YjRkYzY4MTI1YWY3OTllOTFmYjI3XzItMS0xLTEtNzIxNTE_2f4e8d55-53c6-4ed6-818f-25ca16668b79"
      unitRef="usd">-76000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTozNjFmOWMzZDRhN2I0ZGM2ODEyNWFmNzk5ZTkxZmIyNy90YWJsZXJhbmdlOjM2MWY5YzNkNGE3YjRkYzY4MTI1YWY3OTllOTFmYjI3XzItMy0xLTEtNzIxNTE_9d52f0fc-25ab-41ad-b4a9-388eba5eabf9"
      unitRef="usd">155000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTozNjFmOWMzZDRhN2I0ZGM2ODEyNWFmNzk5ZTkxZmIyNy90YWJsZXJhbmdlOjM2MWY5YzNkNGE3YjRkYzY4MTI1YWY3OTllOTFmYjI3XzItNS0xLTEtNzIxNTE_a9ee012f-af41-49eb-b103-1878e1e9311b"
      unitRef="usd">80000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTozNjFmOWMzZDRhN2I0ZGM2ODEyNWFmNzk5ZTkxZmIyNy90YWJsZXJhbmdlOjM2MWY5YzNkNGE3YjRkYzY4MTI1YWY3OTllOTFmYjI3XzMtMS0xLTEtNzIxNTE_c7ea7402-4c39-47c8-9bbe-fb3891f7b052"
      unitRef="usd">64000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTozNjFmOWMzZDRhN2I0ZGM2ODEyNWFmNzk5ZTkxZmIyNy90YWJsZXJhbmdlOjM2MWY5YzNkNGE3YjRkYzY4MTI1YWY3OTllOTFmYjI3XzMtMy0xLTEtNzIxNTE_b181ae0b-69bc-4b09-aa39-a4be0e743a44"
      unitRef="usd">97000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTozNjFmOWMzZDRhN2I0ZGM2ODEyNWFmNzk5ZTkxZmIyNy90YWJsZXJhbmdlOjM2MWY5YzNkNGE3YjRkYzY4MTI1YWY3OTllOTFmYjI3XzMtNS0xLTEtNzIxNTE_76b4c063-a311-4c86-9084-9cbe209c4437"
      unitRef="usd">20000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTozNjFmOWMzZDRhN2I0ZGM2ODEyNWFmNzk5ZTkxZmIyNy90YWJsZXJhbmdlOjM2MWY5YzNkNGE3YjRkYzY4MTI1YWY3OTllOTFmYjI3XzQtMS0xLTEtNzIxNTE_25914789-199e-4e12-a208-1d111a06f7c6"
      unitRef="usd">279000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTozNjFmOWMzZDRhN2I0ZGM2ODEyNWFmNzk5ZTkxZmIyNy90YWJsZXJhbmdlOjM2MWY5YzNkNGE3YjRkYzY4MTI1YWY3OTllOTFmYjI3XzQtMy0xLTEtNzIxNTE_7a38d92c-4ea7-4c93-bfb9-dd631e4fa606"
      unitRef="usd">272000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTozNjFmOWMzZDRhN2I0ZGM2ODEyNWFmNzk5ZTkxZmIyNy90YWJsZXJhbmdlOjM2MWY5YzNkNGE3YjRkYzY4MTI1YWY3OTllOTFmYjI3XzQtNS0xLTEtNzIxNTE_8d68d0bc-dc58-47b0-9679-a9f91bee33a4"
      unitRef="usd">207000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTozNjFmOWMzZDRhN2I0ZGM2ODEyNWFmNzk5ZTkxZmIyNy90YWJsZXJhbmdlOjM2MWY5YzNkNGE3YjRkYzY4MTI1YWY3OTllOTFmYjI3XzUtMS0xLTEtNzIxNTE_f23d2e60-02f2-460e-94f8-62be3bc9d7ad"
      unitRef="usd">267000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTozNjFmOWMzZDRhN2I0ZGM2ODEyNWFmNzk5ZTkxZmIyNy90YWJsZXJhbmdlOjM2MWY5YzNkNGE3YjRkYzY4MTI1YWY3OTllOTFmYjI3XzUtMy0xLTEtNzIxNTE_48d803bb-5708-4fe0-b4d8-c924ae5d7e7b"
      unitRef="usd">524000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTozNjFmOWMzZDRhN2I0ZGM2ODEyNWFmNzk5ZTkxZmIyNy90YWJsZXJhbmdlOjM2MWY5YzNkNGE3YjRkYzY4MTI1YWY3OTllOTFmYjI3XzUtNS0xLTEtNzIxNTE_0638ec82-6caf-47ab-b043-9bd53026b24a"
      unitRef="usd">307000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTozNjFmOWMzZDRhN2I0ZGM2ODEyNWFmNzk5ZTkxZmIyNy90YWJsZXJhbmdlOjM2MWY5YzNkNGE3YjRkYzY4MTI1YWY3OTllOTFmYjI3XzctMS0xLTEtNzIxNTE_87c53128-e648-444e-ba1d-28e387f56e5a"
      unitRef="usd">-179000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTozNjFmOWMzZDRhN2I0ZGM2ODEyNWFmNzk5ZTkxZmIyNy90YWJsZXJhbmdlOjM2MWY5YzNkNGE3YjRkYzY4MTI1YWY3OTllOTFmYjI3XzctMy0xLTEtNzIxNTE_fd1834db-c1d5-4896-956d-1e982b97b894"
      unitRef="usd">-82000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTozNjFmOWMzZDRhN2I0ZGM2ODEyNWFmNzk5ZTkxZmIyNy90YWJsZXJhbmdlOjM2MWY5YzNkNGE3YjRkYzY4MTI1YWY3OTllOTFmYjI3XzctNS0xLTEtNzIxNTE_ff119c43-4d2f-4976-979f-c0e8a9117a22"
      unitRef="usd">1000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTozNjFmOWMzZDRhN2I0ZGM2ODEyNWFmNzk5ZTkxZmIyNy90YWJsZXJhbmdlOjM2MWY5YzNkNGE3YjRkYzY4MTI1YWY3OTllOTFmYjI3XzgtMS0xLTEtNzIxNTE_0ab53d34-d6b9-44d7-a11a-bb073d581466"
      unitRef="usd">-30000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTozNjFmOWMzZDRhN2I0ZGM2ODEyNWFmNzk5ZTkxZmIyNy90YWJsZXJhbmdlOjM2MWY5YzNkNGE3YjRkYzY4MTI1YWY3OTllOTFmYjI3XzgtMy0xLTEtNzIxNTE_480bb27d-b8dd-485a-a132-d957a1d16226"
      unitRef="usd">-23000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTozNjFmOWMzZDRhN2I0ZGM2ODEyNWFmNzk5ZTkxZmIyNy90YWJsZXJhbmdlOjM2MWY5YzNkNGE3YjRkYzY4MTI1YWY3OTllOTFmYjI3XzgtNS0xLTEtNzIxNTE_0d59a5b8-fa8b-41b1-b45e-3e1eefa719a9"
      unitRef="usd">-25000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTozNjFmOWMzZDRhN2I0ZGM2ODEyNWFmNzk5ZTkxZmIyNy90YWJsZXJhbmdlOjM2MWY5YzNkNGE3YjRkYzY4MTI1YWY3OTllOTFmYjI3XzktMS0xLTEtNzIxNTE_3e524303-1249-4a90-9e46-4fcad2955d49"
      unitRef="usd">267000000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTozNjFmOWMzZDRhN2I0ZGM2ODEyNWFmNzk5ZTkxZmIyNy90YWJsZXJhbmdlOjM2MWY5YzNkNGE3YjRkYzY4MTI1YWY3OTllOTFmYjI3XzktMy0xLTEtNzIxNTE_15fbfcad-d936-472b-831e-bd31fc9271df"
      unitRef="usd">-132000000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTozNjFmOWMzZDRhN2I0ZGM2ODEyNWFmNzk5ZTkxZmIyNy90YWJsZXJhbmdlOjM2MWY5YzNkNGE3YjRkYzY4MTI1YWY3OTllOTFmYjI3XzktNS0xLTEtNzIxNTE_1a55592b-2731-4655-88dc-7ac0fab4a0bd"
      unitRef="usd">72000000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTozNjFmOWMzZDRhN2I0ZGM2ODEyNWFmNzk5ZTkxZmIyNy90YWJsZXJhbmdlOjM2MWY5YzNkNGE3YjRkYzY4MTI1YWY3OTllOTFmYjI3XzEwLTEtMS0xLTcyMTUx_2a5be7ba-a5e5-4ae8-8c80-c4d8cbff053d"
      unitRef="usd">58000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTozNjFmOWMzZDRhN2I0ZGM2ODEyNWFmNzk5ZTkxZmIyNy90YWJsZXJhbmdlOjM2MWY5YzNkNGE3YjRkYzY4MTI1YWY3OTllOTFmYjI3XzEwLTMtMS0xLTcyMTUx_e346e13c-a611-41c9-93b8-a55c36afc906"
      unitRef="usd">-237000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTozNjFmOWMzZDRhN2I0ZGM2ODEyNWFmNzk5ZTkxZmIyNy90YWJsZXJhbmdlOjM2MWY5YzNkNGE3YjRkYzY4MTI1YWY3OTllOTFmYjI3XzEwLTUtMS0xLTcyMTUx_6bedf318-1616-4069-9a29-70d01e5978ea"
      unitRef="usd">48000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTozNjFmOWMzZDRhN2I0ZGM2ODEyNWFmNzk5ZTkxZmIyNy90YWJsZXJhbmdlOjM2MWY5YzNkNGE3YjRkYzY4MTI1YWY3OTllOTFmYjI3XzExLTEtMS0xLTcyMTUx_783ac827-957e-4e6f-8067-510d5f70032d"
      unitRef="usd">325000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTozNjFmOWMzZDRhN2I0ZGM2ODEyNWFmNzk5ZTkxZmIyNy90YWJsZXJhbmdlOjM2MWY5YzNkNGE3YjRkYzY4MTI1YWY3OTllOTFmYjI3XzExLTMtMS0xLTcyMTUx_ab69d807-806a-4434-a131-41dddd65a566"
      unitRef="usd">287000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTozNjFmOWMzZDRhN2I0ZGM2ODEyNWFmNzk5ZTkxZmIyNy90YWJsZXJhbmdlOjM2MWY5YzNkNGE3YjRkYzY4MTI1YWY3OTllOTFmYjI3XzExLTUtMS0xLTcyMTUx_059612cb-9da0-4cde-a961-0db51e9fc834"
      unitRef="usd">355000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90ZXh0cmVnaW9uOmU3ZWQ4YWYyMzA4NDQxODdiZThlNGNkYTNkMGQ3M2U4XzU0OTc1NTgxOTU5Mg_010c6715-2f72-446e-8e60-29521ee4c9b7"
      unitRef="usd">-71000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90ZXh0cmVnaW9uOmU3ZWQ4YWYyMzA4NDQxODdiZThlNGNkYTNkMGQ3M2U4Xzg0MA_517e3a9d-5796-4938-b390-fd8cb7dcea9d"
      unitRef="usd">23000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90ZXh0cmVnaW9uOmU3ZWQ4YWYyMzA4NDQxODdiZThlNGNkYTNkMGQ3M2U4Xzg0NA_df968d2b-5c5c-4854-ae0a-209d9e6d0ca1"
      unitRef="usd">35000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <syk:IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90ZXh0cmVnaW9uOmU3ZWQ4YWYyMzA4NDQxODdiZThlNGNkYTNkMGQ3M2U4XzU0OTc1NTgxOTYwMA_fb8f3655-5210-4fe8-8219-f3bfa9a9663a"
      unitRef="usd">56000000</syk:IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized>
    <syk:IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90ZXh0cmVnaW9uOmU3ZWQ4YWYyMzA4NDQxODdiZThlNGNkYTNkMGQ3M2U4XzEwMDA_90b13117-6d18-43e9-8b28-98a59208071d"
      unitRef="usd">283000000</syk:IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized>
    <syk:IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90ZXh0cmVnaW9uOmU3ZWQ4YWYyMzA4NDQxODdiZThlNGNkYTNkMGQ3M2U4XzEwMDQ_b159c916-bf8f-4f86-94d2-5197f5a2312a"
      unitRef="usd">41000000</syk:IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90ZXh0cmVnaW9uOmU3ZWQ4YWYyMzA4NDQxODdiZThlNGNkYTNkMGQ3M2U4XzQxMjg_8ec67f87-1b26-4dba-a954-49e8f797bbec">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.463%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Deferred Income Tax Assets and Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Deferred income tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Product-related liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;State income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Research and development capitalization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;International interest expense carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net operating loss and other credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total deferred income tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,712&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,861&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Less valuation allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(285)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(164)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net deferred income tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,427&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,697&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Deferred income tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,037)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(891)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Undistributed earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total deferred income tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(1,084)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(1,005)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net deferred income tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,343&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,692&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Reported as:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Noncurrent deferred income tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Noncurrent liabilities&#x2014;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(67)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(68)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,343&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,692&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsInventory
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzItMS0xLTEtNzIxNTE_9e76b32c-8802-4220-84b9-1b1b49e43e25"
      unitRef="usd">516000000</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsInventory
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzItMy0xLTEtNzIxNTE_aa619e20-ad74-42dc-ae92-b07553bc17f0"
      unitRef="usd">513000000</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzMtMS0xLTEtNzIxNTE_12491e5f-3560-4f38-b089-c29dca33de74"
      unitRef="usd">26000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzMtMy0xLTEtNzIxNTE_c6edb87b-90d7-4bd8-a1b2-f64360d4e314"
      unitRef="usd">39000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzQtMS0xLTEtNzIxNTE_eaa4dea5-1bd4-4a54-9a99-2828acdd51aa"
      unitRef="usd">155000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzQtMy0xLTEtNzIxNTE_299c6881-f349-4a0e-8501-5805ef113d41"
      unitRef="usd">501000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther>
    <syk:DeferredTaxAssetsDepreciationAndAmortization
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzUtMS0xLTEtNzIxNTE_006a9352-0272-4a9e-b906-8cccf2598977"
      unitRef="usd">1038000000</syk:DeferredTaxAssetsDepreciationAndAmortization>
    <syk:DeferredTaxAssetsDepreciationAndAmortization
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzUtMy0xLTEtNzIxNTE_04cfb655-367f-48d6-bdaa-b7ad565e3625"
      unitRef="usd">1194000000</syk:DeferredTaxAssetsDepreciationAndAmortization>
    <us-gaap:DeferredTaxAssetsStateTaxes
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzYtMS0xLTEtNzIxNTE_d8f7eb39-f8f4-49e8-b6e2-b75005dc7fc0"
      unitRef="usd">153000000</us-gaap:DeferredTaxAssetsStateTaxes>
    <us-gaap:DeferredTaxAssetsStateTaxes
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzYtMy0xLTEtNzIxNTE_a6a3d8fd-8bfb-4352-a1e4-45b7e6cdbe82"
      unitRef="usd">128000000</us-gaap:DeferredTaxAssetsStateTaxes>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzctMS0xLTEtNzIxNTE_fd02aa80-6248-411f-b426-63e6e82a756a"
      unitRef="usd">73000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzctMy0xLTEtNzIxNTE_705dd734-824e-47d5-b793-5f45205c5ed4"
      unitRef="usd">63000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <syk:DeferredTaxAssetsResearchAndDevelopmentCapitalization
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzgtMS0xLTEtODI5NzM_9d462828-14d6-4fec-ab84-4c4cf262efd1"
      unitRef="usd">204000000</syk:DeferredTaxAssetsResearchAndDevelopmentCapitalization>
    <syk:DeferredTaxAssetsResearchAndDevelopmentCapitalization
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzgtMy0xLTEtODI5NzM_7595ecd1-adea-42fe-90ef-6954b49694af"
      unitRef="usd">0</syk:DeferredTaxAssetsResearchAndDevelopmentCapitalization>
    <us-gaap:DeferredTaxAssetInterestCarryforward
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzktMS0xLTEtODI5ODM_42a019d7-5378-4161-94a3-c42d0f32fac0"
      unitRef="usd">135000000</us-gaap:DeferredTaxAssetInterestCarryforward>
    <us-gaap:DeferredTaxAssetInterestCarryforward
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzktMy0xLTEtODI5ODM_0da4a9ef-8d08-487b-b5a4-806d25184bc8"
      unitRef="usd">0</us-gaap:DeferredTaxAssetInterestCarryforward>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzgtMS0xLTEtNzIxNTE_69d5f4b0-9a5a-4538-a9d6-934c45758c6d"
      unitRef="usd">247000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzgtMy0xLTEtNzIxNTE_7367d67e-382e-4de2-b7a1-3a78a9978612"
      unitRef="usd">232000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzktMS0xLTEtNzIxNTE_c1c78528-459e-4993-ba2a-72dbab0cb19d"
      unitRef="usd">165000000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzktMy0xLTEtNzIxNTE_83b2de38-363f-4ff3-a6ef-2f1e18a8f57f"
      unitRef="usd">191000000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzEwLTEtMS0xLTcyMTUx_fa773ae4-7bc4-4101-8750-f886156c4fce"
      unitRef="usd">2712000000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzEwLTMtMS0xLTcyMTUx_074535dd-8024-4eed-ab83-1a0216b5bbc2"
      unitRef="usd">2861000000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzExLTEtMS0xLTcyMTUx_1e4a14b5-b8e3-4023-bdd1-65d50c1e000f"
      unitRef="usd">285000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzExLTMtMS0xLTcyMTUx_53840986-9435-4570-880d-51502cfbe9f4"
      unitRef="usd">164000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzEyLTEtMS0xLTcyMTUx_48e6c0f5-2411-4de9-a76b-83e4ff00f248"
      unitRef="usd">2427000000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzEyLTMtMS0xLTcyMTUx_f7fc8fea-4de9-475d-b12e-3be9453b92bd"
      unitRef="usd">2697000000</us-gaap:DeferredTaxAssetsNet>
    <syk:DeferredTaxLiabilitiesDepreciationAndAmortization
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzE0LTEtMS0xLTcyMTUx_4936186d-f97f-49a2-837e-80bbd2d55abb"
      unitRef="usd">1037000000</syk:DeferredTaxLiabilitiesDepreciationAndAmortization>
    <syk:DeferredTaxLiabilitiesDepreciationAndAmortization
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzE0LTMtMS0xLTcyMTUx_dbc31d66-4f62-46d3-a431-4dc3dc861694"
      unitRef="usd">891000000</syk:DeferredTaxLiabilitiesDepreciationAndAmortization>
    <us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzE1LTEtMS0xLTcyMTUx_3ec22372-dbdb-4f04-847f-471e8356c75f"
      unitRef="usd">47000000</us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings>
    <us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzE1LTMtMS0xLTcyMTUx_04d7e931-d7c1-4cb5-b7ae-450aef1ec736"
      unitRef="usd">114000000</us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzE3LTEtMS0xLTcyMTUx_533d52d1-79b4-4394-9db3-97442e1eec21"
      unitRef="usd">1084000000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzE3LTMtMS0xLTcyMTUx_23de48b1-1159-4075-9ee5-28d12f94a777"
      unitRef="usd">1005000000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzE4LTEtMS0xLTcyMTUx_be9fbd47-a406-4e2b-a468-ea56eec84009"
      unitRef="usd">1343000000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzE4LTMtMS0xLTcyMTUx_53cefd60-c505-4b42-a47e-16330e8618f8"
      unitRef="usd">1692000000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzIwLTEtMS0xLTcyMTUx_5335bc7a-0b5d-4a44-a60e-098ad5848f7f"
      unitRef="usd">1410000000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzIwLTMtMS0xLTcyMTUx_b6dcd622-d41c-4c2e-b9c8-7e24d52e0ae7"
      unitRef="usd">1760000000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzIxLTEtMS0xLTcyMTUx_e91b33bd-6836-487c-babe-0b3a54a03edf"
      unitRef="usd">67000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzIxLTMtMS0xLTcyMTUx_d276fd91-31c3-4e71-894e-394a79889037"
      unitRef="usd">68000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzIyLTEtMS0xLTcyMTUx_e9232f8a-770c-4262-9df8-33e2660b4209"
      unitRef="usd">1343000000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTphZTY0YzY2MzcxNGQ0ZjgwYWVlNjI5ZjZjODJmNzM1MC90YWJsZXJhbmdlOmFlNjRjNjYzNzE0ZDRmODBhZWU2MjlmNmM4MmY3MzUwXzIyLTMtMS0xLTcyMTUx_4c9cde52-e57d-4ba8-a3c6-5e5d5cb3152e"
      unitRef="usd">1692000000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90ZXh0cmVnaW9uOmU3ZWQ4YWYyMzA4NDQxODdiZThlNGNkYTNkMGQ3M2U4XzEwNzA_3b360267-0cda-4c13-bbec-079b2f199f78"
      unitRef="usd">66000000</us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90ZXh0cmVnaW9uOmU3ZWQ4YWYyMzA4NDQxODdiZThlNGNkYTNkMGQ3M2U4XzEwNzc_2244674a-cddc-45dc-976e-d11dd1fa0912"
      unitRef="usd">150000000</us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90ZXh0cmVnaW9uOmU3ZWQ4YWYyMzA4NDQxODdiZThlNGNkYTNkMGQ3M2U4XzEyMjE_73c26fa7-84b8-46f1-a734-600dcdaf0f4a"
      unitRef="usd">544000000</us-gaap:OperatingLossCarryforwards>
    <syk:OperatingLossCarryforwardsSubjectToValuationAllowance
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90ZXh0cmVnaW9uOmU3ZWQ4YWYyMzA4NDQxODdiZThlNGNkYTNkMGQ3M2U4XzEyMjk_989316c2-8ab6-4b1d-9958-54f9d1633852"
      unitRef="usd">155000000</syk:OperatingLossCarryforwardsSubjectToValuationAllowance>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i8e50f83f7596461c955c6b530bef94eb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90ZXh0cmVnaW9uOmU3ZWQ4YWYyMzA4NDQxODdiZThlNGNkYTNkMGQ3M2U4XzE0NTg_af0c7999-688e-4a23-be91-4ad16335e3e5"
      unitRef="usd">377000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="ia7a76123b7f64330919b0f229f73daa6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90ZXh0cmVnaW9uOmU3ZWQ4YWYyMzA4NDQxODdiZThlNGNkYTNkMGQ3M2U4XzE1MTg_484a5d9a-b8fe-41c7-b947-76a3e923349e"
      unitRef="usd">167000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90ZXh0cmVnaW9uOmU3ZWQ4YWYyMzA4NDQxODdiZThlNGNkYTNkMGQ3M2U4XzE2MjE_4a697158-523b-4132-88a2-6e10bbea5756"
      unitRef="usd">133000000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardValuationAllowance
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90ZXh0cmVnaW9uOmU3ZWQ4YWYyMzA4NDQxODdiZThlNGNkYTNkMGQ3M2U4XzE2Mjk_bcff555c-6dac-4028-9fe3-f74c9b961d26"
      unitRef="usd">91000000</us-gaap:TaxCreditCarryforwardValuationAllowance>
    <us-gaap:SummaryOfIncomeTaxContingenciesTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90ZXh0cmVnaW9uOmU3ZWQ4YWYyMzA4NDQxODdiZThlNGNkYTNkMGQ3M2U4XzQxMzY_d9577d0f-7f49-41eb-a848-320f20a688e8">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.750%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.258%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Uncertain Income Tax Positions&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Beginning uncertain tax positions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;444&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;457&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Increases related to current year income tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Increases related to prior year income tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Decreases related to prior year income tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(178)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Settlements of income tax audits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Statute of limitations expirations and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Ending uncertain tax positions&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;286&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;444&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Reported as:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Noncurrent liabilities&#x2014;Income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:SummaryOfIncomeTaxContingenciesTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTowOGVhMDQ2OTY1Njc0ZGIwYTRiNWIyNWJlYjEyZTY1NS90YWJsZXJhbmdlOjA4ZWEwNDY5NjU2NzRkYjBhNGI1YjI1YmViMTJlNjU1XzItMS0xLTEtNzIxNTE_0e89cea8-960c-48cf-a45a-77c015e1673e"
      unitRef="usd">444000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i98963cf23d234ec1ac275e66bcfd76dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTowOGVhMDQ2OTY1Njc0ZGIwYTRiNWIyNWJlYjEyZTY1NS90YWJsZXJhbmdlOjA4ZWEwNDY5NjU2NzRkYjBhNGI1YjI1YmViMTJlNjU1XzItMy0xLTEtNzIxNTE_ede183b6-30d2-4147-a4f2-7c79ec17cfac"
      unitRef="usd">457000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTowOGVhMDQ2OTY1Njc0ZGIwYTRiNWIyNWJlYjEyZTY1NS90YWJsZXJhbmdlOjA4ZWEwNDY5NjU2NzRkYjBhNGI1YjI1YmViMTJlNjU1XzMtMS0xLTEtNzIxNTE_5e111e2b-55bc-4d11-abf3-e09e44ed734a"
      unitRef="usd">17000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTowOGVhMDQ2OTY1Njc0ZGIwYTRiNWIyNWJlYjEyZTY1NS90YWJsZXJhbmdlOjA4ZWEwNDY5NjU2NzRkYjBhNGI1YjI1YmViMTJlNjU1XzMtMy0xLTEtNzIxNTE_eed722f5-eb78-49b8-80d0-3decb4c92a6d"
      unitRef="usd">13000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTowOGVhMDQ2OTY1Njc0ZGIwYTRiNWIyNWJlYjEyZTY1NS90YWJsZXJhbmdlOjA4ZWEwNDY5NjU2NzRkYjBhNGI1YjI1YmViMTJlNjU1XzQtMS0xLTEtNzIxNTE_d74fbb01-60d0-48be-bba3-8ad27d3e84ec"
      unitRef="usd">34000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTowOGVhMDQ2OTY1Njc0ZGIwYTRiNWIyNWJlYjEyZTY1NS90YWJsZXJhbmdlOjA4ZWEwNDY5NjU2NzRkYjBhNGI1YjI1YmViMTJlNjU1XzQtMy0xLTEtNzIxNTE_aca2f7a7-2beb-449c-99c4-b5a39ff5142a"
      unitRef="usd">4000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTowOGVhMDQ2OTY1Njc0ZGIwYTRiNWIyNWJlYjEyZTY1NS90YWJsZXJhbmdlOjA4ZWEwNDY5NjU2NzRkYjBhNGI1YjI1YmViMTJlNjU1XzUtMS0xLTEtODYyNDA_e3fa2aff-6510-4a32-b67e-9a7b35b1bcbf"
      unitRef="usd">178000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTowOGVhMDQ2OTY1Njc0ZGIwYTRiNWIyNWJlYjEyZTY1NS90YWJsZXJhbmdlOjA4ZWEwNDY5NjU2NzRkYjBhNGI1YjI1YmViMTJlNjU1XzUtMy0xLTEtODYyNDg_79916f71-6e01-4581-9cbe-0dc0fdbf5fdf"
      unitRef="usd">18000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTowOGVhMDQ2OTY1Njc0ZGIwYTRiNWIyNWJlYjEyZTY1NS90YWJsZXJhbmdlOjA4ZWEwNDY5NjU2NzRkYjBhNGI1YjI1YmViMTJlNjU1XzYtMS0xLTEtNzIxNTE_db27e285-8a7b-42ef-8bdc-a0c1a13504fe"
      unitRef="usd">13000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTowOGVhMDQ2OTY1Njc0ZGIwYTRiNWIyNWJlYjEyZTY1NS90YWJsZXJhbmdlOjA4ZWEwNDY5NjU2NzRkYjBhNGI1YjI1YmViMTJlNjU1XzYtMy0xLTEtNzIxNTE_81a5518b-237c-49d6-b811-4389543a05b6"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTowOGVhMDQ2OTY1Njc0ZGIwYTRiNWIyNWJlYjEyZTY1NS90YWJsZXJhbmdlOjA4ZWEwNDY5NjU2NzRkYjBhNGI1YjI1YmViMTJlNjU1XzctMS0xLTEtNzIxNTE_c59938fc-66a7-440b-a7b6-c921cddfc918"
      unitRef="usd">6000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTowOGVhMDQ2OTY1Njc0ZGIwYTRiNWIyNWJlYjEyZTY1NS90YWJsZXJhbmdlOjA4ZWEwNDY5NjU2NzRkYjBhNGI1YjI1YmViMTJlNjU1XzctMy0xLTEtNzIxNTE_3c54dfe4-0b04-4832-bb84-2b487789564f"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTowOGVhMDQ2OTY1Njc0ZGIwYTRiNWIyNWJlYjEyZTY1NS90YWJsZXJhbmdlOjA4ZWEwNDY5NjU2NzRkYjBhNGI1YjI1YmViMTJlNjU1XzgtMS0xLTEtNzIxNTE_e82311e0-9941-4339-9989-8629120ce8bb"
      unitRef="usd">12000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTowOGVhMDQ2OTY1Njc0ZGIwYTRiNWIyNWJlYjEyZTY1NS90YWJsZXJhbmdlOjA4ZWEwNDY5NjU2NzRkYjBhNGI1YjI1YmViMTJlNjU1XzgtMy0xLTEtNzIxNTE_150251e7-c26c-48c8-8e6f-1bd8ec814168"
      unitRef="usd">12000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTowOGVhMDQ2OTY1Njc0ZGIwYTRiNWIyNWJlYjEyZTY1NS90YWJsZXJhbmdlOjA4ZWEwNDY5NjU2NzRkYjBhNGI1YjI1YmViMTJlNjU1XzEwLTEtMS0xLTcyMTUx_2f29081e-5e7c-4f48-8b31-1877f5a9869b"
      unitRef="usd">286000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTowOGVhMDQ2OTY1Njc0ZGIwYTRiNWIyNWJlYjEyZTY1NS90YWJsZXJhbmdlOjA4ZWEwNDY5NjU2NzRkYjBhNGI1YjI1YmViMTJlNjU1XzEwLTMtMS0xLTcyMTUx_f4ca387e-2e27-4ef8-a3a0-c6a14341ee20"
      unitRef="usd">444000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTowOGVhMDQ2OTY1Njc0ZGIwYTRiNWIyNWJlYjEyZTY1NS90YWJsZXJhbmdlOjA4ZWEwNDY5NjU2NzRkYjBhNGI1YjI1YmViMTJlNjU1XzEyLTEtMS0xLTcyMTUx_6036c189-e7ba-467a-bdcb-ebf5d3459791"
      unitRef="usd">286000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90YWJsZTowOGVhMDQ2OTY1Njc0ZGIwYTRiNWIyNWJlYjEyZTY1NS90YWJsZXJhbmdlOjA4ZWEwNDY5NjU2NzRkYjBhNGI1YjI1YmViMTJlNjU1XzEyLTMtMS0xLTcyMTUx_d80fd1c9-34ac-4539-a3f2-5634436c4dfb"
      unitRef="usd">444000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90ZXh0cmVnaW9uOmU3ZWQ4YWYyMzA4NDQxODdiZThlNGNkYTNkMGQ3M2U4XzI2MTg_5f5e0608-8390-4408-89a4-fd932d6f2da3"
      unitRef="usd">289000000</us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense>
    <us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90ZXh0cmVnaW9uOmU3ZWQ4YWYyMzA4NDQxODdiZThlNGNkYTNkMGQ3M2U4XzI2MjU_2bdd0dd0-a535-4ceb-adfe-0c9c7fcd2aa9"
      unitRef="usd">445000000</us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense>
    <us-gaap:IncomeTaxReconciliationTaxSettlements
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90ZXh0cmVnaW9uOmU3ZWQ4YWYyMzA4NDQxODdiZThlNGNkYTNkMGQ3M2U4XzU0OTc1NTgxOTYwOA_4a581936-681e-4560-ab5d-b865a79c1876"
      unitRef="usd">162000000</us-gaap:IncomeTaxReconciliationTaxSettlements>
    <syk:IncomeTaxExpenseBenefitTaxSettlementReleaseOfAccruedInterest
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzAvZnJhZzplN2VkOGFmMjMwODQ0MTg3YmU4ZTRjZGEzZDBkNzNlOC90ZXh0cmVnaW9uOmU3ZWQ4YWYyMzA4NDQxODdiZThlNGNkYTNkMGQ3M2U4XzU0OTc1NTgxOTYxNw_b3b02f9b-7a8e-4667-877f-03fb23d31d72"
      unitRef="usd">-50000000</syk:IncomeTaxExpenseBenefitTaxSettlementReleaseOfAccruedInterest>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90ZXh0cmVnaW9uOjU2Yjk3OTZmMzkxZTQ1YTRhMzVjOGE4ZjJjYWZhMjhiXzE5NDA_90acb7e8-8850-43c1-a40b-e8d09b763944">RETIREMENT PLANS&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Defined Contribution Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We provide certain employees with defined contribution plans and other types of retirement plans. A portion of our retirement plan expense under the defined contribution plans is funded with Stryker common stock. The use of Stryker common stock represents a non-cash operating activity that is not reflected in our Consolidated Statements of Cash Flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.436%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Plan expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Expense funded with Stryker common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Stryker common stock held by plan:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Dollar amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Shares (in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Value as a percentage of total plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:1pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Defined Benefit Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Certain of our subsidiaries have both funded and unfunded defined benefit pension plans covering some or all of their employees. The majority of our defined benefit pension plans have projected benefit obligations in excess of plan assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Discount Rate&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The discount rates were selected using a hypothetical portfolio of high quality bonds on December 31 that would provide the necessary cash flows to match our projected benefit payments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Expected Return on Plan Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The expected return on plan assets is determined by applying the target allocation in each asset category of plan investments to the anticipated return for each asset category based on historical and projected returns. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.436%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Components of Net Periodic Pension Cost&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net periodic benefit cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(72)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(63)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Amortization of prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Recognized actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Curtailment gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net periodic benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(74)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Changes in assets and benefit obligations recognized in OCI:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net actuarial gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(117)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Recognized net actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Prior service credit and transition amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Curtailment gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total recognized in other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;252&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;138&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total recognized in net periodic benefit cost and OCI&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;193&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;64&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(175)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Weighted-average rates used to determine net periodic benefit cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate used to determine projected benefit obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The actuarial gain (loss) for all pension plans was primarily related to a change in the discount rate used to measure the benefit obligations of those plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Investment Strategy&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The investment strategy for our defined benefit pension plans is to meet the liabilities of the plans as they fall due and to maximize the return on invested assets within appropriate risk tolerances.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.474%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Benefit obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(673)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,036)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Funded status&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(253)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(493)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Reported as:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Noncurrent assets&#x2014;other assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Current liabilities&#x2014;accrued compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Noncurrent liabilities&#x2014;other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(271)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(491)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Pre-tax amounts recognized in AOCI:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Unrecognized net actuarial gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(215)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Unrecognized prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;44&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(208)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.474%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Change in Benefit Obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Beginning projected benefit obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,036&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,118&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Foreign exchange impact&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Employee contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Actuarial (gains) losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(354)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Curtailment gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Ending projected benefit obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;673&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,036&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Ending accumulated benefit obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;645&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;987&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.474%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Change in Plan Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Beginning fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;543&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;522&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Actual return&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(109)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Employer contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Employee contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Foreign exchange impact&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Ending fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;420&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;543&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.770%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.649%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.649%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.652%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Allocation of Plan Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023 Target&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022 Actual&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021 Actual&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;100&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;100&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;100&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.220%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.220%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.220%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Valuation of Plan Assets &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;46&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;319&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;55&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;420&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;55&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;389&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;99&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;543&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Our Level 3 pension plan assets consist primarily of guaranteed investment contracts with insurance companies. The insurance contracts guarantee us principal repayment and a fixed rate of return. The $44 decrease in Level 3 pension plan assets is primarily driven by the change in the corresponding pension liability. We expect to contribute $19 to our defined benefit pension plans in 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Estimated Future Benefit Payments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2028-2032&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:DefinedContributionPlanDisclosuresTableTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90ZXh0cmVnaW9uOjU2Yjk3OTZmMzkxZTQ1YTRhMzVjOGE4ZjJjYWZhMjhiXzE5MjA_302b6d2c-ef99-40e8-9eb7-6326056a62b6">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.436%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Plan expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Expense funded with Stryker common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Stryker common stock held by plan:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Dollar amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Shares (in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Value as a percentage of total plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DefinedContributionPlanDisclosuresTableTextBlock>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTowNTIyMjMxOGU1OTE0ZjFkYmU5ZWRkOTA5OWVlZDkwMC90YWJsZXJhbmdlOjA1MjIyMzE4ZTU5MTRmMWRiZTllZGQ5MDk5ZWVkOTAwXzEtMS0xLTEtNzIxNTE_60f83b9e-fd42-4757-89c5-1ebe5e50c049"
      unitRef="usd">305000000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTowNTIyMjMxOGU1OTE0ZjFkYmU5ZWRkOTA5OWVlZDkwMC90YWJsZXJhbmdlOjA1MjIyMzE4ZTU5MTRmMWRiZTllZGQ5MDk5ZWVkOTAwXzEtMy0xLTEtNzIxNTE_6d3e5ad8-0b7e-4fa6-98a3-02f7c1b92c69"
      unitRef="usd">259000000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTowNTIyMjMxOGU1OTE0ZjFkYmU5ZWRkOTA5OWVlZDkwMC90YWJsZXJhbmdlOjA1MjIyMzE4ZTU5MTRmMWRiZTllZGQ5MDk5ZWVkOTAwXzEtNS0xLTEtNzIxNTE_eb0e797e-c6b7-4669-b966-4a44d3321070"
      unitRef="usd">235000000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTowNTIyMjMxOGU1OTE0ZjFkYmU5ZWRkOTA5OWVlZDkwMC90YWJsZXJhbmdlOjA1MjIyMzE4ZTU5MTRmMWRiZTllZGQ5MDk5ZWVkOTAwXzItMS0xLTEtNzIxNTE_627d38bc-384e-4b34-a9a1-3e09d4a2ed15"
      unitRef="usd">41000000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTowNTIyMjMxOGU1OTE0ZjFkYmU5ZWRkOTA5OWVlZDkwMC90YWJsZXJhbmdlOjA1MjIyMzE4ZTU5MTRmMWRiZTllZGQ5MDk5ZWVkOTAwXzItMy0xLTEtNzIxNTE_6c872665-e5ea-4a2b-80e8-a1ae16d1dc7a"
      unitRef="usd">37000000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTowNTIyMjMxOGU1OTE0ZjFkYmU5ZWRkOTA5OWVlZDkwMC90YWJsZXJhbmdlOjA1MjIyMzE4ZTU5MTRmMWRiZTllZGQ5MDk5ZWVkOTAwXzItNS0xLTEtNzIxNTE_51eb9dcd-6638-48ea-9d7c-bd3d19dbc1ca"
      unitRef="usd">34000000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <syk:DefinedContributionRetirementPlansCommonStockValueHeldByCompany
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTowNTIyMjMxOGU1OTE0ZjFkYmU5ZWRkOTA5OWVlZDkwMC90YWJsZXJhbmdlOjA1MjIyMzE4ZTU5MTRmMWRiZTllZGQ5MDk5ZWVkOTAwXzQtMS0xLTEtNzIxNTE_9785c03c-056a-4d5a-ae8b-2fc883b20467"
      unitRef="usd">522000000</syk:DefinedContributionRetirementPlansCommonStockValueHeldByCompany>
    <syk:DefinedContributionRetirementPlansCommonStockValueHeldByCompany
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTowNTIyMjMxOGU1OTE0ZjFkYmU5ZWRkOTA5OWVlZDkwMC90YWJsZXJhbmdlOjA1MjIyMzE4ZTU5MTRmMWRiZTllZGQ5MDk5ZWVkOTAwXzQtMy0xLTEtNzIxNTE_27450322-1dca-4fe1-9c84-b6559099bae9"
      unitRef="usd">582000000</syk:DefinedContributionRetirementPlansCommonStockValueHeldByCompany>
    <syk:DefinedContributionRetirementPlansCommonStockValueHeldByCompany
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTowNTIyMjMxOGU1OTE0ZjFkYmU5ZWRkOTA5OWVlZDkwMC90YWJsZXJhbmdlOjA1MjIyMzE4ZTU5MTRmMWRiZTllZGQ5MDk5ZWVkOTAwXzQtNS0xLTEtNzIxNTE_6c4621fc-37a1-434c-bf96-6b82a96ef4b6"
      unitRef="usd">542000000</syk:DefinedContributionRetirementPlansCommonStockValueHeldByCompany>
    <syk:DefinedContributionRetirementPlansCommonStockHeldByCompany
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTowNTIyMjMxOGU1OTE0ZjFkYmU5ZWRkOTA5OWVlZDkwMC90YWJsZXJhbmdlOjA1MjIyMzE4ZTU5MTRmMWRiZTllZGQ5MDk5ZWVkOTAwXzUtMS0xLTEtNzIxNTE_ab574414-b0e4-4a3e-9ef9-0064fbf6aff6"
      unitRef="shares">2100000</syk:DefinedContributionRetirementPlansCommonStockHeldByCompany>
    <syk:DefinedContributionRetirementPlansCommonStockHeldByCompany
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTowNTIyMjMxOGU1OTE0ZjFkYmU5ZWRkOTA5OWVlZDkwMC90YWJsZXJhbmdlOjA1MjIyMzE4ZTU5MTRmMWRiZTllZGQ5MDk5ZWVkOTAwXzUtMy0xLTEtNzIxNTE_b560ec7b-c6ef-45c3-a764-de318d80b582"
      unitRef="shares">2200000</syk:DefinedContributionRetirementPlansCommonStockHeldByCompany>
    <syk:DefinedContributionRetirementPlansCommonStockHeldByCompany
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTowNTIyMjMxOGU1OTE0ZjFkYmU5ZWRkOTA5OWVlZDkwMC90YWJsZXJhbmdlOjA1MjIyMzE4ZTU5MTRmMWRiZTllZGQ5MDk5ZWVkOTAwXzUtNS0xLTEtNzIxNTE_cc8c7a4b-b0c4-4252-a945-2799b9d3ae70"
      unitRef="shares">2200000</syk:DefinedContributionRetirementPlansCommonStockHeldByCompany>
    <syk:TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTowNTIyMjMxOGU1OTE0ZjFkYmU5ZWRkOTA5OWVlZDkwMC90YWJsZXJhbmdlOjA1MjIyMzE4ZTU5MTRmMWRiZTllZGQ5MDk5ZWVkOTAwXzYtMS0xLTEtNzIxNTE_be9ac28a-1a26-4928-a1b3-f291b7f80a8a"
      unitRef="number">0.10</syk:TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany>
    <syk:TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTowNTIyMjMxOGU1OTE0ZjFkYmU5ZWRkOTA5OWVlZDkwMC90YWJsZXJhbmdlOjA1MjIyMzE4ZTU5MTRmMWRiZTllZGQ5MDk5ZWVkOTAwXzYtMy0xLTEtNzIxNTE_f1dfe0b1-79ea-41a6-a189-59f88fe45110"
      unitRef="number">0.10</syk:TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany>
    <syk:TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTowNTIyMjMxOGU1OTE0ZjFkYmU5ZWRkOTA5OWVlZDkwMC90YWJsZXJhbmdlOjA1MjIyMzE4ZTU5MTRmMWRiZTllZGQ5MDk5ZWVkOTAwXzYtNS0xLTEtNzIxNTE_121631a8-1b88-4d0a-85a3-125c4192cee6"
      unitRef="number">0.11</syk:TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany>
    <us-gaap:ScheduleOfCostsOfRetirementPlansTableTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90ZXh0cmVnaW9uOjU2Yjk3OTZmMzkxZTQ1YTRhMzVjOGE4ZjJjYWZhMjhiXzE5Mzc_eed571e7-7afc-47b1-987f-3c1f9d945ead">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.436%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Components of Net Periodic Pension Cost&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net periodic benefit cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(72)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(63)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Amortization of prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Recognized actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Curtailment gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net periodic benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(74)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Changes in assets and benefit obligations recognized in OCI:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net actuarial gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(117)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Recognized net actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Prior service credit and transition amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Curtailment gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total recognized in other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;252&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;138&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total recognized in net periodic benefit cost and OCI&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;193&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;64&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(175)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Weighted-average rates used to determine net periodic benefit cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate used to determine projected benefit obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfCostsOfRetirementPlansTableTextBlock>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzItMS0xLTEtNzIxNTE_137d5c0a-3193-46a3-b047-5901b44eb899"
      unitRef="usd">56000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzItMy0xLTEtNzIxNTE_5de2dbee-4a8d-4ac3-9149-d0d06663ed8c"
      unitRef="usd">72000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzItNS0xLTEtNzIxNTE_72b3274b-05d5-44f5-b71c-56c5fa12b6cb"
      unitRef="usd">63000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzMtMS0xLTEtNzIxNTE_f9e23426-9bbe-4c47-97e1-536986f24c44"
      unitRef="usd">10000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzMtMy0xLTEtNzIxNTE_1d60b5be-7a68-4fad-bf6f-59ded5fef4f0"
      unitRef="usd">7000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzMtNS0xLTEtNzIxNTE_221f43b8-6b62-46fa-bc4f-0c9785b86766"
      unitRef="usd">8000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzQtMS0xLTEtNzIxNTE_3890a843-1f03-4837-87ff-2cbbe1d1f778"
      unitRef="usd">15000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzQtMy0xLTEtNzIxNTE_0db2e0c6-dd26-41f9-bb14-10503373ae04"
      unitRef="usd">11000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzQtNS0xLTEtNzIxNTE_0b2c8768-4c33-439d-a7b4-d7cf6f03f5ee"
      unitRef="usd">13000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzUtMS0xLTEtNzIxNTE_1acaa279-c4fa-4a9b-81d6-509c8d8a099e"
      unitRef="usd">-1000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzUtMy0xLTEtNzIxNTE_778981fa-1d52-4d1e-8c8b-ae7e7585a62b"
      unitRef="usd">-1000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzUtNS0xLTEtNzIxNTE_df1fdb38-a27f-40c5-872a-1b2846300b6b"
      unitRef="usd">-1000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzYtMS0xLTEtNzIxNTE_f2795b64-a454-4fa5-8e0e-c79fc78747be"
      unitRef="usd">-9000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzYtMy0xLTEtNzIxNTE_e0bb229c-1373-412f-812f-613ef3ccf623"
      unitRef="usd">-16000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzYtNS0xLTEtNzIxNTE_1769ff82-eaa4-4688-9f4b-bff8948291f9"
      unitRef="usd">-13000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzctMy0xLTEtNzIxNTE_721df5a9-75b6-4218-9421-7ffafc1e71ef"
      unitRef="usd">9000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzgtMS0xLTEtNzIxNTE_61610930-4123-4f5e-b08c-a899498a80be"
      unitRef="usd">59000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzgtMy0xLTEtNzIxNTE_0a634809-3bfd-48c3-9fdd-b3cd9de81b4c"
      unitRef="usd">74000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzgtNS0xLTEtNzIxNTE_84e0bfc2-2c43-4979-9ee2-a90be251a5e6"
      unitRef="usd">70000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzEwLTEtMS0xLTcyMTUx_c14310b1-a7ea-4210-a6ee-886c4baadbbe"
      unitRef="usd">244000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzEwLTMtMS0xLTcyMTUx_974c11d3-93bd-4d55-910a-a862abd19496"
      unitRef="usd">132000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzEwLTUtMS0xLTcyMTUx_ab0a16f3-027c-4353-8a78-4ae099cb893a"
      unitRef="usd">-117000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzExLTEtMS0xLTcyMTUx_31fa7d57-4d25-4cbc-9de4-0f223d433c7a"
      unitRef="usd">-9000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzExLTMtMS0xLTcyMTUx_73d11572-d108-46c6-91b7-3f1d28710e3a"
      unitRef="usd">-16000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzExLTUtMS0xLTcyMTUx_0bd0c71a-1520-4f93-b197-bb05c4dc41fa"
      unitRef="usd">-13000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzEyLTEtMS0xLTcyMTUx_bd83aa21-55ca-474c-90fe-fa2832c73e18"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzEyLTMtMS0xLTcyMTUx_03366e51-005a-4618-90a2-c977752d421e"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzEyLTUtMS0xLTcyMTUx_e7f9e511-2193-43fb-b57b-a57571e16e0b"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzEzLTMtMS0xLTcyMTUx_d94e0e3f-0f81-49d1-863b-13eabb64b941"
      unitRef="usd">-9000000</us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzEzLTUtMS0xLTcyMTUx_ebfb7c50-41d7-40de-b7c0-42df0063d4c0"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzE0LTEtMS0xLTcyMTUx_f15077b1-fdf8-40d0-9d27-acad3a5f6a17"
      unitRef="usd">-252000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzE0LTMtMS0xLTcyMTUx_be0ab169-dcae-4d63-8448-29129ac252fe"
      unitRef="usd">-138000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzE0LTUtMS0xLTcyMTUx_4b0df818-1c26-492b-a9ee-055beaeef937"
      unitRef="usd">105000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzE1LTEtMS0xLTcyMTUx_fd42abb1-76e2-406f-8fe7-8d127f77d50a"
      unitRef="usd">193000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzE1LTMtMS0xLTcyMTUx_f176b370-b951-4930-89ad-e24a7339ab46"
      unitRef="usd">64000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzE1LTUtMS0xLTcyMTUx_61e5ff8c-2521-43e4-bf4b-8f41f288ee09"
      unitRef="usd">-175000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzE4LTEtMS0xLTcyMTUx_bbc27537-4261-4f31-b30d-269bf0e54312"
      unitRef="number">0.011</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzE4LTMtMS0xLTcyMTUx_ce7e8c35-a745-4df8-9b8e-52e2db1c5cee"
      unitRef="number">0.008</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzE4LTUtMS0xLTcyMTUx_c9068688-0d00-471d-bccb-90b696c3f53c"
      unitRef="number">0.010</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzE5LTEtMS0xLTcyMTUx_4a152bbd-63f7-4558-9d96-fd7a8bfd2904"
      unitRef="number">0.031</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzE5LTMtMS0xLTcyMTUx_a06e8c94-c5f2-45b0-915d-37da23316e6b"
      unitRef="number">0.025</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzE5LTUtMS0xLTcyMTUx_9f53e608-5dcc-433c-8cca-533479da21b7"
      unitRef="number">0.029</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzIwLTEtMS0xLTcyMTUx_c1728cfd-7409-4f6a-8bc4-0e7299f45612"
      unitRef="number">0.026</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzIwLTMtMS0xLTcyMTUx_64e34663-98e9-4e49-bbe4-9540b9977601"
      unitRef="number">0.026</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzIwLTUtMS0xLTcyMTUx_43623222-88e8-4ec0-a499-38c85586ea20"
      unitRef="number">0.029</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <syk:WeightedAverageUsedInDeterminationOfProjectedBenefitObligations
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzIxLTEtMS0xLTcyMTUx_3b9f0112-d624-40c8-b924-a090d4c3e463"
      unitRef="number">0.033</syk:WeightedAverageUsedInDeterminationOfProjectedBenefitObligations>
    <syk:WeightedAverageUsedInDeterminationOfProjectedBenefitObligations
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzIxLTMtMS0xLTcyMTUx_c99da592-5209-4a18-ae57-94d510c44e9a"
      unitRef="number">0.011</syk:WeightedAverageUsedInDeterminationOfProjectedBenefitObligations>
    <syk:WeightedAverageUsedInDeterminationOfProjectedBenefitObligations
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpkYmNlOGExMmM5ZTI0MTZkYTMxN2U1NDhkYmJjYjAzNy90YWJsZXJhbmdlOmRiY2U4YTEyYzllMjQxNmRhMzE3ZTU0OGRiYmNiMDM3XzIxLTUtMS0xLTcyMTUx_ff6ed87c-9398-471a-b916-e11b34ae6ff7"
      unitRef="number">0.008</syk:WeightedAverageUsedInDeterminationOfProjectedBenefitObligations>
    <us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90ZXh0cmVnaW9uOjU2Yjk3OTZmMzkxZTQ1YTRhMzVjOGE4ZjJjYWZhMjhiXzE5Mzg_22692aa6-7b38-44f5-b302-d0b70433f053">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.474%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Benefit obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(673)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,036)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Funded status&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(253)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(493)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Reported as:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Noncurrent assets&#x2014;other assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Current liabilities&#x2014;accrued compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Noncurrent liabilities&#x2014;other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(271)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(491)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Pre-tax amounts recognized in AOCI:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Unrecognized net actuarial gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(215)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Unrecognized prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;44&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(208)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo2YTExZGY5ZjA4MDM0NmZmOGRkMWY4MzJmNjAyZmNkMi90YWJsZXJhbmdlOjZhMTFkZjlmMDgwMzQ2ZmY4ZGQxZjgzMmY2MDJmY2QyXzEtMS0xLTEtNzIxNTE_e3e1dfe0-cc43-436b-afd8-b222e7b095e9"
      unitRef="usd">420000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo2YTExZGY5ZjA4MDM0NmZmOGRkMWY4MzJmNjAyZmNkMi90YWJsZXJhbmdlOjZhMTFkZjlmMDgwMzQ2ZmY4ZGQxZjgzMmY2MDJmY2QyXzEtMy0xLTEtNzIxNTE_2c95fe7e-7cfd-451a-af5b-c56880691b8d"
      unitRef="usd">543000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo2YTExZGY5ZjA4MDM0NmZmOGRkMWY4MzJmNjAyZmNkMi90YWJsZXJhbmdlOjZhMTFkZjlmMDgwMzQ2ZmY4ZGQxZjgzMmY2MDJmY2QyXzItMS0xLTEtNzIxNTE_1b4ba712-4783-4271-a759-3cf34fb74876"
      unitRef="usd">673000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo2YTExZGY5ZjA4MDM0NmZmOGRkMWY4MzJmNjAyZmNkMi90YWJsZXJhbmdlOjZhMTFkZjlmMDgwMzQ2ZmY4ZGQxZjgzMmY2MDJmY2QyXzItMy0xLTEtNzIxNTE_11765ec5-4bef-473e-a50f-245dcd5a1f3b"
      unitRef="usd">1036000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo2YTExZGY5ZjA4MDM0NmZmOGRkMWY4MzJmNjAyZmNkMi90YWJsZXJhbmdlOjZhMTFkZjlmMDgwMzQ2ZmY4ZGQxZjgzMmY2MDJmY2QyXzMtMS0xLTEtNzIxNTE_a87be1cc-395e-4728-8f5a-6efc3ab9bffc"
      unitRef="usd">-253000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo2YTExZGY5ZjA4MDM0NmZmOGRkMWY4MzJmNjAyZmNkMi90YWJsZXJhbmdlOjZhMTFkZjlmMDgwMzQ2ZmY4ZGQxZjgzMmY2MDJmY2QyXzMtMy0xLTEtNzIxNTE_9e7b789a-960f-42cb-b320-b9fde4f0c261"
      unitRef="usd">-493000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="ic116179f0d574741a8ce9a0151e5f880_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo2YTExZGY5ZjA4MDM0NmZmOGRkMWY4MzJmNjAyZmNkMi90YWJsZXJhbmdlOjZhMTFkZjlmMDgwMzQ2ZmY4ZGQxZjgzMmY2MDJmY2QyXzUtMS0xLTEtODExMjM_1d224ac5-c528-41d8-8a0c-14697607637f"
      unitRef="usd">21000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i054f5c7fa9df497fafb3f4d6748a7c59_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo2YTExZGY5ZjA4MDM0NmZmOGRkMWY4MzJmNjAyZmNkMi90YWJsZXJhbmdlOjZhMTFkZjlmMDgwMzQ2ZmY4ZGQxZjgzMmY2MDJmY2QyXzUtMy0xLTEtODQxNzY_de4b4b25-c94d-4195-85e4-36aacd09ced2"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="id8603ec155204c1e91b9af77be41b5ec_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo2YTExZGY5ZjA4MDM0NmZmOGRkMWY4MzJmNjAyZmNkMi90YWJsZXJhbmdlOjZhMTFkZjlmMDgwMzQ2ZmY4ZGQxZjgzMmY2MDJmY2QyXzUtMS0xLTEtNzIxNTE_07187597-d3b7-4a5c-81c5-8a63f437675a"
      unitRef="usd">-3000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="id0aab17a929c4fdf94f5c9f278870a98_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo2YTExZGY5ZjA4MDM0NmZmOGRkMWY4MzJmNjAyZmNkMi90YWJsZXJhbmdlOjZhMTFkZjlmMDgwMzQ2ZmY4ZGQxZjgzMmY2MDJmY2QyXzUtMy0xLTEtNzIxNTE_8f075452-e9a6-4fe6-aeae-df31e6d3edd5"
      unitRef="usd">-2000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="ic37ff66ffd7045788387e658a219637c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo2YTExZGY5ZjA4MDM0NmZmOGRkMWY4MzJmNjAyZmNkMi90YWJsZXJhbmdlOjZhMTFkZjlmMDgwMzQ2ZmY4ZGQxZjgzMmY2MDJmY2QyXzYtMS0xLTEtNzIxNTE_4dd126b1-4c4e-4c17-9a14-85926cc8db18"
      unitRef="usd">-271000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="iafd18aa56bd8454499c7770cf7cae651_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo2YTExZGY5ZjA4MDM0NmZmOGRkMWY4MzJmNjAyZmNkMi90YWJsZXJhbmdlOjZhMTFkZjlmMDgwMzQ2ZmY4ZGQxZjgzMmY2MDJmY2QyXzYtMy0xLTEtNzIxNTE_d1542429-41fe-4e8f-9848-fedfa337c2a9"
      unitRef="usd">-491000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax
      contextRef="id79a9c944a1046b6aaca9c9fb9f6bebe_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo2YTExZGY5ZjA4MDM0NmZmOGRkMWY4MzJmNjAyZmNkMi90YWJsZXJhbmdlOjZhMTFkZjlmMDgwMzQ2ZmY4ZGQxZjgzMmY2MDJmY2QyXzgtMS0xLTEtNzIxNTE_4dd7126a-2b1d-470a-a859-2ddb9e0d0bd7"
      unitRef="usd">-33000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax
      contextRef="i5af6528a025a4ecc83f861806bda8793_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo2YTExZGY5ZjA4MDM0NmZmOGRkMWY4MzJmNjAyZmNkMi90YWJsZXJhbmdlOjZhMTFkZjlmMDgwMzQ2ZmY4ZGQxZjgzMmY2MDJmY2QyXzgtMy0xLTEtNzIxNTE_ccd546a8-decc-4c8e-b5de-246789eb9f02"
      unitRef="usd">215000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax
      contextRef="id79a9c944a1046b6aaca9c9fb9f6bebe_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo2YTExZGY5ZjA4MDM0NmZmOGRkMWY4MzJmNjAyZmNkMi90YWJsZXJhbmdlOjZhMTFkZjlmMDgwMzQ2ZmY4ZGQxZjgzMmY2MDJmY2QyXzktMS0xLTEtNzIxNTE_637b9405-5636-4f3f-8dc3-77b207eab21f"
      unitRef="usd">11000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax
      contextRef="i5af6528a025a4ecc83f861806bda8793_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo2YTExZGY5ZjA4MDM0NmZmOGRkMWY4MzJmNjAyZmNkMi90YWJsZXJhbmdlOjZhMTFkZjlmMDgwMzQ2ZmY4ZGQxZjgzMmY2MDJmY2QyXzktMy0xLTEtNzIxNTE_e67d2372-bc68-4a8a-ad2e-85061a916d48"
      unitRef="usd">7000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo2YTExZGY5ZjA4MDM0NmZmOGRkMWY4MzJmNjAyZmNkMi90YWJsZXJhbmdlOjZhMTFkZjlmMDgwMzQ2ZmY4ZGQxZjgzMmY2MDJmY2QyXzEwLTEtMS0xLTcyMTUx_1450a223-6c1c-4f19-acef-11807d1b90df"
      unitRef="usd">44000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo2YTExZGY5ZjA4MDM0NmZmOGRkMWY4MzJmNjAyZmNkMi90YWJsZXJhbmdlOjZhMTFkZjlmMDgwMzQ2ZmY4ZGQxZjgzMmY2MDJmY2QyXzEwLTMtMS0xLTcyMTUx_d7d627db-0633-47e0-86bf-ea1732932880"
      unitRef="usd">-208000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax>
    <us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90ZXh0cmVnaW9uOjU2Yjk3OTZmMzkxZTQ1YTRhMzVjOGE4ZjJjYWZhMjhiXzE5NTU_9d14108c-7432-4952-9968-5b1e51e331ea">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.474%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Change in Benefit Obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Beginning projected benefit obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,036&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,118&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Foreign exchange impact&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Employee contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Actuarial (gains) losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(354)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Curtailment gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Ending projected benefit obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;673&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,036&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Ending accumulated benefit obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;645&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;987&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo0YWY4NmM4NDVjM2M0OTYwYTlmZjU5N2M2NzkwNDJjNi90YWJsZXJhbmdlOjRhZjg2Yzg0NWMzYzQ5NjBhOWZmNTk3YzY3OTA0MmM2XzItMS0xLTEtNzIxNTE_931ad2bb-3989-4f73-b311-7c2a63319728"
      unitRef="usd">1036000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i98963cf23d234ec1ac275e66bcfd76dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo0YWY4NmM4NDVjM2M0OTYwYTlmZjU5N2M2NzkwNDJjNi90YWJsZXJhbmdlOjRhZjg2Yzg0NWMzYzQ5NjBhOWZmNTk3YzY3OTA0MmM2XzItMy0xLTEtNzIxNTE_fd8243fe-7e17-4e77-b738-5dd2a5b24ad0"
      unitRef="usd">1118000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo0YWY4NmM4NDVjM2M0OTYwYTlmZjU5N2M2NzkwNDJjNi90YWJsZXJhbmdlOjRhZjg2Yzg0NWMzYzQ5NjBhOWZmNTk3YzY3OTA0MmM2XzMtMS0xLTEtNzIxNTE_effabd9c-10f8-439d-a146-033045f924d5"
      unitRef="usd">56000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo0YWY4NmM4NDVjM2M0OTYwYTlmZjU5N2M2NzkwNDJjNi90YWJsZXJhbmdlOjRhZjg2Yzg0NWMzYzQ5NjBhOWZmNTk3YzY3OTA0MmM2XzMtMy0xLTEtNzIxNTE_4f316759-a12b-4f8c-a0ac-316cfa11be47"
      unitRef="usd">72000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo0YWY4NmM4NDVjM2M0OTYwYTlmZjU5N2M2NzkwNDJjNi90YWJsZXJhbmdlOjRhZjg2Yzg0NWMzYzQ5NjBhOWZmNTk3YzY3OTA0MmM2XzQtMS0xLTEtNzIxNTE_8a81c7f8-8465-4156-a457-0a5669cb02f4"
      unitRef="usd">10000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo0YWY4NmM4NDVjM2M0OTYwYTlmZjU5N2M2NzkwNDJjNi90YWJsZXJhbmdlOjRhZjg2Yzg0NWMzYzQ5NjBhOWZmNTk3YzY3OTA0MmM2XzQtMy0xLTEtNzIxNTE_da66b8e5-553d-4783-a287-41356ad403b3"
      unitRef="usd">7000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo0YWY4NmM4NDVjM2M0OTYwYTlmZjU5N2M2NzkwNDJjNi90YWJsZXJhbmdlOjRhZjg2Yzg0NWMzYzQ5NjBhOWZmNTk3YzY3OTA0MmM2XzUtMS0xLTEtNzIxNTE_446a88dc-d833-439f-8d96-bf03b8e323b5"
      unitRef="usd">-56000000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo0YWY4NmM4NDVjM2M0OTYwYTlmZjU5N2M2NzkwNDJjNi90YWJsZXJhbmdlOjRhZjg2Yzg0NWMzYzQ5NjBhOWZmNTk3YzY3OTA0MmM2XzUtMy0xLTEtNzIxNTE_3cc53474-ff55-4172-a68e-1fea19fdbf8e"
      unitRef="usd">-70000000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo0YWY4NmM4NDVjM2M0OTYwYTlmZjU5N2M2NzkwNDJjNi90YWJsZXJhbmdlOjRhZjg2Yzg0NWMzYzQ5NjBhOWZmNTk3YzY3OTA0MmM2XzYtMS0xLTEtNzIxNTE_2c2da7d4-5a31-4f81-b6bd-b3938f812621"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo0YWY4NmM4NDVjM2M0OTYwYTlmZjU5N2M2NzkwNDJjNi90YWJsZXJhbmdlOjRhZjg2Yzg0NWMzYzQ5NjBhOWZmNTk3YzY3OTA0MmM2XzYtMy0xLTEtNzIxNTE_2f1d3ced-480d-44f2-aedf-4665b1c99589"
      unitRef="usd">8000000</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo0YWY4NmM4NDVjM2M0OTYwYTlmZjU5N2M2NzkwNDJjNi90YWJsZXJhbmdlOjRhZjg2Yzg0NWMzYzQ5NjBhOWZmNTk3YzY3OTA0MmM2XzctMS0xLTEtNzIxNTE_3ae5e3ae-667d-425b-9151-9980d0416fbd"
      unitRef="usd">354000000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo0YWY4NmM4NDVjM2M0OTYwYTlmZjU5N2M2NzkwNDJjNi90YWJsZXJhbmdlOjRhZjg2Yzg0NWMzYzQ5NjBhOWZmNTk3YzY3OTA0MmM2XzctMy0xLTEtNzIxNTE_aefc2ab7-c274-4aa3-bbe2-def4a0670767"
      unitRef="usd">71000000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanCurtailments
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo0YWY4NmM4NDVjM2M0OTYwYTlmZjU5N2M2NzkwNDJjNi90YWJsZXJhbmdlOjRhZjg2Yzg0NWMzYzQ5NjBhOWZmNTk3YzY3OTA0MmM2XzktMS0xLTEtNzIxNTE_9d026896-7e2b-4f21-88d0-7270b374440b"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanCurtailments>
    <us-gaap:DefinedBenefitPlanCurtailments
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo0YWY4NmM4NDVjM2M0OTYwYTlmZjU5N2M2NzkwNDJjNi90YWJsZXJhbmdlOjRhZjg2Yzg0NWMzYzQ5NjBhOWZmNTk3YzY3OTA0MmM2XzktMy0xLTEtNzIxNTE_93f40cf9-0afa-4720-81e7-d9941c5b39c9"
      unitRef="usd">-23000000</us-gaap:DefinedBenefitPlanCurtailments>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo0YWY4NmM4NDVjM2M0OTYwYTlmZjU5N2M2NzkwNDJjNi90YWJsZXJhbmdlOjRhZjg2Yzg0NWMzYzQ5NjBhOWZmNTk3YzY3OTA0MmM2XzEwLTEtMS0xLTcyMTUx_a26a855a-8ad8-44e1-972c-34a3ea1f4fc4"
      unitRef="usd">24000000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo0YWY4NmM4NDVjM2M0OTYwYTlmZjU5N2M2NzkwNDJjNi90YWJsZXJhbmdlOjRhZjg2Yzg0NWMzYzQ5NjBhOWZmNTk3YzY3OTA0MmM2XzEwLTMtMS0xLTcyMTUx_64fb6b5d-16e3-4d82-a74b-077de8ddcc48"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo0YWY4NmM4NDVjM2M0OTYwYTlmZjU5N2M2NzkwNDJjNi90YWJsZXJhbmdlOjRhZjg2Yzg0NWMzYzQ5NjBhOWZmNTk3YzY3OTA0MmM2XzExLTEtMS0xLTcyMTUx_73330dc8-8cbe-47be-bd99-01be0b16a526"
      unitRef="usd">673000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo0YWY4NmM4NDVjM2M0OTYwYTlmZjU5N2M2NzkwNDJjNi90YWJsZXJhbmdlOjRhZjg2Yzg0NWMzYzQ5NjBhOWZmNTk3YzY3OTA0MmM2XzExLTMtMS0xLTcyMTUx_88248231-cc37-4728-82a4-b4bc5403962e"
      unitRef="usd">1036000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo0YWY4NmM4NDVjM2M0OTYwYTlmZjU5N2M2NzkwNDJjNi90YWJsZXJhbmdlOjRhZjg2Yzg0NWMzYzQ5NjBhOWZmNTk3YzY3OTA0MmM2XzEyLTEtMS0xLTcyMTUx_6f95b478-8735-4759-a28c-18225f55494f"
      unitRef="usd">645000000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo0YWY4NmM4NDVjM2M0OTYwYTlmZjU5N2M2NzkwNDJjNi90YWJsZXJhbmdlOjRhZjg2Yzg0NWMzYzQ5NjBhOWZmNTk3YzY3OTA0MmM2XzEyLTMtMS0xLTcyMTUx_91b5ef39-4c19-480d-bb48-59b4f46e53e1"
      unitRef="usd">987000000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90ZXh0cmVnaW9uOjU2Yjk3OTZmMzkxZTQ1YTRhMzVjOGE4ZjJjYWZhMjhiXzE5MTU_2e6b46c2-cdc1-4614-afb8-add5a9abfe56">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.474%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Change in Plan Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Beginning fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;543&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;522&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Actual return&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(109)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Employer contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Employee contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Foreign exchange impact&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Ending fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;420&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;543&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.220%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.220%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.220%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Valuation of Plan Assets &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;46&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;319&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;55&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;420&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;55&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;389&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;99&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;543&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTozYTFiYTI5YjZjYWM0NTI5YjBmZDQ2ZjBhNjc3ODNlYi90YWJsZXJhbmdlOjNhMWJhMjliNmNhYzQ1MjliMGZkNDZmMGE2Nzc4M2ViXzItMS0xLTEtNzIxNTE_f0465f48-56d4-49fc-8930-fb489f4a9a52"
      unitRef="usd">543000000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
      contextRef="i98963cf23d234ec1ac275e66bcfd76dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTozYTFiYTI5YjZjYWM0NTI5YjBmZDQ2ZjBhNjc3ODNlYi90YWJsZXJhbmdlOjNhMWJhMjliNmNhYzQ1MjliMGZkNDZmMGE2Nzc4M2ViXzItMy0xLTEtNzIxNTE_47421595-9e0b-4760-931a-41b1f109c850"
      unitRef="usd">522000000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTozYTFiYTI5YjZjYWM0NTI5YjBmZDQ2ZjBhNjc3ODNlYi90YWJsZXJhbmdlOjNhMWJhMjliNmNhYzQ1MjliMGZkNDZmMGE2Nzc4M2ViXzMtMS0xLTEtNzIxNTE_6ade1a9b-e34a-4198-94b3-37ce61858316"
      unitRef="usd">-109000000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTozYTFiYTI5YjZjYWM0NTI5YjBmZDQ2ZjBhNjc3ODNlYi90YWJsZXJhbmdlOjNhMWJhMjliNmNhYzQ1MjliMGZkNDZmMGE2Nzc4M2ViXzMtMy0xLTEtNzIxNTE_c159dbbe-dc2e-46a4-8b86-13154467954c"
      unitRef="usd">17000000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTozYTFiYTI5YjZjYWM0NTI5YjBmZDQ2ZjBhNjc3ODNlYi90YWJsZXJhbmdlOjNhMWJhMjliNmNhYzQ1MjliMGZkNDZmMGE2Nzc4M2ViXzQtMS0xLTEtNzIxNTE_5c457035-aeef-41d4-9f98-5b9204fcb222"
      unitRef="usd">19000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTozYTFiYTI5YjZjYWM0NTI5YjBmZDQ2ZjBhNjc3ODNlYi90YWJsZXJhbmdlOjNhMWJhMjliNmNhYzQ1MjliMGZkNDZmMGE2Nzc4M2ViXzQtMy0xLTEtNzIxNTE_4cae7497-866c-4654-a3d0-0743fe2c693e"
      unitRef="usd">33000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTozYTFiYTI5YjZjYWM0NTI5YjBmZDQ2ZjBhNjc3ODNlYi90YWJsZXJhbmdlOjNhMWJhMjliNmNhYzQ1MjliMGZkNDZmMGE2Nzc4M2ViXzUtMS0xLTEtNzIxNTE_70667279-4a75-446f-ae62-b70306beb9e6"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTozYTFiYTI5YjZjYWM0NTI5YjBmZDQ2ZjBhNjc3ODNlYi90YWJsZXJhbmdlOjNhMWJhMjliNmNhYzQ1MjliMGZkNDZmMGE2Nzc4M2ViXzUtMy0xLTEtNzIxNTE_d9d8f91a-ce29-4597-9e58-1d52dacd9df4"
      unitRef="usd">8000000</us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTozYTFiYTI5YjZjYWM0NTI5YjBmZDQ2ZjBhNjc3ODNlYi90YWJsZXJhbmdlOjNhMWJhMjliNmNhYzQ1MjliMGZkNDZmMGE2Nzc4M2ViXzYtMS0xLTEtNzIxNTE_e7164858-368e-45f0-a3fa-2c877039cb66"
      unitRef="usd">-24000000</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTozYTFiYTI5YjZjYWM0NTI5YjBmZDQ2ZjBhNjc3ODNlYi90YWJsZXJhbmdlOjNhMWJhMjliNmNhYzQ1MjliMGZkNDZmMGE2Nzc4M2ViXzYtMy0xLTEtNzIxNTE_43500f3c-ef08-4c72-86af-34ab0777f740"
      unitRef="usd">-29000000</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTozYTFiYTI5YjZjYWM0NTI5YjBmZDQ2ZjBhNjc3ODNlYi90YWJsZXJhbmdlOjNhMWJhMjliNmNhYzQ1MjliMGZkNDZmMGE2Nzc4M2ViXzgtMS0xLTEtNzIxNTE_15bb946e-1c93-4e34-a67b-3c1b8299da91"
      unitRef="usd">14000000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTozYTFiYTI5YjZjYWM0NTI5YjBmZDQ2ZjBhNjc3ODNlYi90YWJsZXJhbmdlOjNhMWJhMjliNmNhYzQ1MjliMGZkNDZmMGE2Nzc4M2ViXzgtMy0xLTEtNzIxNTE_fb36e37a-8dce-468b-8b96-f9d716269d64"
      unitRef="usd">8000000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTozYTFiYTI5YjZjYWM0NTI5YjBmZDQ2ZjBhNjc3ODNlYi90YWJsZXJhbmdlOjNhMWJhMjliNmNhYzQ1MjliMGZkNDZmMGE2Nzc4M2ViXzktMS0xLTEtNzIxNTE_d659ffc2-21ed-4784-abe4-b9582c5e5c8c"
      unitRef="usd">420000000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTozYTFiYTI5YjZjYWM0NTI5YjBmZDQ2ZjBhNjc3ODNlYi90YWJsZXJhbmdlOjNhMWJhMjliNmNhYzQ1MjliMGZkNDZmMGE2Nzc4M2ViXzktMy0xLTEtNzIxNTE_c955ce48-7281-4764-8b11-2d46a6b5ff1b"
      unitRef="usd">543000000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90ZXh0cmVnaW9uOjU2Yjk3OTZmMzkxZTQ1YTRhMzVjOGE4ZjJjYWZhMjhiXzE5MjY_f8bbb8d2-c766-4d34-9a1d-ecd201a1642f">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.770%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.649%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.649%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.652%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Allocation of Plan Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023 Target&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022 Actual&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021 Actual&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;100&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;100&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;100&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i58b96ce29b8a42aea4c5893906463ce3_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpmMjFjMTgyMDE1ODU0ZjY1OGU3MzgzZTdjMjhjNDUwYS90YWJsZXJhbmdlOmYyMWMxODIwMTU4NTRmNjU4ZTczODNlN2MyOGM0NTBhXzItMS0xLTEtNzIxNTE_ddb2d66f-246d-4992-a636-b2c0399c0799"
      unitRef="number">0.25</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i58b96ce29b8a42aea4c5893906463ce3_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpmMjFjMTgyMDE1ODU0ZjY1OGU3MzgzZTdjMjhjNDUwYS90YWJsZXJhbmdlOmYyMWMxODIwMTU4NTRmNjU4ZTczODNlN2MyOGM0NTBhXzItMy0xLTEtNzIxNTE_5c24cef2-25e9-46e6-a4dc-ecf053da403e"
      unitRef="number">0.27</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i0e072f5fbda04e4ca99129d167dfe999_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpmMjFjMTgyMDE1ODU0ZjY1OGU3MzgzZTdjMjhjNDUwYS90YWJsZXJhbmdlOmYyMWMxODIwMTU4NTRmNjU4ZTczODNlN2MyOGM0NTBhXzItNS0xLTEtNzIxNTE_2111b919-f0b8-4f7a-944d-6e266f60dc44"
      unitRef="number">0.23</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i1683d20c41d847f185c1386f0f3dc4c4_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpmMjFjMTgyMDE1ODU0ZjY1OGU3MzgzZTdjMjhjNDUwYS90YWJsZXJhbmdlOmYyMWMxODIwMTU4NTRmNjU4ZTczODNlN2MyOGM0NTBhXzMtMS0xLTEtNzIxNTE_eacd49de-4605-4025-aea0-e24df177fa37"
      unitRef="number">0.41</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i1683d20c41d847f185c1386f0f3dc4c4_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpmMjFjMTgyMDE1ODU0ZjY1OGU3MzgzZTdjMjhjNDUwYS90YWJsZXJhbmdlOmYyMWMxODIwMTU4NTRmNjU4ZTczODNlN2MyOGM0NTBhXzMtMy0xLTEtNzIxNTE_7d415ce3-7760-4715-8295-cdb5da1d09b7"
      unitRef="number">0.38</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="ibe98d7ecbed04b7286e7baabd289cc71_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpmMjFjMTgyMDE1ODU0ZjY1OGU3MzgzZTdjMjhjNDUwYS90YWJsZXJhbmdlOmYyMWMxODIwMTU4NTRmNjU4ZTczODNlN2MyOGM0NTBhXzMtNS0xLTEtNzIxNTE_8b5595c6-1dd6-493b-8a43-750dede18fd6"
      unitRef="number">0.41</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i779788123a93436181d9161accb7424e_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpmMjFjMTgyMDE1ODU0ZjY1OGU3MzgzZTdjMjhjNDUwYS90YWJsZXJhbmdlOmYyMWMxODIwMTU4NTRmNjU4ZTczODNlN2MyOGM0NTBhXzQtMS0xLTEtNzIxNTE_7ae03a4f-7cb2-48af-b403-8d826c62f00d"
      unitRef="number">0.34</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i779788123a93436181d9161accb7424e_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpmMjFjMTgyMDE1ODU0ZjY1OGU3MzgzZTdjMjhjNDUwYS90YWJsZXJhbmdlOmYyMWMxODIwMTU4NTRmNjU4ZTczODNlN2MyOGM0NTBhXzQtMy0xLTEtNzIxNTE_ed542f58-a10e-4a77-9b38-9840ea65880f"
      unitRef="number">0.35</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i561834c74eee46c8bba248e767b8abd2_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpmMjFjMTgyMDE1ODU0ZjY1OGU3MzgzZTdjMjhjNDUwYS90YWJsZXJhbmdlOmYyMWMxODIwMTU4NTRmNjU4ZTczODNlN2MyOGM0NTBhXzQtNS0xLTEtNzIxNTE_c65aaf21-1522-400b-abec-705a12fd5660"
      unitRef="number">0.36</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpmMjFjMTgyMDE1ODU0ZjY1OGU3MzgzZTdjMjhjNDUwYS90YWJsZXJhbmdlOmYyMWMxODIwMTU4NTRmNjU4ZTczODNlN2MyOGM0NTBhXzUtMS0xLTEtNzIxNTE_4eca798d-0b4c-4323-aff8-1218dd671353"
      unitRef="number">1</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpmMjFjMTgyMDE1ODU0ZjY1OGU3MzgzZTdjMjhjNDUwYS90YWJsZXJhbmdlOmYyMWMxODIwMTU4NTRmNjU4ZTczODNlN2MyOGM0NTBhXzUtMy0xLTEtNzIxNTE_07a838d0-fd94-40c0-82cd-c507d2cfc3b7"
      unitRef="number">1</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTpmMjFjMTgyMDE1ODU0ZjY1OGU3MzgzZTdjMjhjNDUwYS90YWJsZXJhbmdlOmYyMWMxODIwMTU4NTRmNjU4ZTczODNlN2MyOGM0NTBhXzUtNS0xLTEtNzIxNTE_92a950ab-708c-497d-ac2a-65c891a8e91b"
      unitRef="number">1</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic638fcfdbb6a416d92b8a3b7c9c78967_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzItMS0xLTEtNzIxNTE_1fd2d7f0-4547-450c-8829-c235bd14e72a"
      unitRef="usd">18000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="id537c1a6699e44bd890ba7e54ef23a6d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzItMi0xLTEtNzIxNTE_47fd97e8-b3cc-4299-82ad-469da15a2da7"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i1a7ea0b36abd4a6cb52f66b4b312169e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzItMy0xLTEtNzIxNTE_da5ac394-edc6-49b2-aa91-8c07d3e1f1a7"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic4059183a5b54d6798538edc19c050cf_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzItNC0xLTEtNzIxNTE_b664fa83-f79f-46f8-8bfe-9495d4e6bc1c"
      unitRef="usd">18000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i8522801ceae048788c0fce97e5d37ab5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzMtMS0xLTEtNzIxNTE_3adc3666-cee9-4400-8627-df7cf4b9f27e"
      unitRef="usd">21000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i6eb65c14e5914f63978a0d0069999ab8_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzMtMi0xLTEtNzIxNTE_bdaa3fed-4ee1-4826-9879-6297e5b9b66e"
      unitRef="usd">99000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i2cc1146a58874a6eb8ef302951c2aecd_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzMtMy0xLTEtNzIxNTE_cce58250-d614-4bce-aaf0-e332e1ffd6ab"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i58b96ce29b8a42aea4c5893906463ce3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzMtNC0xLTEtNzIxNTE_49738a63-722b-43ab-9b39-707be307f18c"
      unitRef="usd">120000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5df6f1a799424f859f0ab765aa4d61d1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzQtMS0xLTEtNzIxNTE_cc522919-f191-45f7-832a-b42baadeca34"
      unitRef="usd">2000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ica6e290960a44739ba644626546b3852_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzQtMi0xLTEtNzIxNTE_ebe844e7-da08-4846-aa4d-4e4b41ac4ed6"
      unitRef="usd">151000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5a0b0ee47ce04183ad042932b91b34ce_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzQtMy0xLTEtNzIxNTE_303eea08-6a88-4670-a422-3d64431dc254"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic5010ff9bb614d35ae3367ed2df39f6b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzQtNC0xLTEtNzIxNTE_a0abb8f2-8524-4ffa-9347-27be8a2056f3"
      unitRef="usd">153000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i1eaacfb68128466f93e71b1251c20bea_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzUtMS0xLTEtNzIxNTE_74338329-19a8-483c-b8e5-13e3caf528d2"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i4ffb4a3bde3947f88266050517970e80_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzUtMi0xLTEtNzIxNTE_f35d2ed2-484d-4454-b95e-f1f48fbf3db5"
      unitRef="usd">69000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib3d6dbee4de64017afe0c8e13e01299a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzUtMy0xLTEtNzIxNTE_bc3b1dbd-896a-4002-90c0-f25ac38ef9c8"
      unitRef="usd">55000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib19f498ef30f4326a72ede1108304255_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzUtNC0xLTEtNzIxNTE_758083cf-447e-452c-8884-daa8c8a44a6b"
      unitRef="usd">129000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia2d532877fe14293a0c7af8376dd383a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzYtMS0xLTEtNzIxNTE_50162eca-d7a9-4877-bf82-7b46ff79cfc4"
      unitRef="usd">46000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5847988c48e945ff89b5383f616f507c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzYtMi0xLTEtNzIxNTE_21871946-dd75-4928-99b1-f983e90fd8ab"
      unitRef="usd">319000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i6d64b78c8a794c42aa5ea20736299864_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzYtMy0xLTEtNzIxNTE_ccc86d09-362d-4a75-90d6-46cf168f0b75"
      unitRef="usd">55000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzYtNC0xLTEtNzIxNTE_10d26de1-ad60-4225-b33a-b059658bfab3"
      unitRef="usd">420000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i34080018fa394c35b4a7f8033b8e1796_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzgtMS0xLTEtNzIxNTE_6637712f-5b1e-4192-9036-c742152acb16"
      unitRef="usd">21000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i210fd2367de749efa9a2e625851d0bd8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzgtMi0xLTEtNzIxNTE_3fecb000-de12-41ac-a38c-b92475d926f8"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iaa8b9dcdddf64372b0059d96cea46c50_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzgtMy0xLTEtNzIxNTE_91334d83-6961-4f86-962d-bc2f5368a86c"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia6bb811c5e3d4e62aa7eb329cbe0c9b7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzgtNC0xLTEtNzIxNTE_73bfd3d2-9ae5-4b77-9ae1-c50ba535b1b2"
      unitRef="usd">21000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iee87b668135841238e75f21caf1cda6f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzktMS0xLTEtNzIxNTE_bae66a46-f924-489f-8b97-d5a1e20683a3"
      unitRef="usd">28000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="icd8cfa9e07864166b0bc1f6192348149_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzktMi0xLTEtNzIxNTE_5ebb2cfc-dac4-4c84-91df-3cfe1dadcc51"
      unitRef="usd">119000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib37f5d53c40e4ad5af1d22e367b1ff8c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzktMy0xLTEtNzIxNTE_449695c0-1eef-4d8c-b4eb-ddb9c8c4a2e6"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i0e072f5fbda04e4ca99129d167dfe999_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzktNC0xLTEtNzIxNTE_347bc88e-2171-474d-be3e-20e83426dac2"
      unitRef="usd">147000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i3ecf88ddf1cd4958a23d17b1f094f7d0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzEwLTEtMS0xLTcyMTUx_ec37c5f7-5b1c-4390-a600-315ab7a77d95"
      unitRef="usd">2000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5a8294b0f5d74e708266fe817d78a47a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzEwLTItMS0xLTcyMTUx_dbeb077b-f5ce-41ba-bdc8-6b9e55942e9c"
      unitRef="usd">202000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5570209ef64543bfba07e2abea804238_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzEwLTMtMS0xLTcyMTUx_c931b24a-6c87-4f06-989b-8400acc6a5c5"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i7f7e6cbe52c44cb79b943e8593f46867_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzEwLTQtMS0xLTcyMTUx_f00b473b-3560-40a6-895f-bc3e3dec59a6"
      unitRef="usd">204000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i848d92fcbcf64897bfd1cc126a3aa1a9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzExLTEtMS0xLTcyMTUx_9b85357d-69cb-478e-88ad-bb7270fa6f01"
      unitRef="usd">4000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ibade722fea764961b1d9d387629073e2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzExLTItMS0xLTcyMTUx_73d0b56d-2edc-4324-8d22-0db669841ca2"
      unitRef="usd">68000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia6c76d2fefcd444b82889ab47088a661_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzExLTMtMS0xLTcyMTUx_0ed4137b-9b5d-450f-aaa0-93b511c94d6a"
      unitRef="usd">99000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i7dfe7c27f3e347c2825a7b6348357a60_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzExLTQtMS0xLTcyMTUx_97504416-360c-46e1-9081-0a070e2e7340"
      unitRef="usd">171000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="icb345be38a2145ec8f2df1b4c28dc6d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzEyLTEtMS0xLTcyMTUx_85473527-289a-48d7-a564-7289d82d8138"
      unitRef="usd">55000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5e94767eea5f4452a8497953475e7b32_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzEyLTItMS0xLTcyMTUx_37b5aa92-df90-486b-8ae5-994357cf9c6a"
      unitRef="usd">389000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i33ec7e34209e4d64ba95fe5eb1edee60_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzEyLTMtMS0xLTcyMTUx_77f619c5-2331-4902-8d68-c4047115f54f"
      unitRef="usd">99000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZToyZmExMzJiNTllMTM0YjAwOTRhNTRkMjFmZjUwYmRkYS90YWJsZXJhbmdlOjJmYTEzMmI1OWUxMzRiMDA5NGE1NGQyMWZmNTBiZGRhXzEyLTQtMS0xLTcyMTUx_ef8246f7-0490-4a55-b25f-1bdda23b00d4"
      unitRef="usd">543000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="i555016f434ae4cd48b50f24fbe1586b3_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90ZXh0cmVnaW9uOjU2Yjk3OTZmMzkxZTQ1YTRhMzVjOGE4ZjJjYWZhMjhiXzE3MjY_35f33624-a25a-4fd7-8fb9-3a06cad765e1"
      unitRef="usd">-44000000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear
      contextRef="i6d64b78c8a794c42aa5ea20736299864_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90ZXh0cmVnaW9uOjU2Yjk3OTZmMzkxZTQ1YTRhMzVjOGE4ZjJjYWZhMjhiXzE4Njc_1247fd41-0c75-4162-b4e5-eb62e6f221f7"
      unitRef="usd">19000000</us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear>
    <us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90ZXh0cmVnaW9uOjU2Yjk3OTZmMzkxZTQ1YTRhMzVjOGE4ZjJjYWZhMjhiXzE5Mjk_4fdd0181-b713-4ca5-b4df-a70f6dfb4fe0">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Estimated Future Benefit Payments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2028-2032&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo2MWNkN2NjMmE1YWY0NDlhODY3YmEwMzNjY2MxOTMwMC90YWJsZXJhbmdlOjYxY2Q3Y2MyYTVhZjQ0OWE4NjdiYTAzM2NjYzE5MzAwXzItMC0xLTEtNzIxNTE_3dcf0beb-cada-4112-b5d9-297cc404b287"
      unitRef="usd">22000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo2MWNkN2NjMmE1YWY0NDlhODY3YmEwMzNjY2MxOTMwMC90YWJsZXJhbmdlOjYxY2Q3Y2MyYTVhZjQ0OWE4NjdiYTAzM2NjYzE5MzAwXzItMS0xLTEtNzIxNTE_3e2a0d8d-f399-477c-b5e5-feb527fa8849"
      unitRef="usd">26000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo2MWNkN2NjMmE1YWY0NDlhODY3YmEwMzNjY2MxOTMwMC90YWJsZXJhbmdlOjYxY2Q3Y2MyYTVhZjQ0OWE4NjdiYTAzM2NjYzE5MzAwXzItMi0xLTEtNzIxNTE_6e282277-20ac-4044-93eb-e25ede565de9"
      unitRef="usd">23000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo2MWNkN2NjMmE1YWY0NDlhODY3YmEwMzNjY2MxOTMwMC90YWJsZXJhbmdlOjYxY2Q3Y2MyYTVhZjQ0OWE4NjdiYTAzM2NjYzE5MzAwXzItMy0xLTEtNzIxNTE_5ceafd37-68f3-4f7d-a812-9934ef83d69f"
      unitRef="usd">23000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo2MWNkN2NjMmE1YWY0NDlhODY3YmEwMzNjY2MxOTMwMC90YWJsZXJhbmdlOjYxY2Q3Y2MyYTVhZjQ0OWE4NjdiYTAzM2NjYzE5MzAwXzItNC0xLTEtNzIxNTE_b3fdc00f-c899-44fe-bf13-8d0d35262663"
      unitRef="usd">25000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzMvZnJhZzo1NmI5Nzk2ZjM5MWU0NWE0YTM1YzhhOGYyY2FmYTI4Yi90YWJsZTo2MWNkN2NjMmE1YWY0NDlhODY3YmEwMzNjY2MxOTMwMC90YWJsZXJhbmdlOjYxY2Q3Y2MyYTVhZjQ0OWE4NjdiYTAzM2NjYzE5MzAwXzItNS0xLTEtNzIxNTE_0976c1a2-5559-4fc6-bae6-76a8e392f757"
      unitRef="usd">146000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter>
    <us-gaap:QuarterlyFinancialInformationTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90ZXh0cmVnaW9uOjBjZjk2ZDhiMTlhMDQ4NTJiZjdiMGRlNjhhZGM3ODBjXzYw_7a48193f-c507-4783-9f51-ad92e527f18e">SUMMARY OF QUARTERLY DATA (UNAUDITED)&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.031%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.368%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022 Quarters&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Mar 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Jun&#160;30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Sep 30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Dec 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,275&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,493&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,479&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,202&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Earnings (loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net earnings (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;323&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;656&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;816&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;563&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net earnings (loss) per share of common stock:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Dividends declared per share of common stock&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021 Quarters&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Mar 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Jun&#160;30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Sep 30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Dec 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,953&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,294&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,160&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,701&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Earnings before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;302&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;592&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;438&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;662&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net earnings per share of common stock:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Dividends declared per share of common stock&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:QuarterlyFinancialInformationTextBlock>
    <us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90ZXh0cmVnaW9uOjBjZjk2ZDhiMTlhMDQ4NTJiZjdiMGRlNjhhZGM3ODBjXzY3_8364b0fe-a8c6-4f40-8418-af60eec580d1">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.031%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.368%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022 Quarters&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Mar 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Jun&#160;30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Sep 30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Dec 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,275&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,493&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,479&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,202&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Earnings (loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net earnings (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;323&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;656&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;816&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;563&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net earnings (loss) per share of common stock:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Dividends declared per share of common stock&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021 Quarters&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Mar 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Jun&#160;30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Sep 30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Dec 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,953&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,294&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,160&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,701&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Earnings before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;302&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;592&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;438&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;662&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net earnings per share of common stock:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Dividends declared per share of common stock&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock>
    <us-gaap:Revenues
      contextRef="i8beea1d5ee1f4b6081ce02f6910e2cab_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzEtMS0xLTEtNzIxNTE_6fac5ff8-18e5-49ad-a561-89aee6ccd155"
      unitRef="usd">4275000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7d0292cedd974224858a44410249e5e0_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzEtMi0xLTEtNzIxNTE_d18f118d-31ee-4b25-8d8b-45be77c4ca97"
      unitRef="usd">4493000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iec7ff50d4aea4a64b1a222ed6cddad1e_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzEtMy0xLTEtNzIxNTE_18b8bff5-86af-427d-8f30-c8d2bbe78163"
      unitRef="usd">4479000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i05c365347626469281b193639de4b1a1_D20221001-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzEtNC0xLTEtNzIxNTE_7d71b452-b39e-4ca0-a9a3-1988d5f92197"
      unitRef="usd">5202000000</us-gaap:Revenues>
    <us-gaap:GrossProfit
      contextRef="i8beea1d5ee1f4b6081ce02f6910e2cab_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzItMS0xLTEtNzIxNTE_d62052a1-a73c-485d-ac71-292f2a9bdeb1"
      unitRef="usd">2734000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i7d0292cedd974224858a44410249e5e0_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzItMi0xLTEtNzIxNTE_14ee1fef-7c1a-459c-8f44-80f7163ab348"
      unitRef="usd">2826000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="iec7ff50d4aea4a64b1a222ed6cddad1e_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzItMy0xLTEtNzIxNTE_4d0c2df8-1201-4b8e-91df-014030ef4aa4"
      unitRef="usd">2782000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i05c365347626469281b193639de4b1a1_D20221001-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzItNC0xLTEtNzIxNTE_ccf68032-307a-4e8c-8a47-c4ebec6aa64c"
      unitRef="usd">3236000000</us-gaap:GrossProfit>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i8beea1d5ee1f4b6081ce02f6910e2cab_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzMtMS0xLTEtNzIxNTE_ffafabb0-e890-45a7-a098-f567ee09c2b0"
      unitRef="usd">386000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i7d0292cedd974224858a44410249e5e0_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzMtMi0xLTEtNzIxNTE_a4804128-e2e9-4fb8-b413-6348260ea4e5"
      unitRef="usd">720000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="iec7ff50d4aea4a64b1a222ed6cddad1e_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzMtMy0xLTEtNzIxNTE_3af08352-f93d-42b9-9110-6e242e58c19f"
      unitRef="usd">816000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i05c365347626469281b193639de4b1a1_D20221001-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzMtNC0xLTEtNzIxNTE_32e2ec42-d487-460b-8d15-3650c0771651"
      unitRef="usd">761000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i8beea1d5ee1f4b6081ce02f6910e2cab_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzQtMS0xLTEtNzIxNTE_18fb759a-21c0-4542-b20f-39a016ad372d"
      unitRef="usd">323000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i7d0292cedd974224858a44410249e5e0_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzQtMi0xLTEtNzIxNTE_996ca8f1-aeef-4913-99ba-6a222ff951ff"
      unitRef="usd">656000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iec7ff50d4aea4a64b1a222ed6cddad1e_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzQtMy0xLTEtNzIxNTE_61b3107c-1225-42e9-af0f-8c044f2534aa"
      unitRef="usd">816000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i05c365347626469281b193639de4b1a1_D20221001-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzQtNC0xLTEtNzIxNTE_f3d42405-5826-4a53-8a32-eafb8b90f80a"
      unitRef="usd">563000000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i8beea1d5ee1f4b6081ce02f6910e2cab_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzYtMS0xLTEtNzIxNTE_e1b57293-8ca3-4afc-acc7-1532dac3286f"
      unitRef="usdPerShare">0.86</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i7d0292cedd974224858a44410249e5e0_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzYtMi0xLTEtNzIxNTE_bd841383-7408-4a68-91a4-e96a54ba6417"
      unitRef="usdPerShare">1.73</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="iec7ff50d4aea4a64b1a222ed6cddad1e_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzYtMy0xLTEtNzIxNTE_11a15855-aa48-45f5-8164-d5b6b935746f"
      unitRef="usdPerShare">2.16</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i05c365347626469281b193639de4b1a1_D20221001-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzYtNC0xLTEtNzIxNTE_a1e19bd4-a863-4427-add9-46a63366d913"
      unitRef="usdPerShare">1.48</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i8beea1d5ee1f4b6081ce02f6910e2cab_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzctMS0xLTEtNzIxNTE_f9332811-ee5a-4992-8081-f344ea97eb82"
      unitRef="usdPerShare">0.84</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i7d0292cedd974224858a44410249e5e0_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzctMi0xLTEtNzIxNTE_364be7e8-d647-4cf4-951d-3ef78f3bb556"
      unitRef="usdPerShare">1.72</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="iec7ff50d4aea4a64b1a222ed6cddad1e_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzctMy0xLTEtNzIxNTE_907eff18-bf46-489f-87bc-6cdc58a15967"
      unitRef="usdPerShare">2.14</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i05c365347626469281b193639de4b1a1_D20221001-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzctNC0xLTEtNzIxNTE_757cc93d-e575-472c-9852-9337b721b945"
      unitRef="usdPerShare">1.47</us-gaap:EarningsPerShareDiluted>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i8beea1d5ee1f4b6081ce02f6910e2cab_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzExLTEtMS0xLTcyMTUx_12c30dcf-9b25-49a3-b9be-97a4577f54df"
      unitRef="usdPerShare">0.695</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i7d0292cedd974224858a44410249e5e0_D20220401-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzExLTItMS0xLTcyMTUx_06f16154-b0c3-44ee-9ee8-b13c8af5da0f"
      unitRef="usdPerShare">0.695</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="iec7ff50d4aea4a64b1a222ed6cddad1e_D20220701-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzExLTMtMS0xLTcyMTUx_9fa633de-e398-41bb-977a-e197faca18a3"
      unitRef="usdPerShare">0.695</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i05c365347626469281b193639de4b1a1_D20221001-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzExLTQtMS0xLTcyMTUx_a9e34bcf-7bc4-463e-92b9-61c239031ff2"
      unitRef="usdPerShare">0.750</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:Revenues
      contextRef="ib1975d811d9f4de7bc2dc66e567577a2_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzE0LTEtMS0xLTcyMTUx_3e399d0f-c322-4b2e-b1df-47cc9797413a"
      unitRef="usd">3953000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i06d24da15c2a4301868cb2cf91cc084f_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzE0LTItMS0xLTcyMTUx_9e20a8e9-f573-4c74-a95c-a790cf6d5cfe"
      unitRef="usd">4294000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i28ee17ac872e4181a4e2ee167127995d_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzE0LTMtMS0xLTcyMTUx_34f0fe35-a180-4d5e-a801-136c3f0b7f06"
      unitRef="usd">4160000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6b8d2fac04db45dda920f25320d94772_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzE0LTQtMS0xLTcyMTUx_f4bae1d7-9f98-42b5-ae9a-dff21ac71a8c"
      unitRef="usd">4701000000</us-gaap:Revenues>
    <us-gaap:GrossProfit
      contextRef="ib1975d811d9f4de7bc2dc66e567577a2_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzE1LTEtMS0xLTcyMTUx_67a9e264-aa26-4698-9a58-3a247304e779"
      unitRef="usd">2509000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i06d24da15c2a4301868cb2cf91cc084f_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzE1LTItMS0xLTcyMTUx_c04e67c5-5b3f-45fc-b6f1-40b7513d7b56"
      unitRef="usd">2772000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i28ee17ac872e4181a4e2ee167127995d_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzE1LTMtMS0xLTcyMTUx_cebda823-ffea-4936-b790-c8e0fc1c951e"
      unitRef="usd">2642000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i6b8d2fac04db45dda920f25320d94772_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzE1LTQtMS0xLTcyMTUx_d16db7a5-d9d8-418d-be01-afda51851bf9"
      unitRef="usd">3045000000</us-gaap:GrossProfit>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ib1975d811d9f4de7bc2dc66e567577a2_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzE2LTEtMS0xLTcyMTUx_0cabb52f-3380-43f8-b173-fe4d1ab1f78b"
      unitRef="usd">367000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i06d24da15c2a4301868cb2cf91cc084f_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzE2LTItMS0xLTcyMTUx_82e89c7a-4128-4e70-b472-167b579f8061"
      unitRef="usd">662000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i28ee17ac872e4181a4e2ee167127995d_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzE2LTMtMS0xLTcyMTUx_27dee18b-57e9-48f6-9b78-1560035db137"
      unitRef="usd">495000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i6b8d2fac04db45dda920f25320d94772_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzE2LTQtMS0xLTcyMTUx_0aae9ed7-1fa9-4cb9-aba1-7cbc6e57756d"
      unitRef="usd">757000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="ib1975d811d9f4de7bc2dc66e567577a2_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzE3LTEtMS0xLTcyMTUx_e505b850-abf8-493c-86ec-930788943267"
      unitRef="usd">302000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i06d24da15c2a4301868cb2cf91cc084f_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzE3LTItMS0xLTcyMTUx_e50aa7ad-26ff-46bb-a64f-e0af221e023b"
      unitRef="usd">592000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i28ee17ac872e4181a4e2ee167127995d_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzE3LTMtMS0xLTcyMTUx_1c0a73b8-6a14-45c1-a90e-a6dc0f904b81"
      unitRef="usd">438000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i6b8d2fac04db45dda920f25320d94772_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzE3LTQtMS0xLTcyMTUx_eab9d061-7749-4350-9048-7f167ae04b7b"
      unitRef="usd">662000000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="ib1975d811d9f4de7bc2dc66e567577a2_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzE5LTEtMS0xLTcyMTUx_2459cb1b-a957-42e2-a63e-e539a33c744e"
      unitRef="usdPerShare">0.80</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i06d24da15c2a4301868cb2cf91cc084f_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzE5LTItMS0xLTcyMTUx_6bffbbf6-23bf-4ac2-ad47-a5ba3a77e03c"
      unitRef="usdPerShare">1.57</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i28ee17ac872e4181a4e2ee167127995d_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzE5LTMtMS0xLTcyMTUx_2438b470-0453-4f30-8148-21eb0d1a9678"
      unitRef="usdPerShare">1.17</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i6b8d2fac04db45dda920f25320d94772_D20211001-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzE5LTQtMS0xLTcyMTUx_c5748027-0254-4946-b609-e938b3787e54"
      unitRef="usdPerShare">1.75</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ib1975d811d9f4de7bc2dc66e567577a2_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzIwLTEtMS0xLTcyMTUx_1c41fbd0-c02e-47a4-b681-48bd5bd21c7c"
      unitRef="usdPerShare">0.79</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i06d24da15c2a4301868cb2cf91cc084f_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzIwLTItMS0xLTcyMTUx_816932ac-16d1-4df6-8852-de53ca5bd5eb"
      unitRef="usdPerShare">1.55</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i28ee17ac872e4181a4e2ee167127995d_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzIwLTMtMS0xLTcyMTUx_2038cab9-e116-4c82-a6fc-099450b6dfe9"
      unitRef="usdPerShare">1.14</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i6b8d2fac04db45dda920f25320d94772_D20211001-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzIwLTQtMS0xLTcyMTUx_f92af474-731b-4582-bad8-6302b4024f6b"
      unitRef="usdPerShare">1.73</us-gaap:EarningsPerShareDiluted>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ib1975d811d9f4de7bc2dc66e567577a2_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzI0LTEtMS0xLTcyMTUx_50751d18-5a19-4122-ae36-b2ac42cecb26"
      unitRef="usdPerShare">0.630</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i06d24da15c2a4301868cb2cf91cc084f_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzI0LTItMS0xLTcyMTUx_7b522d2e-8de5-4496-8366-7f25a6a3512f"
      unitRef="usdPerShare">0.630</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i28ee17ac872e4181a4e2ee167127995d_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzI0LTMtMS0xLTcyMTUx_d853aa41-5cb3-4c73-b412-f881fa4963da"
      unitRef="usdPerShare">0.630</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i6b8d2fac04db45dda920f25320d94772_D20211001-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzYvZnJhZzowY2Y5NmQ4YjE5YTA0ODUyYmY3YjBkZTY4YWRjNzgwYy90YWJsZTpkM2EwOTE1YzZkMWM0ZjYwYTE5NTE5NjU5OGZhMmJmOS90YWJsZXJhbmdlOmQzYTA5MTVjNmQxYzRmNjBhMTk1MTk2NTk4ZmEyYmY5XzI0LTQtMS0xLTcyMTUx_cc20bdfc-82a1-4fcd-9450-0c68a9fa3638"
      unitRef="usdPerShare">0.695</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90ZXh0cmVnaW9uOjU1ZjRhZjk2ZTllODQ3NmJiODMxZTU1MTE1MDBmZWRhXzE5NTA_964760d2-4b77-48f4-9cbd-4fff0d61cad5">SEGMENT AND GEOGRAPHIC DATA&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We segregate our operations into two reportable business segments: (i) MedSurg and Neurotechnology and (ii) Orthopaedics and Spine which aligns to our internal reporting structure and how the Company manages its businesses.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Corporate and Other category shown in the table below includes corporate and administration, corporate initiatives and share-based compensation, which includes compensation related to employee stock options, restricted stock units and performance stock unit grants and director stock options and restricted stock unit grants.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.693%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.693%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Segment Results&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;MedSurg and Neurotechnology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Orthopaedics and Spine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;18,449&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;17,108&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;14,351&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;MedSurg and Neurotechnology&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Orthopaedics and Spine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Segment depreciation and amortization &lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,154&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,147&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;954&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Corporate and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,278&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,272&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,076&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;MedSurg and Neurotechnology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Orthopaedics and Spine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Segment operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,033&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,987&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,002&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Items not allocated to segments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Corporate and Other&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(649)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(605)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(503)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Acquisition and integration-related charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(585)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(242)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Amortization of intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(627)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(619)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(472)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Restructuring-related and other charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(349)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(386)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(458)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Goodwill impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(216)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Medical device regulations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(140)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(107)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Recall-related matters&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(103)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Regulatory and legal matters&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Consolidated operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,841&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,584&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,223&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.693%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.693%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Segment Assets and Capital Spending&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;MedSurg and Neurotechnology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Orthopaedics and Spine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;17,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total segment assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;35,578&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;33,367&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;33,340&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Corporate and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;36,884&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;34,631&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;34,330&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Purchases of property, plant and equipment:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;MedSurg and Neurotechnology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Orthopaedics and Spine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total segment purchases of property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;348&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;362&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;342&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Corporate and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total purchases of property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;588&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;525&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;487&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We measure the financial results of our reportable segments using an internal performance measure that excludes acquisition and integration-related charges, restructuring-related and other charges, goodwill impairment, reserves for certain product recall matters and reserves for certain legal and regulatory matters. Identifiable assets are those assets used exclusively in the operations of each business segment or allocated when used jointly. Corporate assets are principally property, plant and equipment, and noncurrent assets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The countries in which we have local revenue generating operations have been combined into the following geographic areas: the United States (including Puerto Rico); Europe, Middle East, Africa; Asia Pacific; and other foreign countries, which include Canada and countries in the Latin American region. Net sales are reported based on the geographic area of the Stryker location where the sales to the customer originated. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.750%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Geographic Information&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net Property, Plant and Equipment&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Europe, Middle East, Africa&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Asia Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other countries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;18,449&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;17,108&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;14,351&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,970&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,833&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90ZXh0cmVnaW9uOjU1ZjRhZjk2ZTllODQ3NmJiODMxZTU1MTE1MDBmZWRhXzEwNA_64f070c7-6fa8-456d-b727-2c4be0ff81e5"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90ZXh0cmVnaW9uOjU1ZjRhZjk2ZTllODQ3NmJiODMxZTU1MTE1MDBmZWRhXzE5NTM_77b370f0-27f4-4773-834c-1a52aedddc6b">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.693%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.693%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Segment Results&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;MedSurg and Neurotechnology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Orthopaedics and Spine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;18,449&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;17,108&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;14,351&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;MedSurg and Neurotechnology&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Orthopaedics and Spine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Segment depreciation and amortization &lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,154&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,147&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;954&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Corporate and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,278&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,272&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,076&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;MedSurg and Neurotechnology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Orthopaedics and Spine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Segment operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,033&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,987&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,002&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Items not allocated to segments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Corporate and Other&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(649)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(605)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(503)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Acquisition and integration-related charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(585)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(242)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Amortization of intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(627)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(619)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(472)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Restructuring-related and other charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(349)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(386)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(458)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Goodwill impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(216)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Medical device regulations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(140)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(107)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Recall-related matters&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(103)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Regulatory and legal matters&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Consolidated operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,841&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,584&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,223&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock>
    <us-gaap:Revenues
      contextRef="i47bbb5ea95dc45349b14191d69f1c992_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzEtMS0xLTEtNzIxNTE_bb5b30f0-9439-4f01-9633-8c84e80ad484"
      unitRef="usd">10611000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i49c69f29d3694f059d9bf2a004976b17_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzEtMi0xLTEtNzIxNTE_62a20652-827f-4081-a994-c30111e4d1b2"
      unitRef="usd">9538000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i60771115f5654e2ba9c33e5226dec383_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzEtMy0xLTEtNzIxNTE_e91f8a02-95af-4d79-954e-87e89b152dbc"
      unitRef="usd">8345000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6324e0271e4c436692bbcb9e623fc2e8_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzItMS0xLTEtNzIxNTE_a4ffe27d-c919-4ffb-8499-888157f08fdd"
      unitRef="usd">7838000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i81c6954ba7174d4d90e932296c08e140_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzItMi0xLTEtNzIxNTE_ccae3ca4-0fcf-4a5b-ba91-a1a5ad4d66f0"
      unitRef="usd">7570000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i378661c47c334191b9979c19bbafc9b1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzItMy0xLTEtNzIxNTE_0908ca23-8788-4590-84eb-0760484d3d02"
      unitRef="usd">6006000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzMtMS0xLTEtNzIxNTE_98bcdcdc-3f2f-4c00-bc46-44ff0f4529d4"
      unitRef="usd">18449000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzMtMi0xLTEtNzIxNTE_6d875a94-7eb6-4323-8b8d-4ce5f06abd4a"
      unitRef="usd">17108000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzMtMy0xLTEtNzIxNTE_608224b8-248a-4107-929f-19eb61977978"
      unitRef="usd">14351000000</us-gaap:Revenues>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i47bbb5ea95dc45349b14191d69f1c992_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzQtMS0xLTEtNzIxNTE_2956f4e9-b747-42a2-a598-d97f0b6d1c5f"
      unitRef="usd">540000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i49c69f29d3694f059d9bf2a004976b17_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzQtMi0xLTEtNzIxNTE_f811945b-1c40-4e47-ad93-1e4408b221fa"
      unitRef="usd">518000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i60771115f5654e2ba9c33e5226dec383_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzQtMy0xLTEtNzIxNTE_142bac26-3922-4037-82a3-6a3bd228a82e"
      unitRef="usd">496000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i6324e0271e4c436692bbcb9e623fc2e8_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzUtMS0xLTEtNzIxNTE_e3e9e071-078f-4fab-a4d9-9cd1b5a9e3c0"
      unitRef="usd">614000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i81c6954ba7174d4d90e932296c08e140_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzUtMi0xLTEtNzIxNTE_05c72769-eac8-4906-a7fe-d43af57e1da2"
      unitRef="usd">629000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i378661c47c334191b9979c19bbafc9b1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzUtMy0xLTEtNzIxNTE_ccd82c69-bbd7-4efc-bcb1-ab155707b1c4"
      unitRef="usd">458000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i9f531e84880c46bbbe92b1c8ce7c31a6_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzYtMS0xLTEtNzIxNTE_5fcb1c3c-c528-44c2-9967-62a4a6b910ba"
      unitRef="usd">1154000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ie984aa38d0f0495d8a86b02fb27192a6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzYtMi0xLTEtNzIxNTE_d6ad46f9-3664-4ed3-ab60-56013d39d6ee"
      unitRef="usd">1147000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ib3f309c92d20420689d59a657fb1d10b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzYtMy0xLTEtNzIxNTE_e78db8f5-2f23-4706-9ca2-eaf8f26281b9"
      unitRef="usd">954000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i90ea3f9a188b4371a80590a32f3162a6_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzctMS0xLTEtNzIxNTE_18a1688f-c4f3-47e5-9edd-9b357cee2f17"
      unitRef="usd">124000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i95cdabbaebc1412494ff81e987370623_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzctMi0xLTEtNzIxNTE_00213b65-43d9-4d4e-bf62-53eceebf7667"
      unitRef="usd">125000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="idba55220993f4de4874efcaf00cabe63_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzctMy0xLTEtNzIxNTE_63d00607-b037-4ba6-8185-4035cc59d78b"
      unitRef="usd">122000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzgtMS0xLTEtNzIxNTE_58e051f8-199a-4962-8e98-2614456f9c65"
      unitRef="usd">1278000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzgtMi0xLTEtNzIxNTE_a55614d1-ea60-4894-8b9a-f76709a3b0ce"
      unitRef="usd">1272000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzgtMy0xLTEtNzIxNTE_58b72e42-e6f0-409a-9c85-101c1368e647"
      unitRef="usd">1076000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:OperatingIncomeLoss
      contextRef="i47bbb5ea95dc45349b14191d69f1c992_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzktMS0xLTEtNzIxNTE_ef2ec429-79f3-4c54-bd3d-065a313c98e4"
      unitRef="usd">2737000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i49c69f29d3694f059d9bf2a004976b17_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzktMi0xLTEtNzIxNTE_c8c950d9-fe95-4f4b-82b2-114987c89e96"
      unitRef="usd">2807000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i60771115f5654e2ba9c33e5226dec383_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzktMy0xLTEtNzIxNTE_ece30319-1524-49db-8da9-e8320f0ceb21"
      unitRef="usd">2414000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6324e0271e4c436692bbcb9e623fc2e8_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzEwLTEtMS0xLTcyMTUx_b622532a-8994-46ee-879f-70604ee6bb8b"
      unitRef="usd">2296000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i81c6954ba7174d4d90e932296c08e140_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzEwLTItMS0xLTcyMTUx_b82f5c46-5bb0-418e-8986-ceadfb2a953f"
      unitRef="usd">2180000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i378661c47c334191b9979c19bbafc9b1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzEwLTMtMS0xLTcyMTUx_92f99e7b-619b-470c-8be8-b7a0f8c972df"
      unitRef="usd">1588000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i9f531e84880c46bbbe92b1c8ce7c31a6_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzExLTEtMS0xLTcyMTUx_654fd3ce-878c-42db-b6ab-7d7eb4d5948c"
      unitRef="usd">5033000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="ie984aa38d0f0495d8a86b02fb27192a6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzExLTItMS0xLTcyMTUx_db956ff6-a6ea-4ed0-928d-39546686c338"
      unitRef="usd">4987000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="ib3f309c92d20420689d59a657fb1d10b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzExLTMtMS0xLTcyMTUx_58a0be55-1638-4f35-b1d3-c1a856ffb6cd"
      unitRef="usd">4002000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="ic8e39c420c4d438997d9ba32c31cd4a4_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzEzLTEtMS0xLTcyMTUx_d97d2ec3-3070-4eca-ae43-69879de3b57d"
      unitRef="usd">-649000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="if20e557008044e5fb9d0332c0e98ca51_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzEzLTItMS0xLTcyMTUx_c6bcf21f-a375-4681-b132-7ea4622a35c8"
      unitRef="usd">-605000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i5cccfcfd1f224a4e8c544848a6c32027_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzEzLTMtMS0xLTcyMTUx_0ac36a01-e99a-469c-99b4-9cf86dea0a99"
      unitRef="usd">-503000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="ic8e39c420c4d438997d9ba32c31cd4a4_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzE0LTEtMS0xLTcyMTUx_43f5c894-5168-481e-ab72-cd377e7c3435"
      unitRef="usd">150000000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="if20e557008044e5fb9d0332c0e98ca51_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzE0LTItMS0xLTcyMTUx_286f19d1-ba42-45de-8d0f-65d48e5e478b"
      unitRef="usd">585000000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i5cccfcfd1f224a4e8c544848a6c32027_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzE0LTMtMS0xLTcyMTUx_1ac73b36-5b02-4532-a57c-b9390bbc8964"
      unitRef="usd">242000000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ic8e39c420c4d438997d9ba32c31cd4a4_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzE1LTEtMS0xLTcyMTUx_d13312f7-cc1e-492e-b765-4f9d0eca9085"
      unitRef="usd">627000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="if20e557008044e5fb9d0332c0e98ca51_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzE1LTItMS0xLTcyMTUx_facc26fa-0415-4086-8707-691a652e3174"
      unitRef="usd">619000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i5cccfcfd1f224a4e8c544848a6c32027_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzE1LTMtMS0xLTcyMTUx_59dd5f03-02bf-477d-ae2c-f89e84a2fd42"
      unitRef="usd">472000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:RestructuringCosts
      contextRef="ic8e39c420c4d438997d9ba32c31cd4a4_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzE2LTEtMS0xLTcyMTUx_ea16927d-67d1-4c00-bdaf-6994daa016f6"
      unitRef="usd">349000000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="if20e557008044e5fb9d0332c0e98ca51_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzE2LTItMS0xLTcyMTUx_41d5c87d-7a75-4119-a6cd-87c40fce57eb"
      unitRef="usd">386000000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="i5cccfcfd1f224a4e8c544848a6c32027_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzE2LTMtMS0xLTcyMTUx_e9230a2f-b932-4c32-8b3c-07af566dda7e"
      unitRef="usd">458000000</us-gaap:RestructuringCosts>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ic8e39c420c4d438997d9ba32c31cd4a4_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzE3LTEtMS0xLTgyMTU5_6f6a669b-14ed-49c9-8253-e400431e9322"
      unitRef="usd">216000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="if20e557008044e5fb9d0332c0e98ca51_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzE3LTItMS0xLTgyNjEz_18a50b60-04bf-4c10-b0e0-435d672bb5c8"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i5cccfcfd1f224a4e8c544848a6c32027_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzE3LTMtMS0xLTg0MjE4_590d7223-17e9-41c9-b70f-c549a2c88298"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <syk:MedicalDeviceRegulationsExpense
      contextRef="ic8e39c420c4d438997d9ba32c31cd4a4_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzE3LTEtMS0xLTcyMTUx_aada19d8-9c5b-4a08-8fcf-a51bcb652330"
      unitRef="usd">140000000</syk:MedicalDeviceRegulationsExpense>
    <syk:MedicalDeviceRegulationsExpense
      contextRef="if20e557008044e5fb9d0332c0e98ca51_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzE3LTItMS0xLTcyMTUx_8eb5fb17-05b8-4146-a8d5-bf9f55f81bb3"
      unitRef="usd">107000000</syk:MedicalDeviceRegulationsExpense>
    <syk:MedicalDeviceRegulationsExpense
      contextRef="i5cccfcfd1f224a4e8c544848a6c32027_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzE3LTMtMS0xLTcyMTUx_b06ca359-2623-40c3-9f44-d47de0af73f8"
      unitRef="usd">81000000</syk:MedicalDeviceRegulationsExpense>
    <syk:RejuvenateABGIIHipRecallCharges
      contextRef="ic8e39c420c4d438997d9ba32c31cd4a4_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzE4LTEtMS0xLTcyMTUx_25869dfe-d58b-4f5c-b7f4-99070acf40d0"
      unitRef="usd">-15000000</syk:RejuvenateABGIIHipRecallCharges>
    <syk:RejuvenateABGIIHipRecallCharges
      contextRef="if20e557008044e5fb9d0332c0e98ca51_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzE4LTItMS0xLTcyMTUx_5a262a67-51c6-44b5-a8c8-b39c59e43548"
      unitRef="usd">103000000</syk:RejuvenateABGIIHipRecallCharges>
    <syk:RejuvenateABGIIHipRecallCharges
      contextRef="i5cccfcfd1f224a4e8c544848a6c32027_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzE4LTMtMS0xLTcyMTUx_d5d34fdc-a224-4dd8-96ff-f92f0ca94c0b"
      unitRef="usd">17000000</syk:RejuvenateABGIIHipRecallCharges>
    <us-gaap:LegalFees
      contextRef="ic8e39c420c4d438997d9ba32c31cd4a4_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzE5LTEtMS0xLTcyMTUx_9620ef3c-4dbf-40ed-8166-52ecb9fb9553"
      unitRef="usd">76000000</us-gaap:LegalFees>
    <us-gaap:LegalFees
      contextRef="if20e557008044e5fb9d0332c0e98ca51_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzE5LTItMS0xLTcyMTUx_3925071a-8226-45db-89cf-8ffe08d9417a"
      unitRef="usd">-2000000</us-gaap:LegalFees>
    <us-gaap:LegalFees
      contextRef="i5cccfcfd1f224a4e8c544848a6c32027_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzE5LTMtMS0xLTcyMTUx_107c3218-9565-46dd-9902-b427ecda8ceb"
      unitRef="usd">6000000</us-gaap:LegalFees>
    <us-gaap:NetIncomeLoss
      contextRef="ic8e39c420c4d438997d9ba32c31cd4a4_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzIwLTEtMS0xLTcyMTUx_6fe138c8-3a49-4d2d-bc49-715ef0332878"
      unitRef="usd">2841000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if20e557008044e5fb9d0332c0e98ca51_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzIwLTItMS0xLTcyMTUx_293400ce-213c-4255-9e1b-bbde8c383da2"
      unitRef="usd">2584000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5cccfcfd1f224a4e8c544848a6c32027_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo5MWRjM2JjZDJjMWY0ZDQyYWM4NDk0MWNjNTgxYzM5ZS90YWJsZXJhbmdlOjkxZGMzYmNkMmMxZjRkNDJhYzg0OTQxY2M1ODFjMzllXzIwLTMtMS0xLTcyMTUx_54245ea0-8c74-4410-8b8d-f2d389007872"
      unitRef="usd">2223000000</us-gaap:NetIncomeLoss>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90ZXh0cmVnaW9uOjU1ZjRhZjk2ZTllODQ3NmJiODMxZTU1MTE1MDBmZWRhXzE5NTk_2d68f97c-f5ff-491a-ba3d-3565048aeced">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.693%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.693%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Segment Assets and Capital Spending&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;MedSurg and Neurotechnology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Orthopaedics and Spine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;17,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total segment assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;35,578&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;33,367&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;33,340&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Corporate and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;36,884&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;34,631&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;34,330&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Purchases of property, plant and equipment:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;MedSurg and Neurotechnology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Orthopaedics and Spine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total segment purchases of property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;348&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;362&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;342&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Corporate and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total purchases of property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;588&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;525&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;487&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:Assets
      contextRef="i8fc2a97b3bea475a937cf78e3d486fb9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo2YmNmOWE4MjUzYzY0OThiYWFhZmQ4MjA2ZGNlYzkyMi90YWJsZXJhbmdlOjZiY2Y5YTgyNTNjNjQ5OGJhYWFmZDgyMDZkY2VjOTIyXzItMS0xLTEtNzIxNTE_8979fe23-b62a-4fb0-93cc-55a033f55867"
      unitRef="usd">18283000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i0025a70b3c024f7ead4a7871ca53fd09_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo2YmNmOWE4MjUzYzY0OThiYWFhZmQ4MjA2ZGNlYzkyMi90YWJsZXJhbmdlOjZiY2Y5YTgyNTNjNjQ5OGJhYWFmZDgyMDZkY2VjOTIyXzItMi0xLTEtNzIxNTE_f8bd7fe7-227c-48fd-a001-ade36b7809e5"
      unitRef="usd">15218000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i2dd3298582d043a884e887664abad745_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo2YmNmOWE4MjUzYzY0OThiYWFhZmQ4MjA2ZGNlYzkyMi90YWJsZXJhbmdlOjZiY2Y5YTgyNTNjNjQ5OGJhYWFmZDgyMDZkY2VjOTIyXzItMy0xLTEtNzIxNTE_faff5561-d43a-47e7-85e4-c97462e14c32"
      unitRef="usd">15250000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ibd7588c5ae9148c78b08f844142d9e5f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo2YmNmOWE4MjUzYzY0OThiYWFhZmQ4MjA2ZGNlYzkyMi90YWJsZXJhbmdlOjZiY2Y5YTgyNTNjNjQ5OGJhYWFmZDgyMDZkY2VjOTIyXzMtMS0xLTEtNzIxNTE_60246455-6649-4116-8ab3-51dd4d375e74"
      unitRef="usd">17295000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i715d57ade67c48388266154e58153628_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo2YmNmOWE4MjUzYzY0OThiYWFhZmQ4MjA2ZGNlYzkyMi90YWJsZXJhbmdlOjZiY2Y5YTgyNTNjNjQ5OGJhYWFmZDgyMDZkY2VjOTIyXzMtMi0xLTEtNzIxNTE_6de25165-ab7b-49ce-810c-e210cb0c5055"
      unitRef="usd">18149000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="if13c14f2e2cb47afbc845ae42bcab920_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo2YmNmOWE4MjUzYzY0OThiYWFhZmQ4MjA2ZGNlYzkyMi90YWJsZXJhbmdlOjZiY2Y5YTgyNTNjNjQ5OGJhYWFmZDgyMDZkY2VjOTIyXzMtMy0xLTEtNzIxNTE_3b2cdcdc-9c46-4a97-9067-0b5be7f61cc4"
      unitRef="usd">18090000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i29115a5568cc447b9a3b7fc6da47a4c0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo2YmNmOWE4MjUzYzY0OThiYWFhZmQ4MjA2ZGNlYzkyMi90YWJsZXJhbmdlOjZiY2Y5YTgyNTNjNjQ5OGJhYWFmZDgyMDZkY2VjOTIyXzQtMS0xLTEtNzIxNTE_10e42960-d78b-44a0-94a9-102ccec939c8"
      unitRef="usd">35578000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i4aef5c47c71047fe98565c8a3de0fb4a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo2YmNmOWE4MjUzYzY0OThiYWFhZmQ4MjA2ZGNlYzkyMi90YWJsZXJhbmdlOjZiY2Y5YTgyNTNjNjQ5OGJhYWFmZDgyMDZkY2VjOTIyXzQtMi0xLTEtNzIxNTE_3d8aa018-2219-4568-9567-45db5c5a1209"
      unitRef="usd">33367000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i9d0d6ebb9d7845e3a21c28c263da57f5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo2YmNmOWE4MjUzYzY0OThiYWFhZmQ4MjA2ZGNlYzkyMi90YWJsZXJhbmdlOjZiY2Y5YTgyNTNjNjQ5OGJhYWFmZDgyMDZkY2VjOTIyXzQtMy0xLTEtNzIxNTE_dd13dbbf-7de6-4161-bb06-43cc8cb88261"
      unitRef="usd">33340000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i33ba2adb3bd4472c8913fc71b0db21bd_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo2YmNmOWE4MjUzYzY0OThiYWFhZmQ4MjA2ZGNlYzkyMi90YWJsZXJhbmdlOjZiY2Y5YTgyNTNjNjQ5OGJhYWFmZDgyMDZkY2VjOTIyXzUtMS0xLTEtNzIxNTE_6fb78fab-bc23-4946-aab7-ba7445444e3f"
      unitRef="usd">1306000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i07d6396dc54146d6aee48aa19fc60e02_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo2YmNmOWE4MjUzYzY0OThiYWFhZmQ4MjA2ZGNlYzkyMi90YWJsZXJhbmdlOjZiY2Y5YTgyNTNjNjQ5OGJhYWFmZDgyMDZkY2VjOTIyXzUtMi0xLTEtNzIxNTE_c7f687d6-c0f7-4ae1-9fb8-f01298daba19"
      unitRef="usd">1264000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="icf905d3d98e04a87989918e7e14042cb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo2YmNmOWE4MjUzYzY0OThiYWFhZmQ4MjA2ZGNlYzkyMi90YWJsZXJhbmdlOjZiY2Y5YTgyNTNjNjQ5OGJhYWFmZDgyMDZkY2VjOTIyXzUtMy0xLTEtNzIxNTE_dd3d09f7-cab9-498e-8c4e-94e7c21a91bd"
      unitRef="usd">990000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo2YmNmOWE4MjUzYzY0OThiYWFhZmQ4MjA2ZGNlYzkyMi90YWJsZXJhbmdlOjZiY2Y5YTgyNTNjNjQ5OGJhYWFmZDgyMDZkY2VjOTIyXzYtMS0xLTEtNzIxNTE_dbd97b65-e676-4701-ad42-c2f67047c285"
      unitRef="usd">36884000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo2YmNmOWE4MjUzYzY0OThiYWFhZmQ4MjA2ZGNlYzkyMi90YWJsZXJhbmdlOjZiY2Y5YTgyNTNjNjQ5OGJhYWFmZDgyMDZkY2VjOTIyXzYtMi0xLTEtNzIxNTE_7d058b5a-f649-48b8-8395-245b3a3e4e4f"
      unitRef="usd">34631000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i98963cf23d234ec1ac275e66bcfd76dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo2YmNmOWE4MjUzYzY0OThiYWFhZmQ4MjA2ZGNlYzkyMi90YWJsZXJhbmdlOjZiY2Y5YTgyNTNjNjQ5OGJhYWFmZDgyMDZkY2VjOTIyXzYtMy0xLTEtNzIxNTE_1f131e95-ceeb-444d-a865-c4433a768ffe"
      unitRef="usd">34330000000</us-gaap:Assets>
    <syk:CapitalExpendituresDuringPeriod
      contextRef="i47bbb5ea95dc45349b14191d69f1c992_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo2YmNmOWE4MjUzYzY0OThiYWFhZmQ4MjA2ZGNlYzkyMi90YWJsZXJhbmdlOjZiY2Y5YTgyNTNjNjQ5OGJhYWFmZDgyMDZkY2VjOTIyXzgtMS0xLTEtNzIxNTE_fe83b386-63fd-4934-adf6-bb7392970a19"
      unitRef="usd">173000000</syk:CapitalExpendituresDuringPeriod>
    <syk:CapitalExpendituresDuringPeriod
      contextRef="i49c69f29d3694f059d9bf2a004976b17_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo2YmNmOWE4MjUzYzY0OThiYWFhZmQ4MjA2ZGNlYzkyMi90YWJsZXJhbmdlOjZiY2Y5YTgyNTNjNjQ5OGJhYWFmZDgyMDZkY2VjOTIyXzgtMi0xLTEtNzIxNTE_599aa2cf-d724-4340-9bce-e051688dadd5"
      unitRef="usd">197000000</syk:CapitalExpendituresDuringPeriod>
    <syk:CapitalExpendituresDuringPeriod
      contextRef="i60771115f5654e2ba9c33e5226dec383_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo2YmNmOWE4MjUzYzY0OThiYWFhZmQ4MjA2ZGNlYzkyMi90YWJsZXJhbmdlOjZiY2Y5YTgyNTNjNjQ5OGJhYWFmZDgyMDZkY2VjOTIyXzgtMy0xLTEtNzIxNTE_18ef41e2-ff55-492e-88ce-3eedd3e48ad3"
      unitRef="usd">192000000</syk:CapitalExpendituresDuringPeriod>
    <syk:CapitalExpendituresDuringPeriod
      contextRef="i6324e0271e4c436692bbcb9e623fc2e8_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo2YmNmOWE4MjUzYzY0OThiYWFhZmQ4MjA2ZGNlYzkyMi90YWJsZXJhbmdlOjZiY2Y5YTgyNTNjNjQ5OGJhYWFmZDgyMDZkY2VjOTIyXzktMS0xLTEtNzIxNTE_a8c4554a-70a0-4440-aa7f-085583525534"
      unitRef="usd">175000000</syk:CapitalExpendituresDuringPeriod>
    <syk:CapitalExpendituresDuringPeriod
      contextRef="i81c6954ba7174d4d90e932296c08e140_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo2YmNmOWE4MjUzYzY0OThiYWFhZmQ4MjA2ZGNlYzkyMi90YWJsZXJhbmdlOjZiY2Y5YTgyNTNjNjQ5OGJhYWFmZDgyMDZkY2VjOTIyXzktMi0xLTEtNzIxNTE_771fd6a9-ae55-40a9-9730-38b64f66e877"
      unitRef="usd">165000000</syk:CapitalExpendituresDuringPeriod>
    <syk:CapitalExpendituresDuringPeriod
      contextRef="i378661c47c334191b9979c19bbafc9b1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo2YmNmOWE4MjUzYzY0OThiYWFhZmQ4MjA2ZGNlYzkyMi90YWJsZXJhbmdlOjZiY2Y5YTgyNTNjNjQ5OGJhYWFmZDgyMDZkY2VjOTIyXzktMy0xLTEtNzIxNTE_ff65b4a9-490f-4eca-baba-f906582d3f4c"
      unitRef="usd">150000000</syk:CapitalExpendituresDuringPeriod>
    <syk:CapitalExpendituresDuringPeriod
      contextRef="i9f531e84880c46bbbe92b1c8ce7c31a6_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo2YmNmOWE4MjUzYzY0OThiYWFhZmQ4MjA2ZGNlYzkyMi90YWJsZXJhbmdlOjZiY2Y5YTgyNTNjNjQ5OGJhYWFmZDgyMDZkY2VjOTIyXzEwLTEtMS0xLTcyMTUx_9feab779-a831-4f5d-8109-46059a12dc53"
      unitRef="usd">348000000</syk:CapitalExpendituresDuringPeriod>
    <syk:CapitalExpendituresDuringPeriod
      contextRef="ie984aa38d0f0495d8a86b02fb27192a6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo2YmNmOWE4MjUzYzY0OThiYWFhZmQ4MjA2ZGNlYzkyMi90YWJsZXJhbmdlOjZiY2Y5YTgyNTNjNjQ5OGJhYWFmZDgyMDZkY2VjOTIyXzEwLTItMS0xLTcyMTUx_7dd53be7-b5f5-41a4-bc43-81f8d7e5dca0"
      unitRef="usd">362000000</syk:CapitalExpendituresDuringPeriod>
    <syk:CapitalExpendituresDuringPeriod
      contextRef="ib3f309c92d20420689d59a657fb1d10b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo2YmNmOWE4MjUzYzY0OThiYWFhZmQ4MjA2ZGNlYzkyMi90YWJsZXJhbmdlOjZiY2Y5YTgyNTNjNjQ5OGJhYWFmZDgyMDZkY2VjOTIyXzEwLTMtMS0xLTcyMTUx_9a5b0eef-4cd2-4e91-95a0-9849010bdccb"
      unitRef="usd">342000000</syk:CapitalExpendituresDuringPeriod>
    <syk:CapitalExpendituresDuringPeriod
      contextRef="i90ea3f9a188b4371a80590a32f3162a6_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo2YmNmOWE4MjUzYzY0OThiYWFhZmQ4MjA2ZGNlYzkyMi90YWJsZXJhbmdlOjZiY2Y5YTgyNTNjNjQ5OGJhYWFmZDgyMDZkY2VjOTIyXzExLTEtMS0xLTcyMTUx_6980cb5b-aa39-407e-be90-0c982d309d61"
      unitRef="usd">240000000</syk:CapitalExpendituresDuringPeriod>
    <syk:CapitalExpendituresDuringPeriod
      contextRef="i95cdabbaebc1412494ff81e987370623_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo2YmNmOWE4MjUzYzY0OThiYWFhZmQ4MjA2ZGNlYzkyMi90YWJsZXJhbmdlOjZiY2Y5YTgyNTNjNjQ5OGJhYWFmZDgyMDZkY2VjOTIyXzExLTItMS0xLTcyMTUx_dd9740a0-fb68-4fb2-beb8-9d3046e53aea"
      unitRef="usd">163000000</syk:CapitalExpendituresDuringPeriod>
    <syk:CapitalExpendituresDuringPeriod
      contextRef="idba55220993f4de4874efcaf00cabe63_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo2YmNmOWE4MjUzYzY0OThiYWFhZmQ4MjA2ZGNlYzkyMi90YWJsZXJhbmdlOjZiY2Y5YTgyNTNjNjQ5OGJhYWFmZDgyMDZkY2VjOTIyXzExLTMtMS0xLTcyMTUx_0305a379-2fa5-404f-95f8-a500ef987f46"
      unitRef="usd">145000000</syk:CapitalExpendituresDuringPeriod>
    <syk:CapitalExpendituresDuringPeriod
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo2YmNmOWE4MjUzYzY0OThiYWFhZmQ4MjA2ZGNlYzkyMi90YWJsZXJhbmdlOjZiY2Y5YTgyNTNjNjQ5OGJhYWFmZDgyMDZkY2VjOTIyXzEyLTEtMS0xLTcyMTUx_4fe3ac48-be23-4f39-af29-8d1f38587079"
      unitRef="usd">588000000</syk:CapitalExpendituresDuringPeriod>
    <syk:CapitalExpendituresDuringPeriod
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo2YmNmOWE4MjUzYzY0OThiYWFhZmQ4MjA2ZGNlYzkyMi90YWJsZXJhbmdlOjZiY2Y5YTgyNTNjNjQ5OGJhYWFmZDgyMDZkY2VjOTIyXzEyLTItMS0xLTcyMTUx_94b35e28-8e5b-48ce-856f-c2c2765321c4"
      unitRef="usd">525000000</syk:CapitalExpendituresDuringPeriod>
    <syk:CapitalExpendituresDuringPeriod
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTo2YmNmOWE4MjUzYzY0OThiYWFhZmQ4MjA2ZGNlYzkyMi90YWJsZXJhbmdlOjZiY2Y5YTgyNTNjNjQ5OGJhYWFmZDgyMDZkY2VjOTIyXzEyLTMtMS0xLTcyMTUx_3cddddd5-99f1-4296-bf4e-f6d4d941ab50"
      unitRef="usd">487000000</syk:CapitalExpendituresDuringPeriod>
    <us-gaap:ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90ZXh0cmVnaW9uOjU1ZjRhZjk2ZTllODQ3NmJiODMxZTU1MTE1MDBmZWRhXzE5NTU_8104b673-d64b-4563-83c4-38f84fbdb55c">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.750%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Geographic Information&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net Property, Plant and Equipment&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Europe, Middle East, Africa&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Asia Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other countries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;18,449&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;17,108&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;14,351&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,970&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,833&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock>
    <us-gaap:Revenues
      contextRef="iaff1db63800141a4a0f466e4edd07697_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTphZmEzY2Y2ZjU1OTQ0MjViYmQyNWQxMjAxYTcxYzVmNC90YWJsZXJhbmdlOmFmYTNjZjZmNTU5NDQyNWJiZDI1ZDEyMDFhNzFjNWY0XzMtMS0xLTEtNzIxNTE_17e694b1-9581-4e4c-b7e0-454d2985c0a3"
      unitRef="usd">13638000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2c40ed4f092642e6ae3512f7b314ae33_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTphZmEzY2Y2ZjU1OTQ0MjViYmQyNWQxMjAxYTcxYzVmNC90YWJsZXJhbmdlOmFmYTNjZjZmNTU5NDQyNWJiZDI1ZDEyMDFhNzFjNWY0XzMtMi0xLTEtNzIxNTE_590f270c-c60e-4b77-8fb3-73ba2e695bb3"
      unitRef="usd">12321000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia16521f0e141452ca6e75ab7d3a68848_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTphZmEzY2Y2ZjU1OTQ0MjViYmQyNWQxMjAxYTcxYzVmNC90YWJsZXJhbmdlOmFmYTNjZjZmNTU5NDQyNWJiZDI1ZDEyMDFhNzFjNWY0XzMtMy0xLTEtNzIxNTE_77152d53-0c12-4ef3-8ad0-d8ba8d70369e"
      unitRef="usd">10455000000</us-gaap:Revenues>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i32ee708de8b14883887f6bab85af5750_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTphZmEzY2Y2ZjU1OTQ0MjViYmQyNWQxMjAxYTcxYzVmNC90YWJsZXJhbmdlOmFmYTNjZjZmNTU5NDQyNWJiZDI1ZDEyMDFhNzFjNWY0XzMtNS0xLTEtNzIxNTE_17ba9ebc-0ab6-4336-8597-6227b2032500"
      unitRef="usd">1791000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ic8163b2c12c64eeaab735b00242896b8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTphZmEzY2Y2ZjU1OTQ0MjViYmQyNWQxMjAxYTcxYzVmNC90YWJsZXJhbmdlOmFmYTNjZjZmNTU5NDQyNWJiZDI1ZDEyMDFhNzFjNWY0XzMtNi0xLTEtNzIxNTE_a2e8c824-8362-4877-877c-1925a1c1cca7"
      unitRef="usd">1717000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Revenues
      contextRef="if2968c9c4a80487baea572af89e9b685_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTphZmEzY2Y2ZjU1OTQ0MjViYmQyNWQxMjAxYTcxYzVmNC90YWJsZXJhbmdlOmFmYTNjZjZmNTU5NDQyNWJiZDI1ZDEyMDFhNzFjNWY0XzQtMS0xLTEtNzIxNTE_266542a4-d4b3-46ce-bd54-8b6e2215324e"
      unitRef="usd">2348000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic5182e3f5e754340a7c52da0e4f360ec_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTphZmEzY2Y2ZjU1OTQ0MjViYmQyNWQxMjAxYTcxYzVmNC90YWJsZXJhbmdlOmFmYTNjZjZmNTU5NDQyNWJiZDI1ZDEyMDFhNzFjNWY0XzQtMi0xLTEtNzIxNTE_3ee68657-59f2-405b-99a3-0184685faa73"
      unitRef="usd">2299000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic5147ef358704bf8901cba0f588770d3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTphZmEzY2Y2ZjU1OTQ0MjViYmQyNWQxMjAxYTcxYzVmNC90YWJsZXJhbmdlOmFmYTNjZjZmNTU5NDQyNWJiZDI1ZDEyMDFhNzFjNWY0XzQtMy0xLTEtNzIxNTE_02282f07-5605-496c-9032-fff79ab3cf59"
      unitRef="usd">1818000000</us-gaap:Revenues>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i3272d42ee7e948fbb68b77a14396aa85_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTphZmEzY2Y2ZjU1OTQ0MjViYmQyNWQxMjAxYTcxYzVmNC90YWJsZXJhbmdlOmFmYTNjZjZmNTU5NDQyNWJiZDI1ZDEyMDFhNzFjNWY0XzQtNS0xLTEtNzIxNTE_7d8adcfe-27b3-4600-9632-2c7e3668f171"
      unitRef="usd">995000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i33d7288e19cb441d99394153a6e748b6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTphZmEzY2Y2ZjU1OTQ0MjViYmQyNWQxMjAxYTcxYzVmNC90YWJsZXJhbmdlOmFmYTNjZjZmNTU5NDQyNWJiZDI1ZDEyMDFhNzFjNWY0XzQtNi0xLTEtNzIxNTE_8e0f018b-fe19-4971-8003-2f5d20271059"
      unitRef="usd">941000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Revenues
      contextRef="i78278663438d4595a6f4289bf181420b_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTphZmEzY2Y2ZjU1OTQ0MjViYmQyNWQxMjAxYTcxYzVmNC90YWJsZXJhbmdlOmFmYTNjZjZmNTU5NDQyNWJiZDI1ZDEyMDFhNzFjNWY0XzUtMS0xLTEtNzIxNTE_9edae722-361d-4e81-bc76-f17fd3121fea"
      unitRef="usd">1885000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i83b775090133468ca2cef1c982a32a0c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTphZmEzY2Y2ZjU1OTQ0MjViYmQyNWQxMjAxYTcxYzVmNC90YWJsZXJhbmdlOmFmYTNjZjZmNTU5NDQyNWJiZDI1ZDEyMDFhNzFjNWY0XzUtMi0xLTEtNzIxNTE_57a0d058-cd91-485c-8428-66c4f6a7811c"
      unitRef="usd">1973000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i10ac7111c8bc45da98d1f4aa86d42db5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTphZmEzY2Y2ZjU1OTQ0MjViYmQyNWQxMjAxYTcxYzVmNC90YWJsZXJhbmdlOmFmYTNjZjZmNTU5NDQyNWJiZDI1ZDEyMDFhNzFjNWY0XzUtMy0xLTEtNzIxNTE_f0f13095-0b72-4895-a3c6-da5382edfcc4"
      unitRef="usd">1630000000</us-gaap:Revenues>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i4879614c45bc4f1a9d1ba8afae2d3a18_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTphZmEzY2Y2ZjU1OTQ0MjViYmQyNWQxMjAxYTcxYzVmNC90YWJsZXJhbmdlOmFmYTNjZjZmNTU5NDQyNWJiZDI1ZDEyMDFhNzFjNWY0XzUtNS0xLTEtNzIxNTE_fdb61d6a-91b6-46da-a5ec-6cb4646416ad"
      unitRef="usd">76000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ida0ef91d6b564bd5942bcd3208562cde_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTphZmEzY2Y2ZjU1OTQ0MjViYmQyNWQxMjAxYTcxYzVmNC90YWJsZXJhbmdlOmFmYTNjZjZmNTU5NDQyNWJiZDI1ZDEyMDFhNzFjNWY0XzUtNi0xLTEtNzIxNTE_8efc7426-ee5b-4732-9391-225e9aa0e4a5"
      unitRef="usd">76000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Revenues
      contextRef="i1b32b057330540a1b4c98f8a0860c359_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTphZmEzY2Y2ZjU1OTQ0MjViYmQyNWQxMjAxYTcxYzVmNC90YWJsZXJhbmdlOmFmYTNjZjZmNTU5NDQyNWJiZDI1ZDEyMDFhNzFjNWY0XzYtMS0xLTEtNzIxNTE_d9cd30c0-b0d5-45c4-abdc-ab48d3a6859a"
      unitRef="usd">578000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i63f67a9dc38243c0bc739802cfd40502_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTphZmEzY2Y2ZjU1OTQ0MjViYmQyNWQxMjAxYTcxYzVmNC90YWJsZXJhbmdlOmFmYTNjZjZmNTU5NDQyNWJiZDI1ZDEyMDFhNzFjNWY0XzYtMi0xLTEtNzIxNTE_c83c2c9b-74ea-4a09-a398-1ece57b3f273"
      unitRef="usd">515000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5b61af8b172d4c17bf0aaddfbae515ae_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTphZmEzY2Y2ZjU1OTQ0MjViYmQyNWQxMjAxYTcxYzVmNC90YWJsZXJhbmdlOmFmYTNjZjZmNTU5NDQyNWJiZDI1ZDEyMDFhNzFjNWY0XzYtMy0xLTEtNzIxNTE_c25d79c3-0e7e-4f19-84ac-138c69bf183c"
      unitRef="usd">448000000</us-gaap:Revenues>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i05478418b05443d89b6397fa59b450bc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTphZmEzY2Y2ZjU1OTQ0MjViYmQyNWQxMjAxYTcxYzVmNC90YWJsZXJhbmdlOmFmYTNjZjZmNTU5NDQyNWJiZDI1ZDEyMDFhNzFjNWY0XzYtNS0xLTEtNzIxNTE_63b12b82-121b-4ab3-9f5f-b09554a7ab8e"
      unitRef="usd">108000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i6c78e2c8fe11461fa0a6bbdff48c2aad_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTphZmEzY2Y2ZjU1OTQ0MjViYmQyNWQxMjAxYTcxYzVmNC90YWJsZXJhbmdlOmFmYTNjZjZmNTU5NDQyNWJiZDI1ZDEyMDFhNzFjNWY0XzYtNi0xLTEtNzIxNTE_91973596-4077-4adc-85a4-d75b232933af"
      unitRef="usd">99000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Revenues
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTphZmEzY2Y2ZjU1OTQ0MjViYmQyNWQxMjAxYTcxYzVmNC90YWJsZXJhbmdlOmFmYTNjZjZmNTU5NDQyNWJiZDI1ZDEyMDFhNzFjNWY0XzctMS0xLTEtNzIxNTE_b97e10cd-9fea-4416-9ae7-d465ed1a0a11"
      unitRef="usd">18449000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3511c36c793f448d96b5694ce3bc7f88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTphZmEzY2Y2ZjU1OTQ0MjViYmQyNWQxMjAxYTcxYzVmNC90YWJsZXJhbmdlOmFmYTNjZjZmNTU5NDQyNWJiZDI1ZDEyMDFhNzFjNWY0XzctMi0xLTEtNzIxNTE_db3d8778-2d78-45d6-bf0e-2dc59fe5f77b"
      unitRef="usd">17108000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1e2f46dee94e49ac8571cb5fd32a72be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTphZmEzY2Y2ZjU1OTQ0MjViYmQyNWQxMjAxYTcxYzVmNC90YWJsZXJhbmdlOmFmYTNjZjZmNTU5NDQyNWJiZDI1ZDEyMDFhNzFjNWY0XzctMy0xLTEtNzIxNTE_057fcc4c-2c26-477e-a2c5-6de7a355b98b"
      unitRef="usd">14351000000</us-gaap:Revenues>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i6192daadf4b64fcd96cda7971eb2051f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTphZmEzY2Y2ZjU1OTQ0MjViYmQyNWQxMjAxYTcxYzVmNC90YWJsZXJhbmdlOmFmYTNjZjZmNTU5NDQyNWJiZDI1ZDEyMDFhNzFjNWY0XzctNS0xLTEtNzIxNTE_fff7b713-1155-49b9-b112-f2fbe98cdce2"
      unitRef="usd">2970000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i6a8dd02eebae4ec58f362588b7ee80e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xMzkvZnJhZzo1NWY0YWY5NmU5ZTg0NzZiYjgzMWU1NTExNTAwZmVkYS90YWJsZTphZmEzY2Y2ZjU1OTQ0MjViYmQyNWQxMjAxYTcxYzVmNC90YWJsZXJhbmdlOmFmYTNjZjZmNTU5NDQyNWJiZDI1ZDEyMDFhNzFjNWY0XzctNi0xLTEtNzIxNTE_b2c6a83a-6c75-4987-b8f8-a5eaa5909aa3"
      unitRef="usd">2833000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:AssetImpairmentChargesTextBlock
      contextRef="i767af96f95ca4aee85700946429afb87_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xNDIvZnJhZzpiYzY3MDMzM2RlYWE0NTlmYWFiYzAyYjVkMjEyODYzMS90ZXh0cmVnaW9uOmJjNjcwMzMzZGVhYTQ1OWZhYWJjMDJiNWQyMTI4NjMxXzIwNTI_08f8fe53-ef89-45d3-9c15-65921f2a9db1">ASSET IMPAIRMENTS&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The government in China has launched regional and national programs for volume-based procurement (VBP) of high-value medical consumables to reduce healthcare costs. Each VBP program has specific requirements to award contracts to the lowest bidders who are able to satisfy the quality and quantity requirements. The successful bidders may be guaranteed sales volume for certain products, while unsuccessful bidders may lose unit sales volume. The prices required for a successful bid have negatively impact our affected commercial operations in China, including those for joint replacement, trauma and certain neurovascular products. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;As a result of the outcome of certain regional programs for our trauma products and the national VBP program for hips and knees we recorded charges of $105 to impair certain long-lived and intangible assets in 2021. These charges were included in selling, general and administrative expenses. The national VBP program for spine products took place in the third quarter of 2022 and we were unsuccessful in our bid. As a result we are exiting the spine business in China. Related asset impairments recognized in 2022 were not significant and we do not expect any significant impairments related to future VBP programs. Our business in China represented approximately 2.4% of our revenues for the year ended December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;In addition to asset impairments in connection with VBP program results, we recognized asset impairments of $47 in 2022 for long-lived and intangible assets primarily as a result of the exit of certain product lines.</us-gaap:AssetImpairmentChargesTextBlock>
    <us-gaap:AssetImpairmentCharges
      contextRef="id9dcd044683643db85814ccb7429b46b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xNDIvZnJhZzpiYzY3MDMzM2RlYWE0NTlmYWFiYzAyYjVkMjEyODYzMS90ZXh0cmVnaW9uOmJjNjcwMzMzZGVhYTQ1OWZhYWJjMDJiNWQyMTI4NjMxXzEwOTk1MTE2MzE0Mjk_31ec4f50-ebac-4358-888c-604c782eb1a7"
      unitRef="usd">105000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="if6f51256944449edba93c596bb051076_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xNDIvZnJhZzpiYzY3MDMzM2RlYWE0NTlmYWFiYzAyYjVkMjEyODYzMS90ZXh0cmVnaW9uOmJjNjcwMzMzZGVhYTQ1OWZhYWJjMDJiNWQyMTI4NjMxXzEyODI_84906e69-b433-4f4c-93e8-00376d2f5260"
      unitRef="number">0.024</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:AssetImpairmentCharges
      contextRef="i86612b3448fd4cf8a845faec1531511e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xNDIvZnJhZzpiYzY3MDMzM2RlYWE0NTlmYWFiYzAyYjVkMjEyODYzMS90ZXh0cmVnaW9uOmJjNjcwMzMzZGVhYTQ1OWZhYWJjMDJiNWQyMTI4NjMxXzE0MDc_bc4c8866-b8ea-49f5-96e9-208363253144"
      unitRef="usd">47000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i0a67a3c2c8da44f8b02b124c5c7e4f00_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xNzgvZnJhZzpkM2Y2NjgxNTE1NDc0ZWM5YTE0ZTRkYjliNjIxYWYwNC90YWJsZTo3YmFmYjJmZGViYzY0YWExYmQ0MTQyODM0MzMyOGU0ZS90YWJsZXJhbmdlOjdiYWZiMmZkZWJjNjRhYTFiZDQxNDI4MzQzMzI4ZTRlXzE3LTMtMS0xLTcyMTUx_5a267da6-22d8-40f9-a26e-a9a3eead04f2"
      unitRef="usd">167000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="icad1710138264073bfe29669fd2b4227_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xNzgvZnJhZzpkM2Y2NjgxNTE1NDc0ZWM5YTE0ZTRkYjliNjIxYWYwNC90YWJsZTo3YmFmYjJmZGViYzY0YWExYmQ0MTQyODM0MzMyOGU0ZS90YWJsZXJhbmdlOjdiYWZiMmZkZWJjNjRhYTFiZDQxNDI4MzQzMzI4ZTRlXzE3LTUtMS0xLTcyMTUx_0a9a9709-34b7-48c4-927f-c34ee7fdfd3a"
      unitRef="usd">41000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="icad1710138264073bfe29669fd2b4227_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xNzgvZnJhZzpkM2Y2NjgxNTE1NDc0ZWM5YTE0ZTRkYjliNjIxYWYwNC90YWJsZTo3YmFmYjJmZGViYzY0YWExYmQ0MTQyODM0MzMyOGU0ZS90YWJsZXJhbmdlOjdiYWZiMmZkZWJjNjRhYTFiZDQxNDI4MzQzMzI4ZTRlXzE3LTctMS0xLTcyMTUx_107efa3d-5436-4302-b616-dc044f26391f"
      unitRef="usd">52000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesAdjustments
      contextRef="icad1710138264073bfe29669fd2b4227_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xNzgvZnJhZzpkM2Y2NjgxNTE1NDc0ZWM5YTE0ZTRkYjliNjIxYWYwNC90YWJsZTo3YmFmYjJmZGViYzY0YWExYmQ0MTQyODM0MzMyOGU0ZS90YWJsZXJhbmdlOjdiYWZiMmZkZWJjNjRhYTFiZDQxNDI4MzQzMzI4ZTRlXzE3LTktMS0xLTcyMTUx_8092ee1b-728d-485f-a059-16ae35a0caf9"
      unitRef="usd">2000000</us-gaap:ValuationAllowancesAndReservesAdjustments>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i558ca518d7ef47a69b7c90dd2d54b4c0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xNzgvZnJhZzpkM2Y2NjgxNTE1NDc0ZWM5YTE0ZTRkYjliNjIxYWYwNC90YWJsZTo3YmFmYjJmZGViYzY0YWExYmQ0MTQyODM0MzMyOGU0ZS90YWJsZXJhbmdlOjdiYWZiMmZkZWJjNjRhYTFiZDQxNDI4MzQzMzI4ZTRlXzE3LTExLTEtMS03MjE1MQ_ae418d2c-017e-40cd-85a6-ccfddb14ed06"
      unitRef="usd">154000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ibb94cefe14cf4d4ca3781d438a3518be_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xNzgvZnJhZzpkM2Y2NjgxNTE1NDc0ZWM5YTE0ZTRkYjliNjIxYWYwNC90YWJsZTo3YmFmYjJmZGViYzY0YWExYmQ0MTQyODM0MzMyOGU0ZS90YWJsZXJhbmdlOjdiYWZiMmZkZWJjNjRhYTFiZDQxNDI4MzQzMzI4ZTRlXzE4LTMtMS0xLTcyMTUx_064e81a7-96c5-45b1-917f-59a930ee70ef"
      unitRef="usd">131000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i318eeab7dffd46df8caadd99e8f388be_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xNzgvZnJhZzpkM2Y2NjgxNTE1NDc0ZWM5YTE0ZTRkYjliNjIxYWYwNC90YWJsZTo3YmFmYjJmZGViYzY0YWExYmQ0MTQyODM0MzMyOGU0ZS90YWJsZXJhbmdlOjdiYWZiMmZkZWJjNjRhYTFiZDQxNDI4MzQzMzI4ZTRlXzE4LTUtMS0xLTcyMTUx_54eadad4-3aa6-4189-8d2e-21123704b58a"
      unitRef="usd">61000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i318eeab7dffd46df8caadd99e8f388be_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xNzgvZnJhZzpkM2Y2NjgxNTE1NDc0ZWM5YTE0ZTRkYjliNjIxYWYwNC90YWJsZTo3YmFmYjJmZGViYzY0YWExYmQ0MTQyODM0MzMyOGU0ZS90YWJsZXJhbmdlOjdiYWZiMmZkZWJjNjRhYTFiZDQxNDI4MzQzMzI4ZTRlXzE4LTctMS0xLTcyMTUx_fe10be90-fe74-4da8-85e9-39df553fd432"
      unitRef="usd">23000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesAdjustments
      contextRef="i318eeab7dffd46df8caadd99e8f388be_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xNzgvZnJhZzpkM2Y2NjgxNTE1NDc0ZWM5YTE0ZTRkYjliNjIxYWYwNC90YWJsZTo3YmFmYjJmZGViYzY0YWExYmQ0MTQyODM0MzMyOGU0ZS90YWJsZXJhbmdlOjdiYWZiMmZkZWJjNjRhYTFiZDQxNDI4MzQzMzI4ZTRlXzE4LTktMS0xLTcyMTUx_aacdb613-7da6-4a55-937d-f74f510c3418"
      unitRef="usd">2000000</us-gaap:ValuationAllowancesAndReservesAdjustments>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i0a67a3c2c8da44f8b02b124c5c7e4f00_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xNzgvZnJhZzpkM2Y2NjgxNTE1NDc0ZWM5YTE0ZTRkYjliNjIxYWYwNC90YWJsZTo3YmFmYjJmZGViYzY0YWExYmQ0MTQyODM0MzMyOGU0ZS90YWJsZXJhbmdlOjdiYWZiMmZkZWJjNjRhYTFiZDQxNDI4MzQzMzI4ZTRlXzE4LTExLTEtMS03MjE1MQ_8274822e-ab57-4ea7-aaec-018320d403c7"
      unitRef="usd">167000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ia3f2576e657245638084e8d8a7407dfb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xNzgvZnJhZzpkM2Y2NjgxNTE1NDc0ZWM5YTE0ZTRkYjliNjIxYWYwNC90YWJsZTo3YmFmYjJmZGViYzY0YWExYmQ0MTQyODM0MzMyOGU0ZS90YWJsZXJhbmdlOjdiYWZiMmZkZWJjNjRhYTFiZDQxNDI4MzQzMzI4ZTRlXzE5LTMtMS0xLTcyMTUx_75035cae-0303-40b1-be7c-64b7aaf402fa"
      unitRef="usd">88000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i5211b3936fb24755baa1b6cb7bb0a9ad_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xNzgvZnJhZzpkM2Y2NjgxNTE1NDc0ZWM5YTE0ZTRkYjliNjIxYWYwNC90YWJsZTo3YmFmYjJmZGViYzY0YWExYmQ0MTQyODM0MzMyOGU0ZS90YWJsZXJhbmdlOjdiYWZiMmZkZWJjNjRhYTFiZDQxNDI4MzQzMzI4ZTRlXzE5LTUtMS0xLTcyMTUx_e49e4505-40a8-45f3-a71b-1c8a8a08a582"
      unitRef="usd">65000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i5211b3936fb24755baa1b6cb7bb0a9ad_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xNzgvZnJhZzpkM2Y2NjgxNTE1NDc0ZWM5YTE0ZTRkYjliNjIxYWYwNC90YWJsZTo3YmFmYjJmZGViYzY0YWExYmQ0MTQyODM0MzMyOGU0ZS90YWJsZXJhbmdlOjdiYWZiMmZkZWJjNjRhYTFiZDQxNDI4MzQzMzI4ZTRlXzE5LTctMS0xLTcyMTUx_6b2cc6f2-c442-4877-89ce-8998695bfe9e"
      unitRef="usd">22000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesAdjustments
      contextRef="i5211b3936fb24755baa1b6cb7bb0a9ad_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xNzgvZnJhZzpkM2Y2NjgxNTE1NDc0ZWM5YTE0ZTRkYjliNjIxYWYwNC90YWJsZTo3YmFmYjJmZGViYzY0YWExYmQ0MTQyODM0MzMyOGU0ZS90YWJsZXJhbmdlOjdiYWZiMmZkZWJjNjRhYTFiZDQxNDI4MzQzMzI4ZTRlXzE5LTktMS0xLTcyMTUx_4812beb0-fdde-4a18-a5aa-70a030ae8999"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesAdjustments>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ibb94cefe14cf4d4ca3781d438a3518be_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNlYzQ2MDEzYTBhZDQ2MDhiODlmOTdlNDMzZGQzNDE3L3NlYzpjZWM0NjAxM2EwYWQ0NjA4Yjg5Zjk3ZTQzM2RkMzQxN18xNzgvZnJhZzpkM2Y2NjgxNTE1NDc0ZWM5YTE0ZTRkYjliNjIxYWYwNC90YWJsZTo3YmFmYjJmZGViYzY0YWExYmQ0MTQyODM0MzMyOGU0ZS90YWJsZXJhbmdlOjdiYWZiMmZkZWJjNjRhYTFiZDQxNDI4MzQzMzI4ZTRlXzE5LTExLTEtMS03MjE1MQ_a963d821-e9a9-4dcb-b8dd-422c393241d1"
      unitRef="usd">131000000</us-gaap:ValuationAllowancesAndReservesBalance>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>111
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MSH(P"?K\R+DZ!>:"?G*G?P%02P,$%     @ /8)*5H C7H;'!0  CQ@  !@
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MZX;1E%4* +^O.)>'!S5 ]S^(Q?]02P,$%     @ /8)*5BZ&/:N< @  W@8
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M]/E<6+Y<<NV^9-O[!A[)6VUDW8,Q@IJ);J2/?1WV .'X""#J =%K0'($$/>
M^*V I >X4OM=*JX."VIHEBJY)<IZ(YN=N&(Z-*;/A&W[O5&XRQ!GLKD46G)6
M4 ,%N3<X8$^-)C]*<DV58&*MR:<E56BLP+"<\C-R3G2%%KT;F""WC'-LHTY]
M@T%9:C_O YAU 41' @@C<BN17)-K44#QDL#';(:4HEU*L^@DXP+R$8G#SR0*
MHNA 0/.WP\,#\,7;X<&);.*A0;'CBX_PW8A<UO#<&O)GNM)&X7WY>ZC8'5ER
MF,QJR)5N: X3#T5"@]J EWW\$(Z#KX<*]9YDBW<B>U'$9"AB<HH]FPK#S@O&
M6RLRNV,+CSEO\<B14LF:X,G.6TZ=&,F2#,Y0-UP^ :*,S!^(;*P'W@D\]!W/
MV:$V=.%<NG"L\FZR9!2G_F:_NIW/>,\G>.FQ..71U<'?N_DUJ+534$URV0K3
MW9C!.HCTU&G3*_L,Q;O3VF>:3OEOJ5HSS)A#B93!Z,N%1U2GIMW"R,;IRTH:
M5"LWK? ! F4=<+^4TNP6]@?#DY;]!U!+ P04    "  ]@DI6X0S)()X#  #-
M#   &    'AL+W=O<FMS:&5E=',O<VAE970U+GAM;*U7WV_;-A#^5PBM*!J@
MCGY8DNW4-I#8*]J';$&S; _#'FCI;!&A2)>D[6Q__4A*46V)%@+4+Y9(???Q
MOKLC>9X>N'B6!8!"+R5E<N852FUO?%]F!9187O,M,/UES46)E1Z*C2^W G!N
MC4KJ1T&0^B4FS)M/[=R#F$_Y3E'"X$$@N2M++/Z] \H/,R_T7B>^D4VAS(0_
MGV[Q!AY!/6T?A![Y#4M.2F"2<(8$K&?>;7BS#*V!1?Q)X""/WI&1LN+\V0R^
MYC,O,!X!A4P9"JP?>U@ I89)^_&])O6:-8WA\?LK^V<K7HM980D+3O\BN2IF
MWMA#.:SQCJIO_/ %:D&)X<LXE?87'2KL*/)0MI.*E[6Q]J DK'KBESH01P9A
M>L8@J@VBMD%\QF!8&PS?:A#7!K&-3"7%QF&)%9Y/!3\@8=":S;S88%IK+9\P
MD_=')?17HNW4?,&9Y)3D6$&.'I5^Z*0JB?@:+7BI2ZDP.=X#^LHR7@(:H*?'
M)?KP[@J]0X2A>T*I3I^<^DH[8RC]K%[XKEHX.K-P&*%[SE0AT:\LA_R4P-<J
M&BG1JY2[J)=Q"=DU&H8?411$D<.AQ=O-0X?Y\NWF08^:89.8H>4;GN%K<G$V
M%7_?KJ02>N/\XXI^Q1Z[V<UI<B.W.(.9IXDEB#UX\_>_A&GPR16Y2Y(M+T1V
M$M6XB6K<QS[_39^D@ 4C;..LV<HZL=;FR-S/HV$RGOK[XVAT0>%D$I^"E@Y0
M,IDTH!/OD\;[I+<F?E<%")2=% .IBN$#Y5)>?40,;,$H_.*2EURR*"Y)MKP0
MV4E8TR:L:6]1W&/Q# JO*" )V4X01<!9'15->I330=BJC2YDV"J,+B)P5\6H
M<7_4Z_Y#?0MO*78?Q*/.BN$X;?GMP 3MDNYB!N,SOH\;W\>]OC\QW:Q0\I^^
M?#:Z29%5'8.\0EI0#I)LF+V9"L@W[IR,NXY'+6U=2!*TI'4A@V3DEC9II$UZ
MI7TF#+.,8(ID<Y3KXYI)BDW'X](RZ6H)6^6SZ&+B=-)2T\4,XC!VRPF#'YU"
MT"OH#ZZT&/ZS9U"]RLD6"5OY6#A :=2JV:4#-$B2\(S.HXXH[-6Y<&AS"@F[
MET6:MB\+)RIJUY\#I???N"7%/^KS2A ;VR]+G8P=4U6?U,PV/?FM[41;\W>F
M5[?]XP^:JM'79^'&[$,*:TT97(^T2Z+JG:N!XEO;3:ZXTKVI?2WT_PT0!J"_
MKSE7KP.S0/,/9OX_4$L#!!0    ( #V"2E9'!H8V.0<  &0A   8    >&PO
M=V]R:W-H965T<R]S:&5E=#8N>&ULK9IM;]LV$,>_"N$5>P#26GS04Y<86%-L
M*]!N0;.'UXS$Q$0ET9-HI_GV.\F.98M'V@7R)I&=(_4_\G@_'IG+1]-^Z99*
M6?*UKIKN:K:T=O5V/N^*I:IE]\:L5 -_N3=M+2U\;!_FW:I5LAP:U=6<15$R
MKZ5N9HO+X;N;=G%IUK;2C;II2;>N:]D^O5.5>;R:T=GS%Y_UP]+V7\P7EROY
MH&Z5_7MUT\*G^;Z74M>JZ;1I2*ONKV:_T+?70O0-!HM_M'KL#IY)[\J=,5_Z
M#Q_*JUG4*U*5*FS?A81?&W6MJJKO"73\M^MTMG]GW_#P^;GW7P?GP9D[V:EK
M4_VK2[N\FF4S4JI[N:[L9_/XN]HY%/?]%:;JAI_D<6L;YS-2K#MKZEUC4%#K
M9OM;?MT-Q$$#*CP-V*X!.[<!WS7@@Z-;98-;[Z65B\O6/)*VMX;>^H=A;(;6
MX(UN^FF\M2W\54,[N[@V36<J74JK2O).5K(I%+GMN^O(:_+W[7ORXZN?R"NB
M&_))5Q6,?'<YM_#BOOF\V+WDW?8ES/.2]ZIX0SB]("QB#&E^?7YS>MQ\#N[N
M?69[G]G0'_?YO&Y;U5@BNP[<Q-S9MA=X^WYEO>U6LE!7,U@ZG6HW:K;X_CN:
M1#]CSKU09T>N\KVK/-3[XEIV2R*;DA3]@_IOK3>R M]1K[==Q4-7_?+?+&@F
MQ.5\<^B-:\3R Z,CE6*O4@15?I+M%V7E7:5(IXIUJZU6J,)M-\G!R[.I/M<D
MC7%U\5Y='%3W2U&8-0P99*U"P?B!S M2J:XCLH(L.*P8<T]>T5C 8J%)VB^6
M/E1_PER('7T\3N*)$XC1L'(P-Y*]&TDPZC\T&YAXT\+0OL6$)2\9\R_4V9&C
MZ=[1]$0T6=5J675#X'?KU:KRA%/J##,%^DWFPC5*<HI/1;97F 45_@MDZX-D
MU9H"X@B3EKD1(+*),M>&)9Z5F.^5Y4%EO^I& TQ*\F!,B0K+L9?2B3+$B,<Y
M+HU&(ZJBH+B_C)45C-L^CE$21>[(Y?ET@6%6G'H&CQ[ E 85WK1J)75)U%?8
M9G5J&X'&+E4++#\%G5W?1ZDK2Z?"7:,D\60&.@*1!B&T&]DS)#)DQ;#4&5W,
M+**I1^8(,\J#*>RFA>UK:Y\NR HV*G88W9YI*]A76C2IT2 >OS6KO51OQ^Z/
ME*1A3'X$?R_(W5I7I6X>ML&E:T@B&U7[F$Y='M*4Y],)0ZR2./',UPA.&B;G
M)UDLX:OVZ7BF4)TN\D243',Q8L4SX0O_D8PTR*-=^*]"T85J3APU<18YBP&Q
M$GGFT3Q"CH8I]_%X P(%'50O$':%EGU]A.IU4<8R[NA%K)+$LX>B(_)HF'G!
MM7M!&H4/,<*X/(VFDA&KC'./Y)&%- S#WX"!CU#TH,)<Q%&198XRQ(SEU#/[
M;$0A"Z/PSX$INK&R>="P(>V\(\A<TH'.Z:2C5B+RR!QYR,(\_,,TSU"!TEK!
M$V2LIC"U(E9^#15@+N:HH-/1Q:S2Q*?ZH#P,TW [N,VH/:#3)1T3R;0FP:Q8
MXHE/-N*0A8N[;=H*B.-NMDPRIV+"S$3"/7M<-N**B;/*[$K+.UUY:SH6A-XW
M%]LOU-NQSR/QV)FUXDH^]84BZK +,8AM/IT5Q I2AV=21M2Q,.I 8+N&50AK
ML-^B>EG!7&I1*J;[!LPJRCT\9B/;6)AM'_8IPA,R"*(.WKK3AE1W7FDCQE@8
M8^_U1I<*V!6:8 Q'SJK#JC=?2AB1Q<+(>IY>V,N4Z^+TVL,*-2?+ND8B\F0'
M/A*,APGVK!0IE4Z(YBZK:.J>4R%6PK>-X2/1>)AHSTFMEG9W3M6?_93J#H4O
M1P!%\VFUC%AY2B4^,HQ_2T5W:D1=/B4\FF8DQ$K$PI.1^,$)99AB'TWS\-JJ
MMAY&\0("HJC6?8&S5S^.-2K>Q1>E63PMG#$S)E)/0N CY7BX*#N5J[A;6KGG
M)8A13CW)@(\PXF$8.?N84V& @2EQ!A*QRIAGT\5',/%S:K!3"EW>L(@ETX,Q
MQ(SF:>PYWN$CEW@:W-'<+F6KEJ8J5=O],%0O]@F5&<3;MVYI7JJW8Z='XO$P
M\:Y-79N&=-847R[(J^@-C0!^+=G(:HWBCR-GE\X,!6V.E8[PXR?@5Y:ZW\_T
MM;S4Y6O=D$*N-,05*A-A7\0=C" %7)9[HEV,]!-A^GU65L)7@#_9-OUA#GK;
M@2$L=2X+,#,N,I_&$74BC#H@]+I>5\/-X.X,$S:-L #Z2]R-(I7!CZZ%B[/7
MC$U3'F85^XH.,7)/G,.][LR%*I"#RB2ATV,GS$QDJ0?28D2?.*> .\AYY'M9
MKWX^7[Y[&8<5>)B9O\ 3![=V8?0=9X9]3B _PL(K357)%NH@")O!'?0R;/>"
M]$ 9Y)>I_+#15OS\X J\__^#3[)]T$U'*G4/K:(W*7C?;J_TMQ^L60VWXG?&
M6E,/CTLE8<1[ _C[O3'V^4-_T;[_QXK%_U!+ P04    "  ]@DI6('KS!W8"
M  #:!0  &    'AL+W=O<FMS:&5E=',O<VAE970W+GAM;*U474_;,!3]*U<9
MFD!BS4=+V5@:"8H0>T"JJ-@>ICVXSFUCX=B9[;;LW^_:"5&9 N)A+XD_[CD^
MY]KWYGMM'FV%Z."IELK.HLJYYB*.+:^P9G:D&U2TL]:F9HZF9A/;QB K ZB6
M<98DT[AF0D5%'M86ILCUUDFA<&' ;NN:F3]7*/5^%J71\\*]V%3.+\1%WK -
M+M$]- M#L[AG*46-R@JMP.!Z%EVF%_.)CP\!WP7N[<$8O).5UH]^\JV<18D7
MA!*Y\PR,?CN<HY2>B&3\[CBC_D@//!P_L]\$[^1EQ2S.M?PA2E?-HL\1E+AF
M6^GN]?X6.S]GGH]K:<,7]FWL]$L$?&N=KCLP*:B%:O_LJ<O# 2"=O +(.D#V
M7L"X XR#T599L'7-'"MRH_=@?#2Q^4'(34"3&Z'\+2Z=H5U!.%?,M;):BI(Y
M+.&*2:8XPM+363A>,(/*5>@$9]*>P"=X6%[#\=$)'(%0<">DI*NP>>Q(B>>+
M>7?J57MJ]LJIU\A',$Y/(4NR;  ^?S\\?0F/R7^?A*Q/0A;XQJ_P+1W9IZ?I
M0*_A1BA*@F 2%MJ*\-9^7JZL,_3B?@U9;;DGP]R^"B]LPSC.(BHSBV:'4?'Q
M0SI-O@X9_T]D+](P[M,P?HN]N.1<;Q5=O$&.8L=6$D^!22IT_RJ&K+=\9X'/
M]XM=D9Y-\GAWZ&@@9GK>Q[P0.NF%3MX4.M=U3=="Q<$?3Z%A!G9,;A&.Z5&6
M6DIF+#1(O:JB!WPR)+SE/S\0E8S2?X2_'=,*CP\JSW>].V8V0EF0N"94,CHG
MWZ;M).W$Z284XTH[*NTPK*CYHO$!M+_6VCU/?'WW[;SX"U!+ P04    "  ]
M@DI66\%>AM$&  ":-0  &    'AL+W=O<FMS:&5E=',O<VAE970X+GAM;+U;
M76_;-A3]*X17;"U0QR+U8;E+##2VA 98UR!9MX=A#XI$QT+UX8ITTO[[4;)B
MF13-6,5-7Q+)XCV7NH>7XCVBSA_+Z@M;4\K1MSPKV,5HS?GFW63"XC7-(W96
M;F@AKJS**H^X.*WN)VQ3T2AIC/)L0BS+F^116HSFY\UOU]7\O-SR+"WH=878
M-L^CZOLES<K'BQ$>/?UPD]ZO>?W#9'Z^B>[I+>6?-]>5.)OL49(TIP5+RP)5
M='4Q>H_?A;95&S0M_D[I(SLX1O6MW)7EE_KD*KD8676/:$9C7D-$XM\#7= L
MJY%$/[ZVH*.]S]KP\/@)/6QN7MS,7<3HHLS^21.^OACY(Y305;3-^$WY^(&V
M-^36>'&9L>8O>FS;6B,4;QDO\]98]"!/B]W_Z%L;B ,#;!\Q(*T!.=7 ;@UL
MQ8!,CQ@XK8&C>O"/&+BM@:L8.-X1 Z\U\)K8[X+51'H9\6A^7I6/J*I;"[3Z
MH*&KL18!3HMZ9-WR2EQ-A1V?+\J"E5F:1)PFZ):+?V+8<(8^K=#M.JKHNLP2
M6K'?4/!UF_+O:(P^WR[1ZU=O$*LO,Y06Z&.:96*4L+?HU>'I^82+#M9N)G';
MF<M=9\B1SOQ5\BC3F"W,9HLRS\4@O>5E_$5CO31;OT^2M![D48:NHS097Q5H
M$6U2?4\",]8-Y2*9122#J"K2XEX7@_"9[L3Q-M]F#1^?^)I62-R>F#36=38_
M4'15Q&5.T>L_2L;>R/ 3P?U^ )#] ""-/^>(OTMZGQ9U7T6"9E$14Q1QM*3Q
M&;+Q6T0L/-/Q:,2L9\-W;!/%]&(D>LYH]4!'\U]_P9[UNX[='9C;@-4SX</<
MGIY/'@XI[#?!'O'E1H&F$9XZ2JNPWVKL6=Z^D11$>Q]$>U@0WSZEQRG!-&(/
M#>8.S)>"Z9RY2CPA70:08"$0F$2CLZ?1:=#M(S2*W!)/9R:R2W#6'+VI)[1F
M8E$GPG]ORBQ#XNGV&%7)?SI:'4A:(<&6D& !)%@(!":Q[^[9=XU)?,78MID
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MMVI"*(PS-V-!,$(6@=)">[E#7Y$[)TIK5 HK]^L2#FQ E^#$G><2@BTRMX9
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MD%RD%+NR?36VB Q@=$57VG(K8]<CI0Q_TA16Z+Z%63N.[!'6-5M2T_P G(^
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M0<BH'IM2)P3W?%")[Y!=1"#SZ>I7_S18PG@T<?+()3T"K'* <OZKYU-Y.BK
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M >-K@XXZ/)""Z3\V5_\%4$L#!!0    ( #V"2E; ^G]9QP@  &P5   9
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M<];!;,K](\;-"U=YPK%Q(M<$Q\L-N'JBG4GK_EY==K_2198RWIQXJIBSXY>
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ME=QX@GP G^V*T&(A**2E-H+R?1/>(^93G4 _2\:%&%S^>G7K0X9[N\+T2F?
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MEQ]15\@@](=/R,@Q#(>7@EG>?9F>\HWS<NG@U#%6K;0M>(*QUJV&$F<S=%%
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MDQ<'(^73]2J]1-?)E6;A(D1+'FLY,/$$?%\Z.'UXX0VV=]S3?P%02P,$%
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MAIQ$#Y&&('Q*V^ -=BSMOX&CONGD.UC8R@1!Q8OFZ4OFJ:'(9#1^Q4D-=J<
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MD3D #<DO%AMD76H[30]X37=R$)H67,:/8FI/S(ZG=!V_"H5C-TB;R-T38Q#
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M=1_I_(55C?LP=J>L594[W0B\\&I:@.<KI6QW01OT7TK/_P!02P,$%     @
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M)>:2&=5[7.Z:N;<Z.MD_D**UT6X8OG/G"ZY?S^4:S9OGM\/%=MWJ)SO"^I3
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M>""!>I41E=OI*G*;=.+P+()7F=S;8TBJJJ?(50.DU,USH7;KH-R>]YCM:LH
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M,Z7#\X!%)SP(;.@MMM\2ZMD=5F%Z1B'L$PUB.<!O;EBZJJR(!)#=*Y#*)9Z
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M%/YOO>BSAS2?$)91.-,US(EMOO,VG!Z,% LZ2K$9_'/%F" 7=[9E)RH@F)A
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M,07R2[H^ESGMD QW>_JUIT(' 01GY33K'F-C]05CD/>6A@OJ,&XO16V.G3@
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M-:FJXU<+(U>NR\ZDH9[MIDMZ)*&R O1_+J4Y+.P!];-K\C=02P,$%     @
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MHG8;Z/]2*;LW7(##^SWY!E!+ P04    "  ]@DI68)@U:"H#  #F!@  &0
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MV%>-<&>,U6A6?EA;\ 7M)EK_M;\/+KHQ^*S>72:WPJPD1:]P2:;1<$P)-]V
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ML*AU^\9I!U8U[EVQ5!8KP7V6^"P4FA;@_Y7"X[P;D(/^H3G[%U!+ P04
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M98S*[70CQ5)JVH#UE5)F=T,"V@^2E_\#4$L#!!0    ( #V"2E9L7YJH1 ,
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MM0/0^E(INQ^X#0YO^NP_4$L#!!0    ( #V"2E8P8YQ(K 4  .4-   9
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M>2O46O-F(W."6&3\B3^4PDPNIQ8LX?QIWJ->=ZCL!"IEY$[5=F/(;5V(XD>
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M/H+1T LB^H0+4>CCE:)"F,6G;,<T)#'+2!BENXQ"MT,:\GX9<"JOL'C^ZQZ
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M.]U]5'0W5C7N(/^@+'P6N.$&OL.$Q@GP?J6@+_L;-#!\V<W^!U!+ P04
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M>.VD9<$,CI7XS'-;C((W >2X9&MAYVK['AL]/L%,">.?L*U]!X, LK6QJFS
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MKCY^>'WLE\7'#_.7U>/#K/YE,5B^/#U-%__\L7Z<?_GA*KG:/?#KP]W]:O/
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M;1"_6M].0[4*U02J2513J*91S:":136':I[2VIW=)(A&E]H)-D(C0ZA6H9I
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M8.[*&X6KL%9)60%",RF(@O4TN.Q>S,;6WAE\9[#5!^_$9K*2\MXNKM-IT+%
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MQ2$;V-**ZUMQN('&S]#PI8(K^TL.3:[GD+126N0-&!7DK*A7^MC4X03@1Z\
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M<99.ZIBE]/>L)$P4T6T:EF)9'3J27\7R-DIO#Z9D.N..5,PYE,:@-(ZBJ?-
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M<VAE970T."YX;6RU6-MNVS@0_15"6RP<((DNON2RMH'&ZFX--&V0;'<?%OO
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M'+ Y,?>?"-S[H=E1PH5W")=7=CW;JL,W[ZV';,R-,_C1AT:GA G'A4F7^N3
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M'PK:7RB^3H[)S+G2ICOY&(!>!82IH+]?<JZ>+TP#V=&L\7]02P,$%     @
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MN* I&[4[0.]G2MF'A9OCFKE]]#]02P,$%     @ /8)*5IUCK0UB P  _ P
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MQ5=>>;!,R93GW.[]5"YV&8K8JY2T+P>R26EY=*R\$'Q9'*9ZX4+PN/BX8'[
MTCQ ?O_*N?BXR!]0'^";_ =02P,$%     @ /8)*5N3UF>_D!@  -S,  !D
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M)9KKPC4+<S^#L@O,_$I*?.G8.Z.[\=,_4$L#!!0    ( #V"2E:S[?[<B 8
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MGIM@S8)MYP6K:KXMM3I,94;@P.($"VW:AH55-=^66AVD,B'P.B8$:DQ(<R'
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ME./X1L3[_-<0#[$0\2Y_N>7^FB?9 /G])I8;0?$F^X%%^8.:Y?]02P,$%
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M^A,\'F5]R:E?M"AMV_\D-%XB[.,&+X8@C0%^SX30;R]F@O:JN?@74$L#!!0
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MWQ&ITOQ,*R]P<LC.%3:$<Y)FEWL$(T1E@+B_)82?"[*!\F!Q]"]02P,$%
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M(ZB"T1R4-=R6G!-/G<.'<7?A:XK?1.%G?:RK+M;HC5C#"&XID$+!ESK'_%#
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MXI*VF>SJE:ZC16-?\+705 _89D$E'DH#H/F-$/JE8SXP%(W)?U!+ P04
M"  ]@DI6)KL8:8D'   6*P  &0   'AL+W=O<FMS:&5E=',O<VAE970W,2YX
M;6R]6EUOVS84_2N$5PPMD-0FY8^X2PPD5KL%6->@6;>'80^T1-O<)-$CJ:3K
MKQ])*99%4DR<:GU))/GRZ)XKWLO#C_-[QO\66T(D^)QGA;@8;*7<O1D.1;(E
M.1:OV8X4ZI<UXSF6ZI9OAF+'"4Y-HSP;HM%H.LPQ+0:+<_/LAB_.62DS6I ;
M#D29YYC_>T4R=G\Q@(.'!Q_I9BOU@^'B?(<WY);(3[L;KNZ&>Y24YJ00E!6
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MG )A#/3W.>=J,S$!F@=:\A=02P,$%     @ /8)*5LDTDVY% P  91   !D
M  !X;"]W;W)K<VAE971S+W-H965T-S0N>&ULM5A=;]HP%/TK5B9-K321.(1
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M&: ^W^:Y_'%2/A+6/ *X_!]02P,$%     @ /8)*5H%?YH+B @  3PD  !D
M  !X;"]W;W)K<VAE971S+W-H965T-S8N>&ULM59=;]HP%/TK5E9-(*T-"1!8
M!Y$*;%JE=D*MNCU,>S#)#5AU[,QVH/WWNTX@ PK1NK&7Q%_G^)SKC^O!2JI'
MO0 PY"GE0@^=A3'9I>OJ: $IU1<R X$]B50I-5A5<U=G"FA<@%+N^JU6X*:4
M"2<<%&U3%0YD;C@3,%5$YVE*U?,(N%P-'<_9--RQ^<+8!C<<9'0.]V >LJG"
MFENQQ"P%H9D41$$R=*Z\RW'?CB\&?&6PTEME8IW,I'RTE>MXZ+2L(. 0&<M
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MG&$$."1(V;KHH3M5IN^R8F169,"9-)A/B^("7SR@[ #L3Z0TFXJ=H'I#A;\
M4$L#!!0    ( #V"2E8MX-ET5 (  #D&   9    >&PO=V]R:W-H965T<R]S
M:&5E=#<W+GAM;(V576_:,!2&_XJ551.5-A(<$A@+D4I9M5U40J!N%],N3#B
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MG8]@&VU@Q9 '5MI5XC)+EW%R6"G6JT"RBZ!A%:AF0S4'JKE0S8-J/E1C4"V
M:@NH%J*T;M^V\1AC_I:;LM"T#%2SH9H#U5RHYD$U'ZHQJ!9 M054"U%:=T;N
M-IQCRL,Y0[Y+**>&MBU4LZ&: ]5<J.9!-1^J,:@6F-040-34CV2A2FS'4H66
M>G[R+;.-QICR*\O<+'_;QT5\W".,TY*O\\/J\$/.DZCD*V6YB?(U?<Y=K@]N
M+6@V!JHY4,V%:AY4\Z$:@VJ!2<PAI%E$$)LJM&94:U&S$IGG]Q'--JQBRL,J
M?VI>.[DYN*&@(1:HYD U%ZIY4,V':@RJ!:88.:'GM2,+J7GMJ$+9O'9F&V(Q
MY2&6>UZ4^7Y9[O-J>^^X=JK76EFYX;ET/06-LT U&ZHY4,V%:AY4\Z$:@VJ!
M*<9//ACD)B!5.!//UX=4H2S18K:)%E.>:.EYI4^Y,KB%H$D6J.9 -1>J>5#-
MAVH,J@6FF#NAK_1)% K-(ROIMDV;7C'EZ95/]7> HD19\6_QDBLY7^^3P[8>
MO0*"QEF@F@W5'*CF0C4/JOE0C4&UP!2G%?J@4=]8)0NI+]I1A3/M_/JGC9>8
M\GF*[GG51LEQ>VX;E27/Z2:"1DF@F@W5'*CF0C4/JOE0C4&UP!2G*M+$0P@+
MHJQJ(?':82%9.#W?0FVPPY0'.^Y?5CY9_OVP.Y3P=;5BDC42--<!U6RHYD U
M%ZIY4,V':@RJ!::8P_@PI3;EQ#IQ!NF0TLY_2<9L0QVF/-31<P)PN3*X>:!Q
M#JCF0#47JGE0S8=J#*H%C78ZL;H^,XD+^5"%UHR8,)TJU'7B=-*XV'!>VE$9
M75]N>;[F=SQ)"F69[=.R#EF<W%KM #W5T_%<W.BCL7#[K7;!-.+V0+L(#[>/
M6_[Z<A>M^:<H7\=I4:W+GJJ[4C].JT>;Q^O-\9<RVUV-M)'RF)5EMCW\N.'1
MBN=U0?7WIRPK7W^I[^ YR[\>GL[U?P%02P,$%     @ /8)*5O><G:-X!
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M^L=(@3)-9]8[2$J4-> -\SKU^1F\87Z8BM47I< XJ"=)Q8/4@J#1="C&D>X
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M[YI..50NJ/+2A9LBB<EM/$ONDYG0$E+YV=\R2)H%I=E0F@.EN5":!Z7Y4%H
MI8506H2B-:UZJ"Y1A\^9UB&K$J90F@6EV5": Z6Y4)H'I?E06@"EA5!:A*(U
MC7RH@E'E93#RM Y: P.E65":#:4Y4)H+I7E0F@^E!36MF82-13>T@D#3$%28
MB0)'NG(ZK3O4IZC2+?0GIW5&JT/&2)#508M.H#0;2G.Z38@+;=2#TGPH+>@V
M(6&WL C5MZ9+#I4@JKP4Y$^VI#GA=X8T6:1DEFU3EB<GOFR@E2%0F@6EV5":
M Z6Y4)H'I?E06@"EA5!:A*(U77LH2%'-Y\SND(4,4RC-@M)L*,V!TEPHS8/2
M?"@M@-)"*"U"T9H_1C[4S6CRNAEI=B?7GNM3*,V"TFPHS8'27"C-@])\*"VH
M:<=WK$-#L&<GBE/;26!4QS5_?7AZQTX[U*QHTJWTIZ9V-;7Q6S[!3_ZF\M;/
M=@JT# 5*<P0S(MA[=:&->E":#Z4%'9=(V&WB(E3G=C[I'STT9$WS1?4HG&*7
MM.V>'; _NG_<SDWUT)$?CK]3+WU5<#Q0+Z/=PW0.^-VS?=['^2))"[*B][PI
MY8W!1Y[O'I>S>\.R3?7(DD\98]FZ>KFD\9SF90#__#[+V..;LH']0XLF_P-0
M2P,$%     @ /8)*5J_AFQ5> P  Y P  !D   !X;"]W;W)K<VAE971S+W-H
M965T.#(N>&ULM5?);MLP$/V5@5H$"9!$B[<LMH'8[F(@:0T';0]%#XPTMHA(
MI$K2=@OTXTM2BF*GLM"TRL7F-F_F/<Y(H_Z&BWL9(RKXD29,#IQ8J>S"=648
M8TKD*<^0Z9T%%RE1>BJ6KLP$DL@:I8D;>%[730EESK!OUV9BV.<KE5"&,P%R
ME:9$_!QAPC<#QW<>%N9T&2NSX [[&5GB+:I/V4SHF5NB1#1%)BEG(' Q<*[\
MB[%O#>R)SQ0W<FL,ALH=Y_=F,HT&CF<BP@1#92"(_EOC&)/$(.DXOA>@3NG3
M&&Z/']#?6O*:S!V1..;)%QJI>."<.1#A@JP2->>;]U@0ZAB\D"?2_L*F..LY
M$*ZDXFEAK"-(*<O_R8]"B"T#O[O'("@,@J<&[3T&K<*@98GFD5E:$Z+(L"_X
M!H0YK=',P&ICK34;RLPUWBJA=ZFV4\,K*76N3-.,4*%O1TDXG* B-)%'< *?
M;B=P^/H(7@-E<$.31"LO^Z[2CHVY&Q9.1KF38(\3/X ;SE0LX0V+,-H%<'7$
M9=C!0]BCH!9Q@N$IM/QC"+P@J AH_/?F?DTXK5+%EL5K[\&[YFQY<JWS,0(K
MJ 3"(I@R1=B2WB58K%8I5PMLBOA"9B3$@:.K5*)8HS,\>.5WO<LJU@V![6C0
M+C5H6_36'@UF0C];A/IY#+.$,&45>/-]13.35O#U6A^'J<)4?JN2H=VD# V!
M[<C0*67HU*9"7E#TL:"JV-9"/)=M#M:Q8.:IO1[Z7J?OKBM(=$L2W5H24W:B
MKS-$*6%^0-+L<G(,'U6,XL^<MO=<>_=5 M2Z?ZX #8'M*-4KE>J]8-;WFI2A
M(; =&<Y*&<[^/^O/_DC4=J_,TYQ#K9=_Y'!><CBOY3#'-;(5PD+P%,;Z?25T
MCZ%?QRJ&L7T1Z_0?(0MCW>_<PR]XAWPI2!;3T)P.T1C8UF1.I=D?OY]^N*K2
MH3:,Y]YZ0V [BOG>8_?@O6#Z%^ -*=$4VJX46XV47YL^NSD@3 X<$OUX!"V0
MV3BJ5*#HSH*MHO!.O:#]I"[J?3^7F[O5+^JL7MHV6D+(5TSE/5BY6K;J5[9!
M?;(^,BV\[4,?8?+^_X:()642$EQH2.^TI\M>Y"UU/E$\LUWI'5>ZM.PPUI\A
M*,P!O;_@7#U,C(/RPV;X&U!+ P04    "  ]@DI6D9 $=7L#  !A"@  &0
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M@*B= )UGBIIQO7 7-%/E[']02P,$%     @ /8)*5J.@9$9V P  KQ<   T
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M*G:W8I?<0,@0@0Q/"/DM ) 1 AF=!E*OV%276P 9(Y#Q$2'_X 57F6!-;ZX
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MGO$B6QCF/_R=1D$4^_V:J[HHIJ[L3OVE>?[VXZRW'Y9]^1=02P,$%     @
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M/_SC^.59CZZ?GO/9\@_]FU]02P$"% ,4    "  ]@DI6!T%-8H$   "Q
M$               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    (
M #V"2E:L@L1J[@   "L"   1              "  :\   !D;V-0<F]P<R]C
M;W)E+GAM;%!+ 0(4 Q0    ( #V"2E:97)PC$ 8  )PG   3
M  "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ /8)*5O$)
M8==$"@  UE<  !@              ("!#0@  'AL+W=O<FMS:&5E=',O<VAE
M970Q+GAM;%!+ 0(4 Q0    ( #V"2E8;.[X>/P(  ,4%   8
M  " @8<2  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4    "  ]
M@DI6@"->AL<%  "/&   &               @('\%   >&PO=V]R:W-H965T
M<R]S:&5E=#,N>&UL4$L! A0#%     @ /8)*5BZ&/:N< @  W@8  !@
M         ("!^1H  'AL+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0
M   ( #V"2E;A#,D@G@,  ,T,   8              " @<L=  !X;"]W;W)K
M<VAE971S+W-H965T-2YX;6Q02P$"% ,4    "  ]@DI61P:&-CD'  !D(0
M&               @(&?(0  >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L!
M A0#%     @ /8)*5B!Z\P=V @  V@4  !@              ("!#BD  'AL
M+W=O<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    ( #V"2E9;P5Z&T08
M )HU   8              " @;HK  !X;"]W;W)K<VAE971S+W-H965T."YX
M;6Q02P$"% ,4    "  ]@DI6BL0M;KP(  #\*@  &               @('!
M,@  >&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%     @ /8)*5ENY
M;NOF'   OU8  !D              ("!LSL  'AL+W=O<FMS:&5E=',O<VAE
M970Q,"YX;6Q02P$"% ,4    "  ]@DI6[%?T]ED*  "]&0  &0
M    @('06   >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    (
M #V"2E; ^G]9QP@  &P5   9              " @6!C  !X;"]W;W)K<VAE
M971S+W-H965T,3(N>&UL4$L! A0#%     @ /8)*5AYE5;&%!P  =1,  !D
M             ("!7FP  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"
M% ,4    "  ]@DI6:).P%'\#  #R!P  &0              @($:=   >&PO
M=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    ( #V"2E:Y'%.=KP8
M .\.   9              " @=!W  !X;"]W;W)K<VAE971S+W-H965T,34N
M>&UL4$L! A0#%     @ /8)*5BZFAHRJ#   HR   !D              ("!
MMGX  'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"% ,4    "  ]@DI6
M>:HR/?\&  #U#P  &0              @(&7BP  >&PO=V]R:W-H965T<R]S
M:&5E=#$W+GAM;%!+ 0(4 Q0    ( #V"2E;E?0C*@P@  #45   9
M      " @<V2  !X;"]W;W)K<VAE971S+W-H965T,3@N>&UL4$L! A0#%
M  @ /8)*5KH5-CUS!0  E L  !D              ("!AYL  'AL+W=O<FMS
M:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4    "  ]@DI6>R'BAY8)  #8&0
M&0              @($QH0  >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+
M 0(4 Q0    ( #V"2E9AC=.@6PD  -\7   9              " @?ZJ  !X
M;"]W;W)K<VAE971S+W-H965T,C$N>&UL4$L! A0#%     @ /8)*5FEWNU!=
M P  " @  !D              ("!D+0  'AL+W=O<FMS:&5E=',O<VAE970R
M,BYX;6Q02P$"% ,4    "  ]@DI6QQ:V#HT'   M$@  &0
M@($DN   >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( #V"
M2E9F47=<E00  /@)   9              " @>B_  !X;"]W;W)K<VAE971S
M+W-H965T,C0N>&UL4$L! A0#%     @ /8)*5O-6O S,'   ,%P  !D
M         ("!M,0  'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q02P$"% ,4
M    "  ]@DI6GP8*K0P%  #8"P  &0              @(&WX0  >&PO=V]R
M:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    ( #V"2E9]M;A$(@0  "T*
M   9              " @?KF  !X;"]W;W)K<VAE971S+W-H965T,C<N>&UL
M4$L! A0#%     @ /8)*5H3?!N#6 P  @@D  !D              ("!4^L
M 'AL+W=O<FMS:&5E=',O<VAE970R."YX;6Q02P$"% ,4    "  ]@DI6_\3D
M+V<#  #+!P  &0              @(%@[P  >&PO=V]R:W-H965T<R]S:&5E
M=#(Y+GAM;%!+ 0(4 Q0    ( #V"2E9@F#5H*@,  .8&   9
M  " @?[R  !X;"]W;W)K<VAE971S+W-H965T,S N>&UL4$L! A0#%     @
M/8)*5A# 5A(E P  ,0<  !D              ("!7_8  'AL+W=O<FMS:&5E
M=',O<VAE970S,2YX;6Q02P$"% ,4    "  ]@DI6D?/OT&$$  !T"@  &0
M            @(&[^0  >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4
M Q0    ( #V"2E8/.>Q3$@0  +$)   9              " @5/^  !X;"]W
M;W)K<VAE971S+W-H965T,S,N>&UL4$L! A0#%     @ /8)*5K,&2AO/ P
M0 @  !D              ("!G (! 'AL+W=O<FMS:&5E=',O<VAE970S-"YX
M;6Q02P$"% ,4    "  ]@DI6-WT7_'8&  "\$0  &0              @(&B
M!@$ >&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4 Q0    ( #V"2E:4
M#81\0 <  )P4   9              " @4\- 0!X;"]W;W)K<VAE971S+W-H
M965T,S8N>&UL4$L! A0#%     @ /8)*5FQ?FJA$ P  WP<  !D
M     ("!QA0! 'AL+W=O<FMS:&5E=',O<VAE970S-RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( #V"2E:"Y=W0R@(  "D'   9              "
M@04] 0!X;"]W;W)K<VAE971S+W-H965T-#(N>&UL4$L! A0#%     @ /8)*
M5J]7V_4N!P  -#   !D              ("!!D ! 'AL+W=O<FMS:&5E=',O
M<VAE970T,RYX;6Q02P$"% ,4    "  ]@DI6K/3:]%P"  #3!0  &0
M        @(%K1P$ >&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0
M   ( #V"2E8(]8G;JP(  ,8'   9              " @?Y) 0!X;"]W;W)K
M<VAE971S+W-H965T-#4N>&UL4$L! A0#%     @ /8)*5N\8$@ ]"0  )F4
M !D              ("!X$P! 'AL+W=O<FMS:&5E=',O<VAE970T-BYX;6Q0
M2P$"% ,4    "  ]@DI6FL::JJ\%  !A*0  &0              @(%45@$
M>&PO=V]R:W-H965T<R]S:&5E=#0W+GAM;%!+ 0(4 Q0    ( #V"2E92YE;$
M'00  #45   9              " @3I< 0!X;"]W;W)K<VAE971S+W-H965T
M-#@N>&UL4$L! A0#%     @ /8)*5E7%4VYF"@  ;F<  !D
M ("!CF ! 'AL+W=O<FMS:&5E=',O<VAE970T.2YX;6Q02P$"% ,4    "  ]
M@DI6@(6U\S$&   7.0  &0              @($K:P$ >&PO=V]R:W-H965T
M<R]S:&5E=#4P+GAM;%!+ 0(4 Q0    ( #V"2E:LDGYJI 4  *8E   9
M          " @9-Q 0!X;"]W;W)K<VAE971S+W-H965T-3$N>&UL4$L! A0#
M%     @ /8)*5F&EP8S' P  PQ0  !D              ("!;G<! 'AL+W=O
M<FMS:&5E=',O<VAE970U,BYX;6Q02P$"% ,4    "  ]@DI6.(;0''@#  ##
M"P  &0              @(%L>P$ >&PO=V]R:W-H965T<R]S:&5E=#4S+GAM
M;%!+ 0(4 Q0    ( #V"2E:=8ZT-8@,  /P,   9              " @1M_
M 0!X;"]W;W)K<VAE971S+W-H965T-30N>&UL4$L! A0#%     @ /8)*5E)N
M#5&K!0  S"<  !D              ("!M((! 'AL+W=O<FMS:&5E=',O<VAE
M970U-2YX;6Q02P$"% ,4    "  ]@DI6Y/69[^0&   W,P  &0
M    @(&6B $ >&PO=V]R:W-H965T<R]S:&5E=#4V+GAM;%!+ 0(4 Q0    (
M #V"2E:3-]&G8 (  /T%   9              " @;&/ 0!X;"]W;W)K<VAE
M971S+W-H965T-3<N>&UL4$L! A0#%     @ /8)*5K/M_MR(!@  QB@  !D
M             ("!2)(! 'AL+W=O<FMS:&5E=',O<VAE970U."YX;6Q02P$"
M% ,4    "  ]@DI6M=.%%38#  !+"@  &0              @($'F0$ >&PO
M=V]R:W-H965T<R]S:&5E=#4Y+GAM;%!+ 0(4 Q0    ( #V"2E8"CCB"Z00
M -T4   9              " @72< 0!X;"]W;W)K<VAE971S+W-H965T-C N
M>&UL4$L! A0#%     @ /8)*5F'C8FQ.!0  &QX  !D              ("!
ME*$! 'AL+W=O<FMS:&5E=',O<VAE970V,2YX;6Q02P$"% ,4    "  ]@DI6
MH/+VZS<$  ";&   &0              @($9IP$ >&PO=V]R:W-H965T<R]S
M:&5E=#8R+GAM;%!+ 0(4 Q0    ( #V"2E8LH8PMI <  %PS   9
M      " @8>K 0!X;"]W;W)K<VAE971S+W-H965T-C,N>&UL4$L! A0#%
M  @ /8)*5A[UI\W7!   YA@  !D              ("!8K,! 'AL+W=O<FMS
M:&5E=',O<VAE970V-"YX;6Q02P$"% ,4    "  ]@DI6M:V+! T$  !V#@
M&0              @(%PN $ >&PO=V]R:W-H965T<R]S:&5E=#8U+GAM;%!+
M 0(4 Q0    ( #V"2E8A4?B6TP,  &04   9              " @;2\ 0!X
M;"]W;W)K<VAE971S+W-H965T-C8N>&UL4$L! A0#%     @ /8)*5JZF\-6:
M P  3PX  !D              ("!OL ! 'AL+W=O<FMS:&5E=',O<VAE970V
M-RYX;6Q02P$"% ,4    "  ]@DI6WT6BAK($  !]$@  &0
M@(&/Q $ >&PO=V]R:W-H965T<R]S:&5E=#8X+GAM;%!+ 0(4 Q0    ( #V"
M2E8HYQBBE0,  !@+   9              " @7C) 0!X;"]W;W)K<VAE971S
M+W-H965T-CDN>&UL4$L! A0#%     @ /8)*5@%_&P-! P  0 H  !D
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M=#<T+GAM;%!+ 0(4 Q0    ( #V"2E9[28)V?P8   XX   9
M  " @6_C 0!X;"]W;W)K<VAE971S+W-H965T-S4N>&UL4$L! A0#%     @
M/8)*5H%?YH+B @  3PD  !D              ("!)>H! 'AL+W=O<FMS:&5E
M=',O<VAE970W-BYX;6Q02P$"% ,4    "  ]@DI6+>#9=%0"   Y!@  &0
M            @($^[0$ >&PO=V]R:W-H965T<R]S:&5E=#<W+GAM;%!+ 0(4
M Q0    ( #V"2E;"XL2B=04  $\;   9              " @<GO 0!X;"]W
M;W)K<VAE971S+W-H965T-S@N>&UL4$L! A0#%     @ /8)*5I.\=Q3!#
MR*4  !D              ("!=?4! 'AL+W=O<FMS:&5E=',O<VAE970W.2YX
M;6Q02P$"% ,4    "  ]@DI6]YR=HW@$  !,&   &0              @(%M
M @( >&PO=V]R:W-H965T<R]S:&5E=#@P+GAM;%!+ 0(4 Q0    ( #V"2E9F
M3=X+]@8  ,!(   9              " @1P' @!X;"]W;W)K<VAE971S+W-H
M965T.#$N>&UL4$L! A0#%     @ /8)*5J_AFQ5> P  Y P  !D
M     ("!20X" 'AL+W=O<FMS:&5E=',O<VAE970X,BYX;6Q02P$"% ,4
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M+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( #V"2E8T3CM]>@(    Q   :
M          "  5L@ @!X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4
M Q0    ( #V"2E8@< [9) (  *DO   3              "  0TC @!;0V]N
E=&5N=%]4>7!E<UTN>&UL4$L%!@    !; %L ]!@  &(E @    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>500</ContextCount>
  <ElementCount>477</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>119</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - COVER PAGE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/COVERPAGE</Role>
      <ShortName>COVER PAGE</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - Consolidated Statements Of Earnings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/ConsolidatedStatementsOfEarnings</Role>
      <ShortName>Consolidated Statements Of Earnings</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - Consolidated Statements Of Earnings (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/ConsolidatedStatementsOfEarningsParenthetical</Role>
      <ShortName>Consolidated Statements Of Earnings (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - Consolidated Statements of Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome</Role>
      <ShortName>Consolidated Statements of Comprehensive Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - Consolidated Balance Sheets (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/ConsolidatedBalanceSheetsParentheticals</Role>
      <ShortName>Consolidated Balance Sheets (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Statement - Consolidated Statements Of Shareholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity</Role>
      <ShortName>Consolidated Statements Of Shareholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Statement - Consolidated Statements Of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows</Role>
      <ShortName>Consolidated Statements Of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/SignificantAccountingPolicies</Role>
      <ShortName>Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Revenue Recognition</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/RevenueRecognition</Role>
      <ShortName>Revenue Recognition</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Derivative Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/DerivativeInstruments</Role>
      <ShortName>Derivative Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Accumulated Other Comprehensive (Loss) Income (AOCI)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCI</Role>
      <ShortName>Accumulated Other Comprehensive (Loss) Income (AOCI)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Acquisitions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/Acquisitions</Role>
      <ShortName>Acquisitions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Contingencies and Commitments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/ContingenciesandCommitments</Role>
      <ShortName>Contingencies and Commitments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Goodwill and Other Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/GoodwillandOtherIntangibleAssets</Role>
      <ShortName>Goodwill and Other Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Capital Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/CapitalStock</Role>
      <ShortName>Capital Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Debt and Credit Facilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/DebtandCreditFacilities</Role>
      <ShortName>Debt and Credit Facilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Retirement Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/RetirementPlans</Role>
      <ShortName>Retirement Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Summary of Quarterly Data (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/SummaryofQuarterlyDataUnaudited</Role>
      <ShortName>Summary of Quarterly Data (Unaudited)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Segment and Geographic Data</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/SegmentandGeographicData</Role>
      <ShortName>Segment and Geographic Data</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Asset Impairments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/AssetImpairments</Role>
      <ShortName>Asset Impairments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/SignificantAccountingPoliciesPolicies</Role>
      <ShortName>Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.stryker.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - Revenue Recognition (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/RevenueRecognitionTables</Role>
      <ShortName>Revenue Recognition (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.stryker.com/role/RevenueRecognition</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.stryker.com/role/FairValueMeasurements</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - Derivative Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/DerivativeInstrumentsTables</Role>
      <ShortName>Derivative Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.stryker.com/role/DerivativeInstruments</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - Accumulated Other Comprehensive (Loss) Income (AOCI) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCITables</Role>
      <ShortName>Accumulated Other Comprehensive (Loss) Income (AOCI) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCI</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - Acquisitions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/AcquisitionsTables</Role>
      <ShortName>Acquisitions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.stryker.com/role/Acquisitions</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - Contingencies and Commitments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/ContingenciesandCommitmentsTables</Role>
      <ShortName>Contingencies and Commitments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.stryker.com/role/ContingenciesandCommitments</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - Goodwill and Other Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsTables</Role>
      <ShortName>Goodwill and Other Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.stryker.com/role/GoodwillandOtherIntangibleAssets</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - Capital Stock (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/CapitalStockTables</Role>
      <ShortName>Capital Stock (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.stryker.com/role/CapitalStock</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - Debt and Credit Facilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/DebtandCreditFacilitiesTables</Role>
      <ShortName>Debt and Credit Facilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.stryker.com/role/DebtandCreditFacilities</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.stryker.com/role/IncomeTaxes</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - Retirement Plans (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/RetirementPlansTables</Role>
      <ShortName>Retirement Plans (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.stryker.com/role/RetirementPlans</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - Summary of Quarterly Data (Unaudited) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/SummaryofQuarterlyDataUnauditedTables</Role>
      <ShortName>Summary of Quarterly Data (Unaudited) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.stryker.com/role/SummaryofQuarterlyDataUnaudited</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - Segment and Geographic Data (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/SegmentandGeographicDataTables</Role>
      <ShortName>Segment and Geographic Data (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.stryker.com/role/SegmentandGeographicData</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - Significant Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/SignificantAccountingPoliciesDetails</Role>
      <ShortName>Significant Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/SignificantAccountingPoliciesPolicies</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - Revenue Recognition - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/RevenueRecognitionNarrativeDetails</Role>
      <ShortName>Revenue Recognition - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - Revenue Recognition - Disaggregated Sales Analysis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails</Role>
      <ShortName>Revenue Recognition - Disaggregated Sales Analysis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - Revenue Recognition - Changes in Contract Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/RevenueRecognitionChangesinContractLiabilitiesDetails</Role>
      <ShortName>Revenue Recognition - Changes in Contract Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - Fair Value Measurements (Valuation Of Financial Instruments By Pricing Categories) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails</Role>
      <ShortName>Fair Value Measurements (Valuation Of Financial Instruments By Pricing Categories) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000045 - Disclosure - Fair Value Measurements (Available-For-Sale Securities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/FairValueMeasurementsAvailableForSaleSecuritiesDetails</Role>
      <ShortName>Fair Value Measurements (Available-For-Sale Securities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0000046 - Disclosure - Fair Value Measurements (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/FairValueMeasurementsNarrativeDetails</Role>
      <ShortName>Fair Value Measurements (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0000047 - Disclosure - Derivative Instruments (Forward Currency Exchange Contracts) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails</Role>
      <ShortName>Derivative Instruments (Forward Currency Exchange Contracts) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/DerivativeInstrumentsTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0000048 - Disclosure - Derivative Instruments (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails</Role>
      <ShortName>Derivative Instruments (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/DerivativeInstrumentsTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0000049 - Disclosure - Derivative Instruments (Movements out of OCI) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails</Role>
      <ShortName>Derivative Instruments (Movements out of OCI) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/DerivativeInstrumentsTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0000050 - Disclosure - Accumulated Other Comprehensive (Loss) Income (AOCI) (Schedule of Amounts Recognized in Other Comprehensive Income (Loss)) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails</Role>
      <ShortName>Accumulated Other Comprehensive (Loss) Income (AOCI) (Schedule of Amounts Recognized in Other Comprehensive Income (Loss)) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCITables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0000051 - Disclosure - Acquisitions (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/AcquisitionsNarrativeDetails</Role>
      <ShortName>Acquisitions (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/AcquisitionsTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0000052 - Disclosure - Acquisitions (Allocation Of The Preliminary Purchase Price To The Acquired Net Assets Of Acquisitions) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails</Role>
      <ShortName>Acquisitions (Allocation Of The Preliminary Purchase Price To The Acquired Net Assets Of Acquisitions) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/AcquisitionsTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0000053 - Disclosure - Contingencies and Commitments (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/ContingenciesandCommitmentsNarrativeDetails</Role>
      <ShortName>Contingencies and Commitments (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/ContingenciesandCommitmentsTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>0000054 - Disclosure - Commitments and Contingencies (Lease Cost) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/CommitmentsandContingenciesLeaseCostDetails</Role>
      <ShortName>Commitments and Contingencies (Lease Cost) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>0000055 - Disclosure - Contingencies and Commitments (Future Purchase Obligations and Minimum Lease Payments) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails</Role>
      <ShortName>Contingencies and Commitments (Future Purchase Obligations and Minimum Lease Payments) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/ContingenciesandCommitmentsTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>0000056 - Disclosure - Goodwill and Other Intangible Assets (Goodwill) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets (Goodwill) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>0000057 - Disclosure - Goodwill and Other Intangible Assets (Summary of the Company's Other Intangible Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets (Summary of the Company's Other Intangible Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>0000058 - Disclosure - Goodwill and Other Intangible Assets (Estimated Amortization Expense) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsEstimatedAmortizationExpenseDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets (Estimated Amortization Expense) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>0000059 - Disclosure - Capital Stock (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/CapitalStockNarrativeDetails</Role>
      <ShortName>Capital Stock (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/CapitalStockTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>0000060 - Disclosure - Capital Stock (Option Grant Assumptions) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/CapitalStockOptionGrantAssumptionsDetails</Role>
      <ShortName>Capital Stock (Option Grant Assumptions) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/CapitalStockTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>0000061 - Disclosure - Capital Stock (Summary of Stock Option Activity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails</Role>
      <ShortName>Capital Stock (Summary of Stock Option Activity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/CapitalStockTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>0000062 - Disclosure - Capital Stock (Summary of RSU and PSU Activity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails</Role>
      <ShortName>Capital Stock (Summary of RSU and PSU Activity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/CapitalStockTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>0000063 - Disclosure - Debt and Credit Facilities (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails</Role>
      <ShortName>Debt and Credit Facilities (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/DebtandCreditFacilitiesTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>0000064 - Disclosure - Debt and Credit Facilities (Maturities Of Long-Term Debt Disclosures) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails</Role>
      <ShortName>Debt and Credit Facilities (Maturities Of Long-Term Debt Disclosures) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/DebtandCreditFacilitiesTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>0000065 - Disclosure - Income Taxes (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/IncomeTaxesTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>0000066 - Disclosure - Income Taxes (Schedule of Reconciliation of U.S. Statutory Income Tax Rate to Company's Effective Income Tax Rate from Continuing Operations) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails</Role>
      <ShortName>Income Taxes (Schedule of Reconciliation of U.S. Statutory Income Tax Rate to Company's Effective Income Tax Rate from Continuing Operations) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/IncomeTaxesTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>0000067 - Disclosure - Income Taxes (Schedule of Earnings before Income Taxes) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Schedule of Earnings before Income Taxes) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/IncomeTaxesTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>0000068 - Disclosure - Income Taxes (Schedule of Provision for Income Taxes) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Schedule of Provision for Income Taxes) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/IncomeTaxesTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>0000069 - Disclosure - Income Taxes (Schedule of Difference in Income Tax Effects Comprising Company's Deferred Income Tax Assets and Liabilities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails</Role>
      <ShortName>Income Taxes (Schedule of Difference in Income Tax Effects Comprising Company's Deferred Income Tax Assets and Liabilities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/IncomeTaxesTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>0000070 - Disclosure - Income Taxes (Schedule of Unresolved Income Tax Positions) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/IncomeTaxesScheduleofUnresolvedIncomeTaxPositionsDetails</Role>
      <ShortName>Income Taxes (Schedule of Unresolved Income Tax Positions) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/IncomeTaxesTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>0000071 - Disclosure - Retirement Plans (Schedule of Defined Contribution Plan Disclosures) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/RetirementPlansScheduleofDefinedContributionPlanDisclosuresDetails</Role>
      <ShortName>Retirement Plans (Schedule of Defined Contribution Plan Disclosures) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/RetirementPlansTables</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>0000072 - Disclosure - Retirement Plans (Schedule of Funded Status and Components of the Amounts Recognized in the Consolidated Balance Sheets and in Accumulated Other Comprehensive Gain (Loss), Before the Effect of Income Taxes) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails</Role>
      <ShortName>Retirement Plans (Schedule of Funded Status and Components of the Amounts Recognized in the Consolidated Balance Sheets and in Accumulated Other Comprehensive Gain (Loss), Before the Effect of Income Taxes) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/RetirementPlansTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>0000073 - Disclosure - Retirement Plans (Schedule of Change in Benefit Obligations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/RetirementPlansScheduleofChangeinBenefitObligationsDetails</Role>
      <ShortName>Retirement Plans (Schedule of Change in Benefit Obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/RetirementPlansTables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>0000074 - Disclosure - Retirement Plans (Change in Plan Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/RetirementPlansChangeinPlanAssetsDetails</Role>
      <ShortName>Retirement Plans (Change in Plan Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/RetirementPlansTables</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>0000075 - Disclosure - Retirement Plans (Schedule of Target and Actual Allocation of Plan Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/RetirementPlansScheduleofTargetandActualAllocationofPlanAssetsDetails</Role>
      <ShortName>Retirement Plans (Schedule of Target and Actual Allocation of Plan Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/RetirementPlansTables</ParentRole>
      <Position>74</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>0000076 - Disclosure - Retirement Plans (Schedule of Valuation of the Company's Pension Plan Assets by Pricing Categories) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails</Role>
      <ShortName>Retirement Plans (Schedule of Valuation of the Company's Pension Plan Assets by Pricing Categories) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/RetirementPlansTables</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>0000077 - Disclosure - Retirement Plans (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/RetirementPlansNarrativeDetails</Role>
      <ShortName>Retirement Plans (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/RetirementPlansTables</ParentRole>
      <Position>76</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>0000078 - Disclosure - Retirement Plans (Expected Benefit Payments) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/RetirementPlansExpectedBenefitPaymentsDetails</Role>
      <ShortName>Retirement Plans (Expected Benefit Payments) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/RetirementPlansTables</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>0000079 - Disclosure - Summary of Quarterly Data (Unaudited) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/SummaryofQuarterlyDataUnauditedDetails</Role>
      <ShortName>Summary of Quarterly Data (Unaudited) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/SummaryofQuarterlyDataUnauditedTables</ParentRole>
      <Position>78</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>0000080 - Disclosure - Segment and Geographic Data (Sales And Other Financial Information By Business Segment) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails</Role>
      <ShortName>Segment and Geographic Data (Sales And Other Financial Information By Business Segment) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/SegmentandGeographicDataTables</ParentRole>
      <Position>79</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>0000081 - Disclosure - Segment and Geographic Data (Segment Information) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/SegmentandGeographicDataSegmentInformationDetails</Role>
      <ShortName>Segment and Geographic Data (Segment Information) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/SegmentandGeographicDataTables</ParentRole>
      <Position>80</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>0000082 - Disclosure - Segment and Geographic Data (Geographic Information on Net Sales and Long-Lived Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails</Role>
      <ShortName>Segment and Geographic Data (Geographic Information on Net Sales and Long-Lived Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/SegmentandGeographicDataTables</ParentRole>
      <Position>81</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>0000083 - Disclosure - Asset Impairments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/AssetImpairmentsDetails</Role>
      <ShortName>Asset Impairments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/AssetImpairments</ParentRole>
      <Position>82</Position>
    </Report>
    <Report instance="syk-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>0000084 - Disclosure - Schedule II Valuation and Qualifying Accounts (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/ScheduleIIValuationandQualifyingAccountsDetails</Role>
      <ShortName>Schedule II Valuation and Qualifying Accounts (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 5 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount, us-gaap:FiniteLivedIntangibleAssetUsefulLife, us-gaap:PropertyPlantAndEquipmentUsefulLife -  syk-20221231.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-K" original="syk-20221231.htm">syk-20221231.htm</File>
    <File>ex10i2023nqstockoptionawar.htm</File>
    <File>ex10ii2023rsuawardletteran.htm</File>
    <File>ex10iii2023psuawardlettera.htm</File>
    <File>ex21i1231202210k.htm</File>
    <File>ex23i1231202210k.htm</File>
    <File>ex31i1231202210k.htm</File>
    <File>ex31ii1231202210k.htm</File>
    <File>ex32i1231202210k.htm</File>
    <File>ex32ii1231202210k.htm</File>
    <File>ex3iiamendedbylaws-nov2022.htm</File>
    <File>ex4xx1231202210k.htm</File>
    <File>syk-20221231.xsd</File>
    <File>syk-20221231_cal.xml</File>
    <File>syk-20221231_def.xml</File>
    <File>syk-20221231_lab.xml</File>
    <File>syk-20221231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>syk-20221231_g1.jpg</File>
    <File>syk-20221231_g2.jpg</File>
    <File>syk-20221231_g3.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1">http://fasb.org/srt/2022</BaseTaxonomy>
    <BaseTaxonomy items="1473">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="56">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>117
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "syk-20221231.htm": {
   "axisCustom": 0,
   "axisStandard": 31,
   "baseTaxonomies": {
    "http://fasb.org/srt/2022": 1,
    "http://fasb.org/us-gaap/2022": 1473,
    "http://xbrl.sec.gov/dei/2022": 56
   },
   "contextCount": 500,
   "dts": {
    "calculationLink": {
     "local": [
      "syk-20221231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "syk-20221231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "syk-20221231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "syk-20221231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "syk-20221231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "syk-20221231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 755,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 11,
    "http://xbrl.sec.gov/dei/2022": 4,
    "total": 15
   },
   "keyCustom": 31,
   "keyStandard": 446,
   "memberCustom": 49,
   "memberStandard": 66,
   "nsprefix": "syk",
   "nsuri": "http://www.stryker.com/20221231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - COVER PAGE",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.stryker.com/role/COVERPAGE",
     "shortName": "COVER PAGE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - Significant Accounting Policies",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.stryker.com/role/SignificantAccountingPolicies",
     "shortName": "Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - Revenue Recognition",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.stryker.com/role/RevenueRecognition",
     "shortName": "Revenue Recognition",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - Fair Value Measurements",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.stryker.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - Derivative Instruments",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.stryker.com/role/DerivativeInstruments",
     "shortName": "Derivative Instruments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - Accumulated Other Comprehensive (Loss) Income (AOCI)",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCI",
     "shortName": "Accumulated Other Comprehensive (Loss) Income (AOCI)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - Acquisitions",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.stryker.com/role/Acquisitions",
     "shortName": "Acquisitions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - Contingencies and Commitments",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.stryker.com/role/ContingenciesandCommitments",
     "shortName": "Contingencies and Commitments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - Goodwill and Other Intangible Assets",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.stryker.com/role/GoodwillandOtherIntangibleAssets",
     "shortName": "Goodwill and Other Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - Capital Stock",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://www.stryker.com/role/CapitalStock",
     "shortName": "Capital Stock",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - Debt and Credit Facilities",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://www.stryker.com/role/DebtandCreditFacilities",
     "shortName": "Debt and Credit Facilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorFirmId",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "false",
     "longName": "0000002 - Document - Audit Information",
     "menuCat": "Cover",
     "order": "2",
     "role": "http://www.stryker.com/role/AuditInformation",
     "shortName": "Audit Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorFirmId",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - Income Taxes",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://www.stryker.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - Retirement Plans",
     "menuCat": "Notes",
     "order": "21",
     "role": "http://www.stryker.com/role/RetirementPlans",
     "shortName": "Retirement Plans",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:QuarterlyFinancialInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - Summary of Quarterly Data (Unaudited)",
     "menuCat": "Notes",
     "order": "22",
     "role": "http://www.stryker.com/role/SummaryofQuarterlyDataUnaudited",
     "shortName": "Summary of Quarterly Data (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:QuarterlyFinancialInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - Segment and Geographic Data",
     "menuCat": "Notes",
     "order": "23",
     "role": "http://www.stryker.com/role/SegmentandGeographicData",
     "shortName": "Segment and Geographic Data",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetImpairmentChargesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - Asset Impairments",
     "menuCat": "Notes",
     "order": "24",
     "role": "http://www.stryker.com/role/AssetImpairments",
     "shortName": "Asset Impairments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetImpairmentChargesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - Significant Accounting Policies (Policies)",
     "menuCat": "Policies",
     "order": "25",
     "role": "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies",
     "shortName": "Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - Revenue Recognition (Tables)",
     "menuCat": "Tables",
     "order": "26",
     "role": "http://www.stryker.com/role/RevenueRecognitionTables",
     "shortName": "Revenue Recognition (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - Fair Value Measurements (Tables)",
     "menuCat": "Tables",
     "order": "27",
     "role": "http://www.stryker.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - Derivative Instruments (Tables)",
     "menuCat": "Tables",
     "order": "28",
     "role": "http://www.stryker.com/role/DerivativeInstrumentsTables",
     "shortName": "Derivative Instruments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - Accumulated Other Comprehensive (Loss) Income (AOCI) (Tables)",
     "menuCat": "Tables",
     "order": "29",
     "role": "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCITables",
     "shortName": "Accumulated Other Comprehensive (Loss) Income (AOCI) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - Consolidated Statements Of Earnings",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings",
     "shortName": "Consolidated Statements Of Earnings",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - Acquisitions (Tables)",
     "menuCat": "Tables",
     "order": "30",
     "role": "http://www.stryker.com/role/AcquisitionsTables",
     "shortName": "Acquisitions (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - Contingencies and Commitments (Tables)",
     "menuCat": "Tables",
     "order": "31",
     "role": "http://www.stryker.com/role/ContingenciesandCommitmentsTables",
     "shortName": "Contingencies and Commitments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - Goodwill and Other Intangible Assets (Tables)",
     "menuCat": "Tables",
     "order": "32",
     "role": "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsTables",
     "shortName": "Goodwill and Other Intangible Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - Capital Stock (Tables)",
     "menuCat": "Tables",
     "order": "33",
     "role": "http://www.stryker.com/role/CapitalStockTables",
     "shortName": "Capital Stock (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - Debt and Credit Facilities (Tables)",
     "menuCat": "Tables",
     "order": "34",
     "role": "http://www.stryker.com/role/DebtandCreditFacilitiesTables",
     "shortName": "Debt and Credit Facilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - Income Taxes (Tables)",
     "menuCat": "Tables",
     "order": "35",
     "role": "http://www.stryker.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - Retirement Plans (Tables)",
     "menuCat": "Tables",
     "order": "36",
     "role": "http://www.stryker.com/role/RetirementPlansTables",
     "shortName": "Retirement Plans (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - Summary of Quarterly Data (Unaudited) (Tables)",
     "menuCat": "Tables",
     "order": "37",
     "role": "http://www.stryker.com/role/SummaryofQuarterlyDataUnauditedTables",
     "shortName": "Summary of Quarterly Data (Unaudited) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - Segment and Geographic Data (Tables)",
     "menuCat": "Tables",
     "order": "38",
     "role": "http://www.stryker.com/role/SegmentandGeographicDataTables",
     "shortName": "Segment and Geographic Data (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeTermOfContract",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - Significant Accounting Policies (Details)",
     "menuCat": "Details",
     "order": "39",
     "role": "http://www.stryker.com/role/SignificantAccountingPoliciesDetails",
     "shortName": "Significant Accounting Policies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeTermOfContract",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - Consolidated Statements Of Earnings (Parenthetical)",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.stryker.com/role/ConsolidatedStatementsOfEarningsParenthetical",
     "shortName": "Consolidated Statements Of Earnings (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "syk:PercentageofServiceRevenueRecognizeoverTime",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - Revenue Recognition - Narrative (Details)",
     "menuCat": "Details",
     "order": "40",
     "role": "http://www.stryker.com/role/RevenueRecognitionNarrativeDetails",
     "shortName": "Revenue Recognition - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "syk:PercentageofServiceRevenueRecognizeoverTime",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i05c365347626469281b193639de4b1a1_D20221001-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - Revenue Recognition - Disaggregated Sales Analysis (Details)",
     "menuCat": "Details",
     "order": "41",
     "role": "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails",
     "shortName": "Revenue Recognition - Disaggregated Sales Analysis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "iaab182c6b3bb44d086bbe15590d6e157_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i6a8dd02eebae4ec58f362588b7ee80e9_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - Revenue Recognition - Changes in Contract Liabilities (Details)",
     "menuCat": "Details",
     "order": "42",
     "role": "http://www.stryker.com/role/RevenueRecognitionChangesinContractLiabilitiesDetails",
     "shortName": "Revenue Recognition - Changes in Contract Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiabilityRevenueRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i6192daadf4b64fcd96cda7971eb2051f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - Fair Value Measurements (Valuation Of Financial Instruments By Pricing Categories) (Details)",
     "menuCat": "Details",
     "order": "43",
     "role": "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails",
     "shortName": "Fair Value Measurements (Valuation Of Financial Instruments By Pricing Categories) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i6192daadf4b64fcd96cda7971eb2051f_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i6192daadf4b64fcd96cda7971eb2051f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - Fair Value Measurements (Available-For-Sale Securities) (Details)",
     "menuCat": "Details",
     "order": "44",
     "role": "http://www.stryker.com/role/FairValueMeasurementsAvailableForSaleSecuritiesDetails",
     "shortName": "Fair Value Measurements (Available-For-Sale Securities) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i6192daadf4b64fcd96cda7971eb2051f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MarketableSecuritiesGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - Fair Value Measurements (Narrative) (Details)",
     "menuCat": "Details",
     "order": "45",
     "role": "http://www.stryker.com/role/FairValueMeasurementsNarrativeDetails",
     "shortName": "Fair Value Measurements (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MarketableSecuritiesGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i5f5265baf4a34824aa6bfc4b935f0cc6_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - Derivative Instruments (Forward Currency Exchange Contracts) (Details)",
     "menuCat": "Details",
     "order": "46",
     "role": "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails",
     "shortName": "Derivative Instruments (Forward Currency Exchange Contracts) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i18c253d682754db68c1f963844f236c0_D20220101-20221231",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:MaximumRemainingMaturityOfForeignCurrencyDerivatives1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromHedgeInvestingActivities",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - Derivative Instruments (Narrative) (Details)",
     "menuCat": "Details",
     "order": "47",
     "role": "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails",
     "shortName": "Derivative Instruments (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "icd05c426dad44fd5b836e9f3d2fa90e5_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i18c253d682754db68c1f963844f236c0_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ForeignCurrencyTransactionGainLossBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000049 - Disclosure - Derivative Instruments (Movements out of OCI) (Details)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails",
     "shortName": "Derivative Instruments (Movements out of OCI) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i18c253d682754db68c1f963844f236c0_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ForeignCurrencyTransactionGainLossBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i6a8dd02eebae4ec58f362588b7ee80e9_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000050 - Disclosure - Accumulated Other Comprehensive (Loss) Income (AOCI) (Schedule of Amounts Recognized in Other Comprehensive Income (Loss)) (Details)",
     "menuCat": "Details",
     "order": "49",
     "role": "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails",
     "shortName": "Accumulated Other Comprehensive (Loss) Income (AOCI) (Schedule of Amounts Recognized in Other Comprehensive Income (Loss)) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - Consolidated Statements of Comprehensive Income",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome",
     "shortName": "Consolidated Statements of Comprehensive Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000051 - Disclosure - Acquisitions (Narrative) (Details)",
     "menuCat": "Details",
     "order": "50",
     "role": "http://www.stryker.com/role/AcquisitionsNarrativeDetails",
     "shortName": "Acquisitions (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i6192daadf4b64fcd96cda7971eb2051f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000052 - Disclosure - Acquisitions (Allocation Of The Preliminary Purchase Price To The Acquired Net Assets Of Acquisitions) (Details)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails",
     "shortName": "Acquisitions (Allocation Of The Preliminary Purchase Price To The Acquired Net Assets Of Acquisitions) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i0e2ff09ffaf04bd7b9e7b8d473abbcb6_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "syk:Changeinaccrualforrecallexpenses",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000053 - Disclosure - Contingencies and Commitments (Narrative) (Details)",
     "menuCat": "Details",
     "order": "52",
     "role": "http://www.stryker.com/role/ContingenciesandCommitmentsNarrativeDetails",
     "shortName": "Contingencies and Commitments (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i6192daadf4b64fcd96cda7971eb2051f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000054 - Disclosure - Commitments and Contingencies (Lease Cost) (Details)",
     "menuCat": "Details",
     "order": "53",
     "role": "http://www.stryker.com/role/CommitmentsandContingenciesLeaseCostDetails",
     "shortName": "Commitments and Contingencies (Lease Cost) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i6192daadf4b64fcd96cda7971eb2051f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i6192daadf4b64fcd96cda7971eb2051f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000055 - Disclosure - Contingencies and Commitments (Future Purchase Obligations and Minimum Lease Payments) (Details)",
     "menuCat": "Details",
     "order": "54",
     "role": "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails",
     "shortName": "Contingencies and Commitments (Future Purchase Obligations and Minimum Lease Payments) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i6192daadf4b64fcd96cda7971eb2051f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i6192daadf4b64fcd96cda7971eb2051f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000056 - Disclosure - Goodwill and Other Intangible Assets (Goodwill) (Details)",
     "menuCat": "Details",
     "order": "55",
     "role": "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails",
     "shortName": "Goodwill and Other Intangible Assets (Goodwill) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillImpairmentLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000057 - Disclosure - Goodwill and Other Intangible Assets (Summary of the Company's Other Intangible Assets) (Details)",
     "menuCat": "Details",
     "order": "56",
     "role": "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails",
     "shortName": "Goodwill and Other Intangible Assets (Summary of the Company's Other Intangible Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i6192daadf4b64fcd96cda7971eb2051f_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i6192daadf4b64fcd96cda7971eb2051f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000058 - Disclosure - Goodwill and Other Intangible Assets (Estimated Amortization Expense) (Details)",
     "menuCat": "Details",
     "order": "57",
     "role": "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsEstimatedAmortizationExpenseDetails",
     "shortName": "Goodwill and Other Intangible Assets (Estimated Amortization Expense) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i6192daadf4b64fcd96cda7971eb2051f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "syk:CommonAndPreferredStockSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000059 - Disclosure - Capital Stock (Narrative) (Details)",
     "menuCat": "Details",
     "order": "58",
     "role": "http://www.stryker.com/role/CapitalStockNarrativeDetails",
     "shortName": "Capital Stock (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "syk:CommonAndPreferredStockSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000060 - Disclosure - Capital Stock (Option Grant Assumptions) (Details)",
     "menuCat": "Details",
     "order": "59",
     "role": "http://www.stryker.com/role/CapitalStockOptionGrantAssumptionsDetails",
     "shortName": "Capital Stock (Option Grant Assumptions) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i6192daadf4b64fcd96cda7971eb2051f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - Consolidated Balance Sheets",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.stryker.com/role/ConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i6192daadf4b64fcd96cda7971eb2051f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i6a8dd02eebae4ec58f362588b7ee80e9_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000061 - Disclosure - Capital Stock (Summary of Stock Option Activity) (Details)",
     "menuCat": "Details",
     "order": "60",
     "role": "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails",
     "shortName": "Capital Stock (Summary of Stock Option Activity) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i6a8dd02eebae4ec58f362588b7ee80e9_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i568e131aeee143118e9dfb0c69d84d35_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000062 - Disclosure - Capital Stock (Summary of RSU and PSU Activity) (Details)",
     "menuCat": "Details",
     "order": "61",
     "role": "http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails",
     "shortName": "Capital Stock (Summary of RSU and PSU Activity) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "icb6424572e1a40e48c885f2c92dfe789_D20220101-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i6192daadf4b64fcd96cda7971eb2051f_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommercialPaper",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000063 - Disclosure - Debt and Credit Facilities (Narrative) (Details)",
     "menuCat": "Details",
     "order": "62",
     "role": "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails",
     "shortName": "Debt and Credit Facilities (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i6192daadf4b64fcd96cda7971eb2051f_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommercialPaper",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i6192daadf4b64fcd96cda7971eb2051f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000064 - Disclosure - Debt and Credit Facilities (Maturities Of Long-Term Debt Disclosures) (Details)",
     "menuCat": "Details",
     "order": "63",
     "role": "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails",
     "shortName": "Debt and Credit Facilities (Maturities Of Long-Term Debt Disclosures) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i6192daadf4b64fcd96cda7971eb2051f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000065 - Disclosure - Income Taxes (Narrative) (Details)",
     "menuCat": "Details",
     "order": "64",
     "role": "http://www.stryker.com/role/IncomeTaxesNarrativeDetails",
     "shortName": "Income Taxes (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000066 - Disclosure - Income Taxes (Schedule of Reconciliation of U.S. Statutory Income Tax Rate to Company's Effective Income Tax Rate from Continuing Operations) (Details)",
     "menuCat": "Details",
     "order": "65",
     "role": "http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails",
     "shortName": "Income Taxes (Schedule of Reconciliation of U.S. Statutory Income Tax Rate to Company's Effective Income Tax Rate from Continuing Operations) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000067 - Disclosure - Income Taxes (Schedule of Earnings before Income Taxes) (Details)",
     "menuCat": "Details",
     "order": "66",
     "role": "http://www.stryker.com/role/IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetails",
     "shortName": "Income Taxes (Schedule of Earnings before Income Taxes) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000068 - Disclosure - Income Taxes (Schedule of Provision for Income Taxes) (Details)",
     "menuCat": "Details",
     "order": "67",
     "role": "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails",
     "shortName": "Income Taxes (Schedule of Provision for Income Taxes) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i6192daadf4b64fcd96cda7971eb2051f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsInventory",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000069 - Disclosure - Income Taxes (Schedule of Difference in Income Tax Effects Comprising Company's Deferred Income Tax Assets and Liabilities) (Details)",
     "menuCat": "Details",
     "order": "68",
     "role": "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails",
     "shortName": "Income Taxes (Schedule of Difference in Income Tax Effects Comprising Company's Deferred Income Tax Assets and Liabilities) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i6192daadf4b64fcd96cda7971eb2051f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsInventory",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i6a8dd02eebae4ec58f362588b7ee80e9_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000070 - Disclosure - Income Taxes (Schedule of Unresolved Income Tax Positions) (Details)",
     "menuCat": "Details",
     "order": "69",
     "role": "http://www.stryker.com/role/IncomeTaxesScheduleofUnresolvedIncomeTaxPositionsDetails",
     "shortName": "Income Taxes (Schedule of Unresolved Income Tax Positions) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i98963cf23d234ec1ac275e66bcfd76dc_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i6192daadf4b64fcd96cda7971eb2051f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - Consolidated Balance Sheets (Parentheticals)",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://www.stryker.com/role/ConsolidatedBalanceSheetsParentheticals",
     "shortName": "Consolidated Balance Sheets (Parentheticals)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i6192daadf4b64fcd96cda7971eb2051f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:DefinedContributionPlanDisclosuresTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanCostRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000071 - Disclosure - Retirement Plans (Schedule of Defined Contribution Plan Disclosures) (Details)",
     "menuCat": "Details",
     "order": "70",
     "role": "http://www.stryker.com/role/RetirementPlansScheduleofDefinedContributionPlanDisclosuresDetails",
     "shortName": "Retirement Plans (Schedule of Defined Contribution Plan Disclosures) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:DefinedContributionPlanDisclosuresTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanCostRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanServiceCost",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000072 - Disclosure - Retirement Plans (Schedule of Funded Status and Components of the Amounts Recognized in the Consolidated Balance Sheets and in Accumulated Other Comprehensive Gain (Loss), Before the Effect of Income Taxes) (Details)",
     "menuCat": "Details",
     "order": "71",
     "role": "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails",
     "shortName": "Retirement Plans (Schedule of Funded Status and Components of the Amounts Recognized in the Consolidated Balance Sheets and in Accumulated Other Comprehensive Gain (Loss), Before the Effect of Income Taxes) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCostsOfRetirementPlansTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i6a8dd02eebae4ec58f362588b7ee80e9_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanBenefitObligation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000073 - Disclosure - Retirement Plans (Schedule of Change in Benefit Obligations (Details)",
     "menuCat": "Details",
     "order": "72",
     "role": "http://www.stryker.com/role/RetirementPlansScheduleofChangeinBenefitObligationsDetails",
     "shortName": "Retirement Plans (Schedule of Change in Benefit Obligations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i6a8dd02eebae4ec58f362588b7ee80e9_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000074 - Disclosure - Retirement Plans (Change in Plan Assets) (Details)",
     "menuCat": "Details",
     "order": "73",
     "role": "http://www.stryker.com/role/RetirementPlansChangeinPlanAssetsDetails",
     "shortName": "Retirement Plans (Change in Plan Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i98963cf23d234ec1ac275e66bcfd76dc_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i6192daadf4b64fcd96cda7971eb2051f_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000075 - Disclosure - Retirement Plans (Schedule of Target and Actual Allocation of Plan Assets) (Details)",
     "menuCat": "Details",
     "order": "74",
     "role": "http://www.stryker.com/role/RetirementPlansScheduleofTargetandActualAllocationofPlanAssetsDetails",
     "shortName": "Retirement Plans (Schedule of Target and Actual Allocation of Plan Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i6192daadf4b64fcd96cda7971eb2051f_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i6192daadf4b64fcd96cda7971eb2051f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000076 - Disclosure - Retirement Plans (Schedule of Valuation of the Company's Pension Plan Assets by Pricing Categories) (Details)",
     "menuCat": "Details",
     "order": "75",
     "role": "http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails",
     "shortName": "Retirement Plans (Schedule of Valuation of the Company's Pension Plan Assets by Pricing Categories) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "ia2d532877fe14293a0c7af8376dd383a_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000077 - Disclosure - Retirement Plans (Narrative) (Details)",
     "menuCat": "Details",
     "order": "76",
     "role": "http://www.stryker.com/role/RetirementPlansNarrativeDetails",
     "shortName": "Retirement Plans (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i555016f434ae4cd48b50f24fbe1586b3_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i6192daadf4b64fcd96cda7971eb2051f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000078 - Disclosure - Retirement Plans (Expected Benefit Payments) (Details)",
     "menuCat": "Details",
     "order": "77",
     "role": "http://www.stryker.com/role/RetirementPlansExpectedBenefitPaymentsDetails",
     "shortName": "Retirement Plans (Expected Benefit Payments) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i6192daadf4b64fcd96cda7971eb2051f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i05c365347626469281b193639de4b1a1_D20221001-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000079 - Disclosure - Summary of Quarterly Data (Unaudited) (Details)",
     "menuCat": "Details",
     "order": "78",
     "role": "http://www.stryker.com/role/SummaryofQuarterlyDataUnauditedDetails",
     "shortName": "Summary of Quarterly Data (Unaudited) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i05c365347626469281b193639de4b1a1_D20221001-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GrossProfit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000080 - Disclosure - Segment and Geographic Data (Sales And Other Financial Information By Business Segment) (Details)",
     "menuCat": "Details",
     "order": "79",
     "role": "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails",
     "shortName": "Segment and Geographic Data (Sales And Other Financial Information By Business Segment) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i576cd39821c64afe9e29c4e4b0a645cc_I20191231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000008 - Statement - Consolidated Statements Of Shareholders' Equity",
     "menuCat": "Statements",
     "order": "8",
     "role": "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity",
     "shortName": "Consolidated Statements Of Shareholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i576cd39821c64afe9e29c4e4b0a645cc_I20191231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i6192daadf4b64fcd96cda7971eb2051f_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000081 - Disclosure - Segment and Geographic Data (Segment Information) (Details)",
     "menuCat": "Details",
     "order": "80",
     "role": "http://www.stryker.com/role/SegmentandGeographicDataSegmentInformationDetails",
     "shortName": "Segment and Geographic Data (Segment Information) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i98963cf23d234ec1ac275e66bcfd76dc_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i05c365347626469281b193639de4b1a1_D20221001-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000082 - Disclosure - Segment and Geographic Data (Geographic Information on Net Sales and Long-Lived Assets) (Details)",
     "menuCat": "Details",
     "order": "81",
     "role": "http://www.stryker.com/role/SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails",
     "shortName": "Segment and Geographic Data (Geographic Information on Net Sales and Long-Lived Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "if2968c9c4a80487baea572af89e9b685_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "id9dcd044683643db85814ccb7429b46b_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetImpairmentCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000083 - Disclosure - Asset Impairments (Details)",
     "menuCat": "Details",
     "order": "82",
     "role": "http://www.stryker.com/role/AssetImpairmentsDetails",
     "shortName": "Asset Impairments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "id9dcd044683643db85814ccb7429b46b_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetImpairmentCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i0a67a3c2c8da44f8b02b124c5c7e4f00_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000084 - Disclosure - Schedule II Valuation and Qualifying Accounts (Details)",
     "menuCat": "Details",
     "order": "83",
     "role": "http://www.stryker.com/role/ScheduleIIValuationandQualifyingAccountsDetails",
     "shortName": "Schedule II Valuation and Qualifying Accounts (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "ia3f2576e657245638084e8d8a7407dfb_I20191231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000009 - Statement - Consolidated Statements Of Cash Flows",
     "menuCat": "Statements",
     "order": "9",
     "role": "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows",
     "shortName": "Consolidated Statements Of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20221231.htm",
      "contextRef": "i767af96f95ca4aee85700946429afb87_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 119,
   "tag": {
    "country_CN": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CHINA",
        "terseLabel": "CHINA"
       }
      }
     },
     "localname": "CN",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.stryker.com/role/AssetImpairmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States",
        "verboseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r835",
      "r836",
      "r837"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.stryker.com/role/AuditInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r835",
      "r836",
      "r837"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.stryker.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r835",
      "r836",
      "r837"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.stryker.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r835",
      "r836",
      "r837"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r838"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r832"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance",
        "label": "Entities [Table]",
        "terseLabel": "Entities [Table]"
       }
      }
     },
     "localname": "EntitiesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r831"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r831"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r831"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Information [Line Items]",
        "terseLabel": "Entity Information [Line Items]"
       }
      }
     },
     "localname": "EntityInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r839"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r831"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r831"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r831"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r831"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r840"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r835",
      "r836",
      "r837"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r830"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r834"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security",
        "terseLabel": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r833"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_AsiaPacificMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region of Asia Pacific.",
        "label": "Asia Pacific [Member]",
        "terseLabel": "Asia Pacific"
       }
      }
     },
     "localname": "AsiaPacificMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r303",
      "r349",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r367",
      "r371",
      "r435",
      "r436",
      "r437",
      "r438",
      "r440",
      "r441",
      "r443",
      "r445",
      "r446",
      "r774",
      "r775",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780",
      "r781",
      "r782",
      "r901",
      "r902",
      "r955",
      "r956"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataSegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r303",
      "r349",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r367",
      "r371",
      "r435",
      "r436",
      "r437",
      "r438",
      "r440",
      "r441",
      "r443",
      "r445",
      "r446",
      "r774",
      "r775",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780",
      "r781",
      "r782",
      "r901",
      "r902",
      "r955",
      "r956"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock": {
     "auth_ref": [
      "r954"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of contractual obligation by timing of payment due. Includes, but is not limited to, long-term debt obligation, lease obligation, and purchase obligation.",
        "label": "Contractual Obligation, Fiscal Year Maturity [Table Text Block]",
        "terseLabel": "Future Purchase Obligations and Minimum Lease Payments"
       }
      }
     },
     "localname": "ContractualObligationFiscalYearMaturityScheduleTableTextBlock",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of judicial proceeding, alternative dispute resolution or claim.",
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Judicial proceeding, alternative dispute resolution or claim. For example, but not limited to, name of case, category of litigation, or other differentiating information.",
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r430",
      "r431",
      "r432",
      "r433",
      "r572",
      "r721",
      "r738",
      "r760",
      "r761",
      "r806",
      "r821",
      "r829",
      "r903",
      "r936",
      "r937",
      "r938",
      "r939",
      "r940",
      "r941"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upper limit of the provided range.",
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsNarrativeDetails",
      "http://www.stryker.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r430",
      "r431",
      "r432",
      "r433",
      "r572",
      "r721",
      "r738",
      "r760",
      "r761",
      "r806",
      "r821",
      "r829",
      "r903",
      "r936",
      "r937",
      "r938",
      "r939",
      "r940",
      "r941"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lower limit of the provided range.",
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsNarrativeDetails",
      "http://www.stryker.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r373",
      "r723",
      "r808",
      "r827",
      "r898",
      "r899",
      "r906",
      "r944"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by product and service, or group of similar products and similar services.",
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r373",
      "r723",
      "r808",
      "r827",
      "r898",
      "r899",
      "r906",
      "r944"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product or service, or a group of similar products or similar services.",
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r430",
      "r431",
      "r432",
      "r433",
      "r528",
      "r572",
      "r600",
      "r601",
      "r602",
      "r697",
      "r721",
      "r738",
      "r760",
      "r761",
      "r806",
      "r821",
      "r829",
      "r893",
      "r903",
      "r937",
      "r938",
      "r939",
      "r940",
      "r941"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Range [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsNarrativeDetails",
      "http://www.stryker.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r430",
      "r431",
      "r432",
      "r433",
      "r528",
      "r572",
      "r600",
      "r601",
      "r602",
      "r697",
      "r721",
      "r738",
      "r760",
      "r761",
      "r806",
      "r821",
      "r829",
      "r893",
      "r903",
      "r937",
      "r938",
      "r939",
      "r940",
      "r941"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Range [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsNarrativeDetails",
      "http://www.stryker.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r374",
      "r375",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759",
      "r763",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r809",
      "r828",
      "r906"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Geographical area.",
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.stryker.com/role/AssetImpairmentsDetails",
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r374",
      "r375",
      "r746",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759",
      "r763",
      "r764",
      "r809",
      "r828",
      "r906"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by geographical components.",
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.stryker.com/role/AssetImpairmentsDetails",
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsAbstract",
     "nsuri": "http://fasb.org/srt/2022",
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureLineItems",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.stryker.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureTable": {
     "auth_ref": [
      "r304",
      "r305",
      "r306",
      "r308",
      "r309",
      "r773"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureTable",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.stryker.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "syk_A050ConvertibleNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "0.50% Convertible Notes",
        "label": "0.50% Convertible Notes [Member]",
        "terseLabel": "0.50% Convertible Notes"
       }
      }
     },
     "localname": "A050ConvertibleNotesMember",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_A150ConvertibleNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.50% Convertible Notes",
        "label": "1.50% Convertible Notes [Member]",
        "terseLabel": "1.50% Convertible Notes"
       }
      }
     },
     "localname": "A150ConvertibleNotesMember",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_AccruedCompensationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Compensation",
        "label": "Accrued Compensation [Member]",
        "terseLabel": "Accrued Compensation"
       }
      }
     },
     "localname": "AccruedCompensationMember",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_AssetImpairmentsOtherThanGoodwillImpairment": {
     "auth_ref": [],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Impairments, Other Than Goodwill Impairment",
        "label": "Asset Impairments, Other Than Goodwill Impairment",
        "terseLabel": "Asset impairments"
       }
      }
     },
     "localname": "AssetImpairmentsOtherThanGoodwillImpairment",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "syk_AuditorInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Auditor Information",
        "label": "Auditor Information [Abstract]"
       }
      }
     },
     "localname": "AuditorInformationAbstract",
     "nsuri": "http://www.stryker.com/20221231",
     "xbrltype": "stringItemType"
    },
    "syk_AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the fair value of debt securities which are expected to mature after one through three years of the balance sheet date and which are categorized neither as held-to-maturity nor trading securities.",
        "label": "Available for sale Securities, Debt Maturities, After One Through Three Years, Fair Value",
        "verboseLabel": "Due after one year through three years"
       }
      }
     },
     "localname": "AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "syk_BusinessCombinationConsiderationTransferredIncludingConvertibleNotes": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Consideration Transferred, Including Convertible Notes",
        "label": "Business Combination, Consideration Transferred, Including Convertible Notes",
        "terseLabel": "Purchase price of acquisitions, including convertible notes"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredIncludingConvertibleNotes",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "syk_BusinessCombinationConsiderationTransferredPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Consideration Transferred, Price Per Share",
        "label": "Business Combination, Consideration Transferred, Price Per Share",
        "terseLabel": "Consideration transferred, price per share (in dollars per share)"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredPricePerShare",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt": {
     "auth_ref": [],
     "calculation": {
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Debt",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Debt",
        "negatedTerseLabel": "Debt"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "syk_CapitalExpendituresDuringPeriod": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capital Expenditures During Period",
        "label": "Capital Expenditures During Period",
        "terseLabel": "Capital Expenditures During Period"
       }
      }
     },
     "localname": "CapitalExpendituresDuringPeriod",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "syk_CapitalStockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capital Stock [Abstract]",
        "label": "Capital Stock [Abstract]",
        "terseLabel": "Capital Stock [Abstract]"
       }
      }
     },
     "localname": "CapitalStockAbstract",
     "nsuri": "http://www.stryker.com/20221231",
     "xbrltype": "stringItemType"
    },
    "syk_Changeinaccrualforrecallexpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in accrual for recall expenses",
        "label": "Change in accrual for recall expenses",
        "terseLabel": "Recall-related payments"
       }
      }
     },
     "localname": "Changeinaccrualforrecallexpenses",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows",
      "http://www.stryker.com/role/ContingenciesandCommitmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "syk_CommonAndPreferredStockSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common And Preferred Stock, Shares Authorized",
        "label": "Common And Preferred Stock, Shares Authorized",
        "terseLabel": "Common and Preferred Stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonAndPreferredStockSharesAuthorized",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "syk_ContractWithCustomerLiabilityNetAdvanceConsiderationReceivedDuringPeriod": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Liability, Net Advance Consideration Received During Period",
        "label": "Contract With Customer, Liability, Net Advance Consideration Received During Period",
        "terseLabel": "Net advance consideration received during the period"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityNetAdvanceConsiderationReceivedDuringPeriod",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionChangesinContractLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "syk_CreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Credit Agreement [Member]",
        "label": "Credit Agreement [Member]",
        "terseLabel": "Credit Agreement"
       }
      }
     },
     "localname": "CreditAgreementMember",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_CustomerAndDistributorRelationshipsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer and Distributor Relationships",
        "label": "Customer and Distributor Relationships [Member]",
        "terseLabel": "Customer and distributor relationships"
       }
      }
     },
     "localname": "CustomerAndDistributorRelationshipsMember",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_DeferredTaxAssetsDepreciationAndAmortization": {
     "auth_ref": [],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Depreciation And Amortization",
        "label": "Deferred Tax Assets, Depreciation And Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DeferredTaxAssetsDepreciationAndAmortization",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "syk_DeferredTaxAssetsResearchAndDevelopmentCapitalization": {
     "auth_ref": [],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Research And Development Capitalization",
        "label": "Deferred Tax Assets, Research And Development Capitalization",
        "terseLabel": "Research and development capitalization"
       }
      }
     },
     "localname": "DeferredTaxAssetsResearchAndDevelopmentCapitalization",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "syk_DeferredTaxLiabilitiesDepreciationAndAmortization": {
     "auth_ref": [],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Liabilities Depreciation And Amortization",
        "label": "Deferred Tax Liabilities Depreciation And Amortization",
        "negatedTerseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesDepreciationAndAmortization",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "syk_DefinedContributionRetirementPlansCommonStockHeldByCompany": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Contribution Retirement Plans Common Stock Held by Company",
        "label": "Defined Contribution Retirement Plans Common Stock Held by Company",
        "terseLabel": "Stryker common stock held by plan, shares"
       }
      }
     },
     "localname": "DefinedContributionRetirementPlansCommonStockHeldByCompany",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofDefinedContributionPlanDisclosuresDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "syk_DefinedContributionRetirementPlansCommonStockValueHeldByCompany": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Contribution Retirement Plans Common Stock Value Held by Company",
        "label": "Defined Contribution Retirement Plans Common Stock Value Held by Company",
        "terseLabel": "Stryker common stock held by plan, amount"
       }
      }
     },
     "localname": "DefinedContributionRetirementPlansCommonStockValueHeldByCompany",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofDefinedContributionPlanDisclosuresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent": {
     "auth_ref": [],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Foreign Earnings Repatriation, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Earnings Repatriation, Percent",
        "terseLabel": "Tax related to repatriation of foreign earnings"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent": {
     "auth_ref": [],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Transfer Of Intellectual Property, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Transfer Of Intellectual Property, Percent",
        "terseLabel": "Intellectual property transfers"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "syk_EndoscopyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Endoscopy [Member]",
        "label": "Endoscopy [Member]",
        "terseLabel": "Endoscopy"
       }
      }
     },
     "localname": "EndoscopyMember",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value, Liabilities Measured on Recurring Basis, Deferred Compensation Plan Liabilities",
        "label": "Fair Value Liabilities Measured On Recurring Basis Deferred Compensation Plan Liabilities",
        "verboseLabel": "Deferred compensation arrangements"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "syk_GaussMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gauss",
        "label": "Gauss [Member]",
        "terseLabel": "Gauss"
       }
      }
     },
     "localname": "GaussMember",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Goodwill and Long-Lived Assets Impairment Tests Policy [Policy Text Block]",
        "label": "Goodwill and Long-Lived Assets Impairment Tests Policy [Policy Text Block]",
        "terseLabel": "Goodwill, Intangibles and Long-Lived Asset Impairment Tests"
       }
      }
     },
     "localname": "GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "syk_HipsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hips [Member]",
        "label": "Hips [Member]",
        "terseLabel": "Hips"
       }
      }
     },
     "localname": "HipsMember",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_InProcessRDOtherIntangibleAssetsAndPropertyPlantAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In-Process R&amp;D, Other Intangible Assets and Property, Plant and Equipment",
        "label": "In-Process R&amp;D, Other Intangible Assets and Property, Plant and Equipment [Member]",
        "terseLabel": "In-Process R&amp;D, Other Intangible Assets and Property, Plant and Equipment"
       }
      }
     },
     "localname": "InProcessRDOtherIntangibleAssetsAndPropertyPlantAndEquipmentMember",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/AssetImpairmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_IncomeTaxExpenseBenefitTaxSettlementReleaseOfAccruedInterest": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax Expense (Benefit), Tax Settlement, Release Of Accrued Interest",
        "label": "Income Tax Expense (Benefit), Tax Settlement, Release Of Accrued Interest",
        "negatedTerseLabel": "Tax settlement, release of accrued interest"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefitTaxSettlementReleaseOfAccruedInterest",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income tax expense (benefit), Portion of Net Operating Loss Carryforward Recognized",
        "label": "Income tax expense (benefit), Portion of Net Operating Loss Carryforward Recognized",
        "terseLabel": "Net operating loss carryforward recognized"
       }
      }
     },
     "localname": "IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "syk_InstrumentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instruments [Member]",
        "label": "Instruments [Member]",
        "terseLabel": "Instruments"
       }
      }
     },
     "localname": "InstrumentsMember",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_KneesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Knees [Member]",
        "label": "Knees [Member]",
        "terseLabel": "Knees"
       }
      }
     },
     "localname": "KneesMember",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_LandBuildingsAndImprovementsGross": {
     "auth_ref": [],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Land, Buildings and Improvements, Gross",
        "label": "Land, Buildings and Improvements, Gross",
        "terseLabel": "Land, buildings and improvements"
       }
      }
     },
     "localname": "LandBuildingsAndImprovementsGross",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "syk_LongLivedAssetsAndIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-Lived Assets and Intangible Assets",
        "label": "Long-Lived Assets and Intangible Assets [Member]",
        "terseLabel": "Long-Lived Assets and Intangible Assets"
       }
      }
     },
     "localname": "LongLivedAssetsAndIntangibleAssetsMember",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/AssetImpairmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_MedSurgAndNeurotechnologyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "MedSurg and Neurotechnology",
        "label": "MedSurg and Neurotechnology [Member]",
        "terseLabel": "MedSurg and Neurotechnology"
       }
      }
     },
     "localname": "MedSurgAndNeurotechnologyMember",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails",
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_MedicalDeviceRegulationsExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical Device Regulations Expense",
        "label": "Medical Device Regulations Expense",
        "negatedTerseLabel": "Medical device regulations"
       }
      }
     },
     "localname": "MedicalDeviceRegulationsExpense",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "syk_MedicalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical [Member]",
        "label": "Medical [Member]",
        "terseLabel": "Medical"
       }
      }
     },
     "localname": "MedicalMember",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_MovementInContractLiabilitiesRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Movement In Contract Liabilities",
        "label": "Movement In Contract Liabilities [Roll Forward]",
        "terseLabel": "Movement In Contract Liabilities [Roll Forward]"
       }
      }
     },
     "localname": "MovementInContractLiabilitiesRollForward",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionChangesinContractLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "syk_NeuroCranialMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Neuro Cranial",
        "label": "Neuro Cranial [Member]",
        "terseLabel": "Neuro Cranial"
       }
      }
     },
     "localname": "NeuroCranialMember",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_NeurovascularMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Neurovascular",
        "label": "Neurovascular [Member]",
        "terseLabel": "Neurovascular"
       }
      }
     },
     "localname": "NeurovascularMember",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_OperatingLossCarryforwardsSubjectToValuationAllowance": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Loss Carryforwards, Subject to Valuation Allowance",
        "label": "Operating Loss Carryforwards, Subject to Valuation Allowance",
        "terseLabel": "Operating loss carryforwards, subject to full valuation allowance"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsSubjectToValuationAllowance",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "syk_OrthopaedicsAndSpineMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Orthopaedics and Spine",
        "label": "Orthopaedics and Spine [Member]",
        "terseLabel": "Orthopaedics and Spine"
       }
      }
     },
     "localname": "OrthopaedicsAndSpineMember",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails",
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_OtherForeignCountriesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other foreign countries [Member]",
        "label": "Other foreign countries [Member]",
        "terseLabel": "Other foreign countries"
       }
      }
     },
     "localname": "OtherForeignCountriesMember",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_OtherIncomeexpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Income (expense) [Member]",
        "label": "Other Income (expense) [Member]",
        "terseLabel": "Other income (expense), net",
        "verboseLabel": "Other (income) expense, net"
       }
      }
     },
     "localname": "OtherIncomeexpenseMember",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_OtherOrthopaedicsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Orthopaedics",
        "label": "Other Orthopaedics [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherOrthopaedicsMember",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of Closing Stock Price Represents Purchase Price Under ESPP",
        "label": "Percentage of Closing Stock Price Represents Purchase Price Under ESPP",
        "terseLabel": "Percentage of closing stock price under ESPP"
       }
      }
     },
     "localname": "PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "syk_PercentageofServiceRevenueRecognizeoverTime": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of Service Revenue Recognize over Time",
        "label": "Percentage of Service Revenue Recognize over Time",
        "terseLabel": "Percentage of sales recognized as services over time (less than)"
       }
      }
     },
     "localname": "PercentageofServiceRevenueRecognizeoverTime",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "syk_PerformanceStockUnitPsusMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance Stock Unit (PSUs) [Member]",
        "label": "Performance Stock Unit (PSUs) [Member]",
        "terseLabel": "Performance Stock Units (PSUs)",
        "verboseLabel": "Performance Stock Units (PSUs)"
       }
      }
     },
     "localname": "PerformanceStockUnitPsusMember",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails",
      "http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails",
      "http://www.stryker.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_PureWickMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PureWick",
        "label": "PureWick [Member]",
        "terseLabel": "PureWick"
       }
      }
     },
     "localname": "PureWickMember",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_RecallMattersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Recall Matters",
        "label": "Recall Matters [Member]",
        "terseLabel": "Recall Matters"
       }
      }
     },
     "localname": "RecallMattersMember",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reclassification Adjustments Out of Accumulated Other Comprehensive Income (AOCI) [Abstract]",
        "label": "Reclassification Adjustments Out of Accumulated Other Comprehensive Income (AOCI) [Abstract]",
        "terseLabel": "Reclassification Adjustments Out of Accumulated Other Comprehensive Income (AOCI) [Abstract]"
       }
      }
     },
     "localname": "ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract",
     "nsuri": "http://www.stryker.com/20221231",
     "xbrltype": "stringItemType"
    },
    "syk_RejuvenateABGIIHipRecallCharges": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rejuvenate / ABG II Hip Recall Charges",
        "label": "Rejuvenate / ABG II Hip Recall Charges",
        "negatedLabel": "Recall-related matters"
       }
      }
     },
     "localname": "RejuvenateABGIIHipRecallCharges",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "syk_SaleOfInventorySteppedUpToFairValueAtAcquisition": {
     "auth_ref": [],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of Inventory, Stepped-Up to Fair Value at Acquisition",
        "label": "Sale of Inventory, Stepped-Up to Fair Value at Acquisition",
        "terseLabel": "Sale of inventory stepped up to fair value at acquisition"
       }
      }
     },
     "localname": "SaleOfInventorySteppedUpToFairValueAtAcquisition",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "syk_SeniorUnsecuredNotes0.250due2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Notes 0.250% due 2024 [Member]",
        "label": "Senior Unsecured Notes 0.250% due 2024 [Member]",
        "terseLabel": "Senior Unsecured Notes 0.250% due 2024",
        "verboseLabel": "0.250% Notes due 2024"
       }
      }
     },
     "localname": "SeniorUnsecuredNotes0.250due2024Member",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE",
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_SeniorUnsecuredNotes0.750due2029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Notes 0.750% due 2029 [Member]",
        "label": "Senior Unsecured Notes 0.750% due 2029 [Member]",
        "terseLabel": "Senior Unsecured Notes 0.750% due 2029",
        "verboseLabel": "0.750% Notes due 2029"
       }
      }
     },
     "localname": "SeniorUnsecuredNotes0.750due2029Member",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE",
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_SeniorUnsecuredNotes0600Due2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Notes 0.600% due 2023",
        "label": "Senior Unsecured Notes 0.600% due 2023 [Member]",
        "terseLabel": "Senior Unsecured Notes 0.600% due 2023"
       }
      }
     },
     "localname": "SeniorUnsecuredNotes0600Due2023Member",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_SeniorUnsecuredNotes1.000due2031Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Notes 1.000% due 2031 [Member]",
        "label": "Senior Unsecured Notes 1.000% due 2031 [Member]",
        "terseLabel": "Senior Unsecured Notes 1.000% due 2031",
        "verboseLabel": "1.000% Notes due 2031"
       }
      }
     },
     "localname": "SeniorUnsecuredNotes1.000due2031Member",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE",
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_SeniorUnsecuredNotes1.125Due2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Notes, 1.125% Due 2023 [Member]",
        "label": "Senior Unsecured Notes, 1.125% Due 2023 [Member]",
        "terseLabel": "1.125% Notes due 2023"
       }
      }
     },
     "localname": "SeniorUnsecuredNotes1.125Due2023Member",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_SeniorUnsecuredNotes1.150Due2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Notes, 1.150% Due 2025 [Member]",
        "label": "Senior Unsecured Notes, 1.150% Due 2025 [Member]",
        "terseLabel": "Senior Unsecured Notes, 1.150% Due 2025"
       }
      }
     },
     "localname": "SeniorUnsecuredNotes1.150Due2025Member",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_SeniorUnsecuredNotes1.950Due2030Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Notes, 1.950% Due 2030 [Member]",
        "label": "Senior Unsecured Notes, 1.950% Due 2030 [Member]",
        "terseLabel": "Senior Unsecured Notes, 1.950% Due 2030"
       }
      }
     },
     "localname": "SeniorUnsecuredNotes1.950Due2030Member",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_SeniorUnsecuredNotes2.125Due2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Notes, 2.125% Due 2027 [Member]",
        "label": "Senior Unsecured Notes, 2.125% Due 2027 [Member]",
        "terseLabel": "2.125% Notes due 2027"
       }
      }
     },
     "localname": "SeniorUnsecuredNotes2.125Due2027Member",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_SeniorUnsecuredNotes2.625Due2030Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Notes, 2.625% Due 2030",
        "label": "Senior Unsecured Notes, 2.625% Due 2030 [Member]",
        "terseLabel": "2.625% Notes due 2030"
       }
      }
     },
     "localname": "SeniorUnsecuredNotes2.625Due2030Member",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_SeniorUnsecuredNotes2.900due2050Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Notes, 2.900% due 2050 [Member]",
        "label": "Senior Unsecured Notes, 2.900% due 2050 [Member]",
        "terseLabel": "Senior Unsecured Notes, 2.900% due 2050"
       }
      }
     },
     "localname": "SeniorUnsecuredNotes2.900due2050Member",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_SeniorUnsecuredNotes3.375due2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Notes 3.375% due 2024 [Member]",
        "label": "Senior Unsecured Notes 3.375% due 2024 [Member]",
        "terseLabel": "Senior Unsecured Notes 3.375% due 2024"
       }
      }
     },
     "localname": "SeniorUnsecuredNotes3.375due2024Member",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_SeniorUnsecuredNotes3.375due2025MemberMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Notes 3.375% due 2025 [Member]",
        "label": "Senior Unsecured Notes 3.375% due 2025 [Member] [Member]",
        "terseLabel": "Senior Unsecured Notes 3.375% due 2025"
       }
      }
     },
     "localname": "SeniorUnsecuredNotes3.375due2025MemberMember",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_SeniorUnsecuredNotes350Due2026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Notes 3.50% due 2026",
        "label": "Senior Unsecured Notes 3.50% due 2026 [Member]",
        "terseLabel": "Senior Unsecured Notes 3.50% due 2026"
       }
      }
     },
     "localname": "SeniorUnsecuredNotes350Due2026Member",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_SeniorUnsecuredNotes3650Due2028Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Notes 3.650% due 2028 [Domain]",
        "label": "Senior Unsecured Notes 3.650% due 2028 [Member]",
        "terseLabel": "Senior Unsecured Notes 3.650% due 2028"
       }
      }
     },
     "localname": "SeniorUnsecuredNotes3650Due2028Member",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_SeniorUnsecuredNotes4.375due2044Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Notes 4.375% due 2044 [Member]",
        "label": "Senior Unsecured Notes 4.375% due 2044 [Member]",
        "terseLabel": "Senior Unsecured Notes 4.375% due 2044"
       }
      }
     },
     "localname": "SeniorUnsecuredNotes4.375due2044Member",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_SeniorUnsecuredNotes410Due2043Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Notes 4.10% due 2043 [Member]",
        "label": "Senior Unsecured Notes 4.10% due 2043 [Member]",
        "verboseLabel": "Senior Unsecured Notes 4.10% due 2043"
       }
      }
     },
     "localname": "SeniorUnsecuredNotes410Due2043Member",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_SeniorUnsecuredNotes4625Due2046Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Notes 4.625% due 2046",
        "label": "Senior Unsecured Notes 4.625% due 2046 [Member]",
        "terseLabel": "Senior Unsecured Notes 4.625% due 2046"
       }
      }
     },
     "localname": "SeniorUnsecuredNotes4625Due2046Member",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_SeniorUnsecuredNotesDueNovember2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Notes, Due November 2023 [Member]",
        "label": "Senior Unsecured Notes, Due November 2023 [Member]",
        "verboseLabel": "Senior Unsecured Notes, 1.125%, due 2023"
       }
      }
     },
     "localname": "SeniorUnsecuredNotesDueNovember2023Member",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_SeniorUnsecuredNotesDueNovember2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Notes, Due November 2027 [Member]",
        "label": "Senior Unsecured Notes, Due November 2027 [Member]",
        "verboseLabel": "Senior Unsecured Notes,2.125%, due 2027"
       }
      }
     },
     "localname": "SeniorUnsecuredNotesDueNovember2027Member",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_SeniorUnsecuredNotesDueNovember2030Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Notes, Due November 2030 [Member]",
        "label": "Senior Unsecured Notes, Due November 2030 [Member]",
        "verboseLabel": "Senior Unsecured Notes, 2.625% due 2030"
       }
      }
     },
     "localname": "SeniorUnsecuredNotesDueNovember2030Member",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value",
        "terseLabel": "Shares vested during the period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Performance Period",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Performance Period",
        "terseLabel": "Performance period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "syk_SpineMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Spine [Member]",
        "label": "Spine [Member]",
        "terseLabel": "Spine"
       }
      }
     },
     "localname": "SpineMember",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_SpineReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Spine Reporting Unit",
        "label": "Spine Reporting Unit [Member]",
        "terseLabel": "Spine Reporting Unit"
       }
      }
     },
     "localname": "SpineReportingUnitMember",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_TermLoanDueFebruary222025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan Due February 22, 2025",
        "label": "Term Loan Due February 22, 2025 [Member]",
        "terseLabel": "Term Loan Due February 22, 2025"
       }
      }
     },
     "localname": "TermLoanDueFebruary222025Member",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_TermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan",
        "label": "Term Loan [Member]",
        "terseLabel": "Term Loan"
       }
      }
     },
     "localname": "TermLoanMember",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total Percentage of Defined Contribution Retirement Plan Assets Value Held by Company",
        "label": "Total Percentage of Defined Contribution Retirement Plan Assets Value Held by Company",
        "terseLabel": "Stryker common stock held by plan, value as a percentage of total plan assets"
       }
      }
     },
     "localname": "TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofDefinedContributionPlanDisclosuresDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "syk_TraumaandExtremitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trauma and Extremities [Member]",
        "label": "Trauma and Extremities [Member]",
        "terseLabel": "Trauma and Extremities"
       }
      }
     },
     "localname": "TraumaandExtremitiesMember",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_VoceraMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vocera",
        "label": "Vocera [Member]",
        "terseLabel": "Vocera"
       }
      }
     },
     "localname": "VoceraMember",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails",
      "http://www.stryker.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_WeightedAverageUsedInDeterminationOfProjectedBenefitObligations": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Used in the Determination of the Projected Benefit Obligations",
        "label": "Weighted Average Used in the Determination of the Projected Benefit Obligations",
        "terseLabel": "Weighted-average discount rate used to determine projected benefit obligations"
       }
      }
     },
     "localname": "WeightedAverageUsedInDeterminationOfProjectedBenefitObligations",
     "nsuri": "http://www.stryker.com/20221231",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]"
       }
      }
     },
     "localname": "AOCIAttributableToParentNetOfTaxRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableTradeCurrent": {
     "auth_ref": [
      "r0",
      "r13"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Trade, Current",
        "verboseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableTradeCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r379",
      "r380"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, less allowance of $154 ($167 in 2021)"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r3",
      "r218",
      "r232"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Accrued Income Taxes, Current",
        "verboseLabel": "Income taxes"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesNoncurrent": {
     "auth_ref": [
      "r5",
      "r218",
      "r232"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.",
        "label": "Accrued Income Taxes, Noncurrent",
        "terseLabel": "Income taxes"
       }
      }
     },
     "localname": "AccruedIncomeTaxesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "auth_ref": [
      "r28",
      "r35",
      "r177",
      "r843",
      "r844",
      "r845"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "terseLabel": "Pension Plans"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember": {
     "auth_ref": [
      "r30",
      "r35",
      "r177",
      "r283",
      "r284",
      "r843"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to prior service cost (credit) component of defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment, Net Prior Service Attributable to Parent [Member]",
        "terseLabel": "Accumulated Defined Benefit Plans Adjustment, Net Prior Service Attributable to Parent"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r101",
      "r249"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "terseLabel": "Less allowance for depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": {
     "auth_ref": [
      "r274",
      "r283",
      "r284",
      "r653",
      "r790",
      "r843"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]",
        "terseLabel": "Hedges"
       }
      }
     },
     "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": {
     "auth_ref": [
      "r270",
      "r271",
      "r272",
      "r274",
      "r283",
      "r284",
      "r843"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.",
        "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member]",
        "terseLabel": "Marketable Securities"
       }
      }
     },
     "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r32",
      "r34",
      "r35",
      "r260",
      "r733",
      "r743",
      "r744"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "periodEndLabel": "Accumulated Other Comprehensive Income (Loss), End of Period",
        "periodStartLabel": "Accumulated Other Comprehensive Income (Loss), Beginning of Period",
        "verboseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails",
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r282",
      "r283",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r31",
      "r35",
      "r177",
      "r690",
      "r739",
      "r740",
      "r843",
      "r844",
      "r845",
      "r863",
      "r864",
      "r865"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r26",
      "r35",
      "r177",
      "r283",
      "r284",
      "r676",
      "r677",
      "r678",
      "r679",
      "r681",
      "r843"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Financial Statement Translation"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Acquired Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Acquired Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r90"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Weighted average life of intangible assets",
        "verboseLabel": "Weighted Average Amortization Period (Years)"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails",
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r10"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "verboseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r606",
      "r607",
      "r608",
      "r863",
      "r864",
      "r865",
      "r926"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentForAmortization": {
     "auth_ref": [
      "r58",
      "r95"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.",
        "label": "Amortization",
        "terseLabel": "Amortization of intangible assets"
       }
      }
     },
     "localname": "AdjustmentForAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r141",
      "r142",
      "r574"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "verboseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net earnings to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r604"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-Based Payment Arrangement, Expense",
        "terseLabel": "Share-based payment expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r261",
      "r381",
      "r389"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, allowance"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheetsParentheticals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForNotesReceivableMember": {
     "auth_ref": [
      "r857",
      "r858",
      "r859",
      "r860",
      "r861"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allowance for portion expected to be uncollectible of receivable from written agreement to receive, at specified future date, money consisting of principal and accrued interest.",
        "label": "SEC Schedule, 12-09, Allowance, Notes Receivable [Member]",
        "terseLabel": "SEC Schedule, 12-09, Allowance, Notes Receivable"
       }
      }
     },
     "localname": "AllowanceForNotesReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r58",
      "r88",
      "r95"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "negatedTerseLabel": "Amortization of intangible assets",
        "terseLabel": "Amortization of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings",
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r331"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Anti-dilutive shares excluded from calculation of dilutive employee stock options (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarningsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Capital Stock [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetBackedSecuritiesMember": {
     "auth_ref": [
      "r815",
      "r875"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities that are primarily serviced by the cash flows of a discrete pool of receivables or other financial assets for example, but not limited to, credit card receivables, car loans, recreational vehicle loans, and mobile home loans.",
        "label": "Asset-Backed Securities [Member]",
        "verboseLabel": "Corporate and asset-backed debt securities"
       }
      }
     },
     "localname": "AssetBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetImpairmentCharges": {
     "auth_ref": [
      "r58",
      "r98"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
        "label": "Asset Impairment Charges",
        "terseLabel": "Asset impairments"
       }
      }
     },
     "localname": "AssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AssetImpairmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetImpairmentChargesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the details of the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value. Disclosure may also include a description of the impaired asset and facts and circumstances leading to the impairment, amount of the impairment loss and where the loss is located in the income statement, method(s) for determining fair value, and the segment in which the impaired asset is reported.",
        "label": "Asset Impairment Charges [Text Block]",
        "terseLabel": "Asset Impairments"
       }
      }
     },
     "localname": "AssetImpairmentChargesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AssetImpairments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r215",
      "r231",
      "r253",
      "r298",
      "r357",
      "r363",
      "r369",
      "r387",
      "r435",
      "r436",
      "r438",
      "r439",
      "r440",
      "r442",
      "r444",
      "r446",
      "r447",
      "r651",
      "r654",
      "r668",
      "r826",
      "r901",
      "r902",
      "r934"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets",
      "http://www.stryker.com/role/SegmentandGeographicDataSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets",
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r244",
      "r265",
      "r298",
      "r387",
      "r435",
      "r436",
      "r438",
      "r439",
      "r440",
      "r442",
      "r444",
      "r446",
      "r447",
      "r651",
      "r654",
      "r668",
      "r826",
      "r901",
      "r902",
      "r934"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r202"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "terseLabel": "Total assets measured at fair value"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "auth_ref": [
      "r83",
      "r383",
      "r731"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "Due in one year or less"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent": {
     "auth_ref": [
      "r82",
      "r395"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.",
        "label": "Debt Securities, Available-for-Sale, Current",
        "terseLabel": "Available-for-sale marketable securities:",
        "verboseLabel": "Marketable securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets",
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableforsaleSecuritiesMember": {
     "auth_ref": [
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Available-for-Sale Securities [Member]",
        "verboseLabel": "Available-for-sale marketable securities:"
       }
      }
     },
     "localname": "AvailableforsaleSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r575",
      "r576",
      "r577",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails",
      "http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails",
      "http://www.stryker.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r186",
      "r191"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingAndBuildingImprovementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and any addition, improvement, or renovation to the structure, for example, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Building and Building Improvements [Member]",
        "terseLabel": "Building and Improvements"
       }
      }
     },
     "localname": "BuildingAndBuildingImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r648",
      "r819",
      "r820"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails",
      "http://www.stryker.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r159",
      "r160",
      "r648",
      "r819",
      "r820"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails",
      "http://www.stryker.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails",
      "http://www.stryker.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r166",
      "r167",
      "r168"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Aggregate purchase price of acquisitions"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]",
        "terseLabel": "Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1": {
     "auth_ref": [
      "r650",
      "r851"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of right to a contingent consideration asset.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Asset",
        "negatedTerseLabel": "Reduction of contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh": {
     "auth_ref": [
      "r169"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of any change recognized during the period in the high-end of the estimated range of outcomes (undiscounted) of a liability assumed in a business combination arising from an item of contingent consideration.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Range of Outcomes, Contingent Consideration, Liability, Value, High",
        "terseLabel": "Future milestone payments"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r170",
      "r649"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Acquisitions"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/Acquisitions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationIntegrationRelatedCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.",
        "label": "Business Combination, Integration Related Costs",
        "negatedTerseLabel": "Acquisition and integration-related charges"
       }
      }
     },
     "localname": "BusinessCombinationIntegrationRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r162"
     ],
     "calculation": {
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets": {
     "auth_ref": [
      "r162"
     ],
     "calculation": {
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.",
        "label": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets",
        "terseLabel": "Deferred income tax assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "auth_ref": [
      "r162"
     ],
     "calculation": {
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "negatedTerseLabel": "Deferred income tax liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r161",
      "r162"
     ],
     "calculation": {
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Intangible assets:"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "auth_ref": [
      "r161",
      "r162"
     ],
     "calculation": {
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of inventory recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": {
     "auth_ref": [
      "r162"
     ],
     "calculation": {
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other",
        "negatedTerseLabel": "Other liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "auth_ref": [
      "r162"
     ],
     "calculation": {
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r162"
     ],
     "calculation": {
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "totalLabel": "Purchase price, net of cash acquired of $281"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAcquiredFromAcquisition": {
     "auth_ref": [
      "r49"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).",
        "label": "Cash Acquired from Acquisition",
        "terseLabel": "Cash Acquired from Acquisition"
       }
      }
     },
     "localname": "CashAcquiredFromAcquisition",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r60",
      "r247",
      "r783"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "verboseLabel": "Available-for-sale marketable securities"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r55",
      "r60",
      "r63"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents at end of year",
        "periodStartLabel": "Cash and cash equivalents at beginning of year"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r55",
      "r208"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Change in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths": {
     "auth_ref": [
      "r200"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.",
        "label": "Cash Flow Hedge Gain (Loss) to be Reclassified within 12 Months",
        "terseLabel": "Cash flow hedge gain (loss) to be reclassified within twelve months"
       }
      }
     },
     "localname": "CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r182"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedging"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CertificatesOfDepositMember": {
     "auth_ref": [
      "r226"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest. Certificates of deposit (CD) are typically Federal Deposit Insurance Corporation (FDIC) insured.",
        "label": "Certificates of Deposit [Member]",
        "terseLabel": "Certificates of deposit"
       }
      }
     },
     "localname": "CertificatesOfDepositMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r257",
      "r258",
      "r259",
      "r298",
      "r325",
      "r326",
      "r328",
      "r330",
      "r337",
      "r338",
      "r387",
      "r435",
      "r438",
      "r439",
      "r440",
      "r446",
      "r447",
      "r477",
      "r478",
      "r481",
      "r485",
      "r492",
      "r668",
      "r762",
      "r841",
      "r852",
      "r866"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommercialPaper": {
     "auth_ref": [
      "r1",
      "r216",
      "r233"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of short-term borrowings using unsecured obligations issued by banks, corporations and other borrowers to investors. The maturities of these money market securities generally do not exceed 270 days.",
        "label": "Commercial Paper",
        "terseLabel": "Commercial paper"
       }
      }
     },
     "localname": "CommercialPaper",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r104",
      "r426",
      "r427",
      "r748",
      "r900"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Contingencies and Commitments"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Capital shares reserved for future issuance"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "verboseLabel": "Dividends declared per share of common stock (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/SummaryofQuarterlyDataUnauditedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r863",
      "r864",
      "r926"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock",
        "verboseLabel": "Common Stock, $.10 Par Value"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE",
      "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails",
      "http://www.stryker.com/role/ConsolidatedBalanceSheets",
      "http://www.stryker.com/role/ConsolidatedBalanceSheetsParentheticals"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "verboseLabel": "Common stock, authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r9",
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Ending balance, shares",
        "periodStartLabel": "Beginning balance, shares"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValueOutstanding": {
     "auth_ref": [
      "r9"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of all classes of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares exclude common shares repurchased by the entity and held as treasury shares.",
        "label": "Common Stock, Value, Outstanding",
        "verboseLabel": "Common stock, $0.10 par value"
       }
      }
     },
     "localname": "CommonStockValueOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]",
        "terseLabel": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Deferred Tax Assets [Abstract]",
        "terseLabel": "Deferred income tax assets:"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Deferred Tax Liabilities [Abstract]",
        "terseLabel": "Deferred income tax liabilities:"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r37",
      "r278",
      "r280",
      "r287",
      "r728",
      "r735"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r48",
      "r286",
      "r727",
      "r734"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "Accumulated Other Comprehensive (Loss) Income (AOCI)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCI"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r68",
      "r69",
      "r205",
      "r206",
      "r377",
      "r747"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AssetImpairmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r68",
      "r69",
      "r205",
      "r206",
      "r377",
      "r745",
      "r747"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AssetImpairmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r68",
      "r69",
      "r205",
      "r206",
      "r377",
      "r747",
      "r946"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AssetImpairmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r68",
      "r69",
      "r205",
      "r206",
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration risk (as a percent)"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AssetImpairmentsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r68",
      "r69",
      "r205",
      "r206",
      "r377",
      "r747"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AssetImpairmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r175",
      "r791"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation and Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r905"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "terseLabel": "Changes in Contract Liabilities"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r494",
      "r495",
      "r505"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "periodEndLabel": "Ending contract liabilities",
        "periodStartLabel": "Beginning contract liabilities",
        "terseLabel": "Contract liabilities"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionChangesinContractLiabilitiesDetails",
      "http://www.stryker.com/role/RevenueRecognitionNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination": {
     "auth_ref": [
      "r807"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration from customer has been received or is due, from business combination.",
        "label": "Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination",
        "terseLabel": "Contract liabilities acquired"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionChangesinContractLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r506"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "negatedTerseLabel": "Revenue recognized from beginning of year contract liabilities"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionChangesinContractLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r815",
      "r817",
      "r945"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate debt securities"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r78",
      "r362",
      "r363",
      "r364",
      "r365",
      "r371",
      "r870"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfRevenue": {
     "auth_ref": [
      "r43",
      "r298",
      "r387",
      "r435",
      "r436",
      "r438",
      "r439",
      "r440",
      "r442",
      "r444",
      "r446",
      "r447",
      "r668",
      "r901"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
        "label": "Cost of Revenue",
        "terseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails",
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of sales",
        "verboseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfSalesPolicyTextBlock": {
     "auth_ref": [
      "r907"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cost of product sold and service rendered.",
        "label": "Cost of Goods and Service [Policy Text Block]",
        "terseLabel": "Cost of Sales"
       }
      }
     },
     "localname": "CostOfSalesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r855",
      "r918",
      "r920"
     ],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "United States federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r855",
      "r918"
     ],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense (Benefit)",
        "terseLabel": "International"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r157",
      "r632",
      "r640",
      "r855"
     ],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Total current income tax expense"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Current income tax expense (benefit):"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r855",
      "r918",
      "r920"
     ],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "United States state and local"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerRefundLiabilityCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current regulatory liabilities generally represent obligations to make refunds to customers for various reasons including overpayment.",
        "label": "Customer Refund Liability, Current",
        "terseLabel": "Accrued product liabilities"
       }
      }
     },
     "localname": "CustomerRefundLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "verboseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtCurrent": {
     "auth_ref": [
      "r255"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of debt and lease obligation, classified as current.",
        "label": "Debt, Current",
        "terseLabel": "Current maturities of debt"
       }
      }
     },
     "localname": "DebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets",
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r108",
      "r296",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r464",
      "r471",
      "r472",
      "r474"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "verboseLabel": "Debt And Credit Facilities"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r2",
      "r3",
      "r4",
      "r217",
      "r220",
      "r229",
      "r303",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r454",
      "r460",
      "r461",
      "r462",
      "r463",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r683",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805",
      "r853"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsNarrativeDetails",
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails",
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Basis spread on variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r210",
      "r211",
      "r448",
      "r683",
      "r802",
      "r803"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Debt face amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r462",
      "r667",
      "r802",
      "r803"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "verboseLabel": "Fair value of senior unsecured notes"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r19",
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Stated interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsNarrativeDetails",
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails",
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r20",
      "r303",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r454",
      "r460",
      "r461",
      "r462",
      "r463",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r683",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805",
      "r853"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsNarrativeDetails",
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails",
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtLongtermAndShorttermCombinedAmount": {
     "auth_ref": [],
     "calculation": {
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the aggregate of total long-term debt, including current maturities and short-term debt.",
        "label": "Debt, Long-Term and Short-Term, Combined Amount",
        "totalLabel": "Total debt"
       }
      }
     },
     "localname": "DebtLongtermAndShorttermCombinedAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r855",
      "r919",
      "r920"
     ],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "United States federal"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r157",
      "r855",
      "r919"
     ],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "terseLabel": "International"
       }
      }
     },
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r614",
      "r615"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Noncurrent deferred income tax assets"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets",
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r58",
      "r157",
      "r633",
      "r639",
      "r640",
      "r855"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income tax (benefit) expense",
        "totalLabel": "Total deferred income tax expense (benefit)"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows",
      "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Deferred income tax expense (benefit):"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r6",
      "r7",
      "r219",
      "r228",
      "r627"
     ],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Total deferred income tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r614",
      "r615"
     ],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "negatedTerseLabel": "Noncurrent liabilities\u2014Other liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r855",
      "r919",
      "r920"
     ],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "terseLabel": "United States state and local"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetInterestCarryforward": {
     "auth_ref": [
      "r917"
     ],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible interest carryforward.",
        "label": "Deferred Tax Asset, Interest Carryforward",
        "terseLabel": "International interest expense carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetInterestCarryforward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r628"
     ],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Total deferred income tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsInventory": {
     "auth_ref": [
      "r154",
      "r917"
     ],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.",
        "label": "Deferred Tax Assets, Inventory",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "DeferredTaxAssetsInventory",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r916"
     ],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "totalLabel": "Net deferred income tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r916"
     ],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Net deferred income tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r154",
      "r917"
     ],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Net operating loss and other credit carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r154",
      "r917"
     ],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets, Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsStateTaxes": {
     "auth_ref": [],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from state taxes.",
        "label": "Deferred Tax Assets, State Taxes",
        "terseLabel": "State income taxes"
       }
      }
     },
     "localname": "DeferredTaxAssetsStateTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r154",
      "r917"
     ],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther": {
     "auth_ref": [
      "r154",
      "r917"
     ],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves and accruals, classified as other.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other",
        "terseLabel": "Other accrued expenses"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves": {
     "auth_ref": [
      "r154",
      "r917"
     ],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves, classified as other.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves",
        "terseLabel": "Product-related liabilities"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r629"
     ],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedTerseLabel": "Less valuation allowances"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings": {
     "auth_ref": [
      "r917"
     ],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from undistributed earnings of subsidiary and other recognized entity not within country of domicile. Includes, but is not limited to, other basis differences.",
        "label": "Deferred Tax Liabilities, Undistributed Foreign Earnings",
        "negatedLabel": "Undistributed earnings"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesUndistributedForeignEarnings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation": {
     "auth_ref": [
      "r537"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level.",
        "label": "Defined Benefit Plan, Accumulated Benefit Obligation",
        "terseLabel": "Ending accumulated benefit obligations"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofChangeinBenefitObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax": {
     "auth_ref": [
      "r29",
      "r35",
      "r910"
     ],
     "calculation": {
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax": {
     "auth_ref": [
      "r35",
      "r548"
     ],
     "calculation": {
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax",
        "negatedTerseLabel": "Unrecognized net actuarial gain (loss)"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax": {
     "auth_ref": [
      "r35",
      "r548"
     ],
     "calculation": {
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of accumulated other comprehensive (income) loss for cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, Prior Service Cost (Credit), before Tax",
        "terseLabel": "Unrecognized prior service credit"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets": {
     "auth_ref": [
      "r522",
      "r817"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.",
        "label": "Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)",
        "terseLabel": "Actual return"
       }
      }
     },
     "localname": "DefinedBenefitPlanActualReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansChangeinPlanAssetsDetails",
      "http://www.stryker.com/role/RetirementPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActuarialGainLoss": {
     "auth_ref": [
      "r518"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)",
        "negatedTerseLabel": "Actuarial (gains) losses"
       }
      }
     },
     "localname": "DefinedBenefitPlanActuarialGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofChangeinBenefitObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": {
     "auth_ref": [
      "r511",
      "r544",
      "r563",
      "r817",
      "r818"
     ],
     "calculation": {
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Gain (Loss)",
        "terseLabel": "Recognized actuarial loss"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit": {
     "auth_ref": [
      "r511",
      "r545",
      "r564",
      "r817",
      "r818"
     ],
     "calculation": {
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Prior Service Cost (Credit)",
        "negatedTerseLabel": "Amortization of prior service cost and transition amount"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfPriorServiceCostCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent": {
     "auth_ref": [
      "r214",
      "r230",
      "r509",
      "r510",
      "r527",
      "r817"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans.",
        "label": "Assets for Plan Benefits, Defined Benefit Plan",
        "periodEndLabel": "Ending fair value of plan assets",
        "periodStartLabel": "Beginning fair value of plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansChangeinPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate": {
     "auth_ref": [
      "r549"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets": {
     "auth_ref": [
      "r551",
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-Term Rate of Return on Plan Assets",
        "terseLabel": "Expected return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease": {
     "auth_ref": [
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase",
        "terseLabel": "Expected return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Assumptions Used in Calculations [Abstract]",
        "terseLabel": "Defined Benefit Plan, Assumptions Used in Calculations [Abstract]"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligation": {
     "auth_ref": [
      "r513"
     ],
     "calculation": {
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Benefit Obligation",
        "negatedTerseLabel": "Benefit obligations",
        "periodEndLabel": "Ending projected benefit obligations",
        "periodStartLabel": "Beginning projected benefit obligations"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofChangeinBenefitObligationsDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid": {
     "auth_ref": [
      "r520",
      "r570"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Benefit Obligation, Benefits Paid",
        "negatedTerseLabel": "Benefits paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofChangeinBenefitObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant": {
     "auth_ref": [
      "r517"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contributions received by defined benefit plan from participant which increase benefit obligation.",
        "label": "Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant",
        "terseLabel": "Employee contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofChangeinBenefitObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis": {
     "auth_ref": [
      "r528",
      "r529",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r553",
      "r815",
      "r816",
      "r817"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by defined benefit plan asset investment.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Axis]",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Axis]"
       }
      }
     },
     "localname": "DefinedBenefitPlanByPlanAssetCategoriesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofTargetandActualAllocationofPlanAssetsDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember": {
     "auth_ref": [
      "r815"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash and cash equivalent in which defined benefit plan asset is invested.",
        "label": "Defined Benefit Plan, Cash and Cash Equivalents [Member]",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "DefinedBenefitPlanCashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]",
        "terseLabel": "Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]"
       }
      }
     },
     "localname": "DefinedBenefitPlanChangeInBenefitObligationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofChangeinBenefitObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]",
        "terseLabel": "Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]"
       }
      }
     },
     "localname": "DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansChangeinPlanAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanContributionsByEmployer": {
     "auth_ref": [
      "r524",
      "r531",
      "r566",
      "r815",
      "r816",
      "r817",
      "r818"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer",
        "terseLabel": "Employer contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanContributionsByEmployer",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansChangeinPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanCurtailments": {
     "auth_ref": [
      "r515"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of (increase) decrease in benefit obligation of defined benefit plan from event reducing expected years of future service of present employees or eliminating accrual of benefits for some or all future services of present employees.",
        "label": "Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Curtailment",
        "terseLabel": "Curtailment gain"
       }
      }
     },
     "localname": "DefinedBenefitPlanCurtailments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofChangeinBenefitObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanDebtSecurityMember": {
     "auth_ref": [
      "r909"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument issued by corporation, government and governmental agency, municipality, and other institution; in which defined benefit plan asset is invested.",
        "label": "Defined Benefit Plan, Debt Security [Member]",
        "terseLabel": "Debt securities"
       }
      }
     },
     "localname": "DefinedBenefitPlanDebtSecurityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofTargetandActualAllocationofPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "terseLabel": "Defined Benefit Plan Disclosure [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansNarrativeDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofTargetandActualAllocationofPlanAssetsDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanEquitySecuritiesMember": {
     "auth_ref": [
      "r815",
      "r817"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security representing ownership in corporation or other legal entity for which ownership is represented by share of stock, in which defined benefit plan asset is invested. Includes, but is not limited to, common stock, preferred stock, convertible security, stock right and stock warrant.",
        "label": "Defined Benefit Plan, Equity Securities [Member]",
        "terseLabel": "Equity securities"
       }
      }
     },
     "localname": "DefinedBenefitPlanEquitySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofTargetandActualAllocationofPlanAssetsDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter": {
     "auth_ref": [
      "r538"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years",
        "terseLabel": "2028-2032"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansExpectedBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths": {
     "auth_ref": [
      "r538"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansExpectedBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive": {
     "auth_ref": [
      "r538"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansExpectedBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour": {
     "auth_ref": [
      "r538"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansExpectedBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree": {
     "auth_ref": [
      "r538"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansExpectedBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo": {
     "auth_ref": [
      "r538"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansExpectedBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear": {
     "auth_ref": [
      "r539",
      "r818"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution expected to be received by defined benefit plan from employer in next fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year",
        "terseLabel": "Estimated future employer contributions in next fiscal year"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "auth_ref": [
      "r511",
      "r543",
      "r562",
      "r817",
      "r818"
     ],
     "calculation": {
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "terseLabel": "Expected return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFairValueOfPlanAssets": {
     "auth_ref": [
      "r521",
      "r529",
      "r531",
      "r532",
      "r815",
      "r816",
      "r817"
     ],
     "calculation": {
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.",
        "label": "Defined Benefit Plan, Plan Assets, Amount",
        "terseLabel": "Fair value of plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanFairValueOfPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation": {
     "auth_ref": [
      "r519"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Foreign exchange impact"
       }
      }
     },
     "localname": "DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofChangeinBenefitObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFundedStatusOfPlan": {
     "auth_ref": [
      "r509",
      "r527",
      "r817"
     ],
     "calculation": {
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.",
        "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan",
        "totalLabel": "Funded status"
       }
      }
     },
     "localname": "DefinedBenefitPlanFundedStatusOfPlan",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Information about Plan Assets [Abstract]",
        "terseLabel": "Defined Benefit Plan, Information about Plan Assets [Abstract]"
       }
      }
     },
     "localname": "DefinedBenefitPlanInformationAboutPlanAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "auth_ref": [
      "r511",
      "r516",
      "r542",
      "r561",
      "r817",
      "r818"
     ],
     "calculation": {
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.",
        "label": "Defined Benefit Plan, Interest Cost",
        "negatedTerseLabel": "Interest cost",
        "terseLabel": "Interest cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanInterestCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofChangeinBenefitObligationsDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "auth_ref": [
      "r540",
      "r559",
      "r817",
      "r818"
     ],
     "calculation": {
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "negatedTotalLabel": "Net periodic benefit cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]",
        "terseLabel": "Components of Net Periodic Pension Cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid": {
     "auth_ref": [
      "r526",
      "r911"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Plan Assets, Benefits Paid",
        "negatedLabel": "Benefits paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansChangeinPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant": {
     "auth_ref": [
      "r525"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contributions received by defined benefit plan from participant which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Plan Participant",
        "terseLabel": "Employee contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansChangeinPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r523"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Foreign exchange impact"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansChangeinPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage": {
     "auth_ref": [
      "r528",
      "r817"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of target investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.",
        "label": "Defined Benefit Plan, Plan Assets, Target Allocation, Percentage",
        "terseLabel": "Target plan asset allocations"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsTargetAllocationPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofTargetandActualAllocationofPlanAssetsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments": {
     "auth_ref": [
      "r512",
      "r546",
      "r565"
     ],
     "calculation": {
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from event reducing expected years of future service of present employees or eliminating accrual of defined benefits for some or all future services of present employees.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Curtailment",
        "terseLabel": "Curtailment gain"
       }
      }
     },
     "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanServiceCost": {
     "auth_ref": [
      "r514",
      "r541",
      "r560",
      "r817",
      "r818"
     ],
     "calculation": {
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Service Cost",
        "negatedTerseLabel": "Service cost",
        "terseLabel": "Service cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanServiceCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofChangeinBenefitObligationsDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations": {
     "auth_ref": [
      "r908"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of actual investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.",
        "label": "Defined Benefit Plan, Plan Assets, Actual Allocation, Percentage",
        "terseLabel": "Actual plan asset allocations"
       }
      }
     },
     "localname": "DefinedBenefitPlanWeightedAverageAssetAllocations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofTargetandActualAllocationofPlanAssetsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedContributionPlanCostRecognized": {
     "auth_ref": [
      "r571"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for defined contribution plan.",
        "label": "Defined Contribution Plan, Cost",
        "terseLabel": "Plan expense"
       }
      }
     },
     "localname": "DefinedContributionPlanCostRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofDefinedContributionPlanDisclosuresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanDisclosuresTableTextBlock": {
     "auth_ref": [
      "r131"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of defined contribution pension plans or defined contribution other postretirement plans, separately for pension plans and other postretirement benefit plans.",
        "label": "Defined Contribution Plan Disclosures [Table Text Block]",
        "terseLabel": "Defined Contribution Plan Disclosures"
       }
      }
     },
     "localname": "DefinedContributionPlanDisclosuresTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of discretionary contributions made by an employer to a defined contribution plan.",
        "label": "Defined Contribution Plan, Employer Discretionary Contribution Amount",
        "terseLabel": "Expense funded with Stryker common stock"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerDiscretionaryContributionAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofDefinedContributionPlanDisclosuresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r58",
      "r99"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r58",
      "r352"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssets": {
     "auth_ref": [
      "r267",
      "r268",
      "r667",
      "r789"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset",
        "terseLabel": "Interest rate swap asset",
        "verboseLabel": "Foreign currency exchange forward contracts"
       }
      }
     },
     "localname": "DerivativeAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails",
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r24",
      "r189",
      "r212",
      "r266",
      "r789"
     ],
     "calculation": {
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DerivativeFairValueOfDerivativeNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Subject to Master Netting Arrangement, before Offset",
        "terseLabel": "Derivative asset"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "auth_ref": [
      "r24",
      "r189",
      "r212",
      "r266",
      "r789"
     ],
     "calculation": {
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DerivativeFairValueOfDerivativeNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Subject to Master Netting Arrangement, before Offset",
        "negatedTerseLabel": "Derivative liability"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeNet": {
     "auth_ref": [
      "r667"
     ],
     "calculation": {
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of the assets less the liabilities of a derivative or group of derivatives.",
        "label": "Derivative, Fair Value, Net",
        "totalLabel": "Derivative, fair value, net"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "auth_ref": [
      "r924"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.",
        "label": "Derivative, Gain (Loss) on Derivative, Net",
        "terseLabel": "Unrealized gains (losses) on designated hedges"
       }
      }
     },
     "localname": "DerivativeGainLossOnDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r187",
      "r190",
      "r193",
      "r194",
      "r789"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails",
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r201",
      "r658"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "Derivative Instruments"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstruments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r184",
      "r187",
      "r193"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r184",
      "r187",
      "r193",
      "r194",
      "r198",
      "r199",
      "r657"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r922",
      "r923"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Notional amount",
        "verboseLabel": "Derivative, notional amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r179",
      "r180",
      "r181",
      "r184",
      "r185",
      "r192",
      "r193",
      "r195",
      "r197",
      "r199",
      "r658"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeTermOfContract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period the derivative contract is outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Derivative, Term of Contract",
        "terseLabel": "Derivative term (up to)"
       }
      }
     },
     "localname": "DerivativeTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r179",
      "r180",
      "r184",
      "r185",
      "r196",
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Derivatives"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax": {
     "auth_ref": [
      "r929"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification from other comprehensive income (loss) to earnings from the sale or complete or substantially complete liquidation of an investment in a foreign entity.",
        "label": "Derivatives used in Net Investment Hedge, Gain (Loss), Reclassified to Earnings, Net of Tax",
        "terseLabel": "Derivatives used in Net Investment Hedge, Gain (Loss), Reclassified to Earnings, Net of Tax",
        "verboseLabel": "Net investment hedges expected to be reclassified to cost of sales and other income (expense)"
       }
      }
     },
     "localname": "DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r184"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Designated as Hedging Instrument"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DevelopedTechnologyRightsMember": {
     "auth_ref": [
      "r165"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.",
        "label": "Developed Technology Rights [Member]",
        "terseLabel": "Developed technology",
        "verboseLabel": "Developed technologies"
       }
      }
     },
     "localname": "DevelopedTechnologyRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails",
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r504",
      "r808",
      "r809",
      "r810",
      "r811",
      "r812",
      "r813",
      "r814"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r906"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Schedule of Disaggregated Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DividendsCash": {
     "auth_ref": [
      "r119",
      "r225"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred.",
        "label": "Dividends, Cash",
        "negatedLabel": "Cash dividends declared"
       }
      }
     },
     "localname": "DividendsCash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsPayableCurrent": {
     "auth_ref": [
      "r17"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Dividends Payable, Current",
        "terseLabel": "Dividend payable"
       }
      }
     },
     "localname": "DividendsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Domestic Tax Authority"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EMEAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regions of Europe, Middle East and Africa.",
        "label": "EMEA [Member]",
        "terseLabel": "Europe, Middle East, Africa"
       }
      }
     },
     "localname": "EMEAMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "verboseLabel": "Net earnings per share of common stock:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r288",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r323",
      "r325",
      "r328",
      "r329",
      "r330",
      "r332",
      "r661",
      "r662",
      "r729",
      "r736",
      "r796"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "verboseLabel": "Basic net earnings per share of common stock (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings",
      "http://www.stryker.com/role/SummaryofQuarterlyDataUnauditedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r288",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r325",
      "r328",
      "r329",
      "r330",
      "r332",
      "r661",
      "r662",
      "r729",
      "r736",
      "r796"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "verboseLabel": "Diluted net earnings per share of common stock (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings",
      "http://www.stryker.com/role/SummaryofQuarterlyDataUnauditedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r674"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "terseLabel": "Effect of exchange rate changes on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r617"
     ],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective income tax, percent",
        "totalLabel": "Effective income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesNarrativeDetails",
      "http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r300",
      "r617",
      "r642"
     ],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "United States federal statutory rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r913",
      "r921"
     ],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent",
        "terseLabel": "Foreign income tax at rates other than 21%"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses": {
     "auth_ref": [
      "r913",
      "r921"
     ],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to impairment loss.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Percent",
        "terseLabel": "Goodwill impairment"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "auth_ref": [
      "r913",
      "r921"
     ],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r913",
      "r921"
     ],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "United States state and local income taxes, less federal deduction"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic": {
     "auth_ref": [
      "r913",
      "r921"
     ],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to domestic income tax settlement.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Settlement, Domestic, Percent",
        "terseLabel": "United States federal audit settlement"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmbeddedDerivativeFinancialInstrumentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument embedded in host contract.",
        "label": "Embedded Derivative Financial Instruments [Member]",
        "terseLabel": "Embedded Derivative Financial Instruments"
       }
      }
     },
     "localname": "EmbeddedDerivativeFinancialInstrumentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r17"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued compensation"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r605"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Compensation cost not yet recognized"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Compensation cost not yet recognized, period for recognized"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.",
        "label": "Employee Stock [Member]",
        "terseLabel": "Employee Stock Purchase Plans"
       }
      }
     },
     "localname": "EmployeeStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "terseLabel": "Employee Stock Option"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r112",
      "r240",
      "r282",
      "r283",
      "r284",
      "r310",
      "r311",
      "r312",
      "r314",
      "r320",
      "r322",
      "r336",
      "r388",
      "r493",
      "r606",
      "r607",
      "r608",
      "r635",
      "r636",
      "r660",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r681",
      "r690",
      "r739",
      "r740",
      "r741"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails",
      "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity",
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r663",
      "r664",
      "r666"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value Measurements, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r462",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r664",
      "r694",
      "r695",
      "r696",
      "r802",
      "r803",
      "r815",
      "r816",
      "r817"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails",
      "http://www.stryker.com/role/RetirementPlansNarrativeDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r665"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r462",
      "r531",
      "r536",
      "r664",
      "r694",
      "r815",
      "r816",
      "r817"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "verboseLabel": "(Level 1)"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r462",
      "r531",
      "r536",
      "r664",
      "r695",
      "r802",
      "r803",
      "r815",
      "r816",
      "r817"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "(Level 2)",
        "verboseLabel": "(Level 2)"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r462",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r664",
      "r696",
      "r802",
      "r803",
      "r815",
      "r816",
      "r817"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "verboseLabel": "(Level 3)"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails",
      "http://www.stryker.com/role/RetirementPlansNarrativeDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues": {
     "auth_ref": [
      "r204"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances",
        "terseLabel": "Additions"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease": {
     "auth_ref": [
      "r203"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)",
        "negatedLabel": "Change in estimate"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": {
     "auth_ref": [
      "r204"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements",
        "negatedLabel": "Settlements"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r203"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Ending",
        "periodStartLabel": "Beginning"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r462",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r694",
      "r695",
      "r696",
      "r802",
      "r803",
      "r815",
      "r816",
      "r817"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails",
      "http://www.stryker.com/role/RetirementPlansNarrativeDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOptionTextBlock": {
     "auth_ref": [
      "r207",
      "r669"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a company's election to apply the fair value option for measurement and reporting of eligible financial assets and liabilities (as defined), as well as certain other eligible items (as defined) included in the statement of financial position, whether such option is elected for a single eligible item or a group of similar eligible items and is in addition to other disclosures concerning fair value which the company may be required to provide. Such disclosure might be expected to include: (1) for items included in the statement of financial position: (a) the reasons for electing a fair value option for each eligible item or group of similar eligible items; (b) if the fair value option is elected for some but not all eligible items within a group of similar eligible items: (i) a description of those similar items and the reasons for partial election and (ii) information of how the group of similar items relates to individual balance sheet line items; (c) for each line item in the statement of financial position that includes an item or items for which the fair value option has been elected: (i) information of how each line item in the statement of financial position relates to major categories of assets and liabilities presented in accordance with other fair value disclosures and (ii) the aggregate carrying amount of ineligible items included in each line item in the balance sheet, if any; (d) the difference between the aggregate fair value and the aggregate unpaid principal balance (assuming contractual principal amounts and fair value option elected) of: (i) loans and long-term receivables (other than securities otherwise reported at fair value) and (ii) long-term debt instruments; (e) for loans held as assets for which the fair value option has been elected: (i) the aggregate fair value of loans that are 90 days or more past due, (ii) if the policy is to recognize interest income separately from other changes in fair value, the aggregate fair value of loans in nonaccrual status, and (iii) the difference between the aggregate fair value and the aggregate unpaid principal balance for loans that are 90 days or more past due, in nonaccrual status, or both; (f) for investments that would have been accounted for under the equity method if the entity had not chosen to apply the fair value option, the information required for such investments, if material either individually or in the aggregate; (2) for items included in the income statement: (a) the amounts of gains and losses from fair value changes included in earnings and in which line in the income statement those gains and losses are reported whether or not combined with gains and losses from items required to be accounted for at fair value; (b) a description of how interest and dividends are measured and where they are reported in the income statement; (c) for loans and other receivables held as assets: (i) the estimated amount of gains or losses included in earnings attributable to changes in instrument-specific credit risk and (ii) how the gains or losses attributable to changes in instrument-specific credit risk were determined; (d) for liabilities with fair values that have been significantly affected during the reporting period by changes in the instrument-specific credit risk: (i) the estimated amount of gains and losses from fair value changes included in earnings that are attributable to changes in the instrument-specific credit risk, (ii) qualitative information about the reasons for those changes, and (iii) how the gains and losses attributable to changes in instrument-specific credit risk were determined; and (3) certain other disclosures as required or determined to be provided.",
        "label": "Fair Value, Option [Text Block]",
        "terseLabel": "Financial Instruments"
       }
      }
     },
     "localname": "FairValueOptionTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r384",
      "r385",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r396",
      "r397",
      "r398",
      "r473",
      "r490",
      "r658",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r799",
      "r877",
      "r878",
      "r879",
      "r947",
      "r948",
      "r949",
      "r950",
      "r951",
      "r952",
      "r953"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Finite-lived intangible asset, useful life"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r251",
      "r419"
     ],
     "calculation": {
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "verboseLabel": "Less Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r96"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsEstimatedAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r96"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "verboseLabel": "2027"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsEstimatedAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r96"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsEstimatedAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r96"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsEstimatedAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r96"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsEstimatedAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r417",
      "r418",
      "r419",
      "r420",
      "r724",
      "r725"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails",
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r94",
      "r725"
     ],
     "calculation": {
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "verboseLabel": "Gross Carrying Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r89",
      "r93"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails",
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r94",
      "r724"
     ],
     "calculation": {
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Net Carrying Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign Tax Authority [Member]",
        "terseLabel": "Foreign Tax Authority"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into.",
        "label": "Foreign Currency Contracts, Liability, Fair Value Disclosure",
        "terseLabel": "Foreign currency exchange forward contracts"
       }
      }
     },
     "localname": "ForeignCurrencyContractsLiabilityFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": {
     "auth_ref": [
      "r670",
      "r671",
      "r672",
      "r673"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), before Tax",
        "terseLabel": "Foreign currency transaction gains (losses)"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r682"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Currency Translation"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ForeignExchangeContractMember": {
     "auth_ref": [
      "r789",
      "r815",
      "r824"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange Contract [Member]",
        "terseLabel": "Foreign currency exchange forward contracts"
       }
      }
     },
     "localname": "ForeignExchangeContractMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails",
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignGovernmentDebtSecuritiesMember": {
     "auth_ref": [
      "r909",
      "r945"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt security issued by government not domiciled in United States of America (US).",
        "label": "Debt Security, Government, Non-US [Member]",
        "terseLabel": "Foreign government debt securities"
       }
      }
     },
     "localname": "ForeignGovernmentDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GeographicConcentrationRiskMember": {
     "auth_ref": [
      "r67",
      "r747"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that a specified dollar value on the balance sheet or income statement in the period from one or more specified geographic areas is to a corresponding consolidated, segment, or product line amount. Risk is the materially adverse effects of economic decline or antagonistic political actions resulting in loss of assets, sales volume, labor supply, or source of materials and supplies in a US state or a specified country, continent, or region such as EMEA (Europe, Middle East, Africa).",
        "label": "Geographic Concentration Risk [Member]",
        "terseLabel": "Geographic Concentration Risk"
       }
      }
     },
     "localname": "GeographicConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AssetImpairmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r250",
      "r404",
      "r726",
      "r800",
      "r826",
      "r882",
      "r889"
     ],
     "calculation": {
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      },
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Goodwill, Ending balance",
        "periodStartLabel": "Goodwill, Beginning balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails",
      "http://www.stryker.com/role/ConsolidatedBalanceSheets",
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r407",
      "r800"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Additions and adjustments"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Goodwill and Other Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "auth_ref": [
      "r86",
      "r91"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Goodwill and Other Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r58",
      "r405",
      "r410",
      "r416",
      "r800"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "negatedTerseLabel": "Goodwill impairment",
        "terseLabel": "Goodwill impairment"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows",
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings",
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails",
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r158",
      "r890"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Translation and Purchase Accounting Adjustments",
        "terseLabel": "Foreign exchange"
       }
      }
     },
     "localname": "GoodwillTranslationAndPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r41",
      "r298",
      "r357",
      "r362",
      "r368",
      "r371",
      "r387",
      "r435",
      "r436",
      "r438",
      "r439",
      "r440",
      "r442",
      "r444",
      "r446",
      "r447",
      "r668",
      "r798",
      "r901"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "terseLabel": "Gross profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings",
      "http://www.stryker.com/role/SummaryofQuarterlyDataUnauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r184",
      "r657"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r184"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r184"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain": {
     "auth_ref": [
      "r103"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name of the impaired assets to be held and used by the entity.",
        "label": "Impaired Long-Lived Assets Held and Used, Asset Name [Domain]",
        "terseLabel": "Impaired Long-Lived Assets Held and Used, Asset Name [Domain]"
       }
      }
     },
     "localname": "ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AssetImpairmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis": {
     "auth_ref": [
      "r103"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the categories used to group impaired long-lived assets held and used by the type of asset.",
        "label": "Impaired Long-Lived Assets Held and Used by Type [Axis]",
        "terseLabel": "Impaired Long-Lived Assets Held and Used by Type [Axis]"
       }
      }
     },
     "localname": "ImpairedLongLivedAssetsHeldAndUsedByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AssetImpairmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InProcessResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process.",
        "label": "In Process Research and Development [Member]",
        "verboseLabel": "In-process research and development"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperations": {
     "auth_ref": [
      "r42",
      "r59",
      "r173",
      "r315",
      "r316",
      "r317",
      "r318",
      "r327",
      "r330"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent.",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent",
        "terseLabel": "Segment operating income"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r299",
      "r641"
     ],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r39",
      "r213",
      "r222",
      "r238",
      "r357",
      "r362",
      "r368",
      "r371",
      "r730",
      "r798"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      },
      "http://www.stryker.com/role/IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Earnings before income taxes",
        "verboseLabel": "Earnings (loss) before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings",
      "http://www.stryker.com/role/IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetails",
      "http://www.stryker.com/role/SummaryofQuarterlyDataUnauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r299",
      "r641"
     ],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "International"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r421",
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]",
        "verboseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameAxis": {
     "auth_ref": [
      "r147"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of taxing authority.",
        "label": "Income Tax Authority, Name [Axis]",
        "terseLabel": "Income Tax Authority, Name [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority, Name [Domain]",
        "terseLabel": "Income Tax Authority, Name [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxContingencyLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Tax Contingency [Line Items]",
        "terseLabel": "Income Tax Contingency [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxContingencyLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxContingencyTable": {
     "auth_ref": [
      "r148",
      "r149",
      "r150",
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Income Tax Contingency [Table]",
        "terseLabel": "Income Tax Contingency [Table]"
       }
      }
     },
     "localname": "IncomeTaxContingencyTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r300",
      "r618",
      "r625",
      "r631",
      "r637",
      "r643",
      "r645",
      "r646",
      "r647"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r914"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations.",
        "label": "Income Tax Examination, Penalties and Interest Accrued",
        "terseLabel": "Accrued interest and penalties"
       }
      }
     },
     "localname": "IncomeTaxExaminationPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r301",
      "r321",
      "r322",
      "r355",
      "r616",
      "r638",
      "r644",
      "r737"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      },
      "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income taxes",
        "totalLabel": "Total income tax expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails",
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings",
      "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r281",
      "r612",
      "r613",
      "r625",
      "r626",
      "r630",
      "r634"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationTaxSettlements": {
     "auth_ref": [
      "r913"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income tax settlements. Including, but not limited to, domestic tax settlement, foreign tax settlement, state and local tax settlement, and other tax settlements.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Settlement, Amount",
        "terseLabel": "Tax settlement amount"
       }
      }
     },
     "localname": "IncomeTaxReconciliationTaxSettlements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r62"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Cash paid for income taxes, net of refunds"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableTrade": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Payable, Trade",
        "verboseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableTrade",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "verboseLabel": "Income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "verboseLabel": "Accrued expenses and other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedLabel": "Other, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InformationByCategoryOfDebtSecurityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by category of debt security, either available-for-sale or held-to-maturity.",
        "label": "Debt Security Category [Axis]",
        "terseLabel": "Debt Security Category [Axis]",
        "verboseLabel": "Schedule of Gain (Loss) on Investments, Including Marketable Securities and Investments Held at Cost, Reported Amounts, by Category [Axis]"
       }
      }
     },
     "localname": "InformationByCategoryOfDebtSecurityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r87",
      "r92"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Other intangibles, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r47",
      "r468",
      "r476",
      "r804",
      "r805"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "terseLabel": "Interest expense, debt"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r290",
      "r292",
      "r294"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid for interest on debt"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r823"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "verboseLabel": "Interest rate swap"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails",
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r85",
      "r787"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r263",
      "r784",
      "r826"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "totalLabel": "Total inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory, Net [Abstract]",
        "terseLabel": "Inventories:"
       }
      }
     },
     "localname": "InventoryNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r246",
      "r262",
      "r333",
      "r399",
      "r400",
      "r401",
      "r722",
      "r792"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves": {
     "auth_ref": [
      "r85",
      "r842"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. This amount is net of valuation reserves and adjustments.",
        "label": "Inventory, Raw Materials and Supplies, Net of Reserves",
        "terseLabel": "Materials and supplies"
       }
      }
     },
     "localname": "InventoryRawMaterialsAndSuppliesNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r85",
      "r788"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work in process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.",
        "label": "Investments Classified by Contractual Maturity Date [Table Text Block]",
        "terseLabel": "Available-for-sale Securities"
       }
      }
     },
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r933"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Lease, Cost"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Minimum lease payments"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LegalFees": {
     "auth_ref": [
      "r44"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.",
        "label": "Legal Fees",
        "negatedTerseLabel": "Regulatory and legal matters"
       }
      }
     },
     "localname": "LegalFees",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r689"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r689"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r689"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r689"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r689"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r689"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r16",
      "r298",
      "r387",
      "r435",
      "r436",
      "r438",
      "r439",
      "r440",
      "r442",
      "r444",
      "r446",
      "r447",
      "r652",
      "r654",
      "r655",
      "r668",
      "r797",
      "r901",
      "r934",
      "r935"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities [Abstract]",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r12",
      "r221",
      "r235",
      "r826",
      "r854",
      "r880",
      "r928"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities &amp; shareholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and shareholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r18",
      "r245",
      "r298",
      "r387",
      "r435",
      "r436",
      "r438",
      "r439",
      "r440",
      "r442",
      "r444",
      "r446",
      "r447",
      "r652",
      "r654",
      "r655",
      "r668",
      "r826",
      "r901",
      "r934",
      "r935"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r202"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Liabilities, Fair Value Disclosure",
        "terseLabel": "Total liabilities measured at fair value"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Fair Value Disclosure [Abstract]",
        "terseLabel": "Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Line of Credit Facility [Line Items]",
        "terseLabel": "Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r14"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "auth_ref": [
      "r14"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).",
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "verboseLabel": "Borrowing capacity on existing facilities"
       }
      }
     },
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "auth_ref": [
      "r14",
      "r853"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Line of Credit Facility [Table]",
        "terseLabel": "Line of Credit Facility [Table]"
       }
      }
     },
     "localname": "LineOfCreditFacilityTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r4",
      "r220",
      "r233",
      "r461",
      "r475",
      "r802",
      "r803"
     ],
     "calculation": {
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.",
        "label": "Long-Term Debt",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Unclassified [Abstract]",
        "terseLabel": "Long-term Debt, Unclassified [Abstract]"
       }
      }
     },
     "localname": "LongTermDebtAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": {
     "auth_ref": [
      "r107",
      "r303",
      "r904"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r107",
      "r303",
      "r466"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": {
     "auth_ref": [
      "r107",
      "r303",
      "r466"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r107",
      "r303",
      "r466"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r107",
      "r303",
      "r466"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r107",
      "r303",
      "r466"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r256"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt, excluding current maturities",
        "verboseLabel": "Total long-term debt"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets",
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r105",
      "r106",
      "r429",
      "r430",
      "r431",
      "r896",
      "r897"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyEstimateOfPossibleLoss": {
     "auth_ref": [
      "r430",
      "r431",
      "r434"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.",
        "label": "Loss Contingency, Estimate of Possible Loss",
        "terseLabel": "Estimate of possible loss"
       }
      }
     },
     "localname": "LossContingencyEstimateOfPossibleLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyLossInPeriod": {
     "auth_ref": [
      "r895"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of loss pertaining to the specified contingency that was charged against earnings in the period, including the effects of revisions in previously reported estimates.",
        "label": "Loss Contingency, Loss in Period",
        "terseLabel": "Charges during period"
       }
      }
     },
     "localname": "LossContingencyLossInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MachineryAndEquipmentGross": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment, Gross",
        "terseLabel": "Machinery and equipment"
       }
      }
     },
     "localname": "MachineryAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment [Member]",
        "terseLabel": "Machinery and Equipment"
       }
      }
     },
     "localname": "MachineryAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MarketableSecuritiesGainLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized and realized gain (loss) on investment in marketable security, including other-than-temporary impairment (OTTI).",
        "label": "Marketable Securities, Gain (Loss)",
        "terseLabel": "Marketable securities, gain (loss)"
       }
      }
     },
     "localname": "MarketableSecuritiesGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesPolicy": {
     "auth_ref": [
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment classified as marketable security.",
        "label": "Marketable Securities, Policy [Policy Text Block]",
        "terseLabel": "Marketable Securities"
       }
      }
     },
     "localname": "MarketableSecuritiesPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MaterialReconcilingItemsMember": {
     "auth_ref": [
      "r77"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Items used in reconciling reportable segments' amounts to consolidated amount. Excludes corporate-level activity.",
        "label": "Segment Reconciling Items [Member]",
        "terseLabel": "Segment Reconciling Items"
       }
      }
     },
     "localname": "MaterialReconcilingItemsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum amount of time remaining before foreign currency exchange rate derivatives mature or expire, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Maximum Remaining Maturity of Foreign Currency Derivatives",
        "terseLabel": "Maximum term"
       }
      }
     },
     "localname": "MaximumRemainingMaturityOfForeignCurrencyDerivatives1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_NatureOfOperations": {
     "auth_ref": [
      "r339",
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.",
        "label": "Nature of Operations [Text Block]",
        "terseLabel": "Nature of Operations"
       }
      }
     },
     "localname": "NatureOfOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r291"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by (used in) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r291"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r55",
      "r56",
      "r59"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r40",
      "r59",
      "r223",
      "r237",
      "r243",
      "r276",
      "r279",
      "r284",
      "r298",
      "r313",
      "r315",
      "r316",
      "r317",
      "r318",
      "r321",
      "r322",
      "r327",
      "r357",
      "r362",
      "r368",
      "r371",
      "r387",
      "r435",
      "r436",
      "r438",
      "r439",
      "r440",
      "r442",
      "r444",
      "r446",
      "r447",
      "r662",
      "r668",
      "r798",
      "r901"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net earnings (loss)",
        "totalLabel": "Net earnings",
        "verboseLabel": "Net earnings"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows",
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings",
      "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity",
      "http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails",
      "http://www.stryker.com/role/SummaryofQuarterlyDataUnauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetInvestmentHedgingMember": {
     "auth_ref": [
      "r183"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedges of a net investment in a foreign operation.",
        "label": "Net Investment Hedging [Member]",
        "terseLabel": "Net Investment Hedging"
       }
      }
     },
     "localname": "NetInvestmentHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "New Accounting Pronouncements Not Yet Adopted and Accounting Pronouncements Recently Adopted"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Countries excluding the United States of America (US).",
        "label": "Non-US [Member]",
        "terseLabel": "International"
       }
      }
     },
     "localname": "NonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r184"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Not Designated as Hedging Instrument"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "terseLabel": "Other (income) expense, net",
        "verboseLabel": "Other income (expense), net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails",
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r869"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r357",
      "r362",
      "r368",
      "r371",
      "r798"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Segment net earnings (loss)",
        "totalLabel": "Operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings",
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r932"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease, Expense",
        "terseLabel": "Lease expense"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r685"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Lease liabilities, current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CommitmentsandContingenciesLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r686"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes current operating lease liability.",
        "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CommitmentsandContingenciesLeaseCostDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r685"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Lease liabilities, noncurrent"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CommitmentsandContingenciesLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r686"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes noncurrent operating lease liability.",
        "label": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CommitmentsandContingenciesLeaseCostDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r684"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "verboseLabel": "Right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CommitmentsandContingenciesLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r686"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes operating lease right-of-use asset.",
        "label": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CommitmentsandContingenciesLeaseCostDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r688",
      "r825"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted-average discount rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CommitmentsandContingenciesLeaseCostDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r687",
      "r825"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted-average remaining lease term (years)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CommitmentsandContingenciesLeaseCostDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r153"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Operating loss carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r371"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r252"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "verboseLabel": "Other noncurrent assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r30",
      "r32",
      "r547"
     ],
     "calculation": {
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), after Tax",
        "negatedTerseLabel": "Prior service cost and transition amount"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r29",
      "r32",
      "r174",
      "r176"
     ],
     "calculation": {
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent",
        "negatedTotalLabel": "Total recognized in OCI"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r27",
      "r32",
      "r547"
     ],
     "calculation": {
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax",
        "terseLabel": "Net actuarial gain (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r35",
      "r38",
      "r283",
      "r675",
      "r677",
      "r681",
      "r843"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "terseLabel": "OCI"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax": {
     "auth_ref": [
      "r33",
      "r282"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss) before Reclassifications, Tax",
        "terseLabel": "Income taxes"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax": {
     "auth_ref": [
      "r32",
      "r36",
      "r125"
     ],
     "calculation": {
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of increase (decrease) to other comprehensive income from settlement and curtailment gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), after Tax",
        "terseLabel": "Curtailment gain"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r25"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Financial statement translation"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r38",
      "r112",
      "r277",
      "r280",
      "r286",
      "r675",
      "r680",
      "r681",
      "r727",
      "r734",
      "r843",
      "r844"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive income (loss)",
        "totalLabel": "Total other comprehensive income (loss), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails",
      "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity",
      "http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income (loss), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "auth_ref": [
      "r29",
      "r32"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "negatedTerseLabel": "Pension plans"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax": {
     "auth_ref": [
      "r32",
      "r36",
      "r275",
      "r547"
     ],
     "calculation": {
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax",
        "negatedTerseLabel": "Recognized net actuarial loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, Tax",
        "totalLabel": "Total recognized in net periodic benefit cost and OCI"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r270",
      "r273"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax",
        "terseLabel": "Marketable securities"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentAssetsMember": {
     "auth_ref": [
      "r186",
      "r198"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current assets.",
        "label": "Other Current Assets [Member]",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current liabilities.",
        "label": "Other Current Liabilities [Member]",
        "terseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherDebtSecuritiesMember": {
     "auth_ref": [
      "r876",
      "r881",
      "r909",
      "r927"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments in debt securities classified as other.",
        "label": "Other Debt Obligations [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible assets classified as other.",
        "label": "Other Intangible Assets [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r17",
      "r826"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "verboseLabel": "Accrued expenses and other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r21"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other noncurrent liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLongTermDebt": {
     "auth_ref": [
      "r4",
      "r220",
      "r233"
     ],
     "calculation": {
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt classified as other.",
        "label": "Other Long-Term Debt",
        "terseLabel": "Other long-term debt"
       }
      }
     },
     "localname": "OtherLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLongTermInvestmentsMember": {
     "auth_ref": [
      "r945"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term investments classified as other.",
        "label": "Other Long-Term Investments [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherLongTermInvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofTargetandActualAllocationofPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNoncurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent assets.",
        "label": "Other Noncurrent Assets [Member]",
        "terseLabel": "Other noncurrent assets"
       }
      }
     },
     "localname": "OtherNoncurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "terseLabel": "Other noncurrent liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain": {
     "auth_ref": [
      "r84"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Provides the categories of debt securities, available-for-sale or held-to-maturity, on which an entity may recognize other than temporary impairments (OTTI) for which a portion related to credit losses has been recognized in earnings and a portion related to all other factors has been recognized in other comprehensive income.",
        "label": "Other than Temporary Impairment, Credit Losses Recognized in Earnings, Categories of Investments [Domain]",
        "terseLabel": "Other than Temporary Impairment, Credit Losses Recognized in Earnings, Categories of Investments [Domain]",
        "verboseLabel": "Gain (Loss) on Investments, Including Marketable Securities and Investments Held at Cost, Categories of Investments [Domain]"
       }
      }
     },
     "localname": "OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PatentsMember": {
     "auth_ref": [
      "r165"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.",
        "label": "Patents [Member]",
        "terseLabel": "Patents"
       }
      }
     },
     "localname": "PatentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r846",
      "r847"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedTerseLabel": "Other investing, net"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividends": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.",
        "label": "Payments of Dividends",
        "negatedLabel": "Payments of dividends"
       }
      }
     },
     "localname": "PaymentsOfDividends",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r289"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-Based Payment Arrangement",
        "negatedTerseLabel": "Cash paid for taxes from withheld shares"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Acquisitions, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireMarketableSecurities": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for purchase of marketable security.",
        "label": "Payments to Acquire Marketable Securities",
        "negatedLabel": "Purchases of marketable securities"
       }
      }
     },
     "localname": "PaymentsToAcquireMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property, plant and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r528",
      "r530",
      "r536",
      "r552",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r568",
      "r569",
      "r571",
      "r573",
      "r817"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "Retirement Plans"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlans"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PlanAssetCategoriesDomain": {
     "auth_ref": [
      "r528",
      "r529",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r553",
      "r815",
      "r816",
      "r817"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined benefit plan asset investment.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Domain]",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Domain]"
       }
      }
     },
     "localname": "PlanAssetCategoriesDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofTargetandActualAllocationofPlanAssetsDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r8",
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par per share"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "auth_ref": [
      "r264",
      "r402",
      "r403",
      "r786"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromHedgeInvestingActivities": {
     "auth_ref": [
      "r293",
      "r846"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow for a financial contract that meets the hedge criteria as either a cash flow hedge, fair value hedge, or hedge of a net investment in a foreign operation.",
        "label": "Proceeds from Hedge, Investing Activities",
        "terseLabel": "Proceeds from settlement of net investment hedges"
       }
      }
     },
     "localname": "ProceedsFromHedgeInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows",
      "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-Term Debt",
        "terseLabel": "Proceeds from issuance of long-term debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r848",
      "r850"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other financing, net"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfShortTermDebt": {
     "auth_ref": [],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Proceeds from (Repayments of) Short-Term Debt",
        "terseLabel": "Proceeds and payments on short-term borrowings, net"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.",
        "label": "Proceeds from Sale and Maturity of Marketable Securities",
        "terseLabel": "Proceeds from sales of marketable securities"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductLiabilityAccrualPeriodExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of loss reported during the period pertaining to product liability.",
        "label": "Product Liability Accrual, Period Expense",
        "terseLabel": "Recall charges, net"
       }
      }
     },
     "localname": "ProductLiabilityAccrualPeriodExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows",
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Property, plant and equipment:"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r102"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r100",
      "r248"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "totalLabel": "Total property, plant and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AssetImpairmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r102",
      "r236",
      "r732",
      "r826"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Net Property, Plant &amp; Equipment",
        "totalLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets",
      "http://www.stryker.com/role/SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r102",
      "r749",
      "r750"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r100"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Property, plant and equipment useful life"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_PurchaseObligationFiscalYearMaturityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase Obligation, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Purchase obligations"
       }
      }
     },
     "localname": "PurchaseObligationFiscalYearMaturityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_QuarterlyFinancialDataAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Quarterly Financial Data [Abstract]",
        "terseLabel": "Quarterly Financial Data [Abstract]"
       }
      }
     },
     "localname": "QuarterlyFinancialDataAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_QuarterlyFinancialInformationTextBlock": {
     "auth_ref": [
      "r66",
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.",
        "label": "Quarterly Financial Information [Text Block]",
        "terseLabel": "Summary of Quarterly Data (Unaudited)"
       }
      }
     },
     "localname": "QuarterlyFinancialInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/SummaryofQuarterlyDataUnaudited"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "auth_ref": [
      "r871",
      "r872",
      "r873",
      "r874"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.",
        "label": "Receivable [Policy Text Block]",
        "terseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "ReceivablesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis": {
     "auth_ref": [
      "r284"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by item reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Axis]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Axis]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain": {
     "auth_ref": [
      "r284"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Item reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Domain]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Domain]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r284"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies item reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Member]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r75",
      "r77"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]",
        "terseLabel": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]"
       }
      }
     },
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofUnresolvedIncomeTaxPositionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear": {
     "auth_ref": [
      "r894"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of recorded unconditional purchase obligation maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Recorded Unconditional Purchase Obligation, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "RecordedUnconditionalPurchaseObligationDueAfterFifthYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear": {
     "auth_ref": [
      "r428"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of recorded unconditional purchase obligation to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Recorded Unconditional Purchase Obligation, to be Paid, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "RecordedUnconditionalPurchaseObligationDueInFifthYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear": {
     "auth_ref": [
      "r428"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of recorded unconditional purchase obligation to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Recorded Unconditional Purchase Obligation, to be Paid, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "RecordedUnconditionalPurchaseObligationDueInFourthYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear": {
     "auth_ref": [
      "r428"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of recorded unconditional purchase obligation to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Recorded Unconditional Purchase Obligation, to be Paid, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "RecordedUnconditionalPurchaseObligationDueInSecondYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear": {
     "auth_ref": [
      "r428"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of recorded unconditional purchase obligation to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Recorded Unconditional Purchase Obligation, to be Paid, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "RecordedUnconditionalPurchaseObligationDueInThirdYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear": {
     "auth_ref": [
      "r428"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of recorded unconditional purchase obligation to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Recorded Unconditional Purchase Obligation, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "RecordedUnconditionalPurchaseObligationDueWithinOneYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfDebt": {
     "auth_ref": [
      "r849"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.",
        "label": "Repayments of Debt",
        "terseLabel": "Repayments of debt"
       }
      }
     },
     "localname": "RepaymentsOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-Term Debt",
        "negatedTerseLabel": "Payments on long-term debt",
        "terseLabel": "Repayments of long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsNarrativeDetails",
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReportingUnitAxis": {
     "auth_ref": [
      "r415",
      "r416",
      "r800"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by reporting unit.",
        "label": "Reporting Unit [Axis]",
        "terseLabel": "Reporting Unit [Axis]"
       }
      }
     },
     "localname": "ReportingUnitAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReportingUnitDomain": {
     "auth_ref": [
      "r415",
      "r416",
      "r800"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Level of reporting at which goodwill is tested for impairment.",
        "label": "Reporting Unit [Domain]",
        "terseLabel": "Reporting Unit [Domain]"
       }
      }
     },
     "localname": "ReportingUnitDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r144",
      "r239",
      "r942"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research, development and engineering expenses"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research, Development and Engineering Expenses"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted Stock Units (RSUs)",
        "verboseLabel": "Restricted Stock Units (RSUs)"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails",
      "http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails",
      "http://www.stryker.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringCosts": {
     "auth_ref": [
      "r58"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Costs",
        "negatedTerseLabel": "Restructuring-related and other charges"
       }
      }
     },
     "localname": "RestructuringCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r11",
      "r119",
      "r234",
      "r742",
      "r744",
      "r826"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "verboseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r240",
      "r310",
      "r311",
      "r312",
      "r314",
      "r320",
      "r322",
      "r388",
      "r606",
      "r607",
      "r608",
      "r635",
      "r636",
      "r660",
      "r739",
      "r741"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerMember": {
     "auth_ref": [
      "r377",
      "r868"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue from Contract with Customer Benchmark [Member]",
        "terseLabel": "Revenue from Contract with Customer Benchmark"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AssetImpairmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r507",
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognition"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRecognitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue Recognition [Abstract]",
        "terseLabel": "Revenue Recognition [Abstract]"
       }
      }
     },
     "localname": "RevenueRecognitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r793",
      "r794"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r285",
      "r298",
      "r348",
      "r349",
      "r361",
      "r366",
      "r367",
      "r373",
      "r374",
      "r377",
      "r387",
      "r435",
      "r436",
      "r438",
      "r439",
      "r440",
      "r442",
      "r444",
      "r446",
      "r447",
      "r668",
      "r730",
      "r901"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Net sales"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings",
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails",
      "http://www.stryker.com/role/SummaryofQuarterlyDataUnauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r35",
      "r930",
      "r931"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCITables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable": {
     "auth_ref": [
      "r89"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the major classes of acquired finite-lived intangible assets showing the amount, any significant residual value, weighted average amortization period, and other characteristics. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.",
        "label": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]",
        "terseLabel": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock": {
     "auth_ref": [
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans. This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.",
        "label": "Schedule of Allocation of Plan Assets [Table Text Block]",
        "terseLabel": "Schedule of Allocation of Plan Assets"
       }
      }
     },
     "localname": "ScheduleOfAllocationOfPlanAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r65"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Capital Stock [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r159",
      "r160",
      "r648"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails",
      "http://www.stryker.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": {
     "auth_ref": [
      "r159",
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]",
        "terseLabel": "Allocation Of The Preliminary Purchase Price To The Acquired Net Assets Of Acquisitions"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock": {
     "auth_ref": [
      "r122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of beginning and ending balances of the fair value of plan assets of pension plans and/or other employee benefit plans showing separately, if applicable, the effects during the period attributable to each of the following: actual return on plan assets, foreign currency exchange rate changes, contributions by the employer, contributions by plan participants, benefits paid, business combinations, divestitures, and settlements.",
        "label": "Schedule of Changes in Fair Value of Plan Assets [Table Text Block]",
        "terseLabel": "Schedule of Changes in Fair Value of Plan Assets"
       }
      }
     },
     "localname": "ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock": {
     "auth_ref": [
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in the benefit obligation of pension plans and/or other employee benefit plans from the beginning to the end of the period, showing separately, if applicable, the effects of the following: service cost, interest cost, contributions by plan participants, actuarial gains and losses, foreign currency exchange rate changes, benefits paid, plan amendments, business combinations, divestitures, curtailments, settlements, and special and contractual termination benefits.",
        "label": "Schedule of Changes in Projected Benefit Obligations [Table Text Block]",
        "terseLabel": "Schedule of Changes in Accumulated Postemployment Benefit Obligations"
       }
      }
     },
     "localname": "ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of Provision for Income Taxes"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock": {
     "auth_ref": [
      "r126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the costs related to the various types of retirement plans including defined benefit pension plan cost, defined contribution plan cost, other postretirement benefit plan cost, and net periodic benefit cost.",
        "label": "Schedule of Costs of Retirement Plans [Table Text Block]",
        "terseLabel": "Schedule of Costs of Retirement Plans"
       }
      }
     },
     "localname": "ScheduleOfCostsOfRetirementPlansTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r20",
      "r113",
      "r116",
      "r117",
      "r118",
      "r209",
      "r210",
      "r211",
      "r227",
      "r802",
      "r804",
      "r856"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table Text Block]",
        "verboseLabel": "Maturities Of Long-Term Debt Disclosures"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r152"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Difference in Income Tax Effects Comprising Company's Deferred Income Tax Assets and Liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r126",
      "r127",
      "r128",
      "r129",
      "r130"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansNarrativeDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofTargetandActualAllocationofPlanAssetsDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock": {
     "auth_ref": [
      "r126",
      "r127",
      "r128",
      "r129",
      "r130"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of one or more of the entity's defined benefit pension plans or one or more other defined benefit postretirement plans, separately for pension plans and other postretirement benefit plans including the entity's schedule of fair value of plan assets for defined benefit or other postretirement plans.",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table Text Block]",
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "auth_ref": [
      "r192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "terseLabel": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "auth_ref": [
      "r188"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of derivative instruments (including nonderivative instruments that are designated and qualify as hedging instruments) of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.",
        "label": "Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location [Table Text Block]",
        "terseLabel": "Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location"
       }
      }
     },
     "localname": "ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r145"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Reconciliation of U.S. Statutory Income Tax Rate to Company's Effective Income Tax Rate from Continuing Operations"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock": {
     "auth_ref": [
      "r79"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the names of foreign countries in which material long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets are located, and amount of such long-lived assets located in that country or foreign geographic area.",
        "label": "Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country [Table Text Block]",
        "terseLabel": "Geographic Information on Net Sales and Long-Lived Assets"
       }
      }
     },
     "localname": "ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock": {
     "auth_ref": [
      "r124"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.",
        "label": "Schedule of Expected Benefit Payments [Table Text Block]",
        "terseLabel": "Schedule of Expected Benefit Payments"
       }
      }
     },
     "localname": "ScheduleOfExpectedBenefitPaymentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r663",
      "r664"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r89",
      "r93"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Summary of the Company's Other Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r800"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r800",
      "r882",
      "r883",
      "r884",
      "r885",
      "r886",
      "r887",
      "r888",
      "r889",
      "r890",
      "r891",
      "r892"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Changes in the Net Carrying Amount of Goodwill by Segment"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r102"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AssetImpairmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock": {
     "auth_ref": [
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.",
        "label": "Quarterly Financial Information [Table Text Block]",
        "terseLabel": "Summary of Quarterly Data"
       }
      }
     },
     "localname": "ScheduleOfQuarterlyFinancialInformationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/SummaryofQuarterlyDataUnauditedTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r73",
      "r74",
      "r76",
      "r86"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataSegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r73",
      "r74",
      "r76",
      "r86"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Sales and Other Financial Information by Business Segment"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock": {
     "auth_ref": [
      "r133",
      "r134",
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.",
        "label": "Share-Based Payment Arrangement, Activity [Table Text Block]",
        "terseLabel": "Summary of RSU and PSU Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r132",
      "r134",
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Summary of Stock Option Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r138"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Fair Value Assumptions"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShortTermDebtTable": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.",
        "label": "Schedule of Short-Term Debt [Table]",
        "terseLabel": "Schedule of Short-term Debt [Table]"
       }
      }
     },
     "localname": "ScheduleOfShortTermDebtTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r109",
      "r110",
      "r111",
      "r113",
      "r114",
      "r115",
      "r116",
      "r117",
      "r118",
      "r119",
      "r257",
      "r258",
      "r259",
      "r337",
      "r477",
      "r478",
      "r479",
      "r481",
      "r485",
      "r490",
      "r492",
      "r806",
      "r841",
      "r852"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r93"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Estimated Amortization Expense"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember": {
     "auth_ref": [
      "r925"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap that has its variable-rate leg referenced to Secured Overnight Financing Rate (SOFR) with no additional spread over SOFR on variable-rate leg.",
        "label": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]",
        "terseLabel": "SOFR"
       }
      }
     },
     "localname": "SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r345",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r371",
      "r377",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r424",
      "r425",
      "r800",
      "r944"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]",
        "verboseLabel": "Segment [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails",
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r345",
      "r346",
      "r347",
      "r357",
      "r360",
      "r365",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r376",
      "r377",
      "r378"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment and Geographic Data"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicData"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataSegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock": {
     "auth_ref": [
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption.",
        "label": "Selling, General and Administrative Expenses, Policy [Policy Text Block]",
        "terseLabel": "Selling, General and Administrative Expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r822"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "terseLabel": "Vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r592"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedTerseLabel": "Shares, Cancelled (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r592"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average grant date fair value, Cancelled (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r590"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Shares, Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r590"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average grant date fair value, Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails",
      "http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r587",
      "r588"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Shares, Nonvested at December 31 (in shares)",
        "periodStartLabel": "Shares, Nonvested at January 1 (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r587",
      "r588"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Weighted average grant date fair value, Outstanding at December 31 (in dollars per share)",
        "periodStartLabel": "Weighted average grant date fair value, Outstanding at January 1 (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r591"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedTerseLabel": "Shares, Vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r591"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average grant date fair value, Vested (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r601"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Expected dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockOptionGrantAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected stock price volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockOptionGrantAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r602"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockOptionGrantAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Shares, Exercisable at December 31 (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price, Exercisable at December 31 (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r594"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value of options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "negatedTerseLabel": "Shares, Cancelled or forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "auth_ref": [
      "r912"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of share options (or share units) granted during the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures",
        "terseLabel": "Shares, Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted-average fair value per share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockOptionGrantAssumptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r140"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value, Options outstanding at December 31"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r579",
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Shares, Options outstanding at December 31 (in shares)",
        "periodStartLabel": "Shares, Options outstanding at January 1 (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r579",
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Weighted average exercise price, Options outstanding at December 31 (in dollars per share)",
        "periodStartLabel": "Weighted average exercise price, Options outstanding at January 1 (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted Average Exercise\u00a0Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [
      "r595"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value, Options expected to vest"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "terseLabel": "Shares, Options expected to vest (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price, Options expected to vest (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": {
     "auth_ref": [
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period",
        "terseLabel": "Shares issued under the ESPP"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r575",
      "r576",
      "r577",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Equity Award [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails",
      "http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails",
      "http://www.stryker.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price, Exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price, Cancelled or forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price, Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r578",
      "r597",
      "r598",
      "r599",
      "r600",
      "r603",
      "r609",
      "r610"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Share-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": {
     "auth_ref": [
      "r139"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit",
        "terseLabel": "Options exercised during period, exercise price range, lower range limit"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit": {
     "auth_ref": [
      "r139"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit",
        "terseLabel": "Options exercised during period, exercise price range, upper range limit"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r599"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected option life (years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockOptionGrantAssumptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r140"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value, Exercisable at December 31"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted-average remaining contractual term, Exercisable at December 31 (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted-average remaining contractual term, Options outstanding at December 31 (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted-average remaining contractual term, Options expected to vest (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r64",
      "r295"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r242",
      "r345",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r371",
      "r377",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r422",
      "r424",
      "r425",
      "r800",
      "r944"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]",
        "verboseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails",
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataSegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r257",
      "r258",
      "r259",
      "r298",
      "r325",
      "r326",
      "r328",
      "r330",
      "r337",
      "r338",
      "r387",
      "r435",
      "r438",
      "r439",
      "r440",
      "r446",
      "r447",
      "r477",
      "r478",
      "r481",
      "r485",
      "r492",
      "r668",
      "r762",
      "r841",
      "r852",
      "r866"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r23",
      "r112",
      "r240",
      "r282",
      "r283",
      "r284",
      "r310",
      "r311",
      "r312",
      "r314",
      "r320",
      "r322",
      "r336",
      "r388",
      "r493",
      "r606",
      "r607",
      "r608",
      "r635",
      "r636",
      "r660",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r681",
      "r690",
      "r739",
      "r740",
      "r741"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails",
      "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity",
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity",
      "http://www.stryker.com/role/ContingenciesandCommitmentsNarrativeDetails",
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails",
      "http://www.stryker.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.stryker.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r310",
      "r311",
      "r312",
      "r336",
      "r723"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity",
      "http://www.stryker.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.stryker.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r8",
      "r9",
      "r112",
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture",
        "verboseLabel": "Issuance of common stock under stock compensation and benefit plans, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r8",
      "r9",
      "r112",
      "r119",
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "negatedTerseLabel": "Shares, Exercised (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r8",
      "r9",
      "r119",
      "r135"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "verboseLabel": "Issuance of common stock under stock compensation and benefit plans"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Remaining shares authorized to be repurchased"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Shareholders' equity"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r171",
      "r172",
      "r178",
      "r240",
      "r241",
      "r283",
      "r310",
      "r311",
      "r312",
      "r314",
      "r320",
      "r388",
      "r493",
      "r606",
      "r607",
      "r608",
      "r635",
      "r636",
      "r660",
      "r675",
      "r676",
      "r681",
      "r690",
      "r740",
      "r741",
      "r854",
      "r880",
      "r928"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total shareholders' equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets",
      "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r120",
      "r297",
      "r478",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r491",
      "r493",
      "r659"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Capital Stock"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/CapitalStock"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SummaryOfIncomeTaxContingenciesTextBlock": {
     "auth_ref": [
      "r146",
      "r149",
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Summary of Income Tax Contingencies [Table Text Block]",
        "terseLabel": "Schedule of Unresolved Income Tax Positions"
       }
      }
     },
     "localname": "SummaryOfIncomeTaxContingenciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental cash flow disclosure:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "auth_ref": [
      "r153"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Tax Credit Carryforward, Amount",
        "terseLabel": "Tax credit carryforward, amount"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxCreditCarryforwardValuationAllowance": {
     "auth_ref": [
      "r151"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from tax credit carryforwards for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Tax Credit Carryforward, Valuation Allowance",
        "terseLabel": "Tax credit carryforward, valuation allowance"
       }
      }
     },
     "localname": "TaxCreditCarryforwardValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r163"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "terseLabel": "Trade name"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TrademarksMember": {
     "auth_ref": [
      "r163"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.",
        "label": "Trademarks [Member]",
        "terseLabel": "Trademarks"
       }
      }
     },
     "localname": "TrademarksMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradingSecuritiesDebt": {
     "auth_ref": [
      "r80",
      "r254",
      "r382",
      "r785"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in net income (trading).",
        "label": "Debt Securities, Trading",
        "terseLabel": "Trading marketable securities"
       }
      }
     },
     "localname": "TradingSecuritiesDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r384",
      "r385",
      "r473",
      "r490",
      "r658",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r877",
      "r878",
      "r879",
      "r947",
      "r948",
      "r949",
      "r950",
      "r951",
      "r952",
      "r953"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax": {
     "auth_ref": [
      "r269",
      "r656"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification from accumulated other comprehensive income (AOCI) of gain (loss) from increase (decrease) in fair value of net investment hedge.",
        "label": "Gain (Loss) on Derivative Used in Net Investment Hedge, after Tax",
        "terseLabel": "After-tax gain (loss) recognized in AOCI related to designated net investment hedges"
       }
      }
     },
     "localname": "TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_USGovernmentAgenciesDebtSecuritiesMember": {
     "auth_ref": [
      "r795",
      "r815",
      "r943"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debentures, notes, and other debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae). Excludes US treasury securities and debt issued by government-sponsored Enterprises (GSEs), for example, but is not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB).",
        "label": "US Government Agencies Debt Securities [Member]",
        "verboseLabel": "United States agency debt securities"
       }
      }
     },
     "localname": "USGovernmentAgenciesDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USTreasurySecuritiesMember": {
     "auth_ref": [
      "r795",
      "r815",
      "r817",
      "r943"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years).",
        "label": "US Treasury Securities [Member]",
        "verboseLabel": "United States treasury debt securities"
       }
      }
     },
     "localname": "USTreasurySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnamortizedDebtIssuanceExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.",
        "label": "Unamortized Debt Issuance Expense",
        "verboseLabel": "Unamortized debt issuance costs"
       }
      }
     },
     "localname": "UnamortizedDebtIssuanceExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r611",
      "r620"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Ending uncertain tax positions",
        "periodStartLabel": "Beginning uncertain tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofUnresolvedIncomeTaxPositionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation": {
     "auth_ref": [
      "r915"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from foreign currency translation.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Foreign Currency Translation",
        "negatedTerseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofUnresolvedIncomeTaxPositionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r621"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "negatedTerseLabel": "Decreases related to prior year income tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofUnresolvedIncomeTaxPositionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": {
     "auth_ref": [
      "r623"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities",
        "negatedTerseLabel": "Settlements of income tax audits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofUnresolvedIncomeTaxPositionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense": {
     "auth_ref": [
      "r619"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense",
        "negatedTerseLabel": "Interest expense and penalties included in other income (expense), net"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r622"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Increases related to current year income tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofUnresolvedIncomeTaxPositionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r621"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Increases related to prior year income tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofUnresolvedIncomeTaxPositionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense": {
     "auth_ref": [
      "r914"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense for an underpayment of income taxes.",
        "label": "Unrecognized Tax Benefits, Interest on Income Taxes Expense",
        "terseLabel": "Unrecognized tax benefits, interest on income tax expense"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "auth_ref": [
      "r624"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "negatedTerseLabel": "Statute of limitations expirations and other"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofUnresolvedIncomeTaxPositionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnsecuredDebt": {
     "auth_ref": [
      "r4",
      "r220",
      "r233"
     ],
     "calculation": {
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of uncollateralized debt obligations (with maturities initially due after one year or beyond the operating cycle if longer).",
        "label": "Unsecured Debt",
        "terseLabel": "Unsecured debt"
       }
      }
     },
     "localname": "UnsecuredDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r70",
      "r71",
      "r72",
      "r340",
      "r341",
      "r342",
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesAdjustments": {
     "auth_ref": [
      "r862"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in valuation and qualifying accounts and reserves from adjustment.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Increase (Decrease) Adjustment",
        "terseLabel": "Effect of Changes in Foreign Currency Exchange Rates"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesBalance": {
     "auth_ref": [
      "r304",
      "r309"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount",
        "periodEndLabel": "Balance at End of Period",
        "periodStartLabel": "Balance\u00a0at Beginning of Period"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesBalance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": {
     "auth_ref": [
      "r307"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense",
        "terseLabel": "Charged\u00a0to Costs &amp; Expenses"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDeductions": {
     "auth_ref": [
      "r308"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction",
        "terseLabel": "Uncollectible Amounts Written Off, Net of Recoveries"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDeductions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDomain": {
     "auth_ref": [
      "r304",
      "r305",
      "r306",
      "r308",
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesTypeAxis": {
     "auth_ref": [
      "r304",
      "r305",
      "r306",
      "r308",
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r867"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted, Adjustment",
        "terseLabel": "Effect of dilutive employee stock compensation (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r324",
      "r330"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "totalLabel": "Diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted-average shares outstanding (in millions):"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r323",
      "r330"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "verboseLabel": "Basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 7
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(a)",
   "Topic": "720",
   "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126976462&loc=d3e36027-109320",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e7008-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "https://asc.fasb.org/topic&trid=2303972",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613673-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(iii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=127000641&loc=SL5629052-113961",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "https://asc.fasb.org/topic&trid=2229140",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "825",
   "URI": "https://asc.fasb.org/topic&trid=2134543",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62652-112803",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=116652737&loc=d3e64164-112818",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(21))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL34724391-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i),(j),(k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "27",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3581-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(n))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(1)))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(2)))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column D))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e543-108305",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900988&loc=d3e1280-108306",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900988&loc=SL124452896-108306",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e689-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL6284393-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "https://asc.fasb.org/topic&trid=2126998",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.13)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25383-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "https://asc.fasb.org/topic&trid=2134417",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1731-114919",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "https://asc.fasb.org/topic&trid=2235017",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e7008-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109998896-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "270",
   "URI": "https://asc.fasb.org/topic&trid=2126967",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14217-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=126980362&loc=d3e28228-110885",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123602790&loc=d3e30226-110892",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "https://asc.fasb.org/topic&trid=2175825",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r762": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r763": {
   "Footnote": "2",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r764": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "29",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r765": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column B",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r766": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column C",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r767": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column D",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r768": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column E",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r769": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column F",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r770": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column G",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r771": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column H",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r772": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column I",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r773": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "09",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r774": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(i)",
   "Subsection": "01",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r775": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(i)",
   "Subsection": "02",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r776": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(A)",
   "Subsection": "01",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r777": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(A)",
   "Subsection": "02",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r778": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(B)",
   "Subsection": "01",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r779": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(B)",
   "Subsection": "02",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8475-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r780": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(C)",
   "Subsection": "02",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r781": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "01",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r782": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "02",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r796": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r797": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r798": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r799": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r800": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r801": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r802": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r803": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r804": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r805": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r806": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r807": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r808": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r809": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r810": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r811": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r812": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r813": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r814": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r815": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r816": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r817": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r818": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4587-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r819": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26626-111562",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r820": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r821": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r822": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r823": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r824": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r825": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r826": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r827": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r828": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r829": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r830": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r831": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r832": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r833": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r834": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r835": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r836": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r837": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r838": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r839": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27340-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r840": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r841": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r842": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r843": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r844": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r845": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r846": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r847": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r848": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r849": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r850": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r851": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r852": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r853": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r854": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r855": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r856": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r857": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r858": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(1)))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r859": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(2)))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r860": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column D))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r861": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r862": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r863": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r864": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r865": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r866": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r867": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r868": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r869": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r870": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r871": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r872": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r873": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r874": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r875": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r876": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r877": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r878": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r879": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r880": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r881": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r882": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r883": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r884": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r885": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r886": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r887": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r888": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r889": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r890": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r891": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r892": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r893": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r894": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25383-109308",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r895": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r896": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r897": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r898": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r899": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r900": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r901": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r902": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r903": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r904": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r905": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r906": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r907": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "705",
   "URI": "https://asc.fasb.org/topic&trid=2122478",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r908": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r909": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r910": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r911": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r912": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r913": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r914": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r915": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r916": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r917": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r918": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r919": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r920": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r921": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r922": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r923": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r924": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r925": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=124256753&loc=SL5864739-113975",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r926": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r927": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r928": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r929": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r930": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r931": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r932": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r933": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r934": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r935": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r936": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r937": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r938": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r939": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r940": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r941": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r942": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r943": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r944": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r945": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r946": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r947": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r948": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r949": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r950": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r951": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r952": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r953": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r954": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "303",
   "Subparagraph": "(5)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r955": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(ii)",
   "Subsection": "01",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r956": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)",
   "Subsection": "01",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "https://asc.fasb.org/topic&trid=2144416",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2420-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>118
<FILENAME>0000310764-23-000017-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000310764-23-000017-xbrl.zip
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M=O^:@ J%/I]K4@EEQN3$(61G(2<(F7:\;,A56_J>43.W!!XD0&,*O>A#K_)
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MV#/NB*WH0OSPMY6%W="H%328I$V@8(46#IB9$J[Z:U(D99RPU60#D.*3$F6
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MX-$#B0E*B''GR0IA7'A+':3;1-US3T_.S@['RH.%L_-R>^OY[LQFLU][NVU
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M9J88;2IJ&.HBHFH'GFI7U<RO-+^>V8:9];0ERVV&GPM-@F&I-&=K\Z)%3+N
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MGN^_TB^>[VSOOMA1\.?P('X1OWJ^>]!7>G_[Q>#@?W;V?OARQ,2K@ZW=5]\
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M\N;8)P.N,&[/<\8G2?#81NTE8'X3W@:/_ U+;< VN^)GN[ A8E*NT9$_3M5
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MPC)T*^J.<HZ ([K/OU<P$S87"M](;YK6'BA-Q/V//FV< QL/MV[TC$C 07J
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M/?.IJNQ)-(:AR9&;HD+R8J,5-9:8,(X$6"9#32J!<2M[_%'&)S3KVF)7,G%
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M0Z(SG6%7Q,'-'=8<_R9+:*R2V"*F\"*X%KMO<]3[&G;:\,M&8<DALJ4P\*T
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M#=[!M],2%B37N?-GM_NY9'7[DVF<WK)?!EVU^+K<=V<%:48^L;-RF$>C"..
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MX+(YW"T>7OLX9JP)"=(J'CU\-6D4OM4&B46.^MH'JT?\.G3-SB[$K^56U!<
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M.\-@2ZH;@E&A&J/"(++B(+ ^)W(MRGA,E5B&%W4UF*T+)(C:,TWQTFEA K!
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MNKO&651:.HB_3%(+G4T*QK*:$(*>:KHD:G&@N\(SIMV>ESQ9K5("PTX5>2I
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M5<1.S<OI5-*Y%X)^:4=/759N?H5:]W>>G%K_D*QX2D2W*&?WQ] Q2>"HPOH
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M)<C'B8@?S..)K?($B#A@"$$VD4,U4D.PB50.[Q1P$K($!IG3O(#0[F26XQ.
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M+2)S_ELSB)W7UIYX7,PM0YD+%:&<I3.HF4(RP3VEH3(/ J8[Y:QVB*& <(K
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MR]>(N*H$1*RP_)A;0?PI92!'N":4YH-)E#0,3HW',E0,:SA!%"0JO"@]#E.
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M I#/$;G*;TD_-%4UO:&&SM_9*7LQFJ+$2;K"(?FSNIY? H=DN3W6-L&!P"J
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MK;;D]V3_PRODQY +NDP;ZV5'#>T,GA&D0V1]?!80L>(<PA";B!1C/5XSFU5
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MX^]4>(\GPOV"+6\1'#S-7CQ3KGGWFPROYB#.S-;7(ZY_XI*S<%?T.Y*J9W5
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M9IQT@YV=?5N/@*1#.=X&8,.BA+Q7L8@IG>:32+_(/+-P],>?WALX^ND)-"4
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MCZFF'T4PDL-; 5H'[(\:J@3_B@1L'6+$(ZKE#]]O;^^]"V2D?['7)WF2WL
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MO&P+&#.0\6^" OP$\DZYI1@NX[YA[:&UFA^Q6K:LT[/9GS@&S0)Y38:Q*JP
M]> +3*<YDTQ=CE[=BCNILR8EIJG>*7GO.K*E#E)%%/EMDF+7/!4'OR#8Y:_P
MCZYS2J4I^A4AR!+.O)1?L1M])K%)GLFC2'7RA!D<IT_F%@/>(J?0N+C<LAA@
M$?8 V^U1(OC(QAS]1128#IIA.:5=# .T0/F<R0#7A1+2)Y*.#0J^D23,;Q'1
MP(<SIXVO\L:7X'Q_%!,.+RP>Y>!LU*GTH>SXQ7NZBEG'H UPA_H:K.VO!V-X
M_JVE8Q_5_L'5$):P$@A<'(,*)MI]C\<L5!E6<QCT PIOZS'8 GF"2%!?-^B=
M<%FL"(,Q?:B__L4:'\_4NONO"O#Q6*7$VVS;79-D?XXNWCM[W5KCGM<GW-TW
M0+BN>M!D/BZNM,<BI&D#& $N=+>8S 5W*XF0FJXH09,+0N"79#@L)B:]*;6=
MA(-L> M_U$KL\+$7_BVN^7!P1;=DP07V%""5U8#"7?2O+AQ.S#4?+VJ=F^ON
MHD6:PU'!RKF8 2U<;9ZGP V2L*R[.72UQFF[,L59Y\JE-FZ^./(V^#I[H.,"
M@^-P>N\2%:Y*%9;+Z#T[/YESP?:SP#-G49%7V)EMO+?OPT7U/;"$Q0&"R:\3
MD-H9\%V+.N&!?"%G(!POBU?$^!78DP5Y=!60:Q8P+D5)%$D:.B )3M,T;1\L
MK$1:1-*T9B?FR;G^YSJCQ@.UZ)0!+VQS\!)4DD6)*B%?6/87*9J%L1U&Q(U1
M;DC@LU1-R%4-J%JY]->14!'*TRI:A^L/'HE[S)N@N21I:2HK'KM</+9_^O+9
M_$L>9EB5DRR2 *]['U=1KF_)W?AVQMFD"JU(]U'2_;^]R][YS*0[9U?N&R;J
M5>AV%;K]ZW")3Z?_?79\\>IQVZ5%AG\35BLVY,7X(;G)M.ERJR;+8+-BDOU-
M# ^P89FTTN:@BA3O@!LK1F'=,18F,JO!A,5^M7?J+8>%C:104?DE/&P*I%)P
ME]XE0R\HG!$ 69S)?Q82S6(;6K5+W_BN*JXC8? 8ZY9\C)_D5S74P,,\<BJ@
MZ;2N0^/MINJ&FCQHP("T&_PL,FX 8AJOWB1 6)U@3:S3,C1O5--N6&0VO VC
M!T!]B #L#.U'ME4CNED<9H[_(>EDTW9F^K3KJ[8V6'^I&1@P*[S,[+]':T,7
MG?%2".Q;=:/<:G>.I\X/9[,V7*?5&R<A.>49Y@#K>&4<^I (;NSEEW;HZBI*
MPO0[7'_/,B@?>X*P9@HN5*G_^MQ&KKRU,=A]U;X/SUZ3!>0A+*^\6HY<A,<Z
MF2P9B%V;R*+$H0KDI4^G_^X))9,Z1+_S7!_0$:D=KL[/VIA*5&]]>^X"7_RC
MANHT"^?AU^N32L<#GFWO_%G$7SC>'/IWHK:@*)6'CZ:(*TAP2<H(RA9\SYZ]
M$IIH+<^J-5A-ZVAQ*2UZ' O,2O:5%YBV[_?AF+VQ7-_*3'KY7(2D$(:XC2Z!
MA(+? SD4!:=[,._!5H?<4MB3V54V9+:S]!*=(F5Q#(&MA\605VV83!0/D?S3
M0-0<1>7,+0SSVX8#U<<VJC*UWLEE[#Q8$ 3OON5GNP DIK#<87!@$HFA- S9
M;ZUN%ZD4U\T3JA$$*57@D!"7B'#WX5I\AH$ALO%9Z\QWO'DLJ.%O+7[0#*YC
M*-8CSD\B_2)S9 L=2S9:2> CQ$@49D%*3:=%AHT'>"N\!ADOEIRSI%#);R$Y
MYQ3;SB84OP?9CH FU.$-SIV,L[<B"6;1&556 MO"'UT+%&HR%V,03B&R2TK@
MH4,&(2M'QDJU\1S6PE@@YP)$!3"6],'=BXWG[+!DPZ#, 76'LTU5FY'%&VO%
M2U[J!KV,3NM3>YMT6AK6=5B_]95K_!%V5<6%G$V#YS00ZAG D+3YK<F5Q>@B
MXN@_,,^^$U$A2]:FHMP.6:)<I2EWZ%%N $]$%#=.( 29()MT7D[Z&N:$ T06
MZ'45--?8&244GP2EUX0[%97>^AA(=8;P:\B1L42<6\#0H@*'A(,IJ(<*+B^)
MBA03?!$/2",O#)(8Y">6NB=PR,WOXEZD(8)5PR"T">)ENSB0:QVPS12<59%Z
MCV50.J&Q:>77851D:)*Y5A;9HR'BIYD&R^6]?EL5X2LO^5_"2[XJUE\5ZZ^*
M]5?%^JMB_56Q_C<4ZZ_RE!88QCT_!46OC[ER5POH(;7*06YWC1Q,=XS\)K#*
MC)!OO>!,GSQ@BW&)]'3DL]Q"JA:,[?CM;.]Q%J762-J'IY-PG:D,-KP8$QJM
MJ'M**O&IQ\)&IJFNEV9<KC,$>U/D6:)QR.,L&6&K0:SHP%I /40SA)1<T?H3
MQ0@Q:(JOBY*,$H5#L&=C6ZYK'0;DH=0/0VL]SI4N1,N:VRK#11BUQ/4;PCBU
M1YQ"!"77)WJ8W>_8TY8?3;YNFC_9X\W(N^75Y4;H;GD74<N[G-[3Y0B@36<2
MU^)K<"+1NRVBX/.$2A6,VV4Q3.*S:WK@BFPE=O0.N+MU+H;DB;K*TX<OU'DW
M()<GNFSBH#=)560-MA(K\?R$17FF\'QUH]AG5RM_Y)  \!J)+=0HS;^ TQ*Q
M!Q:]HN3GLB6B]]@"P*M"%MAQ%(,BKD%VJ8"8 AWB3JCH"1W45MK/:VD_OP7_
M<]I[X5*!/WL'S45D!OS6ZZ/?<W'!'SS[ \FQ5HZ&$U-A>>M52NM\*G+^9\PV
M,#ZON=MQDD[T["A##/Z389<4U]U<:RQI0?U/L(LOE;)B'EFH1B-LU\RA6NP%
MG 7W>(J  79L\E*$*DN&_ U5'.!XI/BH^$YFU!6E2T?[?Z2(""U9W -+3,?$
MTG038 1 22; &#'0RR%J-P@.:[/&AE#*\&2;I,&!8GQ1DF+NEFDN]Z"_Q5"&
MRMQK6+VR,=OFEY"Z@_&<B#HDEUY'R-(9=4]."=EWE*3>"'*,.W^AU#^^#>XW
ML3 .JQ19@0EZ5.&E\]"P_NN!M5F5Z>F;- %&L<9"7OJ:>+U3JIRS!/==5R,C
M@LN86N!HC9EU+;=?.D;-L-2X7_@H?Y8T1K<[(=,C%52+*-,+-)+WTG1ML C8
MN6G3PX7%N%(>&?SN<%U$]@7!B#,=L@.EF)5S!T@\A!F-B@AAKY%L,BF_E&!@
MW-XQ!HS9?8<5;I%J2@7D+FSC1"QWW,Y=<T>=IHAT^WN2?M&-A4Y-L:';@5P-
M\91E#^-!$IDFL%>__VHZP%+"RPR%CKIG!26[Y+<@J6YN>?U,@2.O'EXFZ?@1
MDHB9I7E#SAD70VD)%1M<:,TFKX82]5VD;W!<5 \0?M3I(OPPVGE>>;,RH1SC
MU$S]N,M"XH=V'W-S/Y=OTI-F;XG9M._C),.$GR%7XL=T'"4>YV!-=Z;B%KQ9
M8[#/D5V&?<Z)5M?IC!H-#+?AB4[^>7:(GB+2;O-\DA&@%46MZ1_+N[H92XPN
M2 EN$&QFNN'Q!OHED\.-D4+JR^AS*$<".$Q79).OR['O3H+ZABEN.GD#,#U*
M5_R2=,#=[W > X:K@81O9(>5_/L4>\C$Q MAH8S3P=KY3][K/W5 YZG;M.3!
M6WRT"O_S.S78.S@*#_8.Q/[AYN[H\.AP=V__8&_WZ.#@4 Z/PIW_W=[[[MLC
MO@?;;SK<VVR;[,[<K7ME:WYCH/KB269FLUMM'GNU_%66K2[%-M-X1;DO2[G]
MZ\\?>A^_C7;GXM-:T>Z*=I]&NY]/^]<7V)U\]EK5%?G^)<BWF6#Z%Y]ZYV>]
MI2+B%>6N*/=Q*@GZGZ^N5I0[$_C="O_]N2'ELT^H#O;.KX/33Y<?+WX_/0W.
M+Z[/WI\=DR=C<0$9[:,U7O$*_-V0(=RY3[%I8ZP]3KJZ)97(9_)2D2'\W2^R
M3 G,B\B2)-9E-1K:%'_'.  '+DK/-@DENM*BH_V67$OHN]UUH"?U 053!RC(
M^'-844&I&*,"P?K&0*_P0)4KB@3 M(<P996[:D;CI186BX^]Z$-JUXE#Y!H7
M T'_+RP/%3$Z\?6,NT%OE&M/.+^50+?M2^WBV3LZ'-O1&S$J4HH^P#2XSS/&
MKO18\$U94_D?/\@##J3JEX0:/V>8/6!\\R?4H1#=A>?!WL[!UL9GXS<WCSB6
M6#?#Q:W!&OZB_?^O[5QKYHS'/_<7<58,Z&UG.M&90!0'O_#<N/.#08G*>6D^
M553>:LG-Q#RP E6%%#$UR $_]W7<U%'K($V^R%3<2'-_-[C*15X0ZBY0AYR4
MFJ6WGQZ,B.%L:";+$OCP0FTZY457I<DTLXT3,D:7EW&&J)0$2:G*A;(>-&7M
MP'B+X$'5(]O1W>@=8HDKDVN*6IFPD]\3U]R[$&X_&_;;T9O6!-Y"<MG5Z?'G
M_MGUV>E5\+'WVQ)H ==^NFD)9@%;10@-QF-P%C!\9(Z#*:1DJ<ZR:B!M8+]>
M46^/H)$V[R6LBRZ4-&]M:T%3*93U2F%;.]#85A4F2*8(2SSF@+X;3GWZLU2[
MKL'>1"Q.,:"OY>0'>M8G,P8C.4Q>A(\_$-Z!>%"4<$IX,5D"? FXH1V<?F5]
MM0@HHCH3&G-I*IU26.]6, 1"5@RT;J'[ZB#\ [_4AG\[:#22H"HRFYD7<'RT
M;1NUTF"@A^F.FP3F&.,3&0Z^"@(_=9:.)BJ+ZM60>[D?H%*&G=8VXQ54>%RB
ML6#\#I]$'>6F!AYBJ-*A1BSV3L(C^].#)9@E1X+2$ ;2QQM)8M[*@;P5T<B6
M.V-S&:UB?@)QGU"6=:D/"V)Z8,ZQT1OK?5F 6\N8<*W=\.R"P1V\:68^G %#
MP6;%V,T>?L4<:G^W-@\K?H:-G7V_L_1?"]+AD=R]T_\^_J5W_N$4JXJO^Q<?
M%R\ZVMP4)DT! 0;(Y,DFJ+UJ</$_3WC\< [A\;=?$#U3T7-K*5-S,N\KGW\&
MKK>BS3,06BWK$B#_E8J'%F.A]3J#Y3:BM!O*S/-!,F+J"UAJ%(?* E:4D#A@
M;FQ,G%(;+9(P3/V$+H4-"SR=K4'LM%M(.FVP/,$>:0XH7CEWLVQVV0-.M0+5
M3@!3G1,LXN-Z0P-,IV4IY8 HC*Q\<J."V7H4S&0B$46]V59Z;Z$_4^_\^FSC
M^*+?_WR)DFWQ8@YTN5QMP%#3@MPG1"RH'S-W-#X>K2TB>(L@]!6@9@6'<9(@
MM(M19>$;E^X[O%51"*>-J32YCPV8C/'G9'#.X&"Z_$P%UD.JDXG7EL,K(Q?J
MSECLW&\6,O>.5Q)A_=3$-JF?"SJ\12G1=QUHF%S&0%_10TG$<!ILB?,J;GM*
M.>3)G>=RS)A/\L,IQQ1KS#+M/$_+8FB:^)F-TVXU>:-VNS-I#*M\CM)HKL[.
M/_0N+_JGKXT\OBI5_Q:3[[_ T(;E0JEP2<I6<&K*8!;G*QPE493<XYAL7H$N
M"DTE(6(BWB3Q@.V=:6VE*6=_MHCVYJP9G,]'E7QE\BLY76U,H;%;6*8+YJA,
MJAI.T$['&J&84AU;-F6^T"B?9H<.=M:VUM=&Z[9\QD,QA=UZ7R!830;2(P_6
MCF_%!$.;VX='6$B\N1^<AMUUVQSRZGW/ZPUY6^[LG3DTWB@);[C<U\/E%8RK
M:EV.UL7X*8DEH2_V;--O%"TP4S$!T5>JOT(3A7R^';\>WZM=)J=$,?A#Q]_L
M*NP=V/F_[QG_;\FO9OJ[42$< A5P6^,!X]7GUN3R0D#8$=8,DS (P(363=E&
M#$%!DGKZ0[S1.J!$[\$=V% J#>=GT0-2_0:5-=.,I0E#<)<(A/C?9V=GP8G2
M!QJH BVOT'[>A8U.M)$&.VJ7[G!SW5^[%B*9!U#@-]4#_U7!PA^!0^%\ *"8
M/I4+(?\X3W(+>K\8(7/F]$^AO=-)BD<Z2X:4E6*^(U_'K0B3>^^K$=SDSMW0
M:X]8/?[&<(N]&9<#P(X?NR<>6T4;F"+HU>.$([^9+-^K*UPMTB:^D=[T4'G@
MT*C=7)=%7BA3O6B+NV(*LJ58K+4FNS=@ A K@ DSHU@WX2FCQ%M@ED@8*%-"
M02T!C%/Q+";%3!V8'0W%$TR7:Y>8T_B[#7J(W,8+C:B3*97>H<N):U _QRK/
MU@WBN+\?.FEGH!$A3-#E/@D&189^GRP(Q0-90OQ&';KA!O3ZI;RZ>OF>LTZB
M3".E(6&HS<0)X]R65)KW9;.]<.K,"&B#(U6&SE\.$:.Q%>[*ZGJ6U77Q^?J7
MH/>^?W8\>^?B;ZI@>KNX0,MACSV"G@%G]#:)B.E=BZ]R08AA'FLR*ET9^]_8
M7UM3[2\M$TW38RT"ROA>J&HFH'@'O5$*W,\\CG/6#&N]02&:2B G3(<L98AX
MQHV5Z^B,)T0MC&3(:M]BOF&V1SKTATI0@$("'L #);B6@I (DFV<K0@((E/J
M.N6WE6*((H0W<MCE-B%!KP!R[5L936D6_TP8S>6(A:["FL_>P"="0 -C;H8:
M731?7@(;9H9N%SJR",R-(HL7#M]^L5!'S1D007N\>6K\F!K!%P1144K-KLV_
M[VZR^6<55DXQ78+;F7+SVXI83YL)PC6UQYCAS=@0PX::.5?QF<%F;A_RS(CS
M'-TB2\E.WD2F57O_-"+_$RD1 JM'F$PF/W9A>=TEPB:G0*PS'>M=TMA-[[?^
M\GJ21>B+I>Q#\FV286[948U[7-N^6RJK)@#;_EB>X]'HI$?[Y8XCVI%B@-AT
M?JKO\\R*"?9#,5U[*"?$&TI<SC$5QDW<#2YG?[WU$1M(,FWA8^"==5#F4PZ,
M+=C?A"& A>[%0UPJ,2)@6H579_[>ZZ$PEE=%B45AX==@ 6'B7ON;Z@-Z/FL
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MY.32NT3!*5>#DM.E5(RBB3?KR\Q$A2:4M*[8D H;8: _&ND(9&Y 8]CVKE#
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M+ER(Q,ROBDY;H)-(PD+C!J?OJ>7UZ#E<M96TP*5,-J8Q] @W2H:9D=K.1O)
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ML$=4=C/+(T[Z:\_FQJR^N]O[%U!+ P04    "  ]@DI6TW9_."8(   3(P
M%    &5X,S%I,3(S,3(P,C(Q,&LN:'1MY5I;<]NV$GX_OP*5YR3VC.ZR;%EV
M/*/(RE03U_;82M,^G0')I8ACDF !4++ZZ[L+4-;5B=(TC>OFP1&)!;"7;[]=
MD#S[X>*Z/_KU9L BD\3LYL/;RV&?E2JUVL=6OU:[&%VP'T<_7;+#:KW!1HJG
M6A@A4Q[7:H.K$BM%QF3=6FTZG5:GK:I4X]KHMD9+'=9B*354 Q.4SL_H#OX%
M'IS_Y^R'2H5=2#]/(#7,5\ -!"S7(AVSCP'H>U:I%%)]F<V4&$>&->O-%OLH
MU;V8<#=NA(GA?+[.6<U=G]7L)F>>#&;G9X&8,!&\*8FVWSIJ@P>MHT[KL-DY
MZG .[;!SW&YW6K[?"O[70"5K*.[F:#.+X4TI$6DE MJ_>]BL'K<S<SH5@8FZ
MC7K]OR4K>GX6RM3@?@KGNY]NF8W%##R8"H_%..U:DTINZGS8E[%4W;VZ_7=*
M(Y60)R*>=5_WE.#QZ[)&YU<T*!&Z82U^A^X)ZF2OIH6>.#D6*<SU;C1)T\%#
M)#QA6*NQ+PY6]?R\AEN,VS[)QSB ^FOL:M37##O>:EA_<#L:OAOV>Z/A]16[
M?L=N;H=7_>%-[Y(-?AGT/XR&/P_P-DH,;I^I"3<?;N\^]*Y&;'3-[@9]:TBK
MWGRFVJ*+1S\.V%WO]FWO:G!7N?[E<O KZ_5'Y/QF_4_H_6EX)5R-,0N-S"S4
MEQ;Y?ZZ-"&??R/KM>30LL_<P$2GK5=FE]&29^:!("V8B;E[MM3NG;!<'K.J^
M<X)]#Y,;5<:&+.(38 I-ARERM8F$9KTTS7G,;B&3RC"9LG=2):Q1K[QGH50H
M VP&7#%( YQR 3XD'JA7>XVC^FFK429&;S(9LCNC9O>@D.L5KL2INJ C3TY?
MF!^;Z,>W7*,KT%7)C-VG<AI#,(:R<Z=R?@PD:)9*K(NX(D>D\73&\M2H'%!/
MK)2V:*+;.$OPBO1B(??QEF(R08HWTLEM"*08 :VYFI%(PN_!ANAQ38WW E0&
MMXQMQ<4]2, 7"BLLBJ4X'34),%332/@1TSG]6<R?@H)B$3(@$3K&4DQ5?2I,
MA ;J#'RK(*V;H6HR0#,G."U@WFS9#2\1 *U/ 0!8*%)T,45KX=(R1A_%<5@M
MC8L4\RNQB8*__3BG_,*P+?FOC"$7*IZQ#+U.@"$@Q?$"$44P]-K6"+K ]G=E
MDLAC%$ 82(R5W4Y;?7RN(Q;&<JKG&%$P%MI@<V@8IYM.;]2RO!1J/5=F0]N7
M&.U#C/9HQ36O]CK-QO&I+N)9% Y*#QF& B_W]8'UVY!Q!39"Z''AQ6#Y%! 6
M7BQT1#-(+$%V((:@ZT!H/Y8ZQWG$&TK&+E29DCX$>%NS?8Q, !AJY_[!@Q_Q
M= RLAREYF\<HT6CQ2J.]#TZ+1CMP5^Y24,5.'41H?49YNX0<%TG29>>-PI6-
M0MQH7C>6\8025'QL;?VK,9+Q@/BI$D-HNJVC[]]?[/,#AJ52X_[H/4NPGP]M
MF;C?Y[G>?0J1L <8IF(G1^LR5[@ 9NM$:,L!* 6I78?:FP5[+#.0@IC;N!>\
MOHA=N6 G&A3()*B+EK$(['%/YYX6@>!*D '"51_+B2FME&NJ"#93M"T?EC'P
M/(D*X4'/3LHX L[/8TY$AV99)1:5!6>X.K5<7O&7!R2(7(3S(?@FW//\<.5M
MX&KGA-Z U^Y4L#/*$)D3$1!XN)8I)\[C&H%'30<ABJM@'EW$F^">B(694?G9
MMBUAW0+!QMC!=$5TJ6FQU/I0&)3EV()J3 \JE[XO56 5L.W+&%*L@C%"#4<@
M(PR3"+9F#DZ(=9$ANWT:4%^ C'\:Q'R$V&#"X]SF-_D?PA![##%!S^DMO<)K
MO0M3N<OMC8/%$DY$EM&N/?%D;I[>>Q<NY8_20+U7^/EFE7GSKLZF!S@?S(\Q
MM,'+YY> ^,5Y=S-*=(0IF@ [L@:"+^ 3JD+2]W-%45BB_)7U$JD-WJ&'#+B*
M]G&)WW*L%;CH_H9PB!#"[%Z3*]3$3A?L68N.8?:TZW0Y<)I$7#_61.(%"SD(
M+&%:ZPLRF^&)ZA[BXN"U)E_^"H=47UC3W/Z:IMD^H@CF&"POLI)(8AD3BP2E
MV'Y!'=SH<#!6'/L;(Y5^+#KV!BZ6X&'< &RE/4]B0:.10*!.=OH^8@991A.+
MX?_47\W!#;_E E6V<,Y3WQ[$#OY%_7 /#Z[400@,.!T)Z'#A"\#P%.7AL2^=
M K\GOG<5W#*^[3WLPY'Y(?:+@EZTD.Y MB6=>8 3-3QF\Q: %+T*"F.LL:4H
MNW*CL=;H/$FP _X=K!D%6VX]Z/^+2@FUJCVL&*'"5"IC ,"F/H;0/E4J8EUV
M%"S2B8PG0#R<\G'Q<$P5; %)%LL9X.@TDHX?^ J2,/)?69*>9N!OT^DU.AF]
MEC&V12X$/ 05J J&)>:9AN[\QRF281;S65>DULUVTFGQ0-V3QLBD2Z^T)D2J
M6/T*W:R:;KAXVW5R4CVN'],++X-ZFF"^<?$NK&K?A=5,L#EV5#TZ;CPY6J\^
M/?:I50_;U4[SZ>$_O>QAM5D_V6G9FG6$<P:Z6V<\?5-JE=9"UFUF#ZRQ&GF*
MXKK'G;/_KBRSKRXO,(U62TAA\C_2FG?@J9R>;#?J]KU"ZT58]6KO$#L?^Y>]
M'_P\O+)OG:[?7J]8MR,4ZV1D:2>/["!:4 Z]E4-99A_KL+D?GK]G5][A?7]O
M/G^']2,N5)GU(P$A&SR G]/1FEV['MQV+S=X>A:!_1)CW9\U6WFVE+:U;RLR
MZ3XNZ;IGBA/8^-IB@3];O>J+*=Q#$.9F<\IG/M H_KK/1>R'*^=_ %!+ P04
M    "  ]@DI6X$ M72,(  !G(P  %0   &5X,S%I:3$R,S$R,#(R,3!K+FAT
M;>5:;5,;MQ;^WE^AFFD",WXWA& (,XXQC:=<PX!S<_NIHUV=M55V5UM):^/^
M^GN.M,8V-HEIVH;29,9X5T?2>7G.<XYV??+]V65W^/-5CXUM$K.KC^\O^EU6
MJM1JGUK=6NUL>,8^#/]SP?:K]08;:IX:::5*>5RK]08E5AI;F[5KM>ET6IVV
MJDJ/:L/K&BVU7XN5,E 55I1.3^@.?@(7I]^=?%^IL#,5Y@FDEH4:N 7!<B/3
M$?LDP-RR2J60ZJILIN5H;%FSWFRQ3TK?R@GWXU;:&$[GZYS4_/5)S6UR$B@Q
M.ST1<L*D>%>242BBB!^UFJTPW!<A#SBT@H8(ZB'^/VSR7QJH9 W%_1QC9S&\
M*R4RK8R!]F_O-ZN'!YD]GDIAQ^U&O?Y#R8F>GD0JM;B?QOG^JU]F;3$+=[;"
M8SE*V\ZDDI\Z'PY5K'1[I^[^'=-()>*)C&?MUQTM>?RZ;-#Y%0-:1G[8R-^A
M?80ZN:MIH2=.CF4*<[T;3=*T=S>6@;2LU=B5<F]5T2^KN,&ZS9-"# 3H/\>P
M1OV!98<;+>OVKH?]\WZW,^Q?#MCE.;NZ[@^Z_:O.!3OO#SKX%;]=GJ-$[_J9
MFG#U\?KF8V<P9,-+=M/K.D-:]>8SU19=//S08S>=Z_>=0>^F<OF_B][/K-,=
MDO.;]3^@]^?AE7 ]PC2T*G-87UKDU]Q8&<W^(NLW)U*_S'Z,(4W9396]5S!.
M8Y!IF86@215FQ]R^VCEX>\RV\<*J 5MGV;>PNU%EK,_&? ),PT3"%!G;CJ5A
MG33-><RN(5/:,I6R<Z43UJA7?F*1TB@#; 9<,T@%3CF#$)( ]*N=QIOZ<:M1
M)EYO,A6Q&ZMGMZ"1\36NQ*G&H"./CE^8'YOHQ_?<H"O05<F,W:9J&H,80=F[
M4WL_"@6&I0JK(Z[(9<IX.F-Y:G4.J"?62U<ZT6V<)7A%>K&(AWA+,Y4@T5OE
MY=8$4HR ,5S/2"3AM^!"=+^FP7L"E<$M8U=W<0\2"*7&.HMB*4Y'302&:CJ6
MX9B9G#X6\Z>@H5B$#$BDB;$@4VV?2CM& TT&H5.0ULU0-270S E.$RR8+;OA
M)0*@]3D  (MDBBZF:"U<6L;HHS@.ZZ5QF6)^)2Y1\'L8YY1?&+8E_Y4QY%+'
M,Y:AUPDP!*0X7B"B"(9YL#6"3K@NKTP2>8P"" .%L7+;&:=/R,V81;&:FCE&
M-(RDL=@B6L;IIM<;M2POA=K,E5G3]B5&>Q^C/5QQS:N=M\W&X;$IXED4#DH/
M%442+W?-GO-;GW$-+D+H<1G$X/@4$!9!+,V89I!8@NQ #$'70IHP5B;'><0;
M6L4^5)E6(0B\;=@N1D8 AMJ[OW<7CGDZ M;!E+S.8Y1HM'BE<; +7HO&@?!7
M_E)2V4X]1&A]1GF[A!P?2=)EZXVBE8TBW&A>-Y;QA!)4?%QM_;,QDG%!_%2)
M(;+MUIMOWV3L\CV&I=+@_N@]1[!?#FV9N#_DN=E^"I%P !BF8B=/ZRK7N !F
MZT0:QP$H!:E;A]J;!7LL,Y"&F+NX%[R^B%VY8"<:E,@DJ(M1L13NT&?RP$@A
MN99D@/35QW%B2BOEABJ"RQ3CRH=C##Q5HD)XW'.3,HZ "_.8$]&A64Z)167!
M&;Y.+9=7_!8 "2(7X7P0?PGW/#]<!6NXVCJAU^"U/15LC3)$YD0* @\W*N7$
M>=P@\*CI($1Q+>;11;Q)'LA8VAF5GTW;$M8=$%R,/4Q71)>:%D>M=X5!68XM
MJ,'TH'(9ADH+IX!K7T:08A6,$6HX AEAF$2P-?-P0JS+#-GM\X!Z C+^:1 +
M$6*]"8]SE]_D?X@B[#'D!#UG-O0*K\TV3.4O-S<.#DLX$5G&^/8D4+E]?.]M
MN)3?2P/U7M&7FU46S+LZEQ[@?3 _QM &+Y]?!/&+]^YZE.@(4S0!;N0!")[
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M=&WM?6N3VT:6Y??]%5@[IJ<8 954>EB6U-,1U;+<H]WV8R1U=\RG#9  B[!
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M<[#E#(<G\SD,+L:($BF*(YG(L#>/RTJE6K#9WUFA,]AIYE[Y8*1N&,],K:I
MCAXCEU+2\R"AD&F(.T7:GJADFY(*X&@3 &,HNH F,]<H\#<!@"C1'+T(L$(+
M6*<">T7"QU0(V-2==&Z[@9O=EAWGTV*=6UH0):(!Z(V+9EL[5&4VWW*[-WBC
M12/Z@PQWATI:G1E.QV?1=]*SA: A&R(297;<(-K$81L<Z=*<6RE+1./F[OS7
MQR.Y54CXXM1"PM^7'UC%O*$\T'= 1'><4>%WXVK/^*$H,%F#*H L6;)D)WO*
M(%HL54,OGF%MU5@-U:26KB<KLBQKANJ6R\Y#I!N@OI>C@*/IAGAC,:$I;""-
ML/BP08B?[4'90@$%_I/CK$)=K,PV*W+I&>*6;K*=M  F&F$$5I%W H+3=8+?
MD4C# 496)%RVDY4>"-<8$H9^F"IF25DX?TP?0'=:%"YM,GKHZ&U7T%N;-\*F
M8!MIS[LCICU'W"=_M@XKO]OA4!IL$%HWPT\.?:1.NS)HTX&9IGI->E-<-KI]
MM1RWPR?N#2?&-@$%0IVH5@B=$P)3&K'"Q>L;\*JF-S(.Q+GKEH)1MQ-9I 6!
M#^[T @*_"E;I5.^LTO@/3TWCOV0C[>CKK"^Y8&K2#1XZ5D?LA4D#$"\KH"K4
MQHL7Z9YNZ$G$ZT:)"91(D?YZY(?[;>)TPT3; ,M!0JB $:^H9]@0BP. )2%&
M)*!)>BA&D_P@&Q@,G?$V(%61M-NJ<,B^A3MZGEAQB0YV%5-K2&""0%5BV]0/
M)V-*3L;(&YW]@"&X/,,0;SA9.R*?IK7DIPUD[XV@<C;F];(;".G'>A#4"*(Z
MON1</[.<*\%A&1G"&8#&Y[T*CY$Y1W3R@^KA, 9,!S-$$K/1TF7+0N+H36=A
MIO*2ZYFZ'!T-!MJ18 0Q0V&S\:JZ@[([B)[&38IA!13>O;(=4@]A P!)O;KF
MRS%!UTV)JU!&\22OH8][U[?EPD[2K$"["WM=.D@URB>RGIW409[J0KLV*K$(
M5$S!0MH'H4O"," 7E,&HR9H*9>>[/;6*1W.,E<WRZ-1LEI\QMW-)Q4FPKZ(9
MDQ]=.ZCCM&)0_IG_!=@ @#N!3'4\THW)X\[>HQ"&Y ?6-(PK3H(]X)VY12_$
MBT=#PB\OGBN,"F%KZ:7<?G\T')\A4B=Q-D0T<).ID,0..W6*?*3)JKQ<C#I0
MX@J!H(+["MF^0@0 \W!#QBAUO(LVFOI& &:O5<:5>-F75$==&#-DEDHD@FVY
MD6GP<D?&2Y"-5]B]&G@D=:][50A*/=HB;9"#'=,M(]6C?J2DCVN>^'V,HWRX
M];H18[ 8 I2SJ7M]3!":L.>4E)TUWJ+M=@8,@E".7[0V,AV9G]6<T?445NV@
MB8_KQ3+!%18./E:D>_%8SJ6FLW8A"&L/M)8&&Q^\WE97&2>QVX*[/(!B BN"
M2Y6B$^H:.F'(_/^6X"6P.F_M,/6!-;/3&WRVFO$Y0.O]NBES23WFS79.\/F5
MK=\)SQD) E2;HXN6<3]V,#1(L!F3')H'478RMH%-&S\VTG&]&WT9M+%R+?0<
MKL,O=)4P"PF?Z*J:7T9&YG-,[":/K-=#;9Q]SVCA6_6FE4LI&?JQ-3R$[3XF
MLO>J#PD655W05Y M)N'SHH>;>V7LMODVWJ$HEL6*Z(QSJSWG,]TY+(B;NYRD
M;NJ:,DI%-3"D*X^L]0=*WI%-B/X.T5'H$7,%G3$AC1KBJ!PK'B6B'>&=9]\X
MD\;V]RUKR;(): 47>TCF#=7PB-&BD+WK$R6G8>\[X:$X!Z]Y_>&'REW5/6?_
M':'.<8U @NT?F32._23-PFS29YJRWD_JZ.\NRR5^]4FT[<U8^YBH_J2.,_H&
MQ31HZ,")OW-0\YS@;D^S_GL-(*7!7/! 0.$A4P)_V3;$V3%[;3ELFA,\PAP1
MU3XF;,C#Z;?)I!KY@2)([()3#K#W#MQAE^%3'KGX,<(I48_MLXMOGL3.DL?@
M&.EG%#2_FTQ:V*9WTC#)._ZX!_?@9*_,:!X]Z5<XGL.' WU$=O1@Z.T,3WD@
M#_$; 7C9$^J4)[;9MBV\.Q,_/=*/!%M,FO-)IY5TELH^2/81B#0V9K(Z8!CX
M*S;I&!D,3W;JJ:F-/'!.A+HE4/,L<%2,OUMP0V+UT2Q2"'V(=)P6MU:1+JC)
MQ#K[4*ZW:P6_B=@2VB\#?6E6,J;XI %Q&6>_/$17Q.IM#C%&X*A#Y2MC0*5.
M",XS.!<W37+V$*E1*;9+XMSUKG_@>M='Z-BQ83+>8=7=LLJ0IEP=UH-4%T%E
M'$'ZW;P[Y91]CS7C8^\#%(>U'AB,3$=V#: @5\5TLP(^1)I\ZD1%UWN?D+L;
M7[\S8DSDE9<G :2P5_6O6VS*,'E&S='TW,Z?;9G]C_A0Y[Z^'N@CW;_9\?9+
M2)XJ$9)FL=BV5O+%LK,VC+A_=;&$(0()B4@F<0$C;\0D\#61ZYECL5TP>'>Z
M9X%O/*-A"2>&TTW!LBF>Q:Q:@.<)MQF9JG@E]A[]3@:71_KWCK^/?P.B0UQ]
M#0Q%[,<6;[^4,]Q1>F2=P[5"#!ND;CZ93_.OG^N6;>FP1*"C/V[K3/%>?DGP
M')K@.9I0[( 0$\:Q&>B4,P64MJW$#ST;N!$"I8^XMUA"2C3X@NA N*HER=?V
MX7PW:#<_.NR9"Q?=1I$=(.+P7D(%RQTO9=2DL! ;9N%A'3WFJ73#7?)#,1)"
M1K0KY*1&WNOK'M]-,FO-G)X) H>-#J95I>*+MKCG$.%D[V\W"WCPP*\JP5&!
M?QPDAX:1V*#?41T7L:K?4;98%8ATVBF1&MAM(W&.I83;.I4>_&C/GM=,15U*
M:DX$@0C+I0HD'(@--M]>CTGIO%A@M1%"FVA"AP;6%;FP/1:JV4KLA%"!7#S4
MZNK'?:\M%H#[1,M*,S("Z#UWYHD=<D^O4W:YU)"TZ.P @=)B!ZFQQ_8<\>,R
M]#O/<!A(0!'0]'!DIST15UXXCV_2OO4C-Z&+7JB82>G+TM]^3$S48[08]E0Q
M^U[ZK8'L@0,Q#?)'<(4N!!H-(Y/&06A5]#B()?;QV^V*SP82#!,Q++NN&LXS
M6)P.&M'DJ9Q5P-C:4;AK#64273_SRT5 T$)R$M5I)-@R/E67_#'BX:<;SI-
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M+Q9Q5#L'^4CO>#4L#:8Z_0 VUX=TS^J[O?;MXWTB4LWLQ.42:K=%L[$PT+<
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M<GA=!)J#O96<<N.&073^I35;IQ0NL)@ISB2[XBFGWB'(L<ZNBK FF"L.,9(
MA=DU9<@V!2/4F6F^VY9$6P#P^2)G,E:*KN$.&CLFAVHT(SUMHI< (X@N@NRD
MC"^R]BH)$9LTV'IVSL&1@)\J_\"KM!G?MDEX.P_(Z]!F<P*P(M?8(RI>6VWC
MD.!TWL[G''VGWP[^X$.M::S(X&-]8/,7XU:72&9KAX-#>&6L+FKZLARFVB'I
M276-UO<C0?G&*CYC8E[::ZQ-2ZP7<,\K/ICM)F<#Q(1[<G:=E54F3;(HD7?
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MK6SEEIZCGZ*8TC6^A7&RXE_9KR=7V7))0Y>6 C\$HO(HQF^-6!JK;OX6AI8
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MT2[ZUXT8/CV]B*&H)BB$4$W#CF+<7K5VG%!,X6G IZTRU.!8&FT!L6/U:U+
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MV%&)A5654:63$Y> @%OT/L&*MP4,%+3EUUR1S5;DO# K7"M!+,.EUR+0ALT
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M5RR _22@,<$/:P=\#=A5R3]996V+I]O-5GF+/! &RFB8H^0G'!S>D)7T1E<
M1Q:AN@ .-&^K&KA0O@322K*Y"ASF[VWVWI7X5IJ1,&J:#T\<'P0^EP.OAU^;
M2P"/9#"KW^#/=J,/XB -W(^FQ>_#\HE\A9!E=V@%_%*>-L\L3;JR0-&0)>>D
MV]?\(YBP,%3BR):O(^?V7/N5+CC!+:6M^*23/<#KB0?7=' J)"L;EVX??>6
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MY#Q9]X'M#7J8D2.&+\-CF,$%PKR4_LPPUJZ_FW%2?*_X\Q0^DI'G19:OO#M
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MV*2.-TLY">XCQV=U<5/WJZG&KY8@E-J 6)F\UKRD5VZ9(;K&P= AX.-AAT?
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MKWUXTK77OE&M@V66U\&,G$II&*MB&XPH?.6  BBF&?RA3?18HY-WL_+>U58
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M2']B64&MVH@Q]+:>UJC+PJYHH6V./L#9:3[4KS&)L;,WJB+/%[-)'1<L2)C
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M9LRJFR^][/N4W7L?XA@.Q7YQ+;6<ACQ+ 4S34.D>3&]&?DDIT2, ]!EHA[O
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MH.U03@W*^@R[G>T4R;V&?VSCFOO-4:D1/%'>*]Z//;F [Z)D!<>S1(Y#*EH
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M801;]\+-,VS!=^5\3\F5H7B/<XNZ1EUUYQ<CH^,G?"MA/BR9<D1UT-Z <>G
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M\[-H,S4;4%)7G #U[O3M=Z_?/9+/#CV&92@6;[4W'6I\H&C>!NI^HXEH6#\
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M%YG(G;*$+<.NS9EO7\A;TS#8_XAMO0+=DE!\82)FW\CXHSWVEXI&)()K+M@
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M,OH.4(\N^EB++\D#DX9?^-(+"BE@'?%R( >OD.42EQ&'T\C\?&D?*Z*4<WJ
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M1(%VXV,56KL/>R](K.OJRK'>FGT(I?Y^SJS;X&7W9=MH>M:<F<<220L):>-
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M5F#[5IS$-,"]ZFLEP1N=V=]G==Y0W+$J,%C2<P&2SG[E^6,4]F$OH@_A93M
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M3T^)?$%X)PQ!%X H3>I^#$029=JQ$<'\Z7J94_D?[2"1?(9K;5R0(XB9!D'
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M*O)%)JT3T7;EJ@J;WZYB/U;G)4!*[B=?5H%BFMU<J)M@!5RKE4859T#AY_A
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MFESBXI>X^$7Z:=#4]_58OB58_\.7_N=<]RR!H%$X*E*(I#(Z1_PC)=5,C>>
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M)XX:(K252(&^Y+6E'C&+K-Y1_9/+F+:MK^)G?:NW1;\]:Y.;A$G&]M6XH5'
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MLS(VIB->AOF)05-G1 [7;E5"MQ:,&*JECE_B YW]<#"?@#6HZ6 +)07!<?!
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MD\0X*;N4$N1%I]4E[:JH.%J35U5?3@T36Y71%36I<F&;4]D;E3X#U232A\R
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MC@]Y>058M)T]4EKR/G#O%,N0H)<7VT)>JO-]W<<0%@Q,+-IZ+'-9(MJ84!C
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M&OIB(&8B*+W5>FK46_O!$&K-)FJ.L_-_;5$C-R37=\"BRKD$SC7%FGJ.CE-
MWWUJ7I7-!8JS5" (9<V+Q)F,!M5[>C8L&60(I>435:_&_@4ML TQI9!,4*HZ
MMJ">];3,S%9;A[!AW$35J[%%0G.VQ1J,%,V=G$7V6-"1X6:C1.<G ?#7>+0C
MUC#(B,^8C>.4JP9]%:<I-\_14F+(GK ,8>WXQ,V1CM*'@+$Z3Z2.$EQ/G&)B
MRJ+1OD7&(<R-3]P<Z2@]VQ2P"&>L!4IFA(+1Y&9*TCB?IM+Q732%*QC?O?/9
M*$$+50>8;;85:K*5();4> BS\!-/KT"LEV!RELA!8@7]/Y.G%#)3-1$U71I
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M[4=35\TK,"1C@*&P%5\USZ@N%(AY )6_GX*/_]JG4$\!@H$8D(::E-6 O*:
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M"SK/Q=@RMDG5R\)G@[.J!;-H3EI1I5O+.3=O5+?U259RG ;0EN93\'%?T[G
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MD.61%*6N[P4L" (L2'<,7],L+\!$?4IL<'%;DEH9DEJ7KGK4]GU7UYG%S8"
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MFC0(13*W[K4(?C1WZM[R)NH"Q_FF9]JA;Q#'LGQ*==]FO@-../5HL 9QY[5
MWC.'I'^+KM]E/$]'&4!!_MKG-!"+#Z++#_^&?TJ#ES-B@[U+-0KB67-]UPL]
M\$],,PA,HCL_$-^3>_)B' -F!U&B]GG4ZQ?O3'M8O+^*@J+_3M>T_]D2UWWX
M=SZDR8=_^]EO<+?\63[DQJ-PP2J-HU[R#D,0/(,G%(B$Z@(_S6#A*DOCF YS
M_J[ZX7T0Y<.8CH'\XRCAJKCI_8!F/5B<GQ9%.GAGP=HNP>'$R$/Y$O$^^?5D
MV5U-+KT  !5!]>;RZZ[XZK<BN/F=YW8];?'76E>OO_M-/#NK+JB@-\0Y+W ?
M[ K!]+];YM;,QLNMZ,-"$=4FRC\T\>=]^7V1#N=\.00E&R6]=YJBBU=,UO";
M -0=,8%KJKZ'):;9N^H%(=":&M)!%(_?_6L;^R7]JY/3)%>!WZ)0?IU'/_D[
M#W @?KN26W;@9H&P$@2Z@0#\>KA_NK>KG)QNG^Z=3)/,JBSQ9&_GZ_'^Z?[>
MB;)]N*OL_=_.[]N'G_>4G:.#@_V3D_VCPY=>-YF[[F\T[P,I%&G247:[.UW%
MT"SBW7NM\[AY55#SZ>CX0/DW2+DD30Y' W@&4TIA>,Q#3+6T'1IZ=NA9C!+*
MN8N=Z3QB$\.CH>_.]>N5A*(6"WCT;C=E(Y3UJ$6VR@,+\^^QOYM>_FD<7YZ9
M!Z/@?._R^V?O_&AP&)_]_,LXV-W[>7;ZL?]]%W_N1T>[\>#H-(@/=P]^?O_\
MU\_#W3WS3Q.O'9Y__W:@'9YO7Q\8>U=GW_["G\G9><_Z?GYA?C_]Z^>!<7QQ
M\/.OZT/=O?[3^#X^^\;L@]T+Z_#;OG'T>4\[^WFF'^YN_SS[V8^//N^;1Z=_
MP[N^_CS[MG]U^.W@,OC\-PE^_T_\W8@O_?/TZNCT0C\[/R-GI\?GA^=?M8/=
MP_.CSU_AG0R>>68=GA[VS\ZW]3/='1_^9-<_ MLP'<8TU?8 0H1H@>KZMJ7Z
MW )3WJ:ZY3A;'W1-_4/HF@D6/BCW(ICG%?P60<$O)?!\P3\1G;-?$J_K6(N_
MOO7>VQ_LVEWCKD^>KU1T]Q:M4BD&8WB-JN']#33<@%LZO"<K*U^3B*4!5PY.
M%G"U3GXEN:16?7J.WDZ2$;;Z&Z99L:6$:3:@!3P=8 (FZSL_36.?@J%8^.GU
M6C+^I\C__-4^_'P8'YY^O?H.S'UV"N_Y_"D^&^SIAZ?[UX>#,^OHV]?QP>X9
M^;Z[5][S-[S+2KZ?IMJ9\16N^QA_/X_[A[M_:6??_H[.3K_J!^=[!JS3^GX*
M[SKO7QS\[5[]>;I=')QHUW^>LO'!Z=?K'PPP$?C$4,$+1,%A4M6WN:=2PP@#
MFSNN9_.M#__\A^<0^_VL[*A%1\D']Z/FF(<W9<"]:?FA:DG0[_;AX=?M/Y7C
MO2]'QZ?*EZ_')U^W#T^5TR,%;(E3,!@4W52.CA7=>A.\58X^*:>_[RD-,Z,V
M,;9W3O%KW3/)%%!6PJ";;W6 5Z44?:Z$40[P5\:<9@JX+SQX#CW]1?A%>]);
MFF+K=P%\H@[@G7V\30WH6,6UJ3Q92_Y^L&*_/CB]^*$;MN;XNJV&04A5PC17
M=1DXG3P,-(<YFLX#ZTG%\,XHRP!?GP21G $>[HJS5XDNSPNH1]T (&" -#5M
M7?5-D*MV2"P=O@H-C6U]V.5,!DDP;C M43L*(F&AG+WAYDN;"CU,<YZI\)PF
M_M'Q799I+%AF:UBVAN7S&I:G&:PO$ODT&VY<'IT>6 ?G^^1PEXV_#P[,P\]?
M]:/3^!RDF_;]_*]KN'=\\.TOX\SX:]:XM Y^7HP/SGO:X<__#,Y^,NW[Z5<P
M1@^LH]/C >P%UKM__7WW^_GW3W.,2\T./->T0Y6!JE))R W5LS1+U6T\U_5<
M'I+*N"2;9UR>'F\?GNP+*_)5&I@[Z6 0Y7@& #8F"/=DA$KOW5.:EWLBPO\)
MWG8H7K:63/NH4-#X!]&"T':9IE*B@<FH<:9ZML]5FX2.Y5NFQ4*"1SRZJILZ
MAAD?$P^*!CTES]C_;N7CBQHC/WIZ]WS8VU)H7"SX9EIM6>;P^B%J' AA>+WU
MVU)HVNE:=]),__R';FOOGSO*>G-U\V7.D_/6,>]%>0&JLSB$;UX=?YWI/UQ,
M9#%]7:6A"3:^$7HJ]F900Y,1HN/T,<_<^G!R>GSVQ]ZQLG-T_&66Q8Z.MT]?
MX##BKA3^9N^:LD)@7DE#):LQKM!<R8<<BRIYH$2)$A6YPOHT@R6^O8OQ;ZV$
M\>^:7=TC#SE-U*VNYIEW.DU<@<>:7:(Y2W^JTW6(NWP0V  ":TU 8.I=8MWM
ML:6;-FW VG<^0;ZWRR:?M&$Z9S]A9:-&L"5%T8(LGAKO@*MYTVW+\8IAEE[B
M<]8T#"4=-W#*0#^!PW;:'QR>;I/#SW^9!Z=Q?(!ZZ2>LY?1 /_J,:SF;==S
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MHF%]UE]_G "S]*1LSL=YP0?Y>X4G09JS= B P&MAG8-1 E=+5JHOJ^05B)4
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MIM8UY9U+G4JOZUW#6WSK0Q_K=HE^MX#7_=YHD(<]M07!2X' >GC8TW!>//?
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MU4A6Z=%UIH,O0KH@%H7;$"J#<L]RD#0.)A(CC/#;09H7,R9"/C/4-T?@@=W
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MQ,-1C">&XBL!GQX5[FC3. 3JC5@NSNPOR\QUD=$ILR@P3P&=[MFT O!C)MH
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M>"9"!\H><C2V4OM/=I>SCH?L=B70^C@5OMJXO,'40EUOR[QN#"S.,V8W#+_
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ML**A3Y$F-O%C[@,9=^'(3V.KZ"3R.HZ8*L:S6:(C)D*AF7M7A,"6C"G$J<[
MT_-(E_OX UP*SI$R[L&AFH-Q0&I9A"\D1#(&97,8ZV \\3 J#[/1^9MCUA7H
MI\9$N.!D=S*5Q^"[O1E\?R1#IXP[YUCRG.1\:3K&V%RAI,9YW(C7KU/)]CV;
MF:F#GT3><NYQ6@B//L#6JGLO'B)&>:8BZ#'DA//$E/*@A_36'2\CVH(W"A?2
M*WZ*4N)AW&V7:\00<2 (+ZKXJ= [=VP$6>)0N1V%H2'O(XH%4E678#@Y\(I
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MB>,PQT2=:FMA-9F(;\FR39XP$=*K$E\$P 248U[Q2&[#)L7OZ?I)E%)"@V
MI"I)MX!!XZ$$6L^7':HD4^O'@0)<3_RU)!2.-("/B1X1.A6QX#':9P(*7+10
MW14PV48L8:* @_?H\P Y6F!*SQ+H.^5[OFB$EQ ?<E=I H%^(&L+T0_@285[
MEB91+>-?4Q84= :6Z(]XQ=@0?D2:GC?BB7 M_W468\;L;#B4NE=AX9S6-P0'
M<T0'@.,"<IV*9FX6Z*9D3U;,GNEPCCN?1V;@:"VY #</0(MERT)D5<8XMD4B
M$T9K% ;\./+2S"U/A^#](QO&XJF/:/)+886J$4DT/F6N-U40TFJD0A/! 8YG
MQ3TQNA=%2)+J9%/CAI*27*"+6(=I!6ZPG-]E"B(3VZP,<PXK :G#Q _'BQGQ
MTNGR1CZ,U"_Y]2-?P2\$&3]%HR G*M1&@C\Y27=*98[YZX)#$'IS:K' W"VU
MQE NAV<P1$T AGGQ7*6GNA0-0MH=RP4.&?!PI$3IDPB$@_1>D%XAI8=9H%P
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M1V"%/X*_7.#E$J+G=!&,? \_]QD."!@5 ?X-;JXX3."'V(S]O\AP4/=?ED"
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M711_/EH7X3/5"P3!7[S_(-Z%$@&,TAX7C!'E/JP&[-+B17'[F^O4&:5<"WT
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MGS]<\^3J..*XPB,X8Q,J=L,#(X;^*4(N)GBF4E0X-$3S.S;TYFIVZ7^!OUC
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M;,2FPO:B:CX*AXA@ @5.),^6HM4O/VU$R $;9:4#V0K??/GGQ5N3RE%#GFQ
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MU;B"UH1:$Q8U8;OYFO#SQ>6Y<7/Z\?SVW\:'BYNSWZYN?K_>+)*PU_AAHH"
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MX(<3TYBP@$7>C*PB;S3W S].(@+:^3[#Z!GO:B.AW136JB)"VP7#:-OK=[<
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MM?WE<GX'L@M^6:P J^._(S:$G6D/;>.:1'?;V(&V9_;$F:VS!IHS>^+,0/L
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M3U_W94)()L*KZ.#G)*]$_6Z60.@X9;'"JNGL3T2(+U$X]I/:'#*^Z 4M&H^
MA[XF!B' 2T)IS<01/! A82 &74<<)-+=)(%=&;C!XU@\!)GXT[\2-H\QLX=B
MS$ (36.BKB/_*A>?RU_1004J[:T5M9B=@2$HPIA_9[&,X S'L %X.9NQ81*%
M@3^$C\P78<!%&!SLB,W]Y5P<!2,,:)WQ I./7O05B(#R3.XVO&8\(T_,B]"V
M8'',3VZV'HH1\=7/O+LP,H&5C,WH&4D$S$*51(\@M?/ X/!X>.#9>.P/?3CH
M/A/+CY>+!3P1M@#;!L\H6BXRS;$,QMX]N(48*9*AT+G_[0D[IR["EK$2)4"5
M+"$);O:CUO<)6_Y5G?1:AU>D(MY:%;89 Y<4UTT?EFJ1%L_5)V=1*8/,4L7,
ME7$,PH ;$4KY>Q5);<*(CFOU.KV=AQ'!([;[NX].5N^Q3[_2<?I56NR!'CO8
MJJ;BN>CIVFZ%.GUTL$E0F"<E#A\H_\)OBQ(WN EI@/**M>UV4A5.H5G8F)W8
MC=E):XN=;*!=ML' JRA%-I'2!FQS$Q%NP#9;VUP(]<4SO)8QK1>6-Q_)B+2M
M-UW!:FW;-CN]FE7/'V8*H!;QNHIXRQQTM8AK$6^NB _,5J=F8!6''W2Y>W"(
M>H.C=VO7]-DD</2CE+AVW2 <M,357.)<+7$';@;>)F!2F$-7 6NSG,,7P3T+
MDC!ZQ$3\8H%5,@M,XHX]/S+NO=F2?<_HE>H=KG(JV,[+1IWLVNAK$$F=;E?3
M=,<T;?>K0=(]#>"L"UO^_K>^8SOOJ\&;!M'5MK0*V35-6Y9[.)H^8T7)6JL@
MQ ZNI]2._F3^DYJPAR%L'1*EY7K@FL5)M!PFRPB6>2++<K-2WN'4BR:%,J(M
MW>ZZJ,3.MK=,.8]?]9:I&4F=;0U53=)GI73;>_N52+JGO$1=V+*]/:5%_7F:
M;AN.T31]GJ;MP]%4FZ=5,4_K$I;^C*V2WLP8L7M_R(R(39:\L^QE%FG-G/0#
MNN@-I6A'4W37)GXU**I#T3H4K>FJZ:I-TXI]4A.V*C9_]4+2Y14WIR-LSG]Y
M[\ZK#(JH!FGT5/A<WT^WK2<2[;AE0A^>8SD\3K=F_1;Z\.C#4XG#,S!!BO79
MJ6C&\ C&A=6O!^!XQH5I:5V1UHX>'%H=;FAI?5:WUJR']'BD]>E1C%5#N[UF
M,?.BX=0T/K![-@L)#IA**\\#6"AC6')IG'];L"!^ J_\L("DV29&A4TP91-,
M;&(+R-)>!E0KX'%[A,0O,$SQ#=WL(X1@*MZAX*'/EB-\VI09#Y&?L)-P/,97
M#D%L$0W6AT7 *O%(>'',$&!Y2QQ4EKU4Q4"U>D5H7X3ZSZ_=5=:.N-'R"0BX
M/4:472-<1HA?G?C!$I[K!PAR3>2EI0?A/54ZT.-@)VS"IYO@:B-&*'\J4/:1
M#*73:*UU@Q35:*T:K75_']5HK94)&6JTUHKN1*.UKHM+UA_?4Z.U-FF;&JUU
MHPB(QOFK#<Z?;;8[[7K%US22I9;PK23<<3M:PK6$-U;"!WVMP0]>WU!O%,->
MW5+"30(Q/$Z!<[3 :8';8QV!UG '+A3034>ZFZLVG]2$K4J;7%V@,5X3N:UF
MW<-O^KVWNAF[.<W8FJX:,&/?*J1E=;0.::BL:[KN#2BC#DGHO4"-U0P7\(WM
M;F%#:9S%Y^G9<C0]=TC/WN#@Y-20MT632:N,W=*SJ^G9 'KJ6)X.DM;KDYJP
M.OJ\7;YM>Y VL3,-E?-J)*E@6A:+(2L/E;-;-KQ&J:0^.T=Y=FS7U6='GQU]
M=K8O46Y5O@2_,B=GWRG!8P 1LBJ/K7EP\:MX+>HQ"6M7"VM5F*&%]3EAU29Q
M99A19W2V&S:#'TY,XQ,+6.3-J'+R=#3W S].$&GKGF608VO!V0ZWJW*XMG17
M$V577GY7FX*U<7BS$5. S]R.U?J)(YZYO2+D&?RDK6">_1(F4_X(_"5]*D5L
M$[6IAJQ:A4=+S#8":B-@-C]",+38,J[9F$7XF<LP88;=P;\B=MI9&-"AH4=\
M] ,O& +]C)L$?D!?-<9A9(R7$=7#^@'\:TX5'99Q(7;WP&"#"8N 0 0DYR7I
M0H;A? ZT\04113U(&#T:P"P6)V&0WT#"AM, >#MYY+AL$6&Z$;#<8AG!CF.B
M\.?PSE_&QL7<FR *'3[ZS(M&(!_7(8B1/XQA41$S@M"8A<$$%KZ(PCM"/8-O
MWS'ZTG#JLWM1[1NQ(2J2D?&C;;=P(?#BY9#1B\= 1./>FRWIRQQK;H*(0_#7
MV ?MDY$#50[^PS1B8 X[N2.>>P^P-D['/T*@C&>P^6(6/C+8.\+5P4>6"\2D
M W8H:'2I])#X"7;C$GZT72"Z%Z>KMFISM%Z*')@_0,X*=*#KKAPDU[+3@V0\
M3/WA5&(&QD3I#(QP' Y!F(#@(S^&GR'M/9#081@3CY,HY-([9=YH")=40A_T
M%[@].D;C,1VW8,QKG?#+BXC%\1+^^&[>:+"^NB'*:; ^#=:WOX]JL+[*!(\U
M6%]%=Z+!^M;%J.L/[Z;!^IJT30W6]_3.--!3W8">NF:[4_D\JH8RTQ+^/1+N
M5#Y5JR5<2_B+=]LQW6[-AL5IN+ZJ"1'F?;0,5;T*H%$2UZM^58J6N(9)G(:U
MU8A]3?MD SK0RH_.%55UJ$4'A4%Y$A/M*!#0;+>OX8MV2$_7W@)O0M/S>?D<
MM ].3PUY5L1'T#ICIS)N:9VQ6WH>1F=H6[0JMFCU<J+[Q^*M&^J.T](H1CNU
M1#M;W-*:GL_2LUT!^=1(<L6;WCXX3YI$3T?3<\?T/ SZI+9$JV*)UB4J>IVU
MJ:'Y.6,3;V;,O21AT7&,@NAM<;MK'_PY<CH:P'W7 GIX^=1QT&(<]/"QZ0;1
M\^ C"C1==5RT5I]L0%QT5RBQ^0H7C=:W>Y)4L!2H:[;<FO695!'I4I^=(SP[
M';/7J=EH:WUV]-FIQ-EIP]G1]TY5LU='@&:(<%!:_JK"C5WT0#1:6MVZ]>1H
M:3UJ::U9W^OQ2&N]H&*O&5!N9ISQ(CX3$<!J@UHIUCZ4:T> 5\(7??.CW7EK
M&C_:+9<RQ3_:/8E+:690E!S*54%+3=%&/7K4'0O8V$\((#3BKQ+)9A4:U:,P
M($)GLF\^_TO$8#_W+.: I81M2="6=RQ.#/B_#X\AQ%#\8<3FGA_@U\([("1U
M]] K?_MX<6N<!A[0VA\:9^%99/S1;AD?V3Q$\-M_,F\4&_?A;!DDB&S)5Q@;
M"P]. _SM4>)?WCVFD+2+"%X= ?75#?R+3I$Q]1>(QCI:#A&6MC8R<"&P1>46
MB?_9/D=+@@(EH-J(W?OA,L:?^O%P%B+&Z#7[<WG/ N0'823_\NGBPO@,5)AY
MT<DE&WXENL0$@8H?>!E3ZD'/5H_.E(I'W/M^..(*[KQ<$YX""Q/_/_P PN&\
M !8&$Q^OJE/$;8XKN)/R,U'<B9_MA!"H8T(I_K'K]$!'=NT!UY'MGK-629Z%
M<] K7%_@3TR.#"R@>N,<)#)]E8ZA<OC&?@2Z[Z\E*">0C_2SXQ E1OUY2^UZ
MC''U IL9/\Y550$T.S:Z],O^$<GJIS </?AP(5VD6.(57/M3&KMXX4[DCC)T
M=!5:V[&[ZIV%;+Y9(,[SW3*&_\0K2.K') U7"P([!Q/B(AB&<U;!A9>+0K9P
MGQ:N@'^7X/=S['Y@J]W)P/@%T#C\*(45MRWC>3SS/(W4/Q5ZB<5VVK";1<AU
MTCL20_^>9<C<B&^L?$N0MY5]Q;L#$5PFZ[^R OH(OZX-P'BG;;4[N\>5;KN6
MV][LL74'*/Z W(P,;XXH]G2;PI-G= &R;T,&KB^<!#Z[(/T0*"TX(]2"]>#'
M("@+-O3'OCIUX$6@ND]2I%QDZ5;>)[WL=N'XKO&[U3^G4;;Y"3NY SWS]<0;
MPUE[Y\T>O,?XAY_SNA(.D'BIVX55%8_N3K9KMS90\)P[([PKZ6)ZMPQ %^"G
M?OC'S>WUOW\]OS;.KJZ_7%V?WEY<71J'^A]IXX]7UY\-NW7R:YF"5<B[HG64
MWQ5TVMTL''Y=T6#A0K"DW;=<URT\HFHW76Y\1EB\]G)C-!S7ZO^4W7>Y:\[I
M*/,TS%4_MWS6!9G'RV#LW8,$X:4"-@XL+D#E,@7/@)4'#7#.1C918[TY5#$;
M8JWE(,>0Y*C-#0=I0W24&3];SD1986IFRR!35<8)7K:5D4*KK)PQD'A</WUX
M"CO&*X V@O&%.2L/]60,&^&5$. &OC_\4!M;1 \[T<-.]+ 3/>SD*>M1#SNI
M"Z?TL)-*[D0/.]'#3IJ\33WL9*.2#@V47QN@?,?LMVM6,*1'06@)WTK".WT-
M<:TEO,D2[CBNEO!#MVS4>Q  ILZU#-6KD+WV$J<M3RUQ^Y6XFC4^-DGB_C][
M;]K<MK$L#/\5E-_D/G85P6!?[%Q7*;;LJW,LR9&5XW*^I ; 0()- CP *(G^
M]6_WS&#A)HH2)8+4I%(V30*S]/3>/=U[6WWN*+VB*2L^5Y1T-**1,AYAH#8F
M2:Y<D<&8WHOR=JQ0CRZKIFT:I(;C2)AN&*:6UPV0RG)TW2KSM:=PU?N2A6P:
MIEK?[&PYNET(.FVCL]F.U=[6S77%E*QGO@JFINY+F&X:3WVK&S"5O25F1)3D
M'YM7I23_V#Q,M\@_]M8AM?*:]W/P1SF&*RV?3<-T;15*PG2E0\KMB.-4>J2F
MS86U19/$]=4PM25,-PY3Z8W:/%1E;],&P2QI]VP<IMZZ;GD)TY6*E-T1GX?T
M14F_R6-G!JPM]"5,5RM2ZQIBTA>U&JH?Y\NW/0?ODZ'+N+O,$9%PE5ZHARI/
M6[3N]Q2FG<)W"5?IC5H)V6,:X?Q*1*^2$*OCLG;G6 ;R.3B@=$N3QLZF8:JM
M&QV5,%T%4T_O!DBE_VDF%TJB^N9A*OW7>P73O?4_\59 =01/].EY#BZHE[K]
M2EHW&]28I"6^<9AV)$5/.IVF.8?6UR7KV*9DES!=#=-UK2WI:+J+ML0\2UC+
M '.=!O2"#!ZD,^V8#NY*LV;CPL2XNRB1T%R9@=\-_)0NIAEAU)%KD'L$T_M%
MDR1<.P_7/7 U+2YW=< :/J]3-EOL[#'[TG<#-'<OR+IAD'2P*IK5,[M?D'BS
MQ_  %BQI1]+.-.T8DG8D[4C:61L69L_R?4D['8T-/"8M=@0!L7^IQ+^NG,;]
MRD$_(VRU^X[$UJZ<AL36%=AJ=;]]PW/%U@7]YV]MM"R^$?MO;^]1NV@OZC!?
ME>4\XIVK7Q[>C&A:T%<][)'ZT-[1C["')9W V1Y$]^V7M-Y#2DOEFA3*RU]T
MVX-_O_S%U,Q7+/+Y\A?#\5]5/=9[O#LW_L!;@)]?-KW9\2$<28Q;]V7'D>>:
M=S>MUI/TBA8EWH=4<EJ.\Y1W8\<FXCEV^"[( &MWD3#,QY070LWA!?SN%UM3
MJH0V&!-?H7%,PS*YHDI!RW) V;BB)_E?:8)/?BGAA4*)*1 7C"W 49(;A8RC
MI,3>[\J$DKR Y>L6O G$>W&)__#ZRAF- 80PV4E64D77\6,VSI5W6<KHDZWE
M0Y*2-(33XG/A&@HV;#S.Q1' OX;LY@*'8=4*?3$,=>#RPQ')1:=T[(:^$*A-
M0_4:2M5 40XP2;'_.4("V0=.SJY2!"7OH(X_!!E6]@ 88KF/@DT[H"4;4/G7
M.*5\<CR?D^R*#@/8"_MFYA2^,O[3+F+;[R"1+"9T0>+GY*95UJ0[BUY"V8""
M#>HC+N=P'@Q+=*.O_]K#OYQ?V<D!&AN_,G1<2M+-4"WJ8"-6K]54'U7(]_C4
MQTA>=XR%_"%"PLP9IM8C9JD"8C<IRCP)QC@YC)LRQ(878"* (!S/."B2* %"
MHD4?&'Q-'+V9+<V HE@&0EA6/(!WV.LA'%V2(N,:9-<TOVTX."L"[Q;C 8,9
M<I7#<9Z-*. 0_,F+/Q=\5?@6'VJ6],H<L A 48B"AW2 :QD#D$8X5EY.E("6
MUQ28 0[R?9PG192$B\=&,(V!)R.HATE9 E>C176@ZX&6@2>$^0FP$G@1L*?D
M<P%:# 'R':2UQ0P"NZ(?BMTN7?1VV0$NL3Z01BH BOQB]$P;*"E7?G'ZNJL
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MPQ]*$OWOBR2DH>5HNDDT$L$'+_#\V'>I99I19%JZ^X]MOVB_)%8_)/E%DK;
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M14IE2"8 >EQX-0[B"HZ3LVG&:74U!Z",8X<9?-N@91MNU3$1)2! *(#7#&0
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M??OWX9GR[O3L\^G9P?G1Z8FRK?\,S3"4#Z=GQXJNJ?^>.:%9UCK-HJQI',1
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M24B5G%Z,!RQQYEDXUZ5]W0U*E7!=&;-PUV\T*L&Y%)QKIQ=(D$K*WPY<'1D
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MZ\WR)<-&!V14T-?5AS=14HP&9/(Z21GXV$MOIF? !KXSRV43\I_?7"=1>8D
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M!O<XST'OA!?"/*.P_&R8A I-KY(\2[%A?%]IDCGX0@;9=95$5; Q1GD"\TT
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ME)AQQY<Y ?4G)<,*"8;D.W-45GZ)VGZ9U]]?TOY%OS<]%)XTDSM!#M!';P$
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M$]ZP?9RRO#0>4L:P,0;M8/Z4&7VM6;OHZ5R&=RL.CS.?B]H%6G5;K^FQ<E
MOV"9W"ST+#*J.,"KY.MK. G,9*GD/\8%IL0_8!(F8M/*R<VF%\E[U=DQGX=H
M/-^.=;>FPI6PZ9M5,[9U"DP'>;JI*Y3 !)B]P3%A)0I/0X%19+4&HOP7YD]*
M4CLXA 2Z;A /$*>.PY0,;1CJ,7%8Y91AH+V-I'QEN,-Z&S-[K):19)'P &%^
M0Q9D>17.6[8RU W@-R!+\6/+>04 QH6G%)D,R;G/K2:S!3XDGLAR)P!.[Q;@
M4K!P9NVS8C%].!KNB)OYLHZJT"JBQ[-@ZH6T?+/S?BDV^TR.7MO7)&*=0O"Q
MC.^(ME(EA&BO<[J;0(>8;$H9[[/,?^:60A"T_'EM)VH-8R;4JC@LR_X3X96X
MI0K@?-,*0!4#8NI!R\\WOWV6U 2/#"G!7(;6"?8Q:E%#@3U7)2<UV$8;SUL3
M@:K<@HLL$TQ49OHF&>&U@1Z_YH @*<H: UGT&[-VI]-0IBYA5)Q@R3DQU0 U
M8!0F)&^\CAB38L1V767PLZT%DQ7NP=U2&1@QPEEQ<LY+KK R8[M-M%&3BO)E
MA$0\38>L_)W[IFARU3E)8=+45$X[DNRB $B=?RYRND1\4" /8&E^P0CTE]^3
MF]=IEGX &XY9)#C[&8W_]\6XB%X@?B!$V1>)Z[@D]IW8MT-B$4H]V]4TWW(L
MPR=QX+G_O,=M:KJFJ_A!-TS]!>PXA,4-BO]]H3HOF'F#0ZL7A(Q>5U&\HWIE
MG[*B>*%@4@0\!L^SRV:1^9])\#Z[^F2<77TSC\?1]\.KOS_ZWT^')X-O/_\T
MCM\?_OQV_L?EW^_Q\V5R^GXP/#V/!B?OCW_^_?'/GR?O#\U/)CX[^O[WUV/M
MY/O!S;%Q>/WMZY_XV?KV_<+^^_L/\^_S/W\>&V<_CG_^>7.B>\;)Q!^&PP_I
MZ1">^_HA.?G^8?CM^_'D[^]GWX_/0^ODZ]GE\?<?U]]^AC]//W[X\>WG-^N3
M>3:@_W<V^?MK- H,RX$UZ=^^'AG'7_].CG_^:WCR\?CFY.>%_O?'P\GI^1_?
M3WX>6]^^GGT_^7X9G_S\9I]\_\LZQG5\A[T<_!-J)K4BSU0]+795RS=,U0\<
MJIJF:^DA(:%IN"_>&KKS^V_3Y_AV+G B#(=%V"82#FO4%#*@]C' 5S7C DPB
M@PDPC598@BA<]/,9Y@1'.[*0I".L&RSLP&JL)B.[S5?B)M2.Z;8I;()SM;8U
MQEE ;8YQ\L2!\*K&!9UE>\!;E<O)"#D.O]^E_XJ38ZRGSJZNF;;8$)/=%;NN
M_2XSH<<Y_LZW"."?%HJ<^?&L#!9S2Z<N2RRD42 JS.+#JU,P*KO.YMW].AL'
M8\YX+*Y^7!150(QK#MR6%NZ=E+L%:E]20><7-9LQ(C/*'R@W*K62"\(9E8QI
M>RTKKZU!"O4<SP^%07-0A*5!(EVWWKP]_6@N>IX5LXR"!SBH2)^>CA!/2RJ0
MVB=9>T%,<F%:*8MZ\,L="V< FD#I ;JV(*E65LUE*V>V=XL.4E^?6*(\H:K.
MLB.F+!(6A5RE-/=:3J>:%S!:FKKI,LL/JJM27%\+9YA *^P]F+0NH,RY?5IG
MA)RL'2[/Z]QO :G%>1&S4\\3=]O16R6<-1>QEMZTW!T#N\EI;&AN@"E#_,B%
M<11S(W0Q>2VRFQL\76)"UY16DXH(=*,]C:08M"X9#OB=D9:>CY)66+@\ZYXG
ME5ZC:3U 7Q-;HR QIG8WTJ@MK$LAI>&$D@CM=&[YBB'R)OL'I>UXQ'_@BQFG
MBU2"8LHI#)L0.>--ZBOS,#>@97[D&CM;+L.V<[UV4HY'7+BU*(A==2QGH"/
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M80@MTHI6O5[?-$"C&RMS):R";9-E(/(>BEO':V<'M= #]WP;:E2PG!JUE:S
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MQF51DA07K[Q,4@7F&V"]A5<R"+_/0?AG=5N0H_J&;[C8LS*^HK #3F GXV%
M\].8R?OBM"&S:=>O3"Z\@^3_OJ!6.8GTT"=4M0,?#(V &BH! T/UX\B.#"T*
M?*RK:KI>W^B0[U?>]=T0]3[T;H6DWJ>EWADW@>?0T(Q=6_6MV >]/=15W_>
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M4CG_3699@:D$'*,*.A"-?(YIPJ4J\:H!?&&A307@BP3XI/$0D$L6@S2 A:7
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M>"":4F"6$M A_7#(^H@#=4Z'[$SC+4+L.GCKCW(A.K!F&/(SGIV'WK!$O"_
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M%!D0QB7("L(4J0[BZH*_('9Y$3M_[WY!;%.(K16W0\$BRVE:.LP X\J#"=)
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MHXF.+=(<C&,.4>.X8TDI83)+9_;B]6P;?N=FQ!3\SAN_D_T;%2/!*@%*(9Y
M;'/O5>N!"\*IP])ZF>04Q@W4'"GX;0U^YV;I%/S.&;^3YI!4";,F2, 2)_S*
MA%]M+05%4:34&>HDSOB=Q5.QN&.+]IDNK3"'EN7L9ES'.E[GVZ]-'>OV95[?
M*JY93<JW&@BEL-$CJ;=>R#IR;(C! 0Q6#)B7"HS& CQQ1FEG',[Q6JSTKEPE
M^"XF!;O =P[PG;!\6$SJ-W*:[)U<0L'[!%\2<V*GD0IIBD.T23D5_*X4?A>3
MCEWPVSQ^)RT?H0D/@@0(Q&-@--E %D>=?A#'D<5,>[ZQ14I;RP75LCZ_JCK7
ML9>=?UP5MO[GC3%0*EN7<HCMJ&Q=R'A6,JX7K_:*&ZE14D_<T1P_FZPBJB,8
M:Z)$6@JNDIB2K!1Y+:RV%JRV\-+5=[):">!MD/(F[$?!G7"&6. L$F Q.D@4
MR$%9$PRBUE"4]><F%0T4X2ND5TBO_:2W\,K61<K-SFN3=G6:.$ZT1T =2KR6
M!#DD56XA.\0BEFDV8\@GBDM :BM[T+8;8W"CG"(5OK@3TWL?.@,S"IWQ[U55
MA,HFSP62JU_"_UYT/R58]$:/BT5<88_@_.S/\2P=QMVK.7J3INBPEWDL___N
MS92\"</1H.M&P><7MGO^^S_<>F=AMZG8S=4,56$C9=XIX)Y;8-H&L,1B",I+
MSX*PGK&-K9)SM5(0GY\Q5B#> HA/&&:1N(AX,LRTQKE&HLDAC8A#P$8R3"DV
M-I=J*N=Z;8?X4P8T%F _/;!KJ5^8N:3),#@F<=J[#0/#L0,NB>8JL;E6>F.+
ME1:V"W +O!A;'=TI#(WB&UIGW]#\S*R92/E5>O"^W^NY03##L!/&_Z;_/KW(
M0W^;_L=;0G&J-T?Q];XV$IN0Q#H!F_O?,N\-6,0Y(!9HM%$3SGQ51NN.^M;M
M\S\5IWHASM95_5XT719&G(X1)WL&&>ZY1Q*<="XQHO.0I"X#8:VW0EK#0ZX3
M5&/#:SPMS%J;4F07#BX<O#3B=7X'FT6\+B]5UR*2&;$\5XVB+#=U2TL$C(@8
MO ^&*FF1HU5)-ZH;R*8NAZ<S%6VYRV'1,:..#>^[O5Z.5^['SF4P@W4X+IV"
M"851WB,2@C6!!<=5I()PI:Q,)CT*^N^]!:C00F/-T5B]QQ1G*$2&$6@7)##K
M.5@;%+B(=+0B8(E)#FS3K$YCI6_-<L-;*RVHBX1Z0A.\L7%$\B"$==%+X5T%
M[P<<GQ1XMP?>EY.EKK5*^L1#I)H#<PJ!HM@#"91X$3T*2HSA72^A5^"]W/!.
M6[?P0@:EM&$:VRQ)/=<J 9T@)BMX8UW@O43PGC1""&8D6L1 <1*!12M!"X(!
MISG&A"0[EM*-+;9):3TSLIR3-G].^B-C(Z2_WV-F%'_3JOF;IC&RL";>&!^9
M%2PZKX7S1FJ)@R6(XUBIL =4Q2PTW0J:/MBI-_N*3"*>(UBX4$F%T:C!>&(!
M&RMC9-JSW$\0;ZH[C*SBVB^N_4*U#5%M\6>M'-5.Q@,+9Y)5*R%*19,BY@(L
MU0R,1M;@X"ASYCY_5J':0K6%:INAVN);7#FJG70^Y%Y6V! *UN?<46X=J! -
M8,]U=%8(8LE]OL5"M=^Y0JYOY/J6246D=_/P3[V=*_36GWB*6N\0.KHX/S\-
MN3J<.1T[A>)I_W/'=X?NM#^\&(3G]YXXMWUJFIO%J6I0RV>2MS;.X%MSF&[/
M]<_"N$=,51@Y>_X&(:9GG#I3HG5*Z.X!F%H)M4?LS'S2TGB'F[UJ_1SGY?,J
MK:F#4$)KIU,K]=XU*I@D6!@&CG6N (L=:"$P(..\$<&(I$\WMCBJU^]YG'18
M(D.L,$SK&:;QQ(#",+,S3"W6@M-HA0.<\U09IABL9!8<090(K+2C>F-+W-$=
MJS!,89BG9IC&D^H+P\S,,/5P#\RT8 X$XQ*8XHEAA#8@(T;2Q6@-41M;E,P<
MR[6X)D!3!9HLB_$W"H,P'.7"7#[86E.<.YP72\B)*T1]<S#?QBN@\-YC>.]U
MS79+NY$B40C .=:-<6[!!DG!.4QME%8JXC+O31FBWJ)0U9G#4]M-%@][KN5F
MD3F8:(5%9F*1"?O,:B*L-A@2O2<6P1[E/J@2HE A:N2#H"&SR,P>H/9%PA=Z
M67IZF8-]5NAE%GJ9-,Z4HH8$BT#+W"$0699K$D802#OAG"!*\40OJ$UY=)5Q
M]J^1L:<A_>N[G[;^._VX_NI;UW(AKY8K:&S]MQW\Z]L1_H,_-B.B,+J&5'6=
MY]U1^@[W8Y"1ZA VA(YQKG^6[N$R)_OV^J,P[(SZG1?]7G6DG[L8=Z[*BYO3
MSM$H_:%JZ?7L(0]9C?/#AN;JOCA+CW+>'W;S]#\?Y#;*W4_AE\]=/SJY9H9;
MGQK/V7-T\Q%CTWU?C.[_R%US4$WSS36KR(8T%Z?F?!B>7__RRW4/VVZO&LGJ
M0[^<F<'[;@^N;B3;X!/+JOJ^\<LW]_0,C>_KROJ_^N:KEY]5+TTL]O%KG#U+
M&O_>E]$S?.]K/[HLH_\_>^_:W,:1I(W^%03?<W;'$2QMW2_V>Q2AD62O9H>D
M+5'CD;\HZBI"(@$N $JB?OW)K.[&E=2-- V2;<_0$M'HKJJN?/+)K+P\$/+K
M;KN]<0?FJ^(.GN#;G S\">#&;(J%^^#.Q[!SIEA#/ -:G.;)8(I=NN<7C>%Z
M^(D=[#X,I[!13D%YE&%.#[XA1N%;5^3+$G4CZ\7UJLA>!H[+/W'H55'&'*6F
M3'CJ$_S!!NN*,UD*D9*0S+QV9J?[TM%DL6)O,@F3[-\17T! ?_3''_SY=.>_
M5A;E!*2N':G0,)5U>;]F9+ULD0!'FU<*A&(\J<W<?P2-E"=X%2#LX?-7__/T
M^>#QP?-?#YX_.GQVL#_XJ_Y!#\W@YX/G>P-&R?^LO=9U/-Z JJ7/UH P'(_C
MNPW8&Y^VKT3:!T*(M5NLPJ98E8NW9]/9L)Q?MW+\S"O<>;A_</CTQ>#P -[4
M_HN#?SY[\NCPZ9/!S\_V'^T_?O;HGX,7A_"+O:?[AR\V5=C7[758RYT+%OKF
M5N*+@5GSA1BP 1FT#'S_[ 3N$Z_!+[A*LE_ _ !$HQ_-'@$% : %E/P5.$<<
MYNDA/.GON*W^6L;]<>_)H_=_C/YQ],>G\:>]3WMJ_^UOY_N_/ /V'2D\4Q[
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M7Q2AAZTN18;2:IG&VD.-5$V[(=8="V>SI3/#9?VT"U\+&+D+E*^.I]%E0'U
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M+7FHQV\(8&_P/Y4/',\ZM%I1Z_B+$U_C QHW4YFOZ0 (P;(G?1Y2<'O=SR^
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MKI[P"Q3SDLMY&>-@J#6(O)PW5=LN&L_NFK^W%NMM7,>K/. _IZM48;4J''R
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ML778F@EW6*/(EVSE!0-<E %=-*7#F/=0F7,Y U!]WX#+ T!NC-"M;L]F$=K
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MO6G7XN%..2FA$\7.REEXRXUV5BL>3(Y"]Q[NFY/(-:X-%A!U5 ;B&7-$:I-
MKSL+8BD%%24[+_W.P_[,Z:Y)9,G:^4*3+YS**&3@$OXIN<04I7*B9]HW)9$;
M424V:&:#("45D$@1'7':%A)URB"1V%&:[CP46R215_5NW^UL[^NMT[KMV=Y7
M+L.J,;_+>$8QBXBF;).16BA/K;0TJ:L$J-S],JPWA5IO-I@]\^BSL4CJI0#4
M\EBT(A?BK63"JNRI5CL/^:ZZH&/L[2K"VA?+V ) Z>'SLE)DQ3E9/#,J,SS5
M"(%R016U25)F@ND[#6P'?*X'&K&4.).1:&#?1%H;2: Z$"9RC"P69TJN\,DV
MPQIZ^.SALX?/ZX%/1TM0VB0M))/,\2!I+-1'Y:W2+(2^"<!6P.>ZS<R"<RIY
M3Q+/F4@7.#;]+O GY27P4DZ]1?ADO&>??_)IV?:!W<%D=C0^]9B$/:VUMU^<
MPC5?4W'[^YV*_3WN1]#C_XSR9NW]*P=N;,?<OIDD; \/N'K2950Y\VB3]EPJ
M25TTC DIF*0V,G&5IIJ]JO\&5?_TPT;?S!R*RA;4O*&8DQ&9(U9X00I:OEX8
M$P6>(=-MRKJ\(=.D!Y:M!Q:F.#/21EILD%I*QSG7BJN453+9A_XD_.: 9:W9
MHW6V9)XYR49H(KG6Q&O*B8F*>WAK7*$+6[HK)WOUP-(#R_4#2XPRZVA#3DDJ
MJZPWT3/NE:#,"Y_[ _V; Y:U#H78/Y([0XGB6"N1N42"8H+P0(-S-*@D\$1_
MJX#E/L3._O?P]/*^:?<S+$AA_P$:E=;)2IVY=SD',(-DD3SQ*YV^]RCR+2CR
M<</NL8)I;XTFFN8$*)(5IJ%+DJWQ/*:0M75@][ ^%_VN"26%-ZRIE"70(A/5
M/DAC6()?:J8"[S/5;E HUVP&AI8;SY9HPRV10EOB*6CZI#R(I,Y:. Y"R:]<
MEJT7RBT32F.],C((FX.506:74@"98UB1GH>@>KY]<T*YQK>%4*[03 EW*1"I
MDB;!!D8B(*A7*G++@6]+ODW] N[#8<GAQ)^=^'H$]_3C;))/AK/A9SH7W\\4
M6&>ES4PEE:F00,&M"ED @ "[TU;(OBSR3>'*^28#3RFZI"*1M.(*R\32((B@
M4L>@%0<PV'EHS'6U.]HB!^$]%TKJBC9&2JNLDSQPG[(NOLAL&'6>Y9Z!WYQ0
MKC'P5 )/-&:"Q7&Q;&(D5G%/?/2:8?J =1F$TME>*.^84&8#C%MYZ83P ,#"
M6AI5U-S$(*4S/0._0:%<8^")69$H ][-HP-U20/QAAK"DPLA%::83F 6VRMG
ML?4>[V^2KAKYUKN\5S-A.2M%<"QADF5Q,FACB^=*>AXTTZHGW#<$(Y\V"'>,
M7(60L;]H*D0:;8BC4A&5,O44U#M-;.>A8+UW[:X))6,L:L:=BTG)E)F'/X<@
M0C#1\BAE3[AO3BC7"+>F12I%*8DA64SWI,2Y8(G1R7.;4PPL@%"**U=GZX5R
MRX0R!!F*-T5K[26/VLGDX*=11G/8$CWAOD&A7"/<SKNB1$F$2<:)#%X1"[2&
M  >/#+=-+%@R\>J$NW=YWU!YMKMKMP=JK;) X((I,AD3>([P&Y^Q^JI4KB?<
M-P0C=(-P^RBH"E00134ZTW(FM@CX >:0X44*ZP!&&-^F*H^],^TZA%(F;YAQ
MZ.BVTN7@++..92XIEX'[OM/V#0KE&N&.E'J1HR9)B4!D!@5O U5$2PLLS!5I
M9!7*.YCP<L^%4H$H4A/^?_;>M*FM)%L7_BL*WG/NK8IP<G(>7#>(H RNID]+
ME&W<+OCBR!$$&F@-9OCU[\HM"80D7 B$V<*[HAN#M(<<UGK6D&OPGC +#,H<
M35(%39R(#)BT*M+V YER1N$F@1,<)4% CQ;ERGFY41<&SG2$JT1CBB:?!9>(
M)Y_JX'YPTLCXOI^K4,;2DU[O0AF,@HHN.-4I.!X"<29&'1T#\00LD*HR;:7
M+3+O4N>4*28#<H%QQ#51R$6>D- R)1Z]C45OA3=T@3I1]DH9R[+@"WL3*_S\
MB?$S*:\C5EC0$'@@WA!%)0&+*S MK==5G;:2X.>,,6:9L%X*B5*,%'%#%<J^
M*\2,I0PD(@&Y6."GFJ]B7^%GA9\5?JX&/XER*7@ILS$,IG'2%!B28RN3$]9J
M615J*PE^SMC-4@#=1&T0V,D><14CLC%@E ()0EL@X5QD@;Q1<CX[H\+/E1Z<
ME0_M#KJ#^=:A#RR,-QKM6P9K&KI#UXHW2_YSR8'5K\IZ"PIK'='4RQP\Q'G
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M:. 338GWB]3^%^'3G\$-\2D.!JW%Y6A>H[7SFK2)J:VK@&DY8)IO/\DUQSP
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M%+GH,&QP\,@RHY!T21M0 ;V,H/G)^>H,!9<OL\<DTL1EB$6U*&,],#'Q3J3
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M!)M =<C%G-Z =E@A8(6 %0(N:K26!)7"V<0MXYIR:Z5+GCO#1,+>RPH!RX2
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M8V 8)WB8,<F)R *&F5H@0[]:E)AV8*3F90SH.O:Z%7HLBQXSYU<49V][Q(C
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MJ&:G/^@-1R-XP%S>U"X>BY8J G\Z;8@BA+/D7$HD&"J$2LPPFRJT?!Z6V;T
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MJXP"CX]B05)!O)5#O*G<$L^'7BU)2$<5$0^!((LU000<!*6]"520M4U8P^>
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M//KS1O6GJ9JC^F]*;G MK_TSWB"W^AO9H.QV=_W98(G9 !OMIK>=<TI^/.&
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MNM*BNN("3"_J=<_&T?;*VJH+X0'^3L&BR\YH=7DM]U5EZ"!#<'6@9T+P\XO
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M,_Z23LD(+35B!CNP8YQ&)EB*$I$!QQ"E56EM4VR(6U Y/HA.^:7@5!^TJBX
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M>/>]TV'/'XV:Q)VT!G5_O=QR;MP7M[_>Z ]/3]M5C69N.%SW2X65&5.0KS?
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M< W[?/SY&)YQMK?_)_Z\_?7LX/C?[=U/?XKFR;^/FR<?SYK[,);I?.7)#KA
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MB* C([R ZJ.":FLZL!R2"40CPFC*L1V%+ X!B20<]Q0 -C>BE^N&%U MH%I
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MW"2;A$<>W%ILL6&.F;5-<V>>K (:!30>&C1*".4V #&=8DV:>J4<HIIQQ%/
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M '@$5.2W0V^?XU*#ZE,AJ*8Q(B>2!??-$>1LU$CI()E1'&P^+'6C^RM]G[8
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MUX>]P./ZPN-421NW7 GA& I64\2%L<C!.B/B+,;2P7LJ;&P*5F=WGO%=X+'
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M_Y'NO7E'#K=>\KVM77S0/H C?OG>:$X%54[>G<-U7C3V7XI&>^?B\ 2N9_^
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MB%M#D<94H"0<F'?EO=(ET[%D.I9,QP?*=+P5T)9,QW5!WRD*+6V((2>>,"(
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M9+Y0/7X?/9<8Y ;; +]HITTR"@2*A< X44>$JHV;L(R'Y$<-\(%K!-?0+ST
M):MMA&2$M]S&J 4<S7#)J;')Z?F@>ETOMJ(;;#7[V3 ,>W$?#OU7WD)^=-'U
M8]$]_=JX>'_2V#\^:=##]N$^B-I6Z_A@_U,3Q)$UWAR<'YZ$DX/][?.]5U.B
MVWX'[^^2O3>[#+[9VMMZQ_<^OSYN?/[[>'?+X\.3O]L-VCC>W=_A_[G8IJ .
M1])@K15EB)E@$7=1(LV, W;N4A#66N[("*I T, AR@@0+7,Q)!:<L%P&:I)R
M7CO+1,A;YWZC%@$03G,:2&\8-S:WMO_:K[UL;-5>O=_>VMFOO7[Y:N??._L[
MVQ]F4["NBOC<'?O?G_SZQ>901I)&&244D%FKN2'1@;LHL%3)N-7>X0?R<0P>
M<RV_4W%<WXNA.9@P$G=>^V8!GX?]&M!=V_%P/@ .N,S!L(K> YS80:W*#/IF
MFZTJ:0S\]0184U%JH#W@'Z&*_0#A@><,7*@38P F_FK,U>&L%?L>G3E9GVE[
M$RYG3-QK<'8X9@XD@/]^UAP<7[F8C%Y5&A*\_RUV;,7Q/^=X0*]R%JIO-7.G
MN-$W;:OUXY-7JZ>O![86\@,?=PEW.K77T?6&MG<^#M''6I7%5T7MX<'9A6)S
M! M0@4!CH)2#1%MIA0/H$TEA*R(=Q>;@?_K7L;D,@S^V?5Y;'U]6N6,WL_3F
M^<'EV=[^U[QC2'<O7IXWMKX<F2B" HJ&:%08G!.GD7'1(\DXX!-+@64S2^H_
MZ[C@1EE\E?]::W5!'.V77JRHV4AM815R^XRL!3\DB%8*("K%<M'V<D)@%B;P
M9;*FUUSV77K9%<^_A8FSLY]/\B'Z81:[O6^QU\DB6GL]4E10^O?Y*__\L/?Z
M_;]JIZWAHFZS TM! 5,%N&L<QV IUHD (ENCI;1T;)CIV#!/R^<<_GI=0(&E
M-OL?P%^V8:_S"3 O0UF^9K)*7O(C"^7)UR/)),& !,APE<>\)(XLT^ [XQ1L
MLD&'5-60*CK'::[7=CJ7&-6+I[:YV)82U8)[8;0106?:JYG5SO@0*58I2G'C
M+:6)#+R':S@?;4NG+ \K%/=_W*7.7@=EE'&M/6*,9>HF%3)Y_E>*WGH%3YPK
MO[$IQ6RYP 04+I&GOD[6M!+0S$C^ZH*WFNG)%K 0/^@"%E9["=]RW _H8@<H
M2T9#L+'Y;MOV>[,];(]SI"LRU6T#[ZQXRJD]K9ROG.<&WW41SC#H#P!E,SBF
M7K>]8":E,D(+ 333<FZ#4\IXS0$*38 _R?PYYW-0\-_P!/;2JXI[O1Y1K_/=
MT8W\U>WUNF=P>:_L*;PS.+^9Z7Y^JG-PUMCR%[O[NZ*Q_Y'O[?LCY< = /\8
M89<,X@0[E$OL47860J#6!TS!=+\0>([R@#@M(@H2,!B$08: $X@"P*,(Q&L+
ML.RH]G[^9FH1A?M&T9.OO''R[HAQ08WA'B49(^*1,Z0QX0@,F,&*VA!USM=Y
M0>?@Z,]A\]% DM";Y(7G'XN(,#$4O.N0P,CPY(.1/ECPJ,&1IEB0=&,1?G4)
MN&\SWOZVD>SC!Q0?6D"_?M_]<N084&9E-8I$ G6S 4@<9CFH2+V,5$G! 9XZ
MW5EL<A,@Z%^S7Z/0XJP7?YX+A6:L()C0+SW;KIT=-WWED7?/^M4F7.60C'S_
MX6G&0694#B'T1P8R&]DJ%1=,:PY09*]^$69Q9;]6_(QHW&]L\(,_CF'8BB.V
M>24K\GF'";\><4$8)S*AQ&).3LIIW SPDBAO&!82!$%,A_T>N$;1F#JGXF<E
MBK^J,Z1UCG_^[FTK% FI2R)O==A?GY+>L.YQD8NEN*[E\@_+1%WBY1^6X#J7
M/W][M1YM=;'L]I6JA*Y"J:J>$(_J,'\T!W *?X-BS _#=CO'K< D5&E4M0RL
M"]2@_K2KW*-\](:EQ L<?LY2CFJ\'[_N.$?7[F>E5OBFMX;/[YXS&WJ.-WV]
M'>]O='M"4X!]QE_?_//XY K;JINU,/D0.TWP:8:=_GA7I-,=Q/X?-U"$VS>O
MO\$Q;M0"Y2XG>)R+O&NK[UM=[>_;A3\\&BTX"F!^CBHC3GG,@V&1)T)<2(0'
M'(S#U@;&;QR/N>[E[HPW$K/A_S#(-0 _TE?7?Y=MU.#I%*[A&%S;+^3@Q'\_
M?+.-#TX:K;TW!V3W9.<"KH/O[G^":WJ)=S],-7AJ'XB]-]O?][8^-1L7K[\>
M[+]O[M*/_/#DX_GN2;Z/+]\;GS^=[&Z]^_Z?BW<SG:M-%,RY8%$T. _W\01I
M'BARV%/F(HF!F+Q=3.;MS-T*E6ZJ0G*M.N[/5Z!&]]NXR3ZN0IWL+E,=5Z+I
MWOS[7+CIWNJTS5M\",I28&]V5_GCQ.0_B2WEA\:UZ<:E,45%+#$(GCQ%G":%
MM,88)8R3T$8RG0MZA%ZE\:L/U :T8,KJ8PJF@4A&I.2&!YD,C]CED5H@FBX1
M-7^COF#*DC%EJAFF2T%%I1P2N04F9RDA%SU' "4V;]R3:JJSI*LT\?VN(YV7
MX=,]&0]'8^TM2Y%JS[F/2GN%H_;)64*]E;%X.(^NM1]G/!S')% SIY'T6"(.
M)!QI%S'2EBB"C<3&T)Q[*.=DU=S.P[FI"OW*P_F]"JV&E;X<(T;F.SC/;4+B
M4A"C&/+E0L+,5(.<(<_!?"LM".*"9$.>&!+&,IP;-T3"P3DP9H6F$I:)I<O0
M1R*"")I$[%WD1D0@U4Z::#@743 3"K%^$'V<(M88<^E4)(B:",YZM 9I*C'R
MC#LPTU2(7% OS&SCF/6=$EJV#JZ:26ES,4:5&\<M]Y9$%E2*@0H/HD$+L7YT
MK3V8(=9<Z91H$HCEQ#M.HT?&.XP")T+;H*-6H+6LSN;TA2M;![]3H%U[7B.B
M(M7\5J3ZIM&^]3/BMT.+8L27"P?3I%JJG'QO+5)6<\1MM$@GIA%1@ ,R>7C!
M9",^VZ]V[2/NSUP?)7;* :EFQ@<NF-<Z.<Z48L$3P=E/RLJ*/BY9'Z=(-:-:
M1/!TD54Y.9X8AXRV&)F4B K:X>AHUD>V0OI8HM5+)-74*AV= T^711Y\,H$Z
M6',N%5;,15E(]:-K[>PD><X<%1%'I!P'*QIS*HXE"F&5&;5(DL1JDOR\PK\2
MK;YQM)K=@5@_W>C8[1"C&/+E0L(TL?:"!Y:C8RFD@#@+&CEN!?P@3EE)'(MQ
M8]/@.QOR$JU>,7UT(>FH4\(D8)ZXL)H*IX%G8RPUXZ(0ZP?1QREBS<$J>VP2
M(H$;Q#57R%$3$%AN#4N,#2$^MW\MT>HG&JW&3/B G4Y2:"XI,SRWDPJ:) !G
MCDL:R.-K[9<98JUL\K!JN:6D '=8,8HL+!<BU#H!I$<Y@:M$]Z41Z^<4K?Y[
MV(F3<+4HX>HEP$6QXLO%@VE6G1*1S&N/@$$#J\ZS'ZS0%"FBI9(I>4;=QJ;D
MLWVT2[AZO?61<"#1PFL=/>>:.,TI)\0*Y[@";EU8]</HXW2X6D4JA (:+9(#
M^YP$,H1*Y*(E)$4BC>19'U>I8*.$JY?(J@G6@F@?P;/2W IB$C-@+0GV) 9A
M5&'5CZZU7V=8M>?6$6Q!:Y/+HU!R)J4.&,4DD_58<R_T<G- GE.X^K)\E-R!
M6#_=\-CM$*,8\N5"PC2Q9HQ*[G! P>5ZBZ@-LDERE.O6F%%8*).'P?-5"H^5
M</4R]-%2\)VH9YP"L3:$N)BTE$Y'03B3QA5B_2#Z.$6L@W DZ.C 1!N<FR1R
M<'0MRP-5A$HXZ93XJNEC"5<OD5@+12VQP>?.W]R(X)RS1.9HE 2/2YI"K!]=
M:[?/LL:.R+4_W]W_^/W(4A\XJ"=*7M-QV:*F' D6C75">.]99M;SFH&7>/7O
MLZM[_G@2L)8E8+T$P"AV?-F(\/$Z(H!ODX0!7SMI)1!7A"'KO$&4AAS2S#5L
M>=]YSMS1$K%><X7DEA,:*(F&<:*3H]$DJD5*42LF3"'6#Z.0_KI"\ERI&&Q$
MX/0$Q*7TR&H2$(DZ&,<-9XEDA9P=KEE"UD^"65,6M&8VZ6 IQQ$[8AA0M@@+
M#TKJ=&'6CZ^VWV>8=1!1@K',U8K:(>YR@,IX@B@Q)!"IO'/ K.D26QX^RYCU
MN.6A*D'K)6!&L>7+!H4I<LV 7?%('6(!?&Z.$Y!K$RC2#A@W<S;2D*/6=R?7
M)6J]8@HIB)""J\!(TCQ%ZU* '\SGO21IG2WD^F$4<HI<LZB!]2J"$G$,<:LT
MLEQ[Y(+T!!,?.+$;F_KN^2 E;/WH2CF77#/BJ)31&^?S$%]OK=1$<>DM!KHF
M2C[("JCM^0RY]LG#JGF),$\$\3R#VG#-4<"YZ99+VN1^XJP^;P!L"5O?+&RM
M*F*M2]1Z"7A1[/BR 6&*6&O%.-/5Z%(G$4\,_&YI @HL^$0L(9[AW(:@Y%D_
M-87D#"?LJ<XN+N>$.66=$<Y%YQ@S.A5B_3 *.46L W6&**#3.!*!. T::8(Y
M$L;D1KE64BI632%+U'J9Q-H&)54B0,@"IPEK[<$P@FH"00N*%V*] FI[,4.L
MF1 &$\F1Q"E/7V8<&64<DH9X*IR-,:LMKJO2&.3V^2 5L38E8KT$O"AV?-F
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MA)62D2;%HW2.<>R)YSP8S[4JY'H%U);.D&NJ$\:6:!2<2XAS&Y%Q(8 4)9\
M6 UC(D>M<6D/<N<Y,8R4P/42(*.8\F5CPG3@FGH>A*7(B%Q[05UN\N4X8BQ1
M%W("+@FYAG&5XF0E<+V4P+76UH?@%=@ ;KRQ- 2J0Y(X1-#*$KA^((6<XM94
M:>-QY"AJ"D;::(5T3 K9 (O%F(N)L)RBM4H*60+72^36CKBHJB:+#/0P4<LM
MQPI;(:PU/I'"K1]?;=EL1HC%3),@D98\3TX5\!O'"5F21TS'R+1R&YN\3I;&
MK9]3X/KE::_9&J5:<U:"UDO BV+'EPT(4\2:"PE>()AP:<#CYL1:Y)+'*"7)
M1 (Q9#QN;#)#5RA&5H+62U%(PV1(S*60I\,88K6"]?8RN<"P#Z6&\8$4<KJ&
M41O+8HJ(4AX0QYXAFW(!A.;1&<)H2&K5%+($K9=(K$/"6&F=3&226XTM2]9Q
M3VV,A%+F"K%^?+7E,\3:>4-P4ABQJ"+BUENDE2<()Q^(E\&:$#.Q7MZTF.<4
MM-ZUY^-,:WZ[P>9/-SYV.[@H9GS9>##%JY736,!Z()]T#EA' 7@@,<*2@H5G
MQF!6F7&Y0O&Q$K!>AD+*Z+PTR1'O"-?:&QL=Z*BP*?A$62EA?""%G Y86^:M
MTQ0QZL'1=5X@%S7((W&6,(L-53PKY"JUF"\!ZV6.-@^YAM5)(BCGEDF'L3,\
M1*:9Y8:5WB KH+9BMJ,UU80[[9 CR2/N@6%K["1RF 7K%:4:D\RK2Z;U76?%
M\-O-BGFZ ;+; 48QY,M&A"EF+7RP0*XLLL(%Q!,';/"8(BJ,@E]D%!R8M=%L
MA0)D)6*]#(6,05(JM00=M%RK:"@SVFO*K,?$EUDQ#Z604\S:4P:K$B3"2G+$
M+4Y(RY20]T(RIN"G3UDA2\3ZB4:LP:$"5\KYH*GER3F7&#:^&@-AJ%6X,.M'
M5]N=V2F,@<)J10%4FML<H>(&62HM\C)H;T1R(7>AIW53TJSOUAQ$E.8@R\"+
M8L>7#0@SQ-KR +0*P7)@<+4Y19;IB +.>6(D"$D!$"2_LQTO(>L54\@D/#?:
M8:>9YSYB2^$0C'#%"7'P:R'6#Z.04\0Z!2PMI0K!6CBPT!I7D\T1D^ "@[]#
M)'6KII!SB359T%]=28N^'WOM6JMK._<:57R>GCTV*B6*%:4Y%\U2IP)E6J0@
MO,;FYIO8_^YVON1U*OBS./[,#HXS.N5=,X(TB0EQP3$R)AB$=63.19F"U!N;
M>D[SP!)I6V]]3,0I:X*@46#NE#%>VQ09#RXPX[V[*2&XKH^IVVO; 1S^^^"/
MU/P> [J(O6[1TX7U=(HG*,N(P)*A(+A%7#.*C.,"$:N%L4YP:8&X____GP8$
M_7.%=/4W0;C0[)^V['F^V/AK]5Z]3RY.@]8EL+$W.(Z]>PW_/$\?3!)#@[4A
M<2=Y\L%DDJ^,(M%1+$BZ*06JUJ?PH-OCZ^PX FLU(]3G=DZ" ;X2@;0#Z^4-
M%Y$!^AK&-C97::A04<FEJ*35(6 :H[.11R]T8I(*K9V*4>-XX_W&HI)W5\GI
MUD[2RN2!Z"B<9UI3Z9'US"*;C+8&U,Z8W"-FY:O/URPRHN9'1KH#VP(-<(/[
M"(W\[GNNVPNQAP;=TS_RTO2[K6:H3>[TMZBT&D_POQ:EWS>_Z4>%X/EW^PBL
M**-N1N !(/#+3OAPW.T-\N^ONFT'UQ=>MN$A3[FHG6$;A>X C8];0'LQT)[M
M/D^23S10C11+&'&%"=+,*W!6'9>8,QR%!]!F+_"<R4X3#7DPHG [O_C&BOG(
M :Z"JL\959=$; NJ/@:J3E%AR9RA3FC$A G@G0J)#*8.V2A$#"$))S.JTA=<
MF8*J2R/GO_ ,5%V)50S=_3OV^S4_[/5B9U #A1SVFH-F[)=@WLH&\S+ OAHM
M6$'1):+H;/-VR7-<3W"DJ&6(8^:1DRHA"ZPTIJB<MP90] 4ILY&>GK8ND0Y=
M:FM1R 45<GHR$L>$2>.1E$KG 888Z60CXMQ$J8Q-8M6"[D\]P-<"IH\RO2^A
MON*4KFZH[^I&2Z/;\84^+1VM9_MS,RXXTYR@:/.<=F]I;G\DD _"84^)3D0!
M?2(OM)B%[.*$%A0M*+I:H;V"H@^!HE.<5R2ID_<>V4@PXHD$I+D')S0ED[0(
MWDDR#N7-YOP7%+U&PR<7,KYD4T'D-68N'J:1SI4;9G!+H3MTK3ASQ\MHU?/
M5SG?W_G54UV7',>/@(5=N(:+&"I?I];L]X>VXR/<9W\P$S"]<\AD->[ZYC9U
MWGVM>0AH2<['%<FIBMG'<K/]_31V^K%8R,4LY&Q;16.8DYY'Y"0FB$M/D&%1
M(R7A9<HB#BIL;(I5JHA;4HRV@,SZ@\R2N'D!F26#S/2..N'!FR#!L2$<<2$E
M,B8&9 )SSCBAA,YUMZL$,HMSL=6+/<_7K[^ZO5[W#"ZQYNVI]<W!>0VT+'YO
M]@?YQ00OM>9N8]^Y;&\U[G_A2,=3 LQEA83A(O;2JUX,S<'KD<"<OX]MV^S
M@[H4L%=C^2I!CB6BZVS_OJB4M8E:I!@3B#,MD:. KMA2'US^._J-3?J"W!U@
M5Z^NN(#2^H/2LB*L!90>$92FLPVB42IERH<-@%(("3E/&/R9O%54QN#QZH'2
MTXW O;;-7NV;;0UCK9MJ_=AI=GN@E./V0K5.=[  X2L>\MI@ZQ+S)G\TDLS"
M]"G+4@'1Y8'H[FP#N>B\#]$0Y*VVB-.D$9 YBIPV5'LOHQ,X%V6^,"M5F%D"
M= 5^EI\(6N#GWN%GNEV>THHRJU%(T2,NK$*62XR$\C$H6#:;&\,3]H*M5 YW
M1>+^>V!=*VY.+JL!@M-K>O@[-+^-7LV"VNP,[7BOOWH=?DPWH6EV*@UPK:[_
M^F?;?D=GS3 X_H/5&6/_^+/=[(Q?H*,7IJYLT#W=N.G!9[_ZY^C07,.Q>=:\
M*X=HV]X7./GHUO,6\]6G=#+L#YKI?#FH8'Z'"G2""E<?Z4CG))"+) TP#J'@
M>U9S ]1#JMQ>227C1G@!WXGA959CDX1++D2I).5,1:V]"PQ@(Q$IE#0;F_O'
ML9:ND=D!O#*?T-;.;+\6X5&T<[/KVK"? YS_-^SF/YKC9MBU'KS7?W&E?*=F
M.Z%FJTJ[?CZ^F[B._9JS??@JW-SX(%G6OT7X;N]K'-1.0<+&7S]OQE;HPZ79
M06W0[7[-I^O"QWT^:G7%(/NQUSK/5Y13@/N3.QEMCU]B7;]>^S!T_8&%IV1;
MK?,:_,@?[0Y[DYWTFF_9?K^9FG!!9\W!<;-3^W?\%ELU.CGFE>=UW(R]/*/D
MO#Y/"<;*.BVNZR%KOY>=20/T6ASM[+R !^U;PXPXM5[\OV$S2TZ*L(;-48)6
MM=;=X2 __^I3U2//"^RK,,.5:/EHK<_@^..#5C)6Z^96)?F5;CO6_CD^[[]>
MU#IQ\ (D8P 6*M3^:P&3JJ2RR<AD<G=A"V94*(P-EYP:FYQ61UN9T6."";H9
MM9\\E/%NUY-HIW+XGV/LVY\Z]K,9[K7?P?N[9._-+H-OMO:VWO&]SZ^/&Y__
M/M[=\OCPY.]V@S; Q.[P_UQL4[B>(Q"@))*4B$N50ZJ!(Q>H0+F]MA<Q4&K(
MQB9CLZFW+Q9:3"8(\4QZ95CB7(-[YH0TW$?FO$I:5XM))HMY Z)4%G-Z,=\=
M":R9! **K$\1<4](=J ,,HDSGK#Q-H:?+696]446E$2:N PQ&AZYL1ZTDW@G
M4F#4*NIBM:!XLJ"X+.C""WJQ<Y0X(=8;B:3"H**<6:0I"2@R<#2PQ@$ $A:4
MS XPRXB<43%/$:"D6MV\#'-L86W6&%;/VD</%#C/-[0!?M$@2<FHR!D+@7&B
MC@C#\QC?XYG0F0SHRH0V]O:W:X344.U_KC'D)1B;:0'.IF_??M]J]GVKVP=V
MM@_'_RM3WL>6WXN7$_EM->BGKWMO7K=W3W;/0 8Q.%SLH W.TO[[$W"Z+@ZW
M_@(9!\=K1GX_LL//[_C!YX-S.!YO@#.UMQ6:A_O'K<:;!CA=C:^[;]ZQ['C]
M)Y]WZ^41M30EG3P*1F'$X2^P+ERBQ!0)+&+K<)HFQM13<+H(F 7C>+3!B*@=
M)=HE!E"C]0;P7&]/X<$#<8Q =1JO]G:W:_LO_[/]8=8)6EIB\UWXVN]OZ?HC
MP,EKK3B%MP,'@ZF3P9Q2CKT"&RKD1E;:7W/:N=?QV^-.78>+"IP:08V.A <
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M7+(*D ,(QMIU_%A45V^10?5@NGJ_$\\+XMU#-+<@WHH@WOEUQ$LD@9GR%LE
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MJ=6+H]87^/+TK7YJ_=]&U*6]ZPVB[Y_TX"D$P)0)F RO0.;-]#:?]<+T_B?
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M_C4-_Q\?'1'&&R*12SJ!Y>=V@3Q0)(A125@8 IH3 7Y$2J\O2U<.YY7GEN=
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M*^S]LP%25I.MBLS@)Y,OKXE;DC-Y_ND8K@^X^M?][K[X</0:[Q]]^ 3?^7I
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M1D6"!)-&RT3A%;XP=_SVV%.*79MFI _@WA0C7<5(Y_P;$B1V NQ36:ES%Y>
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M%P!;#X#-YVU;R;C&!C&7 N(ZR\VD$)!C/I@0-7$\R\WP F %P+88P!X@B[T
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MM(ZGTL"RI$:(3=P"O@M*WU$ I]Y&D7"!+:4,24_ 14S$(.MC0@268A6(,S@
M_^*\AM-3RWDP;K&2XLX:#+;AB> %KY\>7C>LC+0@][TB]UP_DZ""I"HXA"5C
MB*N(D98NH6B)8M0PJG5N(H?K+0GN6F'ZB""Z7&>!1U4Y?UYI_P]?]W[0D>,H
MW\A3%CP_.'KWT03""=8>*<XHXD909 SXBL*1*$ADC$1;!,^+X'G^PB/ZV'JZ
M%%>'^;D-OG3;WV)Q?G[5 V2J77AX"^W"E>3.[_K1HC;_!&YZZ]3F%]_IKQ%
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M:");M,A>7A19CABYM9$5G6JB3 PLYN28B1ZU]B#1ITGF99/9,LE,6RZYQV)
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M="*.-FHILT3F,FH&X USRAAFR8\+)B@M9&GL:.Q8XI!C8\==L:,3@<Q.JQ!
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M3[=H(M35+]ZE7X_[]-N_<'K/)RLC+(81UI6@PV,\&IU]9OH<OOB"O]^DQW!
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M8!P.OKTX=%UGY:O;A1[D'L5K7_3]#I#,O1A%"_#>+8]W9]>A''(MBF/"^\#
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M2_+?DMQND/3VR"4+SGHC@.1*DBTB^"QB<*$$E%D%X5K@: $"[0:.2HYD=YK
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M9CB=YL8EY;0]><"R<[:*_;+*7/$(6N?\%E3IIM@9& F>ZS'!(T]N-*X@"NA
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MAR>.QPX,_KC)NU-:+2?;ON<*/1"(I>+9.7(B+IXF.J\;CN7PXS.Y0HOGIS
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M)J,<F^#91)2#4MMIYE4]RS/,#&J:64LO.-E6P6B9JF+KH+%M(<HAX4S"V;'
MF4R//6P$FPJ>%+6"4=3 IJ1-LY %>[.0I91A+*6H:XIC*+I=V$J"[+Y03!Z
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M*6".G]6E@'D=MUFM\D>IVD"5[:+4*-7>&=5Q 5/ZO5S^3NK?:I5W(EOJ@?N
MZ6NXZ32B08;<MJ5P280+_<G8(ZGW U?*E>/G<"E77B<4<755JI+S'/ER<U5O
M3!P7D>'S55SXG0Z\"5<2YA3YWNNOY,$3X&ZA;GJIYB;9RTH LA+ <54"R*]>
M">"LZ3L#^%\[ZG9^^_\!4$L#!!0    ( #V"2E9]_NOV(Q8  *+W   0
M<WEK+3(P,C(Q,C,Q+GAS9.U=:W/;-M;^WE^!U9=-9U:V)-M)G&FR(]^RGM>)
MO+ZTNY\Z$ 5*:"A"!4#'ZJ]_#P#>)%Y TDK*+M7IM!:)<P&>@\LY. !_^N?S
MTD-/A O*_/>]X<&@AXCOL!GUY^][CP]7_;>]?W[XX8>?_M;O_^?L[@9=,"=8
M$E^B<TZP)#/TE<H%^F5&Q!?D<K9$OS#^A3[A?O^#)CIGJS6G\X5$H\'H:/LM
M?S<Z.CZ='DT'_==O">X?.U.G__;X9-H_.L5'KP=OWY#1]/@?\W=OW@[(\&CD
M]&?D]'7_^ @/^OCMU.W/1H[K.@,R&(X,TV?Q3C@+LL0(*N:+=\_B?6\AY>K=
MX>'7KU\/OAX=,#X_' T&P\/_?+JYUT5[85F/^E\V2C]/N1>5/SI4KZ=8D*BX
M6&^6%I*OOQ!^X+ E$(Q&P]'1,"JK.-$2WM07$OM.S'LF>5^N5T3DT\#K0_5:
MR1GT!\/^""1A*3F=!I)<,;Z\("X.//F^%_B_!]BC+B4S@-8C"KR- JG7$O,Y
MD9_QDH@5=HB]=A]^0$@U.5VN&)?(SU"Z6$RUQH)+3=9#!IX;YF"I;4Z5%%!4
M5RY3_I!X4JA???7KX%G,>H?5I0:B/\=X54MRFL9(#Y_4T2!E:\/3T]/#9V4\
M^1KDVH,NWU=_]H>C_M&PAM@BPZHN&W[U([I=Z)!TG'HZ1'0OU"&WLQ39@HU2
M_Q85U=",!'$.YNSIT&&!#WVHBBWFD40_ZECA!K,9H75D1\75'SDRL>\SJ>G5
MD_#9:D5]EYD'\$CA]RX"\8ZXT5B8&6=S>HK^WSO,'<X\2[<Z7'&V(EQ2(M)C
MM&:PX,1]WX.1NA^-6;]Z>'H BD0E,OPW#5&]/@02XMTD%8EHE2T =VA_CYBF
M:7&]5YS4K3>0")@N-,Q_]>H[V*M;?2!Q N]_HO8SXM:M/9!0GS:HO*)^@/>(
MSM[WSB<_7][=CC]>]I!Z_GAW7;BJT%*3\A'3B&VBSX>!_F>(^LERM(\T)5*D
M/QUN$VRQ"@293?P/^N]M&P^)PR(EA%O649ENLUUSR<*'44.6-.\XF%%Y#8,N
M7VI-*K9RALS:V*/-QM8,4(I#A]K\G/F">72FW)][J(1>4HN)>XFY#VZ3J&KI
M-C963(X B)A2]8 4Q^2%0!,714SW,,7M>XLY/%@024'='6&VR=,*X'%] -&K
M#1D_=AY0YIZS)51L07Q!G\BU#V"1%\&9S]$*YDE%,)F+-O@C(Z"C0)YA3[F9
M]PM"9).1<Y/>"M+K,I!"7L@PVP,B-\>S%\.SQ<T*UIOJ8&T-BV(_+D[<^P4T
MR8)Y,\+%Y>\!E>L7SG(Y#*T8OJT^Q:79_QT9 7L8W7,L%E<>^_K2=67"QPK:
M:770%%>DV78(JGLZ]ZD+ XTOQXZ.R\'2[!9:R %WO"),Y3QL$ T'RA^CPO&8
M"#A1>"7\4,(011P[A,X=>2)^0.Z(P^:&:45(<@BM. RW<0B9H!27#K7]%:;\
M9^P%Y!/!JD'T.%&Q^?-IK0B,MA%0?)!FA-*<.H3"!>'T"710S@LT<U 'A7Q:
M*PI'VR@D?%"*48= @$$X6"HM@!S6I7S#Z;MA0AB_;SPYOZX:M:O!T0K8\39@
M*>Y(L]]R4U\I"3^&WBIZI:1T:94]=F!!*C2WJEUI@\0*R$D6D(2\0PT-BTVU
M<B&^6K9@?P96N*2RSA!6QL$*P^MM&#:X(6"'4OPZA,M'QF9?J0=>MQE]KJ$F
M_IQ./3(6HGKPQLK&BM";;80BEAH<,W0E7)%AVR&@SO&*2NS=2^9\J=ICTB16
M -YFNH@A1YJ^0RU]0:92C2^<S*B\P@[UJ*SN 1916]O_-+O6FDHS,FE>*&'6
M(3#,PN0!/U<&($UA:_11QN$.%T*:O$/-?$<D-1[5+8SA59MZF\K:W#E^=<0!
M:18=:O+[8+G$?,W<?P>82\*]]066^-'':A->Y6U6"SA9N%@AR3C:(4>UHQ7S
M1(HI>A6S[9*+<$_FRCYA(/Y(V)SCU8(ZJCFJ E1$;D4FXWR'K/2<D##3V'0(
M#[WRNUZN,.5UW(<,F;7]L[ZT8H%2/#K4ZBJG?A9XY/I:Q>"T,F"&_]99YFMP
MI,+@M/C,9/5@>2V>5KPRKG;$'UU?HUB"[CV)C"BJ+M K+:93(UO99L4N-SXJ
M;X",,GZZ90,$O8K^ZA)PV2V-!PQ.<?5E6P&Y%9Z,DYZS+X)>&6Y= B1WDZ,6
M)F4<K+!D7/>"S9(N0I.[\U$+FC(.5FARO/J\'90N(E-CXZ,67O7YVE \RH0)
MFFRK=!/C9+>C)H@90BM*F>A"FDD76[]DRZ06&'8^5FPR88;2#9@N@F7;0JF%
M6$5F5M@R,8@JNS)=1"^]UU*O;V4)K:AD(A,;6S5=;/Z"79>:Z[PR'E90,N&'
MXOV;+B*4VI:IA4J6SHI$)HB0WM3I8MMO[=/4#!;DT5HQR(D4;.[T=!$'RV9-
M+5RJ\;+BE D=5-K^Z21X!1LY]5 K9V*%*Q-.*-D3ZB1(96'H"R(QK7S@J1(K
M&V#'=3/ZT:N0=9=0RP:D/V/.=9"L'F85&%D1JY+[#T]CQGO$-%-H,CR?<S+7
M)Y0PC#MC'WMK06MVNR:<K9AFH@_YF&Y(0EH4BF3M8=9,SQ?@ZQ-!?16_X=B1
M-Q1/0[?FI4!7X6V%.A.QR(<ZE(6HCR)I*"6NDVCG[D'%&^<3]XKZV'<H]E(;
M%V?K6PX3ES\_ASXS9[RV&>Q8J-4^,K&3PKVR)&5@XJ)8C8U=F[,U"C5!B2H_
M[HTG:L3Q$S2#6H1>,:Z&TWOB!+S!6-&0N=48,C&;0F.(A?5!6E^)0XF\/>)Q
M2S5<N%7C9<4S$_DIQ#/FW4WL<O>TP;*_8CX[#S@GOK.^?';T)!G-CS7[[(M$
M6)'.Q)>*]M5#B2@2B2*9\;S?T>Z;BT_#[EN-EQ743#"J"-1][\TV]R?V%-YT
M%$CF3LZO=P!A(4\KE)7S7F(1"&2HJ*-)E>@@JC7R5J+,5N:.ESI[-71N_B S
MZF>)#:%B4<\FOJ=&-HLZV5$.3IP4#*86JHH2794_F,<K8J)9=M4\DV2:AM-$
M*0NK 5C2>SH^)Z0;8^QYX370$_=A06XY\>@2'%B^O@TXK'X$45XK>6#P4M-Q
M,OM,I,G>F+AI5LT!_@9*6$TD$^?;-)%$)>72@UR4T@I%:FF7GJ 'IDM$JB'0
M+<IO >(TXVX:7$E26,/AH0Y'JREDXH"6A+..#Q^IMM MGVJK&W"<P4,3LBZ:
MU3E:T<QF/*6P,UBFT7VE)2 EHJMP%G:EJT!"$T:#W63JT;E65A7[!!HL@Z5N
MO5N\UN5WUH>;"K8:1R:*9^GJ1I%DO$^IH@N'RB!C1)$ZW30D6R)I]+Z>E=3E
M:C6!3."O6IYJ5&J/;1X*<8H1O%3N$/;7(K?@;L&O+=9J'8WNE@%7,4F%@B(H
MU.7OHHAB;T5Y*%T*29?*20=OFTOZAU;W\GD%GG7-]>$N)%EM)1.#K&8KL6R4
M%HY"Z=VTC'1J>U.7H(R%%<M,$'(K3[[K:_Y4XTY6BNE'KK+=A B6JP;>?W5^
M-N1>9X)]6\@9]DCS1RD!>R#CV3,%P]@!(Z=RW1S.*ERMH&8">%N@IN9;\R1$
M.1*T!S>&X>[^$::CV_O''4);R-,*;/9P7R&P($1/I""FX[@6'#=JO -;C9L5
MRYPK?XN/,75\ BUH]$]8AHE!$_>&^?,'HC[,.I5)L]9.I7BI'"OLF0!;&>R)
M8!4*5Z+[2K:A24G?6T4CM'X=?B^[^'6XMXSO:!FILXP-A_DR#E8D,W'2S7.1
M'1_,4TV;)#.HS !?F;=6CKF/]^I#*8%D?!V7OP.W7[(H4G7INL21<8I#^%Y]
M1-U$I0/JSR<KPG$#!^M/5=%J7I9CM^G$BTV=U9/'@_L#%"N>(D5*-R19*OP6
MZY\IIK]5GU0");78VW1L,-%'!Z?$99RDBNS &*V\K5:4B=466U'\]40C;:/D
M'N\8DUO.GJ@  =!(NT7;PMF*=2;66HQU+ J!K#W2^4A?4!@9598SH7Y<P(R6
M0N>S00OZ\V@:N"!0&)9P<4D3RX:57>,S7=];*ZN%92+ Q1:6J*F2 %,S2Z@J
M2G1-S461NFF"<$] +9%3.N_M]#M81&77Z?OKM;?5OZ2M/OI0)^8]I7"^98V2
M(QNSMUG.F]*O&&Q:3B(O;06QR&X"OW7'36I 4%*(3E[C=!HH<:I$XT#>#@19
MC<'ZC86MH<1(1FG1NMP^7%.(UE7@S\QG6(,PQVW%?'U,1N6LY!R T)DL!=]/
M!@;4+SUI\1%37QT\.--N#KPVHSQS&Z_F_XHULQI^SB4/989OJFIB#G&28%C;
M*.4G_X"(208J_FJUXD5]Z_D45?GP1,D_D&D!S=JT@5)A[^84&JJYOX'Z9\0'
M>3*5PKFCGF 78#7(G*LHR@S22%26$\K<2$S=HR\B2-2/)HF'E=E9D<WLB621
M3=#4DVF7,P0+^]@#YG.B=K#&C@RPEQS/8>Z.,&XHRVH F:V4\JYMA.N)P8A'
MJ:-(*KJU-Y$"V.)+6#;2@6_5%,I2/7?ZTFMHOJ$"5F/*;)R4&U-R+TTF,3E4
M*VU/:+J_HZ; RAI?,E?.Q8IWA;M1.[X7N]7$*HO:4=Z%61<U.YE4CZ<5Q,S>
M11;$2$2\GNOV42++C;4U;^>LQLP*8_9"U6KWWW81OX*[:\,K&8U[G[JN#1S:
MI5;Y;'T6".H3(4(6-:'>N5R;5;S-WMI:=LUN=%%DY.:G[XJ+E5%WQ47J1.SV
M=K2!IWF>:K,=V4DA7ZL=9&*IY780ODQ)VB.<1B+YE6HBYG\F4G<AM7/&_/D-
M+'MF37R_G8NUVD?VX[EE]I%ZD!X8X%]UMX091?1&G$J;U.ITVB?<_F)KS:M(
M"JBMF&:B=IG/OG82C:H?:ZW996MRM:*7B<S5_ CL_S:R/QT^BW=XM:(P_*@G
MYK?O,Z.[?@1/B&?\&(6[6'_Y-3QMJS8CB#G0^HDLIX3W$)X*?8?B^Y[D >DA
M'R_)^UYQ>5\=WYUZ)"K_/.4>?;<BG+*94O-];Q:8C,T>$@$PIU+O2'[D+%B]
M[YGBL 1?]I TQ27OJ[_$NQE;8NI?PSO%J'=85)E[XE/&'T$I)U!7#JFO_@X/
MAJ.3BX",!J.C\JI5I6Y!16\)=Y15S@ES[PE_H@[9O'/[#\*>"'^@2Y*NK8L]
M$5>W%H]O6.>5T<->Z;'RT%0V8CR_CL.:%2%:1K'S&IDGP!Y&G0J5B2X=!M7$
MU@W'4YF<M1B[X*9.?/*P +GS!?R/D/\2S$5\K6XAP+L486\MZ@M8GLGHU=3L
MFT(KDBF5M9IPR7P8J?FZ0G^'T<XR7FT4:4'/O?1G3#ALM2Y7.U.L!:KGC8_'
M!T=O3F9J?#P^KC^ZYE&WH*(/' =+#.N(RV?)R=(<O"JM7!E%"RH490<^X.>-
M_$58W#CFG,;8W[A9HW!,:<"I^=#AZ$-HWVCL4-=&:6UO>5@G<V1Z@6'%-P[D
M@G&5%%+8$I7IO]5$HP79ZSGAH,H*0TLZ*J)68<@LHVB!,4=[^]AQ."SS87(#
MV\.>%RY'13%B5L(ZM?N.T]PM#)B_4.=+.6S;I5H 5=Z8/SHX'0STF'\RJ#]C
MY%&WH*)C95)$Y]2!*6E9Y74K(6A!=3[!8!;P.73^SR3@T.[.PF<>FUL6+5:R
M%E0MSZB.3@;&Q7M=WR"SM"VH9/3Y@U^H7)P'0H*SSJ/I>JTNXIT]J5%+)3K2
M67B,$IP^HN*2%X%R8&ZUNB63WZX$O&#(_:;+ SWKW9&56LGX\T>?R@I^1F[Y
M%MA#[,BEUFSA-U-F$P5,P!4F9UA_>,VL9M)#D]KT3I$6FL7.Y;1U[6CNP-$W
MP($4G<-?J=O8Z%JZ ,DYPK"=<*E7PWH%_"_BS<[68>)2F2/1F.6?O**.MGI!
MGRFL)A7GC8$.G$%?&./6UXT#N-HK*&R+Y@R_;5A."ZG@8>A->L8)G8/>@0+4
MYB^7DK1@P$Q?HF4+,N:7_9/#B[6ZEQZROT&WS>/;TA$N_6&<4LO-*=@">\U=
MF<;!M=&)4;7!ZK:01PLJ;7:A)'X.'?AIF.ZGEF JIQ?6H>$E(?Y<'<4YQYRO
M7?/-L.343Z&I[XI]2RT^#V[P9#ZK;S8!PJ/!40/WO(!!"XSE%YAJ%NK^X">
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M*L)7KTPZHK.V)(0V3C:_F;XGUAW=]1^*8+WJM>$.Q,6J?#D%9:2S8<'6+/>
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MCQ_*='+RP[\FTS^&7P/ _US\T:O)Z?ET^/G+_ ?!A+S]V^F_":E\E)&!<1A
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MWO67/D/R=I99#T[0XN3XTN-+47LOE0)KL1:;X62=J<1 U-:S:&0HNO7ET@T
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ML1__#*>KI!_#C"[&0RBI9B$+MCBX G0,'0\R*M^Z.M1Z)$>D!PU$W<.R\)I
MY(SY6JW-->U/+[ R[KRHL0^H/"DK+P6\LA9JDUL>F8L"6]^";(/OB)2E-UIZ
M-4NWJJ2FR"U3)140J!3YA"[1RB<**,DD#S'H$EJ?H3S7LI?/SF-J3']_10G6
M5/?:!-CWBIJMF-VX1.(NM.RUHJ;.UA8? F3F:O]<+L!SZ>KAIQ#>><UM3Y5,
MGG=%S7[491LV>E"3!\K\,>:4B[6!5$8R^&H)'J>3 6<P<HV"N>99BL^CK.)6
ME&U>5G$;>1^N8=>ODZ_+!L>3L_FDO'OUIG&>P;W/[RG?8+/QW,H[$%D(DP4Q
M8XTJ.7O%M>3:^N2]%HJM7V+N?57[IEN,*X^)[.N2>>TG3<9]"$P!C\&;F QI
M<']A8&];91;<:MZSB"HEUX5XOURM:_L[K-%1&4GR/FNPTB*YIT;2Q D&=$1O
M3 K6YM:I45O >QH]+K;1BGM.AYIST>LM5]>0.W)*4_3.@F7UT,O2:NQ+"D >
M<=0Y8+"FOXX'SSB:LHW*'8;'7B\ZEEXLE\:)8!V!L#7:F"<(-=>4IHU'6X,Y
M0W\WK0?OOM)&);:7Y!,/"V0J2D,V!"#6]%(5(P2R+" '[WD(MG#9>@-[JF&!
M.W"[6>S>-C+>9YC6)KB^Y=B]K7C;-%YK%Z'O4RD"PY25( =0URY5'NLZZ2)P
MF3US63OK6^\2SR%VKQ==V$;6!XK=JS5J4JJC98R!*K2HAF@S,,Y**L(I#/&;
MCMW;BL,=8O>V(6!/!29S,5)H1D!2A52/H[SC F263.O(D976.O&T"TQVT8&N
M MYWJQ-,/!JK&=@@$RB1JJ7$"NC C!*2IV+WD27U=.(UNYN-S>2][Z#*3;!]
M#ZK<FL5MPN9VH6#?094AZ)BR]2#0TG+F?*R1YQ$2T]+Q3),C]G>>]1R"*GO3
MCFTDO_>@2DS"&E]#264R9%([#C7U$[S**D3)D-O610N>4U#E5MQM%52YC>![
M":I<&X2S[!_I?:VS0:-T6I.U:S3$+!+P9) +U,'HUJ;E W".P;AH)>T>@HSN
M@;:JJK<!N)Z,BP>!'<:Z:$;C9NK1@8,>]I&'07J,4KDHP4A=:D^H BYX!!TE
M+6NV=@IKG=E^  5YQ+XXC'YL(_H>].+59#9_5SZ&T66U3&<+,S(%R(+\9:52
M!D\#!%&\B)X$84KKR/P[(/9O1S0DZ79EHTX2;F@\S,[_6-9*78X5_SJEB8&K
M&JG*^YB4A(*1D_V,&6+" C[&),NB1.>MN),[44$//?\8"&TFOWNG<<L8L!<I
MG9V<C>J1V+)T\N3D=(I?ZEKX%>O-^W(4+]Z]>O,Q?<%\-L))69:AK)?RD\_C
MX7]A'H[O_O'R#^LC=H\@VR>Z[O%G!Y/EK>@UG[A.V4<1LE4E:R^]TH9<D:!U
M+,(-]@FTV[[S(-*KE[V]##Z07HH4$@/-D@)ELZKECC@(C=H5;K.VK4V4;3%V
MW8LK+2_F\^DPGLVKT_)I\C[4BM:K:)@/D]&(W-(_PS0/:(%2HC &Q7,/B@D/
M7M96WAPM:A%3^YS_+>#M?[GO59]N;^E]$=7#2<&&<KD,N&+6FR"\AQP-^<FT
MD=4RZ1%T4"B<=YS9UL$L6T(\@&[U1?=MM>J1J]X:8:S'N PIO0KN6QI?5]"M
M4+P(Q4 $ST#)9"'(+(#,+I>LX=[IUMG@'> >K\KMB\.^>FYL!WU1C!.9(&@1
M3-2B9LHJ",&2.Q\R,YDIIVSK:OZ[(?VN=!V8Z^&H=>G'?\"O.#[#@7-:I.00
MLN-(_I[70#\J-2-::<V8#;QUH\@; (Y7.W:7<P^U<W^;C">G6)N.U+BBJJ2O
MEV[_H*C@1<U@YDX54,5R"$7F>ISCA+>T+?O601SW@CE>96@C_[N*H=N<I]-(
M+_"\Q#&)?3XHT7/EN0 3ZCF0R0Z\CK(&'Z&UWN7(V]<U60OE>)6BA>SOJH3I
MTR"Y-)J$LLX;,II0YP#*N9IAE0)@4M)RK6*TO?0+_&:=JN:LW-4<NV\G/1CR
M]8JWP%6L<$NLO58S<#*[,3(OT+6^XN_DI/<FD>7=ON B6^T""#2D'JDP8H_F
M?1)&&QN3%N9 9Q9[3=G:[Q%87P0]E62ORYNCU_]Y-IR?U_%-QC4'?'$?+#&Q
M;%4 GX,&%9P#IY2")'7,B,*GYJ?1#P(Z5)A-?VHPZ8N./DJ<W<1T<<>X":B>
MHF_6 CI,U$U#XFY7,&LF];VIA"*_1(5D(7.:!LJ0(1."8Q!+XBB-(+NU=666
M/:K"(_$U^]:$;83=@P9<6QK)*OI]/,4PJK>K5XGPJQSXBQ "SZ7)OAYPR&S)
MRJT]C*TOD**V24N%RK0^4MH6X_[=A ;4WF^YM.>EWQN\GZO ,5_XN^]'83R[
MZM*W*D:4D\A%9$#!R*B+GD% 98$\F)19M>]8ZR)AVR$\,AUJS4F_*]%*M4GS
M;W3<6_K>JUX'UGMF48!#(>K1F@!O.0=7?+3(N2V\=;+)EA"/3(>:L]+#==LU
MN&N;A%Z@Y%))H90$C%;2-D[NI&/2@DGHG2G"QN:M7#=#=F0JTXJ#'B[*;E_>
MO3N;ORL;.(K+6HU!IZ*]JD=]M-D:)!_1*PY9LY"YDBS[UH$!7? >O=^]-S)[
M6+)VQ;Z:J1N@[\E_[X;\,([^_C2ED8IVH+D'(ZWC*+PEGR09!"EK3D$HM*U$
M+4%P1Z.+$I&WOE=ZBDKZR!'$<]71;=A]0KIY88_$Y+SQQ8'FF=P?EQ()SB(L
M>OE9VIIL:5V'OQOB_=N*^]2/1JJY [E[SH1&6PLR<P.+P@"*AP+.+8H6FJ0L
M,FY#ZU"_)Y@)O3=3L145>T^3W@3<]S3IK6G<*@UV%P[VGB:M"T.FK"8>N0:"
MY2"RJ !3E%X'3+IYN8WGE2;=GWYL(_J]I$E'J0-7S@)/P=56$@F\*(F^BEDG
M1Y!<ZT+M3SY->BN2'DV3WD;"^TJ3+E'9PJ0$[QTIN*X'=XXKD$XQS[..5MZ*
M^GW6:=*[$-I,?GM*D_[/L^%LN,QL"=/IHF1,E[SF!Q[7(A%Y4[2W,H>-5++8
M;(1#K8RLU;J-%4F&I)TIS@\>?'*WM?/EV6PXQMGLVBO>7L:@Z4 JH7."[&IS
M0EM#.SUWP'A@7/*"/K0^[WT(3]=]8O5L,K+C<%G@\A5)=)@7,>R3\>+8ON!T
MBID/0HB)19F JWJ@P)V!H$."I%$E452*HO4]VS;X]K\8-=.4VYM+;[0TWG>V
MP/E^.DSX'J<?OX0I#I*-L=32-%CJY:#"2#:7SX"ZN))=">)VOXNU^]*N[S\"
M5=F;^!M:IUMBI@UY=):'X\_T@:\XG0_)X_]M,D<26.2^T ! YWHI64P"AS6J
MW$L?%2)+R-NJS[U8OCU5:D-++X5KX_RJU.:-[L+57LRD_HE^$3[C()K$. 91
M>Y[IVB VU@- \@.9#8XA:8EO'76T.;HC4*F>*>DE"N TG"^:IKTK;R?CSY]P
M>E+1#TB#M=/%DC/'4TWC31"3]Q L^10EDWL@VM_PK\=R1(K11-P])-"^&"T^
M@WFQ4;X,,\SU )I<PL4RN,KF5!F%T;7GF,M8R[4K<+QXR%H[7Z07*K6^(MH,
MV1&I2 ]4])!8NW[CK/F_I-PWMM 7Y*723Q=*_VI1I/?-^-,7_%"_>E?>G<WK
M\</LGC]^.PQQ.!K.S_\91F?X[\//7P9:.B.=TF!=(KL?DZS=U 5P:Z)SP<5@
M6Y=4.MA@CTBMGX?"])!OO*K@]JZLD>WLY?FU[Y:7>XI9GIFU$$NDK4!IL@B2
M8X#,D$F0M=>I=9[DMACWE2O9FS;V2LI3R8U<,[3%]8^6,7&C:,,HMO971EM#
ME,EI29I'S72A(?5_F'?(R_9^Z;]GY>M"0P]W9>M@U2^GN I7V01@3Q?NCX([
MS*5[$RHW4(_N/!Q$89))M/1R ]G7%*R< @0L!J*4Q6D3F&O>=_5 BO+(Y?MA
M]&0;\3<^WOSG))$!MFKJE7@HS)&%56P!I77MYY$U2)NX%UHEL]'MZ_5G/@E#
MN(NX)PUDU?@6XQ_A[#)Y,A66E#(1? PUW<4G""PKR$7Y[+U1F;L-*+OVR&-B
M;%=)]=)^ZOK)XF)1$4Q:)1@#'44&Q9D&KQ0':YF543*#S8M<W$7Q35AR'87?
M^]G_;^$RU'@37+TUK%N/Z5#-ZKIQ]J *=!1X[^O#-7Q.Z:*SBX H%)D>2H"+
M*  ]:3\*D4/S2N3[581'V]+M1P^VD7-C(^P%U^SVY>3%KJ6XR#(%#\7K>@9F
M/3AK:2.4F?9#J53BF_0-N?\-AV@IUX*!27/Q-;;27K![46$H+A64D$*]=]9!
M0H@.P7*>F(HI*:<V(?7>-QP#J6W$M_<@QXM;H)KH4SY]P?=3' U/AN,P/7]_
M-DU?P@P7H2V?)O3+"RNWUDEY,9MAO5N\_J@V89(] &H;:-FWQ&Z%:JJDC7=%
ML^10(6IOF:CI79ZC"DZ'0<_8>@SVS R1N22!*1G)1.:IUO',(#*C(:.-C+6^
M@-ASL.=5$YTWF=:981E6WV I[I7\7XSSZC)IB#/Z'2U)^=79M-;Z6'Z2GH+#
MK_4O9X,28T@A.<@T>>K)3BT D@5D)K4E,<;4O)WG/L;U)+SXW31S@PO(PZI!
M#VF6+<?X,R[CWCZ%OY:?'HB25+"1 T.E0674$ +6^KX236(Z6-4Z>JS7 7U7
M[AZ([_'BH<7@:OFX,;WNG+P_:Q!]@)0<355G ]GTA@3OA.*Q,*M%ZQ+PO0SD
MNQ8W)+J'([J6@UHD;/TV&:?K^\_ <.3(/ ,AD0:8&0-?. >1:"8'+#K%U@GT
MO0_JNU;WI  -8XCO":#OL/'$^: PGS#D3&YXO1"+HD TH4!RB:.73@2U8XY#
M)UQ'H(\'IZN'N.6>[)YKOQPX(R-7VH/)B488?*PFO89D1&%8O'"Z+V^XOU$=
M@3H_41783ZSUSB.\VCNN_6ZQJPRRS$HX*R$R(9>- CV-&EP6NA3/8N!/6='O
M']EW9>]3%7H(F6[K!\S#^/-P<3K#@@LJUOI;NC;D24Q 2-J IHG,D]'6NJ?M
M\ET.Y;M*-R6[AV91_YA,\I_#T6A VX4- 1.DDFGS,%:!CVC %EV8L%H%UKI\
MP.K=1Z0E.XGS+JWN0$O3"O[ZA1CG Y5LE"P)0,$-*+V(11"ZQB((SHN+OCR1
ML]7'AG)$2O<4R+ZKP[Y[C?@ESE\J,_AV^/7ZPKD<RK]P^/G+G%;9KS@-G_'W
M&9:ST=MAP4&J)52+\X"EQC_6EN8^>@TB2FUJJW-1VG=QVQWO$6GCWFA;<X3?
M^6:J-DRX' #)[)IT!A930,\Y1$62H27=0?1>0-(E"66TX-@Z@/4!.$>D,:V$
MOD8A.E_J;!VXJTWR,AM-BV9-X^3T5>".07".UY)G-C7//7^6:9%=%*974IYZ
M6F1AGCFC"W AR++$2#-"RP26AL62DX*IUF5#GWM:Y%;T;Y@6N0T-!\ERVP3@
M][3(K:G<.MUM%QX.HC NU7*:+@!FQFF6>$6;+OFM22=G3;'9RWTL+$\W+;)?
M/=E&_'VF14;+3,XA @]DAR^]OF)K^'&PRF1#?M\F-YM//2UR*W'?EQ:YC:QZ
MB*-[P,5Z>?YK^(_)]%5MQK!07E?K'$M;P HDJ%):LK=0 G(G4W%6^M2Z'^@6
M\+X)4Z(ONGJ(!GH ZA70ZWD/&\#MR=C8$NIA3(_>J-]<Q9KQUH-QLBUL4WC@
M3"MPNC86$3Z"%X9#L#:7Z 1+MO5EQ9-0LT<,EZ>J9=O0U=BT>74VFT].</IB
MG'\>SN;383RC#W_ 9;/+V9?AZ2K/*F=E-><9C/>!0-;R%\F004"[N'-%&;91
MFMK&+]R_4=0K;9.^9=Z#_?0S?L71Y!3S)TQ?QI/1Y//YAWHRO8+'HC$E)0?)
MY0S*L0"N2 /62!EKU=P06[?!>P32<2I-'WSTL$M]FH:,=:@K/(87RTL@-]"1
M5ZA<IF$F[X"L_UB\XY*%UH$:MS$<MT)TDOB]9G'+9-C+^HYIB+,PKC503X:+
M]LDM&H!L\_3N::H[C^56SBF/6&IU0^=DJ/VB?5+.()<I,LEM"H-M7M3Q^N:R
M%<WEQ0/C+K&D'=3^V* L>7 Q<0;%!_+?(M?<MG:$[Z+HNA35'GM74CROW[X9
MO\?I<)('QKOLE4(@$CBHFE+B78B@O1,\U3Y(MG4OJ0?@['^!ZLCY[36HE:A[
ML%]N07L]FP]/:.SORGOZ15V6ZP<&D29=R5:!Y9Z1I9\51 P)T-@BI2^)^]8W
MDAL!.S;-:"#^UL[/HBSQ<!Q2FIZ%49E,IYC":'3116LV4#1,DVC@6>*B";$"
M,J$$V,R$*8%QDQ[;HC9YS[-ENKD0>SBJ>W>ZJ"D]_OP6PPQ7==<QHS>2"9"6
M#&15"IE,9#M#C#EEYKR-K+5INA;(LZ6^G7A[:(=Q<^4A(VIY.)T]*R9'!C(N
M8HDUC3/: "EC,#*B6MAH/:[T*R3[BC#I=4'?2:R'CAZ93>>#10GZ92'7($(L
M$L$HTE7%H@"/I8 Q(42!Y"R%C:YTZ:G7E(&^NU*$&R\\U#5."^(F7078<O->
M@;AP>S>!L<WURB9\MC]?>/RZI(/P;]/707(]$IG(;A*2!9!2D3'( H.HZ:M"
MKC(7P@CD&^7 'YK >RXBVO.WC< :\_8K2>KD[.0"2."HG0H2#//DZMD4P3/:
M88JS24DEDM<;'1L\PMR-E^[/>.HD]DD+F;6L1UB!A+^N 1%6<&F<@61]!I5%
M@,BC L9\*(J\,:=;[(,W7OH,R=M99HUGWEL2U.=E[QVRN9>]X&520C@.W%0G
M"\F+#LX4\$'88IARW&\4?/\(@W???"0F34>1-O1;[Z+Y1']Q<5FP"::&ALY]
M./9O]73EYUZJ.PJWUYE]#5N0H=":4L"BK'WB; &'T4)(P=8<M"*=>':$/V E
M[8/O;63:^.3Q_=D4_S5,?ZPN;GE.T@:R_Q37-7(V0JQ%!VNRE^5,!95N[;]K
MSQEO/G6_&VP;*4^:B*AQ[>8/B_/,7\-\CM.KJL/&RX &5 R*3#=K((2 M.VD
MDB*R+&W<@+$UCW[FM'45UEY*-*]2>\-X68KK]D7]ZO>[WTQO^X;NM].=QG3K
MAEIJ-%YX'2-*XLRYS(HS-"NDL#QI/]CV96V*,%R=8@;K4M2:]"B13BIK.#C'
M$80LS@G,T836Z<MW0#0K+8%<(:/)!B5KFAX\EQHN7?N01R%L%EKHUL?2ARLM
MT8W+>^M);"/#'FZ:5SC>G)R&X71QXE[O-IWDQ:3L0!I.GB8* V2E"$ TS@9N
MA3>M4X;6(SD6GCO(MX> MQ6J#Y/1Z)?)],\PS0,;:'_SF8'5MA;9I0W/6720
M:74M629G!.N)\FLPCH7O727;PSWRY5+##6V'4B0(B_*S)<0:8V=!<VD2#T[8
MS4XZ.R_7NX]A54W@Y[/I</SY(EBG'C@S)PVPK!.-R]52 J* S'5E+4RFWBH<
MK<-S.!7>6>GN4>+.TNY1FS]-PWBV##Q_,<ZK-A8O4IJ<+<[67N3_.)LM0P\'
MQ:&B/=4 6;FU[67TX&O!B2Q\]E&YDD1?BK\%S./1F[ZXZ2'@XI[]60DLQDD%
MAB=R(GV0$*-'<,%Q&R*ODCB _=-E\9>96\L<&!;(GT55(.9,LUA8)4+&0"-^
MHHO_52[GI8(MCLR9""8Y'R%*X>L^7<![1IK$O"JY*!UY:_?C'BC["HMI:ZNT
MD.NAPV+N! RMTGT_+I^[S(G3NA:>T9K$XFF1B=I"T$6!T$%;<KPR-J^A_""@
MPV=%=V#\MA8UDWP/CLX%EE4C\PW ])3,? /(85*5&Q)U6P4Z2[EWZK%8+GW6
M@)RG6M ATCH9 ED=7 H1O7?-S]WV0/DC:</[8GP;X3:^C_H5\\>SZ6<R,W_#
ML^ED?IE?>'&"[ZS)CJPU2+8F<M23-6^5 >%IK%R(I-DFR;^/O.8 P="[$S#I
M1WJ-[Z[>3>=?)J<!\S#-"-_'4U+@51B,KVG$M..9K!VH&I[M;4;0-3-'8@S1
M^0TXO?\-SY7.1C+K83'^@*>3:77]?B=)+E>?8K/1I=919C3&E LX31Z6C>@D
MEH@IM&X:= ?$,9EAW23<PT'-#4 KTV #2#T98&O@',8,ZTC40[1WD'+?<WX%
M+<I@,3$P7HMZVQ6AWLH#YR8&+Y@NH?5)W-Z(?\08VP/O6PBWL1FVV&IN8%I%
M4,2B4N "BH^T[^C:ND9&15M9Y)%%M DWV:OO>_[^=^K.@I\TEMJ]=M<^XTX^
MGIV<A.GYI- O7TU.3L/X?+;V@_T%IFP-H?_(E6Y2N17:@L)[;8-1@2P!E8O+
M7(FLO= YD)UH'PUMV1I-[U7^KXXQG2)KQY@ 14L%BF$MO*<*)!&++-%8;ENG
MLF^#[Z =#X(,PJ*C'<+6"S>?'/@L ^@0B?W ;-!R_[)Y0AT/>M.TIAT0MJ%Q
MOR5%_S&M5UY:,,=1.)*$K9G/0H)C5H,4P8?H8S"NM9H]ANF(5:DI'?LMW/@B
MI;.3LU&H6GY239?_6MST#G@R42K/@;M4 YT% V^R!^V0)16C-JGU$>OV*+]-
ME6I!V7Z+T=8V13(I*34F,*[Z1R75(+F0@&N>:I"W5&*/Q4 /TEKJ*2C/ME3T
M$*5Q=6#VN$"N%T2]2*US5D0K/93$2"[2(,3@D+1<>2EMXBA;[VR= .\KFF!O
MRK4_^IY*.,(V!7M-$DR'4"!S0^-349-A2':B\XDQG0(3>8^&U],KX-Z[SG2H
MYKX-=T^AO/8&<+]7<^^!^JYUMG?@[0FH6U9:,B9J7)J4H(2($),68+0U7(:<
MT;5N*OHDU*QA-?=]:MDV=/6@78\5B>8F%1^RJ[5F.*B82 J&OLW)UV 5U!A;
MNP//OFCW5I1N6;1[&SYZ.-!:%:-?6WY>)F;K?F^]S*""10C,<)!!)C0H@PBM
M5>4!.,>M)JUXZ&%%>1_F-=IM!49(7J)U8*2IAQW)TBIJ)"3GK2,53MZTOGN^
M >"XU6!W6?=PL+0H+W\2IG^L\.BBD4>=@=E,:U50'!S2\*3)P@OAO/:M4P5N
M8SAN^CM)O(<3HS?C]]-)PMGL \Z0GORE]BQ9;FC5O[\ 69AQ(?H 5G DD,Q
MT II1W/&.>](!JU=[XV ';>NM.?FK@*ISM67U]V,KW0[!I5SRF 2SS4%,H-?
MU!EQQ6F-RB?=VJ]Y ,YQ*TLK'NZJB.ZA:4@X'<[#Z.-\DOYHT27DH<<U: NR
M,=I;H2BL2.[)_&>L6,58]-G4%D^8%(F=Z3QX\,D=0RG&\V$>CL[J$S]B.IO2
MN''V^J\T.LO++O,UMN5LOK!%WY7783H>CC_/WN/TXY<PQ:L#[>*"PEI,40E+
M_TB>(&1%)HK.SO-(CG>)C2=Q*^R=6@=,3DZ6:;DT)IQ.,2]86KQ@]N)L_F4R
M'?X7YH%4*3#D!I2JIGLM[UJ_AQ =YJ*\XIX]HKY;O.X -VN'T*,;[0=Z(*('
M-_L1=$QQ+3)CM7R-!\6\ $]V'ABC$HH@Z'>M [>^:](Z]ZL=37TXXC?0O0_3
M=]-%;EK^9QB=X4H2@U0B\EI-FN5,*),DE 45E"CJ;WA*I76.^F;(OBM5*]IZ
M</:7"^EZO7?.U@AL!<QX18LG%[1NJ@"F*.NC+BSRY@>!]\/Y1M6H%4$]'!-<
M@W:O>BM9W4VMP*?(0%4=CSI71[285)(@]6Y]=K0!K.^ZU(2P'DX.UFW%[\[F
M,W)A,PED@!@\R[;F^? (2D=R6$-AH+6+3*/7A'(/)M,U2-^H+K4DZM[CA2XE
M30C5!SR]*)_T?CKY/ TG'[ *N!91NEQ$KS[SXJ166.*#P+5%&QWH&J>E$J<9
M(+  SSXY+4V,J75R[>YHOU'MVQ.]=Q73--PT5P<]B[E3CW.G7TF D^DO9_.S
M*;Z9S<["..' 9J=0I0126@G*%@.1/ ] S:,J2C%66I^S;PWR&U7#?LF\JWVV
M\[)8X;VDV5"["]>F?<LZ<]-I;92R*'9R?O61]^&\_NA%+6WW[G1Q/?WZ+YRF
MX0POF[U^FM"@WXSGT^%X-DP+4V)@%+?%<PY.*@<JE@PU !;0%(?&2\9X\Y#A
M/8SK&]7Q)Z<R=Z>%ZV=:W/:W?A_3VQ:3?3FT]Z-P-;SWTV'"1;^AMY,_<;K\
M:G@RG ]D3DQ)FO)L4:0Z< O1+6KJ&VU<E-%LUFZP\W1H,Y[OT^"P*G)7_?V3
M4O_?3T]OC(U;]*4$2PZEUC0VU"3TH""@]%:ZU,.Y9)_C^:[^AU61-0?LG:]I
M7I^<CB;G2-*=?B6,Z\?ZVV3\%6<U";!N;K/%+G;]]Z\FL_EOD_G_Q?D'3)//
MX^75@8\B84 :2O"@LJG-'B.GX16/MD@E;>M@A]X&\XUJ_M-0CC5JW_EBJ;>1
M+>T\<GXN?E0_1XZW*,&9K&HYMMKXU&8(FJM:(+IXQX7PZ=G,A;4C_#Y!GIH:
MK9DUG6_,=O:'7O_GV7!^_F8\FT_/%H5$%]%9G[Z$\86G] ]ZQ/S23;I5#&/Q
MRY_#''\)P^G2:5):\Y2L FMJ7C%F [XX!=$X[G(Q]<=/Q<]N/?AO=*X]&?EO
MI7QKIN'.EX^+TE^[2N$*/D\%N2?1VQ@*J,@]$"T2;,JT\3H,4=VZVUY?6JTS
MDF],D0] WQKMV_F:<M&BDMP90D33XEUY-9K,2#C+*]6%?X.GY!'5"?;^\FZ"
M?KQPC%[/3D\'T42>T05(/M7M"S-$;R(XPQV:%+.^W>M^?=//+B"^09W;'VEK
MU*W[;>:N,V;IH-?;AQIM?M&$*##%A%<*T-5B6I$6\1B5@.A40II 5BCU5.R&
M=0/XQM3W\$JP1J4[WX->*U'13;C+FA51.Z<TTR"12U A9?!.2*"I2:ZTYC1+
MFY\R-AW!WNK6/ E5/ASY3Z7(S6)FUL[+BTH%UCIC:YMDJV-MF&P8C< G8,E;
M'VB/86JC1N_;Y%-<!_ $"M7L71%NUZ?<F9 ^^J\\MM;/[EOLKX8QSO7X_5HF
MV29CZJN#3P_C.4R5FPYJLNU^OB^.GXO^,AF"5@$A"LMK"U8/@8L 17*!N43&
MR=+^5O7VD;(Y3UQMMZ&VEVX+LSEY?/.+:-9:3'[VX>/OJUHMF9&;1Y9.XD61
MN>,U."X-Z&!T+2,N[.ULO@9]%QX =( ..P?G_$X'AU:$->Z\1/9(F4Q/:JS?
M);+WL[-5TC4R:147&4K.",K5C VC-7":@SH('27>2H>X[_3G@;=\P_K1F((>
MEIK+V[(*;57PQ3D7O2^ R6502M.84Y90FT([9:/BK/4"LP;&-ZPVK<BY-T&O
MKSH)EVTI:/$+)(J/O[](Y$$-Y^=M"B<\_ORVE12V',^MT@HIZ,!2\DP95%$6
M+Y27S$93BM5<RL%VK^H8Z%_K>+PKBW==G9H$&:WW%FM+FGIMYCQ$# Z$HZU)
MY,28:WWVNA;(T[T%OXP4N-Y8W2MG0P@94JUBH[3-X$PPD Q-PF"<<:)Y3LY>
M1[C_Q;>[?N[O<KJS3O10VV$/H_W_V_NVYK9R),WW_2_9@_OE92-L5U6/(]QV
MK5W=$_NDP"4ALT<FO23E;L^OWP0ODDR1$LF#<TC155'A5E%NXD-F LA[OK]=
MO$ V&4Q*)LBYCBFG74.(14 643A1!#X:P_H2A'^YN3-4.DXHI<,?J"-$[!3N
MHD9I+5<F!+K$O *1K0!E18) ^@&XX(3V)2?M6FO:0^WMSY-TDI/40<!Z:.?1
MWS[_L>#'W3Y31JX9+V!$J"' $L%K:\GH$EJZ4B2*UJV+AMK;GP?I) >I@X#U
M,32GMWT2%PJ.'FY5>Y&8UPQ(N\ZU!9"'().'PGC2+'.?5.MF>@-N[\_C=)+C
MU$W,>NCL,IPR&V-@T4D$%A(ILV2_ NW-@,I><.FU#KYU,L6)[*6SY,*SN>,/
M#T\*TIJ:1AZT(:&L?GF/KHY%0)]3=CJ9UOVASHP$?WI^3BM5+\J<W9\<5_0B
M<9T\ ^2*+)$0,X2L7>T59[)-015\.:;N_ON^2'6C/^$_PX-\D.2^J--[:(V5
MMB;R4 )$(^N0()&(B=Q"L9I9K25J\W(,@[,O\#L'V3__<]RG#+]@A]CSA& V
MV1RY FVKF8BZ]K>PG$P35T+QAF7U<D*8!V[^S\-\GH>Y3QE^B4ZYVRG.GJ>"
MB4A*2:J9A3R 8BG5;DT(003..6;IPLMYE@_9^9_'^#R/<6_2^S+=@,_3 (7"
M($@?24;0/6:- 2<*UI:P,8O"!'W\8D[PL;9QEYK-A>_H]?<'0\,+T]PDJ4 *
ME4 YX<'9P($TO!!#C$+8YD[7W7"&JJ;LP976B,;G6><8HK'%24=J [-DVA=6
M[YT$-9=6>\V=YZW'B)Y9G6-'KCY9M'@(=5]*T=<^>_JS:/&@HL6#Q&2(ZJ]C
M>/Q2Y)<78V@/")AJ27*-OT86%+#,@L;,C7:M;[R7([<'%2V>G=@>PMK!BQ:=
MED&104[44G5HF28=Q-+[XM!ER8B,/+8>WO0S%"T>Q/.#BA8/8=BP18MD)QIE
MO86@ NTYJD+V+FDIUF)A7AHA]$;^^<];M'B,?#1FP<ZKIF41VB\8ZZ2?-U/,
MH_EO(8UN%OTZ&LSMW?>;NQ>>';6'C9(S(Z1UP:2$7"H,WKDDBD1N'3'&%7>U
M[R+=WH)J>WXH/RSR_=X>Y5B(NM) PIKY%8V$R$V 5!NG)IUB2*TG$#P)J.O+
M5VEZ[Q"AKU\-][DB;K"<K .]"#8Q4R 4KT$S)A(K*=GF U5W81G^/FLG YL/
M5Q-Z]U""]2,NNJ9'LT]?IQCRA_$_PG14K>N/88[\JHA:^XL*DC>$4_-0:X(C
MB)*DD%%X(UOGPNR+[7+EI!$_>M&<ORY?\]F'4C%?62UHUZ* 823,=(\7<#FK
MZN#7*B7IZ7UJKBS_B.&2Y* 3?7M( MBVT[^%?X^^W'YY/9E.)_\:C:_?A*_T
MF_GW*^F+MCY&2-PGTN"R(Q7<%TB%AT+Z5HJF=;7E(?@N24YZXTM/PV[K')-P
M\WOX2AHYD\J(&#WP6NVEDF"U8I)#+(X4<W1:8?-"_A\A7)(D=*%N#T'*'Q^R
MM^,Y3LEVKV_7<F3N?3?A*^F<LHK3AH.@/W0F@T_: #QRRSF)J9:M=>O]T5V2
MB/3$DQYFSZZQ_?KOZE7 Q0OH,&BO<@$F:KM=XPPXJP*@L;(Z"%AL/@AH"XQ+
MDH>N5.YAMNNVS2YC?)P%YC3=9[X8NL],0/!:.X@J,1]3\BFT-D!V@ADJ-CZL
MWG XG<\E0O[CQ;8,=2B5I0D.@@R,[&JI(%A$,I>$* %SE*9UKNAC%*>*E3?B
M[I//Q\%4[L$*_1'1PW#H'KAZ"GGOPG2:L'57GCTI AT)/J1 .)ZS<5I#=HR#
M$BR MUC5&^4=#Q)3\P9 PPK",W'@H>3@$#HWY'^-__R!TR_O)F'\RRW^AG%Z
M&Z;?A2"NZ'772ELPDE$$%0,H6R?$JB+ RU 8X?9*;.0<;XW!/;/,\/IA&UY,
M^B%DXS#K\DE[=3W%A0*Q A08]V2<( EQUG4*I 5G2@:3LHJ%(?>;N:A;.;OU
MRR^ G]V)UL--_:-RLFRIC1A,;3OJBXZ@G$L0F"Y0^X.B(M*7X%K[@QZAN"R5
MK2.5>W D_XAHW7)_#TP]J6O;\)Q&5>O*JR=9WX'0O1_^%3:#TB>A%'!>")M1
MI)D8I&=%%9F"][S(UI'GX9C_C'HV!.\/H6\O$<-ODYMO-1SQ8[!BE;J5'(^L
M*(@V&U )Z2>9(^V6E11D4EG(YN'#)P"=H*5(9YX]"B&V(G@/>0</@]D+<7?6
M&<])W%'3@TG*#8D[:9F Z)UG$J,UK>/'FQ@NZ^GO1.$>HG\/\:P5VCT0]?3L
M/T9SFD>_&Y>>8'D'$O=P^6]!1N:%(@O$@72<[(^H/3BL!R8*G6THAFZH%\KT
M9Q[[OGE^"&7[J &IH^<P?_B&TW&MIOQM- [C1._0(M X*=.[W[P=9_SWIW^%
MK_4W:[,TYX2,GK@299V)J&K32IT G1&9JR2=:MX5M0O@X16%KAS?K.L8C%T[
MU8@!LJK_%N:K>8@?RKO)^+KZN.I?_64TJX&J6O?=/-_Z@#5[R\0^=M\;.=HQ
M9N9$0H=&*<FDRU:@R"F9JH&6L"M'^X#E.UXZ-8&A>K?>W85'K=4I.:<!I7&@
M,LFGJW.LO&7HO5$8-_V]W6^21R@&3*,1WC!>,T*#<A:4EAR\X 52R"B%MB$W
M'X%TSFDT'26B0^[,(8SHP;3Z^WBVO-(7^1S53*CCU2%F3V!\,HOM@C2)VYB3
MD;QU'/P' "^>\<>3LP?=ZN$=>A6U=,)R V2P$Y9<+,1D/61KDR=54B2>6F?$
M/%C_Q7/V:&+VX!9?="3Y 5#)3C#/2)\2CHR"&!WX8&LZ9^*<M+IL?&N/V",0
M+Y[%W<C:@Q>D8JAXZ/GX\FJ</WV>3.?UYS>3+Y%VG-=50=%Q@YI,0"\$[5F0
M--I@0*"+V:@0LFIM'.^'[,5+1 \,Z"E[^LWM=$K;OHH\&A7I9N(^UC0_E\!Y
M50"9,$X9&8QJ78;^8/F+8/@QI.PAJ_GA1?1^,DXK5,999>IV9(B*;&@OP27&
M04JIO-?2M'=];T?RXGG=@, ]Y#3_?1R^T"TS^I^E#OEV-KNM1>JKK.NKLHCF
M60?&R C*TK/D2BS@,)"J:3&1+=%<0W\*T8L7@X8$?RP.MH\4]X]8Z30:7S\N
MVO+*<=1*DL*"&A32=14XS\!+9B:4R&7S5IF'(7SQXM(C0QZ+CVM=N;]NR.@Q
MLE)#Q:YH>MN$(8!2UMH=8TLP1?GFY3$[H+QX@6A!XL><]PU[1U:M=?W0+4/%
M6D4I3$F$J$[-PVP@FA)!)$\;%C&F]AUUG\ S5(5,8\XW(_$95\8@:<$:>82"
MD>XODQ,$93DD*7+P4<AB6TO*^53&M&/P\\4QAQ!ZR%J(?7#]K,4Q!_%LWZ*(
M8P@^I$#P(+162H!6M2V@#Q&<UB3\G G&413.^[T1SJ\XIA<Y.(3.C8MC/N%X
M-)G>Q3+>3^8X^^46WT^^+50KXH]<]TF+2OM"(&U"!JIJMMZ0=<0,YYYSC$YL
MN)NV%E/LO> 9%5@<Q)])W\1M7#JS#20SC!'0!P YR7R4WI%Q$W*=8JXA1*FJ
MM]SQF%)!PX[D_J/%+I3SW8@ZP+F7?Y%6YP5"M2[I8DJ&E"1HPT1-(!+@2><A
MFU;XP%PJ298CV?YXM0OE>T>R-@PJ[I3,OPC-?D08,?OBI %)KQV]<TC&;>02
MBK QLE2RVFSWM_]Y?[3:A3*^(UD;1AEW(>1_X7IU)ZV+.(4O095HJVU,5K)0
M'@*F&A0)00G'5$1W).,?KW:AC.](UH9QPSWNI!7"%<[$Z6*RQ=/-5"L+Z!$B
M_39%L-PE9X@6VA_+_EUK7J@0-"%QPV#C3IQK434K?%)RR6K+2&[UHHR;0?!.
M07**6Q]0\K1/3^I]UKI4UG<A:<- XWXVB%TK)9H;Q-HVR)'EH5PT$$R69)(8
M@;&8I/T^U?)[+WBAS.].W(:QQ9T2:M8BZM8 3<C>DU*2G$9027'23(J&[(4N
M7!K)]+$*WZ/%+I3SW8C:,"2X6R&U:X74KQ!:,C^M<F2$Z%!=VU) ""9 \2@0
M@T/,Z6@]?W.U"^5[1[(VC CN5DC]2C0E6R'T22DEZW0^2]M63LLZ\H6N)F6X
MUE(G+/EH/7]SM0ME?$>R;G'I-/?D_? :W:'$E*0N9(/X+"2H$"2X7)L]<;JN
ME#>9;?9,/.ZIOW#^=R?N%A%H[M;C?V%L>3U)OM9'K94V23)$922(V@5PSDKP
MR=B,W@34QZIZCU>[4.9W).L6SC?WZRF^O)W4VN%<7-#<U3"#D"20F*JOF902
MCFBS"=%J%$?R?7.M"^5Z)Y)NX7ESEYZZ<SNHM=.1GB.K+$FDDS5G76H++BFR
M/71,Z((2CQHD[\_U1ZM=*M^[D74+YYO[])01>BF;:[>#<\F60):'\$J3"N(D
MQ,0$H$N1)\MBX<?J>(\6NU2^=R+J%K8W]]^)O_C5.Z37&DABP6AN T2C?<UK
M3V1V9@5T+^F,/&5QM"W_>+4+97Q'LF[A?"<WWKKWY@J*$61)DBD!A=G:_PDC
M!)Y,C2?JS*.2+N\3E_WQ6R^ DQW(M(5CMGT;BK=C^A'_"/]N,M#OJ6_KWCIB
M;ZR;@_OH.G1T.SI2A)1SW)<HLX[.QH E.7?UU!=WG0^Q^N8WD_%\-+[&<?K^
M[BX#6(0DO X!DF0D#D%ZLLR2 QVRXXYE*>7&>]A@4L03@+HF[OU:"J9*O+M5
M:M^!Y4JWM-B'KSA=3-ZDK5=7HY,2N)&ICHFBNZM@!CIHH8[_,3:V[G.]/[KA
M+YYV<K*9Y-<33WKI!S'%-+D>UW(H@OD:QT3X^>P.]^\X#C>U1<NK<=Z8"'(E
M/6F_4BF(*$*=J"LAR)0ATZ=6*W32M>\><33<2Y*OH;C6.-]LB6].5_X22USB
M_KV6XTW&D_(>YZN3,;Y^-YG-WM"[\+U,IG4<\,>[#5_5H8:NU $T9&"1"B9(
M+R@F@2S(R"9')O,^Z0EMT%R"6)V(-SUTRKBCS:__#E]&X\4=N^TPO$II>DMP
MB\J!:>6AQ.!K;"Z +VC 9V\*2D6D:]U0[D"(ER!?0W"GAW8<.^5]=A6592HZ
MLBG28@(:R7KT)D)F3))E(HH2K;OK[$9S22+2B.:-L^=VH_IT&_])JMX?DUH$
MNAQP?W,S^5>M*+]B2ANM> $;:I/N.GW+*8[ 4+OL3$(K]G&T'[7X)<C$,)3O
MH95')<*B8/PAX%7O&*DM:JL*1$N E-.<U*]L(3'O7*U'U4XWOCF>@',)8M*:
MZCTT^=@*;8O<<L5X%D*#"YP>/&NP)@X(,,G2WI%TJRB&$([+O$_ZY$8/K4!V
M&GE+)>G#^($';6W<<1&=CR38@5Z0VIF*@4-Z+9E.2B%*+G)K#\\1,"])F/KF
M4@]-0NZ=4H1\7%N:+ 2?/OB$\_FRQ\#L2C$9A$8/&"Q=F=DYB%FHZB<P46(I
M'%LWGMH+V"4)3WM.-,XC?&"Q+41W)=X_ /R(-QAF^*&LS+:UZ%\EEKTDI.!1
M5MR2?HHAD@TGM#7%2Y[WB3QWP7 )PC(H'UJF(SY%DF5/#;+?<A#>0D'%:H1/
M0@BQ=E/D43'&@\'2UQVS"6:HIC0#W":=Z'PNS6GN=O/J=OYY,AW-O]?0\*+_
M@BA&9F_4>B1&)KV^9E<CZE)RD=IOUJ&W$YM':$[5K*81MW?)4#>J]]"@9#NR
M5:K /MAZZEKS%*[3=*YIQ<.]1*,# X86DB*YD<8*<+[J45$C.)<]"*N918%2
MN]9-LX<7CF>ZV9Q"-@ZA>Q^=C0C9;#Y*;ZHG:+H><2=5"(Q>6T#FR08+FD$T
M(8,/&2/=GJG8UA[\K4!.J*%VYM5F:Z/.A.XAP>&WR11'U^,?,2$3.=F"P+FI
M\PV5@*@]@V"-L)@$]Z5U.\QM."Z(]YW)O//@MTR\^XCST72AIOY^$\:S=;^_
M2?GMMJ:NU7Z1M[,ZJ6CRY>MD7(WO29E_QJ43>78?YB;J?Z[I/+/)S2C7 2^O
MPTUU&7[ZC#BO7S :DQ%V^^7VIOYR,6>@?N44/]=K^AO^E<A= QJOL1#=Z-?+
MA*%)>> L.CXA\"7NLGNBXDO<]5,)E#E'CG6\J]!)95U[A'#A$)'1]\F<KU[B
MAKOV*"QU"L/*^5%W?3\J[-Z$9CPSGR6'*+"6W1H!=10N.(FH;-(FFM8)GGL!
MZ]ZA<7.1MV.B^)=EU").;A>?O9K-B&NO(IV/D.97J'QD.D9@R4A0,C@B2\E@
M@E:2)8[<]4^,YW&>(NN\M2P][O38,[]ZT)8>8[YK</VAW,.]BDKZP),&;7T!
MY76DEYT,AMK(@E[UY(/M7ZRV0CL'26K-YV<%JSN3>NDHNPES]>.'>#.Z7E#G
MJCBNC)017' *%!>&E,.<07--/R=>S&;GB1[DZ!&LGU*&NC&GAUS.+6+^0+%9
M2OJ5R8);CH'X7.<M*(9D6 H&B!')\L10U  7T2-</Z4$=61/+P/5-C$^J<DN
M%=;W.*\J[:SJM+C2:DF)O1*L)%[;N211\P]S"M6'(8%I:P,J(9*RO8O:\?A_
M2I$<B-V]#'D[;B^_3T>3Z2><?ALE,NIF\V6FT_VVK(I>UJ(/(Z.K]48:7*FE
MZ[6\6:ABU  &09.M_"G0@PA!#_FQ1VWK'KT3I5BK,W"SZ+FPF,8: RFWLB"/
MFM/#<@XB_*>D]L+2'O)S[P>_/-['[,$X^F5\W>G F?,,N%75K6TT!$9DBXY[
M2;^+4K1.X3X(X%"9+/V[4/KCR[EDN=R-J/KU_]V.YM_O?;6+D&P,HNZ)#D/=
M!UGP!0+* E(;%9Q(I;#FDO84H-,/9FHN!YL2UXP?/7A4-C"MPG;[@.HI]V4K
MH-,DO31DW&8Q?S.J#R<2BO-0HB)CA7 IS@R$) /8G*-W/KB@6ROY XK",RDN
M@TO" <3N00(>Z%E;+L=7^9^WL_FBL<XNLV#=TLJX(I- "+EZBZU%\)DK2-5'
MDV/1J7F^?R/HPZO7#01A<GHN]A _>A@Z?E?_=F5#/796*^=CU?U42K6&(8 S
MI.6;7/-_2O9,M\[TWH7E\I68)ESHP:._#=?J[.R#K"<E9C>JTV@R;;BWATAT
M('T/[]@3"&6PM6V8@V1M;007+025.1!*SV340G#WPH7B&9UF:)DXA.*-FP2M
MJI?JXTK$68!:MU4/(@11QR=%VJ;2GEZY8 T@.J&M],+;?3I:[EQ@>#VB%0<F
MK<G7@VJP< *^GXS3[71:!ZDN?(\K:$J[&$-]XL)B8KISX"3A*UH8:;E6NOEX
M^B?@O'@Y:$WR'F[[#6CO1B&.;D:U#] Z;=P'742*8%AU&ZK P=NBP/@L=?%%
ML-3:]?4<IDN5BV[$WZDG#I*X_4>87N,\C/.K-+\--[5YPY),DP>94#VD4A^T
M;H_)S<?O?R/=6#N==$K5/5*GEY!6H9SDI$*H+'+*:7>Z\4$0AD@ IH=.FZ3J
M?$U%-G!&1=J1M$ OG@S<1%U4:T_&B1* [^F[9,(][7\GNY18%:[QJO#:(D!'
MR)G58*]/$#RS@ 7IEO!8DFD_P/T8I.<0)NTJ3\_'19OS;) TX/_"T?7G.>97
MWW!* !<;N$<^N]+%6N-5AA(TO1@\,(C:TA^%>\Q1.U%:-U(\&.3/(5\M.=6#
MXG>8%RQFEIDEW884CCH\*2#4H>@@!.FJ)8<D9.N<NQ<<:N\B2/WQY5Q"[5M2
MGK_?7<9OPARO)]/:A[2Z54+B-?\DDP)<6R@X%:MU1#>Q5X)TZV"Y,OWGI>^"
M]S(\V ?)R//IZ4UXU<.%M@76RD3;!UA//NV=H$[CTNZ-G9,^>3&HL" /7*M(
M-[8L=0Y $1"TBR!\,CQ'9T)HK4 -+"3/N+A/+R.'L&"0>JEEF/E3'4CTT#OC
MN%*HG0(7%R.(D@:79 %64D0KLF:;_>][>)RV8QM>Q6[$SF??GP:\&,10J].4
M5BC7;1A**"Z&H(#+FO)"6B!X)"V1BU!CR8K3^]R_/^01KLN5E8X\Z,O=_FXR
MOJZSL=Z.O^$RFV0MQ49:1CI9 "](@)5  U'5[3,KT))X:]6\G?V3B"Y%-AK2
M_;1^]KOVR(L>$C6Z&,;?9[\OW_9[EU;\_OMTE$;CZP=4;.]\[PZF1X]\8TIM
MCE4CHYX4'V$$DTH+ZYCP7FNAN;?).;?;3=\=UQ"^>Y%R#M%SH.=3@(H^0TB>
M3H1F/(B8@A"M&UB?R'>_O6:?\\Q,RA;05>^<M@YB3>++R'*A%\,;[-_Q<+:-
M%;I*S+&=% [A2@]:WH&9@]X%Z5."P$N-'20+SCH#@94B8B'(KO5C_H)]IEW$
MIS^^O$2?*2E)0L54($9?]225P;G"(09%VJ\HP=C^K^X7[C,]2$8Z^$P/X=6@
M;K!]@/WI,^W$SKW]8<?P8E!A(1V8JTB/,3+'0!7%($JC@2[MY+CT&9N/RWFY
M/M-^9.00%@SB,WT39I]?C7/]G^JR^Q9N'MC;)3F?3?' O&>U[X$$%Y4%XY*0
MFA4E=>L.T(<A/">_QT&L??8M:L:70;RH.[R]J4B>I$ HHN*TAH/3A--+Z:.2
MP1C5OXIS_I[WMI+3@!<]W#QO)M.ODRGM_(&S]QZ<ITM5.6DA62\682FZ9S.I
M==IHH^BR9:YU"N*3@"Y%.MI1O8?RMH6S=RLPIY2/T03(M>!"N2* ;K984R&2
M#;[$R%M'8':"N111:$/M'IK.W;F07G^_^_$_1SBE13Y_?X??\&:ACSG/12XU
M;=]BIKU[!SY( 22C6A:M3&[>N7 _9)=O*?? H1ZNDSMH?\-0-[X('#W&NSI*
M^X#MR7 ^".AIC.D^.+Y+J'IC5P]:S&&@F><Y:N1@%Q>K<+J.E/.0>4Z*,2]X
M;CXVX_2R]8P-?G:B=0B7^A2IM^.OM_/9@@)\'>_V+KG %>2<2B4"AUB39V()
MT7"MN'"M'39/P!E>$^J1D;M$IB,7^IC(LP6:6&OPDG.ODH"LE0=%S 0Z. 4X
M*P)5MO1/Z]C5$W!^-@$YA@L#W2!R!8U+I51.## %VK)59/4SH:!@85HPQ=L7
MLST!YV<3D&.X<(J\I?=A.@WST3=LEGSTZ!N;9Q ]C7DC#4@98QT&A[%$E6.,
M21%+I=>9EX08-M. 'GWY$+D\ECN1,Z-[0PA<9K>YQ!DDH\UBTCF7_7O;!\GE
M658^$\UOI^,/#Y*IKDHRU<,1 1U;!%TTO;)9 0:)FE654/:?>KL+W;EF]!PB
M-_OT(6[ FV&"#O_^BFF.^;=;PHJ_TB4U^5[[)H_GTU&\751OOJ=[X#<B6;CY
MOQBF5\$7S5%R8$G5K&*6(4;%P''DV9O@F//]QR,.A?USR%V_W#QY92Y!,JX4
M#3;6\(NL1@03=(1B45E&GP)KG:CX@K/,NHA6?WPYERRS/5THP=K,E&75Y1M
M!;JZZ<@DJ#4XI 1EA:QUW=,E><P/DHSC/.:'<.CDWLQ]P/[I,6_)\4YNS6/8
M=7(92\:R$CT"8TZ"\KP6^# +)B:FT&C!8VO]_PQDJXW'?#C1.H1+ _N[M"@R
M:$70;"1H5@:(V1$13/ NH2I:MU:S7K"_ZR!&'N#O.H0+.TW%EOZN3TO%*XSS
M7W%R/0U?/X_2+V$>/H4;G+T:+R?N_#8:AW$:A9L'LW]>?W]].R-5839;?<7Q
M'K+V&+K[U'JFRX873JH@C>1:HRQ*%Q=%"H8G,MI4"D[HJ_9P.IIXRR_[B%\G
MT_EH?/U@Q7M;19<81" +16-.H&@_$)!)0)^$B\9SWKQ]WCZXNMZR[V_K4?Y0
MEHM4C7BUZNS*,U3!: O6,#*\BU#@LH^ J&-"+5TJK0V+W6B&OV.;2\7FU=J(
M]#TXX3[2+3^^Q=E5E+($1 ?"<]I>J6I'D1E$M(49+V)H7KRT7OL"&7X467LI
M#_@Z1;I:%WUSD9ZT!5W'^=67NO'_68XY5L8QD84$(TPMPD\.O$$.!3-SJC@=
M3?L9U,_CND"Q:,Z./I)XOV*-E-7=UQ&%=2KLE;=6\IP9Y+P8DJDK))E .I-9
M2D+)U+H+X188%R@078G=0_;N/9+?B![573\:WQ+"%=3:0;.@#R&2->!88628
MUDHJL@] 6HU!<YX16[\5SZ.Z0.EHS(H>AC2OE?0WDR^1M/B*Z>UXCM=+>!]Q
M,<^ISFB:7=6F =*% MIE7?NU>S)-18*BLV4Z1&U]ZW3O_=%=H/#TQ)H>IB$_
M?/T^E+?57+P>D8Z\"E.3<>E4-)'T8AY *593WNO(!F^L5TF[(%L/0G@:T04*
M2T,6]#"=^"/.YM/;-+^=UK8\"Y&-$0WM2M>T!0_*!@,QAPB"YUKFA(SIUCKK
M8Q07* @=2?V8^;8K\_\ZF>1_C6YNWG[Y&D;3NON%EF0#UTXI!<76">X>)81,
M=Q83W%G!N"RJM4JZ'<D%"D$#DC\6!-=E)M;?,(]2N/D%Z\S'CWA=!T56_:?F
MF(QG>$5WD)*Y!G2S15 ZU&$PGH&7R"T:K=*F@;)U,M8SRUP0JUL3]3&_?1=^
M?\1_WGY#TEKPU>N_OGW[GZ.O'Y&@WKSY7$=&S*YRU!$1(YB2+"BI$4)"!3H5
MQSRFDDW9@]_/+'-A_&Y)U"V^JLZ^R'=X'6Y^0T(B,4B5<P"ON )E> (OJD):
M)),)N8[-^YK<+7Y!3.]&V"TL[NR/?(_S!YX.5%$5[43-!R-E$AG9'59)8%(Q
M9IDS0;2.[?X X )9?3R!M["[LR_Q/C_KB8V__K[ZY3)+RPN9DS(.M,IV*:*!
M,P'1>:&49E'IYM&WPV$.E5W9N\#TS:)3IUC.IO.K-Z343&Y&>>D$J21;Y-<D
M]-X6LF69J9T/175["%WJ/% 5!<,BS5[)X[3$ RFC_[J7L-VKGSYELB=^3YK2
MO>5LW:V(UHDS>V Z)!?R8)DX1:IC*QX]R?(.!!Z*^<HA&J5%K0(V='^:3#9.
M)-7(,)5U-C'B7C659\7T'3F(0_+\$+KVT?-_'5Q;)UNLDMF"DT;S;,#DVB5)
M(=FUFNP<HS5]$E$ZUGRR[G8HPRF@[?BT*X+9@<@]Y+7<]<EZ/QFOD*V H;9*
MAV+!ED@ZL9(*0O8*F#>I>,>*4JWG#.T$<P'\;T/H'D[_WPC3=%0+'TFC3*.;
MJN'4/:\KN)GBW(5,IF\NH!AI-S%HTIYCCC8;8;5N[6)X&M$%R$)#DO>0V/)I
M3O"J?&YDEBX?OQB+*(S4V\@-[3LIVG+*#(15R17/(J;6M=I/ KIT^Z ]5_H0
MF57N\?)H[ .FIWJI'X"<IAZJ(:,V1: SE?LH!OX!%'.*^Y D)(,25)&%[L=:
MGHQ1:H-<1=4Z07H EC]3IC04QP\A;DN3<!D"^W0[O7XUSN_Q=CJ98_H\GMQ,
MKM=3RZ2V3 :O@?'LZ&:S 9S6KKZ+AFPBJZ+>,Z[XU#(G\T,?PX!)/]1K: -4
M:!^F\\^3KZ%&.&N=R:>O),#K[JB.,=(V2*^)J5HFG%"Q6"#7TBGT1K'R7.7/
MTRN\5'8VHMG.(SI(_=?R\P>Z2@_U73O7Z+%^:[]];=1GV9B*<,ZDP*WRW@67
M@F0Z2ZU$%,SLKL_:N=P ]5?".!LE1I"9# ]%-@<$2<:($YA0BA $;YTI.D3]
MU2J7C@S?5 +=AYI95]NVT^G,A0SD)%7*.46C6^_NK-,6#^'VH[3%PTG:^)UY
M$[Z.YN%FD3*31[71S>R71>[<[V0)3_*5<,DQ2:81\JR [*!(5E$RX+G+B$4H
M;>,>C\TSRUP0:UL3M=<^0?N;R'44LM6D'@?K25L.GGX2N8 (HF27,A*W_XQJ
M-[L8^F;1&4>U2=U#GEBJ%:0>5&0:?' 9=/!1)9W0J;TZ;EQ\5/L@?C\?U3Z$
M[D,%-O?!]#-%M0_BT3X1SF,(/!3SN?8VE\@(%K)EWC[9X@I8C#X8K3"*GR&J
MW9SGA]!UP*BVTL'8%!!*--79$N@ZTU9#2AR=U-Q'TSJ <=Y1[8/XM&=4^Q B
M#QK5CK(X%K. :*I*;&H #VM_ZHPL!L694JW;@I][5+L+_]L0N@_;XTF?O"]&
ML\@L2,D*J<P"ZUTG@=&/7J?(DF[=#O=B@IC'J(/MN=)[$',?,#]K$/,@1CT9
MTCJ&RKT',7TR2AG.J_]^T5B$@2^U#"3KQ.B.9$&VGEYT[D',AAP_@+@#!S&Y
MT=8Y05B\L*!2X/1XA4A_"*6Q=IG9'+3W$H.8!S'@@"#F(=0;+HC)E%>J8 "1
MF:BY5+7O1[20C'/),"_D9N/[%Q;$/):=C6AVTB#F_7\]4%<FX_<X7_1-I+__
M;C*^?C?ZAGD9 6D?XSP:0G\AT#94V8B0,EVD=RHD$@ E37')>5F*BE*76$S>
M&2$]&LT  524,DF?,A@AZ<0([<$[9T"XG*WS43!6^GGH>PV@WC758X:9&"5=
MQ(DVJ:0/-=70 %KCC,\Y:VR]OS/O57@(QW?V*CR$K#TX-WZ?3LC$FW^OS?OG
M='77L>=?Z];I3%UAXK9N!+1VU8M'#[!33H-.AI= =W=NWCWJ*3P7* ;-R'\F
M$5?F3 [(-,@LZPR_5%/:U2)3D22[6-I2\RR2%QYQ[2(^?;/H'"*N=[;D_>,?
MEJWZT=BHO2G@I<3:($M!D$& *,D*%*G8T**4>"> E^1H.XCKD];4;QQ]6^WL
M(:25 ;,/J(:QUYU A@^^-F+4I"\J#R<"WI+ARBU8EB(H[B1$90+HFBC/7/!^
MOSZIY\7Z)T*P@W+^ .(VY'B:W([)8KWZ^Z>KX#7&F%R=5!?H(HL*G N68*#B
MB,C5IE_M!_;.,/WE>O+M/U;?N.3PZC_N&7R_WK!AM4:$GW2B6@]6QJ]_^_75
MNCR!,^9)>04A"CT_I.34[C@DF-Q%7S1IM;IU&^/[U5\R-SO2LO']^VHV"K^'
M-"JCM*X\-M'0X@;(:B4Y4\%!2,( 8]++@MD'OU=OR&?NW4<+OV2>=J=DP]#E
MPI&[& TSF>+H>OQF<7V,<)V&(:SGT9,*:904H'Q2X$L%J#,36@BCW4;Q]G;O
M]^XE7C0K&U)O9X/YEG[PA8/TOMEH!W?VKF_J[I7>"^/F>"0?4S!D.)<25,XB
MHE18(L^%3)T4XM6N+^W)D79OZ6>#.2O/@3EI0:$MX)@F.= \1$O2H5SK4/#S
MJ)H4V-Q3<]W6,KJ\F$X%O-1.)!EK=7IBD IC!J6+S+=.C-N.9'BG86-)V%I^
MTXW@O23)C1.A6?6Y'\W^^W><U@_"-?*K$AEFD2TP*4N]^S1$%RUDNVAN@4*$
M]GERN_%<G$@T(WZO7N2=1%AZJ#2&$.@5A)QJ[%G5O9?:7C$ZIZ50Q6)_KN.G
ML0WE+^Y93'IAQ:E=Q#O/P.OOKW&</G\)T_]>MDX0JKK3$V2LJ8::5#&7(H+3
MGJS@F)BPK8?B/H?I] [DEH+PW*74A2$]7$R/\:W1K7NB[(&OIZ3-Y["=)H^S
M+4>?%9<&[#B%V*0DE5=&0#:F1EKHF@Y<2X+MDI>:3I-LK?F>1ER>R0$]K;0<
MPH4>I&25WK&>(#8-:?Y?H_GG-[>S^>0+3M>.GE*M4N_!<I,(I) 0?/; M>8R
M21MC:ETYL!>PX17DMOS<GFO3D!E#&%"OO_]!_]?%27'T\@97CT;(=5QM0O#1
M9Q F$F)7=,+^KY0[.#^;UG(4&WHH*7D$K0);'8]]H VEJ]S#.ALUY3@6/B<:
M'>D_A'+R *()@B7K Z2@ZH33) ABY,!C]G2[*<E#:^_CX*)QN$K2NV0<0O8>
M).(^NO$(Y+K40I9@$ZOY :JVA64URS!;2%8DM"J9S%L[YYX%=08*R+$LW)SJ
MUI3^+4M=GLP<$<D9:XL!*VOKP%0D>&F0E"')1;+!6['79?%R4^MZT#':D7QG
M@+!U,M4^H'ZV?+J#&+575M4Q5!XLGRX8=(P[>@YM'7:M)0*]B"3I] \2;)/8
M7G[Y\V+]4?ET[3E_"'%[R*=[\_Z*UZ?,1P-)2KK(.#*(0OK:5AB-1-JN?.KY
M/RR?[LW[<TGQ.(CPDTY4Z\%9L S_XF:UVW_B3::GZN\SS \T6XW6>1X*".2D
M9632;!V2-F,"NN!#4HJW+MPZ!-]%/O6],^JQ4*G^A6KQP?OP9:T8[P.X)Z_#
MP6!/XXOHC_\'"UH+YO5@H!X.W!K/O<X>$C<%E!4,0B'@O$0RR+S*J%I/H3\3
M:7O&O7'&PG8(SQHWZM@ 20#?ULKRZQ'=[<N/5H9XSA*5Y@)DP@"J,'K.!=WS
M2O"< OT;U3[CK?==;W@?1\]LF_1,\\9]/MZ.Z=U/.)M]_&61M[N)D$#O5 Q6
MZ L31F2,=<J"K.TRL,Y6*I!#MD(P)G&O@>C=D5RR+ W,IV%ZD*QTS[=O_Q%N
M;A<>P3#._^<VW(S*]]'X^E5:V!I=6HP<N$*##B)=]K29PYUUEK8X&612+.?@
ME ]*A" SEUSEJT,7.]XQ<O?]K[9^_VA6D]QNI_CN+D4ODCR%&"-H95<%5U'E
M# EM-C)@T6&OKN//.$P.!M954[M?\.9F\J\PIC-)2W_$&4Z_X>QUN*D?74EE
M$F=.@C:>K"72*<!)F\&1;"K'ZK^MK<V]@ WK>.A7:C;UL?:<Z<%G\33(91I[
M_F/R9C);7.%U#,$,KSP]#<@-D<7J&I;3"$$P!%T\=Q)3($H-*DX[@/Z\XM6"
M<SW8E4^#_H5>CU1_.[OR.A65D@<9 RD'GM6\G\B \Y)-,LEG;!T7WQ?;SRM4
M1_*GAZR;IW&^RO^\G<T79617='V&HE.HA?:6[E=>+>HHH!A/1C4+-H;6?HF]
MP?V\DG0LAQJ&6 ][IEGFCDDI@9ND@+1?!]YJ#R6CXX%'K;@YO0+5CQ*]=+B[
M%$)AUM1Y4C6XH@3X4C@(79T"Q6J^7XN 1@KT("5 PQV;?OEQ+N5 3XOTG1>4
MB!>"#PQ\T)QNA&#!)\>A2$G;BDH*/>SC?ZJH6,]2<="5?11WAE<A5X'D/3#V
M% /;!]]IPEY]\/<P_?%XYIQ*D'RQC#/#*G49866%S/-DP*E2I\!&(W/K^M?3
M"= SD:QSD9]#>-*#W-Q!^VTR?3^9X^PC)AQ]J]?ONJM(MM9F+B#[.FX%,8'+
M3$'1665C2Q:J=3>E9T$-'XQHS\O-G@M-&;'3N79DB.$1%Q>T0\Q?_N/7ZE>?
MU6#)K^/;+SA=]1Z=S?>(*1P@*77!V;VHU*4/BR@TV,)="*'%P.!7<;:H$VM]
M=G[\\JY#R6HX;/F5[R?C=#N=5L6Y+>+M:PQ^PK=SY=$ L:<(<FA@;_5Q_2.&
M&?[O__7_ 5!+ P04    "  ]@DI6,<@>9R1N  "$M   $P   '-Y:RTR,#(R
M,3(S,5]G,2YJ<&?LNPDXE&W;.'Y+45+:5%+(&K*'K)-D2_8]28RQFQ$S9)V6
M)XHBLA1%2O:EK"&FR$[VG63?]RS#F/M_WU-Z>M[W^=[W_?[OMQV_X[D=,W-?
MY[6>RW5NUP7L!+\"^RXJJRD#5%14@"KT!X"SP%X%*XPE"K "H(<*'-B3HW3#
MSAH -#0 /@BR$Z"E.@!0PW70'T!U#-A!>0< 2RKFG^_V5*=^M-D&?8G WP G
M]'&A$J6\'X(^$?YVP/8?[5.@'T& CG03 'CV;?U2UL&F;8O!8EQM,<YLBHIL
MHL(BXFRG-"R0=F@8R O  &EA*6G1LVPB(M+B4M)BD@! ^XAZ:Q:J[8^V_WP_
M&AI">:<6%@: T-#?WU]0?5\M"$+OV[96M6WX!?7/%5;!Y/@^FZ2TB 2;B*BT
ML(@TU/G/8-!#0T7]@P(TOU*)ROMW*E']]BN5ME%MS47U8-O/-="S =\?U1_K
MH/R"G> ,0$^AC[FB!K#M%Z[=I-3W +\!]#MW[MRUDW[7+OK]N^EV[V=DH*=G
M8#QZ\"#CP8-']]-3GA\_?_Y0[=F]>\_>/?OV[MUW:._>O8?@K[V'OG?9_Z\,
M 'X ]N\$^($7U%3LP+;]5-3[J< ^"#$Z\!,5 EKE#BK*\P-!:H!JV_8=-+0[
M=]'MIOK;2HA"U%N5^R"F4E%OV[YM!RW-SAW4]&)0Y7[J[2</B.Q0T+$XR'[]
MEBC-H9"XM^<Y.!EU/UJ*G7&YW:1(RQ6J-S^P@'05/_PRZP[WA<?Z5DJEK[ 2
M1YH-!E&+V;^5M>"&EI1YPN+OYH1_:AW^]CJWO&UDV=#:S2\B(:^B?71%4L7(
MQMT_,C&_LF-L=3^P;1NTVNV4-='2[!"G+.&DR('MT JNLQ_<(7HKY!"\@H^Z
M3?-BG)8#+K=#%?48D:YG%KAHX 70<HN7-D.+>'7$2LE  HL:_+F$_W@%/+\O
M >P&Z*DI<^X'$,"R?CCZ=6QPBZ>OBG8UITZ@:7H6N^JUOMSH0)_9]=-7!9Z2
MQ7V+<,<[6)XLW#=,>'^9%_7IS DYE7Z#AK<SF!8O.3X0^)JJIE7 ^9Z'C,<_
MF-L(P9,_MH# ^V1\P]S"<Q!P$0*!3FG\:CB73+^)_'L?VX_K9')P8/3$5_IG
M]N7RX2H]2%O<PV56O?15SV 0V%ELX5T?VR;]V>BRG+K49SFCUO21V?0TMQ4:
MB=A&\0<V32C\UPY4HV\1_L&EH**6M]F8=X-]D4HF>]P$+K%$3R,%'&)ZW:1B
M*GT7+_H\YQI$&!,JA#HN":69J=,>3#K<I&S6IF,>IWC/P=&5WWI,>ZRH9Z/F
M,;["OZ/[-'*V_DNC34LVRZ,.%0$9WHR&)9;06"\U#RU3$#B*-Q:33_JZ>6U\
M]<'NE"JW(WIQN5GMT;N9<9(&*P&S.*R3#7'5$Y'PK5BI%00"M=*Z8HU+,@MG
M7UW+ESFVVN(PD"YHMZ<P=0\.PB"O064<?TM-Z_+[)9+]IL,4"!AE3*1/,)E;
MHQ71$L&:19*'C^7A$69%OM$E 7%D,?F2Y2_!'5TMGH+&E:@SXEUL1F;^K1ZN
M9693'>B^'$^M%1"(-^X?DET^V%R21DBY/)4]79%7%UF0;L&0W9C3ZO Z+;TD
M" 14QLF6%WU,)_/0FOBVS]'1$="\/!PL10)9U*C/!\:<KCDP;X:GO'N/2%M#
M&"+*^]4GF9"M'N7)3SIGA*<<!5:R\"(/UPU[R'L)WR(<DTGYK?UI_4.T4S:7
MSX@E/?.F"TY^BL+J,+8/NNFHI[]L:.YB><Z2F4R._%82>M$'QS5&N H"%8&>
M+'J%6LKI3Z66[U675(NW#I5K.*C[>$$H2,U]FP"!N]EM&3&G?+Q!@"FC0DXI
M_XOSI\_G/J4V'0.!UQN2\:&Q[FH>8ZU:"_%?<D,_/V[ON2J/>R22Q220T8&/
M\[IB-CXL0V)=XP>!Z$W&F'!W71 XQGJ%G/6-A1#LW^PJ7Q]LS2'@*L<7*R1A
M;OJ\<#T=WYA\GW=Y>^0MUH6G9.'+?6-)9R45WPWI'%L  ;N.E_C X,S53>OE
M0KP.DJE5)/5P(/]VB>Z/C,6S-@6YG;4G()3J\*GKTLUZ8.-<2=ZWHG5"6\FK
MEK?+)>M7>!UO%<QL<N%FKSN83LI%R]66D9,W'2=9]5P7JSZA\B[+,4^\/VQ<
M:3@TTT<:\3(GS:AWD+/Q#^3O+]LDB24NT[F8NTXZ?6Q]&X3ND%J^)6&FE^\;
MN&HD'DT6)917:N=W-(RWH\P SWS+H>+YL^C5WC$G-4T,6?Z$%@CPC8- /NMF
M[<OU1+*$-/[*Y\R$L2'?AIKW?LCW"!]#61"XW6MJFOP6VKFFZUIZFSR-_4'R
MQ?B IR#P"03(U4C\A$%I-\DW=;D@8YT0-"V=E36UP7B RD(0W>&E64-06S=[
MX)X8_$W^KAUOS_J@%EDZ4RRIMNS.O+7HJM)7$!C:L_)M;B$P)!JE5(]ZTL68
M4ZO873.Q+G2'N"R?/M7HB5_K7<]M%5MX<ZJRSJDKTD@)M=Q^[ 0R6F]WK<N)
MZ=XYEXO>@PT0&J] 0.LA"/2\*/:?RE0@3#&TU<5$!DY(<K>8)OLT'VNN94+V
M%3S(G79_V<._(K;4$6P" B/Z^(D%P@;V"($SL;[09JUH\KG,I+G9!%-#PL82
M0#B$E/H<S<N2?FE3  O)G).C92D('"C61B[7?7ZR"M1-4G?)1I\2;9<D9[LI
M@L"40U=DPXGK!>;Z\H4V]'MR$<=J?>OC_=H>FQ8+]X^(,?-@2)87-3^"@"R^
M0I"0\$KFS'.?^,%6=R=R?N<I,\3:(CFD"0220XBV!A!M8R\N%V:X&]Z(&-3O
MM@\AKI[X['5BHZU-LQ)?F<HZ5+NNHD).4!F)XY+W:%W_C->SYC+1BG(^92TA
MH+&O0N2FI%O_MWRIHMGL)1 8[#)P7&58\, K9TX:RFUR%Z>E![F9<C+O55>9
MDL^.)LYU]ZN[;R9L2)>/]VM[8K1!X/!T>=P+F^5C75&]D>.^C<>&@BIE^M;I
M>I"0I _.EO2/.5[)7\M<+\><6R^SN3 IDU+1@.^:R?B@\CJT9:*MX)';''XR
M']^^:3YZ0*_Z*TY9K]VT33I"QC-QX@2N]<H@LU-0[TS'A;E-L6*CCF^"9'1#
M4\8W?!#YQ?:]X:K4MR9E0("](".SI3"X52O]UDQZGI%ZGS5S.GI]-F[C:59]
M/?/S"4038?,$H1X2SERW3DB(C"9E)I!9GG+A5\XM'ZVQ??MB3;3#1#VF?[W-
MCG=),+F-KV9R;M('P50L7#"3&]8XE%?$O+WD#OTW$%#M-T@# 5IB8!((,'N8
M.T[YB)U^2+"=P)KFE_D\90A>5V^63UF>2XF]3&Z7=M=D?(#0:MM08I3P,=>S
M;M" -(GO3&T#H5*;>DJ3;1OP(0U #&6%ZDV^,P8!Q_74X !%\Y4'-/J70>"E
M>S/381\AFZ+> M8%'[*0='];4+Z-=D/1L1K'"I^3.?*5,JZQ!K>5PIK[""\W
M1WJP0D2&1/S 9?Q2#^-P& B 31"W('-1<G\Y-DDLR:;OL5E=<HY?XWIW7[KK
M-,WIA [TIM#<Z5@2RC<%!'HAI#9<,C='S=;5>"$A^"-TQ+3?R/?%INEZD6W5
MQ[AVZS/[>E/[2C[L[)[34C8PRN\I3'FRW,09^LP\#:\O?:3]8K?T<^;T-*=4
M]NRL]FW6QQ9FO/ A#J?3KT'T6U!:=D@<&[)I>APU]58P8[UL.BFG,%^BG=9O
M*+='4G(UTCGTH@<M/I#EYEP::_ZF-R%W,\W&L=\\<7*W?%,V)F[2$[*8 _B\
MPF^A:EHQ(/! :,&_73YU.<73=\_1]C:T&,8UTZ$V7[HVY=9$CYZ;4^*JT9--
MR_6/K;YYRYY9&17I!1BD2&HJ8U#TWC%/WTKIJ=,%L_F02Y'768R9RB2E&I&Y
M"4\PI()-GHD>4L=FZV;#&L9,?=+\VP9^0?(;8HZ!.+<^1SIP$;-Y;CW?IJTA
M-6Q@>&==027'Z6W'=P3OP20<[\>,IZ ,BFRR6[^\7DZ=1*BMMY)LEIE=^,[>
M&GRK^*31?5JP?[+-?5T<HEC4<_Y$G>9U-TG-2M?GFEQ.*?G&"M<=E)O>YZ:A
MYZ8%'3) (& NU<<UN:]UD?5QL.\%9M.@R>[2KQ+KT:<3^KU H%3P(V?8Z)B/
M^82/5D)'BV>Z>0YO>CHF&;_TNI[9!W\Y4ZWM"PC,1^A-".KV+X@L:ZQ(S11)
M)#Q^[9B5U;1IKAO(2G;M\(1(#@(IL;J%1FU:N;Z?\S9\NR;68VU=3[!$)F?;
MO#9 3,06&*TW04(HU.X;9ZX]><2JPTD_X%CW\8I\!S-47&5;PABFSY4@A=O%
M&7_V2=N@94N@"?=[SQZ]W;E<:50/^RJ+NA^$JO&"7> ,(_;WN$E,4!@X>UY-
M8_MVBB]]^CC598":F4OE.!QU ,#Q;9+ 3CB*$984D3B^31;8+0*5A(7YA:&'
MTH^+TF\?]>&FCZG&^R_5N%VDDC2Y0T.IDZ;4C<#U/R(4 -CM[ +%9UHXK#,.
M"Q7A< ?0=L7J66(PCI06:F@L"H7&.6V]P[^*CBYPF8'25\_N!MSBO!T6[O/[
MF"@730LGE+Z2L?[/R;YWT';!8*SU4%B<LY:E/1("TP/:@ N @?ZL 39 #T !
M6  '.%.ZT#G_;+TUS'E'+/K'BN@M<7:.6#LT94BHO(O26E'#1/T[%67@]ML$
M_H#Q@5\PUG+&VF'0KA#T" 4O9RQZ"PD(24N7GP5=&U>-WVM<T(J_%]#8WPN7
M+!U=?Q8T;;!N/PM*3HX7?A8@.OX^]'FD@\T/0OP(H715SBM2HBSXW8J-S0J#
MLSR'^0IL/2HNZ+^#G7?\^W;G7:ST#=!890Y=1RSPRW/>T8KMS^"ZKHY8"ES[
MAN,YW9]@.C<4$HMQN6"!M?@I%=HVVJY;4@&___A5I! !98W]L^'U(?G^,[@>
MTO$[7-L%><[D)W@?T@7C;&2+@I@+\<L.;;-%L;UPA2ZTIO,8+!;CY(A!V_SH
M0K]5 R_A%_B>+;BNG8WMKQ6[MRJ@M?T$PY)#/?-]#3]B>:JM7XI4<5/J]OZ.
M >+F]U[;]U"*\-YEH929_EBF7J*4=VWUHZ+TXMGWG<S SPB:TG:9\JX*"%E;
M0S6.T#?-CT[?(7%/HWY"1"G?EZ'O+8@XY5O@=PAES#7*.[23P#]]J,?AZO_Z
M.@HM=OZ@Z/=\S;GOGQ]U+#_I]+U\#'ZC-ONY^N]/%9SG >#\D"ND(5P #\ !
MTA4N@#G@".D.&^@C"@@#(A#NYH [5&,)_-Q2?WA^@5'&J_H'#7X^ORL0 (US
MA 413DG16&)P:"O7O]F_2*S(%CJPT/\B<,#?2"9P_G<)IBQ#]Z> 4I9&X^IH
MAT2Y&CI>@K<8U1_FV4&I@UX.0!]:2D'MPB]CT]JX8'#.?P#18%SL;.Q^:D\E
M/;B3%@4&E?=8X+ 8%10:Y6*!15%RBOH>SEO*G^Y[8Q@"UZ@YV;#]#^!/C7-Q
M_(,)H1#_CQ -5YL_FAD:"T>LOH7-'V![D2BH'^H&5LU555_CTI8BV[D%_D/C
M7;88%T\%1SN;+4HQ?$=>=0L,4]<*96V!HVBR76XH%^R?-#?< O^Q^6Y+&T6,
M(\;E%^+N_][AO,K/"G@9FA@T_+L+BW&&S)4KZE?"T3E"A/P[*+TE127^'7RW
M"ZSX_@9,V6FGOO>#/ML0\\#O\/V45ZKO&FK[(4H)9B@UI4Q/Z23[@V OH \_
M]/H5L@$O*'G0HW_E/?_*>_Z5]_PK[_E7WO.OO.=?><^_\IY_Y3W_RGO^E??\
M*^_Y>]Z3$D><I'C.9M\C#2AN A0 *RB,MX2"=S9 &["%WK'0QY7R!B< C_R3
M%FR (O3']C,1L)5CV?X]CT +[/P^%SC D&Z+Q3I+"PFA704MX+A$$(EQ$KIA
MX2PD(B@L!,@B;CA;(!U06#9+%!0=R['/%1'8V>RLY-B-Q#6$-9P54;9VJIXN
M*#U/37VDIP-2RHH=(;^'3O:&] TG9R<4UH+MAI,CVE7ZAAP[971IZ!T&"[&S
M49I@'>38OU^:,=;09E/$N*#8Q 4E!)#"$I)LDE*"(N*2DF<D3U,NT0@)BPF)
M"0N(BDF?$98^(\KVXV&'IMLEZV)E+:U[0?G';%!)COT'7N[N[H+N8H(8%QLA
M$2DI*2%A42%140&HA8"K!QIK<4, [<I!&>/[(!=0KD@7.TH^E TN6T"1/5:.
MG7T+#R?GGR/_*<5^::BA\8^;.CG];.V*U459_^/6KG X+*2+<L7@7) HJ#G'
M[YV5W+#_F<Y*;B@T]F=W*^3/OLXX%T<*I:R00BA'E!/4S!7J+_)SG<Y;&?H_
MG^YG]4]2.$LKNJ LL% PC\$X;K'Z']Z/^J47Z@+TD6.'6P@(2PJ(2.AO75?Z
MWD@#8V5G[?%K(RD!T;/Z6[>J!(3/_-X4DCDK"ZS%O])80T-:#>V*M4##B20Y
M=@@B:&=G)6TA8746)8P4$Q"7$CTC<.;,6:2 E*@D2N",J(2PE96%F(BHE>16
M_PL8) ZF'MS_N]Q;89#0&#\))"TN(BXA(G7FK("%Q-FS B(BDF<%I*S/H@0L
MI$2LK*6L12VM4:BMT;YGIBP<?QT57I45-**HDI38624%<5$Q83$1$25QA?-G
MSYR74!8651*5%#FKI,C.9H64ML:X.%E (F+G9&&#$K)W1MFPL_V^%$JR!:(E
M1!BQ[SMAE^P/-% N=FXH*V47C!,;142E[?Z$,)(BXI;6HL(H 2D120N!,^)2
M%@)28L)G!)#65J(HE"3*2DKL#/N/_E;_OU#XWA?S[Y!!Z ^(J=JY0C+I\1WV
M?>/KH:[_*'XO.]JQ43:6M 425@9R[*X6$"G8?P#_'3K _=UM4>A_*(??F[EB
MK+'N%BXH!1L(WW]Q^WSOB;2U0-N@(#TMM(7Z?X07$H.&$W>_X^9LX6(!Z6B4
MBZL<NS7,^N]BXXRV8<-BV'Z1H7\RL-5WZ?FS87_.R?;O3/!/.?*O;=G_/8[(
M"OU!\F2%_EXZOS?YQ2I1S)W0#WL'FUJAG[86*K']#SQ_3?+7)']-\M<D?TWR
MUR1_3?+?-LGOH3<*;27'X\Z#D =[H*B>ZE]_MOW^4/]\X$'^T(;JU]I_\?E^
M8%BU;9B::O_6@>$G@!4^==Y&_<N] =J=-#NV[Z*FVT8%[(8:Y.X#ME%1;Z>B
MIH:GW$:S"T>UC7K[_AT':$[2'F0'=HH<4A#E8-RE<_ZP!:?8$=WKMXY:AG I
MQKV=YS[C0L?TL4F<9T!/XO9"Z,L+^JY*RI(JR%,&AD;'LDJ;!Q>M[F ?_X9Z
ME5W6,L1[UGH)QR<EK:IVT=CDLHVMG;V;^PT/S[M^_O?N!X2%1T0^>1H5_SHA
M,2DY)2<W+_]=0>&G\HK*JNJ:UK;VCLZN[N&1T;'QB<EORRNK:\1U&"\((QKJ
MW\\XH=*.[=2TVW92[0+H*'CMA_&"CQEW;-^^G89FAQ.$U_[M)P_L$*$!V \J
MZ-"*6ARZOO/\+8X01MTXR\-BN]YR?FQ2=)D_,G#[#%>HWE'DA8676=SB3/H2
M2E8\=*YW'BMC8:0,4#A#R=_N4K!:XCT6%I\#GS>&?S]P/*5B9'WVYYGC[T>>
MJL:V-^X]27I7U3F^)J5F8N=Q_VER0777!)%/^N)E>\^ J)3"FN[)=<H!K]D?
MSR?[A_H+5Z^NSA9W%&]DXN9\I_J\_@+\+P',P<;_>G8D"Y'X,HG/O ?(IEXJ
M _)Z Q@W$(@+F.WM]5E2Z-0#@5?HE]-:<SNX:RMPXLK=@>7=&[0^BO?)S!*C
M&=))AD\3EKIU!SAVS1:W1X/ MT/N2QT@\'X4!+JLUSQ H'=CKL\K$]^HT]]@
M3EZ"6J"B!\9 P'6.@)M-ER%R@P "!$8'%L>(KTC*:V.+S".QZPH3&0U?F,L8
M2]S<UVG7&G(10=J6A9F^Z(L[$>]E.!+<VB<K;H@97[;+U>G0*[KQ340D.]4K
M$_<M[7^92XNGOB#F$^?&G@;T]20>45BZ\U'Q8:]'#=TI1)?=VBTAO]!@'@,M
MC2,1Z)NA=K+.%32)UDB'4"WYS8Y"S3^G3S$(**C@Y? ;GS&;$1C_V,V&$JCQ
M.C>^U(M\Q?LNL8R4(6TT;%,C_Q$$U#9KB]S]72WS]RZ0)QT?AI/.W[%W2YCH
MN;$34=3GD9<7T1:_02\H<12GH,A<^^K*W>'3E7U>J1G_1P3[3R2]Z;]>TN,B
M28((LJS0" $$_/$U0ILM6!6(S"6>,1!95Z&WC WR02\0P.2N[0>!^]1O\*M5
M;OYPB\JK/UH4P]+LM7IUZLO_**"$IN\."+#.KH) &<$%!&9'\R'$U!BVJ&6:
MN:8& IL%_$.19$Z&$-:-C54"U"U/_O\(._^$O\U_\??_:?ZV_,7?_Z?YV_H?
M\[<9X>-V^,/D3+[9^R(Q;T=R8??1#XE<A?GMHZ4S)_*#Z8\F9WQ&T_7Z"CX2
MUL-PIGJQ0GT-$#8@4'H3!!YK:;>W:J,;1G<U/94., J5"C9I*)))B;YB_?ED
MQD3Z6X)MBA+93^HX:_GF1B9V.P@TZA"J7OTPG:.L?S"=[,'?3><3_'?3N;JY
MXP0I #$G15@Q*;$ @57Y#8A)_9#3LGAJRVDA^O_JM/Q?'5G7?,W ?,EP[2"I
M6B*XU-N\],L:"%Q:[E-YMS%*>/,"!)0VZSOP?>L:$P\F[7URA2)SU^<LRR+(
M7!)=&<=L+[^.F[^J?6M("';:R#]D%/;&2,$3P??ZZUD'):L:'O74;K)B.XPQ
M>P;"^V4J-XH@KL]+TV<:S-7G*R!6O:RNK0I.5A.73%)LL4V-K=)$\3?[4[,V
M8$<,!%Z\(H2H;(Y)DFLEZQ#DL7Y8.LBW@\A*K*O/^C=.]PN#P$:L#RPWZW0R
MQ$/X+Z[XZ6SO,FAG^, 211@_-3>L P(>]2"05;_$  (%JY!P&>U9B!QN4/6N
M&._S7U0?\EL! =5B@:XP8DUZR'L0*/(JL@4!YCMHM'=[?1UAU=WGJT3%5,5F
MS'!/;EA[:ERBZ WO$+_[33U]7B\_+MTA9N.%^D<(L9TRYJ-X/#XN;<[68LED
M,U"1'+"1^08$@BS=EIT.RX@8K<KI=3"/!C.MX)[NU*LTX9+-<BCD/V4IUU'(
MP?H_+3MI(?C2E_@0_69.M:48X<\?]6L7,D>^[;^-;ZM'G%,YY$ ^_0'6*LQ7
M(\ENK#48PI2=R'.;I:4A)\VKQ>VRO@<]YFJN)GT>MG'9ICOTYGGFWNI:HW:Y
M-;^C5W6II!T9H#6FS?H5!O*HJ(=4M.L.BRQ_FV]K[&AL53)2,5'3.5:K9:!N
M0%V]0TEVX:P5UC(M?I\JQ*[6S!^;7_]C/V$^#C%"N^!5(+-[:-7;.R=EBOQE
M,KU,OKT_6CISJ++F0=T[V3Y98?U<:6N)#E7KO)6K$?:7GR3<3O'+2 A]R71
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M<9Q;P6FRTF-;U:$L/?VVTZLNXYT'E4X"!N[N+[V&WF7"URUVI  RKJ(];.L
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MO*]9KA)*4E+3%?G 3%+G?XG1^G<O_-T<]O\&W?W_^ *<.OA_ %!+ P04
M"  ]@DI6A/6WNICD   N!P$ $P   '-Y:RTR,#(R,3(S,5]G,BYJ<&?LNV=4
M4]_7+AJDUPC26Q105$1$:=*B(DU$4%0Z49$NH-(A)!3I341 4$%!I!,IH4/H
M"(A4"45*Z)V$$C8AY>3W/[>=]WW'O>?><3[<<^^[QEX?DCVSLN>:<S[/,_<>
MFS9.FP.=O*-GJ =B8&  N8,\0"#:%$@'Q'CBQ#\'?3#1#V8V9F8F)F8.5E86
M-BX.+BY.#DY.;AZ^D]P\O#R<G"<%3_*>XA<0$. ""PD+\@OS\0OP_[,( R/]
M-TS,[,S,[/S<G-S\_[<'K07$RW8"S/B'D4$*=(*7@9&7@=8!@H! #,P,_QJ@
M_V4PG*!?(PLK&SL')]T ?1)T@H&1\003XS]733\;3#\/8N)EYCNC>)/EU/VG
MK%*O^*^&)G]ED[Y5WBKP8 @O<^W9ZS!V#D$A81'1L^=DSU^XJ*2LHJIV75WG
MMJZ>OH'A';.'CQZ;6UA:V3]W<'1R=G'U\O;Q]?,/" Q_$Q$9%1T3^R[E?6I:
M^H>,S)S<;WG?\PL*BRHJJ]#5-;5U]6WM'9U=W3][>H='1O^,8<<G)G'S"XM+
MRRNK:^N$W;W] ^(A<$3ZQR\&$"/#_SK^0[]XZ7Z=8&)B9&+]QR^&$W[_&/ R
M,9]19.&[>9_UZ:M34E=#V?AO)7\M;V67OO8 +_#L]1"'H(P2[BSA']?^Y=E_
MGV-A_X\\^]\<^]_]F@1Q,3+0@\?("X*"*&8YL>=!.8TT4/<L;QE<KEC7R8WI
MFJ/6]O/?>B82%TVB:"!>68+CUU<N?ERFZJ?]R14(CP!Q;'>97&]>!@WTW OC
MCK#]C'*;/$:V:L$V&^^T![O.+*'J9N[?3=.-5$W^/6IJD7U#[J<'51E6.MK'
MG-=P2R+LFM-9K]8-6TLL[Q)9^PMAQ"V+6-$\177TUVQNUO@X7CQ.%)63:R.U
MNTTRIQX7Y?[ZF&'^13MU(4N5X%N1)=>LVY#Y1W[I@KCSRQ.)4;/**RN?S-_T
M7.%_M1O^R74J;=+YS_;.HF=XW\4%N=]A+FH[A^.'L7*J[7XIKJ(LV5XO%35_
M2#?K7340'TL-#N88ZG@0X>PNDWE4G/5P?JVG=9_C?$[-Z?,YL:#S*"9">KP/
M"C!$\=L9._\P>*SV=HN#56=GHS\(\L:'\[-9>V#PG\FMVG>G8?'/2?/-D+/S
MORX')*)"<N_=]T853TQ,D-R&LGY?DRL,S^78>^<*6_)Z%GL>5:OYY%];_O^]
MR;A" \6JPEP)>6N_X3_*J;<J-:5+(6 @]O>A;)_YU#F-KW.C=N>:J,,$P=S7
MZH8:O$?S:,U@'!+04S;@NW+[5%M9<W_\%?(&D"N@^>A%N\!GG&_>HSN4NCQ9
MH;7\>42KL5D"AX5ZMJO*\3O,<J!3)XSW<@8NF4GA>&HG6019-YH]BO#!I1:6
M^L>N6%>/S-<>5YL>R6TS:%(M(!'.0%R[CBY^.<+[X1'63;K7A,SJ3,9\#K0Q
MSG@\7V+[HBV6\D=8?_&C(?GH&]7HYTH?GM#G<NL-]4(-B1J]/Q!>D^V,SWY_
MSTHD \DXG$L0BM4\(UFU5C@9@RK]Z.+%KB8]V_2<S%.K;5?, .U(9)V[62;=
M/;M[W15S,(Y=M4@\@TK'1YYH.G_+O?EQOJ3#]M[9_&!>G%E+6[.;'9^[S]!4
M$#)C7R)AU#SMBDU[!U]7Q3D][0=7H7>6T)ZQDX*I+_$Q,@W)/&*;:V_!HW.0
MMH]%)LHU;>_?_4U]ZS+T-+W@2$AYWLK(4K_@EH_P4MH M-'"FAL0/?3/CW]5
M9]2&>QFK^-FB\/H=HOF(9U/3_NHKASIC\0?%#THGXUS.-I1O34([C<4LFR+'
ME.MB72RDY+H_I>R?J_^L_Z!Z^,5B?4/&DS#%--\RQA9?Q,D4"^O2<R[,\U\Y
M/5]V2VO=64&)K&W<)WMD.@SO U@IE@]IAZ?%.0Y6G28BP5$;R[4](Z5J9.T!
MB_T[.W_62TH2#>><'W7K<!O>8=_IQ_P<S%ZX',$?\4"C,/VX1YCQ0*JF\=J"
M%K0SR[EBS^\V@T\R6U>@UPC:/RIB$4]J["OK?-FRT.<O'-)<QYA)1#)8.:?5
MZ]! 3_M76F4B/G]8:MU_L:MV@(*\\8]3&U"\GR;5!'$<\> $8J=<-K"V/(TC
M#&]:1UQ/IJND(9UV:*!(1?+->0S;]XJ-@BEVE+NUBQ>#FE;@8=G(W>;P!R-;
MVZ68T3NA*?&O]E%99!\:2!I12@/98KZ@;HYIZD.CJ$)K$$?W=*'[ERXN%,7S
M&1RVE,'3XY;+Z]Z7OY\K''K@%^]^P<JF:)M44_[]VD6[;IY"P[I[?>8Y]75#
M;K!32O*"N+F@R-K//"*G;<>U,]9(8\&8+F,.)XX-'Q!UKXN-PHZZ@$^/7"(X
M5J6YR+ZO59"I_3U$51[Q'\!9XF?>8XGI[C[\L(W'NJ#0=44[96WY^;_MG&;*
MK8-1/R)V\O:M=^0:Y"?5EU*7O"_J<S_V_$R_])*DIR,^&K;/^B^7+%O.(1(Q
M?>-C/.4$,;U!-/NELF^I3DEB85T&*S.-[3C/&-EA35WN-/*DG4JWSJ *CS!2
MH:L8;DH#)0\?KF)ZFUXX09Y=?'[R%_YE;-'WKTHCKD1/X\=)1O"A/B/I?''O
M'P?6KY;JW<:Z"^S@#P=+MIY\[$\SN[IML6#R 6R6]3Z3GG"G+!H3QY7&AG_Z
MYF=]8"(]/Y7453O !%=$$R3#:@[3^;IV*YDL2"">:S8JE4\F)2M]G"%!5K]Z
M42-JFJ*[Y8WV'4<^XMH.,7G,MTI+ZIL4RFJ,2\WMBQ+-TN9ES<#W'JPD'8R3
M?&/S<FRTEA.>:D9=-6+RZ/Y;<*X,NR]P,1:M-IK8+WN8S7Z^MJ?S'\Q'R_P+
M\_\GGQ?3:GR($I*D!37%&]O@6K/8!DL2\9URO]1R2^]@R495?>*-G]#A.D4$
M=OU *ZSQR+;)/7_>S2A]4C_;K9@$47.Y3ZFQJ(J/S\B_?X0.@G8VB:]K"U[K
M^OBM\JFL1'HN(M7<$( ZY;FFI8>17(P;B\_K/6H]O>A;1O)_,"\4>[-.XLX/
M[4B,! X![L3MEOBR7HV-+YZ0-YO0T-)0]=JX=FDR]:ZQZ+B?#SC]X.M>TAMO
M%8)0M/REEG-7IQ;55L-3J,$;(\W7+(H N_X%VV+FMB^,%:G0.3G/5BI#%3ZX
M<W2P7V;G"@=7"/R+4^@1-35_/@G<.1\L:<3^W#GUI_LZRTT6E.S<7SW.*$5_
M]7*814E6NJVV0' C%7&KTW%TPY&_J).Z#2E;28>?JN,%PG;Y7BU;+P:];2<Y
MUF$@R)]+1300UMZN&(>,5*$*CTEA8DDNE@+O<\^W_I0JWLAF=_=ILEH_VOF>
ML!*\]$B/=0T&C<:);]=P#_4%OR.^+93U<,"CFW;<9[I]-$=8N=K\$SU][QLY
M-?7'!3^;O85G3M@:/GK;;2]H3Z6!?JJ5"9+ )]R(#Z9UH43CL>$9B[.(%]Z<
M@U2!5:OT\"UE3^XIYT.%,Y%L0X*W7Z@\? *Y@W,"1)=-_J[WEI,,>4Q6=8/-
M>9]XU?<F< A?](^]PZXL9WMGLFHJSE;%*2.D-#SNTXJ5:4I*H%U_\*^]4J%?
MMJ^[-Y?BLYUO1 1F?WC6U-=%/3WDW1!D;>S*ZR71LZ2R?1YT/$XB/=3F!5SR
M@6<.];YN?7^.*]3:\H]SOA&BVHL5!.]>MG)Q+VO;VN-?,I"(AHX(K"S:J'Y>
MM+PLI?25W;P(6R?K7U"Z,U2#1KGYU#6K7FE=>/7^[T?3A /KV;T1DGZF?]]=
M?(EZH,VJWU292,OQE==D/UG-^$>8<'DH^>PIING%X,^- W<7W0<PL#&T%" F
M^_&XW_(N(H8'O(>ZB1^(V(3+V1.#E*Y[/$\]\M/^1@/=V;MZ[U2_F]/[2LW'
MHFH69I5+X8_=?0T;8&6]TSR?'%TB(WDL7'TD]"^C\N>J-66[8;NJZ[,'4R2.
M;4WCG/XBN/Q0?B@G.N=22=%5W[GP(R=HA-L&C&U+N?0Q/<K+"?G_BK)P69_^
MB)#^L'O)HU\Q3,^N](_.-U0D<G4UVCF(PP-<S!_<=_E^D'W5%V-, S&*/_;4
MGW@ZS1IP"PN3N];2R#D?BM-ZY?%-+\@/=OF17>T!Y,X&.8!PJ]MRZ.S(_I]D
MZJ!*CTQ,U442.'"2P-JZ!37[O%+^N43&*T5253_[*5W.I#OA-5Z$3*\W+&R?
MB7,A]RCCAGX"?7)MCWI>_H@O^$T]6*@<FMQ21M1#I2LL?N6?>JQ67UI8EKE_
MA,B_@!_1_?B8\"BW2#%LHG$"(L[%PXI5RYV/(B>F8W2IC[9(/*$.N :!JO*X
MOGCQ2DG+I$+E/B )9UL3C8Y!+39EGDN!2!6T= 9:_&;JP@&!(@C!D=*+L:__
MR#2-E7RLGDW,UQ)?3[@;A#*;#DM(GWU]V X^XMO4CCK")@ [5+TM&+4!LX>"
MXV<BLR2&YGXDZF5(_9:(.E<G[X83*$,7V=HUD8?0[>D7BVI%R'+C\QYBORHO
M13&&MM]4?U\7D#J,SG6GW+/!7&G'$?X4/TQOD)LRN5:&QY+CZF&4P$X:Z O'
M<!$I^,/(_K';HV<;7&["]J-S#)GEL#*<2V^:Y.?K'N]@K[4??'N??^%R"1T:
MUZ_103[D?_:IJ4\55>B [>M0SR!G/T*HAKG_YC/*XS^-_M/H/XW^T^A_M-%U
M5!15H9%0'>8C-LNU/G/JXV]G3.5!7HQ3"VB',E6_=7WA$]XM[_\%&OC_SU,N
M_4_S>7^=FZ-GRT?A1GGC,[=?R9R:EE*GW%0>-5]*BD8P D[$2!HH+ G8:9NY
M</Q@#>/D%C]A()T2V-U]U@02P0C5HX%PWOY@:B1%C*YH[&D@4>B_^7R41)70
MP)M1 X&H__K-@L\N9.OFL10@A&/=NH#'MF2*C(KI$CA:/$77'0+TCB:OH</B
M7^:B&2N@C__M8E"<%_#?+!Y/ [7*-K,OSIN<#*6!8.4T$*'^*)>X2XEIED3T
MSW+M:R';HAX&'3<]<I<Y]FG[^9'CVLL3/*^K.'4.8MD7ZB.O?_5Y=X'_JOJG
M2-:WNH8VF#8:Z.A<LP -],.VAAIKM7[^Y'U=?M!_.&T4NI+BFR4 SCFQ 2$@
M;_N4(=I!3[ \X-TUE9=%=2*:D@<H_$:W()*O$9SKGVL2:W$);?3*B\LK7LWL
MDX=D%<,0%@+M C-.]LM<\Z_43[08+\ZU.WU1WS2@K*V9C5*,>8)\DW42T"!
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MU?-)YO4IRM#2SL"Q]PFHDUM[LPIBG ;B0=(35\ :".JL47^C'D_L\XUS<W:
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M>P<XBRCD^4@ +]1$;8OUC5H_,DJ-J'V6W/\R\=7F<Y/?F-O.+ $*6W2"/S=
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M@/9)Y\![=46&OGW!DB5+]T^/&SBTBF^WH)[DA$(^J ^T02=K;"A?E&B@N#U
MMKUOWDCXL?#6,'TWBPKN)W]:81QK_D7))!L2VCM. 2'PIWABW%==OE;*!^]T
MQZOOGN_Y+69]2(*8V2WI,G*<SPF5E#U^2.VK!V]=GU,9WA%1FCTY03V\,Y:F
MV>,N:R/^^F<0:OZ*V_(. _"1V$CYM(EMG^P./P.@<ZP1VV.[DPN_ZBVZIR4=
M;TI#9O_JWR7 $'0NC6B\3Y@BHH%DIW/).&AXW)Q^'>S2>F952 ^/_]]O_Y#I
M?!,C$4J)M0? !3/ 5)=HL7_^_+V"TI79GT9Y!0A;TVHCQ56;O406ANND[_1J
M6,R>BB.J-@'X>EB")J]OIGF',?>-T DRND'7O3<O:MKG>CN"-=Y\;-14&@=E
MH0Y#T+ WWN/>* $X1SW!8:D^NJOPR6V]%\A3Y"DOZJI X$K+['_A[CV#FHKB
MM=_0!*FB=(2@@* (V "E)%AH(@8+THE*EZ;2 H9$1(I($5%0$((B@K2 -*5%
M.H@(T@)!2$A4:B"AA UI;SSG_7#OW+ESSYT[<\\[[X?])9/9V6OOM9[_[UE9
MZ]E@7$!+ &R$H^$_A-0'7 7[#3A/O(\;Y93<$+0XT'< =OZ'6<TCR,R[6,QK
ML"2'C_.36-/3#=N/P,QNQ9TR:3+SSA^7'=5#633L%3Y7^KEMVR)&O0PQPGCW
M=%8J<370%#S[VO2!WMN[.7DISQLFR77@16?)Y16SI<4[V@)KE&Z,$/0.5@6)
M&((<)0+ZYNF=T4>ZZVGGPRR: J52OZZS?'%%,:XT]6YP;7T=G5\LY,G,7MK?
MC-EK@@FV>8:6_H\?2CSDAPGG[-Q)YI_]-SN(%6&7X[R(4IS1?*F$X37X,F:O
M/Q-S:5S]4NT%BC8%>$;R"A?T\GS#;)'AV^81MY0B"@^O:7GLH3!NRB??9;:W
M,\JP83PSY,M:HJCI]Y04-/*XRLDN/T0_N9AZCUX&RS2G83MD@5L20VM_Q\(/
MM_\H19B -?15OOXRD88CKIBO(&#+J<QC!-0 A"__!YD>CI%='%%N\73RWO[P
M;,/\LNL=9KZ-UD=LQ+MD0>1NI@VJ#[J7)46?A)Q "B'(HY4UAXJ+RF.-^KX&
M'E!VUU#X%J&3,6@P[ ^O@U&/,V1J6]EO@O^,W:N=[CIL>W7FL]YEJ!+3(WD7
M4K,4-<ASNJ;SK<?H\*ZXXD,EC;ICQ?%(E>)^SE/_>T<\?]Q'IX0)?>K [W>4
MHH';>,Q+7*;26 C;#H]=M(&Q1X.:WUK8_:=RB8J*@N)W=3:R>.7R![RNH2-$
M&7F'_1S;;%2\P%@#ACDS/VS*Q]TSCG[K'8[WS.>32"]";.+:I%(QGUYNUM?1
M?'Z,=.8KC>F^RW2B>;P]/!D0L4<8<>QLVYEY*[-0>"2O,,G .6.8VI8N[.3&
MZF3[&O%*-^1GU.& NS%W*R6A2G.MNSB]<!F4!O)^+=!$W[)OR/_;UDPU.6>U
MM_08,]E1V?-"WS;HC&EF?L!JLK98/-*"&83ZW@H91^DB;"E6[:\\<?3+2>JV
M%6:8@$O5Q_V^I9.%0POU[TXCL U^!5*#^D^-BZF'F1X(CZG942Y(%#/;G1%E
M"BM=)#R>L+QPLU-/(>^+XM0H11'[!27/@HZTRK#,:%S0X[#R7!75'R87(IC#
M0?9B#4W[,U<"2GB4<IC]'G<;*CU /\F1VVJ3\$8:4 HXX3/Y@W_:$*S@F]&'
M;T*\U<I4[[W)E,MFVG%&/51JY% 'V)@B/):BC)HJ[*L_+,(Y*!;)^(JMGR^0
M^L$%J2#T&5AVE6;Z!?QR!40&L==G*M+O4\;1)UR0G<S>X7LLDT=,1P)1J%4"
M$4*RZF";M*,4:YV.4NVC:JI4@T8_;Q<]V_*!9I_MBKQN+]P/56$Y,R\[L<S'
M>3*9Z+&'-E-&&D\^5=<TJNF=]_1"JX^YV9LJU:^. Q@02I8S#J[)1;P! MH@
M*HV\1C^BANBU$L-< Q[]%FQ3 #<'MX[MA/)0)1ZX]Q%!YH)F#3%19*KQMYX>
M.Y_54&^_SJF*;LDQ83-CQW9BK7 <.@!-T/J:B3C?Z2%,&ZO/VCK^:SO+Z.BG
MOX;?UFP46#H;:<D@X"GI0Q'3&3"&"@*P:S18_"PMZZ5$9:[!\(\!8T+G([/I
MNZYWTL8VH%39"M;UH69U3VB[N[+M^.;?YNN?XQQN5Y<KNQX]9F52SPE?'+47
M_H-)A>SBC*D: UN%2%<<S2,._.34^UBU1\J?='N3JMW_*8HI?A)=DY@,@0;,
M:(R] YIF*\3.#ZO7WOB4;9/Q>B:&)!N8V?T+/W3*7O@[M!ZV[!W$M';UW^'$
MEJ1+(IC6X/GHYX_DPO<G_587%X&&Q_8.WO.P)>&>PNNVVJ9$3*%D='P9_:"R
MP5KF]4^Y,9W)IY7?BPO061:1JK_Q1!E[X7:4'M#$=$/>'/$>0NK0JB%*3ZNK
M-V,NDH[2#Y.6D2^OI<W>-]D3, GU)$X:$QE!M)7"R-)%,;+4_J60OXLY'8>/
M/MBV'LB:XJG(7S75L0T+&;[U=*HPF4C0/T\OWX,\3&M(W,1**GO[ZQG8*'KO
M\WUVS$IV#=J>_HA8Y]BVFIRO2V>DDG!2@^6('/\/S<F+\[7:PQ>'Z[\>,_\U
MIVBFLZG$&_DIG(%6-: 'Z]\XA80/A:5*KISQ5(I>T'.R?FRX-JGU+(+C\R5]
M:FI6/AEBB 0UT_"/ RFMXQHM#:]O/;^B0, ^OQ\P3] 6F/W(D68%LY^S+$(?
MT'QA=?3TA^%N;K\0Y^U?UA2[[3%ZBMP3D?GF9NRBE$M#*6J46#M3Y#>>PS,(
MD<5W] S%!L[9T=3!Y*_W1F9:";RQMI>=RP5Y#CY1XH*Z.X$>.M$AT1X?=)^
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M!XP0]F.6.RV$\6H,I;X8S7G]H,A]H,2ZOGZ>;*^5D7=6@_(PJD#JL]__ HD
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MT?US-TQ?A_(X%?TD_19<TQ]*LX<FP>4K->&/X8+A9M'=A^:NC?I.B>E[QC:
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M,BC8*2TR^S,^3$*L8P8TM&+UVC>D]*!9AV64>R^IJK?'3&<)_7@-40]+C#Y
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MJ%;G1A6\'[9$RFL+,FLY_L-@S^WVRFR1OVWQ[>JM4;=-#I9?3U$JB1JA*%[
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ML,0#P*U%!"+:(U=645>',?7ZK2SW_@<TTH#:C13C"."G'Y=F7H>#T,,&<(;
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M*HTUBJ'S46HOCN^=L^Z!KA9U/ >MPMNP'Y3NQ"PC]?!SWT-H4E5M'7O2IXV
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M V)158R-II^6@&0V>1KB)01^]*GU!N<Z.H)*+%%N;K??3]?F)\B]-JR((04
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MWJP :ZW/.;QD/_E +ZA=5^Y#%GATU32['# %A$=T,+7CAS+B_HX*\^%M<T1
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MN1[JBCA1+>I@C<K.2!;=_^T-I7&BE[VC6ZLM+-&1*2V^2N:]%U7Y;0$FQD"
M7%E#+IG^J"-,2:9OL8L_K23-8X6<4V,J03YU2W4DK(.%X$D%/'Z*ZXC%CL3<
M"Q2%\8>QY]*+<#Z1%O C:;];%Z>WQ@I9*'T@^1&6=M* &[J,Y34;IU.9_=G/
MD^#OL9Q\5%'8A6;;(C-CT_PRF6@-YX.,U'C-+#8*$&-49O=Z%LG'H0[M02B[
M?V!]8G3J645L:['@K>-3T//ZU%:>@[:FGUI$<GU"E":M&68XL>W@<DMPS,0+
MW!4LGN2XFM?-S\4Q\"V6-F"YUG#V@-&3Y_;,HOY-1-6W19B-"V>_=/X]HT5R
M0'[(SS%9CJE^I"1^N#HA<J_KZJ@L'/*M3WE77-7F= O3D8U9HKD:[1#&OR_%
MR\S8S_#@MN\%?E-[G1[H2Q=P&K[ZY=G8Z2SUK?0%1.MKI".&+!:IPG7!$(15
M--Z2=V^S AYO<&08A;WQ_=+W@>%DKNR^@?MYI0&N([%H8\?!I<3*>E9\4(U#
MD*YEA(?C2NH:0-#V+:"+<DM__7 N+D1]9U@\Q[&&"@"9P0MU']O3JCAS41 J
MU8)L]6QQ\;DE+44+UA*#T3MC>GTL+GL DYA1@AC65<75(-9.D)!;]+D9MYA1
MTE5 \/Y3=EH,_G3R\N-6JTG4>8]V=3 [23BBNJXI8E&@>EC[<]2M@YG07LW"
M]59HY/;+P>?U8=U#%$(D2 =:IS\XI75BC%C$U7W8P?%[?$DL=BEZ6IFY(=C8
M.-)ZW-/WRVJ[918F)LG*<'M;L?Z+34[-/-YVJ2]V[X[8#N6Y](;Y64W>.V&G
M%M&F\:^ZXJ\7]9[%>1<U/R>^>$J-.%*:^=@@M&,IK1?_<-A#4WEGL+NX?R4&
M(1-9:C,?<&!AK:?LLZ8H:'W (T5$'8F)YT=!/>3-\D .QQOHS97M=48](>]A
MK_GIXO\>C/F?2[;$U[/_!5!+ P04    "  ]@DI61*&@64C"  "M[P  $P
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M*&N_'B!O:+1MD/]E[R1TK-WT2(;_]9U*1TN$<X^L"OCG!#FM%3&^P9K.8OG
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MRX65)B%X:=."4/.G;H\^P!1I[^YM+CWCIV\M^'#FS2G.)N<!BT@:F2-,GB1
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M(T]U"LG'BO;8\CEX3A1A^%2+3>#@9<DX,_R)[)MP]LY$OL21\*EYED,K=H_
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M9HP^W>RF1LZ'QL%?80(CMI=BN,#$(X8_[ F>9B<$9WI8BKT6]LP0D.2"#$%
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M"K_X;'((NL(T9FVB$:X:NP8LEQMS 9'O%X9M+%YU/-"[\[@3>CNQ=@XP:@-
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M[P=I 22 <#8!4.[61K8:*@T_PM4>9TO#3;&9G-F<"IF1X]LRKQA>U3_D;?1
M#;'&2# D!M?'-@'+AV/2U*XFG/I(2LP=3RW-U)"<OI*GO![T1#FY]S<>%.RM
MDK2*\?"],_WE04<\"SW%Y"9M;[>(7+P1Q^WTF_8!=0$ R9_X;)"B\)YR;UBF
M#JCTN.:!H6Y%IM'9.T\U/\A[F>6<ZZ9\\RWB2"<LP4[@#8GO"%Y-:+:EXJ5
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MB*> _;S*U:.1IQ]O.3V.1]8>L6L)[G<3G)588R!? WZD=<,%O(Z2[,TC"?N
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MP(%"-.G][K6SC OL) EDC&\Z_/"R&3IT(S&G+:.@A.?V2[=*;JUE _/U-_0
M_7?&QS\*T'_B%1"0:P8^Q)YQQI8T66?BIF)%]CWY$]4FHR\858F-%,BZ.Z6/
M6HEV!1VBR%)KZXQF9 7="R \'X?9/7Q/M?BM*Z[<8(DD6>P=7CRV]2@)I$E0
M.?F5%!D^9\C(='$@Z5TGM]\L]VDIF0J3C"F/-Q5ZT2ULQSN?+X@G01":(+,A
MKJ@ER:-B][\T2W[Q/K+S<DI46SR!^Z93>@) I)P2[A($%#)Y38=H0=1B5SCO
M-.0^-.PK8G5,0YU%WCYL#IT^]^'+9X3OO(O8*6]=-M;+." #O$]@NP5F1.!=
M4U)DHCZ\;Q"8VDZ=*\LXW8ZU0-\%CK,W(KA GALL).9&M?=3.GGEY,DI71_A
MYBRU14Y^VFGC\!J.2<??<OJ7:1_Q*X^W;F=&B@G=6^[+TEWHX/^2:9ITN_):
MEW+*;DV-<?="G]-%/^8+G]Z7PCHJR[+*_,;4P=J;-5M$6RIRO9Q[6$M\D::<
ML*ZP98(#LRU7.HJ0'U=ZYF>K607->!W]4:\O8]+IHQAB(=9YJAQ=^(;^<T_V
M I(OW8('0[;-WB^KG8DO*.JRU2^ON>W R[,\NP\0.=RP''!=LL"BY>[IE>@6
MI=T@6SC3:Y/(37>S^7"NG*_?79K@ZB1FB*LBE9E8DF-2N0_(YA'827B>L]O-
M=6SEX10(FXKN0J^QX^K-_5UIIVRK0)=25M1R/J%#;:81%7 VDN6&)GP N^+2
M0]V.J)XR(2I34\OO40MFK"*305MK=T_M _J"("GX!@.)@ 'O?0#7@FSW]?5;
MYR4MYRC@[\^&,0<H)][I+&BB8GT/@MHEHNT:*3>1FQ <$D#JT2$]PJJ;<+NJ
M$"8;[[^VT4^XE,B7AYKY%$,V7J =72.+=\F.GZ?Q=CC)4G:*1[P<Q/"<#MNH
M+O !F/8@A5-=-Y&:VV_YM>+K:"-M,[O]^T@S 1-YZSKFK(ED'I_5F_6DD@4C
M" ]Y%3=14FH2A%)1^%)?K[@HGM&0BO&LI&JY$O>DGI:2>F9LGUU-GN[R')V_
MZ/$LA^(O6J)A3NANE9X>:4I%B7^X(.-R73(H?-ED!!@/9PV;8;O0-LLC_-L"
M;_"WYW?KOF?'!]H1KW\?=7JVG#Q'] A<;-B:1#B;L"^#A>ML9]DCIH&DY()1
MUQI1M]DV 9=(.X>JNH"K:RS2<O/BH\#[M]<Q80-B*ST1#6QX9.,^@"T_'"X(
M$U,S2IJIL3V$D6)3T?^6FH@>OVL$H\/:@["J['5$-*^5?%F2_KBA>G''7?A$
M$F0MD%:)7<U&LG][*K_GN?S\'B9 TY$JE.GVT,9N/?@-,_MY&0'%S/JZPF$J
M9F?"X9_(W]0GO_W/=8V4NGQ,<TP'').;_>6>K1N**L@XJ@?^@?ZE\:OTW/\N
M&:A_-O*BH9V/*9AKRDXV8MUZ>ES)E5%F#I!MY/8K29;G%XF9_XZ,UG]GK/>?
M<YPM<WX:\TOSQ']+#.K?42[3:ZDAYON\F+JL$B'STC(J3*H$&]SU<.AOO* 7
MQU+_CN-L]NM._%W0_2_NTG#=/7LEORNOWIXV,5TS_#\BV BU:NLAG<E?-27K
MP/0:2.6$Y)EFB-;)03.N.K36Z<$7T\6ZQ2=/-'LG%IW@@KU7B'N>9+!K(^6N
M&D-RV^K+C%W/-,%?:+ES?[0&WEW'-5O_*MEJVR4:RDL[.D8^!5,NL5-H1+,J
M,=O>:A,M2VZSJ>O3U>0^7>,$_G2L:Q TDY-3XM]:?Q@" E+4!F5_@Z2?6,LC
M1!0>-'Y9Q2JD<JV0%$;?I5^Z9NR]B'Y@ZLL=^L* 7D%D8XL>.&5X'IWU%52R
MV>.R2GU\,<B[#>.+%"5)T)W*(#4&Y *.(H)X&E@I?!Z"+0+>UU/]9UMJGI)Y
M;HU+'+Y89*_\19T]W5@A,91!9$6'>\FRQ:JE)[ML,L=O A'= &0.;QP@/CSY
M4GB-*PF=2X?%Q2I_P<840]0$'9T09&*HN7]&#=/ZH>:CANC2V0=4Z=&F1R9N
M_@I]^6BGZ6MJH!L>.'\?<%FI^-8?_^/OT#+?+])0#C]K%/P='Y+A7^H[^BL[
M[G>URK*"WX6O+O'^I'R5\?)OVG>2[O]1(N@["H>@<)-I1[OPX!:UW7#:.7B_
MY;CT0H228*PPU![J8W["NN=@(=?[_E@'_F/+NC.MQJKB/G9,;2C2.?"J#ED#
MVM:,W6UC3QBN,:Y\1_*;L"L=X-1KJ$XI6XE,5?7D]Y@)CED[^.)PXU>7F,U]
MP/CP&!JR03J+:#8953?7\@JI8\4V$FQQ;YY/MG[H%%XJQ]/2+RSV9GXN0M$-
M $V$78H3"6"/1A^ RZT@RC?6I,@&M*]TEV'.RMFH1DO#HME&5[1XD)^( B%]
MH-*RC@WI%T.O&Z8[(;(3GC*@OKK(,3FM.V</ 8);L4#N11$-?';:+/(8F%I@
M./QP4;9L G5N=JMP/MXQGEC%4FW)Q,+ WP@8C@\ K9XB7R:E$8NIL0T\\ $M
M.7R2JTUE H7I#20C(>6XE\PT)-8QL26HP^MLZOET\56G#HF,'?J&?L@1AJH;
MDL*P@O3 9<6?]_ZX^P4^EZ2VN9?I-Y]X)]2]FWV+HH.7R" *)_UVJ&Q'D*QO
M[P/B < _DCWP8)*_U:>4>-&PEFREZ!O'>62YOU:?CN4(-C;X1O?8;,LDX#Y
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M6 TSF@7S5S[RB"@@\.J7]U/<8$F?2]Q34_M,6$Y<9-U\G##O>T@Y9UK$)PX
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MC#MA#IWFRDU)5]R6O;&OX[[:*>@.HM_/@+H$2CJ=I9 %:"2OK$+OZ.]Z"9/
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MT%I9$FCU,R]5 -$@0RP;]AU &DGKN.-A9B=BLCL\>FF(F)U=>&S4O%;3^,0
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MODB!?0Q;:PI<AY'WOQ^8>+_!?8WPF4=]K9V!]Y*:';C2#>Q*)GCE,JN!GO2
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MMSTCZ!WF=*UX"ET^-IRT;9 ^XGLJ$&7[ILXCM)<81W&<>%]7'U-"=G*2?%]
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M?YX"6[.SK30+5/("7E [W6.AD%2M-:44(RF[IC=MS0W7$#L]G%$D7:F8IU^
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MO1")(<\82'/UTPZEF*$P9HP%&*8T3"#"0MDX&"'(?$$2'F.));?BM&,CS8W
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ML0%3<@.I! =\$V[Z%]M39S/X30^=G8,Z^IES#T\M,M R@Y[0X+=.;*='S59
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MPJJNHUOQYK:Y<$>>LHHLNW*'M8RV_=7<SI_9.G*]61E[EZ%53(>1]U4#6]U
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MIKUALX5(<)(HJPA&C"D/3(8AI+K[#>>1CUF"8Q0;;TU=+L[<.*CU)'18FN"
MK^L66]4W 9Y.%[D?8Z;.;WE-B__8^_MU)YHS'0I>MQT*P($.!6!KDDTZ3^;;
M;=/.UT3;<I/,F]5>GCN83^SY.1ADLKU!=X#T]Q =/G68+7W[G61+?9KS+B^^
MD&6O/U&OZJWZUUU7Q4KXRK9./.@+KI<^K!N_10$,HX2GF*F?AHE=%2M+"6R^
MWFG*6_U"BM]%59^1#BV2;3L+$?8%$T+ 1+ 0HC"FD#*&8.2Q)(Q8S!$S"BV<
M8 XF:7+1B0]E7L!2*0 >#TW*7\:=%3._:$2L1[8N^J7+,]VXZB7N6IE->PEW
M/M- O!QY4;:C3^I7#81FU],:^IB!]7^:IS0175_)#QW6O2I%&V1PEZ^J;+56
M+D.;TYNOMHE=RL=B 4DP]!DC$"'N0XJ)6GQBGH8I2H*$6,5=#1=E;@S8%0K,
MFH#*BOP HE$&O**-.C]9LM\%\V1&A-.@/S(G=L"WD:Q*#?"V [[5Y*<;L%4&
M;+49)2'O<E!=E3,:+LBTU8XN!FRO&-+E3QQHRV]C+#^*ZM=5(<BR;K=3IPC6
M*=(D6WW(RR[()?6C-."2P1AAW6 MD<J,U"5I$Y2D!,LP"8U*J0\58&XLVK/D
MOPRUY&WGP-!H'!'9D1E2!VW?O(C_U:*"5UK8GU[VPSEJ5-Z3FF3=;\@/Q=65
M=6D[_+3FY4!P]NS+H<\9WEWGJ[IU$7*,:.!3B)'4%;<YA:FN)BD)X[[ $0D#
MXT"I_H/G1EN;OC%:./LF.C56IVGH$@3&=DJ-E!_4*Z>OZ44]<NH'3=X;IR_^
MH9XX+WY_G;;BO2"GG:)-;W^(@F6EN"\R)C[GRZ5:#/2-BYA202@GRF;A@?8!
M V6SD!!B]6DSZ@7<9]PJ]V9R%>9&'WL%T3K!_Z__ZL?>_UV+/VT#\@&OA9D9
M->_)GN)PT%'[\AX0!RKJ=6" &HU1_-SKS>1,^I\/4. ?JCWZ\ ERW3W] DD&
MKJK:&Q+\DQIDI<=[EZW(BJGA/RL3^DLNB\UOWJ^X^/'E#_*D?],ZE#+F(?4\
M"H4G(XAP2B$A(8,AIT@$<8 \L[(33J29VUKWY=.[SY9KV4638;@L307QV"M,
MHP?8B LVF@ M,'BE\?^I]_M:'Z 5:BYP[^$[P=85YU\DR[3T[0*V/29V\M!A
MI'I?Y$^BJ)YU0]_J=L7?_GV=/6FJ_[44<KW\D$FQH#+""?,#*#WB013X'B2Q
MQV$D0YDDH92$6U&GP9AS(\A.Y!OPI(6NH_%%)S98UW*#I1+<CD5-T#?C2L>8
MCLR(6SCO-W!N)+X!C<S@PRD\K1G/ B%'O&8RXJ3L90'!+D?9W#KP %SKL*J:
MLY_/6?G[:[%BWW3 2IOT@](D1&E =% QALAC$4QYS*%(HA0C/R:86O7].C?@
MW#CHA;Q "PPV$@_,NCJ+N>&1M4,DQSZ8O@A$^W-G0V1<G2Z?&V[:,V1#Y?=.
MBDWO&T8T;X3,5MMZB>KU^"BJ^SH(/V.;X^BRVL1MT(3(()82!E0HUU'Z&.)$
M64*IE()('(4\)C;$8RO _(CH\2E?Z4PV73!'UUSNA%=_697ZP]+BVU&1]:R8
M4=.86(]]A-.(#C:56]5O;U["W?U*:P!>-1E!;@O&78JC(V*S'GY2HAL*SB[Q
M#7[.Q,=4VOBKGM^OE!3KIE*=KDSW]1M9M7N#'_-5D^>D=__>=4=4. ID$G$8
MHHA!%*<2TH AF"2"IGXB:8JL,E"G%7]N)-P<1U##8PMZZ-BBP0'T@&BK458*
MBNVAQ@8-]=>UWG+0K-]FL_VF$0(M1);&Y\2OW\A'8:._5/,_!ION?9KN7.RB
M:;WVF=@PX?\QSL,NFAAG9V&72>'*?^E*P+];5^NBBZCM"L'KWL1?U9LH%CY!
MGI!$0I'J)#6*)"1IP&% O)1BCT?(+JYUJ"!S6TK5!Q==ZJP83L%0I\4]L%=Q
M7C;=*!H]MK]M-&D;J->ZC.FZV*$YF@MC*,:571D[L,Z[-);/&UC<*UMEE?B0
M?=?AM)5Z,74IPMNR%%7Y"_F/O+C3-;<_JO>W*^\EF,^Q3"'UF?)-F$00^]B#
M,O2)<D[B6$96X7.6X\^-$1OQ82T_V"H &@UN0*T#J)4 6HNA1;\L9\F,/4?$
M?F32= ^[?3&P8>"Y*@=F.?JT!<&&0;-7$FS@8^Q+^FS;O^9E>4>*XKD-Q"J_
MK*FN8?TUU[42&EMWN<S_( J'!4K]@!-E%A*/<H@"@J#Z20(Q]BCB$2=^9'3,
M-EB"N9'AME7R4FD!6%^-&U VBH J!W*M?-?OG3Z = J9EXP9-F.G:7&2>1B9
M&'O=JO44W+V<@B_;*=AH 6ZG0M^\1L_HLS!169Y19L.J#,]%2)ZHO#/LN9,5
MV[E([7Y]G<L>--O3AITXY+^J1U=O2"6V!;52CT=4> GDW,?*SB<4IBS$,(Q0
MC*(T"'@0+9J";%\J4E2S.8DXJYH-3^PJ.!Y5;'(@2)L#\: %!UP'M4I=FTLO
ME^)%X@0@%?A_R&I-BF?@@U?9"O!\N21%J0OE@5+C^-/L#AK.OWF$AB21)(!I
MA$*(J,>4624H#+TH#0,2!Y*D[9OW=L7_,[]WG7JS>^O>"%:'U(+P/]%[-YMC
M+Z=OTG_&P["]?+$:(J Q<EK'<(YS_H]S4G9>I?]LYV?&DWB%4S5SV08:K<J7
M:D1=E]E*E.47\5!+=/LC*Q=1PA$/_!A&..00>13!-$4Q1+H!(O5DXF-A%=%R
M:K2Y;8MTLH'?M'2VL1\G<:611WGD19!1I*UT&>K-* *ICYC@?IRFC-A5TW2&
M[#2U,T?$UM ><(77V NU(5#VBZ,) *Y6K9-C3;N<F*B]Q_-&-PT-=J#5FZQD
MRURWS]CV)Y7,QWX<2DB3,((H00)2ST\@DVD:(B2\B" [BC@RTOS(H2X-=;OB
M.XT9K&MR'8/6-$;A8KA&#T%0.&U%!+^-TJKU# [.@@<.CS)Q;,!)5?>/_D]?
M;GF@550Z"8VOF>*5%?\BBN\9$V5[,AQ)X>%860RZD0U$$J7*8A 1#!/BDS0F
MG,K$Z-#JU"ASL\!:0>OLR592RX/XTZ">.5=R!=7(-# ()?/3"!,43I& >D"/
M -2_MA__Z6=/<^I@HM[F9,'HXJ'-/[]\$\NE=B3)ZGD1\%C$ 1<P%$BG9'$?
M$LXE#'F,B P0P<(HE^#PX^?VH3<2@EI$T,IHV\GS!7RGO^S+01GYD[;"8T!;
MSD-J7]"&\\7C)FZ[>4B5_3:;!Z\:')TLBD+'MARL\[L($R03WPMA%*,$J@]5
M-^P5&,8^(W$@L$\C:1F$?&J\N7W*G;C]DN2;4N1=<7+K8.23B#,:\D#0 'HB
M5+:12"-(2)K ).28A@GWN>;*O"++Z1'?C#H>XE_U&( ?P'VO%+Q;W$W]*&=H
MCNY/M1">*NKN-&S;!!AWT=DG1YLZ"-M$]0.QUD:W#2-V]=1"D%*\$<W_WZ]N
M&2O6@G_("&TW(!9^&BL33*90)'I'/$(84A8G, @]Z7F)E"0*[+9E3(:=WQY-
M*V-',67M?>3U^=]R*[<=WQA-@!GIN 9U9.;IQ 6O.H%_4CP..I _&"!J33\V
M$#GB(*,A)R4B&Q!VV<CJ7E>9<$T<];N\T/]H?ZY/"UG;B\J+PT2DA$$I="DS
M#T>0>D$"/64$\<!/=,,<^_@O:SGF&:SU6CQDJY4.AMD&R>C<7%WR#)!:HTO3
MY,[-CPB3,,&^A +K,M9IDD <!@(B&@JUI$@_I*%ME-0$LS-^2-/;)DKI:A-C
M;,R.!_7(BTPC*9!Y42<K@DY8W8MC/Y=QS/1$0\Q&RTL\-_Z5$Q(-X3F?B6CZ
MH&&+DV[HP?*'E6[IH6SQ[OG=<EA^%N5ZJ6.PWRF=[Q6+%$VE%W7M?5YF=9S+
M GF4LR@-88(#7]G3B0<)]RCD@?HS#I59C>1B)1YT$Y&OYILF+F0S^G1Q\^GN
M23BFE]KJ  K1]-6I<O"D50#/.KFXY_\_=:K8D:>3B37CT\GF:1J*[:M3;Q_T
M.;8U\3<J <T%H%:J+7A5WW)_=M*L&=@ERHY(V8E(D_*T2Q!WJ=OILP<& K)O
M@J^7XI/4^3"LCF3\)+>KR%?=FFL;0R%2'R.=8A*@,%5V+"8P]=*:O%,OI!YG
MPJ[:O-7P<]OT[J37-NM6?OVOVM*Z'6#!6LZ'&=V.A_+(Q&H$,/BMEA^,$@8S
M##I7 71V@T\;43<(F+T0NV%/&<9U'X1ZIMCF"&J.[39MGKM*'6_6XJ,:[^L?
M8OE=_)*OJF_E D?8IU39J$E",$2ZO08-0@D#+%))I$S#V*K"WU!!YL9_ZH4-
M[>AM\!28$=T4P(Y,>8T*-Z"7C*RUN-GL!C_?:,N?"G!/,MY6%OJT<I@_<RF(
MCLAOL!B3TN"E8.T2XL7/&[KC_%TL\R?MRK)OJWR9/SQ_UADHF];! 68,,:2L
M/9) A$D(TPC'4-E[4<P0QEY@U8K]S'AS([J-N*#:R&N[,WD:X!@%/&+"A[&O
MTVA3W>O>5R:V]!)&F"]]GUD>,#J$>*KX[SV0!\1^GX;9=+O7&72CQRYTF&U%
M!8VL(S17,L3%V0;NZ=$FWJXU4GU_<];LML'5X'1#);+<IA36N5"<)@FBE,$T
M20+=481!C!,.N<<#B7B""8TMJ[X=&F=N++T1LY>=/"C3[!BN9NSA *V166,(
M4$,JKIV"P5UEM8.C3%U![92J!RJEG;Q\H'>;KQZ^BN)1IZ?\0JIU44<B?!9/
MK=&HW.HB4\,^Z7&WE5M#0I+03V,8!4Q'41($*6,A] CU?)R26'A6N;[#Q)@;
ME=B7SAT(OZ%?.SJH8WNU2@&H-0!:!5WQL5;B>9S*N)?!Y<I_'2;$M-[K14#M
M^:Z7/6UH>[6N:<\GV06*?B4_>L%8VWY'/L-1C ,88.XI'XNED":40Q9&B>_C
M) JH59UP\Z'G1F^'HO5[\9M_L>VV9CP%9G0W#K C4]S+[E$;A/79;D_P49H8
MV>/EK"^;\< 3=VBS!62_5YOU$X;QUY&MOFVXSJ8*P2>Y,1R[T]^W/RK=F(PN
MU8UEM9 RC1!))8P%EA 1/X)8_1OR* QE&&#F<:N&;@YEFQL#GMI>W^IW S8:
MZH]ZZS=U2H+?MFH"K:>EI^ER]LVX]4IS.C+YCC&=;U?*-6N:-3KDZA'P=T3F
M+B6;E.U'@'1W.1ACB&'KQ7[]6IV3_EF4HOB^J7 @8TXX#01,D.0ZR-R'Q$\8
MY''$0N1)' EJLQ"8##HWAO_R]@YTX04WP ^@AV\.56YN<I@Z709V?#":%3."
M=HWUR,P[%LS6Q&J#FR/&-!IR4BJT 6&7XZSNM2]R<Y>ORGR9\7J(]XHLN\_"
M(V%,&)?Z,%E9K2R-(2&20)P@15>^'WDL,*UQ<VR0N9'3"SE!+>B $C='(3W-
M-*Z &MVA'H"158&;<R!<4-_FZ*,G*V]S3KE^=9NSUP[=FUO5+O+?LNK;W;JL
M<F5/UW%]BE<V-M1.1&LH?1^%0: ^_Y!!A)7I@CT901H'*/9Q%"6AE0\[0(;9
MD<4W75BVU*G!G39&N<'.YL1TUVY4I,=GFP;9/Y3XH)/_9HMXK<K-_@PH#[.Q
M;)C(OM>!R&/&(U\ LK,]/WL))M[\&PS1_B[@\$?9UP-[T[:YN>]R;W7%YX60
MV!,TQ- 3(H8H)K%NX2=@E(I04AX@DA@5%CHZPMSHKA.RRXY28M;%XLTK@QT&
M\C2+.8%G9(ZR1L:J1MA)[0>5"3O\Q,DJA9U4J%\L[/2%ER96W>6E/D7X+*JL
MJ+>(='K#;B*/3U$<4$%T!JP/4:K^AE/,(*<1(9@*@:55HTZ[X>=& ?V\GUI^
M_9>M!G7VS^#$*J/Y,#-YQD-Y[%T;$X G2JRR@<YY8I71X%=*K+(!YGABE=53
MAF8/%,KTK;+OHM?;XJ_*?]1MV%X__ZO@#]GJX;/.6]<IJ]^RI]?/33&OS;;Y
MAS;YZ_7SH8=]SLK?:XD7"66,AYHG)5;6$&<84IZ$D*28D(A'$2-6.]O3B3XW
MCMT*VV_F<P.T\N"55O^GE@ L]\(G?!O,6'J><SRVK>A@>@<D"$R-M+-<@\D$
MGSAM8>H)V<^ F%R"BRLA,.4.K.LB*W6#)AT+5(AO^@Q7#ZQET\+O6(PDC9,D
ME!SZ,DP@\I,4IM@/(/%#$I. JI]:K4P7RC.WY>9%*O]6H;9YW N5ND*L#4L-
MKI\P:!9M[?[1YV9"1\!J6J:JNG )ON[+, R2YEIU&2Z![D2AAHL>.XR;FV(0
M"X$"$7'%KB%" 40A%I RXD-$L7("XIC1.+"I^-T\UHHI)ROL/:3\80N3[X4X
M\7$(1:(<)91P!@GB%$I)!4T9)3BRVDL: -,$"\J0ZCHM0&8D;Z_VR%Q]1F-K
MEGVIH".R;!\Z*>>]5&27NG9^:QFY\OQ[\X#WCT\D*UYV[?QKGO,_LN5R^[L%
M0=2+&9)01DA Y 4>I'$:0@\3#^FN31Z/C()9[,:=Y<<)LJWLAD$MEFB?_I!'
MQ'"*+QWTQ+YI#3(M.>A$[UTP#KR\/1>IO:]KP/Q"@'\$N,W#CX:!UI"TNKDF
M7C\(_2;BR/)ITP0A#5-Q$Y<T\/9A%N9;4N@*X>6]*.K>S9N,-1+$'B$^4LZ\
M[MF;ABFDD? @XB(D*0X3+_3L"K,<&\KFPYBF(LM']56(5EKPI+Z'4LNK745E
MY3_F*U!6RK:WS!8\BK295>8"O9'9NQ-1'].#6LA1LO[.(>'(H#LZS*0FWCEE
M=XV^L]</;A9S:&>RJ;J2"!$PQ10XB:G.OJ,P]0.IC$"?*E"CB'I&II_!6',S
M]]J=H6UV52?LH/(KIT V(PE'T(W,$X-1&]+TY1P>[GJ]'!UIZA8OYU0^T-GE
M["WVWF-GJNB0P7SU\"'[+GCCDFZ-EZ^BK,K[?)FQY^;/7F!00D28! 3&DH<0
M(<PA216K^![VPDB$GN1&E?<N%V5NI--I<P/>*P]A]: 3[)HLH[K:2*T=V#7M
M0:V?N;MTX>R==U"GFY.1V6SC)AV:@7)O"D"C"?BM_;_).8+KV3'W;Z>;I8E<
MW@EFR\H7=@/P"??XP@$F\YC= -%WHAT]T54KLSJF/J/K^KC_]?/;QZ=E_BR*
M!2)QRC'V8.Q)M= E-(8XY '47C:E4<)#;'5J83SRW-:U3B[E9/?DO;01UC'8
MS0SJ4< <>4$ZU-[JIM\XH$WFZ90 ]!ET:HS9!NL,<J.UOSHV[I7;7IV!XWR[
MJW,/&.KIJV]=L>)GY0U\^8,\M06$$0MCW]/EKR72C1;C&%*?"$5:C/GJ1RRF
MS+81[*&!YK<9V,D)"B4H*)6DME[]04!-'?I+01K=EV_1T1("+>((]9=/H^#,
M@S\XR,3.^RE%]_WVDU?;N^ROUZ7BF+*\RQ]IMJHM<9TAG?&V'-#7@JS*34_J
MY5JWL%07J.^PTD[HQ[P2Y2*.)4I2ID,! V7/2.1#$N(8IA'S(H((0Y%1/* K
M@>9FYMRK!WW3G=&>BHS5APJ$_7V=M6VM;G1IPD81;0=UFH"55L7<070RD^>=
M^*GG9V0RZ]0!/7UJ8VFK$>BII#=@NKGJ:04^7F&NS%WZJ>=L(L=^DKFS<NU=
M GW"P7<RS&1NODM0^LZ^T^<.#*37YVVO%;-S'1HJ5F6SBUX4NHI%?8S_^GE[
M3=O3YO8/4O!/3S7WO_TA"I:5HGR_:C)R_R9TSP3!;Y68Y$%TO[_7"\<B"-(D
M]F@"?6680Q3@%.(XQI#&2.I"9PA[5LVYIA5_;JMR)RL@C;! M-(VR_0-Z*3G
MX%6V CQ?+DG1"PZP#=>?]ETQ<S;F^P:,O.[72L%:*]!7'?1UU]LD_0M;_4$-
M@.Y;UMIO&Q!TW9H&AANP>;U:)#97@1H+AQD$5YE#5PD'TPH_;7["529F+YWA
M.E*,V[=2E]1_EWT7"P\C&O.8P3A@""(A D@$#R'GD5H5/1%0WRH2Q5: N2UJ
MZ@-+QNE3N8'<;&49$\B1UX9!?2FU#M,WIMQ%;^*&E)OA9]F(<A><H0TH]YXS
MC-L^BNJ.E-_NB_R[\E'XZ^=?2^V9M#645P^WK,J^UV7N%B)*8S]!##+FI1!1
M$L TU65#XR1.O"1!"8ELLK_,A[;BLPDRQ'1<+E.B*YN\D5W;9*_69=W0XR<@
M.PT V:A@1W\6LV)&?.-@/3+E:9BUU."^#_.O'<P;X<'M>9BMR<X>,4<T9S'P
MI 1G#\@NM0UXPL!T5<;R]4K39QU,8=\ Y_@#9O1Y;(4$G92CQ+F?!\-5ZN+Q
M@:9-9SRK\%Z*X_D[+CL%?_M#.TE"=_9:!('$*:(<2JP+4H:1!TD4)5#@B'$I
M/,X)LXMSWQMC;@[$YG17-#+> *ZD'';^W8?2[O![($!3G7R_[;!Y<PJ;P8?>
M![1W?.+='^$JQ]T'5#QVUGWHTLO[AFZ6*4DQHR%-(9>,0<1DJLNL<1BG49#&
M*/$B9M5!^- @<_O(ZRC8:MNC\M<56Y*RS&2F##Z#A<T<7</-@@LQ&WM#8*>E
MIRU<%W7U',D".#C$U3IRGEOU3UX[, VV"9X3=3TNP7M5YN^:/D>+,* )#2(,
M6<1T@8-4E[GRE#'@85T *V*8&>6C&(\X-YI0ME:Q5J\XZVT<6V; G@79C""<
M0C<R6W2RPJ(1MM_ X :T\CK,C36%QE62[-GQILV6-55_+VW6^,8+"CF])NQW
MP;\(UG8(;B-!/=\CGA<P&,F(*K^"^A#S1!&-#$@J8IE*G-B%UIX8S>;3F":^
M]BXOGO(ZME:GY-3EGR"M9:^=#5!N-!A0\^@(Y(:[$6Y@''L[HD:L$1-LY1PA
M#-< #Y?%E(Z,-'V%I=,J'RR[=.:6@0%&NNK$MWRI[BC?_GV=5<\;RSI$). D
M(3")B+). H(@T=T/TQC' 1-IP(A5B^_C0\W-+*E/JUM)_PF(6E;+6)SCL)KQ
MA!NP1J:)OI#_!!HQP6W59)#4%2VK'-P3O=:-XL6<!\E5$,GQ@:8-^#BK\%YP
MQOD[+JG>H:M3OE-BZKRA;+7.5@_M::=.'Q(R+]HJEE_)#U&^_:$&5F-D*U(\
MUYW1=,]7G7&4+]5(#]U^S"(2ZK^0>C!A2#?PT.F+ 1(P\FB:"$I%I O3FY].
MCBCKW(XS-_5R:*V1COS7=3$JK=.0RB'C3#"6<4!UXZ6ZR#/B*86IC$+(2)12
MBGT12F2;^36+*9[&O-U,\JME73YXUG-MNB\_B_D;?7^_7_59\SO8J@JVNG8S
MVEY?J]LT7]^J!SK]7)>V&742G);&&4?2*Y36&17RPZ5YQAURX(ZIE()5F]+7
M:FB=AOA9:"RS958+]TY)ECVL7ESQ)E,W:BLS(\L%YZ$D2$K(91!!)"(?8IK$
MT/?2,/"E[P7,JG> "Z'FYN"T\O96#$":9.02Y'6USDI7ZPS\_V:Y&^MB @TW
M;">>EK'W=#MU>IS?Y#^_5.D&='.W>UU?L1N=),#<[@([Q-O51K$+D:;=2W8(
MXMYVL\MG#]Q,$@\ZI+5MG!Z(*,)>1*$?R1BB !%(8H1@X@5I)!/JAPQ9[1_U
MGSXW1FV%L^T\?Q@YY?]Z--&5SI/8UQ$#$4QIRM0ZY@M$<<0#G]BY1X.QF\:A
M:<5S I[A_MI00,;>4C-^C^QWRPZI[&J#[,6SI]T3.Z36WC;8P8LN;6[550-K
M&NB%J8@IC0FD'A40(2^"Q M]Z$4QP=0C(@SMDF</CS,[YNMU/=I4PAO4[/ 8
ML(9?].5PC?UM#T'J@GY/!W%PWL?IY2A7ZL]T4-7C?9<.7^ZJ*E_G#>MNL0LO
MB&F@EG-(0X]#1%)E!6%.8!*$0EE +.:<+U;B08<(?+VD(E]_5*.7'C<O_=[8
M8VY_M>&M+#^Q;34$Y1 CXC.%,HGTB4%"!*0TD)#Q6'"&4Q*1X+*"A];P7B.D
MVCFN9M3K#JV1&?AP&<,-?'>GX'-0K? 0*J.5*'PQV)7K$AY2_'PQPH-W#2/I
MNMF)WK-L(J]ZL5AM]$[DB\A/L%3&F_H#)3R!6"H+3CE;7BQ1P)%O%8IY;L"Y
M44C3HV>U$1@LMQ+;,<I9J,TXQ26 ([-*@]U6UGX\Y@@A4Z;(.&*6L\--RBVF
MRN^RB_%]E_J$ARM=U&$8;;F+?R/+=5,BHRS7C\W/=CKGZD"'U-/T$U*BC48)
M4Q$E,)$2>5Z2(B^U8B.WXLV-N_I^U3N2%4"K($!/_J%^J)/)M'5?IYZB";W>
M$[6.:OVV%8\V*O:G<:(^R2XGP+F[[42X*WGI+H$][MP['678<G"X<J#.*5;B
MO*@AV"^3=/=-__7]ZO91)R!_DL=NZ2)):8J2- T]R"/=PCD-4IC*4*T702P9
MCX@(>&BS2DPB]=P6CZVX.X4]^SK>@$9+77ZMT5.SV=%;AR8X3O/:F*U'LWL9
M1EZFCM9ZO<;;8;UX33I;CM:T:62>=*F;=!IV5\!I!Q^V,.J:,;<KKO^GH]&_
MDZ668;>75"CBD"4>AW$225WS/848Q0(*G/I^0 BC0MHL;$:CSFYATM62>N+:
M+25F0)LM!<[A&YG*:^1TXM\NA#>CMMX:!)<C+C4;<U(NM()AE\OL;KYTST;7
M+<U7>H1/<A,;U58%:?>C=WQZ/T2)1Z,81H)1B)@0$!-=P8>'$4,L#'EB5=/C
M EGFQEM]?[\N#U9JHT?FQ8MH]J$[,O939;O],NH$3+C7LM5#_ZL7+=KJ EZU
MVOPTT;;*8&"=[Z'82W*E#9/!D!W?'1G^R$M9]HTH%)$W$:K*F*P;>)3O5YL>
MP9]D6SV0+._SIG6-WLVM-W.WGW/,0NDQX<.(2 :1I *F01S"A-&48\DE]:PJ
MICF6;\YLO%40]#347NNV;;;>0N^T!)V:-[UM]:'$[6;V;<E\\CF=D."=3.=$
MW.]T'IRO!VZDN](:X13:X^N&VV&F[H93__%5C:J<"AU:\E%]8VV\.*<T"))0
M0LI3 9'O84B\)(!>R$*<R#A"PFH7?0PAY[:J=*4>M,!#@_;'F$O#Y>'*,S3R
M&M',BI9RC"2"$;&[>L>7$R+^@_1U.0^RN^XM!F-=5CCQBRB^9TP<EO"C;K16
MZB8Q6HSRJZZMT?^]#AK\F%?_+BJ= O>PROZWDK[N+O,N+]H?Z>O\A1]3'\N$
MZ[P-'?J'*:0!\76;48DXCX276-4YFE;\N2T-+WI=Z7ADW684/(L*%!M%;G2/
M,Z5*O2NT_?&PRH\3O25F2\M\YWYLQ^109,^61.KB%8W27<"/UE*WQJS?C<^]
M=^-^^V[TE'5?SW+:.7)<'',BX:]2:7/:B3E6MG-B*2[PB.B)U;M=O.GIUFMZ
M"V"GZ=IGH5?RIJ-I??*[)DM=(-E?T""D*:((AHRE$&'?ASB,0XA)2(D4H2!<
M6#M,T^HPMT6SDQMVG4*+3G+ MJ(#75!]TPRRWK8A%7@C6!W!#$*_;B/Z+$A1
M#FD=.O%K9.&KS??EF'!5/=9$U+*'J$;B0._0#1J@!P?0>#CV':\SERY=RXDU
MF-[SO,X4'71,KR3*)24QOY(?FQ@J]MQDL*<)BT3 ?,@\79.*,@:I\BSU"AI$
ML0Q8Z%DMF4='FMO"UCMV[HDZK#S <7C-EA(GH(U,^ /Q&ECI[P063NOT'1KG
M"E7V3JA[N$;>J1LN/0U_IQBH$A^R[[IM7J7>@4P]O:[SO9L_1*A,(T02B&*N
M[.W42V#J>0RF$181$P&2,AEVXFTLP]QHY<OZ\9$4S_IXL_HF:M.(K)[_J01-
M*N96&=!H,_30VGR2; ^F1X%^PL/G1GY8*["/]T2GRM8@.C\Y-I?@2J?#UA =
M/P&V?]0PCORL'-KLNW[B7KSR_T_=NS4WCF/IHG^%$6?F[*P(HS= @"2PSY,K
M+]5Y(CO3)]/5$Q/UH,#5R6E9\DAR5GI^_0%(2J(MB0(HD&8]=)?3)H&U/A ?
M%H!U,86$*"4I0-REE!." *$+!1A!1&F*F#9!Q=A/=S4UQFNJ4JZ3O<AAI-:!
MJA]WQ<%J8(K:"SFLC_=Y,")134='HS+*>85?$H?'&_WXX6:U5(]R%\+_5!41
MX_/Z>+7Q9)Q1[JJ6%!RD0KNBBT4.F#NN5% 8HB7GE 1E ?;I=&J<84> S^>)
MM+OD.Y<_?*$#DP-Y(>W''K'Q&YA'&G%WF3R>DD;@W?54(W,\2@E!*!*Y>'4Y
M*LV$@/"2<(+>#:.>]=._9I_UXVKY=L47)9\WF6P4+U)%F+5$D&2 8(D )5J#
MG#*CB( <95X[L^/-3XU.*@F31D0_(CF!6S=E7([&P.3P#(CS"7Z\OJ2EK#PJ
MJS/. 9%YUL]K?RK>%-FM=TV&]IF*X%"*445R)UX:A<ZZ!=X2UYFGXL5;K%LN
MNSN'W77;8U>OS')U;__AG+D.''D_N9&Q_WUQYB$S25-"!. %58! 3H' AH,\
MQYRD:493&I;@>S31IT:MQ]WZU\_\^O?:O_#JWP-0!;T>\_??HG!Y\,9 GU+H
M\=F4/I 13]V&_#9&CP09=N0&#!(92/!7CQ\9=D!\0DL&EN""W*'NBF&EO]L]
MQ*["AJN@5%=*LAOM.5^O2U/6W:\_Z\T7<\M_SE0NE! P!]P0NT2R7+B[FQ1D
MC LL<UHP&>1;?($L4UOSOKS]V".Q:,]Q\%M?1D)WX 6CO@-[IL8V_+LN/'>U
M+2]WH,U58O5Q2XC5*'+"TLM@C9G+M*<DXZ<YO0RRHQE0+VRR'X'>KK@J%W?[
MRM7OM-C,E"R*@N "%#1SU]HT!Y09 F0JI<ISRE5!0ZCQ:"]3([U&R.2>K_ZE
MZQ+)?6O1'T?5C^@NQFI@"G/BM.K.7R6-P/$XJ1.!2&QSO(]1>:13S9<,T?UP
MW^H86]MNZVSG(L::<$V.<@4QX0!KS@$1K #4" PDI)G.&<<Y#+K.[>IL:DS0
MBM[?"MLSDK838C\^B 7<X+30 [,>=1O.@Q&M:D-'5R/7;#BO]&'%!H]W^M&&
MM3P^5A$V;@/X=ZWN+"\U1^48&B5DH0'3TI(&T090"A' HD@YPXPKQD-(XW17
M4Z,,9YOO14T:6</(H@-8/ZJ( ]?@-S3'D!J@%L-Y-"(Q14='H_+$>85?LH3'
M&_TXXK>5W;G<K):FW,P$PAG6N:N3Z:YC!4Y=^18*E%"*R(+FC-C-A(O2\R.%
M5MM!++#K8;AONQ(M>:AD"YO[;< R(S."B  9X7;W19@ #',-%.?(X QB!%4(
MB_8%; 3:C .8'SOVA&%@.JP1N.E&()C[CN@:B>S:+8_*;D=4>DEGQQX)XR^E
MR]G[Q:;</'W5=Z5+J[S8N-P9LQPB:\$H!"BD*2"<:< S8ZRAPXA *;3_\YJ3
MISJ8VL2L94SV0B9.2K\I>A+$[GD: YJ!)VL@*M[3]ISJ1^;N6LN_W2U__&_[
M:CUM[0_[V7JRP5&F[#EUMO/V['.QJGXZ#S.YT>K#X^9QM4VEV<0EKO]3\]4'
M^XG,4I8JC!0&BEEKA5#- #6YM594RC*H"-8LJ+)33SFF1@7VH\HO+5SI-P"^
M!R*#PSKX6<FQ4I=;+9):C?U?:T6N$J=)XE09L@YF$):#%<CTD^*5*V<&076^
MI&98<^%.LM4E4WVOI&N/VVU]S8SDA% ,H'&W/1@CP)5@(,])@0TD2J1>1[U=
MG4R-U.J+V+*Y>FU$_27 #[\3490:+.T6#M#"I2W+L#44$24 Z0))DADJ)9O]
MT"NQ' O3=F=#H_JFAO67I)$V%JK=RT,LI ;F_FT4[/,/KX>G\DF8_/V58\ U
MDM=R7]B"_)C/X='AS7SRU=%\FL\)W_9L/OMLV.I2A3^NGF9O/\\XEBF&"EJJ
MXPP0HRNG*@H4U3SGN25&XU7L?=_DU%:.MW__^/G:;YJV<.GFKG[:#LQ4W8IZ
M3ZQ#W3IVL\W#M='8_&-O+[::&F5:'8J^G41'_M)[KZI7*ZUN^<]MN/;/[>^:
MN*BO>JU7/_3Z>J&:L*EU-7]GSJ$_I9D"2$D""%<<,)QJ(+"&&>2XR'B0E\X%
MLDQMDM;+!7<BV@U5PW&!3CR7#(WW3G8,P(??S5825YEQ:CVNJI]W?WB_M0.W
MVE0.[UM]KNK,(%$WM9?"&F]CVUN2L3>WET)V9(-[<9/AF]SWQMA-],Z!TO;Y
ME6^<]Z3%H9R7E97Z8;G2Y=WB/5^Y1&/KK_J!;U;UGVZTG12+S4P:G6K%,. \
M3>V6N"! 2"D!SE2J6$8A9UZ^X?%$FAK#N@F^TG/N#JPV2_OC7F+GI&QJA1+=
M:.2_KXDT@N<WB^./R]"W$UN%VA7%G$[)<Z6NDD:M9*M7TE:L"J-WJHT^9OX[
MU_'';J1][FAC&+0QC@MWQS8Z4D>C;;KC M/>HD=NN=_NY$C9XGW.[(_*=E":
MDN]235W+_WXL[?)NU_-MIH?2KN[KM9TYRCD:+>PG]C3C7%O+'#&[I&J[N#*#
M ,^1!!(SNW^A&80DJ*K/(%).;;W="79QV?H((^BWO7GU<1EXO3U>EGZO8M+6
M<9M];ZMEM05JZ9DTBEXEYT<Z1@GZ>",Q7,GY"#*^=HGY>#![E)2/V-E 1>!.
MU2O:E:.K!-HFB:[O0]^5/TJKCG+KWRS34"-4<$"XS '))+-KATB!8!G)<FW_
M3(/"4@:7>&KKR,[+0#5")D^EG@?6]QE^G/U6F$F-WL"K381Z ZW2HBV]6YXG
M6]6K'<>(A>EB#=-85>HNEG=:)>MBP1]<ORY:QS&7J^JWZ^O'S??ERJVEOR]L
MB]\V2_FONGJ!\]795C#0-ZM2ZJ].G]\?'O2J^NE3>5]N9C3+F-2(@(P+%T/M
MJI@6K !"*\VI9,C(\%(\ PD[M46J*1.1Z$9PNUH]KER44%V;[FKWA^3!J914
M']15\NBTJO^1S)U>,5:U2)_#)0O:^(,\XEIVM")=K=>N,(Y.*JV2K_4X5XK5
M_T@^=8YSI*4J[@ ,NDI%$G4""U1<T/W6ILA]]DRB;%>VQ6;=N'.97.(\0P)
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M(\H0)J0$)N<:D)1+(#)7'B9/LX((H0P-BM@*[']J$[P2,- 2"87<;\(/".3
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M4*"(+SH=H2-GFQ@MF,17F79XB?<[H]3"_5#^T!_*M17 %9Q<W]IME^9FXUS
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MJH6M;6]OEPL7^:47TCD6[#K:7SLR9J!&&'#!#"!2%H#IU(!4::XA20W/@[(
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M(E:O"<(EWHU81U]CWXB=5_O(C9C'2WUC*5HY#G9W]S.D,H:ID@ REMN]A"2
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MH6]^TX7[&.K&OI;K?_WZ]*M>R._W?/6OZY_E>L9@1EVU,D"$S  Q,K6;4%8
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MGCU4.5B^;?AJX[?6#")K"%6]E'A UM)WY6)A)>Y9ICSJ:.8LI6FA$4 ZXX!
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MSLY?.9&P#S#G<P9[M=+3S\I:;>7F Y>5Y]:[Y3TO%[,"8Y4I+ #CKO(8RE/
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M68@Z^IH:)[B:&+).OBI;PEXEO#OT*AAC/SZ(A-S0)P06M"9C[=MGH,6.5_.
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M(=*$/]')J'.^6]&7T_[,TST]3.NZXM:&<$>XB[O6=NG3+C0-8H4%RB%($2D
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MY'S97KA$3BIXJK=7R0]X1O53J?[.O18IWZOS9JQS!L[GRS]=A.4LA0R;5&9
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MZ@>PSD7,B1091#E/(*8QAIQ@ ;E2'$4QCC!S:E Z#-)7[%S?P#\8\*??&\/
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M7!T;C2!."54J85RDW(?WCXPS-0;?F@E:._V8^!B<;IP: *2!V7$?GP'4)L[
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M6R%0IX0#=]\^"XQI%%O5C#Q+K'2&2LU/*(&$9X)D@EME(Y^WP8FQIO82>'N
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M"Q.:9&G,(45(0IQD G+-E>&/2!MB)GDFI5?E17OGJ;%#:YS?R;A]P!Q+)OK
M,$9QA L"_A40K[WM7^NPO=.X50VO'=BK7]C[@/_.V-W"/-%"E>67=U5IZ>XL
M0G-P82&//O)M3X.,1W%DXJ@X5K:951K!7$8,II3'49[Q3'"G6H4PYDSM$;];
MP,8E\*5Z\;^[:>0V.J?.FB-+50?+4V\]]WV5 /-Z?F=LW-D:F(F"3E2/DM<
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M<90P2*7D,!7<+*H52E7,>J1J1W1AHNG;MI'X6\OG\[E91HW?+[S']V'@-?9
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MGY[GRY]*-<O PWLIGY:+[ZJTFD5VVZ2L:+[[=[MV^;1<_Z=:=PZ82YTCRJ2
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M(5&L<H[].DR,9_O48L#65L!J8X%JK 7/UMR7 J%R.9^S50F>[2EDBT=HK="
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M59*E#*8)L=4^F3T?J3@4.H]PRE*$N9<@P.%AIL:*;331,;-7GX(CH'J%71=
M-5+,Y8%2WX#K" AAHZW7@UPCU#KBZ)$XZ]BG_2A JF)VNY&%F8F/=D)L3C7.
M<$)BSB&-8_/<DRR"7$IN-Q,4RB2BF7*JS3YP[ZD][(UYH+7/[1$_!-KIY_I"
M*(;>6'1%P?D1/N'O@>>V5.*O#\OO?S-7U8^L^6'WI!ZZURB/YPDGVF?RU$?Z
MKG;$\LF\WG_<;M:/2_NZ_V1FKGX?YR25#!&H4,[M<ZDA)3R"L8IC9INMJMQ+
M7O_X4%-[3&M+@3$5;&V] =;:GBV$CF+LNA8)@=S@*XV^H/581)S#(]@2X>A
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M:EK^J&L A)YHS46#22EO $0OZ7#(HSPE6JL?NM^U$KK4[ILUK\MTD575:QA
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MS@#PS +0F=!S8!=M'ML=*13MUH$J7__:^ VQ<X?28TB=@Q*3A]"Y W4J9&[
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M:C!XO@H7N4(];C$C:ZWF4.#(%4K#HD?.C_?*YTN"A211C&$>1OJX&1%($IS
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M;IZJB7LP#GRKJSP>S*L7HYV!^_NTB;K!3#NLG[WTP1L7_?%*ZPY1[K5+[WH
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M1 P'5MMU3EK,C>M:(X!N766;+. R"&:+W-&A'9D\.U0/U24["_2196L#Z(P
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MX+LB74UUHD/;*$FS-!:ZD@]*=+W$1$)*$(%!IG[FDJ28&!V_#U-C;M376K$
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M@5%.$40B22%E20A%'N4B3T0J4ZL3P=-BYD9O_0Y$K*>GC]Y @UKTS(BD3G;
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M/WXJ\]GI3W^?S?\8?P\ _[+ZC][,SB[FXY-ORY\$$_+VW\[_44CEHXP,C,,
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MR7UDAH-DVI+5317]&D$:,K?19V4%.Q N=U?;"R[RA<+E2.$.TKZ(ZRU@+[>
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MXF(YJETYC&=U_(ZL+QLE!V^] *>SB29F[<U#S?0.OZ/IA)V>>KUVB>.A*'\
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MOC9A3(&,M23;[:W2GA A$VM]5_=4&GMJL-WE,=>IF@;@6^_+W]I&&T2N96#
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M]Q+2[[UO>]?[>&D/P)+<$,O(,*%T$@*8K WQO(C@G.7T6^,M6F/0->\WODU
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M#^ER4.$A=XOW?ZG-[>(>5#9R<K9;"UWA*5A6,C<%M*GO3VPP$.OMM ]>ITR
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M;PL4%+5I'TH(F1GR>9,-Q$K6S6^9'Z*GWQ9C'4&HF0(& *;?%[07WBV6X]-
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MSM:FEKG.2LBL0 K&&%&XQ.;5N_O0-9 D6AML-5?$ ,#UJ+_YH+OY[Q1ZU/I
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M(ON@,0?6O('A0P3U"Z=V>M]U-72T$H: J#7MF^O5*)E A@J"#:5.H*^991<
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MNP/<W(I<'^'F9E2(=4F[NK$KK--W/$/TCD17#(LA".-,ZW?Z[2@[_4ZT-IF
M ?0X\OB_:S:>%^E:AF\NR7L]/_^&L^5:_Q_.PNS6/YT$JS6S=7NLK^6'*7MR
M!EFAJ(0YSQ+]1]U+PCXZ!; Q6>-F#X9 S;P/%7;ALEW6+6SBD?3CJLYV>3V.
M[C$+$A-3D04!3!9R3!4W$'FHZPJ49TZQZ%CK9-<^=(Y[\PZ(W*,IKP/S_\B(
MV,HG'<K:IW=[3.>KQ:(V!*S?"C?[%-[.7IW7#4WORU/_Y$H+BG'#+$59K$X%
M5S(+\)%EX);Q)!6FK%J_UAZ%L7$3*T<X OW!HX,S\]C4BSIK],_9/"YQ\;TF
MJ#9C*FISZRR1CM;\+C_>\_LNKY'U9TUR1I6"D)"99:!"<76K3(),LD&IE# \
MM+[UAV!D7(>F0\!N,?;KN.CI9N7"OJ)X0A)OE\NZH\G*($.BL+MF=^F^RYE$
MD2T4DY./P?#<OE%P"$;&]:]>[D%JAYX3MD5/"&$S??W^<H%)K5AEG-DZ%2Y6
MI[;4[1DU*UHD>LDL+ZT3S4=A;%S_[3_NB#5 UZ&[67H\=)]PM3K;*'?"1$A&
M!@Y2>[I^ G?@G2D0F!4Q)I>-;EV2,!PWX[X=_L<=KWUQ=-)GZGFWV(:@T28+
MPM4U(M'$.N&<0W;"6F94YJX7PW5X4#78,^O+/4GMT--T5<A0SWF36)(O+B!$
MM %4'=U!?FX"$[V3,DH2=.O8Z'F*QC411\B@-51(IPN%'QT"^URE5M.-,S__
MHL$VR^S(XS$VR!CK(\]8(,7$R>R+ M%F"4&RQ!5G.OG60[>&W"#S?+W?[V%U
M^;MZU4]G[V?X?S$LK@F:<!<1BS*0<J+ (LKJ!&FR*$G&()-2P34?+G 0Q9VT
M-1R*K-W*-INJ<>2:A:?G2][E]%6A[R-&/W]=S"^^?*7_PS73-S9BDKUA(C$%
MD=55\UJ2\XXI (FB"..5M=;_Y,)L2U$GE3:MP#FBNAJ6)AS!E/\1%HMU861C
MR_W@<P<SU,]S< R[;+&$P D8/NG:>&@M>"\3.!=RL(Z7X@;;23& 7?Y$FEF+
M=M-6Z8,KR5"())VB"[K.!PPRD"?K?/ A1%%":^[N4M"QW=Q%\_?MY@%B[N!I
M8ML1Y47*H'/2-;;V9-YU@.!C (\Z8=":XJW6#]\MMQP,!JM#M+_GJH)=5-$!
MPH:;,>ZR01DI&"^.XGR5"J-3F\BA$%QB]&39L#4F_\,7%>P$O:,M*M@%!QT<
MB)^.MT^B6)N=@*2< L62@>CK1IZBZ0I![CBVS@_\IZXIV DZNZXIV$6/711"
M7QNS=]?=#@&#5):KZ@\%4,*002,G"5+!R)04W#7?BOZ0BG&#VH8F_D !=W!Y
M_1X6_Z;X+-Z&^S_I)-4#. G"9*ZS ;D.KTN)X#BYT2K4QR&F0DRMW\6?HZ<3
MSW!/7<\'$GP'(!KVJ;(V>?&)B\9JXP-8%>K:[! @:E<C/,9B=,R:YL[A$=CJ
MY"9L ^G>8'!HB<7G05_P'MM.LOQMOO@K+/)5]\O]A1 'O.,=]'4MDH3M^&V4
M.WR4H%>S_'\P?ZE=HXE^M$E+/WR<]N1E1E<*A'I+*UZW^'*?@*EB+"H=VKOT
M!Y#;;@;"QF5*.C)1M 29LR6C%#/YP-5E"BQ87CCRYB-\[I'0RQZ889'S]+B$
MW?70@9OPJ-BN?)Y??EQ*[R.>;:J$ODZ_;;8I%G0J>0M6U^F]@=-M'YP&5G??
M&.>C%*VGA.]':2^@W ,<6^Q+:ZRI#O#X"!N7:00?M>%Y/00@D.RLB> 9<V!3
M5-)D+:1IW0S\)#&]H&HX),R'4$L'^*HS_7X[F_]UR=!E%@EE9@$IHC.FEMLK
MN][+'B&BDS:';+1L?9T]2LBXN&JDY$>&*1XF\0Y@\P>N;A*;=SDI*AN5HP7M
MUL?*86W?D%!R";FV<Y"(&F/G:6K&C5V' 5 CV7> HF>77TJMG),,:WN"H"A:
M*CH1,8!Q4F9EHTYFN!%W>ZZH/<)&OF$<I[VDWA6"'ME4:$I)SI4,/+*ZLKGN
MI+18 ",FI:2V0?Z_1;.[:WV71;.[J* #.#V_XS3E6(KT&9**"D@^-4!6=7$!
MDL,HF='-@[Q3732[D]YW6C2[BQ(Z0-2E?7Z#2V)IHYMZX)+"4L@F@]>>#ES0
M#)Q5'K2)6H=LI0O8&$J/4S)NHW-+L]9 TEWBY?)$)2P^):\@V51W3**'6"0#
MG4MT%#L4Y5I?/D_1TD54=I">?PJ=/83> 7BN&,#\:GG)TXVQOUJ%QUA0(C H
M41:24Q;@1(Y )P]]BCS)Y@7'6Y#5&Z3VT?\#OZBM,CK UQ_S6;[FZI(%)Y%"
M3E^7=6,B>\PYN)PR(+&5+'?6B-:6[!$RNHCSV^+G4&%W@)=?PEF8)?ST%7'U
MKO[MJ\M:9\S19 T"HZP=W05\\K$NC&4N!,LLMKZ$GJ)EW#[CE@Y0$VEWBIJK
ML,+5SOH40%CG0.EB(1H7('F?+..J,-.Z2_UI:D:>9]=$VUM : _1=P"B=?GN
MY;:/S0CNRRO41&X2>@^,8E10/@KPF!79W<0SR\%DT7KBZ%.T] >@?73]6,G]
MH8+O!4!D@],CK"C%O=$F 2;&Z[9 #C%:1YJ//B<E)(K6J>EGR!EY'." ,&H@
M_EZ0='DB[HP[7S.C&5-99W+D1""7SMH(0;E:,2ATC0&";IX)>I:@D2??#7\I
M'::"7O!T<S0>X<<8':-P(,UF4F4B_S%Q\)PG)/>28LW6_1,_HVGD@6]'N:,.
M4T0'P+H)1MY=UUK'0I0R92C89+*FU0)0$,JA6)&C+2(Z-MP;VKL^U@P/\_BZ
MGXR[@LD?\ZJ"<+8IBY_HQ"*W3D%228%R5D!($>E 24Y'K*:S6N\[?(J67I[&
M]E3RDZ Y0.(=(.?W\/?T_.+\(]:KMU:M;.:H_'A?[FW4N&%XR2<AYTS>'H4+
MOK[X&0IHHQ$&Z(]M] PMBZW7E.U%:"\5(FTP-[RN.@#D#>W7HSIJ!_J=A7\3
MAMIG9BG22+'VZSI/!EPYL#%;^G-CG!NN$.EINGIYN6U]Q3721/_HNIXI.O%6
MR:P$!QGK&$GNL6Z45'27%ZD8#U:F]F]RV]'62WK\*"C;3R.M6_@& ]P?=(1$
M+!:SLH#1U(FE3(.S=%5;;UTR&)Q0PVV&?8JJ7MS[HX!L5RWL?Y'-5^'LN*VA
M#2;";?>Y@S5['F4BW"&]>=9J$9,DP)3B:^6X!Z<Y R8X&J[1Y##< 1ZQJW/;
MUIY??KR=D8KQIF_\,N'SRX_'/JR6P&ZB^L(L_8^N_.@CJV_U]6W="+#")>8Y
M*XZUG@E[/.YZB8>'Q?OA+8)'04\'KND31739,2VET6!4G3-3A^P'[3D@+REY
MPX..K2^7 \I2.VHH/ YNMJMXW46)74+Q,C5O4PE)" .")P?*:PW>, 7&6)Y5
M8BFJUM-43JKB=2<];UOQNHO0.P#/-D66Q6=C$2,D6>>MU88[9RBJ"W7U(6JR
M(:[])(A3K7C=2?][5+SNHHPN\/5,UU3)/+M<$+A1%"06IR"6X@!URD$Y$84[
MQH"5WCH4N[:9S13:%3@?Z<!B4>O,9 &6=0#%:HJ!LSK-13(GN3.,#3?_YJ2:
M'W?2^B[-C[NHH ,X/=]WEV/.*=D"T2D+RIE,<5@TP*Q,P9?"A6J^?_!$FQ]W
MTOM.S8^[**$#1+V=T6?A<O61+OA/?X5O5UTOAAE=*) /I:YM,8)!#"X .H:.
M!QF5;SVYYG%*>K&8C3'40.Q=C ;^E<C.&?.MA/IT%F9I&LYN^1B7W#'NO!!6
M BI/1X.7 G6W"NAB$X_,18&MJP1VH:^7U]K&4!M,11W<7GN.E5(4Q*B2"@A4
MBB(HE^B.%@649)*'&'0)K=,6 XZ".P(D3RY>: R"#J#^]* BG:TM/@3(S-79
MSER Y]+5)),0WGG-[4"#"E[(E+F=D+#UE+E=U-(!OIX96<684R[6A049R2NI
MHSR<3@:<P<@U"N::M_0=."YLA'ES.ZE[^W%AN\B^ Q0]>P)O:C<,>I\$>A*6
MJ"E,@^"]+FMG-U@OZ7_#E2$_1UDOM52G:W#W4W)7T+U7P9V2*]X:<KZK8TP1
MF(7 1 "7A/92Q&#T<%4'?=;,M]/[MF7TNRBAB\CXPV*>$//R-Q)C/;BXN>'O
MU%),&,8Z^B9"BG6*=^ ,7-"<(G^K38D4V.G6EG4;NGI)N@P&L^;*Z>#^^KP(
ML^7&,KS*_WVQ<29^FR\>.!?$;%I@6.(;W/P__8WWY7/X>Q*54D5R!:ZV3BE-
M]L"G*.FWP:*KK0*Y-1P/I[KC&+D-6(^LV Z@?'O^,EX)\_/\%_R(Z2PLE],R
MQ;Q9./[Y+SS[CK_/9ZNORXG/07$5/-C:<J X8MWJ8LFSR=EKS9Q/K0='[$EJ
MQWYF&] >0X4=(/569]6?R[I?\.&AO&+^-N.?YU=["*^/:(I&%LP!N*[CIG4B
M.:?:]!R++#99IW+KY'@SXGMI#CB"6WI,-7>[:OY1B?\^_[[9Q#6_6,W+^]=O
M&S<8//GY@S4:;,=1!PT' FT(]:4Y18MUSU]=!H2)@J-0LC&AX  #(SMH.-BD
M,K@T3@3K@(+":C)X@E 'A*#7'FT]56&X&J\3+]W?!3D_6R.UBQXZ,-U/E.PR
M%:7AV@)B'0BB8H1 K@?DX#TG0U&X;#V9I>_Z^CV4NUT1_"Z2[A(OEYG_P#!E
M)0PX71L1/1:@,Q6!R^R9R^2]^M;WSTD5P>^DYVV+X'<1>@?@V:;NNL[82ZE*
MAS%&=W%$"-%F8)R55(13&.+_*X+?1_][%,'OHHP.\/78).)<C!2:$>&ILE"?
M);WC F263.O(D976>#J=L<^'X.=087> EV>KK3'QNAZ9@0UU6;A(U>JS CHP
MHRA&2\4>H\VVMZ:)PQVA9E+O"D&/U"N&H&/*U@/%%W0:G(^U>RA"8EHZGDE*
M<;A=JR?5V;"3UG?I;-A%!1W Z?FB>DS"&E_[/V0RY$(Z#C5E!UYE%:)DR&WK
MQ/ZI=C;LI/>=.AMV44('B'JB,&:S5];[^NY%4G%:DW=G-,0L$O!DD O4P>C6
MKM$SY/3R@GFX@6LE\W[A<[4<%*-4+DHP4I>Z/*V "QY!1TEGPM9U?*VG,#Q+
MT+@74C.U;P>G/73014G0Z_ER];Y\"F?7TX>=+<S(%" +BA642AD\B01$\2)Z
M$ITIK=NL'A#1)73V4?']%^B#I#TJ8)8__KV97+V1#O[]#6=+O)I8K;R/24DH
M&#EYC)@A)@I??8Q)%A5S#/<>BA^\KSWW^>-&6^WAT$R6'=BDQ\;@,:X\IE*@
M9"[K7MB:R& *> S>Q&2RM</5#;SKK6ZZ98R^GXP[@,F]Z;_K^C%RXTD9U[7D
M6.COU'J$3#(1/FNPLCX &B/!F6#H2*$W)I'8<NOGKAW(ZR7.VA,*CX=7S?72
M >3:%<CPR%+TSH)EM7_>4JCI"]ELPUC4.6"P9KC4T3'JH(XZ7OP0N(ZCTV9@
M;EOR]"JEB_.+LYKQWVRJF9_3)W\E7Z+*FT2P<2]>O7_]]E/ZBOGB#.=ET[M0
MI3/_,IO^+^;I[.$_WOS#^A'[%TP=D[H6Y5:C2?/ 8JWJ3-Y@/=VKR5Z^KW5B
MS_)VP]=U"0XIL3;TTYD4]>4H%0;>6 J5I?*)(7>8PA;^?&.R#C4(6WS=NB)X
M[:\1)]EJ1Y$8&K\1@3/DYB=AM+$Q:6%:.R&[T#>.%S(VUNZ;@\$TVH'[<AUP
M_OH_%]/5C\K:?+8NHZLI+(F)9:L"^!Q(5L$Y<$HI2%+'C"A\LJV3?<\2-*Y7
M/!P.YD,II0.$W>/A,J&AK/ J) N9DXR4$;Y6(3"()7&41H3(6S=</4K(N(AJ
MJ.C[LV\.EGH'T+EUX,BC_G.VP'!6W9\;7_S*#;_,:GDN3?9>@Y-U^1FKRQ*M
M+Y"BMDE+A<JT+@??E<9Q =< %D\;Q_8ZZ@N#;[!0>)E_P1G]8O7A+,R6-V[)
MU=2*G$0NHFZ]IV!31<\@((5^T>:4&;'-6>N1-+M1.&ZD/BC^6NNG+_1='2,Z
M97=:##^L!7\UP=AZSRP*<"@$J&(%>,LYN.*C1<YMX:US2#N2..Z3_Z#X:ZZA
MO@#X:#?V)5=<*BF4DH#1KE<2$4-,6JA+U9TIPL;F_?/;43;N\\R@<&NECPY0
M=C_:IQ#__58A_GJ(6="I:*^@>$X.A4&*M+SBD#4+F2O)LF\]_/<0>L<UP$>+
M88^FTA.&[]7COB4'.!D$*6MU1JBMB%%+$-R1%*)$Y*UW>!Y&\;@QS/&0U0C2
M>ZCYA$%]:8%B<M[XXD#S7+<_IT2"M@CKO3"6KA5;6D^:/8SBTP3U/MAJ!.L]
M%-T!K)^KV$1;9TUR ^N^!,5# >?6#\<F*8N,V]!Z.&.WQ=%'<Q1:*:1?;%W-
M22T,F;*:0, U$/D.(HL*,$7I=<"DF[=RG&CE]$YJWZER>A<== "HAY6\4>K
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M('[=) PF104OZEXA[E2I=3X<0I&Y-M\[X2TY(+[U*+$GB1EW2OFQ@-1&%QV
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M#8JJ!JH8>[[.>@CS=!926ER$LS*G[Z_6&3=CS)<316(QB025977E#9(K'[,
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M2.H0Z]\Q?[I8?*'[^0^\6,Q7F+[.YF?S+S\NMW4X:[(K64*R=8"^HWO96V5
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M6@:_A"7F*B6R[)<:7) #L!Y<O_SEQ\W?N5S?L^;XANU9_G 69K?JKI@,0:N
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MR&U"H&O3*Q#9UJGU(D&PT8 +3FA?<M*NFU5?._+6>83PGW 6#P#;BS:)F\?
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M]X;_@['-12KYE<-OK;1).E R$D_:!7#.2O#)V(S>!-3[^L8/OVT[Z)QVTOA
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M"R \>HDQB:@'&X72WH+=CK;?45SYV/&[$01W(9>2''A;TV>*UYU..8,R,J+
M$%ENO63@>&K[M5\/P=/]R_),VNO +-ARNBWN>L#J1":.WM6MW4P;4"(X<,DR
M,%)P3<9X+O>KKEN!<1=)XR+N7,AX')!-U-0/ZGZJSWK(E"(S6@F9P2HZQ@I)
M8#%F!XICT2XZKZ0=!GM/$S:N*S0N ANJK!\<;EVZA^Q8D8RM%5:9(3%1HH$@
M0P:-Q@G..+>B=53M&9+&=4Y&OOU:J*D?U.V0(DG*,V\3 ^4$<1.4AZ"$@92]
M0LNDS6F@:V\'1>,6NHV+N19*ZF*)V>9CCY%B=(+%E)',9T[>?2$;VJ%AL,Y>
ME>"(W_9+SXXFM]\XY2D.R;GTU\'M>,WJUM;==0"3M1Q3$G2LUS5\@4%(DH-,
MUNM,QJ^(K4<*[D?9N/[)V8"R Z -M=81%A]O)+G'&VJC R8.II0Z@:Z./F%,
M0R@\HB,CQ)7V"]+WIV_<BW%L7#;78$?HO-\H<H\K@2A3KE,[>:1WIW@+GEL)
M6:@H)=,8Y6 WY9.4C>O+C(W(AEKK"(N[V/$82RU7!L=X!$7F-TG,<[!<*E2J
ME*!;.S7/D#2N5S,V^EKHJ0._9A<;66F2C7000J'3$^C@D)6M(=8:X^"D+[+U
M7H8N+[FA_)$6<G])F>#KOLN$TSLW]KK2<U5'42RGJ[K3<SN4XL$A>[5:X>4J
MD/DQ#7&[Y*]Q%GE "@?+0)]+JF?(7@>7"DH;(>I:RFOH=Z'VZV HUJ+A">]W
MIG:=O2:1+^:U-OY]N1;[C<!O+Y!HB[:,@=61[)2ZN\<ED8#DD 1+.AK5>@["
M7H3UFY,^!"4/ I+-==*1V7C#R+OY=V)QL?PQ$8%I9SB#D/5Z1H.%B"8!/5M"
M6F64]:V+RG93,W+2N;WJ=YB%)^JA1T35D[C]VM98^4C:6WY?#V]?SS,+L]7U
MER;%")MLBK5MG;B5T9,E["P4IX3(FF'(K3-^IU$\<C+Z_,@<3I\O%KWKAK8)
MN7Y!%>/ (-+C(G0!7U=F!6E9$-&27SA4_/$(<D=.9'>*V\,U.?( C0=LOD$B
M(VV'ALWK6/#EY?2_UW^<8,1D=390$[-09RU!<)&#HG_0ZE2,WV>$YR&?.7+N
M>C"8#2K['B_"=0!_[3].,FJ#*M)Y<(HN=BL$>,4D<,VC#*G$DH8*:#]"SKB#
M5D:XR([41(^@>G@G5WG2?Z^/T/6T[T]?2!N_A!7FN]_P>K&ZG @=2;I1@C""
MCE/AL<Z2$V XUR01$T5L72$[!!_C#E_IXCT>5O>]/=35^B!JOA"G;_ [SA;?
MZC"$U^';]#+,KE\-5XH7@IX)KQ29SSHA!.T]_5%ZCX:L:\>.>;'W^?!Q1ZF<
M^>ENKHT.K]OK?K&[&SV(IVB]1$:@X;DZ: 6"MQJD$<;PQ"3FH1*#3]$U[G24
M\U^')^NF0[RMGMBMAN1+>>\*D*&2Z"C5$?8B*LA"J)@\DE'<.G9] 'GC3D89
MX3%NI*DN0;AQZ74RF!Q=W=+5R+^2]#OF(3.K$F<NL^&CV?O'78;;EC(&M@Y6
M0(\P^MN23L8$>8Y%*P8>75TLQ%1-)7'0VK/,22RE><KM<4I&7H4R HP.5T '
M]3$/N'AD@QIZ+D)D#I1'DI)4%EP0-<%CR(5Q,LHR>,KCR+UV_*^4V#A1->-O
M7=_)V>]X.4F:G).4,UC#=)U=D2 $LB4#W;TR"IDLMAX__Q@=^\'JKY1W.%3X
M'=Q:.Z1TI\SG1E1T'Z?L)()<)_F2RA"C#&"SXH';G&1S6.U/7;^]2 ,4HIRJ
MG7[B8S^5D^W.J$3I-1TE!<XD.J7"UY4W=*BB\49Y\IN#V&?B^\$?W&4MRLG:
M?SPX-H JNGPG[_#YQSQ/28#3>'5YTR1P/6YRDKF6*4@'V3!!%SD:\"5S8";+
M&APT.;>>YWHXE5V6I+0"Z)F4=RI*AVGJN,/I1,4L"HL&LJW!0?*MP4DGP/O:
MQ<>*<;'U!K>GZ.FRGF0HT)VLD),OP>$\U#LL5=,UJL)E'64C;*B'IG84\%P@
ML>@+-XS.TE PVT%2OQT=IUAU+?70@0NQHUF@<J)#'0+A.01?&"CKB!,7+-10
M<I&:<]E\[.IN:OI=(M4"3"=*OZ,X[&,W;F4GQRPMO=[ 70TK9RXA6!:A%"FT
MBEZ)-%3UQPZ2^EW\U!11)^CA!2ZB'JY3:G(O@-AC!QK1^ )[T.Y+]J8+[3]:
M(N./.8EC,?M^AZ8/B]5TW3'<N,5PGX\:3$\'\WF.IK_"3#77MY>.+.30.44V
MD2C.2,G)PF]=B#I@T]^])3EKB:?%Q7SZWVNK\+H<[NV?:7:5Z4R\^KJX(H?G
M RY)^M7#_;QX^V?X.IVOO_TC7EXMYZN/B]GLUVTYB0TINNAJ )K5IY\D%3-#
M2$$;YEAV)K:.U0[-4\>MA@=@\_YCVQ42.C "=_ _42X)53<$\2P5&1V2K%H>
MD$0>77&V9E=:9TYWD#(N#OO"RZ*]\H[&X#=<3A=U^-#R<D@DTD6PQ+#"6D9Z
M-:MU5.LA_YL1AA_6--Q]+R?9>9&,3U!J*E!94^AR2 Y0!IV#8W49^GF >R#E
MXX:67R+.AX1&OU?SXUQ_(&Z7C_%L<LFN2$B,;@&E(X*S)5<WLJX<XB8VGR78
M@NYQ Y%_G</0 A;]'H4W> C/B"4ZRQ)85\=VUR*1Z+D#8:,7*KED=>MAKRWH
M'C>,^A*/PG"PZ"?!?A#K=Q9P_^?T\@M]?]74U>67Q7*37W.EL.@]!\YMG6UO
MZ[9.Z<#PDI!^,26U+N%NRL"X@>&_SAEI"I3N#\O'S4YON@1^$L)OX=L*WY=7
MW[[-IBG$&=:NX*M+^M)OTZ_3R^V"VYRRU(Q>4*?(CE2.K@U'-PE=&T+1;XJ2
ML76YR@!LC-L:^Q(/SME T_WQ>?P*V58&;;RP]./S,LQ7LTTI6T+.A"-MI.!)
M&[DD<+*0<@S'I)B2JOFTWD:DC]NO^Q*/R:#@Z/YH3%1PNF0;@ BO$^$%@Z S
M\16D<\+9P)IOUSDE?#I8M^]+A.Y!RCLQ?/IVG@?+MI.TILNU,?=A1N?L3EZ8
MV)S7D0_S33DG?4S]CMM,RPG9U08?VB+/VIKW1AG7>V,X;JE\),N%*KND>*PQ
M2@6*"?)+19U06!*9"=&BUJWG/!] 7H/BH\?T4$>/?+PYE)-0#"N1?'.M,QUQ
MR5D=!ZZ@;OU+M?3=I@%Z0I\G;/P^A2%0]$AA4F,==1!*W,'46[K;%C]P646X
MQ/K5L/QQ]YLV+]-$\219"1'H92%N@T/PP9-DC68JQ<P5;WTJ3Z-X_(Z%$:$Z
MA%;';^:ZS^F]QXYD_G4Q_W2Y2/^J?;?X=YSE7WYLR[PFJ98J"EO TJ^U> +!
M%8^@/'.&V\RXW+.UZQ0RQF]I&!*5Y];32X+DSUSRDI++00*7F@Z>HR/H.5G>
M/JHH>/212=<:C8<#<= AFET!\7CMC(S!==<.N8VIJN\"WS]FZ/_,]NUD@GLG
M3Q61LJSK?8.M'9>17$HI$J0:^K9:\7P[F^$)3+:C:/PQG$-C="3M-</LF1SW
M7Z^J#[J.+->Z[-O.O$6Y_(+;V,FM:3Z=TU=)A*O%;)IKW.N7,*NS-SY]P4UA
M]W3^*J6KKU>S^I?K64+KLG#\0OJ>?L>_A>F\#JWZ!<N"K*<ON*D=7Y0[5<P#
M1 HZYG+0T$3'?(\="_'!1EW7,\A<XW"^[FBHH^Z#5>1P!A-9\]4%YX^%;../
M%16_X[9^;9INMJ:M+F^O61=SY-& M+6^LPXH]BHP\-[3BQR5<GF M<4'T?AR
M(B2'8&N'VSF,YOH)EMSA[Q,NOT\3KD<$ERP1&;G)TJ9"7K,.$-%'T#D'XZ)'
M;ULOAGJ2H-'7$P^(A6>!=ZQB^LFE/>3I9G)K92IY:V)"#EIB+3W!6M1.OR!&
MF9A+9.4-T-O\!$6C;QT>$VY'JZ9GO-5AZ8D^8Y-G?#^_=30F49H@ WH((B5R
M*X*"X!4"M\5HFZ,K.,"0T[WI&WW?\)A8;*2V+M_;N[.@WI=U#>N=F_XUD3B]
MG-B4HI-60-0BDCC72W64!".3%=J4E,( @T2.H'3TQ<1CPK2Y*GN^2G]FMOJ:
MJ^ILUA)2RY"+Q""*X$'E:(E#Z4!)EYWQ.20IS@S6.^2-&VOK"J''*JW+>_0V
M;D(2O0Y]O+G"SXO75[76:+8N>I[0@Y"(.0<R&4O.H*M9%Z& T=.1T&G5ONW]
M6%K'+=T=&:D#J+-+V#XNU(FU,A?A ]@0^*8#WB%Q*"QCF?ZF^-"ZR75?VL8M
ME1T9E@W4U<_XNH<AXTUD^"';=4S1'_.P>3TP7Y_'5YL!,V^NEO3K1B[TC>_+
MY_#GQ#%M)"L.2O("5-U>0!20A 27TGJ54VP=T1V2GY=397-*N+,;1'1P5^^2
M16637J=96*VF99HV.LG_O%I=5H74(OA7[U^_^U#_E[6RUC_G ]T2RQNMW97C
MKXOEG1?N1EB6)4LV%P=KD:PPP\@R"V24E>*3<T65I%K;*:,R_'+JA88X7_UA
MJA_7<_\[J3[.]YSNU<;K?NI:XE$E%H4!$W3ME$\)0K*)_DAN#QJFR;X<[:$Z
MBJ674_)TGK=J>%ST?UKJ1?#K='ZSC_%]N;U-?E_,MW_X^4JILKM9['(CESI)
MQ<>2((E0;Q'2GF-&0R@N);)V!;+6X9W!F7HY!5A#O3[GQT;')MXCYN[M:WS-
M[(=J^I*,+C<%;+4E^//BPUKA$\]LY)Q%2+[N_9-B/2B8 SVT'K,T3#9O:QF*
ME_%W*_?UF R(A/XC X/:J?4"\<H&NCH2F:BU?QY5!J>Y!BD3)[$E7]*YC+&A
M>1U_1?38;TXW2.ICYO_]7,UJ=?7UVWJLQ!^K.CGX=9BEJTTS_>U&CCKQT3$T
MD#,IB*S4##ZQ=7->[<USSLD!ENH<0^KX6ZG'*1ALK\<.+*=GV;QA<G[Q>,R\
MRKT6/'^DEVNB=416N_J-]>1K^2QK4IP##TD(5#ZY,'SQS2D<]%:9. #H#@7Z
M< CX2^#_NJ;IM\7\@MS_K]>U3=NZ)BML4<9F8#5CI0B^$(U1D(M4Q2/G49^A
MXJ<I3[V54[Z$,](0)7^)4U/OBO?E[F-^/19UD@RWSKL,)0M/-XB,X*TSX)R.
MW/%01!YHE,0@_/16\/D23DLC=(S<Z?J?.+WX0F?^U7=<A@O<2/L-T@__.IW?
M%!<N_KF^&+;<OX^SZ<5V!IW73,@@$Q@LLDY,8A!1(3"Z*Z)4(N#]T52/MK>>
M2$9OE:##X??<.NO@(K_N:;SIX[WKB]\9M?2YQL(F3M>%!)X!M\J 2C4@S&*$
MZ+B7]'=1BM:[4PXB<"^H^I?NF0ZGLQX 2?I:"^WM?UU-+W_<MM:^^G.ZFL0@
M*CL68F5!>5T@H"P@M5'!B50*:P[ IP@:UUL<$ CW(==,*QU [!X/;Q9?PW0^
MB8J3\1 5,$WT*\X,A+3>B)NC=SZXH%OO4'R4D)$AU4[1B]92[P Z=]KTGTLH
M/=XU\@_\&G$Y<<85F01"R)[8MA;!9ZX@A5*W 16=L'5-92/2QX5G Q MQM=H
M!T"^.X'BM\4V:U./N-7*^6@$>%7;\+(+X$RQ8'(J-I7L6?-PU2Y:Q@TSG>]Q
M;:*+3C&U/:$R6!L#.DC6UNZ.2):NRAR(&\]DU.2QMIX_L)N:<:^P-MK> T)'
MB'[D> G=Q<LKS'?]J.WMZH,(01#IY-4'\N8]W;/!&D!T0EOIA;?[C$+<^0']
M0>(8[2U:B[*#2V5=+O#[8IXVN^(VX?(M*TJ[&$.]:H/,Q(ISX"3Q4[0PTG*M
MM&T]X?4)<L9]KAICJ+7X^T/2G5796WZD#[J(%,$PK,/D P=OBP+CL]3%%\%2
MZ^#"<S2-FSLX#Z9.4T0'P'IH']Z:A[_1W[PCCWHU83PS7_>[1E&9POK0\[I?
M1B(JF[2)IG5\82_"QH78^:SL]EKJ$GKOYF6Q_+K17UQ<W9G >6?TIX],D]A8
M,A*4#(ZX+;FV1RC)$D?NAD?B\W3V5HES,ESVF-345'==XO/7,%VN9\&^+W>'
M_RBZ\WG2H&V-GGA-9UKG LD(Y+XD'^SPD'R4M-Y0V!HCSX+R=(5UB<,'J=M)
M<5P9*2.XX!0H+@P0$QDTU_3[Q LYXH-C\ %9O=5:G1U_IRFJGWZ^1T[6G2G"
MF\,U,5EPRS$05%"3Y<OJ=@O!ZG@^E"I@#28/?P\^H*NW$J;S7X*GJ:K/MH2G
M1DYO>CNVG1C;T5*;\=.U)4.PDKAR I(0=1-Y"L1[EL"TM0&5$$FU;NYI27]O
M%4UGA_.95-_SY;N?"!Y/^=U*PZKH)=-UZ%]T9/\'7:=654] ,"54,>H,KE03
M5GJ;IM?IF6@)B"[MXCW$<,NM$Z58JS-P4WF4Q4),,9 K( ORJ#F]@SW _S"4
MGW$27X\H/TZ]S4R<,RUH>?TES"]P^M"]&&)/RO,?-NBZD@-Y'6%K2&$N:I<)
M9)I[4 G)F(ZH +5*(O*8\OU5=R][:\A&(^\>:N3CW87)VLE<1V#[NBM9"7)Q
M'4\2H@\H;<EH</C.L7TH?3D;1 [!V?.7:7,M=FD1/ S &%/0%F- 1:5 66_
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M=SE<?_:XD:.&&K]_+QTEW Y>SK\M%ZO5A^6"[LQ)#"78% IDU+6@'>M$9,7
M(KK(=."I>0[GSL>/&Y\9$!K'BK@#=+R;TT6-==/BKR2QFB6:SJ^F\XOWWW"Y
MF9GY"Y;%$C??]SG\B:NW?Y+$2%LDQN6/=0:K[ANK^:7%C#[FXMV<R,,5B0)E
M45($H,-"HDAT1H+(F>1J'+=2!Z];CT@=D)UQHS4#HK<7"'11)O0[7M[*8T)N
M>]%"2]!BO7PT*XBU <AF;9GUS$O7&L$_$3!NQ&5 S!TOY@[NS+=A.2>0KS[@
M\M,7DN0O835-$\&\+[7$74@=">K,@U>.D!^E*J98RU7KTIU'"1DW[#$@9DX7
M>Q<WS'TVWDQG5^0'3:+2S$HFP8AU@B:3NUJW.Q7KA$UTATK>.H6^@Y1QXPQG
M1- QHN\"0Z\77[\NYI\N%^E?;Z;?IYF<Y5NF,,WH/WG";"@DJ ).FCI1"1FX
M' P(;K+U@LM@!JC)>):N<1?W#HBNYDII"+7&82F\J+&W,,]_P\7%,GS[,DU5
MC)_"#%>OYGD]C^M&P._F9#U^77_F+S]^N5I-Y[A:;7_$"1&LYC0T"78-*YE&
M<;'M1WS$;XLE&?L7-_ O16>'-H"(Q=2)>QD<!@%:*<L8L\Z)UI-U=M%RLB%_
M5?L4WI?-#ZZ%Z=M/JL6[FIC1'G(H= 8]\>NR-I"<\8SSDJ5O'0793<W(#70M
MD/# N&\C^@XL_=O&A_N"^NGH;O]RT_[@A<R)W%L25:8GQ/ Z/H()B,X+188&
M&1NM$TQ'D#ER0\D0L!M:62/B<;6\)/-BOEK,IGG-QCKFLNXG3.B]+2P!,W58
MA(@>HM %$)V*@F&19J_+C#[B#M3H3[<PV_WIO73_#J3P15/I=X>?;8N@<HA&
M:5%'MM&9(T,4O(P)O&$JZVQBQ+W28 <C:,RNW58Z?1(B1PBX@T=O&_>=7UR_
MVMN6ST NB^;9@,EU'+-""T&C J,U?26B=*QU%?L.4GJ"S#$ZOC^^N(' .\#-
MS3#OW\D+WG"R902U53H4"[;$3(Q(!2%[!<R;5+QC1:G68?2=Q(QC^ R&G39"
M[P ]_R >EM/:;)D6Y!ROLTA51M=3^ICBM9H'2JFM%HQ>\!ATJLF":+,15NO6
MGNG3%(V3#AP,1PW%WP&8/I$FUK5I]X(JFP<^QB(*(_,O<D-R2HI$E#(#855R
MQ;.(J763_Y,$]=+</ZP5W5XW783BK\-UVR&EKE;/)@G)H 159*'#6/MI,4IM
MD*NH6G>?_$3 R Y9.]7>!\W14A[3Z_KQK\D_,'^Z6EZ\FN??\6JYN,3T9;Z8
M+2Y^;"]6J2V3P6M@/#LZ234@IFOA$,F(O VKHKZ7I'D0"=_C8[H(,AZCO,4P
MDAP9%.^7EU\6WP+F::I)@4_?Z+!<+RRI _*,H)<[IFKS<^*"Q0*YCO%!;Q0K
MSV5&GOZ$+@)_)T*AD?QZ,%1V/[F_W<R'T"4&$=" QDPF%Z\]1L@DH$_"1>,Y
M;]ZRL ]=O4QR/I/9TEI3':#OB42-9ZB"T>0]&A;I: H%+OL(B#HFU-*ETMJ0
M>2DYLM,UOW^^[! U= "HFQKY*&4)B Z$IT.F2IUW6&0&$6UAQHL8FJ] /J@!
MX6R9K>9@.4K$'4#C#=(GI^E:$O3[&6[[R%Y]K8+Z[_77)W0W,Y%%+<0R&I1(
M#CS9 5 PDZU0G(ZF_:B)Y^D:^:4;&E+-5=,!W&YBZG?*C+VUDF?R.',69!O6
M_@QO9 +I3&8I"253ZX*X1\@8MZ9[<#"=*O@.L/-\0\2DH \A*B3GHM:QA%JG
M4&0 :34&S7E&;/V^/4_5N)7?@R.KL5HZ -IUF.SUXFN<SC?Q_/DE7FS8^8BS
M<(GY]6)%AF#=T"%=**!=INO7UZ0T7<)0-'FV.D1M?>N5G_M3-V[!^.# &TA-
MAP/0;P XQXOZB9^;X?#N0_^^O*OUJQ=3<D.VPTXU2J>BB>1Z\ !*L>HVDZ6I
MO+%>)>V";)WX?YJB<4O(!\=;0W7T@[&/N+I<7J7+JR6);'-88D1#PM!U?JX'
M98.!F$,$P7-=[HV,Z=;6_D,J]L*2>[%8.E'L_>#G;XM%_O=T-GOW]5N8+JO0
MUJ:E#5P[I104&QT= 900,EVX3'!G!>.RJ-8V_>.4[(4C_V)QU$#\XV-IFT::
MIC![@]^G"3_BQ=5L8SO6(3/S%4[H E6R#G:(V2(H'2P$Y1EXB=RBT2K==Q)W
M)>2>^IC](IKLQ<&EM83[P,Q'_.?5=R3+#U_]\K=W[_X^_?81B</9ZR]A>8&K
M28XZ(F($4Y(%)35"2*A I^*8QU2R*7M@YIF/V0\S+R\,WEK"IV*FR7/U&_VL
MV:](I$L,4N4<P"NN-DDG+ZI+4"23";F.L77EVLV'[P>9EQL,/T[*XU\J-YF?
MG\8@H(JJ:%=KSI',>63D/%HE@4G%F&7.!-%Z:M/ATR;XRXUS'R_M7L?#[>HV
MW7S]C@ 'Z+/=^1F#]M'NQ]G0?;*2>Q4(<4" B:"<4> 9XX1'R[)#E8)H/3EN
MJ#[98^HHT(IL=680K#= DF!UJD\!$43)+F4D\+1F?Z 6Q_-WUAZ"G18MCH<H
MJ[L6M77A:)$%>6*I5CUX4)%I\,%ET,%'<B82NOTFZ_Q_TN)XD,*?;W$\1/K=
MX6=;:,BUM[E$1N0CVX2\@M<*6(P^D,>)<;_[^J_2XGB03O=I<3Q$P!TDWG9U
MW"D=C$T!H413:X@#'1UM-:3$T4G-?32M.T->3HOC03K>L\7Q$(%W@)O=W791
M%L=B%A!-KOYG[<+"Q  SLA@49TJUM@A?4HOC*=AI(_0.T/-T>XPO1K/(+$C)
M"J@LL-[)Y(_2;[U.D27=>BK-7ZPK[1C#I[UN>@#:3UT6/AFE#.>U&V)=N<?
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MR6<\KQ=\2]MX Y=Z N21NNH>@Z_R/Z]6E^L) !.Z[$/1*=0AAY9> UYK<Z*
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M='1E<F%N+FAT;5!+ 0(4 Q0    ( #V"2E9.-O-?9VT  #P5 P >
M      "  5V[  !E>#$P:6EI,C R,W!S=6%W87)D;&5T=&5R82YH=&U02P$"
M% ,4    "  ]@DI6G1U7?ED0  "H<@$ %               @ $ *0$ 97@R
M,6DQ,C,Q,C R,C$P:RYH=&U02P$"% ,4    "  ]@DI6Z;YL[_D#   6%
M%               @ &+.0$ 97@R,VDQ,C,Q,C R,C$P:RYH=&U02P$"% ,4
M    "  ]@DI6TW9_."8(   3(P  %               @ &V/0$ 97@S,6DQ
M,C,Q,C R,C$P:RYH=&U02P$"% ,4    "  ]@DI6X$ M72,(  !G(P  %0
M            @ $.1@$ 97@S,6EI,3(S,3(P,C(Q,&LN:'1M4$L! A0#%
M  @ /8)*5IZ,B2/<!   /A0  !0              ( !9$X! &5X,S)I,3(S
M,3(P,C(Q,&LN:'1M4$L! A0#%     @ /8)*5N !(S#6!   4Q0  !4
M         ( !<E,! &5X,S)I:3$R,S$R,#(R,3!K+FAT;5!+ 0(4 Q0    (
M #V"2E;-3W;2(6   !<X @ >              "  7M8 0!E>#-I:6%M96YD
M961B>6QA=W,M;F]V,C R,BYH=&U02P$"% ,4    "  ]@DI6L!BWN)6&  !!
M+ , %               @ '8N $ 97@T>'@Q,C,Q,C R,C$P:RYH=&U02P$"
M% ,4    "  ]@DI6)V/%GBW/ P##%3( $               @ &?/P( <WEK
M+3(P,C(Q,C,Q+FAT;5!+ 0(4 Q0    ( #V"2E9]_NOV(Q8  *+W   0
M          "  ?H.!@!S>6LM,C R,C$R,S$N>'-D4$L! A0#%     @ /8)*
M5B$X*!5%*P  DK<! !0              ( !2R4& '-Y:RTR,#(R,3(S,5]C
M86PN>&UL4$L! A0#%     @ /8)*5C&J[!OG>0  *S@% !0
M ( !PE & '-Y:RTR,#(R,3(S,5]D968N>&UL4$L! A0#%     @ /8)*5C'(
M'F<D;@  A+0  !,              ( !V\H& '-Y:RTR,#(R,3(S,5]G,2YJ
M<&=02P$"% ,4    "  ]@DI6A/6WNICD   N!P$ $P              @ $P
M.0< <WEK+3(P,C(Q,C,Q7V<R+FIP9U!+ 0(4 Q0    ( #V"2E9$H:!92,(
M *WO   3              "  ?D=" !S>6LM,C R,C$R,S%?9S,N:G!G4$L!
M A0#%     @ /8)*5B> DYNY:0$ 0>H. !0              ( !<N ( '-Y
M:RTR,#(R,3(S,5]L86(N>&UL4$L! A0#%     @ /8)*5F@N<J%LU0  M+8)
M !0              ( !74H* '-Y:RTR,#(R,3(S,5]P<F4N>&UL4$L%!@
0   4 !0 1P4  /L?"P    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
